Citrus Sinensis ID: 047292
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 728 | 2.2.26 [Sep-21-2011] | |||||||
| Q39202 | 832 | G-type lectin S-receptor- | yes | no | 0.969 | 0.848 | 0.428 | 1e-162 | |
| Q9FLV4 | 872 | G-type lectin S-receptor- | no | no | 0.947 | 0.791 | 0.320 | 2e-88 | |
| Q9XID3 | 829 | G-type lectin S-receptor- | no | no | 0.905 | 0.794 | 0.325 | 1e-86 | |
| P17801 | 817 | Putative receptor protein | N/A | no | 0.917 | 0.817 | 0.327 | 1e-82 | |
| O64477 | 828 | G-type lectin S-receptor- | no | no | 0.936 | 0.823 | 0.337 | 9e-79 | |
| Q39203 | 797 | G-type lectin S-receptor- | no | no | 0.896 | 0.819 | 0.326 | 2e-78 | |
| O65238 | 872 | G-type lectin S-receptor- | no | no | 0.918 | 0.767 | 0.300 | 1e-70 | |
| Q8RWZ5 | 821 | G-type lectin S-receptor- | no | no | 0.401 | 0.355 | 0.448 | 2e-69 | |
| Q8RY65 | 635 | Protein NSP-INTERACTING K | no | no | 0.447 | 0.513 | 0.393 | 4e-63 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.910 | 0.780 | 0.277 | 2e-62 |
| >sp|Q39202|RLK1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 OS=Arabidopsis thaliana GN=RLK1 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 571 bits (1471), Expect = e-162, Method: Compositional matrix adjust.
Identities = 321/749 (42%), Positives = 446/749 (59%), Gaps = 43/749 (5%)
Query: 1 TIIWHANEDNHPV-LAPRGSTLELTATG-LLLKDPGGQAIWDEKPNKIVSDAAMLDTGNF 58
TI+WHA N L P GS + LTA G L++ DP GQ +W VS D GNF
Sbjct: 83 TIVWHAQAVNTTTGLVPNGSKVTLTADGGLVIADPRGQELWRALSGGSVSRGRFTDDGNF 142
Query: 59 VLIASGNHS--DYAWQSFKSPTDTILPTQILDLGSVLVSRLTETNLSKGRFELHFSN-GS 115
VL G+ + W SF++PTDT+LP Q +++G L SR TET+ KGRF L + G+
Sbjct: 143 VLFRDGSEDSDEVLWSSFENPTDTLLPNQNIEVGRNLSSRRTETSFKKGRFSLRLEDDGN 202
Query: 116 LEFIPVAWPSRFQ---YKSYYTSNTSSANSSESGHQLVFNESADIYIV-KNNGQIVQLPL 171
L+ + + + Y YY SNT+ N+ G QLVFN+S +IY++ +NN + V
Sbjct: 203 LQLHSLNAETASESDIYSQYYESNTNDPNNP--GIQLVFNQSGEIYVLQRNNSRFVVKDR 260
Query: 172 WAQLSPRADHYFRATLDFDGVFAEYAHSKNSSTNQGWFPTRTLPDSMCTRLATDIGSGIC 231
S A Y + + A G D+MC+ +G+ C
Sbjct: 261 DPDFSIAAPFYISTGFLLSTIIPKEARRIVGGCLLGL-----CRDNMCSP-DDALGNMAC 314
Query: 232 GFNSYCSL-QNGRPFCDCPPGYVLVDPNNRFRGCKPNF-WQGFGPDDGSRNAQ-ELYEIR 288
G+N+ CSL N RP C+CP +VL DP+N + C P+F Q P++ + N+ LYE
Sbjct: 315 GYNNICSLGNNKRPKCECPERFVLKDPSNEYGDCLPDFEMQTCRPENQTANSDVNLYEFI 374
Query: 289 EFNNVDWPLGDYERLEPSNQTECEISCLQDCSCAVAIYDGNR---CWKKKLPLSNGWLRD 345
+WP GDYE ++ C+ SCL DC CA I+ NR CWKKK PLS+G
Sbjct: 375 TLEKTNWPFGDYESYANYDEERCKASCLSDCLCAAVIFGTNRDLKCWKKKFPLSHGERSP 434
Query: 346 TEFSKVLFKVRKGDFPAFSDNSGSKKERGPLFLLGAFLLGGSILCNAFLLLAILIFFKWR 405
S KVR K+ L + + LLG S AF++ ++
Sbjct: 435 RGDSDTFIKVRNRSIADVPVTGNRAKKLDWLIIACSVLLGTS----AFVIFDTSCSYRKT 490
Query: 406 RRK---YENNVQD-----STTSAT--NLRFFSYDELKDATDGFKEELGRGSFGIVYKGVL 455
++ +N +D +TT+A NLR F+Y EL +AT F EELGRG+FGIVYKG L
Sbjct: 491 KKSKNMMKNQARDIGRTTATTTANELNLRVFTYGELAEATRDFTEELGRGAFGIVYKGYL 550
Query: 456 KTASGN--AIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513
+ A G+ +AVKKLDRL + E+EFK+EV IG+ HHKNLV+L+GFC+E ++++VYEF
Sbjct: 551 EVAGGSEVTVAVKKLDRLDLDNEKEFKNEVKVIGQIHHKNLVRLIGFCNEGQSQMIVYEF 610
Query: 514 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFS 573
+ GTLAN +F P+P W R I++ IARG++YLHE C+ IIHCDIKPQNILLD Y++
Sbjct: 611 LPQGTLANFLFRRPRPSWEDRKNIAVAIARGILYLHEECSEQIIHCDIKPQNILLDEYYT 670
Query: 574 PKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCR 633
P+ISDFGL+KLLL + + T T IRGT+GYVAPEW +N+P+++KVDVYS+GVMLLEI+CC+
Sbjct: 671 PRISDFGLAKLLLMNQTYTLTNIRGTKGYVAPEWFRNSPITSKVDVYSYGVMLLEIVCCK 730
Query: 634 RSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDP 693
++V++ E IL +WAYDC+ +GRL+ L + D AM D + +++ IA+WCIQE+
Sbjct: 731 KAVDL----EDNVILINWAYDCFRQGRLEDLTEDDSEAMNDMETVERYVKIAIWCIQEEH 786
Query: 694 SKRPTMKVVMQMLEGLLEVPNPPWSSSFS 722
RP M+ V QMLEG+++V +PP S +S
Sbjct: 787 GMRPNMRNVTQMLEGVIQVFDPPNPSPYS 815
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 327 bits (839), Expect = 2e-88, Method: Compositional matrix adjust.
Identities = 243/759 (32%), Positives = 369/759 (48%), Gaps = 69/759 (9%)
Query: 1 TIIWHANEDNHPVLAPRGSTLELTATGLLLKDPGGQAIW-DEKPNKIVSDAAMLDTGNFV 59
TI+W N N PV + + LEL ATG L+ +W N V A M ++GNF+
Sbjct: 79 TIVWSPNR-NSPV--TKEAVLELEATGNLVLSDQNTVVWTSNTSNHGVESAVMSESGNFL 135
Query: 60 LIASG-NHSDYAWQSFKSPTDTILPTQILDLGSVLVSRLTETNLSKGRFELHFSNGSLEF 118
L+ + WQSF P+DT+LP Q L + L S + + ++ + SL
Sbjct: 136 LLGTEVTAGPTIWQSFSQPSDTLLPNQPLTVSLELTSNPSPSRHGHYSLKMLQQHTSLSL 195
Query: 119 -----IPVAWPSRFQY-----KSYYTSNTSSANSSESGHQLVFNESA--DIYIVKN---- 162
I + + + Y S T + ++ ++V+ ES+ +Y+ KN
Sbjct: 196 GLTYNINLDPHANYSYWSGPDISNVTGDVTAVLDDTGSFKIVYGESSIGAVYVYKNPVDD 255
Query: 163 --------NGQIVQLPLWAQLSPRADHYFRATLDFDGVFAEYAHSKNSSTNQGWFPTRTL 214
N + + P+ +L L+ +G Y + + + W P
Sbjct: 256 NRNYNNSSNLGLTKNPVLRRL----------VLENNGNLRLYRWDNDMNGSSQWVPEWAA 305
Query: 215 PDSMCTRLATDIGSGICGFNSYCSLQNGRPFCDCP--PGYVLVDPNNRFRGCKPNFWQGF 272
+ C DI +GICG N C+L + DC PG V + + C N
Sbjct: 306 VSNPC-----DI-AGICG-NGVCNLDRTKKNADCLCLPGSVKLPDQENAKLCSDNS-SLV 357
Query: 273 GPDDGSRNAQELYEIREFNNVDWPLGDYERLEP----SNQTECEISCLQDCSCAVAIY-- 326
+ + N ++I ++ + +E SN +C CL DC C ++Y
Sbjct: 358 QECESNINRNGSFKISTVQETNYYFSERSVIENISDISNVRKCGEMCLSDCKCVASVYGL 417
Query: 327 --DGNRCWKKKLPLSNGWLRDTEFSKVLFKVRKGDFPAFSDNSGSKKERGPLFLLGAFLL 384
+ CW K L+ G RD S + K R + + N+ K R L L+
Sbjct: 418 DDEKPYCWILK-SLNFGGFRDPG-STLFVKTRANESYPSNSNNNDSKSRKSHGLRQKVLV 475
Query: 385 GGSILCNAFL--LLAILIFFKW-RRRKYENNVQDSTTSATNLRFFSYDELKDATDGFKEE 441
++ L LL +L+++ R+R + ++S + F+Y +L++ T+ F +
Sbjct: 476 IPIVVGMLVLVALLGMLLYYNLDRKRTLKRAAKNSLILCDSPVSFTYRDLQNCTNNFSQL 535
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFC 501
LG G FG VYKG + A +AVK+LDR EREF +EV+ IG HH NLV+L G+C
Sbjct: 536 LGSGGFGTVYKGTV--AGETLVAVKRLDRALSHGEREFITEVNTIGSMHHMNLVRLCGYC 593
Query: 502 DEALNRLLVYEFMGNGTLANLIFAIPKP----DWNLRVRISLEIARGLVYLHEGCNVPII 557
E +RLLVYE+M NG+L IF+ + DW R I++ A+G+ Y HE C II
Sbjct: 594 SEDSHRLLVYEYMINGSLDKWIFSSEQTANLLDWRTRFEIAVATAQGIAYFHEQCRNRII 653
Query: 558 HCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKV 617
HCDIKP+NILLD F PK+SDFGL+K++ +HS TMIRGTRGY+APEW+ N P++ K
Sbjct: 654 HCDIKPENILLDDNFCPKVSDFGLAKMMGREHSHVVTMIRGTRGYLAPEWVSNRPITVKA 713
Query: 618 DVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSR 677
DVYS+G++LLEI+ RR+++M + E WAY G +D +A+
Sbjct: 714 DVYSYGMLLLEIVGGRRNLDMSYDAED-FFYPGWAYKELTNGTSLKAVDKRLQGVAEEEE 772
Query: 678 LHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNPP 716
+ K L +A WCIQ++ S RP+M V+++LEG + N P
Sbjct: 773 VVKALKVAFWCIQDEVSMRPSMGEVVKLLEGTSDEINLP 811
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 321 bits (823), Expect = 1e-86, Method: Compositional matrix adjust.
Identities = 243/746 (32%), Positives = 377/746 (50%), Gaps = 87/746 (11%)
Query: 3 IWHANEDNHPVLAPRGSTLELTATGLLLKDPGGQAIWDEKPNKI-VSDAAMLDTGNFVLI 61
IW A + RGS T+ L L + G +WD K +++ V+ ++ DTG F+L+
Sbjct: 74 IWSAG-----TVDSRGSLRLHTSGSLRLTNGSGTTVWDSKTDRLGVTSGSIEDTGEFILL 128
Query: 62 ASGNHSDYAWQSFKSPTDTILPTQILDLGSVLVSRLTETNLSKGRFELHFSNGSLEFIPV 121
N S W SF +PTDTI+ +Q G +L S L F+L S + +
Sbjct: 129 --NNRSVPVWSSFDNPTDTIVQSQNFTAGKILRSGLYS-------FQLERSGN----LTL 175
Query: 122 AWPSRFQYKSYYTSNTSSANSSESGHQLVFNESADIYIVKNNGQIVQLPLWAQLSPRADH 181
W + Y ++ SS +S+ S +L + + I ++N L A++ D+
Sbjct: 176 RWNTSAIYWNH--GLNSSFSSNLSSPRLSLQTNGVVSIFESN-----LLGGAEIVYSGDY 228
Query: 182 ----YFR-ATLDFDGVFAEYAHSKNSS--TNQGWFPTRTLPDSMCTRLATDIGSGICGFN 234
FR LD DG Y+ + +S N W + + + G CG
Sbjct: 229 GDSNTFRFLKLDDDGNLRIYSSASRNSGPVNAHW-----------SAVDQCLVYGYCGNF 277
Query: 235 SYCSLQNGRPFCDCPP-GYVLVDPNNRFRGCKPNFWQGFGPDDGSRNAQELYEIREFNNV 293
CS + P C CP + VD N+R +GCK G+ +L R F
Sbjct: 278 GICSYNDTNPICSCPSRNFDFVDVNDRRKGCKRKV--ELSDCSGNTTMLDLVHTRLFTYE 335
Query: 294 DWPLGDYERLEPSNQTECEISCLQD--CSCAVAIYDGN-RCWKKKLPLS--NGW----LR 344
D P + E + + C +CL C +V++ DG+ CW+K P S G+ +
Sbjct: 336 DDP--NSESFF-AGSSPCRANCLSSVLCLASVSMSDGSGNCWQKH-PGSFFTGYQWPSVP 391
Query: 345 DTEFSKVLFKVRKGDFPAFS--DNSGSKKERGPLFLLGAFLLGGSILCNAFLLLAILIFF 402
T + KV V + D++ SK + +++ +++ L+A+ I
Sbjct: 392 STSYVKVCGPVVANTLERATKGDDNNSK--------VHLWIVAVAVIAGLLGLVAVEIGL 443
Query: 403 KWRRRKYENNVQDSTTSATNLRF-------FSYDELKDATDGFKEELGRGSFGIVYKGVL 455
W + ++ T L + F+Y EL+ T FKE+LG G FG VY+GVL
Sbjct: 444 WWCCCRKNPRFGTLSSHYTLLEYASGAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVL 503
Query: 456 KTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 515
+ +AVK+L+ + Q E++F+ EV+ I THH NLV+L+GFC + +RLLVYEFM
Sbjct: 504 TNRT--VVAVKQLEGIEQG-EKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMR 560
Query: 516 NGTLANLIFAIPKPD---WNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYF 572
NG+L N +F W R I+L A+G+ YLHE C I+HCDIKP+NIL+D F
Sbjct: 561 NGSLDNFLFTTDSAKFLTWEYRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNF 620
Query: 573 SPKISDFGLSKLL-LSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC 631
+ K+SDFGL+KLL D+ + +RGTRGY+APEWL N P+++K DVYS+G++LLE++
Sbjct: 621 AAKVSDFGLAKLLNPKDNRYNMSSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLELVS 680
Query: 632 CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDS--DEAAMADRSRLHKWLMIAMWCI 689
+R+ ++ E+ + + WAY+ + +G A++D+ E D ++ + + + WCI
Sbjct: 681 GKRNFDVS-EKTNHKKFSIWAYEEFEKGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWCI 739
Query: 690 QEDPSKRPTMKVVMQMLEGLLEVPNP 715
QE P +RPTM V+QMLEG+ E+ NP
Sbjct: 740 QEQPLQRPTMGKVVQMLEGITEIKNP 765
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P17801|KPRO_MAIZE Putative receptor protein kinase ZmPK1 OS=Zea mays GN=PK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 308 bits (788), Expect = 1e-82, Method: Compositional matrix adjust.
Identities = 251/766 (32%), Positives = 362/766 (47%), Gaps = 98/766 (12%)
Query: 1 TIIWHANEDNHPVLAPRGSTLELTATG-LLLKDPGGQAIWDEKPNKI--VSDAAMLDTGN 57
TI+W AN D PV A R S L L G ++L D G A+W N V A +LDTGN
Sbjct: 85 TIVWSANPD-RPVHARR-SALTLQKDGNMVLTDYDGAAVWRADGNNFTGVQRARLLDTGN 142
Query: 58 FVLIASGNHSDYAWQSFKSPTDTILPTQILDLGSVLVSRLTETNLSKGRFELHFSNGSL- 116
V+ SG ++ WQSF SPTDT LPTQ++ + LV T + S G + FS+ S+
Sbjct: 143 LVIEDSGGNT--VWQSFDSPTDTFLPTQLITAATRLVP--TTQSRSPGNYIFRFSDLSVL 198
Query: 117 -------EFIPVAWPSRFQYKSYYTSNTSSANSSESGHQLVFNESADIYIVKNNGQIVQL 169
+ + WP Q + Y + NS+ G + +S + ++ Q
Sbjct: 199 SLIYHVPQVSDIYWPDPDQ--NLYQDGRNQYNSTRLG---MLTDSG--VLASSDFADGQA 251
Query: 170 PLWAQLSPRADHYFRATLDFDGVFAEYAHSKNSSTNQGWFPTRTLPDSMCTRLATDIGSG 229
+ + + P R TLD DG Y+ + + + T P ++ G
Sbjct: 252 LVASDVGPGVKR--RLTLDPDGNLRLYSMNDSDGSWSVSMVAMTQPCNI---------HG 300
Query: 230 ICGFNSYCSLQNGRPFCDCPPGYVLVDPNNRFRGCKPNFWQGFGPDDGSRNAQELYEIRE 289
+CG N C + P C CPPGY +P N GC R +
Sbjct: 301 LCGPNGICHY-SPTPTCSCPPGYATRNPGNWTEGC-----MAIVNTTCDRYDKRSMRFVR 354
Query: 290 FNNVDWPLGDYERLEPSNQTECEISCLQDCSCAVAIYD--GNRCWKK------------- 334
N D+ D + L + C C+ DC+C Y C+ K
Sbjct: 355 LPNTDFWGSDQQHLLSVSLRTCRDICISDCTCKGFQYQEGTGSCYPKAYLFSGRTYPTSD 414
Query: 335 ------KLP----LSNGWL-RDTEFSKV--------LFKVRKGDFPAFSDNSGSKKERGP 375
KLP +SN + R F V + K + FP G + +
Sbjct: 415 VRTIYLKLPTGVSVSNALIPRSDVFDSVPRRLDCDRMNKSIREPFPDVHKTGGGESK--- 471
Query: 376 LFLLGAFLLGGSILCNAFLLLAILIFFKWRRRKYENNVQDSTTSA--TNLRFFSYDELKD 433
F F+ ++ +F+ A K R E + A +N R +SY EL
Sbjct: 472 WFYFYGFIAAFFVVEVSFISFAWFFVLKRELRPSELWASEKGYKAMTSNFRRYSYRELVK 531
Query: 434 ATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKN 493
AT FK ELGRG G VYKGVL+ +AVKKL+ + Q +E F++E+S IGR +H N
Sbjct: 532 ATRKFKVELGRGESGTVYKGVLE--DDRHVAVKKLENVRQGKE-VFQAELSVIGRINHMN 588
Query: 494 LVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP---DWNLRVRISLEIARGLVYLHE 550
LV++ GFC E +RLLV E++ NG+LAN++F+ DW R I+L +A+GL YLH
Sbjct: 589 LVRIWGFCSEGSHRLLVSEYVENGSLANILFSEGGNILLDWEGRFNIALGVAKGLAYLHH 648
Query: 551 GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH-TMIRGTRGYVAPEWLK 609
C +IHCD+KP+NILLD F PKI+DFGL KLL S + + +RGT GY+APEW+
Sbjct: 649 ECLEWVIHCDVKPENILLDQAFEPKITDFGLVKLLNRGGSTQNVSHVRGTLGYIAPEWVS 708
Query: 610 NAPVSAKVDVYSFGVMLLEIICCRRSVEM-----ELEEESRAILTDWAYDCYVEGR---- 660
+ P++AKVDVYS+GV+LLE++ R E+ E+ R ++ +EG
Sbjct: 709 SLPITAKVDVYSYGVVLLELLTGTRVSELVGGTDEVHSMLRKLVR--MLSAKLEGEEQSW 766
Query: 661 LDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQML 706
+D +DS + + + +A+ C++ED SKRPTM+ +Q L
Sbjct: 767 IDGYLDSKLNRPVNYVQARTLIKLAVSCLEEDRSKRPTMEHAVQTL 812
|
Probable receptor. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Zea mays (taxid: 4577) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 295 bits (755), Expect = 9e-79, Method: Compositional matrix adjust.
Identities = 257/761 (33%), Positives = 362/761 (47%), Gaps = 79/761 (10%)
Query: 1 TIIWHANEDNHPVLAPRGSTLELTATGLLLKDPGGQA-IWDEKPNKIVS----DAAMLDT 55
TI+W AN D V S +++ L+L D Q +W N S +A + D
Sbjct: 70 TILWVANRD-KAVSDKNSSVFKISNGNLILLDGNYQTPVWSTGLNSTSSVSALEAVLQDD 128
Query: 56 GNFVLIASGNH--SDYAWQSFKSPTDTILP-TQI-LDLGSVLVSRLTE----TNLSKGRF 107
GN VL G+ ++ WQSF P DT LP +I LD + RLT + S G F
Sbjct: 129 GNLVLRTGGSSLSANVLWQSFDHPGDTWLPGVKIRLDKRTGKSQRLTSWKSLEDPSPGLF 188
Query: 108 ELHFSNGSLEFIPVAWPSRFQYKSYYTSNTSSA---NSSESGHQLVFNESADIYIVKNNG 164
L + + W +Y S N S + E ++N S +
Sbjct: 189 SLELDESTA--YKILWNGSNEYWSSGPWNPQSRIFDSVPEMRLNYIYNFS---FFSNTTD 243
Query: 165 QIVQLPLWAQLSPRADHYFRATLDFDGVFAEYAHSKNSSTNQGWFPTRTLPDSMCTRLAT 224
++ QL + R +D G ++ + N+ W + P C
Sbjct: 244 SYFTYSIYNQL-----NVSRFVMDVSGQIKQFTWLEG---NKAWNLFWSQPRQQCQVYR- 294
Query: 225 DIGSGICGFNSYCSLQNGRPFCDCPPGYVLVDPNNRFRGCKPNFWQGFGPDDGSRNAQEL 284
CG CS PFC CP G FR W G EL
Sbjct: 295 -----YCGSFGICS-DKSEPFCRCPQG---------FRPMSQKDWDLKDYSAGCVRKTEL 339
Query: 285 Y----EIREFNNV-DWPLGD-YERLEPSNQTECEISCLQDCSCAVAIYD--GNRC--WKK 334
+I +F + + L D E L ++ + C +C DCSC YD ++C W K
Sbjct: 340 QCSRGDINQFFRLPNMKLADNSEVLTRTSLSICASACQGDCSCKAYAYDEGSSKCLVWSK 399
Query: 335 KLPLSNGWLRDTEFSKVLFKVR--KGDFPAFSDNSGSKKERGPLFLLGAFLLGGSILCNA 392
+ L+ L D +F +R D P SG +G +F GA +LG +
Sbjct: 400 DV-LNLQQLEDENSEGNIFYLRLAASDVPNVG-ASGKSNNKGLIF--GA-VLGSLGVIVL 454
Query: 393 FLLLAILIFFKWRRRKYENNVQDSTTSATNLRFFSYDELKDATDGFKEELGRGSFGIVYK 452
LL+ ILI RR++ D T SA FSY EL++AT F ++LG G FG V+K
Sbjct: 455 VLLVVILILRYRRRKRMRGEKGDGTLSA-----FSYRELQNATKNFSDKLGGGGFGSVFK 509
Query: 453 GVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512
G L +S IAVK+L+ ++Q E++F++EV IG H NLV+L GFC E +LLVY+
Sbjct: 510 GALPDSSD--IAVKRLEGISQG-EKQFRTEVVTIGTIQHVNLVRLRGFCSEGSKKLLVYD 566
Query: 513 FMGNGTLANLIFAIPKPD-----WNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNIL 567
+M NG+L + +F + W LR +I+L ARGL YLH+ C IIHCDIKP+NIL
Sbjct: 567 YMPNGSLDSHLFLNQVEEKIVLGWKLRFQIALGTARGLAYLHDECRDCIIHCDIKPENIL 626
Query: 568 LDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLL 627
LD F PK++DFGL+KL+ D SR T +RGTRGY+APEW+ ++AK DVYS+G+ML
Sbjct: 627 LDSQFCPKVADFGLAKLVGRDFSRVLTTMRGTRGYLAPEWISGVAITAKADVYSYGMMLF 686
Query: 628 EIICCRRSVEMELEEESRAILTDWAYDCYV-EGRLDALIDSD-EAAMADRSRLHKWLMIA 685
E++ RR+ E E+ R WA +G + +L+D E D + + +A
Sbjct: 687 ELVSGRRNTEQSENEKVR-FFPSWAATILTKDGDIRSLVDPRLEGDAVDIEEVTRACKVA 745
Query: 686 MWCIQEDPSKRPTMKVVMQMLEGLLEVPNPPWSSSFSIAVT 726
WCIQ++ S RP M V+Q+LEG+LEV PP+ S V
Sbjct: 746 CWCIQDEESHRPAMSQVVQILEGVLEVNPPPFPRSIQALVV 786
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 294 bits (752), Expect = 2e-78, Method: Compositional matrix adjust.
Identities = 238/729 (32%), Positives = 347/729 (47%), Gaps = 76/729 (10%)
Query: 1 TIIWHANEDNHPVLAPRGSTLELTATG-LLLKDPGGQAIWDEKPNKIVSDAAMLDTGNFV 59
T +W AN PV P STLELT+TG L++ + +W + +D +TGN +
Sbjct: 67 THVWVANRI-RPVSDPDSSTLELTSTGYLIVSNLRDGVVWQTDNKQPGTDFRFSETGNLI 125
Query: 60 LIASGNHSDYAWQSFKSPTDTILPTQILDLGSVLVSRLTETNLSKGRFELHFSNGSLEFI 119
LI + WQSF +PTDT LP + + + S + + S G + L S EF
Sbjct: 126 LI--NDDGSPVWQSFDNPTDTWLPGMNVTGLTAMTSWRSLFDPSPGFYSLRLSPSFNEFQ 183
Query: 120 PVAWPSRFQYKSYYTSNTSSANSSESGHQLVFN-ESADIYIVKNNGQIVQLPLWAQLSPR 178
V + + + + + E ++ + Y + + PL + PR
Sbjct: 184 LVYKGTTPYWSTGNWTGEAFVGVPEMTIPYIYRFHFVNPYTPTASFWYIVPPLDSVSEPR 243
Query: 179 ADHYFRATLDFDGVFAEYAHSKNSSTNQGWFPTRTLPDSMCTRLATDIGSGICGFNSYCS 238
+ +G +Y + Q W P+ C +CG +CS
Sbjct: 244 LTRFMVGA---NGQLKQYTWDPQT---QSWNMFWLQPEDPCRVY------NLCGQLGFCS 291
Query: 239 LQNGRPFCDCPPGYVLVDPNNRFRGCKPNFWQGFGPDDGSRNAQELYEIREFNNVDWPLG 298
+ +P C C G FR W+ DG R +E + E ++ +G
Sbjct: 292 SELLKP-CACIRG---------FRPRNDAAWRSDDYSDGCR--RENGDSGEKSDTFEAVG 339
Query: 299 D--------YERLEPSNQTECEISCLQDCSCAVAIYDGNRCWKKKLPLSNGWLRDTEFSK 350
D RL+ S ++ C +CL + SC V Y + + K
Sbjct: 340 DLRYDGDVKMSRLQVS-KSSCAKTCLGNSSC-VGFYHKEK---------------SNLCK 382
Query: 351 VLFKVRKGDFPAFSDNSGSKKERGPLFLLGAFLLGGSILCNAFLLLAILIFFKWRRRKYE 410
+L + P NS + + L GSI F LL LI K R++ +
Sbjct: 383 ILLES-----PNNLKNSKGNISKSIIILCSVV---GSISVLGFTLLVPLILLKRSRKRKK 434
Query: 411 NNVQDSTTSAT-NLRFFSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLD 469
QD A NL+ FS+ EL+ AT+GF +++G G FG V+KG L S +AVK+L+
Sbjct: 435 TRKQDEDGFAVLNLKVFSFKELQSATNGFSDKVGHGGFGAVFKGTLP-GSSTFVAVKRLE 493
Query: 470 RLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPK 528
R E EF++EV IG H NLV+L GFC E L+RLLVY++M G+L++ L PK
Sbjct: 494 RPGSG-ESEFRAEVCTIGNIQHVNLVRLRGFCSENLHRLLVYDYMPQGSLSSYLSRTSPK 552
Query: 529 P-DWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS 587
W R RI+L A+G+ YLHEGC IIHCDIKP+NILLD ++ K+SDFGL+KLL
Sbjct: 553 LLSWETRFRIALGTAKGIAYLHEGCRDCIIHCDIKPENILLDSDYNAKVSDFGLAKLLGR 612
Query: 588 DHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSV--------EME 639
D SR +RGT GYVAPEW+ P++ K DVYSFG+ LLE+I RR+V E E
Sbjct: 613 DFSRVLATMRGTWGYVAPEWISGLPITTKADVYSFGMTLLELIGGRRNVIVNSDTLGEKE 672
Query: 640 LEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTM 699
E E + WA ++G +D+++DS + + + +A+WCIQ++ RP M
Sbjct: 673 TEPE-KWFFPPWAAREIIQGNVDSVVDSRLNGEYNTEEVTRMATVAIWCIQDNEEIRPAM 731
Query: 700 KVVMQMLEG 708
V++MLEG
Sbjct: 732 GTVVKMLEG 740
|
Serine/threonine-protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65238|Y5537_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370 OS=Arabidopsis thaliana GN=At5g35370 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 268 bits (684), Expect = 1e-70, Method: Compositional matrix adjust.
Identities = 235/783 (30%), Positives = 356/783 (45%), Gaps = 114/783 (14%)
Query: 1 TIIWHANEDNHPVLAPRGSTLELTATGLLLKDPGGQAI--WDEKP-NKIVSDAAMLDTGN 57
+ IW +N D+ PV + T+ LT G+ + + G I W V + D GN
Sbjct: 84 STIWSSNRDS-PVSS--SGTMNLTPQGISVIEDGKSQIPVWSTPVLASPVKSLRLTDAGN 140
Query: 58 FVLIASGNHSDYAWQSFKSPTDTILPTQILDLGSVLVSRLTETNLSKG--RFELHFSNGS 115
+L+ N S W+SF PTD+I+ Q L LG L ++ ++ S G +F + S+G
Sbjct: 141 LLLLDHLNVS--LWESFDFPTDSIVLGQRLKLGMFLSGSVSRSDFSTGDYKFLVGESDGL 198
Query: 116 LEFIPVA-WPSRFQYKSYYTSNTSSANSSESGHQLVFNESADIYIVKNNGQIVQLPLWAQ 174
+++ W R ++ SN + + ++ + ++ NG +V + +
Sbjct: 199 MQWRGQNYWKLRMHIRANVDSNFPV--------EYLTVTTSGLALMARNGTVVVVRV--A 248
Query: 175 LSPRADHYFR-ATLDFDGVFAEYAHS-KNSSTN-QGWFPTRTLPDSMCTRLATDIGSGIC 231
L P +D FR A +D G F S KN T G + +P +C +L G+C
Sbjct: 249 LPPSSD--FRVAKMDSSGKFIVSRFSGKNLVTEFSGPMDSCQIP-FVCGKL------GLC 299
Query: 232 GFNSYCSLQNGRPFCDCPPGYVLVDPNNRFRGCKPNFWQGFGPDDGSRNAQELYEIREFN 291
++ Q+ C CP + +D C P S + E R +
Sbjct: 300 NLDNASENQS----CSCPD-EMRMDAGKGV--CVP--------VSQSLSLPVSCEARNIS 344
Query: 292 NVDWPLG-DYERLEPSNQTE-------CEISCLQDCSCAVAIYDGNR--CWKKKLPLSNG 341
++ LG Y ++ E C C ++CSC Y+ C+ K +
Sbjct: 345 YLELGLGVSYFSTHFTDPVEHGLPLLACHDICSKNCSCLGVFYENTSRSCYLVKDSFGSL 404
Query: 342 WLRDTE------FSKVLFKVRKGDFPAFSDNSGSKKERGPLFLLGAFLLGGSILCNAFLL 395
L V +RK + + G+ G F + A +L + C+ F L
Sbjct: 405 SLVKNSPENHDLIGYVKLSIRKTN----AQPPGNNNRGGSSFPVIALVL---LPCSGFFL 457
Query: 396 LAILIFFKWRR---RKYENNVQDSTTSATNL--------------RFFSYDELKDATDGF 438
L L WRR +Y + + T + + F ++EL+ AT+ F
Sbjct: 458 LIALGLLWWRRCAVMRYSSIREKQVTRPGSFESGDLGSFHIPGLPQKFEFEELEQATENF 517
Query: 439 KEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLL 498
K ++G G FG VYKG L + IAVKK+ +EF +E++ IG H NLV+L
Sbjct: 518 KMQIGSGGFGSVYKGTLPDET--LIAVKKITNHGLHGRQEFCTEIAIIGNIRHTNLVKLR 575
Query: 499 GFCDEALNRLLVYEFMGNGTLANLIFAIPKP--DWNLRVRISLEIARGLVYLHEGCNVPI 556
GFC LLVYE+M +G+L +F+ P +W R I+L ARGL YLH GC+ I
Sbjct: 576 GFCARGRQLLLVYEYMNHGSLEKTLFSGNGPVLEWQERFDIALGTARGLAYLHSGCDQKI 635
Query: 557 IHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAK 616
IHCD+KP+NILL +F PKISDFGLSKLL + S T +RGTRGY+APEW+ NA +S K
Sbjct: 636 IHCDVKPENILLHDHFQPKISDFGLSKLLNQEESSLFTTMRGTRGYLAPEWITNAAISEK 695
Query: 617 VDVYSFGVMLLEIICCRRSVEMELEEESRAILTD--------------------WAYDCY 656
DVYS+G++LLE++ R++ S ++ D +A D +
Sbjct: 696 ADVYSYGMVLLELVSGRKNC--SFRSRSNSVTEDNNQNHSSTTTTSTGLVYFPLYALDMH 753
Query: 657 VEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNPP 716
+GR L D K + IA+ C+ E+P+ RPTM V+ M EG + + NP
Sbjct: 754 EQGRYMELADPRLEGRVTSQEAEKLVRIALCCVHEEPALRPTMAAVVGMFEGSIPLGNPR 813
Query: 717 WSS 719
S
Sbjct: 814 MES 816
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 264 bits (675), Expect = 2e-69, Method: Compositional matrix adjust.
Identities = 135/301 (44%), Positives = 192/301 (63%), Gaps = 9/301 (2%)
Query: 426 FSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSA 485
F+Y +L+ AT+ F +LG+G FG VY+G L G+ +AVKKL+ + Q + +EF++EVS
Sbjct: 483 FAYKDLQSATNNFSVKLGQGGFGSVYEGTL--PDGSRLAVKKLEGIGQGK-KEFRAEVSI 539
Query: 486 IGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPD----WNLRVRISLEI 541
IG HH +LV+L GFC E +RLL YEF+ G+L IF D W+ R I+L
Sbjct: 540 IGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGT 599
Query: 542 ARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRG 601
A+GL YLHE C+ I+HCDIKP+NILLD F+ K+SDFGL+KL+ + S T +RGTRG
Sbjct: 600 AKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHVFTTMRGTRG 659
Query: 602 YVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRL 661
Y+APEW+ N +S K DVYS+G++LLE+I R++ + E + +A+ EG+L
Sbjct: 660 YLAPEWITNYAISEKSDVYSYGMVLLELIGGRKNYDPS-ETSEKCHFPSFAFKKMEEGKL 718
Query: 662 DALIDSDEAAM-ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNPPWSSS 720
++D + R+ + + A+WCIQED RP+M V+QMLEG+ V PP SS+
Sbjct: 719 MDIVDGKMKNVDVTDERVQRAMKTALWCIQEDMQTRPSMSKVVQMLEGVFPVVQPPSSST 778
Query: 721 F 721
Sbjct: 779 M 779
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RY65|NIK2_ARATH Protein NSP-INTERACTING KINASE 2 OS=Arabidopsis thaliana GN=NIK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 243 bits (620), Expect = 4e-63, Method: Compositional matrix adjust.
Identities = 133/338 (39%), Positives = 189/338 (55%), Gaps = 12/338 (3%)
Query: 381 AFLLGGSILCNAFLLLAILIFFKWRRRKYE-------NNVQDSTTSATNLRFFSYDELKD 433
A + G S+ C L++ WRRR + N NLR F++ EL+
Sbjct: 248 AVVFGVSLTCVCLLIIGFGFLLWWRRRHNKQVLFFDINEQNKEEMCLGNLRRFNFKELQS 307
Query: 434 ATDGF--KEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQER-EREFKSEVSAIGRTH 490
AT F K +G+G FG VYKG L G+ IAVK+L + E +F++E+ I
Sbjct: 308 ATSNFSSKNLVGKGGFGNVYKGCLH--DGSIIAVKRLKDINNGGGEVQFQTELEMISLAV 365
Query: 491 HKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHE 550
H+NL++L GFC + RLLVY +M NG++A+ + A P DW R RI+L RGL+YLHE
Sbjct: 366 HRNLLRLYGFCTTSSERLLVYPYMSNGSVASRLKAKPVLDWGTRKRIALGAGRGLLYLHE 425
Query: 551 GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKN 610
C+ IIH D+K NILLD YF + DFGL+KLL + S T +RGT G++APE+L
Sbjct: 426 QCDPKIIHRDVKAANILLDDYFEAVVGDFGLAKLLDHEESHVTTAVRGTVGHIAPEYLST 485
Query: 611 APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEA 670
S K DV+ FG++LLE+I R++E R + DW E +L+ ++D D
Sbjct: 486 GQSSEKTDVFGFGILLLELITGLRALEFGKAANQRGAILDWVKKLQQEKKLEQIVDKDLK 545
Query: 671 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEG 708
+ DR + + + +A+ C Q P RP M V++MLEG
Sbjct: 546 SNYDRIEVEEMVQVALLCTQYLPIHRPKMSEVVRMLEG 583
|
Involved in defense response to geminivirus infection (By similarity). Phosphorylates RPL10A in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 241 bits (615), Expect = 2e-62, Method: Compositional matrix adjust.
Identities = 221/796 (27%), Positives = 347/796 (43%), Gaps = 133/796 (16%)
Query: 3 IWHANEDNHPVL--APRGSTLELTATGLLLKDPGGQAIWDEKP----------------N 44
IW+ N ++ V+ A R + + + L++ + G + D K N
Sbjct: 68 IWYGNIEDKAVVWVANRATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTNNNN 127
Query: 45 KIVSDAAMLDTGNFVLIASGNHSDYAWQSFKSPTDTILPTQILDLG------SVLVSRLT 98
++VS + DTGNFVL + + W+SF PTDT LP + + VS +
Sbjct: 128 RVVS---IHDTGNFVL-SETDTDRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRS 183
Query: 99 ETNLSKGRFELHFS-NGSLEFIPVAWPSRFQYKSYYTSNTSSANSSESGHQLVFNESADI 157
ET+ S G + L +G+ E + + N + S + +F ++
Sbjct: 184 ETDPSPGNYSLGVDPSGAPEIV------------LWEGNKTRKWRSGQWNSAIFTGIPNM 231
Query: 158 YIVKNNGQIVQLPLWAQLSPRADHYFRATLDFDGVFAEYAHSKNSS--------TNQGWF 209
++ N + L + YF V + N + T + W
Sbjct: 232 SLLTN--YLYGFKLSSPPDETGSVYFTYVPSDPSVLLRFKVLYNGTEEELRWNETLKKWT 289
Query: 210 PTRTLPDSMCTRLATDIGSGICGFNSYCSLQNGRPFCDCPPGYVLVDPNNRFRGCKPNFW 269
++ PDS C + CG C ++ C C GY V N RGC+
Sbjct: 290 KFQSEPDSECDQYNR------CGKFGICDMKGSNGICSCIHGYEQVSVGNWSRGCRRR-- 341
Query: 270 QGFGPDDGSRNAQ----ELYEIREFNNVDWPLGDYERLEPSNQTECEISCLQDCSC-AVA 324
P RN E ++ D+ + ++ ++P +C CL++CSC A +
Sbjct: 342 ---TPLKCERNISVGEDEFLTLKSVKLPDFEIPEHNLVDPE---DCRERCLRNCSCNAYS 395
Query: 325 IYDGNRC--WKKKLPLSNGWLRDTEFSKVLFKVRKGDFPAFSDNSGSKKERGPLFLLGAF 382
+ G C W + L L+ E +R D +N +K L+G
Sbjct: 396 LVGGIGCMIWNQDLVD----LQQFEAGGSSLHIRLAD-SEVGENRKTKIAVIVAVLVGVI 450
Query: 383 LLGGSILCNAFLLLAILIFFKWRRRK-----YENNVQDS------------TTSA----- 420
L+G + L+ ++++R+K Y D+ TTSA
Sbjct: 451 LIG----------IFALLLWRFKRKKDVSGAYCGKNTDTSVVVADLTKSKETTSAFSGSV 500
Query: 421 -----------TNLRFFSYDELKDATDGF--KEELGRGSFGIVYKGVLKTASGNAIAVKK 467
+ L FS + + AT+ F + ELGRG FG VYKGVL+ G IAVK+
Sbjct: 501 DIMIEGKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLE--DGREIAVKR 558
Query: 468 LDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIP 527
L + + EFK+E+ I + H+NLV+LLG C E ++LVYE+M N +L +F
Sbjct: 559 LSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDET 618
Query: 528 KP---DWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKL 584
K DW LR I IARGL+YLH + IIH D+K N+LLD +PKISDFG++++
Sbjct: 619 KQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARI 678
Query: 585 LLSDHSRTHTM-IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEE 643
+ + +T+ + GT GY++PE+ S K DVYSFGV+LLEI+ +R+ + E
Sbjct: 679 FGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEH 738
Query: 644 SRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVM 703
L +A+ Y GR + L+D + + + +AM C+Q+ ++RP M V+
Sbjct: 739 GS--LIGYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVL 796
Query: 704 QMLE---GLLEVPNPP 716
MLE L P P
Sbjct: 797 LMLESDTATLAAPRQP 812
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 728 | ||||||
| 224138692 | 776 | predicted protein [Populus trichocarpa] | 0.982 | 0.921 | 0.648 | 0.0 | |
| 255583185 | 787 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.973 | 0.900 | 0.566 | 0.0 | |
| 357482135 | 803 | Kinase-like protein [Medicago truncatula | 0.978 | 0.886 | 0.527 | 0.0 | |
| 356540555 | 802 | PREDICTED: G-type lectin S-receptor-like | 0.971 | 0.881 | 0.531 | 0.0 | |
| 357482147 | 800 | Kinase-like protein [Medicago truncatula | 0.972 | 0.885 | 0.529 | 0.0 | |
| 356495581 | 801 | PREDICTED: G-type lectin S-receptor-like | 0.972 | 0.883 | 0.530 | 0.0 | |
| 356495583 | 809 | PREDICTED: G-type lectin S-receptor-like | 0.971 | 0.873 | 0.516 | 0.0 | |
| 224099309 | 801 | predicted protein [Populus trichocarpa] | 0.957 | 0.870 | 0.519 | 0.0 | |
| 224103119 | 799 | predicted protein [Populus trichocarpa] | 0.969 | 0.883 | 0.497 | 0.0 | |
| 225436281 | 810 | PREDICTED: G-type lectin S-receptor-like | 0.965 | 0.867 | 0.5 | 0.0 |
| >gi|224138692|ref|XP_002326666.1| predicted protein [Populus trichocarpa] gi|222833988|gb|EEE72465.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 959 bits (2478), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 472/728 (64%), Positives = 573/728 (78%), Gaps = 13/728 (1%)
Query: 1 TIIWHANEDNHPVLAPRGSTLELTATGLLLKDPGGQAIWDEKPNKIVSDAAMLDTGNFVL 60
TI+WH+N N+P+ PRGS +ELT++ L+L +P G IW P V AAMLDTGNFVL
Sbjct: 50 TIVWHSN-GNNPL--PRGSKVELTSSNLVLTNPKGLIIWQANPATPVISAAMLDTGNFVL 106
Query: 61 IASGNHSDYAWQSFKSPTDTILPTQILDLGSVLVSRLTETNLSKGRFELHFSNGSLEFIP 120
+ S Y W++FK+PTDTILPTQ LDLGS L SRLTETN SKGRFEL+FSNGSLE P
Sbjct: 107 -KGNDSSTYIWETFKNPTDTILPTQTLDLGSKLFSRLTETNYSKGRFELNFSNGSLELNP 165
Query: 121 VAWPSRFQYKSYYTSNTSSANSSESGHQLVFNESADIYIVKNNGQIVQLPLWAQLSPRAD 180
+AWPS FQY YY+SNT +A+ ESG++LVFNESA++YIVK NG+I Q P W +++ D
Sbjct: 166 IAWPSEFQYDHYYSSNTYNADPYESGYRLVFNESANVYIVKLNGEIAQFPDWNRINYTGD 225
Query: 181 HYFRATLDFDGVFAEYAHSKNSSTNQGWFPTRTLPDSMCTRLATDIGSGICGFNSYCSLQ 240
+Y+RATL FDGVF +Y+ KNS+TNQGW+P +++P MCT + DIGSG CGFNSYCS+Q
Sbjct: 226 NYYRATLGFDGVFTQYSLPKNSTTNQGWWPVQSIPLDMCTAIFNDIGSGPCGFNSYCSIQ 285
Query: 241 -NGRPFCDCPPGYVLVDPNNRFRGCKPNFWQGFGPDDGSRNAQELYEIREFNNVDWPLGD 299
N +P CDCPPGYV +DPNNR GCKP F QG G DDG + +ELYEIR+F+NV+WPL D
Sbjct: 286 ENRKPTCDCPPGYVFLDPNNRLGGCKPTFPQGCGLDDGRGDPEELYEIRQFDNVNWPLND 345
Query: 300 YERLEPSNQTECEISCLQDCSCAVAIYDGNRCWKKKLPLSNGWLRDTEFSKVLFKVRKGD 359
YERL P NQT+CE SCL DCSCAVAI+DG +CWKK+LPLSNG T FSK LFKVRK
Sbjct: 346 YERLSPYNQTQCEKSCLYDCSCAVAIFDGRQCWKKRLPLSNGRYMRTGFSKTLFKVRKEV 405
Query: 360 FPAFSDNSGSKKERGPLFLLGAFLLGGSILCNAFLLLA-ILIFFKWRRRKYENNVQDSTT 418
P+ N GS KE+ P+ LLGA LLG S N LL+ LI F+ R RK + DS+
Sbjct: 406 PPSGYCNVGSDKEK-PV-LLGA-LLGSSAFLNVILLVVTFLILFRRRERKVKKAGPDSSI 462
Query: 419 SATNLRFFSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQERERE 478
+ LR F+Y EL++ATDGF EELGRGSFGIVYKG ++++SGNAIAVKKLD+LAQERERE
Sbjct: 463 YFSTLRSFTYKELEEATDGFMEELGRGSFGIVYKGFMRSSSGNAIAVKKLDKLAQERERE 522
Query: 479 FKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRIS 538
F++EVSAIG THHKNLV+LLG+CDE +RLL+YEFM NGTLAN +F +P+PDW+ RV+I+
Sbjct: 523 FRTEVSAIGETHHKNLVRLLGYCDEGSHRLLIYEFMSNGTLANFLFTLPRPDWHQRVKIA 582
Query: 539 LEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRG 598
L +ARGL+YLH C PIIHCDIKPQNILLD FS +ISDFGL+KLLLS+ +RT TMIRG
Sbjct: 583 LGVARGLLYLHGECEFPIIHCDIKPQNILLDDSFSARISDFGLAKLLLSNQTRTRTMIRG 642
Query: 599 TRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELE--EESRAILTDWAYDCY 656
TRGYVAPEW KN PV+AKVDVYSFGV+LLEIICCRRSV M+LE EE RAILTDWAYDCY
Sbjct: 643 TRGYVAPEWFKNVPVTAKVDVYSFGVLLLEIICCRRSVVMDLEEGEEERAILTDWAYDCY 702
Query: 657 VEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNPP 716
+ GR+ L+D+D+ AM D+ RL KW+ ++MWCIQE+PSKRPTMK+V++MLEG L+V PP
Sbjct: 703 IGGRIYHLVDNDKVAMDDKERLKKWVEVSMWCIQEEPSKRPTMKMVLEMLEGFLDV--PP 760
Query: 717 WSSSFSIA 724
S F ++
Sbjct: 761 LQSPFPLS 768
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255583185|ref|XP_002532358.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223527945|gb|EEF30031.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 803 bits (2074), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 413/729 (56%), Positives = 526/729 (72%), Gaps = 20/729 (2%)
Query: 1 TIIWHANEDNHPVLAPRGSTLELTATGLLLKDPGGQAIWDEKPNKIVSDAAMLDTGNFVL 60
TI+W AN D A +GS LE++ GLLL DPGGQ IW+++ VS AAMLDTGNFVL
Sbjct: 71 TIVWDANGDKP---AQQGSKLEVSVNGLLLTDPGGQLIWEQQ-TATVSYAAMLDTGNFVL 126
Query: 61 IASGNHSDYAWQSFKSPTDTILPTQILDLGSVLVSRLTETNLSKGRFELHFSNGSLEFIP 120
+ N+SDY W+SFK+PTDTILP+Q L+ G+ L SRL ETN S+GRF+L+F NG L+ P
Sbjct: 127 V--DNNSDYLWESFKNPTDTILPSQALEPGTFLFSRLAETNYSRGRFQLYFLNGDLQLSP 184
Query: 121 VAWPSRFQYKSYYTSNTSSANSSESGHQLVFNESADIYIVKNNGQIVQLPLWAQ--LSPR 178
V WP++ QY +Y++S TSS++SS SG+QLVFN+S DIY+VK +G V+LP W Q +P
Sbjct: 185 VGWPTKVQYGAYFSSGTSSSDSSVSGYQLVFNQS-DIYMVKTDGVTVRLP-WQQQDTAPS 242
Query: 179 -ADHYFRATLDFDGVFAEYAHSKNSSTNQGWFPTRTLPDSMCTRLATDIGSGICGFNSYC 237
A +Y+RATLD++GV +Y K S +++ W + +P +C+ + IGSG CG+NS C
Sbjct: 243 LAGNYYRATLDYNGVLTQYVCPKGSGSDRSWSIVQYIPQDICSAIFNGIGSGACGYNSIC 302
Query: 238 SLQNGRPFCDCPPGYVLVDPNNRFRGCKPNFWQGFGPDDGSRNAQELYEIREFNNVDWPL 297
+ NGRP C CP GY +D NN F GCKP+F G G D S N ++LYE RE V+WPL
Sbjct: 303 TEVNGRPNCACPLGYSFIDQNNLFGGCKPDFPLGCGVADASENMEDLYEFRELQYVNWPL 362
Query: 298 GDYERLEPSNQTECEISCLQDCSCAVAIYDGNRCWKKKLPLSNGWLRDTEFSKVLFKVRK 357
GDYERL P + EC+ SCLQDC CA AIY + CWKK++PL+NG L S L KVRK
Sbjct: 363 GDYERLSPYSVEECKTSCLQDCMCAAAIYGSSICWKKRIPLANGRLEKGN-SLALIKVRK 421
Query: 358 GDFPAFSD-NSGSKKERGPLFLLGAFLLGGSILCNAFLLLAI-LIFFKWRRRKYENNVQD 415
G A KK++ L G+ LG S++ NAF L + LI F RK +Q
Sbjct: 422 GAPLAQPGLTCIKKKKQDKTILFGS--LGTSLVLNAFFLFTVPLILFLKLNRKSNKVLQL 479
Query: 416 STTSATNLRFFSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQER 475
ST TNL FSY EL++ATD FKE++GRGS IVYKG+LK + N IAVKKLD+L+QE
Sbjct: 480 STLLETNLHMFSYKELEEATDNFKEQVGRGSSAIVYKGILKCSPNNVIAVKKLDKLSQEA 539
Query: 476 EREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRV 535
E+EF++E+ IG+T HKNLV+LLGFC+E +RLLVY+FM GTLAN + IPKP+WN+R
Sbjct: 540 EKEFRTEMKVIGKTCHKNLVRLLGFCEEGSHRLLVYQFMTRGTLANFLLGIPKPEWNIRA 599
Query: 536 RISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM 595
+I LEIARGL+YLHE C PIIHCDIKP+NILLD YF+ KISDFGLSKLLLS+ SRT T+
Sbjct: 600 QIVLEIARGLLYLHEECEAPIIHCDIKPENILLDEYFTAKISDFGLSKLLLSNQSRTMTL 659
Query: 596 IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDC 655
IRGTRGYVAPEW +N V+AKVDVYSFGV+LLEIICC+++V +LE+E ILT+W YDC
Sbjct: 660 IRGTRGYVAPEWFRNVAVTAKVDVYSFGVVLLEIICCKKNVS-KLEDEKDGILTEWVYDC 718
Query: 656 YVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNP 715
E RLDA+I+ DE A+AD+ RL+ W+ +A+WC QEDPS RP+MK V+QMLEG E+P+
Sbjct: 719 LQEERLDAVIEFDEEAVADKERLNSWVRMAIWCTQEDPSTRPSMKTVLQMLEGFTEIPSL 778
Query: 716 P---WSSSF 721
P +SS+F
Sbjct: 779 PKYSFSSNF 787
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357482135|ref|XP_003611353.1| Kinase-like protein [Medicago truncatula] gi|355512688|gb|AES94311.1| Kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 778 bits (2008), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 391/741 (52%), Positives = 521/741 (70%), Gaps = 29/741 (3%)
Query: 1 TIIWHA---NEDNHPVLAPRGSTLELTATGLLLKDPGGQAIWDEKPNKIVSDAAMLDTGN 57
TI+W A N N+ VLAP GS ++LT+ GL L +P ++IW +PN IVS MLD GN
Sbjct: 72 TIVWSAKDMNNSNNLVLAPTGSQVQLTSGGLTLTNPQNESIWTAQPNDIVSYGTMLDNGN 131
Query: 58 FVLIASGNHSDYAWQSFKSPTDTILPTQILDLGSVLVSRLTETNLSKGRFELHFSNG--S 115
FVL+ N S W+SFK PTDT+LP Q L+LG+ L SR +ETN + GRF+L+F++ +
Sbjct: 132 FVLV--NNKSAIVWESFKFPTDTLLPNQSLELGATLTSRFSETNFTSGRFQLYFNDDDHN 189
Query: 116 LEFIPVAWPSRFQYKSYYTSNTSSANSSESGHQLVFNESADIYIVKN-NGQIVQLPLWAQ 174
L P+AWP++F+Y YY ++ ++S S LVF+ES DIY+ N NG P Q
Sbjct: 190 LMLSPLAWPTQFRYNFYYRIEVNNNSASSS---LVFDESGDIYVETNKNGTTRIKPQGTQ 246
Query: 175 -----LSPRADHYFRATLDFDGVFAEYAHSKNSSTNQGWFPTRTLPDSMCTRLATDIGSG 229
L P+ +Y+RA LD+ GV +Y+H +++ QGW R +PD++C + ++GSG
Sbjct: 247 WKNLDLDPKL-YYYRAILDYYGVLTQYSHPRDTKAKQGWTIMRYVPDNICIAIFNEMGSG 305
Query: 230 ICGFNSYCSLQNGRPFCDCPPGYVLVDPNNRFRGCKPNFWQGFGPDDG---SRNAQELYE 286
CG+NSYCS++N RP C CP GY L+DP+N+F GC+ NF G G D+G + ++LYE
Sbjct: 306 TCGYNSYCSMENQRPTCKCPYGYSLIDPSNQFGGCQLNFTLGCGADNGEGLNVKPEDLYE 365
Query: 287 IREFNNVDWPLGDYERLEPSNQTECEISCLQDCSCAVAIYDGNRCWKKKLPLSNGWLRDT 346
NV+WPL DYER++P +Q +C+ SCL DC C+V ++ CWKK+ PL+NG ++
Sbjct: 366 FTVLTNVNWPLSDYERMQPYSQHDCQQSCLHDCMCSVVVFSNQNCWKKRSPLANG-REES 424
Query: 347 EFSKVLFKVRKGDFPAF--SDNSGSKKERGPLFLLGAFLLGGSILCNAFLLLAILIFFKW 404
+ VL K R S ++ KK+ +L L+G ++ N+ LL A+++
Sbjct: 425 GGNLVLIKTRVSPLGKIGASPSTNLKKDNQVNPILRGLLIGSAVF-NSILLAAVVLVTLL 483
Query: 405 RRRKYENNVQDSTTSATNLRFFSYDELKDATDGFKEELGRGSFGIVYKGVLKTA-SGNAI 463
+ ++ V +T TNL FSYD LK+AT GF EELGRGSFGIV+KG LK A S N +
Sbjct: 484 KPKRV---VVGTTLLETNLCSFSYDALKEATWGFIEELGRGSFGIVFKGELKAATSCNVV 540
Query: 464 AVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLI 523
AVK+LDRLAQ+RE+EFK+E+ AIG+T HKNLV+L+G+CDE ++R+LVYEFM NG+LAN++
Sbjct: 541 AVKRLDRLAQDREKEFKTELRAIGKTCHKNLVKLIGYCDEGMHRMLVYEFMNNGSLANIL 600
Query: 524 FAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSK 583
F KP WN R+ +L IARGLVYLHE C+ PIIHCDIKPQNIL+D YF+ KISDFGL+K
Sbjct: 601 FGQTKPTWNQRIGFALGIARGLVYLHEECDTPIIHCDIKPQNILIDEYFTAKISDFGLAK 660
Query: 584 LLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVE-MELEE 642
LLL+D SRT TMIRGTRGYVAPEW KN PV+AKVDVYSFG MLLEI+CCR+SV ME E
Sbjct: 661 LLLADQSRTKTMIRGTRGYVAPEWFKNVPVTAKVDVYSFGAMLLEIVCCRKSVVLMESGE 720
Query: 643 ESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVV 702
E +AILTDWA DCY+EGR+DAL+++D+ A+ D RL KW+ IA+WCIQE P RPTM++V
Sbjct: 721 EEKAILTDWACDCYMEGRIDALVENDQEALDDIDRLEKWIKIAIWCIQEHPEMRPTMRMV 780
Query: 703 MQMLEGLLEVPNPPWSSSFSI 723
MQMLEG+++VPNPP SFS+
Sbjct: 781 MQMLEGVVQVPNPPSPFSFSL 801
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356540555|ref|XP_003538753.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 772 bits (1993), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 389/732 (53%), Positives = 513/732 (70%), Gaps = 25/732 (3%)
Query: 1 TIIWHANEDNHPVLAPRGSTLELTATGLLLKDPGGQAIWDEKPNKIVSDAAMLDTGNFVL 60
TI+W+A + AP GS ++LT GL L P G++IW +P+ +S AMLDTGNFVL
Sbjct: 71 TIVWNAKANETLATAPAGSQVQLTLEGLTLTSPKGESIWKAQPSVPLSYGAMLDTGNFVL 130
Query: 61 IASGNHSDYAWQSFKSPTDTILPTQILDLGSVLVSRLTETNLSKGRFELHFSNGSLEFIP 120
+ +S + W+SFK+PTDT+LP Q L+L L SRL +TN + GRF+L+F NG L P
Sbjct: 131 V--NKNSTFEWESFKNPTDTLLPNQFLELDGKLTSRLQDTNYTTGRFQLYFQNGVLLLSP 188
Query: 121 VAWPSRFQYKSYYTSNTSSANSSESGHQLVFNESADIYIVKNNGQIV--QLPLW--AQLS 176
+AWP++ +Y+ YY ++S S +LVF+E +IY+ + NG + Q P W + L
Sbjct: 189 LAWPTQLRYRYYY-----RIDASHSASRLVFDELGNIYVERVNGTRIRPQGPTWGNSSLD 243
Query: 177 PRADHYFRATLDFDGVFAEYAHSKNSSTNQGWFPTRTLPDSMCTRLATDIGSGICGFNSY 236
P+ ++Y+RATL+F+GVF +YAH + ++ QGW R +P ++CT + + GSG CG+NSY
Sbjct: 244 PK-EYYYRATLEFNGVFTQYAHPRTNNAYQGWTIMRYVPGNICTAIFNEYGSGSCGYNSY 302
Query: 237 CSLQNGRPFCDCPPGYVLVDPNNRFRGCKPNFWQGFGPDDGSRNAQELYEIREFNNVDWP 296
CS++N RP C CP GY +VDP+N F GC+PNF G D ++ +ELYE+ EF + ++P
Sbjct: 303 CSMENDRPTCKCPYGYSMVDPSNEFGGCQPNFTLACGVDVKAQ-PEELYEMHEFRDFNFP 361
Query: 297 LGDYERLEPSNQTECEISCLQDCSCAVAIYDGNRCWKKKLPLSNG---WLRDTEFSKVLF 353
LGDYE+ +P +Q EC SCL DC CA+A+ GN CW K+LPLSNG + D F +
Sbjct: 362 LGDYEKKQPYSQQECRQSCLHDCICAMAVLGGNTCWMKRLPLSNGRVIHVNDQHFVYIKT 421
Query: 354 KVRK-----GDFPAFSDNSGSKKERGPLFLLGAFLLGGSILCNAFLLLAILIFFKWRRRK 408
+VR+ G + SKKE G +L L+G + + +LL + +F + K
Sbjct: 422 RVRRDFYDPGANEELPPGADSKKEDGAKPILLGSLIGSLVFISISMLLCAVSWFILLKPK 481
Query: 409 YENNVQD-STTSATNLRFFSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKK 467
V + TNL F+Y+ L+ AT GF EE+GRGSFGIVYKG L+ AS N IAVK+
Sbjct: 482 LTRLVPAIPSLLETNLHSFTYETLEKATRGFCEEIGRGSFGIVYKGQLEAASCNVIAVKR 541
Query: 468 LDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIP 527
LDRLAQERE+EF++E+SAIG+T HKNLV+L+GFCDE +NRLLVYEFM NGTLA+++F
Sbjct: 542 LDRLAQEREKEFRAELSAIGKTCHKNLVRLIGFCDEGINRLLVYEFMSNGTLADILFGQS 601
Query: 528 K-PDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLL 586
K P WN RV ++L IARGL+YLHE C+ IIHCDIKPQNIL+D +F+ KISDFGL+KLLL
Sbjct: 602 KAPIWNTRVGLALGIARGLLYLHEECDSAIIHCDIKPQNILIDEHFNAKISDFGLAKLLL 661
Query: 587 SDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSV-EMELEEESR 645
D +RT+TMIRGTRGYVAPEW KN V+ KVDVYSFGVMLLEIICCRR+V ME EEE +
Sbjct: 662 FDQTRTNTMIRGTRGYVAPEWFKNIAVTVKVDVYSFGVMLLEIICCRRNVLTMEAEEEEK 721
Query: 646 AILTDWAYDCYVEGR-LDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704
ILTDWAYDCY+EGR +DAL+++DE A++D RL KW+ IA WCI E+P RPTM +VM
Sbjct: 722 VILTDWAYDCYIEGRNIDALVENDEEALSDNGRLEKWIKIAFWCINENPEVRPTMGMVML 781
Query: 705 MLEGLLEVPNPP 716
MLEG +EVPNPP
Sbjct: 782 MLEGFVEVPNPP 793
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357482147|ref|XP_003611359.1| Kinase-like protein [Medicago truncatula] gi|355512694|gb|AES94317.1| Kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 770 bits (1989), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 390/737 (52%), Positives = 518/737 (70%), Gaps = 29/737 (3%)
Query: 1 TIIWHA--NEDNHPVLAPRGSTLELTATGLLLKDPGGQAIWDEKPNKIVSDAAMLDTGNF 58
TI+W A +N+ V AP GS ++LT+ GL L G++IW +PN VS M DTGNF
Sbjct: 73 TIVWSAKNTNNNNLVQAPTGSQVQLTSGGLTLTTQQGESIWTAQPNTAVSYGIMHDTGNF 132
Query: 59 VLIASGNHSDYAWQSFKSPTDTILPTQILDLGSVLVSRLTETNLSKGRFELHFSNG--SL 116
VL+ +S W+SFK PTDT+LP Q L+LG + SR +ETN + GRF+L+F + +L
Sbjct: 133 VLV--NKNSSIVWESFKFPTDTLLPNQSLELGGNITSRFSETNYTSGRFQLYFRDDDHNL 190
Query: 117 EFIPVAWPSRFQYKSYYTSNTSSANSSESGHQLVFNESADIYIVKN-NGQIVQLPLWAQ- 174
P+AWP++ +YK YY + +++ SS LVF+ES DIY+ N NG +P Q
Sbjct: 191 MLSPLAWPTQLRYKFYYRIDVNNSASSS----LVFDESGDIYVETNKNGTTRIIPQGTQW 246
Query: 175 ----LSPRADHYFRATLDFDGVFAEYAHSKNSSTNQGWFPTRTLPDSMCTRLATDIGSGI 230
L P+ +Y+RATLD+ GV +Y+H +++ QGW R +PD++C + ++GSG
Sbjct: 247 KNLDLDPKL-YYYRATLDYYGVLTQYSHPRDTKAKQGWTIMRYVPDNICIAIFNEMGSGT 305
Query: 231 CGFNSYCSLQNGRPFCDCPPGYVLVDPNNRFRGCKPNFWQGFGPDDG---SRNAQELYEI 287
CG+NSYCS++N RP C CP GY L+DP+N+F GC+ NF G G ++G + +ELYE
Sbjct: 306 CGYNSYCSMENQRPTCKCPYGYSLIDPSNQFGGCQLNFTLGCGDNNGEGLNVKPEELYEF 365
Query: 288 REFNNVDWPLGDYERLEPSNQTECEISCLQDCSCAVAIYDGNRCWKKKLPLSNGWLRDTE 347
+VDWPL DYE+++P +Q +C+ SCL DC CAVA+++ N CWKK+LP++NG + +
Sbjct: 366 TVLRDVDWPLSDYEKMQPYSQQDCQQSCLHDCMCAVAVFNNNTCWKKRLPIANGRAQ-SG 424
Query: 348 FSKVLFKVRKGDF-PAFSDNSGSKKERGPLFLLGAFLLGGSILCNAFLLLAILIFFKWRR 406
VL K R F P+ + + K +R L G LL S + N+ LL A++ +
Sbjct: 425 GQLVLVKTRVSPFGPSSTTHDLKKDDRVKPILQG--LLISSTVFNSILLAAVVFMTLLKP 482
Query: 407 RKYENNVQDSTTSATNLRFFSYDELKDATDGFKEELGRGSFGIVYKGVLKTASG-NAIAV 465
++ VQ +T TNL FSYD LK+AT GF EELGRGSFGIVYKG LK S N +AV
Sbjct: 483 KRV---VQAATLVETNLCSFSYDALKEATWGFSEELGRGSFGIVYKGELKAGSTCNVVAV 539
Query: 466 KKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFA 525
K+LDRL ++RE+EFK+E+ AIG+T HKNLV+L+GFCDE L+R+LVYEFM NG+LAN++F
Sbjct: 540 KRLDRLVEDREKEFKTELRAIGKTCHKNLVRLVGFCDEGLHRMLVYEFMSNGSLANILFG 599
Query: 526 IPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLL 585
KP WN RV +L IARGLVYLHE C+ PIIHCDIKPQNIL+D YF+ KISDFGL+KLL
Sbjct: 600 ETKPIWNQRVGFALGIARGLVYLHEECDTPIIHCDIKPQNILIDEYFTAKISDFGLAKLL 659
Query: 586 LSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVE-MELEEES 644
L+D SRT+TM+RGTRGYVAPEW KN PV+AKVDVYSFG MLLEI+CCR+SV ME EE
Sbjct: 660 LADQSRTNTMVRGTRGYVAPEWFKNVPVTAKVDVYSFGAMLLEIVCCRKSVVLMESGEEE 719
Query: 645 RAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704
+AILTDWA DCY+EGR+DAL+++D+ A+ D RL KW+ IA+WCIQE P RPTM++VMQ
Sbjct: 720 KAILTDWACDCYMEGRIDALVENDQEALDDIDRLEKWIKIAIWCIQEHPEMRPTMRMVMQ 779
Query: 705 MLEGLLEVPNPPWSSSF 721
MLE +++VP+PP SF
Sbjct: 780 MLEDVVKVPDPPSPFSF 796
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356495581|ref|XP_003516653.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 751 bits (1940), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 388/732 (53%), Positives = 503/732 (68%), Gaps = 24/732 (3%)
Query: 1 TIIWHANEDNHPVLAPRGSTLELTATGLLLKDPGGQAIWDEKPNKIVSDAAMLDTGNFVL 60
T++W A + AP GS +++T GL L P G +IW KP VS+ AML+ GNFVL
Sbjct: 72 TVVWSAKTEYKLATAPTGSHVQITKEGLSLTSPEGDSIWRAKPEATVSEGAMLNNGNFVL 131
Query: 61 IASGNHSDYAWQSFKSPTDTILPTQILDLG--SVLVSRLTETNLSKGRFELHFSNGSLEF 118
+ G+ + WQSF +PTDT+LP Q L LG VL SR T+TN + GRF+L+F + ++
Sbjct: 132 LNGGSEYENMWQSFDNPTDTLLPNQSLQLGLGGVLTSRFTDTNYTTGRFQLYFQDFNVML 191
Query: 119 IPVAWPSRFQYKSYY--TSNTSSANSSESGHQLVFNESADIYIVKNNGQIVQ-LPLWAQL 175
P+A+PS+ +Y YY ++ S N+S +LVF++S +IY+ G + LP
Sbjct: 192 SPLAFPSQLRYNPYYHAINDASVGNAS----RLVFDKSGEIYVETTGGTRNRILPQVDNT 247
Query: 176 SPRADHYFRATLDFDGVFAEYAHSKNSSTNQGWFPTRTLPDSMCTRLATDIGSGICGFNS 235
+Y+RATLDF GVF YAH +N+S W +PD++C + D GSG CG+NS
Sbjct: 248 LDTEVNYYRATLDFSGVFTLYAHPRNTSGQPRWRIMNYVPDNICDAIFNDYGSGSCGYNS 307
Query: 236 YCSLQNGRPFCDCPPGYVLVDPNNRFRGCKPNFWQGFGPDDGSRNAQELYEIREFNNVDW 295
YCS++N RP C+CP GY LVDP+N GC+PNF G D + +ELYE+ N ++
Sbjct: 308 YCSMENDRPTCNCPYGYSLVDPSNESGGCQPNFTLACGAD-VQQPPEELYEMHVAKNFNF 366
Query: 296 PLGDYERLEPSNQTECEISCLQDCSCAVAIYDGNRCWKKKLPLSNGW---LRDTEFSKVL 352
PLGDYE++EP +Q EC+ +CL DC CAVAI + + CW K+LPL NG +RD F +
Sbjct: 367 PLGDYEKVEPYSQQECQQACLHDCMCAVAILEVDTCWMKRLPLGNGRQLPIRDQHFVYIK 426
Query: 353 FKVRKGDFPAFSDNS-----GSKKE-RGPLFLLGAFLLGGSILCNAFLLLAILIFFKWRR 406
++ +P ++ SKKE R +LG+ + S++ N+ LL A+ +FF +
Sbjct: 427 TRLSPDFYPGLANRELPAAPDSKKENRAKSIILGSLI--ASLVVNSILLAAVALFF-LLK 483
Query: 407 RKYENNVQDSTTSATNLRFFSYDELKDATDGFKEELGRGSFGIVYKGVLKTA-SGNAIAV 465
K + +Q S TNL FS++ LK+AT+ F +ELGRGS GIVYKG L+TA S N IAV
Sbjct: 484 PKLKKVIQASALLETNLHSFSFEALKEATEDFCKELGRGSCGIVYKGKLETADSCNVIAV 543
Query: 466 KKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFA 525
K+LDRLAQERE+EF++E+SAIG+T HKNLV+L+GFCD+ +NRLLVYEFM NGTLA+++F
Sbjct: 544 KRLDRLAQEREKEFRTELSAIGKTSHKNLVRLIGFCDQGINRLLVYEFMSNGTLADILFG 603
Query: 526 IPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLL 585
KP WNLRV L IARGLVYLHE C+ IIHCDIKPQNIL+D +F+ KISDFGL+KLL
Sbjct: 604 HSKPIWNLRVGFVLGIARGLVYLHEECDSAIIHCDIKPQNILIDEHFNAKISDFGLAKLL 663
Query: 586 LSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSV-EMELEEES 644
L D SRT+TMIRGTRGYVAPEW KN V+ KVDVYSFGVMLLE ICCRRSV ME EEE
Sbjct: 664 LFDQSRTNTMIRGTRGYVAPEWFKNVAVTVKVDVYSFGVMLLENICCRRSVMTMEPEEEE 723
Query: 645 RAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704
+AILTDWAYDC VEGRL AL+++D A++D RL +W+ IA+WCIQEDP RPTM V Q
Sbjct: 724 KAILTDWAYDCCVEGRLHALVENDREALSDIGRLQRWVKIAIWCIQEDPEMRPTMGKVNQ 783
Query: 705 MLEGLLEVPNPP 716
MLEGL+EV NPP
Sbjct: 784 MLEGLVEVANPP 795
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356495583|ref|XP_003516654.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 734 bits (1896), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 379/734 (51%), Positives = 498/734 (67%), Gaps = 27/734 (3%)
Query: 1 TIIWHANEDNHPVLAPRGSTLELTATGLLLKDPGGQAIWDEKPNKIVSDAAMLDTGNFVL 60
T++W A +DN AP GS L++T GL L +P G IW VS+ AMLD+GNFVL
Sbjct: 76 TVVWSARKDNKLATAPAGSKLQITQEGLSLTNPKGDFIWTASSKDFVSEGAMLDSGNFVL 135
Query: 61 IASGNHSDYAWQSFKSPTDTILPTQILDLGSVLVSRLTETNLSKGRFELHFSNGSLEFIP 120
+ S WQSF+ PTDT+LP Q L LG +L SRLT+TN + GRF+L+F G+L P
Sbjct: 136 L--NGSSANVWQSFEHPTDTLLPNQSLQLGGMLTSRLTDTNYTTGRFQLYFDGGNLLLSP 193
Query: 121 VAWPSRFQYKSYYTSNTSSANSSESGHQLVFNESADIYIVKNNGQIVQ---------LPL 171
+AWPS+ +YKSY + +S N+S +L+FN S DIY+ NG +Q
Sbjct: 194 LAWPSQLRYKSYPVID-ASGNAS----RLLFNISGDIYVETTNGNRIQPQGQKWVSNSSS 248
Query: 172 WAQLSPRADHYFRATLDFDGVFAEYAHSKNSSTNQGWFPTRTLPDSMCTRLATDIGSGIC 231
L+P + ++RATLD GVF +YAH +N++ QGW R +PD +C + GSG C
Sbjct: 249 SLDLNPEMN-FYRATLDPSGVFTQYAHPRNNTARQGWIIMRYVPDDICNIIFDRFGSGSC 307
Query: 232 GFNSYCSLQNGRPFCDCPPGYVLVDPNNRFRGCKPNFWQGFGPDDGSRNAQELYEIREFN 291
G+NSYC ++N RP C+C GY LVDP+N+F GC+PNF G D + ++LY + + +
Sbjct: 308 GYNSYCDMENERPTCNCLDGYSLVDPSNQFGGCQPNFTLACGADVQAP-PEQLYHMLQSS 366
Query: 292 NVDWPLGDYERLEPSNQTECEISCLQDCSCAVAIYDGNRCWKKKLPLSNGWLRDT-EFSK 350
++P DYE+++P Q EC CL DC CAVAI+ + CW K+LPLSNG + D +
Sbjct: 367 RYNFPEADYEKIQPYTQQECLQFCLHDCMCAVAIFGLDTCWMKRLPLSNGRVTDVNDHHF 426
Query: 351 VLFKVRKGD--FPAFSD----NSGSKKERGPLFLLGAFLLGGSILCNAFLLLAILIFFKW 404
V K+R +P ++ + S KE G +L L+G ++ L L+
Sbjct: 427 VYIKIRNSRDFYPGVNEELPPGADSNKEDGAKPILMGSLIGSLVVNGILLATVALLVLLK 486
Query: 405 RRRKYENNVQDSTTSATNLRFFSYDELKDATDGFKEELGRGSFGIVYKGVLKTA-SGNAI 463
+ K V ++ TNL FSY+ LK+AT GF EELGRGS GIVYKG L+ S N I
Sbjct: 487 PKLKVAVPVAAASLLETNLHSFSYEALKEATWGFSEELGRGSCGIVYKGKLEAEDSCNVI 546
Query: 464 AVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLI 523
AVK+LDRLAQERE+EF++E+SAIG+T HKNLV+L+GFCD+ +NRLLVYEFM NGTLA+++
Sbjct: 547 AVKRLDRLAQEREKEFRTELSAIGKTSHKNLVRLIGFCDQGINRLLVYEFMSNGTLADIL 606
Query: 524 FAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSK 583
F KP+WN RV +L IARGLVYLHE C+ PIIHCDIKPQNIL+D +F+ KISDFGL+K
Sbjct: 607 FGHSKPNWNTRVGFALGIARGLVYLHEECDTPIIHCDIKPQNILIDEHFNTKISDFGLAK 666
Query: 584 LLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELE-E 642
LLLSD SRT+TMIRGTRGYVAPEW KN V+ KVDVYSFG+MLLEIICCRRSV ME E
Sbjct: 667 LLLSDQSRTNTMIRGTRGYVAPEWFKNVAVTVKVDVYSFGIMLLEIICCRRSVVMEEPGE 726
Query: 643 ESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVV 702
E +A+L DWA DCY+EGR+DAL++++E A++D+ RL KW+ IA+WCI E+P RPT+ +V
Sbjct: 727 EEKAVLADWACDCYMEGRIDALVENEEEALSDKERLQKWIKIAIWCIHENPEMRPTIGMV 786
Query: 703 MQMLEGLLEVPNPP 716
+QMLEG ++V NPP
Sbjct: 787 VQMLEGFVQVSNPP 800
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224099309|ref|XP_002334494.1| predicted protein [Populus trichocarpa] gi|222872794|gb|EEF09925.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 723 bits (1867), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 374/720 (51%), Positives = 486/720 (67%), Gaps = 23/720 (3%)
Query: 1 TIIWHANEDNHPVLAPRGSTLELTAT-GLLLKDPGGQAIW-DEKPNKIVSDAAMLDTGNF 58
TI+W+AN D AP GS LTA G+ L DP G+ +W E +V+ AM D GNF
Sbjct: 76 TIVWYANGDKP---APTGSKAVLTANRGISLTDPQGRELWRSETIIGVVAYGAMTDKGNF 132
Query: 59 VLIASGNHSDYAWQSFKSPTDTILPTQILDLGSVLVSRLTETNLSKGRFELHFSN-GSLE 117
VL SD W+SFK+P DT+LP+Q+LD G L SR +E N S GRF+L ++ G+LE
Sbjct: 133 VL--QDRVSDKLWESFKNPADTLLPSQVLDRGMTLSSRQSENNFSMGRFQLKLTDDGNLE 190
Query: 118 FIPVAWPSRFQYKSYYTSNTSSA-NSSESGHQLVFNESADIYIVKNNGQIVQLPLWAQLS 176
+ PS + + YY S T +SS G+Q+VFNES +YI++ N QI L S
Sbjct: 191 LATINLPSDYTNEPYYKSGTDGGLDSSSPGYQVVFNESGYLYILRENDQIFSLTQRVTAS 250
Query: 177 PRADHYFRATLDFDGVFAEYAHSKNSSTNQGWFPTRTLPDSMCTRLATDIGSGICGFNSY 236
D Y RATL+FDG+F +Y H K S+ N+ W P + PD++C GSG CGFNS
Sbjct: 251 T-GDFYRRATLNFDGLFTQYYHPKASTGNERWTPIWSQPDNICQASFVSSGSGTCGFNSV 309
Query: 237 CSLQNGR-PFCDCPPGYVLVDPNNRFRGCKPNFWQGFGPDDGSRNAQELYEIREFNNVDW 295
C L + R P C+CP GY L+DP++++ C+PN+ Q D+ + ++LY+ E N DW
Sbjct: 310 CRLNSDRRPICECPGGYSLLDPSDQYGSCRPNYTQSCEEDEVA-PVEDLYDFEELTNTDW 368
Query: 296 PLGDYERLEPSNQTECEISCLQDCSCAVAIY-DGNRCWKKKLPLSNGWLRDTEFSKVLFK 354
P DY L+P + +C SCL DC CAVAI+ G+ CWKKKLPLSNG ++ K L K
Sbjct: 369 PTSDYALLKPFTEEKCRQSCLNDCMCAVAIFRSGDMCWKKKLPLSNGRVQTNLDGKALLK 428
Query: 355 VRKGDF----PAFSDNSGSKKERGPLFLLGAFLLGGSILCNAFLLLAILI--FFKWRRRK 408
VR+ + P F +N KK+R L L+G+ LG S+ N L+ AI + FF +RRR
Sbjct: 429 VRRSNVNPRSPYFPNN---KKDRDGLILVGSVFLGCSVFVNFLLVCAIFMCFFFIYRRRT 485
Query: 409 YENNVQDSTTSATNLRFFSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKL 468
+D TNLR F+Y EL +AT+GFKEELGRG+FG+VYKGV+ S +AVKKL
Sbjct: 486 KRIPQKDGAVE-TNLRCFTYQELAEATEGFKEELGRGAFGVVYKGVVHIGSSIVVAVKKL 544
Query: 469 DRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPK 528
+ +A++R REFK+EV+ IG+THHKNLV+LLGFC+E RLLVYEFM NG+L++ IF K
Sbjct: 545 NNVAEDRVREFKTEVNVIGQTHHKNLVRLLGFCEEGDQRLLVYEFMSNGSLSSFIFQDAK 604
Query: 529 PDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD 588
P W +R++I+ +ARGL+YLHE C+ IIHCDIKPQNILLD Y++ +ISDFGL+KLLL D
Sbjct: 605 PGWKIRIQIAFGVARGLLYLHEECSNQIIHCDIKPQNILLDEYYNARISDFGLAKLLLLD 664
Query: 589 HSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAIL 648
S+THT IRGT+GYVAPEW +N PV+ KVDVYS+GV+LLEIICCRR+V+ + E +AIL
Sbjct: 665 QSQTHTAIRGTKGYVAPEWFRNLPVTVKVDVYSYGVLLLEIICCRRNVDSKATIEEQAIL 724
Query: 649 TDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEG 708
TDWAYDCY EG LDAL+ SD A+ D +L ++LMIA WCIQEDPS RPTM+ V QMLEG
Sbjct: 725 TDWAYDCYREGTLDALVGSDTGALDDIEKLERFLMIAFWCIQEDPSLRPTMRKVTQMLEG 784
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224103119|ref|XP_002334088.1| predicted protein [Populus trichocarpa] gi|222839594|gb|EEE77931.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 695 bits (1794), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 366/735 (49%), Positives = 490/735 (66%), Gaps = 29/735 (3%)
Query: 1 TIIWHANEDNHPVLAPRGSTLELTAT-GLLLKDPGGQAIWDEKPNKIVSD---AAMLDTG 56
TI+W+AN D AP GS LTA G+ L DP G+ +W + I+ D AM DTG
Sbjct: 76 TIVWYANGDKP---APTGSKAVLTANRGISLTDPQGRELW--RSETIIGDVAYGAMTDTG 130
Query: 57 NFVLIASGNHSDYAWQSFKSPTDTILPTQILDLGSVLVSRLTETNLSKGRFELHF-SNGS 115
NFVL SD W+SFK+P DT+LP+Q+LD G L SR +ETN S GRF+L +G+
Sbjct: 131 NFVL--RDRVSDKLWESFKNPADTLLPSQVLDRGMTLSSRQSETNFSMGRFQLKLRDDGN 188
Query: 116 LEFIPVAWPSRFQYKSYYTSNTSSA-NSSESGHQLVFNESADIYIVKNNGQIVQLPLWAQ 174
L + PS + + YY S T +SS G+Q+VFNES +YI++ N QI L
Sbjct: 189 LVLATINLPSDYTNEPYYKSGTDGGLDSSSPGYQVVFNESGYLYILRKNDQIFSLTQRVT 248
Query: 175 LSPRADHYFRATLDFDGVFAEYAHSKNSSTNQGWFPTRTLPDSMCTRLATDIGSGICGFN 234
S D Y RATL+FDGVF +Y H K S+ N+ W P + PD++C + GSG CGFN
Sbjct: 249 AS-TGDFYHRATLNFDGVFTQYYHPKASTGNERWTPIWSQPDNICQASSVSAGSGTCGFN 307
Query: 235 SYCSLQ-NGRPFCDCPPGYVLVDPNNRFRGCKPNFWQGFGPDDGSRNAQELYEIREFNNV 293
S C L +GRP C+CP GY L+DP++++ C+PN+ Q D+ + ++LY+ E N
Sbjct: 308 SVCRLNSDGRPICECPGGYSLLDPSDQYGSCRPNYTQSCEEDEVA-PVEDLYDFEELTNT 366
Query: 294 DWPLGDYERLEPSNQTECEISCLQDCSCAVAIY-DGNRCWKKKLPLSNGWLRDTEFSKVL 352
DWP DY L+P + +C SCL DC CAVAI+ G+ CWKKKLPLSNG ++ +K L
Sbjct: 367 DWPTSDYALLQPFTEEKCRQSCLNDCMCAVAIFRSGDMCWKKKLPLSNGRVQTIVDAKAL 426
Query: 353 FKVRKGDF----PAFSDNSGSKKERGPLFLLGAFLLGGSILCNAFLLLAILI--FFKWRR 406
KVR+ + P F +N KK+R L L+G+ LG S+ N L+ AI + FF +RR
Sbjct: 427 LKVRRSNVNPRSPYFPNN---KKDRDGLILVGSVFLGCSVFVNFLLVCAICMGFFFIYRR 483
Query: 407 RKYENNVQDSTTSATNLRFFSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVK 466
R +D TNLR F+Y EL +AT+GFKEELGRG+FG+VY+GV+ S +AVK
Sbjct: 484 RTKRIPQKDGAVE-TNLRCFTYQELAEATEGFKEELGRGAFGVVYRGVVHIGSSIVVAVK 542
Query: 467 KLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAI 526
KL+ +A++R REFK+EV+ IG+THHKNLV+LLGFC+E RLLVYEFM NG+L++ IF
Sbjct: 543 KLNNVAEDRVREFKTEVNVIGQTHHKNLVRLLGFCEEGDQRLLVYEFMSNGSLSSFIFQD 602
Query: 527 PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLL 586
KP W +R++I+ +ARGL+YLHE + IIHCDIKPQNILLD + +ISDFGL+KLL
Sbjct: 603 AKPGWKIRIQIAFGVARGLLYLHE--DSQIIHCDIKPQNILLDESLNARISDFGLAKLLK 660
Query: 587 SDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRA 646
+D ++T T IRGT+GYVAPEW KN PV+ KVD YSFG++LLE++CCR++ E+ +E +
Sbjct: 661 TDQTKTTTAIRGTKGYVAPEWFKNLPVTTKVDTYSFGILLLELVCCRKNFEINAMQEHQI 720
Query: 647 ILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQML 706
+L DWA DC EG+L+ L++ DE AM D R+ +++M+A+WCIQEDPS RP MK V+QML
Sbjct: 721 VLADWACDCLKEGKLNLLVEEDEEAMEDMKRVERFVMVAIWCIQEDPSLRPGMKKVVQML 780
Query: 707 EGLLEVPNPPWSSSF 721
EG ++V PP SSF
Sbjct: 781 EGGVQVSVPPDPSSF 795
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225436281|ref|XP_002269411.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 687 bits (1774), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 362/724 (50%), Positives = 481/724 (66%), Gaps = 21/724 (2%)
Query: 1 TIIWHANEDNHPVLAPRGSTLELTATG-LLLKDPGGQAIW--DEKPNKIVSDAAMLDTGN 57
T++W+AN N AP GS +ELT+ G +L DP G IW D N I++ A MLD GN
Sbjct: 81 TLVWYANGGNP---APEGSKVELTSEGQFILSDPKGNKIWEPDSSINGIIAYALMLDNGN 137
Query: 58 FVLIASGNHSDYAWQSFKSPTDTILPTQILDLGSVLVSRLTETNLSKGRFELHF-SNGSL 116
FVL +S YAW+SFKSP+DTILP QILD+G L SR E N SKGRF+L +G+
Sbjct: 138 FVLTNGSGNSGYAWESFKSPSDTILPGQILDIGGTLSSRRAEGNYSKGRFQLRLIPDGNF 197
Query: 117 EFIPVAWPSRFQYKSYYTSNTSSANSSESGHQLVFNESADIYIVKNNGQIVQLPLWAQLS 176
+ + +YY SNT S + +GHQ++FNES +Y+V NG IV L +S
Sbjct: 198 VLNTLDVLTDTPTDAYYWSNTYSEDRKNAGHQVIFNESGSLYVVLWNGNIVNLRSENIVS 257
Query: 177 PRADHYFRATLDFDGVFAEYAHSKNSSTNQGWFPTRTLPDSMCTRLATDIGSGICGFNSY 236
R D+Y R TLDFDG+F Y K S+ N W P+ ++P +C+ + GSGICGFN++
Sbjct: 258 TR-DNYHRGTLDFDGIFTIYTRPK-STANGSWVPSWSIPKDICSENWGESGSGICGFNTH 315
Query: 237 CSL-QNGRPFCDCPPGYVLVDPNNRFRGCKPNFWQGFGPDDGSRNAQELYEIREFNNVDW 295
C L NGRP C+C PG+ +DP+N F GCK + Q P G N ++YE E N+ W
Sbjct: 316 CILDSNGRPICECLPGFSYIDPSNNFSGCKQDRPQKCEP--GGSNPGDIYEKGELINIFW 373
Query: 296 P-LGDYERLEP-SNQTECEISCLQDCSCAVAIYDGNRCWKKKLPLSNGWLRDTEFSKVLF 353
P ++E L P N+ +C SCL DC+C VA+ G+ C KK+LPL+NG + + K
Sbjct: 374 PNSSNFEELRPLENEEDCWKSCLYDCNCIVAVPIGSACEKKRLPLTNGRVDGSTNRKAFI 433
Query: 354 KVRKGDF----PAFSDNSGSKKERGPLFLLGAFLLGGSILCNAFLLLAILIFFKWRRRKY 409
K+ K D P + K + L L+G+FLLGGS+ N FLL A + + R +
Sbjct: 434 KLPKPDASSCEPPIQNPEEKSKGQATLILVGSFLLGGSVFLN-FLLAAAISLVRLRSGQE 492
Query: 410 ENNVQ-DSTTSATNLRFFSYDELKDATDGFKEELGRGSFGIVYKGVLKTA-SGNAIAVKK 467
+ +S+ N+R F+Y EL++ATDGF+E LGRG+FG VYKGVL ++ S +AVK
Sbjct: 493 RQKITGESSILERNIRSFTYKELEEATDGFREVLGRGAFGTVYKGVLSSSNSRTHVAVKN 552
Query: 468 LDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIP 527
LDRLAQERE EFK+E S I THHKNLV+LLGFCDE ++LLVYEFM NGTLA+ +F
Sbjct: 553 LDRLAQERENEFKTEASIIAMTHHKNLVRLLGFCDEGPHKLLVYEFMSNGTLASFLFGDS 612
Query: 528 KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS 587
+PDW R+ ++ IARG++YLHE C+ IIHCDIKPQNILLD F+ +ISDFGL+KLL+S
Sbjct: 613 RPDWKKRMGLAFGIARGIMYLHEECSTQIIHCDIKPQNILLDDSFTARISDFGLAKLLMS 672
Query: 588 DHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAI 647
D SRT T IRGT+GYVAPEW +N P++AKVDVYS+GVMLLEII CR+S++++ +E AI
Sbjct: 673 DQSRTLTAIRGTKGYVAPEWFRNKPIAAKVDVYSYGVMLLEIIGCRKSLDLQPGKEEEAI 732
Query: 648 LTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLE 707
LTDWAYDCY GR++ L+++DE A + + +M+A+WCIQEDP+ RP+M+ V+QMLE
Sbjct: 733 LTDWAYDCYQGGRVEKLVENDEEARNYMRTVERLVMVAIWCIQEDPALRPSMRNVIQMLE 792
Query: 708 GLLE 711
G+ E
Sbjct: 793 GVAE 796
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 728 | ||||||
| TAIR|locus:2026155 | 829 | AT1G34300 [Arabidopsis thalian | 0.392 | 0.344 | 0.456 | 6.1e-92 | |
| TAIR|locus:2059103 | 828 | AT2G19130 [Arabidopsis thalian | 0.645 | 0.567 | 0.370 | 2.5e-81 | |
| TAIR|locus:2116525 | 821 | SD2-5 "S-domain-2 5" [Arabidop | 0.417 | 0.370 | 0.441 | 7e-76 | |
| TAIR|locus:2182603 | 872 | AT5G35370 [Arabidopsis thalian | 0.298 | 0.248 | 0.484 | 1.4e-73 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.417 | 0.358 | 0.388 | 7.6e-67 | |
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.399 | 0.371 | 0.399 | 8.2e-65 | |
| TAIR|locus:2197734 | 814 | AT1G61370 [Arabidopsis thalian | 0.416 | 0.372 | 0.373 | 1.2e-61 | |
| TAIR|locus:2197649 | 821 | AT1G61360 [Arabidopsis thalian | 0.414 | 0.367 | 0.365 | 3.1e-61 | |
| TAIR|locus:2061466 | 634 | AT2G23950 [Arabidopsis thalian | 0.391 | 0.449 | 0.420 | 3.3e-59 | |
| TAIR|locus:2146102 | 638 | NIK1 "NSP-interacting kinase 1 | 0.413 | 0.471 | 0.407 | 3.8e-58 |
| TAIR|locus:2026155 AT1G34300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 690 (248.0 bits), Expect = 6.1e-92, Sum P(3) = 6.1e-92
Identities = 135/296 (45%), Positives = 198/296 (66%)
Query: 426 FSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSA 485
F+Y EL+ T FKE+LG G FG VY+GVL + +AVK+L+ + Q E++F+ EV+
Sbjct: 474 FTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRT--VVAVKQLEGIEQG-EKQFRMEVAT 530
Query: 486 IGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPD---WNLRVRISLEIA 542
I THH NLV+L+GFC + +RLLVYEFM NG+L N +F W R I+L A
Sbjct: 531 ISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKFLTWEYRFNIALGTA 590
Query: 543 RGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH-TMIRGTRG 601
+G+ YLHE C I+HCDIKP+NIL+D F+ K+SDFGL+KLL +R + + +RGTRG
Sbjct: 591 KGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRYNMSSVRGTRG 650
Query: 602 YVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRL 661
Y+APEWL N P+++K DVYS+G++LLE++ +R+ ++ E+ + + WAY+ + +G
Sbjct: 651 YLAPEWLANLPITSKSDVYSYGMVLLELVSGKRNFDVS-EKTNHKKFSIWAYEEFEKGNT 709
Query: 662 DALIDS--DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNP 715
A++D+ E D ++ + + + WCIQE P +RPTM V+QMLEG+ E+ NP
Sbjct: 710 KAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEGITEIKNP 765
|
|
| TAIR|locus:2059103 AT2G19130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 728 (261.3 bits), Expect = 2.5e-81, Sum P(2) = 2.5e-81
Identities = 191/515 (37%), Positives = 264/515 (51%)
Query: 231 CGFNSYCSLQNGRPFCDCPPGYVLVDPNNRFRGCKPNFWQGFGPDDGSRNAQELY----E 286
CG CS PFC CP G FR W G EL +
Sbjct: 296 CGSFGICS-DKSEPFCRCPQG---------FRPMSQKDWDLKDYSAGCVRKTELQCSRGD 345
Query: 287 IREFNNV-DWPLGDY-ERLEPSNQTECEISCLQDCSCAVAIYD--GNRC--WKKKLPLSN 340
I +F + + L D E L ++ + C +C DCSC YD ++C W K + L+
Sbjct: 346 INQFFRLPNMKLADNSEVLTRTSLSICASACQGDCSCKAYAYDEGSSKCLVWSKDV-LNL 404
Query: 341 GWLRDTEFSKVLFKVR--KGDFPAFSDNSGSKKERXXXXXXXXXXXXXSILCNXXXXXXX 398
L D +F +R D P SG + +L
Sbjct: 405 QQLEDENSEGNIFYLRLAASDVPNVGA-SGKSNNKGLIFGAVLGSLGVIVLV----LLVV 459
Query: 399 XXXXKWRRRKYENNVQ-DSTTSATNLRFFSYDELKDATDGFKEELGRGSFGIVYKGVLKT 457
++RRRK + D T SA FSY EL++AT F ++LG G FG V+KG L
Sbjct: 460 ILILRYRRRKRMRGEKGDGTLSA-----FSYRELQNATKNFSDKLGGGGFGSVFKGALPD 514
Query: 458 ASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNG 517
+S IAVK+L+ ++Q E++F++EV IG H NLV+L GFC E +LLVY++M NG
Sbjct: 515 SSD--IAVKRLEGISQG-EKQFRTEVVTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNG 571
Query: 518 TLANLIFAIPKPD-----WNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYF 572
+L + +F + W LR +I+L ARGL YLH+ C IIHCDIKP+NILLD F
Sbjct: 572 SLDSHLFLNQVEEKIVLGWKLRFQIALGTARGLAYLHDECRDCIIHCDIKPENILLDSQF 631
Query: 573 SPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICC 632
PK++DFGL+KL+ D SR T +RGTRGY+APEW+ ++AK DVYS+G+ML E++
Sbjct: 632 CPKVADFGLAKLVGRDFSRVLTTMRGTRGYLAPEWISGVAITAKADVYSYGMMLFELVSG 691
Query: 633 RRSVEMELEEESRAILTDWAYDCYV-EGRLDALIDSD-EAAMADRSRLHKWLMIAMWCIQ 690
RR+ E E+ R WA +G + +L+D E D + + +A WCIQ
Sbjct: 692 RRNTEQSENEKVR-FFPSWAATILTKDGDIRSLVDPRLEGDAVDIEEVTRACKVACWCIQ 750
Query: 691 EDPSKRPTMKVVMQMLEGLLEVPNPPWSSSFSIAV 725
++ S RP M V+Q+LEG+LEV PP+ S V
Sbjct: 751 DEESHRPAMSQVVQILEGVLEVNPPPFPRSIQALV 785
|
|
| TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 662 (238.1 bits), Expect = 7.0e-76, Sum P(3) = 7.0e-76
Identities = 140/317 (44%), Positives = 201/317 (63%)
Query: 410 ENNVQDSTTSATNLRFFSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLD 469
E+N ++ S +RF +Y +L+ AT+ F +LG+G FG VY+G L G+ +AVKKL+
Sbjct: 469 EDNFLENL-SGMPIRF-AYKDLQSATNNFSVKLGQGGFGSVYEGTLP--DGSRLAVKKLE 524
Query: 470 RLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP 529
+ Q + +EF++EVS IG HH +LV+L GFC E +RLL YEF+ G+L IF
Sbjct: 525 GIGQGK-KEFRAEVSIIGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDG 583
Query: 530 D----WNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLL 585
D W+ R I+L A+GL YLHE C+ I+HCDIKP+NILLD F+ K+SDFGL+KL+
Sbjct: 584 DVLLDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLM 643
Query: 586 LSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESR 645
+ S T +RGTRGY+APEW+ N +S K DVYS+G++LLE+I R++ + E +
Sbjct: 644 TREQSHVFTTMRGTRGYLAPEWITNYAISEKSDVYSYGMVLLELIGGRKNYDPS-ETSEK 702
Query: 646 AILTDWAYDCYVEGRLDALIDSD--EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVM 703
+A+ EG+L ++D + D R+ + + A+WCIQED RP+M V+
Sbjct: 703 CHFPSFAFKKMEEGKLMDIVDGKMKNVDVTDE-RVQRAMKTALWCIQEDMQTRPSMSKVV 761
Query: 704 QMLEGLLEVPNPPWSSS 720
QMLEG+ V PP SS+
Sbjct: 762 QMLEGVFPVVQPPSSST 778
|
|
| TAIR|locus:2182603 AT5G35370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 542 (195.9 bits), Expect = 1.4e-73, Sum P(4) = 1.4e-73
Identities = 107/221 (48%), Positives = 143/221 (64%)
Query: 426 FSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSA 485
F ++EL+ AT+ FK ++G G FG VYKG L + IAVKK+ +EF +E++
Sbjct: 505 FEFEELEQATENFKMQIGSGGFGSVYKGTLPDET--LIAVKKITNHGLHGRQEFCTEIAI 562
Query: 486 IGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP--DWNLRVRISLEIAR 543
IG H NLV+L GFC LLVYE+M +G+L +F+ P +W R I+L AR
Sbjct: 563 IGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLFSGNGPVLEWQERFDIALGTAR 622
Query: 544 GLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYV 603
GL YLH GC+ IIHCD+KP+NILL +F PKISDFGLSKLL + S T +RGTRGY+
Sbjct: 623 GLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLLNQEESSLFTTMRGTRGYL 682
Query: 604 APEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEES 644
APEW+ NA +S K DVYS+G++LLE++ R++ S
Sbjct: 683 APEWITNAAISEKADVYSYGMVLLELVSGRKNCSFRSRSNS 723
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 526 (190.2 bits), Expect = 7.6e-67, Sum P(3) = 7.6e-67
Identities = 123/317 (38%), Positives = 180/317 (56%)
Query: 413 VQDSTTSATNLRFFSYDELKDATDGF-KE-ELGRGSFGIVYKGVLKTASGNAIAVKKLDR 470
++ + + L FS + + AT+ F KE ELGRG FG VYKGVL+ G IAVK+L
Sbjct: 504 IEGKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLE--DGREIAVKRLSG 561
Query: 471 LAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP- 529
+ + EFK+E+ I + H+NLV+LLG C E ++LVYE+M N +L +F K
Sbjct: 562 KSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQA 621
Query: 530 --DWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS 587
DW LR I IARGL+YLH + IIH D+K N+LLD +PKISDFG++++
Sbjct: 622 LIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGG 681
Query: 588 DHSRTHTM-IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRA 646
+ + +T+ + GT GY++PE+ S K DVYSFGV+LLEI+ +R+ + E
Sbjct: 682 NQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHGSL 741
Query: 647 ILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQML 706
I +A+ Y GR + L+D + + + +AM C+Q+ ++RP M V+ ML
Sbjct: 742 I--GYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLML 799
Query: 707 EG---LLEVPNPPWSSS 720
E L P P +S
Sbjct: 800 ESDTATLAAPRQPTFTS 816
|
|
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 519 (187.8 bits), Expect = 8.2e-65, Sum P(3) = 8.2e-65
Identities = 121/303 (39%), Positives = 178/303 (58%)
Query: 423 LRFFSYDELKDATDGFK--EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFK 480
L F D + +AT GF +LG+G FG VYKG L A G +AVK+L R +++ EFK
Sbjct: 450 LPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTL--ACGQEVAVKRLSRTSRQGVEEFK 507
Query: 481 SEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP---DWNLRVRI 537
+E+ I + H+NLV++LG+C + R+L+YE+ N +L + IF + DW RV I
Sbjct: 508 NEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIFDKERRRELDWPKRVEI 567
Query: 538 SLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM-I 596
IARG++YLHE + IIH D+K N+LLD + KISDFGL++ L D + +T +
Sbjct: 568 IKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGLARTLGGDETEANTTRV 627
Query: 597 RGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCY 656
GT GY++PE+ + S K DV+SFGV++LEI+ RR+ EE + L A+ +
Sbjct: 628 VGTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSGRRNRGFR-NEEHKLNLLGHAWRQF 686
Query: 657 VEGRLDALIDSD-EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQML--EGLLEVP 713
+E + +ID + D S + + + I + C+Q+DP RP M VV+ ML E LL P
Sbjct: 687 LEDKAYEIIDEAVNESCTDISEVLRVIHIGLLCVQQDPKDRPNMSVVVLMLSSEMLLLDP 746
Query: 714 NPP 716
P
Sbjct: 747 RQP 749
|
|
| TAIR|locus:2197734 AT1G61370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 510 (184.6 bits), Expect = 1.2e-61, Sum P(3) = 1.2e-61
Identities = 117/313 (37%), Positives = 175/313 (55%)
Query: 422 NLRFFSYDELKDATDGFKEE--LGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREF 479
++ FF + T+ F E LG+G FG VYKG L+ G IA+K+L + + EF
Sbjct: 485 DVNFFDMQTILTITNNFSMENKLGQGGFGPVYKGNLQ--DGKEIAIKRLSSTSGQGLEEF 542
Query: 480 KSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP---DWNLRVR 536
+E+ I + H+NLV+LLG C E +LL+YEFM N +L IF K DW R
Sbjct: 543 MNEIILISKLQHRNLVRLLGCCIEGEEKLLIYEFMANKSLNTFIFDSTKKLELDWPKRFE 602
Query: 537 ISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM- 595
I IA GL+YLH + ++H D+K NILLD +PKISDFGL+++ + +T
Sbjct: 603 IIQGIACGLLYLHRDSCLRVVHRDMKVSNILLDEEMNPKISDFGLARMFQGTQHQANTRR 662
Query: 596 IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDC 655
+ GT GY++PE+ S K D+Y+FGV+LLEII +R + EE + +L ++A+D
Sbjct: 663 VVGTLGYMSPEYAWTGMFSEKSDIYAFGVLLLEIITGKRISSFTIGEEGKTLL-EFAWDS 721
Query: 656 YVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNP 715
+ E L+D D ++ S + + + I + CIQ+ RP + VM ML +++P P
Sbjct: 722 WCESGGSDLLDQDISSSGSESEVARCVQIGLLCIQQQAGDRPNIAQVMSMLTTTMDLPKP 781
Query: 716 PWSSSFSIAVTES 728
F++ V ES
Sbjct: 782 K-QPVFAMQVQES 793
|
|
| TAIR|locus:2197649 AT1G61360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 492 (178.3 bits), Expect = 3.1e-61, Sum P(3) = 3.1e-61
Identities = 115/315 (36%), Positives = 179/315 (56%)
Query: 409 YENNVQDSTTSATNLRFFSYDELKDATDGFK--EELGRGSFGIVYKGVLKTASGNAIAVK 466
+++++Q S N FF +L+ AT+ F +LG+G FG VYKG L+ G IAVK
Sbjct: 471 WKSDLQSQDVSGLN--FFEIHDLQTATNNFSVLNKLGQGGFGTVYKGKLQ--DGKEIAVK 526
Query: 467 KLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAI 526
+L + + EF +E+ I + H+NL++LLG C + +LLVYE+M N +L IF +
Sbjct: 527 RLTSSSVQGTEEFMNEIKLISKLQHRNLLRLLGCCIDGEEKLLVYEYMVNKSLDIFIFDL 586
Query: 527 PKP---DWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSK 583
K DW R I IARGL+YLH + ++H D+K NILLD +PKISDFGL++
Sbjct: 587 KKKLEIDWATRFNIIQGIARGLLYLHRDSFLRVVHRDLKVSNILLDEKMNPKISDFGLAR 646
Query: 584 LLLSDHSRTHT-MIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEE 642
L + + T + GT GY++PE+ S K D+YSFGV++LEII + +
Sbjct: 647 LFHGNQHQDSTGSVVGTLGYMSPEYAWTGTFSEKSDIYSFGVLMLEIITGKEISSFSYGK 706
Query: 643 ESRAILTDWAYDCYVE-GRLDALI-DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMK 700
+++ +L+ +A+D + E G ++ L D D++ + + + I + C+Q RP +K
Sbjct: 707 DNKNLLS-YAWDSWSENGGVNLLDQDLDDSDSVNSVEAGRCVHIGLLCVQHQAIDRPNIK 765
Query: 701 VVMQMLEGLLEVPNP 715
VM ML ++P P
Sbjct: 766 QVMSMLTSTTDLPKP 780
|
|
| TAIR|locus:2061466 AT2G23950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 587 (211.7 bits), Expect = 3.3e-59, Sum P(2) = 3.3e-59
Identities = 122/290 (42%), Positives = 175/290 (60%)
Query: 422 NLRFFSYDELKDATDGF--KEELGRGSFGIVYKGVLKTASGNAIAVKKL-DRLAQERERE 478
NLR F++ EL ATDGF K LG G FG VY+G K G +AVK+L D +
Sbjct: 283 NLRSFTFRELHVATDGFSSKSILGAGGFGNVYRG--KFGDGTVVAVKRLKDVNGTSGNSQ 340
Query: 479 FKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRIS 538
F++E+ I H+NL++L+G+C + RLLVY +M NG++A+ + A P DWN R +I+
Sbjct: 341 FRTELEMISLAVHRNLLRLIGYCASSSERLLVYPYMSNGSVASRLKAKPALDWNTRKKIA 400
Query: 539 LEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRG 598
+ ARGL YLHE C+ IIH D+K NILLD YF + DFGL+KLL + S T +RG
Sbjct: 401 IGAARGLFYLHEQCDPKIIHRDVKAANILLDEYFEAVVGDFGLAKLLNHEDSHVTTAVRG 460
Query: 599 TRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVE 658
T G++APE+L S K DV+ FG++LLE+I R++E + + +W + E
Sbjct: 461 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSVSQKGAMLEWVRKLHKE 520
Query: 659 GRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEG 708
+++ L+D + DR + + L +A+ C Q P+ RP M V+QMLEG
Sbjct: 521 MKVEELVDRELGTTYDRIEVGEMLQVALLCTQFLPAHRPKMSEVVQMLEG 570
|
|
| TAIR|locus:2146102 NIK1 "NSP-interacting kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 578 (208.5 bits), Expect = 3.8e-58, Sum P(2) = 3.8e-58
Identities = 130/319 (40%), Positives = 189/319 (59%)
Query: 404 WRRRKYEN---NVQDST----TSATNLRFFSYDELKDATDGF--KEELGRGSFGIVYKGV 454
WR+R +N +V+D S NLR F + EL+ AT+ F K LG+G +G VYKG+
Sbjct: 271 WRQRHNQNTFFDVKDGNHHEEVSLGNLRRFGFRELQIATNNFSSKNLLGKGGYGNVYKGI 330
Query: 455 LKTASGNAIAVKKL-DRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513
L +AVK+L D A E +F++EV I H+NL++L GFC +LLVY +
Sbjct: 331 L--GDSTVVAVKRLKDGGALGGEIQFQTEVEMISLAVHRNLLRLYGFCITQTEKLLVYPY 388
Query: 514 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFS 573
M NG++A+ + A P DW++R RI++ ARGLVYLHE C+ IIH D+K NILLD Y
Sbjct: 389 MSNGSVASRMKAKPVLDWSIRKRIAIGAARGLVYLHEQCDPKIIHRDVKAANILLDDYCE 448
Query: 574 PKISDFGLSKLLLSDHSRTH--TMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC 631
+ DFGL+KLL DH +H T +RGT G++APE+L S K DV+ FG++LLE++
Sbjct: 449 AVVGDFGLAKLL--DHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELVT 506
Query: 632 CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSD--EAAMADRSRLHKWLMIAMWCI 689
+R+ E + ++ DW + E +L+ L+D + + D L + + +A+ C
Sbjct: 507 GQRAFEFGKAANQKGVMLDWVKKIHQEKKLELLVDKELLKKKSYDEIELDEMVRVALLCT 566
Query: 690 QEDPSKRPTMKVVMQMLEG 708
Q P RP M V++MLEG
Sbjct: 567 QYLPGHRPKMSEVVRMLEG 585
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q39202 | RLK1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4285 | 0.9697 | 0.8485 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pg.C_scaffold_1505000001 | hypothetical protein (801 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 728 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-52 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-50 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-50 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-43 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-42 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-41 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-37 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-36 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-33 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-29 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-27 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-27 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-26 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-26 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-25 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-24 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-23 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-23 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-23 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-23 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-23 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 9e-23 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-22 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-22 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-22 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-22 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-22 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-21 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-21 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-21 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 9e-21 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 9e-21 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-20 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-20 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-20 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-20 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-19 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-19 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-19 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-19 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-19 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 8e-19 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 9e-19 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-18 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-18 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-18 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-18 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 4e-18 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-18 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-18 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-18 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-18 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-17 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-17 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-17 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-17 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-17 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-17 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-17 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-17 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-17 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 9e-17 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 9e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-16 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-16 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-16 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-16 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-16 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-16 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-15 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-15 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-15 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-15 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-15 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-15 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-15 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-14 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-14 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-13 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-13 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 7e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-13 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 8e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-12 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-12 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-12 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-12 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-12 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-12 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 8e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-11 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-11 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-11 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-11 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 9e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-10 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-10 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 7e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 9e-10 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-09 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-08 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-08 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 8e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-07 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-07 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-07 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 2e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-07 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 4e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 8e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-06 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 8e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 8e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 0.001 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.002 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 0.002 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.003 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.003 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 178 bits (455), Expect = 7e-52
Identities = 84/269 (31%), Positives = 121/269 (44%), Gaps = 58/269 (21%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDR-LAQEREREFKSEVSAIGRTHHKNLVQLLGF 500
LG G FG VY K +G +A+K + + + E E+ + + +H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKK-TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 501 CDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRVRISLEIARGLVYLHEGCNVPIIHC 559
++ + LV E+ G+L +L+ + +RI L+I GL YLH IIH
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHS---NGIIHR 116
Query: 560 DIKPQNILLDH-YFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPE-WLKNAPVSAKV 617
D+KP+NILLD K++DFGLSKLL SD S T I GT Y+APE L S K
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT-IVGTPAYMAPEVLLGKGYYSEKS 175
Query: 618 DVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSR 677
D++S GV+L E L L D
Sbjct: 176 DIWSLGVILYE--------------------------------LPELKD----------- 192
Query: 678 LHKWLMIAMWCIQEDPSKRPTMKVVMQML 706
+ +Q+DP KRP+ K +++ L
Sbjct: 193 ------LIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 176 bits (450), Expect = 1e-50
Identities = 75/271 (27%), Positives = 121/271 (44%), Gaps = 25/271 (9%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQERERE-FKSEVSAIGRTHHKNLVQ 496
E+LG GSFG VY K +G +A+K + + +++RE E+ + + H N+V+
Sbjct: 3 ILEKLGEGSFGKVYLARDKK-TGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVR 61
Query: 497 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPI 556
L ++ LV E+ G L +L+ + + +I L YLH I
Sbjct: 62 LYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG---I 118
Query: 557 IHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAK 616
+H D+KP+NILLD K++DFGL++ L + T + GT Y+APE L
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLAR-QLDPGEKLTTFV-GTPEYMAPEVLLGKGYGKA 176
Query: 617 VDVYSFGVMLLEIICCRR--SVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMAD 674
VD++S GV+L E++ + + +L E + I S EA
Sbjct: 177 VDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGK-----PKPPFPPPEWDISPEAKD-- 229
Query: 675 RSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705
L+ + +DP KR T + +Q
Sbjct: 230 -------LI--RKLLVKDPEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 9e-50
Identities = 89/270 (32%), Positives = 137/270 (50%), Gaps = 19/270 (7%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKNLV 495
+LG GSFG VYK K +G +AVK L + ++ ++++ + E+ + R H N+V
Sbjct: 3 LLRKLGSGSFGTVYKAKHK-GTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIV 61
Query: 496 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVP 555
+L+ ++ + LV E+ G L + + + +I+L+I RGL YLH
Sbjct: 62 RLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHS---NG 118
Query: 556 IIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNA-PVS 614
IIH D+KP+NILLD KI+DFGL+K LL S T GT Y+APE L
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT-FVGTPWYMAPEVLLGGNGYG 177
Query: 615 AKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMAD 674
KVDV+S GV+L E++ + E + + + L ++ DE +
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQL---------IRRILGPPLEFDEPKWSS 228
Query: 675 RSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704
S K L+ C+ +DPSKRPT + ++Q
Sbjct: 229 GSEEAKDLIK--KCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 1e-43
Identities = 88/281 (31%), Positives = 130/281 (46%), Gaps = 37/281 (13%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNA---IAVKKLDRLAQERER-EFKSEVSAIGRTHHKN 493
++LG G+FG VYKG LK +AVK L A E ER EF E S + + H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 494 LVQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIARGLVYLHEGC 552
+V+LLG C + +V E+M G L + L K ++++L+IA+G+ YL
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLES-- 120
Query: 553 NVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD---HSRTHTM--IRGTRGYVAPEW 607
+H D+ +N L+ KISDFGLS+ + D R I+ ++APE
Sbjct: 121 -KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK----WMAPES 175
Query: 608 LKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMELEEESRAILTDWAYDCYVEGRLDALI 665
LK+ ++K DV+SFGV+L EI M EE + RL
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDG--------YRLPRPE 227
Query: 666 DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQML 706
+ + L++ LM + C DP RPT +++ L
Sbjct: 228 NCPD-------ELYE-LM--LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 7e-42
Identities = 88/278 (31%), Positives = 129/278 (46%), Gaps = 32/278 (11%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNA---IAVKKLDRLAQERER-EFKSEVSAIGRTHHKN 493
++LG G+FG VYKG LK G +AVK L A E++ EF E + + H N
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 494 LVQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIARGLVYLHEGC 552
+V+LLG C E +V E+M G L + L PK + + +L+IARG+ YL
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLES-- 120
Query: 553 NVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYV---APEWLK 609
IH D+ +N L+ KISDFGLS+ L D RG + + APE LK
Sbjct: 121 -KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY---YRKRGGKLPIRWMAPESLK 176
Query: 610 NAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDW-AYDCYVEGRLDALIDSD 668
++K DV+SFGV+L EI L E+ +++ + G +
Sbjct: 177 EGKFTSKSDVWSFGVLLWEI--------FTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNC 228
Query: 669 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQML 706
+ D + + C EDP RPT ++++L
Sbjct: 229 PPELYD---------LMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 151 bits (385), Expect = 1e-41
Identities = 85/282 (30%), Positives = 129/282 (45%), Gaps = 39/282 (13%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNA---IAVKKLDRLAQERER-EFKSEVSAIGRTHHKN 493
++LG G+FG VYKG LK +AVK L A E++ EF E + + H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 494 LVQLLGFCDEALNRLLVYEFMGNGTL-----ANLIFAIPKPDWNLRVRISLEIARGLVYL 548
+V+LLG C E ++V E+M G L N + D + +L+IARG+ YL
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSD---LLSFALQIARGMEYL 119
Query: 549 HEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYV---AP 605
IH D+ +N L+ KISDFGLS+ L D + ++G + + AP
Sbjct: 120 ES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD---DYYKVKGGKLPIRWMAP 173
Query: 606 EWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDW-AYDCYVEGRLDAL 664
E LK ++K DV+SFGV+L EI L EE +++ + +G
Sbjct: 174 ESLKEGKFTSKSDVWSFGVLLWEI--------FTLGEEPYPGMSNAEVLEYLKKGYRLPK 225
Query: 665 IDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQML 706
+ + + + C EDP RPT ++++L
Sbjct: 226 PPNCPPELYK---------LMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 5e-37
Identities = 63/197 (31%), Positives = 101/197 (51%), Gaps = 9/197 (4%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKK--LDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
E LGRGSFG VY + K +G +AVK L ++E + E+ + H N+V+
Sbjct: 6 ELLGRGSFGSVYLALDKD-TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRY 64
Query: 498 LGFC-DEALNRLLVY-EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVP 555
G DE N L ++ E++ G+L++L+ K + + + +I GL YLH
Sbjct: 65 YGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG--- 121
Query: 556 IIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM-IRGTRGYVAPEWLKNAPVS 614
I+H DIK NIL+D K++DFG +K L + T +RGT ++APE ++
Sbjct: 122 IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYG 181
Query: 615 AKVDVYSFGVMLLEIIC 631
D++S G ++E+
Sbjct: 182 RAADIWSLGCTVIEMAT 198
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 91/288 (31%), Positives = 132/288 (45%), Gaps = 46/288 (15%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAI--AVKKLDRLAQERER-EFKSEVSAIGRTHHKNLVQ 496
++LG G+FG VYKG LK G AVK L A E ER +F E + + H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 497 LLGFCDEALNRLLVYEFMGNGTL------ANLIFAIPKPD---WNLRVRISLEIARGLVY 547
LLG C E LV E+M G L + +F P+ + +++IA+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 548 LHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD---HSRTHTM--IRGTRGY 602
L +H D+ +N L+ KISDFGLS+ + D +T IR +
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----W 173
Query: 603 VAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMELEEESRAILTDWAYDCYVEGR 660
+APE LK+ ++K DV+SFGV+L EI + + EE + R
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG--------YR 225
Query: 661 LDALID-SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLE 707
L DE + + LM + C Q DP RPT +++ LE
Sbjct: 226 LPKPEYCPDE--LYE-------LM--LSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 61/191 (31%), Positives = 102/191 (53%), Gaps = 7/191 (3%)
Query: 439 KEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLL 498
E++G+G FG VYK +G +A+K + ++E++ + +E+ + + H N+V+
Sbjct: 5 LEKIGKGGFGEVYK-ARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYY 63
Query: 499 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR-ISLEIARGLVYLHEGCNVPII 557
G + +V EF G+L +L+ + + ++ + E+ +GL YLH + II
Sbjct: 64 GSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGII 120
Query: 558 HCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKV 617
H DIK NILL K+ DFGLS LSD +TM+ GT ++APE + P K
Sbjct: 121 HRDIKAANILLTSDGEVKLIDFGLSA-QLSDTKARNTMV-GTPYWMAPEVINGKPYDYKA 178
Query: 618 DVYSFGVMLLE 628
D++S G+ +E
Sbjct: 179 DIWSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 61/202 (30%), Positives = 103/202 (50%), Gaps = 23/202 (11%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
E++G G+ G VYK A+G +A+KK+ RL ++ + +E+ + H N+V
Sbjct: 23 NLEKIGEGASGEVYKAT-DRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNIVDY 80
Query: 498 LG--FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR-------VRISLEIARGLVYL 548
+ L +V E+M G+L ++I N + E+ +GL YL
Sbjct: 81 YDSYLVGDEL--WVVMEYMDGGSLTDII------TQNFVRMNEPQIAYVCREVLQGLEYL 132
Query: 549 HEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWL 608
H + +IH DIK NILL S K++DFG + L + S+ ++++ GT ++APE +
Sbjct: 133 H---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPEVI 188
Query: 609 KNAPVSAKVDVYSFGVMLLEII 630
K KVD++S G+M +E+
Sbjct: 189 KRKDYGPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 85/281 (30%), Positives = 131/281 (46%), Gaps = 47/281 (16%)
Query: 441 ELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQERER-EFKSEVSAIGRTHHKNLVQLLG 499
LG+GS G+VYK K +G A+KK+ E R + E+ + +V+ G
Sbjct: 8 VLGQGSSGVVYKVRHK-PTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 500 -FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRV--RISLEIARGLVYLHEGCNVPI 556
F E + V E+M G+LA+L+ + K V I+ +I +GL YLH + I
Sbjct: 67 AFYKEGEISI-VLEYMDGGSLADLLKKVGK--IPEPVLAYIARQILKGLDYLHTKRH--I 121
Query: 557 IHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAK 616
IH DIKP N+L++ KI+DFG+SK+L + + +T + GT Y++PE ++ S
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYSYA 180
Query: 617 VDVYSFGVMLLEIICC----------RRSVEMELEEESRAILTDWAYDCYVEGRLDALID 666
D++S G+ LLE C + EL + AI L A
Sbjct: 181 ADIWSLGLTLLE---CALGKFPFLPPGQPSFFELMQ---AICDGPPP------SLPAEEF 228
Query: 667 SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLE 707
S E D I+ C+Q+DP KRP+ ++L+
Sbjct: 229 SPE--FRD--------FISA-CLQKDPKKRPS---AAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 121 bits (302), Expect = 2e-29
Identities = 74/283 (26%), Positives = 119/283 (42%), Gaps = 28/283 (9%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDR---LAQEREREFKSEVSAIGR-THHKN 493
+LG GSFG VY + +A+K L + + F E+ + H N
Sbjct: 4 ILRKLGEGSFGEVYLARDRKL----VALKVLAKKLESKSKEVERFLREIQILASLNHPPN 59
Query: 494 LVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP---DWNLRVRISLEIARGLVYLHE 550
+V+L F + + LV E++ G+L +L+ I + + + I +I L YLH
Sbjct: 60 IVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS 119
Query: 551 GCNVPIIHCDIKPQNILLDHY-FSPKISDFGLSKLLLSDHSRTH-----TMIRGTRGYVA 604
IIH DIKP+NILLD K+ DFGL+KLL S + + GT GY+A
Sbjct: 120 KG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
Query: 605 PEWLK---NAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRL 661
PE L A S+ D++S G+ L E++ E E + + +
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236
Query: 662 DALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704
L S+ ++ + + + +DP R + +
Sbjct: 237 SPLSPSNPELISKAAS-----DLLKKLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 73/274 (26%), Positives = 122/274 (44%), Gaps = 33/274 (12%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
+G+G FG V G + G +AVK L + + F +E S + H NLVQL
Sbjct: 10 LGATIGKGEFGDVMLGDYR---GQKVAVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQL 65
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRI--SLEIARGLVYLHEGCNVP 555
LG + +V E+M G+L + + + + L ++ +L++ G+ YL E
Sbjct: 66 LGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---N 122
Query: 556 IIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSA 615
+H D+ +N+L+ K+SDFGL+K + S+ + + APE L+ S
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAK----EASQGQDSGKLPVKWTAPEALREKKFST 178
Query: 616 KVDVYSFGVMLLEIICCRRS--VEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMA 673
K DV+SFG++L EI R + L++ + + + EG +
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEA-PEGCPPEVYK------- 230
Query: 674 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLE 707
+M W + DP+KRPT K + + L
Sbjct: 231 --------VMKDCWEL--DPAKRPTFKQLREQLA 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (284), Expect = 5e-28
Identities = 72/197 (36%), Positives = 107/197 (54%), Gaps = 16/197 (8%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLD--RLAQEREREF-KSEVSAIGRTHHKNLVQLL 498
LG+GSFG V V K +G A+K L ++ + +E E +E + + R +H +V+L
Sbjct: 1 LGKGSFGKVLL-VRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59
Query: 499 -GFCDEALNRL-LVYEFMGNGTLANLIFAIPK-PDWNLRVR-ISLEIARGLVYLHEGCNV 554
F E +L LV E+ G L + + + + R R + EI L YLH ++
Sbjct: 60 YAFQTE--EKLYLVLEYAPGGELFSHLSKEGRFSEE--RARFYAAEIVLALEYLH---SL 112
Query: 555 PIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVS 614
II+ D+KP+NILLD K++DFGL+K L S+ SRT+T GT Y+APE L
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGKGYG 171
Query: 615 AKVDVYSFGVMLLEIIC 631
VD +S GV+L E++
Sbjct: 172 KAVDWWSLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 7e-27
Identities = 55/199 (27%), Positives = 105/199 (52%), Gaps = 9/199 (4%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLD--RLAQEREREFKSEVSAIGRTHHKNLV 495
+ +GRG+FG+VYKG L +G+ +A+K++ ++ +E + E+ + H N+V
Sbjct: 4 LGDLIGRGAFGVVYKG-LNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIV 62
Query: 496 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHE-GCNV 554
+ +G + + + ++ E+ NG+L +I +L ++ +GL YLHE G
Sbjct: 63 KYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG--- 119
Query: 555 PIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVS 614
+IH DIK NIL K++DFG++ L +++ GT ++APE ++ + S
Sbjct: 120 -VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV-GTPYWMAPEVIEMSGAS 177
Query: 615 AKVDVYSFGVMLLEIICCR 633
D++S G ++E++
Sbjct: 178 TASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 64/226 (28%), Positives = 94/226 (41%), Gaps = 41/226 (18%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLD--RLAQE-------REREFKSEVSAIGR 488
F + +G GSF V K + A+K LD +L +E E+E + R
Sbjct: 5 FGKIIGEGSFSTVVLAKEKE-TNKEYAIKILDKRQLIKEKKVKYVKIEKE------VLTR 57
Query: 489 -THHKNLVQLLG-FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLV 546
H +++L F DE N V E+ NG L I D + EI L
Sbjct: 58 LNGHPGIIKLYYTFQDEE-NLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALE 116
Query: 547 YLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIR--------- 597
YLH + IIH D+KP+NILLD KI+DFG +K+L + S
Sbjct: 117 YLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 598 ----------GTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCR 633
GT YV+PE L P D+++ G ++ +++ +
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 66/209 (31%), Positives = 107/209 (51%), Gaps = 25/209 (11%)
Query: 439 KEELGRGSFGIVYKGVLKTASGNAIAVKKLD-RLAQEREREF-KSEVSAIGRTHHKNLVQ 496
+++G+GSFG VY V + + G +K++D E+ERE +EV + + +H N+++
Sbjct: 5 IKQIGKGSFGKVYL-VRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK 63
Query: 497 LLGFCD--EALNRLL-VYEFMGNGTLANLI-----FAIPKPD---WNLRVRISLEIARGL 545
+ + E +L V E+ G L+ I P P+ + V++ L L
Sbjct: 64 ---YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL----AL 116
Query: 546 VYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAP 605
YLH I+H DIKPQNI L K+ DFG+SK+L S T++ GT Y++P
Sbjct: 117 KYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSP 172
Query: 606 EWLKNAPVSAKVDVYSFGVMLLEIICCRR 634
E +N P + K D++S G +L E+ +
Sbjct: 173 ELCQNKPYNYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 65/210 (30%), Positives = 110/210 (52%), Gaps = 29/210 (13%)
Query: 441 ELGRGSFGIVYKGVLKT-ASGNA---IAVKKLDRLAQERER-EFKSEVSAIGRTHHKNLV 495
ELG+GSFG+VY+G+ K G +A+K ++ A RER EF +E S + + ++V
Sbjct: 13 ELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVV 72
Query: 496 QLLGFCDEALNRLLVYEFMGNGTLANLIFA----------IPKPDWNLRVRISLEIARGL 545
+LLG L+V E M G L + + + + P ++++ EIA G+
Sbjct: 73 RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132
Query: 546 VYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLL-SDHSRTHTMIRGTRG--- 601
YL +H D+ +N ++ + KI DFG+++ + +D+ R +G +G
Sbjct: 133 AYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYR-----KGGKGLLP 184
Query: 602 --YVAPEWLKNAPVSAKVDVYSFGVMLLEI 629
++APE LK+ + K DV+SFGV+L E+
Sbjct: 185 VRWMAPESLKDGVFTTKSDVWSFGVVLWEM 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 22/205 (10%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLD-RLAQERERE-FKSEVSAIGRTHHKNLVQL 497
E +G+GSFG V K V + + G + K++D E+E++ SEV+ + H N+V+
Sbjct: 6 ETIGKGSFGTVRK-VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVR- 63
Query: 498 LGFCDEALNR-----LLVYEFMGNGTLANLIFAIPKPDWNLRV------RISLEIARGLV 546
+ D ++R +V E+ G LA LI K + RI ++ L
Sbjct: 64 --YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKE--RKYIEEEFIWRILTQLLLALY 119
Query: 547 YLHEGCNVP--IIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVA 604
H + ++H D+KP NI LD + K+ DFGL+K+L D S T + GT Y++
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMS 178
Query: 605 PEWLKNAPVSAKVDVYSFGVMLLEI 629
PE L + K D++S G ++ E+
Sbjct: 179 PEQLNHMSYDEKSDIWSLGCLIYEL 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 76/269 (28%), Positives = 121/269 (44%), Gaps = 34/269 (12%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVK--KLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG 499
+G G+FG VY V +G +AVK ++ + +E E+ + H NLV+ G
Sbjct: 8 IGGGTFGKVYTAV-NLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 500 FCDEALNRLLVYEFM---GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPI 556
++R VY FM GTL L+ D ++ +L++ GL YLH I
Sbjct: 67 V---EVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH---GI 120
Query: 557 IHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRG---YVAPEWLKNAPV 613
+H DIKP NI LDH K+ DFG + L ++ + ++ G Y+APE +
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180
Query: 614 SAK---VDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYV-EGRLDALIDSDE 669
D++S G ++LE+ +R EL+ E + +V G + DS +
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKRPWS-ELDNE-------FQIMFHVGAGHKPPIPDSLQ 232
Query: 670 AAMADRSRLHKWLMIAMWCIQEDPSKRPT 698
+ + L + C++ DP KRPT
Sbjct: 233 LSPEGKDFLDR-------CLESDPKKRPT 254
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 63/210 (30%), Positives = 111/210 (52%), Gaps = 21/210 (10%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQERERE----------FKSEVSAIGRT 489
E +G+G++G VY L +G +AVK+++ A R +SE+ +
Sbjct: 7 ELIGKGTYGRVYLA-LNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 490 HHKNLVQLLGFCDEALNRLLVY-EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYL 548
H N+VQ LGF + L ++ E++ G++ + + + + L + ++ GL YL
Sbjct: 66 DHLNIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYL 124
Query: 549 HEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLL--LSDHSRTHTMIRGTRGYVAPE 606
H + I+H D+K N+L+D KISDFG+SK + D+ + +M +G+ ++APE
Sbjct: 125 H---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSM-QGSVFWMAPE 180
Query: 607 WLKNAP--VSAKVDVYSFGVMLLEIICCRR 634
+ + SAKVD++S G ++LE+ RR
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 82/289 (28%), Positives = 139/289 (48%), Gaps = 47/289 (16%)
Query: 441 ELGRGSFGIVYKGV----LKTASGNAIAVKKLDRLAQERER-EFKSEVSAIGRTHHKNLV 495
ELG+GSFG+VY+G +K + +AVK ++ A RER EF +E S + ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 496 QLLGFCDEALNRLLVYEFMGNGTLANLIFAI----------PKPDWNLRVRISLEIARGL 545
+LLG + L+V E M +G L + + ++ P P ++++ EIA G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 546 VYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRG---- 601
YL+ +H D+ +N ++ H F+ KI DFG+++ D T +G +G
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPV 185
Query: 602 -YVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGR 660
++APE LK+ + D++SFGV+L EI L E+ L++ E
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEI--------TSLAEQPYQGLSN-------EQV 230
Query: 661 LDALIDSDEAAMADR--SRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLE 707
L ++D D R+ + + C Q +P RPT ++ +L+
Sbjct: 231 LKFVMDGGYLDQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 2e-23
Identities = 78/283 (27%), Positives = 117/283 (41%), Gaps = 49/283 (17%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
F +ELG G FG+V+ G + AI K+ R E +F E + + H NLVQL
Sbjct: 8 FLKELGSGQFGVVHLGKWRGKIDVAI---KMIREGAMSEDDFIEEAKVMMKLSHPNLVQL 64
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLIFAIP---KPDWNLRVRISLEIARGLVYLHEGCNV 554
G C + +V E+M NG L N + +W L + ++ + YL
Sbjct: 65 YGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDM--CSDVCEAMEYLESNG-- 120
Query: 555 PIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTR---GYVAPEWLKNA 611
IH D+ +N L+ K+SDFGL++ +L D +T +GT+ + PE +
Sbjct: 121 -FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ---YTSSQGTKFPVKWAPPEVFDYS 176
Query: 612 PVSAKVDVYSFGVMLLEIICC------RRSVEMELEEESRAILTDWAYDCYVEGRLDALI 665
S+K DV+SFGV++ E+ R S +E S RL
Sbjct: 177 RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY------------RL---- 220
Query: 666 DSDEAAMADRSRL--HKWLMIAMWCIQEDPSKRPTMKVVMQML 706
R +L + I C E P RP K ++ L
Sbjct: 221 --------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 3e-23
Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 12/202 (5%)
Query: 429 DELKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGR 488
EL +E+G G FG+V+ G +A+K + R E +F E + +
Sbjct: 4 SELT-----LVQEIGSGQFGLVWLGYWL--EKRKVAIKTI-REGAMSEEDFIEEAQVMMK 55
Query: 489 THHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIP-KPDWNLRVRISLEIARGLVY 547
H LVQL G C E LV+EFM +G L++ + A K + + L++ G+ Y
Sbjct: 56 LSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAY 115
Query: 548 LHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEW 607
L +IH D+ +N L+ K+SDFG+++ +L D + T + + +PE
Sbjct: 116 LESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEV 172
Query: 608 LKNAPVSAKVDVYSFGVMLLEI 629
+ S+K DV+SFGV++ E+
Sbjct: 173 FSFSKYSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 4e-23
Identities = 63/202 (31%), Positives = 103/202 (50%), Gaps = 14/202 (6%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNA---IAVKKLDRLAQERER-EFKSEVSAIGRTHHKN 493
F ++LG G FG V N +AVK L+ +E+ R +F+ E+ + H+N
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 494 LVQLLGFCDEALNR--LLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIARGLVYLHE 550
+V+ G C++ R L+ E++ +G+L + L + + + S +I +G+ YL
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG- 126
Query: 551 GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRG---TRGYVAPEW 607
+ IH D+ +NIL++ KISDFGL+K+L D + G Y APE
Sbjct: 127 --SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APEC 183
Query: 608 LKNAPVSAKVDVYSFGVMLLEI 629
L+ + S+ DV+SFGV L E+
Sbjct: 184 LRTSKFSSASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 5e-23
Identities = 67/193 (34%), Positives = 98/193 (50%), Gaps = 7/193 (3%)
Query: 439 KEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLL 498
K +LG G +G VY+GV K +AVK L E E EF E + + H NLVQLL
Sbjct: 11 KHKLGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLL 68
Query: 499 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWN--LRVRISLEIARGLVYLHEGCNVPI 556
G C ++ EFM G L + + + + N + + ++ +I+ + YL E N
Sbjct: 69 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL-EKKN--F 125
Query: 557 IHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAK 616
IH D+ +N L+ K++DFGLS+L+ D H + + APE L S K
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 185
Query: 617 VDVYSFGVMLLEI 629
DV++FGV+L EI
Sbjct: 186 SDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 7e-23
Identities = 81/278 (29%), Positives = 130/278 (46%), Gaps = 47/278 (16%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVK--KLDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
E +G G FG V +G +G +AVK K D AQ F E + + + HHKNLV+L
Sbjct: 12 EIIGEGEFGAVLQG---EYTGQKVAVKNIKCDVTAQA----FLEETAVMTKLHHKNLVRL 64
Query: 498 LG-FCDEALNRLLVYEFMGNGTLANLI-----FAIPKPDWNLRVRISLEIARGLVYLHEG 551
LG L +V E M G L N + + ++ SL++A G+ YL
Sbjct: 65 LGVILHNGLY--IVMELMSKGNLVNFLRTRGRALVSVIQL---LQFSLDVAEGMEYLE-- 117
Query: 552 CNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNA 611
+ ++H D+ +NIL+ K+SDFGL+++ S + + APE LK+
Sbjct: 118 -SKKLVHRDLAARNILVSEDGVAKVSDFGLARV----GSMGVDNSKLPVKWTAPEALKHK 172
Query: 612 PVSAKVDVYSFGVMLLEIICCRRS--VEMELEEESRAILTDWAYDCYVEGRLDALIDSDE 669
S+K DV+S+GV+L E+ R+ +M L+E + + ++ E
Sbjct: 173 KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYR------------MEPPE 220
Query: 670 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLE 707
AD ++ LM + W + +P KRP+ + + LE
Sbjct: 221 GCPAD---VYV-LMTSCW--ETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 7e-23
Identities = 84/334 (25%), Positives = 156/334 (46%), Gaps = 34/334 (10%)
Query: 392 AFLLLAI----LIFFKWRR----RKYENNVQDST--TSATNLRFFSYDELKDATDGFKEE 441
AFL+LA+ +F + R ++ EN +D T + + + D KEE
Sbjct: 638 AFLVLALVAFGFVFIRGRNNLELKRVEN--EDGTWELQFFDSKVSKSITINDILSSLKEE 695
Query: 442 --LGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG 499
+ RG G YKG +G VK+++ + SE++ +G+ H N+V+L+G
Sbjct: 696 NVISRGKKGASYKGKSIK-NGMQFVVKEINDVNSIPS----SEIADMGKLQHPNIVKLIG 750
Query: 500 FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHC 559
C L++E++ L+ ++ + W R +I++ IA+ L +LH C+ ++
Sbjct: 751 LCRSEKGAYLIHEYIEGKNLSEVLRNL---SWERRRKIAIGIAKALRFLHCRCSPAVVVG 807
Query: 560 DIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDV 619
++ P+ I++D P + L LL +D + YVAPE + ++ K D+
Sbjct: 808 NLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFIS-----SAYVAPETRETKDITEKSDI 861
Query: 620 YSFGVMLLEIICCRRSVEMELE-EESRAILTDWAYDCYVEGRLDALIDS--DEAAMADRS 676
Y FG++L+E++ + + E S + +WA CY + LD ID +++
Sbjct: 862 YGFGLILIELLTGKSPADAEFGVHGS---IVEWARYCYSDCHLDMWIDPSIRGDVSVNQN 918
Query: 677 RLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710
+ + + +A+ C DP+ RP V++ LE
Sbjct: 919 EIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952
|
Length = 968 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 9e-23
Identities = 83/282 (29%), Positives = 139/282 (49%), Gaps = 39/282 (13%)
Query: 442 LGRGSFGIVYKGVLKTA--SGNAIAVKKLDRLAQERER-EFKSEVSAIGRTHHKNLVQLL 498
+G G FG V++G+LK A+A+K L E++R +F SE S +G+ H N+++L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 499 GFCDEALNRLLVYEFMGNGTLANLI------FAIPKPDWNLRVRISLEIARGLVYLHEGC 552
G + +++ E+M NG L + F+ + LR IA G+ YL
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR-----GIAAGMKYL---S 124
Query: 553 NVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRG--YVAPEWLKN 610
++ +H D+ +NIL++ K+SDFGLS++L D T+T G + APE +
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184
Query: 611 APVSAKVDVYSFGVMLLEIICC--RRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSD 668
++ DV+SFG+++ E++ R +M E +AI D + RL A +D
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI-----NDGF---RLPAPMDCP 236
Query: 669 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710
A LM+ W Q+D ++RP ++ +L+ LL
Sbjct: 237 SAVYQ--------LMLQCW--QQDRARRPRFVDIVNLLDKLL 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 9e-23
Identities = 80/292 (27%), Positives = 138/292 (47%), Gaps = 56/292 (19%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAI--AVKKLDRLAQERER-EFKSEVSAIGRTHHKNLVQ 496
+ +G G FG V +G LK I A+K L + +++R +F +E S +G+ H N+++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 497 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR-----------VRISLEIARGL 545
L G ++ +++ E+M NG+L D LR V + IA G+
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSL----------DKFLRENDGKFTVGQLVGMLRGIASGM 119
Query: 546 VYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM-----IRGTR 600
YL E V H D+ +NIL++ K+SDFGLS+ L + T IR T
Sbjct: 120 KYLSEMNYV---HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT- 175
Query: 601 GYVAPEWLKNAPVSAKVDVYSFGVMLLEIICC--RRSVEMELEEESRAILTDWAYDCYVE 658
APE + ++ DV+SFG+++ E++ R +M ++ +A+ +
Sbjct: 176 ---APEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY------- 225
Query: 659 GRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710
RL +D A L++ LM + C Q+D ++RPT ++ L+ ++
Sbjct: 226 -RLPPPMDCPSA-------LYQ-LM--LDCWQKDRNERPTFSQIVSTLDKMI 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 1e-22
Identities = 76/266 (28%), Positives = 124/266 (46%), Gaps = 32/266 (12%)
Query: 439 KEELGRGSFGIVYKGVLKTASGNAIAVKKLD-RLAQERER-EFKSEVSAIGRTHHKNLVQ 496
++G+GSFG+V+K V K A A+K++D RER E E + + +++
Sbjct: 5 LNKIGKGSFGVVFKVVRK-ADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIR 63
Query: 497 LL-GFCDEA-LNRLLVYEFMGNGTLANLIFAI---PKPDWNLRVRISLEIARGLVYLHEG 551
F D+ LN +V E+ NG L L+ P P+ + R ++I GL +LH
Sbjct: 64 YYESFLDKGKLN--IVMEYAENGDLHKLLKMQRGRPLPE-DQVWRFFIQILLGLAHLHSK 120
Query: 552 CNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNA 611
I+H DIK N+ LD Y + KI D G++KLL + + +T++ GT Y++PE ++
Sbjct: 121 ---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYLSPELCEDK 176
Query: 612 PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAA 671
P + K DV++ GV+L E CC + + IL + G +
Sbjct: 177 PYNEKSDVWALGVVLYE--CCTGKHPFDANNQGALILK------IIRGVFPPVSQMYSQQ 228
Query: 672 MADRSRLHKWLMIAMWCIQEDPSKRP 697
+A C+ +D +RP
Sbjct: 229 LAQLIDQ---------CLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 4e-22
Identities = 61/194 (31%), Positives = 101/194 (52%), Gaps = 14/194 (7%)
Query: 441 ELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFK---SEVSAIGRTHHKNLVQL 497
ELG G+ G+V K VL +G +AVK + RL E K E+ + + + +V
Sbjct: 8 ELGAGNSGVVSK-VLHRPTGKIMAVKTI-RLEIN-EAIQKQILRELDILHKCNSPYIVGF 64
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRV--RISLEIARGLVYLHEGCNVP 555
G + + E+M G+L ++ + R+ +I++ + +GL YLHE
Sbjct: 65 YGAFYNNGDISICMEYMDGGSLDKILKEVQGR-IPERILGKIAVAVLKGLTYLHE--KHK 121
Query: 556 IIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSA 615
IIH D+KP NIL++ K+ DFG+S L++ ++T GT Y+APE ++ S
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV---GTSSYMAPERIQGNDYSV 178
Query: 616 KVDVYSFGVMLLEI 629
K D++S G+ L+E+
Sbjct: 179 KSDIWSLGLSLIEL 192
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 4e-22
Identities = 74/272 (27%), Positives = 122/272 (44%), Gaps = 30/272 (11%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG 499
+LG G FG V++G+ K AI + K D L ++++F+ EV A+ R HK+L+ L
Sbjct: 12 RKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLL--KQQDFQKEVQALKRLRHKHLISLFA 69
Query: 500 FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR----ISLEIARGLVYLHEGCNVP 555
C ++ E M G+L L F L V ++ ++A G+ YL E
Sbjct: 70 VCSVGEPVYIITELMEKGSL--LAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---N 124
Query: 556 IIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSA 615
IH D+ +NIL+ K++DFGL++L+ D + + + APE + S
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK-WTAPEAASHGTFST 183
Query: 616 KVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEG-RLDALIDSDEAAMAD 674
K DV+SFG++L E+ V + YD G R+ +
Sbjct: 184 KSDVWSFGILLYEMF-TYGQVPYP------GMNNHEVYDQITAGYRMPCPAKCPQE---- 232
Query: 675 RSRLHKWLMIAMWCIQEDPSKRPTMKVVMQML 706
++K +M+ W +P RP+ K + + L
Sbjct: 233 ---IYK-IMLECWAA--EPEDRPSFKALREEL 258
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 5e-22
Identities = 60/197 (30%), Positives = 96/197 (48%), Gaps = 15/197 (7%)
Query: 441 ELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG- 499
ELG G+FG VYK K A A K + ++E +F E+ + H N+V L
Sbjct: 12 ELGDGAFGKVYKAQHKETGLFA-AAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEA 70
Query: 500 -FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR-ISLEIARGLVYLHEGCNVPII 557
F + L L+ EF G L +++ + + ++R + ++ L +LH +I
Sbjct: 71 YFYENKLWILI--EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVI 125
Query: 558 HCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWL-----KNAP 612
H D+K NILL K++DFG+S S + T I GT ++APE + K+ P
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKDNP 184
Query: 613 VSAKVDVYSFGVMLLEI 629
K D++S G+ L+E+
Sbjct: 185 YDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 5e-22
Identities = 73/277 (26%), Positives = 120/277 (43%), Gaps = 46/277 (16%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLD-RLAQEREREFK-SEVSAIGRTHHKNLVQLLG 499
LG+GS+G VYK V + + A+K++D ++ERE +E+ + +H N++
Sbjct: 8 LGKGSYGSVYK-VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNII---S 63
Query: 500 FCDEAL--NRL-LVYEFMGNGTLANLIFAIPKPD--------WNLRVRISLEIARGLVYL 548
+ + L N+L +V E+ G L+ I K W RI +++ RGL L
Sbjct: 64 YKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW----RIFIQLLRGLQAL 119
Query: 549 HEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWL 608
HE I+H D+K NILL KI D G+SK+L + ++T GT Y+APE
Sbjct: 120 HE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI---GTPHYMAPEVW 173
Query: 609 KNAPVSAKVDVYSFGVMLLEIICCRRSVEME-LEEESRAILTDWAYDCYVEGRLDALIDS 667
K P S K D++S G +L E+ E +++ + G+ +
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR---------GKYPPIPPI 224
Query: 668 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704
+ + +Q P RP ++
Sbjct: 225 YSQDLQN---------FIRSMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 6e-22
Identities = 66/220 (30%), Positives = 108/220 (49%), Gaps = 37/220 (16%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGN----AIAVKKLDRLAQERER-EFKSEVSAIGRTHHK 492
F EELG G+FG VYKG L + ++A+K L A+ + + EF+ E + H
Sbjct: 9 FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68
Query: 493 NLVQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLR---------------VR 536
N+V LLG C + +++E++ +G L L+ P D +
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 537 ISLEIARGLVYL--HEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS-DHSRTH 593
I+++IA G+ YL H +H D+ +N L+ + KISDFGLS+ + S D+ R
Sbjct: 129 IAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQ 183
Query: 594 TM----IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEI 629
+ +R ++ PE + + + D++SFGV+L EI
Sbjct: 184 SKSLLPVR----WMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 7e-22
Identities = 62/199 (31%), Positives = 101/199 (50%), Gaps = 20/199 (10%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKL-DRLAQEREREFKSEVSAIGRTHHKNLVQLL 498
E++G+G+FG VYKGVLK +AVK L + +R+F E + + H N+V+L+
Sbjct: 1 EKIGKGNFGDVYKGVLKG--NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLI 58
Query: 499 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR----ISLEIARGLVYLHEGCNV 554
G C + +V E + G+L + K L V+ +SL+ A G+ YL
Sbjct: 59 GVCVQKQPIYIVMELVPGGSLLTF---LRKKKNRLTVKKLLQMSLDAAAGMEYLESKN-- 113
Query: 555 PIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTR----GYVAPEWLKN 610
IH D+ +N L+ KISDFG+S+ + +T+ G + + APE L
Sbjct: 114 -CIHRDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNY 169
Query: 611 APVSAKVDVYSFGVMLLEI 629
+++ DV+S+G++L E
Sbjct: 170 GRYTSESDVWSYGILLWET 188
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 3e-21
Identities = 79/279 (28%), Positives = 132/279 (47%), Gaps = 52/279 (18%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKL--DRLAQEREREFKSEVSAIGRTHHKNLVQLLG 499
+GRG+FGIV+ K I +K++ +++ ++ ++E + H N+++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVI-IKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 500 --FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLE-------IARGLVYLHE 550
D+AL ++V E+ GTLA I R L+ + L+ LH
Sbjct: 67 NFLEDKAL--MIVMEYAPGGTLAEYI--------QKRCNSLLDEDTILHFFVQILLALHH 116
Query: 551 GCNVPIIHCDIKPQNILLD-HYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLK 609
I+H D+K QNILLD H KI DFG+SK+L S S+ +T++ GT Y++PE +
Sbjct: 117 VHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL-SSKSKAYTVV-GTPCYISPELCE 174
Query: 610 NAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALI---- 665
P + K D+++ G +L E+ +R+ E L AL+
Sbjct: 175 GKPYNQKSDIWALGCVLYELASLKRAFEAA--------------------NLPALVLKIM 214
Query: 666 DSDEAAMADR-SRLHKWLMIAMWCIQEDPSKRPTMKVVM 703
A ++DR S + L+++M + DPSKRP + +M
Sbjct: 215 SGTFAPISDRYSPDLRQLILSM--LNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 3e-21
Identities = 66/217 (30%), Positives = 106/217 (48%), Gaps = 33/217 (15%)
Query: 438 FKEELGRGSFGIVYKGVLKTAS-GNA---IAVKKLDRLAQERERE-FKSEVSAIGRTHHK 492
K ELG G+FG V+ G N +AVK L A R+ F+ E + H+
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 493 NLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR---------------VRI 537
N+V+ G C E ++V+E+M +G L + + PD ++I
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRS-HGPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 538 SLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS-DHSRT--HT 594
+++IA G+VYL + +H D+ +N L+ + KI DFG+S+ + + D+ R HT
Sbjct: 128 AVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHT 184
Query: 595 M--IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEI 629
M IR ++ PE + + + DV+SFGV+L EI
Sbjct: 185 MLPIR----WMPPESIMYRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 4e-21
Identities = 68/197 (34%), Positives = 102/197 (51%), Gaps = 15/197 (7%)
Query: 440 EELGRGSFGIVYKGVLKTASGN--AIAVKKL-DRLAQEREREFKSEVSAIGRTHHKNLVQ 496
+ELG G+FG V KGV SG +AVK L ++EF E S + + H +V+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 497 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPK-PDWNLRVRISLEIARGLVYLHEGCNVP 555
L+G C + +LV E G L + + P +L+ ++ ++A G+ YL E +
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKE-LAHQVAMGMAYL-ESKH-- 115
Query: 556 IIHCDIKPQNILL--DHYFSPKISDFGLSKLLL--SDHSRTHTMIRGTRGYVAPEWLKNA 611
+H D+ +N+LL H KISDFG+S+ L SD+ R T R + APE +
Sbjct: 116 FVHRDLAARNVLLVNRHQ--AKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYG 173
Query: 612 PVSAKVDVYSFGVMLLE 628
S+K DV+S+GV L E
Sbjct: 174 KFSSKSDVWSYGVTLWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 59/192 (30%), Positives = 97/192 (50%), Gaps = 7/192 (3%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREF-KSEVSAIGRTHHKNLVQLL 498
E +G+GSFG VYK + K + +A+K +D E E E + E+ + + + +
Sbjct: 7 ECIGKGSFGEVYKAIDKR-TNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYY 65
Query: 499 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIH 558
G + ++ E+ G G+ +L+ + + I E+ GL YLHE IH
Sbjct: 66 GSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF-ILREVLLGLEYLHEE---GKIH 121
Query: 559 CDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVD 618
DIK NILL K++DFG+S L S S+ +T + GT ++APE +K + K D
Sbjct: 122 RDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSGYDEKAD 180
Query: 619 VYSFGVMLLEII 630
++S G+ +E+
Sbjct: 181 IWSLGITAIELA 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 6e-21
Identities = 61/204 (29%), Positives = 105/204 (51%), Gaps = 30/204 (14%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
E+LG GS+G VYK + K +G +A+K + +E +E E+S + + +V+
Sbjct: 7 ILEKLGEGSYGSVYKAIHKE-TGQVVAIKVV--PVEEDLQEIIKEISILKQCDSPYIVKY 63
Query: 498 LG--FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISL---EIA-------RGL 545
G F + L +V E+ G G++++++ +L EIA +GL
Sbjct: 64 YGSYFKNTDL--WIVMEYCGAGSVSDIMKIT---------NKTLTEEEIAAILYQTLKGL 112
Query: 546 VYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAP 605
YLH + IH DIK NILL+ K++DFG+S L ++ +T+I GT ++AP
Sbjct: 113 EYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAP 168
Query: 606 EWLKNAPVSAKVDVYSFGVMLLEI 629
E ++ + K D++S G+ +E+
Sbjct: 169 EVIQEIGYNNKADIWSLGITAIEM 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 9e-21
Identities = 66/209 (31%), Positives = 111/209 (53%), Gaps = 27/209 (12%)
Query: 441 ELGRGSFGIVY----KGVLKTASGNAIAVKKLDRLAQERER-EFKSEVSAIGRTHHKNLV 495
ELG+GSFG+VY KGV+K +A+K ++ A RER EF +E S + + ++V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 496 QLLGFCDEALNRLLVYEFMGNGTLANLIFAI-PK---------PDWNLRVRISLEIARGL 545
+LLG + L++ E M G L + + ++ P+ P ++++ EIA G+
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 546 VYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRG---- 601
YL+ +H D+ +N ++ F+ KI DFG+++ D T +G +G
Sbjct: 133 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPV 185
Query: 602 -YVAPEWLKNAPVSAKVDVYSFGVMLLEI 629
+++PE LK+ + DV+SFGV+L EI
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 9e-21
Identities = 73/218 (33%), Positives = 106/218 (48%), Gaps = 28/218 (12%)
Query: 431 LKDATDGF--KEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGR 488
L D T F E +G G++G VYK K A+K +D + ++ E E K E + + +
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLV-AIKIMD-IIEDEEEEIKEEYNILRK 58
Query: 489 -THHKNLVQLLGF--------CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR----V 535
++H N+ G D+ L LV E G G++ +L+ + K L+
Sbjct: 59 YSNHPNIATFYGAFIKKNPPGNDDQL--WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA 116
Query: 536 RISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM 595
I E RGL YLHE +IH DIK QNILL K+ DFG+S L S R +T
Sbjct: 117 YILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF 173
Query: 596 IRGTRGYVAPEWL---KNAPVS--AKVDVYSFGVMLLE 628
I GT ++APE + + S A+ DV+S G+ +E
Sbjct: 174 I-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (231), Expect = 1e-20
Identities = 67/199 (33%), Positives = 100/199 (50%), Gaps = 16/199 (8%)
Query: 439 KEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKS----EVSAIGRTHHKNL 494
E+LG G++G+VYK +G +A+KK+ RL E E S E+S + H N+
Sbjct: 4 LEKLGEGTYGVVYKAR-DKKTGEIVALKKI-RLDNEEE-GIPSTALREISLLKELKHPNI 60
Query: 495 VQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRVRISLEIARGLVYLHEGCN 553
V+LL LV+E+ L + P P NL I ++ RGL Y H
Sbjct: 61 VKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR- 118
Query: 554 VPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS-DHSRTHTMIRGTRGYVAPEWLKNAP 612
I+H D+KPQNIL++ K++DFGL++ + TH ++ T Y APE L +
Sbjct: 119 --ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV--TLWYRAPEILLGSK 174
Query: 613 V-SAKVDVYSFGVMLLEII 630
S VD++S G + E+I
Sbjct: 175 HYSTAVDIWSVGCIFAEMI 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 1e-20
Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 20/203 (9%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKL-----DRLAQERE-REFKSEVSAIGRTHHKN 493
E LG+G++G VY G+ T G IAVK++ + LA E+E + + EV + H N
Sbjct: 6 EVLGKGAYGTVYCGL--TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63
Query: 494 LVQLLGFCDEALNRLLVYEFMGNGTLANLI--FAIPKPDWNLRVRISLEIARGLVYLHEG 551
+VQ LG C + + EF+ G++++++ F P P+ + + +I G+ YLH
Sbjct: 64 IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFG-PLPEPVFC-KYTKQILDGVAYLHNN 121
Query: 552 CNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLL-----SDHSRTHTMIRGTRGYVAPE 606
C ++H DIK N++L K+ DFG ++ L HS + GT ++APE
Sbjct: 122 C---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 607 WLKNAPVSAKVDVYSFGVMLLEI 629
+ + K D++S G + E+
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEM 201
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 55/197 (27%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKS----EVSAIGRTHHKNLV 495
++G G++G+VYK K +G +A+KK+ + E+ + +H N++
Sbjct: 5 GKIGEGTYGVVYKARDKL-TGEIVAIKKIKL--RFESEGIPKTALREIKLLKELNHPNII 61
Query: 496 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR-ISLEIARGLVYLHEGCNV 554
+LL + LV+EFM + L LI + ++ ++ +GL + H
Sbjct: 62 KLLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH--- 117
Query: 555 PIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPV- 613
I+H D+KP+N+L++ K++DFGL++ S R +T TR Y APE L
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVVTRWYRAPELLLGDKGY 176
Query: 614 SAKVDVYSFGVMLLEII 630
S VD++S G + E++
Sbjct: 177 STPVDIWSVGCIFAELL 193
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 3e-20
Identities = 69/207 (33%), Positives = 111/207 (53%), Gaps = 26/207 (12%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKK--LDRLAQEREREFKSEVSAIGRT-------HHK 492
+G GSFG VY G + +SG +AVK+ L ++ + +S + A+ R H+
Sbjct: 8 IGSGSFGSVYLG-MNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 493 NLVQLLGFCDEALNRLLVY-EFMGNGTLANLIF---AIPKPDWNLRVRISLEIARGLVYL 548
N+VQ LG + L ++ E++ G++A L+ A + VR +I +GL YL
Sbjct: 67 NIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVR---QILKGLNYL 122
Query: 549 HEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLL----LSDHSRTH-TMIRGTRGYV 603
H N IIH DIK NIL+D+ KISDFG+SK L LS + ++G+ ++
Sbjct: 123 H---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 604 APEWLKNAPVSAKVDVYSFGVMLLEII 630
APE +K + K D++S G +++E++
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEML 206
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 3e-20
Identities = 81/307 (26%), Positives = 137/307 (44%), Gaps = 72/307 (23%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKS--------EVSAIGR-TH 490
++LG G+FG VY K +G +A+KK+ +++F S EV ++ +
Sbjct: 5 KQLGDGTFGSVYLARNKE-TGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNE 56
Query: 491 HKNLVQLLGFCDEAL---NRL-LVYEFMGNGTLANLIFA-IPKPDWNLRVR-ISLEIARG 544
H N+V+L E + L V+E+M G L L+ KP +R I +I +G
Sbjct: 57 HPNIVKLK----EVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQG 111
Query: 545 LVYLHE-GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYV 603
L ++H+ G H D+KP+N+L+ KI+DFGL++ + S +T TR Y
Sbjct: 112 LAHIHKHG----FFHRDLKPENLLVSGPEVVKIADFGLAREIRS--RPPYTDYVSTRWYR 165
Query: 604 APE-WLKNAPVSAKVDVYSFGVMLLEIICCR-----RSVEMELEEESR--AIL-----TD 650
APE L++ S+ VD+++ G ++ E+ R S E+++ + ++L D
Sbjct: 166 APEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSS---EIDQLYKICSVLGTPTKQD 222
Query: 651 W------------AYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPT 698
W + + L LI + D L+ ++ DP KRPT
Sbjct: 223 WPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAID-------LI--KDMLRWDPKKRPT 273
Query: 699 MKVVMQM 705
+Q
Sbjct: 274 ASQALQH 280
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 4e-20
Identities = 83/287 (28%), Positives = 140/287 (48%), Gaps = 41/287 (14%)
Query: 439 KEELGRGSFGIVYKGVLKTASG--NAIAVKKLDRLAQERER-EFKSEVSAIGRTHHKNLV 495
+E +G G FG V +G LK +A+K L E++R +F SE S +G+ H N++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 496 QLLGFCDEALNRLLVYEFMGNGTLANLI------FAIPKPDWNLRVRISLEIARGLVYLH 549
L G ++ +++ EFM NG L + + F + + LR IA G+ YL
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR-----GIAAGMKYLS 123
Query: 550 EGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR-THTMIRGTR---GYVAP 605
E + +H D+ +NIL++ K+SDFGLS+ L D S T+T G + + AP
Sbjct: 124 E---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 606 EWLKNAPVSAKVDVYSFGVMLLEIICC--RRSVEMELEEESRAILTDWAYDCYVEGRLDA 663
E + ++ DV+S+G+++ E++ R +M ++ AI D+ RL
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY--------RLPP 232
Query: 664 LIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710
+D A LH+ LM+ W Q+D + RP ++ L+ ++
Sbjct: 233 PMDCPTA-------LHQ-LMLDCW--QKDRNARPKFGQIVSTLDKMI 269
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 4e-20
Identities = 56/192 (29%), Positives = 99/192 (51%), Gaps = 10/192 (5%)
Query: 441 ELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG- 499
++G GS GIV K+ +G +AVKK+D Q+R +EV + H N+V++
Sbjct: 26 KIGEGSTGIVCIATDKS-TGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSS 84
Query: 500 -FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIH 558
+ L +V EF+ G L +++ + + + L + + L +LH +IH
Sbjct: 85 YLVGDEL--WVVMEFLEGGALTDIVTHT-RMNEEQIATVCLAVLKALSFLH---AQGVIH 138
Query: 559 CDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVD 618
DIK +ILL K+SDFG + + R +++ GT ++APE + P +VD
Sbjct: 139 RDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPEVISRLPYGTEVD 197
Query: 619 VYSFGVMLLEII 630
++S G+M++E++
Sbjct: 198 IWSLGIMVIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 2e-19
Identities = 60/197 (30%), Positives = 98/197 (49%), Gaps = 26/197 (13%)
Query: 459 SGNAIAVKKLDRLAQERERE---FKSEVSAIGRTHHKNLVQLL--GFCDEALNRLLVYEF 513
+G+ +A+K L A E E + F+ E + R +H N+V LL G L V+E+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL-LFAVFEY 60
Query: 514 MGNGTLANLIF---AIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILL-- 568
+ TL ++ A+P + R+ L++ L H N I+H D+KPQNI++
Sbjct: 61 VPGRTLREVLAADGALPAGE---TGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQ 114
Query: 569 -DHYFSPKISDFGLSKLLLSDH-------SRTHTMIRGTRGYVAPEWLKNAPVSAKVDVY 620
K+ DFG+ LL +RT ++ GT Y APE L+ PV+ D+Y
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVL-GTPTYCAPEQLRGEPVTPNSDLY 173
Query: 621 SFGVMLLEIICCRRSVE 637
++G++ LE + +R V+
Sbjct: 174 AWGLIFLECLTGQRVVQ 190
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 55/197 (27%), Positives = 96/197 (48%), Gaps = 17/197 (8%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKL------DRLAQEREREFKSEVSAIGRTHHKNLV 495
+G G+ GIV+K + +G +A+KK+ + + RE K A+ H +V
Sbjct: 8 IGEGAHGIVFKAKDR-ETGETVALKKVALRRLEGGIPNQALREIK----ALQACQHPYVV 62
Query: 496 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR-ISLEIARGLVYLHEGCNV 554
+LL +LV E+M L+ ++ +P +V+ + +G+ Y+H
Sbjct: 63 KLLDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA---N 118
Query: 555 PIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAP-V 613
I+H D+KP N+L+ KI+DFGL++L + R ++ TR Y APE L A
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKY 178
Query: 614 SAKVDVYSFGVMLLEII 630
VD+++ G + E++
Sbjct: 179 DPGVDLWAVGCIFAELL 195
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 2e-19
Identities = 68/273 (24%), Positives = 124/273 (45%), Gaps = 34/273 (12%)
Query: 442 LGRGSFG--IVYKGVLKTASGNAIAVKKLD--RLAQEREREFKSEVSAIGRTHHKNLVQL 497
LG+G+FG +Y+ +T + + K+++ RL+++ R+ +E+ + H N++
Sbjct: 8 LGKGAFGEATLYR---RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAY 64
Query: 498 LG-FCDEALNRLLV-YEFMGNGTLANLIFAIPKPDWNLRVRISL--EIARGLVYLHEGCN 553
F D+ N LL+ E+ GTL + I + + + +I + Y+H+
Sbjct: 65 YNHFMDD--NTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK--- 119
Query: 554 VPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPV 613
I+H DIK NI L K+ DFG+SK+L S++S T++ GT Y++PE +
Sbjct: 120 AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKY 178
Query: 614 SAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMA 673
+ K D+++ G +L E++ +R+ + + Y V LI
Sbjct: 179 NFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELI-------- 230
Query: 674 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQML 706
+ +Q+DP KRPT V+
Sbjct: 231 ---------SLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 2e-19
Identities = 63/204 (30%), Positives = 102/204 (50%), Gaps = 28/204 (13%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKL-----DRLAQEREREFKSEVSAIGRTHHKNL 494
E LG GSFG VY+G L G+ AVK++ + QE ++ + E++ + + H N+
Sbjct: 6 ELLGSGSFGSVYEG-LNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64
Query: 495 VQLLGFC--DEALNRLLVYEFMGNGTLANLIF---AIPKPDWNLRVRISLEIARGLVYLH 549
VQ LG ++ L L E + G+LA L+ + P+P L R +I GL YLH
Sbjct: 65 VQYLGTEREEDNLYIFL--ELVPGGSLAKLLKKYGSFPEPVIRLYTR---QILLGLEYLH 119
Query: 550 EGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRG---YVAPE 606
+ +H DIK NIL+D K++DFG++K + + +G ++APE
Sbjct: 120 ---DRNTVHRDIKGANILVDTNGVVKLADFGMAK-----QVVEFSFAKSFKGSPYWMAPE 171
Query: 607 WL-KNAPVSAKVDVYSFGVMLLEI 629
+ + D++S G +LE+
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEM 195
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 3e-19
Identities = 86/285 (30%), Positives = 142/285 (49%), Gaps = 45/285 (15%)
Query: 442 LGRGSFGIVYKGVLKTASGN--AIAVKKLDRLAQERER-EFKSEVSAIGRTHHKNLVQLL 498
+G G FG V G LK +A+K L E++R +F SE S +G+ H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 499 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISL-----EIARGLVYLHEGCN 553
G ++ ++V E+M NG+L + K D V I L IA G+ YL +
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAF---LRKHDGQFTV-IQLVGMLRGIASGMKYL---SD 124
Query: 554 VPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRG------YVAPEW 607
+ +H D+ +NIL++ K+SDFGLS++L D +T TRG + APE
Sbjct: 125 MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT----TRGGKIPIRWTAPEA 180
Query: 608 LKNAPVSAKVDVYSFGVMLLEIICC--RRSVEMELEEESRAILTDWAYDCYVEGRLDALI 665
+ ++ DV+S+G+++ E++ R EM ++ +AI + Y RL A +
Sbjct: 181 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI--EEGY------RLPAPM 232
Query: 666 DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710
D A LH+ LM+ W Q+D ++RP + ++ +L+ L+
Sbjct: 233 DCPAA-------LHQ-LMLDCW--QKDRNERPKFEQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 3e-19
Identities = 58/191 (30%), Positives = 101/191 (52%), Gaps = 8/191 (4%)
Query: 441 ELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGF 500
++G GS GIV +K+ SG +AVKK+D Q+R +EV + H+N+V++
Sbjct: 27 KIGEGSTGIVCIATVKS-SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85
Query: 501 CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLH-EGCNVPIIHC 559
+V EF+ G L +++ + + + L + + L LH +G +IH
Sbjct: 86 YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA-VCLAVLKALSVLHAQG----VIHR 140
Query: 560 DIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDV 619
DIK +ILL H K+SDFG + + R +++ GT ++APE + P +VD+
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLPYGPEVDI 199
Query: 620 YSFGVMLLEII 630
+S G+M++E++
Sbjct: 200 WSLGIMVIEMV 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 5e-19
Identities = 68/222 (30%), Positives = 103/222 (46%), Gaps = 22/222 (9%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTH-----HKNLVQ 496
LG+G FG V A+G A KKLD+ +R ++ K E A+ +
Sbjct: 1 LGKGGFGEVC-ACQVKATGKMYACKKLDK---KRLKKRKGEQMALNEKKILEKVSSRFIV 56
Query: 497 LLGFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNL-RVRI-SLEIARGLVYLHEGCN 553
L + E + L LV M G L I+ + +P + R + +I GL +LH
Sbjct: 57 SLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---Q 113
Query: 554 VPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPV 613
I++ D+KP+N+LLD + + +ISD GL+ + L + GT GY+APE L+
Sbjct: 114 RRIVYRDLKPENVLLDDHGNVRISDLGLA-VELKGGKKIKGRA-GTPGYMAPEVLQGEVY 171
Query: 614 SAKVDVYSFGVMLLEIICCR-----RSVEMELEEESRAILTD 650
VD ++ G L E+I R R ++E EE R L
Sbjct: 172 DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEM 213
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 5e-19
Identities = 54/195 (27%), Positives = 92/195 (47%), Gaps = 8/195 (4%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
+LG G FG V++G+ + +AVK L + ++F +E + + H L+QL
Sbjct: 10 LLRKLGAGQFGEVWEGLWNNTT--PVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQL 66
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNL--RVRISLEIARGLVYLHEGCNVP 555
C +V E M G+L + L + ++ ++A G+ YL E N
Sbjct: 67 YAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL-EAQN-- 123
Query: 556 IIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSA 615
IH D+ +N+L+ K++DFGL++++ D + + APE S
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSI 183
Query: 616 KVDVYSFGVMLLEII 630
K DV+SFG++L EI+
Sbjct: 184 KSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 6e-19
Identities = 65/201 (32%), Positives = 101/201 (50%), Gaps = 19/201 (9%)
Query: 442 LGRGSFGIVYKGVLKTASGNAI--AVKKLDRLAQERERE-FKSEVSAIGRTHHKNLVQLL 498
+G+G FG VY G L + G I AVK L+R+ E E F E + H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 499 GFC--DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR----ISLEIARGLVYLHEGC 552
G C E L+V +M +G L N I N V+ L++A+G+ YL
Sbjct: 63 GICLPSEGSP-LVVLPYMKHGDLRNFI---RSETHNPTVKDLIGFGLQVAKGMEYL---A 115
Query: 553 NVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS---DHSRTHTMIRGTRGYVAPEWLK 609
+ +H D+ +N +LD F+ K++DFGL++ + HT + ++A E L+
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 610 NAPVSAKVDVYSFGVMLLEII 630
+ K DV+SFGV+L E++
Sbjct: 176 TQKFTTKSDVWSFGVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 8e-19
Identities = 60/193 (31%), Positives = 94/193 (48%), Gaps = 7/193 (3%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
F +ELG G FG+V G + AI K+ + E EF E + + H+ LVQL
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAI---KMIKEGSMSEDEFIEEAKVMMKLSHEKLVQL 64
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLIFAIPK-PDWNLRVRISLEIARGLVYLHEGCNVPI 556
G C + +V E+M NG L N + K + + + ++ G+ YL
Sbjct: 65 YGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QF 121
Query: 557 IHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAK 616
IH D+ +N L+D K+SDFGLS+ +L D + + + PE L + S+K
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSK 181
Query: 617 VDVYSFGVMLLEI 629
DV++FGV++ E+
Sbjct: 182 SDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 8e-19
Identities = 66/193 (34%), Positives = 100/193 (51%), Gaps = 19/193 (9%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVK--KLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG 499
+G+G FG V G + GN +AVK K D AQ F +E S + + H NLVQLLG
Sbjct: 14 IGKGEFGDVMLGDYR---GNKVAVKCIKNDATAQA----FLAEASVMTQLRHSNLVQLLG 66
Query: 500 FCDEALNRL-LVYEFMGNGTLANLIFAIPKP--DWNLRVRISLEIARGLVYLHEGCNVPI 556
E L +V E+M G+L + + + + + ++ SL++ + YL E N
Sbjct: 67 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-EANN--F 123
Query: 557 IHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAK 616
+H D+ +N+L+ K+SDFGL+K + S T + + APE L+ S K
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTK 179
Query: 617 VDVYSFGVMLLEI 629
DV+SFG++L EI
Sbjct: 180 SDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (216), Expect = 9e-19
Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNL 494
F + LG GSFG V V SG A+K L + + ++ +E + H L
Sbjct: 5 FIKTLGTGSFGRV-MLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFL 63
Query: 495 VQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRV--RISLEIAR--------G 544
V L G + N LV E++ G L + LR R +AR
Sbjct: 64 VNLYGSFQDDSNLYLVMEYVPGGELFSH----------LRKSGRFPEPVARFYAAQVVLA 113
Query: 545 LVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVA 604
L YLH + I++ D+KP+N+LLD KI+DFG +K + RT+T+ GT Y+A
Sbjct: 114 LEYLH-SLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVK---GRTYTLC-GTPEYLA 166
Query: 605 PEWLKNAPVSAKVDVYSFGVMLLEIIC 631
PE + + VD ++ G+++ E++
Sbjct: 167 PEIILSKGYGKAVDWWALGILIYEMLA 193
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 74/281 (26%), Positives = 130/281 (46%), Gaps = 48/281 (17%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQERE--REFKSEVSAIGRTHHKNLV 495
E +G G+ +VY + + +A+K++D L + + E + EV A+ + +H N+V
Sbjct: 5 LIEVIGVGATAVVYAAICL-PNNEKVAIKRID-LEKCQTSVDELRKEVQAMSQCNHPNVV 62
Query: 496 QLLGFCDEALNRLL--VYEFMGNGTLANLI-FAIPKP--DWNLRVRISLEIARGLVYLHE 550
+ + + L V ++ G+L +++ + P+ D + + E+ +GL YLH
Sbjct: 63 KY--YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120
Query: 551 GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM---IRGTRGYVAPEW 607
IH DIK NILL S KI+DFG+S L RT + GT ++APE
Sbjct: 121 NGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177
Query: 608 LKNAP-VSAKVDVYSFGVMLLEIICCR---------RSVEMELEEESRAILTDWAYDCYV 657
++ K D++SFG+ +E+ + + + L+ + ++ T Y Y
Sbjct: 178 MEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKY- 236
Query: 658 EGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPT 698
S+ + MI++ C+Q+DPSKRPT
Sbjct: 237 ------------------SKSFR-KMISL-CLQKDPSKRPT 257
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 64/197 (32%), Positives = 102/197 (51%), Gaps = 16/197 (8%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKS---EVSAIGRTHHKNLVQLL 498
+G G++GIVY+ T SG +A+KK+ R+ ER+ S E++ + H N+V+L
Sbjct: 15 IGEGTYGIVYRA-RDTTSGEIVALKKV-RMDNERDGIPISSLREITLLLNLRHPNIVELK 72
Query: 499 GFC--DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR-ISLEIARGLVYLHEGCNVP 555
+ LV E+ LA+L+ +P P +V+ + L++ RGL YLHE
Sbjct: 73 EVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--- 128
Query: 556 IIHCDIKPQNILLDHYFSPKISDFGLSKLL-LSDHSRTHTMIRGTRGYVAPEWLKNAPVS 614
IIH D+K N+LL KI+DFGL++ L T ++ T Y APE L
Sbjct: 129 IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV--TLWYRAPELLLGCTTY 186
Query: 615 AK-VDVYSFGVMLLEII 630
+D+++ G +L E++
Sbjct: 187 TTAIDMWAVGCILAELL 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 63/202 (31%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAI--AVKKL--DRLAQEREREFKSEVSAIGRTHHKNLV 495
++LG GSFG+V +G T+ G I AVK L D+L + +F E + + H+NL+
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL-SDIMDDFLKEAAIMHSLDHENLI 59
Query: 496 QLLGFC-DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRV--RISLEIARGLVYLHEGC 552
+L G L ++V E G+L + + + + +++IA G+ YL
Sbjct: 60 RLYGVVLTHPL--MMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK- 116
Query: 553 NVPIIHCDIKPQNILLDHYFSP---KISDFGLSKLLL--SDHSRTHTMIRGTRGYVAPEW 607
IH D+ +NILL S KI DFGL + L DH ++ + APE
Sbjct: 117 --RFIHRDLAARNILL---ASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPES 171
Query: 608 LKNAPVSAKVDVYSFGVMLLEI 629
L+ S DV+ FGV L E+
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 60/201 (29%), Positives = 98/201 (48%), Gaps = 16/201 (7%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKS---EVSAIGRTHHKNLVQLL 498
+ +G++G V+ K ++G+ A+K + + R+ + E + + +V+L
Sbjct: 1 ISKGAYGRVFL-AKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY 59
Query: 499 -GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPII 557
F + N LV E++ G LA+L+ + D ++ EI L YLH + II
Sbjct: 60 YSFQGKK-NLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLH---SNGII 115
Query: 558 HCDIKPQNILLDHYFSPKISDFGLSK-------LLLSDHSRTHTMIRGTRGYVAPEWLKN 610
H D+KP NIL+D K++DFGLSK + L+D + I GT Y+APE +
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG 175
Query: 611 APVSAKVDVYSFGVMLLEIIC 631
S VD +S G +L E +
Sbjct: 176 QGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 66/211 (31%), Positives = 107/211 (50%), Gaps = 33/211 (15%)
Query: 442 LGRGSFGIVYKGVLKTASGNA----IAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQ 496
LG G+FG VY+G+ + G+A +AVK L ++ E +F E + + +H+N+V+
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 497 LLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPD--WNLRVR----ISLEIARGLVYLH 549
L+G E L R ++ E M G L + L P+P+ +L ++ + ++A+G YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 550 EGCNVPIIHCDIKPQNILLDHYFSP------KISDFGLSKLLLSDHSRTHTMIRGTRG-- 601
E IH DI +N LL KI+DFG+++ D R +G R
Sbjct: 134 EN---HFIHRDIAARNCLLT---CKGPGRVAKIADFGMAR----DIYRASYYRKGGRAML 183
Query: 602 ---YVAPEWLKNAPVSAKVDVYSFGVMLLEI 629
++ PE + ++K DV+SFGV+L EI
Sbjct: 184 PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 74/216 (34%), Positives = 106/216 (49%), Gaps = 14/216 (6%)
Query: 442 LGRGSFGIVYKGVLK-TASGNAIAVKKLDRLAQEREREF----KSEVSAIGRTHHKNLVQ 496
LG+GSFG V LK T A+ V K D + Q+ + E K ++ G+ H L Q
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGK--HPFLTQ 60
Query: 497 LLGFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVP 555
L C + +RL V E++ G L I + D + EI GL +LHE
Sbjct: 61 LHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER---G 116
Query: 556 IIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSA 615
II+ D+K N+LLD KI+DFG+ K + T T GT Y+APE L P
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC-GTPDYIAPEILSYQPYGP 175
Query: 616 KVDVYSFGVMLLEIICCRRSVEMELEEES-RAILTD 650
VD ++ GV+L E++ + E + E+E ++IL D
Sbjct: 176 AVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED 211
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 82/291 (28%), Positives = 134/291 (46%), Gaps = 50/291 (17%)
Query: 442 LGRGSFGIVYKGVLKTASGNA-----IAVKKLDRLAQERER-EFKSEVSAIGRTHHKNLV 495
LG G+FG VY+G G +AVK L + A ++E+ EF E + +H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 496 QLLGFCDEALNRLLVYEFMGNGTLANLIFA-----IPKPDWNLR--VRISLEIARGLVYL 548
+LLG C + ++ E M G L + + P L+ + I L++A+G VYL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 549 HEGCNVPIIHCDIKPQNILLDH--YFSP---KISDFGLSK-LLLSDHSRTHTMIRGTR-- 600
+ + IH D+ +N L+ Y + KI DFGL++ + SD+ R G
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYR----KEGEGLL 175
Query: 601 --GYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYV- 657
++APE L + + + DV+SFGV++ EI + L ++ L + +V
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEI--------LTLGQQPYPALNNQEVLQHVT 227
Query: 658 -EGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLE 707
GRL + + LM W +DPS+RPT + ++L+
Sbjct: 228 AGGRLQKPENCPDKIYQ--------LMTNCW--AQDPSERPTFDRIQEILQ 268
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 4e-18
Identities = 59/190 (31%), Positives = 98/190 (51%), Gaps = 6/190 (3%)
Query: 441 ELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGF 500
++G GS GIV K +G +AVKK+D Q+R +EV + HH+N+V +
Sbjct: 29 KIGEGSTGIVCIATEK-HTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNS 87
Query: 501 CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCD 560
+V EF+ G L +++ + + + L + R L YLH N +IH D
Sbjct: 88 YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-ATVCLSVLRALSYLH---NQGVIHRD 143
Query: 561 IKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVY 620
IK +ILL K+SDFG + + + +++ GT ++APE + P +VD++
Sbjct: 144 IKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEVDIW 202
Query: 621 SFGVMLLEII 630
S G+M++E+I
Sbjct: 203 SLGIMVIEMI 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 4e-18
Identities = 36/111 (32%), Positives = 49/111 (44%), Gaps = 12/111 (10%)
Query: 1 TIIWHANEDNHPVLAPRGSTLELTATG-LLLKDPGGQAIW--DEKPNKIVSDAAMLDTGN 57
T++W AN N L TL L + G L+L D G+ +W + A + D GN
Sbjct: 3 TVVWVANRLNP--LTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGN 60
Query: 58 FVLIASGNHSDYAWQSFKSPTDTILPTQILDLGSV-----LVSRLTETNLS 103
VL + WQSF PTDT+LP Q + L S + T+ S
Sbjct: 61 LVLYDNSG--KVLWQSFDHPTDTLLPGQKDGNVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 4e-18
Identities = 66/197 (33%), Positives = 94/197 (47%), Gaps = 14/197 (7%)
Query: 439 KEELGRGSFGIVYKGVLKTASGNA-IAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
+ +LG G FG V+ G T +G +AVK L E F E + + H LVQL
Sbjct: 11 ERKLGAGQFGEVWMG---TWNGTTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQL 66
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR----VRISLEIARGLVYLHEGCN 553
C E +V E+M G+L L F LR V ++ +IA G+ YL E N
Sbjct: 67 YAVCSEEEPIYIVTEYMSKGSL--LDFLKSGEGKKLRLPQLVDMAAQIAEGMAYL-ESRN 123
Query: 554 VPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPV 613
IH D+ +NIL+ KI+DFGL++L+ D + + APE
Sbjct: 124 Y--IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRF 181
Query: 614 SAKVDVYSFGVMLLEII 630
+ K DV+SFG++L EI+
Sbjct: 182 TIKSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 4e-18
Identities = 65/224 (29%), Positives = 105/224 (46%), Gaps = 41/224 (18%)
Query: 426 FSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQERE-REFKSEVS 484
F+ ++LKD E+GRG+FG V K +L SG +AVK++ E+E + ++
Sbjct: 1 FTAEDLKD-----LGEIGRGAFGTVNK-MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLD 54
Query: 485 AIGRTHH-KNLVQLLG---------FC----DEALNRL--LVYEFMGNGTLANLIFAIPK 528
+ R+ +V+ G C D +L++ VYE + + I
Sbjct: 55 VVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYE-VLKSVIPEEILG--- 110
Query: 529 PDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD 588
+I++ + L YL E + IIH D+KP NILLD + K+ DFG+S L+
Sbjct: 111 -------KIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161
Query: 589 HSRTHTMIRGTRGYVAPEWL---KNAPVSAKVDVYSFGVMLLEI 629
++T G R Y+APE + + DV+S G+ L E+
Sbjct: 162 IAKTRDA--GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEV 203
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 5e-18
Identities = 77/219 (35%), Positives = 112/219 (51%), Gaps = 20/219 (9%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVK--KLDRLAQERERE---FKSEVSAIGRTHHKNLVQ 496
LG+GSFG V LK SG AVK K D + Q+ + E + + ++ R +H L Q
Sbjct: 3 LGKGSFGKVMLARLKE-SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQ 60
Query: 497 LLGFCDEALNRLL-VYEFMGNGTLANLIFAIPKP---DWNLRVRISLEIARGLVYLHEGC 552
L C + +RL V EF+ G +L+F I K D + EI L++LH+
Sbjct: 61 LY-CCFQTPDRLFFVMEFVNGG---DLMFHIQKSRRFDEARARFYAAEITSALMFLHDK- 115
Query: 553 NVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAP 612
II+ D+K N+LLDH K++DFG+ K + + T T GT Y+APE L+
Sbjct: 116 --GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC-GTPDYIAPEILQEML 172
Query: 613 VSAKVDVYSFGVMLLEIICCRRSVEMELEEE-SRAILTD 650
VD ++ GV+L E++C E E E++ AIL D
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 211
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 5e-18
Identities = 62/197 (31%), Positives = 98/197 (49%), Gaps = 14/197 (7%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKNLVQLL 498
LG G+ G V K LK +G A+K + + +++ E+ +V+
Sbjct: 7 SRLGEGAGGSVTKCRLK-NTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYY 65
Query: 499 G-FCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIA----RGLVYLHEGC 552
G F DE+ + + + E+ G+L ++ + K + ++ +IA +GL YLH
Sbjct: 66 GAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR- 124
Query: 553 NVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAP 612
IIH DIKP NILL K+ DFG+S L++ + T T GT Y+APE ++ P
Sbjct: 125 --KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT---GTSFYMAPERIQGKP 179
Query: 613 VSAKVDVYSFGVMLLEI 629
S DV+S G+ LLE+
Sbjct: 180 YSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 6e-18
Identities = 62/205 (30%), Positives = 103/205 (50%), Gaps = 25/205 (12%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQERE-------REFKSEVSAIGRTHHK 492
E+G G++G VYK +G +A+KK+ R+ E RE + + + H
Sbjct: 5 AEIGEGAYGTVYKARDLN-TGRFVALKKV-RVPLSEEGIPLSTLREI-ALLKQLESFEHP 61
Query: 493 NLVQLLGFC-----DEALNRLLVYEFMGNGTLANLIFAIPKP---DWNLRVRISLEIARG 544
N+V+LL C D L LV+E + + LA + PKP ++ + ++ RG
Sbjct: 62 NIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIK-DLMRQLLRG 119
Query: 545 LVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVA 604
+ +LH I+H D+KPQNIL+ KI+DFGL+++ + + T ++ T Y A
Sbjct: 120 VDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV--TLWYRA 174
Query: 605 PEWLKNAPVSAKVDVYSFGVMLLEI 629
PE L + + VD++S G + E+
Sbjct: 175 PEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 6e-18
Identities = 65/202 (32%), Positives = 103/202 (50%), Gaps = 15/202 (7%)
Query: 438 FKEELGRGSFGIVYK---GVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNL 494
F ++LG+G+FG V L+ +G +AVKKL E R+F+ E+ + H N+
Sbjct: 8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67
Query: 495 VQLLGFCDEA--LNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIARGLVYLHEG 551
V+ G C A N LV E++ G+L + L + D + + +I +G+ YL
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS- 126
Query: 552 CNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIR--GTRG--YVAPEW 607
+H D+ +NIL++ KI DFGL+K+L D + + +R G + APE
Sbjct: 127 --KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD--KEYYKVREPGESPIFWYAPES 182
Query: 608 LKNAPVSAKVDVYSFGVMLLEI 629
L + S DV+SFGV+L E+
Sbjct: 183 LTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 7e-18
Identities = 63/210 (30%), Positives = 102/210 (48%), Gaps = 16/210 (7%)
Query: 426 FSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSA 485
+ YDE + + LG+G++GIVY ++ IA+K++ + E++
Sbjct: 5 YEYDENGE-----RVVLGKGTYGIVYAA-RDLSTQVRIAIKEIPERDSRYVQPLHEEIAL 58
Query: 486 IGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLI---FAIPKPDWNLRVRISLEIA 542
H+N+VQ LG E + E + G+L+ L+ + K + + + +I
Sbjct: 59 HSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL 118
Query: 543 RGLVYLHEGCNVPIIHCDIKPQNILLDHYFSP-KISDFGLSKLLLSDHSRTHTMIRGTRG 601
GL YLH+ I+H DIK N+L++ Y KISDFG SK L + T T GT
Sbjct: 119 EGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF-TGTLQ 174
Query: 602 YVAPEWLKNAP--VSAKVDVYSFGVMLLEI 629
Y+APE + P A D++S G ++E+
Sbjct: 175 YMAPEVIDKGPRGYGAPADIWSLGCTIVEM 204
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 7e-18
Identities = 63/201 (31%), Positives = 98/201 (48%), Gaps = 21/201 (10%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKS----EVSAIGRTHHKNLV 495
+G G++G+V K K A+G +A+KK E + + K EV + + H+N+V
Sbjct: 7 GVVGEGAYGVVLKCRNK-ATGEIVAIKKF--KESEDDEDVKKTALREVKVLRQLRHENIV 63
Query: 496 QLLGFCDEALNRL-LVYEFMGNGTLANLIFAIPK---PDWNLRVR-ISLEIARGLVYLHE 550
L RL LV+E++ TL L+ A P PD VR ++ + + Y H
Sbjct: 64 NLKEAFRRK-GRLYLVFEYVER-TLLELLEASPGGLPPD---AVRSYIWQLLQAIAYCHS 118
Query: 551 GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWL-K 609
IIH DIKP+NIL+ K+ DFG ++ L + + T TR Y APE L
Sbjct: 119 H---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVG 175
Query: 610 NAPVSAKVDVYSFGVMLLEII 630
+ VDV++ G ++ E++
Sbjct: 176 DTNYGKPVDVWAIGCIMAELL 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 8e-18
Identities = 69/274 (25%), Positives = 118/274 (43%), Gaps = 31/274 (11%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
F +ELG G FG+V+ G K + +A+K ++ A E +F E + + H LVQL
Sbjct: 8 FMKELGSGQFGVVHLG--KWRAQIKVAIKAINEGAMS-EEDFIEEAKVMMKLSHPKLVQL 64
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLI---FAIPKPDWNLRVRISLEIARGLVYLHEGCNV 554
G C + +V EFM NG L N + D + + + ++ G+ YL
Sbjct: 65 YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKD--MLLSMCQDVCEGMEYLERN--- 119
Query: 555 PIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVS 614
IH D+ +N L+ K+SDFG+++ +L D + + + + PE + S
Sbjct: 120 SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYS 179
Query: 615 AKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMAD 674
+K DV+SFGV++ E+ + M E++S + +
Sbjct: 180 SKSDVWSFGVLMWEVFTEGK---MPFEKKS---------------NYEVVEMISRGFRLY 221
Query: 675 RSRL--HKWLMIAMWCIQEDPSKRPTMKVVMQML 706
R +L + C E P RPT +++ +
Sbjct: 222 RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 56/196 (28%), Positives = 96/196 (48%), Gaps = 11/196 (5%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKL--DRLAQEREREFKS---EVSAIGRTHHKNLVQ 496
LG+G+FG VY +G +AVK++ D + E ++E + E+ + H+ +VQ
Sbjct: 10 LGQGAFGRVYLCY-DVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 497 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPI 556
G + + E+M G++ + + A + + + +I G+ YLH I
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN---MI 125
Query: 557 IHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM--IRGTRGYVAPEWLKNAPVS 614
+H DIK NIL D + K+ DFG SK L + S M + GT +++PE +
Sbjct: 126 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYG 185
Query: 615 AKVDVYSFGVMLLEII 630
K DV+S G ++E++
Sbjct: 186 RKADVWSVGCTVVEML 201
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 58/205 (28%), Positives = 100/205 (48%), Gaps = 30/205 (14%)
Query: 442 LGRGSFGIVYKGVLKTASGNA---IAVKKL-DRLAQEREREFKSEVSAIGRTHHKNLVQL 497
LG G+FG VYKGV +A+K L + + + +E E + H ++V+L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRI----SLEIARGLVYLHEGCN 553
LG C + L+ + M L L+ + N+ + ++IA+G+ YL E
Sbjct: 75 LGICLSS-QVQLITQLM---PLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE--- 127
Query: 554 VPIIHCDIKPQNILLDHYFSP---KISDFGLSKLLLSDHSRTH-----TMIRGTRGYVAP 605
++H D+ +N+L+ +P KI+DFGL+KLL D H I+ ++A
Sbjct: 128 KRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK----WMAL 180
Query: 606 EWLKNAPVSAKVDVYSFGVMLLEII 630
E + + + K DV+S+GV + E++
Sbjct: 181 ESILHRIYTHKSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 53/196 (27%), Positives = 101/196 (51%), Gaps = 11/196 (5%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQERE-REFKSEVSAIGRTHH---KNLV 495
E +GRG++G VY+G +G +A+K ++ + + + + EV+ + + N+
Sbjct: 7 ELIGRGAYGAVYRGK-HVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNIT 65
Query: 496 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVP 555
+ G + ++ E+ G++ L+ A P + + V I E+ L Y+H+ V
Sbjct: 66 KYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV-IIREVLVALKYIHK---VG 121
Query: 556 IIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPV-S 614
+IH DIK NIL+ + + K+ DFG++ LL + S+ T + GT ++APE +
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKYYD 180
Query: 615 AKVDVYSFGVMLLEII 630
K D++S G+ + E+
Sbjct: 181 TKADIWSLGITIYEMA 196
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 64/206 (31%), Positives = 105/206 (50%), Gaps = 22/206 (10%)
Query: 442 LGRGSFGIVYKGVLKTASGNA--IAVK--KLDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
LG G FG V +G L G+ +AVK KLD EF SE + + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 498 LGFCDEALNR------LLVYEFMGNGTLANLIFA-----IPK--PDWNLRVRISLEIARG 544
+G C EA + +++ FM +G L + + +P+ P L ++ ++IA G
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTL-LKFMVDIALG 125
Query: 545 LVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS-DHSRTHTMIRGTRGYV 603
+ YL N IH D+ +N +L + ++DFGLSK + S D+ R + + ++
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 604 APEWLKNAPVSAKVDVYSFGVMLLEI 629
A E L + ++K DV++FGV + EI
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEI 208
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 54/191 (28%), Positives = 101/191 (52%), Gaps = 7/191 (3%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQERERE-FKSEVSAIGRTHHKNLVQLL 498
E +G+GSFG V+KG+ + +A+K +D E E E + E++ + + + +
Sbjct: 10 ERIGKGSFGEVFKGI-DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68
Query: 499 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIH 558
G + ++ E++G G+ +L+ A P ++ + + EI +GL YLH IH
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK-EILKGLDYLHSEKK---IH 124
Query: 559 CDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVD 618
DIK N+LL K++DFG++ L + +T + GT ++APE ++ + +K D
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYDSKAD 183
Query: 619 VYSFGVMLLEI 629
++S G+ +E+
Sbjct: 184 IWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 67/198 (33%), Positives = 101/198 (51%), Gaps = 21/198 (10%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG 499
E LG+G+FG V+KG LK + A+ K D L QE + +F SE + + H N+V+L+G
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKED-LPQELKIKFLSEARILKQYDHPNIVKLIG 59
Query: 500 FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR----VRISLEIARGLVYLH-EGCNV 554
C + +V E + G L F K D L+ V+ +L+ A G+ YL + C
Sbjct: 60 VCTQRQPIYIVMELVPGGDF--LSFLRKKKD-ELKTKQLVKFALDAAAGMAYLESKNC-- 114
Query: 555 PIIHCDIKPQNILLDHYFSPKISDFGLSKL----LLSDHSRTHTMIRGTRGYVAPEWLKN 610
IH D+ +N L+ KISDFG+S+ + S I+ T APE L
Sbjct: 115 --IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWT----APEALNY 168
Query: 611 APVSAKVDVYSFGVMLLE 628
S++ DV+S+G++L E
Sbjct: 169 GRYSSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-17
Identities = 53/204 (25%), Positives = 100/204 (49%), Gaps = 18/204 (8%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLD---RLAQERER---EFKSEVSAIGRTHHKN 493
++LG G+F Y +G +AVK++ + E+E + E+ + R +H +
Sbjct: 6 QQLGTGAFSSCY-QARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 494 LVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCN 553
++++LG E + L E+M G++++L+ + + + ++ RGL YLHE
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN-- 122
Query: 554 VPIIHCDIKPQNILLD---HYFSPKISDFGLSKLLLSDHSRT---HTMIRGTRGYVAPEW 607
IIH D+K N+L+D +I+DFG + L + + + GT ++APE
Sbjct: 123 -QIIHRDVKGANLLIDSTGQRL--RIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179
Query: 608 LKNAPVSAKVDVYSFGVMLLEIIC 631
L+ DV+S G +++E+
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMAT 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 30/219 (13%)
Query: 431 LKDATDGFK--EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGR 488
L+D F+ E +G G++G VYKG +G A+K +D + ++ E E K E++ + +
Sbjct: 11 LRDPAGIFELVEVVGNGTYGQVYKG-RHVKTGQLAAIKVMD-VTEDEEEEIKLEINMLKK 68
Query: 489 -THHKNLVQLLGFC--------DEALNRLLVYEFMGNGTLANLIFAIP----KPDWNLRV 535
+HH+N+ G D+ L LV EF G G++ +L+ K DW
Sbjct: 69 YSHHRNIATYYGAFIKKSPPGHDDQL--WLVMEFCGAGSVTDLVKNTKGNALKEDW--IA 124
Query: 536 RISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM 595
I EI RGL +LH +IH DIK QN+LL K+ DFG+S L R +T
Sbjct: 125 YICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF 181
Query: 596 IRGTRGYVAPEWLK-----NAPVSAKVDVYSFGVMLLEI 629
I GT ++APE + +A + D++S G+ +E+
Sbjct: 182 I-GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 66/206 (32%), Positives = 90/206 (43%), Gaps = 31/206 (15%)
Query: 443 GRGSFGIVYKGVLKTASGNAIAVK---KLDRLAQEREREFKSEVSAIGRTHHKNLVQL-L 498
G+G+FG V V K + A+K K + + R +E + +H LV L
Sbjct: 9 GKGAFGKVCI-VQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67
Query: 499 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNL---------RVRISL-EIARGLVYL 548
F DE N LV + + G L ++L +V+ + EI L YL
Sbjct: 68 SFQDEE-NMYLVVDLLLGGDLR----------YHLSQKVKFSEEQVKFWICEIVLALEYL 116
Query: 549 HEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWL 608
H IIH DIKP NILLD I+DF ++ + D T T GT GY+APE L
Sbjct: 117 HSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS--GTPGYMAPEVL 171
Query: 609 KNAPVSAKVDVYSFGVMLLEIICCRR 634
S VD +S GV E + +R
Sbjct: 172 CRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 5e-17
Identities = 84/297 (28%), Positives = 133/297 (44%), Gaps = 52/297 (17%)
Query: 442 LGRGSFGIV----YKGVLKTASGNAIAVKKLDRLAQERE-REFKSEVS---AIGRTHHKN 493
LG G+FG V G+ + +AVK L A E++ + SE+ IG+ HKN
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--HKN 77
Query: 494 LVQLLGFCDEALNRLLVYEFM--GN-----------GTLANLIFAIPKPDWNLR----VR 536
++ LLG C + +V E+ GN G A+ P P+ L V
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRP-PEETLTQKDLVS 136
Query: 537 ISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS-DHSRTHTM 595
+ ++ARG+ +L + IH D+ +N+L+ KI+DFGL++ + D+ R T
Sbjct: 137 FAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN 193
Query: 596 IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDC 655
R ++APE L + + + DV+SFGV+L EI S I + +
Sbjct: 194 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGS-------PYPGIPVEELFKL 246
Query: 656 YVEG-RLD-ALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710
EG R++ + E LM W E PS+RPT K +++ L+ +L
Sbjct: 247 LKEGYRMEKPQNCTQELYH---------LMRDCW--HEVPSQRPTFKQLVEDLDRML 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 5e-17
Identities = 72/288 (25%), Positives = 124/288 (43%), Gaps = 46/288 (15%)
Query: 435 TDGFKEE--LGRGSFGIVYKGVLKTASGNAIAVKKLDRL----AQEREREFKSEVSAIGR 488
FK E +G+G F +VYK + G +A+KK+ A+ R+ K E+ + +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAI-CLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQ 58
Query: 489 THHKNLVQLL-GFCDEALNRL-LVYEFMGNGTLANLI--FA-----IPKPD-WNLRVRIS 538
H N+++ L F + N L +V E G L+ +I F IP+ W V
Sbjct: 59 LDHPNVIKYLASFIEN--NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFV--- 113
Query: 539 LEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRG 598
++ L ++H I+H DIKP N+ + K+ D GL + S + H+++ G
Sbjct: 114 -QLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-G 168
Query: 599 TRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVE 658
T Y++PE + + K D++S G +L E+ + + + L
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD-----KMNLYS-------- 215
Query: 659 GRLDALIDSDEAAMADRSRLHKWL--MIAMWCIQEDPSKRPTMKVVMQ 704
L I+ + + L +++ CI DP KRP + V+Q
Sbjct: 216 --LCKKIEKCDYPPLPADHYSEELRDLVSR-CINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 6e-17
Identities = 58/194 (29%), Positives = 96/194 (49%), Gaps = 12/194 (6%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKS----EVSAIGRTHHKNLVQL 497
+G GS+G+V K K +G +A+KK L E ++ K E+ + + H+NLV L
Sbjct: 9 VGEGSYGMVMKCKHKE-TGQIVAIKKF--LESEDDKMVKKIAMREIRMLKQLRHENLVNL 65
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPII 557
+ LV+EF+ + L +L D + + +I RG+ + H + II
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH---SHNII 122
Query: 558 HCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAK- 616
H DIKP+NIL+ K+ DFG ++ L + +T TR Y APE L +
Sbjct: 123 HRDIKPENILVSQSGVVKLCDFGFARTLAAP-GEVYTDYVATRWYRAPELLVGDTKYGRA 181
Query: 617 VDVYSFGVMLLEII 630
VD+++ G ++ E++
Sbjct: 182 VDIWAVGCLVTEML 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 6e-17
Identities = 66/248 (26%), Positives = 110/248 (44%), Gaps = 40/248 (16%)
Query: 438 FKEELGRGSFGIVY----KGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKN 493
K ELG G+FG V+ +L +AVK L ++ ++F+ E + H++
Sbjct: 9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQH 68
Query: 494 LVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNL----------------RVRI 537
+V+ G C E L+V+E+M +G L N PD + + I
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 538 SLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH-----SRT 592
+ +IA G+VYL ++ +H D+ +N L+ KI DFG+S+ + S RT
Sbjct: 128 ASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 184
Query: 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWA 652
IR ++ PE + + + D++SFGV+L EI + +L A
Sbjct: 185 MLPIR----WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE-------A 233
Query: 653 YDCYVEGR 660
+C +GR
Sbjct: 234 IECITQGR 241
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 6e-17
Identities = 73/219 (33%), Positives = 109/219 (49%), Gaps = 30/219 (13%)
Query: 431 LKDATDGFK--EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGR 488
L+D F+ E +G G++G VYKG +G A+K +D E E E K E++ + +
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKG-RHVKTGQLAAIKVMDVTGDEEE-EIKQEINMLKK 58
Query: 489 -THHKNLVQLLGF--------CDEALNRLLVYEFMGNGTLANLIFAIP----KPDWNLRV 535
+HH+N+ G D+ L LV EF G G++ +LI K +W
Sbjct: 59 YSHHRNIATYYGAFIKKNPPGMDDQL--WLVMEFCGAGSVTDLIKNTKGNTLKEEW--IA 114
Query: 536 RISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM 595
I EI RGL +LH+ +IH DIK QN+LL K+ DFG+S L R +T
Sbjct: 115 YICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF 171
Query: 596 IRGTRGYVAPEWLK-----NAPVSAKVDVYSFGVMLLEI 629
I GT ++APE + +A K D++S G+ +E+
Sbjct: 172 I-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 7e-17
Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 30/207 (14%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKS---EVSAIGRTHH-KNLV 495
EELGRG++G+V K + +G +AVK++ A +E K ++ R+ V
Sbjct: 7 EELGRGAYGVVDK-MRHVPTGTIMAVKRIR--ATVNSQEQKRLLMDLDISMRSVDCPYTV 63
Query: 496 QLLG---------FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLV 546
G C E ++ L +F L IP+ + +I++ I + L
Sbjct: 64 TFYGALFREGDVWICMEVMDTSL-DKFYKKVYDKGL--TIPED---ILGKIAVSIVKALE 117
Query: 547 YLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPE 606
YLH +V IH D+KP N+L++ K+ DFG+S L+ ++ T+ G + Y+APE
Sbjct: 118 YLHSKLSV--IHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK--TIDAGCKPYMAPE 173
Query: 607 W----LKNAPVSAKVDVYSFGVMLLEI 629
L K DV+S G+ ++E+
Sbjct: 174 RINPELNQKGYDVKSDVWSLGITMIEL 200
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 7e-17
Identities = 58/198 (29%), Positives = 97/198 (48%), Gaps = 15/198 (7%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVK--KLDRLAQEREREFKSEVSAIGRTHHKNLV 495
+ +G G++G VYK A+G +A+K KL+ + + E+S + H N+V
Sbjct: 7 LIQRIGSGTYGDVYKAR-DIATGELVAIKVIKLE--PGDDFEIIQQEISMLKECRHPNIV 63
Query: 496 QLLGFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVR-ISLEIARGLVYLHEGCN 553
G ++L +V E+ G G+L ++ P L++ + E +GL YLHE
Sbjct: 64 AYFG-SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE--- 119
Query: 554 VPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWL---KN 610
IH DIK NILL K++DFG+S L + ++ + I GT ++APE +
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAVERK 178
Query: 611 APVSAKVDVYSFGVMLLE 628
K D+++ G+ +E
Sbjct: 179 GGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 8e-17
Identities = 66/221 (29%), Positives = 107/221 (48%), Gaps = 17/221 (7%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKS---EVSAIGRTHHKNLVQLL 498
LG+G FG V ++ A+G A KKL++ ++ + ++ E + + H + +V L
Sbjct: 1 LGKGGFGEVSACQMR-ATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLA 59
Query: 499 GFCDEALNRLLVYEFMGNGTLANLIFAI----PKPDWNLRVRISLEIARGLVYLHEGCNV 554
+ LV M G L I+ + P + +I GL +LH+
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR--- 116
Query: 555 PIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVS 614
II+ D+KP+N+LLD+ + +ISD GL+ L S+T GT G++APE L+
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-GTPGFMAPELLQGEEYD 175
Query: 615 AKVDVYSFGVMLLEIICCR-----RSVEMELEEESRAILTD 650
VD ++ GV L E+I R R ++E +E + IL D
Sbjct: 176 FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND 216
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 9e-17
Identities = 69/270 (25%), Positives = 132/270 (48%), Gaps = 27/270 (10%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVK--KLDRLAQEREREFKSEVSAIGRTHHKNLV 495
++E LG G+ G VYK + +AVK LD + E +++ SE+ + + ++
Sbjct: 5 YQEILGHGNGGTVYK-AYHLLTRRILAVKVIPLD-ITVELQKQIMSELEILYKCDSPYII 62
Query: 496 QLLG-FCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCN 553
G F E NR+ + EFM G+L ++ IP+ + RI++ + +GL YL +
Sbjct: 63 GFYGAFFVE--NRISICTEFMDGGSL-DVYRKIPEH---VLGRIAVAVVKGLTYL---WS 113
Query: 554 VPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPV 613
+ I+H D+KP N+L++ K+ DFG+S L++ ++T+ GT Y+APE +
Sbjct: 114 LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV---GTNAYMAPERISGEQY 170
Query: 614 SAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMA 673
DV+S G+ +E+ R ++++ +++ C ++D D +
Sbjct: 171 GIHSDVWSLGISFMELALGRFPY-PQIQKNQGSLMPLQLLQC--------IVDEDPPVLP 221
Query: 674 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVM 703
K++ C+++ P +RP + +M
Sbjct: 222 VGQFSEKFVHFITQCMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 9e-17
Identities = 65/214 (30%), Positives = 99/214 (46%), Gaps = 25/214 (11%)
Query: 438 FKEELGRGSFGIVYKGVLKTAS---GNAIAVKKL-DRLAQEREREFKSEVSAIGRTHHKN 493
F EELG +FG +YKG L +A+K L D ++ EF+ E S + HH N
Sbjct: 9 FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68
Query: 494 LVQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLR----------------VR 536
+V LLG + +++E++ G L LI P D +
Sbjct: 69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 537 ISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS-DHSRTHTM 595
I+++IA G+ YL +H D+ +NIL+ KISD GLS+ + S D+ R
Sbjct: 129 IAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185
Query: 596 IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEI 629
++ PE + S+ D++SFGV+L EI
Sbjct: 186 SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 56/191 (29%), Positives = 98/191 (51%), Gaps = 7/191 (3%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQERERE-FKSEVSAIGRTHHKNLVQLL 498
E +G+GSFG VYKG+ + +A+K +D E E E + E++ + + + +
Sbjct: 10 ERIGKGSFGEVYKGI-DNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYY 68
Query: 499 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIH 558
G + ++ E++G G+ +L+ P + + I EI +GL YLH IH
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYI-ATILREILKGLDYLHSERK---IH 124
Query: 559 CDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVD 618
DIK N+LL K++DFG++ L + +T + GT ++APE +K + K D
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDFKAD 183
Query: 619 VYSFGVMLLEI 629
++S G+ +E+
Sbjct: 184 IWSLGITAIEL 194
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 25/204 (12%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQERE---REFKSEVSAIGRTHHKNLVQ 496
++G G++G VYK K +G +A+KK+ R+ E+E E+ + + H N+V+
Sbjct: 5 AQIGEGTYGQVYKARNKK-TGELVALKKI-RMENEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 497 LLGFCDEAL--NRLLVYEFMG---NGTLAN--LIFAIPKPDWNLRVRISLEIARGLVYLH 549
L + +V+E+M G L + + F ++ ++ GL YLH
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTES----QIK-CYMKQLLEGLQYLH 117
Query: 550 EGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHT--MIRGTRGYVAPEW 607
I+H DIK NIL+++ K++DFGL++ +S +T +I T Y PE
Sbjct: 118 -SNG--ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI--TLWYRPPEL 172
Query: 608 LKNAPV-SAKVDVYSFGVMLLEII 630
L A +VD++S G +L E+
Sbjct: 173 LLGATRYGPEVDMWSVGCILAELF 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 1e-16
Identities = 55/194 (28%), Positives = 100/194 (51%), Gaps = 12/194 (6%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG 499
E++G+G+ G VY + A+G +A+K+++ Q ++ +E+ + H N+V L
Sbjct: 25 EKIGQGASGTVYTAI-DVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLD 83
Query: 500 ---FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPI 556
DE +V E++ G+L +++ + + + E + L +LH +
Sbjct: 84 SYLVGDELW---VVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLHSN---QV 136
Query: 557 IHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAK 616
IH DIK NILL S K++DFG + + S+ TM+ GT ++APE + K
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 195
Query: 617 VDVYSFGVMLLEII 630
VD++S G+M +E++
Sbjct: 196 VDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 41/210 (19%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRT-----------H 490
LG G++ +VYK +G +A+KK+ + E K I T
Sbjct: 8 LGEGTYAVVYKAR-DKETGRIVAIKKI------KLGERKEAKDGINFTALREIKLLQELK 60
Query: 491 HKNLVQLLG-FC-DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR------ISLEIA 542
H N++ LL F +N LV+EFM L +I D ++ + L
Sbjct: 61 HPNIIGLLDVFGHKSNIN--LVFEFME-TDLEKVI-----KDKSIVLTPADIKSYMLMTL 112
Query: 543 RGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR-THTMIRGTRG 601
RGL YLH I+H D+KP N+L+ K++DFGL++ S + + TH ++ TR
Sbjct: 113 RGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV--TRW 167
Query: 602 YVAPEWLKNAPV-SAKVDVYSFGVMLLEII 630
Y APE L A VD++S G + E++
Sbjct: 168 YRAPELLFGARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 79.4 bits (195), Expect = 3e-16
Identities = 55/191 (28%), Positives = 101/191 (52%), Gaps = 7/191 (3%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQERERE-FKSEVSAIGRTHHKNLVQLL 498
E++G+GSFG V+KG+ + +A+K +D E E E + E++ + + + +
Sbjct: 10 EKIGKGSFGEVFKGI-DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68
Query: 499 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIH 558
G + ++ E++G G+ +L+ P + + I EI +GL YLH IH
Sbjct: 69 GSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQI-ATILREILKGLDYLHSEKK---IH 124
Query: 559 CDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVD 618
DIK N+LL + K++DFG++ L + +T + GT ++APE +K + +K D
Sbjct: 125 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSKAD 183
Query: 619 VYSFGVMLLEI 629
++S G+ +E+
Sbjct: 184 IWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 79.8 bits (196), Expect = 3e-16
Identities = 52/191 (27%), Positives = 98/191 (51%), Gaps = 6/191 (3%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG 499
E++G+G+ G VY + A+G +A+K+++ Q ++ +E+ + + N+V L
Sbjct: 25 EKIGQGASGTVYTA-IDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 83
Query: 500 FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHC 559
+V E++ G+L +++ + + + E + L +LH +IH
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALDFLHSN---QVIHR 139
Query: 560 DIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDV 619
DIK NILL S K++DFG + + S+ TM+ GT ++APE + KVD+
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 198
Query: 620 YSFGVMLLEII 630
+S G+M +E++
Sbjct: 199 WSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 77/300 (25%), Positives = 132/300 (44%), Gaps = 54/300 (18%)
Query: 438 FKEELGRGSFGIVY----KGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKN 493
K ELG G+FG V+ + T +AVK L ++F+ E + H++
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 494 LVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRV-----------------R 536
+V+ G C + ++V+E+M +G L + A PD + V
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRA-HGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 537 ISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSK-LLLSDHSRT--H 593
I+ +IA G+VYL + +H D+ +N L+ KI DFG+S+ + +D+ R H
Sbjct: 128 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 184
Query: 594 TM--IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDW 651
TM IR ++ PE + + + DV+SFGV+L EI + +L
Sbjct: 185 TMLPIR----WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE------- 233
Query: 652 AYDCYVEGRLDALIDSDEAAMADRSRL--HKWLMIAMWCIQEDPSKRPTMKVVMQMLEGL 709
+C +GR+ +R R+ + I + C Q +P +R +K + ++L L
Sbjct: 234 VIECITQGRV-----------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-16
Identities = 76/303 (25%), Positives = 133/303 (43%), Gaps = 57/303 (18%)
Query: 442 LGRGSFGIVYKGVLKTASGNA----IAVKKLDRLAQERE-REFKSEVSAIGRTHHKNLVQ 496
LG G FG V K G A +AVK L A E R+ SE + + + +H ++++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 497 LLGFCDEALNRLLVYEFMGNGTL----------------------ANLIFAIPKPDWNLR 534
L G C + LL+ E+ G+L ++ + + +
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 535 VRISL--EIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592
IS +I+RG+ YL E + ++H D+ +N+L+ KISDFGLS+ + + S
Sbjct: 128 DLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS-- 182
Query: 593 HTMIRGTRG-----YVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAI 647
++ ++G ++A E L + + + DV+SFGV+L EI+ + + E
Sbjct: 183 --YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFN 240
Query: 648 LTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLE 707
L Y R++ + E LM+ W +++P KRPT + + LE
Sbjct: 241 LLKTGY------RMERPENCSEEMYN--------LMLTCW--KQEPDKRPTFADISKELE 284
Query: 708 GLL 710
++
Sbjct: 285 KMM 287
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 5e-16
Identities = 75/284 (26%), Positives = 119/284 (41%), Gaps = 34/284 (11%)
Query: 440 EELGRGSFGIVYKGVLKTASGNA-IAVKKLDRLAQERER-EFKSEVSAIGRTHHKNLVQL 497
+E+G G FG V G A + VK+L A E+ F EV +H N++Q
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLI-----FAIPKPDWNLRVRISLEIARGLVYLHEGC 552
LG C E++ LLV EF G L N + ++ R++ E+A GL++LH+
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-- 118
Query: 553 NVPIIHCDIKPQNILLDHYFSPKISDFGLS-KLLLSDHSRTHTMIRGTRGYVAPEW---- 607
IH D+ +N L S KI D+GL+ + D+ T ++APE
Sbjct: 119 -ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 608 ---LKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDAL 664
L + K +++S GV + E+ ++ L+D V D
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWEL--------FTAADQPYPDLSDEQVLKQVVREQDIK 229
Query: 665 IDSD--EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQML 706
+ + +DR W + +C DP RPT + V ++L
Sbjct: 230 LPKPQLDLKYSDR-----WYEVMQFCWL-DPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 6e-16
Identities = 64/197 (32%), Positives = 100/197 (50%), Gaps = 17/197 (8%)
Query: 441 ELGRGSFGIVYKGVLKTASG-NAIAVKKLDRLAQER--EREFKSEVSAIGRTHHKNLVQL 497
ELG G+FG V KG+ K +AVK L + + E E + + + + +V++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLIFAIPK--PDWNLRVRISLEIARGLVYLHEGCNVP 555
+G C EA + +LV E G L N K + N+ + +++ G+ YL E
Sbjct: 62 IGIC-EAESWMLVMELAELGPL-NKFLQKNKHVTEKNI-TELVHQVSMGMKYLEET---N 115
Query: 556 IIHCDIKPQNILL--DHYFSPKISDFGLSKLLLSDHS--RTHTMIRGTRGYVAPEWLKNA 611
+H D+ +N+LL HY KISDFGLSK L +D + + T + + APE +
Sbjct: 116 FVHRDLAARNVLLVTQHY--AKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY 173
Query: 612 PVSAKVDVYSFGVMLLE 628
S+K DV+SFGV++ E
Sbjct: 174 KFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 6e-16
Identities = 69/207 (33%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 442 LGRGSFGIVYKGVLK-TASGNAIAVKKLDRLAQERERE---FKSEVSAIGRTHHKNLVQL 497
LG+GSFG V K T AI + K D + Q+ + E + V A+ L QL
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP-FLTQL 66
Query: 498 LGFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPI 556
C + ++RL V E++ G L I + K V + EIA GL +LH + I
Sbjct: 67 HS-CFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLH---SKGI 122
Query: 557 IHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAK 616
I+ D+K N++LD KI+DFG+ K + T T GT Y+APE + P
Sbjct: 123 IYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC-GTPDYIAPEIIAYQPYGKS 181
Query: 617 VDVYSFGVMLLEIICCRRSVEMELEEE 643
VD ++FGV+L E++ + + E E+E
Sbjct: 182 VDWWAFGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 8e-16
Identities = 64/200 (32%), Positives = 110/200 (55%), Gaps = 18/200 (9%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQERE---REFKSEVSAIGRTHHKNLVQ 496
E++G G++G+VYKG K +G +A+KK+ RL E E E+S + H N+V
Sbjct: 6 EKIGEGTYGVVYKGRNKK-TGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHPNIVC 63
Query: 497 LLGFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDW--NLRVRISL-EIARGLVYLHEGC 552
L + +RL L++EF+ + L + ++PK + V+ L +I +G+++ H
Sbjct: 64 LQDVLMQE-SRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR- 120
Query: 553 NVPIIHCDIKPQNILLDHYFSPKISDFGLSKLL-LSDHSRTHTMIRGTRGYVAPEWLKNA 611
++H D+KPQN+L+D+ K++DFGL++ + TH ++ T Y APE L +
Sbjct: 121 --RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV--TLWYRAPEVLLGS 176
Query: 612 P-VSAKVDVYSFGVMLLEII 630
P S VD++S G + E+
Sbjct: 177 PRYSTPVDIWSIGTIFAEMA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 8e-16
Identities = 59/206 (28%), Positives = 94/206 (45%), Gaps = 25/206 (12%)
Query: 442 LGRGSFGIVYKGVLK-TASGNA---IAVKKLD-RLAQEREREFKSEVSAIGRTHHKNLVQ 496
LGRG FG V+ K + VK L + + EF+ E+ + HKN+V+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 497 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNL---------RVRISLEIARGLVY 547
LLG C EA ++ E+ G L + A D L +V + +IA G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 548 LHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD---HSRTHTM-IRGTRGYV 603
L N +H D+ +N L+ K+S LSK + + R + +R ++
Sbjct: 133 LS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR----WL 185
Query: 604 APEWLKNAPVSAKVDVYSFGVMLLEI 629
APE ++ S K DV+SFGV++ E+
Sbjct: 186 APEAVQEDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 73/272 (26%), Positives = 117/272 (43%), Gaps = 27/272 (9%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKL-DRLAQEREREFKSEVSAIGRTHHKNLVQLL 498
E +GRG+FG V+ G L+ A +AVK + L + + +F E + + H N+V+L+
Sbjct: 1 ERIGRGNFGEVFSGRLR-ADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 59
Query: 499 GFCDEALNRLLVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPII 557
G C + +V E + G + P+ +++ A G+ YL I
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 558 HCDIKPQNILLDHYFSPKISDFGLSKLLLSD-HSRTHTMIRGTRGYVAPEWLKNAPVSAK 616
H D+ +N L+ KISDFG+S+ ++ T M + + APE L S++
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176
Query: 617 VDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVE--GRLDALIDSDEAAMAD 674
DV+SFG++L E L A L++ +E RL +A
Sbjct: 177 SDVWSFGILLWE--------AFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYR- 227
Query: 675 RSRLHKWLMIAMWCIQEDPSKRPTMKVVMQML 706
LM W + DP +RP+ V Q L
Sbjct: 228 -------LMERCW--EYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 75/273 (27%), Positives = 128/273 (46%), Gaps = 34/273 (12%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
+ELG+G++G VYK VL +G +A+K++ RL + E +F + + H +
Sbjct: 5 VLDELGKGNYGSVYK-VLHRPTGVTMAMKEI-RLELD-ESKFNQIIMELDILHKAVSPYI 61
Query: 498 LGFCDEALNRLLVY---EFMGNGTLANLI---FAIPKPDWNLRVRISLEIARGLVYLHEG 551
+ F VY E+M G+L L A ++ RI+ + +GL +L E
Sbjct: 62 VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121
Query: 552 CNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLK-- 609
N IIH D+KP N+L++ K+ DFG+S L++ ++T+ G + Y+APE +K
Sbjct: 122 HN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI---GCQSYMAPERIKSG 176
Query: 610 ----NAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALI 665
N + + DV+S G+ +LE+ R E Y + +L A++
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE------------TYAN-IFAQLSAIV 223
Query: 666 DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPT 698
D D + +A C+ + P++RPT
Sbjct: 224 DGDPPTLPSGYSDDAQDFVAK-CLNKIPNRRPT 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 61/195 (31%), Positives = 95/195 (48%), Gaps = 11/195 (5%)
Query: 441 ELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGF 500
ELG G+FG VYK K A A K +D ++E ++ E+ + H N+V+LL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLA-AAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 70
Query: 501 CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISL-EIARGLVYLHEGCNVPIIHC 559
N ++ EF G + ++ + +P ++R+ + L YLHE IIH
Sbjct: 71 FYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHR 127
Query: 560 DIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWL-----KNAPVS 614
D+K NIL K++DFG+S R + I GT ++APE + K+ P
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRPYD 186
Query: 615 AKVDVYSFGVMLLEI 629
K DV+S G+ L+E+
Sbjct: 187 YKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 57/195 (29%), Positives = 90/195 (46%), Gaps = 13/195 (6%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKNLVQLL 498
LG G FG V V + A+K + + ++ SE + +H +V+L
Sbjct: 1 LGVGGFGRVEL-VKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY 59
Query: 499 -GFCDEALNRLLVYEFMGNGTLANLIFAIPK-PDWNLRVRISLEIARGLVYLHEGCNVPI 556
F D+ +L+ E+ G L ++ ++ R I+ + YLH N I
Sbjct: 60 RTFKDKKYIYMLM-EYCLGGELWTILRDRGLFDEYTARFYIA-CVVLAFEYLH---NRGI 114
Query: 557 IHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAK 616
I+ D+KP+N+LLD K+ DFG +K L +T T GT YVAPE + N
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAK-KLKSGQKTWTFC-GTPEYVAPEIILNKGYDFS 172
Query: 617 VDVYSFGVMLLEIIC 631
VD +S G++L E++
Sbjct: 173 VDYWSLGILLYELLT 187
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 65/197 (32%), Positives = 99/197 (50%), Gaps = 17/197 (8%)
Query: 441 ELGRGSFGIVYKGVLKTASGN---AIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
ELG G+FG V KGV K AI V K + R+ E E + + + +V++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRD-EMMREAEIMHQLDNPYIVRM 60
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDW----NLRVRISLEIARGLVYLHEGCN 553
+G C EA +LV E G L F K D N+ V + +++ G+ YL EG N
Sbjct: 61 IGVC-EAEALMLVMEMASGGPLNK--FLSGKKDEITVSNV-VELMHQVSMGMKYL-EGKN 115
Query: 554 VPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS--RTHTMIRGTRGYVAPEWLKNA 611
+H D+ +N+LL + KISDFGLSK L +D S + + + + APE +
Sbjct: 116 --FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFR 173
Query: 612 PVSAKVDVYSFGVMLLE 628
S++ DV+S+G+ + E
Sbjct: 174 KFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 2e-15
Identities = 52/191 (27%), Positives = 98/191 (51%), Gaps = 6/191 (3%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG 499
E++G+G+ G VY + A+G +A+++++ Q ++ +E+ + + N+V L
Sbjct: 26 EKIGQGASGTVYTA-MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 500 FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHC 559
+V E++ G+L +++ + + + E + L +LH +IH
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLHSN---QVIHR 140
Query: 560 DIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDV 619
DIK NILL S K++DFG + + S+ TM+ GT ++APE + KVD+
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 199
Query: 620 YSFGVMLLEII 630
+S G+M +E+I
Sbjct: 200 WSLGIMAIEMI 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 60/202 (29%), Positives = 105/202 (51%), Gaps = 23/202 (11%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQERE-------REFKSEVSAIGRTHHK 492
E++G G++G+VYK K +G +A+KK+ RL E E RE +S + +H
Sbjct: 5 EKIGEGTYGVVYKARDKL-TGEIVALKKI-RLETEDEGVPSTAIRE----ISLLKELNHP 58
Query: 493 NLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRV--RISLEIARGLVYLHE 550
N+V+LL LV+EF+ + L + + P + + ++ +G+ Y H
Sbjct: 59 NIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 551 GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLL-LSDHSRTHTMIRGTRGYVAPEWLK 609
++H D+KPQN+L+D + K++DFGL++ + + TH ++ T Y APE L
Sbjct: 118 H---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 172
Query: 610 NAP-VSAKVDVYSFGVMLLEII 630
+ S VD++S G + E++
Sbjct: 173 GSRQYSTPVDIWSIGCIFAEMV 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 75/295 (25%), Positives = 127/295 (43%), Gaps = 47/295 (15%)
Query: 438 FKEELGRGSFGIVY----KGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKN 493
K ELG G+FG V+ + +AVK L + ++F E + H++
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 494 LVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNL--------------RVRISL 539
+V+ G C E ++V+E+M +G L + A PD L + I+
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRA-HGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 540 EIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS-DHSRT--HTM- 595
+IA G+VYL + +H D+ +N L+ KI DFG+S+ + S D+ R HTM
Sbjct: 128 QIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML 184
Query: 596 -IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYD 654
IR ++ PE + + + DV+S GV+L EI + +L +
Sbjct: 185 PIR----WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VIE 233
Query: 655 CYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGL 709
C +GR+ R+ + + + C Q +P R +K + +L+ L
Sbjct: 234 CITQGRV---------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 3e-15
Identities = 50/191 (26%), Positives = 98/191 (51%), Gaps = 6/191 (3%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG 499
E++G+G+ G V+ + A+G +A+K+++ Q ++ +E+ + + N+V L
Sbjct: 25 EKIGQGASGTVFTAI-DVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLD 83
Query: 500 FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHC 559
+V E++ G+L +++ + + + E + L +LH +IH
Sbjct: 84 SFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAA-VCRECLQALEFLHAN---QVIHR 139
Query: 560 DIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDV 619
DIK N+LL S K++DFG + + S+ TM+ GT ++APE + KVD+
Sbjct: 140 DIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 198
Query: 620 YSFGVMLLEII 630
+S G+M +E++
Sbjct: 199 WSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 61/197 (30%), Positives = 99/197 (50%), Gaps = 11/197 (5%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLD--RLAQER-EREFKSEVSAIGRTHHKNLVQLL 498
LG+G FG V +K +G A KKLD RL ++ E+ E + + + +V L
Sbjct: 1 LGKGGFGEVCAVQVKN-TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59
Query: 499 GFCDEALNRLLVYEFMGNGTLANLIFAIPKP--DWNLRVRISLEIARGLVYLHEGCNVPI 556
+ + LV M G L I+ + + + + S +I G+++LH + I
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDI 116
Query: 557 IHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAK 616
++ D+KP+N+LLD + ++SD GL+ L +T T GT GY+APE LK P S
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVEL--KDGKTITQRAGTNGYMAPEILKEEPYSYP 174
Query: 617 VDVYSFGVMLLEIICCR 633
VD ++ G + E++ R
Sbjct: 175 VDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 24/212 (11%)
Query: 438 FKEELGRGSFGIVYKG-VLKTASGNAIAVKKL-DRLAQEREREFKSEVSAIGRT-HHKNL 494
F++ +G G+FG V K + K A+K++ + +++ R+F E+ + + HH N+
Sbjct: 11 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 495 VQLLGFCDEALNRLLVYEFMGNGTLANLI-----------FAIPKPDWNLR-----VRIS 538
+ LLG C+ L E+ +G L + + FAI + + +
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 539 LEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRG 598
++ARG+ YL + IH D+ +NIL+ + KI+DFGLS+ + TM R
Sbjct: 131 ADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRL 185
Query: 599 TRGYVAPEWLKNAPVSAKVDVYSFGVMLLEII 630
++A E L + + DV+S+GV+L EI+
Sbjct: 186 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 54/197 (27%), Positives = 97/197 (49%), Gaps = 17/197 (8%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG 499
++LG G FG V+ G +A+K L + + E F +E + + + H LV+L
Sbjct: 12 KKLGAGQFGEVWMGYYN--GHTKVAIKSLKQGSMSPE-AFLAEANLMKQLQHPRLVRLYA 68
Query: 500 FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRI------SLEIARGLVYLHEGCN 553
+ ++ E+M NG+L + + K +++ I + +IA G+ ++ E N
Sbjct: 69 VVTQE-PIYIITEYMENGSLVDFL----KTPEGIKLTINKLIDMAAQIAEGMAFI-ERKN 122
Query: 554 VPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPV 613
IH D++ NIL+ KI+DFGL++L+ + + + APE +
Sbjct: 123 Y--IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 180
Query: 614 SAKVDVYSFGVMLLEII 630
+ K DV+SFG++L EI+
Sbjct: 181 TIKSDVWSFGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 64/199 (32%), Positives = 102/199 (51%), Gaps = 25/199 (12%)
Query: 441 ELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEV-SAIGRT----HHKNLV 495
ELG G+ G+V K VL SG I +KL L E K + + I R H N
Sbjct: 8 ELGAGNGGVVTK-VLHRPSG-LIMARKLIHL------EIKPAIRNQIIRELKVLHECNSP 59
Query: 496 QLLGF-----CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHE 550
++GF D ++ + E M G+L ++ + N+ +IS+ + RGL YL E
Sbjct: 60 YIVGFYGAFYSDGEISICM--EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLRE 117
Query: 551 GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKN 610
I+H D+KP NIL++ K+ DFG+S L+ S ++ + GTR Y++PE L+
Sbjct: 118 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFV-GTRSYMSPERLQG 172
Query: 611 APVSAKVDVYSFGVMLLEI 629
+ + D++S G+ L+E+
Sbjct: 173 THYTVQSDIWSLGLSLVEM 191
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-15
Identities = 61/198 (30%), Positives = 105/198 (53%), Gaps = 15/198 (7%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKS---EVSAIGRTHHKNLVQ 496
E++G G++G+VYK K +G +A+KK+ RL E E + E+S + +H N+V+
Sbjct: 6 EKIGEGTYGVVYKARNKL-TGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHPNIVK 63
Query: 497 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRIS--LEIARGLVYLHEGCNV 554
LL LV+EF+ + L + A P L + S ++ +GL + H
Sbjct: 64 LLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH--- 119
Query: 555 PIIHCDIKPQNILLDHYFSPKISDFGLSKLL-LSDHSRTHTMIRGTRGYVAPEWLKNAPV 613
++H D+KPQN+L++ + K++DFGL++ + + TH ++ T Y APE L
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGCKY 177
Query: 614 -SAKVDVYSFGVMLLEII 630
S VD++S G + E++
Sbjct: 178 YSTAVDIWSLGCIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 4e-15
Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 33/208 (15%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSA---------IGRTHHK 492
+G G++G+V V +G +A+KK+ F + A + H+
Sbjct: 8 IGSGAYGVVCSAV-DKRTGRKVAIKKI-------SNVFDDLIDAKRILREIKLLRHLRHE 59
Query: 493 NLVQLLG-FCDEALNRL----LVYEFMGNGT-LANLIFAIPKPDWNLRVR-ISLEIARGL 545
N++ LL + +V E M T L +I + P+P + ++ +I RGL
Sbjct: 60 NIIGLLDILRPPSPEDFNDVYIVTELM--ETDLHKVIKS-PQPLTDDHIQYFLYQILRGL 116
Query: 546 VYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRG--TRGYV 603
YLH N +IH D+KP NIL++ KI DFGL++ + D + TR Y
Sbjct: 117 KYLHS-AN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYR 173
Query: 604 APEWLKNAP-VSAKVDVYSFGVMLLEII 630
APE L ++ + +D++S G + E++
Sbjct: 174 APELLLSSSRYTKAIDIWSVGCIFAELL 201
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-15
Identities = 54/221 (24%), Positives = 102/221 (46%), Gaps = 39/221 (17%)
Query: 441 ELGRGSFGIVYK----GVLKTASGNAIAVKKL-DRLAQEREREFKSEVSAIGRTHHKNLV 495
++G+G+FG V++ G+L +AVK L + + + + +F+ E + + H N+V
Sbjct: 12 DIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIV 71
Query: 496 QLLGFCDEALNRLLVYEFMGNGTLANLI--------------------FAIPKPDWN--L 533
+LLG C L++E+M G L + + +
Sbjct: 72 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131
Query: 534 RVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLS-KLLLSDHSRT 592
++ I+ ++A G+ YL E +H D+ +N L+ KI+DFGLS + +D+ +
Sbjct: 132 QLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 188
Query: 593 HTM----IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEI 629
IR ++ PE + + + DV+++GV+L EI
Sbjct: 189 SENDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 5e-15
Identities = 77/279 (27%), Positives = 121/279 (43%), Gaps = 43/279 (15%)
Query: 440 EELGRGSFGIVYKGVLKTASGNA-IAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLL 498
++LG G FG V+ G T +GN +AVK L E F E + + H LVQL
Sbjct: 12 KKLGNGQFGEVWMG---TWNGNTKVAVKTLKPGTMSPE-SFLEEAQIMKKLRHDKLVQLY 67
Query: 499 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR----VRISLEIARGLVYLHEGCNV 554
E +V E+M G+L L F L+ V ++ ++A G+ Y+ +
Sbjct: 68 AVVSEE-PIYIVTEYMSKGSL--LDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---M 121
Query: 555 PIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVS 614
IH D++ NIL+ KI+DFGL++L+ + + + APE +
Sbjct: 122 NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 615 AKVDVYSFGVMLLEIICCRR------SVEMELEEESRAILTDWAYDCYVEGRLDALIDSD 668
K DV+SFG++L E++ R + LE+ R DC +
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPIS---------- 231
Query: 669 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLE 707
LH+ LM+ W ++DP +RPT + + LE
Sbjct: 232 ---------LHE-LMLQCW--KKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-15
Identities = 64/246 (26%), Positives = 115/246 (46%), Gaps = 49/246 (19%)
Query: 438 FKEELGRGSFGIVY----KGVLK---------TASGNAIAVKKLDRLAQERER-EFKSEV 483
KE+LG G FG V+ +G+ + +AVK L + R +F E+
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 484 SAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLI--------FA----IPKPDW 531
+ R + N+++LLG C ++ E+M NG L + F IP
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 532 NLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS-DHS 590
+ ++++IA G+ YL ++ +H D+ +N L+ ++++ KI+DFG+S+ L S D+
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185
Query: 591 RTHTMIRGTRGYVAPEWLKNAPV-----SAKVDVYSFGVMLLEI-ICCRRSVEMELEEES 644
R I+G R + W+ + + DV++FGV L E+ C+ E+
Sbjct: 186 R----IQG-RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCK--------EQP 232
Query: 645 RAILTD 650
++L+D
Sbjct: 233 YSLLSD 238
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-15
Identities = 55/191 (28%), Positives = 97/191 (50%), Gaps = 8/191 (4%)
Query: 441 ELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGF 500
++G GS GIV K SG +AVK +D Q+R +EV + H+N+V++
Sbjct: 28 KIGEGSTGIVCIAREK-HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKS 86
Query: 501 CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLH-EGCNVPIIHC 559
++ EF+ G L +++ + + + + + L YLH +G +IH
Sbjct: 87 YLVGEELWVLMEFLQGGALTDIVSQTRLNEEQI-ATVCESVLQALCYLHSQG----VIHR 141
Query: 560 DIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDV 619
DIK +ILL K+SDFG + D + +++ GT ++APE + P +VD+
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRTPYGTEVDI 200
Query: 620 YSFGVMLLEII 630
+S G+M++E++
Sbjct: 201 WSLGIMVIEMV 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 6e-15
Identities = 63/201 (31%), Positives = 96/201 (47%), Gaps = 16/201 (7%)
Query: 440 EELGRGSFG--IVYK-GVLKTASGNAIAVKKLDR-LAQEREREFKSEVSAIGRTHHKNLV 495
LG G FG +Y +G +AVK L R Q+ +K E++ + +H+N+V
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 496 QLLGFCDEALNR--LLVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEIARGLVYLHEG 551
+ G C E + L+ E++ G+L + + PK NL + + +I G+ YLH
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYL---PKHKLNLAQLLLFAQQICEGMAYLHSQ 126
Query: 552 CNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRG--YVAPEWLK 609
IH D+ +N+LLD+ KI DFGL+K + H G + A E LK
Sbjct: 127 ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183
Query: 610 NAPVSAKVDVYSFGVMLLEII 630
S DV+SFGV L E++
Sbjct: 184 ENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 59/210 (28%), Positives = 103/210 (49%), Gaps = 25/210 (11%)
Query: 440 EELGRGSFGIVYKGVL--KTASGNAIAVKKLD--RLAQEREREFKSEVSAIGRTHHKNLV 495
+++G GSFG K +L G +K+++ +++ + E + EV+ + H N+V
Sbjct: 6 KKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIV 62
Query: 496 QLLGFCDEALNRLLVYEFMGNGTLANLIFA---IPKP-----DWNLRVRISLEIARGLVY 547
Q +E N +V ++ G L I A + P DW ++I L +
Sbjct: 63 QYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW------FVQICLALKH 116
Query: 548 LHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEW 607
+H+ I+H DIK QNI L + K+ DFG++++L S T I GT Y++PE
Sbjct: 117 VHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEI 172
Query: 608 LKNAPVSAKVDVYSFGVMLLEIICCRRSVE 637
+N P + K D+++ G +L E+ + + E
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-14
Identities = 66/212 (31%), Positives = 100/212 (47%), Gaps = 7/212 (3%)
Query: 435 TDGFKEELGRGSFGIVYKGVLK-TASGNAIAVKKLDRLAQEREREFKS-EVSAIGRTHHK 492
F LG+GSFG V K T AI + K D + Q+ + E E +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 493 NLVQLLGFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEG 551
+ L C + ++RL V E++ G L I + K V + EI+ GL +LH
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120
Query: 552 CNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNA 611
II+ D+K N++LD KI+DFG+ K + D T T GT Y+APE +
Sbjct: 121 ---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFC-GTPDYIAPEIIAYQ 176
Query: 612 PVSAKVDVYSFGVMLLEIICCRRSVEMELEEE 643
P VD +++GV+L E++ + + E E+E
Sbjct: 177 PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 62/201 (30%), Positives = 109/201 (54%), Gaps = 20/201 (9%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKS---EVSAIGRTHHKNLVQ 496
E++G G++G+VYK + + IA+KK+ RL QE E + E+S + H N+V+
Sbjct: 8 EKIGEGTYGVVYKARDRV-TNETIALKKI-RLEQEDEGVPSTAIREISLLKEMQHGNIVR 65
Query: 497 L--LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISL--EIARGLVYLHEGC 552
L + ++ L LV+E++ + L + + P N R+ + +I RG+ Y H
Sbjct: 66 LQDVVHSEKRL--YLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH- 121
Query: 553 NVPIIHCDIKPQNILLDHYF-SPKISDFGLSKLL-LSDHSRTHTMIRGTRGYVAPEWLKN 610
++H D+KPQN+L+D + K++DFGL++ + + TH ++ T Y APE L
Sbjct: 122 --RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--TLWYRAPEILLG 177
Query: 611 A-PVSAKVDVYSFGVMLLEII 630
+ S VD++S G + E++
Sbjct: 178 SRHYSTPVDIWSVGCIFAEMV 198
|
Length = 294 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 3e-14
Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 20/206 (9%)
Query: 442 LGRGSFGIVYKGVLKT--ASGNAIAVK--KLDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
LG+G FG V + LK+ S +AVK K D + EF E + + H N+++L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 498 LGFC--DEALNRL----LVYEFMGNGTLANLIFA--IPKPDWNLR----VRISLEIARGL 545
+G A RL ++ FM +G L + I + + L VR ++IA G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 546 VYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS-DHSRTHTMIRGTRGYVA 604
YL + IH D+ +N +L+ + ++DFGLSK + S D+ R + ++A
Sbjct: 127 EYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183
Query: 605 PEWLKNAPVSAKVDVYSFGVMLLEII 630
E L + + DV++FGV + EI+
Sbjct: 184 LESLADNVYTTHSDVWAFGVTMWEIM 209
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-14
Identities = 68/209 (32%), Positives = 102/209 (48%), Gaps = 7/209 (3%)
Query: 438 FKEELGRGSFGIVYKGVLK-TASGNAIAVKKLDRLAQEREREFKS-EVSAIGRTHHKNLV 495
F LG+GSFG V K T AI + K D + Q+ + E E + + +
Sbjct: 4 FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFL 63
Query: 496 QLLGFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNV 554
L C + ++RL V E++ G L I + + V + EIA GL +LH +
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLH---SK 120
Query: 555 PIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVS 614
II+ D+K N++LD KI+DFG+ K + D T T GT Y+APE + P
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFC-GTPDYIAPEIIAYQPYG 179
Query: 615 AKVDVYSFGVMLLEIICCRRSVEMELEEE 643
VD ++FGV+L E++ + E E E+E
Sbjct: 180 KSVDWWAFGVLLYEMLAGQAPFEGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 4e-14
Identities = 65/225 (28%), Positives = 97/225 (43%), Gaps = 45/225 (20%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKL---DRLAQEREREFKSEVSAIGRTHHKNLVQLL 498
+GRG+FG V+ V +G A+K L D + + + ++E + +V+L
Sbjct: 9 IGRGAFGEVWL-VRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY 67
Query: 499 -GFCDEALNRL-LVYEFMGNGTLANL--IFAIPKPDWNLRVRISLEIARGLVYLHE-GCN 553
F DE L LV E+M G L NL + + R I+ E+ L +H+ G
Sbjct: 68 YSFQDE--EHLYLVMEYMPGGDLMNLLIRKDVFPEET-ARFYIA-ELVLALDSVHKLGF- 122
Query: 554 VPIIHCDIKPQNILLDHYFSPKISDFGLSK-------------------------LLLSD 588
IH DIKP NIL+D K++DFGL K + D
Sbjct: 123 ---IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRD 179
Query: 589 HSRTHTMIR---GTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEII 630
H + GT Y+APE L+ P + D +S GV+L E++
Sbjct: 180 HKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 5e-14
Identities = 59/207 (28%), Positives = 102/207 (49%), Gaps = 27/207 (13%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDR------LAQEREREFKSEVSAIGRT-HHK 492
E +G G++G+V + T SG +A+KK+ LA+ RE K I R H
Sbjct: 11 ENIGSGAYGVVCSAI-DTRSGKKVAIKKIPHAFDVPTLAKRTLRELK-----ILRHFKHD 64
Query: 493 NLVQLLGFC----DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISL-EIARGLVY 547
N++ + + + +V + M + L ++I + +P +R L ++ RGL Y
Sbjct: 65 NIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHS-DQPLTEEHIRYFLYQLLRGLKY 122
Query: 548 LHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS---DHSRTHTMIRGTRGYVA 604
+H +IH D+KP N+L++ +I DFG+++ L S +H T TR Y A
Sbjct: 123 IHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRA 179
Query: 605 PEWLKNAP-VSAKVDVYSFGVMLLEII 630
PE L + P + +D++S G + E++
Sbjct: 180 PELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 5e-14
Identities = 67/209 (32%), Positives = 112/209 (53%), Gaps = 24/209 (11%)
Query: 439 KEELGRGSFGIVYKGVLKTASGNAIAVKKL-D--RLAQEREREFKSEVSAIGR-THHKNL 494
++LG+G++GIV+K + + + +A+KK+ D R A + +R F+ E+ + H N+
Sbjct: 12 LQKLGKGAYGIVWKAIDRR-TKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNI 69
Query: 495 VQLLGFCDEALNR--LLVYEFMGNGTLANLIFA-IPKPDWNLRVR-ISLEIARGLVYLHE 550
V+LL ++ LV+E+M L +I A I + ++ R I ++ + L Y+H
Sbjct: 70 VKLLNVIKAENDKDIYLVFEYM-ETDLHAVIRANILE---DVHKRYIMYQLLKALKYIHS 125
Query: 551 GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIR-----GTRGYVAP 605
G NV IH D+KP NILL+ K++DFGL++ LS+ TR Y AP
Sbjct: 126 G-NV--IHRDLKPSNILLNSDCRVKLADFGLAR-SLSELEENPENPVLTDYVATRWYRAP 181
Query: 606 EWLKNAPVSAK-VDVYSFGVMLLEIICCR 633
E L + K VD++S G +L E++ +
Sbjct: 182 EILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 6e-14
Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 27/209 (12%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLD-------RLAQEREREFKSEVSAIG----R 488
E LG G+FG VYK K N +A+K+++ + +ER++ VS + +
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 489 THHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPD--------WNLRVRISLE 540
H N+V+ E +V + + L ++ + WN+ V++ L
Sbjct: 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL- 124
Query: 541 IARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTR 600
L YLH+ I+H D+ P NI+L I+DFGL+K T + GT
Sbjct: 125 ---ALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQ--KQPESKLTSVVGTI 177
Query: 601 GYVAPEWLKNAPVSAKVDVYSFGVMLLEI 629
Y PE +KN P K DV++FG +L ++
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 8e-14
Identities = 67/210 (31%), Positives = 113/210 (53%), Gaps = 30/210 (14%)
Query: 438 FKEELGRGSFGIVYK----GVLKTASGNAIAVKKLDRLAQERERE-FKSEVSAIGRTH-- 490
F + LG G+FG V + G+ K+ + +AVK L A ERE SE+ + +H
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIM--SHLG 96
Query: 491 -HKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPD-----WNLRVRISLEIARG 544
H+N+V LLG C L++ E+ G L N F K + +L + S ++A+G
Sbjct: 97 NHENIVNLLGACTIGGPILVITEYCCYGDLLN--FLRRKRESFLTLEDL-LSFSYQVAKG 153
Query: 545 LVYL-HEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRG-TR-- 600
+ +L + C IH D+ +N+LL H KI DFGL++ +++D ++ +++G R
Sbjct: 154 MAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMND---SNYVVKGNARLP 206
Query: 601 -GYVAPEWLKNAPVSAKVDVYSFGVMLLEI 629
++APE + N + + DV+S+G++L EI
Sbjct: 207 VKWMAPESIFNCVYTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 21/200 (10%)
Query: 441 ELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG- 499
ELG G+FG VYK K +G A K ++ ++E ++ E+ + +H +V+LLG
Sbjct: 19 ELGDGAFGKVYKAKNKE-TGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGA 77
Query: 500 -FCDEALNRLLVYEFMGNG----TLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNV 554
+ D L ++ EF G + L + +P + R LE L YLH ++
Sbjct: 78 FYWDGKLW--IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLE---ALQYLH---SM 129
Query: 555 PIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAP-----EWLK 609
IIH D+K N+LL K++DFG+S + R + I GT ++AP E +K
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-GTPYWMAPEVVMCETMK 188
Query: 610 NAPVSAKVDVYSFGVMLLEI 629
+ P K D++S G+ L+E+
Sbjct: 189 DTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 81/298 (27%), Positives = 141/298 (47%), Gaps = 38/298 (12%)
Query: 430 ELKDATDGFKE--ELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEV-SAI 486
ELKD D F++ ELG G+ G+V+K V SG +A +KL L E + ++++ +
Sbjct: 1 ELKD--DDFEKISELGAGNGGVVFK-VSHKPSGLIMA-RKLIHL--EIKPAIRNQIIREL 54
Query: 487 GRTHHKNLVQLLGF-----CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEI 541
H N ++GF D ++ + E M G+L ++ + + ++S+ +
Sbjct: 55 QVLHECNSPYIVGFYGAFYSDGEIS--ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 112
Query: 542 ARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRG 601
+GL YL E I+H D+KP NIL++ K+ DFG+S L+ + + GTR
Sbjct: 113 IKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRS 167
Query: 602 YVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRL 661
Y++PE L+ S + D++S G+ L+E+ R + +E + + C VEG
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELM-----FGCPVEG-- 220
Query: 662 DALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNPPWSS 719
D E+ + R R + + P RP M + ++L+ ++ P P S
Sbjct: 221 ----DPAESETSPRPRPPGRPLSSY-----GPDSRPPM-AIFELLDYIVNEPPPKLPS 268
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 64/206 (31%), Positives = 105/206 (50%), Gaps = 34/206 (16%)
Query: 442 LGRGSFGIVY--KGVLKTASGNAIAVKKL--------DRLAQEREREFKSEVSAIGRTHH 491
LG+GSFG V+ + + +G A+K L DR+ + ER+ +EV +H
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV------NH 57
Query: 492 KNLVQL-LGFCDEALNRLLVYEFMGNGTL-----ANLIFAIPKPDWNLRVRISL-EIARG 544
+V+L F E L+ +F+ G L ++F + D V+ L E+A
Sbjct: 58 PFIVKLHYAFQTEG-KLYLILDFLRGGDLFTRLSKEVMFT--EED----VKFYLAELALA 110
Query: 545 LVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVA 604
L +LH ++ II+ D+KP+NILLD K++DFGLSK + + ++ GT Y+A
Sbjct: 111 LDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMA 166
Query: 605 PEWLKNAPVSAKVDVYSFGVMLLEII 630
PE + + D +SFGV++ E++
Sbjct: 167 PEVVNRRGHTQSADWWSFGVLMFEML 192
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 62/205 (30%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 441 ELGRGSFGIVYKGVLK-TASGNAIAVKKLDR------LAQEREREFKSEVSAIGRTHHKN 493
ELG+G++GIV T+ +A+KK+ LA+ RE K G HKN
Sbjct: 7 ELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG---HKN 63
Query: 494 LVQLLGF---CDEALNRLLVYEFMGNGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLH 549
+ L N L +YE + L +I + P D + + I +I GL Y+H
Sbjct: 64 ITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFI-YQILCGLKYIH 122
Query: 550 EGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRG---TRGYVAPE 606
NV +H D+KP N+L++ KI DFGL++ + + TR Y APE
Sbjct: 123 SA-NV--LHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPE 179
Query: 607 -WLKNAPVSAKVDVYSFGVMLLEII 630
L + +DV+S G +L E++
Sbjct: 180 IMLSFQSYTKAIDVWSVGCILAELL 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 52/197 (26%), Positives = 93/197 (47%), Gaps = 16/197 (8%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG 499
++LG G FG V+ G ++ +AVK L + + F E + + H LV+L
Sbjct: 12 KKLGAGQFGEVWMGYYNNST--KVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYA 68
Query: 500 FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRI------SLEIARGLVYLHEGCN 553
+ ++ E+M G+L + + K D +V + S +IA G+ Y+
Sbjct: 69 VVTKEEPIYIITEYMAKGSLLDFL----KSDEGGKVLLPKLIDFSAQIAEGMAYIERK-- 122
Query: 554 VPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPV 613
IH D++ N+L+ KI+DFGL++++ + + + APE +
Sbjct: 123 -NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 181
Query: 614 SAKVDVYSFGVMLLEII 630
+ K DV+SFG++L EI+
Sbjct: 182 TIKSDVWSFGILLYEIV 198
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 63/216 (29%), Positives = 106/216 (49%), Gaps = 32/216 (14%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAI--AVKKLDRLAQERE-REFKSEVSAIGRT-HHKN 493
F++ +G G+FG V + ++K G + A+K L A E + R+F E+ + + HH N
Sbjct: 6 FEDVIGEGNFGQVIRAMIKK-DGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPN 64
Query: 494 LVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPK-------PDWNLR------------ 534
++ LLG C+ NR +Y + NL+ + K P +
Sbjct: 65 IINLLGACE---NRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 535 VRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHT 594
++ + ++A G+ YL E IH D+ +N+L+ + KI+DFGLS+ + T
Sbjct: 122 LQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR--GEEVYVKKT 176
Query: 595 MIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEII 630
M R ++A E L + + K DV+SFGV+L EI+
Sbjct: 177 MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 63/205 (30%), Positives = 94/205 (45%), Gaps = 18/205 (8%)
Query: 440 EELGRGSFGIVYKGVLKTASGNA-IAVKKLDRLAQERE-REFKSEVSAIGRTHHKNLVQL 497
+E+G G FG V G + + A + VK+L A +E +F E H NL+Q
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLIFAIPK-----PDWNLRVRISLEIARGLVYLHEGC 552
LG C E LLV EF G L + + K PD R++ EIA GL++LH+
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN- 119
Query: 553 NVPIIHCDIKPQNILLDHYFSPKISDFGLSKL-LLSDHSRTHTMIRGTRGYVAPEWLKN- 610
IH D+ +N LL + KI D+GLS D+ T + ++APE +
Sbjct: 120 --NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 611 ------APVSAKVDVYSFGVMLLEI 629
+ + +V+S GV + E+
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 3e-13
Identities = 57/179 (31%), Positives = 81/179 (45%), Gaps = 32/179 (17%)
Query: 545 LVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKL----LLSDHSRTHTMIRGTR 600
L+ +H + +IH DIK NILL K+ DFG SK+ + D RT GT
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC---GTP 209
Query: 601 GYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEME-LEEESRAILTDWAYDCYVEG 659
YVAPE + P S K D++S GV+L E++ +R + E +EE L G
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA---------G 260
Query: 660 RLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM------LEGLLEV 712
R D L S M + I + DP +RP+ ++ M + GLLE+
Sbjct: 261 RYDPLPPSISPEMQE---------IVTALLSSDPKRRPSSSKLLNMPICKLFISGLLEI 310
|
Length = 496 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 68/220 (30%), Positives = 97/220 (44%), Gaps = 21/220 (9%)
Query: 442 LGRGSFGIVYKGVLKTASG-NAI-AVKKLDRLAQEREREFKSE---VSAIGRTHHKNLVQ 496
LGRG FG V K AI A+KK D +A++ E H LV
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 497 LLGFCDEALNRL-LVYEFMGNGTLANLI----FAIPKPDWNLRVRISLEIARGLVYLHEG 551
L C + + + V E+ G L I F+ P+ V + + GL YLHE
Sbjct: 67 LFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRA-----VFYAACVVLGLQYLHEN 120
Query: 552 CNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNA 611
I++ D+K N+LLD KI+DFGL K + RT T GT ++APE L
Sbjct: 121 ---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC-GTPEFLAPEVLTET 176
Query: 612 PVSAKVDVYSFGVMLLEIICCRRSVEMELEEES-RAILTD 650
+ VD + GV++ E++ + EEE +I+ D
Sbjct: 177 SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND 216
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 57/196 (29%), Positives = 98/196 (50%), Gaps = 15/196 (7%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVK---KLDRLAQEREREFKSEVSAIGRTHHKNLVQ 496
+ + +G+FG VY K ++G+ A+K K D +A+ + K+E + + V
Sbjct: 2 KPISKGAFGSVYLAK-KRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 497 LLGFCDEALNRL-LVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNV 554
L + ++ + L LV E++ G A+LI + P+ + I+ E+ G+ LH+
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIA-EVVLGVEDLHQR--- 116
Query: 555 PIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVS 614
IIH DIKP+N+L+D K++DFGLS+ L + GT Y+APE +
Sbjct: 117 GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK-----FVGTPDYLAPETILGVGDD 171
Query: 615 AKVDVYSFGVMLLEII 630
D +S G ++ E +
Sbjct: 172 KMSDWWSLGCVIFEFL 187
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 65/227 (28%), Positives = 111/227 (48%), Gaps = 21/227 (9%)
Query: 430 ELKDATDGFKE--ELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEV-SAI 486
ELKD D F+ ELG G+ G+V K ++ I +KL L E + ++++ +
Sbjct: 1 ELKD--DDFERISELGAGNGGVVTK--VQHKPSGLIMARKLIHL--EIKPAIRNQIIREL 54
Query: 487 GRTHHKNLVQLLGF-----CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEI 541
H N ++GF D ++ + E M G+L ++ + + ++S+ +
Sbjct: 55 QVLHECNSPYIVGFYGAFYSDGEIS--ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV 112
Query: 542 ARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRG 601
RGL YL E I+H D+KP NIL++ K+ DFG+S L+ + + GTR
Sbjct: 113 LRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRS 167
Query: 602 YVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAIL 648
Y++PE L+ S + D++S G+ L+E+ R + +E AI
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIF 214
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 69/208 (33%), Positives = 99/208 (47%), Gaps = 13/208 (6%)
Query: 442 LGRGSFGIVYKGVLK-TASGNAIAVKKLDRLAQERERE---FKSEVSAIGRTHHKNLVQL 497
LG+GSFG V LK T AI K D + ++ + E + V A+ H L L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALA-WEHPFLTHL 61
Query: 498 LGFCDEALNRLL--VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVP 555
FC L V E++ G L I + + D + EI GL +LH+
Sbjct: 62 --FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK---G 116
Query: 556 IIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSA 615
II+ D+K N+LLD KI+DFG+ K ++ + T GT Y+APE LK +
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAPEILKGQKYNE 175
Query: 616 KVDVYSFGVMLLEIICCRRSVEMELEEE 643
VD +SFGV+L E++ + E E+E
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGEDEDE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 62/202 (30%), Positives = 97/202 (48%), Gaps = 22/202 (10%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNLVQLL 498
LG+G+FG V V + A+G A+K L + +A++ +E + T H L L
Sbjct: 3 LGKGTFGKVIL-VREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL- 60
Query: 499 GFCDEALNRL-LVYEFMGNGTL-----ANLIFAIPKPDWNLRVRI-SLEIARGLVYLHEG 551
+ + +RL V E+ G L +F+ R R EI L YLH
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED------RARFYGAEIVSALGYLHSC 114
Query: 552 CNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNA 611
+++ D+K +N++LD KI+DFGL K +SD + T GT Y+APE L++
Sbjct: 115 ---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDN 170
Query: 612 PVSAKVDVYSFGVMLLEIICCR 633
VD + GV++ E++C R
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 7e-13
Identities = 70/225 (31%), Positives = 104/225 (46%), Gaps = 28/225 (12%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTH-----HKNLVQ 496
LG+G FG V ++ A+G A KKL++ +R ++ K E A+ + V
Sbjct: 8 LGKGGFGEVCACQVR-ATGKMYACKKLEK---KRIKKRKGEAMALNEKQILEKVNSRFVV 63
Query: 497 LLGFCDEALNRL-LVYEFMGNGTLANLIFAIPKP--DWNLRVRISLEIARGLVYLHEGCN 553
L + E + L LV M G L I+ + P D V + EI GL LH
Sbjct: 64 SLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE-- 121
Query: 554 VPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIR---GTRGYVAPEWLKN 610
I++ D+KP+NILLD Y +ISD GL+ IR GT GY+APE +KN
Sbjct: 122 -RIVYRDLKPENILLDDYGHIRISDLGLAV-----EIPEGETIRGRVGTVGYMAPEVVKN 175
Query: 611 APVSAKVDVYSFGVMLLEIICCR-----RSVEMELEEESRAILTD 650
+ D + G ++ E+I + R +++ EE R + D
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKED 220
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 7e-13
Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 29/208 (13%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLD-----RLAQEREREFKSEVSAIGRTHHKNLVQ 496
+G G++G+V +G +A+KK+ Q RE K + R H+N++
Sbjct: 13 IGEGAYGMVCSAT-HKPTGVKVAIKKISPFEHQTFCQRTLREIK----ILRRFKHENIIG 67
Query: 497 LLGFCD-------EALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYL 548
+L D E+ N + +V E M L LI + +++ + +I RGL Y+
Sbjct: 68 IL---DIIRPPSFESFNDVYIVQELM-ETDLYKLIKTQHLSNDHIQYFL-YQILRGLKYI 122
Query: 549 HEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKL--LLSDHSRTHTMIRGTRGYVAPE 606
H NV +H D+KP N+LL+ KI DFGL+++ DH+ T TR Y APE
Sbjct: 123 H-SANV--LHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPE 179
Query: 607 -WLKNAPVSAKVDVYSFGVMLLEIICCR 633
L + + +D++S G +L E++ R
Sbjct: 180 IMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 8e-13
Identities = 53/194 (27%), Positives = 97/194 (50%), Gaps = 15/194 (7%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLD-----RLAQEREREFKSEVSAIGRTHHKNLVQ 496
+G G+FG V+ V S + A+K + RL QE+ +E + H +++
Sbjct: 9 VGTGTFGRVHL-VRDRISEHYYALKVMAIPEVIRLKQEQH--VHNEKRVLKEVSHPFIIR 65
Query: 497 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPI 556
L + ++ E++ G L + + + + + + EI L YLH + I
Sbjct: 66 LFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLH---SKEI 122
Query: 557 IHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAK 616
++ D+KP+NILLD K++DFG +K L RT T+ GT Y+APE +++ +
Sbjct: 123 VYRDLKPENILLDKEGHIKLTDFGFAKKL---RDRTWTLC-GTPEYLAPEVIQSKGHNKA 178
Query: 617 VDVYSFGVMLLEII 630
VD ++ G+++ E++
Sbjct: 179 VDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 1e-12
Identities = 75/276 (27%), Positives = 123/276 (44%), Gaps = 43/276 (15%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKL-----DRLAQEREREFKSEVSAIGRT-HHKNLV 495
+G G+ G VYK V+ +G A+K + D + ++ RE I R +H N+V
Sbjct: 82 IGSGAGGTVYK-VIHRPTGRLYALKVIYGNHEDTVRRQICREI-----EILRDVNHPNVV 135
Query: 496 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVP 555
+ D ++ EFM G+L A D ++ +I G+ YLH
Sbjct: 136 KCHDMFDHNGEIQVLLEFMDGGSLEGTHIA----DEQFLADVARQILSGIAYLHRR---H 188
Query: 556 IIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSA 615
I+H DIKP N+L++ + KI+DFG+S++L ++ + GT Y++PE +
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINTDLNHG 247
Query: 616 KV-----DVYSFGVMLLEIICCRRSVEMELEEESRAILTDWA-YDCYVEGRLDALIDSDE 669
D++S GV +LE R + + DWA C + + E
Sbjct: 248 AYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ-------GDWASLMCAI-----CMSQPPE 295
Query: 670 A-AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704
A A A R H I+ C+Q +P+KR + ++Q
Sbjct: 296 APATASREFRH---FISC-CLQREPAKRWSAMQLLQ 327
|
Length = 353 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 68/211 (32%), Positives = 104/211 (49%), Gaps = 23/211 (10%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFK---SEVSA-IGRTHHKNLVQL 497
+G+GSFG V K A G AVK L + A +++E K +E + + H LV L
Sbjct: 3 IGKGSFGKVLLAKHK-ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 498 LGFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVR---ISLEIARGLVYLHEGCN 553
+ + ++L V +++ G L F + + R + EIA L YLH
Sbjct: 62 -HYSFQTADKLYFVLDYVNGG---ELFFHLQRERSFPEPRARFYAAEIASALGYLHS--- 114
Query: 554 VPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPV 613
+ II+ D+KP+NILLD ++DFGL K + +HS+T + GT Y+APE L+ P
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGI-EHSKTTSTFCGTPEYLAPEVLRKQPY 173
Query: 614 SAKVDVYSFGVMLLEIIC------CRRSVEM 638
VD + G +L E++ R + EM
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 72/280 (25%), Positives = 116/280 (41%), Gaps = 47/280 (16%)
Query: 441 ELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGF 500
+LG+G FG V+ G + AI K + E F E + + H LV L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE---AFLQEAQIMKKLRHDKLVPLYAV 69
Query: 501 CDEALNRLLVYEFMGNGTLANLI-------FAIPKPDWNLRVRISLEIARGLVYLHEGCN 553
E +V EFMG G+L + + +P+ V ++ +IA G+ Y+
Sbjct: 70 VSEE-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQ-----LVDMAAQIADGMAYIER--- 120
Query: 554 VPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPV 613
+ IH D++ NIL+ KI+DFGL++L+ + + + APE
Sbjct: 121 MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 180
Query: 614 SAKVDVYSFGVMLLEIICCRR-----SVEME-LEEESRAILTDWAYDCYVEGRLDALIDS 667
+ K DV+SFG++L E++ R V E LE+ R C
Sbjct: 181 TIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGC------------ 228
Query: 668 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLE 707
LH+ + + C ++DP +RPT + + LE
Sbjct: 229 -------PESLHELMKL---CWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 59/197 (29%), Positives = 95/197 (48%), Gaps = 21/197 (10%)
Query: 441 ELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGF 500
+LG G+ G V K V +G +A K + A+ R K + + H ++ F
Sbjct: 12 DLGAGNGGSVSK-VKHIPTGTVMAKKVVHIGAKSSVR--KQILRELQIMHECRSPYIVSF 68
Query: 501 CDEALNR---LLVYEFMGNGTLANLIFAIPKPDWNLRV----RISLEIARGLVYLHEGCN 553
LN + EFM G+L I K + V +I++ + GL YL+ N
Sbjct: 69 YGAFLNENNICMCMEFMDCGSLD----RIYKKGGPIPVEILGKIAVAVVEGLTYLY---N 121
Query: 554 V-PIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAP 612
V I+H DIKP NIL++ K+ DFG+S L++ + T GT Y++PE ++
Sbjct: 122 VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV---GTSTYMSPERIQGGK 178
Query: 613 VSAKVDVYSFGVMLLEI 629
+ K DV+S G+ ++E+
Sbjct: 179 YTVKSDVWSLGISIIEL 195
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 16/203 (7%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNLVQLL 498
+GRG FG V + V + A+G+ A+K + + LAQE F+ E + ++ + QL
Sbjct: 9 VGRGHFGEV-QVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67
Query: 499 GFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRVRISL-EIARGLVYLHEGCNVPI 556
+ N LV E+ G L +L+ D ++ + L E+ + +H+ +
Sbjct: 68 YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDM-AQFYLAELVLAIHSVHQ---MGY 123
Query: 557 IHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAK 616
+H DIKP+N+L+D K++DFG + L ++ + GT Y+APE L K
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGK 183
Query: 617 ------VDVYSFGVMLLEIICCR 633
D +S GV+ E+I R
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 1e-12
Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRT----------HH 491
+G G++G V T +G +A+KKL R F+S + A RT H
Sbjct: 23 VGSGAYGQVCSAFD-TKTGRKVAIKKLSR-------PFQSAIHA-KRTYRELRLLKHMDH 73
Query: 492 KNLVQLLG-FC-DEALNRL----LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGL 545
+N++ LL F +L LV MG L N++ D +++ + +I RGL
Sbjct: 74 ENVIGLLDVFTPASSLEDFQDVYLVTHLMG-ADLNNIVKCQKLSDDHIQF-LVYQILRGL 131
Query: 546 VYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAP 605
Y+H + IIH D+KP NI ++ KI DFGL++ D T + TR Y AP
Sbjct: 132 KYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHT--DDEMTGYV--ATRWYRAP 184
Query: 606 EWLKN-APVSAKVDVYSFGVMLLEIICCR 633
E + N + VD++S G ++ E++ +
Sbjct: 185 EIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 63/207 (30%), Positives = 100/207 (48%), Gaps = 32/207 (15%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFK---SEVSAIGRTHHKNLVQLL 498
+G+G+FG VY+ V K + A+K L + ++E E + + RT ++
Sbjct: 1 IGKGTFGQVYQ-VRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIV 59
Query: 499 G--FCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNL---------RVRISL-EIARGL 545
G F + + L LV ++M G L W+L R + + E+ L
Sbjct: 60 GLKFSFQTDSDLYLVTDYMSGGELF----------WHLQKEGRFSEDRAKFYIAELVLAL 109
Query: 546 VYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAP 605
+LH+ I++ D+KP+NILLD + DFGLSK L+D+ T+T GT Y+AP
Sbjct: 110 EHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC-GTTEYLAP 165
Query: 606 E-WLKNAPVSAKVDVYSFGVMLLEIIC 631
E L + VD +S GV++ E+ C
Sbjct: 166 EVLLDEKGYTKHVDFWSLGVLVFEMCC 192
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 67/232 (28%), Positives = 103/232 (44%), Gaps = 44/232 (18%)
Query: 438 FKEELGRGSFGIVY--------KGVLKTASGNA-------IAVKKLDRLAQERER-EFKS 481
F E+LG G FG V+ K + N +AVK L A + R +F
Sbjct: 9 FVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLK 68
Query: 482 EVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLA-----------NLIFAIPKPD 530
EV + R N+ +LLG C ++ E+M NG L L
Sbjct: 69 EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLS 128
Query: 531 WNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSK-LLLSDH 589
++ + ++ +IA G+ YL E N +H D+ +N L+ ++ KI+DFG+S+ L SD+
Sbjct: 129 FSTLLYMATQIASGMRYL-ESLN--FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDY 185
Query: 590 SRTHTMIRGTRGYVAP-EWLKNAPV-----SAKVDVYSFGVMLLEIIC-CRR 634
R ++G P W+ V + K DV++FGV L EI+ CR
Sbjct: 186 YR----VQGRA--PLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE 231
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 64/208 (30%), Positives = 95/208 (45%), Gaps = 13/208 (6%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRT------HHKNLV 495
LG+GSFG V+ LK + A+K L + + + E + + + H L
Sbjct: 3 LGKGSFGKVFLAELK-GTNQFFAIKALKKDVVLMDDDV--ECTMVEKRVLSLAWEHPFLT 59
Query: 496 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVP 555
L N V E++ G L I + K D + EI GL +LH +
Sbjct: 60 HLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH---SKG 116
Query: 556 IIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSA 615
I++ D+K NILLD KI+DFG+ K + ++T T GT Y+APE L +
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEILLGQKYNT 175
Query: 616 KVDVYSFGVMLLEIICCRRSVEMELEEE 643
VD +SFGV+L E++ + EEE
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGHDEEE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 61/197 (30%), Positives = 97/197 (49%), Gaps = 15/197 (7%)
Query: 439 KEELGRGSFGIVYKGVLKTASGNAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNLV 495
E LG GSFG V K +G A+K L + L ++ + E S + H +V
Sbjct: 23 GETLGTGSFGRVRIAKHKG-TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIV 81
Query: 496 QLL-GFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCN 553
++ F DE NR+ + EF+ G L + + ++ E+ YLH +
Sbjct: 82 NMMCSFQDE--NRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHS-KD 138
Query: 554 VPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPV 613
II+ D+KP+N+LLD+ K++DFG +K + RT T+ GT Y+APE +++
Sbjct: 139 --IIYRDLKPENLLLDNKGHVKVTDFGFAKKV---PDRTFTLC-GTPEYLAPEVIQSKGH 192
Query: 614 SAKVDVYSFGVMLLEII 630
VD ++ GV+L E I
Sbjct: 193 GKAVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 67/224 (29%), Positives = 105/224 (46%), Gaps = 26/224 (11%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTH-----HKNLVQ 496
LG+G FG V ++ A+G A K+L++ +R ++ K E A+ + V
Sbjct: 8 LGKGGFGEVCACQVR-ATGKMYACKRLEK---KRIKKRKGESMALNEKQILEKVNSQFVV 63
Query: 497 LLGFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEIARGLVYLH-EGC 552
L + E + L LV M G L I+ + P + + + EI GL LH E
Sbjct: 64 NLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN- 122
Query: 553 NVPIIHCDIKPQNILLDHYFSPKISDFGLS-KLLLSDHSRTHTMIRGTRGYVAPEWLKNA 611
++ D+KP+NILLD Y +ISD GL+ K+ + R GT GY+APE L N
Sbjct: 123 ---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV---GTVGYMAPEVLNNQ 176
Query: 612 PVSAKVDVYSFGVMLLEIICCR-----RSVEMELEEESRAILTD 650
+ D + G ++ E+I + R +++ EE R +L
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET 220
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 34/203 (16%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDR------LAQEREREFKSEVSAIGRTHHKNLV 495
+G G+FG+V +G +A+KK+ + LA+ RE K + H+N++
Sbjct: 18 VGMGAFGLVCSAR-DQLTGQNVAIKKIMKPFSTPVLAKRTYRELK----LLKHLRHENII 72
Query: 496 QLLGFCDEALNRL----LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEG 551
L D ++ L V E +G L L+ + P ++ +I RGL Y+H
Sbjct: 73 SL---SDIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQY-FLYQILRGLKYVH-- 125
Query: 552 CNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPE----W 607
+ ++H D+KP NIL++ KI DFGL++ + D T + TR Y APE W
Sbjct: 126 -SAGVVHRDLKPSNILINENCDLKICDFGLAR--IQDPQMTGYV--STRYYRAPEIMLTW 180
Query: 608 LKNAPVSAKVDVYSFGVMLLEII 630
K +VD++S G + E++
Sbjct: 181 QK---YDVEVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 19/204 (9%)
Query: 442 LGRGSFGIVYKGVL-KTASGNAIAVK--KLDRLAQEREREFKSEVSAIGRTHHKNLVQLL 498
LG G FG V +G L + S +AVK K+ + +F SE + H N+++L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 499 GFCDEALNR------LLVYEFMGNGTLANLIFAIPKPDW------NLRVRISLEIARGLV 546
G C + + +++ FM +G L + + D + V+ +IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 547 YLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS-DHSRTHTMIRGTRGYVAP 605
YL + IH D+ +N +L+ + ++DFGLSK + + D+ R + + ++A
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 606 EWLKNAPVSAKVDVYSFGVMLLEI 629
E L + + K DV+SFGV + EI
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 71/285 (24%), Positives = 121/285 (42%), Gaps = 53/285 (18%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLD-RLAQEREREF-KSEVSAIGRTHHKNLV 495
F +G+GS+G V V G +KKL+ R A RER+ + E + + H N+V
Sbjct: 4 FVRVVGKGSYGEV-SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV 62
Query: 496 Q--------------LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEI 541
++GFC+ + E G N + +W ++I
Sbjct: 63 AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVV-----EW------FVQI 111
Query: 542 ARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRG 601
A L YLHE I+H D+K QN+ L K+ D G++++L + T+I GT
Sbjct: 112 AMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPY 167
Query: 602 YVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCY--VEG 659
Y++PE N P + K DV++ G + E+ + + + D Y +EG
Sbjct: 168 YMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK----------DMNSLVYRIIEG 217
Query: 660 RLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704
+L + + + L+ M + P KRP++K +++
Sbjct: 218 KLPPMPKDYSPELGE-------LIATMLSKR--PEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 29/206 (14%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKL--DRLAQERERE---FKSEVSAIGRTHHKNLVQ 496
LGRG+FG VY +G +AVK++ D +QE +E + E+ + H +VQ
Sbjct: 10 LGRGAFGEVYL-CYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 497 LLGFC--DEALNRLLVY-EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCN 553
G C D +L ++ E+M G++ + + A N+ R + +I +G+ YLH
Sbjct: 69 YYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM- 126
Query: 554 VPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM---------IRGTRGYVA 604
I+H DIK NIL D + K+ DFG SK R T+ + GT +++
Sbjct: 127 --IVHRDIKGANILRDSAGNVKLGDFGASK-------RIQTICMSGTGIKSVTGTPYWMS 177
Query: 605 PEWLKNAPVSAKVDVYSFGVMLLEII 630
PE + K DV+S ++E++
Sbjct: 178 PEVISGEGYGRKADVWSVACTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 55/193 (28%), Positives = 91/193 (47%), Gaps = 13/193 (6%)
Query: 441 ELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGF 500
+LG+G FG V+ G + AI K ++ E F E + + H+ LVQL
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLVQLYAV 69
Query: 501 CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR----VRISLEIARGLVYLHEGCNVPI 556
E +V E+M G+L L F + LR V ++ +IA G+ Y+ +
Sbjct: 70 VSEE-PIYIVTEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNY 123
Query: 557 IHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAK 616
+H D++ NIL+ K++DFGL++L+ + + + APE + K
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 617 VDVYSFGVMLLEI 629
DV+SFG++L E+
Sbjct: 184 SDVWSFGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 66/215 (30%), Positives = 103/215 (47%), Gaps = 12/215 (5%)
Query: 442 LGRGSFGIVYKGVLK-TASGNAIAVKKLDRLAQERERE---FKSEVSAIGRTHHKNLVQL 497
LG+GSFG V LK T AI V K D + Q+ + + + + A+ H L L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHPFLTAL 61
Query: 498 LGFCDEALNRLL-VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPI 556
C + +RL V E++ G L I K D + E+ L++LH +
Sbjct: 62 HC-CFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH---GV 117
Query: 557 IHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAK 616
I+ D+K NILLD K++DFG+ K + + T T GT Y+APE L+
Sbjct: 118 IYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC-GTPDYIAPEILQELEYGPS 176
Query: 617 VDVYSFGVMLLEIICCRRSVEMELEEE-SRAILTD 650
VD ++ GV++ E++ + E + E++ +IL D
Sbjct: 177 VDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD 211
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 2e-12
Identities = 63/199 (31%), Positives = 98/199 (49%), Gaps = 16/199 (8%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNLVQLL 498
LG+G+FG V V + ASG A+K L + +A++ +E + T H L L
Sbjct: 3 LGKGTFGKVIL-VREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL- 60
Query: 499 GFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISL---EIARGLVYLHEGCNV 554
+ + +RL V E++ G L F + + R EI L YLH G
Sbjct: 61 KYSFQTKDRLCFVMEYVNGG---ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG--- 114
Query: 555 PIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVS 614
I++ D+K +N++LD KI+DFGL K ++D + T GT Y+APE L++
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC-GTPEYLAPEVLEDNDYG 173
Query: 615 AKVDVYSFGVMLLEIICCR 633
VD + GV++ E++C R
Sbjct: 174 RAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 60/198 (30%), Positives = 101/198 (51%), Gaps = 15/198 (7%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQERE-REFKSEVSAIGRTHH-KNLVQL 497
E+G G+ G VYK K +G+ +AVK++ R + E + ++ + ++H +V+
Sbjct: 21 GEIGSGTCGQVYKMRFKK-TGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKC 79
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVP 555
G+ + + E M L L+ I P P+ ++ ++++ I + L YL E V
Sbjct: 80 YGYFITDSDVFICMELMST-CLDKLLKRIQGPIPE-DILGKMTVAIVKALHYLKEKHGV- 136
Query: 556 IIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSA 615
IH D+KP NILLD + K+ DFG+S L+ S+ T G Y+APE + +
Sbjct: 137 -IHRDVKPSNILLDASGNVKLCDFGISGRLVD--SKAKTRSAGCAAYMAPERIDPPDPNP 193
Query: 616 K----VDVYSFGVMLLEI 629
K DV+S G+ L+E+
Sbjct: 194 KYDIRADVWSLGISLVEL 211
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 62/206 (30%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLD---RLAQEREREFKSEVSAIGRTHHKNLVQLL 498
+G GSFG +Y K+ S + + +K++D +E+E K EV + + H N+V
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCV-IKEIDLTKMPVKEKEAS-KKEVILLAKMKHPNIVTFF 65
Query: 499 GFCDEALNRLLVYEFMGNGTLANLIF----AIPKPDWNLR--VRISLEIARGLVYLHEGC 552
E +V E+ G L I + D L V+ISL GL ++H+
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL----GLKHIHDR- 120
Query: 553 NVPIIHCDIKPQNILLD-HYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNA 611
I+H DIK QNI L + K+ DFG+++ L +T + GT Y++PE +N
Sbjct: 121 --KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV-GTPYYLSPEICQNR 177
Query: 612 PVSAKVDVYSFGVMLLEIICCRRSVE 637
P + K D++S G +L E+ + E
Sbjct: 178 PYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 57/198 (28%), Positives = 97/198 (48%), Gaps = 13/198 (6%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKL--DRLAQERERE---FKSEVSAIGRTHHKNLVQ 496
LG+G+FG VY +G +AVK++ D + E +E + E+ + H+ +VQ
Sbjct: 10 LGQGAFGRVYL-CYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 497 LLGFCDEALNRLL--VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNV 554
G + + R L E M G++ + + + N+ + + +I G+ YLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM-- 126
Query: 555 PIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD-HSRTHTM-IRGTRGYVAPEWLKNAP 612
I+H DIK NIL D + K+ DFG SK L + S T + GT +++PE +
Sbjct: 127 -IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEG 185
Query: 613 VSAKVDVYSFGVMLLEII 630
K D++S G ++E++
Sbjct: 186 YGRKADIWSVGCTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 26/209 (12%)
Query: 442 LGRGSFGIVYKGVLKT--ASGNAIAVKKLDRLAQERE-REFKSEVSAIGRT-HHKNLVQL 497
+G G+FG V K +K +A A+K++ A + + R+F E+ + + HH N++ L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDA-AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLI-----------FAIPKPDWNLR-----VRISLEI 541
LG C+ L E+ +G L + + FAI + + + ++
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 542 ARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRG 601
ARG+ YL + IH D+ +NIL+ + KI+DFGLS+ + TM R
Sbjct: 122 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVR 176
Query: 602 YVAPEWLKNAPVSAKVDVYSFGVMLLEII 630
++A E L + + DV+S+GV+L EI+
Sbjct: 177 WMAIESLNYSVYTTNSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 72/295 (24%), Positives = 114/295 (38%), Gaps = 60/295 (20%)
Query: 439 KEELGRGSFGIVYKGVLKTASGNAI--AVK--KLDRLAQEREREFKSEVSAIGRTHHKNL 494
+G G FG VY+GV + I AVK K RE+ F E + + H ++
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK-FLQEAYIMRQFDHPHI 69
Query: 495 VQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRI----SLEIARGLVYLHE 550
V+L+G E V+ M L L + ++L + S +++ L YL
Sbjct: 70 VKLIGVITEN----PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE- 124
Query: 551 GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH-----SRTHTMIRGTRGYVAP 605
+ +H DI +N+L+ K+ DFGLS+ L D S+ I+ ++AP
Sbjct: 125 --SKRFVHRDIAARNVLVSSPDCVKLGDFGLSR-YLEDESYYKASKGKLPIK----WMAP 177
Query: 606 EWLKNAPVSAKVDVYSFGVMLLEIICC---------RRSVEMELEEESRAILTDWAYDCY 656
E + ++ DV+ FGV + EI+ V +E R + +C
Sbjct: 178 ESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPP---NC- 233
Query: 657 VEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711
L+ LM W DPSKRP + L +L+
Sbjct: 234 ------------------PPTLYS-LMTKCWAY--DPSKRPRFTELKAQLSDILQ 267
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 19/201 (9%)
Query: 441 ELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKS--EVSAIGRTH---HKNLV 495
E+G G++G VYK SG+ +A+K + E + EV+ + R H N+V
Sbjct: 7 EIGVGAYGTVYKA-RDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIV 65
Query: 496 QLLGFC-----DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISL--EIARGLVYL 548
+L+ C D LV+E + + L + +P P L + RGL +L
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 549 HEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWL 608
H C I+H D+KP+NIL+ K++DFGL+++ + T ++ T Y APE L
Sbjct: 125 HANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV--TLWYRAPEVL 179
Query: 609 KNAPVSAKVDVYSFGVMLLEI 629
+ + VD++S G + E+
Sbjct: 180 LQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 24/203 (11%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKS----EVSAIGRTHHKNLV 495
++G GS+G+V+K + +G +A+KK + E + K E+ + + H NLV
Sbjct: 7 SKIGEGSYGVVFKCRNRE-TGQIVAIKKF--VESEDDPVIKKIALREIRMLKQLKHPNLV 63
Query: 496 QLLGFCDEALNRL----LVYEFMGNGTLANLIFAIPKP-DWNLRVRISLEIARGLVYLHE 550
L+ E R LV+E+ + T+ N + P+ +L +I + + + + H+
Sbjct: 64 NLI----EVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHK 118
Query: 551 -GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWL- 608
C IH D+KP+NIL+ K+ DFG ++ +L+ +T TR Y APE L
Sbjct: 119 HNC----IHRDVKPENILITKQGQIKLCDFGFAR-ILTGPGDDYTDYVATRWYRAPELLV 173
Query: 609 KNAPVSAKVDVYSFGVMLLEIIC 631
+ VDV++ G + E++
Sbjct: 174 GDTQYGPPVDVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 64/219 (29%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 428 YDELKDATDGFK--EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSA 485
+D D +D ++ E +G+G++G V+K VL +G+ AVK LD + + + E ++E +
Sbjct: 10 FDSFPDPSDTWEIIETIGKGTYGKVFK-VLNKKNGSKAAVKILDPI-HDIDEEIEAEYNI 67
Query: 486 I-GRTHHKNLVQLLG--FCDEALN---RLLVYEFMGNGTLANLIFAIPKPDWNLR----V 535
+ + H N+V+ G + + N LV E G++ +L+ K +
Sbjct: 68 LKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIA 127
Query: 536 RISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM 595
I E GL +LH IH D+K NILL K+ DFG+S L S R +T
Sbjct: 128 YILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS 184
Query: 596 IRGTRGYVAPEWLK-----NAPVSAKVDVYSFGVMLLEI 629
+ GT ++APE + ++ A+ DV+S G+ +E+
Sbjct: 185 V-GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 8e-12
Identities = 66/215 (30%), Positives = 105/215 (48%), Gaps = 17/215 (7%)
Query: 429 DELKDATDGFK--EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAI 486
+ L D TD ++ E +G+G++G VYK V G+ AVK LD ++ E E ++E + +
Sbjct: 15 ESLGDPTDTWEIIETIGKGTYGKVYK-VTNKKDGSLAAVKILDPISDVDE-EIEAEYNIL 72
Query: 487 -GRTHHKNLVQLLGFCDEALNRL-----LVYEFMGNGTLANLIFAIPKPDWNL-RVRISL 539
+H N+V+ G +A + LV E G++ L+ + L IS
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISY 132
Query: 540 EIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGT 599
+ L+ L N IIH D+K NILL K+ DFG+S L S R +T + GT
Sbjct: 133 ILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GT 191
Query: 600 RGYVAPEWLK-----NAPVSAKVDVYSFGVMLLEI 629
++APE + + A+ DV+S G+ +E+
Sbjct: 192 PFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 8e-12
Identities = 81/300 (27%), Positives = 132/300 (44%), Gaps = 52/300 (17%)
Query: 442 LGRGSFGIVYKGVL------KTASGNAIAVKKLDRLAQERE-REFKSEVSA---IGRTHH 491
LG G FG V K +AVK L A +++ + SE+ IG+ H
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK--H 77
Query: 492 KNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFA--------------IPKPDWNLR--V 535
KN++ LLG C + ++ E+ G L + A +P+ + V
Sbjct: 78 KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 536 RISLEIARGLVYL-HEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS-DHSRTH 593
+ ++ARG+ YL + C IH D+ +N+L+ KI+DFGL++ + + D+ +
Sbjct: 138 SCAYQVARGMEYLASQKC----IHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193
Query: 594 TMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAY 653
T R ++APE L + + + DV+SFGV+L EI S I + +
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGS-------PYPGIPVEELF 246
Query: 654 DCYVEG-RLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEV 712
EG R+D + H+ MI C PS+RPT K +++ L+ +L V
Sbjct: 247 KLLKEGHRMD----------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 62/207 (29%), Positives = 98/207 (47%), Gaps = 27/207 (13%)
Query: 441 ELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQERE-------REFKSEVSAIGRTHHKN 493
++G G++G VYK K +G +A+KK+ RL E+E RE K + + +H+N
Sbjct: 14 QIGEGTYGQVYKARDKD-TGELVALKKV-RLDNEKEGFPITAIREIK----ILRQLNHRN 67
Query: 494 LVQL----------LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIAR 543
+V L L F + LV+E+M + + L + + ++
Sbjct: 68 IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLE 127
Query: 544 GLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYV 603
GL Y H +H DIK NILL++ K++DFGL++L S+ SR +T T Y
Sbjct: 128 GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYR 184
Query: 604 APE-WLKNAPVSAKVDVYSFGVMLLEI 629
PE L +DV+S G +L E+
Sbjct: 185 PPELLLGEERYGPAIDVWSCGCILGEL 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 64/243 (26%), Positives = 108/243 (44%), Gaps = 40/243 (16%)
Query: 438 FKEELGRGSFGIVY-------------KGVLKTASGNA--IAVKKLDRLAQERER-EFKS 481
FKE+LG G FG V+ + G +AVK L A + R +F
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68
Query: 482 EVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFA---------------- 525
EV + R N+++LLG C + ++ E+M NG L + +
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 526 ---IPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLS 582
+P ++ + ++L+IA G+ YL ++ +H D+ +N L+ + KI+DFG+S
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 583 K-LLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEII-CCRRSVEMEL 640
+ L D+ R ++A E + + DV++FGV L EI+ C+ EL
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGEL 245
Query: 641 EEE 643
+E
Sbjct: 246 TDE 248
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 23/211 (10%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNLVQLL 498
+G+GSFG V K G AVK L + L ++ ++ +E + + + + L
Sbjct: 3 IGKGSFGKVLLAKRKL-DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 499 GFCDEALNRL-LVYEFMGNGTLANLIFAIPK----PDWNLRVRISLEIARGLVYLHEGCN 553
+ + +L V +F+ G L F + + P+ R + EIA L YLH +
Sbjct: 62 HYSFQTTEKLYFVLDFVNGG---ELFFHLQRERSFPEPRARFYAA-EIASALGYLH---S 114
Query: 554 VPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPV 613
+ I++ D+KP+NILLD ++DFGL K ++ S T T GT Y+APE ++ P
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA-QSDTTTTFCGTPEYLAPEVIRKQPY 173
Query: 614 SAKVDVYSFGVMLLEII------CCRRSVEM 638
VD + G +L E++ CR EM
Sbjct: 174 DNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 67/240 (27%), Positives = 114/240 (47%), Gaps = 42/240 (17%)
Query: 438 FKEELGRGSFGIVY----KGVLK--------TASGNA---IAVKKLDRLAQERER-EFKS 481
FKE+LG G FG V+ +G+ K SGN +AVK L A + R +F
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 482 EVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTL-----------ANLIFAIPKPD 530
E+ + R N+++LL C + ++ E+M NG L A +
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 531 WNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS-DH 589
++ + ++ +IA G+ YL ++ +H D+ +N L+ ++ KI+DFG+S+ L S D+
Sbjct: 129 YSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY 185
Query: 590 SRTHTMIRGTRGYVAPEWLKNAPV-----SAKVDVYSFGVMLLEIIC-CRRSVEMELEEE 643
R I+G R + W+ + + DV++FGV L EI+ C+ +L +E
Sbjct: 186 YR----IQG-RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 52/210 (24%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 430 ELKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRT 489
E+ + +++LG G FG V+ + A+ K ++ E F +E + +
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE---AFLAEANVMKTL 58
Query: 490 HHKNLVQLLGFCDEALNRLLVY---EFMGNGTLANLIFAIPKPDWNLRVRI------SLE 540
H LV+L + + +Y EFM G+L + + K D + + S +
Sbjct: 59 QHDKLVKL----HAVVTKEPIYIITEFMAKGSLLDFL----KSDEGSKQPLPKLIDFSAQ 110
Query: 541 IARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTR 600
IA G+ ++ + IH D++ NIL+ KI+DFGL++++ + +
Sbjct: 111 IAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPI 167
Query: 601 GYVAPEWLKNAPVSAKVDVYSFGVMLLEII 630
+ APE + + K DV+SFG++L+EI+
Sbjct: 168 KWTAPEAINFGSFTIKSDVWSFGILLMEIV 197
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 63/211 (29%), Positives = 97/211 (45%), Gaps = 43/211 (20%)
Query: 442 LGRGSFGIV---YKGVLKTASGNAIAVKKLDR------LAQEREREFKSEVSAIGRTHHK 492
+G G+ GIV Y V G +A+KKL R A+ RE + +HK
Sbjct: 24 IGSGAQGIVCAAYDTVT----GQNVAIKKLSRPFQNVTHAKRAYRELV----LMKLVNHK 75
Query: 493 NLVQLLG-FC-----DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRV---RISLEIAR 543
N++ LL F +E + LV E M ANL I + + R+S + +
Sbjct: 76 NIIGLLNVFTPQKSLEEFQDVYLVMELMD----ANLCQVI-----QMDLDHERMSYLLYQ 126
Query: 544 ---GLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTR 600
G+ +LH + IIH D+KP NI++ + KI DFGL++ + T ++ TR
Sbjct: 127 MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TR 181
Query: 601 GYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC 631
Y APE + VD++S G ++ E+I
Sbjct: 182 YYRAPEVILGMGYKENVDIWSVGCIMGEMIR 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 62/202 (30%), Positives = 103/202 (50%), Gaps = 23/202 (11%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQER---EREFKSEVSAIGRTHHKNLVQLL 498
+G G+FG+V+ V G +A+KK+ + Q +R F+ E+ + H N++ L
Sbjct: 8 IGYGAFGVVW-SVTDPRDGKRVALKKMPNVFQNLVSCKRVFR-ELKMLCFFKHDNVLSAL 65
Query: 499 --------GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISL-EIARGLVYLH 549
+E +V E M L +I + P+P + V++ L +I RGL YLH
Sbjct: 66 DILQPPHIDPFEEIY---VVTELM-QSDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLH 120
Query: 550 EGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLK 609
+ I+H DIKP N+L++ KI DFGL+++ D S+ T T+ Y APE L
Sbjct: 121 ---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILM 177
Query: 610 NAP-VSAKVDVYSFGVMLLEII 630
+ ++ VD++S G + E++
Sbjct: 178 GSRHYTSAVDIWSVGCIFAELL 199
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 63/222 (28%), Positives = 103/222 (46%), Gaps = 25/222 (11%)
Query: 430 ELKDATDGFKEELGRGSFGIVYKG-VLKTASG---NAIAVKKL-DRLAQEREREFKSEVS 484
E+ +T F EELG FG VYKG + TA G A+A+K L D+ EFK E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 485 AIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDW-----NLRVRIS 538
R H N+V LLG + +++ + + L L+ P D + V+ +
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 539 LE----------IARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS- 587
LE IA G+ +L ++H D+ +N+L+ + KISD GL + + +
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177
Query: 588 DHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEI 629
D+ + +++PE + S D++S+GV+L E+
Sbjct: 178 DYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEV 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 19/212 (8%)
Query: 425 FFSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLD---RLAQEREREFKS 481
F D K TD E+G GSFG VY + +A+KK+ + + E+ ++
Sbjct: 8 FSKDDPEKLFTD--LREIGHGSFGAVYFAR-DVRTNEVVAIKKMSYSGKQSNEKWQDIIK 64
Query: 482 EVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR-ISLE 540
EV + + H N ++ G LV E+ G+ ++++ KP + + I
Sbjct: 65 EVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEIAAICHG 123
Query: 541 IARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTR 600
+GL YLH IH DIK NILL + K++DFG + L+ S ++ + GT
Sbjct: 124 ALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLV----SPANSFV-GTP 175
Query: 601 GYVAPE---WLKNAPVSAKVDVYSFGVMLLEI 629
++APE + KVDV+S G+ +E+
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 61/197 (30%), Positives = 97/197 (49%), Gaps = 17/197 (8%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTH-----HKNLVQ 496
LG+G FG V ++ A+G A KKL++ +R ++ K E A+ + V
Sbjct: 8 LGKGGFGEVCACQVR-ATGKMYACKKLEK---KRIKKRKGESMALNEKQILEKVNSRFVV 63
Query: 497 LLGFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEIARGLVYLHEGCN 553
L + E + L LV M G L I+ + + + V + EI GL LH+
Sbjct: 64 SLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE-- 121
Query: 554 VPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPV 613
I++ D+KP+NILLD + +ISD GL+ + + + GT GY+APE +KN
Sbjct: 122 -RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVVKNERY 178
Query: 614 SAKVDVYSFGVMLLEII 630
+ D ++ G +L E+I
Sbjct: 179 TFSPDWWALGCLLYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 19/216 (8%)
Query: 423 LRFFSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGNA---IAVKKLDRLAQERER-E 478
LR ELK + LG G+FG VYKG+ +A+K L+ + E
Sbjct: 1 LRILKETELKRV-----KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE 55
Query: 479 FKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRVRI 537
F E + H +LV+LLG C +L V + M +G L + + L +
Sbjct: 56 FMDEALIMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNW 114
Query: 538 SLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIR 597
++IA+G++YL E ++H D+ +N+L+ KI+DFGL++LL D +
Sbjct: 115 CVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA--D 169
Query: 598 GTR---GYVAPEWLKNAPVSAKVDVYSFGVMLLEII 630
G + ++A E + + + DV+S+GV + E++
Sbjct: 170 GGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 71/293 (24%), Positives = 129/293 (44%), Gaps = 39/293 (13%)
Query: 430 ELKDATDGFKEELGRGSFGIVYKGVLKTASGNA--IAVKKL-DRLAQEREREFKSEVSAI 486
EL + + + LG G FG + +G LK S +A+ L + ++ R F +E +
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTL 60
Query: 487 GRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLE----IA 542
G+ H N+V+L G ++V E+M NG L + + K + L + +A
Sbjct: 61 GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSF---LRKHEGQLVAGQLMGMLPGLA 117
Query: 543 RGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT-HTMIRGTRG 601
G+ YL E + +H + +L++ KIS F L D S +T + G
Sbjct: 118 SGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKSP 171
Query: 602 --YVAPEWLKNAPVSAKVDVYSFGVMLLEIICC--RRSVEMELEEESRAILTDWAYDCYV 657
+ APE ++ S+ DV+SFG+++ E++ R +M ++ +A+ +
Sbjct: 172 VLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF------ 225
Query: 658 EGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710
RL A + LH+ LM+ W Q++ +RP + +L ++
Sbjct: 226 --RLPAPRNCPNL-------LHQ-LMLDCW--QKERGERPRFSQIHSILSKMV 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 68/232 (29%), Positives = 110/232 (47%), Gaps = 39/232 (16%)
Query: 426 FSYDELKDATDGFKEELGRGSFGIVYK----GVLKTASGNAI--AVKKLDRLAQERE-RE 478
FS D+L + LG G FG V G+ K A+ AVK L A E++ +
Sbjct: 12 FSRDKLT-----LGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSD 66
Query: 479 FKSEVSA---IGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFA---------- 525
SE+ IG+ HKN++ LLG C + ++ E+ G L + A
Sbjct: 67 LVSEMEMMKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 124
Query: 526 ----IPKPDWNLR--VRISLEIARGLVYL-HEGCNVPIIHCDIKPQNILLDHYFSPKISD 578
+P + V + ++ARG+ YL + C IH D+ +N+L+ KI+D
Sbjct: 125 DIARVPDEQMTFKDLVSCTYQVARGMEYLASQKC----IHRDLAARNVLVTENNVMKIAD 180
Query: 579 FGLSKLLLS-DHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEI 629
FGL++ + + D+ + T R ++APE L + + + DV+SFGV++ EI
Sbjct: 181 FGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 21/202 (10%)
Query: 445 GSFGIVYKGVLKTASGN---AIAVKKL-DRLAQEREREFKSEVSAIGRTHHKNLVQLLGF 500
G+FG ++ G+L + VK + D ++ + E + H+N++ +L
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76
Query: 501 CDEALNRLLV-YEFMGNGTLANLIFAIPK--PDWNLR-------VRISLEIARGLVYLHE 550
C E V Y +M G L L + N + V ++++IA G+ YLH
Sbjct: 77 CIEDGEPPFVLYPYMNWGNL-KLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH- 134
Query: 551 GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD--HSRTHTMIRGTRGYVAPEWL 608
+IH DI +N ++D KI+D LS+ L H R + ++A E L
Sbjct: 135 --KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK-WMALESL 191
Query: 609 KNAPVSAKVDVYSFGVMLLEII 630
N S+ DV+SFGV+L E++
Sbjct: 192 VNKEYSSASDVWSFGVLLWELM 213
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 58/195 (29%), Positives = 100/195 (51%), Gaps = 11/195 (5%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKS--EVSAIGRTHHKNLVQL 497
E+LG GS+ VYKG+ + +G +A+K + + E F + E S + H N+V L
Sbjct: 11 EKLGEGSYATVYKGISRI-NGQLVALKVIS-MKTEEGVPFTAIREASLLKGLKHANIVLL 68
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISL-EIARGLVYLHEGCNVPI 556
V+E+M + LA + P VR+ + ++ RGL Y+H I
Sbjct: 69 HDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHI 124
Query: 557 IHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAP-VSA 615
+H D+KPQN+L+ + K++DFGL++ S S+T++ T Y P+ L A S+
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSEVVTLWYRPPDVLLGATDYSS 183
Query: 616 KVDVYSFGVMLLEII 630
+D++ G + +E++
Sbjct: 184 ALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 58/214 (27%), Positives = 106/214 (49%), Gaps = 17/214 (7%)
Query: 424 RFFSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGNAI----AVKKL-DRLAQERERE 478
R EL+ + LG G FG V+KG+ G++I A+K + DR ++ +E
Sbjct: 2 RILKETELRKL-----KLLGSGVFGTVHKGIW-IPEGDSIKIPVAIKTIQDRSGRQTFQE 55
Query: 479 FKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRVRI 537
+ A+G H +V+LLG C A + LV + G+L + + D +
Sbjct: 56 ITDHMLAMGSLDHAYIVRLLGICPGA-SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW 114
Query: 538 SLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR-THTMI 596
++IA+G+ YL E ++H ++ +NILL +I+DFG++ LL D + ++
Sbjct: 115 CVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEH 171
Query: 597 RGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEII 630
+ ++A E + + + DV+S+GV + E++
Sbjct: 172 KTPIKWMALESILFGRYTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 68/220 (30%), Positives = 104/220 (47%), Gaps = 25/220 (11%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNLVQLL 498
LG+G+FG V V + A+G A+K L + +A++ +E + T H L L
Sbjct: 3 LGKGTFGKVIL-VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL- 60
Query: 499 GFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISL---EIARGLVYLHEGCNV 554
+ + +RL V E+ G L F + + R EI L YLH +
Sbjct: 61 KYAFQTHDRLCFVMEYANGG---ELFFHLSRERVFTEERARFYGAEIVSALEYLH---SR 114
Query: 555 PIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVS 614
+++ DIK +N++LD KI+DFGL K +SD + T GT Y+APE L++
Sbjct: 115 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDYG 173
Query: 615 AKVDVYSFGVMLLEIICCR---------RSVEMELEEESR 645
VD + GV++ E++C R R E+ L EE R
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR 213
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 83/308 (26%), Positives = 132/308 (42%), Gaps = 72/308 (23%)
Query: 442 LGRGSFGIVYKGVLKTASG---------NAIAVKKLDRLAQERE-REFKSEVSA---IGR 488
LG G FG V V+ A G +AVK L A E++ + SE+ IG+
Sbjct: 26 LGEGCFGQV---VMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82
Query: 489 THHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFA------------IPKPDWNLR-- 534
HKN++ LLG C + ++ E+ G L + A P+ L
Sbjct: 83 --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140
Query: 535 --VRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS-DHSR 591
V + ++ARG+ YL + IH D+ +N+L+ KI+DFGL++ + D+ +
Sbjct: 141 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 197
Query: 592 THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRS----VEME-----LEE 642
T R ++APE L + + + DV+SFGV+L EI S V +E L+E
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE 257
Query: 643 ESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVV 702
R D +C ++ M+ C PS+RPT K +
Sbjct: 258 GHR---MDKPSNC----------------------TNELYMMMRDCWHAVPSQRPTFKQL 292
Query: 703 MQMLEGLL 710
++ L+ +L
Sbjct: 293 VEDLDRIL 300
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 6e-11
Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 15/199 (7%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKL--DRLAQERERE---FKSEVSAIGRTHHKNLVQ 496
LG+G+FG VY +G +A K++ D + E +E + E+ + H+ +VQ
Sbjct: 10 LGQGAFGRVYL-CYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 497 LLG-FCDEALNRLLVY-EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNV 554
G D A L ++ E+M G++ + + A ++ + + +I G+ YLH
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM-- 126
Query: 555 PIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIR---GTRGYVAPEWLKNA 611
I+H DIK NIL D + K+ DFG SK L + + T IR GT +++PE +
Sbjct: 127 -IVHRDIKGANILRDSAGNVKLGDFGASKRLQTI-CMSGTGIRSVTGTPYWMSPEVISGE 184
Query: 612 PVSAKVDVYSFGVMLLEII 630
K DV+S G ++E++
Sbjct: 185 GYGRKADVWSLGCTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 7e-11
Identities = 58/198 (29%), Positives = 104/198 (52%), Gaps = 17/198 (8%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKS--EVSAIGRTHHKNLVQL 497
E+LG GS+ VYKG K +G +A+K + RL +E F + E S + H N+V L
Sbjct: 11 EKLGEGSYATVYKGKSKV-NGKLVALKVI-RLQEEEGTPFTAIREASLLKGLKHANIVLL 68
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLIFAIP---KPDWNLRVRISLEIARGLVYLHEGCNV 554
LV+E++ + L + P P+ N+++ + ++ RGL Y+H+
Sbjct: 69 HDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPE-NVKLFL-FQLLRGLSYIHQRY-- 123
Query: 555 PIIHCDIKPQNILLDHYFSPKISDFGLSKL-LLSDHSRTHTMIRGTRGYVAPE-WLKNAP 612
I+H D+KPQN+L+ K++DFGL++ + H+ ++ ++ T Y P+ L +
Sbjct: 124 -ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWYRPPDVLLGSTE 180
Query: 613 VSAKVDVYSFGVMLLEII 630
S +D++ G + +E+I
Sbjct: 181 YSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 7e-11
Identities = 35/91 (38%), Positives = 54/91 (59%), Gaps = 4/91 (4%)
Query: 540 EIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGT 599
EI+ L +LH+ II+ D+KP+NILLD K++DFGL K + + + THT GT
Sbjct: 108 EISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC-GT 163
Query: 600 RGYVAPEWLKNAPVSAKVDVYSFGVMLLEII 630
Y+APE L + VD +S G ++ +++
Sbjct: 164 IEYMAPEILMRSGHGKAVDWWSLGALMYDML 194
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 8e-11
Identities = 67/228 (29%), Positives = 105/228 (46%), Gaps = 26/228 (11%)
Query: 416 STTSATNLR-------FFSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKL 468
ST+ A +L+ FF D K TD E+G GSFG VY + +A+KK+
Sbjct: 2 STSRAGSLKDPEIAELFFKEDPEKLFTD--LREIGHGSFGAVYFA-RDVRTNEVVAIKKM 58
Query: 469 D---RLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFA 525
+ + E+ ++ EV + R H N ++ G LV E+ G+ ++L+
Sbjct: 59 SYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC-LGSASDLLEV 117
Query: 526 IPKPDWNLRVR-ISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKL 584
KP + + I+ +GL YLH +IH DIK NILL K++DFG + +
Sbjct: 118 HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASI 174
Query: 585 LLSDHSRTHTMIRGTRGYVAPE---WLKNAPVSAKVDVYSFGVMLLEI 629
+S GT ++APE + KVDV+S G+ +E+
Sbjct: 175 ASPANS-----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 9e-11
Identities = 60/196 (30%), Positives = 93/196 (47%), Gaps = 15/196 (7%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDR---LAQEREREFKSEVSAIGRT-HHKNLVQL 497
+G+GSFG V K+ G+ AVK L + L ++ + +E + + + H LV L
Sbjct: 3 IGKGSFGKVLLAKRKS-DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISL---EIARGLVYLHEGCNV 554
A V +++ G L F + + L R E+A + YLH ++
Sbjct: 62 HYSFQTAEKLYFVLDYVNGG---ELFFHLQRERCFLEPRARFYAAEVASAIGYLH---SL 115
Query: 555 PIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVS 614
II+ D+KP+NILLD ++DFGL K + T T GT Y+APE L+ P
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC-GTPEYLAPEVLRKEPYD 174
Query: 615 AKVDVYSFGVMLLEII 630
VD + G +L E++
Sbjct: 175 RTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 9e-11
Identities = 54/202 (26%), Positives = 95/202 (47%), Gaps = 20/202 (9%)
Query: 441 ELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIG------RTHHKNL 494
E+G G++G V+K G +A+K++ R+ E S + + H N+
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLETFEHPNV 66
Query: 495 VQLLGFC-----DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRV--RISLEIARGLVY 547
V+L C D LV+E + + L + +P+P + ++ RGL +
Sbjct: 67 VRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 548 LHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEW 607
LH ++H D+KPQNIL+ K++DFGL+++ + T ++ T Y APE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAPEV 180
Query: 608 LKNAPVSAKVDVYSFGVMLLEI 629
L + + VD++S G + E+
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 57/195 (29%), Positives = 97/195 (49%), Gaps = 16/195 (8%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKL-DRLAQEREREFK-SEVSAIGRTHHKNLVQLLG 499
+G G++G+V K K + +A+KK D E +E E+ + +N+V+L
Sbjct: 9 VGEGAYGVVLKCRHKE-TKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVEL-- 65
Query: 500 FCDEALNR----LLVYEFMGNGTLANLIFAIPKPDWNLRVRISL-EIARGLVYLHEGCNV 554
EA R LV+E++ L L+ +P +VR + ++ + + + H+
Sbjct: 66 --KEAFRRRGKLYLVFEYVEKNML-ELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN--- 119
Query: 555 PIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVS 614
I+H DIKP+N+L+ H K+ DFG ++ L + +T TR Y +PE L AP
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYG 179
Query: 615 AKVDVYSFGVMLLEI 629
VD++S G +L E+
Sbjct: 180 KAVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 62/207 (29%), Positives = 103/207 (49%), Gaps = 33/207 (15%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQER---EREFKSEVSAIGRTHHKNLVQ 496
+++G G++G V L +G +A+KKL R Q +R ++ E+ + H+N++
Sbjct: 21 KQVGSGAYGTVCSA-LDRRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMKHENVIG 78
Query: 497 LLGF--CDEALNRL----LVYEFMGNGTLANLIFAIPKPDWNLRVRISL---EIARGLVY 547
LL D +L+R LV FMG L L+ K + RI ++ +GL Y
Sbjct: 79 LLDVFTPDLSLDRFHDFYLVMPFMGT-DLGKLM----KHEKLSEDRIQFLVYQMLKGLKY 133
Query: 548 LHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPE- 606
+H IIH D+KP N+ ++ KI DFGL++ +D T ++ TR Y APE
Sbjct: 134 IHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR--QTDSEMTGYVV--TRWYRAPEV 186
Query: 607 ---WLKNAPVSAKVDVYSFGVMLLEII 630
W+ + VD++S G ++ E++
Sbjct: 187 ILNWMH---YTQTVDIWSVGCIMAEML 210
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 56/197 (28%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFK---SEVSAIGRTHHKNL 494
F LG GSFG V K +A+K+ ++ ++++ SE + +H
Sbjct: 34 FIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFC 93
Query: 495 VQLLG-FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCN 553
V L G F DE+ LV EF+ G + + ++ + +I YL +
Sbjct: 94 VNLYGSFKDESY-LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQ---S 149
Query: 554 VPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPV 613
+ I++ D+KP+N+LLD K++DFG +K++ +RT+T+ GT Y+APE L N
Sbjct: 150 LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV---DTRTYTLC-GTPEYIAPEILLNVGH 205
Query: 614 SAKVDVYSFGVMLLEII 630
D ++ G+ + EI+
Sbjct: 206 GKAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 58/196 (29%), Positives = 95/196 (48%), Gaps = 17/196 (8%)
Query: 441 ELGRGSFGIVYKGVLKTASGNAIAVKKLD---RLAQEREREFKSEVSAIGRTHHKNLVQL 497
E+G GSFG VY + + +AVKK+ + E+ ++ EV + + H N ++
Sbjct: 28 EIGHGSFGAVYFAT-NSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR-ISLEIARGLVYLHEGCNVPI 556
G + LV E+ G+ ++L+ KP + + I+ +GL YLH +
Sbjct: 87 KGCYLKEHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---M 142
Query: 557 IHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPE---WLKNAPV 613
IH DIK NILL K++DFG + S S ++ + GT ++APE +
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFGSA----SKSSPANSFV-GTPYWMAPEVILAMDEGQY 197
Query: 614 SAKVDVYSFGVMLLEI 629
KVDV+S G+ +E+
Sbjct: 198 DGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 58/197 (29%), Positives = 93/197 (47%), Gaps = 17/197 (8%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTH-----HKNLVQ 496
LG+G FG V ++ A+G A KKL++ +R ++ K E A+ + V
Sbjct: 8 LGKGGFGEVCACQVR-ATGKMYACKKLEK---KRIKKRKGEAMALNEKRILEKVNSRFVV 63
Query: 497 LLGFCDEALNRL-LVYEFMGNGTLANLIFAIPKP--DWNLRVRISLEIARGLVYLHEGCN 553
L + E + L LV M G L I+ + P D + + E+ GL L
Sbjct: 64 SLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE-- 121
Query: 554 VPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPV 613
I++ D+KP+NILLD +ISD GL+ + + + + GT GY+APE + N
Sbjct: 122 -RIVYRDLKPENILLDDRGHIRISDLGLA-VQIPEGETVRGRV-GTVGYMAPEVINNEKY 178
Query: 614 SAKVDVYSFGVMLLEII 630
+ D + G ++ E+I
Sbjct: 179 TFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 60/196 (30%), Positives = 95/196 (48%), Gaps = 15/196 (7%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNLVQLL 498
+G+GSFG V K A AVK L + L ++ E+ SE + + + + L
Sbjct: 3 IGKGSFGKVLLARHK-AEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 499 GFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRI---SLEIARGLVYLHEGCNV 554
F + ++L V +++ G L + + + L R + EIA L YLH ++
Sbjct: 62 HFSFQTADKLYFVLDYINGG---ELFYHLQRERCFLEPRARFYAAEIASALGYLH---SL 115
Query: 555 PIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVS 614
I++ D+KP+NILLD ++DFGL K + + T T GT Y+APE L P
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC-GTPEYLAPEVLHKQPYD 174
Query: 615 AKVDVYSFGVMLLEII 630
VD + G +L E++
Sbjct: 175 RTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 69/232 (29%), Positives = 109/232 (46%), Gaps = 33/232 (14%)
Query: 409 YENNVQDSTTSATNLRFFSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKL 468
Y V DST + Y +LK +G G+ GIV T G +AVKKL
Sbjct: 8 YSVQVADSTFTVLK----RYQQLK--------PIGSGAQGIVC-AAFDTVLGINVAVKKL 54
Query: 469 DRLAQER---EREFKSEVSAIGRTHHKNLVQLLGF------CDEALNRLLVYEFMGNGTL 519
R Q + +R ++ E+ + +HKN++ LL +E + LV E M
Sbjct: 55 SRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD---- 109
Query: 520 ANLIFAIPKPDWNLRVRISL-EIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISD 578
ANL I + R+ L ++ G+ +LH + IIH D+KP NI++ + KI D
Sbjct: 110 ANLCQVIHMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILD 166
Query: 579 FGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEII 630
FGL++ ++ T ++ TR Y APE + VD++S G ++ E++
Sbjct: 167 FGLARTACTNFMMTPYVV--TRYYRAPEVILGMGYKENVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 30/203 (14%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKS--------EVSAIGR-THHK 492
+G G+F V K +G A+K + ++ FKS E+ A+ R + H
Sbjct: 7 IGEGTFSEVLK-AQSRKTGKYYAIKCM-------KKHFKSLEQVNNLREIQALRRLSPHP 58
Query: 493 NLVQLLGFC-DEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISL-EIARGLVYLH 549
N+++L+ D RL LV+E M + L LI +P RV+ + ++ + L ++H
Sbjct: 59 NILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH 117
Query: 550 EGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT-HTMIRGTRGYVAPE-W 607
I H DIKP+NIL+ K++DFG + +S+ +T TR Y APE
Sbjct: 118 -RNG--IFHRDIKPENILIKDDIL-KLADFGSCR---GIYSKPPYTEYISTRWYRAPECL 170
Query: 608 LKNAPVSAKVDVYSFGVMLLEII 630
L + K+D+++ G + EI+
Sbjct: 171 LTDGYYGPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 57/207 (27%), Positives = 100/207 (48%), Gaps = 28/207 (13%)
Query: 441 ELGRGSFGIVY------KGVLKTASGNAIAVKKLD-RLAQEREREFKSEVSAIGRTHHKN 493
+LG G FG V +G +G +AVK L + K E+ + +H+N
Sbjct: 11 DLGEGHFGKVELCRYDPEG---DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 67
Query: 494 LVQLLGFCDEALNR--LLVYEFMGNGTLANLIFAIP--KPDWNLR--VRISLEIARGLVY 547
+V+ G C E L+ EF+ +G+L + P K NL+ ++ +++I +G+ Y
Sbjct: 68 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKNKINLKQQLKYAVQICKGMDY 124
Query: 548 LHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRG----YV 603
L + +H D+ +N+L++ KI DFGL+K + +D + + ++ +
Sbjct: 125 LG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD--KEYYTVKDDLDSPVFWY 179
Query: 604 APEWLKNAPVSAKVDVYSFGVMLLEII 630
APE L + DV+SFGV L E++
Sbjct: 180 APECLIQSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 48/160 (30%), Positives = 78/160 (48%), Gaps = 35/160 (21%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKS--EVSAIGRTHHKNLVQL 497
++LG GS+ VYKG K +G +A+K++ RL E F + E S + H N+V L
Sbjct: 11 DKLGEGSYATVYKGRSKL-TGQLVALKEI-RLEHEEGAPFTAIREASLLKDLKHANIVTL 68
Query: 498 --LGFCDEALNRLLVYEFM-----------GNGTLANLIFAIPKPDWNLRVRISL-EIAR 543
+ + L LV+E++ G G + VR+ L ++ R
Sbjct: 69 HDIIHTKKTLT--LVFEYLDTDLKQYMDDCGGGLSMH------------NVRLFLFQLLR 114
Query: 544 GLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSK 583
GL Y H+ ++H D+KPQN+L+ K++DFGL++
Sbjct: 115 GLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 54/196 (27%), Positives = 92/196 (46%), Gaps = 17/196 (8%)
Query: 441 ELGRGSFGIVYKGVLKTASGNAIAVKKLD---RLAQEREREFKSEVSAIGRTHHKNLVQL 497
E+G GSFG VY + +A+KK+ + + E+ ++ EV + + H N +Q
Sbjct: 22 EIGHGSFGAVYFA-RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR-ISLEIARGLVYLHEGCNVPI 556
G LV E+ G+ ++L+ KP + + ++ +GL YLH + +
Sbjct: 81 RGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNM 136
Query: 557 IHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPE---WLKNAPV 613
IH D+K NILL K+ DFG + ++ + GT ++APE +
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX-----FVGTPYWMAPEVILAMDEGQY 191
Query: 614 SAKVDVYSFGVMLLEI 629
KVDV+S G+ +E+
Sbjct: 192 DGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 5e-10
Identities = 35/93 (37%), Positives = 54/93 (58%), Gaps = 4/93 (4%)
Query: 538 SLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIR 597
+ E+ L LH+ +I+ D+KP+NILLD+ + DFGL KL + D +T+T
Sbjct: 99 TAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC- 154
Query: 598 GTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEII 630
GT Y+APE L + VD ++ GV+L E++
Sbjct: 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEML 187
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 53/196 (27%), Positives = 93/196 (47%), Gaps = 14/196 (7%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG 499
+ +G G++G VYK +G AVK + + + E+ + H N+V G
Sbjct: 15 QRVGSGTYGDVYKA-RNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFG 73
Query: 500 --FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR-ISLEIARGLVYLHEGCNVPI 556
E L + E+ G G+L + I+ + P L++ + E +GL YLH
Sbjct: 74 SYLSREKL--WICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAYLHSKGK--- 127
Query: 557 IHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWL---KNAPV 613
+H DIK NILL K++DFG++ + + ++ + I GT ++APE KN
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKNGGY 186
Query: 614 SAKVDVYSFGVMLLEI 629
+ D+++ G+ +E+
Sbjct: 187 NQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 5e-10
Identities = 78/298 (26%), Positives = 133/298 (44%), Gaps = 52/298 (17%)
Query: 442 LGRGSFGIVYK----GVLKTASGNA--IAVKKLDRLAQERE-REFKSEVS---AIGRTHH 491
LG G FG V + G+ K+ +AVK L A +++ + SE+ IG+ H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGK--H 77
Query: 492 KNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFA--IPKPDWNLR--------------V 535
KN++ LLG C + ++ E+ G L + A P PD+ V
Sbjct: 78 KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 536 RISLEIARGLVYLH-EGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS-DHSRTH 593
+ ++ARG+ YL C IH D+ +N+L+ KI+DFGL++ + D+ +
Sbjct: 138 SCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193
Query: 594 TMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAY 653
+ R ++APE L + + + DV+SFG+++ EI S I + +
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGS-------PYPGIPVEELF 246
Query: 654 DCYVEG-RLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710
EG R+D + H+ M+ C P++RPT K +++ L+ +L
Sbjct: 247 KLLREGHRMDKPSNCT----------HELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 23/203 (11%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKNLVQLL 498
+G G++G V T +G +AVKKL R Q +R ++ E+ + H+N++ LL
Sbjct: 25 VGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 82
Query: 499 GF------CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGC 552
+E + LV MG L N++ D +++ I +I RGL Y+H
Sbjct: 83 DVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH--- 137
Query: 553 NVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH-TMIRGTRGYVAPEWLKN- 610
+ IIH D+KP N+ ++ KI DFGL++ H+ T TR Y APE + N
Sbjct: 138 SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNW 192
Query: 611 APVSAKVDVYSFGVMLLEIICCR 633
+ VD++S G ++ E++ R
Sbjct: 193 MHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 59/204 (28%), Positives = 96/204 (47%), Gaps = 30/204 (14%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFC 501
+GRG FG VY G K +G A+K LD+ +R + + E A+ + + ++ L+
Sbjct: 2 IGRGGFGEVY-GCRKADTGKMYAMKCLDK---KRIKMKQGETLAL---NERIMLSLVSTG 54
Query: 502 DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR------------ISLEIARGLVYLH 549
D + Y F L ++ + D + + + EI GL ++H
Sbjct: 55 DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMH 114
Query: 550 EGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT--HTMIRGTRGYVAPEW 607
N +++ D+KP NILLD + +ISD GL+ D S+ H + GT GY+APE
Sbjct: 115 ---NRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASV-GTHGYMAPEV 166
Query: 608 L-KNAPVSAKVDVYSFGVMLLEII 630
L K + D +S G ML +++
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 15/199 (7%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNLVQLL 498
LG+G+FG V V + A+G A+K L + +A++ +E + + H L L
Sbjct: 3 LGKGTFGKVIL-VKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL- 60
Query: 499 GFCDEALNRL-LVYEFMGNGTLANLIFAIPKPD--WNLRVRI-SLEIARGLVYLHEGCNV 554
+ + +RL V E+ G L F + + R R EI L YLH NV
Sbjct: 61 KYSFQTHDRLCFVMEYANGG---ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNV 117
Query: 555 PIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVS 614
++ D+K +N++LD KI+DFGL K + D + T GT Y+APE L++
Sbjct: 118 --VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEVLEDNDYG 174
Query: 615 AKVDVYSFGVMLLEIICCR 633
VD + GV++ E++C R
Sbjct: 175 RAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 7e-10
Identities = 60/224 (26%), Positives = 97/224 (43%), Gaps = 49/224 (21%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQERERE-FK----SEVSAIGRTHHKNL 494
+LG G+FG VYK +G +A+KK+ E++ F E+ + + H N+
Sbjct: 14 GKLGEGTFGEVYKARQI-KTGRVVALKKI---LMHNEKDGFPITALREIKILKKLKHPNV 69
Query: 495 VQLLGFC----DEALNRL----LVYEFMG---NGTLANLIFAIPKPDWNLRVR----ISL 539
V L+ D++ + +V +M +G L N P L L
Sbjct: 70 VPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLEN-------PSVKLTESQIKCYML 122
Query: 540 EIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD----------H 589
++ G+ YLH N I+H DIK NIL+D+ KI+DFGL++
Sbjct: 123 QLLEGINYLH--ENH-ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGG 179
Query: 590 SRTHTMIRGTRGYVAPEWL---KNAPVSAKVDVYSFGVMLLEII 630
+R +T + TR Y PE L + + VD++ G + E+
Sbjct: 180 TRKYTNLVVTRWYRPPELLLGERR--YTTAVDIWGIGCVFAEMF 221
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 7e-10
Identities = 55/200 (27%), Positives = 104/200 (52%), Gaps = 28/200 (14%)
Query: 445 GSFGIVYKGVLKTASGNAIAVKKLDRLAQERE-------REFKSEVSAIGRTHHKNLVQL 497
G++G+VY+ K +G +A+KKL ++ +E+E RE + H N+V +
Sbjct: 16 GTYGVVYRARDKK-TGEIVALKKL-KMEKEKEGFPITSLREINILLKL----QHPNIVTV 69
Query: 498 ----LGFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVR-ISLEIARGLVYLHEG 551
+G L+++ +V E++ + L +L+ + +P V+ + L++ G+ +LH+
Sbjct: 70 KEVVVG---SNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN 125
Query: 552 CNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNA 611
I+H D+K N+LL++ KI DFGL++ + +T + T Y APE L A
Sbjct: 126 W---ILHRDLKTSNLLLNNRGILKICDFGLAR-EYGSPLKPYTQLVVTLWYRAPELLLGA 181
Query: 612 PV-SAKVDVYSFGVMLLEII 630
S +D++S G + E++
Sbjct: 182 KEYSTAIDMWSVGCIFAELL 201
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 9e-10
Identities = 37/101 (36%), Positives = 57/101 (56%), Gaps = 8/101 (7%)
Query: 534 RVRISL-EIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS-R 591
VR+ + EI L +LH+ + II+ DIK +NILLD ++DFGLSK L++ R
Sbjct: 106 EVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEER 162
Query: 592 THTMIRGTRGYVAPEWLKNAPV--SAKVDVYSFGVMLLEII 630
++ GT Y+APE ++ VD +S GV+ E++
Sbjct: 163 AYSFC-GTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 53/201 (26%), Positives = 97/201 (48%), Gaps = 22/201 (10%)
Query: 442 LGRGSFGIVYKGVLKTASGNA---IAVKKL-DRLAQEREREFKSEVSAIGRTHHKNLVQL 497
LG G+FG VYKG+ +A+K+L + + + +E E + + ++ +L
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLIFAIPK---PDWNLRVRISLEIARGLVYLHEGCNV 554
LG C + +L + + M G L + + + L ++IA+G+ YL E
Sbjct: 75 LGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLN--WCVQIAKGMNYLEER--- 128
Query: 555 PIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPV- 613
++H D+ +N+L+ KI+DFGL+KLL +D H G V +W+ +
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYH----AEGGKVPIKWMALESIL 184
Query: 614 ----SAKVDVYSFGVMLLEII 630
+ + DV+S+GV + E++
Sbjct: 185 HRIYTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 32/206 (15%)
Query: 442 LGRGSFGIVYKGVLKTASGNA---IAVKKL-DRLAQEREREFKSEVSAIGRTHHKNLVQL 497
LG G+FG VYKG+ N +A+K L + + + +E E + + +L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRIS--------LEIARGLVYLH 549
LG C + +L V + M G L + + + RI ++IA+G+ YL
Sbjct: 75 LGICLTSTVQL-VTQLMPYGCLLDYV-------RENKDRIGSQDLLNWCVQIAKGMSYLE 126
Query: 550 EGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLK 609
E V ++H D+ +N+L+ KI+DFGL++LL D + H G V +W+
Sbjct: 127 E---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYH----ADGGKVPIKWMA 179
Query: 610 NAPV-----SAKVDVYSFGVMLLEII 630
+ + + DV+S+GV + E++
Sbjct: 180 LESILHRRFTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 63/194 (32%), Positives = 90/194 (46%), Gaps = 11/194 (5%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKL--DRLAQERERE---FKSEVSAIGRTHHKNLVQ 496
LG+GSFG V LK G AVK L D + + + E + V A+ + L
Sbjct: 3 LGKGSFGKVLLAELK-GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALA-WENPFLTH 60
Query: 497 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPI 556
L + V EF+ G L I + D + EI GL +LH I
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK---GI 117
Query: 557 IHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAK 616
I+ D+K N++LD KI+DFG+ K + +R T GT Y+APE L+ +
Sbjct: 118 IYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAPEILQGLKYTFS 176
Query: 617 VDVYSFGVMLLEII 630
VD +SFGV+L E++
Sbjct: 177 VDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 26/215 (12%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKS--EVSAIGRTHHKNLVQL 497
E+LG G++ V+KG K N +A+K++ RL E + EVS + H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTE-NLVALKEI-RLEHEEGAPCTAIREVSLLKDLKHANIVTL 69
Query: 498 LGFCDEALNRLLVYEFMGNGTLANL-----IFAIPKPDWNLRVRISL-EIARGLVYLHEG 551
+ LV+E++ + I ++ V+I L +I RGL Y H
Sbjct: 70 HDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHN------VKIFLYQILRGLAYCHRR 123
Query: 552 CNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPE-WLKN 610
++H D+KPQN+L++ K++DFGL++ S ++T++ T Y P+ L +
Sbjct: 124 ---KVLHRDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLGS 179
Query: 611 APVSAKVDVYSFGVMLLEIICCR-----RSVEMEL 640
+ S ++D++ G + E+ R +VE EL
Sbjct: 180 SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDEL 214
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 49/202 (24%), Positives = 94/202 (46%), Gaps = 20/202 (9%)
Query: 439 KEELGRGSFGIVYKGVLKTASGNAIAVKKL---DRLAQEREREFKSEVSAIGRTHHKNLV 495
++++GRG F VY+ G +A+KK+ D + + + E+ + + +H N++
Sbjct: 7 EKKIGRGQFSEVYRATC-LLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVI 65
Query: 496 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPK-----PD---WNLRVRISLEIARGLVY 547
+ E +V E G L+ +I K P+ W V ++ L +
Sbjct: 66 KYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFV----QLCSALEH 121
Query: 548 LHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEW 607
+H + ++H DIKP N+ + K+ D GL + S + H+++ GT Y++PE
Sbjct: 122 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 177
Query: 608 LKNAPVSAKVDVYSFGVMLLEI 629
+ + K D++S G +L E+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 56/206 (27%), Positives = 101/206 (49%), Gaps = 27/206 (13%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKS--EVSAIGRTHHKNLVQL 497
++LG G++ V+KG K + N +A+K++ RL E + EVS + H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKL-TENLVALKEI-RLEHEEGAPCTAIREVSLLKNLKHANIVTL 68
Query: 498 LGFCDEALNRLLVYEFMGN---------GTLANLIFAIPKPDWNLRVRISLEIARGLVYL 548
LV+E++ + G L ++ N+++ ++ RGL Y
Sbjct: 69 HDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSM--------HNVKI-FMFQLLRGLSYC 119
Query: 549 HEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPE-W 607
H+ I+H D+KPQN+L++ K++DFGL++ S ++T++ T Y P+
Sbjct: 120 HKR---KILHRDLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVL 175
Query: 608 LKNAPVSAKVDVYSFGVMLLEIICCR 633
L + S +D++ G +L E+ R
Sbjct: 176 LGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 61/200 (30%), Positives = 99/200 (49%), Gaps = 17/200 (8%)
Query: 442 LGRGSFGIVYKGVLK-TASGNAIAVKKLDRLAQEREREFKSEVSAIGRT--HHKNLVQLL 498
+GRGS+ V LK T A+ V K + + + + ++ + T +H LV L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 499 GFCDEALNRL-LVYEFMGNGTLANLIFAIPK----PDWNLRVRISLEIARGLVYLHEGCN 553
C + +RL V EF+ G +L+F + + P+ + R S EI+ L +LHE
Sbjct: 63 S-CFQTESRLFFVIEFVSGG---DLMFHMQRQRKLPEEHARF-YSAEISLALNFLHER-- 115
Query: 554 VPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPV 613
II+ D+K N+LLD K++D+G+ K + T T GT Y+APE L+
Sbjct: 116 -GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC-GTPNYIAPEILRGEDY 173
Query: 614 SAKVDVYSFGVMLLEIICCR 633
VD ++ GV++ E++ R
Sbjct: 174 GFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 52/205 (25%), Positives = 97/205 (47%), Gaps = 26/205 (12%)
Query: 439 KEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL----AQEREREFKSEVSAIGRTHHKNL 494
++++GRG F VY+ +A+KK+ A+ R+ K E+ + + +H N+
Sbjct: 7 EKKIGRGQFSEVYRATC-LLDRKPVALKKVQIFEMMDAKARQDCVK-EIDLLKQLNHPNV 64
Query: 495 VQLLG--FCDEALNRLLVYEFMGNGTLANLIFAIPK-----PD---WNLRVRISLEIARG 544
++ L D LN +V E G L+ +I K P+ W V ++
Sbjct: 65 IKYLDSFIEDNELN--IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFV----QLCSA 118
Query: 545 LVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVA 604
+ ++H + ++H DIKP N+ + K+ D GL + S + H+++ GT Y++
Sbjct: 119 VEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMS 174
Query: 605 PEWLKNAPVSAKVDVYSFGVMLLEI 629
PE + + K D++S G +L E+
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 34/206 (16%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL---- 497
+GRG FG VY G K +G A+K LD+ +R + + E A+ +LV
Sbjct: 2 IGRGGFGEVY-GCRKADTGKMYAMKCLDK---KRIKMKQGETLALNERIMLSLVSTGDCP 57
Query: 498 ----LGFCDEALNRL-LVYEFMGNGTL-----ANLIFAIPKPDWNLRVRISLEIARGLVY 547
+ + ++L + + M G L + +F+ + +R + EI GL +
Sbjct: 58 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS----EAEMRFYAA-EIILGLEH 112
Query: 548 LHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT--HTMIRGTRGYVAP 605
+H N +++ D+KP NILLD + +ISD GL+ D S+ H + GT GY+AP
Sbjct: 113 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASV-GTHGYMAP 164
Query: 606 EWL-KNAPVSAKVDVYSFGVMLLEII 630
E L K + D +S G ML +++
Sbjct: 165 EVLQKGVAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 63/236 (26%), Positives = 104/236 (44%), Gaps = 34/236 (14%)
Query: 408 KYENNVQDSTTSATNLRFFSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKK 467
+YE + T +D +K +GRG+FG V + V +S A+K
Sbjct: 27 RYEKAAEKITKLRMKAE--DFDVIK--------VIGRGAFGEV-QLVRHKSSKQVYAMKL 75
Query: 468 LDRLAQERERE---FKSEVSAIGRTHHKNLVQL-LGFCDEALNRLLVYEFMGNGTLANLI 523
L + + + F E + + + +VQL F D+ +V E+M G L NL+
Sbjct: 76 LSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY-LYMVMEYMPGGDLVNLM 134
Query: 524 --FAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGL 581
+ IP+ W + E+ L +H ++ IH D+KP N+LLD K++DFG
Sbjct: 135 SNYDIPE-KWA--RFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGT 188
Query: 582 SKLLLSD---HSRTHTMIRGTRGYVAPEWLKNAPVSA----KVDVYSFGVMLLEII 630
+ ++ T GT Y++PE LK+ + D +S GV L E++
Sbjct: 189 CMKMDANGMVRCDTAV---GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 32/218 (14%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKS--EVSAIGRTHHKNLVQL 497
++LG G++ VYKG K + N +A+K++ RL E + EVS + H N+V L
Sbjct: 12 DKLGEGTYATVYKGRSKL-TDNLVALKEI-RLEHEEGAPCTAIREVSLLKDLKHANIVTL 69
Query: 498 LGFCDEALNRLLVYEFMGN---------GTLANLIFAIPKPDWNLRVRISLEIARGLVYL 548
+ LV+E++ G N+ N+++ + ++ RGL Y
Sbjct: 70 HDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINM--------HNVKLFL-FQLLRGLNYC 120
Query: 549 HEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPE-W 607
H ++H D+KPQN+L++ K++DFGL++ S ++T++ T Y P+
Sbjct: 121 HRR---KVLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVVTLWYRPPDIL 176
Query: 608 LKNAPVSAKVDVYSFGVMLLEIICCR-----RSVEMEL 640
L + S ++D++ G + E+ R +VE +L
Sbjct: 177 LGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQL 214
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 52/196 (26%), Positives = 103/196 (52%), Gaps = 11/196 (5%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFK-SEVSAIGRTHHKNLVQLL 498
E+LG G++ VYKG +T +G +A+K++ A+E E+S + H+N+V+L
Sbjct: 6 EKLGEGTYATVYKGRNRT-TGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLH 64
Query: 499 GFCDEALNRLLVYEFMGNGTLANL-IFAIPKP-DWNLRVRISLEIARGLVYLHEGCNVPI 556
+LV+E+M + + D N + ++ +G+ + HE +
Sbjct: 65 DVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RV 121
Query: 557 IHCDIKPQNILLDHYFSPKISDFGLSKLL-LSDHSRTHTMIRGTRGYVAPEWLKNAPV-S 614
+H D+KPQN+L++ K++DFGL++ + ++ ++ ++ T Y AP+ L + S
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPDVLLGSRTYS 179
Query: 615 AKVDVYSFGVMLLEII 630
+D++S G ++ E+I
Sbjct: 180 TSIDIWSVGCIMAEMI 195
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 5e-09
Identities = 52/168 (30%), Positives = 79/168 (47%), Gaps = 13/168 (7%)
Query: 444 RGSFGIVYKGVLKTASGNAIAVK---KLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGF 500
RG+FG VY G K + AVK K D + + + ++E A+ + +V L
Sbjct: 14 RGAFGKVYLG-RKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYS 72
Query: 501 CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCD 560
A N LV E++ G + +L+ D + V+ E+A L YLH IIH D
Sbjct: 73 LQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH---GIIHRD 129
Query: 561 IKPQNILLDHYFSPKISDFGLSK------LLLSDHSRTHTMIRGTRGY 602
+KP N+L+ + K++DFGLSK L + D T +M + Y
Sbjct: 130 LKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKPKNDY 177
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 6e-09
Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 27/203 (13%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDR--LAQERE-REFKSEVSAIGRTHHKNLVQ 496
++G+G +G V+ K +G +A+K++ + L + E R +E + T + LV+
Sbjct: 7 TQVGQGGYGQVFLA-KKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVK 65
Query: 497 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIAR--------GLVYL 548
LL + L E++ G L+ NL V +S + AR + L
Sbjct: 66 LLYAFQDDEYLYLAMEYVPGGDFRTLLN-------NLGV-LSEDHARFYMAEMFEAVDAL 117
Query: 549 HEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWL 608
HE + IH D+KP+N L+D K++DFGLSK ++ + ++++ G+ Y+APE L
Sbjct: 118 HE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV---TYANSVV-GSPDYMAPEVL 170
Query: 609 KNAPVSAKVDVYSFGVMLLEIIC 631
+ VD +S G ML E +C
Sbjct: 171 RGKGYDFTVDYWSLGCMLYEFLC 193
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 6e-09
Identities = 76/295 (25%), Positives = 116/295 (39%), Gaps = 65/295 (22%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLD--------RLAQEREREFKSEVSAIGRTHH 491
E LG+G+F +YKGVL+ S I + F S + + H
Sbjct: 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSH 60
Query: 492 KNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP---DWNLRVRISLEIARGLVYL 548
K+LV+L G C ++V E++ G L + W L V L A L YL
Sbjct: 61 KHLVKLYGVC-VRDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQL--ASALHYL 117
Query: 549 HEGCNVPIIHCDIKPQNILLDHY-----FSP--KISDFGLSKLLLSDHSRTHTMIRGTRG 601
+ ++H ++ +NIL+ Y + P K+SD G+ +LS R +
Sbjct: 118 EDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI-----P 169
Query: 602 YVAPEWLKNAPVSAKV--DVYSFGVMLLEIICCR--------RSVEMELEEESRAILTDW 651
++APE ++N S + D +SFG LLE IC S E E + + L
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLE-ICSNGEEPLSTLSSSEKERFYQDQHRLP-- 226
Query: 652 AYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQML 706
DC L LI C DP+KRP+ + +++ L
Sbjct: 227 MPDC---AELANLI--------------------NQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 56/197 (28%), Positives = 94/197 (47%), Gaps = 14/197 (7%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQERERE---FKSEVSAIGRTHHKNLVQLL 498
+GRG+FG V + V +S A+K L + + + F E + + +VQL
Sbjct: 51 IGRGAFGEV-QLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 499 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIH 558
+ +V E+M G L NL+ P+ + + E+ L +H ++ +IH
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTA-EVVLALDAIH---SMGLIH 165
Query: 559 CDIKPQNILLDHYFSPKISDFGLS-KLLLSDHSRTHTMIRGTRGYVAPEWLK----NAPV 613
D+KP N+LLD + K++DFG K+ + R T + GT Y++PE LK +
Sbjct: 166 RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQGGDGYY 224
Query: 614 SAKVDVYSFGVMLLEII 630
+ D +S GV L E++
Sbjct: 225 GRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 7e-09
Identities = 54/197 (27%), Positives = 92/197 (46%), Gaps = 16/197 (8%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG 499
+ +G G++G VYK +G A+K + E + E+ + H N+V G
Sbjct: 15 QRIGSGTYGDVYKA-RNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFG 73
Query: 500 FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR-ISLEIARGLVYLHEGCNVPIIH 558
+ EF G G+L + I+ + P ++ +S E +GL YLH + +H
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLH---SKGKMH 129
Query: 559 CDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAK-- 616
DIK NILL K++DFG+S + + ++ + I GT ++APE A V K
Sbjct: 130 RDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEV---AAVERKGG 185
Query: 617 ----VDVYSFGVMLLEI 629
D+++ G+ +E+
Sbjct: 186 YNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 8e-09
Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 27/203 (13%)
Query: 442 LGRGSFGIV---YKGVLKTASGNAIAVKKLDRLAQER---EREFKSEVSAIGRTHHKNLV 495
+G G+ GIV Y +L+ +A+KKL R Q + +R ++ E+ + +HKN++
Sbjct: 32 IGSGAQGIVCAAYDAILE----RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNII 86
Query: 496 QLLGF------CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISL-EIARGLVYL 548
LL +E + +V E M ANL I + R+ L ++ G+ +L
Sbjct: 87 GLLNVFTPQKSLEEFQDVYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 549 HEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWL 608
H + IIH D+KP NI++ + KI DFGL++ + T ++ TR Y APE +
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVI 197
Query: 609 KNAPVSAKVDVYSFGVMLLEIIC 631
VD++S G ++ E+I
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIK 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 50/208 (24%), Positives = 95/208 (45%), Gaps = 38/208 (18%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKS---EVSAIGRTHHKNLVQ 496
E++G G++G V+K + + +A+K++ RL + E S E+ + HKN+V+
Sbjct: 6 EKIGEGTYGTVFKAKNRE-THEIVALKRV-RLDDDDEGVPSSALREICLLKELKHKNIVR 63
Query: 497 L-------------LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIAR 543
L +CD+ L + Y NG D + ++ +
Sbjct: 64 LYDVLHSDKKLTLVFEYCDQDLKK---YFDSCNG----------DIDPEIVKSFMFQLLK 110
Query: 544 GLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLL-LSDHSRTHTMIRGTRGY 602
GL + H ++H D+KPQN+L++ K++DFGL++ + + ++ T Y
Sbjct: 111 GLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV--TLWY 165
Query: 603 VAPEWLKNAPV-SAKVDVYSFGVMLLEI 629
P+ L A + S +D++S G + E+
Sbjct: 166 RPPDVLFGAKLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 45/151 (29%), Positives = 76/151 (50%), Gaps = 15/151 (9%)
Query: 440 EELGRGSFGIVYKGVLKTASGNA-IAVKKLDRLAQERER-EFKSEVSAIGRTHHKNLVQL 497
+E+G G FG V + T +G A + VK+L A +E+ EF + H N++Q
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR-------VRISLEIARGLVYLHE 550
LG C EA+ LLV+E+ G L + + + W+ R R++ EIA G+ ++H+
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSY---LSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK 117
Query: 551 GCNVPIIHCDIKPQNILLDHYFSPKISDFGL 581
+H D+ +N L + K+ D+G+
Sbjct: 118 ---HNFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 74/292 (25%), Positives = 126/292 (43%), Gaps = 60/292 (20%)
Query: 440 EELGRGSFGIVYKGVLKTASGN-----------AIAVKKLDRLAQEREREFKSEVSAIGR 488
E LGRG+ +Y G+L + + +K LD ++ F S + +
Sbjct: 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQ 60
Query: 489 THHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPD-----WNLRVRISLEIAR 543
HK++V L G C + ++V EF+ G L +F K D W +V + ++A
Sbjct: 61 VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LFMHRKSDVLTTPWKFKV--AKQLAS 116
Query: 544 GLVYLHEGCNVPIIHCDIKPQNILL-----DHYFSP--KISDFGLSKLLLSDHSRTHTMI 596
L YL + ++H ++ +NILL D P K+SD G+ +LS +
Sbjct: 117 ALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERI- 172
Query: 597 RGTRGYVAPEWLKNAPV-SAKVDVYSFGVMLLEIICCRRSVEME---LEEESRAILTDWA 652
++APE ++++ S D +SFG L E IC + ++ L E+ R
Sbjct: 173 ----PWIAPECVEDSKNLSIAADKWSFGTTLWE-ICYNGEIPLKDKTLAEKER------- 220
Query: 653 YDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704
+ EG+ L+ +AD LM C+ DP++RP + +M+
Sbjct: 221 ---FYEGQC-MLVTPSCKELAD-------LMTH--CMNYDPNQRPFFRAIMR 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 2e-08
Identities = 59/230 (25%), Positives = 93/230 (40%), Gaps = 46/230 (20%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNLVQLL 498
+GRG+FG V + V K +G+ A+KKL + L +E+ ++E + + +V+L
Sbjct: 9 IGRGAFGEV-RLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLY 67
Query: 499 -GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPII 557
F DE L+ E++ G + L+ K D IA ++ + + I
Sbjct: 68 YSFQDE-NYLYLIMEYLPGGDMMTLLM---KKDTFTEEETRFYIAETILAIDSIHKLGYI 123
Query: 558 HCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH------------------TMIR-- 597
H DIKP N+LLD K+SDFGL L H M
Sbjct: 124 HRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKR 183
Query: 598 -----------------GTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEII 630
GT Y+APE + + D +S GV++ E++
Sbjct: 184 KAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 61/202 (30%), Positives = 99/202 (49%), Gaps = 27/202 (13%)
Query: 442 LGRGSFGIV---YKGVLKTASGNAIAVKKLDRLAQER---EREFKSEVSAIGRTHHKNLV 495
+G G+ GIV Y VL +A+KKL R Q + +R ++ E+ + +HKN++
Sbjct: 25 IGSGAQGIVCAAYDAVLD----RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNII 79
Query: 496 QLLGF------CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISL-EIARGLVYL 548
LL +E + LV E M ANL I + R+ L ++ G+ +L
Sbjct: 80 SLLNVFTPQKSLEEFQDVYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHL 135
Query: 549 HEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWL 608
H + IIH D+KP NI++ + KI DFGL++ + T ++ TR Y APE +
Sbjct: 136 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVI 190
Query: 609 KNAPVSAKVDVYSFGVMLLEII 630
VD++S G ++ E++
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 58/203 (28%), Positives = 100/203 (49%), Gaps = 26/203 (12%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKL-----DRLAQERE-REFKSEVSAIGRTHHKNLV 495
+GRG++GIV + + +A+KK+ +R+ +R RE K + H+N++
Sbjct: 13 IGRGAYGIVCSAK-NSETNEKVAIKKIANAFDNRIDAKRTLREIK----LLRHLDHENVI 67
Query: 496 QLLGF----CDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISL-EIARGLVYLH 549
+ EA N + +VYE M T + I + + + L ++ RGL Y+H
Sbjct: 68 AIKDIMPPPHREAFNDVYIVYELMD--TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH 125
Query: 550 EGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS-RTHTMIRGTRGYVAPEWL 608
+ ++H D+KP N+LL+ KI DFGL++ T ++ TR Y APE L
Sbjct: 126 ---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV--TRWYRAPELL 180
Query: 609 KN-APVSAKVDVYSFGVMLLEII 630
N + + +DV+S G + E++
Sbjct: 181 LNCSEYTTAIDVWSVGCIFAELL 203
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 62/247 (25%), Positives = 99/247 (40%), Gaps = 41/247 (16%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVK---KLDRLAQEREREFKSEVSAIGRTHHKNLVQLL 498
+GRG+FG V + V K +G+ A+K K D L +E+ ++E + +V++
Sbjct: 9 IGRGAFGEV-RLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMF 67
Query: 499 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIH 558
+ LN L+ EF+ G + L+ K D IA ++ + + IH
Sbjct: 68 YSFQDKLNLYLIMEFLPGGDMMTLLM---KKDTLTEEETQFYIAETVLAIDSIHQLGFIH 124
Query: 559 CDIKPQNILLDHYFSPKISDFGLSKLLLSDH------------------------SRTHT 594
DIKP N+LLD K+SDFGL L H + T
Sbjct: 125 RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAET 184
Query: 595 MIR----------GTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEES 644
R GT Y+APE + D +S GV++ E++ E +E+
Sbjct: 185 WKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQET 244
Query: 645 RAILTDW 651
+ +W
Sbjct: 245 YKKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 23/207 (11%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQERE---REFKSEVSAIGRTHHKN-LV 495
E++G G++G VYK K +G +A+KK RL + E E+S + +V
Sbjct: 7 EKIGEGTYGKVYKARDKN-TGKLVALKK-TRLEMDEEGIPPTALREISLLQMLSESIYIV 64
Query: 496 QLLGF--CDEALNRL---LVYEFMGNGTLANLIFAIPKP----DWNLRVRISLEIARGLV 546
+LL +E + LV+E++ + + P ++ +G+
Sbjct: 65 RLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA 124
Query: 547 YLHEGCNVPIIHCDIKPQNILLDHYFSP-KISDFGLSK-LLLSDHSRTHTMIRGTRGYVA 604
+ H+ ++H D+KPQN+L+D KI+D GL + + S TH ++ T Y A
Sbjct: 125 HCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV--TLWYRA 179
Query: 605 PEWLKNAP-VSAKVDVYSFGVMLLEII 630
PE L + S VD++S G + E+
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCIFAEMS 206
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 54/227 (23%), Positives = 93/227 (40%), Gaps = 53/227 (23%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKS--------------EVSAIG 487
LG G++G V K T +G +A+KK+ + + E+ +
Sbjct: 17 LGEGTYGKVEKA-YDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMN 75
Query: 488 RTHHKNLVQLLG-FCDEA-LNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRIS------- 538
H+N++ L+ + + +N LV + M L ++ + ++R++
Sbjct: 76 EIKHENIMGLVDVYVEGDFIN--LVMDIM-ASDLKKVV--------DRKIRLTESQVKCI 124
Query: 539 -LEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSK-----LLLSDHSRT 592
L+I GL LH +H D+ P NI ++ KI+DFGL++ S+
Sbjct: 125 LLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181
Query: 593 HTMIRG--------TRGYVAPEWLKNAP-VSAKVDVYSFGVMLLEII 630
TM R T Y APE L A VD++S G + E++
Sbjct: 182 ETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELL 228
|
Length = 335 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 59/198 (29%), Positives = 95/198 (47%), Gaps = 19/198 (9%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQE--REREFKSEVSAIGRTHHKNLVQLLG 499
+G G++G V T +AVKKL R Q R E+ + H+N++ LL
Sbjct: 23 VGSGAYGSVCSA-YDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLD 81
Query: 500 FCD-----EALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCN 553
E N + LV MG L N++ D +++ I ++ RGL Y+H +
Sbjct: 82 VFTPATSIENFNEVYLVTNLMG-ADLNNIVKCQKLSDEHVQFLI-YQLLRGLKYIH---S 136
Query: 554 VPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKN-AP 612
IIH D+KP N+ ++ +I DFGL++ +D T + TR Y APE + N
Sbjct: 137 AGIIHRDLKPSNVAVNEDCELRILDFGLAR--QADDEMTGYV--ATRWYRAPEIMLNWMH 192
Query: 613 VSAKVDVYSFGVMLLEII 630
+ VD++S G ++ E++
Sbjct: 193 YNQTVDIWSVGCIMAELL 210
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 36/214 (16%)
Query: 440 EELGRGSFGIVYKGVLK------TASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKN 493
E LG+G+F ++KG+ + + +K LD+ + F S + + HK+
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60
Query: 494 LVQLLGFCDEALNRLLVYEFMGNGTL-------ANLIFAIPKPDWNLRVRISLEIARGLV 546
LV G C ++V E++ G+L NLI W L V + ++A L
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINIS----WKLEV--AKQLAWALH 114
Query: 547 YLHEGCNVPIIHCDIKPQNILL-----DHYFSP---KISDFGLSKLLLSDHSRTHTMIRG 598
+L + + H ++ +N+LL +P K+SD G+S +L ++
Sbjct: 115 FLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE-----ILLE 166
Query: 599 TRGYVAPEWLKNAP-VSAKVDVYSFGVMLLEIIC 631
+V PE ++N +S D +SFG L EI
Sbjct: 167 RIPWVPPECIENPQNLSLAADKWSFGTTLWEIFS 200
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 4e-08
Identities = 33/113 (29%), Positives = 52/113 (46%), Gaps = 20/113 (17%)
Query: 535 VRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSK--------LLL 586
+ I +I + Y+H + ++H D+KP NILL + I D+G + LL
Sbjct: 116 LSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172
Query: 587 SDHSRTHTM---------IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEII 630
D + I GT Y+APE L P S D+Y+ GV+L +++
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 4e-08
Identities = 40/157 (25%), Positives = 72/157 (45%), Gaps = 19/157 (12%)
Query: 443 GRGSFGIVYKGVLKTAS-GNAIAVKKLDRLAQEREREFKS---EVSAIGRTHHKNLVQLL 498
GRG++G VYK K G A+KK ++ +S E++ + H+N+V L+
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68
Query: 499 GFCDEALNRL--LVYEFMGNGTLANLIF-----AIPKPDWNLRVRISLEIARGLVYLHEG 551
E ++ L++++ + + F + P ++ + +I G+ YLH
Sbjct: 69 EVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVK-SLLWQILNGVHYLHSN 127
Query: 552 CNVPIIHCDIKPQNILLDHYFSP----KISDFGLSKL 584
++H D+KP NIL+ KI D GL++L
Sbjct: 128 W---VLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 439 KEELGRGSFGIVYKGVLKTA-SGNAIAVKK---LDRLAQEREREFKSEVSAIGRTHHKNL 494
++ LG+GSFG VY K A + + V K + L + E + + H +
Sbjct: 5 QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAI 64
Query: 495 VQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR----VRISLEIARGLVYLHE 550
V+ E ++ E+ L + + L +++ G+ Y+H+
Sbjct: 65 VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124
Query: 551 GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS--DHSRTHTMIRGTRGYVAPEWL 608
I+H D+K +NI L + KI DFG+S+LL+ D + T T GT Y++PE L
Sbjct: 125 R---RILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATTFT---GTPYYMSPEAL 177
Query: 609 KNAPVSAKVDVYSFGVMLLEIIC 631
K+ +K D++S G +L E+ C
Sbjct: 178 KHQGYDSKSDIWSLGCILYEMCC 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 41/115 (35%), Positives = 65/115 (56%), Gaps = 7/115 (6%)
Query: 535 VRI-SLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH-SRT 592
VR S EI L +LH+ + I++ DIK +NILLD ++DFGLSK LS+ RT
Sbjct: 107 VRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERT 163
Query: 593 HTMIRGTRGYVAPEWLKNAPVSAK-VDVYSFGVMLLEIICCRRSVEMELEEESRA 646
++ GT Y+APE ++ K VD +S G+++ E++ +E E +++
Sbjct: 164 YSFC-GTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS 217
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 5e-08
Identities = 57/204 (27%), Positives = 102/204 (50%), Gaps = 15/204 (7%)
Query: 442 LGRGSFG-IVYKGVLKTASGNAIAVKKLDRLAQEREREF-KSEVSAIGRTHHKNLVQLLG 499
+GRGS+ ++ + KT A+ V K + + + + ++ ++E + + + L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 500 FCDEALNRLL-VYEFMGNGTLANLIFAIPK----PDWNLRVRISLEIARGLVYLHEGCNV 554
C + +RL V E++ G +L+F + + P+ + R S EI+ L YLHE
Sbjct: 63 SCFQTESRLFFVIEYVNGG---DLMFHMQRQRKLPEEHARF-YSAEISLALNYLHER--- 115
Query: 555 PIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVS 614
II+ D+K N+LLD K++D+G+ K L T T GT Y+APE L+
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPEILRGEDYG 174
Query: 615 AKVDVYSFGVMLLEIICCRRSVEM 638
VD ++ GV++ E++ R ++
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 6e-08
Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 35/208 (16%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFK-----SEVSAIG--------- 487
+G GSFG+VY+ + S +A+KK+ + Q + RE + ++ I
Sbjct: 74 IGNGSFGVVYEAICIDTS-EKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTEC 132
Query: 488 -RTHHKN--LVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARG 544
+ + KN L ++ F + +++ + + N L + + S ++ R
Sbjct: 133 FKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKL----------YSYQLCRA 182
Query: 545 LVYLHEGCNVPIIHCDIKPQNILLD-HYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYV 603
L Y+H I H D+KPQN+L+D + + K+ DFG +K LL+ R+ + I +R Y
Sbjct: 183 LAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ-RSVSYI-CSRFYR 237
Query: 604 APEWLKNAP-VSAKVDVYSFGVMLLEII 630
APE + A + +D++S G ++ E+I
Sbjct: 238 APELMLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 8e-08
Identities = 59/230 (25%), Positives = 91/230 (39%), Gaps = 49/230 (21%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFK---SEVSAIGRTHHKNLVQ 496
+ LG+G G V+ LK +G A+K LD+ + + K +E + H L
Sbjct: 7 KLLGKGDVGRVFLVRLK-GTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPT 65
Query: 497 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIAR--------GLVYL 548
L LV ++ G L L+ P +S E+AR L YL
Sbjct: 66 LYASFQTETYLCLVMDYCPGGELFRLLQRQPGK------CLSEEVARFYAAEVLLALEYL 119
Query: 549 HEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLL----------LSDHSRTHTMIR- 597
H + I++ D+KP+NILL +SDF LSK L SR ++
Sbjct: 120 H---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176
Query: 598 -----------------GTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEII 630
GT Y+APE + + VD ++ G++L E++
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 45/143 (31%), Positives = 74/143 (51%), Gaps = 13/143 (9%)
Query: 501 CDEALNRL-LVYEFMGNGTLANLIFAIPK----PDWNLRVRISLEIARGLVYLHEGCNVP 555
C + +RL LV E++ G +L+F + + P+ + R + EI L +LHE
Sbjct: 64 CFQTTSRLFLVIEYVNGG---DLMFHMQRQRKLPEEHARF-YAAEICIALNFLHER---G 116
Query: 556 IIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSA 615
II+ D+K N+LLD K++D+G+ K L T T GT Y+APE L+
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC-GTPNYIAPEILRGEEYGF 175
Query: 616 KVDVYSFGVMLLEIICCRRSVEM 638
VD ++ GV++ E++ R ++
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 36/109 (33%), Positives = 56/109 (51%), Gaps = 5/109 (4%)
Query: 540 EIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGT 599
EI L +LH+ + II+ DIK +NILLD ++DFGLSK D GT
Sbjct: 113 EIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGT 169
Query: 600 RGYVAPEWLKNAPV--SAKVDVYSFGVMLLEIICCRRSVEMELEEESRA 646
Y+AP+ ++ VD +S GV++ E++ ++ E+ S+A
Sbjct: 170 IEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQA 218
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 32/91 (35%), Positives = 52/91 (57%), Gaps = 4/91 (4%)
Query: 539 LEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRG 598
+++ G+ ++HE ++H DIK +NI L K+ DFG ++LL S + T + G
Sbjct: 107 VQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-G 162
Query: 599 TRGYVAPEWLKNAPVSAKVDVYSFGVMLLEI 629
T YV PE +N P + K D++S G +L E+
Sbjct: 163 TPYYVPPEIWENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 30/97 (30%), Positives = 46/97 (47%), Gaps = 11/97 (11%)
Query: 537 ISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMI 596
I +I GL YLH IIH D+K +NI ++ I D G ++ +
Sbjct: 162 IEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-----PAF 213
Query: 597 RGTRGYV---APEWLKNAPVSAKVDVYSFGVMLLEII 630
G G V APE L ++K D++S G++L E++
Sbjct: 214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 50/165 (30%), Positives = 78/165 (47%), Gaps = 40/165 (24%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQERE-------REFKSEVSAIGRTHHKNL 494
+G+G+FG V+K K + +A+KK+ + E+E RE K + H+N+
Sbjct: 20 IGQGTFGEVFKARHKK-TKQIVALKKV-LMENEKEGFPITALREIK----ILQLLKHENV 73
Query: 495 VQLLGFCD---EALNR-----LLVYEFMGNGTLANLIFAIPKPDWNLRVRISL-EIAR-- 543
V L+ C NR LV+EF + LA L+ N V+ +L EI +
Sbjct: 74 VNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLS-------NKNVKFTLSEIKKVM 125
Query: 544 -----GLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSK 583
GL Y+H I+H D+K NIL+ K++DFGL++
Sbjct: 126 KMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 2e-07
Identities = 27/80 (33%), Positives = 37/80 (46%), Gaps = 8/80 (10%)
Query: 1 TIIWHANEDNHPVLAPRGSTLELTATG-LLLKDPGGQAIW--DEKPNKIVSDAAMLDTGN 57
T++W AN DN P TL L + G L++ D G +W + +LD GN
Sbjct: 42 TVVWVANRDN-PS--GSSCTLTLQSDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGN 98
Query: 58 FVLIASGNHSDYAWQSFKSP 77
VL S + + WQSF P
Sbjct: 99 LVLYDSDGN--FLWQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 51/175 (29%), Positives = 88/175 (50%), Gaps = 27/175 (15%)
Query: 538 SLEIARGLVYL-HEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMI 596
S ++A+G+ +L + C IH D+ +NILL H KI DFGL++ + +D ++ ++
Sbjct: 220 SYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIRND---SNYVV 272
Query: 597 RGTR----GYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWA 652
+G ++APE + N + + DV+S+G++L EI S + +S+
Sbjct: 273 KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK------F 326
Query: 653 YDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLE 707
Y EG + S E A ++ + K C DP KRPT K ++Q++E
Sbjct: 327 YKMIKEG---YRMLSPECAPSEMYDIMK------SCWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 3/100 (3%)
Query: 537 ISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMI 596
I + R + YLHE IIH DIK +NI ++H + DFG + + ++ +
Sbjct: 187 IERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGW 243
Query: 597 RGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSV 636
GT APE L P VD++S G++L E+ C S+
Sbjct: 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 22/199 (11%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQER---EREFKSEVSAIGRTHHKNLVQLL 498
+G G++G V + K +G +A+KKL R Q +R ++ E++ + H+N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKR-TGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHENVIGLL 80
Query: 499 GF------CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGC 552
DE + LV +M T I P + ++ + ++ GL Y+H
Sbjct: 81 DVFTSAVSGDEFQDFYLVMPYMQ--TDLQKIMGHPLSEDKVQYLV-YQMLCGLKYIHSA- 136
Query: 553 NVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKN-A 611
IIH D+KP N+ ++ KI DFGL++ +D T ++ TR Y APE + N
Sbjct: 137 --GIIHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTGYVV--TRWYRAPEVILNWM 190
Query: 612 PVSAKVDVYSFGVMLLEII 630
+ VD++S G ++ E++
Sbjct: 191 HYNQTVDIWSVGCIMAEML 209
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 54/177 (30%), Positives = 85/177 (48%), Gaps = 23/177 (12%)
Query: 538 SLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHT-MI 596
S ++ARG+ +L + IH D+ +NILL KI DFGL++ + D
Sbjct: 180 SFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSA 236
Query: 597 RGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVE--MELEEESRAILTDWAYD 654
R ++APE + + + + DV+SFGV+L EI S +++ EE L D
Sbjct: 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT-- 294
Query: 655 CYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711
R+ A E A + R +M+A W Q DP +RPT ++++L LL+
Sbjct: 295 -----RMRA----PENATPEIYR----IMLACW--QGDPKERPTFSALVEILGDLLQ 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 4e-07
Identities = 25/77 (32%), Positives = 36/77 (46%), Gaps = 8/77 (10%)
Query: 1 TIIWHANEDNHPVLAPRGSTLELTATG-LLLKDPGGQAIW--DEKPNKIVSDAAMLDTGN 57
T++W AN DN TL L + G L+L D G+ +W + +LD GN
Sbjct: 41 TVVWVANRDNP---VSDSCTLTLQSDGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGN 97
Query: 58 FVLIASGNHSDYAWQSF 74
V+ S ++ WQSF
Sbjct: 98 LVIYDSDG--NFLWQSF 112
|
Length = 114 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 6e-07
Identities = 61/247 (24%), Positives = 98/247 (39%), Gaps = 41/247 (16%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVK---KLDRLAQEREREFKSEVSAIGRTHHKNLVQLL 498
+GRG+FG V + V K +G+ A+K K D L +E+ ++E + +V++
Sbjct: 9 IGRGAFGEV-RLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMF 67
Query: 499 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIH 558
+ N L+ EF+ G + L+ K D IA ++ + + IH
Sbjct: 68 YSFQDKRNLYLIMEFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQLGFIH 124
Query: 559 CDIKPQNILLDHYFSPKISDFGLSKLLLSDH------SRTHT------------------ 594
DIKP N+LLD K+SDFGL L H + TH
Sbjct: 125 RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAET 184
Query: 595 ----------MIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEES 644
GT Y+APE + D +S GV++ E++ E +E+
Sbjct: 185 WKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQET 244
Query: 645 RAILTDW 651
+ +W
Sbjct: 245 YRKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 7e-07
Identities = 56/207 (27%), Positives = 98/207 (47%), Gaps = 24/207 (11%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL---L 498
LG GS G+V+ V + +AVKK+ + + E+ I R H N+V++ L
Sbjct: 13 LGCGSNGLVFSAV-DSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVL 71
Query: 499 GFCDEALNRLL-----------VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVY 547
G L + V E+M LAN++ P + + R+ ++ RGL Y
Sbjct: 72 GPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLSEEHARL-FMYQLLRGLKY 129
Query: 548 LHEGCNVPIIHCDIKPQNILLD-HYFSPKISDFGLSKLLLSDHSRTHTMIRG--TRGYVA 604
+H NV +H D+KP N+ ++ KI DFGL++++ +S + G T+ Y +
Sbjct: 130 IHSA-NV--LHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRS 186
Query: 605 PEWLKNAPVSAK-VDVYSFGVMLLEII 630
P L + K +D+++ G + E++
Sbjct: 187 PRLLLSPNNYTKAIDMWAAGCIFAEML 213
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 8e-07
Identities = 56/197 (28%), Positives = 91/197 (46%), Gaps = 14/197 (7%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQERERE---FKSEVSAIGRTHHKNLVQLL 498
+GRG+FG V + V ++ A+K L + + + F E + + +VQL
Sbjct: 51 IGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 499 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIH 558
+ +V E+M G L NL+ P+ R + E+ L +H ++ IH
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA-EVVLALDAIH---SMGFIH 165
Query: 559 CDIKPQNILLDHYFSPKISDFGLS-KLLLSDHSRTHTMIRGTRGYVAPEWLK----NAPV 613
D+KP N+LLD K++DFG K+ R T + GT Y++PE LK +
Sbjct: 166 RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYY 224
Query: 614 SAKVDVYSFGVMLLEII 630
+ D +S GV L E++
Sbjct: 225 GRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 34/95 (35%), Positives = 52/95 (54%), Gaps = 8/95 (8%)
Query: 538 SLEIARGLVYL-HEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS--DHSRTHT 594
S ++ARG+ +L C IH D+ +NILL KI DFGL++ + D+ R
Sbjct: 179 SFQVARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 234
Query: 595 MIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEI 629
R ++APE + + + + DV+SFGV+L EI
Sbjct: 235 A-RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEI 268
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 42/137 (30%), Positives = 63/137 (45%), Gaps = 19/137 (13%)
Query: 509 LVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNIL 567
+V E++ G A L+ I P R+ + E L YLH N I+H D+KP N+L
Sbjct: 78 MVMEYVEGGDCATLLKNIGALPVDMARMYFA-ETVLALEYLH---NYGIVHRDLKPDNLL 133
Query: 568 LDHYFSPKISDFGLSKL--------LLSDHSRTHT------MIRGTRGYVAPEWLKNAPV 613
+ K++DFGLSK+ L H T + GT Y+APE +
Sbjct: 134 ITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY 193
Query: 614 SAKVDVYSFGVMLLEII 630
VD ++ G++L E +
Sbjct: 194 GKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (121), Expect = 1e-06
Identities = 40/163 (24%), Positives = 69/163 (42%), Gaps = 19/163 (11%)
Query: 490 HHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLH 549
+ N ++L +L+ +++ +G L +L+ K +I ++ L LH
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLH 126
Query: 550 EGCNVPIIHCDIKPQNILLDHYFSPK----ISDFGLSKLLLSDHSRTHTMIRGTRGYVAP 605
IIH DIK +N+L Y K + D+GL K T + GT Y +P
Sbjct: 127 ---KHNIIHNDIKLENVL---YDRAKDRIYLCDYGLCK-----IIGTPSCYDGTLDYFSP 175
Query: 606 EWLKNAPVSAKVDVYSFGVMLLEIICCR----RSVEMELEEES 644
E +K D ++ GV+ E++ + + EL+ ES
Sbjct: 176 EKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLES 218
|
Length = 267 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQERERE---FKSEVSAIGRTHHKNLVQL- 497
+GRG+FG V LK A A+K L++ + E F+ E + ++ + L
Sbjct: 9 IGRGAFGEVAVVKLKNAD-KVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLI--FAIPKPDWNLRVRISLEIARGLVYLHEGCNVP 555
F DE N LV ++ G L L+ F P+ R ++ E+ + +H+ +
Sbjct: 68 YAFQDEN-NLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLA-EMVIAIDSVHQ---LH 122
Query: 556 IIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLK-----N 610
+H DIKP NIL+D +++DFG L+ D + ++ GT Y++PE L+
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGK 182
Query: 611 APVSAKVDVYSFGVMLLEII 630
+ D +S GV + E++
Sbjct: 183 GKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 45/191 (23%), Positives = 92/191 (48%), Gaps = 31/191 (16%)
Query: 529 PDWNLRV----RISLEIARGLVYL-HEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSK 583
W L + R S ++A+G+ +L + C IH D+ +N+LL KI DFGL++
Sbjct: 205 DSWPLDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLAR 260
Query: 584 LLLSDHSRTHTMIRGTR----GYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEME 639
+++D ++ +++G ++APE + + + + DV+S+G++L EI +S
Sbjct: 261 DIMND---SNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS---- 313
Query: 640 LEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTM 699
IL + + V+ + + D + + ++ M C +P++RPT
Sbjct: 314 ---PYPGILVNSKFYKMVK-------RGYQMSRPDFAPPEIYSIMKM-CWNLEPTERPTF 362
Query: 700 KVVMQMLEGLL 710
+ Q+++ L
Sbjct: 363 SQISQLIQRQL 373
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 34/160 (21%), Positives = 73/160 (45%), Gaps = 12/160 (7%)
Query: 477 REFKSEVSAIGRTHHKNLVQLLGF----CDEALNRLLVYEFMGNGTLANLIFAIPKPDWN 532
++E+ + R N++++ GF D+ L+ E+ G L ++ +
Sbjct: 63 DITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFK 122
Query: 533 LRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592
++ ++++ +GL L++ N P + ++ + L+ + KI GL K+L S +
Sbjct: 123 TKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKN 180
Query: 593 HTMIRGTRGYVAPEWLKN--APVSAKVDVYSFGVMLLEII 630
+ Y + + L + + + K D+YS GV+L EI
Sbjct: 181 VNFM----VYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIF 216
|
Length = 283 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 6e-06
Identities = 48/191 (25%), Positives = 77/191 (40%), Gaps = 51/191 (26%)
Query: 538 SLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM-I 596
S ++A+G+ +L + IH D+ +NILL KI DFGL++ + D
Sbjct: 185 SFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241
Query: 597 RGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEI----------------ICCRRSVEMEL 640
R ++APE + + + + DV+SFGV+L EI C R L
Sbjct: 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR------L 295
Query: 641 EEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMK 700
+E +R D+ + LD C +PS+RPT
Sbjct: 296 KEGTRMRAPDYTTPEMYQTMLD-------------------------CWHGEPSQRPTFS 330
Query: 701 VVMQMLEGLLE 711
+++ L LL+
Sbjct: 331 ELVEHLGNLLQ 341
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 8e-06
Identities = 13/67 (19%), Positives = 24/67 (35%), Gaps = 3/67 (4%)
Query: 291 NNVDWPLGDYERLEPSNQTECEISCLQDCSCAVAIYD--GNRCWKKKLPLSNGWLRDTEF 348
+V P + + EC +CL +CSC Y+ C L+N +
Sbjct: 18 PDVKLPDNAS-AITAISLEECREACLSNCSCTAYAYNNGSGGCLLWNGLLNNLRSLSSGG 76
Query: 349 SKVLFKV 355
+ ++
Sbjct: 77 GTLYLRL 83
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 31/92 (33%), Positives = 44/92 (47%), Gaps = 4/92 (4%)
Query: 545 LVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLS-KLLLSDHSRTHTMIRGTRGYV 603
L YLH IIH D+K +NI LD + + DFG + KL + GT
Sbjct: 198 LAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETN 254
Query: 604 APEWLKNAPVSAKVDVYSFGVMLLEIICCRRS 635
+PE L P AK D++S G++L E+ +
Sbjct: 255 SPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 28/208 (13%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKNLVQ 496
E +G+GS+G+V + T +G +A+KK++ + + R + E+ + H ++V+
Sbjct: 6 EVIGKGSYGVVCSAI-DTHTGEKVAIKKINDVFEHVSDATRILR-EIKLLRLLRHPDIVE 63
Query: 497 LLGFC-----DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEG 551
+ E + +V+E M + L +I A ++ R L Y+H
Sbjct: 64 IKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA 122
Query: 552 CNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNA 611
NV H D+KP+NIL + KI DFGL+++ +D T T I T YVA W + A
Sbjct: 123 -NV--FHRDLKPKNILANADCKLKICDFGLARVAFND---TPTAIFWT-DYVATRWYR-A 174
Query: 612 P---------VSAKVDVYSFGVMLLEII 630
P + +D++S G + E++
Sbjct: 175 PELCGSFFSKYTPAIDIWSIGCIFAEVL 202
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 2e-05
Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 40/224 (17%)
Query: 440 EELGRGSFGIVY----KGVLKTASGNAIAVKKLDRLAQERER-EFKSEVSAIGRTHHKNL 494
+++G G FG V+ K + AI+ + L +ERE+ + EV+ + HKN+
Sbjct: 19 KKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL----KEREKSQLVIEVNVMRELKHKNI 74
Query: 495 VQLLG-FCDEALNRL-LVYEFMGNGTLANLIFA----IPKPDWNLRVRISLEIARGLVYL 548
V+ + F ++A +L ++ EF G L+ I K + + V I+ ++ L Y
Sbjct: 75 VRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYC 134
Query: 549 HEGCNVP----IIHCDIKPQNILLDHYFS-----------------PKISDFGLSKLLLS 587
H + P ++H D+KPQNI L KI DFGLSK +
Sbjct: 135 HNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK-NIG 193
Query: 588 DHSRTHTMIRGTRGYVAPEWLKNAPVS--AKVDVYSFGVMLLEI 629
S H+ + GT Y +PE L + S K D+++ G ++ E+
Sbjct: 194 IESMAHSCV-GTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL 236
|
Length = 1021 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 48/158 (30%), Positives = 73/158 (46%), Gaps = 35/158 (22%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKL--------DRLAQER-EREFKSEVSAIGRTHHK 492
+G+G+FG V + V K +G A+K L D+LA + ER+ +E +
Sbjct: 9 IGKGAFGEV-RLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAE------SDSP 61
Query: 493 NLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGC 552
+V L +A L+ EF+ G L ++ ++ S ++ R Y+ E C
Sbjct: 62 WVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLI-----KYDT---FSEDVTR--FYMAE-C 110
Query: 553 NVPI--------IHCDIKPQNILLDHYFSPKISDFGLS 582
+ I IH DIKP NIL+D K+SDFGLS
Sbjct: 111 VLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 7e-05
Identities = 62/237 (26%), Positives = 98/237 (41%), Gaps = 55/237 (23%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKL---DRLAQEREREFKSEVSAIGRTHHKNLVQLL 498
+G G+FG V V K + A+K L D L + + K+E + ++ +V+L
Sbjct: 9 IGIGAFGEVCL-VRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLY 67
Query: 499 -GFCDEALNRLLVYEFMGNGTLANLI--FAIPKPDWNLRVRISLEIARGLVYLHEGCNVP 555
F D+ N V +++ G + +L+ I + D R I+ E+ + +H +
Sbjct: 68 YSFQDKD-NLYFVMDYIPGGDMMSLLIRLGIFEEDL-ARFYIA-ELTCAIESVH---KMG 121
Query: 556 IIHCDIKPQNILLDHYFSPKISDFGL---------SKLLL-SDHSRTHTM---------- 595
IH DIKP NIL+D K++DFGL SK DH R +M
Sbjct: 122 FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEID 181
Query: 596 ----------------------IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEII 630
+ GT Y+APE L + D +S GV+L E++
Sbjct: 182 RCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 8e-05
Identities = 59/250 (23%), Positives = 100/250 (40%), Gaps = 34/250 (13%)
Query: 465 VKKLDRLAQEREREF-KSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLI 523
V K L ER+ + +SE+ + H +V+ LL+ E+ G L I
Sbjct: 97 VAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI 156
Query: 524 FA-----IPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISD 578
+P ++ + + + +I L +H ++H D+K NI L K+ D
Sbjct: 157 KQRLKEHLPFQEYEVGL-LFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGD 212
Query: 579 FGLSKLLLSDHS-RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVE 637
FG SK S + GT Y+APE + S K D++S GV+L E++ R +
Sbjct: 213 FGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFK 272
Query: 638 MELEEESRAILTDWAYD---CYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPS 694
+ E + YD C V + AL+D + ++P+
Sbjct: 273 GPSQREIMQQVLYGKYDPFPCPVSSGMKALLDP--------------------LLSKNPA 312
Query: 695 KRPTMKVVMQ 704
RPT + ++
Sbjct: 313 LRPTTQQLLH 322
|
Length = 478 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 21/202 (10%)
Query: 442 LGRGSFGIVYKGVLKTASGNAI-AVKKLDRLAQERERE---FKSEVSAIGRTHHKNLVQL 497
+GRG+FG V V+K I A+K L++ + E F+ E + + + + L
Sbjct: 9 IGRGAFGEV--AVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTL 66
Query: 498 -LGFCDEALNRL-LVYEFMGNGTLANLI--FAIPKPDWNLRVRISLEIARGLVYLHEGCN 553
F DE N L LV ++ G L L+ F P+ R IA ++ +H
Sbjct: 67 HYAFQDE--NYLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR----FYIAEMVLAIHSIHQ 120
Query: 554 VPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKN--- 610
+ +H DIKP N+LLD +++DFG + D + ++ GT Y++PE L+
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMED 180
Query: 611 --APVSAKVDVYSFGVMLLEII 630
+ D +S GV + E++
Sbjct: 181 GMGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 40/105 (38%), Positives = 52/105 (49%), Gaps = 12/105 (11%)
Query: 426 FSYDELKDATDGFKEELGRGSFGIVYK----GVLKTASGNAIAVKKLDRLAQERE-REFK 480
F D LK + LGRG+FG V + G+ KTA+ +AVK L A E R
Sbjct: 4 FPRDRLK-----LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM 58
Query: 481 SEVSA-IGRTHHKNLVQLLGFCDEALNRLLV-YEFMGNGTLANLI 523
SE+ I HH N+V LLG C + L+V EF G L+N +
Sbjct: 59 SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYL 103
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 29/96 (30%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 538 SLEIARGLVYL-HEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH---SRTH 593
+ ++ARG+ +L + C +H D+ +N+LL KI DFGL++ ++ D S+
Sbjct: 243 TYQVARGMEFLASKNC----VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGS 298
Query: 594 TMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEI 629
T + ++APE + + + DV+S+G++L EI
Sbjct: 299 TFL--PVKWMAPESIFDNLYTTLSDVWSYGILLWEI 332
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 34/124 (27%), Positives = 59/124 (47%), Gaps = 10/124 (8%)
Query: 510 VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYL-HEGCNVPIIHCDIKPQNILL 568
+ LI P + V S ++A G+ +L + C +H D+ +N+L+
Sbjct: 217 LPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNC----VHRDLAARNVLI 272
Query: 569 DHYFSPKISDFGLSKLLLSDH---SRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVM 625
KI DFGL++ ++ D S+ T + ++APE + N + DV+SFG++
Sbjct: 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFL--PLKWMAPESIFNNLYTTLSDVWSFGIL 330
Query: 626 LLEI 629
L EI
Sbjct: 331 LWEI 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 31/92 (33%), Positives = 46/92 (50%), Gaps = 6/92 (6%)
Query: 438 FKEELGRGSFGIVYK----GVLKTASGNAIAVKKLDRLAQERERE-FKSEVSAIGRT-HH 491
F + LG G+FG V + G+ K+ + +AVK L A ERE SE+ + +H
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 98
Query: 492 KNLVQLLGFCDEALNRLLVYEFMGNGTLANLI 523
N+V LLG C L++ E+ G L N +
Sbjct: 99 INIVNLLGACTVGGPTLVITEYCCYGDLLNFL 130
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 38/105 (36%), Positives = 52/105 (49%), Gaps = 16/105 (15%)
Query: 426 FSYDELKDATDGFKEELGRGSFGIVYK----GVLKTASGNAIAVKKLDRLAQERE-REFK 480
F D LK + LGRG+FG V + G+ K+AS +AVK L A E +
Sbjct: 4 FPRDRLK-----LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALM 58
Query: 481 SEVSA---IGRTHHKNLVQLLGFCDEALNRLLV-YEFMGNGTLAN 521
+E+ IG HH N+V LLG C + L+V E+ G L+N
Sbjct: 59 TELKILIHIG--HHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSN 101
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 37/106 (34%), Positives = 51/106 (48%), Gaps = 15/106 (14%)
Query: 426 FSYDELKDATDGFKEELGRGSFGIVYK----GVLKTASGNAIAVKKLDRLAQERERE-FK 480
F D L+ F + LG G+FG V + G+ K + +AVK L A ERE
Sbjct: 35 FPRDNLQ-----FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALM 89
Query: 481 SEV---SAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLI 523
SE+ S +G HKN+V LLG C L++ E+ G L N +
Sbjct: 90 SELKILSHLG--QHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFL 133
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 7e-04
Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 19/201 (9%)
Query: 442 LGRGSFGIVYKGVLKT-ASGNAIAVKKLDRLAQERERE---FKSEVSAIGRTHHKNLVQL 497
+GRG+FG V V+K +G A+K L++ + E F+ E + + + L
Sbjct: 9 IGRGAFGEV--AVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNL 66
Query: 498 -LGFCDEALNRLLVYEFMGNGTLANLI--FAIPKPDWNLRVRISLEIARGLVYLHEGCNV 554
F DE N LV ++ G L L+ F P+ R ++ E+ + +H+ +
Sbjct: 67 HYAFQDEN-NLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLA-EMVLAIDSVHQ---L 121
Query: 555 PIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLK----- 609
+H DIKP N+LLD +++DFG LL+D + + GT Y++PE L+
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDG 181
Query: 610 NAPVSAKVDVYSFGVMLLEII 630
+ D +S GV + E++
Sbjct: 182 KGRYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 55/223 (24%), Positives = 91/223 (40%), Gaps = 46/223 (20%)
Query: 442 LGRGSFGIVYKGVLKTASGNA-----------------------IAVKKLDRLAQERERE 478
LG+G+ +Y G L+ G + +K LD ++
Sbjct: 3 LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62
Query: 479 FKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLI----FAIPKPDWNLR 534
F S + + H +L + G C ++V EF+ +G L + +P W +
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPV-AWKIT 121
Query: 535 VRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHY-----FSP--KISDFGLSKLLLS 587
V + ++A L YL + ++H ++ +NILL SP K+SD G+S LS
Sbjct: 122 V--AQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALS 176
Query: 588 DHSRTHTMIRGTRGYVAPEWLKN-APVSAKVDVYSFGVMLLEI 629
R + ++APE + +S D +SFG LLEI
Sbjct: 177 REERVERI-----PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 58/238 (24%), Positives = 94/238 (39%), Gaps = 53/238 (22%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKL---DRLAQEREREFKSEVSAIGRTHHKNLVQLL 498
LG G+FG V K + A+K L D L + + K+E + ++ +V+L
Sbjct: 9 LGIGAFGEVCLA-RKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLY 67
Query: 499 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIH 558
+ N V +++ G + +L+ + +L E+ + +H+ + IH
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHK---MGFIH 124
Query: 559 CDIKPQNILLDHYFSPKISDFGL---------SKLLLS-DHSRTHTM------------- 595
DIKP NIL+D K++DFGL SK S DH R +M
Sbjct: 125 RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCR 184
Query: 596 -----------------------IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEII 630
+ GT Y+APE L + D +S GV+L E++
Sbjct: 185 CGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.002
Identities = 49/218 (22%), Positives = 86/218 (39%), Gaps = 47/218 (21%)
Query: 441 ELGRGSFGIVYKGVLK-TASGNAIAVKK--LDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
+G+ ++ + K + +AVKK LD ++E + + E+ + H N++
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64
Query: 498 LGFCDEALNRL-LVYEFMGNGTLANLI---FAIPKPDWNLRVRISLEIARGLVYLH-EGC 552
+ + L +V M G+ +L+ F P+ + I ++ L Y+H +G
Sbjct: 65 V-TSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF-ILKDVLNALDYIHSKGF 122
Query: 553 NVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMI-RGTRGYV-------- 603
IH +K +ILL G K++LS + +MI G R V
Sbjct: 123 ----IHRSVKASHILLS----------GDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSS 168
Query: 604 -------APEWLKN--APVSAKVDVYSFGVMLLEIICC 632
+PE L+ + K D+YS G I C
Sbjct: 169 VKNLPWLSPEVLQQNLQGYNEKSDIYSVG-----ITAC 201
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 38/118 (32%), Positives = 54/118 (45%), Gaps = 16/118 (13%)
Query: 442 LGRGSFGIVYK----GVLKTASGNAIAVKKLDRLAQERE-REFKSEVSA-IGRTHHKNLV 495
LG G+FG V + G+ K +S N +AVK L A E + SE+ I +H N+V
Sbjct: 15 LGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVV 74
Query: 496 QLLGFCDEALNRLLV-YEFMGNGTLANLI---------FAIPKPDWNLRVRISLEIAR 543
LLG C + L+V EF G L+N + + P R R +E +R
Sbjct: 75 NLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSR 132
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.003
Identities = 33/94 (35%), Positives = 49/94 (52%), Gaps = 10/94 (10%)
Query: 541 IARGLV----YLH-EGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLL-SDHSRTHT 594
+AR L+ Y+H EG IIH DIK +N+L++ + DFG + S + H
Sbjct: 265 VARQLLSAIDYIHGEG----IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY 320
Query: 595 MIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLE 628
I GT APE L P + VD++S G+++ E
Sbjct: 321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 728 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.79 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.78 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.75 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.74 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.73 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.68 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.67 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.67 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.66 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.66 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.64 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.64 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.63 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.63 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.61 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.53 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.52 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.51 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.49 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.32 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.31 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.25 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.21 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.16 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.14 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.12 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.08 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.08 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.05 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.97 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.95 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.94 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.88 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.87 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 98.82 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.72 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.68 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.55 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.48 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.41 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.37 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.37 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.36 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.1 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.04 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.02 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.98 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.94 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.93 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.91 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.91 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.86 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.81 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 97.79 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 97.53 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.5 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.49 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.39 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.34 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.32 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.18 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.16 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.11 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.89 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.84 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.49 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 96.46 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.25 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.04 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.04 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 95.92 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.8 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.78 | |
| PLN02236 | 344 | choline kinase | 95.71 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.59 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.21 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 94.81 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 94.8 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 94.68 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.52 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-52 Score=444.40 Aligned_cols=287 Identities=45% Similarity=0.770 Sum_probs=250.5
Q ss_pred CccccCHHHHHHHHhhHH--hhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEee
Q 047292 422 NLRFFSYDELKDATDGFK--EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG 499 (728)
Q Consensus 422 ~~~~~~~~el~~~~~~~~--~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g 499 (728)
..+.|++.|+..||++|. ..||+|+||.||+|.+. ++..||||++........++|.+|+.++.+++|||||+|+|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~--~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlG 138 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLS--DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLG 138 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEEC--CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEE
Confidence 678899999999999999 58999999999999996 45899999887654331556999999999999999999999
Q ss_pred eeecCC-cceeEeeccCCCCHHHHHhcCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEE
Q 047292 500 FCDEAL-NRLLVYEFMGNGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKI 576 (728)
Q Consensus 500 ~~~~~~-~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl 576 (728)
||.+.+ +++||||||++|+|.++|+... .++|.+|++||.++|+||+|||+.+.+.||||||||+|||||+++++||
T Consensus 139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred EEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 999999 4999999999999999999875 8899999999999999999999998889999999999999999999999
Q ss_pred ccccCccccccCCCcccccc-cCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHh
Q 047292 577 SDFGLSKLLLSDHSRTHTMI-RGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDC 655 (728)
Q Consensus 577 ~Dfgla~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 655 (728)
+|||+|+..... ....... .||.+|+|||++..+..+.|+|||||||+|+||+||+++.+...... ...+..|+...
T Consensus 219 sDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~-~~~l~~w~~~~ 296 (361)
T KOG1187|consen 219 SDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRG-ELSLVEWAKPL 296 (361)
T ss_pred cCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcc-cccHHHHHHHH
Confidence 999999765441 1111112 79999999999999999999999999999999999999887554222 22267888888
Q ss_pred hhcCccceeccchhh-hhhcH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 047292 656 YVEGRLDALIDSDEA-AMADR-SRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEV 712 (728)
Q Consensus 656 ~~~~~~~~~~d~~~~-~~~~~-~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 712 (728)
+.++.+.+++|+.+. ..... +++.++..++.+|++.+|++||+|.||+++|+.+...
T Consensus 297 ~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 297 LEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 999999999999976 55554 6888999999999999999999999999999766544
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=390.10 Aligned_cols=263 Identities=27% Similarity=0.403 Sum_probs=223.4
Q ss_pred HHHHHHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCccee
Q 047292 430 ELKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLL 509 (728)
Q Consensus 430 el~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 509 (728)
++......+.++||+|.||.|+.|.++ ....||+|.++.. ....+.|.+|+.+|++|+|+|||+++|+|.....++|
T Consensus 202 ei~r~~l~l~~~LG~G~FG~V~~g~~~--~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyI 278 (468)
T KOG0197|consen 202 EIPREELKLIRELGSGQFGEVWLGKWN--GSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYI 278 (468)
T ss_pred eecHHHHHHHHHhcCCccceEEEEEEc--CCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEE
Confidence 556666778899999999999999996 3458999999775 3345788999999999999999999999999999999
Q ss_pred EeeccCCCCHHHHHhc--CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcccccc
Q 047292 510 VYEFMGNGTLANLIFA--IPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS 587 (728)
Q Consensus 510 v~e~~~~gsL~~~l~~--~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 587 (728)
|||||+.|+|.++|+. ...+...+.+.++.|||+||+||+++ ++|||||.++||||+++..+||+|||||+...+
T Consensus 279 VtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 279 VTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGD 355 (468)
T ss_pred EEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCC
Confidence 9999999999999997 46788999999999999999999997 999999999999999999999999999997666
Q ss_pred CCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceecc
Q 047292 588 DHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALID 666 (728)
Q Consensus 588 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 666 (728)
+.........-+..|.|||.+....++.|||||||||+||||+| |+.|+......+.... ++
T Consensus 356 ~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~-----------------le 418 (468)
T KOG0197|consen 356 DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLEL-----------------LE 418 (468)
T ss_pred CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHH-----------------Hh
Confidence 66555555556889999999999999999999999999999999 6777765544432221 22
Q ss_pred chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCC
Q 047292 667 SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNP 715 (728)
Q Consensus 667 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~ 715 (728)
.......+..++..+.+++..||+.+|++|||++.+...|+.+.....+
T Consensus 419 ~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~~ 467 (468)
T KOG0197|consen 419 RGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTSTEG 467 (468)
T ss_pred ccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcccC
Confidence 2233334455677888999999999999999999999999988765443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=388.06 Aligned_cols=251 Identities=35% Similarity=0.553 Sum_probs=208.8
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcE-EEEEEecccchhh--HHHHHHHHHHhccccccceeeEeeeeecCC-cceeEeec
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNA-IAVKKLDRLAQER--EREFKSEVSAIGRTHHKNLVQLLGFCDEAL-NRLLVYEF 513 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~-vavK~l~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~lv~e~ 513 (728)
+.+.||+|+||+||+|.++ |.. ||||++....... .+.|.+|+.+|.+++|||||+++|+|.+.. ..++||||
T Consensus 45 ~~~~iG~G~~g~V~~~~~~---g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWR---GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred hhhhcccCCceeEEEEEeC---CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 4466999999999999996 445 9999997643222 569999999999999999999999999988 79999999
Q ss_pred cCCCCHHHHHhc--CCCCChHHHHHHHHHHHHHHHHhhhcCCCC-eeecCCCCCCEEEcCCC-ceEEccccCccccccCC
Q 047292 514 MGNGTLANLIFA--IPKPDWNLRVRISLEIARGLVYLHEGCNVP-IIHCDIKPQNILLDHYF-SPKISDFGLSKLLLSDH 589 (728)
Q Consensus 514 ~~~gsL~~~l~~--~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~-iiH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~~~ 589 (728)
+++|+|.++++. ...+++..+++++.|||+||.|||++ + ||||||||+|||++.++ ++||+|||+++......
T Consensus 122 ~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 122 MPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 999999999998 57899999999999999999999997 6 99999999999999997 99999999998764432
Q ss_pred CcccccccCCccccCccccc--CCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccc
Q 047292 590 SRTHTMIRGTRGYVAPEWLK--NAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDS 667 (728)
Q Consensus 590 ~~~~~~~~gt~~y~aPE~~~--~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 667 (728)
...+...||+.|||||++. ...|+.|+|||||||+||||+||+.||............ ...+.
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v-------~~~~~------- 263 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAV-------VVGGL------- 263 (362)
T ss_pred -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHH-------HhcCC-------
Confidence 2233367999999999999 569999999999999999999999999876552221111 11111
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 668 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 668 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
....+......+..++.+||+.||.+||++.+|+.+|+.+..
T Consensus 264 --Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 264 --RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred --CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 111122255677889999999999999999999999997654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=362.60 Aligned_cols=248 Identities=27% Similarity=0.386 Sum_probs=209.4
Q ss_pred HhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc-chhhHHHHHHHHHHhccccccceeeEeeeeecCCc-ceeEeeccCC
Q 047292 439 KEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALN-RLLVYEFMGN 516 (728)
Q Consensus 439 ~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-~~lv~e~~~~ 516 (728)
...||+|..|+|||+.++ .+++.+|+|.+... .....+++.+|+++++..+||+||+++|.|..... ..|+||||++
T Consensus 84 ~~~lG~G~gG~V~kv~Hk-~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDg 162 (364)
T KOG0581|consen 84 LGVLGSGNGGTVYKVRHK-PTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDG 162 (364)
T ss_pred hhhcccCCCcEEEEEEEc-CCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCC
Confidence 468999999999999998 67899999999543 34456899999999999999999999999999985 9999999999
Q ss_pred CCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccccc
Q 047292 517 GTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMI 596 (728)
Q Consensus 517 gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 596 (728)
|+|++++...+.+++..+-+|+.+|++||.|||+. ++||||||||+|||++..|.+||+|||.++.+.+. .....
T Consensus 163 GSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~a~tf 237 (364)
T KOG0581|consen 163 GSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---IANTF 237 (364)
T ss_pred CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---hcccc
Confidence 99999999889999999999999999999999974 49999999999999999999999999999987554 33456
Q ss_pred cCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhH--hhhhhHHHHHHHhhhcCccceeccchhhhhhc
Q 047292 597 RGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEE--ESRAILTDWAYDCYVEGRLDALIDSDEAAMAD 674 (728)
Q Consensus 597 ~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 674 (728)
.||..|||||.+.+..|+.++||||||+.++|+.+|+.|+...... ..... ......+....+.+
T Consensus 238 vGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~L-----l~~Iv~~ppP~lP~-------- 304 (364)
T KOG0581|consen 238 VGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFEL-----LCAIVDEPPPRLPE-------- 304 (364)
T ss_pred cccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHH-----HHHHhcCCCCCCCc--------
Confidence 7999999999999999999999999999999999999998765111 11111 12222222222221
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 675 RSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 675 ~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
..+.+++..++..||++||.+||+++|+++.
T Consensus 305 ~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 305 GEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred ccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1456778899999999999999999999864
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=361.17 Aligned_cols=204 Identities=30% Similarity=0.459 Sum_probs=183.8
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
|.+.++||+|+||+||+|+++ .++..||||.+... ..+..+-+..|+++|+.++|||||++++++..++..||||||
T Consensus 12 y~~~~~iG~GsfavVykg~h~-~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEy 90 (429)
T KOG0595|consen 12 YELSREIGSGSFAVVYKGRHK-KSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEY 90 (429)
T ss_pred ceehhhccCcceEEEEEeEec-cCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEe
Confidence 345577999999999999998 45699999999665 455567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCC------CceEEccccCcccccc
Q 047292 514 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHY------FSPKISDFGLSKLLLS 587 (728)
Q Consensus 514 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~------~~~kl~Dfgla~~~~~ 587 (728)
|.+|+|.++++.+..+++.....++.|||.||++||++ +||||||||.||||+.. -.+||+|||+|+.+..
T Consensus 91 C~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~ 167 (429)
T KOG0595|consen 91 CNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP 167 (429)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence 99999999999999999999999999999999999998 99999999999999864 4589999999998853
Q ss_pred CCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhh
Q 047292 588 DHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESR 645 (728)
Q Consensus 588 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~ 645 (728)
. ....+.+|++-|||||+++.++|+.|+|+||+|++||++++|+.||+.....+..
T Consensus 168 ~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~ 223 (429)
T KOG0595|consen 168 G--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELL 223 (429)
T ss_pred h--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHH
Confidence 2 3345678999999999999999999999999999999999999999977666543
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=394.83 Aligned_cols=265 Identities=27% Similarity=0.422 Sum_probs=221.6
Q ss_pred HHHHHHhhHHhhhCCCceeEEEEeeeeC----CCCcEEEEEEecccchh-hHHHHHHHHHHhccccccceeeEeeeeecC
Q 047292 430 ELKDATDGFKEELGRGSFGIVYKGVLKT----ASGNAIAVKKLDRLAQE-REREFKSEVSAIGRTHHKNLVQLLGFCDEA 504 (728)
Q Consensus 430 el~~~~~~~~~~lg~G~fg~Vy~g~~~~----~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 504 (728)
++......+.++||+|+||+||+|.... .....||||.+++.... ..++|++|++++..++|||||+++|+|.++
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 3444445677899999999999997642 33468999999887666 678999999999999999999999999999
Q ss_pred CcceeEeeccCCCCHHHHHhcCC--------------CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcC
Q 047292 505 LNRLLVYEFMGNGTLANLIFAIP--------------KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDH 570 (728)
Q Consensus 505 ~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~ 570 (728)
+..+||+|||..|+|.+||+.+. +++..+.+.||.|||.||+||.++ .+|||||..+|+||.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceecc
Confidence 99999999999999999998431 267788999999999999999997 9999999999999999
Q ss_pred CCceEEccccCccccccCCC-cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhH
Q 047292 571 YFSPKISDFGLSKLLLSDHS-RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAIL 648 (728)
Q Consensus 571 ~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~ 648 (728)
+..+||+||||++....... +......-+.+|||||.|...+||.+||||||||+|||++| |+.|+.....++....
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~- 717 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC- 717 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHH-
Confidence 99999999999997754433 33334456889999999999999999999999999999998 7889887665553332
Q ss_pred HHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCC
Q 047292 649 TDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPN 714 (728)
Q Consensus 649 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 714 (728)
...+++ ...++.++.++..|+..||+.+|++||+++||-..|+.......
T Consensus 718 -------i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 718 -------IRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred -------HHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 233333 22344567788999999999999999999999999998765443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=361.14 Aligned_cols=251 Identities=27% Similarity=0.430 Sum_probs=206.5
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchh-------hHHHHHHHHHHhccccccceeeEeeeeecCCc
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQE-------REREFKSEVSAIGRTHHKNLVQLLGFCDEALN 506 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 506 (728)
..+-+.+.||+|+||.|-+|..+ .+|+.||||++++.... ......+|+++|++++|||||+++++++..+.
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~-~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEK-KTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEc-ccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 34556688999999999999866 78999999999652211 22346799999999999999999999999999
Q ss_pred ceeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCC---CceEEccccCcc
Q 047292 507 RLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHY---FSPKISDFGLSK 583 (728)
Q Consensus 507 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~---~~~kl~Dfgla~ 583 (728)
.||||||++||+|.+++.....+.+..-..+++|++.|+.|||++ ||+||||||+|||+..+ ..+||+|||+|+
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred eEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccchhh
Confidence 999999999999999999999999999999999999999999998 99999999999999765 889999999999
Q ss_pred ccccCCCcccccccCCccccCcccccCCCC---CCccchhhHHHHHHHHHhCCcCcchhhhHh-hhhhHHHHHHHhhhcC
Q 047292 584 LLLSDHSRTHTMIRGTRGYVAPEWLKNAPV---SAKVDVYSFGVMLLEIICCRRSVEMELEEE-SRAILTDWAYDCYVEG 659 (728)
Q Consensus 584 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---s~~~DVwSlGvil~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~ 659 (728)
... ......+.+||+.|.|||++.++.. ..+.|+||+||+||-+|+|.+||....... ....+ ..|
T Consensus 328 ~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI--------~~G 397 (475)
T KOG0615|consen 328 VSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQI--------LKG 397 (475)
T ss_pred ccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHH--------hcC
Confidence 875 3445667889999999999976643 347899999999999999999998654433 22222 111
Q ss_pred ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 660 RLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 660 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
+.. + ......+..++.++++.+||..||++||++.|+++
T Consensus 398 ~y~--f----~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 398 RYA--F----GPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred ccc--c----cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 111 0 11123445677889999999999999999999875
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=370.17 Aligned_cols=248 Identities=26% Similarity=0.360 Sum_probs=212.9
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeE
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 510 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 510 (728)
.+|...+.||+|+|+.||.++.. .+|+.||+|++.+.. ....+.+.+|+++.++|+|||||+++++|++....|||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~-~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDL-DTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEc-CCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEE
Confidence 34555678999999999999874 578999999996632 33456789999999999999999999999999999999
Q ss_pred eeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC
Q 047292 511 YEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 590 (728)
.|+|++++|.+++..+..+++..+..+..||+.||.|||++ +|||||||..|+||+++.++||+|||||..+..+..
T Consensus 97 LELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 97 LELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred EEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCccc
Confidence 99999999999999889999999999999999999999997 999999999999999999999999999998876544
Q ss_pred cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhh
Q 047292 591 RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEA 670 (728)
Q Consensus 591 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 670 (728)
+. .+.+|||.|+|||++....++..+||||+||++|-||.|++||+...-.+....+.. .+-.++
T Consensus 174 rk-~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~------~~Y~~P-------- 238 (592)
T KOG0575|consen 174 RK-KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL------NEYSMP-------- 238 (592)
T ss_pred cc-ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh------cCcccc--------
Confidence 43 456899999999999999999999999999999999999999997766554443321 011111
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 671 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 671 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
.....+..+++.++|++||.+|||+++|+.
T Consensus 239 ----~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 239 ----SHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ----cccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 122345678999999999999999999985
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=336.33 Aligned_cols=260 Identities=25% Similarity=0.320 Sum_probs=210.5
Q ss_pred HHHHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecc--cchhhHHHHHHHHHHhccccccceeeEee-eeecCCc-c
Q 047292 432 KDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDR--LAQEREREFKSEVSAIGRTHHKNLVQLLG-FCDEALN-R 507 (728)
Q Consensus 432 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g-~~~~~~~-~ 507 (728)
..+.+.+.++||+|.||+|||+... .+|..||.|.++- ...+..+++..|+.+|++|+|||||++++ -+.+... +
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~-~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl 95 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCL-LDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL 95 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeec-cCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence 3455778899999999999999876 6789999999863 33445678999999999999999999998 4444444 8
Q ss_pred eeEeeccCCCCHHHHHhc----CCCCChHHHHHHHHHHHHHHHHhhhcCCC-CeeecCCCCCCEEEcCCCceEEccccCc
Q 047292 508 LLVYEFMGNGTLANLIFA----IPKPDWNLRVRISLEIARGLVYLHEGCNV-PIIHCDIKPQNILLDHYFSPKISDFGLS 582 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~~l~yLH~~~~~-~iiH~dlk~~NIll~~~~~~kl~Dfgla 582 (728)
+||||++..|+|..++.. .+.+++..+++++.|++.||.++|.+-.. -|+||||||.||+|+.+|.+||+|||++
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence 999999999999999874 35789999999999999999999983221 3999999999999999999999999999
Q ss_pred cccccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccc
Q 047292 583 KLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLD 662 (728)
Q Consensus 583 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (728)
+.+.+.... .....|||.||+||.+.+.+|+.|+||||+||++|||.....||....-.+... ....+...
T Consensus 176 r~l~s~~tf-A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~--------KI~qgd~~ 246 (375)
T KOG0591|consen 176 RFLSSKTTF-AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCK--------KIEQGDYP 246 (375)
T ss_pred hHhcchhHH-HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHH--------HHHcCCCC
Confidence 988665443 344679999999999999999999999999999999999999998763322211 22223322
Q ss_pred eeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 047292 663 ALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGL 709 (728)
Q Consensus 663 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 709 (728)
.+. +......+..++..|+..||..||+...+++.+..-
T Consensus 247 ~~p--------~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~ 285 (375)
T KOG0591|consen 247 PLP--------DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSE 285 (375)
T ss_pred CCc--------HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHH
Confidence 222 234566777889999999999999977666666553
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=375.04 Aligned_cols=270 Identities=25% Similarity=0.400 Sum_probs=225.5
Q ss_pred cccCHHHHHHHHhhHH-----------hhhCCCceeEEEEeeeeCCCC--cEEEEEEecccc-hhhHHHHHHHHHHhccc
Q 047292 424 RFFSYDELKDATDGFK-----------EELGRGSFGIVYKGVLKTASG--NAIAVKKLDRLA-QEREREFKSEVSAIGRT 489 (728)
Q Consensus 424 ~~~~~~el~~~~~~~~-----------~~lg~G~fg~Vy~g~~~~~~~--~~vavK~l~~~~-~~~~~~~~~E~~~l~~l 489 (728)
..++|++-.++...|. ++||.|.||+|++|.++.... ..||||.|+... ++...+|+.|..||.++
T Consensus 608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF 687 (996)
T KOG0196|consen 608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF 687 (996)
T ss_pred CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence 3467777777766664 458999999999999985443 479999998754 45568999999999999
Q ss_pred cccceeeEeeeeecCCcceeEeeccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEE
Q 047292 490 HHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILL 568 (728)
Q Consensus 490 ~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll 568 (728)
+||||++|.|+.......+||.|||+||+|+.||+.+ ..+++-++..++++||.||.||.+ +++|||||.++|||+
T Consensus 688 dHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILV 764 (996)
T KOG0196|consen 688 DHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILV 764 (996)
T ss_pred CCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheee
Confidence 9999999999999999999999999999999999987 578999999999999999999998 499999999999999
Q ss_pred cCCCceEEccccCccccccCCCccccc--ccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhh
Q 047292 569 DHYFSPKISDFGLSKLLLSDHSRTHTM--IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESR 645 (728)
Q Consensus 569 ~~~~~~kl~Dfgla~~~~~~~~~~~~~--~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~ 645 (728)
+.+..+|++|||+++.+.++.....+. -.-+.+|.|||.+...++|.++|||||||++||.++ |.+|+-.+..++.-
T Consensus 765 NsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVI 844 (996)
T KOG0196|consen 765 NSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI 844 (996)
T ss_pred ccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHH
Confidence 999999999999999886655333222 224679999999999999999999999999999987 77887655444332
Q ss_pred hhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCC
Q 047292 646 AILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVP 713 (728)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~ 713 (728)
..+ +.......++.++..|.+|++.|||+|..+||.+.+|+.+|++++.-|
T Consensus 845 kaI-----------------e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 845 KAI-----------------EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred HHH-----------------HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 222 222233345667788999999999999999999999999999987443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=344.02 Aligned_cols=240 Identities=27% Similarity=0.344 Sum_probs=203.7
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
.+.+.||+|+||+||+++.+ .+++.+|+|++++.. ....+...+|..+|.+++||.||+++-.|++.+.+|+|+||
T Consensus 28 ~~lkviGkG~fGkV~~Vrk~-dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~ 106 (357)
T KOG0598|consen 28 EILKVIGKGSFGKVFQVRKK-DTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDY 106 (357)
T ss_pred eeeeeeeccCCceEEEEEEc-ccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEec
Confidence 45688999999999999877 788999999997633 23457889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccc
Q 047292 514 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH 593 (728)
Q Consensus 514 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 593 (728)
+.||.|..+|.+...+++..+.-++.+|+.||.|||+. +||||||||+|||||++|+++|+|||+++.........
T Consensus 107 ~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t- 182 (357)
T KOG0598|consen 107 LNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDAT- 182 (357)
T ss_pred cCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccCCCcc-
Confidence 99999999999999999999999999999999999997 99999999999999999999999999999664443333
Q ss_pred ccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhh
Q 047292 594 TMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMA 673 (728)
Q Consensus 594 ~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 673 (728)
.+.+||+.|||||++.+..|+..+|.||||+++|||++|.+||...........+. .+++ ...
T Consensus 183 ~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~--------~~k~---------~~~ 245 (357)
T KOG0598|consen 183 RTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKIL--------KGKL---------PLP 245 (357)
T ss_pred ccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHh--------cCcC---------CCC
Confidence 34789999999999999999999999999999999999999998776554333221 1110 011
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCC
Q 047292 674 DRSRLHKWLMIAMWCIQEDPSKRPT 698 (728)
Q Consensus 674 ~~~~~~~l~~l~~~cl~~dp~~RPt 698 (728)
+.-...+..+++.+.|+.||++|..
T Consensus 246 p~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 246 PGYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred CccCCHHHHHHHHHHhccCHHHhcC
Confidence 1113446678899999999999953
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=325.14 Aligned_cols=261 Identities=21% Similarity=0.296 Sum_probs=204.9
Q ss_pred HhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch--hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCC
Q 047292 439 KEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGN 516 (728)
Q Consensus 439 ~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 516 (728)
.-++|+|+||.|||.+.+ .+|+.||||++....+ ...+-.++|+++|++++|+|+|.++.+|......+||+||++.
T Consensus 7 LgkvGEGSYGvV~KCrnk-~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh 85 (396)
T KOG0593|consen 7 LGKVGEGSYGVVMKCRNK-DTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH 85 (396)
T ss_pred hhccccCcceEEEEeccC-CcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch
Confidence 357999999999999987 6899999999965433 2346678999999999999999999999999999999999988
Q ss_pred CCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccccc
Q 047292 517 GTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMI 596 (728)
Q Consensus 517 gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 596 (728)
--|.++-+.....+...+.+++.|+++|+.|+|++ ++|||||||+||||+.++.+||+|||+|+.+.. .....+..
T Consensus 86 TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~YTDY 161 (396)
T KOG0593|consen 86 TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDNYTDY 161 (396)
T ss_pred HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-Ccchhhhh
Confidence 55555555556788999999999999999999998 999999999999999999999999999998864 23345667
Q ss_pred cCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHH-------HHhhhcCc-c-----c
Q 047292 597 RGTRGYVAPEWLKN-APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWA-------YDCYVEGR-L-----D 662 (728)
Q Consensus 597 ~gt~~y~aPE~~~~-~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~-~-----~ 662 (728)
..|+-|+|||.+.+ .+|....||||+||++.||++|.+.|-..++-+....+.... ...+.... + +
T Consensus 162 VATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP 241 (396)
T KOG0593|consen 162 VATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLP 241 (396)
T ss_pred hhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecC
Confidence 78999999999987 699999999999999999999998887665544332222111 11111111 1 1
Q ss_pred eeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 663 ALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 663 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
+.-+.......-+....-+++++..||+.||.+|++-+|++.
T Consensus 242 ~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 242 EPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 111111111112233446789999999999999999999874
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=339.92 Aligned_cols=266 Identities=25% Similarity=0.286 Sum_probs=211.9
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHhccccccceeeEeeeeecC--CcceeE
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEA--LNRLLV 510 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv 510 (728)
.+...++||+|+||.|||++.. .+|+.||+|++.... ++......+||.+|++|+||||++|.+...+. ..+|||
T Consensus 118 ~feki~kIGeGTyg~VYkAr~~-~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 118 SFEKIEKIGEGTYGQVYKARDL-ETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHhcCcchhheeEeeec-ccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 3445678999999999999865 688999999996543 34457788999999999999999999998776 789999
Q ss_pred eeccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCC
Q 047292 511 YEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH 589 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 589 (728)
+|||++ +|.-++... -++++.++..+++||+.||+|+|++ +|+|||||.+|||||++|.+||+|||||+++....
T Consensus 197 FeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred Eecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 999987 788887764 4789999999999999999999997 99999999999999999999999999999887777
Q ss_pred CcccccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHH----HHhhhcCccc--
Q 047292 590 SRTHTMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWA----YDCYVEGRLD-- 662 (728)
Q Consensus 590 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~-- 662 (728)
....+..+-|.-|.|||++.+. .|+.+.|+||.||||.||++|++.+....+.+....+-... ...|....+.
T Consensus 273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~ 352 (560)
T KOG0600|consen 273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHA 352 (560)
T ss_pred CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcc
Confidence 6667777789999999999876 79999999999999999999999998776655443332221 1112211221
Q ss_pred eeccchh-----hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 663 ALIDSDE-----AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 663 ~~~d~~~-----~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
..+.+.. -.+.........++|+..+|..||.+|.|+.++++.
T Consensus 353 ~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 353 TIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred cccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 1111110 001112234567789999999999999999998864
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=319.95 Aligned_cols=255 Identities=27% Similarity=0.331 Sum_probs=215.6
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
+.+.||.|+||.|.+++.+ .+|..+|+|++++.. .++.++..+|..+|+.+.||+++++.+.+.+...++|||||+
T Consensus 48 ~~~tlGtGSFGrV~LVr~k-~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv 126 (355)
T KOG0616|consen 48 RLKTLGTGSFGRVHLVREK-HSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYV 126 (355)
T ss_pred heeeeccCccceEEEEEEc-cCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEecc
Confidence 4567999999999999988 468999999997633 344577889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccc
Q 047292 515 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHT 594 (728)
Q Consensus 515 ~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 594 (728)
+||.|..+|++.+++++....-+|.||+.||+|||+. +|++|||||+|||||.+|.+||+|||+|+..... .-
T Consensus 127 ~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r----T~ 199 (355)
T KOG0616|consen 127 PGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR----TW 199 (355)
T ss_pred CCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc----EE
Confidence 9999999999999999999999999999999999997 9999999999999999999999999999876432 34
Q ss_pred cccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhc
Q 047292 595 MIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMAD 674 (728)
Q Consensus 595 ~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 674 (728)
+.+|||.|+|||++..+.++.++|.|||||++|||+.|..||...........+ .++++ .++
T Consensus 200 TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI--------~~~~v----------~fP 261 (355)
T KOG0616|consen 200 TLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKI--------LEGKV----------KFP 261 (355)
T ss_pred EecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHH--------HhCcc----------cCC
Confidence 578999999999999999999999999999999999999999877664433322 22221 123
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH-hcCcCCCCCCCCcccccc
Q 047292 675 RSRLHKWLMIAMWCIQEDPSKRPTMKVVMQML-EGLLEVPNPPWSSSFSIA 724 (728)
Q Consensus 675 ~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L-~~~~~~~~~~~~~~~~~~ 724 (728)
......+.+++...|+.|-.+| .--| .+..++..+||.....|.
T Consensus 262 ~~fs~~~kdLl~~LL~vD~t~R------~gnlknG~~dIk~H~wF~~v~W~ 306 (355)
T KOG0616|consen 262 SYFSSDAKDLLKKLLQVDLTKR------FGNLKNGVEDIKNHPWFKGVDWE 306 (355)
T ss_pred cccCHHHHHHHHHHHhhhhHhh------hcCcCCCccccccCcccccccHH
Confidence 3334466778889999999999 2223 366778888887776664
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=378.07 Aligned_cols=260 Identities=27% Similarity=0.444 Sum_probs=215.4
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCCc----EEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCcce
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASGN----AIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRL 508 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 508 (728)
..-.+.+.||+|+||.||.|...+..+. .||||.+++.. .+...+|.+|..+|+.++|||||+++|+|......+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 3344556799999999999999877665 48999997754 455689999999999999999999999999999999
Q ss_pred eEeeccCCCCHHHHHhcC-------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccC
Q 047292 509 LVYEFMGNGTLANLIFAI-------PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGL 581 (728)
Q Consensus 509 lv~e~~~~gsL~~~l~~~-------~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgl 581 (728)
|++|||++|+|..||++. ..++...++.++.|||+|+.||+++ ++|||||.++|+||++...+||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccch
Confidence 999999999999999976 3578889999999999999999997 999999999999999999999999999
Q ss_pred cccccc-CCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcC
Q 047292 582 SKLLLS-DHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEG 659 (728)
Q Consensus 582 a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 659 (728)
|+.+.+ +..+......-+.+|||||.+..+.|+.|+|||||||+|||++| |..||......+..... ...+
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~-------~~gg 921 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDV-------LEGG 921 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHH-------HhCC
Confidence 995543 33333333345779999999999999999999999999999999 55777654433322111 1111
Q ss_pred ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCC
Q 047292 660 RLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVP 713 (728)
Q Consensus 660 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~ 713 (728)
+...+..+.+.+.+++.+||+.+|++||++..|++.++.+....
T Consensus 922 ----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 922 ----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred ----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 22335567788899999999999999999999999998876433
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=355.13 Aligned_cols=261 Identities=30% Similarity=0.394 Sum_probs=212.9
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCC---cEEEEEEecc---cchhhHHHHHHHHHHhccccccceeeEeeeeecCCcce
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASG---NAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRL 508 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~---~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 508 (728)
.-.+.++||+|+||.||+|.++..++ ..||||..+. .......+|.+|.+++++++|||||+++|++....+++
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 33455899999999999999986544 2389999875 34566789999999999999999999999999999999
Q ss_pred eEeeccCCCCHHHHHhcCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcccccc
Q 047292 509 LVYEFMGNGTLANLIFAIP-KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS 587 (728)
Q Consensus 509 lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 587 (728)
+|||++.||+|.++|.+.+ .++..++++++.+.|.||+|||+. ++|||||.++|+|++.++.+||+|||+++....
T Consensus 238 ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~ 314 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ 314 (474)
T ss_pred EEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCcc
Confidence 9999999999999999986 499999999999999999999997 999999999999999999999999999886531
Q ss_pred CCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceecc
Q 047292 588 DHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALID 666 (728)
Q Consensus 588 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 666 (728)
... ......-+.+|+|||.+....|+.++|||||||++||+++ |..|+......+....+.. ++.
T Consensus 315 ~~~-~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~-------~~~------ 380 (474)
T KOG0194|consen 315 YVM-KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVK-------NGY------ 380 (474)
T ss_pred eee-ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHh-------cCc------
Confidence 111 1112245789999999999999999999999999999999 7889887665544332211 010
Q ss_pred chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCC
Q 047292 667 SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNP 715 (728)
Q Consensus 667 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~ 715 (728)
....+......+..++.+||..+|++||+|.++.+.|+.+.....+
T Consensus 381 ---r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 381 ---RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ---cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 0111112334556677799999999999999999999988765554
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=339.46 Aligned_cols=263 Identities=25% Similarity=0.378 Sum_probs=213.6
Q ss_pred HHHHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhH-HHHHHHHHHhccccccceeeEeeeeecCCcceeE
Q 047292 432 KDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQERE-REFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 510 (728)
Q Consensus 432 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~-~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 510 (728)
.+....+.++||+|-||+|.+.... .+..||||+++....... .+|.+|+++|.+++||||++++|+|..++.+++|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeve--g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVE--GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred chhheehhhhhcCcccceeEEEEec--CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 3344457789999999999999875 468999999988776665 8999999999999999999999999999999999
Q ss_pred eeccCCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccC
Q 047292 511 YEFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD 588 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 588 (728)
+|||++|+|.+|+..+ +........+|+.||+.||+||.+- ++|||||.++|+|++.++++||+|||+++-+...
T Consensus 614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccC
Confidence 9999999999999987 3445566788999999999999996 9999999999999999999999999999966443
Q ss_pred C-CcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh--CCcCcchhhhHhhhhhHHHHHHHhhhcCccceec
Q 047292 589 H-SRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC--CRRSVEMELEEESRAILTDWAYDCYVEGRLDALI 665 (728)
Q Consensus 589 ~-~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (728)
. .+......-+.+|||||.+.-.+++.++|||+||+++||+++ ..+||.....+....... ..+..+.....+
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~----~~~~~~~~~~~l 766 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAG----EFFRDQGRQVVL 766 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhh----hhcCCCCcceec
Confidence 3 334444556889999999999999999999999999999876 457887655544322111 111111111111
Q ss_pred cchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 047292 666 DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGL 709 (728)
Q Consensus 666 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 709 (728)
..++.+...+.+++.+||..+-++||+++++...|++.
T Consensus 767 ------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 767 ------SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 12344566788999999999999999999999998764
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=334.62 Aligned_cols=249 Identities=31% Similarity=0.439 Sum_probs=201.1
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCC--cceeEeeccC
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEAL--NRLLVYEFMG 515 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lv~e~~~ 515 (728)
..+.||+|+||.||++... .+|+..|||..........+.+.+|+.+|.+++|||||+++|...... .++++|||++
T Consensus 21 ~~~~lG~Gs~G~V~l~~~~-~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~ 99 (313)
T KOG0198|consen 21 KGKLLGRGSFGSVYLATNK-KTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAP 99 (313)
T ss_pred hhccccCccceEEEEEEec-CCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccC
Confidence 4578999999999999876 448899999987653333677899999999999999999999855444 5899999999
Q ss_pred CCCHHHHHhcCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcC-CCceEEccccCcccccc--CCCc
Q 047292 516 NGTLANLIFAIP-KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDH-YFSPKISDFGLSKLLLS--DHSR 591 (728)
Q Consensus 516 ~gsL~~~l~~~~-~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~-~~~~kl~Dfgla~~~~~--~~~~ 591 (728)
+|+|.+++.+.. ++++..+..+.+||++||+|||++ +||||||||+|||++. ++.+||+|||+++.... ....
T Consensus 100 ~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~ 176 (313)
T KOG0198|consen 100 GGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSD 176 (313)
T ss_pred CCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccccccccc
Confidence 999999999876 799999999999999999999997 9999999999999999 79999999999987753 2223
Q ss_pred ccccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchh-hhHhhhhhHHHHHHHhhhcCccceeccchh
Q 047292 592 THTMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEME-LEEESRAILTDWAYDCYVEGRLDALIDSDE 669 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 669 (728)
......||+.|||||++... ....++|||||||++.||+||+.||... ... .+...........
T Consensus 177 ~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~-------~~~~~ig~~~~~P------- 242 (313)
T KOG0198|consen 177 SELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEA-------EALLLIGREDSLP------- 242 (313)
T ss_pred ccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchH-------HHHHHHhccCCCC-------
Confidence 34457799999999999963 3345999999999999999999999753 111 1111111112112
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047292 670 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQML 706 (728)
Q Consensus 670 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 706 (728)
.++........+++.+|++.+|++|||++++++..
T Consensus 243 --~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 243 --EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred --CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 12223445677899999999999999999999765
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=335.98 Aligned_cols=265 Identities=25% Similarity=0.291 Sum_probs=211.4
Q ss_pred HHHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch-hhHHHHHHHHHHhcccc-ccceeeEeeeeecCC-ccee
Q 047292 433 DATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ-EREREFKSEVSAIGRTH-HKNLVQLLGFCDEAL-NRLL 509 (728)
Q Consensus 433 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~-~~~l 509 (728)
..+|...++||.|+||.||+|+-+ .+++.||||+++..-. -.+..=++|+..|++++ ||||+++.+++.+.+ .+++
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~-~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSK-ETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeec-CCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 456778899999999999999877 5778899999965432 23344578999999998 999999999998888 9999
Q ss_pred EeeccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccC
Q 047292 510 VYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD 588 (728)
Q Consensus 510 v~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 588 (728)
|||||+. +|++++..+ ..+++..+..|+.||++||+|+|.+ |+.|||+||+|||+..+..+||+|||+||...+.
T Consensus 88 VfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred eHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccccC
Confidence 9999964 899999877 5789999999999999999999998 9999999999999999999999999999987543
Q ss_pred CCcccccccCCccccCcccc-cCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHH-------------HHH
Q 047292 589 HSRTHTMIRGTRGYVAPEWL-KNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDW-------------AYD 654 (728)
Q Consensus 589 ~~~~~~~~~gt~~y~aPE~~-~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~-------------~~~ 654 (728)
...+..+.|+-|+|||++ +..-|+.+.|+|++|||++|+.+.++.|-+..+.+....+... ...
T Consensus 164 --pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La 241 (538)
T KOG0661|consen 164 --PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA 241 (538)
T ss_pred --CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence 344556789999999987 5668899999999999999999999988765554332222111 001
Q ss_pred hhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 655 CYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 655 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
....-.+.......+....+. ...++++++.+|++-||.+|||++|.++.
T Consensus 242 ~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 242 SAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 111122233333333333333 67788999999999999999999999875
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=340.72 Aligned_cols=248 Identities=27% Similarity=0.359 Sum_probs=211.4
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccc-cccceeeEeeeeecCCcceeEe
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVY 511 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~ 511 (728)
+.|.+.||+|+|++|++++.+ .+++.+|||++.+.- +...+.+..|-.+|.+| .||.|++|+-.|.+...+|+|+
T Consensus 75 F~Fg~~lGeGSYStV~~A~~~-~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvL 153 (604)
T KOG0592|consen 75 FKFGKILGEGSYSTVVLAREK-ATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVL 153 (604)
T ss_pred cchhheeccccceeEEEeeec-CCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEE
Confidence 457799999999999999987 588999999996532 23346778899999999 8999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 512 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 512 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
||+++|+|.++|.+.+.+++.-...++.+|+.||+|||+. |||||||||+|||||+++++||+|||-|+.+......
T Consensus 154 e~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~ 230 (604)
T KOG0592|consen 154 EYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS 230 (604)
T ss_pred EecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence 9999999999999999999999999999999999999997 9999999999999999999999999999988432211
Q ss_pred ----------cc--ccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcC
Q 047292 592 ----------TH--TMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEG 659 (728)
Q Consensus 592 ----------~~--~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 659 (728)
.. ...+||..|.+||++.+...+..+|+|+|||+||+|+.|++||...++-.....++...+.
T Consensus 231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~----- 305 (604)
T KOG0592|consen 231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYE----- 305 (604)
T ss_pred ccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhccc-----
Confidence 11 3467999999999999999999999999999999999999999987765554444332221
Q ss_pred ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 660 RLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 660 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
+.+...+.+.+|+.+.|..||.+|+|.++|-+.
T Consensus 306 -------------fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 306 -------------FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred -------------CCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 122223566779999999999999999888764
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=306.32 Aligned_cols=263 Identities=24% Similarity=0.280 Sum_probs=207.7
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch--hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
|...++||+|.||.||+|.+. .+|+.||||+++.... .-.....+|++.|+.++|+||+.++++|...+..-||+||
T Consensus 4 Y~~~~~lGEG~~gvVyka~d~-~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 4 YEKLEKLGEGTYGVVYKARDT-ETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhcCcceEEEEEEEec-CCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 445678999999999999865 6899999999965432 2246788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 514 MGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 514 ~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
|+. +|+..++.. ..++..++..++.++++||+|||++ .|+||||||.|+||+++|.+||+|||+|+.+.......
T Consensus 83 m~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 83 MPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred ccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence 975 899999876 4678899999999999999999997 99999999999999999999999999999987654433
Q ss_pred cccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcC---ccceeccch
Q 047292 593 HTMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEG---RLDALIDSD 668 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~d~~ 668 (728)
... .-|.-|+|||.+.+. .|+...|+||.|||+.||+-+.+-|....+-+....+-. +.....+. ++..+.|..
T Consensus 159 ~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~-~LGTP~~~~WP~~~~lpdY~ 236 (318)
T KOG0659|consen 159 THQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFR-ALGTPTPDQWPEMTSLPDYV 236 (318)
T ss_pred ccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHH-HcCCCCcccCccccccccHH
Confidence 222 568999999999765 789999999999999999998877766655443322211 11111111 122222221
Q ss_pred hhh--------hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 669 EAA--------MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 669 ~~~--------~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.-. ..-....+.+++++..++..||.+|++++|++++
T Consensus 237 ~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 237 KIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 111 1223345667999999999999999999999876
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=340.85 Aligned_cols=246 Identities=25% Similarity=0.371 Sum_probs=208.9
Q ss_pred HhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCCCC
Q 047292 439 KEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGT 518 (728)
Q Consensus 439 ~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 518 (728)
.++||+|+.|.||.+... .+++.||||++........+-+.+|+.+|+..+|+|||+++..+...+++|+|||||++|+
T Consensus 278 ~~kigqgaSG~vy~A~~~-~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggs 356 (550)
T KOG0578|consen 278 FKKIGQGATGGVYVARKI-STKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGS 356 (550)
T ss_pred hhhhccccccceeeeeec-cCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCc
Confidence 368999999999999865 5778999999987777777889999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccccccC
Q 047292 519 LANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRG 598 (728)
Q Consensus 519 L~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g 598 (728)
|.+.+... .+++.++..|++++++||+|||.+ +|||||||.+|||++.+|.+||+|||++..+.....+ .....|
T Consensus 357 LTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K-R~TmVG 431 (550)
T KOG0578|consen 357 LTDVVTKT-RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK-RSTMVG 431 (550)
T ss_pred hhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccCc-cccccC
Confidence 99988764 488999999999999999999998 9999999999999999999999999999888665543 344569
Q ss_pred CccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHHHH
Q 047292 599 TRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRL 678 (728)
Q Consensus 599 t~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 678 (728)
|+.|||||+.....|..|.||||||++++||+-|.+||-.+.+-....++. .++. .+ ........
T Consensus 432 TPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa-------~ng~-P~-------lk~~~klS 496 (550)
T KOG0578|consen 432 TPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-------TNGT-PK-------LKNPEKLS 496 (550)
T ss_pred CCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh-------hcCC-CC-------cCCccccC
Confidence 999999999999999999999999999999999999998655443222221 1111 11 11122334
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 679 HKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 679 ~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
..+.+++.+||+.|+.+||+++|+|+.
T Consensus 497 ~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 497 PELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred HHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 567789999999999999999999874
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=324.95 Aligned_cols=259 Identities=25% Similarity=0.340 Sum_probs=206.3
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch-hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
..|++.++||.|..++||+|... ..++.||||++.-..- .....+++|+..++.++||||++++..|..+..+|+||.
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~-p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCI-PTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred cceeEEEEEeccceeEeeeeeec-ccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 34567789999999999999887 5669999999954322 235889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC
Q 047292 513 FMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 513 ~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 590 (728)
||.+|++.+.++.. ..+++..+..|.+++++||.|||.+ |.||||||+.||||+.+|.+||+|||.+..+.....
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 99999999999875 4688999999999999999999998 999999999999999999999999998876644332
Q ss_pred c--cc-ccccCCccccCcccccC--CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceec
Q 047292 591 R--TH-TMIRGTRGYVAPEWLKN--APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALI 665 (728)
Q Consensus 591 ~--~~-~~~~gt~~y~aPE~~~~--~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (728)
+ .. ....||+.|||||+++. ..|+.|+||||||++..||.+|..||....+... ++... .+......
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv--Ll~tL------qn~pp~~~ 253 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV--LLLTL------QNDPPTLL 253 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH--HHHHh------cCCCCCcc
Confidence 2 11 45679999999999653 3789999999999999999999999986544321 11111 11111111
Q ss_pred cchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 666 DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 666 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
-.....+........+.+++..||+.||++|||++++++
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 111111222333446778889999999999999999985
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=345.80 Aligned_cols=259 Identities=28% Similarity=0.390 Sum_probs=201.4
Q ss_pred HHhhHHhhhCCCceeEEEEeeee----CCCCcEEEEEEecccc-hhhHHHHHHHHHHhccc-cccceeeEeeeeecC-Cc
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLK----TASGNAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEA-LN 506 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~----~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-~~ 506 (728)
..+.+.++||+|+||.||+|... ...++.||||++.... ......+.+|+.++..+ +||||+++++++... ..
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP 86 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence 34566788999999999999752 2345689999996533 23346789999999999 899999999988764 45
Q ss_pred ceeEeeccCCCCHHHHHhcC------------------------------------------------------------
Q 047292 507 RLLVYEFMGNGTLANLIFAI------------------------------------------------------------ 526 (728)
Q Consensus 507 ~~lv~e~~~~gsL~~~l~~~------------------------------------------------------------ 526 (728)
.++||||+++|+|.+++...
T Consensus 87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (338)
T cd05102 87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL 166 (338)
T ss_pred eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence 78999999999999998742
Q ss_pred --CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc-ccccccCCcccc
Q 047292 527 --PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR-THTMIRGTRGYV 603 (728)
Q Consensus 527 --~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~ 603 (728)
..+++..+..++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++........ ......++..|+
T Consensus 167 ~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 167 WKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 1356778889999999999999997 9999999999999999999999999999865332221 122334678899
Q ss_pred CcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHH
Q 047292 604 APEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWL 682 (728)
Q Consensus 604 aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~ 682 (728)
|||++.+..++.++||||||+++|||++ |..||......... ......+..... .......+.
T Consensus 244 aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~-------~~~~~~~~~~~~---------~~~~~~~l~ 307 (338)
T cd05102 244 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF-------CQRLKDGTRMRA---------PENATPEIY 307 (338)
T ss_pred CcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHH-------HHHHhcCCCCCC---------CCCCCHHHH
Confidence 9999999999999999999999999997 99998754322110 011111111110 112234677
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 683 MIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 683 ~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
+++.+||+.||.+||++.+|+++|+.++.
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 89999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=338.25 Aligned_cols=239 Identities=30% Similarity=0.442 Sum_probs=201.0
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCCCCH
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTL 519 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 519 (728)
+=||.|+-|.||+|+++ ++.||||+++... ..+|+-|++|+|+||+.+.|+|......+|||||++.|-|
T Consensus 130 eWlGSGaQGAVF~Grl~---netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGRLH---NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhccCcccceeeeecc---CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 45999999999999986 6789999986533 3468889999999999999999999999999999999999
Q ss_pred HHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccccccCC
Q 047292 520 ANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGT 599 (728)
Q Consensus 520 ~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt 599 (728)
.+.|+....++......+.++||.||.|||.+ .|||||||.-||||..+..+||+|||-++..... .....+.||
T Consensus 200 ~~VLka~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFaGT 274 (904)
T KOG4721|consen 200 YEVLKAGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFAGT 274 (904)
T ss_pred HHHHhccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhhhh
Confidence 99999999999999999999999999999998 9999999999999999999999999999876443 223346799
Q ss_pred ccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHHHHH
Q 047292 600 RGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLH 679 (728)
Q Consensus 600 ~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 679 (728)
..|||||+++..+.++|.|||||||+|||||||..||........ .| .+=...+....+..+.+
T Consensus 275 VaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI-------Iw---------GVGsNsL~LpvPstcP~ 338 (904)
T KOG4721|consen 275 VAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI-------IW---------GVGSNSLHLPVPSTCPD 338 (904)
T ss_pred HhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee-------EE---------eccCCcccccCcccCch
Confidence 999999999999999999999999999999999999864322111 00 00011112222344556
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 047292 680 KWLMIAMWCIQEDPSKRPTMKVVMQMLEGL 709 (728)
Q Consensus 680 ~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 709 (728)
.+.-|+++||+..|..||++++|+..|+-.
T Consensus 339 GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 339 GFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred HHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 677789999999999999999999998643
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=338.08 Aligned_cols=261 Identities=28% Similarity=0.420 Sum_probs=206.1
Q ss_pred HHHHHHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeeecCCcc
Q 047292 430 ELKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNR 507 (728)
Q Consensus 430 el~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 507 (728)
|+......+.+.||+|.||+||+|.+. ..||||++... ..+..+.|++|+.++++-+|.||+-+.|+|.....
T Consensus 388 eIp~~ev~l~~rIGsGsFGtV~Rg~wh----GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~- 462 (678)
T KOG0193|consen 388 EIPPEEVLLGERIGSGSFGTVYRGRWH----GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL- 462 (678)
T ss_pred ccCHHHhhccceeccccccceeecccc----cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence 333344456678999999999999986 36999999653 34566899999999999999999999999998877
Q ss_pred eeEeeccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccc
Q 047292 508 LLVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLL 586 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 586 (728)
.||..+++|.+|+.+|+.. .+++....+.||+||++||.|||.+ +|||||||..||+|.++++|||+||||+..-.
T Consensus 463 AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeee
Confidence 9999999999999999876 5788899999999999999999997 99999999999999999999999999997542
Q ss_pred cC-CCcccccccCCccccCcccccCC---CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccc
Q 047292 587 SD-HSRTHTMIRGTRGYVAPEWLKNA---PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLD 662 (728)
Q Consensus 587 ~~-~~~~~~~~~gt~~y~aPE~~~~~---~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (728)
.- .........|..-|||||+++.+ +|+..+||||||+++|||+||..||.....+.... .-++-.
T Consensus 540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIif----------mVGrG~ 609 (678)
T KOG0193|consen 540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIF----------MVGRGY 609 (678)
T ss_pred eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEE----------Eecccc
Confidence 21 11122223467789999999643 78999999999999999999999998433322110 111110
Q ss_pred eeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 663 ALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 663 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
-..|.. ........++.+|+..||..++++||.+.+|+.+|+.++.
T Consensus 610 l~pd~s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 610 LMPDLS---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred cCccch---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 011110 1112234467788899999999999999999999988775
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=331.81 Aligned_cols=242 Identities=22% Similarity=0.288 Sum_probs=203.9
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
+..+||+|+||.||+++-+ .+|..+|+|++++.. ..+...++.|-.+|...+++.||+++-.|++...+||||||+
T Consensus 145 ~Lk~IgkGAfGeVrLarKk-~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEyl 223 (550)
T KOG0605|consen 145 LLKVIGKGAFGEVRLARKK-DTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYL 223 (550)
T ss_pred hheeeccccceeEEEEEEc-cCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEec
Confidence 4467999999999999866 689999999997743 344578899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCC-----
Q 047292 515 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH----- 589 (728)
Q Consensus 515 ~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~----- 589 (728)
|||++..+|.....+++.....++.+++-|+.-||+. |+|||||||+|+|||..|++||+||||+.-+...+
T Consensus 224 PGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~ 300 (550)
T KOG0605|consen 224 PGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESY 300 (550)
T ss_pred CCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhhhhhhh
Confidence 9999999999999999999999999999999999997 99999999999999999999999999986431100
Q ss_pred ----------------Ccc-------------------------cccccCCccccCcccccCCCCCCccchhhHHHHHHH
Q 047292 590 ----------------SRT-------------------------HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLE 628 (728)
Q Consensus 590 ----------------~~~-------------------------~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~e 628 (728)
... .....|||.|||||++.+..|+..+|.||||||+||
T Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyE 380 (550)
T KOG0605|consen 301 RLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYE 380 (550)
T ss_pred cchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHH
Confidence 000 001249999999999999999999999999999999
Q ss_pred HHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCC
Q 047292 629 IICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPT 698 (728)
Q Consensus 629 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt 698 (728)
||.|.+||..+.+.+....+..|........ +.....+..++|.+|+. ||++|.-
T Consensus 381 mLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~--------------~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 381 MLVGYPPFCSETPQETYRKIVNWRETLKFPE--------------EVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhhhccCCC--------------cCcccHHHHHHHHHHhc-CHHHhcC
Confidence 9999999999998888777777653211111 11122567789999888 9999954
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=338.94 Aligned_cols=247 Identities=26% Similarity=0.366 Sum_probs=205.6
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc----ch-hhHHHHHHHHHHhcccc-ccceeeEeeeeecCCcc
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL----AQ-EREREFKSEVSAIGRTH-HKNLVQLLGFCDEALNR 507 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~ 507 (728)
..+.+.+.||+|+||.|+.|... .+++.||+|.+... .. ...+.+.+|+.++++++ ||||++++.++......
T Consensus 17 g~y~~~~~lG~GsfgkV~~a~~~-~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 17 GKYELGRTLGSGSFGKVKLAKHR-LTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred CceeeeeeecCCCCeeEEEeeec-cCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 34556788999999999999876 56799999977553 11 23456778999999998 99999999999999999
Q ss_pred eeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCC-CceEEccccCccccc
Q 047292 508 LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHY-FSPKISDFGLSKLLL 586 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~-~~~kl~Dfgla~~~~ 586 (728)
++||||+.+|+|.+++.+..++.+.....++.|++.|++|+|+. +|+||||||+|||++.+ +++||+|||++....
T Consensus 96 ~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred EEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 99999999999999999988999999999999999999999997 99999999999999999 999999999999874
Q ss_pred cCCCcccccccCCccccCcccccCCC-CC-CccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCcccee
Q 047292 587 SDHSRTHTMIRGTRGYVAPEWLKNAP-VS-AKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDAL 664 (728)
Q Consensus 587 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (728)
.......+.+|++.|+|||++.+.. |+ .++||||+||+||-|++|+.||+.......... ...+..
T Consensus 173 -~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k--------i~~~~~--- 240 (370)
T KOG0583|consen 173 -GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK--------IRKGEF--- 240 (370)
T ss_pred -CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH--------HhcCCc---
Confidence 2233455678999999999999987 85 789999999999999999999987443322211 111110
Q ss_pred ccchhhhhhcHHH-HHHHHHHHHHhcccCCCCCCCHHHHH
Q 047292 665 IDSDEAAMADRSR-LHKWLMIAMWCIQEDPSKRPTMKVVM 703 (728)
Q Consensus 665 ~d~~~~~~~~~~~-~~~l~~l~~~cl~~dp~~RPt~~evl 703 (728)
.++... ...+..++.+||+.+|.+|+++.+|+
T Consensus 241 -------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 241 -------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred -------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 011111 45677899999999999999999999
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=329.78 Aligned_cols=246 Identities=18% Similarity=0.261 Sum_probs=200.0
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhh---HHHHHHHHHHhccccccceeeEeeeeec----CCcceeEee
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQER---EREFKSEVSAIGRTHHKNLVQLLGFCDE----ALNRLLVYE 512 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lv~e 512 (728)
..|++|++|.||+|.+ +++.||||+++...... .+.+.+|+.++.+++||||++++|++.+ ....++|||
T Consensus 26 ~~i~~g~~~~v~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF---NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE---CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence 3589999999999987 47899999997643322 4678899999999999999999999866 446789999
Q ss_pred ccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 513 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 513 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
|+++|+|.+++.....+++....+++.|++.||.|||+. .+++||||||+||++++++.+||+|||+++......
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--- 177 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--- 177 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---
Confidence 999999999999888899999999999999999999973 278899999999999999999999999998653322
Q ss_pred cccccCCccccCcccccC--CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhh
Q 047292 593 HTMIRGTRGYVAPEWLKN--APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEA 670 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~--~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 670 (728)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||......+....+ .......
T Consensus 178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i--------~~~~~~~------- 241 (283)
T PHA02988 178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLI--------INKNNSL------- 241 (283)
T ss_pred -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHH--------HhcCCCC-------
Confidence 22347889999999976 68999999999999999999999999865433221111 0111000
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 047292 671 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710 (728)
Q Consensus 671 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 710 (728)
..+......+.+++.+||+.||++|||++++++.|+.+.
T Consensus 242 -~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 242 -KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred -CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 011123456778999999999999999999999998764
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=322.71 Aligned_cols=265 Identities=29% Similarity=0.437 Sum_probs=200.9
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhcc--ccccceeeEeeeeecCC----cceeE
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGR--THHKNLVQLLGFCDEAL----NRLLV 510 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~~~----~~~lv 510 (728)
.+.+.||+|.||.||||.+. ++.||||++.. +..+.|++|-++... ++|+||+++++.-.... +.+||
T Consensus 213 ~l~eli~~Grfg~V~KaqL~---~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLD---NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred hhHHHhhcCccceeehhhcc---CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 35688999999999999985 58999999963 456788988888776 58999999999876665 78999
Q ss_pred eeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhc------CCCCeeecCCCCCCEEEcCCCceEEccccCccc
Q 047292 511 YEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEG------CNVPIIHCDIKPQNILLDHYFSPKISDFGLSKL 584 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~------~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~ 584 (728)
+||.+.|+|.++|.. ..++|....+|+..+++||+|||+. +++.|+|||||.+||||.+++++.|+|||+|..
T Consensus 287 t~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~ 365 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR 365 (534)
T ss_pred eeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence 999999999999976 4789999999999999999999974 357899999999999999999999999999998
Q ss_pred cccCCCccc-ccccCCccccCcccccCC-CCC-----CccchhhHHHHHHHHHhCCcCc--------chhhhHhhh--hh
Q 047292 585 LLSDHSRTH-TMIRGTRGYVAPEWLKNA-PVS-----AKVDVYSFGVMLLEIICCRRSV--------EMELEEESR--AI 647 (728)
Q Consensus 585 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~-~~s-----~~~DVwSlGvil~elltg~~p~--------~~~~~~~~~--~~ 647 (728)
+........ ....||.+|||||++.+. .+. .+.||||+|.+||||++.-.-+ +...+.+.. -.
T Consensus 366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt 445 (534)
T KOG3653|consen 366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT 445 (534)
T ss_pred ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence 865443322 226799999999999765 333 3799999999999999854322 222221111 00
Q ss_pred HHHHHHHhhhcCcc-ceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCC
Q 047292 648 LTDWAYDCYVEGRL-DALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVP 713 (728)
Q Consensus 648 ~~~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~ 713 (728)
+.+ .+......+. ..+.+. ......+..+.+.+..||..||+-|.|+.=+-+++.++....
T Consensus 446 ~e~-mq~~VV~kK~RP~~p~~----W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 446 LEE-MQELVVRKKQRPKIPDA----WRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred HHH-HHHHHHhhccCCCChhh----hhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 100 1111111111 111111 111234566788999999999999999999999988876544
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=331.91 Aligned_cols=245 Identities=26% Similarity=0.387 Sum_probs=209.0
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
|.+.+.||+|.||.||||+-+ .+.+.||+|.+.+.. ++..+.+.+|+++++.++||||+.+++.|+...++++|.||
T Consensus 4 yhv~e~iG~Gsfg~VYKgrrK-~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~ 82 (808)
T KOG0597|consen 4 YHVYEMIGEGSFGRVYKGRRK-YTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY 82 (808)
T ss_pred hhHHHHhcCCccceeeecccc-cceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence 556789999999999999977 578899999996532 34457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccc
Q 047292 514 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH 593 (728)
Q Consensus 514 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 593 (728)
+.| +|..+|.....++++.+..|+.+++.||.|||++ +|+|||+||.|||++..+++|++|||+|+.+... ....
T Consensus 83 a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t~vl 157 (808)
T KOG0597|consen 83 AVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-TSVL 157 (808)
T ss_pred hhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC-ceee
Confidence 987 9999999999999999999999999999999997 9999999999999999999999999999987553 2344
Q ss_pred ccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhh
Q 047292 594 TMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMA 673 (728)
Q Consensus 594 ~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 673 (728)
+.+.|||-|||||+..+.+|+..+|+||+||++||+++|++||...........+. . |+ ...
T Consensus 158 tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~--------~-------d~---v~~ 219 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSIL--------K-------DP---VKP 219 (808)
T ss_pred eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHh--------c-------CC---CCC
Confidence 56789999999999999999999999999999999999999998654433222110 0 00 011
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 674 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 674 ~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
+......+..++...|+.||.+|.+-.+++.
T Consensus 220 p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 220 PSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred cccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 2244556778889999999999999998874
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=326.92 Aligned_cols=257 Identities=22% Similarity=0.308 Sum_probs=205.0
Q ss_pred HHHhhHHhhhCCCceeEEEEeeeeC--CCCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCccee
Q 047292 433 DATDGFKEELGRGSFGIVYKGVLKT--ASGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLL 509 (728)
Q Consensus 433 ~~~~~~~~~lg~G~fg~Vy~g~~~~--~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 509 (728)
...+.+.+.||+|+||.||+|.++. ..+..||+|.++... ......+.+|+.++.+++||||+++++++......++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 3445667889999999999998753 345689999987643 2334678999999999999999999999999999999
Q ss_pred EeeccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccC
Q 047292 510 VYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD 588 (728)
Q Consensus 510 v~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 588 (728)
||||+++|+|.+++... ..+++..++.++.||+.||+|||++ +++||||||+||+++.++.+|++|||.+......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999999999864 4688999999999999999999997 9999999999999999999999999987654322
Q ss_pred CCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccc
Q 047292 589 HSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDS 667 (728)
Q Consensus 589 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 667 (728)
.........++..|+|||.+.+..++.++||||||+++||+++ |+.||...........+ ..+...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~--------~~~~~~----- 227 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV--------EDGFRL----- 227 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH--------HCCCCC-----
Confidence 2111122335678999999999999999999999999999875 99999755433221111 111100
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 047292 668 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGL 709 (728)
Q Consensus 668 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 709 (728)
.........+.+++.+||+.+|.+||++++|++.|+++
T Consensus 228 ----~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 ----PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ----CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 01112344677899999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=329.79 Aligned_cols=246 Identities=25% Similarity=0.362 Sum_probs=210.5
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchh-hHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCC
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQE-REREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGN 516 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 516 (728)
-.+.||+|.||.||||.+. .+++.||+|++.-...+ ...++++|+.+|.+++++||.+++|.+..+..++++|||+.+
T Consensus 17 ~~~~IgrGsfG~Vyk~~d~-~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~g 95 (467)
T KOG0201|consen 17 KLELIGRGSFGEVYKAIDN-KTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGG 95 (467)
T ss_pred cchhccccccceeeeeeec-cccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcC
Confidence 3478999999999999876 67899999999654433 357899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccccc
Q 047292 517 GTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMI 596 (728)
Q Consensus 517 gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 596 (728)
|++.+.|.....+++..+.-|.++++.||.|||.+ +.+|||||+.|||+.++|.+||+|||++..+.....+. .+.
T Consensus 96 Gsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr-~tf 171 (467)
T KOG0201|consen 96 GSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR-KTF 171 (467)
T ss_pred cchhhhhccCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhcc-ccc
Confidence 99999999888778888999999999999999998 99999999999999999999999999999887666655 567
Q ss_pred cCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHH
Q 047292 597 RGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRS 676 (728)
Q Consensus 597 ~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 676 (728)
.||+.|||||++....|+.|+||||||++.+||++|.+|+....+......+ -+......+..
T Consensus 172 vGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI-----------------pk~~PP~L~~~ 234 (467)
T KOG0201|consen 172 VGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI-----------------PKSAPPRLDGD 234 (467)
T ss_pred cccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec-----------------cCCCCCccccc
Confidence 7999999999999889999999999999999999999998765543322221 11111222224
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 677 RLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 677 ~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
....+.+++..||+.||+.||++.++++.
T Consensus 235 ~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 235 FSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred cCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 45567889999999999999999999863
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=316.38 Aligned_cols=248 Identities=21% Similarity=0.351 Sum_probs=210.6
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch---hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeE
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 510 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 510 (728)
-.+.+.+.||+|+||.|-++... ..|+.||||.+++... ++.-.+++|+++|..|+||||+.++.+|+..+...||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~-~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEH-KSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhc-cCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 45778899999999999998764 6789999999976443 3446788999999999999999999999999999999
Q ss_pred eeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC
Q 047292 511 YEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 590 (728)
|||..+|.|++++..+..+++.....+++||..|+.|+|.+ +++|||||.+|||+|.++++||+|||++.++...
T Consensus 132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~-- 206 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADK-- 206 (668)
T ss_pred EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhccc--
Confidence 99999999999999999999999999999999999999998 9999999999999999999999999999877433
Q ss_pred cccccccCCccccCcccccCCCC-CCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchh
Q 047292 591 RTHTMIRGTRGYVAPEWLKNAPV-SAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDE 669 (728)
Q Consensus 591 ~~~~~~~gt~~y~aPE~~~~~~~-s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 669 (728)
+..++++|++-|.+||++.+.+| .+..|-|||||+||-|+.|.-||+...-......+ ..|..
T Consensus 207 kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQI--------s~GaY-------- 270 (668)
T KOG0611|consen 207 KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQI--------SRGAY-------- 270 (668)
T ss_pred cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHh--------hcccc--------
Confidence 45567889999999999999998 67899999999999999999999865332211111 11111
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047292 670 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQML 706 (728)
Q Consensus 670 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 706 (728)
.+++......-+++|||-.+|++|.|+++|...-
T Consensus 271 ---rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 271 ---REPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ---cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 1222334456699999999999999999998653
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=338.30 Aligned_cols=258 Identities=28% Similarity=0.376 Sum_probs=201.5
Q ss_pred HHHhhHHhhhCCCceeEEEEeeee----CCCCcEEEEEEecccc-hhhHHHHHHHHHHhccc-cccceeeEeeeeecCCc
Q 047292 433 DATDGFKEELGRGSFGIVYKGVLK----TASGNAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALN 506 (728)
Q Consensus 433 ~~~~~~~~~lg~G~fg~Vy~g~~~----~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 506 (728)
...+.+.+.||+|+||.||++... ..++..||||+++... ....+.+.+|+.++..+ +||||++++++|.....
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 344667899999999999999742 2345689999996533 23446788999999999 89999999999999999
Q ss_pred ceeEeeccCCCCHHHHHhcCC-----------------------------------------------------------
Q 047292 507 RLLVYEFMGNGTLANLIFAIP----------------------------------------------------------- 527 (728)
Q Consensus 507 ~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------- 527 (728)
.++||||+++|+|.+++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999986421
Q ss_pred ----------------CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 528 ----------------KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 528 ----------------~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
.+++..+++++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 357788899999999999999997 9999999999999999999999999999866433221
Q ss_pred c-cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchh
Q 047292 592 T-HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDE 669 (728)
Q Consensus 592 ~-~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 669 (728)
. .....++..|+|||.+.+..++.++||||||+++|||++ |..||........ +... ...+....
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~---~~~~----~~~~~~~~------ 337 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK---FYKM----IKEGYRML------ 337 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH---HHHH----HHhCccCC------
Confidence 1 122335678999999999999999999999999999998 7888864322211 1111 11111000
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 047292 670 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGL 709 (728)
Q Consensus 670 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 709 (728)
.+.....++.+++.+||+.||++||++.+|+++|++.
T Consensus 338 ---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 338 ---SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ---CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 0011124677899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=332.32 Aligned_cols=262 Identities=27% Similarity=0.377 Sum_probs=221.3
Q ss_pred CHHHHHHHHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCc
Q 047292 427 SYDELKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALN 506 (728)
Q Consensus 427 ~~~el~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 506 (728)
.--|+.+....+..+||-|.||.||.|+|+ .-...||||.++... ....+|+.|..+|+.++|||+|+++|+|.....
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWK-kyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeee-ccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 334566666667889999999999999998 445789999998753 346899999999999999999999999999999
Q ss_pred ceeEeeccCCCCHHHHHhcCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccc
Q 047292 507 RLLVYEFMGNGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKL 584 (728)
Q Consensus 507 ~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~ 584 (728)
.|||.|||..|+|.++|++.. .++.-.++.++.||+.||+||..+ ++|||||.++|+|+.++..+|++||||+++
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhh
Confidence 999999999999999999863 556667889999999999999987 999999999999999999999999999999
Q ss_pred cccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccce
Q 047292 585 LLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDA 663 (728)
Q Consensus 585 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (728)
+..+....+....-+..|.|||.+....++.|+|||+|||+||||.| |..||-.......+.++
T Consensus 415 MtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LL--------------- 479 (1157)
T KOG4278|consen 415 MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLL--------------- 479 (1157)
T ss_pred hcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHH---------------
Confidence 97776655554455788999999999999999999999999999998 66777654333333222
Q ss_pred eccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 047292 664 LIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710 (728)
Q Consensus 664 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 710 (728)
+.......+..+.+.+.++++.||+-+|.+||++.||-+.+|.++
T Consensus 480 --EkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 480 --EKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred --hccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 222233334556778899999999999999999999999998875
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=327.59 Aligned_cols=261 Identities=24% Similarity=0.355 Sum_probs=199.6
Q ss_pred HhhHHhhhCCCceeEEEEeeeeC---------------CCCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEe
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKT---------------ASGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLL 498 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~---------------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~ 498 (728)
.+.+.++||+|+||.||++.++. ..+..||+|.+.... .....+|.+|+.++.+++|+||++++
T Consensus 6 ~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 85 (304)
T cd05096 6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLL 85 (304)
T ss_pred hCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEE
Confidence 44567889999999999997642 223479999987543 33456799999999999999999999
Q ss_pred eeeecCCcceeEeeccCCCCHHHHHhcC-------------------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeec
Q 047292 499 GFCDEALNRLLVYEFMGNGTLANLIFAI-------------------PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHC 559 (728)
Q Consensus 499 g~~~~~~~~~lv~e~~~~gsL~~~l~~~-------------------~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~ 559 (728)
+++......++||||+++++|.+++... ..+++..+++++.||+.||.|||+. +|+||
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH~ 162 (304)
T cd05096 86 GVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHR 162 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccccc
Confidence 9999999999999999999999998643 2356788899999999999999997 99999
Q ss_pred CCCCCCEEEcCCCceEEccccCccccccCCCc-ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh--CCcCc
Q 047292 560 DIKPQNILLDHYFSPKISDFGLSKLLLSDHSR-THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC--CRRSV 636 (728)
Q Consensus 560 dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt--g~~p~ 636 (728)
||||+|||+++++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ +..|+
T Consensus 163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~ 242 (304)
T cd05096 163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242 (304)
T ss_pred CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCC
Confidence 99999999999999999999999865433221 1222345788999999998899999999999999999997 45676
Q ss_pred chhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 047292 637 EMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEG 708 (728)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 708 (728)
............. ............ .........+.+++.+||+.+|++|||+++|.+.|++
T Consensus 243 ~~~~~~~~~~~~~----~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 243 GELTDEQVIENAG----EFFRDQGRQVYL------FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CcCCHHHHHHHHH----HHhhhccccccc------cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 6443322211111 111111000000 0111233567889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=332.70 Aligned_cols=242 Identities=26% Similarity=0.301 Sum_probs=198.9
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCC
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGN 516 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 516 (728)
+.||+|+||.||++..+ .+++.||+|+++... ......+.+|+.++++++||||+++++.+......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREK-ATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence 36899999999999876 578899999997532 23345678899999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccccc
Q 047292 517 GTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMI 596 (728)
Q Consensus 517 gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 596 (728)
++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~ 155 (323)
T cd05571 80 GELFFHLSRERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTF 155 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccccce
Confidence 99999998888899999999999999999999997 99999999999999999999999999987532221 122335
Q ss_pred cCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHH
Q 047292 597 RGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRS 676 (728)
Q Consensus 597 ~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 676 (728)
.||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ ..+.. ..+..
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~--------~~~~~----------~~p~~ 217 (323)
T cd05571 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI--------LMEEI----------RFPRT 217 (323)
T ss_pred ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHH--------HcCCC----------CCCCC
Confidence 6899999999999999999999999999999999999999754332221111 11110 01112
Q ss_pred HHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047292 677 RLHKWLMIAMWCIQEDPSKRP-----TMKVVMQ 704 (728)
Q Consensus 677 ~~~~l~~l~~~cl~~dp~~RP-----t~~evl~ 704 (728)
....+.+++.+||+.||++|| ++.++++
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 218 LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 234677899999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=337.94 Aligned_cols=255 Identities=27% Similarity=0.383 Sum_probs=213.5
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCc----EEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEe
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGN----AIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 511 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 511 (728)
.-.++||+|+||+||||.+--+ ++ +||+|++.... .+...++++|+.+|.+++||||++++|+|.... +.||.
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pe-ge~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPE-GENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhceeccccceeEEeeeEecC-CceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 3456899999999999998744 43 78999886543 445689999999999999999999999998876 88999
Q ss_pred eccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC
Q 047292 512 EFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 512 e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 590 (728)
+|||.|+|.++++.+ ..+..+..+.|..|||+||.|||++ +++||||.++|||+.+-.++||.|||+++....+..
T Consensus 777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 999999999999876 5788899999999999999999998 999999999999999999999999999998866544
Q ss_pred ccc-ccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccch
Q 047292 591 RTH-TMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSD 668 (728)
Q Consensus 591 ~~~-~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 668 (728)
... ....-.+.|||-|.++...|+.++|||||||++||++| |..|++....++....+ ...
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dll-----------------e~g 916 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLL-----------------EKG 916 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHH-----------------hcc
Confidence 322 22334678999999999999999999999999999999 77899877666544433 222
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCC
Q 047292 669 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVP 713 (728)
Q Consensus 669 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~ 713 (728)
.+...++-....+..++.+||..|+..||+++++...+.+....|
T Consensus 917 eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 917 ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP 961 (1177)
T ss_pred ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence 333345556667888999999999999999999998887765443
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=337.47 Aligned_cols=259 Identities=26% Similarity=0.365 Sum_probs=201.9
Q ss_pred HHHhhHHhhhCCCceeEEEEeeee----CCCCcEEEEEEecccc-hhhHHHHHHHHHHhccc-cccceeeEeeeeecCCc
Q 047292 433 DATDGFKEELGRGSFGIVYKGVLK----TASGNAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALN 506 (728)
Q Consensus 433 ~~~~~~~~~lg~G~fg~Vy~g~~~----~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 506 (728)
...+.+.+.||+|+||.||++... ..++..||+|+++... ......+.+|+++++.+ +|+||+++++.+.....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 345567789999999999998753 2234589999996533 33346788999999999 89999999999999999
Q ss_pred ceeEeeccCCCCHHHHHhcC------------------------------------------------------------
Q 047292 507 RLLVYEFMGNGTLANLIFAI------------------------------------------------------------ 526 (728)
Q Consensus 507 ~~lv~e~~~~gsL~~~l~~~------------------------------------------------------------ 526 (728)
.++||||+++|+|.+++...
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 99999999999999998642
Q ss_pred ----------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc-cccc
Q 047292 527 ----------PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR-THTM 595 (728)
Q Consensus 527 ----------~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~ 595 (728)
..+++..+++++.||++||+|||++ +|+||||||+|||+++++++||+|||+++........ ....
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 1356778899999999999999997 9999999999999999999999999999865433221 1122
Q ss_pred ccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhc
Q 047292 596 IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMAD 674 (728)
Q Consensus 596 ~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 674 (728)
..++..|+|||++.+..++.++||||||+++|||++ |+.||............ ...+..... .
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~-------~~~~~~~~~---------~ 337 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKM-------VKRGYQMSR---------P 337 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHH-------HHcccCccC---------C
Confidence 335678999999999999999999999999999997 99998754322211100 011100000 0
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 047292 675 RSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710 (728)
Q Consensus 675 ~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 710 (728)
......+.+++.+||+.||.+||++.+|+++|++++
T Consensus 338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 011346778999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=318.24 Aligned_cols=253 Identities=23% Similarity=0.291 Sum_probs=201.8
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchh--------------hHHHHHHHHHHhccccccceeeEeee
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQE--------------REREFKSEVSAIGRTHHKNLVQLLGF 500 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~--------------~~~~~~~E~~~l~~l~h~niv~l~g~ 500 (728)
+|.+.++||+|.||.|-+|... .+++.||||++.+.... ..+...+|+.+|++++|+|||+|+.+
T Consensus 98 qy~l~~eiG~G~yGkVkLar~~-~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEv 176 (576)
T KOG0585|consen 98 QYELIKEIGSGQYGKVKLARDE-VDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEV 176 (576)
T ss_pred heehhhhhcCCccceEEEEeec-CCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEe
Confidence 4566789999999999999865 67899999999653211 12478899999999999999999999
Q ss_pred eecC--CcceeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEcc
Q 047292 501 CDEA--LNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISD 578 (728)
Q Consensus 501 ~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~D 578 (728)
..+. ..+|||+||+..|.+...-...+.+++.+.++++.+++.||+|||.+ +||||||||+|+||+++|++||+|
T Consensus 177 LDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VKIsD 253 (576)
T KOG0585|consen 177 LDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVKISD 253 (576)
T ss_pred ecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEEeec
Confidence 8654 57899999999988765444444588999999999999999999998 999999999999999999999999
Q ss_pred ccCccccccCCC----cccccccCCccccCcccccCCC----CCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHH
Q 047292 579 FGLSKLLLSDHS----RTHTMIRGTRGYVAPEWLKNAP----VSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTD 650 (728)
Q Consensus 579 fgla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~----~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~ 650 (728)
||.+........ .......|||.|+|||...+.. .+.+.||||+||+||.|+.|+.||..+...+....+.
T Consensus 254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIv- 332 (576)
T KOG0585|consen 254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIV- 332 (576)
T ss_pred cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHh-
Confidence 999987632211 1122356999999999987632 3568999999999999999999998776655443331
Q ss_pred HHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047292 651 WAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLE 707 (728)
Q Consensus 651 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~ 707 (728)
+..+.....++.-+.+.+++.++|++||++|.++.+|....-
T Consensus 333 ---------------n~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 333 ---------------NDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred ---------------cCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 122222223345667788999999999999999999877653
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=324.52 Aligned_cols=248 Identities=33% Similarity=0.505 Sum_probs=194.2
Q ss_pred HhhhCCCceeEEEEeeee---CCCCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 439 KEELGRGSFGIVYKGVLK---TASGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 439 ~~~lg~G~fg~Vy~g~~~---~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
.+.||.|.||.||+|.+. ...+..|+||.++... .+....|.+|++.+++++||||++++|++......++|+||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 467999999999999987 2334689999996543 334688999999999999999999999999888899999999
Q ss_pred CCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCC-Cc
Q 047292 515 GNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH-SR 591 (728)
Q Consensus 515 ~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~-~~ 591 (728)
++|+|.++|... ..+++..+..|+.||++||.|||+. +++|++|+++||++++++.+||+|||++....... ..
T Consensus 84 ~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~ 160 (259)
T PF07714_consen 84 PGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK 160 (259)
T ss_dssp TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred ccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence 999999999987 6889999999999999999999997 89999999999999999999999999998763222 22
Q ss_pred ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhh
Q 047292 592 THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEA 670 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 670 (728)
..........|+|||.+....++.++||||||+++|||++ |+.|+........... ...+....
T Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~--------~~~~~~~~------- 225 (259)
T PF07714_consen 161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEK--------LKQGQRLP------- 225 (259)
T ss_dssp ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHH--------HHTTEETT-------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--------ccccccce-------
Confidence 2233456788999999999989999999999999999999 6788765433221111 11111111
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047292 671 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQML 706 (728)
Q Consensus 671 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 706 (728)
........+.+++.+||+.+|++||+|++|++.|
T Consensus 226 --~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 --IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp --SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred --eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1112244577899999999999999999999987
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=332.10 Aligned_cols=252 Identities=23% Similarity=0.355 Sum_probs=210.2
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
+.+.||.|+-|.|-+|++. .+|+.+|||++.+. .......+.+|+.+|+.+.|||+++++++++...++|+|.||+
T Consensus 16 LgkTLG~Gstg~vrlakh~-~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv 94 (786)
T KOG0588|consen 16 LGKTLGKGSTGCVRLAKHA-ETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYV 94 (786)
T ss_pred ccccccCCCCceehhhhcc-cccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEec
Confidence 4577999999999999876 78999999999654 2233467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccc
Q 047292 515 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHT 594 (728)
Q Consensus 515 ~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 594 (728)
++|.|++++...+++.+....+++.||+.|+.|+|.. +|+||||||+|+|||..+++||+|||+|.+-.. .....
T Consensus 95 ~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~--gklLe 169 (786)
T KOG0588|consen 95 PGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP--GKLLE 169 (786)
T ss_pred CCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC--Ccccc
Confidence 9999999999999999999999999999999999997 999999999999999999999999999986533 23455
Q ss_pred cccCCccccCcccccCCCC-CCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhh
Q 047292 595 MIRGTRGYVAPEWLKNAPV-SAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMA 673 (728)
Q Consensus 595 ~~~gt~~y~aPE~~~~~~~-s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 673 (728)
+.+|.+.|.|||++++.+| ..++||||.|||||.||||+.||+.++.. .++.+. ..|.. ++
T Consensus 170 TSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir---~LLlKV-----~~G~f-~M--------- 231 (786)
T KOG0588|consen 170 TSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR---VLLLKV-----QRGVF-EM--------- 231 (786)
T ss_pred ccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH---HHHHHH-----HcCcc-cC---------
Confidence 6789999999999999999 67899999999999999999999955433 222221 11211 00
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcCcCCC
Q 047292 674 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM--LEGLLEVP 713 (728)
Q Consensus 674 ~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~--L~~~~~~~ 713 (728)
+.....++.+|+.+|+..||.+|.|++||++. |.+....+
T Consensus 232 Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~ 273 (786)
T KOG0588|consen 232 PSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLP 273 (786)
T ss_pred CCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCC
Confidence 11223456679999999999999999999985 34444333
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=331.80 Aligned_cols=266 Identities=24% Similarity=0.328 Sum_probs=204.4
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
.+.+.+.||+|+||.||++..+ .++..||+|.+.... ......+.+|++++++++|+||+++++++......++||||
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 6 DFERISELGAGNGGVVTKVQHK-PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred cceEEEeecCCCCEEEEEEEEC-CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 3455678999999999999876 567899999986542 23456799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccc
Q 047292 514 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH 593 (728)
Q Consensus 514 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 593 (728)
+++++|.+++.....+++..+..++.|++.||.|||+. .+|+||||||+|||+++++.+||+|||++....... .
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~ 159 (331)
T cd06649 85 MDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---A 159 (331)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc---c
Confidence 99999999998888889999999999999999999985 269999999999999999999999999987653321 2
Q ss_pred ccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcC--c-----------
Q 047292 594 TMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEG--R----------- 660 (728)
Q Consensus 594 ~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~----------- 660 (728)
....|++.|+|||++.+..++.++||||||+++|||++|+.||......+....+..-........ .
T Consensus 160 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (331)
T cd06649 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRP 239 (331)
T ss_pred ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccccc
Confidence 234589999999999999999999999999999999999999975433222111100000000000 0
Q ss_pred -------------cceeccch----hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047292 661 -------------LDALIDSD----EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQML 706 (728)
Q Consensus 661 -------------~~~~~d~~----~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 706 (728)
.....+.. ............+.+++.+||+.||++|||++++++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 240 VSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred ccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 00000000 00000112345688999999999999999999998653
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=372.04 Aligned_cols=257 Identities=27% Similarity=0.546 Sum_probs=205.5
Q ss_pred HhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCCCC
Q 047292 439 KEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGT 518 (728)
Q Consensus 439 ~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 518 (728)
.+.||+|+||.||+|..+ .++..||||+++..... ...|++++++++||||++++|+|.+....++||||+++|+
T Consensus 695 ~~~ig~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~ 769 (968)
T PLN00113 695 ENVISRGKKGASYKGKSI-KNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKN 769 (968)
T ss_pred ccEEccCCCeeEEEEEEC-CCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCc
Confidence 357999999999999875 46789999998653322 2346888999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccccccC
Q 047292 519 LANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRG 598 (728)
Q Consensus 519 L~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g 598 (728)
|.+++. .++|..+.+|+.|+++||+|||+.+..+|+||||||+||+++.++.+++. |+........ ....+
T Consensus 770 L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~ 840 (968)
T PLN00113 770 LSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFI 840 (968)
T ss_pred HHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCccc
Confidence 999996 37899999999999999999997666799999999999999999888875 6655433211 12357
Q ss_pred CccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhh--hhcHH
Q 047292 599 TRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAA--MADRS 676 (728)
Q Consensus 599 t~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~--~~~~~ 676 (728)
++.|+|||++.+..++.++|||||||++|||+||+.|++..... ...+..|.............+++.... ..+.+
T Consensus 841 t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (968)
T PLN00113 841 SSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV--HGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQN 918 (968)
T ss_pred cccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC--CCcHHHHHHHhcCccchhheeCccccCCCCccHH
Confidence 89999999999999999999999999999999999998643221 122334444433333444444443322 23456
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 677 RLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 677 ~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
+..++.+++.+||+.+|++||+|+||+++|+++..
T Consensus 919 ~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 919 EIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred HHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 67788899999999999999999999999998764
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=328.61 Aligned_cols=238 Identities=24% Similarity=0.273 Sum_probs=194.1
Q ss_pred hCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCCCC
Q 047292 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGT 518 (728)
Q Consensus 442 lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 518 (728)
||+|+||.||++... .+++.||+|++.... ......+..|+.++++++||||+++++++......++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~-~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKR-DTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence 799999999999876 567899999986532 2334678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccccccC
Q 047292 519 LANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRG 598 (728)
Q Consensus 519 L~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g 598 (728)
|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....... ......|
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~g 155 (312)
T cd05585 80 LFHHLQREGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNTFCG 155 (312)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-ccccccC
Confidence 999998888899999999999999999999997 999999999999999999999999999875432221 2233568
Q ss_pred CccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHHHH
Q 047292 599 TRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRL 678 (728)
Q Consensus 599 t~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 678 (728)
|+.|+|||.+.+..++.++|||||||++|||++|+.||...........+ ..... ..+....
T Consensus 156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~--------~~~~~----------~~~~~~~ 217 (312)
T cd05585 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKI--------LQEPL----------RFPDGFD 217 (312)
T ss_pred CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHH--------HcCCC----------CCCCcCC
Confidence 99999999999999999999999999999999999999755433221111 11110 0111223
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHH
Q 047292 679 HKWLMIAMWCIQEDPSKRPTMKVV 702 (728)
Q Consensus 679 ~~l~~l~~~cl~~dp~~RPt~~ev 702 (728)
..+.+++.+||+.||.+||++..+
T Consensus 218 ~~~~~li~~~L~~dp~~R~~~~~~ 241 (312)
T cd05585 218 RDAKDLLIGLLSRDPTRRLGYNGA 241 (312)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCH
Confidence 456789999999999999864333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=332.01 Aligned_cols=251 Identities=22% Similarity=0.298 Sum_probs=204.5
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch---hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
.+.+.||+|+||.||+|... .+++.||+|+++.... .....+..|+.++..++|+||+++++++......++||||
T Consensus 4 ~~~~~ig~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 82 (333)
T cd05600 4 QILTQVGQGGYGQVFLAKKK-DTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY 82 (333)
T ss_pred EEEEEEeecCCeEEEEEEEC-CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence 45578999999999999876 4678999999975322 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccc
Q 047292 514 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH 593 (728)
Q Consensus 514 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 593 (728)
+++++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++.... ..
T Consensus 83 ~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~~ 155 (333)
T cd05600 83 VPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----YA 155 (333)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc----cc
Confidence 99999999998888889999999999999999999997 999999999999999999999999999976533 22
Q ss_pred ccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhh
Q 047292 594 TMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMA 673 (728)
Q Consensus 594 ~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 673 (728)
....|++.|+|||++.+..++.++||||||+++|||++|+.||......+....+..+.. .+........
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~----------~~~~~~~~~~ 225 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE----------TLQRPVYDDP 225 (333)
T ss_pred CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccc----------cccCCCCCcc
Confidence 345689999999999999999999999999999999999999976554433222211110 0000000000
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 674 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 674 ~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.......+.+++.+||+.+|.+||+++++++.
T Consensus 226 ~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 226 RFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 11234567789999999999999999999965
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=326.47 Aligned_cols=244 Identities=21% Similarity=0.231 Sum_probs=201.1
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
+.+.+.||+|+||.||++..+ .+++.||+|++.... ......+.+|+.++++++||||+++++++.+....++|||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 3 LERIKTVGTGTFGRVHLVRDR-ISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred ceeeeeeecCCCeEEEEEEEc-CCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 345678999999999999876 468899999986432 2334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 513 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 513 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
|+++++|.+++.....+++.....++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~---- 154 (291)
T cd05612 82 YVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---- 154 (291)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC----
Confidence 999999999999888899999999999999999999997 9999999999999999999999999999865332
Q ss_pred cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAM 672 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 672 (728)
.....|++.|+|||++.+..++.++||||||+++|||++|+.||...........+ ..+.. .
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i--------~~~~~----------~ 216 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI--------LAGKL----------E 216 (291)
T ss_pred cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------HhCCc----------C
Confidence 12345899999999999999999999999999999999999999765443322111 11111 0
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 047292 673 ADRSRLHKWLMIAMWCIQEDPSKRPT-----MKVVMQM 705 (728)
Q Consensus 673 ~~~~~~~~l~~l~~~cl~~dp~~RPt-----~~evl~~ 705 (728)
.+......+.+++.+||+.||.+||+ ++++++.
T Consensus 217 ~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 217 FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 11112345678999999999999995 8887754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=325.95 Aligned_cols=261 Identities=26% Similarity=0.377 Sum_probs=222.0
Q ss_pred HHHHHHhhHHhhhCCCceeEEEEeeeeCC-CCc--EEEEEEecc-cchhhHHHHHHHHHHhccccccceeeEeeeeecCC
Q 047292 430 ELKDATDGFKEELGRGSFGIVYKGVLKTA-SGN--AIAVKKLDR-LAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEAL 505 (728)
Q Consensus 430 el~~~~~~~~~~lg~G~fg~Vy~g~~~~~-~~~--~vavK~l~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 505 (728)
++.++.-.+.+.||.|-||.||+|++.+. .|+ .||||..+. ...+..+.|+.|..+++.++||||++++|+|.+ .
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~ 463 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q 463 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-c
Confidence 34455556678899999999999998654 333 689998876 344556889999999999999999999999976 4
Q ss_pred cceeEeeccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccc
Q 047292 506 NRLLVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKL 584 (728)
Q Consensus 506 ~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~ 584 (728)
..|||||.++-|.|..+|... ..++......++.||..||+|||+. .+|||||.++|||+...--+||+|||+++.
T Consensus 464 P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhh
Confidence 789999999999999999876 5788889999999999999999997 999999999999999999999999999999
Q ss_pred cccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccce
Q 047292 585 LLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDA 663 (728)
Q Consensus 585 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (728)
+..+.....+...-+..|||||.+.-.+++.++|||.|||.+||++. |..||+... +..+..
T Consensus 541 ~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvk-----------------NsDVI~ 603 (974)
T KOG4257|consen 541 LEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVK-----------------NSDVIG 603 (974)
T ss_pred ccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccc-----------------ccceEE
Confidence 98877766666667889999999999999999999999999999997 778987532 222333
Q ss_pred eccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 664 LIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 664 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
.++...+...++.++..|..++.+||..+|.+||++.+|...|+.++.
T Consensus 604 ~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 604 HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 444455555667788899999999999999999999999988877653
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=316.98 Aligned_cols=252 Identities=29% Similarity=0.396 Sum_probs=203.7
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccC
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
..+.++||+|+||.||+|..+ ..++.|++|.+... ......+.+|++++++++|+||+++++++......+++|||++
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~-~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 8 ITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred eEEeeecCCcccceEEEEEEe-cCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 445678999999999999986 46789999998753 3335678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccc
Q 047292 516 NGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH 593 (728)
Q Consensus 516 ~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 593 (728)
+++|.+++... ..+++..++.++.|+++||+|||+. +++||||||+||++++++.+||+|||++...........
T Consensus 86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~ 162 (263)
T cd05052 86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 162 (263)
T ss_pred CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceeecc
Confidence 99999999754 3578899999999999999999987 999999999999999999999999999987644322222
Q ss_pred ccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhh
Q 047292 594 TMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAM 672 (728)
Q Consensus 594 ~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 672 (728)
.....+..|+|||.+.+..++.++||||||+++|||++ |..|+...........+ ..+... .
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~--------~~~~~~---------~ 225 (263)
T cd05052 163 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL--------EKGYRM---------E 225 (263)
T ss_pred CCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH--------HCCCCC---------C
Confidence 22334668999999999999999999999999999998 88888654332221111 111000 0
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 047292 673 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGL 709 (728)
Q Consensus 673 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 709 (728)
........+.+++.+||+.+|++||++.+++++|+.+
T Consensus 226 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 226 RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 1111235677899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=322.48 Aligned_cols=247 Identities=26% Similarity=0.300 Sum_probs=197.5
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch---hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
..+.||+|+||.||++... .+++.||+|.+..... .....+.+|+.++.+++|+||+++++.+.+....++|+||+
T Consensus 4 ~~~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05631 4 HYRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIM 82 (285)
T ss_pred EEEEEecCCCEEEEEEEEe-cCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEec
Confidence 4567999999999999876 5688999999864322 22356789999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 515 GNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 515 ~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++....... .
T Consensus 83 ~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--~ 157 (285)
T cd05631 83 NGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE--T 157 (285)
T ss_pred CCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--e
Confidence 999999888653 3678899999999999999999997 99999999999999999999999999998653322 1
Q ss_pred cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAM 672 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 672 (728)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||...........+.. ...... ..
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~----~~~~~~----------~~ 223 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDR----RVKEDQ----------EE 223 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHH----Hhhccc----------cc
Confidence 2334689999999999999999999999999999999999999975433211111100 000000 01
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 047292 673 ADRSRLHKWLMIAMWCIQEDPSKRPT-----MKVVMQ 704 (728)
Q Consensus 673 ~~~~~~~~l~~l~~~cl~~dp~~RPt-----~~evl~ 704 (728)
........+.+++.+||+.||.+||+ ++++++
T Consensus 224 ~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 224 YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 11223446778999999999999997 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=316.13 Aligned_cols=254 Identities=25% Similarity=0.370 Sum_probs=204.5
Q ss_pred HHHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 433 DATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 433 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
.....+.+.||+|++|.||+|... +++.||+|.++... ...+++.+|+.++++++|+||+++++++......+++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN--NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec--CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 345566789999999999999864 45789999986533 335678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC
Q 047292 513 FMGNGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 513 ~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 590 (728)
|+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||+++.......
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 999999999997654 688999999999999999999997 999999999999999999999999999987653322
Q ss_pred cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchh
Q 047292 591 RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDE 669 (728)
Q Consensus 591 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 669 (728)
........+..|+|||++.+..++.++||||||++++||++ |+.||...........+ ......
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~--------~~~~~~------- 223 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV--------DQGYRM------- 223 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH--------HcCCCC-------
Confidence 22222223457999999999999999999999999999999 88888654332211111 111000
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 047292 670 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGL 709 (728)
Q Consensus 670 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 709 (728)
.........+.+++.+|++.+|.+||+++++++.|+++
T Consensus 224 --~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 224 --PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred --CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 01112235678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=327.88 Aligned_cols=242 Identities=27% Similarity=0.303 Sum_probs=197.8
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCC
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGN 516 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 516 (728)
+.||+|+||.||++..+ .+++.||+|+++... ......+.+|+++++.++||||+++++.+......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREK-ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCC
Confidence 36899999999999875 568899999996532 23345678899999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccccc
Q 047292 517 GTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMI 596 (728)
Q Consensus 517 gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 596 (728)
|+|..++.....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++...... ......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~ 155 (323)
T cd05595 80 GELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTF 155 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Cccccc
Confidence 99999998878889999999999999999999997 99999999999999999999999999987542221 122335
Q ss_pred cCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHH
Q 047292 597 RGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRS 676 (728)
Q Consensus 597 ~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 676 (728)
.|++.|+|||++.+..++.++|||||||++|||++|+.||...........+ ..... ..+..
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~--------~~~~~----------~~p~~ 217 (323)
T cd05595 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI--------LMEEI----------RFPRT 217 (323)
T ss_pred cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH--------hcCCC----------CCCCC
Confidence 6899999999999999999999999999999999999999755433221111 01110 01112
Q ss_pred HHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047292 677 RLHKWLMIAMWCIQEDPSKRP-----TMKVVMQ 704 (728)
Q Consensus 677 ~~~~l~~l~~~cl~~dp~~RP-----t~~evl~ 704 (728)
....+.+++.+||+.||++|| ++.++++
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 218 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 234567899999999999998 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=317.86 Aligned_cols=255 Identities=27% Similarity=0.445 Sum_probs=204.7
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCC----CcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCccee
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTAS----GNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLL 509 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 509 (728)
...+.+.||+|+||.||+|...... ...|++|.+.... ......+.+|+.++.+++|+||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 3456788999999999999875322 2579999986533 3345678999999999999999999999999999999
Q ss_pred EeeccCCCCHHHHHhcC----------------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCc
Q 047292 510 VYEFMGNGTLANLIFAI----------------PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFS 573 (728)
Q Consensus 510 v~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~ 573 (728)
+|||+++++|.+++... ..+++..++.++.|++.||.|||+. +++|+||||+||++++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCc
Confidence 99999999999999754 3467788999999999999999997 9999999999999999999
Q ss_pred eEEccccCccccccCCC-cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHH
Q 047292 574 PKISDFGLSKLLLSDHS-RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDW 651 (728)
Q Consensus 574 ~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~ 651 (728)
+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+....
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~---- 238 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM---- 238 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----
Confidence 99999999986543322 22223346788999999998899999999999999999998 9999875443322111
Q ss_pred HHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 047292 652 AYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGL 709 (728)
Q Consensus 652 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 709 (728)
...+.... ........+.+++.+||+.+|.+||++++|++.|+.+
T Consensus 239 ----i~~~~~~~---------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 239 ----IRSRQLLP---------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred ----HHcCCcCC---------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 11111111 1223346788899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=327.98 Aligned_cols=243 Identities=27% Similarity=0.314 Sum_probs=198.8
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCC
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGN 516 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 516 (728)
+.||+|+||.||++..+ .+++.||+|++.... ......+.+|+.+++.++||||+++++.+......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREK-ASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence 35899999999999875 568899999996532 23346788899999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccccc
Q 047292 517 GTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMI 596 (728)
Q Consensus 517 gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 596 (728)
|+|..++.....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++...... ......
T Consensus 80 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~ 155 (328)
T cd05593 80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKTF 155 (328)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cccccc
Confidence 99999998888899999999999999999999997 99999999999999999999999999987542221 122335
Q ss_pred cCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHH
Q 047292 597 RGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRS 676 (728)
Q Consensus 597 ~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 676 (728)
.||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ ..... ..+..
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~--------~~~~~----------~~p~~ 217 (328)
T cd05593 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI--------LMEDI----------KFPRT 217 (328)
T ss_pred cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHh--------ccCCc----------cCCCC
Confidence 6899999999999999999999999999999999999999754333221111 00100 01112
Q ss_pred HHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 047292 677 RLHKWLMIAMWCIQEDPSKRP-----TMKVVMQM 705 (728)
Q Consensus 677 ~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~ 705 (728)
....+.+++.+||+.||++|| ++.++++.
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 218 LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 234567899999999999997 89998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=321.34 Aligned_cols=265 Identities=21% Similarity=0.237 Sum_probs=202.1
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
+.+.+.||+|+||.||++..+ .+++.||+|+++... ....+.+.+|+.+++.++|+||+++++++......++||||
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07848 3 FEVLGVVGEGAYGVVLKCRHK-ETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY 81 (287)
T ss_pred ceEEEEecccCCEEEEEEEEC-CCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence 345678999999999999876 567899999986532 22346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccc
Q 047292 514 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH 593 (728)
Q Consensus 514 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 593 (728)
++++.+..+......+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (287)
T cd07848 82 VEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY 158 (287)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccc
Confidence 99988776665556788999999999999999999987 999999999999999999999999999987644333333
Q ss_pred ccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHH-------HHHhhh-cCccceec
Q 047292 594 TMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDW-------AYDCYV-EGRLDALI 665 (728)
Q Consensus 594 ~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~-------~~~~~~-~~~~~~~~ 665 (728)
....|++.|+|||++.+..++.++|||||||++|||++|+.||...........+... ....+. ........
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLR 238 (287)
T ss_pred cccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccc
Confidence 3456899999999999999999999999999999999999999754432221111100 000000 00000000
Q ss_pred cch------hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 666 DSD------EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 666 d~~------~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
.+. ............+.+++.+||+.||++|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 239 FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000 000111123346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=330.62 Aligned_cols=244 Identities=25% Similarity=0.278 Sum_probs=200.8
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
+.+.+.||+|+||.||++..+ .+++.||+|.+.... ......+.+|+.++++++||||+++++.+......++|||
T Consensus 20 y~~~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 98 (329)
T PTZ00263 20 FEMGETLGTGSFGRVRIAKHK-GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLE 98 (329)
T ss_pred eEEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEc
Confidence 455678999999999999876 567899999986532 2234678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 513 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 513 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
|+++++|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 99 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--- 172 (329)
T PTZ00263 99 FVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT--- 172 (329)
T ss_pred CCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc---
Confidence 999999999999888889999999999999999999997 99999999999999999999999999998653321
Q ss_pred cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAM 672 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 672 (728)
....|++.|+|||++.+..++.++|||||||++|||++|+.||.......... ...++.+.
T Consensus 173 -~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--------~i~~~~~~---------- 233 (329)
T PTZ00263 173 -FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYE--------KILAGRLK---------- 233 (329)
T ss_pred -ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHH--------HHhcCCcC----------
Confidence 23468999999999999999999999999999999999999997554332211 11111110
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 047292 673 ADRSRLHKWLMIAMWCIQEDPSKRPT-----MKVVMQM 705 (728)
Q Consensus 673 ~~~~~~~~l~~l~~~cl~~dp~~RPt-----~~evl~~ 705 (728)
.+......+.+++.+||+.||.+||+ ++++++.
T Consensus 234 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 234 FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 01112235678999999999999986 6777643
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=328.16 Aligned_cols=204 Identities=27% Similarity=0.389 Sum_probs=177.3
Q ss_pred HHHHHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc-chhhHHHHHHHHHHhccccccceeeEeeeeecCCccee
Q 047292 431 LKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLL 509 (728)
Q Consensus 431 l~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 509 (728)
+....+.+.++||+|+||.||++..+ .++..+|+|.+... .......+.+|++++++++|+||+++++++...+..++
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHK-PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEEC-CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 34455667789999999999999876 56788999988653 23345678999999999999999999999999999999
Q ss_pred EeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCC
Q 047292 510 VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH 589 (728)
Q Consensus 510 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 589 (728)
||||+++++|.+++.....+++..+..++.|+++||.|||+. .+|+|+||||+|||+++++.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 999999999999998878889999999999999999999974 26999999999999999999999999998765322
Q ss_pred CcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhh
Q 047292 590 SRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEL 640 (728)
Q Consensus 590 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~ 640 (728)
......|+..|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 206 (333)
T cd06650 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206 (333)
T ss_pred --ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence 1223458899999999999999999999999999999999999987543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=330.75 Aligned_cols=247 Identities=23% Similarity=0.264 Sum_probs=202.6
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeE
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 510 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 510 (728)
..+.+.+.||+|+||.||+|..+...+..||+|++.... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 345567889999999999998775555789999986432 23346788999999999999999999999999999999
Q ss_pred eeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC
Q 047292 511 YEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 590 (728)
|||+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++++||+|||+++.....
T Consensus 110 ~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-- 184 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-- 184 (340)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC--
Confidence 99999999999999888899999999999999999999997 9999999999999999999999999999865322
Q ss_pred cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhh
Q 047292 591 RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEA 670 (728)
Q Consensus 591 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 670 (728)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........... ...+...
T Consensus 185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~--------i~~~~~~-------- 246 (340)
T PTZ00426 185 --TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQK--------ILEGIIY-------- 246 (340)
T ss_pred --cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHH--------HhcCCCC--------
Confidence 2235689999999999999999999999999999999999999976543322111 1111110
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 047292 671 AMADRSRLHKWLMIAMWCIQEDPSKRP-----TMKVVMQM 705 (728)
Q Consensus 671 ~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~ 705 (728)
.+......+.+++.+||+.+|.+|+ +++++++.
T Consensus 247 --~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 247 --FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred --CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 0111123466899999999999995 88888764
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=314.07 Aligned_cols=249 Identities=27% Similarity=0.432 Sum_probs=199.9
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccC
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
..+.++||+|+||.||++.++ .+..+|+|.+.... .....+.+|+.++++++||||+++++++......++||||++
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~--~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 6 LTFMKELGSGQFGVVHLGKWR--AQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred cEEeeEecCCcCceEEEEEec--cCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 345678999999999999875 45689999886432 234678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccc
Q 047292 516 NGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHT 594 (728)
Q Consensus 516 ~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 594 (728)
+|+|.+++... ..+++..++.++.|++.||+|||+. +|+|+||||+||++++++.+||+|||+++...........
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05114 83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS 159 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceeccC
Confidence 99999999754 4678999999999999999999997 9999999999999999999999999998865433322222
Q ss_pred cccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhh
Q 047292 595 MIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMA 673 (728)
Q Consensus 595 ~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 673 (728)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ ..+.. ...
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i--------~~~~~--~~~------- 222 (256)
T cd05114 160 GAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI--------SRGFR--LYR------- 222 (256)
T ss_pred CCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH--------HCCCC--CCC-------
Confidence 2335668999999998899999999999999999999 88898755432221111 11110 000
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047292 674 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLE 707 (728)
Q Consensus 674 ~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~ 707 (728)
+......+.+++.+||+.+|++||+++++++.|.
T Consensus 223 ~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 223 PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0112246788999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=291.33 Aligned_cols=244 Identities=25% Similarity=0.334 Sum_probs=207.8
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch---hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
++.+.||+|-||.||.|..+ .++..||+|++.+... +.++++.+|+++-..|+||||+++++++.+....||++||
T Consensus 25 eigr~LgkgkFG~vYlarek-ks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEy 103 (281)
T KOG0580|consen 25 EIGRPLGKGKFGNVYLAREK-KSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEY 103 (281)
T ss_pred cccccccCCccccEeEeeec-cCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEe
Confidence 35678999999999999987 6778999999966432 3357899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHh--cCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 514 MGNGTLANLIF--AIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 514 ~~~gsL~~~l~--~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
.++|+|...|. ....+++.....+..|+|.||.|+|.. ++|||||||+|+|++.++.+||+|||-+.... ..
T Consensus 104 a~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p---~~ 177 (281)
T KOG0580|consen 104 APRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SN 177 (281)
T ss_pred cCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC---CC
Confidence 99999999999 456789999999999999999999997 99999999999999999999999999886542 33
Q ss_pred ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhh
Q 047292 592 THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAA 671 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 671 (728)
...+.+||..|+|||...+..++...|+|++|++.||++.|.+||+.....+....+...- +
T Consensus 178 kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~-----------~------- 239 (281)
T KOG0580|consen 178 KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVD-----------L------- 239 (281)
T ss_pred CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcc-----------c-------
Confidence 4456789999999999999999999999999999999999999999877555544442210 1
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 672 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 672 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.++........+++.+|+..+|.+|.+..|++..
T Consensus 240 ~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 240 KFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred cCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 1112223456789999999999999999988753
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=312.60 Aligned_cols=253 Identities=25% Similarity=0.410 Sum_probs=208.1
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
..+.+.++||.|+||.||+|..+. +..+++|.+..........+..|+.+++.++|+||+++++++......++||||
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~--~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN--RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC--CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 456778999999999999998863 789999999876555567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 514 MGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 514 ~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
+++++|.+++... ..+++..++.++.||+.||.|||++ +++|+||||+||++++++.+||+|||++.........
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 9999999999864 4578999999999999999999997 9999999999999999999999999999876433222
Q ss_pred ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhh
Q 047292 592 THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEA 670 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 670 (728)
. ....++..|+|||.+.+..++.++||||||++++||++ |+.||......+....+ ..+..
T Consensus 161 ~-~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~--------~~~~~--------- 222 (261)
T cd05148 161 S-SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI--------TAGYR--------- 222 (261)
T ss_pred c-cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH--------HhCCc---------
Confidence 1 23345778999999998899999999999999999998 78888755433221111 01100
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 047292 671 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGL 709 (728)
Q Consensus 671 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 709 (728)
..........+.+++.+||+.+|.+|||++++++.|+.+
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 223 MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 011122335677899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=313.91 Aligned_cols=252 Identities=23% Similarity=0.367 Sum_probs=202.8
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
.+.+.++||+|+||.||+|... ++..||+|.+.... ...+.+.+|+.+++.++|+||+++++.+......+++|||+
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~--~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 7 SIKLVKKLGAGQFGEVWMGYYN--NSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred HeEEeeecCCcCCceEEEEEec--CCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 3456688999999999999864 55789999986532 23568899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 515 GNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 515 ~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
++++|.+++... ..+++..++.++.|+++||+|||+. +++|+||||+||++++++.+||+|||+++.........
T Consensus 84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05072 84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160 (261)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence 999999999754 4678889999999999999999997 99999999999999999999999999998764433222
Q ss_pred cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAA 671 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 671 (728)
.....++..|+|||.+....++.++||||||+++|||+| |+.||...........+ .......
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~--------~~~~~~~-------- 224 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL--------QRGYRMP-------- 224 (261)
T ss_pred cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHH--------HcCCCCC--------
Confidence 222345678999999998899999999999999999998 88998654333221111 1110000
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 047292 672 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGL 709 (728)
Q Consensus 672 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 709 (728)
........+.+++.+||+.+|++||+++++.+.|+.+
T Consensus 225 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 225 -RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred -CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 0011234577899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=318.28 Aligned_cols=256 Identities=26% Similarity=0.416 Sum_probs=207.4
Q ss_pred hhHHhhhCCCceeEEEEeeeeC----CCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEe
Q 047292 436 DGFKEELGRGSFGIVYKGVLKT----ASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 511 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 511 (728)
+.+.+.||+|+||.||++.... .++..+++|.++.......+.+.+|++++++++|+||+++++++......++||
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (291)
T cd05094 7 IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVF 86 (291)
T ss_pred eEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEE
Confidence 3455789999999999997542 244579999997766666678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcC----------------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceE
Q 047292 512 EFMGNGTLANLIFAI----------------PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPK 575 (728)
Q Consensus 512 e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~k 575 (728)
||+++++|.+++... ..+++..+++++.||+.||+|||++ +|+||||||+||++++++.+|
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 163 (291)
T cd05094 87 EYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVK 163 (291)
T ss_pred ecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence 999999999999753 2378899999999999999999997 999999999999999999999
Q ss_pred EccccCccccccCCC-cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHH
Q 047292 576 ISDFGLSKLLLSDHS-RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAY 653 (728)
Q Consensus 576 l~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 653 (728)
|+|||++........ .......++..|+|||.+.+..++.++||||||+++|||+| |+.||..........
T Consensus 164 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~------- 236 (291)
T cd05094 164 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE------- 236 (291)
T ss_pred ECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-------
Confidence 999999976543322 12233446788999999999999999999999999999999 999986544332111
Q ss_pred HhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 654 DCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 654 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
....+..... .......+.+++.+||+.+|++||++++|+++|+.+.+
T Consensus 237 -~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 237 -CITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred -HHhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 1112211111 11123467789999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=315.79 Aligned_cols=256 Identities=27% Similarity=0.425 Sum_probs=206.1
Q ss_pred HHHhhHHhhhCCCceeEEEEeeeeC----CCCcEEEEEEecccchh-hHHHHHHHHHHhccccccceeeEeeeeecCCcc
Q 047292 433 DATDGFKEELGRGSFGIVYKGVLKT----ASGNAIAVKKLDRLAQE-REREFKSEVSAIGRTHHKNLVQLLGFCDEALNR 507 (728)
Q Consensus 433 ~~~~~~~~~lg~G~fg~Vy~g~~~~----~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 507 (728)
..++.+.+.||+|+||.||+|.... ..++.||+|.++..... ..+.+.+|+++++.++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 4556778999999999999998642 23578999999765443 457899999999999999999999999999999
Q ss_pred eeEeeccCCCCHHHHHhcC--------------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCc
Q 047292 508 LLVYEFMGNGTLANLIFAI--------------PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFS 573 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~l~~~--------------~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~ 573 (728)
++||||+++++|.+++... ..+++..+..++.|++.||.|||++ +++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 9999999999999999753 2467888999999999999999997 9999999999999999999
Q ss_pred eEEccccCccccccCCC-cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHH
Q 047292 574 PKISDFGLSKLLLSDHS-RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDW 651 (728)
Q Consensus 574 ~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~ 651 (728)
+||+|||+++....... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||...........
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~---- 236 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC---- 236 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH----
Confidence 99999999976533222 12223345788999999999999999999999999999999 9999865443322111
Q ss_pred HHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 047292 652 AYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEG 708 (728)
Q Consensus 652 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 708 (728)
...+..... .......+.+++.+||+.+|++||++.||++.|++
T Consensus 237 ----~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 237 ----ITQGRLLQR---------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred ----HHcCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 111111111 11223467789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=331.16 Aligned_cols=260 Identities=24% Similarity=0.333 Sum_probs=202.8
Q ss_pred HHHhhHHhhhCCCceeEEEEeeeeC----CCCcEEEEEEecccch-hhHHHHHHHHHHhcccc-ccceeeEeeeeecCCc
Q 047292 433 DATDGFKEELGRGSFGIVYKGVLKT----ASGNAIAVKKLDRLAQ-EREREFKSEVSAIGRTH-HKNLVQLLGFCDEALN 506 (728)
Q Consensus 433 ~~~~~~~~~lg~G~fg~Vy~g~~~~----~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~ 506 (728)
...+.+.+.||+|+||.||+|+... ..+..||||+++.... ...+.+.+|+++++++. ||||+++++++.+...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 3445567899999999999998632 2234799999965333 33467999999999995 9999999999999999
Q ss_pred ceeEeeccCCCCHHHHHhcC------------------------------------------------------------
Q 047292 507 RLLVYEFMGNGTLANLIFAI------------------------------------------------------------ 526 (728)
Q Consensus 507 ~~lv~e~~~~gsL~~~l~~~------------------------------------------------------------ 526 (728)
.++||||+++|+|.+++...
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 99999999999999988642
Q ss_pred ------------------------------------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcC
Q 047292 527 ------------------------------------PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDH 570 (728)
Q Consensus 527 ------------------------------------~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~ 570 (728)
..+++..+..++.||++||+|||+. +|+||||||+|||+++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeC
Confidence 1356777889999999999999997 9999999999999999
Q ss_pred CCceEEccccCccccccCCCc-ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhH
Q 047292 571 YFSPKISDFGLSKLLLSDHSR-THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAIL 648 (728)
Q Consensus 571 ~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~ 648 (728)
++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||.........
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~--- 349 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF--- 349 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH---
Confidence 999999999999865433221 1222346788999999999999999999999999999997 88888654322111
Q ss_pred HHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 649 TDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 649 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
......+... .........+.+++.+||+.+|++||++.+|+++|+.+++
T Consensus 350 ----~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 350 ----YNKIKSGYRM---------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred ----HHHHhcCCCC---------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 0111111000 0111234567889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=317.86 Aligned_cols=258 Identities=26% Similarity=0.411 Sum_probs=207.3
Q ss_pred HhhHHhhhCCCceeEEEEeeeeC----CCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeE
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKT----ASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 510 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 510 (728)
.+.+.+.||+|+||.||++.... .++..+|+|.+..........+.+|+.++++++|+||+++++++......++|
T Consensus 6 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (288)
T cd05093 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMV 85 (288)
T ss_pred HeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 34566789999999999997532 34467999999776666667899999999999999999999999999999999
Q ss_pred eeccCCCCHHHHHhcCC-------------CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEc
Q 047292 511 YEFMGNGTLANLIFAIP-------------KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKIS 577 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~~-------------~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~ 577 (728)
|||+++++|.+++.... .+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl~ 162 (288)
T cd05093 86 FEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIG 162 (288)
T ss_pred EEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEec
Confidence 99999999999997542 478999999999999999999997 99999999999999999999999
Q ss_pred cccCccccccCCC-cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHh
Q 047292 578 DFGLSKLLLSDHS-RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDC 655 (728)
Q Consensus 578 Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 655 (728)
|||+++....... .......++..|+|||.+.+..++.++||||||++++||++ |+.||.......... .
T Consensus 163 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~--------~ 234 (288)
T cd05093 163 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE--------C 234 (288)
T ss_pred cCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH--------H
Confidence 9999986643322 11222345778999999999999999999999999999999 888886544322111 1
Q ss_pred hhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 047292 656 YVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEV 712 (728)
Q Consensus 656 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 712 (728)
...+..... .......+.+++.+||+.+|.+|||++++++.|+.+...
T Consensus 235 i~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 235 ITQGRVLQR---------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHcCCcCCC---------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 111111111 111234578899999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=312.66 Aligned_cols=256 Identities=25% Similarity=0.380 Sum_probs=204.4
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCC--CCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEe
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTA--SGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 511 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~--~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 511 (728)
.+.+.+.||+|+||.||+|.++.. +...|+||.++... ......|.+|+.++++++|+||+++++++......+++|
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 84 (266)
T cd05033 5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIIT 84 (266)
T ss_pred HceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEE
Confidence 345668899999999999988643 24589999986543 334567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC
Q 047292 512 EFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 512 e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 590 (728)
||+++++|.+++... ..+++..+++++.|++.||+|||+. +|+|+||||+||++++++.+||+|||+++.......
T Consensus 85 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd05033 85 EYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA 161 (266)
T ss_pred EcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence 999999999999764 4688999999999999999999997 999999999999999999999999999987752221
Q ss_pred c-ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccch
Q 047292 591 R-THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSD 668 (728)
Q Consensus 591 ~-~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 668 (728)
. ......++..|+|||.+.+..++.++||||||+++|||++ |..||...........+ ..+....
T Consensus 162 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~--------~~~~~~~----- 228 (266)
T cd05033 162 TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV--------EDGYRLP----- 228 (266)
T ss_pred ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHH--------HcCCCCC-----
Confidence 1 1112335678999999999999999999999999999998 88888644322211111 1110000
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 047292 669 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710 (728)
Q Consensus 669 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 710 (728)
........+.+++.+||+.+|++||++++|++.|++++
T Consensus 229 ----~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~ 266 (266)
T cd05033 229 ----PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266 (266)
T ss_pred ----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 01122346778999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=322.17 Aligned_cols=241 Identities=28% Similarity=0.324 Sum_probs=192.8
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhcc-ccccceeeEeeeeecCCcceeEeeccC
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGR-THHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
+.||+|+||.||+|..+ .+++.||+|.++... ......+..|..++.. .+||||+++++++......++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~ 79 (316)
T cd05592 1 KVLGKGSFGKVMLAELK-GTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 36899999999999876 567899999986532 2233455667777765 489999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccccc
Q 047292 516 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM 595 (728)
Q Consensus 516 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 595 (728)
+|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 80 gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~ 155 (316)
T cd05592 80 GGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAST 155 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccc
Confidence 999999998888899999999999999999999997 99999999999999999999999999997643322 22234
Q ss_pred ccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcH
Q 047292 596 IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADR 675 (728)
Q Consensus 596 ~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 675 (728)
..||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+ .... . ..+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i--------~~~~-~---------~~~~ 217 (316)
T cd05592 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI--------LNDR-P---------HFPR 217 (316)
T ss_pred ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHH--------HcCC-C---------CCCC
Confidence 56899999999999999999999999999999999999999765443221111 0100 0 0111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 047292 676 SRLHKWLMIAMWCIQEDPSKRPTMK-VVM 703 (728)
Q Consensus 676 ~~~~~l~~l~~~cl~~dp~~RPt~~-evl 703 (728)
.....+.+++.+||+.+|.+||++. +++
T Consensus 218 ~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 218 WISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1233566799999999999999875 453
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=293.48 Aligned_cols=262 Identities=23% Similarity=0.281 Sum_probs=209.9
Q ss_pred HHHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeec-----CCcc
Q 047292 433 DATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDE-----ALNR 507 (728)
Q Consensus 433 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-----~~~~ 507 (728)
+.+|.+.++||+|||+-||.++.- .+++.+|+|++.....++.+..++|++..++++||||+++++++.. ..+.
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~-s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGL-STGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred CceEEEeeeecCCCceeeeeeccc-CcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 345667789999999999998743 5678999999987777778899999999999999999999988743 3458
Q ss_pred eeEeeccCCCCHHHHHhcC----CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcc
Q 047292 508 LLVYEFMGNGTLANLIFAI----PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSK 583 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~ 583 (728)
||+++|...|+|.+.+... ..+++.++++|+.+|.+||++||+. ...++||||||.|||+.+.+.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 9999999999999998764 3688999999999999999999996 2359999999999999999999999999988
Q ss_pred ccccCCCc--------ccccccCCccccCccccc---CCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHH
Q 047292 584 LLLSDHSR--------THTMIRGTRGYVAPEWLK---NAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWA 652 (728)
Q Consensus 584 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~---~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~ 652 (728)
...-.-.. ......-|..|+|||.+. +...++++|||||||+||+|+.|..||+.......-.
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl------ 251 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL------ 251 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE------
Confidence 66322111 111234688999999985 4567899999999999999999999998654422110
Q ss_pred HHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 047292 653 YDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710 (728)
Q Consensus 653 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 710 (728)
...+.........+....+.+.+++.+|++.||.+||++.+++..++.++
T Consensus 252 --------aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 252 --------ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred --------EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 01112222222222336778899999999999999999999999998764
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=324.19 Aligned_cols=259 Identities=28% Similarity=0.388 Sum_probs=201.9
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeC----CCCcEEEEEEecccc-hhhHHHHHHHHHHhccc-cccceeeEeeeeec-CCc
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKT----ASGNAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKNLVQLLGFCDE-ALN 506 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-~~~ 506 (728)
..+.+.+.||+|+||.||+|.... .+++.||+|+++... ....+.+..|+.++.++ +|+||++++++|.. ...
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 456678899999999999996532 235789999987533 23346788899999999 89999999998864 456
Q ss_pred ceeEeeccCCCCHHHHHhcC------------------------------------------------------------
Q 047292 507 RLLVYEFMGNGTLANLIFAI------------------------------------------------------------ 526 (728)
Q Consensus 507 ~~lv~e~~~~gsL~~~l~~~------------------------------------------------------------ 526 (728)
.++++||+++++|.+++...
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 78999999999999998642
Q ss_pred -CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc-ccccccCCccccC
Q 047292 527 -PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR-THTMIRGTRGYVA 604 (728)
Q Consensus 527 -~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~a 604 (728)
..+++..+.+++.||+.||+|||+. +|+||||||+||++++++++||+|||+++.+...... ......++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 2567888999999999999999997 9999999999999999999999999999876433221 1223446778999
Q ss_pred cccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHH
Q 047292 605 PEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLM 683 (728)
Q Consensus 605 PE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~ 683 (728)
||++.+..++.++|||||||++|||++ |..||......+. +. .....+.... .+......+.+
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~---~~----~~~~~~~~~~---------~~~~~~~~~~~ 307 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE---FC----RRLKEGTRMR---------APEYATPEIYS 307 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH---HH----HHHhccCCCC---------CCccCCHHHHH
Confidence 999999999999999999999999998 9999864322111 00 0111111100 11122356788
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 684 IAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 684 l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
++.+||+.+|++||++.+|+++|+.++.
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=323.20 Aligned_cols=259 Identities=24% Similarity=0.344 Sum_probs=202.9
Q ss_pred HHHHhhHHhhhCCCceeEEEEeeeeCCCC---cEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCcc
Q 047292 432 KDATDGFKEELGRGSFGIVYKGVLKTASG---NAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNR 507 (728)
Q Consensus 432 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 507 (728)
....+...+.||+|+||.||+|.+..... ..||+|+++... ....+++.+|+.+++.++|+||++++|+|... ..
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~ 83 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 83 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence 34445566889999999999998753221 248999986543 34457899999999999999999999999764 57
Q ss_pred eeEeeccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccc
Q 047292 508 LLVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLL 586 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 586 (728)
++++||+++|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 84 ~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 84 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccccc
Confidence 8999999999999999875 4678889999999999999999997 99999999999999999999999999998765
Q ss_pred cCCCcc-cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCcccee
Q 047292 587 SDHSRT-HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDAL 664 (728)
Q Consensus 587 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (728)
...... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||...........+ ..+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~--------~~~~~~-- 230 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL--------EKGERL-- 230 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH--------hCCCCC--
Confidence 433221 122234678999999999999999999999999999998 89998754333211111 011000
Q ss_pred ccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 665 IDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 665 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
. ........+.+++.+||+.+|.+||++.+++..|..+..
T Consensus 231 ~-------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 231 P-------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred C-------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 0 011123456789999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=327.71 Aligned_cols=240 Identities=26% Similarity=0.317 Sum_probs=203.0
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccc-cccceeeEeeeeecCCcceeEe
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVY 511 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~ 511 (728)
..+.++||+|.||+|+++..+ .+++.+|||++++.. .++.+..+.|.+++... +||.|++++..++.+.++|+||
T Consensus 370 F~~l~vLGkGsFGkV~lae~k-~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvm 448 (694)
T KOG0694|consen 370 FRLLAVLGRGSFGKVLLAELK-GTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVM 448 (694)
T ss_pred eEEEEEeccCcCceEEEEEEc-CCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEE
Confidence 345688999999999999998 467799999997643 34557788899998887 5999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 512 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 512 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
||+.||+ .-++.....+++..+.-++..|+.||.|||++ +|||||||.+|||||.+|++||+|||+++..-.. ..
T Consensus 449 ey~~Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~-g~ 523 (694)
T KOG0694|consen 449 EYVAGGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ-GD 523 (694)
T ss_pred EecCCCc-EEEEEecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCCC-CC
Confidence 9999999 34444557899999999999999999999998 9999999999999999999999999999864322 22
Q ss_pred ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhh
Q 047292 592 THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAA 671 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 671 (728)
...+.+|||.|||||++.+..|+...|.|||||+|||||.|..||..+.+++....+.. | ..
T Consensus 524 ~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~---------------d---~~ 585 (694)
T KOG0694|consen 524 RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN---------------D---EV 585 (694)
T ss_pred ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc---------------C---CC
Confidence 45568899999999999999999999999999999999999999998887776554421 0 11
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCH
Q 047292 672 MADRSRLHKWLMIAMWCIQEDPSKRPTM 699 (728)
Q Consensus 672 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~ 699 (728)
.++.....+.+.++.++|..+|++|.-+
T Consensus 586 ~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 586 RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 2344455677889999999999999766
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=296.63 Aligned_cols=261 Identities=22% Similarity=0.239 Sum_probs=201.0
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhh--HHHHHHHHHHhccccccceeeEeeeeec--CCcceeEeec
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQER--EREFKSEVSAIGRTHHKNLVQLLGFCDE--ALNRLLVYEF 513 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lv~e~ 513 (728)
..+.|++|+||.||+|+++ .+++.||+|+++...+.. .-.-.+|+.+|.+++|||||.+-.+... -+..||||||
T Consensus 80 ~lnrI~EGtyGiVYRakdk-~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~ 158 (419)
T KOG0663|consen 80 KLNRIEEGTYGVVYRAKDK-KTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEY 158 (419)
T ss_pred HHhhcccCcceeEEEeccC-CcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHH
Confidence 3467999999999999987 678999999997644322 2346789999999999999999888754 4568999999
Q ss_pred cCCCCHHHHHhcCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 514 MGNGTLANLIFAIP-KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 514 ~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
++. +|..++...+ ++......-+..|+++|++|||++ .|+|||||++|+|+++.|.+||+|||+|+.+.... ..
T Consensus 159 ~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~-k~ 233 (419)
T KOG0663|consen 159 VEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL-KP 233 (419)
T ss_pred HHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCCc-cc
Confidence 976 8999998875 788899999999999999999997 99999999999999999999999999999886653 34
Q ss_pred cccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceec------
Q 047292 593 HTMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALI------ 665 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 665 (728)
.+...-|.-|+|||.+.+. .|+.+.|+||+|||+.||+++++.|....+.+....+-.. .....+.....+.
T Consensus 234 ~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~l-lGtPte~iwpg~~~lp~~k 312 (419)
T KOG0663|consen 234 YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKL-LGTPSEAIWPGYSELPAVK 312 (419)
T ss_pred CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHH-hCCCccccCCCccccchhh
Confidence 4556679999999999776 7899999999999999999999998876654433222111 0111111111110
Q ss_pred --------cchhhhhhcHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 666 --------DSDEAAMADRS-RLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 666 --------d~~~~~~~~~~-~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
-..+...+... ..+.-.+++...|..||.+|.|++|.++.
T Consensus 313 ~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 313 KMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred ccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 01111111111 22456678888999999999999998864
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=317.01 Aligned_cols=262 Identities=22% Similarity=0.287 Sum_probs=193.9
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch--hhHHHHHHHHHHhccc---cccceeeEeeeee-----cCC
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ--EREREFKSEVSAIGRT---HHKNLVQLLGFCD-----EAL 505 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~g~~~-----~~~ 505 (728)
|.+.++||+|+||.||++.....+++.||+|+++.... .....+.+|+.+++.+ +||||+++++++. ...
T Consensus 3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~ 82 (290)
T cd07862 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 82 (290)
T ss_pred cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence 45667899999999999987545678899998864322 2234556677776655 6999999999985 345
Q ss_pred cceeEeeccCCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcc
Q 047292 506 NRLLVYEFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSK 583 (728)
Q Consensus 506 ~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~ 583 (728)
..++|+||++ ++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++
T Consensus 83 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 83 KLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred cEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 6799999996 5899998764 4578899999999999999999997 99999999999999999999999999998
Q ss_pred ccccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccc-
Q 047292 584 LLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLD- 662 (728)
Q Consensus 584 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 662 (728)
..... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+....+...... .......
T Consensus 159 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~-~~~~~~~~ 235 (290)
T cd07862 159 IYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL-PGEEDWPR 235 (290)
T ss_pred eccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCC-CChhhchh
Confidence 65433 2223455899999999999889999999999999999999999999865543322222111100 0000000
Q ss_pred ------eeccchh---hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 663 ------ALIDSDE---AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 663 ------~~~d~~~---~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
..+.... .....+...+.+.+++.+||+.||++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000000 00011122345678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=326.01 Aligned_cols=244 Identities=25% Similarity=0.293 Sum_probs=197.7
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCC
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGN 516 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 516 (728)
+.||+|+||.||++..+ .+++.||+|+++... ......+..|+++++.++|+||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEK-ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36899999999999875 578899999996532 22345678899999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccccc
Q 047292 517 GTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMI 596 (728)
Q Consensus 517 gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 596 (728)
|+|..++.....+++..+..++.||+.||+|||+. .+|+||||||+|||+++++.+||+|||+++....... .....
T Consensus 80 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~ 156 (325)
T cd05594 80 GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKTF 156 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-ccccc
Confidence 99999998888899999999999999999999972 2899999999999999999999999999875432221 22234
Q ss_pred cCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHH
Q 047292 597 RGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRS 676 (728)
Q Consensus 597 ~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 676 (728)
.||+.|+|||++.+..++.++||||||+++|||++|+.||...........+ ..... ..+..
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i--------~~~~~----------~~p~~ 218 (325)
T cd05594 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI--------LMEEI----------RFPRT 218 (325)
T ss_pred cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH--------hcCCC----------CCCCC
Confidence 6899999999999999999999999999999999999999755433221111 00100 00111
Q ss_pred HHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 047292 677 RLHKWLMIAMWCIQEDPSKRP-----TMKVVMQM 705 (728)
Q Consensus 677 ~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~ 705 (728)
....+.+++.+||+.||++|+ ++.++++.
T Consensus 219 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 219 LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 234567899999999999996 89998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=338.74 Aligned_cols=249 Identities=20% Similarity=0.226 Sum_probs=201.9
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccC
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
+.+.+.||+|+||.||++......++.|++|++..........+..|+.+++.++||||+++++++...+..+|||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 55668899999999999987644477899998765555556678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhc----CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC-
Q 047292 516 NGTLANLIFA----IPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS- 590 (728)
Q Consensus 516 ~gsL~~~l~~----~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~- 590 (728)
+|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 9999988754 34578889999999999999999997 999999999999999999999999999987643322
Q ss_pred cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhh
Q 047292 591 RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEA 670 (728)
Q Consensus 591 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 670 (728)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||........... ...+.....
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~--------~~~~~~~~~------ 291 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQ--------VLYGKYDPF------ 291 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--------HHhCCCCCC------
Confidence 123345689999999999999999999999999999999999999975443221111 111111110
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 671 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 671 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
+......+.+++.+||+.+|++||+++++++
T Consensus 292 ---~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 292 ---PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ---CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1112345778999999999999999999864
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=308.01 Aligned_cols=247 Identities=26% Similarity=0.390 Sum_probs=197.6
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCCCC
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGT 518 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 518 (728)
++||+|+||.||+|..+ .+++.||+|.+.... .+....+.+|++++++++|+||+++++++......++|+||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLR-ADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEe-cCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 46999999999999886 467899999876432 3445779999999999999999999999999999999999999999
Q ss_pred HHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc-cccc
Q 047292 519 LANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT-HTMI 596 (728)
Q Consensus 519 L~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~~~~ 596 (728)
|.+++... ..+++..++.++.|++.||+|||++ +++|+||||+||+++.++.+||+|||++.......... ....
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 99999764 4688999999999999999999987 99999999999999999999999999987653221111 1112
Q ss_pred cCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcH
Q 047292 597 RGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADR 675 (728)
Q Consensus 597 ~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 675 (728)
..+..|+|||.+.+..++.++||||||+++|||++ |..|+...........+ ...... ....
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~--------~~~~~~---------~~~~ 219 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI--------EQGVRL---------PCPE 219 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHH--------HcCCCC---------CCcc
Confidence 23457999999999999999999999999999998 88888654332211111 000000 0111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047292 676 SRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLE 707 (728)
Q Consensus 676 ~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~ 707 (728)
.....+.+++.+||+.+|++||++.+|+++|+
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 22346778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=310.34 Aligned_cols=248 Identities=27% Similarity=0.375 Sum_probs=199.1
Q ss_pred hhCCCceeEEEEeeee-CCCCcEEEEEEecccc--hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCCC
Q 047292 441 ELGRGSFGIVYKGVLK-TASGNAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNG 517 (728)
Q Consensus 441 ~lg~G~fg~Vy~g~~~-~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 517 (728)
+||+|+||.||+|.++ ..++..+|+|+++... ....+++.+|+.+++.++|+||+++++++.. ...++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 6899999999999764 2356789999986432 2345789999999999999999999999864 5678999999999
Q ss_pred CHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc--ccc
Q 047292 518 TLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT--HTM 595 (728)
Q Consensus 518 sL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~--~~~ 595 (728)
+|.+++.....+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++......... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 9999998877889999999999999999999997 99999999999999999999999999998764433211 122
Q ss_pred ccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhc
Q 047292 596 IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMAD 674 (728)
Q Consensus 596 ~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 674 (728)
..++..|+|||.+....++.++||||||+++|||++ |+.||......+....+ ..+.... .+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i--------~~~~~~~---------~~ 220 (257)
T cd05116 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMI--------ESGERME---------CP 220 (257)
T ss_pred CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH--------HCCCCCC---------CC
Confidence 234578999999988889999999999999999998 89999755433221111 1111111 11
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 047292 675 RSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGL 709 (728)
Q Consensus 675 ~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 709 (728)
......+.+++.+||+.||++||++.+|.+.|++.
T Consensus 221 ~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 221 QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 12335677899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=322.92 Aligned_cols=243 Identities=24% Similarity=0.293 Sum_probs=197.1
Q ss_pred hhhCCCceeEEEEeeee--CCCCcEEEEEEecccc----hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 440 EELGRGSFGIVYKGVLK--TASGNAIAVKKLDRLA----QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~--~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
+.||+|+||.||++... ...++.||+|.++... ......+.+|+.+++.++||||+++++.+...+..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999998763 2467899999986532 12335678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccc
Q 047292 514 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH 593 (728)
Q Consensus 514 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 593 (728)
+++++|.+++.....+.+..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++....... ..
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 157 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VT 157 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-cc
Confidence 99999999998888888899999999999999999997 999999999999999999999999999875432222 22
Q ss_pred ccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhh
Q 047292 594 TMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMA 673 (728)
Q Consensus 594 ~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 673 (728)
....|++.|+|||++.+..++.++||||||+++|||++|+.||........... ...+.. . .
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~--------~~~~~~-~---------~ 219 (323)
T cd05584 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDK--------ILKGKL-N---------L 219 (323)
T ss_pred cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHH--------HHcCCC-C---------C
Confidence 335689999999999999999999999999999999999999976543221111 111111 0 0
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047292 674 DRSRLHKWLMIAMWCIQEDPSKRP-----TMKVVMQ 704 (728)
Q Consensus 674 ~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~ 704 (728)
+......+.+++.+||+.+|++|| +++++++
T Consensus 220 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 220 PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 111234567899999999999999 7888766
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=317.59 Aligned_cols=263 Identities=20% Similarity=0.240 Sum_probs=197.6
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch-hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
+.+.++||+|+||.||+|..+ .+++.||+|+++.... .....+.+|+.++++++|+||+++++++......++||||+
T Consensus 7 y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (288)
T cd07871 7 YVKLDKLGEGTYATVFKGRSK-LTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL 85 (288)
T ss_pred ceEeeEEecCCCEEEEEEEEC-CCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCC
Confidence 445678999999999999876 5678999999864322 23456789999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccc
Q 047292 515 GNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH 593 (728)
Q Consensus 515 ~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 593 (728)
++ +|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++....... ..
T Consensus 86 ~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-~~ 160 (288)
T cd07871 86 DS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-TY 160 (288)
T ss_pred Cc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-cc
Confidence 85 899988765 3578889999999999999999997 999999999999999999999999999976532221 22
Q ss_pred ccccCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHH----Hhhh----cCcccee
Q 047292 594 TMIRGTRGYVAPEWLKN-APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAY----DCYV----EGRLDAL 664 (728)
Q Consensus 594 ~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~----~~~~----~~~~~~~ 664 (728)
....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+..... ..+. .......
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd07871 161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY 240 (288)
T ss_pred cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcc
Confidence 33457899999999865 5689999999999999999999999976544332221111000 0000 0000000
Q ss_pred ccchh----hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 665 IDSDE----AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 665 ~d~~~----~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
..+.. ...........+.+++.+||+.||.+|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 241 LFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000 00001112345778999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=310.49 Aligned_cols=249 Identities=28% Similarity=0.410 Sum_probs=199.7
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccC
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
+.+.+.||+|+||.||+|..+ ++..+|+|.+.... .....+.+|+.++++++||||+++++++......+++|||++
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~--~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 6 LTFLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred eEEeeEecCcccceEEEEEec--CCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 456678999999999999765 34579999886532 234678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccc
Q 047292 516 NGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHT 594 (728)
Q Consensus 516 ~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 594 (728)
+++|.+++... ..+++..+++++.||+.||+|||+. +++|+||||+||++++++.+||+|||+++...........
T Consensus 83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05113 83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV 159 (256)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeecC
Confidence 99999999764 4688999999999999999999997 9999999999999999999999999998866443222222
Q ss_pred cccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhh
Q 047292 595 MIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMA 673 (728)
Q Consensus 595 ~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 673 (728)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||...........+ ..+.... .
T Consensus 160 ~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~--------~~~~~~~---------~ 222 (256)
T cd05113 160 GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV--------SQGLRLY---------R 222 (256)
T ss_pred CCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH--------hcCCCCC---------C
Confidence 2335678999999998889999999999999999999 88898654332211111 1111000 0
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047292 674 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLE 707 (728)
Q Consensus 674 ~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~ 707 (728)
.......+.+++.+||+.+|.+||++.+|++.|+
T Consensus 223 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 223 PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 1112356788999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=329.99 Aligned_cols=250 Identities=22% Similarity=0.287 Sum_probs=196.0
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
+.+.||+|+||.||+|... .+++.||+|++.... ......+..|+.++++++|+||+++++++.+....++||||+
T Consensus 5 ~~~~LG~G~~g~Vy~~~~~-~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~ 83 (381)
T cd05626 5 KIKTLGIGAFGEVCLACKV-DTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYI 83 (381)
T ss_pred EEEEEeecCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecC
Confidence 4578999999999999876 578899999996532 233467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC----
Q 047292 515 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS---- 590 (728)
Q Consensus 515 ~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~---- 590 (728)
++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++++||+|||+++.......
T Consensus 84 ~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 84 PGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 9999999998888889999999999999999999997 999999999999999999999999999864321000
Q ss_pred ------------------------------------------cccccccCCccccCcccccCCCCCCccchhhHHHHHHH
Q 047292 591 ------------------------------------------RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLE 628 (728)
Q Consensus 591 ------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~e 628 (728)
.......||+.|+|||++.+..++.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~e 240 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHH
Confidence 00123469999999999999999999999999999999
Q ss_pred HHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHH--hcccCCCCCCCHHHHHHH
Q 047292 629 IICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMW--CIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 629 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~--cl~~dp~~RPt~~evl~~ 705 (728)
|++|+.||...........+..+ ...+ .. . ........+.+++.+ |+..+|..||+++++++.
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~------~~~~-~~-~------~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 241 MLVGQPPFLAPTPTETQLKVINW------ENTL-HI-P------PQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHhCCCCCcCCCHHHHHHHHHcc------cccc-CC-C------CCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 99999999765443322111110 0000 00 0 000112345556655 566777789999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=322.31 Aligned_cols=243 Identities=25% Similarity=0.300 Sum_probs=197.5
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccc-cccceeeEeeeeecCCcceeEeeccC
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
+.||+|+||.||+|..+ .+++.||+|+++... ......+..|.+++..+ +||||+++++++......++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~ 79 (321)
T cd05591 1 KVLGKGSFGKVMLAELK-GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVN 79 (321)
T ss_pred CccccCCCeEEEEEEEC-CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCC
Confidence 36999999999999876 567899999986532 23345677888888866 79999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccccc
Q 047292 516 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM 595 (728)
Q Consensus 516 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 595 (728)
+++|..++.....+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++....... ....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~~ 155 (321)
T cd05591 80 GGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTTT 155 (321)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc-cccc
Confidence 999999998888899999999999999999999997 999999999999999999999999999875432221 2233
Q ss_pred ccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcH
Q 047292 596 IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADR 675 (728)
Q Consensus 596 ~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 675 (728)
..|++.|+|||++.+..++.++||||||+++|||++|+.||...........+ ..+... .+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i--------~~~~~~----------~p~ 217 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESI--------LHDDVL----------YPV 217 (321)
T ss_pred cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHH--------HcCCCC----------CCC
Confidence 56899999999999999999999999999999999999999866543322111 111100 011
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-------CHHHHHHH
Q 047292 676 SRLHKWLMIAMWCIQEDPSKRP-------TMKVVMQM 705 (728)
Q Consensus 676 ~~~~~l~~l~~~cl~~dp~~RP-------t~~evl~~ 705 (728)
.....+.+++.+||+.||++|| +++++++.
T Consensus 218 ~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 218 WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 1234567899999999999999 78887744
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=322.03 Aligned_cols=237 Identities=28% Similarity=0.355 Sum_probs=193.4
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccc-cccceeeEeeeeecCCcceeEeeccC
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
+.||+|+||.||++..+ .+++.||+|++.... ......+..|..++..+ +||||+++++++......++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~ 79 (320)
T cd05590 1 RVLGKGSFGKVMLARLK-ESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVN 79 (320)
T ss_pred CeeeeCCCeEEEEEEEc-CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCC
Confidence 36899999999999876 567899999986532 23345677888888876 79999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccccc
Q 047292 516 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM 595 (728)
Q Consensus 516 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 595 (728)
+|+|.+++.....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...... .....
T Consensus 80 ~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~~ 155 (320)
T cd05590 80 GGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTST 155 (320)
T ss_pred CchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Ccccc
Confidence 999999998888899999999999999999999997 99999999999999999999999999987542221 12233
Q ss_pred ccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcH
Q 047292 596 IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADR 675 (728)
Q Consensus 596 ~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 675 (728)
..||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+ ..+... .+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i--------~~~~~~----------~~~ 217 (320)
T cd05590 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI--------LNDEVV----------YPT 217 (320)
T ss_pred cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH--------hcCCCC----------CCC
Confidence 56899999999999999999999999999999999999999765443322111 111110 011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCH
Q 047292 676 SRLHKWLMIAMWCIQEDPSKRPTM 699 (728)
Q Consensus 676 ~~~~~l~~l~~~cl~~dp~~RPt~ 699 (728)
.....+.+++.+||+.||++||++
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 218 WLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCHHHHHHHHHHcccCHHHCCCC
Confidence 123456789999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=308.59 Aligned_cols=248 Identities=27% Similarity=0.415 Sum_probs=199.1
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccC
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
..+.+.||+|+||.||++..+ ++..+|+|.+.... .....+.+|++++++++|+||+++++++......++|+||++
T Consensus 6 ~~~~~~lg~G~~~~v~~~~~~--~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 6 LTFLKELGSGQFGVVHLGKWR--GKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred cchhhhhccCCCceEEEeEec--CCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 456789999999999999875 45689999986432 234568889999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccc
Q 047292 516 NGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHT 594 (728)
Q Consensus 516 ~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 594 (728)
+++|.+++... ..+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+++...........
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (256)
T cd05059 83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159 (256)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence 99999999764 4678999999999999999999997 9999999999999999999999999999866433222222
Q ss_pred cccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhh
Q 047292 595 MIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMA 673 (728)
Q Consensus 595 ~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 673 (728)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ ..+. . ...
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~--------~~~~-----~----~~~ 222 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV--------SAGY-----R----LYR 222 (256)
T ss_pred CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH--------HcCC-----c----CCC
Confidence 2224557999999999999999999999999999999 78888754333221111 1110 0 001
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047292 674 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQML 706 (728)
Q Consensus 674 ~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 706 (728)
.......+.+++.+||+.+|++||+++++++.|
T Consensus 223 ~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 112345688899999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=313.55 Aligned_cols=255 Identities=25% Similarity=0.356 Sum_probs=199.7
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCc----EEEEEEecccch-hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEe
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGN----AIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 511 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 511 (728)
.+.+.||+|+||.||+|.+.. +++ .+++|.+..... ....++..|+..+++++|+||+++++++.. ...++++
T Consensus 10 ~~~~~lg~G~~~~vy~~~~~~-~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~ 87 (279)
T cd05111 10 RKLKLLGSGVFGTVHKGIWIP-EGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVT 87 (279)
T ss_pred eeccccCccCCcceEEEEEcC-CCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEE
Confidence 345789999999999998753 333 478888754332 234678889999999999999999998864 4578899
Q ss_pred eccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC
Q 047292 512 EFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 512 e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 590 (728)
||+++|+|.+++... ..+++..+..++.||+.||+|||+. +++||||||+||++++++.+||+|||+++.......
T Consensus 88 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T cd05111 88 QLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK 164 (279)
T ss_pred EeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCCCc
Confidence 999999999999764 5689999999999999999999997 899999999999999999999999999986643322
Q ss_pred -cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccch
Q 047292 591 -RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSD 668 (728)
Q Consensus 591 -~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 668 (728)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||...........+ ..+.... .+
T Consensus 165 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~--------~~~~~~~--~~- 233 (279)
T cd05111 165 KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL--------EKGERLA--QP- 233 (279)
T ss_pred ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH--------HCCCcCC--CC-
Confidence 22233456778999999999999999999999999999998 99998755433221111 1111111 00
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCC
Q 047292 669 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVP 713 (728)
Q Consensus 669 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~ 713 (728)
......+.+++.+||..+|.+||++.|+++.|..+...+
T Consensus 234 ------~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 234 ------QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred ------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 011234567889999999999999999999998876544
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=312.90 Aligned_cols=253 Identities=26% Similarity=0.394 Sum_probs=202.6
Q ss_pred hhHHhhhCCCceeEEEEeeee----CCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEe
Q 047292 436 DGFKEELGRGSFGIVYKGVLK----TASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 511 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~----~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 511 (728)
..+.++||+|+||.||++... ..++..+++|.+..........+.+|+++++.++|+||+++++++......++++
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (280)
T cd05092 7 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVF 86 (280)
T ss_pred ceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEE
Confidence 345688999999999998643 2345689999988766666788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCC---------------CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEE
Q 047292 512 EFMGNGTLANLIFAIP---------------KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKI 576 (728)
Q Consensus 512 e~~~~gsL~~~l~~~~---------------~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl 576 (728)
||+++++|.+++.... .+++..++.++.|++.||+|||+. +++|+||||+|||+++++.+||
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~kL 163 (280)
T cd05092 87 EYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKI 163 (280)
T ss_pred ecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEEE
Confidence 9999999999997642 467889999999999999999987 9999999999999999999999
Q ss_pred ccccCccccccCCC-cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHH
Q 047292 577 SDFGLSKLLLSDHS-RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYD 654 (728)
Q Consensus 577 ~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 654 (728)
+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.....
T Consensus 164 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~------ 237 (280)
T cd05092 164 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI------ 237 (280)
T ss_pred CCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH------
Confidence 99999976543221 11222335678999999999999999999999999999998 88888654332211111
Q ss_pred hhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 047292 655 CYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEG 708 (728)
Q Consensus 655 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 708 (728)
..+.... .+......+.+++.+||+.||.+||++++|++.|++
T Consensus 238 --~~~~~~~---------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 238 --TQGRELE---------RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred --HcCccCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 1111000 011223457789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=327.00 Aligned_cols=191 Identities=24% Similarity=0.299 Sum_probs=167.9
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccC
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
+.+.++||+|+||.||++... .+++.||+|+.. ...+.+|++++++++||||+++++++......++|+|++.
T Consensus 94 y~~~~~lg~G~~g~V~~~~d~-~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~ 166 (391)
T PHA03212 94 FSILETFTPGAEGFAFACIDN-KTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK 166 (391)
T ss_pred cEEEEEEcCCCCeEEEEEEEC-CCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence 556688999999999999876 578899999753 2356789999999999999999999999999999999985
Q ss_pred CCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccccc
Q 047292 516 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM 595 (728)
Q Consensus 516 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 595 (728)
++|.+++.....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++............
T Consensus 167 -~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~ 242 (391)
T PHA03212 167 -TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG 242 (391)
T ss_pred -CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccccccccc
Confidence 68999988877889999999999999999999997 99999999999999999999999999997543322223334
Q ss_pred ccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcc
Q 047292 596 IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVE 637 (728)
Q Consensus 596 ~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~ 637 (728)
..||+.|+|||++.+..++.++||||||+++|||++|+.|+.
T Consensus 243 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~ 284 (391)
T PHA03212 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF 284 (391)
T ss_pred ccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 569999999999999999999999999999999999998764
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=315.23 Aligned_cols=253 Identities=28% Similarity=0.431 Sum_probs=199.9
Q ss_pred hhHHhhhCCCceeEEEEeeee---CCCCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEe
Q 047292 436 DGFKEELGRGSFGIVYKGVLK---TASGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 511 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~---~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 511 (728)
..+.++||+|+||.||+|... ...+..|++|.+.... ......+.+|++++++++|+||+++++++......+++|
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 86 (283)
T cd05090 7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLF 86 (283)
T ss_pred ceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEE
Confidence 456688999999999999853 2345789999997533 334467899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcC-----------------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCce
Q 047292 512 EFMGNGTLANLIFAI-----------------PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSP 574 (728)
Q Consensus 512 e~~~~gsL~~~l~~~-----------------~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~ 574 (728)
||+++++|.+++... ..+++..++.++.|++.||+|||++ +++|+||||+||++++++.+
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~~ 163 (283)
T cd05090 87 EYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHV 163 (283)
T ss_pred EcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCCcE
Confidence 999999999998532 2367788899999999999999997 99999999999999999999
Q ss_pred EEccccCccccccCCC-cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHH
Q 047292 575 KISDFGLSKLLLSDHS-RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWA 652 (728)
Q Consensus 575 kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 652 (728)
||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||...........+
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~---- 239 (283)
T cd05090 164 KISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV---- 239 (283)
T ss_pred EeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH----
Confidence 9999999986643321 12222335678999999998889999999999999999998 88888654332211111
Q ss_pred HHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 047292 653 YDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEG 708 (728)
Q Consensus 653 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 708 (728)
....... .+......+.+++.+||+.+|.+||++.+|+++|..
T Consensus 240 ----~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 240 ----RKRQLLP---------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ----HcCCcCC---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111110 111123467789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=312.85 Aligned_cols=255 Identities=25% Similarity=0.426 Sum_probs=200.4
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeC----CCCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCcce
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKT----ASGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRL 508 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 508 (728)
..+.+.++||+|+||.||+|..+. ..+..||+|++.... .....++.+|+.+++.++|+||+++++++......+
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~ 85 (277)
T cd05062 6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 85 (277)
T ss_pred HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeE
Confidence 345566889999999999987642 345689999986432 234567899999999999999999999999999999
Q ss_pred eEeeccCCCCHHHHHhcCC----------CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEcc
Q 047292 509 LVYEFMGNGTLANLIFAIP----------KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISD 578 (728)
Q Consensus 509 lv~e~~~~gsL~~~l~~~~----------~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~D 578 (728)
+||||+++++|.+++.... .+++..++.++.|+++||.|||+. +++|+||||+||++++++.+||+|
T Consensus 86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~d 162 (277)
T cd05062 86 VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEECC
Confidence 9999999999999987532 346788899999999999999997 999999999999999999999999
Q ss_pred ccCccccccCCCc-ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhh
Q 047292 579 FGLSKLLLSDHSR-THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCY 656 (728)
Q Consensus 579 fgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 656 (728)
||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..||........... .
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~--------~ 234 (277)
T cd05062 163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRF--------V 234 (277)
T ss_pred CCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--------H
Confidence 9998765432221 1122345778999999999999999999999999999999 6788865433322111 1
Q ss_pred hcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 047292 657 VEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEG 708 (728)
Q Consensus 657 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 708 (728)
........ .......+.+++.+||+.+|++||++.++++.|++
T Consensus 235 ~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 235 MEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HcCCcCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11111111 11223467789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=300.33 Aligned_cols=262 Identities=24% Similarity=0.305 Sum_probs=202.1
Q ss_pred HhhhCCCceeEEEEeeeeCCCCcEEEEEEecc--cchhhHHHHHHHHHHhccccccceeeEeeeeec-----CCcceeEe
Q 047292 439 KEELGRGSFGIVYKGVLKTASGNAIAVKKLDR--LAQEREREFKSEVSAIGRTHHKNLVQLLGFCDE-----ALNRLLVY 511 (728)
Q Consensus 439 ~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-----~~~~~lv~ 511 (728)
.+.||+|+||.|..+..+ .+|+.||||++.+ ......+...+|+++|+.++|+||+.+.+++.. -...|+|+
T Consensus 27 ~~~iG~GAyGvVcsA~~~-~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~ 105 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDK-RTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVF 105 (359)
T ss_pred cccccCcceeeEEEEEEc-CCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEeh
Confidence 467999999999999877 6779999999974 233456788999999999999999999998854 45679999
Q ss_pred eccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCC-C
Q 047292 512 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH-S 590 (728)
Q Consensus 512 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~-~ 590 (728)
|+| .-+|.+.++..+.++.....-+..||++||+|+|+. +|+||||||+|+|++.+..+||+|||+|+...... .
T Consensus 106 elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~ 181 (359)
T KOG0660|consen 106 ELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFED 181 (359)
T ss_pred hHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeeccccCcc
Confidence 999 568999999888899999999999999999999998 99999999999999999999999999999875431 2
Q ss_pred cccccccCCccccCccccc-CCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHH-------HhhhcCccc
Q 047292 591 RTHTMIRGTRGYVAPEWLK-NAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAY-------DCYVEGRLD 662 (728)
Q Consensus 591 ~~~~~~~gt~~y~aPE~~~-~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~~~ 662 (728)
...+....|.-|.|||++. ...|+...||||.||||.||++|+.-|.+...-.....+....- .........
T Consensus 182 ~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar 261 (359)
T KOG0660|consen 182 GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKAR 261 (359)
T ss_pred cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHH
Confidence 2235567899999999885 56899999999999999999999998866444333222221100 000000000
Q ss_pred eecc------chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 663 ALID------SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 663 ~~~d------~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
..+. +......-+...+..++++.+||..||.+|+|++|.++.
T Consensus 262 ~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 262 PYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000 000011112234567899999999999999999999864
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=306.25 Aligned_cols=250 Identities=28% Similarity=0.372 Sum_probs=200.8
Q ss_pred hhhCCCceeEEEEeeeeCCC--CcEEEEEEecccch-hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCC
Q 047292 440 EELGRGSFGIVYKGVLKTAS--GNAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGN 516 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~--~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 516 (728)
++||+|+||.||+|++...+ +..+|+|.+..... ...+.+.+|+.++++++|+||+++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999876443 36899999875443 34578999999999999999999999876 4567999999999
Q ss_pred CCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc--cc
Q 047292 517 GTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT--HT 594 (728)
Q Consensus 517 gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~--~~ 594 (728)
++|.+++.....+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++......... ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~ 156 (257)
T cd05060 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT 156 (257)
T ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence 99999999888899999999999999999999987 89999999999999999999999999998764333221 11
Q ss_pred cccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhh
Q 047292 595 MIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMA 673 (728)
Q Consensus 595 ~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 673 (728)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||...........+ ...... ..
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~--------~~~~~~---------~~ 219 (257)
T cd05060 157 AGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAML--------ESGERL---------PR 219 (257)
T ss_pred CccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH--------HcCCcC---------CC
Confidence 1223567999999999999999999999999999998 89998755433221111 111100 01
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 047292 674 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710 (728)
Q Consensus 674 ~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 710 (728)
.......+.+++.+||+.+|++||++.+|++.|++..
T Consensus 220 ~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 220 PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 1122346778999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=319.15 Aligned_cols=241 Identities=28% Similarity=0.315 Sum_probs=193.5
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhcc-ccccceeeEeeeeecCCcceeEeeccC
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGR-THHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
+.||+|+||.||+|... .+++.||||+++... ......+..|..++.. ++||||+++++++......++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~ 79 (316)
T cd05619 1 KMLGKGSFGKVFLAELK-GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCC
Confidence 36899999999999876 567899999997532 2234556677888876 489999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccccc
Q 047292 516 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM 595 (728)
Q Consensus 516 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 595 (728)
+|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++....... ....
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 155 (316)
T cd05619 80 GGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KTCT 155 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ceee
Confidence 999999998877889999999999999999999997 999999999999999999999999999875322211 2233
Q ss_pred ccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcH
Q 047292 596 IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADR 675 (728)
Q Consensus 596 ~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 675 (728)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ ..... . .+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i--------~~~~~--~--------~~~ 217 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI--------RMDNP--C--------YPR 217 (316)
T ss_pred ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHH--------HhCCC--C--------CCc
Confidence 56899999999999999999999999999999999999999755433221111 00000 0 011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 047292 676 SRLHKWLMIAMWCIQEDPSKRPTMK-VVM 703 (728)
Q Consensus 676 ~~~~~l~~l~~~cl~~dp~~RPt~~-evl 703 (728)
.....+.+++.+||+.+|++||++. ++.
T Consensus 218 ~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 218 WLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred cCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 1234567899999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=329.21 Aligned_cols=251 Identities=25% Similarity=0.318 Sum_probs=203.7
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
+.+.+.||+|+||.||++... .+++.||||+++... ......+.+|+.++..++|+||+++++++.+....++|||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 3 FEVIKVIGRGAFGEVWLVRDK-DTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred ceEEEEEEeCCcEEEEEEEEC-CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 345578999999999999876 468899999996532 1334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCC---
Q 047292 513 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH--- 589 (728)
Q Consensus 513 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~--- 589 (728)
|+++++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 82 YMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 999999999998888899999999999999999999997 99999999999999999999999999998764432
Q ss_pred -------------------------CcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhh
Q 047292 590 -------------------------SRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEES 644 (728)
Q Consensus 590 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~ 644 (728)
........||+.|+|||.+.+..++.++|||||||++|||++|+.||........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 238 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET 238 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHH
Confidence 1122335689999999999999999999999999999999999999986554332
Q ss_pred hhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 047292 645 RAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPT-MKVVMQM 705 (728)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt-~~evl~~ 705 (728)
...+..+. ..+ ... ........+.+++.+|++ +|.+||+ ++++++.
T Consensus 239 ~~~i~~~~------~~~-~~p-------~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 239 YNKIINWK------ESL-RFP-------PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHhccC------Ccc-cCC-------CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 22221110 000 000 000123467788899997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=314.78 Aligned_cols=268 Identities=25% Similarity=0.349 Sum_probs=200.8
Q ss_pred hHHhhhCCCceeEEEEeeee---CCCCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecC--CcceeE
Q 047292 437 GFKEELGRGSFGIVYKGVLK---TASGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEA--LNRLLV 510 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~---~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv 510 (728)
.+.+.||+|+||.||++..+ ..++..||+|.++... ......+.+|+++++.++|+||+++++++... ...+++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 45678999999999887542 2456789999987543 23456788999999999999999999988653 357899
Q ss_pred eeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC
Q 047292 511 YEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 590 (728)
|||+++++|.+++... .+++..++.++.|++.||.|||++ +|+|+||||+||++++++.+||+|||+++.......
T Consensus 87 ~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 162 (283)
T cd05080 87 MEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162 (283)
T ss_pred ecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence 9999999999999764 589999999999999999999997 999999999999999999999999999987643322
Q ss_pred c--ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccch
Q 047292 591 R--THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSD 668 (728)
Q Consensus 591 ~--~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 668 (728)
. ......++..|+|||.+.+..++.++||||||++++||++|+.|+.......... + ...........+.+.++..
T Consensus 163 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05080 163 YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEM-I-GPKQGQMTVVRLIELLERG 240 (283)
T ss_pred hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhh-h-cccccccchhhhhhhhhcC
Confidence 1 1122335667999999998899999999999999999999999976432211000 0 0000000000011111111
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 047292 669 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710 (728)
Q Consensus 669 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 710 (728)
.....+......+.+++.+||+.+|++||++++|+++|+.+.
T Consensus 241 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 111112223457888999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=311.78 Aligned_cols=255 Identities=25% Similarity=0.339 Sum_probs=201.9
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeC----CCCcEEEEEEecccch-hhHHHHHHHHHHhccccccceeeEeeeeecCCcce
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKT----ASGNAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRL 508 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~----~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 508 (728)
..+.+.++||+|+||.||+|.... ..+..||+|+++.... .....+.+|+.++..++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 446678899999999999998642 2357899999975433 23467889999999999999999999999999999
Q ss_pred eEeeccCCCCHHHHHhcC----------------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCC
Q 047292 509 LVYEFMGNGTLANLIFAI----------------PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYF 572 (728)
Q Consensus 509 lv~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~ 572 (728)
+++||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCC
Confidence 999999999999998532 2367788899999999999999987 999999999999999999
Q ss_pred ceEEccccCccccccCCC-cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHH
Q 047292 573 SPKISDFGLSKLLLSDHS-RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTD 650 (728)
Q Consensus 573 ~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~ 650 (728)
.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..|+......+....
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~--- 238 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM--- 238 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---
Confidence 999999999886543322 11222345778999999988889999999999999999998 7778765433322111
Q ss_pred HHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 047292 651 WAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEG 708 (728)
Q Consensus 651 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 708 (728)
...+.... ........+.+++..||+.+|.+||++++|++.|+.
T Consensus 239 -----i~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 239 -----IRNRQVLP---------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -----HHcCCcCC---------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11111111 111233457789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=322.63 Aligned_cols=246 Identities=25% Similarity=0.381 Sum_probs=191.7
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccC
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
.+.++||+|+||.||++... .+++.||||++.... ......+.+|+++++.++|+||+++++++......++||||++
T Consensus 77 ~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 77 ERVNRIGSGAGGTVYKVIHR-PTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred hhhhhccCCCCeEEEEEEEC-CCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 34578999999999999876 567899999986533 2335678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccccc
Q 047292 516 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM 595 (728)
Q Consensus 516 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 595 (728)
+++|.+. ....+..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++....... ....
T Consensus 156 ~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~ 227 (353)
T PLN00034 156 GGSLEGT----HIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-PCNS 227 (353)
T ss_pred CCccccc----ccCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc-cccc
Confidence 9998653 2345677889999999999999997 999999999999999999999999999987643322 1223
Q ss_pred ccCCccccCcccccC-----CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhh
Q 047292 596 IRGTRGYVAPEWLKN-----APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEA 670 (728)
Q Consensus 596 ~~gt~~y~aPE~~~~-----~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 670 (728)
..|+..|+|||.+.. ...+.++|||||||++|||++|+.||................ ....
T Consensus 228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~-----~~~~--------- 293 (353)
T PLN00034 228 SVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC-----MSQP--------- 293 (353)
T ss_pred cccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh-----ccCC---------
Confidence 468999999998843 234568999999999999999999997432221111110000 0000
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 671 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 671 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
..........+.+++.+||+.||++||+++|+++.
T Consensus 294 ~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 294 PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111233467889999999999999999999975
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=325.61 Aligned_cols=262 Identities=24% Similarity=0.309 Sum_probs=199.9
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHhccccccceeeEeeeeecCC-----cceeE
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEAL-----NRLLV 510 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~lv 510 (728)
+.++||+|+||.||++... .+++.||||++.... ....+.+.+|+++++.++|+||+++++++.... ..++|
T Consensus 4 ~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 82 (372)
T cd07853 4 PDRPIGYGAFGVVWSVTDP-RDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVV 82 (372)
T ss_pred ccceeeeCCCEEEEEEEEC-CCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEE
Confidence 4578999999999999875 568899999986532 233467889999999999999999999998776 78999
Q ss_pred eeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC
Q 047292 511 YEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 590 (728)
+||+. ++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 83 ~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~ 158 (372)
T cd07853 83 TELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158 (372)
T ss_pred eeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence 99996 58888888778899999999999999999999997 999999999999999999999999999987644333
Q ss_pred cccccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHH---------------HHH
Q 047292 591 RTHTMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDW---------------AYD 654 (728)
Q Consensus 591 ~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~---------------~~~ 654 (728)
.......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...........+... ...
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 238 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA 238 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHH
Confidence 333344578999999999875 5789999999999999999999999765433222111110 000
Q ss_pred hhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 655 CYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 655 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
........ ...............+.+.+++.+||+.||++|||++|+++.
T Consensus 239 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 239 HILRGPHK-PPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHhCCCC-CCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000000 000000000111224567889999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=325.51 Aligned_cols=262 Identities=24% Similarity=0.329 Sum_probs=203.2
Q ss_pred HHHHHHhhHHhhhCCCceeEEEEeeeeC----CCCcEEEEEEecccch-hhHHHHHHHHHHhcccc-ccceeeEeeeeec
Q 047292 430 ELKDATDGFKEELGRGSFGIVYKGVLKT----ASGNAIAVKKLDRLAQ-EREREFKSEVSAIGRTH-HKNLVQLLGFCDE 503 (728)
Q Consensus 430 el~~~~~~~~~~lg~G~fg~Vy~g~~~~----~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~ 503 (728)
++......+.++||+|+||.||+|.+.. ..+..||+|+++.... ...+.+..|++++.++. |+||+++++++..
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 3444455567899999999999998642 2446899999975432 23457889999999997 9999999999999
Q ss_pred CCcceeEeeccCCCCHHHHHhcC---------------------------------------------------------
Q 047292 504 ALNRLLVYEFMGNGTLANLIFAI--------------------------------------------------------- 526 (728)
Q Consensus 504 ~~~~~lv~e~~~~gsL~~~l~~~--------------------------------------------------------- 526 (728)
....++|+||+++|+|.++++..
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 99999999999999999998643
Q ss_pred -----------------------------------------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCC
Q 047292 527 -----------------------------------------PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQN 565 (728)
Q Consensus 527 -----------------------------------------~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~N 565 (728)
+.+++..+..++.||+.||+|||+. +++||||||+|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~N 269 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARN 269 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcce
Confidence 1245667888999999999999986 99999999999
Q ss_pred EEEcCCCceEEccccCccccccCCC-cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHh
Q 047292 566 ILLDHYFSPKISDFGLSKLLLSDHS-RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEE 643 (728)
Q Consensus 566 Ill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~ 643 (728)
||+++++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 9999999999999999986533221 11222346788999999998889999999999999999998 888886433222
Q ss_pred hhhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 047292 644 SRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710 (728)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 710 (728)
... .....+... ..+......+.+++.+||+.+|.+||++++|++.|+.++
T Consensus 350 ~~~-------~~~~~~~~~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 QFY-------NAIKRGYRM---------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHH-------HHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 110 001111000 001112346778999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=326.12 Aligned_cols=250 Identities=23% Similarity=0.273 Sum_probs=200.4
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch---hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
+.+.+.||+|+||.||++..+ .+++.||+|+++.... +....+.+|+.+++.++|+||+++++++......++|||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 3 FDVKSLVGRGHFGEVQVVREK-ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred ceEEEEEEeccCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 345678999999999999876 5688999999975322 344678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 513 FMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 513 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
|+++|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.........
T Consensus 82 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 99999999999876 6789999999999999999999997 9999999999999999999999999999876544333
Q ss_pred ccccccCCccccCccccc------CCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceec
Q 047292 592 THTMIRGTRGYVAPEWLK------NAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALI 665 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~------~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (728)
......||+.|+|||++. ...++.++||||||+++|||++|+.||...........+.. ........
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~-------~~~~~~~~ 231 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMN-------FQRFLKFP 231 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHc-------CCCccCCC
Confidence 333456899999999986 45678999999999999999999999976543322211110 00000110
Q ss_pred cchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 666 DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 666 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
+ .......+.+++.+|++ +|.+||+++++++
T Consensus 232 ~-------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 232 E-------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred C-------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 0 11123456778888998 9999999999885
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=317.04 Aligned_cols=249 Identities=23% Similarity=0.326 Sum_probs=210.6
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeeecCCc-ceeEe
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALN-RLLVY 511 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-~~lv~ 511 (728)
.|.+.+++|+|+||.++..+.+ .+...+++|++... .....+...+|+.++++++|||||.+.+.+.+++. .+|||
T Consensus 5 ~Ye~~~~iG~GafG~a~lvrhk-~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 5 NYEVLRQVGRGAFGSALLVRHK-SDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred hhhhhhhcCccccchhhhhhhc-cCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 4567789999999999998877 45678999988543 23334578999999999999999999999999998 99999
Q ss_pred eccCCCCHHHHHhcCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCC
Q 047292 512 EFMGNGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH 589 (728)
Q Consensus 512 e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 589 (728)
+|++||+|.+.+...+ .++++.+.+++.|++.|+.|||++ .|+|||||+.||+++.++.+||+|||+|+.+..+.
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 9999999999998764 678899999999999999999987 99999999999999999999999999999987665
Q ss_pred CcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchh
Q 047292 590 SRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDE 669 (728)
Q Consensus 590 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 669 (728)
. ....+.||+.||.||++.+.+|..|+|||||||++|||++-+++|...........+.. ...
T Consensus 161 ~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~------------~~~---- 223 (426)
T KOG0589|consen 161 S-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINR------------GLY---- 223 (426)
T ss_pred h-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhh------------ccC----
Confidence 3 33456799999999999999999999999999999999999999987655443222211 111
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 670 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 670 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
...+..+..++..++..|++.+|..||++.+++.+
T Consensus 224 -~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 224 -SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 12344556778889999999999999999999876
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=319.46 Aligned_cols=242 Identities=29% Similarity=0.329 Sum_probs=196.8
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccc-cccceeeEeeeeecCCcceeEeeccC
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
+.||+|+||.||++..+ .+++.||+|+++... ......+..|.+++..+ +||||+++++++......++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 79 (318)
T cd05570 1 KVLGKGSFGKVLLAELK-GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVN 79 (318)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 36899999999999876 567899999997532 22345677888888877 79999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccccc
Q 047292 516 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM 595 (728)
Q Consensus 516 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 595 (728)
+++|..++.....+++..+..++.||+.||.|||+. +|+||||||+||++++++.+||+|||+++....... ....
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 155 (318)
T cd05570 80 GGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTST 155 (318)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cccc
Confidence 999999998888899999999999999999999997 999999999999999999999999999875322221 1223
Q ss_pred ccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcH
Q 047292 596 IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADR 675 (728)
Q Consensus 596 ~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 675 (728)
..|++.|+|||++.+..++.++|||||||++|||++|+.||...........+ ..... ..+.
T Consensus 156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i--------~~~~~----------~~~~ 217 (318)
T cd05570 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI--------LEDEV----------RYPR 217 (318)
T ss_pred eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHH--------HcCCC----------CCCC
Confidence 45899999999999999999999999999999999999999755433221111 11110 0111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 047292 676 SRLHKWLMIAMWCIQEDPSKRPTM-----KVVMQ 704 (728)
Q Consensus 676 ~~~~~l~~l~~~cl~~dp~~RPt~-----~evl~ 704 (728)
.....+.+++.+||+.||.+||++ .++++
T Consensus 218 ~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 218 WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 223467789999999999999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=308.14 Aligned_cols=253 Identities=24% Similarity=0.366 Sum_probs=201.3
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
..+.+.++||+|+||.||+|..+ +...||+|+++.... ....+.+|+++++.++|+||+++++++.+ ...++||||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~ 81 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 81 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEec--CCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEc
Confidence 34667789999999999999875 335699999975322 34578999999999999999999998754 557999999
Q ss_pred cCCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 514 MGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 514 ~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
+++++|.+++... ..+++..+..++.|+++||+|||+. +++|+||||+||++++++.+||+|||.++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 9999999999764 3578899999999999999999997 9999999999999999999999999999866443322
Q ss_pred ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhh
Q 047292 592 THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEA 670 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 670 (728)
......++..|+|||.+.+..++.++||||||+++|||+| |+.||........... ...+..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~--------~~~~~~--------- 221 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ--------VERGYR--------- 221 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHH--------HhcCCC---------
Confidence 2223346778999999998899999999999999999999 7778865433221111 011100
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 047292 671 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710 (728)
Q Consensus 671 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 710 (728)
..........+.+++.+|++.+|++||++.+++++|++.+
T Consensus 222 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 222 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 0011233456788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=322.51 Aligned_cols=264 Identities=21% Similarity=0.316 Sum_probs=196.2
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHhccccccceeeEeeeeecC-----Cccee
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEA-----LNRLL 509 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~l 509 (728)
.+.+.||+|+||.||+|+.+ .+++.||||++.... ......+.+|+++++.++||||+++++++... ...++
T Consensus 3 ~i~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 3 KIQEVIGKGSYGVVCSAIDT-HTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred EEEEEEeecCCeEEEEEEEC-CCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 45578999999999999876 568899999986432 23345788999999999999999999988543 24799
Q ss_pred EeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCC
Q 047292 510 VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH 589 (728)
Q Consensus 510 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 589 (728)
||||++ ++|.+++.....+++..+..++.||++||.|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 82 v~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 82 VFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 157 (338)
T ss_pred EEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccccccc
Confidence 999995 68999998888899999999999999999999997 99999999999999999999999999998653322
Q ss_pred C--cccccccCCccccCcccccC--CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHH-------HHhhhc
Q 047292 590 S--RTHTMIRGTRGYVAPEWLKN--APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWA-------YDCYVE 658 (728)
Q Consensus 590 ~--~~~~~~~gt~~y~aPE~~~~--~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~~ 658 (728)
. .......|++.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.... ......
T Consensus 158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (338)
T cd07859 158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN 237 (338)
T ss_pred CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 1 12233568999999999876 678999999999999999999999996543322111110000 000000
Q ss_pred Cccceecc---chhh---hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 659 GRLDALID---SDEA---AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 659 ~~~~~~~d---~~~~---~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
......+. .... ....+.....+.+++.+||+.||++||+++++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000000 0000 00001123456789999999999999999999964
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=304.37 Aligned_cols=255 Identities=25% Similarity=0.304 Sum_probs=194.1
Q ss_pred HhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCC-----cceeEeec
Q 047292 439 KEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEAL-----NRLLVYEF 513 (728)
Q Consensus 439 ~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~lv~e~ 513 (728)
.+.+|.|+||.||+|++.. +++.||||+.-.... .--.|+++|+.++|||||+++-++.... ...+||||
T Consensus 29 ~~liG~GsFg~Vyq~~~~e-~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVley 103 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRE-TEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEY 103 (364)
T ss_pred eEEEeecccceEEEEEEcC-CCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHh
Confidence 3679999999999999874 578999999854322 2246899999999999999999884332 33599999
Q ss_pred cCCCCHHHHHhc----CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcC-CCceEEccccCccccccC
Q 047292 514 MGNGTLANLIFA----IPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDH-YFSPKISDFGLSKLLLSD 588 (728)
Q Consensus 514 ~~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~-~~~~kl~Dfgla~~~~~~ 588 (728)
||. +|.++++. ...++.-.+.-+..||++||+|||+. +|+||||||.|+|+|. .|.+||+|||.|+.+...
T Consensus 104 mP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ 179 (364)
T KOG0658|consen 104 MPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG 179 (364)
T ss_pred chH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence 986 88888874 46777778888999999999999996 9999999999999996 499999999999988665
Q ss_pred CCcccccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHH-------Hhh----
Q 047292 589 HSRTHTMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAY-------DCY---- 656 (728)
Q Consensus 589 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~-------~~~---- 656 (728)
... ....-|+.|+|||.+.+. .|+.+.||||.||++.||+-|+.-|..+........+.+..- ..+
T Consensus 180 epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y 257 (364)
T KOG0658|consen 180 EPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNY 257 (364)
T ss_pred CCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccc
Confidence 544 233458899999999765 899999999999999999999999987655544333322110 000
Q ss_pred hcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 657 VEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 657 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
.+.+..++...............++++++.++|+.+|.+|.++.|++.
T Consensus 258 ~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 258 TEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred ccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 011111111111111122334567889999999999999999999884
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=306.09 Aligned_cols=251 Identities=25% Similarity=0.366 Sum_probs=200.1
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
..+.+.++||+|+||.||++..+ .+..||+|.++.... ....+.+|+.++++++|+|++++++++. ....+++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~--~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWN--GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred HHhhhhheeccccCceEEEEEec--CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 34667789999999999999765 566799999875332 3457899999999999999999999885 4568999999
Q ss_pred cCCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 514 MGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 514 ~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
+++++|.+++... ..+++..++.++.|++.||+|||+. +++|+||||+||++++++.++|+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 9999999999764 4578999999999999999999997 9999999999999999999999999999876443222
Q ss_pred ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhh
Q 047292 592 THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEA 670 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 670 (728)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ ..+...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~--------~~~~~~-------- 222 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV--------ERGYRM-------- 222 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH--------HcCCCC--------
Confidence 2222335678999999998899999999999999999999 88888654332211111 111000
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 047292 671 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEG 708 (728)
Q Consensus 671 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 708 (728)
..+......+.+++.+||+.+|++|||+.++++.|++
T Consensus 223 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 -PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0111223467889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=304.84 Aligned_cols=248 Identities=24% Similarity=0.353 Sum_probs=197.0
Q ss_pred hhCCCceeEEEEeeeeCC-CCcEEEEEEecccch-hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCCCC
Q 047292 441 ELGRGSFGIVYKGVLKTA-SGNAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGT 518 (728)
Q Consensus 441 ~lg~G~fg~Vy~g~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 518 (728)
.||+|+||.||+|.+... .+..||+|++..... ...+.+.+|+.++++++|+||+++++++.. ...++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 489999999999987633 345799999866433 334679999999999999999999999864 57899999999999
Q ss_pred HHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc--ccc
Q 047292 519 LANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT--HTM 595 (728)
Q Consensus 519 L~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~--~~~ 595 (728)
|.+++... ..+++..+++++.|++.||+|||++ +++|+||||+||+++.++.+||+|||++.......... ...
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 99999753 5789999999999999999999997 99999999999999999999999999998654332211 111
Q ss_pred ccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhc
Q 047292 596 IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMAD 674 (728)
Q Consensus 596 ~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 674 (728)
..++..|+|||.+....++.++||||||+++||+++ |..||...........+ ..+.. ...+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~--------~~~~~---------~~~~ 220 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFI--------EQGKR---------LDCP 220 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH--------HCCCC---------CCCC
Confidence 223578999999998889999999999999999996 99998755433221111 11110 0111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 047292 675 RSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGL 709 (728)
Q Consensus 675 ~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 709 (728)
....+.+.+++.+||+.+|++||++.+|.+.|+.+
T Consensus 221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 22345677899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=322.83 Aligned_cols=252 Identities=23% Similarity=0.273 Sum_probs=198.1
Q ss_pred hHHhhhCCCceeEEEEeeeeC--CCCcEEEEEEecccc----hhhHHHHHHHHHHhccc-cccceeeEeeeeecCCccee
Q 047292 437 GFKEELGRGSFGIVYKGVLKT--ASGNAIAVKKLDRLA----QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLL 509 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~--~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 509 (728)
.+.+.||+|+||.||++.... .+++.||+|++.... ......+..|+.++..+ +|+||+++++++......++
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (332)
T cd05614 3 ELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHL 82 (332)
T ss_pred eEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEE
Confidence 355789999999999987632 357899999986532 12335678899999999 59999999999999999999
Q ss_pred EeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCC
Q 047292 510 VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH 589 (728)
Q Consensus 510 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 589 (728)
||||+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~ 159 (332)
T cd05614 83 ILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE 159 (332)
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence 999999999999998888899999999999999999999997 99999999999999999999999999998654433
Q ss_pred CcccccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccch
Q 047292 590 SRTHTMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSD 668 (728)
Q Consensus 590 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 668 (728)
........||+.|+|||++.+. .++.++||||||+++|||++|+.||...........+.. ..... +..
T Consensus 160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~----~~~~~------~~~ 229 (332)
T cd05614 160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR----RILKC------DPP 229 (332)
T ss_pred CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHH----HHhcC------CCC
Confidence 3333345689999999999875 478999999999999999999999964332211111111 00000 000
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 047292 669 EAAMADRSRLHKWLMIAMWCIQEDPSKRP-----TMKVVMQM 705 (728)
Q Consensus 669 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~ 705 (728)
........+.+++.+||+.||++|| +++++++.
T Consensus 230 ----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 230 ----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred ----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 1111234567899999999999999 77777653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=320.41 Aligned_cols=245 Identities=26% Similarity=0.323 Sum_probs=192.7
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccc-cccceeeEeeeeecCCcceeEeeccC
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
+.||+|+||.||++..+ .+++.||+|+++... ......+..|+.++.++ +||||+++++++......++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~ 79 (329)
T cd05618 1 RVIGRGSYAKVLLVRLK-KTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 79 (329)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCC
Confidence 36899999999999876 567899999997532 23345678888888776 89999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccccc
Q 047292 516 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM 595 (728)
Q Consensus 516 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 595 (728)
+++|..++.....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....... ....
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~~~ 155 (329)
T cd05618 80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTST 155 (329)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-cccc
Confidence 999999998888899999999999999999999997 999999999999999999999999999875422221 2233
Q ss_pred ccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhh-hhhHHHHHHHhhhcCccceeccchhhhhhc
Q 047292 596 IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEES-RAILTDWAYDCYVEGRLDALIDSDEAAMAD 674 (728)
Q Consensus 596 ~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 674 (728)
..||+.|+|||++.+..++.++||||||+++|||++|+.||........ ......+.......... ..+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----------~~p 225 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----------RIP 225 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------CCC
Confidence 5689999999999999999999999999999999999999963211110 00011111111111111 011
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCH
Q 047292 675 RSRLHKWLMIAMWCIQEDPSKRPTM 699 (728)
Q Consensus 675 ~~~~~~l~~l~~~cl~~dp~~RPt~ 699 (728)
......+.+++.+||+.||++||+.
T Consensus 226 ~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 226 RSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 1223456789999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=308.22 Aligned_cols=255 Identities=27% Similarity=0.410 Sum_probs=202.7
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCC--cEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASG--NAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~--~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
+...+.||+|+||.||+|..+...+ ..+++|.++... ....+.+..|++++++++|+||+++++++......++|||
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (268)
T cd05063 7 ITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITE 86 (268)
T ss_pred ceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEE
Confidence 3456789999999999999864322 379999986542 3445778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 513 FMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 513 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
|+++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++.........
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 163 (268)
T cd05063 87 YMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG 163 (268)
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceeccccccc
Confidence 99999999999764 5688999999999999999999997 9999999999999999999999999999866433222
Q ss_pred ccc--cccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccch
Q 047292 592 THT--MIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSD 668 (728)
Q Consensus 592 ~~~--~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 668 (728)
... ....+..|+|||++....++.++||||||+++|||++ |+.||...........+ ..+.. .
T Consensus 164 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i--------~~~~~--~---- 229 (268)
T cd05063 164 TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI--------NDGFR--L---- 229 (268)
T ss_pred ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH--------hcCCC--C----
Confidence 111 1223457999999998899999999999999999998 99998654332211111 11100 0
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 047292 669 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710 (728)
Q Consensus 669 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 710 (728)
.........+.+++.+||+.+|++||++.+|++.|++++
T Consensus 230 ---~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 230 ---PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 001122346788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=326.63 Aligned_cols=252 Identities=21% Similarity=0.240 Sum_probs=199.5
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEe
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 511 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 511 (728)
.+.+.+.||+|+||.||++..+ .+++.||+|++.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 44 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05596 44 DFDVIKVIGRGAFGEVQLVRHK-SSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM 122 (370)
T ss_pred HcEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence 4455678999999999999876 568899999996432 223456789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 512 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 512 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
||+++|+|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||++.........
T Consensus 123 Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~ 198 (370)
T cd05596 123 EYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV 198 (370)
T ss_pred cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc
Confidence 999999999998754 577888889999999999999997 9999999999999999999999999999876443322
Q ss_pred ccccccCCccccCcccccCC----CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccc
Q 047292 592 THTMIRGTRGYVAPEWLKNA----PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDS 667 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~~----~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 667 (728)
......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...........+ ........+
T Consensus 199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i--------~~~~~~~~~-- 268 (370)
T cd05596 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI--------MDHKNSLTF-- 268 (370)
T ss_pred cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHH--------HcCCCcCCC--
Confidence 23345699999999998654 4788999999999999999999999865443221111 111000000
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 047292 668 DEAAMADRSRLHKWLMIAMWCIQEDPSK--RPTMKVVMQM 705 (728)
Q Consensus 668 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~--RPt~~evl~~ 705 (728)
.........+.+++.+||+.+|.+ ||+++++++.
T Consensus 269 ----~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 269 ----PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ----CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 001122456778999999999988 9999999754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=307.63 Aligned_cols=253 Identities=26% Similarity=0.404 Sum_probs=199.4
Q ss_pred HHhhhCCCceeEEEEeeeeCCC--CcEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeeecCCc------c
Q 047292 438 FKEELGRGSFGIVYKGVLKTAS--GNAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALN------R 507 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~--~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------~ 507 (728)
+.+.||+|+||.||+|.+.... +..||+|+++.. .......+.+|+..++.++|+||+++++++..... .
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05035 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP 82 (273)
T ss_pred cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCccc
Confidence 4578999999999999876432 478999998643 23345678999999999999999999999866554 7
Q ss_pred eeEeeccCCCCHHHHHhcC------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccC
Q 047292 508 LLVYEFMGNGTLANLIFAI------PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGL 581 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~l~~~------~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgl 581 (728)
++++||+++++|..++... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+
T Consensus 83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCccc
Confidence 9999999999999998543 3578889999999999999999997 999999999999999999999999999
Q ss_pred ccccccCCCcc-cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcC
Q 047292 582 SKLLLSDHSRT-HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEG 659 (728)
Q Consensus 582 a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 659 (728)
++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||......+... ....+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~--------~~~~~ 231 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYD--------YLRHG 231 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHH--------HHHcC
Confidence 98764432221 122335678999999998899999999999999999999 888886543322111 11111
Q ss_pred ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 047292 660 RLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710 (728)
Q Consensus 660 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 710 (728)
.... ........+.+++.+||+.||++||++.++++.|++++
T Consensus 232 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~~ 273 (273)
T cd05035 232 NRLK---------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273 (273)
T ss_pred CCCC---------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 1111 11123456788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=314.79 Aligned_cols=258 Identities=26% Similarity=0.382 Sum_probs=201.6
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCC-cEEEEEEeccc-chhhHHHHHHHHHHhccc-cccceeeEeeeeecCCcceeEee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASG-NAIAVKKLDRL-AQEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~-~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e 512 (728)
+.+.+.||+|+||.||+|..+.... ..+++|.++.. .....+.+.+|+.++.++ +||||+++++++......++++|
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 83 (297)
T cd05089 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIE 83 (297)
T ss_pred ceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEE
Confidence 3456789999999999998864322 35788888753 233456789999999999 79999999999999999999999
Q ss_pred ccCCCCHHHHHhcCC----------------CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEE
Q 047292 513 FMGNGTLANLIFAIP----------------KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKI 576 (728)
Q Consensus 513 ~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl 576 (728)
|+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 84 YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred ecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEE
Confidence 999999999997532 467889999999999999999997 9999999999999999999999
Q ss_pred ccccCccccccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHh
Q 047292 577 SDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDC 655 (728)
Q Consensus 577 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 655 (728)
+|||++....... .......+..|+|||.+.+..++.++||||||+++|||++ |..||...........
T Consensus 161 ~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~-------- 230 (297)
T cd05089 161 ADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK-------- 230 (297)
T ss_pred CCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--------
Confidence 9999986432111 1111223557999999999899999999999999999998 9999875543321111
Q ss_pred hhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCC
Q 047292 656 YVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNP 715 (728)
Q Consensus 656 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~ 715 (728)
...+.. ..........+.+++.+||+.+|.+||+++++++.|+.++....+
T Consensus 231 ~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 231 LPQGYR---------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred HhcCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 111100 001112234677899999999999999999999999988765544
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=313.09 Aligned_cols=264 Identities=23% Similarity=0.334 Sum_probs=200.8
Q ss_pred HHHHhhHHhhhCCCceeEEEEeeeeCC-------------CCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeE
Q 047292 432 KDATDGFKEELGRGSFGIVYKGVLKTA-------------SGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQL 497 (728)
Q Consensus 432 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~-------------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l 497 (728)
.+..+.+.++||+|+||.||++..... ....||+|+++... ......+.+|++++++++|+||+++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 344566778999999999999876421 12358999986532 3345679999999999999999999
Q ss_pred eeeeecCCcceeEeeccCCCCHHHHHhcC------------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCC
Q 047292 498 LGFCDEALNRLLVYEFMGNGTLANLIFAI------------PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQN 565 (728)
Q Consensus 498 ~g~~~~~~~~~lv~e~~~~gsL~~~l~~~------------~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~N 565 (728)
++++......++||||+++++|.+++... ..+++..++.++.|++.||+|||+. +++|+||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhh
Confidence 99999999999999999999999998643 2357888999999999999999997 99999999999
Q ss_pred EEEcCCCceEEccccCccccccCCC-cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh--CCcCcchhhhH
Q 047292 566 ILLDHYFSPKISDFGLSKLLLSDHS-RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC--CRRSVEMELEE 642 (728)
Q Consensus 566 Ill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt--g~~p~~~~~~~ 642 (728)
|++++++.+||+|||++........ .......++..|+|||.+.+..++.++||||||++++||++ +..||......
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 9999999999999999976543221 11222345678999999998899999999999999999998 45677654332
Q ss_pred hhhhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 047292 643 ESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEG 708 (728)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 708 (728)
........ .+......... .........+.+++.+||+.+|++||+|.+|++.|+.
T Consensus 240 ~~~~~~~~----~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 240 QVIENTGE----FFRNQGRQIYL------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHHH----hhhhccccccC------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 21111111 00000000000 0011123578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=303.37 Aligned_cols=246 Identities=26% Similarity=0.380 Sum_probs=198.3
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCCCC
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGT 518 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 518 (728)
+.||+|+||.||+|... ++..+|+|.++... ......+.+|+++++.++|+||+++++++......++||||+++++
T Consensus 1 ~~ig~g~~g~vy~~~~~--~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK--DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred CccCCCCCceEEEEEec--CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence 36899999999999864 57899999986543 3334578999999999999999999999999999999999999999
Q ss_pred HHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccccccc
Q 047292 519 LANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIR 597 (728)
Q Consensus 519 L~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 597 (728)
|.+++... ..+++..++.++.|++.||.|||++ +++|+||||+||++++++.+||+|||++...............
T Consensus 79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 99998754 4678999999999999999999987 9999999999999999999999999998765333222222233
Q ss_pred CCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHH
Q 047292 598 GTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRS 676 (728)
Q Consensus 598 gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 676 (728)
++..|+|||++.+..++.++||||||+++||+++ |..||...........+ ..+... .....
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~--------~~~~~~---------~~~~~ 218 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV--------EKGYRM---------SCPQK 218 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH--------HcCCCC---------CCCCC
Confidence 4678999999998899999999999999999998 88898654333221111 111000 01112
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047292 677 RLHKWLMIAMWCIQEDPSKRPTMKVVMQMLE 707 (728)
Q Consensus 677 ~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~ 707 (728)
....+.+++.+|++.+|++||++.++++.|.
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 2456788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=310.68 Aligned_cols=245 Identities=27% Similarity=0.324 Sum_probs=194.4
Q ss_pred hCCCceeEEEEeeeeCCCCcEEEEEEecccch---hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCCCC
Q 047292 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGT 518 (728)
Q Consensus 442 lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 518 (728)
||+|+||+||++..+ .+++.||+|++..... .....+..|+++++.++|+||+++.+++......++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMR-ATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEc-cCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 799999999999876 5678999999865322 223567889999999999999999999999999999999999999
Q ss_pred HHHHHhc----CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccc
Q 047292 519 LANLIFA----IPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHT 594 (728)
Q Consensus 519 L~~~l~~----~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 594 (728)
|..++.. ...+++..+..++.||+.||.|||+. +|+||||||+||++++++.+||+|||++......... ..
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~ 155 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TK 155 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-cc
Confidence 9988753 24688999999999999999999997 9999999999999999999999999999765433221 22
Q ss_pred cccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhc
Q 047292 595 MIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMAD 674 (728)
Q Consensus 595 ~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 674 (728)
...|++.|+|||.+.+..++.++||||||+++|||++|+.||...........+.. ...... ....
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~----~~~~~~----------~~~~ 221 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ----RILNDS----------VTYP 221 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHH----hhcccC----------CCCc
Confidence 34689999999999999999999999999999999999999975432211111100 000000 0111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 047292 675 RSRLHKWLMIAMWCIQEDPSKRP-----TMKVVMQM 705 (728)
Q Consensus 675 ~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~ 705 (728)
......+.+++.+||+.||++|| +++++++.
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 22345677899999999999999 77777753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=324.74 Aligned_cols=203 Identities=27% Similarity=0.337 Sum_probs=175.7
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
.+.+.||+|+||.||++..+ .+++.||+|++.... ......+..|+.++.+++|+||+++++.+.+....++||||
T Consensus 4 ~~~~~LG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~ 82 (363)
T cd05628 4 ESLKVIGRGAFGEVRLVQKK-DTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEF 82 (363)
T ss_pred eEeEEEEeCCCEEEEEEEEC-CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcC
Confidence 34578999999999999876 568899999996532 22345788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC---
Q 047292 514 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS--- 590 (728)
Q Consensus 514 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~--- 590 (728)
+++|+|.+++.....+++..+..++.|++.||+|||+. +|+||||||+|||++.++++||+|||+++.......
T Consensus 83 ~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~ 159 (363)
T cd05628 83 LPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF 159 (363)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccccccc
Confidence 99999999999888899999999999999999999997 999999999999999999999999999875432110
Q ss_pred -------------------------------cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchh
Q 047292 591 -------------------------------RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEME 639 (728)
Q Consensus 591 -------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~ 639 (728)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 0012346999999999999999999999999999999999999999765
Q ss_pred hhHh
Q 047292 640 LEEE 643 (728)
Q Consensus 640 ~~~~ 643 (728)
...+
T Consensus 240 ~~~~ 243 (363)
T cd05628 240 TPQE 243 (363)
T ss_pred CHHH
Confidence 4433
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=327.30 Aligned_cols=249 Identities=22% Similarity=0.280 Sum_probs=198.2
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
.+.+.||+|+||.||++... .+++.||||++.... ......+.+|+.++..++|+||+++++.+......++||||
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (364)
T cd05599 4 ESIKVIGRGAFGEVRLVQKK-DTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEY 82 (364)
T ss_pred eEEEEEEecCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECC
Confidence 34578999999999999876 568899999996532 23346688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc--
Q 047292 514 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR-- 591 (728)
Q Consensus 514 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-- 591 (728)
+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+......
T Consensus 83 ~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 159 (364)
T cd05599 83 LPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF 159 (364)
T ss_pred CCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence 99999999998888899999999999999999999997 9999999999999999999999999998765321100
Q ss_pred -----------------------------------ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCc
Q 047292 592 -----------------------------------THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSV 636 (728)
Q Consensus 592 -----------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~ 636 (728)
......||+.|+|||++....++.++|||||||++|||++|..||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCC
Confidence 011235899999999999999999999999999999999999999
Q ss_pred chhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 047292 637 EMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPT---MKVVMQ 704 (728)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt---~~evl~ 704 (728)
...........+..+. ..+ .... .......+.+++.+|+. +|.+|++ ++++++
T Consensus 240 ~~~~~~~~~~~i~~~~------~~~-~~~~-------~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 240 CSDNPQETYRKIINWK------ETL-QFPD-------EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCHHHHHHHHHcCC------Ccc-CCCC-------CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 7654433222111110 000 0000 00123355678888886 9999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=317.89 Aligned_cols=241 Identities=27% Similarity=0.311 Sum_probs=193.6
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccc-cccceeeEeeeeecCCcceeEeeccC
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
+.||+|+||.||++..+ .+++.||+|.++... ......+..|..++... +|+||+++++++...+..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 79 (316)
T cd05620 1 KVLGKGSFGKVLLAELK-GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCC
Confidence 36899999999999876 567899999997532 22345567788887754 89999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccccc
Q 047292 516 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM 595 (728)
Q Consensus 516 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 595 (728)
+|+|..++.....+++..+..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++..... ......
T Consensus 80 ~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 155 (316)
T cd05620 80 GGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRAST 155 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCceec
Confidence 999999998877889999999999999999999997 9999999999999999999999999998743211 122234
Q ss_pred ccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcH
Q 047292 596 IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADR 675 (728)
Q Consensus 596 ~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 675 (728)
..||+.|+|||++.+..++.++||||||+++|||++|+.||...........+ .... .. .+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~--------~~~~-~~---------~~~ 217 (316)
T cd05620 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI--------RVDT-PH---------YPR 217 (316)
T ss_pred cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH--------HhCC-CC---------CCC
Confidence 56899999999999999999999999999999999999999765433221111 0000 00 011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 047292 676 SRLHKWLMIAMWCIQEDPSKRPTMK-VVM 703 (728)
Q Consensus 676 ~~~~~l~~l~~~cl~~dp~~RPt~~-evl 703 (728)
.....+.+++.+||+.||++||++. +++
T Consensus 218 ~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 218 WITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1234567899999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=298.08 Aligned_cols=264 Identities=27% Similarity=0.316 Sum_probs=202.1
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch--hhHHHHHHHHHHhccccccc-eeeEeeeeecCC------
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKN-LVQLLGFCDEAL------ 505 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~------ 505 (728)
.+...++||+|+||+||+|+.+ .+|+.||+|++.-... .......+|+.++++++|+| |+++++++....
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~-~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSK-RTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEe-cCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 3445578999999999999987 5679999999965433 23456789999999999999 999999998877
Q ss_pred cceeEeeccCCCCHHHHHhcCC----CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccC
Q 047292 506 NRLLVYEFMGNGTLANLIFAIP----KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGL 581 (728)
Q Consensus 506 ~~~lv~e~~~~gsL~~~l~~~~----~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgl 581 (728)
..++|+||+. -+|..++...+ ..+...+..+..||++||+|||++ +|+||||||.||||+++|.+||+|||+
T Consensus 91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence 7889999995 48999998765 466778999999999999999998 999999999999999999999999999
Q ss_pred ccccccCCCcccccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCc
Q 047292 582 SKLLLSDHSRTHTMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGR 660 (728)
Q Consensus 582 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (728)
|+...-.. +..+...+|.-|.|||++.+. .|+...||||+|||++||++++.-|....+.+....+-... ....+..
T Consensus 167 Ara~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~l-GtP~e~~ 244 (323)
T KOG0594|consen 167 ARAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLL-GTPNEKD 244 (323)
T ss_pred HHHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHc-CCCCccC
Confidence 99664222 234555678999999999877 78999999999999999999998887766543322221111 0000111
Q ss_pred c---ceeccchh----------hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 661 L---DALIDSDE----------AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 661 ~---~~~~d~~~----------~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
. ..+.+... -....+.......+++.+||+.+|.+|.+++.++++
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1 11111110 000001111367789999999999999999999886
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=319.40 Aligned_cols=250 Identities=25% Similarity=0.314 Sum_probs=196.8
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccc-cccceeeEeeeeecCCcceeEeeccC
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
+.||+|+||.||++..+ .+++.||+|+++... ......+..|..++..+ +||||+++++++......++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~ 79 (329)
T cd05588 1 RVIGRGSYAKVLLVELK-KTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVS 79 (329)
T ss_pred CeEeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence 36899999999999876 567899999997532 22345688899999888 79999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccccc
Q 047292 516 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM 595 (728)
Q Consensus 516 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 595 (728)
+|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++...... .....
T Consensus 80 ~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 155 (329)
T cd05588 80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTST 155 (329)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC-Ccccc
Confidence 999999998878899999999999999999999997 99999999999999999999999999987532221 12234
Q ss_pred ccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhh-hhhHHHHHHHhhhcCccceeccchhhhhhc
Q 047292 596 IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEES-RAILTDWAYDCYVEGRLDALIDSDEAAMAD 674 (728)
Q Consensus 596 ~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 674 (728)
..||+.|+|||++.+..++.++||||||+++|||++|+.||........ ......+........... .+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~p 225 (329)
T cd05588 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR----------IP 225 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC----------CC
Confidence 5689999999999999999999999999999999999999964221110 000111111211121110 11
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCC------HHHHHH
Q 047292 675 RSRLHKWLMIAMWCIQEDPSKRPT------MKVVMQ 704 (728)
Q Consensus 675 ~~~~~~l~~l~~~cl~~dp~~RPt------~~evl~ 704 (728)
......+.+++.+||+.||.+||+ ++++++
T Consensus 226 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 226 RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 122345778999999999999997 667653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=291.08 Aligned_cols=252 Identities=27% Similarity=0.346 Sum_probs=205.1
Q ss_pred HHHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecc--cchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeE
Q 047292 433 DATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDR--LAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 510 (728)
Q Consensus 433 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 510 (728)
...+.+.++||+|.|+.||+.... .+|+.+|+|.+.. ....+.+.+.+|+++.+.|+||||+++...+......|||
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~-~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHK-TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhc-cchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 345667899999999999998765 6788888887742 3344568899999999999999999999999999999999
Q ss_pred eeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcC---CCceEEccccCcccccc
Q 047292 511 YEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDH---YFSPKISDFGLSKLLLS 587 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~---~~~~kl~Dfgla~~~~~ 587 (728)
+|+|.|++|..-+-.+--.++...-...+||+++|.|+|.+ +|||||+||.|+++.. .--+||+|||+|..+..
T Consensus 89 Fe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~ 165 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND 165 (355)
T ss_pred EecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence 99999999987776665667778888999999999999998 9999999999999963 33589999999998862
Q ss_pred CCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccc
Q 047292 588 DHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDS 667 (728)
Q Consensus 588 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 667 (728)
........|||+|||||+++..+|+..+|||+-||+||-|+.|..||..+........+....+. +++
T Consensus 166 --g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd----------~~~ 233 (355)
T KOG0033|consen 166 --GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYD----------YPS 233 (355)
T ss_pred --ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccC----------CCC
Confidence 22333456999999999999999999999999999999999999999987666554444322111 111
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 668 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 668 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
..-....++..+++++||..||.+|.|+.|.++
T Consensus 234 ----~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 234 ----PEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ----cccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 111223456678999999999999999998764
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=320.08 Aligned_cols=238 Identities=28% Similarity=0.302 Sum_probs=190.8
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccch---hhHHHHHHHHH-HhccccccceeeEeeeeecCCcceeEeeccC
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ---EREREFKSEVS-AIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
+.||+|+||.||++..+ .+++.||+|++..... .....+..|.. +++.++||||+++++.+......++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHK-ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCC
Confidence 36899999999999876 5788999999865321 22344555554 4677899999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccccc
Q 047292 516 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM 595 (728)
Q Consensus 516 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 595 (728)
+|+|.+++.....+++..+..++.||++||.|||++ +|+||||||+|||+++++.+||+|||+++...... .....
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (323)
T cd05575 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTST 155 (323)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Ccccc
Confidence 999999998888889999999999999999999997 99999999999999999999999999987542221 22234
Q ss_pred ccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcH
Q 047292 596 IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADR 675 (728)
Q Consensus 596 ~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 675 (728)
..||+.|+|||++.+..++.++||||||+++|||++|+.||......+....+ ...... ...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i--------~~~~~~----------~~~ 217 (323)
T cd05575 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI--------LNKPLR----------LKP 217 (323)
T ss_pred ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHH--------HcCCCC----------CCC
Confidence 56899999999999999999999999999999999999999765433221111 111110 011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHH
Q 047292 676 SRLHKWLMIAMWCIQEDPSKRPTMK 700 (728)
Q Consensus 676 ~~~~~l~~l~~~cl~~dp~~RPt~~ 700 (728)
.....+.+++.+||+.||.+||++.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 218 NISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 1234577899999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=307.65 Aligned_cols=255 Identities=21% Similarity=0.324 Sum_probs=203.0
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
+.+.++||+|+||.||+|..+ .+++.||||.+... .......+.+|+++++.++||||+++++++......++++|
T Consensus 4 ~~i~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08228 4 FQIEKKIGRGQFSEVYRATCL-LDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE 82 (267)
T ss_pred eeeeeeeccCCCeeEEEEEEe-CCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence 345678999999999999876 46789999987542 23345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhc----CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccC
Q 047292 513 FMGNGTLANLIFA----IPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD 588 (728)
Q Consensus 513 ~~~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 588 (728)
|+++++|.+++.. ...++...+..++.|+++||.|||++ +++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 9999999988863 24578889999999999999999997 9999999999999999999999999998876433
Q ss_pred CCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccch
Q 047292 589 HSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSD 668 (728)
Q Consensus 589 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 668 (728)
.. ......+++.|+|||.+.+..++.++||||||+++|||++|+.|+........ . +.. ..........
T Consensus 160 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~-~-~~~----~~~~~~~~~~---- 228 (267)
T cd08228 160 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF-S-LCQ----KIEQCDYPPL---- 228 (267)
T ss_pred hH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH-H-HHH----HHhcCCCCCC----
Confidence 22 11234578899999999988899999999999999999999999864432111 0 100 0111111110
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 047292 669 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGL 709 (728)
Q Consensus 669 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 709 (728)
........+.+++.+||+.+|++||++++|++.|+++
T Consensus 229 ----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 229 ----PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred ----ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 0112335677899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=319.19 Aligned_cols=240 Identities=28% Similarity=0.332 Sum_probs=193.7
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccc-cceeeEeeeeecCCcceeEee
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHH-KNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lv~e 512 (728)
.+.+.||+|+||.||+|..+ .+++.||||++.... ......+..|.+++..++| ++|+++++++...+..++|||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 3 NFLMVLGKGSFGKVMLAERK-GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred eEEEEEeeccCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 45678999999999999876 567899999986532 2334677889999998865 568899999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 513 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 513 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
|+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...... ..
T Consensus 82 ~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~ 157 (324)
T cd05587 82 YVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-KT 157 (324)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-Cc
Confidence 999999999998888889999999999999999999997 99999999999999999999999999987532211 12
Q ss_pred cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAM 672 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 672 (728)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...........+ ..... .
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i--------~~~~~----------~ 219 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI--------MEHNV----------S 219 (324)
T ss_pred eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH--------HcCCC----------C
Confidence 23456899999999999999999999999999999999999999765433322111 11110 0
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCH
Q 047292 673 ADRSRLHKWLMIAMWCIQEDPSKRPTM 699 (728)
Q Consensus 673 ~~~~~~~~l~~l~~~cl~~dp~~RPt~ 699 (728)
.+......+.+++.+||+.||.+|++.
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 220 YPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 011123456789999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=311.79 Aligned_cols=262 Identities=24% Similarity=0.350 Sum_probs=203.5
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCC---------------CcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeE
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTAS---------------GNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQL 497 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~---------------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l 497 (728)
..+.+.++||+|+||.||++...... +..||+|++.... ......+.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 34566789999999999998765322 2468999987543 3345789999999999999999999
Q ss_pred eeeeecCCcceeEeeccCCCCHHHHHhcCC-----------CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCE
Q 047292 498 LGFCDEALNRLLVYEFMGNGTLANLIFAIP-----------KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNI 566 (728)
Q Consensus 498 ~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NI 566 (728)
++++......++++||+++++|.+++.... .+++..++.++.|++.||+|||+. +++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhce
Confidence 999999999999999999999999998754 688999999999999999999987 999999999999
Q ss_pred EEcCCCceEEccccCccccccCCC-cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh--CCcCcchhhhHh
Q 047292 567 LLDHYFSPKISDFGLSKLLLSDHS-RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC--CRRSVEMELEEE 643 (728)
Q Consensus 567 ll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt--g~~p~~~~~~~~ 643 (728)
++++++.++|+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ +..|+.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence 999999999999999876533321 22223446778999999998889999999999999999998 567776443222
Q ss_pred hhhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 047292 644 SRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEG 708 (728)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 708 (728)
.... ....+.......... ........+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 242 ~~~~----~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 242 VIEN----AGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HHHH----HHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 1111 111111111111111 111223568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=308.16 Aligned_cols=255 Identities=20% Similarity=0.279 Sum_probs=202.5
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
..+.+.++||+|+||.||+|+.. .+++.||+|++..........+.+|+.++++++|+||+++++.+......++|+||
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~-~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNL-HTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhcchhheeecCCCeEEEEEEEC-CCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 34567789999999999999875 46789999999765445556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccc
Q 047292 514 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH 593 (728)
Q Consensus 514 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 593 (728)
+++++|.+++.....+++..+..++.|+++||.|||+. +|+|+||+|+||++++++.+||+|||++........ ..
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~ 163 (267)
T cd06646 88 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-KR 163 (267)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc-cc
Confidence 99999999998777889999999999999999999987 999999999999999999999999999986643221 12
Q ss_pred ccccCCccccCccccc---CCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhh
Q 047292 594 TMIRGTRGYVAPEWLK---NAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEA 670 (728)
Q Consensus 594 ~~~~gt~~y~aPE~~~---~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 670 (728)
....++..|+|||.+. ...++.++||||||++++||++|+.|+...........+ ..... ..+...
T Consensus 164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~--------~~~~~---~~~~~~ 232 (267)
T cd06646 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--------SKSNF---QPPKLK 232 (267)
T ss_pred CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee--------ecCCC---CCCCCc
Confidence 2345788999999884 445788999999999999999999998643322111000 00000 000000
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047292 671 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQML 706 (728)
Q Consensus 671 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 706 (728)
........+.+++.+||+.+|++||++++|++.|
T Consensus 233 --~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 233 --DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred --cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0112235677899999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=307.96 Aligned_cols=240 Identities=23% Similarity=0.368 Sum_probs=189.5
Q ss_pred hhCCCceeEEEEeeeeCC-----------------------CCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeE
Q 047292 441 ELGRGSFGIVYKGVLKTA-----------------------SGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 497 (728)
Q Consensus 441 ~lg~G~fg~Vy~g~~~~~-----------------------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l 497 (728)
.||+|+||.||+|.+... ....|++|++..........+.+|+.++++++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 589999999999986321 113589999876555556788999999999999999999
Q ss_pred eeeeecCCcceeEeeccCCCCHHHHHhc-CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCC----
Q 047292 498 LGFCDEALNRLLVYEFMGNGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYF---- 572 (728)
Q Consensus 498 ~g~~~~~~~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~---- 572 (728)
++++......++||||+++|+|..++.. .+.+++..++.++.||++||+|||+. +|+||||||+|||+++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999975 46788999999999999999999987 999999999999998644
Q ss_pred ---ceEEccccCccccccCCCcccccccCCccccCcccccC-CCCCCccchhhHHHHHHHHH-hCCcCcchhhhHhhhhh
Q 047292 573 ---SPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKN-APVSAKVDVYSFGVMLLEII-CCRRSVEMELEEESRAI 647 (728)
Q Consensus 573 ---~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvil~ell-tg~~p~~~~~~~~~~~~ 647 (728)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||...........
T Consensus 159 ~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 233 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF 233 (274)
T ss_pred ccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH
Confidence 3799999987644222 12246778999998865 56899999999999999995 68888875433222111
Q ss_pred HHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047292 648 LTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLE 707 (728)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~ 707 (728)
+ .. ...+. ......+.+++.+||+.+|++||++.+|++.|+
T Consensus 234 ~----~~---~~~~~------------~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 234 Y----EK---KHRLP------------EPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred H----Hh---ccCCC------------CCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1 00 00000 011235778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=315.42 Aligned_cols=263 Identities=22% Similarity=0.233 Sum_probs=194.0
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch-hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
+.+.+.||+|+||.||+|..+ .+++.||||++..... .....+.+|+.+++.++|+||+++++++......++||||+
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (303)
T cd07869 7 YEKLEKLGEGSYATVYKGKSK-VNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYV 85 (303)
T ss_pred ceEeeeEEecCCEEEEEEEEC-CCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECC
Confidence 455678999999999999876 4678999999865332 22356788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccc
Q 047292 515 GNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH 593 (728)
Q Consensus 515 ~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 593 (728)
+ ++|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++...... ...
T Consensus 86 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~ 160 (303)
T cd07869 86 H-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-HTY 160 (303)
T ss_pred C-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-ccC
Confidence 6 5787777654 5678889999999999999999997 99999999999999999999999999987543221 122
Q ss_pred ccccCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcC------cccee--
Q 047292 594 TMIRGTRGYVAPEWLKN-APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEG------RLDAL-- 664 (728)
Q Consensus 594 ~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~-- 664 (728)
....+++.|+|||++.+ ..++.++|||||||++|||++|+.||....................... .....
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (303)
T cd07869 161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKP 240 (303)
T ss_pred CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccc
Confidence 33457899999999865 4578999999999999999999999975422111000000000000000 00000
Q ss_pred ------ccchhhhh-hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 665 ------IDSDEAAM-ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 665 ------~d~~~~~~-~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
........ ........+.+++.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 241 ERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000000 00011245678999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=307.17 Aligned_cols=252 Identities=24% Similarity=0.376 Sum_probs=196.4
Q ss_pred HHhhhCCCceeEEEEeeeeCCCC-cEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeeecC------Ccce
Q 047292 438 FKEELGRGSFGIVYKGVLKTASG-NAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEA------LNRL 508 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~-~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~ 508 (728)
+.+.||+|+||.||+|....... ..||+|.++.. .......+..|+++++.++|+||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 45789999999999998763322 36899988653 234457889999999999999999999987432 2468
Q ss_pred eEeeccCCCCHHHHHhc------CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCc
Q 047292 509 LVYEFMGNGTLANLIFA------IPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLS 582 (728)
Q Consensus 509 lv~e~~~~gsL~~~l~~------~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla 582 (728)
+++||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcc
Confidence 99999999999988742 13478899999999999999999997 9999999999999999999999999999
Q ss_pred cccccCCCc-ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCc
Q 047292 583 KLLLSDHSR-THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGR 660 (728)
Q Consensus 583 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (728)
+........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......... ....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~--------~~~~~~ 231 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYD--------YLRQGN 231 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--------HHHcCC
Confidence 876433221 1222345778999999999999999999999999999999 788886543322111 111111
Q ss_pred cceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 047292 661 LDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGL 709 (728)
Q Consensus 661 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 709 (728)
... ........+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 232 ~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 RLK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111 0112234577899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=306.65 Aligned_cols=249 Identities=26% Similarity=0.391 Sum_probs=195.4
Q ss_pred hhhCCCceeEEEEeeeeCCCC-cEEEEEEecccc-hhhHHHHHHHHHHhccc-cccceeeEeeeeecCCcceeEeeccCC
Q 047292 440 EELGRGSFGIVYKGVLKTASG-NAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYEFMGN 516 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~-~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 516 (728)
+.||+|+||.||+|.++..+. ..+++|.++... ......+.+|++++.++ +||||+++++++......+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999998864322 357888887533 34456889999999999 899999999999999999999999999
Q ss_pred CCHHHHHhcCC----------------CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEcccc
Q 047292 517 GTLANLIFAIP----------------KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFG 580 (728)
Q Consensus 517 gsL~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg 580 (728)
++|.+++.... .+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 99999987532 367889999999999999999987 99999999999999999999999999
Q ss_pred CccccccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcC
Q 047292 581 LSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEG 659 (728)
Q Consensus 581 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 659 (728)
++...... ........+..|+|||++....++.++||||||++++||++ |..||........... ...+
T Consensus 158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~--------~~~~ 227 (270)
T cd05047 158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK--------LPQG 227 (270)
T ss_pred Cccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHH--------HhCC
Confidence 98632211 11111224567999999998899999999999999999997 8999865433221111 1111
Q ss_pred ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 047292 660 RLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710 (728)
Q Consensus 660 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 710 (728)
.... ........+.+++.+||+.+|.+||++.++++.|++++
T Consensus 228 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 228 YRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCCC---------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 0000 01112345778999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=318.30 Aligned_cols=243 Identities=26% Similarity=0.321 Sum_probs=192.8
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHh---ccccccceeeEeeeeecCCcceeEe
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAI---GRTHHKNLVQLLGFCDEALNRLLVY 511 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~g~~~~~~~~~lv~ 511 (728)
+.+.||+|+||.||++..+ .+++.||||+++... ....+.+..|++++ +.++||||+++++++......++||
T Consensus 3 i~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~ 81 (324)
T cd05589 3 CLAVLGRGHFGKVLLAEYK-KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM 81 (324)
T ss_pred EEEEEeecCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence 4578999999999999876 568899999997532 22234566666554 5678999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 512 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 512 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
||+++++|..++.. ..+++..+..++.||+.||.|||+. +|+||||||+||++++++.+||+|||+++...... .
T Consensus 82 E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~ 156 (324)
T cd05589 82 EYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG-D 156 (324)
T ss_pred cCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC-C
Confidence 99999999988865 5689999999999999999999997 99999999999999999999999999987542222 1
Q ss_pred ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhh
Q 047292 592 THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAA 671 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 671 (728)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||...........+ ..+...
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i--------~~~~~~--------- 219 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSI--------VNDEVR--------- 219 (324)
T ss_pred cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHH--------HhCCCC---------
Confidence 223456899999999999999999999999999999999999999765443321111 111100
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047292 672 MADRSRLHKWLMIAMWCIQEDPSKRP-----TMKVVMQ 704 (728)
Q Consensus 672 ~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~ 704 (728)
.+......+.+++.+||+.||.+|| ++.++++
T Consensus 220 -~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 220 -YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 1111234567899999999999999 5666665
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=302.02 Aligned_cols=263 Identities=24% Similarity=0.331 Sum_probs=199.0
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhcc--ccccceeeEeeeeecCC----cceeEe
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGR--THHKNLVQLLGFCDEAL----NRLLVY 511 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~~~----~~~lv~ 511 (728)
+.+.||+|.||+||+|.++ |+.||||++.. .+++.+.+|.++.+. |+|+||+.+++.-..+. .+|||.
T Consensus 215 L~e~IGkGRyGEVwrG~wr---Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvT 288 (513)
T KOG2052|consen 215 LQEIIGKGRFGEVWRGRWR---GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVT 288 (513)
T ss_pred EEEEecCccccceeecccc---CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEee
Confidence 4467999999999999996 78999999964 345678888888886 59999999998865443 468999
Q ss_pred eccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhh-----cCCCCeeecCCCCCCEEEcCCCceEEccccCccccc
Q 047292 512 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHE-----GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLL 586 (728)
Q Consensus 512 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~-----~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 586 (728)
+|.++|||.|+|.. ..++....++++..+|.||+|||. +.++.|.|||||++|||+.+++++.|+|+|||....
T Consensus 289 dYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~ 367 (513)
T KOG2052|consen 289 DYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 367 (513)
T ss_pred ecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEec
Confidence 99999999999987 778999999999999999999996 346789999999999999999999999999998765
Q ss_pred cCCC---cccccccCCccccCcccccCCC----C--CCccchhhHHHHHHHHHhC----------CcCcchhhhHhhhhh
Q 047292 587 SDHS---RTHTMIRGTRGYVAPEWLKNAP----V--SAKVDVYSFGVMLLEIICC----------RRSVEMELEEESRAI 647 (728)
Q Consensus 587 ~~~~---~~~~~~~gt~~y~aPE~~~~~~----~--s~~~DVwSlGvil~elltg----------~~p~~~~~~~~~~~~ 647 (728)
.+.. .......||.+|||||++...- + -..+||||||.++||+... +.||....+.+...
T Consensus 368 ~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~- 446 (513)
T KOG2052|consen 368 SDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSF- 446 (513)
T ss_pred ccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCH-
Confidence 4432 2334567999999999996431 1 2369999999999999852 13443211111000
Q ss_pred HHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCC
Q 047292 648 LTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVP 713 (728)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~ 713 (728)
.+ -..-+-..++...+ .....+.+.+..+.++++.||..+|.-|-|+-.|-+.|.++.+.+
T Consensus 447 -ee-MrkVVCv~~~RP~i---pnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~ 507 (513)
T KOG2052|consen 447 -EE-MRKVVCVQKLRPNI---PNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSD 507 (513)
T ss_pred -HH-HhcceeecccCCCC---CcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcCh
Confidence 00 00000001111111 122334567888999999999999999999999999998877544
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=324.15 Aligned_cols=252 Identities=22% Similarity=0.254 Sum_probs=196.6
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEe
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 511 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 511 (728)
.+.+.+.||+|+||.||++..+ .+++.+|+|.+.... ......+.+|+.+++.++||||+++++++......++||
T Consensus 44 ~y~~~~~lG~G~fg~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05621 44 DYDVVKVIGRGAFGEVQLVRHK-SSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM 122 (370)
T ss_pred HCeEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 3455678999999999999876 567899999986422 223456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 512 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 512 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
||+++|+|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||++.........
T Consensus 123 Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~ 198 (370)
T cd05621 123 EYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV 198 (370)
T ss_pred cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccCCce
Confidence 999999999998754 578888999999999999999997 9999999999999999999999999999876433322
Q ss_pred ccccccCCccccCcccccCCC----CCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccc
Q 047292 592 THTMIRGTRGYVAPEWLKNAP----VSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDS 667 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~~~----~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 667 (728)
......||+.|+|||++.+.. ++.++||||||+++|||++|+.||...........+. ..... +.
T Consensus 199 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~--------~~~~~--~~- 267 (370)
T cd05621 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM--------DHKNS--LN- 267 (370)
T ss_pred ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHH--------hCCcc--cC-
Confidence 233456999999999997643 7889999999999999999999997654432221111 10000 00
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 047292 668 DEAAMADRSRLHKWLMIAMWCIQEDPSK--RPTMKVVMQM 705 (728)
Q Consensus 668 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~--RPt~~evl~~ 705 (728)
..........+.+++.+|++.++.+ ||+++++++.
T Consensus 268 ---~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 268 ---FPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ---CCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0001122345567888888755543 8899999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=305.59 Aligned_cols=254 Identities=25% Similarity=0.396 Sum_probs=202.9
Q ss_pred HHHHHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeE
Q 047292 431 LKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 510 (728)
Q Consensus 431 l~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 510 (728)
+...++.+.++||+|+||.||+|..+ +++.||+|.+..... ....+.+|+.++++++|+||+++++++. ....+++
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~--~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYN--GHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYII 78 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecC--CCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEE
Confidence 34556777889999999999999864 567899999875432 3467899999999999999999999874 4578999
Q ss_pred eeccCCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccC
Q 047292 511 YEFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD 588 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 588 (728)
+||+++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 9999999999998754 4678899999999999999999986 9999999999999999999999999999876533
Q ss_pred CCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccc
Q 047292 589 HSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDS 667 (728)
Q Consensus 589 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 667 (728)
.........++..|+|||.+....++.++||||||+++|||++ |+.||...........+ ..+....
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~--------~~~~~~~---- 223 (260)
T cd05067 156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL--------ERGYRMP---- 223 (260)
T ss_pred CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHH--------HcCCCCC----
Confidence 2222223345678999999998889999999999999999999 99998754332211111 1110000
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 047292 668 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEG 708 (728)
Q Consensus 668 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 708 (728)
........+.+++.+||+.+|++||+++++++.|+.
T Consensus 224 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 -----RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 011123468889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=317.92 Aligned_cols=240 Identities=28% Similarity=0.338 Sum_probs=194.1
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccc-cccceeeEeeeeecCCcceeEee
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e 512 (728)
.+.+.||+|+||.||+|..+ .+++.||+|.+.... ......+..|..++..+ +|++|+++++++...+..++|||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 3 NFLMVLGKGSFGKVMLAERK-GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred eEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 34578999999999999876 567899999987532 22334567788888776 68999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 513 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 513 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
|+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...... ..
T Consensus 82 ~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-~~ 157 (323)
T cd05616 82 YVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-VT 157 (323)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-Cc
Confidence 999999999998888899999999999999999999997 99999999999999999999999999987543221 12
Q ss_pred cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAM 672 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 672 (728)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ ..... .
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i--------~~~~~----------~ 219 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI--------MEHNV----------A 219 (323)
T ss_pred cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHH--------HhCCC----------C
Confidence 23356899999999999999999999999999999999999999865443322111 11111 0
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCH
Q 047292 673 ADRSRLHKWLMIAMWCIQEDPSKRPTM 699 (728)
Q Consensus 673 ~~~~~~~~l~~l~~~cl~~dp~~RPt~ 699 (728)
.+......+.+++.+||+.+|.+|++.
T Consensus 220 ~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 220 YPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 111223466789999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=312.77 Aligned_cols=270 Identities=27% Similarity=0.379 Sum_probs=199.9
Q ss_pred hhHHhhhCCCceeEEEEeeee---CCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeec--CCcceeE
Q 047292 436 DGFKEELGRGSFGIVYKGVLK---TASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDE--ALNRLLV 510 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~---~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lv 510 (728)
+.+.+.||+|+||.||++..+ ..+++.|++|++........+.+.+|++++++++|+||+++++++.. ....++|
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 85 (284)
T cd05081 6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLV 85 (284)
T ss_pred ceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEE
Confidence 445678999999999999753 34678999999977666666789999999999999999999998743 3467899
Q ss_pred eeccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCC
Q 047292 511 YEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH 589 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 589 (728)
+||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 86 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 162 (284)
T cd05081 86 MEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK 162 (284)
T ss_pred EEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccccCCC
Confidence 9999999999999764 4688999999999999999999997 99999999999999999999999999998764332
Q ss_pred Ccc--cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccc
Q 047292 590 SRT--HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDS 667 (728)
Q Consensus 590 ~~~--~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 667 (728)
... .....++..|+|||.+.+..++.++||||||++++||++|..++.......... .............+.+.+..
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05081 163 EYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRM-MGNDKQGQMIVYHLIELLKN 241 (284)
T ss_pred cceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhh-cccccccccchHHHHHHHhc
Confidence 211 111223456999999998899999999999999999999876654321110000 00000000000000000000
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 047292 668 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGL 709 (728)
Q Consensus 668 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 709 (728)
.............+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 242 NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 000001112234678899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=314.02 Aligned_cols=264 Identities=27% Similarity=0.354 Sum_probs=207.0
Q ss_pred HHHHHhhHHhhhCCCceeEEEEeeee------CCCCcEEEEEEecccc-hhhHHHHHHHHHHhccc-cccceeeEeeeee
Q 047292 431 LKDATDGFKEELGRGSFGIVYKGVLK------TASGNAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKNLVQLLGFCD 502 (728)
Q Consensus 431 l~~~~~~~~~~lg~G~fg~Vy~g~~~------~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~ 502 (728)
+....+.+.+.||+|+||.||++... ...+..||+|.+.... ....+.+.+|+.+++.+ +|+||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 33445566788999999999999752 1234579999986532 34457899999999999 8999999999999
Q ss_pred cCCcceeEeeccCCCCHHHHHhcC----------------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCE
Q 047292 503 EALNRLLVYEFMGNGTLANLIFAI----------------PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNI 566 (728)
Q Consensus 503 ~~~~~~lv~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NI 566 (728)
.....++||||+++++|.+++... ..+++..++.++.||++||.|||++ +++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence 999999999999999999999753 2357788899999999999999997 999999999999
Q ss_pred EEcCCCceEEccccCccccccCCCcc-cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhh
Q 047292 567 LLDHYFSPKISDFGLSKLLLSDHSRT-HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEES 644 (728)
Q Consensus 567 ll~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~ 644 (728)
++++++.+||+|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |..|+......+.
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 248 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 99999999999999998764332221 222345678999999999899999999999999999998 6777764433322
Q ss_pred hhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCC
Q 047292 645 RAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPN 714 (728)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 714 (728)
...+ ..+.... ........+.+++.+||+.+|.+||++.+|++.|++++....
T Consensus 249 ~~~~--------~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~ 301 (304)
T cd05101 249 FKLL--------KEGHRMD---------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT 301 (304)
T ss_pred HHHH--------HcCCcCC---------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence 1111 1111000 011234567789999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=329.84 Aligned_cols=255 Identities=21% Similarity=0.307 Sum_probs=207.5
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhcccc-ccceeeEeeee-e-----c-CCcce
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTH-HKNLVQLLGFC-D-----E-ALNRL 508 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~-~-----~-~~~~~ 508 (728)
.+.+.|.+|||+.||.+.+. ..+..+|+|++-...+...+.+.+|+.+|++|+ |+|||.+++.. . . .-+.+
T Consensus 40 ~V~~vLAEGGFa~VYla~~~-~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evl 118 (738)
T KOG1989|consen 40 TVEKVLAEGGFAQVYLAQDV-KGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVL 118 (738)
T ss_pred EEEEEEccCCcEEEEEEEec-CCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEE
Confidence 34578999999999999876 344899999997777778899999999999996 99999999932 1 1 24678
Q ss_pred eEeeccCCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccc
Q 047292 509 LVYEFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLL 586 (728)
Q Consensus 509 lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 586 (728)
|.||||++|.|-+++..+ ..+++..+++|+.++++|+++||.. ..+|||||||-+||||+.+++.||||||.+.-..
T Consensus 119 lLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~ 197 (738)
T KOG1989|consen 119 LLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKI 197 (738)
T ss_pred eehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccccccc
Confidence 999999999999999854 5699999999999999999999985 6689999999999999999999999999886442
Q ss_pred cCCCcc--------cccccCCccccCcccc---cCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHh
Q 047292 587 SDHSRT--------HTMIRGTRGYVAPEWL---KNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDC 655 (728)
Q Consensus 587 ~~~~~~--------~~~~~gt~~y~aPE~~---~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 655 (728)
...... .-...-|+.|+|||.+ ++.++++|+|||+|||+||-|.....||+.....
T Consensus 198 ~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l------------- 264 (738)
T KOG1989|consen 198 LSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL------------- 264 (738)
T ss_pred CCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-------------
Confidence 221110 0012368999999977 6789999999999999999999999999855321
Q ss_pred hhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCC
Q 047292 656 YVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVP 713 (728)
Q Consensus 656 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~ 713 (728)
.+++........+.+...+..||+.||++||.+||++-+|+..+-++...+
T Consensus 265 -------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 265 -------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred -------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 222222222333567888999999999999999999999999998876544
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=320.39 Aligned_cols=240 Identities=24% Similarity=0.268 Sum_probs=194.8
Q ss_pred hhhCCCceeEEEEeeee--CCCCcEEEEEEecccch--hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccC
Q 047292 440 EELGRGSFGIVYKGVLK--TASGNAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~--~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
+.||+|+||.||++... ..+++.||+|++..... .....+..|++++++++||||+++++++......++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 56999999999998753 24678999999975332 233567789999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccccc
Q 047292 516 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM 595 (728)
Q Consensus 516 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 595 (728)
+++|.+++.....+++..+..++.||++||+|||+. +|+||||||+||++++++.+||+|||+++....... ....
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~~~~ 157 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KAYS 157 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-ceec
Confidence 999999998877899999999999999999999997 999999999999999999999999999876533322 2233
Q ss_pred ccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcH
Q 047292 596 IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADR 675 (728)
Q Consensus 596 ~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 675 (728)
..|++.|+|||.+.+..++.++||||||+++|||++|+.||...........+ ..... ..+.
T Consensus 158 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i--------~~~~~----------~~p~ 219 (318)
T cd05582 158 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI--------LKAKL----------GMPQ 219 (318)
T ss_pred ccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHH--------HcCCC----------CCCC
Confidence 56899999999999999999999999999999999999999765433221111 11110 0111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHH
Q 047292 676 SRLHKWLMIAMWCIQEDPSKRPTMKV 701 (728)
Q Consensus 676 ~~~~~l~~l~~~cl~~dp~~RPt~~e 701 (728)
.....+.+++.+||+.||++||++.+
T Consensus 220 ~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 220 FLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 12345678999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=318.50 Aligned_cols=250 Identities=25% Similarity=0.335 Sum_probs=208.5
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCc--EEEEEEecccchh-hHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGN--AIAVKKLDRLAQE-REREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~--~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
..+.|+||+|.||.|++|.|...+|+ .||||.++..... ...+|++|+.+|.+|+|+|+++|+|+..+ ....||+|
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 34668999999999999999877775 6899999765444 45789999999999999999999999988 78899999
Q ss_pred ccCCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC
Q 047292 513 FMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 513 ~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 590 (728)
+++.|+|.+.|++. ..+-...+..++.|||.||.||.++ ++|||||.++|+||-..-.+||+||||.+.+.....
T Consensus 191 LaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred hcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 99999999999983 4566778889999999999999998 999999999999999999999999999998855433
Q ss_pred c-cc-ccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhC-CcCcchhhhHhhhhhHHHHHHHhhhcCccceeccc
Q 047292 591 R-TH-TMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICC-RRSVEMELEEESRAILTDWAYDCYVEGRLDALIDS 667 (728)
Q Consensus 591 ~-~~-~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 667 (728)
. .. ....-+..|.|||.++...|+.++|||+|||+||||+|+ ..||-....-.. .+.+|.
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qI-----------------L~~iD~ 330 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQI-----------------LKNIDA 330 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHH-----------------HHhccc
Confidence 2 22 223457789999999999999999999999999999995 567765443222 223444
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047292 668 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQML 706 (728)
Q Consensus 668 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 706 (728)
.+.......+.+.++++++.||..+|.+|||+..|.+.+
T Consensus 331 ~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 331 GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 444445666788999999999999999999999997443
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=326.80 Aligned_cols=248 Identities=22% Similarity=0.276 Sum_probs=193.1
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
+.++||+|+||.||+|... .+++.||+|++.... ......+.+|+.++++++|+||+++++.+.+....++||||+
T Consensus 5 ~~~~LG~G~~g~Vy~a~~~-~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~ 83 (382)
T cd05625 5 KIKTLGIGAFGEVCLARKV-DTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYI 83 (382)
T ss_pred EEEEEEeCCCEEEEEEEEC-CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCC
Confidence 4578999999999999876 567899999986532 233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC----
Q 047292 515 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS---- 590 (728)
Q Consensus 515 ~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~---- 590 (728)
++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++++||+|||++........
T Consensus 84 ~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 84 PGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 9999999998877888999999999999999999997 999999999999999999999999999754311000
Q ss_pred ------------------------------------------cccccccCCccccCcccccCCCCCCccchhhHHHHHHH
Q 047292 591 ------------------------------------------RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLE 628 (728)
Q Consensus 591 ------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~e 628 (728)
.......||+.|+|||++.+..++.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 240 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHH
Confidence 00112458999999999999999999999999999999
Q ss_pred HHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 047292 629 IICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPT---MKVVMQ 704 (728)
Q Consensus 629 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt---~~evl~ 704 (728)
|++|+.||...........+..+. ... .. .........+.+++.+++ .+|.+|++ ++++++
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~------~~~-~~-------p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 241 MLVGQPPFLAQTPLETQMKVINWQ------TSL-HI-------PPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HHhCCCCCCCCCHHHHHHHHHccC------CCc-CC-------CCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 999999997654432221111100 000 00 000111234455666555 49999987 777764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=310.19 Aligned_cols=255 Identities=26% Similarity=0.371 Sum_probs=201.2
Q ss_pred hHHhhhCCCceeEEEEeeeeCC----CCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEe
Q 047292 437 GFKEELGRGSFGIVYKGVLKTA----SGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 511 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~----~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 511 (728)
.+.+.||+|+||.||+|..... ....+++|.+.... ......+.+|+.+++.++||||+++++.+......++++
T Consensus 3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (290)
T cd05045 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIV 82 (290)
T ss_pred cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEE
Confidence 3557899999999999986422 23578999886543 233567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcC------------------------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEE
Q 047292 512 EFMGNGTLANLIFAI------------------------PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNIL 567 (728)
Q Consensus 512 e~~~~gsL~~~l~~~------------------------~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIl 567 (728)
||+++++|.+++... ..+++..++.++.|++.||+|||+. +++||||||+||+
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nil 159 (290)
T cd05045 83 EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVL 159 (290)
T ss_pred EecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEE
Confidence 999999999998642 2467888999999999999999987 9999999999999
Q ss_pred EcCCCceEEccccCccccccCCCc-ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhh
Q 047292 568 LDHYFSPKISDFGLSKLLLSDHSR-THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESR 645 (728)
Q Consensus 568 l~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~ 645 (728)
+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||++++||++ |+.||.........
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~ 239 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF 239 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 999999999999999865333221 1122345678999999998899999999999999999999 88888654433221
Q ss_pred hhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 646 AILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
..+ .... . ..........+.+++.+||+.+|++||++.++++.|++++.
T Consensus 240 ~~~--------~~~~-~--------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 240 NLL--------KTGY-R--------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHH--------hCCC-C--------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 111 1110 0 00011223467789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=312.26 Aligned_cols=256 Identities=28% Similarity=0.368 Sum_probs=202.9
Q ss_pred HhhHHhhhCCCceeEEEEeeeeC----CCCcEEEEEEecccc-hhhHHHHHHHHHHhccc-cccceeeEeeeeecCCcce
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKT----ASGNAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRL 508 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 508 (728)
.+.+.+.||+|+||.||++.... .....+|+|.+.... .+....+.+|+.++.++ +|+||+++++++......+
T Consensus 13 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (293)
T cd05053 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLY 92 (293)
T ss_pred HeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeE
Confidence 34456789999999999998753 233689999987532 33446788999999999 8999999999999999999
Q ss_pred eEeeccCCCCHHHHHhcC----------------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCC
Q 047292 509 LVYEFMGNGTLANLIFAI----------------PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYF 572 (728)
Q Consensus 509 lv~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~ 572 (728)
++|||+++|+|.+++... ..+++..+++++.|++.||.|||+. +|+||||||+||++++++
T Consensus 93 li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~~~ 169 (293)
T cd05053 93 VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDH 169 (293)
T ss_pred EEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcCCC
Confidence 999999999999998642 4578889999999999999999987 999999999999999999
Q ss_pred ceEEccccCccccccCCCc-ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHH
Q 047292 573 SPKISDFGLSKLLLSDHSR-THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTD 650 (728)
Q Consensus 573 ~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~ 650 (728)
.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..|+...........+
T Consensus 170 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~-- 247 (293)
T cd05053 170 VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL-- 247 (293)
T ss_pred eEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHH--
Confidence 9999999999876443221 1222335678999999999999999999999999999998 88888654332221111
Q ss_pred HHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 047292 651 WAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710 (728)
Q Consensus 651 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 710 (728)
..+... ..+......+.+++.+||+.+|++|||++++++.|+.++
T Consensus 248 ------~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 248 ------KEGYRM---------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ------HcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 111100 011122456778999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=318.52 Aligned_cols=243 Identities=27% Similarity=0.275 Sum_probs=192.4
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccch---hhHHHHHHHHH-HhccccccceeeEeeeeecCCcceeEeeccC
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ---EREREFKSEVS-AIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
+.||+|+||.||++..+ .+++.||+|++..... .....+..|.. +++.++|+||+++++.+...+..++||||++
T Consensus 1 ~~lg~G~fg~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHK-AEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCC
Confidence 36899999999999876 4678999999865321 22334444444 5677899999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccccc
Q 047292 516 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM 595 (728)
Q Consensus 516 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 595 (728)
+++|.+++.....+.+.....++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~~ 155 (325)
T cd05602 80 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTST 155 (325)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCccc
Confidence 999999998877888888999999999999999997 99999999999999999999999999987543222 12234
Q ss_pred ccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcH
Q 047292 596 IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADR 675 (728)
Q Consensus 596 ~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 675 (728)
..||+.|+|||++.+..++.++||||||+++|||++|+.||......+....+ ...... ...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i--------~~~~~~----------~~~ 217 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI--------LNKPLQ----------LKP 217 (325)
T ss_pred ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHH--------HhCCcC----------CCC
Confidence 56899999999999999999999999999999999999999765443321111 111100 111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 676 SRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 676 ~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.....+.+++.+||+.+|.+||++.+.+..
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 218 NITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred CCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 223456789999999999999998754433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=312.38 Aligned_cols=256 Identities=27% Similarity=0.367 Sum_probs=202.3
Q ss_pred HhhHHhhhCCCceeEEEEeeee----CCCCcEEEEEEecccc-hhhHHHHHHHHHHhccc-cccceeeEeeeeecCCcce
Q 047292 435 TDGFKEELGRGSFGIVYKGVLK----TASGNAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRL 508 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~----~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 508 (728)
...+.+.||+|+||.||++... ...+..||+|+++... ....+.+.+|+.+++++ +|+||+++++++......+
T Consensus 36 ~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 115 (302)
T cd05055 36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPIL 115 (302)
T ss_pred HeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceE
Confidence 3456688999999999999752 2344589999987543 33346789999999999 7999999999999999999
Q ss_pred eEeeccCCCCHHHHHhcCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccc
Q 047292 509 LVYEFMGNGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLL 586 (728)
Q Consensus 509 lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 586 (728)
++|||+++++|.+++.... .+++.++..++.|++.||+|||++ +|+|+||||+||++++++.+||+|||+++...
T Consensus 116 lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 192 (302)
T cd05055 116 VITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIM 192 (302)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccccccc
Confidence 9999999999999997643 378999999999999999999997 99999999999999999999999999998664
Q ss_pred cCCCc-ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCcccee
Q 047292 587 SDHSR-THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDAL 664 (728)
Q Consensus 587 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (728)
..... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.......... .. ...+....
T Consensus 193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~---~~----~~~~~~~~- 264 (302)
T cd05055 193 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFY---KL----IKEGYRMA- 264 (302)
T ss_pred CCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHH---HH----HHcCCcCC-
Confidence 33221 1122345778999999999999999999999999999998 899986543322111 10 01110000
Q ss_pred ccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 047292 665 IDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGL 709 (728)
Q Consensus 665 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 709 (728)
........+.+++.+||+.+|++||++.++++.|+.+
T Consensus 265 --------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 265 --------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred --------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0111234677899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=309.15 Aligned_cols=257 Identities=27% Similarity=0.441 Sum_probs=201.8
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeC----CCCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCcce
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKT----ASGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRL 508 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 508 (728)
..+.+.++||+|+||.||+|..+. ..+..||+|.+.... ......+.+|+.+++.++|+||+++++++......+
T Consensus 6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (288)
T cd05061 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTL 85 (288)
T ss_pred HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 445667899999999999997642 234589999886433 233456889999999999999999999999999999
Q ss_pred eEeeccCCCCHHHHHhcC----------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEcc
Q 047292 509 LVYEFMGNGTLANLIFAI----------PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISD 578 (728)
Q Consensus 509 lv~e~~~~gsL~~~l~~~----------~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~D 578 (728)
+||||+++|+|.+++... +..++..+..++.|++.||.|||++ +|+||||||+||++++++.+||+|
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~D 162 (288)
T cd05061 86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGD 162 (288)
T ss_pred EEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEECc
Confidence 999999999999999742 3346678899999999999999997 999999999999999999999999
Q ss_pred ccCccccccCCC-cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhh
Q 047292 579 FGLSKLLLSDHS-RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCY 656 (728)
Q Consensus 579 fgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 656 (728)
||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||.....++.... .
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~--------~ 234 (288)
T cd05061 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF--------V 234 (288)
T ss_pred CCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--------H
Confidence 999986543222 11122335678999999999899999999999999999999 6778865433322111 1
Q ss_pred hcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 047292 657 VEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710 (728)
Q Consensus 657 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 710 (728)
..+..... .......+.+++.+||+.+|++||++.++++.|++.+
T Consensus 235 ~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 235 MDGGYLDQ---------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HcCCCCCC---------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 11111110 1112356788999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=307.21 Aligned_cols=257 Identities=24% Similarity=0.340 Sum_probs=202.0
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCc----EEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCccee
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGN----AIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLL 509 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 509 (728)
...+.+.||+|+||.||+|.... +++ .||+|+++... ......+.+|+.+++.++|+||+++++++.. ...++
T Consensus 8 ~~~~~~~lg~G~~g~vy~~~~~~-~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 8 ELKKVKVLGSGAFGTVYKGIWIP-DGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred heeeeeecCCCCCceEEEEEEec-CCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 34456789999999999998753 333 58999986533 3345788999999999999999999999875 45789
Q ss_pred EeeccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccC
Q 047292 510 VYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD 588 (728)
Q Consensus 510 v~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 588 (728)
++||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 99999999999999874 5689999999999999999999997 9999999999999999999999999999876433
Q ss_pred CCcc-cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceecc
Q 047292 589 HSRT-HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALID 666 (728)
Q Consensus 589 ~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 666 (728)
.... .....++..|+|||.+.+..++.++||||||+++|||++ |..||...........+ ..+....
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~--------~~~~~~~--- 231 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL--------EKGERLP--- 231 (279)
T ss_pred cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH--------HCCCcCC---
Confidence 2211 112234678999999999999999999999999999998 88888654332221111 1111000
Q ss_pred chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCC
Q 047292 667 SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVP 713 (728)
Q Consensus 667 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~ 713 (728)
........+.+++.+||+.||++||++.++++.|+.+...+
T Consensus 232 ------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 232 ------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 01122345778999999999999999999999998876555
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=303.78 Aligned_cols=241 Identities=25% Similarity=0.400 Sum_probs=191.0
Q ss_pred hhhCCCceeEEEEeeeeCCC-----------CcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcce
Q 047292 440 EELGRGSFGIVYKGVLKTAS-----------GNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRL 508 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~-----------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 508 (728)
+.||+|+||.||+|...... ...|++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 46899999999999864321 2358999887655555678899999999999999999999999999999
Q ss_pred eEeeccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCc-------eEEcccc
Q 047292 509 LVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFS-------PKISDFG 580 (728)
Q Consensus 509 lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~-------~kl~Dfg 580 (728)
+||||+++++|..++... ..+++..++.++.||++||+|||+. +|+||||||+|||++.++. +|++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999998754 5689999999999999999999997 9999999999999987664 8999999
Q ss_pred CccccccCCCcccccccCCccccCccccc-CCCCCCccchhhHHHHHHHHH-hCCcCcchhhhHhhhhhHHHHHHHhhhc
Q 047292 581 LSKLLLSDHSRTHTMIRGTRGYVAPEWLK-NAPVSAKVDVYSFGVMLLEII-CCRRSVEMELEEESRAILTDWAYDCYVE 658 (728)
Q Consensus 581 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~~DVwSlGvil~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 658 (728)
++...... ....++..|+|||.+. +..++.++||||||+++|||+ +|+.|+......+.... ..
T Consensus 158 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~---------~~ 223 (262)
T cd05077 158 IPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF---------YE 223 (262)
T ss_pred CCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH---------Hh
Confidence 98755322 2234678899999987 567899999999999999998 57777764332221110 01
Q ss_pred CccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047292 659 GRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLE 707 (728)
Q Consensus 659 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~ 707 (728)
+.. ... ......+.+++.+||+.||.+||++++|++.|+
T Consensus 224 ~~~-~~~---------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 224 GQC-MLV---------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred cCc-cCC---------CCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 110 000 111345778999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=310.47 Aligned_cols=249 Identities=27% Similarity=0.313 Sum_probs=198.6
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch---hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
+..+.||+|+||.||++... .+++.||+|++..... .....+.+|+.+++.++|+||+++++.+......++||||
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 3 RHYRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred eEEEEEecCCCeEEEEEEEc-CCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 44578999999999999865 4688999999865322 2235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 514 MGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 514 ~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05605 82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET- 157 (285)
T ss_pred cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc-
Confidence 9999999888654 4688999999999999999999997 999999999999999999999999999987543221
Q ss_pred ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhh
Q 047292 592 THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAA 671 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 671 (728)
.....|++.|+|||++.+..++.++||||||+++|||++|+.||...........+... ..... .
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~----~~~~~----------~ 222 (285)
T cd05605 158 -IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERR----VKEDQ----------E 222 (285)
T ss_pred -cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHH----hhhcc----------c
Confidence 12345899999999999999999999999999999999999999754332211111110 00000 0
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 047292 672 MADRSRLHKWLMIAMWCIQEDPSKRP-----TMKVVMQM 705 (728)
Q Consensus 672 ~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~ 705 (728)
.........+.+++.+||+.||.+|| +++++++.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 223 EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 11222345677899999999999999 88888653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=303.08 Aligned_cols=248 Identities=26% Similarity=0.369 Sum_probs=200.9
Q ss_pred hhhCCCceeEEEEeeeeCCCCc--EEEEEEecccch-hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCC
Q 047292 440 EELGRGSFGIVYKGVLKTASGN--AIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGN 516 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~--~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 516 (728)
++||+|++|.||+|.+....++ .||+|.+..... ...+.+.+|+.++++++|+||+++++.+.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 4689999999999998653443 699999977555 556789999999999999999999999988 889999999999
Q ss_pred CCHHHHHhcCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc--c
Q 047292 517 GTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR--T 592 (728)
Q Consensus 517 gsL~~~l~~~~--~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~--~ 592 (728)
++|.+++.... .+++..++.++.|+++||+|||+. +++|+||||+||+++.++.+||+|||+++........ .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999998754 678999999999999999999997 9999999999999999999999999999876443221 1
Q ss_pred cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAA 671 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 671 (728)
.....++..|+|||.+.+..++.++||||||++++||++ |+.||......+....+. . ......
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~----~---~~~~~~-------- 221 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKID----K---EGERLE-------- 221 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH----h---cCCcCC--------
Confidence 123446788999999999999999999999999999999 999986543332211110 0 000000
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047292 672 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLE 707 (728)
Q Consensus 672 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~ 707 (728)
........+.+++.+||+.+|++||++.+|++.|.
T Consensus 222 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 -RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 01122356778999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=304.17 Aligned_cols=249 Identities=22% Similarity=0.287 Sum_probs=200.3
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc-----hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEe
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA-----QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 511 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 511 (728)
...+.||+|++|.||++... .+++.|++|.+.... ......+.+|++++++++|+||+++++++......++|+
T Consensus 5 ~~~~~lg~g~~~~vy~~~~~-~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 83 (263)
T cd06625 5 RRGKLLGQGAFGRVYLCYDV-DTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM 83 (263)
T ss_pred cccceecCCCceEEEEEEEc-CCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence 44578999999999999865 567899999885422 122357889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 512 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 512 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
||+++++|.+++.....+++.....++.|++.||.|||+. +++|+||+|+||++++++.++|+|||+++........
T Consensus 84 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~ 160 (263)
T cd06625 84 EYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS 160 (263)
T ss_pred EECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence 9999999999998888889999999999999999999997 9999999999999999999999999998765432221
Q ss_pred cc--ccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchh
Q 047292 592 TH--TMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDE 669 (728)
Q Consensus 592 ~~--~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 669 (728)
.. ....++..|+|||.+.+..++.++||||||+++|||++|+.||............ ......
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~--------~~~~~~------- 225 (263)
T cd06625 161 GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKI--------ATQPTN------- 225 (263)
T ss_pred cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHH--------hccCCC-------
Confidence 11 2345788999999999999999999999999999999999998654322111100 000000
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 670 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 670 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
...+......+.+++.+||+.+|.+|||++++++.
T Consensus 226 -~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 -PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 01112233456789999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=305.74 Aligned_cols=254 Identities=27% Similarity=0.400 Sum_probs=201.5
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCC--cEEEEEEeccc-chhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASG--NAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~--~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
+.+.+.||+|+||.||+|..+.... ..|+||.++.. ......+|..|+.++++++||||+++++++......++|||
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 85 (269)
T cd05065 6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITE 85 (269)
T ss_pred eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEe
Confidence 4566889999999999998864322 36999998754 34445789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 513 FMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 513 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
|+++++|.+++... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++.........
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~ 162 (269)
T cd05065 86 FMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 162 (269)
T ss_pred cCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCccc
Confidence 99999999999764 5678999999999999999999997 9999999999999999999999999998765433221
Q ss_pred c-cc-ccc--CCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceecc
Q 047292 592 T-HT-MIR--GTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALID 666 (728)
Q Consensus 592 ~-~~-~~~--gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 666 (728)
. .. ... .+..|+|||.+.+..++.++||||||+++||+++ |..||...........+ .. ...+.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i----~~---~~~~~---- 231 (269)
T cd05065 163 PTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI----EQ---DYRLP---- 231 (269)
T ss_pred cccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHH----Hc---CCcCC----
Confidence 1 11 111 2457999999999999999999999999999887 99998654333211111 00 00000
Q ss_pred chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 047292 667 SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGL 709 (728)
Q Consensus 667 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 709 (728)
........+.+++.+||+.+|.+||++++|+++|+.+
T Consensus 232 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 232 ------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0112234567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=308.04 Aligned_cols=255 Identities=28% Similarity=0.435 Sum_probs=203.3
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeC----CCCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCcce
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKT----ASGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRL 508 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 508 (728)
..+.+.+.||+|+||.||+|..+. ..+..|++|.+.... ......+.+|+.+++.++|+||+++++++......+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 344556789999999999998753 234789999986543 344567899999999999999999999999999999
Q ss_pred eEeeccCCCCHHHHHhcC----------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEcc
Q 047292 509 LVYEFMGNGTLANLIFAI----------PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISD 578 (728)
Q Consensus 509 lv~e~~~~gsL~~~l~~~----------~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~D 578 (728)
+||||+++++|.+++... ..+++..++.++.|++.||.|||+. +++||||||+||++++++.+||+|
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEECC
Confidence 999999999999998653 2367888999999999999999987 999999999999999999999999
Q ss_pred ccCccccccCCC-cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhh
Q 047292 579 FGLSKLLLSDHS-RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCY 656 (728)
Q Consensus 579 fgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 656 (728)
||+++....... .......++..|+|||.+.+..++.++||||||+++||+++ |+.||...........+
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~-------- 234 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV-------- 234 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHH--------
Confidence 999986643322 12233446788999999998889999999999999999998 88888654433221111
Q ss_pred hcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 047292 657 VEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEG 708 (728)
Q Consensus 657 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 708 (728)
..+...... ......+.+++.+||+.+|++|||+.++++.|+.
T Consensus 235 ~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 235 IDGGHLDLP---------ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred hcCCCCCCC---------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 111111111 1124567889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=314.25 Aligned_cols=252 Identities=28% Similarity=0.352 Sum_probs=211.6
Q ss_pred HHHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchh---hHHHHHHHHHHhcccc-ccceeeEeeeeecCCcce
Q 047292 433 DATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQE---REREFKSEVSAIGRTH-HKNLVQLLGFCDEALNRL 508 (728)
Q Consensus 433 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~ 508 (728)
...|.+.++||+|.||.||+++.+ .+|+.+|+|.+.+.... ....+.+|+.+|+++. |||||.+.+.++.....+
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~-~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREK-STGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEec-CCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 344666789999999999999887 56899999999764432 3468999999999998 999999999999999999
Q ss_pred eEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcC----CCceEEccccCccc
Q 047292 509 LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDH----YFSPKISDFGLSKL 584 (728)
Q Consensus 509 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~----~~~~kl~Dfgla~~ 584 (728)
+|||++.||.|.+.+... .+++.....++.|++.++.|||+. +|+||||||+|+|+.. ++.+|++|||++..
T Consensus 113 lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred EEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 999999999999999877 489999999999999999999996 9999999999999963 35799999999998
Q ss_pred cccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCcccee
Q 047292 585 LLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDAL 664 (728)
Q Consensus 585 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (728)
... .......+||+.|+|||++....|+..+||||+|+++|.|++|..||...........+ ..++. -
T Consensus 189 ~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i--------~~~~~--~ 256 (382)
T KOG0032|consen 189 IKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAI--------LRGDF--D 256 (382)
T ss_pred ccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHH--------HcCCC--C
Confidence 765 44556678999999999999999999999999999999999999999987765543322 12221 0
Q ss_pred ccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 665 IDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 665 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
+ .........+.+.+++..++..||.+|+|+.++++.
T Consensus 257 f----~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 257 F----TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred C----CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 1 111122335567789999999999999999999984
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=319.55 Aligned_cols=242 Identities=26% Similarity=0.288 Sum_probs=192.5
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHH-HhccccccceeeEeeeeecCCcceeEeeccC
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVS-AIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
+.||+|+||.||++..+ .+++.||+|++.... ......+..|.. +++.++||||+++++.+......++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRK-LDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCC
Confidence 36899999999999875 578899999986532 223345555555 4677899999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccccc
Q 047292 516 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM 595 (728)
Q Consensus 516 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 595 (728)
+|+|..++.....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...... .....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~ 155 (325)
T cd05604 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTTT 155 (325)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCccc
Confidence 999999998888899999999999999999999997 99999999999999999999999999987532221 12234
Q ss_pred ccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcH
Q 047292 596 IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADR 675 (728)
Q Consensus 596 ~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 675 (728)
..|++.|+|||++.+..++.++||||||+++|||++|+.||......+....+ ....+. + .+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~--------~~~~~~--~--------~~ 217 (325)
T cd05604 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNI--------LHKPLV--L--------RP 217 (325)
T ss_pred ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHH--------HcCCcc--C--------CC
Confidence 56899999999999999999999999999999999999999755433221111 111110 0 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 676 SRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 676 ~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
.....+.+++.+|++.+|.+||++++.++
T Consensus 218 ~~~~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 218 GASLTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred CCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 12345668999999999999998864433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=317.59 Aligned_cols=238 Identities=25% Similarity=0.271 Sum_probs=190.1
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccch---hhHHHHHHHHH-HhccccccceeeEeeeeecCCcceeEeeccC
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ---EREREFKSEVS-AIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
+.||+|+||.||++..+ .+++.||+|++..... .....+..|.. +++.++|+||+++++.+......++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRK-SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 36899999999999876 5678999999865321 22344555554 5788899999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccccc
Q 047292 516 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM 595 (728)
Q Consensus 516 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 595 (728)
+++|..++.....+++..+..++.||++||.|||+. +|+||||||+||+++.++.+||+|||+++...... .....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (321)
T cd05603 80 GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTST 155 (321)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Ccccc
Confidence 999999998877888999999999999999999987 99999999999999999999999999987532221 12233
Q ss_pred ccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcH
Q 047292 596 IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADR 675 (728)
Q Consensus 596 ~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 675 (728)
..|++.|+|||.+.+..++.++|||||||++|||++|+.||........... ...... ..+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~--------i~~~~~----------~~~~ 217 (321)
T cd05603 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDN--------ILHKPL----------QLPG 217 (321)
T ss_pred ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHH--------HhcCCC----------CCCC
Confidence 5689999999999999999999999999999999999999976543222111 111111 0111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHH
Q 047292 676 SRLHKWLMIAMWCIQEDPSKRPTMK 700 (728)
Q Consensus 676 ~~~~~l~~l~~~cl~~dp~~RPt~~ 700 (728)
.....+.+++.+||+.+|.+||+..
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 218 GKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCHHHHHHHHHHccCCHhhcCCCC
Confidence 2234577899999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=325.28 Aligned_cols=250 Identities=23% Similarity=0.277 Sum_probs=196.4
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
.+.++||+|+||.||++..+ .+++.||||++.... ......+.+|++++++++||||+++++++.+....++||||
T Consensus 4 ~~~~~lG~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~ 82 (377)
T cd05629 4 HTVKVIGKGAFGEVRLVQKK-DTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEF 82 (377)
T ss_pred eEeEEEeecCCEEEEEEEEC-CCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeC
Confidence 34578999999999999876 578899999986432 22346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc--
Q 047292 514 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR-- 591 (728)
Q Consensus 514 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-- 591 (728)
+++|+|.+++.....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 83 ~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 159 (377)
T cd05629 83 LPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY 159 (377)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence 99999999998888889999999999999999999997 9999999999999999999999999999643211000
Q ss_pred --------------------------------------------ccccccCCccccCcccccCCCCCCccchhhHHHHHH
Q 047292 592 --------------------------------------------THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLL 627 (728)
Q Consensus 592 --------------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ 627 (728)
......||+.|+|||++.+..++.++|||||||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ 239 (377)
T cd05629 160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMF 239 (377)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhh
Confidence 001245899999999999999999999999999999
Q ss_pred HHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCC---CCHHHHHH
Q 047292 628 EIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKR---PTMKVVMQ 704 (728)
Q Consensus 628 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R---Pt~~evl~ 704 (728)
||++|+.||...........+..+. ..+ .+.+ .......+.+++.+|++ +|.+| +++.++++
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~------~~~-~~p~-------~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~ 304 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRKIINWR------ETL-YFPD-------DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS 304 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHHHHccC------Ccc-CCCC-------CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhc
Confidence 9999999997654433222111110 000 0000 00122456678888997 66665 59999887
Q ss_pred H
Q 047292 705 M 705 (728)
Q Consensus 705 ~ 705 (728)
.
T Consensus 305 h 305 (377)
T cd05629 305 H 305 (377)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=304.67 Aligned_cols=255 Identities=20% Similarity=0.325 Sum_probs=203.8
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
+.+.+.||+|+||.||++..+ .+++.++||.+.... .....++.+|+.+++.++|+||+++++++...+..+++||
T Consensus 4 y~~~~~ig~g~~g~v~~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 4 FRIEKKIGRGQFSEVYRATCL-LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhcccCCeEEEEEeec-CCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 456788999999999999875 467899999875422 2334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhc----CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccC
Q 047292 513 FMGNGTLANLIFA----IPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD 588 (728)
Q Consensus 513 ~~~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 588 (728)
|+++++|.+++.. ...+++..++.++.||++||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 9999999998863 34678899999999999999999997 9999999999999999999999999998766433
Q ss_pred CCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccch
Q 047292 589 HSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSD 668 (728)
Q Consensus 589 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 668 (728)
... .....++..|+|||.+.+..++.++||||||+++|||++|..||........ ... . ..........
T Consensus 160 ~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~-~----~~~~~~~~~~---- 228 (267)
T cd08229 160 TTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SLC-K----KIEQCDYPPL---- 228 (267)
T ss_pred Ccc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH-HHh-h----hhhcCCCCCC----
Confidence 221 2234578899999999999999999999999999999999999864322111 000 0 0001000000
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 047292 669 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGL 709 (728)
Q Consensus 669 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 709 (728)
........+.+++.+||+.+|.+||||.+|+++++++
T Consensus 229 ----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 229 ----PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred ----CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 0112345677899999999999999999999999765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=305.28 Aligned_cols=255 Identities=27% Similarity=0.393 Sum_probs=202.6
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCC--CcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEe
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTAS--GNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 511 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~--~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 511 (728)
.+.+.+.||+|+||.||+|.....+ +..+|+|.++... ......+.+|+.++++++||||+++++++......++||
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (267)
T cd05066 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVT 84 (267)
T ss_pred HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEE
Confidence 3455688999999999999875333 3479999986533 334568899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC
Q 047292 512 EFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 512 e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 590 (728)
||+++++|.+++... ..+++..++.++.|++.||+|||+. +++|+||||+||++++++.++|+|||++........
T Consensus 85 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd05066 85 EYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 161 (267)
T ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccccccc
Confidence 999999999999765 4678899999999999999999997 999999999999999999999999999987654322
Q ss_pred cccc--cccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccc
Q 047292 591 RTHT--MIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDS 667 (728)
Q Consensus 591 ~~~~--~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 667 (728)
.... ...++..|+|||.+.+..++.++||||||+++||+++ |+.||......+....+ ..+. ..
T Consensus 162 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~--------~~~~--~~--- 228 (267)
T cd05066 162 AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI--------EEGY--RL--- 228 (267)
T ss_pred eeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHH--------hCCC--cC---
Confidence 2111 1223567999999999899999999999999999887 99998654332211111 1110 00
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 047292 668 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGL 709 (728)
Q Consensus 668 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 709 (728)
.........+.+++.+|++.+|.+||+|.++++.|+++
T Consensus 229 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 ----PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ----CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 00111234667899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=305.90 Aligned_cols=246 Identities=26% Similarity=0.346 Sum_probs=193.5
Q ss_pred hCCCceeEEEEeeeeCCCCcEEEEEEecccch---hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCCCC
Q 047292 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGT 518 (728)
Q Consensus 442 lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 518 (728)
||+|+||.||++..+ .+++.||+|.+..... .....+..|++++++++||||+++++.+......++||||+++++
T Consensus 1 lg~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVK-NTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEc-cCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence 799999999999876 4688999999864221 223456679999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccccc
Q 047292 519 LANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMI 596 (728)
Q Consensus 519 L~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 596 (728)
|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||++++++.++|+|||++....... .....
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~ 154 (277)
T cd05607 80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQR 154 (277)
T ss_pred HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeecc
Confidence 99888654 3578888999999999999999997 99999999999999999999999999987664322 22234
Q ss_pred cCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHH
Q 047292 597 RGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRS 676 (728)
Q Consensus 597 ~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 676 (728)
.|+..|+|||++.+..++.++|||||||++|||++|+.||...........+. .......+. . ....
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~----~-----~~~~ 221 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELK----RRTLEDEVK----F-----EHQN 221 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHH----HHhhccccc----c-----cccc
Confidence 58899999999999899999999999999999999999986432211111110 001111110 0 0011
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047292 677 RLHKWLMIAMWCIQEDPSKRPTMKVVMQML 706 (728)
Q Consensus 677 ~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 706 (728)
....+.+++.+||+.||.+||+++|+++.+
T Consensus 222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 222 FTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred CCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 234577899999999999999998776444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=302.84 Aligned_cols=252 Identities=27% Similarity=0.402 Sum_probs=190.9
Q ss_pred hhhCCCceeEEEEeeeeC-CCCcEEEEEEecccch-hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCCC
Q 047292 440 EELGRGSFGIVYKGVLKT-ASGNAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNG 517 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 517 (728)
+.||+|+||.||+|.... .++..+++|+++.... .....+.+|+.++++++|+||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998653 3446799999865432 33467899999999999999999999999999999999999999
Q ss_pred CHHHHHhcC-----CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc-
Q 047292 518 TLANLIFAI-----PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR- 591 (728)
Q Consensus 518 sL~~~l~~~-----~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~- 591 (728)
+|.+++... ...++..+..++.|+++||+|||+. +++|+||||+||++++++++||+|||+++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 999999753 2356677889999999999999997 9999999999999999999999999998754332221
Q ss_pred ccccccCCccccCcccccCC-------CCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccce
Q 047292 592 THTMIRGTRGYVAPEWLKNA-------PVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDA 663 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~~-------~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (728)
......++..|+|||++.+. .++.++||||||+++|||++ |+.||......+..... ..+....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~--------~~~~~~~ 229 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT--------VREQQLK 229 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHH--------hhcccCC
Confidence 12234467889999998643 35789999999999999996 99998654333211110 0011111
Q ss_pred eccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047292 664 LIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLE 707 (728)
Q Consensus 664 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~ 707 (728)
..++.... ...+.+.+++..|+ .+|++|||+++|++.|+
T Consensus 230 ~~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11111111 11234566888898 58999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=302.40 Aligned_cols=247 Identities=25% Similarity=0.373 Sum_probs=202.2
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
.+.+.||+|++|.||++..+ .+++.|++|.+... .......+.+|+++++.++|+||+++++++......++|+||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08529 3 EILNKIGKGSFGVVFKVVRK-ADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA 81 (256)
T ss_pred eEeEEecCCCCeEEEEEEEc-CCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence 34578999999999999876 56789999998542 3345678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 515 GNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 515 ~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
++++|.+++... ..+++..++.++.|++.||.|||+. +++|+||||+||++++++.+||+|||+++....... .
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-~ 157 (256)
T cd08529 82 ENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-F 157 (256)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc-h
Confidence 999999999874 5678899999999999999999987 999999999999999999999999999886644322 2
Q ss_pred cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAM 672 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 672 (728)
.....+++.|+|||++.+..++.++||||||++++||++|+.||.......... ....+....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--------~~~~~~~~~--------- 220 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALIL--------KIIRGVFPP--------- 220 (256)
T ss_pred hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH--------HHHcCCCCC---------
Confidence 233457889999999999999999999999999999999999997654322111 111111111
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 673 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 673 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
........+.+++.+||+.+|++||++.++++.
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 221 VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 111233567889999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=303.01 Aligned_cols=250 Identities=26% Similarity=0.384 Sum_probs=198.2
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
.+.+.++||+|+||.||++..+ .+..+++|.+.... ...+.+.+|++++++++|+|++++++++.. ...+++|||+
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~--~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05069 7 SLRLDVKLGQGCFGEVWMGTWN--GTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFM 82 (260)
T ss_pred HeeeeeeecCcCCCeEEEEEEc--CCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcC
Confidence 3556678999999999999875 34579999886432 234678899999999999999999998854 5688999999
Q ss_pred CCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 515 GNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 515 ~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 999999999764 3478899999999999999999987 99999999999999999999999999998664332222
Q ss_pred cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAA 671 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 671 (728)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.... ...+...
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~--------~~~~~~~--------- 222 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQ--------VERGYRM--------- 222 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--------HHcCCCC---------
Confidence 222345678999999998899999999999999999999 8888875433221111 1111000
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 047292 672 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEG 708 (728)
Q Consensus 672 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 708 (728)
.........+.+++.+||+.+|++||++++|+++|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0111234567789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=302.72 Aligned_cols=247 Identities=28% Similarity=0.397 Sum_probs=202.7
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
.+.+.+.||+|+||.||++... ++.||+|.++.... ..+++.+|+.+++.++|+||+++++++......++||||+
T Consensus 7 ~~~~~~~ig~g~~g~v~~~~~~---~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 7 ELKLGATIGKGEFGDVMLGDYR---GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hccceeeeecCCCceEEEEEec---CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 3456688999999999999863 78999999976544 4678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 515 GNGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 515 ~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 9999999998765 689999999999999999999997 999999999999999999999999999987632221
Q ss_pred cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAA 671 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 671 (728)
....+..|+|||.+....++.++||||||++++|+++ |+.||...........+ ..+....
T Consensus 158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~--------~~~~~~~-------- 219 (256)
T cd05039 158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHV--------EKGYRME-------- 219 (256)
T ss_pred --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH--------hcCCCCC--------
Confidence 2234667999999998889999999999999999997 88888654333221111 1110000
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 047292 672 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGL 709 (728)
Q Consensus 672 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 709 (728)
........+.+++.+||+.+|++||++++++++|+.+
T Consensus 220 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 220 -APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred -CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 0112235677899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=313.47 Aligned_cols=255 Identities=27% Similarity=0.410 Sum_probs=199.2
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCc--EEEEEEecccc-hhhHHHHHHHHHHhccc-cccceeeEeeeeecCCcceeE
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGN--AIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLV 510 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~--~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv 510 (728)
.+.+.+.||+|+||.||+|.++. ++. .+++|.++... ......+.+|++++.++ +|+||+++++++......++|
T Consensus 8 ~~~~~~~lg~G~~g~V~~a~~~~-~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 8 DIKFQDVIGEGNFGQVLKARIKK-DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hceeeeeecCCCCceEEEEEEcc-CCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 34566889999999999998763 343 56888876532 33456889999999999 899999999999999999999
Q ss_pred eeccCCCCHHHHHhcC----------------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCce
Q 047292 511 YEFMGNGTLANLIFAI----------------PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSP 574 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~ 574 (728)
+||+++++|.+++... ..+++..++.++.|++.||+|||+. +++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence 9999999999999743 2467889999999999999999987 99999999999999999999
Q ss_pred EEccccCccccccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHH
Q 047292 575 KISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAY 653 (728)
Q Consensus 575 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 653 (728)
||+|||+++...... ......++..|+|||.+.+..++.++||||||++++||+| |..||......+....+
T Consensus 164 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~----- 236 (303)
T cd05088 164 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL----- 236 (303)
T ss_pred EeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH-----
Confidence 999999986431111 1111224667999999988889999999999999999998 99998654333211111
Q ss_pred HhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 047292 654 DCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEV 712 (728)
Q Consensus 654 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 712 (728)
..+.... ........+.+++.+||+.+|++||+++++++.|+.++..
T Consensus 237 ---~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 237 ---PQGYRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred ---hcCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1110000 0111234567899999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=306.92 Aligned_cols=253 Identities=26% Similarity=0.386 Sum_probs=198.6
Q ss_pred hhHHhhhCCCceeEEEEeeeeCC----CCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeE
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTA----SGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 510 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~----~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 510 (728)
+.+.+.||+|+||.||+|.+... .+..|++|.+.... ......+..|+.+++.++|+||+++++++.+....++|
T Consensus 8 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 87 (277)
T cd05036 8 ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFIL 87 (277)
T ss_pred cEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEE
Confidence 34457899999999999988642 45789999886433 33456789999999999999999999999999999999
Q ss_pred eeccCCCCHHHHHhcCC-------CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCC---ceEEcccc
Q 047292 511 YEFMGNGTLANLIFAIP-------KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYF---SPKISDFG 580 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~~-------~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~---~~kl~Dfg 580 (728)
|||+++++|.+++.... .+++..+++++.||+.||+|||+. +++|+||||+||+++.++ .+||+|||
T Consensus 88 ~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~dfg 164 (277)
T cd05036 88 LELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFG 164 (277)
T ss_pred EecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEeccCc
Confidence 99999999999987642 478899999999999999999997 899999999999998654 59999999
Q ss_pred CccccccCCCc-ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhc
Q 047292 581 LSKLLLSDHSR-THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVE 658 (728)
Q Consensus 581 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 658 (728)
+++........ .......+..|+|||++.+..++.++|||||||++|||++ |..||...........+ .. .
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~----~~---~ 237 (277)
T cd05036 165 MARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV----TG---G 237 (277)
T ss_pred cccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH----Hc---C
Confidence 99876322211 1112223568999999999999999999999999999997 88898754433221111 00 0
Q ss_pred CccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 047292 659 GRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEG 708 (728)
Q Consensus 659 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 708 (728)
... ..+......+.+++.+||+.+|++||++.+|++.|+.
T Consensus 238 ~~~----------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 238 GRL----------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred CcC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 000 0111223467789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=326.61 Aligned_cols=250 Identities=20% Similarity=0.258 Sum_probs=195.7
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
.+.+.||+|+||.||++..+ .+++.||||++.... ......+.+|++++++++|+||+++++.+.+.+..++||||
T Consensus 4 ~~~~~lG~G~~g~V~~a~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (376)
T cd05598 4 VKIKTIGIGAFGEVCLVRKV-DTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (376)
T ss_pred eEEEEEEeCCCeEEEEEEEC-CCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence 45578999999999999876 568899999986532 22346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCC----
Q 047292 514 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH---- 589 (728)
Q Consensus 514 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~---- 589 (728)
+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+....
T Consensus 83 ~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~ 159 (376)
T cd05598 83 IPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (376)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence 99999999998888889999999999999999999997 99999999999999999999999999975331000
Q ss_pred --------------------------------------CcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh
Q 047292 590 --------------------------------------SRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC 631 (728)
Q Consensus 590 --------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt 631 (728)
........||+.|+|||++.+..++.++|||||||++|||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~ 239 (376)
T cd05598 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV 239 (376)
T ss_pred cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhh
Confidence 000112468999999999999999999999999999999999
Q ss_pred CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCC---CHHHHHHH
Q 047292 632 CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRP---TMKVVMQM 705 (728)
Q Consensus 632 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP---t~~evl~~ 705 (728)
|+.||......+....+..+. .. .... ........+.+++.+|+ .+|.+|+ ++.++++.
T Consensus 240 G~~Pf~~~~~~~~~~~i~~~~------~~-~~~~-------~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 240 GQPPFLADTPAETQLKVINWE------TT-LHIP-------SQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred CCCCCCCCCHHHHHHHHhccC------cc-ccCC-------CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999998655433222111110 00 0000 00111234455666665 5999999 88888755
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=313.40 Aligned_cols=262 Identities=27% Similarity=0.349 Sum_probs=204.4
Q ss_pred HHHHHhhHHhhhCCCceeEEEEeeeeCC------CCcEEEEEEecccc-hhhHHHHHHHHHHhccc-cccceeeEeeeee
Q 047292 431 LKDATDGFKEELGRGSFGIVYKGVLKTA------SGNAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKNLVQLLGFCD 502 (728)
Q Consensus 431 l~~~~~~~~~~lg~G~fg~Vy~g~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~ 502 (728)
+....+.+.+.||+|+||.||++..... ....+|+|.++... ......+..|++++..+ +|+||+++++++.
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 3344566778999999999999976421 23469999997532 33456788999999999 7999999999999
Q ss_pred cCCcceeEeeccCCCCHHHHHhcCC----------------CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCE
Q 047292 503 EALNRLLVYEFMGNGTLANLIFAIP----------------KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNI 566 (728)
Q Consensus 503 ~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NI 566 (728)
.....++||||+++++|.+++.... .+++..+++++.|++.||+|||+. +++||||||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Ni 171 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 171 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHhe
Confidence 9999999999999999999997542 367889999999999999999986 999999999999
Q ss_pred EEcCCCceEEccccCccccccCCCcc-cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhh
Q 047292 567 LLDHYFSPKISDFGLSKLLLSDHSRT-HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEES 644 (728)
Q Consensus 567 ll~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~ 644 (728)
++++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||........
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~ 251 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 251 (307)
T ss_pred EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence 99999999999999987654322111 111224568999999999999999999999999999998 7788865433222
Q ss_pred hhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 047292 645 RAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEV 712 (728)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 712 (728)
...+ ..+.... ........+.+++.+||+.+|.+||+|.+|++.|+.+++.
T Consensus 252 ~~~~--------~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 252 FKLL--------KEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHHH--------HcCCCCC---------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 1111 1111000 1112234677899999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=307.17 Aligned_cols=259 Identities=24% Similarity=0.338 Sum_probs=204.7
Q ss_pred HHHhhHHhhhCCCceeEEEEeeeeCC---CCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeec-CCcc
Q 047292 433 DATDGFKEELGRGSFGIVYKGVLKTA---SGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDE-ALNR 507 (728)
Q Consensus 433 ~~~~~~~~~lg~G~fg~Vy~g~~~~~---~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~ 507 (728)
...+.+.+.||+|+||.||+|..... .+..|++|++.... ......+.+|+.++++++|+||+++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 34455678899999999999998742 26789999986543 3445778999999999999999999998765 5778
Q ss_pred eeEeeccCCCCHHHHHhcC--------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccc
Q 047292 508 LLVYEFMGNGTLANLIFAI--------PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDF 579 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~l~~~--------~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Df 579 (728)
++++||+++++|.+++... ..+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998754 3578899999999999999999987 9999999999999999999999999
Q ss_pred cCccccccCCCc-ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhh
Q 047292 580 GLSKLLLSDHSR-THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYV 657 (728)
Q Consensus 580 gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 657 (728)
|+++.+...... ......++..|+|||.+.+..++.++||||||+++||+++ |+.||......+....+ .
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~--------~ 233 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYL--------K 233 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHH--------H
Confidence 999865433221 1122345678999999999899999999999999999999 99998754433211111 1
Q ss_pred cCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 658 EGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 658 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
.+.. + .........+.+++.+||+.+|++|||+.++++.|+.+.+
T Consensus 234 ~~~~---~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 234 DGYR---L------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred cCCC---C------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1100 0 0011123467889999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=305.87 Aligned_cols=252 Identities=29% Similarity=0.445 Sum_probs=201.5
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhH--HHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQERE--REFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
.+.+.||+|+||+||++... .+++.+|+|.+........ .....|+.++++++|+||+++++++......++||||+
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~-~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 2 RLVKKLGSGGFGTVYKAKNK-KNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEESSEEEEEEEET-TTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred EEeEEEEeCCCEEEEEEEEC-CCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 34578999999999999876 5677999999976544333 23456999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccc
Q 047292 515 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHT 594 (728)
Q Consensus 515 ~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 594 (728)
++++|.+++.....+++..+..++.|+++||++||+. +|+|+||||+||++++++.++|+|||.+.... .......
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~~~ 156 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNENFN 156 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSEBS
T ss_pred ccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-ccccccc
Confidence 9999999999778889999999999999999999997 99999999999999999999999999997641 2222334
Q ss_pred cccCCccccCccccc-CCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhh
Q 047292 595 MIRGTRGYVAPEWLK-NAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMA 673 (728)
Q Consensus 595 ~~~gt~~y~aPE~~~-~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 673 (728)
...++..|+|||++. +..++.++||||||+++++|++|+.|+...........+........ . . ....
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~-----~----~--~~~~ 225 (260)
T PF00069_consen 157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPL-----P----S--SSQQ 225 (260)
T ss_dssp SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHH-----H----H--HTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccc-----c----c--cccc
Confidence 456889999999998 88899999999999999999999999986522222221111111000 0 0 0000
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 674 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 674 ~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
.......+.+++.+||+.||++||+++++++
T Consensus 226 ~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 226 SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0011267889999999999999999999986
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=331.07 Aligned_cols=250 Identities=26% Similarity=0.304 Sum_probs=199.5
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeeecCC-------
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEAL------- 505 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------- 505 (728)
.|.+.+.||+|+||.||++... .+++.||||++... .......+.+|+.++..++|+|++++...+....
T Consensus 33 rY~i~~~LG~G~fG~Vy~a~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~ 111 (496)
T PTZ00283 33 KYWISRVLGSGATGTVLCAKRV-SDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV 111 (496)
T ss_pred CEEEEEEEecCCCEEEEEEEEc-CCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence 4556788999999999999876 56889999998543 3344567889999999999999999988775432
Q ss_pred -cceeEeeccCCCCHHHHHhcC----CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEcccc
Q 047292 506 -NRLLVYEFMGNGTLANLIFAI----PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFG 580 (728)
Q Consensus 506 -~~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg 580 (728)
..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEecc
Confidence 257999999999999998753 4578889999999999999999997 99999999999999999999999999
Q ss_pred CccccccCCC-cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcC
Q 047292 581 LSKLLLSDHS-RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEG 659 (728)
Q Consensus 581 la~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 659 (728)
+++....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.......... ....+
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~--------~~~~~ 260 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMH--------KTLAG 260 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH--------HHhcC
Confidence 9987643322 22234568999999999999999999999999999999999999997554332111 11111
Q ss_pred ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 660 RLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 660 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.... .+......+.+++.+||+.+|.+||++.++++.
T Consensus 261 ~~~~---------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 261 RYDP---------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1111 111223467789999999999999999999864
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=315.17 Aligned_cols=240 Identities=28% Similarity=0.340 Sum_probs=193.8
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhcccc-ccceeeEeeeeecCCcceeEee
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTH-HKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e 512 (728)
++.+.||+|+||.||++..+ .+++.||+|++.... ......+..|..++..+. |++|+++++++......++|||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 3 NFLMVLGKGSFGKVMLAERK-GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred eEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 45678999999999999875 568899999986532 223456778888888875 6788899999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 513 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 513 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
|+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++....... .
T Consensus 82 y~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~-~ 157 (323)
T cd05615 82 YVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV-T 157 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCCc-c
Confidence 999999999998888899999999999999999999997 999999999999999999999999999875432221 2
Q ss_pred cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAM 672 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 672 (728)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...........+ ......
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i--------~~~~~~---------- 219 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI--------MEHNVS---------- 219 (323)
T ss_pred ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH--------HhCCCC----------
Confidence 23345899999999999999999999999999999999999999765443222111 111110
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCH
Q 047292 673 ADRSRLHKWLMIAMWCIQEDPSKRPTM 699 (728)
Q Consensus 673 ~~~~~~~~l~~l~~~cl~~dp~~RPt~ 699 (728)
.+......+.+++.+||+.+|.+|++.
T Consensus 220 ~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 220 YPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 011123456789999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=308.74 Aligned_cols=263 Identities=24% Similarity=0.357 Sum_probs=202.0
Q ss_pred HHhhHHhhhCCCceeEEEEeeee---CCCCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecC--Ccc
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLK---TASGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEA--LNR 507 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~---~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~ 507 (728)
.++...++||+|+||.||++... ..++..||+|.++... ......+.+|+.+++.++|+||+++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 34556678999999999999753 2457789999987543 33456799999999999999999999998775 567
Q ss_pred eeEeeccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccc
Q 047292 508 LLVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLL 586 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 586 (728)
++||||+++++|.+++... ..+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||+++...
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccccc
Confidence 8999999999999999765 4578999999999999999999997 99999999999999999999999999998764
Q ss_pred cCCCc--ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhh--------hhHHHHHHHhh
Q 047292 587 SDHSR--THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESR--------AILTDWAYDCY 656 (728)
Q Consensus 587 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~ 656 (728)
..... ......++..|+|||.+.+..++.++||||||+++|||++++.|.......... ..... .....
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 239 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTR-LVRVL 239 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHH-HHHHH
Confidence 33221 112344677899999999889999999999999999999987664322110000 00000 00001
Q ss_pred hcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 047292 657 VEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGL 709 (728)
Q Consensus 657 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 709 (728)
..+... .........+.+++.+||+.+|.+||+++++++.|+++
T Consensus 240 ~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 240 EEGKRL---------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HcCccC---------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111100 01112345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=318.94 Aligned_cols=244 Identities=26% Similarity=0.357 Sum_probs=202.7
Q ss_pred hhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCCCCHH
Q 047292 441 ELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLA 520 (728)
Q Consensus 441 ~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 520 (728)
+||+|+||+||.|++. .+...+|||.+........+.+.+|+..-++++|+|||+++|.+.+++..-|.||.+|||+|.
T Consensus 582 VLGKGTYG~VYA~RD~-~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDM-DTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EeecCceeEEEeeccc-cceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 5999999999999887 567889999998776777788999999999999999999999999999999999999999999
Q ss_pred HHHhcC-CCC--ChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEc-CCCceEEccccCccccccCCCcccccc
Q 047292 521 NLIFAI-PKP--DWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLD-HYFSPKISDFGLSKLLLSDHSRTHTMI 596 (728)
Q Consensus 521 ~~l~~~-~~~--~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~~~~ 596 (728)
++|+.. +++ ++..+--+.+||++||.|||++ .|||||||-+|+||+ -.|.+||+|||-++.+..-.. ...+.
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-~TETF 736 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-CTETF 736 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCc-ccccc
Confidence 999875 555 6788888999999999999998 999999999999997 478999999999887643322 33446
Q ss_pred cCCccccCcccccCC--CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhc
Q 047292 597 RGTRGYVAPEWLKNA--PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMAD 674 (728)
Q Consensus 597 ~gt~~y~aPE~~~~~--~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 674 (728)
-||..|||||++..+ .|..++|||||||++.||.||++||...........- -..+ ..-..++
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk----VGmy-----------KvHP~iP 801 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK----VGMY-----------KVHPPIP 801 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh----hcce-----------ecCCCCc
Confidence 699999999999755 5889999999999999999999999755432221110 0000 0112244
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 675 RSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 675 ~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
.+...+...++++|+.++|.+||+++++++
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 566677888999999999999999999986
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=300.73 Aligned_cols=248 Identities=33% Similarity=0.472 Sum_probs=203.5
Q ss_pred hhhCCCceeEEEEeeeeC--CCCcEEEEEEecccchhh-HHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCC
Q 047292 440 EELGRGSFGIVYKGVLKT--ASGNAIAVKKLDRLAQER-EREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGN 516 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~--~~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 516 (728)
+.||+|+||.||++.... ..+..|++|.++...... ...+.+|++.++.++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 468999999999998863 126789999997654433 67899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcC---------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcccccc
Q 047292 517 GTLANLIFAI---------PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS 587 (728)
Q Consensus 517 gsL~~~l~~~---------~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 587 (728)
++|.+++... ..+++..+..++.|++.||+|||++ +++|+||+|+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999885 6789999999999999999999997 999999999999999999999999999987754
Q ss_pred CCC-cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceec
Q 047292 588 DHS-RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALI 665 (728)
Q Consensus 588 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (728)
... .......++..|+|||.+....++.++||||||+++|||++ |..||...........+ ..+...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~--------~~~~~~--- 226 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL--------RKGYRL--- 226 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH--------HcCCCC---
Confidence 331 22233457889999999998899999999999999999999 58888765333221111 111100
Q ss_pred cchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047292 666 DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLE 707 (728)
Q Consensus 666 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~ 707 (728)
.........+.+++.+||+.+|++||+++++++.|+
T Consensus 227 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 ------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 111122456788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=316.43 Aligned_cols=260 Identities=28% Similarity=0.370 Sum_probs=199.5
Q ss_pred HHHhhHHhhhCCCceeEEEEeeee----CCCCcEEEEEEecccc-hhhHHHHHHHHHHhccc-cccceeeEeeeeecC-C
Q 047292 433 DATDGFKEELGRGSFGIVYKGVLK----TASGNAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEA-L 505 (728)
Q Consensus 433 ~~~~~~~~~lg~G~fg~Vy~g~~~----~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-~ 505 (728)
...+.+.+.||+|+||.||+|... ..+++.||||+++... ......+.+|+.++.++ +|+||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 345667889999999999999742 2456789999997533 23346788999999999 789999999988654 4
Q ss_pred cceeEeeccCCCCHHHHHhcC-----------------------------------------------------------
Q 047292 506 NRLLVYEFMGNGTLANLIFAI----------------------------------------------------------- 526 (728)
Q Consensus 506 ~~~lv~e~~~~gsL~~~l~~~----------------------------------------------------------- 526 (728)
..+++|||+++|+|.+++...
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 678999999999999998642
Q ss_pred --------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc-cccccc
Q 047292 527 --------PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR-THTMIR 597 (728)
Q Consensus 527 --------~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~ 597 (728)
..+++..+..++.||++||+|||++ +|+||||||+||++++++++||+|||++......... ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 1256777889999999999999997 9999999999999999999999999999865332221 112234
Q ss_pred CCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHH
Q 047292 598 GTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRS 676 (728)
Q Consensus 598 gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 676 (728)
++..|+|||.+.+..++.++||||||+++|||++ |..|+......... ......+..... +..
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~~~~~~~---------~~~ 306 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-------CRRLKEGTRMRA---------PDY 306 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHH-------HHHHhccCCCCC---------CCC
Confidence 5678999999999999999999999999999997 88888643221110 001111111000 001
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 677 RLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 677 ~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
....+.+++.+||+.+|.+||++.+|++.|+.+++
T Consensus 307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 12357789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=302.59 Aligned_cols=253 Identities=27% Similarity=0.413 Sum_probs=202.8
Q ss_pred HHHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 433 DATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 433 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
...+.+.++||+|+||.||++..+ +++.|+||.+.... ....++.+|+.++++++|+||+++++++......++|||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~--~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN--GTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc--CCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 344556788999999999999865 45789999987533 234678999999999999999999999999899999999
Q ss_pred ccCCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC
Q 047292 513 FMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 513 ~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 590 (728)
|+++++|.+++... ..+++..+..++.|++.||.|||++ +++|+||||+||++++++.+||+|||+++.......
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 99999999999875 3688999999999999999999997 999999999999999999999999999987643322
Q ss_pred cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchh
Q 047292 591 RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDE 669 (728)
Q Consensus 591 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 669 (728)
........+..|+|||.+.+..++.++||||||++++|+++ |+.||........... ...+ ....
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~--------~~~~-~~~~----- 224 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQ--------VERG-YRMP----- 224 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--------HHcC-CCCC-----
Confidence 22222334668999999999899999999999999999999 8999865432221111 0110 0000
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 047292 670 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEG 708 (728)
Q Consensus 670 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 708 (728)
.+......+.+++.+||+.+|.+||+++++.+.|+.
T Consensus 225 ---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 225 ---RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ---CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 011113467889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=320.45 Aligned_cols=254 Identities=21% Similarity=0.240 Sum_probs=197.7
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeE
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 510 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 510 (728)
..+.+.+.||+|+||.||++..+ .+++.+|+|.+.... ......+.+|+.+++.++||||+++++.+......++|
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~~~~-~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLVRHK-STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 121 (371)
T ss_pred hhcEEEEEEeecCCeEEEEEEEC-CCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 44556678999999999999876 567899999986422 22345678999999999999999999999999999999
Q ss_pred eeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC
Q 047292 511 YEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 590 (728)
|||+++|+|.+++... .++...+..++.||+.||+|||+. +|+||||||+|||+++++++||+|||+++.......
T Consensus 122 ~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~ 197 (371)
T cd05622 122 MEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 197 (371)
T ss_pred EcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc
Confidence 9999999999998754 578888899999999999999997 999999999999999999999999999987654333
Q ss_pred cccccccCCccccCcccccCCC----CCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceecc
Q 047292 591 RTHTMIRGTRGYVAPEWLKNAP----VSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALID 666 (728)
Q Consensus 591 ~~~~~~~gt~~y~aPE~~~~~~----~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 666 (728)
.......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...........+. .........
T Consensus 198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~-------~~~~~~~~~- 269 (371)
T cd05622 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM-------NHKNSLTFP- 269 (371)
T ss_pred ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHH-------cCCCcccCC-
Confidence 3334456999999999997543 7889999999999999999999998654432221110 000000011
Q ss_pred chhhhhhcHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 047292 667 SDEAAMADRSRLHKWLMIAMWCIQEDPSK--RPTMKVVMQML 706 (728)
Q Consensus 667 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~--RPt~~evl~~L 706 (728)
........+.+++.+||+..+.+ ||+++++++..
T Consensus 270 ------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 270 ------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred ------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 01122345667888899844433 78999988753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=283.31 Aligned_cols=248 Identities=28% Similarity=0.376 Sum_probs=201.4
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch--------hhHHHHHHHHHHhccc-cccceeeEeeeeecCCcc
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ--------EREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNR 507 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 507 (728)
.-++.||.|..++|-+..++ .++...|+|++..... +..+.-..|+.+|+++ -||+|+++.++++.+...
T Consensus 20 ~pkeilgrgvss~vrRci~k-~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~ 98 (411)
T KOG0599|consen 20 EPKEILGRGVSSVVRRCIHK-ETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFV 98 (411)
T ss_pred ChHHHhcccchhhhhhhhhc-ccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchh
Confidence 34578999999999998877 6778899998854221 1224567899999998 599999999999999999
Q ss_pred eeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcccccc
Q 047292 508 LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS 587 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 587 (728)
++|+|.|+.|.|.++|.+.-.++++...+|++|+.+|++|||.. +|+||||||+|||++++.++||+|||++..+..
T Consensus 99 FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~~l~~ 175 (411)
T KOG0599|consen 99 FLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFACQLEP 175 (411)
T ss_pred hhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceeeccCC
Confidence 99999999999999999988899999999999999999999997 999999999999999999999999999987744
Q ss_pred CCCcccccccCCccccCccccc------CCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCcc
Q 047292 588 DHSRTHTMIRGTRGYVAPEWLK------NAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRL 661 (728)
Q Consensus 588 ~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (728)
. ......+|||+|+|||.+. ...|+...|+|+.|||+|-|+.|.+||-...+......++ +|+.
T Consensus 176 G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Im--------eGky 245 (411)
T KOG0599|consen 176 G--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIM--------EGKY 245 (411)
T ss_pred c--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHH--------hccc
Confidence 3 3456678999999999884 3468889999999999999999999997554333222222 2221
Q ss_pred ceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 662 DALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 662 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
. +- ...-........+++.+||+.||.+|.|++|+++
T Consensus 246 q-F~-----speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 246 Q-FR-----SPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred c-cC-----CcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 0 00 0111223445678999999999999999999885
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=305.55 Aligned_cols=260 Identities=22% Similarity=0.299 Sum_probs=206.0
Q ss_pred HHHHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeE
Q 047292 432 KDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 510 (728)
Q Consensus 432 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 510 (728)
....+.+.+.||+|+||.||++... .+++.||+|++.... ......+.+|+++++.++|+||+++++++......++|
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHI-PTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEc-CCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 3445677899999999999999875 467899999876432 33457889999999999999999999999999999999
Q ss_pred eeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC
Q 047292 511 YEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 590 (728)
|||+++++|.+++.....+++..+..++.+++.||.|||+. .+++|+||+|+||++++++.++|+|||++.......
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence 99999999999998877889999999999999999999973 379999999999999999999999999987543221
Q ss_pred cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhh----hhhHHHHHHHhhhcCccceecc
Q 047292 591 RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEES----RAILTDWAYDCYVEGRLDALID 666 (728)
Q Consensus 591 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~d 666 (728)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||........ ...+........ ......
T Consensus 159 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--- 232 (284)
T cd06620 159 --ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV-QEPPPR--- 232 (284)
T ss_pred --cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh-hccCCC---
Confidence 1234588999999999888999999999999999999999999985443211 111111111111 010000
Q ss_pred chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047292 667 SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQML 706 (728)
Q Consensus 667 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 706 (728)
.........+.+++.+||+.||.+||+++|++++.
T Consensus 233 -----~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 233 -----LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred -----CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 00112334677899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=303.70 Aligned_cols=258 Identities=23% Similarity=0.321 Sum_probs=204.3
Q ss_pred HHHhhHHhhhCCCceeEEEEeeeeCC--CCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCccee
Q 047292 433 DATDGFKEELGRGSFGIVYKGVLKTA--SGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLL 509 (728)
Q Consensus 433 ~~~~~~~~~lg~G~fg~Vy~g~~~~~--~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 509 (728)
...+.+.+.||+|+||.||+|..... ....|++|...... ....+.+.+|+.++++++|+||+++++++.. ...++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 34455668899999999999987533 23478999886654 4455789999999999999999999999875 45789
Q ss_pred EeeccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccC
Q 047292 510 VYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD 588 (728)
Q Consensus 510 v~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 588 (728)
||||+++++|.+++... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++.....
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 99999999999999764 3578999999999999999999987 9999999999999999999999999999876544
Q ss_pred CCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccc
Q 047292 589 HSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDS 667 (728)
Q Consensus 589 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 667 (728)
.........++..|+|||.+....++.++||||||++++|+++ |..||......+....+ ..+....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~--------~~~~~~~---- 228 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI--------ENGERLP---- 228 (270)
T ss_pred cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH--------HcCCcCC----
Confidence 3222223334568999999988889999999999999999996 99998755433221111 1111000
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 668 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 668 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
........+.+++.+|+..+|.+|||+.++++.|+++..
T Consensus 229 -----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 229 -----MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred -----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 111223467789999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=302.23 Aligned_cols=250 Identities=25% Similarity=0.308 Sum_probs=199.9
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccC
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
+.+.++||+|+||.||+|... .++..+++|.+..........+.+|+++++.++|+||+++++++......++|+||++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNK-ETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHhhcccCCCeEEEEEEEC-CCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 456688999999999999876 4678899999876555566788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhc-CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccc
Q 047292 516 NGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHT 594 (728)
Q Consensus 516 ~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 594 (728)
+++|..++.. ...+++..+..++.|+++||.|||+. +++|+||||+||+++.++.+||+|||++........ ...
T Consensus 86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~ 161 (282)
T cd06643 86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RRD 161 (282)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc-ccc
Confidence 9999998765 35689999999999999999999997 999999999999999999999999999876533221 222
Q ss_pred cccCCccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchh
Q 047292 595 MIRGTRGYVAPEWLK-----NAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDE 669 (728)
Q Consensus 595 ~~~gt~~y~aPE~~~-----~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 669 (728)
...++..|+|||++. +..++.++|||||||++|||++|+.||......+....+ . ........
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~---~-----~~~~~~~~---- 229 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKI---A-----KSEPPTLA---- 229 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHH---h-----hcCCCCCC----
Confidence 345889999999984 456788999999999999999999998754332211111 0 00000000
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 670 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 670 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.+......+.+++.+||+.+|.+||++.++++.
T Consensus 230 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 230 ---QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011123467789999999999999999998755
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=308.95 Aligned_cols=263 Identities=24% Similarity=0.333 Sum_probs=201.1
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc-chhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccC
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
.+.+.||+|+||.||++... .++..+++|.++.. .......+.+|++++++++||||+++++++...+..++|+||++
T Consensus 4 ~~~~~lg~G~~g~v~~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~ 82 (308)
T cd06615 4 EKLGELGAGNGGVVTKVLHR-PSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD 82 (308)
T ss_pred eEEeeccCCCCeEEEEEEEc-CCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence 34578999999999999876 46788999988653 23344678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccccc
Q 047292 516 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM 595 (728)
Q Consensus 516 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 595 (728)
+++|.+++.....+++..+..++.|+++||.|||+. .+++|+||||+|||+++++.+||+|||++....... ...
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---~~~ 157 (308)
T cd06615 83 GGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANS 157 (308)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccccc---ccc
Confidence 999999998888889999999999999999999973 389999999999999999999999999987653221 123
Q ss_pred ccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcC-c--------------
Q 047292 596 IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEG-R-------------- 660 (728)
Q Consensus 596 ~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~-------------- 660 (728)
..++..|+|||.+.+..++.++||||||+++|||++|+.||...........+.... ...... .
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 236 (308)
T cd06615 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPV-SEGEAKESHRPVSGHPPDSPRP 236 (308)
T ss_pred CCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCcc-ccccccCCcccccCCCCCccch
Confidence 457889999999988889999999999999999999999986443222111110000 000000 0
Q ss_pred --cceecc----chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047292 661 --LDALID----SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQML 706 (728)
Q Consensus 661 --~~~~~d----~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 706 (728)
..+..+ ..............+.+++.+||+.+|++||++++|++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 237 MAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred hhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 000000 0000000011234578999999999999999999998763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=312.10 Aligned_cols=244 Identities=25% Similarity=0.308 Sum_probs=192.6
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccc-cccceeeEeeeeecCCcceeEeeccC
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
+.||+|+||.||++..+ .+++.||+|+++... ......+..|+.++.++ +|+||+++++++......++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (327)
T cd05617 1 RVIGRGSYAKVLLVRLK-KNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVN 79 (327)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCC
Confidence 36899999999999876 567899999997532 22345688899999888 69999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccccc
Q 047292 516 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM 595 (728)
Q Consensus 516 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 595 (728)
+++|..++.....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++...... .....
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (327)
T cd05617 80 GGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTST 155 (327)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cceec
Confidence 999999998878899999999999999999999997 99999999999999999999999999987532221 12233
Q ss_pred ccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcH
Q 047292 596 IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADR 675 (728)
Q Consensus 596 ~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 675 (728)
..||+.|+|||++.+..++.++||||||+++|||++|+.||.......... ............... .+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~----------~p~ 224 (327)
T cd05617 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN-TEDYLFQVILEKPIR----------IPR 224 (327)
T ss_pred ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccc-cHHHHHHHHHhCCCC----------CCC
Confidence 568999999999999999999999999999999999999996432211100 001111111111110 111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCH
Q 047292 676 SRLHKWLMIAMWCIQEDPSKRPTM 699 (728)
Q Consensus 676 ~~~~~l~~l~~~cl~~dp~~RPt~ 699 (728)
.....+.+++.+||+.||++||++
T Consensus 225 ~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 225 FLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCC
Confidence 123456789999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=305.59 Aligned_cols=261 Identities=22% Similarity=0.324 Sum_probs=199.3
Q ss_pred HhhHHhhhCCCceeEEEEeeee---------------CCCCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEe
Q 047292 435 TDGFKEELGRGSFGIVYKGVLK---------------TASGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLL 498 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~---------------~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~ 498 (728)
.+.+.++||+|+||.||++... ..++..||+|++.... .....++.+|+.+++.++|+||++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~ 85 (296)
T cd05095 6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLL 85 (296)
T ss_pred hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 3556788999999999998532 1233478999997543 33457899999999999999999999
Q ss_pred eeeecCCcceeEeeccCCCCHHHHHhcCC-----------CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEE
Q 047292 499 GFCDEALNRLLVYEFMGNGTLANLIFAIP-----------KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNIL 567 (728)
Q Consensus 499 g~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIl 567 (728)
+++......+++|||+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||||+||+
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Nil 162 (296)
T cd05095 86 AVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCL 162 (296)
T ss_pred EEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheEE
Confidence 99999999999999999999999987642 356678999999999999999997 9999999999999
Q ss_pred EcCCCceEEccccCccccccCCCc-ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh--CCcCcchhhhHhh
Q 047292 568 LDHYFSPKISDFGLSKLLLSDHSR-THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC--CRRSVEMELEEES 644 (728)
Q Consensus 568 l~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt--g~~p~~~~~~~~~ 644 (728)
+++++.++|+|||+++.+...... ......++..|+|||...+..++.++||||||+++|||++ |..||........
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~ 242 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV 242 (296)
T ss_pred EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH
Confidence 999999999999999865433221 1122334678999999888889999999999999999998 6677764433222
Q ss_pred hhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 047292 645 RAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEG 708 (728)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 708 (728)
...... .+........+. ........+.+++.+||+.||++||++.+|++.|++
T Consensus 243 ~~~~~~----~~~~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 243 IENTGE----FFRDQGRQVYLP------KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHH----HHhhccccccCC------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111101 111100000000 011223567789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=308.22 Aligned_cols=262 Identities=27% Similarity=0.414 Sum_probs=204.4
Q ss_pred HhhHHhhhCCCceeEEEEeeee---CCCCcEEEEEEecccchh-hHHHHHHHHHHhccccccceeeEeeeeec--CCcce
Q 047292 435 TDGFKEELGRGSFGIVYKGVLK---TASGNAIAVKKLDRLAQE-REREFKSEVSAIGRTHHKNLVQLLGFCDE--ALNRL 508 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~---~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~ 508 (728)
.+.+.+.||+|+||.||++.+. ..++..||||.++..... ....+.+|+++++.++|+||+++++++.. ....+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 3456688999999999999864 235679999999765443 46789999999999999999999999877 56789
Q ss_pred eEeeccCCCCHHHHHhcCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcccccc
Q 047292 509 LVYEFMGNGTLANLIFAIP-KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS 587 (728)
Q Consensus 509 lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 587 (728)
++|||+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 85 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred EEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 9999999999999998754 689999999999999999999997 999999999999999999999999999987753
Q ss_pred CCCc--ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhh--------hhHHHHHHHhhh
Q 047292 588 DHSR--THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESR--------AILTDWAYDCYV 657 (728)
Q Consensus 588 ~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~ 657 (728)
.... ......++..|+|||.+.+..++.++||||||++++||++|+.|+......... ....... ....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 240 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL-ELLK 240 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH-HHHH
Confidence 3221 111223456799999999889999999999999999999999987653322110 0000000 0000
Q ss_pred cCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 047292 658 EGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGL 709 (728)
Q Consensus 658 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 709 (728)
... ..........++.+++.+||+.+|++||+|.+|+++|+.+
T Consensus 241 ~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 241 EGE---------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cCC---------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 000 0001112235688899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=301.13 Aligned_cols=253 Identities=24% Similarity=0.390 Sum_probs=201.2
Q ss_pred HHHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 433 DATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 433 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
...+.+.++||+|+||.||++... .+..+++|.+... ......+.+|++++++++|+||+++.+++.. ...+++||
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~--~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN--KHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec--CCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 345566788999999999999764 4567999988753 2335678999999999999999999999887 77899999
Q ss_pred ccCCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC
Q 047292 513 FMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 513 ~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 590 (728)
|+++++|.+++... ...++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 99999999999764 4578888999999999999999987 999999999999999999999999999986643322
Q ss_pred cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchh
Q 047292 591 RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDE 669 (728)
Q Consensus 591 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 669 (728)
.......++..|+|||++....++.++|+||||+++||+++ |+.||...........+ ..+....
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~--------~~~~~~~------ 223 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL--------ERGYRMP------ 223 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHH--------hCCCCCC------
Confidence 22222345678999999998889999999999999999999 88888754332211111 1111000
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 047292 670 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGL 709 (728)
Q Consensus 670 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 709 (728)
........+.+++.+||+.+|++||++.+++++|+.+
T Consensus 224 ---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 224 ---RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred ---CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 1112234677899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=300.37 Aligned_cols=254 Identities=21% Similarity=0.289 Sum_probs=201.9
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
..+.+.++||+|+||.||+|... .+++.||+|.++.........+.+|+.+++.++||||+++++.+......++|+||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNV-NTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEc-CCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 35667789999999999999875 56789999998765444556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccc
Q 047292 514 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH 593 (728)
Q Consensus 514 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 593 (728)
+++++|.+++.....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++........ ..
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~-~~ 163 (267)
T cd06645 88 CGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA-KR 163 (267)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCccc-cc
Confidence 99999999998888899999999999999999999997 999999999999999999999999999876543221 22
Q ss_pred ccccCCccccCccccc---CCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhh
Q 047292 594 TMIRGTRGYVAPEWLK---NAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEA 670 (728)
Q Consensus 594 ~~~~gt~~y~aPE~~~---~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 670 (728)
....|+..|+|||.+. ...++.++||||||+++|||++|+.|+............ .. ..........
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~---~~----~~~~~~~~~~--- 233 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM---TK----SNFQPPKLKD--- 233 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh---hc----cCCCCCcccc---
Confidence 3345889999999984 456889999999999999999999998644322111100 00 0000000000
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 671 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 671 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.......+.+++.+||+.+|++||++++|++.
T Consensus 234 ---~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 234 ---KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred ---cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 00122456789999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=312.21 Aligned_cols=264 Identities=29% Similarity=0.367 Sum_probs=206.4
Q ss_pred HHHHHHhhHHhhhCCCceeEEEEeeeeCC------CCcEEEEEEecccc-hhhHHHHHHHHHHhccc-cccceeeEeeee
Q 047292 430 ELKDATDGFKEELGRGSFGIVYKGVLKTA------SGNAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKNLVQLLGFC 501 (728)
Q Consensus 430 el~~~~~~~~~~lg~G~fg~Vy~g~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~ 501 (728)
++....+.+.+.||+|+||.||++..... ....||+|.++... ....+++.+|+++++++ +|+||+++++++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 44555677888999999999999975321 22368999887532 33457899999999999 799999999999
Q ss_pred ecCCcceeEeeccCCCCHHHHHhcC----------------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCC
Q 047292 502 DEALNRLLVYEFMGNGTLANLIFAI----------------PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQN 565 (728)
Q Consensus 502 ~~~~~~~lv~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~N 565 (728)
......++++||+++|+|.+++... ..+++..++.++.|++.||+|||+. +++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccce
Confidence 9999999999999999999998753 2467788999999999999999997 99999999999
Q ss_pred EEEcCCCceEEccccCccccccCCCc-ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHh
Q 047292 566 ILLDHYFSPKISDFGLSKLLLSDHSR-THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEE 643 (728)
Q Consensus 566 Ill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~ 643 (728)
|++++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||.....+.
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 244 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 99999999999999999866432211 1122234567999999999999999999999999999998 778886543332
Q ss_pred hhhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCC
Q 047292 644 SRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVP 713 (728)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~ 713 (728)
....+ ..+.... ........+.+++.+||+.+|.+||++.++++.|+.++...
T Consensus 245 ~~~~~--------~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 245 LFKLL--------KEGHRMD---------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred HHHHH--------HcCCCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 21111 1111111 11122346778999999999999999999999999887433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=299.83 Aligned_cols=251 Identities=27% Similarity=0.437 Sum_probs=193.8
Q ss_pred hhhCCCceeEEEEeeeeCC--CCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeee-cCCcceeEeeccC
Q 047292 440 EELGRGSFGIVYKGVLKTA--SGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCD-EALNRLLVYEFMG 515 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~--~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~~lv~e~~~ 515 (728)
+.||+|+||.||+|..... ....||+|++.... ......+.+|+.+++.++||||+++++++. .+...++++||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 3689999999999986532 34579999985432 344578889999999999999999999875 4556789999999
Q ss_pred CCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC---c
Q 047292 516 NGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS---R 591 (728)
Q Consensus 516 ~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~---~ 591 (728)
+++|.+++... ...++..+..++.|+++||.|||+. +++||||||+|||+++++.+||+|||+++....... .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 99999999764 4567788899999999999999987 999999999999999999999999999976533221 1
Q ss_pred ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCC-cCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhh
Q 047292 592 THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCR-RSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEA 670 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 670 (728)
......++..|+|||.+.+..++.++||||||+++|||++|+ .|+......... ... ..+....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~----~~~----~~~~~~~------- 222 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDIT----VYL----LQGRRLL------- 222 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH----HHH----hcCCCCC-------
Confidence 112234577899999999889999999999999999999965 455433222111 111 1111000
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 047292 671 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710 (728)
Q Consensus 671 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 710 (728)
.+......+.+++.+||+.+|++||++.+|++.|+++.
T Consensus 223 --~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 223 --QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred --CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 01112346778999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=306.04 Aligned_cols=254 Identities=24% Similarity=0.377 Sum_probs=200.8
Q ss_pred HhhHHhhhCCCceeEEEEeeeeC----CCCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCccee
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKT----ASGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLL 509 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 509 (728)
.+.+.+.||+|+||.||++..+. .++..||+|.++... ......+.+|+.++++++|+||+++++++......++
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~l 85 (288)
T cd05050 6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCL 85 (288)
T ss_pred hceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEE
Confidence 34556789999999999998642 356789999986543 3345679999999999999999999999999999999
Q ss_pred EeeccCCCCHHHHHhcC----------------------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEE
Q 047292 510 VYEFMGNGTLANLIFAI----------------------PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNIL 567 (728)
Q Consensus 510 v~e~~~~gsL~~~l~~~----------------------~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIl 567 (728)
++||+++++|.+++... ..+++..++.++.|++.||+|||++ +++||||||+||+
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~nil 162 (288)
T cd05050 86 LFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCL 162 (288)
T ss_pred EEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhheE
Confidence 99999999999999743 2367788899999999999999997 9999999999999
Q ss_pred EcCCCceEEccccCccccccCCC-cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhh
Q 047292 568 LDHYFSPKISDFGLSKLLLSDHS-RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESR 645 (728)
Q Consensus 568 l~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~ 645 (728)
+++++.+||+|||++........ ........+..|+|||.+.+..++.++||||||+++|||++ |..||......+..
T Consensus 163 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~ 242 (288)
T cd05050 163 VGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVI 242 (288)
T ss_pred ecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999876533221 11122234667999999998999999999999999999998 77787644332211
Q ss_pred hhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 047292 646 AILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEG 708 (728)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 708 (728)
. ....+..... .......+.+++.+||+.+|.+||++.|+++.|++
T Consensus 243 ~--------~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 243 Y--------YVRDGNVLSC---------PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred H--------HHhcCCCCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1 1111221111 11223567889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=306.94 Aligned_cols=249 Identities=24% Similarity=0.334 Sum_probs=200.7
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccC
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
+.+.+.||+|+||.||+|+.. .+++.|++|.+..........+.+|+.+++.++|+||+++++.+......++||||++
T Consensus 22 y~~~~~lg~g~~~~v~~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~ 100 (296)
T cd06654 22 YTRFEKIGQGASGTVYTAMDV-ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (296)
T ss_pred eeeEEEecCCCCeEEEEEEEC-CCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccC
Confidence 344577999999999999865 5678999999876555556788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccccc
Q 047292 516 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM 595 (728)
Q Consensus 516 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 595 (728)
+++|.+++.. ..+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||++........ ....
T Consensus 101 ~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~ 175 (296)
T cd06654 101 GGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRST 175 (296)
T ss_pred CCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc-ccCc
Confidence 9999999865 4578889999999999999999997 999999999999999999999999999876533221 1223
Q ss_pred ccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcH
Q 047292 596 IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADR 675 (728)
Q Consensus 596 ~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 675 (728)
..+++.|+|||.+.+..++.++||||||+++|||++|+.||.......... .....+ .... ....
T Consensus 176 ~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~-------~~~~~~-~~~~-------~~~~ 240 (296)
T cd06654 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-------LIATNG-TPEL-------QNPE 240 (296)
T ss_pred ccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH-------HHhcCC-CCCC-------CCcc
Confidence 457889999999999889999999999999999999999997554322110 000000 0000 0111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 676 SRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 676 ~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.....+.+++.+||+.+|++||++++|++.
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred ccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 223457789999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=300.25 Aligned_cols=255 Identities=22% Similarity=0.343 Sum_probs=204.0
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
+.+.+.||+|+||.||+|... .+++.|++|.++.. .......+.+|++++++++|+|++++++.+......++|||
T Consensus 4 y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 82 (267)
T cd08224 4 FKIEKKIGKGQFSVVYKAICL-LDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE 82 (267)
T ss_pred eeeeeeeccCCceEEEEEEEc-CCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence 446678999999999999886 57889999988532 22335688999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcC----CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccC
Q 047292 513 FMGNGTLANLIFAI----PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD 588 (728)
Q Consensus 513 ~~~~gsL~~~l~~~----~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 588 (728)
|+++++|.+++... ..+++..++.++.|+++||.|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 99999999998642 4578899999999999999999997 9999999999999999999999999998765433
Q ss_pred CCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccch
Q 047292 589 HSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSD 668 (728)
Q Consensus 589 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 668 (728)
... .....++..|+|||.+.+..++.++||||||+++|||++|+.||........ . .......+......
T Consensus 160 ~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~-~~~~~~~~~~~~~~--- 229 (267)
T cd08224 160 TTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-----S-LCKKIEKCDYPPLP--- 229 (267)
T ss_pred Ccc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHH-----H-HHhhhhcCCCCCCC---
Confidence 221 2234578899999999998999999999999999999999999864431110 0 00111111111111
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 047292 669 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGL 709 (728)
Q Consensus 669 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 709 (728)
.......+.+++.+||+.+|++||++.+|+++|+++
T Consensus 230 -----~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 230 -----ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred -----hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 112344677899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=302.95 Aligned_cols=241 Identities=22% Similarity=0.384 Sum_probs=190.0
Q ss_pred hhhCCCceeEEEEeeeeCCC------CcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 440 EELGRGSFGIVYKGVLKTAS------GNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
+.||+|+||.||+|..+... ...|++|.+........+.+.+|+.+++.++|+||+++++++......++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 46999999999999875221 235888888665455567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCc--------eEEccccCccc
Q 047292 514 MGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFS--------PKISDFGLSKL 584 (728)
Q Consensus 514 ~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~--------~kl~Dfgla~~ 584 (728)
+++|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++. ++++|||++..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999865 4678999999999999999999997 9999999999999987765 69999998865
Q ss_pred cccCCCcccccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCC-cCcchhhhHhhhhhHHHHHHHhhhcCccc
Q 047292 585 LLSDHSRTHTMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCR-RSVEMELEEESRAILTDWAYDCYVEGRLD 662 (728)
Q Consensus 585 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (728)
... .....++..|+|||++.+. .++.++||||||+++|||++|. .|+............ . ....+
T Consensus 158 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~-----~--~~~~~- 224 (258)
T cd05078 158 VLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY-----E--DRHQL- 224 (258)
T ss_pred cCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH-----H--ccccC-
Confidence 432 1224578889999999874 5799999999999999999996 454432222111100 0 00000
Q ss_pred eeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047292 663 ALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLE 707 (728)
Q Consensus 663 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~ 707 (728)
+......+.+++.+||+.+|++|||+++|++.|+
T Consensus 225 -----------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 225 -----------PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -----------CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1111245778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=308.92 Aligned_cols=258 Identities=26% Similarity=0.370 Sum_probs=201.6
Q ss_pred HHhhHHhhhCCCceeEEEEeeee------CCCCcEEEEEEecccc-hhhHHHHHHHHHHhccc-cccceeeEeeeeecCC
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLK------TASGNAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEAL 505 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~------~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 505 (728)
..+.+.++||+|+||.||++... ......+|+|.++... ......+..|+.+++++ +|+||+++++++....
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 34456688999999999998752 1234578999987532 33456788999999999 6999999999999999
Q ss_pred cceeEeeccCCCCHHHHHhcC----------------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEc
Q 047292 506 NRLLVYEFMGNGTLANLIFAI----------------PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLD 569 (728)
Q Consensus 506 ~~~lv~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~ 569 (728)
..++++||+++|+|.+++... ..+++..+.+++.||+.||.|||++ +++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEc
Confidence 999999999999999999753 2467888999999999999999987 999999999999999
Q ss_pred CCCceEEccccCccccccCCCc-ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhh
Q 047292 570 HYFSPKISDFGLSKLLLSDHSR-THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAI 647 (728)
Q Consensus 570 ~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~ 647 (728)
+++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~ 248 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL 248 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 9999999999999866432211 1112234567999999999899999999999999999999 7888865433322211
Q ss_pred HHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 648 LTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
+ ..+.... ........+.+++.+||+.+|++||++.++++.|+++..
T Consensus 249 ~--------~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 249 L--------REGHRMD---------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred H--------HcCCCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 1 1111111 111223467789999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=299.24 Aligned_cols=246 Identities=28% Similarity=0.386 Sum_probs=196.3
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeee-ecCCcceeEeec
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFC-DEALNRLLVYEF 513 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-~~~~~~~lv~e~ 513 (728)
.+.+.+.||+|+||.||++... +..|++|.++... ..+.+.+|+.++++++|+|++++++++ ......++++||
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~---~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDYR---GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred hCeeeeeecccCCCeEEEEEEc---CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 3455678999999999999763 6789999986532 346789999999999999999999976 455678999999
Q ss_pred cCCCCHHHHHhcCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 514 MGNGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 514 ~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
+++++|.+++.... .+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 99999999997653 478899999999999999999997 99999999999999999999999999987543221
Q ss_pred ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhh
Q 047292 592 THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEA 670 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 670 (728)
....++..|+|||++.+..++.++||||||+++|||++ |+.||...........+ ..+....
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~--------~~~~~~~------- 219 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV--------EKGYKMD------- 219 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH--------hcCCCCC-------
Confidence 12234668999999999899999999999999999998 88888644332211111 0110000
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 047292 671 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGL 709 (728)
Q Consensus 671 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 709 (728)
........+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 220 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 220 --APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred --CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 1112234677899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=300.44 Aligned_cols=252 Identities=28% Similarity=0.403 Sum_probs=187.9
Q ss_pred hhhCCCceeEEEEeeeeCC-CCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCCC
Q 047292 440 EELGRGSFGIVYKGVLKTA-SGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNG 517 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 517 (728)
++||+|+||.||+|..... ....+++|.+.... ......+.+|+.+++.++|+||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 3699999999999975432 34578999876433 333467889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCC-----CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC-c
Q 047292 518 TLANLIFAIP-----KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS-R 591 (728)
Q Consensus 518 sL~~~l~~~~-----~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-~ 591 (728)
+|.+++.... ..++.....++.||+.||+|||+. +|+||||||+|||+++++++||+|||+++....... .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 9999997643 235677889999999999999997 999999999999999999999999999875432211 1
Q ss_pred ccccccCCccccCcccccC-------CCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccce
Q 047292 592 THTMIRGTRGYVAPEWLKN-------APVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDA 663 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~-------~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (728)
......++..|+|||++.. ..++.++||||||+++|||++ |..||.......... . ..... ...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~---~----~~~~~-~~~ 229 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLK---Q----VVREQ-DIK 229 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHH---H----Hhhcc-Ccc
Confidence 1122335678999998743 356889999999999999999 677876443322111 1 01111 111
Q ss_pred eccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047292 664 LIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLE 707 (728)
Q Consensus 664 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~ 707 (728)
...+.. .......+.+++..|+ .||++||++++|++.|.
T Consensus 230 ~~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 230 LPKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 111111 1122334556777788 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=295.96 Aligned_cols=247 Identities=26% Similarity=0.407 Sum_probs=198.2
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccchh-hHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCCCC
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQE-REREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGT 518 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 518 (728)
++||+|+||.||++... . ++.|++|.+...... ....+.+|++++++++|+||+++++++......++|+||+++++
T Consensus 1 ~~lg~g~~g~v~~~~~~-~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLK-G-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEe-C-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 46899999999999875 3 889999998764333 45789999999999999999999999999999999999999999
Q ss_pred HHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccc-ccc
Q 047292 519 LANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH-TMI 596 (728)
Q Consensus 519 L~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-~~~ 596 (728)
|.+++... ..+++..+..++.+++.||+|||++ +++||||||+||+++.++.+||+|||++........... ...
T Consensus 79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 99999764 4678889999999999999999997 999999999999999999999999999986542221111 122
Q ss_pred cCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcH
Q 047292 597 RGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADR 675 (728)
Q Consensus 597 ~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 675 (728)
..+..|+|||.+.+..++.++||||||+++|||+| |..||...........+ .... .. ..+.
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~--------~~~~--~~-------~~~~ 218 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI--------ESGY--RM-------PAPQ 218 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH--------hcCC--CC-------CCCc
Confidence 34567999999998899999999999999999999 77888654332221111 0000 00 0111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 047292 676 SRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEG 708 (728)
Q Consensus 676 ~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 708 (728)
.....+.+++.+||+.+|.+||++++|++.|+.
T Consensus 219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 223467889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=302.29 Aligned_cols=249 Identities=23% Similarity=0.358 Sum_probs=201.1
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
..+...+.||+|+||.||+|... .+++.||+|.+.... ....+.+.+|+.++++++|+||+++++++......++|+|
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDN-RTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEc-CCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 34556688999999999999876 467899999986433 3445678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 513 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 513 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
|+++++|.+++.. ..+++..+..++.|+++||.|||++ +++|+||+|+||++++++.++|+|||++........ .
T Consensus 83 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06642 83 YLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K 157 (277)
T ss_pred ccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch-h
Confidence 9999999998865 4678899999999999999999987 999999999999999999999999999876543221 2
Q ss_pred cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAM 672 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 672 (728)
.....++..|+|||.+.+..++.++||||||++++||++|+.|+........... ...... + .
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~--------~~~~~~-----~----~ 220 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL--------IPKNSP-----P----T 220 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh--------hhcCCC-----C----C
Confidence 2234578899999999999999999999999999999999999864432221110 001110 0 0
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 673 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 673 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
........+.+++.+||+.+|.+||+|.++++.
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 221 LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 111233467789999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=302.26 Aligned_cols=253 Identities=25% Similarity=0.364 Sum_probs=200.7
Q ss_pred hHHhhhCCCceeEEEEeeeeCC----CCcEEEEEEecccchh-hHHHHHHHHHHhccccccceeeEeeeeecCCcceeEe
Q 047292 437 GFKEELGRGSFGIVYKGVLKTA----SGNAIAVKKLDRLAQE-REREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 511 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~----~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 511 (728)
...+.||+|+||.||+|..+.. ..+.|++|.+...... ....+.+|++++++++|+||+++++++.+....++||
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 87 (275)
T cd05046 8 QEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMIL 87 (275)
T ss_pred eeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEE
Confidence 3456799999999999987532 3467999988654433 3567999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCC---------CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCc
Q 047292 512 EFMGNGTLANLIFAIP---------KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLS 582 (728)
Q Consensus 512 e~~~~gsL~~~l~~~~---------~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla 582 (728)
||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+|+||||+||++++++.++|+|||++
T Consensus 88 e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~~~ 164 (275)
T cd05046 88 EYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLS 164 (275)
T ss_pred EecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcccccc
Confidence 9999999999998655 688999999999999999999997 9999999999999999999999999998
Q ss_pred cccccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCcc
Q 047292 583 KLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRL 661 (728)
Q Consensus 583 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (728)
...............++..|+|||.+.+...+.++||||||+++|||++ |..||.......... ....+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~--------~~~~~~~ 236 (275)
T cd05046 165 KDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLN--------RLQAGKL 236 (275)
T ss_pred cccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHH--------HHHcCCc
Confidence 7553332222233346778999999988889999999999999999999 677875432221111 1111111
Q ss_pred ceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 047292 662 DALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEG 708 (728)
Q Consensus 662 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 708 (728)
... ........+.+++.+||+.+|.+||++.+++++|.+
T Consensus 237 ~~~--------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 237 ELP--------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred CCC--------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 100 011223467789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=309.52 Aligned_cols=255 Identities=19% Similarity=0.241 Sum_probs=195.0
Q ss_pred HHhhhCCC--ceeEEEEeeeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 438 FKEELGRG--SFGIVYKGVLKTASGNAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 438 ~~~~lg~G--~fg~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
+.++||+| +|++||++..+ .+++.||+|++.... ......+.+|+.+++.++||||+++++++..+...++|+||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYK-PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeec-ccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 46789999 78999999876 678999999986532 33446788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 514 MGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 514 ~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
+++++|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+++.||+.+.........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999999753 4588999999999999999999997 9999999999999999999999999865443211110
Q ss_pred ------ccccccCCccccCcccccC--CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccce
Q 047292 592 ------THTMIRGTRGYVAPEWLKN--APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDA 663 (728)
Q Consensus 592 ------~~~~~~gt~~y~aPE~~~~--~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (728)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||............ ..+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~--------~~~~~~~ 229 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK--------LNGTVPC 229 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHH--------hcCCccc
Confidence 0112246678999999976 46899999999999999999999999754322111000 0000000
Q ss_pred eccc------------------------------------hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 664 LIDS------------------------------------DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 664 ~~d~------------------------------------~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
.++. .............+.+++.+||+.||++|||++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 230 LLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred cccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0000 0000112233457789999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=302.14 Aligned_cols=249 Identities=24% Similarity=0.376 Sum_probs=195.4
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc-chhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccC
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
.+.+.||+|+||.||+|... .+++.||+|.+... .......+.+|++++++++||||+++++.+......++|+||++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 82 (279)
T cd06619 4 QYQEILGHGNGGTVYKAYHL-LTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMD 82 (279)
T ss_pred hheeeeccCCCeEEEEEEEc-CCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCC
Confidence 45578999999999999876 56789999998643 23445679999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccccc
Q 047292 516 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM 595 (728)
Q Consensus 516 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 595 (728)
+++|..+. .+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++....... ...
T Consensus 83 ~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~---~~~ 152 (279)
T cd06619 83 GGSLDVYR----KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI---AKT 152 (279)
T ss_pred CCChHHhh----cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---ccC
Confidence 99997653 467888899999999999999997 99999999999999999999999999997653321 223
Q ss_pred ccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcH
Q 047292 596 IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADR 675 (728)
Q Consensus 596 ~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 675 (728)
..++..|+|||.+.+..++.++||||||+++|||++|+.||............... ............ ...
T Consensus 153 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~--------~~~ 223 (279)
T cd06619 153 YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQL-LQCIVDEDPPVL--------PVG 223 (279)
T ss_pred CCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHH-HHHHhccCCCCC--------CCC
Confidence 46889999999999999999999999999999999999998653321111000000 011111110000 011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 676 SRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 676 ~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.....+.+++.+||+.+|++||+++++++.
T Consensus 224 ~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 224 QFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 123457789999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=293.44 Aligned_cols=248 Identities=23% Similarity=0.326 Sum_probs=208.8
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccC
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
..+.++||+|+||.|||+.++ .+|..||||++.. ..+.+++..|+.++++.+.+++|+++|.+.....+|+|||||.
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~-EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHR-ESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHh-ccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 446689999999999999987 6799999999865 4457899999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccc
Q 047292 516 NGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHT 594 (728)
Q Consensus 516 ~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 594 (728)
.|+..+.++.+ +.++++.+..+++..++||+|||.- .-||||||+.|||++-+|.+||+|||.|..+.....+ ..
T Consensus 112 AGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK-RN 187 (502)
T KOG0574|consen 112 AGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK-RN 187 (502)
T ss_pred CCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHHh-hC
Confidence 99999999865 6789999999999999999999985 7899999999999999999999999999877544333 34
Q ss_pred cccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhc
Q 047292 595 MIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMAD 674 (728)
Q Consensus 595 ~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 674 (728)
++.||+.|||||++..-.|+.++||||||++..||.-|++|+..-.+......+ .. .+......+
T Consensus 188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI--------PT-------~PPPTF~KP 252 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI--------PT-------KPPPTFKKP 252 (502)
T ss_pred ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec--------cC-------CCCCCCCCh
Confidence 567999999999999999999999999999999999999998754332211111 00 111122234
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 675 RSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 675 ~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.+....+-++++.||-.+|++|-|+-++++.
T Consensus 253 E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 253 EEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred HhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 5567778899999999999999998887653
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=298.87 Aligned_cols=239 Identities=26% Similarity=0.422 Sum_probs=190.6
Q ss_pred hhhCCCceeEEEEeeeeCCCC---------cEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeE
Q 047292 440 EELGRGSFGIVYKGVLKTASG---------NAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 510 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~---------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 510 (728)
+.||+|+||.||+|.+..... ..|++|.+...... ...+.+|+.+++.++|+||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 468999999999999874331 35788877654333 6788999999999999999999999988 788999
Q ss_pred eeccCCCCHHHHHhcCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCC-------ceEEccccCc
Q 047292 511 YEFMGNGTLANLIFAIP-KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYF-------SPKISDFGLS 582 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~-------~~kl~Dfgla 582 (728)
+||+++++|.+++...+ .+++..++.++.||+.||+|||++ +|+||||||+||+++.++ .+||+|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999998765 788999999999999999999987 999999999999999887 7999999998
Q ss_pred cccccCCCcccccccCCccccCcccccCC--CCCCccchhhHHHHHHHHHhC-CcCcchhhhHhhhhhHHHHHHHhhhcC
Q 047292 583 KLLLSDHSRTHTMIRGTRGYVAPEWLKNA--PVSAKVDVYSFGVMLLEIICC-RRSVEMELEEESRAILTDWAYDCYVEG 659 (728)
Q Consensus 583 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DVwSlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~ 659 (728)
..... .....++..|+|||++.+. .++.++||||||+++|||++| ..|+............ ...
T Consensus 156 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~--------~~~ 222 (259)
T cd05037 156 ITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFY--------QDQ 222 (259)
T ss_pred ccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHH--------hcC
Confidence 86533 1223456789999999876 789999999999999999995 6666544322111100 000
Q ss_pred ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047292 660 RLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLE 707 (728)
Q Consensus 660 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~ 707 (728)
.... . .....+.+++.+||+.+|.+||++.+|++.|+
T Consensus 223 ~~~~--~---------~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 HRLP--M---------PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CCCC--C---------CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000 0 00156778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=298.62 Aligned_cols=249 Identities=28% Similarity=0.468 Sum_probs=199.3
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccC
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
..+.+.||+|+||.||++.+. .+..+++|.+..... ....+.+|++++++++|+|++++++++......++|+||++
T Consensus 6 ~~~~~~ig~g~~g~v~~~~~~--~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 6 LTLVQEIGSGQFGLVWLGYWL--EKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred eEEEeeecCcccceEEEEEEe--CCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 345678999999999999875 467899999865322 34578999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccc
Q 047292 516 NGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHT 594 (728)
Q Consensus 516 ~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 594 (728)
+++|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++...........
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05112 83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcccccC
Confidence 99999999764 4578899999999999999999987 9999999999999999999999999998865433222222
Q ss_pred cccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhh
Q 047292 595 MIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMA 673 (728)
Q Consensus 595 ~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 673 (728)
...++.+|+|||.+.+..++.++||||||+++|||++ |+.||...........+ ..+. ....+
T Consensus 160 ~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~--------~~~~--~~~~~------ 223 (256)
T cd05112 160 GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETI--------NAGF--RLYKP------ 223 (256)
T ss_pred CCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH--------hCCC--CCCCC------
Confidence 2335678999999998899999999999999999998 88998754432211111 1110 00111
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047292 674 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLE 707 (728)
Q Consensus 674 ~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~ 707 (728)
......+.+++.+||+.+|++||++.+++++|.
T Consensus 224 -~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 224 -RLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred -CCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 112356788999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=299.94 Aligned_cols=248 Identities=28% Similarity=0.430 Sum_probs=196.0
Q ss_pred hhCCCceeEEEEeeeeC-----CCCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 441 ELGRGSFGIVYKGVLKT-----ASGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 441 ~lg~G~fg~Vy~g~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
.||+|+||.||+|..+. .+++.+++|.+.... ......+.+|+.+++.++|+||+++++++......++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 58999999999998753 223679999886533 234568899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCC-----ceEEccccCc
Q 047292 515 GNGTLANLIFAI-------PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYF-----SPKISDFGLS 582 (728)
Q Consensus 515 ~~gsL~~~l~~~-------~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~-----~~kl~Dfgla 582 (728)
++++|.+++... ..+++..++.++.|++.||.|||+. +++|+||||+||++++++ .+||+|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999743 3467889999999999999999986 899999999999999877 8999999998
Q ss_pred cccccCCC-cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCc
Q 047292 583 KLLLSDHS-RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGR 660 (728)
Q Consensus 583 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (728)
+....... .......++..|+|||++.+..++.++||||||+++|||++ |+.||...........+ ..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~--------~~~~ 230 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV--------TAGG 230 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHH--------hcCC
Confidence 76533221 11222335678999999999999999999999999999998 89998644332211111 1110
Q ss_pred cceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 047292 661 LDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEG 708 (728)
Q Consensus 661 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 708 (728)
.. .........+.+++.+||+.+|.+||++.+|++.|++
T Consensus 231 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 RL---------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred cc---------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 00 1111234567789999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=296.58 Aligned_cols=248 Identities=24% Similarity=0.363 Sum_probs=201.9
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
.+.+.+.||+|+||.||+|..+ .+++.+++|.+..... ..++.+|++++++++|+||+++++.+......++++||+
T Consensus 4 ~y~~~~~i~~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 4 VFDILEKLGEGSYGSVYKAIHK-ETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred cchhhhhhcCCCCeEEEEEEEc-CCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 3556788999999999999876 3578999999875432 678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccc
Q 047292 515 GNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH 593 (728)
Q Consensus 515 ~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 593 (728)
++++|.+++... ..+++..+..++.|+++||.|||+. +++|+||+|+||++++++.+||+|||++........ ..
T Consensus 81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~ 156 (256)
T cd06612 81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KR 156 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-cc
Confidence 999999999753 5789999999999999999999997 999999999999999999999999999887644321 22
Q ss_pred ccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhh
Q 047292 594 TMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMA 673 (728)
Q Consensus 594 ~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 673 (728)
....++..|+|||.+.+..++.++||||||++++||++|+.|+............ .... ...+ ..
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~--------~~~~-~~~~------~~ 221 (256)
T cd06612 157 NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI--------PNKP-PPTL------SD 221 (256)
T ss_pred ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh--------ccCC-CCCC------Cc
Confidence 2344788999999999999999999999999999999999998754332211100 0000 0000 01
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 674 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 674 ~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
+......+.+++.+||+.+|++||++++|++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 222 PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 1122346778999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=333.74 Aligned_cols=257 Identities=23% Similarity=0.313 Sum_probs=199.9
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
+.+.++||+|+||.||+|... .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..+++||
T Consensus 4 YeIi~~LGkGgfG~VYlA~d~-~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME 82 (932)
T PRK13184 4 YDIIRLIGKGGMGEVYLAYDP-VCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP 82 (932)
T ss_pred eEEEEEEecCCCEEEEEEEEC-CCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence 345578999999999999875 568899999986532 2234678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcC-----------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccC
Q 047292 513 FMGNGTLANLIFAI-----------PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGL 581 (728)
Q Consensus 513 ~~~~gsL~~~l~~~-----------~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgl 581 (728)
|+++++|.+++... ...++..+++++.||++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCc
Confidence 99999999998642 2345667889999999999999997 999999999999999999999999999
Q ss_pred ccccccCCC-----------------cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhh
Q 047292 582 SKLLLSDHS-----------------RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEES 644 (728)
Q Consensus 582 a~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~ 644 (728)
++....... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||........
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 986621110 011124589999999999999999999999999999999999999975332211
Q ss_pred hhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhcCcC
Q 047292 645 RAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRP-TMKVVMQMLEGLLE 711 (728)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-t~~evl~~L~~~~~ 711 (728)
.. .. . ..++ ............+.+++.+|++.||++|| +++++++.|+..+.
T Consensus 240 ~~-------~~----~---i~~P-~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 240 SY-------RD----V---ILSP-IEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hh-------hh----h---ccCh-hhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 00 00 0 0000 00000112234567899999999999995 77888888877654
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=291.89 Aligned_cols=249 Identities=22% Similarity=0.255 Sum_probs=201.2
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch---hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
.++.+.||+|.-|+||++.++ .++...|+|++.+... +.....+.|-+||+.++||.++.|++.++.+...+++||
T Consensus 79 f~llk~LG~GdiG~VyL~~l~-~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 79 FRLLKRLGCGDIGTVYLVELR-GTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHcCCCCceeEEEEEec-CCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 345688999999999999987 4558999999976433 334678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcccccc---
Q 047292 513 FMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS--- 587 (728)
Q Consensus 513 ~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~--- 587 (728)
||+||+|..++++. ..+++..+.-++.+++-||+|||.. |||+|||||+||||.++|++.|+||.|+.....
T Consensus 158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 99999999999876 4678889999999999999999985 999999999999999999999999998754310
Q ss_pred -----C--------------------C---C-c-----------------------ccccccCCccccCcccccCCCCCC
Q 047292 588 -----D--------------------H---S-R-----------------------THTMIRGTRGYVAPEWLKNAPVSA 615 (728)
Q Consensus 588 -----~--------------------~---~-~-----------------------~~~~~~gt~~y~aPE~~~~~~~s~ 615 (728)
. . . . .....+||-.|+|||++++...+.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 0 0 0 0 001134889999999999999999
Q ss_pred ccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCC
Q 047292 616 KVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSK 695 (728)
Q Consensus 616 ~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~ 695 (728)
+.|.|+|||+||||+.|+.||......+....+ +...+.-...++....+.+||++.|.+||++
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NI----------------v~~~l~Fp~~~~vs~~akDLIr~LLvKdP~k 378 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNI----------------VGQPLKFPEEPEVSSAAKDLIRKLLVKDPSK 378 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHH----------------hcCCCcCCCCCcchhHHHHHHHHHhccChhh
Confidence 999999999999999999999877655432222 1111111122244567788999999999999
Q ss_pred CCC----HHHHHH
Q 047292 696 RPT----MKVVMQ 704 (728)
Q Consensus 696 RPt----~~evl~ 704 (728)
|.. +.||.+
T Consensus 379 Rlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 379 RLGSKRGAAEIKR 391 (459)
T ss_pred hhccccchHHhhc
Confidence 976 555543
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=323.73 Aligned_cols=259 Identities=22% Similarity=0.293 Sum_probs=189.4
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecC--------Ccc
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEA--------LNR 507 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--------~~~ 507 (728)
+.+.+.||+|+||.||+|... .+++.||||++.... ....+|+.+++.++|+||+++++++... ...
T Consensus 68 y~~~~~LG~G~fg~Vy~~~~~-~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 142 (440)
T PTZ00036 68 YKLGNIIGNGSFGVVYEAICI-DTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL 142 (440)
T ss_pred EEEeEEEEeCCCEEEEEEEEC-CCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence 455678999999999999876 567899999885422 2345799999999999999998876322 235
Q ss_pred eeEeeccCCCCHHHHHh----cCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCC-ceEEccccCc
Q 047292 508 LLVYEFMGNGTLANLIF----AIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYF-SPKISDFGLS 582 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~l~----~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~-~~kl~Dfgla 582 (728)
++||||+++ +|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||++
T Consensus 143 ~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 143 NVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred EEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 689999985 6766654 345788999999999999999999997 999999999999999654 7999999999
Q ss_pred cccccCCCcccccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHH----HH---
Q 047292 583 KLLLSDHSRTHTMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWA----YD--- 654 (728)
Q Consensus 583 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~----~~--- 654 (728)
+....... .....||+.|+|||++.+. .++.++|||||||++|||++|..||...........+.... ..
T Consensus 219 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 296 (440)
T PTZ00036 219 KNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK 296 (440)
T ss_pred hhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 86643221 2234579999999998764 68999999999999999999999997654332211111100 00
Q ss_pred ----hhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 655 ----CYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 655 ----~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.+..-.+............+......+.+++.+||+.||.+|||+.|+++.
T Consensus 297 ~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 297 EMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 000001111111111111222234578899999999999999999999843
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=312.03 Aligned_cols=253 Identities=21% Similarity=0.237 Sum_probs=194.0
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
+.+.+.||+|+||.||++..+ .+++.||+|++.... ....+.+.+|+.++..++|+||+++++++......++|||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 3 FEILKVIGRGAFGEVAVVKMK-NTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred ceEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 345678999999999999876 567899999986422 2234568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhc-CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 513 FMGNGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 513 ~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.........
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred cCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 9999999999976 35788999999999999999999997 9999999999999999999999999998766443332
Q ss_pred ccccccCCccccCcccccC-----CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceecc
Q 047292 592 THTMIRGTRGYVAPEWLKN-----APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALID 666 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~-----~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 666 (728)
......||+.|+|||++.. ..++.++|||||||++|||++|+.||......+....+. .......+..
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~-------~~~~~~~~~~ 231 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM-------NHKEHFQFPP 231 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHH-------cCCCcccCCC
Confidence 3333468999999999863 457889999999999999999999997554332211110 0000000100
Q ss_pred chhhhhhcHHHHHHHHHHHHHhccc--CCCCCCCHHHHHHH
Q 047292 667 SDEAAMADRSRLHKWLMIAMWCIQE--DPSKRPTMKVVMQM 705 (728)
Q Consensus 667 ~~~~~~~~~~~~~~l~~l~~~cl~~--dp~~RPt~~evl~~ 705 (728)
. .......+.+++.+|+.. ++..||+++++++.
T Consensus 232 ~------~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 232 D------VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred c------cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0 011233455667666644 44448899988876
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=304.19 Aligned_cols=247 Identities=25% Similarity=0.308 Sum_probs=196.0
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
..+.||+|+||.||++... .+++.||+|.+.... ......+..|+.++++++|+|++++++.+......++||||+
T Consensus 4 ~~~~ig~G~~g~v~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05630 4 QYRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM 82 (285)
T ss_pred eeEEeecCCCeEEEEEEEc-CCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEec
Confidence 3467999999999999876 568899999986432 222356788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 515 GNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 515 ~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++........
T Consensus 83 ~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-- 157 (285)
T cd05630 83 NGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-- 157 (285)
T ss_pred CCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc--
Confidence 999999998654 3578899999999999999999987 999999999999999999999999999876533221
Q ss_pred cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAM 672 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 672 (728)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||.................. . ...
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~------~--------~~~ 223 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE------V--------QEE 223 (285)
T ss_pred ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh------h--------hhh
Confidence 12345899999999999999999999999999999999999999754321111111110000 0 000
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 047292 673 ADRSRLHKWLMIAMWCIQEDPSKRPT-----MKVVMQ 704 (728)
Q Consensus 673 ~~~~~~~~l~~l~~~cl~~dp~~RPt-----~~evl~ 704 (728)
........+.+++.+||+.||.+||| ++|+++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 224 YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 11122345678999999999999999 888886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=304.71 Aligned_cols=261 Identities=24% Similarity=0.299 Sum_probs=191.5
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch--hhHHHHHHHHHHhccc---cccceeeEeeeeec-----CCc
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ--EREREFKSEVSAIGRT---HHKNLVQLLGFCDE-----ALN 506 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~-----~~~ 506 (728)
.+.+.||+|+||.||++..+ .+++.||+|.++.... .....+.+|+.+++++ +|+||+++++++.. ...
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 3 EPVAEIGVGAYGTVYKARDP-HSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred eEeeEEeecCCeEEEEEEEC-CCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 45578999999999999876 5688999999864322 1234556677777665 69999999998854 345
Q ss_pred ceeEeeccCCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccc
Q 047292 507 RLLVYEFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKL 584 (728)
Q Consensus 507 ~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~ 584 (728)
.++++||+++ +|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 82 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 82 VTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred EEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcccc
Confidence 7899999985 898888764 3578999999999999999999997 999999999999999999999999999986
Q ss_pred cccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHH----Hhhhc-C
Q 047292 585 LLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAY----DCYVE-G 659 (728)
Q Consensus 585 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~----~~~~~-~ 659 (728)
..... ......++..|+|||++.+..++.++|||||||++|||++|+.||...........+..... ..+.. .
T Consensus 158 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07863 158 YSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 235 (288)
T ss_pred ccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence 64322 22334578899999999999999999999999999999999999875543322211111100 00000 0
Q ss_pred cc-ceeccc---hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 660 RL-DALIDS---DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 660 ~~-~~~~d~---~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
.. ...+.. .......+.....+.+++.+||+.||++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 000000 0001111223456778999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=318.14 Aligned_cols=249 Identities=23% Similarity=0.293 Sum_probs=194.7
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
+.+.||+|+||.||++..+ .+++.||+|+++... ......+.+|+.++.+++|+||+++++.+.+....++||||+
T Consensus 5 ~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~ 83 (360)
T cd05627 5 SLKVIGRGAFGEVRLVQKK-DTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFL 83 (360)
T ss_pred EEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCC
Confidence 4578999999999999876 568899999996432 233467888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC----
Q 047292 515 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS---- 590 (728)
Q Consensus 515 ~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~---- 590 (728)
++|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++++||+|||+++.......
T Consensus 84 ~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 84 PGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred CCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 9999999998888899999999999999999999997 999999999999999999999999999875422110
Q ss_pred ------------------------------cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhh
Q 047292 591 ------------------------------RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEL 640 (728)
Q Consensus 591 ------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~ 640 (728)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~ 240 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCC
Confidence 00112468999999999999999999999999999999999999997655
Q ss_pred hHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 047292 641 EEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPT---MKVVMQM 705 (728)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt---~~evl~~ 705 (728)
.......+..+ .....+.+ .......+.+++.+++ .+|.+|++ ++++++.
T Consensus 241 ~~~~~~~i~~~--------~~~~~~p~------~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 241 PQETYRKVMNW--------KETLVFPP------EVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred HHHHHHHHHcC--------CCceecCC------CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 44322221110 00000100 0012234556666666 49999985 5565543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=299.59 Aligned_cols=246 Identities=27% Similarity=0.367 Sum_probs=198.5
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch---------hhHHHHHHHHHHhccccccceeeEeeeeecCCcce
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ---------EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRL 508 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 508 (728)
+.+.||+|+||.||+|... .+++.||+|.+..... +..+.+.+|+.++++++|+||+++++++......+
T Consensus 4 ~~~~ig~g~~~~v~~a~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (267)
T cd06628 4 KGALIGSGSFGSVYLGMNA-SSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLN 82 (267)
T ss_pred ccceeecCCCeEEEEEEec-CCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccE
Confidence 4567999999999999875 4578999998854321 12257889999999999999999999999999999
Q ss_pred eEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccC
Q 047292 509 LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD 588 (728)
Q Consensus 509 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 588 (728)
+++||+++++|.+++.....+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||+++.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06628 83 IFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEAN 159 (267)
T ss_pred EEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence 9999999999999998888889999999999999999999987 9999999999999999999999999999876432
Q ss_pred CCc-----ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccce
Q 047292 589 HSR-----THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDA 663 (728)
Q Consensus 589 ~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (728)
... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...........+ ......
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~- 230 (267)
T cd06628 160 SLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKI--------GENASP- 230 (267)
T ss_pred cccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHH--------hccCCC-
Confidence 111 111235788999999999989999999999999999999999999754332111100 000000
Q ss_pred eccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 664 LIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 664 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
..+......+.+++.+||+.+|.+||++.+|++
T Consensus 231 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 231 --------EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred --------cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 011123356778999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=300.48 Aligned_cols=251 Identities=23% Similarity=0.314 Sum_probs=200.4
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
..+.+.++||+|+||.||+|... .+++.|++|.+........+.+.+|+.+++.++|+||+++++.+......++||||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNK-ETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEEC-CCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 34567789999999999999876 46789999999876666678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 514 MGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 514 ~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
+++++|..++... ..+++..+..++.|++.+|+|||+. +++||||||+||+++.++.+||+|||++....... ..
T Consensus 91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~ 166 (292)
T cd06644 91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QR 166 (292)
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc-cc
Confidence 9999999887653 5689999999999999999999987 99999999999999999999999999987543221 11
Q ss_pred cccccCCccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccc
Q 047292 593 HTMIRGTRGYVAPEWLK-----NAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDS 667 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~-----~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 667 (728)
.....+++.|+|||.+. ...++.++||||||+++|||++|+.|+.......... . ..........
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~---~-----~~~~~~~~~~-- 236 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL---K-----IAKSEPPTLS-- 236 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHH---H-----HhcCCCccCC--
Confidence 22345788999999985 3456889999999999999999999986543322111 1 0111100000
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 668 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 668 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
.+......+.+++.+||+.+|++||+++++++
T Consensus 237 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 237 -----QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred -----CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11122345778999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=299.63 Aligned_cols=251 Identities=24% Similarity=0.330 Sum_probs=201.9
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
.+.+.+.||+|+||.||++... .++..|++|.++.........+..|++++++++|+||+++++.+......++||||+
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHK-ETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEc-CCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 3567789999999999999876 467899999997665666678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccc
Q 047292 515 GNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH 593 (728)
Q Consensus 515 ~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 593 (728)
++++|.+++... ..+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++......... .
T Consensus 85 ~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~ 160 (280)
T cd06611 85 DGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK-R 160 (280)
T ss_pred CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccccc-c
Confidence 999999998764 5689999999999999999999997 9999999999999999999999999998765333221 2
Q ss_pred ccccCCccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccch
Q 047292 594 TMIRGTRGYVAPEWLK-----NAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSD 668 (728)
Q Consensus 594 ~~~~gt~~y~aPE~~~-----~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 668 (728)
....+++.|+|||.+. ...++.++||||||+++|||++|+.||.......... . ...+....+ .
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~---~-----~~~~~~~~~-~-- 229 (280)
T cd06611 161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLL---K-----ILKSEPPTL-D-- 229 (280)
T ss_pred ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHH---H-----HhcCCCCCc-C--
Confidence 2345788999999985 3457789999999999999999999997543322111 1 111110000 0
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 669 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 669 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.+......+.+++.+||+.+|.+||+++++++.
T Consensus 230 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 230 ----QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ----CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 011223456789999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=297.51 Aligned_cols=248 Identities=23% Similarity=0.356 Sum_probs=201.8
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
.+...++||+|+||.||+|..+ .++..||+|.+.... ......+.+|+.+++.++|+||+++++++......++||||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDN-RTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEc-cCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 3445678999999999999876 457899999986432 34457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccc
Q 047292 514 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH 593 (728)
Q Consensus 514 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 593 (728)
+++++|.+++.. ..+++.....++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 84 ~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~ 158 (277)
T cd06640 84 LGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KR 158 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-cc
Confidence 999999999875 4678889999999999999999987 999999999999999999999999999976643322 12
Q ss_pred ccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhh
Q 047292 594 TMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMA 673 (728)
Q Consensus 594 ~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 673 (728)
....++..|+|||.+.+..++.++||||||+++|||++|+.|+...........+ .... ....
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~--------~~~~---------~~~~ 221 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI--------PKNN---------PPTL 221 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh--------hcCC---------CCCC
Confidence 2245788899999999989999999999999999999999998754332211110 0000 0111
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 674 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 674 ~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.......+.+++.+||+.+|++||+++++++.
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 222 TGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred chhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 22344567789999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=311.99 Aligned_cols=253 Identities=20% Similarity=0.241 Sum_probs=195.2
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
+.+.+.||+|+||.||++..+ .+++.||+|.+.... ......+.+|..++..++|+||+++++++...+..++|||
T Consensus 3 y~i~~~lG~G~fg~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E 81 (331)
T cd05624 3 FEIIKVIGRGAFGEVAVVKMK-HTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD 81 (331)
T ss_pred ceEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 345578999999999999876 567899999986522 2234568889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 513 FMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 513 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
|+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 82 y~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 82 YYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred CCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 99999999999873 5788899999999999999999997 9999999999999999999999999999876544333
Q ss_pred ccccccCCccccCcccccC-----CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceecc
Q 047292 592 THTMIRGTRGYVAPEWLKN-----APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALID 666 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~-----~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 666 (728)
......|++.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+.. ...+. . +.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~------~~~~~-~-~p 230 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN------HEERF-Q-FP 230 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHc------CCCcc-c-CC
Confidence 3334568999999999875 4678899999999999999999999975543322111100 00000 0 00
Q ss_pred chhhhhhcHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 047292 667 SDEAAMADRSRLHKWLMIAMWCIQEDPSK--RPTMKVVMQM 705 (728)
Q Consensus 667 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~--RPt~~evl~~ 705 (728)
.. .....+.+.+++.+|+...+++ |++++++++.
T Consensus 231 ~~-----~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 231 SH-----ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred Cc-----cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 00 0112345667888888765544 4688888754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=296.89 Aligned_cols=253 Identities=26% Similarity=0.344 Sum_probs=200.7
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc----------chhhHHHHHHHHHHhcc-ccccceeeEeeeeecC
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL----------AQEREREFKSEVSAIGR-THHKNLVQLLGFCDEA 504 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~~ 504 (728)
+.+.+.||+|+||.||+|..+..+++.+|+|.+... .......+..|+.++.+ ++|+||+++++++...
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 345678999999999999987556789999987532 12233567788888875 7999999999999999
Q ss_pred CcceeEeeccCCCCHHHHHhc----CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEcccc
Q 047292 505 LNRLLVYEFMGNGTLANLIFA----IPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFG 580 (728)
Q Consensus 505 ~~~~lv~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg 580 (728)
...+++|||+++++|.+++.. ...+++..+++++.|++.||.|||+. .+++|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~dfg 159 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFG 159 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEeccc
Confidence 999999999999999988743 34678899999999999999999963 279999999999999999999999999
Q ss_pred CccccccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCc
Q 047292 581 LSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGR 660 (728)
Q Consensus 581 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (728)
++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...........+ .+..
T Consensus 160 ~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~--------~~~~ 229 (269)
T cd08528 160 LAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKI--------VEAV 229 (269)
T ss_pred ceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHH--------hhcc
Confidence 998754432 233455888999999999888999999999999999999999998754332221111 1111
Q ss_pred cceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 047292 661 LDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEG 708 (728)
Q Consensus 661 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 708 (728)
..... .......+.+++.+||+.||++||++.|+..+|+.
T Consensus 230 ~~~~~--------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 230 YEPLP--------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred CCcCC--------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 11000 11123467789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=313.45 Aligned_cols=241 Identities=25% Similarity=0.290 Sum_probs=189.1
Q ss_pred hCCCceeEEEEeeeeCCCCcEEEEEEecccch---hhHHHHHHHHHHhccc---cccceeeEeeeeecCCcceeEeeccC
Q 047292 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ---EREREFKSEVSAIGRT---HHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 442 lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
||+|+||.||+|..+ .+++.||||++..... .....+..|..++.+. +||||+++++.+......++||||++
T Consensus 1 lG~G~~g~Vy~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~ 79 (330)
T cd05586 1 IGKGTFGQVYQVRKK-DTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMS 79 (330)
T ss_pred CCCCCceEEEEEEEC-CCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCC
Confidence 799999999999876 5688999999865322 1223455666666654 69999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccccc
Q 047292 516 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM 595 (728)
Q Consensus 516 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 595 (728)
+|+|.+++.....+++..+..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++....... ....
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~~ 155 (330)
T cd05586 80 GGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTNT 155 (330)
T ss_pred CChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-CccC
Confidence 999999998888899999999999999999999997 999999999999999999999999999875432221 2234
Q ss_pred ccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhc
Q 047292 596 IRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMAD 674 (728)
Q Consensus 596 ~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 674 (728)
..||+.|+|||.+.+. .++.++|||||||++|||++|+.||......+....+ ..+.. .+..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i--------~~~~~-~~~~-------- 218 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI--------AFGKV-RFPK-------- 218 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHH--------HcCCC-CCCC--------
Confidence 5689999999999765 4799999999999999999999999765433221111 11111 0000
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC----CHHHHHH
Q 047292 675 RSRLHKWLMIAMWCIQEDPSKRP----TMKVVMQ 704 (728)
Q Consensus 675 ~~~~~~l~~l~~~cl~~dp~~RP----t~~evl~ 704 (728)
......+.+++.+||+.||.+|| ++.++++
T Consensus 219 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 219 NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 11234566899999999999998 5666654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=307.23 Aligned_cols=193 Identities=23% Similarity=0.355 Sum_probs=159.1
Q ss_pred hhhCCCceeEEEEeeeeC-CCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeec--CCcceeEeeccCC
Q 047292 440 EELGRGSFGIVYKGVLKT-ASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDE--ALNRLLVYEFMGN 516 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lv~e~~~~ 516 (728)
++||+|+||.||+|..+. .+++.||+|.+.... ....+.+|+.++++++||||+++++++.. ....++++||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 579999999999998753 356789999986532 23457889999999999999999998854 4567899999864
Q ss_pred CCHHHHHhcC---------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEE----cCCCceEEccccCcc
Q 047292 517 GTLANLIFAI---------PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILL----DHYFSPKISDFGLSK 583 (728)
Q Consensus 517 gsL~~~l~~~---------~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll----~~~~~~kl~Dfgla~ 583 (728)
+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 787776532 2477888999999999999999997 99999999999999 456789999999998
Q ss_pred ccccCCCc--ccccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcch
Q 047292 584 LLLSDHSR--THTMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEM 638 (728)
Q Consensus 584 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~ 638 (728)
........ ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 76443221 22345689999999999774 589999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=295.52 Aligned_cols=251 Identities=24% Similarity=0.370 Sum_probs=187.1
Q ss_pred hhCCCceeEEEEeeeeCCC-CcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCCCC
Q 047292 441 ELGRGSFGIVYKGVLKTAS-GNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGT 518 (728)
Q Consensus 441 ~lg~G~fg~Vy~g~~~~~~-~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 518 (728)
+||+|+||.||+|...... ...+++|.+.... ......+.+|+.+++.++||||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 6999999999999764322 3456777775433 3345789999999999999999999999999999999999999999
Q ss_pred HHHHHhcC----CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCC-Cccc
Q 047292 519 LANLIFAI----PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH-SRTH 593 (728)
Q Consensus 519 L~~~l~~~----~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~ 593 (728)
|.+++... ...+...+..++.||++||+|||+. +++||||||+|||++.++.+||+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99999754 2355667789999999999999997 99999999999999999999999999986432211 1122
Q ss_pred ccccCCccccCcccccC-------CCCCCccchhhHHHHHHHHHhC-CcCcchhhhHhhhhhHHHHHHHhhhcCccceec
Q 047292 594 TMIRGTRGYVAPEWLKN-------APVSAKVDVYSFGVMLLEIICC-RRSVEMELEEESRAILTDWAYDCYVEGRLDALI 665 (728)
Q Consensus 594 ~~~~gt~~y~aPE~~~~-------~~~s~~~DVwSlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (728)
....++..|+|||++.. ..++.++||||||+++|||+++ ..||......+... . ...+....+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~---~-----~~~~~~~~~~ 230 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLN---H-----VIKDQQVKLF 230 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHH---H-----HHhhcccccC
Confidence 33457889999999853 2457899999999999999975 56775433222111 1 0111111222
Q ss_pred cchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047292 666 DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLE 707 (728)
Q Consensus 666 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~ 707 (728)
++..... ....+.+++..|| .+|++||++++|++.|.
T Consensus 231 ~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 2222111 2245666888899 57999999999999884
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=298.79 Aligned_cols=246 Identities=24% Similarity=0.382 Sum_probs=209.4
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch--hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
|.+.+.||+|.|..|-++++- -+|+.||||++.+... -...++.+|++.|+.++|||||+++.+......+|||+|.
T Consensus 20 YDLekTlG~GHFAVVKLArHV-FTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHV-FTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred ehhhhhhcCCceehhhhhhhh-cccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 556688999999999998775 5799999999976433 2346889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEc-CCCceEEccccCccccccCCCc
Q 047292 514 MGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLD-HYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 514 ~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~-~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
-++|+|.+||.++ ..+.+....+++.||+.|+.|+|+- .+|||||||+|+.+- .-|-+||+|||++..+... +
T Consensus 99 GD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG--~ 173 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG--K 173 (864)
T ss_pred cCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc--c
Confidence 9999999999887 5789999999999999999999985 899999999998775 5688999999998776443 3
Q ss_pred ccccccCCccccCcccccCCCCC-CccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhh
Q 047292 592 THTMIRGTRGYVAPEWLKNAPVS-AKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEA 670 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~~~~s-~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 670 (728)
..++.+|...|-|||++.+..|+ ++.||||||||||-|++|+.||+..++.+....+++..+
T Consensus 174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY----------------- 236 (864)
T KOG4717|consen 174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY----------------- 236 (864)
T ss_pred hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc-----------------
Confidence 45567899999999999999995 579999999999999999999997776665444433222
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 671 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 671 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
..+.....++.++|..||..||++|.+.++|+..
T Consensus 237 -tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 237 -TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred -cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 1233455678889999999999999999999864
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=298.57 Aligned_cols=248 Identities=26% Similarity=0.373 Sum_probs=201.8
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
+.+.+.||.|+||.||+|... .+++.|++|.+.... ......+.+|+.+++.++|+||+++++++.+....++|+||+
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 3 FTLLECIGKGSFGEVYKAIDK-RTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhcCCCCeEEEEEEEC-CCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 456688999999999999876 467899999986543 344567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccc
Q 047292 515 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHT 594 (728)
Q Consensus 515 ~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 594 (728)
++++|.+++... .+++..+..++.|++.||.|||++ +++|+||+|+||++++++.++|+|||+++....... ...
T Consensus 82 ~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~ 156 (274)
T cd06609 82 GGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-KRN 156 (274)
T ss_pred CCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc-ccc
Confidence 999999999865 788999999999999999999997 999999999999999999999999999987754322 222
Q ss_pred cccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhc
Q 047292 595 MIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMAD 674 (728)
Q Consensus 595 ~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 674 (728)
...++..|+|||.+.+..++.++||||||+++|||+||+.||...........+ .......+.+.
T Consensus 157 ~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~--------~~~~~~~~~~~------- 221 (274)
T cd06609 157 TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLI--------PKNNPPSLEGN------- 221 (274)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHh--------hhcCCCCCccc-------
Confidence 345788999999999989999999999999999999999999754322211100 11111111100
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 675 RSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 675 ~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.....+.+++.+||+.+|++||+++++++.
T Consensus 222 -~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 222 -KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred -ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 133457789999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=298.59 Aligned_cols=248 Identities=28% Similarity=0.393 Sum_probs=194.7
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccc-cccceeeEeeeeecC------Ccc
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKNLVQLLGFCDEA------LNR 507 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~------~~~ 507 (728)
.+.+.+.||+|+||.||+|... .+++.||+|.+.... .....+..|+.++.++ +|+||+++++++... ...
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~-~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (272)
T cd06637 7 IFELVELVGNGTYGQVYKGRHV-KTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 84 (272)
T ss_pred hhhHHHheeecCCeEEEEEEEc-CCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence 3556688999999999999876 567899999986543 3346788999999998 799999999998653 457
Q ss_pred eeEeeccCCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcccc
Q 047292 508 LLVYEFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLL 585 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~ 585 (728)
+++|||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||++...
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 85 WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred EEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 8999999999999999864 3578899999999999999999997 9999999999999999999999999998865
Q ss_pred ccCCCcccccccCCccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCc
Q 047292 586 LSDHSRTHTMIRGTRGYVAPEWLK-----NAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGR 660 (728)
Q Consensus 586 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (728)
..... ......|+..|+|||++. +..++.++||||||+++|||++|+.||...........+ ....
T Consensus 162 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~--------~~~~ 232 (272)
T cd06637 162 DRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI--------PRNP 232 (272)
T ss_pred ccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH--------hcCC
Confidence 33221 223355889999999986 346788999999999999999999998644322211110 0011
Q ss_pred cceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 661 LDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 661 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
..... .......+.+++.+||+.+|.+||++.++++
T Consensus 233 ~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 233 APRLK--------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCCCC--------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 11111 1112345778999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=303.97 Aligned_cols=248 Identities=23% Similarity=0.348 Sum_probs=200.8
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCC
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGN 516 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 516 (728)
.+.+.||.|+||.||+|+.. .+++.|++|.+..........+.+|+.+++.++|+||+++++++......++|+||+++
T Consensus 22 ~~~~~lg~g~~g~vy~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 100 (296)
T cd06655 22 TRYEKIGQGASGTVFTAIDV-ATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAG 100 (296)
T ss_pred EEEEEEecCCCeEEEEEEEc-CCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCC
Confidence 34567999999999999865 56889999998765555567889999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccccc
Q 047292 517 GTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMI 596 (728)
Q Consensus 517 gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 596 (728)
++|.+++... .+++.++..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++......... ....
T Consensus 101 ~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~ 175 (296)
T cd06655 101 GSLTDVVTET-CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-RSTM 175 (296)
T ss_pred CcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccccc-CCCc
Confidence 9999988653 588999999999999999999997 9999999999999999999999999998765433221 2234
Q ss_pred cCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHH
Q 047292 597 RGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRS 676 (728)
Q Consensus 597 ~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 676 (728)
.++..|+|||.+.+..++.++||||||+++|||++|+.||...........+ ......... ....
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~--------~~~~~~~~~-------~~~~ 240 (296)
T cd06655 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI--------ATNGTPELQ-------NPEK 240 (296)
T ss_pred CCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------HhcCCcccC-------Cccc
Confidence 5788999999999999999999999999999999999999765443221111 000000000 0111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 677 RLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 677 ~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
....+.+++.+||+.+|.+||++.+|++.
T Consensus 241 ~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 241 LSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred CCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 23356679999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=296.20 Aligned_cols=249 Identities=33% Similarity=0.476 Sum_probs=201.4
Q ss_pred HHhhhCCCceeEEEEeeeeCCC---CcEEEEEEecccchh-hHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 438 FKEELGRGSFGIVYKGVLKTAS---GNAIAVKKLDRLAQE-REREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~---~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
+.+.||+|+||.||+++..... +..||+|.+...... ....+..|+..+..++|+||+++++++......+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 4578999999999999987432 488999999765433 567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCC--CChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 514 MGNGTLANLIFAIPK--PDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 514 ~~~gsL~~~l~~~~~--~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
+++++|.+++..... +++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||+++........
T Consensus 83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 999999999987544 89999999999999999999997 9999999999999999999999999999876544222
Q ss_pred ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhh
Q 047292 592 THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEA 670 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 670 (728)
......+++.|+|||.+.+..++.++||||||++++||++ |+.|+........... .........
T Consensus 160 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~--------~~~~~~~~~------ 225 (258)
T smart00219 160 KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEY--------LKKGYRLPK------ 225 (258)
T ss_pred ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--------HhcCCCCCC------
Confidence 2222336789999999988889999999999999999998 7778765332221111 111111100
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047292 671 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQML 706 (728)
Q Consensus 671 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 706 (728)
.......+.+++.+|++.+|++|||+.++++.|
T Consensus 226 ---~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 ---PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111345677899999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=301.76 Aligned_cols=247 Identities=26% Similarity=0.314 Sum_probs=195.9
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch---hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
..+.||+|+||+||++... .+++.||+|.+..... .....+.+|+++++.++|+|++++.+.+...+..+++|||+
T Consensus 4 ~~~~lg~G~~g~vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05632 4 QYRVLGKGGFGEVCACQVR-ATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIM 82 (285)
T ss_pred EEEEEecCCCeEEEEEEEC-CCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEec
Confidence 3467999999999999876 4688999999865322 22356788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 515 GNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 515 ~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++....... .
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--~ 157 (285)
T cd05632 83 NGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--S 157 (285)
T ss_pred cCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--c
Confidence 999999888654 3689999999999999999999987 99999999999999999999999999987653322 1
Q ss_pred cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAM 672 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 672 (728)
.....|+..|+|||++.+..++.++|+||||+++|||++|+.||...........+.. ...... ..
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~----~~~~~~--~~-------- 223 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDR----RVLETE--EV-------- 223 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH----hhhccc--cc--------
Confidence 2234689999999999999999999999999999999999999975433222111111 000100 00
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 047292 673 ADRSRLHKWLMIAMWCIQEDPSKRPT-----MKVVMQ 704 (728)
Q Consensus 673 ~~~~~~~~l~~l~~~cl~~dp~~RPt-----~~evl~ 704 (728)
........+.+++.+||+.+|++||+ +.++++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 224 YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 11122345678999999999999999 666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=299.11 Aligned_cols=246 Identities=26% Similarity=0.344 Sum_probs=195.0
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCCCCH
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTL 519 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 519 (728)
..||+|+||.||+|... .++..|++|.+........+.+.+|+.++++++|+||+++++++......++|+||+++++|
T Consensus 14 ~~lg~g~~g~v~~~~~~-~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 92 (268)
T cd06624 14 VVLGKGTYGIVYAARDL-STQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSL 92 (268)
T ss_pred EEEecCCceEEEEeEec-CCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCH
Confidence 46999999999999876 46789999998776666677899999999999999999999999999999999999999999
Q ss_pred HHHHhcC-CCC--ChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcC-CCceEEccccCccccccCCCccccc
Q 047292 520 ANLIFAI-PKP--DWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDH-YFSPKISDFGLSKLLLSDHSRTHTM 595 (728)
Q Consensus 520 ~~~l~~~-~~~--~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~ 595 (728)
.+++... ..+ ++..+..++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||++........ ....
T Consensus 93 ~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~-~~~~ 168 (268)
T cd06624 93 SALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CTET 168 (268)
T ss_pred HHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-cccc
Confidence 9999864 344 7788889999999999999987 9999999999999986 67999999999876533222 1222
Q ss_pred ccCCccccCcccccCC--CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhh
Q 047292 596 IRGTRGYVAPEWLKNA--PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMA 673 (728)
Q Consensus 596 ~~gt~~y~aPE~~~~~--~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 673 (728)
..+++.|+|||++... .++.++||||||+++|||++|+.|+.......... +..... .. ....
T Consensus 169 ~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~----~~~~~~--~~---------~~~~ 233 (268)
T cd06624 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM----FKVGMF--KI---------HPEI 233 (268)
T ss_pred CCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH----hhhhhh--cc---------CCCC
Confidence 3478899999998664 37889999999999999999999986432211110 000000 00 0011
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 674 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 674 ~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
+......+.+++.+||+.+|.+||++.++++.
T Consensus 234 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 234 PESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred CcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 12233467789999999999999999999763
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=299.52 Aligned_cols=257 Identities=25% Similarity=0.347 Sum_probs=203.1
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCC---cEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCccee
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASG---NAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLL 509 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 509 (728)
..+.+.+.||+|+||.||+|..+.... ..+|+|.+.... ......+.+|+.++++++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 344566889999999999998763222 268999886543 3345788999999999999999999999987 78899
Q ss_pred EeeccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccC
Q 047292 510 VYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD 588 (728)
Q Consensus 510 v~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 588 (728)
|+||+++|+|.+++... ..+++..+..++.||+.||+|||+. +++|+||||+||++++++.+||+|||+++.....
T Consensus 86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 99999999999999874 4688999999999999999999997 9999999999999999999999999999876433
Q ss_pred CCcc-cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceecc
Q 047292 589 HSRT-HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALID 666 (728)
Q Consensus 589 ~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 666 (728)
.... .....++..|+|||.+....++.++||||||++++|+++ |+.||......+....+ ..+....
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~--------~~~~~~~--- 231 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL--------EKGERLP--- 231 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH--------hCCCCCC---
Confidence 2211 111223568999999988899999999999999999999 99998765443322111 1111000
Q ss_pred chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 667 SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 667 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
.+......+.+++.+||..+|.+||++.++++.|+.+..
T Consensus 232 ------~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 232 ------QPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred ------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 011122356788999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=307.51 Aligned_cols=262 Identities=21% Similarity=0.256 Sum_probs=196.0
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch-hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
+.+.++||+|+||.||+|..+ .+++.||+|.++.... .....+.+|+.++++++|+||+++++++......++||||+
T Consensus 8 y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 86 (309)
T cd07872 8 YIKLEKLGEGTYATVFKGRSK-LTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL 86 (309)
T ss_pred eEEEEEecccCCEEEEEEEec-CCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCC
Confidence 445578999999999999876 4678999999864332 23356788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccc
Q 047292 515 GNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH 593 (728)
Q Consensus 515 ~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 593 (728)
++ +|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+||++++++.+||+|||+++....... ..
T Consensus 87 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~ 161 (309)
T cd07872 87 DK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-TY 161 (309)
T ss_pred CC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc-cc
Confidence 85 888887665 4578889999999999999999997 999999999999999999999999999876433221 12
Q ss_pred ccccCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHH-------HHhhhcC------
Q 047292 594 TMIRGTRGYVAPEWLKN-APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWA-------YDCYVEG------ 659 (728)
Q Consensus 594 ~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~------ 659 (728)
....+++.|+|||.+.+ ..++.++||||||+++|||+||+.||......+....+.... +......
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07872 162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY 241 (309)
T ss_pred ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhh
Confidence 23457889999998865 468999999999999999999999997654432221111100 0000000
Q ss_pred ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 660 RLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 660 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
......... ...........+.+++.+||+.||.+|||++|+++
T Consensus 242 ~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 242 NFPKYKPQP-LINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hcCccCCCc-hhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000000 00001122345678999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=296.57 Aligned_cols=251 Identities=24% Similarity=0.329 Sum_probs=202.8
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccC
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
+.+.+.||+|+||.||++... .+++.+++|.+........+.+.+|+.++++++|+||+++++++......+++|||++
T Consensus 5 ~~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~ 83 (262)
T cd06613 5 YELIQRIGSGTYGDVYKARDI-ATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCG 83 (262)
T ss_pred eEEEEEecCCCceEEEEeEec-CCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCC
Confidence 345578999999999999876 4567899999976555566889999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccc
Q 047292 516 NGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHT 594 (728)
Q Consensus 516 ~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 594 (728)
+++|.+++... ..+++..+..++.|++.||+|||++ +++|+||+|+||++++++.+||+|||++........ ...
T Consensus 84 ~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~ 159 (262)
T cd06613 84 GGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-KRK 159 (262)
T ss_pred CCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh-ccc
Confidence 99999999876 6889999999999999999999997 999999999999999999999999999876543221 122
Q ss_pred cccCCccccCcccccCC---CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhh
Q 047292 595 MIRGTRGYVAPEWLKNA---PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAA 671 (728)
Q Consensus 595 ~~~gt~~y~aPE~~~~~---~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 671 (728)
...++..|+|||.+... .++.++||||||++++||++|+.|+...........+ . ..... .. ..
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~---~-----~~~~~---~~--~~ 226 (262)
T cd06613 160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLI---S-----KSNFP---PP--KL 226 (262)
T ss_pred cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---H-----hccCC---Cc--cc
Confidence 34578889999999877 8899999999999999999999998754432211111 0 00000 00 00
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 672 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 672 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
.........+.+++.+||+.+|.+||++++|+.
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 227 KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 112233456889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=296.57 Aligned_cols=247 Identities=21% Similarity=0.294 Sum_probs=199.6
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc-chhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccC
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
.+.++||+|+||.||++... .+++.+++|.++.. .....+.+.+|+.++++++|+||+++++.+......++++||++
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (255)
T cd08219 3 NVLRVVGEGSFGRALLVQHV-NSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD 81 (255)
T ss_pred eEEEEeeccCCeEEEEEEEc-CCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence 34578999999999999876 46789999988542 23345678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccc
Q 047292 516 NGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH 593 (728)
Q Consensus 516 ~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 593 (728)
+++|.+++... ..++...+..++.|++.||.|||++ +|+|+||||+||++++++.++|+|||+++....... ..
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~ 157 (255)
T cd08219 82 GGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-YA 157 (255)
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc-cc
Confidence 99999988653 4578889999999999999999997 999999999999999999999999999976643222 12
Q ss_pred ccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhh
Q 047292 594 TMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMA 673 (728)
Q Consensus 594 ~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 673 (728)
....+++.|+|||++.+..++.++|+||||+++|+|++|+.||........... ...+....+
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~--------~~~~~~~~~--------- 220 (255)
T cd08219 158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILK--------VCQGSYKPL--------- 220 (255)
T ss_pred ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHH--------HhcCCCCCC---------
Confidence 234588899999999999999999999999999999999999975433221111 111111111
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 674 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 674 ~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
+......+.+++.+||+.||++||++++|+..
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11123456789999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=302.88 Aligned_cols=250 Identities=23% Similarity=0.341 Sum_probs=200.8
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
.+.+.+.||+|+||.||++... .+++.||+|.+........+.+.+|+.+++.++|+||+++++++......++||||+
T Consensus 20 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 20 KYTRFEKIGQGASGTVYTAIDI-ATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hceeeeeeccCCCeEEEEEEEC-CCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 3445678999999999999865 568899999997655555677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccc
Q 047292 515 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHT 594 (728)
Q Consensus 515 ~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 594 (728)
++++|.+++.+ ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++........ ...
T Consensus 99 ~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~~ 173 (297)
T cd06656 99 AGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRS 173 (297)
T ss_pred CCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-CcC
Confidence 99999999865 4578889999999999999999997 999999999999999999999999999876543322 122
Q ss_pred cccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhc
Q 047292 595 MIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMAD 674 (728)
Q Consensus 595 ~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 674 (728)
...+++.|+|||.+.+..++.++||||||+++|+|++|+.||............ ...+ ... ....
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~-------~~~~-~~~-------~~~~ 238 (297)
T cd06656 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------ATNG-TPE-------LQNP 238 (297)
T ss_pred cccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee-------ccCC-CCC-------CCCc
Confidence 345788999999999999999999999999999999999999754332110000 0000 000 0011
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 675 RSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 675 ~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
......+.+++.+||+.+|++||++++|++.
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 239 ERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1223456689999999999999999999883
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=299.84 Aligned_cols=264 Identities=22% Similarity=0.299 Sum_probs=199.5
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
+.+.+.||+|+||.||+|..+ .+++.||+|++.... ....+.+.+|+.++++++|+||+++++++......++||||
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 81 (286)
T cd07847 3 YEKLSKIGEGSYGVVFKCRNR-ETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY 81 (286)
T ss_pred eeeeeeecccCCeEEEEEEEC-CCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence 345578999999999999876 468899999886432 22345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccc
Q 047292 514 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH 593 (728)
Q Consensus 514 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 593 (728)
+++++|..++.....+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++........ ..
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~ 157 (286)
T cd07847 82 CDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DY 157 (286)
T ss_pred cCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc-cc
Confidence 99999988887777899999999999999999999997 999999999999999999999999999987644322 12
Q ss_pred ccccCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHH-------HhhhcCcc-cee
Q 047292 594 TMIRGTRGYVAPEWLKN-APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAY-------DCYVEGRL-DAL 664 (728)
Q Consensus 594 ~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~~-~~~ 664 (728)
....++..|+|||.+.+ ..++.++||||||++++||++|+.||......+....+..... ..+..... ...
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 23346788999999876 4678999999999999999999999975443222111111000 00000000 000
Q ss_pred ccchhhhh-----hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 665 IDSDEAAM-----ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 665 ~d~~~~~~-----~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
..+..... ........+.+++.+||+.+|++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00000000 00112456788999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=308.86 Aligned_cols=252 Identities=20% Similarity=0.248 Sum_probs=193.7
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
.+.++||+|+||.||++..+ .+++.+|+|++.... ......+.+|+.++..++|+||+++++.+......++||||
T Consensus 4 ~~~~~lG~G~fg~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey 82 (332)
T cd05623 4 EILKVIGRGAFGEVAVVKLK-NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDY 82 (332)
T ss_pred eEEEEEEeCCCeEEEEEEEC-CCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEec
Confidence 45578999999999999876 467899999986422 22235588899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 514 MGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 514 ~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
+++|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..........
T Consensus 83 ~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~ 159 (332)
T cd05623 83 YVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 159 (332)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCCcce
Confidence 9999999999873 5788899999999999999999997 99999999999999999999999999987654333333
Q ss_pred cccccCCccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccc
Q 047292 593 HTMIRGTRGYVAPEWLK-----NAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDS 667 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~-----~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 667 (728)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||...........+ ........+..
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i--------~~~~~~~~~p~ 231 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI--------MNHKERFQFPA 231 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHH--------hCCCccccCCC
Confidence 33456899999999986 346789999999999999999999999765433222111 11100000000
Q ss_pred hhhhhhcHHHHHHHHHHHHHhccc--CCCCCCCHHHHHHH
Q 047292 668 DEAAMADRSRLHKWLMIAMWCIQE--DPSKRPTMKVVMQM 705 (728)
Q Consensus 668 ~~~~~~~~~~~~~l~~l~~~cl~~--dp~~RPt~~evl~~ 705 (728)
........+.+++.+|+.. ++..|++++++++.
T Consensus 232 -----~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 232 -----QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -----ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0011234456677777754 44447899998766
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=310.32 Aligned_cols=201 Identities=28% Similarity=0.381 Sum_probs=172.5
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhcccc-c-----cceeeEeeeeecCCcce
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTH-H-----KNLVQLLGFCDEALNRL 508 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~g~~~~~~~~~ 508 (728)
+|.+.+.||+|+||.|-++.+. .+++.||||++++. .....+...|+.+|..++ | -|+|++++++...++.|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~-~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDH-KTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEecccccceeEEEEec-CCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 5666789999999999999765 78999999999874 334567788999999886 3 58999999999999999
Q ss_pred eEeeccCCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCC--CceEEccccCccc
Q 047292 509 LVYEFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHY--FSPKISDFGLSKL 584 (728)
Q Consensus 509 lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~--~~~kl~Dfgla~~ 584 (728)
||+|.+. .+|.++|... ..++...+..|+.||+.||.+||+. +|||+||||+||||.+. ..+||+|||.+..
T Consensus 265 iVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 265 IVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccc
Confidence 9999884 5999999976 4678999999999999999999986 99999999999999753 4799999999986
Q ss_pred cccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhh
Q 047292 585 LLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESR 645 (728)
Q Consensus 585 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~ 645 (728)
..... ....-++.|+|||++.+.+|+.+.||||||||++||++|.+.|..+.+.+..
T Consensus 341 ~~q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl 397 (586)
T KOG0667|consen 341 ESQRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQL 397 (586)
T ss_pred cCCcc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHH
Confidence 53332 2455688999999999999999999999999999999998888766555443
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=303.45 Aligned_cols=255 Identities=25% Similarity=0.395 Sum_probs=198.4
Q ss_pred HHhhhCCCceeEEEEeeeeCCCC---cEEEEEEecccch-hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 438 FKEELGRGSFGIVYKGVLKTASG---NAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~---~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
..+.||+|+||.||+|.....+. ..||+|.+..... .....+.+|+.+++.++|+||+++++++... ..++++||
T Consensus 11 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~ 89 (303)
T cd05110 11 RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQL 89 (303)
T ss_pred eccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehh
Confidence 45689999999999998763322 2578898865432 3345788999999999999999999998754 46799999
Q ss_pred cCCCCHHHHHhcCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc-
Q 047292 514 MGNGTLANLIFAIP-KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR- 591 (728)
Q Consensus 514 ~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~- 591 (728)
+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+|+||||+||++++++.+||+|||+++........
T Consensus 90 ~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 166 (303)
T cd05110 90 MPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEY 166 (303)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccCccccc
Confidence 99999999987653 678899999999999999999997 9999999999999999999999999999876433221
Q ss_pred ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhh
Q 047292 592 THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEA 670 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 670 (728)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||...........+ ..+....
T Consensus 167 ~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~--------~~~~~~~------- 231 (303)
T cd05110 167 NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL--------EKGERLP------- 231 (303)
T ss_pred ccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH--------HCCCCCC-------
Confidence 1122335678999999999999999999999999999998 88888654332221111 1111000
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCC
Q 047292 671 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVP 713 (728)
Q Consensus 671 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~ 713 (728)
........+.+++..||..+|++||+++++++.|+.+...+
T Consensus 232 --~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 232 --QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred --CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 01112345678999999999999999999999998865433
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=311.54 Aligned_cols=262 Identities=23% Similarity=0.273 Sum_probs=193.3
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeeecCC------c
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEAL------N 506 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~ 506 (728)
.+.+.+.||+|+||.||++... .+++.||+|++... .......+.+|+.+++.++||||+++++++.... .
T Consensus 22 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 100 (359)
T cd07876 22 RYQQLKPIGSGAQGIVCAAFDT-VLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD 100 (359)
T ss_pred ceEEEEEeecCCCEEEEEEEEc-CCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence 3455678999999999999875 56889999998643 2334567889999999999999999999986443 4
Q ss_pred ceeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccc
Q 047292 507 RLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLL 586 (728)
Q Consensus 507 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 586 (728)
.++||||+++ +|.+.+. ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 101 ~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 101 VYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred eEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 6999999975 5666654 3477888999999999999999997 99999999999999999999999999997643
Q ss_pred cCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHH---------------HH
Q 047292 587 SDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILT---------------DW 651 (728)
Q Consensus 587 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~---------------~~ 651 (728)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+. ..
T Consensus 175 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (359)
T cd07876 175 TNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT 252 (359)
T ss_pred cCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHH
Confidence 221 2233468999999999999999999999999999999999999997543221110000 00
Q ss_pred HHHhhhcCc------cceeccchh---hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 652 AYDCYVEGR------LDALIDSDE---AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 652 ~~~~~~~~~------~~~~~d~~~---~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
......... ..+.+.... ...........+.+++.+||+.||++|||+.|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000000 000000000 000111123467789999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=293.52 Aligned_cols=249 Identities=23% Similarity=0.330 Sum_probs=202.6
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
+.+.+.||.|+||.||.+... .+++.+++|++... .......+.+|+.++++++|+||+++++++.+....+++|||
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred ceEeeEecccCCceEEEEEEc-CCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 345678999999999998865 56789999987543 344457789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 514 MGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 514 ~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
+++++|.+++... ..+++..+..++.|+++||.|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999999875 4678899999999999999999987 999999999999999999999999999987644332
Q ss_pred ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhh
Q 047292 592 THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAA 671 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 671 (728)
......+++.|+|||.+.+..++.++||||||++++||++|+.||......+....+ ..+.....
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~--------~~~~~~~~------- 221 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKI--------VQGNYTPV------- 221 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--------HcCCCCCC-------
Confidence 223345889999999999888999999999999999999999998754332211111 11111111
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047292 672 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQML 706 (728)
Q Consensus 672 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 706 (728)
.......+.+++.+||+.+|.+||+++++++.+
T Consensus 222 --~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 222 --VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred --ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 112234577899999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=320.26 Aligned_cols=261 Identities=20% Similarity=0.253 Sum_probs=188.9
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhcccc------ccceeeEeeeeecC-Ccc
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTH------HKNLVQLLGFCDEA-LNR 507 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~g~~~~~-~~~ 507 (728)
.+.+.++||+|+||.||++... ..++.||||+++... .....+..|+.+++.++ |.+++++++++... ...
T Consensus 130 ~y~i~~~lG~G~fg~V~~a~~~-~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 130 RFKILSLLGEGTFGKVVEAWDR-KRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred cEEEEEEEEeccCEEEEEEEEc-CCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 3455678999999999999876 467899999996532 22334455666665554 55689999988654 467
Q ss_pred eeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCC---------------
Q 047292 508 LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYF--------------- 572 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~--------------- 572 (728)
++|||++ +++|.+++.....+++..+..|+.||+.||.|||++ .+||||||||+|||++.++
T Consensus 208 ~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~ 284 (467)
T PTZ00284 208 CIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALPPDP 284 (467)
T ss_pred EEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence 8899887 778999998888899999999999999999999973 3899999999999998765
Q ss_pred -ceEEccccCccccccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHH-
Q 047292 573 -SPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTD- 650 (728)
Q Consensus 573 -~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~- 650 (728)
.+||+|||++.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+..
T Consensus 285 ~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~ 360 (467)
T PTZ00284 285 CRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKT 360 (467)
T ss_pred ceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 49999999876432 222345689999999999999999999999999999999999999976443322111111
Q ss_pred -------HHHH--------hh-hcCccceeccchhhh-------hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 651 -------WAYD--------CY-VEGRLDALIDSDEAA-------MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 651 -------~~~~--------~~-~~~~~~~~~d~~~~~-------~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
|... .+ ..+.+....++.... .........+++|+.+||+.||++|||++|+++
T Consensus 361 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 361 LGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred cCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 0000 00 000000011110000 000011345779999999999999999999997
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=295.73 Aligned_cols=247 Identities=23% Similarity=0.355 Sum_probs=197.4
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc------hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEe
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA------QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 511 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 511 (728)
..+.||+|+||.||+|.. .+++.+|+|.++... ......+.+|++++++++|+||+++++++.+....++++
T Consensus 4 ~~~~ig~g~~~~v~~~~~--~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (265)
T cd06631 4 KGEVLGKGAYGTVYCGLT--NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM 81 (265)
T ss_pred ccceEeccCCeEEEEEEE--cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence 456799999999999975 367899999885321 222356899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCC--
Q 047292 512 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH-- 589 (728)
Q Consensus 512 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~-- 589 (728)
||+++++|.+++.....+++..+..++.|++.||+|||+. +|+|+||+|+||++++++.+||+|||++.......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 158 (265)
T cd06631 82 EFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158 (265)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence 9999999999998877888999999999999999999987 89999999999999999999999999987653211
Q ss_pred ---CcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceecc
Q 047292 590 ---SRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALID 666 (728)
Q Consensus 590 ---~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 666 (728)
........++..|+|||.+.+..++.++||||||++++||++|+.||...........+ .........
T Consensus 159 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~------~~~~~~~~~--- 229 (265)
T cd06631 159 GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI------GAHRGLMPR--- 229 (265)
T ss_pred ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHh------hhccCCCCC---
Confidence 11122345788999999999999999999999999999999999999754322111100 000011111
Q ss_pred chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 667 SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 667 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
........+.+++.+||+.+|.+||++.++++
T Consensus 230 ------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 230 ------LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ------CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11123456778999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=316.60 Aligned_cols=191 Identities=24% Similarity=0.232 Sum_probs=164.3
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccC
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
+.+.+.||+|+||.||++... ..++.||||.... ..+.+|++++++++|+||+++++++......++|||++.
T Consensus 171 y~i~~~Lg~G~~G~Vy~a~~~-~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~ 243 (461)
T PHA03211 171 FAIHRALTPGSEGCVFESSHP-DYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR 243 (461)
T ss_pred eEEEEEEccCCCeEEEEEEEC-CCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC
Confidence 445578999999999999876 4678999996432 345789999999999999999999999999999999995
Q ss_pred CCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc-cc
Q 047292 516 NGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR-TH 593 (728)
Q Consensus 516 ~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~ 593 (728)
++|.+++... ..+++..++.|+.||++||.|||+. +|+||||||+||||+.++.+||+|||+++........ ..
T Consensus 244 -~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 319 (461)
T PHA03211 244 -SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH 319 (461)
T ss_pred -CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccccccc
Confidence 6888888664 4689999999999999999999997 9999999999999999999999999999866433221 22
Q ss_pred ccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcc
Q 047292 594 TMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVE 637 (728)
Q Consensus 594 ~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~ 637 (728)
....||+.|+|||++.+..++.++|||||||+||||++|..++.
T Consensus 320 ~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred cccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 23568999999999999999999999999999999999886553
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=302.86 Aligned_cols=264 Identities=24% Similarity=0.319 Sum_probs=199.9
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch--hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
+.+.++||+|+||.||++..+ .+++.||+|++..... ...+.+.+|+++++.++|+||+++++++......++|+||
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 3 YENLGLVGEGSYGMVMKCKHK-ETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred eeEeeeeccCCCeEEEEEEEC-CCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 345678999999999999876 4578999998854322 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccc
Q 047292 514 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH 593 (728)
Q Consensus 514 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 593 (728)
+++++|.++......+++..++.++.||++||+|||+. +++|+||+|+||++++++.++|+|||++....... ...
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~ 157 (286)
T cd07846 82 VDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVY 157 (286)
T ss_pred CCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-ccc
Confidence 99999998887766789999999999999999999997 99999999999999999999999999988664432 222
Q ss_pred ccccCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHH-------HhhhcCc-----
Q 047292 594 TMIRGTRGYVAPEWLKN-APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAY-------DCYVEGR----- 660 (728)
Q Consensus 594 ~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~----- 660 (728)
....++..|+|||++.+ ..++.++||||||++++||++|+.||......+....+..... .......
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 33457889999999875 4578899999999999999999998865433221111111000 0000000
Q ss_pred -cceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 661 -LDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 661 -~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
....................+.+++.+||+.+|.+||+++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00000000000011123456889999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=294.30 Aligned_cols=247 Identities=22% Similarity=0.296 Sum_probs=191.1
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc-----hhhHHHHHHHHHHhccccccceeeEeeeeec--CCccee
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA-----QEREREFKSEVSAIGRTHHKNLVQLLGFCDE--ALNRLL 509 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~l 509 (728)
...+.||+|+||.||++... .++..|++|++.... .+....+.+|+.++++++|+||+++++++.. ....++
T Consensus 5 ~~~~~lg~g~~g~vy~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 83 (266)
T cd06651 5 RRGKLLGQGAFGRVYLCYDV-DTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTI 83 (266)
T ss_pred cccceecCCCCEEEEEEEEc-CCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEE
Confidence 34578999999999999875 467899999885321 2234678899999999999999999998865 356789
Q ss_pred EeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCC
Q 047292 510 VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH 589 (728)
Q Consensus 510 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 589 (728)
++||+++++|.+++.....+++.....++.|++.||+|||+. +|+|+||+|+||+++.++.+||+|||+++......
T Consensus 84 ~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd06651 84 FMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 160 (266)
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence 999999999999998877789999999999999999999987 99999999999999999999999999987653321
Q ss_pred C--cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccc
Q 047292 590 S--RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDS 667 (728)
Q Consensus 590 ~--~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 667 (728)
. .......++..|+|||.+.+..++.++||||||+++|||++|+.||.......... ....... .+
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~-------~~~~~~~-----~~ 228 (266)
T cd06651 161 MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIF-------KIATQPT-----NP 228 (266)
T ss_pred ccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHH-------HHhcCCC-----CC
Confidence 1 11123457889999999999999999999999999999999999997442211110 0000000 00
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 668 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 668 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
..+......+..++ +||..+|++||+++||++
T Consensus 229 ----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 229 ----QLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 01111122334454 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=298.28 Aligned_cols=250 Identities=25% Similarity=0.371 Sum_probs=198.5
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc-chhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
+++.+.||+|+||.||++..+ .++..||+|.++.. .......+.+|+.++++++|+||+++++.+......++|+||+
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 3 IEVLDELGKGNYGSVYKVLHR-PTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhcccCCeEEEEEEEc-CCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 457789999999999999876 46889999988653 2334567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC---CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 515 GNGTLANLIFAI---PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 515 ~~gsL~~~l~~~---~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
++++|..++... ..+++..+..++.|++.||.|||++ .+|+|+||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 157 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-- 157 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc--
Confidence 999999998764 3688999999999999999999974 389999999999999999999999999987653322
Q ss_pred ccccccCCccccCcccccCC------CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceec
Q 047292 592 THTMIRGTRGYVAPEWLKNA------PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALI 665 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~~------~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (728)
.....+++.|+|||.+.+. .++.++||||||+++|||++|+.||...........+. ....+...
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~-----~~~~~~~~--- 228 (286)
T cd06622 158 -AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLS-----AIVDGDPP--- 228 (286)
T ss_pred -cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHH-----HHhhcCCC---
Confidence 1223478899999998654 35889999999999999999999996543222111110 01111111
Q ss_pred cchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 666 DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 666 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.........+.+++.+||+.+|.+||++++++..
T Consensus 229 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 229 ------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred ------CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 1112244567789999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=296.54 Aligned_cols=252 Identities=27% Similarity=0.373 Sum_probs=197.8
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch----------hhHHHHHHHHHHhccccccceeeEeeeeecCCcc
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ----------EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNR 507 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 507 (728)
..+.||+|+||.||+|... .+++.||+|.++.... ...+.+..|+.+++.++|+|++++++++......
T Consensus 5 ~~~~lg~g~~~~vy~~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (272)
T cd06629 5 KGELIGKGTYGRVYLALNV-TTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYL 83 (272)
T ss_pred ecceecccCceEEEEEeec-CCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCce
Confidence 3467999999999999875 4688999998753211 1124688899999999999999999999999999
Q ss_pred eeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcccccc
Q 047292 508 LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS 587 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 587 (728)
++|+||+++++|.+++.....+++..+..++.||+.||.|||+. +++|+||+|+||++++++.++|+|||+++....
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 160 (272)
T cd06629 84 SIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDD 160 (272)
T ss_pred EEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence 99999999999999998888889999999999999999999997 999999999999999999999999999976543
Q ss_pred CCCc-ccccccCCccccCcccccCCC--CCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCcccee
Q 047292 588 DHSR-THTMIRGTRGYVAPEWLKNAP--VSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDAL 664 (728)
Q Consensus 588 ~~~~-~~~~~~gt~~y~aPE~~~~~~--~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (728)
.... ......++..|+|||.+.... ++.++||||||++++|+++|+.|+.......... .. ........
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-------~~-~~~~~~~~ 232 (272)
T cd06629 161 IYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMF-------KL-GNKRSAPP 232 (272)
T ss_pred cccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHH-------Hh-hccccCCc
Confidence 2221 123345788999999987654 7899999999999999999999986432221110 00 00111111
Q ss_pred ccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 665 IDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 665 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
+.. .........+.+++.+||+.+|.+||++++|++.
T Consensus 233 ~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 233 IPP----DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CCc----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 111 1111234567789999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=302.42 Aligned_cols=265 Identities=22% Similarity=0.283 Sum_probs=203.1
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
+.+.+.||+|+||.||+|..+ .+++.|++|+++... ......+.+|++++++++|+||+++++++...+..++++||
T Consensus 3 y~~~~~i~~g~~~~v~~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 3 YEVLGVVGEGAYGVVLKCRNK-ATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred eeEEEEecccCCeeEEEEEeC-CCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 345678999999999999876 457899999986532 22346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccc
Q 047292 514 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH 593 (728)
Q Consensus 514 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 593 (728)
++++.+..++.....+++..+..++.||+.||.|||++ +++|+||+|+||++++++.+||+|||++...........
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (288)
T cd07833 82 VERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL 158 (288)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccc
Confidence 99988877777667789999999999999999999997 999999999999999999999999999987655443233
Q ss_pred ccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHH-------Hhh-hcC-----
Q 047292 594 TMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAY-------DCY-VEG----- 659 (728)
Q Consensus 594 ~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~-------~~~-~~~----- 659 (728)
....++..|+|||++.+. .++.++||||||+++|||++|+.||...........+..... ..+ ...
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 345578899999999888 889999999999999999999999875433221111110000 000 000
Q ss_pred ccceeccch-hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 660 RLDALIDSD-EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 660 ~~~~~~d~~-~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
......+.. ............+.+++.+||+.+|++||+++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000011110 011111223567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=301.60 Aligned_cols=245 Identities=24% Similarity=0.341 Sum_probs=198.1
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCCCCH
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTL 519 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 519 (728)
..||+|+||.||++... .+++.|++|.+..........+.+|+.++..++||||+++++++......++++||+++++|
T Consensus 27 ~~ig~g~~g~v~~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 27 IKIGEGSTGIVCIAREK-HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhcCCCCceeEEEEEEc-CCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 47999999999999875 46789999998654445567788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccccccCC
Q 047292 520 ANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGT 599 (728)
Q Consensus 520 ~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt 599 (728)
.+++.. ..+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||++........ ......++
T Consensus 106 ~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~ 180 (297)
T cd06659 106 TDIVSQ-TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSLVGT 180 (297)
T ss_pred HHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cccceecC
Confidence 987755 5678999999999999999999997 999999999999999999999999999876543322 12234588
Q ss_pred ccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHHHHH
Q 047292 600 RGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLH 679 (728)
Q Consensus 600 ~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 679 (728)
..|+|||++.+..++.++||||||++++||++|+.||...........+ ......... .......
T Consensus 181 ~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~--------~~~~~~~~~-------~~~~~~~ 245 (297)
T cd06659 181 PYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL--------RDSPPPKLK-------NAHKISP 245 (297)
T ss_pred ccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------hccCCCCcc-------ccCCCCH
Confidence 9999999999989999999999999999999999998754332211111 000000000 0011234
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 680 KWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 680 ~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.+.+++.+||+.+|.+||+++++++.
T Consensus 246 ~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 246 VLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 56789999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=292.42 Aligned_cols=248 Identities=23% Similarity=0.337 Sum_probs=198.5
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHhccccccceeeEeeeeec-CCcceeEee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDE-ALNRLLVYE 512 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lv~e 512 (728)
+.+.+.||+|++|.||++..+ .+++.|++|++.... ....+.+.+|++++++++|+|++++++.+.. ....+++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHR-TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEc-CCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 345678999999999999876 457899999986432 3345678999999999999999999998764 445789999
Q ss_pred ccCCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC
Q 047292 513 FMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 513 ~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 590 (728)
|+++++|.+++... ..+++.++..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 99999999999763 4578999999999999999999997 999999999999999999999999999987643322
Q ss_pred cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhh
Q 047292 591 RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEA 670 (728)
Q Consensus 591 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 670 (728)
......+++.|+|||.+.+..++.++||||||++++||++|+.||........... ...+.+..
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~--------~~~~~~~~------- 221 (257)
T cd08223 158 -MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYR--------IIEGKLPP------- 221 (257)
T ss_pred -ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHH--------HHhcCCCC-------
Confidence 22334578899999999999999999999999999999999999875432221111 11111111
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 671 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 671 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
........+.+++.+||+.+|.+||++.++++.
T Consensus 222 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 222 --MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred --CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 112233567789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=312.56 Aligned_cols=265 Identities=19% Similarity=0.203 Sum_probs=199.2
Q ss_pred HHHHHhhHHhhhCCCceeEEEEeeeeC-CCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCccee
Q 047292 431 LKDATDGFKEELGRGSFGIVYKGVLKT-ASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLL 509 (728)
Q Consensus 431 l~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 509 (728)
+....+.+.+.||+|+||.||++.... ..++.|++|.+... ....+|++++++++|+||+++++++......++
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 334456777899999999999987542 34578999988643 235679999999999999999999999999999
Q ss_pred EeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCC
Q 047292 510 VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH 589 (728)
Q Consensus 510 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 589 (728)
+||++. ++|.+++.....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 164 v~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 164 VMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred EehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 999986 68999997778899999999999999999999997 99999999999999999999999999997664432
Q ss_pred C-cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccc--e---
Q 047292 590 S-RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLD--A--- 663 (728)
Q Consensus 590 ~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~--- 663 (728)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.... ......... .
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~-~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSII-RCMQVHPLEFPQNGS 318 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHH-HHhccCccccCCccc
Confidence 2 22234568999999999999999999999999999999999999986543221111111000 000000000 0
Q ss_pred ------------eccch--hhh-hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 664 ------------LIDSD--EAA-MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 664 ------------~~d~~--~~~-~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
...+. ... .........+.+++.+||+.||++||++.+++..
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000 000 0000112356678999999999999999999876
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=300.49 Aligned_cols=263 Identities=24% Similarity=0.281 Sum_probs=198.6
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchh-----hHHHHHHHHHHhccccccceeeEeeeeecCCcceeEe
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQE-----REREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 511 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 511 (728)
.+.+.||+|+||.||+|... .+++.|++|++...... ....+..|++++++++|+||+++++++......++||
T Consensus 3 ~~~~~lg~g~~~~vy~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 3 EKGKKLGEGTYAVVYKARDK-ETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred eeeeeeeeccccEEEEEEEC-CCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 34567999999999999876 45789999999654322 3456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC
Q 047292 512 EFMGNGTLANLIFAIP-KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 512 e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 590 (728)
||+ +++|.+++.... .+++..+..++.||++||.|||+. +++|+||+|+||+++.++.+||+|||+++.......
T Consensus 82 e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 82 EFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred ccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 999 899999998765 789999999999999999999997 999999999999999999999999999987644322
Q ss_pred cccccccCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHH----Hhhh-cCcccee
Q 047292 591 RTHTMIRGTRGYVAPEWLKN-APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAY----DCYV-EGRLDAL 664 (728)
Q Consensus 591 ~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~----~~~~-~~~~~~~ 664 (728)
......+++.|+|||.+.+ ..++.++||||||++++||++|..+|...........+..... ..+. .......
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T cd07841 158 -KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDY 236 (298)
T ss_pred -cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccc
Confidence 1222346778999998865 4678999999999999999999877765443221111110000 0000 0000000
Q ss_pred ccchh-----hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 665 IDSDE-----AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 665 ~d~~~-----~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
..... ...........+.+++.+||+.+|++||+++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 237 VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000 000112234578899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=309.53 Aligned_cols=189 Identities=21% Similarity=0.268 Sum_probs=161.6
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
.+.+.+.||+|+||.||+|... .+++.||+|..... ....|+.++++++|+||+++++++......++|+|++
T Consensus 67 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 67 GYTVIKTLTPGSEGRVFVATKP-GQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred CcEEEEEecCCCCeEEEEEEEC-CCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence 3556678999999999999876 45788999985432 2356899999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccc
Q 047292 515 GNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH 593 (728)
Q Consensus 515 ~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 593 (728)
. ++|.+++... ..+++..+..|+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 140 ~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--~~ 213 (357)
T PHA03209 140 S-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP--AF 213 (357)
T ss_pred C-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCc--cc
Confidence 5 5888887654 5789999999999999999999997 99999999999999999999999999997542221 12
Q ss_pred ccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCc
Q 047292 594 TMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSV 636 (728)
Q Consensus 594 ~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~ 636 (728)
....||+.|+|||++.+..++.++|||||||++|||+++..++
T Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 2345899999999999999999999999999999999976554
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=299.82 Aligned_cols=245 Identities=27% Similarity=0.379 Sum_probs=198.0
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCCCCH
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTL 519 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 519 (728)
..||+|+||.||++... .++..||||++..........+.+|+.+++.++|+||+++++.+...+..++||||+++++|
T Consensus 28 ~~lg~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 28 IKIGEGSTGIVCIATEK-HTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hcccCCCCeEEEEEEEC-CCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 56999999999999865 46789999998765555567789999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccccccCC
Q 047292 520 ANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGT 599 (728)
Q Consensus 520 ~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt 599 (728)
.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+||++++++.+||+|||++........ ......++
T Consensus 107 ~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~ 181 (292)
T cd06658 107 TDIVTH-TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKSLVGT 181 (292)
T ss_pred HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCceeecC
Confidence 998854 4688899999999999999999997 999999999999999999999999999876533322 12234578
Q ss_pred ccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHHHHH
Q 047292 600 RGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLH 679 (728)
Q Consensus 600 ~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 679 (728)
..|+|||.+.+..++.++||||||+++|||++|+.||...........+ . . .+...+. . ......
T Consensus 182 ~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~----~----~-~~~~~~~----~--~~~~~~ 246 (292)
T cd06658 182 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI----R----D-NLPPRVK----D--SHKVSS 246 (292)
T ss_pred ccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----H----h-cCCCccc----c--ccccCH
Confidence 8999999999889999999999999999999999998754332211110 0 0 0000000 0 111233
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 680 KWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 680 ~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.+..++.+||+.+|.+|||++++++.
T Consensus 247 ~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 247 VLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHHHHHccCChhHCcCHHHHhhC
Confidence 56678899999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=308.29 Aligned_cols=244 Identities=27% Similarity=0.409 Sum_probs=197.7
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEe--ccc--chhhHHHHHHHHHHhccccccceeeEeeeeecCCc--ceeEe
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKL--DRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALN--RLLVY 511 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l--~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~--~~lv~ 511 (728)
|.++||+|+|=+||||.+. .+|-.||=-.+ .+. .....+.|..|+.+|+.|+|+||++++..+.+... .-+|.
T Consensus 44 ~~evLGrGafKtVYka~De-~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDE-EEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred hhhhcccccceeeeecccc-ccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 5678999999999999874 66766653222 222 23334789999999999999999999999876555 67999
Q ss_pred eccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEc-CCCceEEccccCccccccCCC
Q 047292 512 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLD-HYFSPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 512 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~-~~~~~kl~Dfgla~~~~~~~~ 590 (728)
|.|..|+|..|+.+.+..+...+..|++||++||.|||++ .++|||||||-+||+|+ ..|.+||+|+|||......+.
T Consensus 123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a 201 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA 201 (632)
T ss_pred ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcccc
Confidence 9999999999999999999999999999999999999996 67999999999999998 568999999999998765543
Q ss_pred cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhh-HhhhhhHHHHHHHhhhcCccceeccchh
Q 047292 591 RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELE-EESRAILTDWAYDCYVEGRLDALIDSDE 669 (728)
Q Consensus 591 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 669 (728)
. .+.|||.|||||... ..|++..||||||+.++||+|+.-||....- .. .+.....|..+..+.+
T Consensus 202 k---svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ--------IYKKV~SGiKP~sl~k-- 267 (632)
T KOG0584|consen 202 K---SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ--------IYKKVTSGIKPAALSK-- 267 (632)
T ss_pred c---eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH--------HHHHHHcCCCHHHhhc--
Confidence 3 378999999999987 7899999999999999999999999864422 22 2233333333322222
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 670 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 670 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
-...++.++|.+||.. ..+|||+.|+|+
T Consensus 268 ------V~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 268 ------VKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ------cCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 1123567799999998 999999999985
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=298.24 Aligned_cols=264 Identities=23% Similarity=0.291 Sum_probs=200.5
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
.+.+.||+|+||.||+|... .+++.|++|++.... ......+.+|+.++++++|+||+++++++......++|+||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 3 KILGRIGEGAHGIVFKAKDR-ETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred eEEeecccCCCcEEEEEEEC-CCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 45678999999999999876 468899999986543 333568899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccc
Q 047292 515 GNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH 593 (728)
Q Consensus 515 ~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 593 (728)
+++|.+++... ..+++..++.++.||++||+|||+. +++|+||||+||++++++.++|+|||++...........
T Consensus 82 -~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 82 -PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred -CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence 99999998754 5689999999999999999999997 999999999999999999999999999987654433233
Q ss_pred ccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHH-------HHhhhc-Ccccee
Q 047292 594 TMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWA-------YDCYVE-GRLDAL 664 (728)
Q Consensus 594 ~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~~-~~~~~~ 664 (728)
....++..|+|||.+.+. .++.++||||||++++||++|+.+|...........+.... +....+ ......
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 345688999999998654 46899999999999999999987776543322211111100 000000 000000
Q ss_pred c--c-c-hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 665 I--D-S-DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 665 ~--d-~-~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
. . . ........+....+.+++.+||+.+|.+||+++++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 0 0 00001111234678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=293.31 Aligned_cols=245 Identities=27% Similarity=0.367 Sum_probs=198.8
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc-----hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA-----QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
..+.||+|+||.||+|..+ .+++.|++|.+.... .+..+.+.+|+.+++.++|+||+++++++......++++|
T Consensus 4 ~~~~ig~g~~~~vy~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 82 (258)
T cd06632 4 KGELLGSGSFGSVYEGLNL-DDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLE 82 (258)
T ss_pred ccceeeecCCceEEEEEEc-CCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEE
Confidence 4467999999999999876 467899999885432 2345789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 513 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 513 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
|+++++|.+++.....+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.+||+|||++....... .
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~--~ 157 (258)
T cd06632 83 LVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS--F 157 (258)
T ss_pred ecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccc--c
Confidence 999999999998877789999999999999999999997 99999999999999999999999999988654332 1
Q ss_pred cccccCCccccCcccccCCC-CCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAP-VSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAA 671 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~-~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 671 (728)
.....++..|+|||.+.... ++.++|+||||+++|||++|+.||.......... ..........
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~-------~~~~~~~~~~-------- 222 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVF-------KIGRSKELPP-------- 222 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHH-------HHHhcccCCC--------
Confidence 23345788999999997776 8999999999999999999999986543211110 0000011111
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 672 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 672 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
.+......+.+++.+||+.+|.+||+++++++
T Consensus 223 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 223 -IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred -cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 11122345678999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=294.09 Aligned_cols=250 Identities=28% Similarity=0.393 Sum_probs=200.1
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch--hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
...+.||+|+||.||+|... .+++.|++|.++.... ...+.+.+|+.++++++|+||+++++++......++|+||+
T Consensus 3 ~~~~~lg~G~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 3 QRGNKIGGGTFGKVYTAVNL-DTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred eeeeEeecCCCcEEEEEEEC-CCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 34578999999999999875 4678999999865443 35678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccc
Q 047292 515 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHT 594 (728)
Q Consensus 515 ~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 594 (728)
++++|.+++.....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++............
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 82 SGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred CCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence 9999999998877788999999999999999999997 9999999999999999999999999999876543322211
Q ss_pred ---cccCCccccCcccccCCC---CCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccch
Q 047292 595 ---MIRGTRGYVAPEWLKNAP---VSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSD 668 (728)
Q Consensus 595 ---~~~gt~~y~aPE~~~~~~---~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 668 (728)
...++..|+|||++.+.. ++.++||||||++++|+++|+.||.......... ... ..+....+..
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~----~~~---~~~~~~~~~~-- 229 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM----FHV---GAGHKPPIPD-- 229 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHH----HHH---hcCCCCCCCc--
Confidence 345788999999998766 8899999999999999999999996432111100 000 0011001100
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 669 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 669 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
.......+.+++.+||+.+|.+||++++++.
T Consensus 230 -----~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 230 -----SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -----ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111345668999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=309.86 Aligned_cols=261 Identities=23% Similarity=0.263 Sum_probs=193.0
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHhccccccceeeEeeeeecC------Ccc
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEA------LNR 507 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~ 507 (728)
+.+.+.||+|+||.||++... ..++.||||++.... ......+.+|+.+++.++|+||+++++++... ...
T Consensus 19 y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 97 (355)
T cd07874 19 YQNLKPIGSGAQGIVCAAYDA-VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDV 97 (355)
T ss_pred eeEEEEeeecCCEEEEEEEec-CCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccccee
Confidence 445578999999999999865 567899999996532 23346788899999999999999999988543 346
Q ss_pred eeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcccccc
Q 047292 508 LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS 587 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 587 (728)
++||||+++ +|.+.+.. .+++..+..++.|+++||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 98 ~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 98 YLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_pred EEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence 999999975 66666643 477888999999999999999997 999999999999999999999999999986533
Q ss_pred CCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHH---------------HH
Q 047292 588 DHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTD---------------WA 652 (728)
Q Consensus 588 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~---------------~~ 652 (728)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||.............. ..
T Consensus 172 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (355)
T cd07874 172 SF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_pred cc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHH
Confidence 21 22334689999999999999999999999999999999999999975432221111000 00
Q ss_pred HHhhhcC-cc-----ceeccchh---hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 653 YDCYVEG-RL-----DALIDSDE---AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 653 ~~~~~~~-~~-----~~~~d~~~---~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
....... .. ........ ...........+.+++.+||+.||++|||+.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000000 00 00000000 000111223567889999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=291.89 Aligned_cols=244 Identities=28% Similarity=0.428 Sum_probs=195.1
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
.+.+.+.||+|+||.||++.. .++.||+|+++... ....+.+|+.++++++|+|++++++++... ..+++|||+
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~---~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 7 KLTLGEIIGEGEFGAVLQGEY---TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HceeeeeeccCCCCceEeccc---CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 345668899999999999864 57789999986532 346789999999999999999999998654 479999999
Q ss_pred CCCCHHHHHhcCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 515 GNGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 515 ~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
++++|.+++.... .+++..++.++.|+++||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 9999999997653 578889999999999999999987 99999999999999999999999999987543221
Q ss_pred cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAA 671 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 671 (728)
.....+..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ ..+... +
T Consensus 155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~--------~~~~~~---~----- 217 (254)
T cd05083 155 -DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECV--------EKGYRM---E----- 217 (254)
T ss_pred -CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH--------hCCCCC---C-----
Confidence 11234567999999998899999999999999999998 88888654433221111 111100 0
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 047292 672 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEG 708 (728)
Q Consensus 672 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 708 (728)
........+.+++.+||+.+|++||++++|++.|++
T Consensus 218 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 -PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 011223567789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=292.52 Aligned_cols=248 Identities=21% Similarity=0.277 Sum_probs=194.2
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc-----hhhHHHHHHHHHHhccccccceeeEeeeeecC--Cccee
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA-----QEREREFKSEVSAIGRTHHKNLVQLLGFCDEA--LNRLL 509 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l 509 (728)
.+.+.||+|+||.||+|..+ .+++.|++|.+.... ......+.+|+.++++++|+||+++++++.+. ...++
T Consensus 5 ~~~~~l~~g~~g~v~~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (265)
T cd06652 5 RLGKLLGQGAFGRVYLCYDA-DTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSI 83 (265)
T ss_pred eEeeEEecCCceEEEEEEEc-CCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEE
Confidence 34578999999999999876 568899999875321 22346788999999999999999999988664 45789
Q ss_pred EeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCC
Q 047292 510 VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH 589 (728)
Q Consensus 510 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 589 (728)
++||+++++|.+++.....+++.....++.|++.||+|||++ +++|+||||+||+++.++.++|+|||+++......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~ 160 (265)
T cd06652 84 FMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC 160 (265)
T ss_pred EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence 999999999999998877788899999999999999999997 99999999999999999999999999988653221
Q ss_pred C--cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccc
Q 047292 590 S--RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDS 667 (728)
Q Consensus 590 ~--~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 667 (728)
. .......++..|+|||.+.+..++.++||||||+++|||++|+.||.......... . ......
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~---~-----~~~~~~------ 226 (265)
T cd06652 161 LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIF---K-----IATQPT------ 226 (265)
T ss_pred ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHH---H-----HhcCCC------
Confidence 1 11223457889999999998889999999999999999999999987442221110 0 000000
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 668 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 668 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
....+......+.+++.+|+. +|++||++++|++.
T Consensus 227 --~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 227 --NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred --CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 011122334456678888885 99999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=297.59 Aligned_cols=261 Identities=25% Similarity=0.309 Sum_probs=194.1
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
.+.+.||+|++|.||+|..+ .+++.||+|+++... ......+.+|+.++++++|+||+++++++..+...++|+||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (285)
T cd07861 3 TKIEKIGEGTYGVVYKGRNK-KTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL 81 (285)
T ss_pred eEeeEecccCceEEEEEEEC-CCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence 34578999999999999875 567899999986432 223467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC---CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 515 GNGTLANLIFAI---PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 515 ~~gsL~~~l~~~---~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
+ ++|.+++... ..+++..+..++.||++||+|||+. +++|+||||+||++++++.+||+|||++....... .
T Consensus 82 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~ 156 (285)
T cd07861 82 S-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-R 156 (285)
T ss_pred C-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-c
Confidence 7 6888888653 4578999999999999999999997 99999999999999999999999999987653322 1
Q ss_pred ccccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHH----Hhhh--------c
Q 047292 592 THTMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAY----DCYV--------E 658 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~----~~~~--------~ 658 (728)
......+++.|+|||.+.+. .++.++||||||++++||+||+.||................. ..+. .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 12223468899999988654 578999999999999999999999975433221111000000 0000 0
Q ss_pred CccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 659 GRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 659 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
........... .........++.+++.+||+.||.+|||+++|++
T Consensus 237 ~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 237 NTFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000000 0001112346678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=310.49 Aligned_cols=262 Identities=23% Similarity=0.240 Sum_probs=194.2
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeeecC------Cc
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEA------LN 506 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~ 506 (728)
.+.+.+.||+|+||.||++... ..++.||||++... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~ 103 (364)
T cd07875 25 RYQNLKPIGSGAQGIVCAAYDA-ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 103 (364)
T ss_pred ceeEEEEeecCCCeEEEEEEEC-CCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCe
Confidence 3455678999999999999865 56789999998653 233456788999999999999999999987543 35
Q ss_pred ceeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccc
Q 047292 507 RLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLL 586 (728)
Q Consensus 507 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 586 (728)
.++||||+++ +|.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 104 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 104 VYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred EEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 6999999975 67777643 477888999999999999999997 99999999999999999999999999998653
Q ss_pred cCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHH---------------H
Q 047292 587 SDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTD---------------W 651 (728)
Q Consensus 587 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~---------------~ 651 (728)
... ......+++.|+|||++.+..++.++|||||||++|||++|+.||...........+.. .
T Consensus 178 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (364)
T cd07875 178 TSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 255 (364)
T ss_pred CCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHH
Confidence 321 22334689999999999999999999999999999999999999975433222111100 0
Q ss_pred HHHhhhcCcc------ceeccchh---hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 652 AYDCYVEGRL------DALIDSDE---AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 652 ~~~~~~~~~~------~~~~d~~~---~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.......... ........ ...........+.+++.+||+.||.+|||+.++++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000000 00000000 000111123467889999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=300.57 Aligned_cols=240 Identities=25% Similarity=0.332 Sum_probs=199.0
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCC
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGN 516 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 516 (728)
++||.|+||.||-+... .+.+.||||++.-. ..+.-+++..|+..|++++|||++.+-|++......|||||||-
T Consensus 32 rEIGHGSFGAVYfArd~-~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl- 109 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDV-RNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL- 109 (948)
T ss_pred HHhcCCccceeEEeecc-CccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-
Confidence 67999999999999876 56789999999542 23445789999999999999999999999999999999999995
Q ss_pred CCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccccc
Q 047292 517 GTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM 595 (728)
Q Consensus 517 gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 595 (728)
|+-.+++.-+ +++.+..+..|..+.+.||+|||+. +.||||||+.|||+++.|.+||+|||.|.+... ...
T Consensus 110 GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-----Ans 181 (948)
T KOG0577|consen 110 GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-----ANS 181 (948)
T ss_pred ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc-----hhc
Confidence 4777777654 5778888999999999999999997 999999999999999999999999999876533 334
Q ss_pred ccCCccccCccccc---CCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhh
Q 047292 596 IRGTRGYVAPEWLK---NAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAM 672 (728)
Q Consensus 596 ~~gt~~y~aPE~~~---~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 672 (728)
+.|||.|||||++. .+.|+-|+||||||++..||.-.++|+..++......-+ .....+ ..
T Consensus 182 FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHI--------AQNesP--------tL 245 (948)
T KOG0577|consen 182 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--------AQNESP--------TL 245 (948)
T ss_pred ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHH--------HhcCCC--------CC
Confidence 67999999999884 568999999999999999999999998766543321111 111111 11
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 673 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 673 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
...+....+..++..||+.-|.+|||.+++++.
T Consensus 246 qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 246 QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 245677788899999999999999999998865
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=301.84 Aligned_cols=263 Identities=21% Similarity=0.241 Sum_probs=196.1
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
+.+.++||+|+||.||+|..+ .+++.||+|.++... ......+.+|+.+++.++|+||+++++++......++|+||+
T Consensus 8 y~~~~~lg~g~~g~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~ 86 (301)
T cd07873 8 YIKLDKLGEGTYATVYKGRSK-LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 86 (301)
T ss_pred eEEeeEeccCcCEEEEEEEEc-CCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecc
Confidence 445678999999999999876 467899999986432 223456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccc
Q 047292 515 GNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH 593 (728)
Q Consensus 515 ~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 593 (728)
+ ++|.+++... ..+++..+..++.||++||+|||+. +|+|+||||+||++++++.+||+|||++........ ..
T Consensus 87 ~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~ 161 (301)
T cd07873 87 D-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-TY 161 (301)
T ss_pred c-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-cc
Confidence 7 5898888764 5678899999999999999999997 999999999999999999999999999876433221 12
Q ss_pred ccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHH-------HHhhhcC-cccee
Q 047292 594 TMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWA-------YDCYVEG-RLDAL 664 (728)
Q Consensus 594 ~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~-~~~~~ 664 (728)
....+++.|+|||.+.+. .++.++||||||+++|||++|+.||......+....+.... +...... .....
T Consensus 162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (301)
T cd07873 162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSY 241 (301)
T ss_pred cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccccc
Confidence 223468899999998654 57889999999999999999999997654332221111100 0000000 00000
Q ss_pred ccchh----hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 665 IDSDE----AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 665 ~d~~~----~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
-.+.. ...........+.+++.+||+.||.+|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 242 NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 00011122345678999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=293.77 Aligned_cols=252 Identities=25% Similarity=0.366 Sum_probs=195.9
Q ss_pred HHhhhCCCceeEEEEeeeeC--CCCcEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeeecCC------cc
Q 047292 438 FKEELGRGSFGIVYKGVLKT--ASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEAL------NR 507 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~--~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~ 507 (728)
+.+.||+|+||.||+|.+.. .+++.||||++... .....+++.+|+.++++++||||+++++++.... ..
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05074 3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIP 82 (273)
T ss_pred chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccce
Confidence 45789999999999998753 34678999998653 2334567899999999999999999999885432 23
Q ss_pred eeEeeccCCCCHHHHHhcC------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccC
Q 047292 508 LLVYEFMGNGTLANLIFAI------PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGL 581 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~l~~~------~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgl 581 (728)
++++||+++|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcccc
Confidence 7889999999999887532 2467888999999999999999987 999999999999999999999999999
Q ss_pred ccccccCCCc-ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcC
Q 047292 582 SKLLLSDHSR-THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEG 659 (728)
Q Consensus 582 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 659 (728)
++........ ......+++.|++||.+....++.++||||||+++|||++ |+.|+...........+ ...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~--------~~~ 231 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL--------IKG 231 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHH--------HcC
Confidence 9866433211 1122335678999999999899999999999999999999 78887654332211111 111
Q ss_pred ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 047292 660 RLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGL 709 (728)
Q Consensus 660 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 709 (728)
... .........+.+++.+||+.+|++||++.++++.|+++
T Consensus 232 ~~~---------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 NRL---------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 100 00112345788899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=301.80 Aligned_cols=194 Identities=23% Similarity=0.353 Sum_probs=158.8
Q ss_pred hhhCCCceeEEEEeeeeC-CCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeee--cCCcceeEeeccCC
Q 047292 440 EELGRGSFGIVYKGVLKT-ASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCD--EALNRLLVYEFMGN 516 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~~~lv~e~~~~ 516 (728)
.+||+|+||.||+|..++ .++..||+|.++... ....+.+|++++++++||||+++++++. .....++|+||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 479999999999998753 355789999986532 2346788999999999999999999884 35567899999875
Q ss_pred CCHHHHHhcC---------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEE----cCCCceEEccccCcc
Q 047292 517 GTLANLIFAI---------PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILL----DHYFSPKISDFGLSK 583 (728)
Q Consensus 517 gsL~~~l~~~---------~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll----~~~~~~kl~Dfgla~ 583 (728)
+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||+ ++++++||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 777776421 2467888999999999999999997 99999999999999 567899999999998
Q ss_pred ccccCCCc--ccccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchh
Q 047292 584 LLLSDHSR--THTMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEME 639 (728)
Q Consensus 584 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~ 639 (728)
........ ......+|+.|+|||.+.+. .++.++||||||+++|||+||+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 76443221 22335689999999999764 5799999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=291.56 Aligned_cols=247 Identities=23% Similarity=0.325 Sum_probs=199.9
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
.+.+.||+|+||.||++... .+++.|++|.+... ......++.+|+.++++++|+||+++++++......++|+||+
T Consensus 3 ~~~~~lg~g~~g~~~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 3 VKVKKIGEGSFGKAILVKSK-EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred eEEEEeccCCceEEEEEEEc-CCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence 45578999999999999876 46789999998643 2334468899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 515 GNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 515 ~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
++++|.+++... ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........ .
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~ 157 (256)
T cd08218 82 EGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-L 157 (256)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-h
Confidence 999999998764 3568889999999999999999997 999999999999999999999999999976543322 1
Q ss_pred cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAM 672 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 672 (728)
.....|++.|+|||++.+..++.++||||||++++||++|+.|+.......... . ...+....
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~---~-----~~~~~~~~--------- 220 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVL---K-----IIRGSYPP--------- 220 (256)
T ss_pred hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHH---H-----HhcCCCCC---------
Confidence 223457889999999999999999999999999999999999987543322111 0 01111111
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 673 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 673 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
........+.+++.+||+.+|.+||+|.+|++.
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 221 VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 111234467789999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=294.69 Aligned_cols=244 Identities=25% Similarity=0.353 Sum_probs=198.9
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCCCCH
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTL 519 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 519 (728)
+.||+|++|.||++..+ .+++.+++|+++.......+.+.+|+.+++.++|+||+++++++......++++||+++++|
T Consensus 25 ~~lg~g~~g~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L 103 (285)
T cd06648 25 VKIGEGSTGIVCIATDK-STGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103 (285)
T ss_pred eEeccCCCeEEEEEEEC-CCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence 58999999999999865 46789999998655555567789999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccccccCC
Q 047292 520 ANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGT 599 (728)
Q Consensus 520 ~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt 599 (728)
.+++.. ..+++..+..++.|++.||+|||++ +++||||+|+||+++.++.++|+|||++........ ......|+
T Consensus 104 ~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~ 178 (285)
T cd06648 104 TDIVTH-TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRKSLVGT 178 (285)
T ss_pred HHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-ccccccCC
Confidence 999987 5688899999999999999999997 999999999999999999999999998876543322 12234588
Q ss_pred ccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHHHHH
Q 047292 600 RGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLH 679 (728)
Q Consensus 600 ~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 679 (728)
..|+|||.+.+..++.++||||||++++||++|+.||...........+ ......... .......
T Consensus 179 ~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~--------~~~~~~~~~-------~~~~~~~ 243 (285)
T cd06648 179 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI--------RDNLPPKLK-------NLHKVSP 243 (285)
T ss_pred ccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH--------HhcCCCCCc-------ccccCCH
Confidence 8999999999888999999999999999999999998654332211111 111100000 0111234
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 680 KWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 680 ~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
.+.+++.+||+.+|++||+++++++
T Consensus 244 ~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 244 RLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHHHHHHHHcccChhhCcCHHHHcc
Confidence 6788999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=299.54 Aligned_cols=253 Identities=21% Similarity=0.260 Sum_probs=200.2
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
.+.+.||+|+||.||++..+ ..++.|++|.+.... ......+.+|+++++.++|+||+++++.+......++||||
T Consensus 4 ~~~~~l~~g~~~~v~~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (305)
T cd05609 4 ETIKLISNGAYGAVYLVRHK-ETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEY 82 (305)
T ss_pred eEeeEeecCCCeeEEEEEEC-CCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEec
Confidence 34578999999999999876 567899999986543 22345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCC----
Q 047292 514 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH---- 589 (728)
Q Consensus 514 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~---- 589 (728)
+++++|.+++.....+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||+++......
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (305)
T cd05609 83 VEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL 159 (305)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence 99999999998878889999999999999999999997 99999999999999999999999999987421110
Q ss_pred ----------CcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcC
Q 047292 590 ----------SRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEG 659 (728)
Q Consensus 590 ----------~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 659 (728)
........++..|+|||.+....++.++|+||||+++|||++|+.||........... ...+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~--------~~~~ 231 (305)
T cd05609 160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ--------VISD 231 (305)
T ss_pred cccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--------HHhc
Confidence 0011123478899999999988999999999999999999999999875433221111 1111
Q ss_pred ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 047292 660 RLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEG 708 (728)
Q Consensus 660 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 708 (728)
....... .......+.+++.+||+.+|++||++.++.+.|+.
T Consensus 232 ~~~~~~~-------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 232 DIEWPEG-------DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred ccCCCCc-------cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 1000000 01123456789999999999999998777777766
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=293.35 Aligned_cols=250 Identities=24% Similarity=0.405 Sum_probs=199.0
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc------hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEe
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA------QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 511 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 511 (728)
..+.||+|+||.||++... .+++.||+|.+.... ......+..|+.++++++|+||+++++++.+.+..++|+
T Consensus 4 ~~~~lg~g~~~~v~~~~~~-~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 82 (268)
T cd06630 4 KGQQLGTGAFSSCYQARDV-KTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV 82 (268)
T ss_pred ccceecCcCceEEEEEEEc-CCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEE
Confidence 3467999999999999865 578899999986432 123468899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCC-ceEEccccCccccccCCC
Q 047292 512 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYF-SPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 512 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~~~~ 590 (728)
||+++++|.+++.....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++ .+||+|||++........
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~ 159 (268)
T cd06630 83 EWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT 159 (268)
T ss_pred eccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence 9999999999998877889999999999999999999997 999999999999998775 599999999887644321
Q ss_pred c---ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccc
Q 047292 591 R---THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDS 667 (728)
Q Consensus 591 ~---~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 667 (728)
. ......++..|+|||.+.+..++.++||||||++++||++|..||...........+ ........
T Consensus 160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~~------- 228 (268)
T cd06630 160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI----FKIASATT------- 228 (268)
T ss_pred cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHH----HHHhccCC-------
Confidence 1 112345788999999999889999999999999999999999998643221111111 00000000
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 668 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 668 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
....+......+.+++.+||+.+|.+||++.++++
T Consensus 229 --~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 229 --APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred --CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 01112233456778999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=328.80 Aligned_cols=251 Identities=22% Similarity=0.288 Sum_probs=193.9
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeeec--CCccee
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDE--ALNRLL 509 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~l 509 (728)
..+.+.++||+|+||.||++... .++..||+|.+... .......|..|+.++++++||||+++++++.. ....+|
T Consensus 13 ~~YeIl~kLG~GgFGtVYLAkdk-~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI 91 (1021)
T PTZ00266 13 NEYEVIKKIGNGRFGEVFLVKHK-RTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI 91 (1021)
T ss_pred CCEEEEEEEecCCCeEEEEEEEC-CCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence 34566788999999999999887 46789999988642 23345678999999999999999999998744 456899
Q ss_pred EeeccCCCCHHHHHhcC----CCCChHHHHHHHHHHHHHHHHhhhcC----CCCeeecCCCCCCEEEcC-----------
Q 047292 510 VYEFMGNGTLANLIFAI----PKPDWNLRVRISLEIARGLVYLHEGC----NVPIIHCDIKPQNILLDH----------- 570 (728)
Q Consensus 510 v~e~~~~gsL~~~l~~~----~~~~~~~~~~i~~qi~~~l~yLH~~~----~~~iiH~dlk~~NIll~~----------- 570 (728)
||||+++++|.++|... ..+++..++.|+.||+.||.|||+.. ..+||||||||+||||+.
T Consensus 92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~ 171 (1021)
T PTZ00266 92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ 171 (1021)
T ss_pred EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence 99999999999998753 46899999999999999999999842 135999999999999964
Q ss_pred ------CCceEEccccCccccccCCCcccccccCCccccCcccccC--CCCCCccchhhHHHHHHHHHhCCcCcchhhhH
Q 047292 571 ------YFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKN--APVSAKVDVYSFGVMLLEIICCRRSVEMELEE 642 (728)
Q Consensus 571 ------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DVwSlGvil~elltg~~p~~~~~~~ 642 (728)
...+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||+||||+||+.||......
T Consensus 172 ~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~ 249 (1021)
T PTZ00266 172 ANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF 249 (1021)
T ss_pred ccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcH
Confidence 2348999999998653322 1233468999999999864 45889999999999999999999999743321
Q ss_pred hhhhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 643 ESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
.. .+ ........ +. .......+.+|+..||+.+|.+||++.++++
T Consensus 250 ~q--li-----~~lk~~p~--lp--------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 250 SQ--LI-----SELKRGPD--LP--------IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HH--HH-----HHHhcCCC--CC--------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 11 11 00111110 00 0112345778999999999999999999984
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=293.59 Aligned_cols=252 Identities=25% Similarity=0.410 Sum_probs=201.2
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
+.+.+.||+|+||.||++..+ .+++.|++|.+.... ......+.+|++++++++|+||+++++.+......++++||+
T Consensus 3 ~~~~~~ig~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 3 LEYLGELGAGNSGVVSKVLHR-PTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred chHHHHhcCCCCeEEEEEEEc-CCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 346688999999999999876 567899999986543 344578899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 515 GNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHE-GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 515 ~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~-~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
++++|.+++... ..+++..+..++.|++.||+|||+ . +++|+||||+||++++++.++|+|||.+.........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~- 157 (265)
T cd06605 82 DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK- 157 (265)
T ss_pred CCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh-
Confidence 999999999876 678889999999999999999998 6 9999999999999999999999999998765332211
Q ss_pred cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAM 672 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 672 (728)
...++..|+|||.+.+..++.++||||||+++++|++|+.|+......... ..... ..........+.
T Consensus 158 --~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~--~~~~~-~~~~~~~~~~~~------- 225 (265)
T cd06605 158 --TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG--IFELL-QYIVNEPPPRLP------- 225 (265)
T ss_pred --cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc--HHHHH-HHHhcCCCCCCC-------
Confidence 155788999999999999999999999999999999999998654211100 00000 111111111110
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 673 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 673 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.......+.+++.+||+.+|++||++.+++..
T Consensus 226 -~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 226 -SGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred -hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 01134567789999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=303.77 Aligned_cols=248 Identities=23% Similarity=0.345 Sum_probs=205.7
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCCC
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNG 517 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 517 (728)
+.-.||.|+||.||+++.+ .++..-|.|++.....+...++.-|++||...+||+||++++.+...+.++|+.|||+||
T Consensus 36 IiGELGDGAFGKVyKA~nk-et~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GG 114 (1187)
T KOG0579|consen 36 IIGELGDGAFGKVYKAVNK-ETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGG 114 (1187)
T ss_pred HHhhhcCccchhhhhhhcc-cchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCc
Confidence 4467999999999999877 556677888888777777889999999999999999999999999999999999999999
Q ss_pred CHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccccc
Q 047292 518 TLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMI 596 (728)
Q Consensus 518 sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 596 (728)
-.+..+... ..+++.++.-+++|++.||.|||++ .|||||||+.|||++-+|.++|+|||.+....... .....+
T Consensus 115 AVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~-qkRDsF 190 (1187)
T KOG0579|consen 115 AVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR-QKRDSF 190 (1187)
T ss_pred hHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHH-hhhccc
Confidence 998887665 6789999999999999999999998 99999999999999999999999999986543322 233456
Q ss_pred cCCccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhh
Q 047292 597 RGTRGYVAPEWLK-----NAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAA 671 (728)
Q Consensus 597 ~gt~~y~aPE~~~-----~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 671 (728)
.|||.|||||+.+ ..+|+.++||||||++|.||.-+.+|.....+...... ........++.+
T Consensus 191 IGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllK--------iaKSePPTLlqP---- 258 (1187)
T KOG0579|consen 191 IGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK--------IAKSEPPTLLQP---- 258 (1187)
T ss_pred cCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHH--------HhhcCCCcccCc----
Confidence 7999999999874 66899999999999999999999998775554432211 122223333332
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 672 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 672 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
......+.+++.+||..||..||++.++++.
T Consensus 259 ---S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 259 ---SHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred ---chhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 3445567789999999999999999998763
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=301.77 Aligned_cols=260 Identities=23% Similarity=0.253 Sum_probs=191.7
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch--hhHHHHHHHHHHhccccccceeeEeeeeecC------Cc
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKNLVQLLGFCDEA------LN 506 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~ 506 (728)
.+.+.+.||+|+||.||++... .+++.||||++..... .....+.+|+.++++++|+||+++++++... ..
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 16 RYQNLTPVGSGAYGSVCSAYDT-RLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhheecccCCCeEEEEEEEC-CCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 3555678999999999999875 4678999999865322 2345678899999999999999999987533 34
Q ss_pred ceeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccc
Q 047292 507 RLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLL 586 (728)
Q Consensus 507 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 586 (728)
.++++|++ +++|.+++.. ..+++..+..++.||+.||.|||++ +|+||||||+||++++++.+||+|||+++...
T Consensus 95 ~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 95 VYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred EEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 68999987 7789887754 5688999999999999999999997 99999999999999999999999999998653
Q ss_pred cCCCcccccccCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHH-------Hhhhc
Q 047292 587 SDHSRTHTMIRGTRGYVAPEWLKN-APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAY-------DCYVE 658 (728)
Q Consensus 587 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~-------~~~~~ 658 (728)
.. .....|++.|+|||++.+ ..++.++||||||+++|||++|+.||...........+..... .....
T Consensus 170 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07878 170 DE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245 (343)
T ss_pred CC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcch
Confidence 32 223458999999999977 5789999999999999999999999965432221111110000 00000
Q ss_pred C-------ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 659 G-------RLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 659 ~-------~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
. .+.......... ......+.+.+++.+||+.||.+|||++|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 246 EHARKYIQSLPHMPQQDLKK-IFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hhHHHHhhccccccchhHHH-hccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 000000000000 000112346789999999999999999999954
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=296.64 Aligned_cols=242 Identities=25% Similarity=0.283 Sum_probs=198.8
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
+.+.+.||+|+||.||++... .+++.||+|.+.... .+....+.+|++++++++||||+++++++......++|||
T Consensus 3 y~~~~~ig~g~~~~vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 3 FEFIKTLGTGSFGRVMLVRHK-GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred eEEEEEeecCCCeEEEEEEEc-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 345678999999999999876 467899999986532 2334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 513 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 513 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
|+++++|.+++.....++...+..++.|+++||.|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 82 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---- 154 (290)
T cd05580 82 YVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---- 154 (290)
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence 999999999998888899999999999999999999997 9999999999999999999999999999876443
Q ss_pred cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAM 672 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 672 (728)
.....+++.|+|||.+.+...+.++||||||+++|||++|+.||...........+ ..+...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~---------- 216 (290)
T cd05580 155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKI--------LEGKVR---------- 216 (290)
T ss_pred CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------hcCCcc----------
Confidence 22345789999999998888999999999999999999999998755432211111 111100
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHH
Q 047292 673 ADRSRLHKWLMIAMWCIQEDPSKRP-----TMKVVM 703 (728)
Q Consensus 673 ~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl 703 (728)
.+......+.+++.+||+.+|.+|| ++++++
T Consensus 217 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 217 FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 0111234667899999999999998 666665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=294.08 Aligned_cols=264 Identities=21% Similarity=0.237 Sum_probs=197.6
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch--hhHHHHHHHHHHhccccccceeeEeeeeecC--CcceeE
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKNLVQLLGFCDEA--LNRLLV 510 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv 510 (728)
.+.+.+.||+|+||.||+|..+ .+++.+++|.++.... .....+.+|+.++.+++||||+++++++... ...++|
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDK-KTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEEC-CCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 3556788999999999999876 4678999999864332 2234677899999999999999999998777 889999
Q ss_pred eeccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCC
Q 047292 511 YEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH 589 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 589 (728)
+||+++ +|.+++... ..+++..+..++.||++||+|||+. +++|+||||+||++++++.+||+|||++.......
T Consensus 85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 999974 999988765 3589999999999999999999997 99999999999999999999999999998765432
Q ss_pred CcccccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHH-------HHhhhc---
Q 047292 590 SRTHTMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWA-------YDCYVE--- 658 (728)
Q Consensus 590 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~~--- 658 (728)
. ......+++.|+|||.+.+. .++.++|+||||++++||++|+.||...........+.... +..+..
T Consensus 161 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 161 K-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred c-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence 1 12233468889999998765 46899999999999999999999997554433222111110 000000
Q ss_pred ---CccceeccchhhhhhcHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 659 ---GRLDALIDSDEAAMADRS-RLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 659 ---~~~~~~~d~~~~~~~~~~-~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
.................. ....+.+++.+||+.+|++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000000111111111 2455678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=294.48 Aligned_cols=263 Identities=23% Similarity=0.254 Sum_probs=199.8
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHhccccccceeeEeeeeecC--CcceeEeec
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEA--LNRLLVYEF 513 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv~e~ 513 (728)
+.++||+|+||.||+|+.. .+++.+++|++.... ......+.+|++++++++|+|++++++++... ...++|+||
T Consensus 3 ~~~~l~~g~~~~vy~~~~~-~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07840 3 KIAQIGEGTYGQVYKARNK-KTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81 (287)
T ss_pred eeEEeccCCCeEEEEEEEC-CCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence 4567999999999999876 457899999997653 33346788999999999999999999999888 889999999
Q ss_pred cCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 514 MGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 514 ~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
+++ +|.+++... ..+++..++.++.||++||+|||+. +++|+||+|+||++++++.+||+|||++..........
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 82 MDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred ccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence 985 898888765 5789999999999999999999997 99999999999999999999999999998765443322
Q ss_pred cccccCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHh----hh---------c
Q 047292 593 HTMIRGTRGYVAPEWLKN-APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDC----YV---------E 658 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~----~~---------~ 658 (728)
.....++..|+|||.+.+ ..++.++||||||++++||++|+.||...........+....... +. .
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 333456788999998765 467899999999999999999999997654432221111110000 00 0
Q ss_pred CccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 659 GRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 659 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
......................+.+++.+||+.+|.+||+++++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000000011111111125678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=290.68 Aligned_cols=253 Identities=26% Similarity=0.382 Sum_probs=201.2
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
+.+.+.||.|+||.||+|... .++..+++|++.... ......+.+|+++++.++|+||+++++.+......++++|++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 81 (267)
T cd06610 3 YELIEVIGVGATAVVYAAICL-PNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYL 81 (267)
T ss_pred ceeeeeecCCCCeEEEEEEEc-CCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEecc
Confidence 345678999999999999876 467899999986432 235578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC---CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 515 GNGTLANLIFAI---PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 515 ~~gsL~~~l~~~---~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++.........
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 82 SGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred CCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 999999999764 4588999999999999999999987 9999999999999999999999999998876543322
Q ss_pred ---ccccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccc
Q 047292 592 ---THTMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDS 667 (728)
Q Consensus 592 ---~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 667 (728)
......++..|+|||.+... .++.++|+||||++++||++|+.||............ . ..... .+..
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~---~-----~~~~~-~~~~ 229 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLT---L-----QNDPP-SLET 229 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHH---h-----cCCCC-CcCC
Confidence 22334588899999999777 7899999999999999999999999754332211110 0 00000 0000
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 668 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 668 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
. .........+.+++.+||+.||++||++++|++
T Consensus 230 ~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 230 G---ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred c---cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0 001123456778999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=290.61 Aligned_cols=250 Identities=26% Similarity=0.367 Sum_probs=198.8
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeeec--CCcceeEee
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDE--ALNRLLVYE 512 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lv~e 512 (728)
.+.+.||.|+||.||++... .+++.+++|.+... .....+.+..|+.+++.++|+||+++++++.. ....+++||
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 3 EVLETIGKGSFGTVRKVRRK-SDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred eeeeeeccCCCeEEEEeeec-CCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 34578999999999999876 46789999988642 33445678899999999999999999997753 455789999
Q ss_pred ccCCCCHHHHHhcC----CCCChHHHHHHHHHHHHHHHHhhhcC--CCCeeecCCCCCCEEEcCCCceEEccccCccccc
Q 047292 513 FMGNGTLANLIFAI----PKPDWNLRVRISLEIARGLVYLHEGC--NVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLL 586 (728)
Q Consensus 513 ~~~~gsL~~~l~~~----~~~~~~~~~~i~~qi~~~l~yLH~~~--~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 586 (728)
|+++++|.+++... ..+++..++.++.||++||.|||..+ ..+++|+||+|+||++++++.+||+|||++....
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~ 161 (265)
T cd08217 82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG 161 (265)
T ss_pred hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccccc
Confidence 99999999998753 57889999999999999999999321 2399999999999999999999999999998764
Q ss_pred cCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceecc
Q 047292 587 SDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALID 666 (728)
Q Consensus 587 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 666 (728)
..... .....+++.|+|||.+.+..++.++||||||+++++|++|+.||.......... ....+...
T Consensus 162 ~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--------~~~~~~~~---- 228 (265)
T cd08217 162 HDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLAS--------KIKEGKFR---- 228 (265)
T ss_pred CCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHH--------HHhcCCCC----
Confidence 43321 223458899999999999889999999999999999999999997654222111 11111111
Q ss_pred chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 667 SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 667 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.........+.+++.+|++.+|++||++++|++.
T Consensus 229 -----~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 229 -----RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -----CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1122334567889999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=290.54 Aligned_cols=248 Identities=23% Similarity=0.362 Sum_probs=199.7
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
.+.+.++||+|+||.||+|... .+++.||+|.+.... ......+.+|+.++.+++|+||+++++++..+...++||||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDN-RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEEC-CCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 3455678999999999999865 467899999886432 33456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccc
Q 047292 514 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH 593 (728)
Q Consensus 514 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 593 (728)
+++++|.+++.. ..+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 84 ~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~~ 158 (277)
T cd06641 84 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KR 158 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh-hh
Confidence 999999999865 4678999999999999999999997 999999999999999999999999999876543221 12
Q ss_pred ccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhh
Q 047292 594 TMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMA 673 (728)
Q Consensus 594 ~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 673 (728)
....++..|+|||.+.+..++.++||||||++++||++|..|+...........+ ....... .
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~~---------~ 221 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI--------PKNNPPT---------L 221 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHH--------hcCCCCC---------C
Confidence 2345788999999999888999999999999999999999998654322211110 1111100 1
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 674 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 674 ~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.......+.+++.+||+.+|.+||++.++++.
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11223456789999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=294.69 Aligned_cols=249 Identities=26% Similarity=0.325 Sum_probs=192.5
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccc-cccceeeEeeeee-----cCCccee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKNLVQLLGFCD-----EALNRLL 509 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~-----~~~~~~l 509 (728)
+.+.+.||+|+||.||++..+ .+++.+++|.++... .....+.+|+.+++.+ +|+||+++++++. .....++
T Consensus 20 ~~~~~~lg~g~~~~vy~~~~~-~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~l 97 (286)
T cd06638 20 WEIIETIGKGTYGKVFKVLNK-KNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWL 97 (286)
T ss_pred eeeeeeeccCCCcEEEEEEEC-CCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEE
Confidence 445578999999999999876 467899999886532 2345788899999999 6999999999873 3456899
Q ss_pred EeeccCCCCHHHHHhc----CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcccc
Q 047292 510 VYEFMGNGTLANLIFA----IPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLL 585 (728)
Q Consensus 510 v~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~ 585 (728)
||||+++++|.+++.. ...+++..+..++.|+++||.|||+. +++||||||+||++++++.+||+|||+++..
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~ 174 (286)
T cd06638 98 VLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQL 174 (286)
T ss_pred EEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCceeec
Confidence 9999999999998753 24678888999999999999999997 9999999999999999999999999998866
Q ss_pred ccCCCcccccccCCccccCcccccC-----CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCc
Q 047292 586 LSDHSRTHTMIRGTRGYVAPEWLKN-----APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGR 660 (728)
Q Consensus 586 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (728)
..... ......|++.|+|||++.. ..++.++||||||+++|||++|+.|+.......... . .....
T Consensus 175 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~---~-----~~~~~ 245 (286)
T cd06638 175 TSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF---K-----IPRNP 245 (286)
T ss_pred ccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh---h-----ccccC
Confidence 43221 2223458999999999853 457889999999999999999999987543221110 0 00000
Q ss_pred cceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 661 LDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 661 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.....++ ......+.+++.+||+.+|++||++.||++.
T Consensus 246 ~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 246 PPTLHQP-------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred CCcccCC-------CCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0011111 1122357789999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=289.73 Aligned_cols=250 Identities=28% Similarity=0.395 Sum_probs=204.8
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch-hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccC
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
.+.+.||+|++|.||+++.+ .+++.|++|++..... .....+.+|+..+.+++|+||+++++++......++|+||++
T Consensus 4 ~~~~~i~~g~~~~v~~~~~~-~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06623 4 ERVKVLGQGSSGVVYKVRHK-PTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD 82 (264)
T ss_pred eeeeeeeecCCeEEEEEEEc-CCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence 35578999999999999887 4688999999876443 446789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccc
Q 047292 516 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHE-GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHT 594 (728)
Q Consensus 516 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~-~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 594 (728)
+++|.+++.....+++..+..++.|+++||+|||+ . +++|+||+|+||+++.++.++|+|||++.......... .
T Consensus 83 ~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~-~ 158 (264)
T cd06623 83 GGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC-N 158 (264)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc-c
Confidence 99999999887889999999999999999999999 7 99999999999999999999999999998764433221 2
Q ss_pred cccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhc
Q 047292 595 MIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMAD 674 (728)
Q Consensus 595 ~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 674 (728)
...++..|+|||.+.+..++.++||||||+++|||++|+.|+............ . ......... ..
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~-~----~~~~~~~~~---------~~ 224 (264)
T cd06623 159 TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELM-Q----AICDGPPPS---------LP 224 (264)
T ss_pred ceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHH-H----HHhcCCCCC---------CC
Confidence 345788999999999999999999999999999999999998765421111111 0 011111111 11
Q ss_pred HH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 675 RS-RLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 675 ~~-~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.. ....+.+++.+||+.+|++||+++++++.
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 225 AEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11 34577889999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=294.21 Aligned_cols=245 Identities=24% Similarity=0.308 Sum_probs=194.7
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
+...+.||+|+||.||+|... .+++.|++|.+... ..+..+.+.+|+++++.++||||+++++++......++|+|
T Consensus 17 y~~~~~lg~g~~g~vy~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e 95 (307)
T cd06607 17 FTDLREIGHGSFGAVYFARDV-RTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVME 95 (307)
T ss_pred hhhheeecCCCCeEEEEEEEc-CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHH
Confidence 556678999999999999876 46789999988532 22344678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhc-CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 513 FMGNGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 513 ~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
|++ |+|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 96 ~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--- 168 (307)
T cd06607 96 YCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--- 168 (307)
T ss_pred hhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC---
Confidence 997 577676654 45689999999999999999999987 9999999999999999999999999998754322
Q ss_pred ccccccCCccccCccccc---CCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccch
Q 047292 592 THTMIRGTRGYVAPEWLK---NAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSD 668 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~---~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 668 (728)
....++..|+|||.+. ...++.++||||||+++|||++|+.|+...........+ ........
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~--------~~~~~~~~---- 234 (307)
T cd06607 169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--------AQNDSPTL---- 234 (307)
T ss_pred --CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHH--------hcCCCCCC----
Confidence 2245788999999884 456889999999999999999999998754332211100 00000000
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047292 669 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQML 706 (728)
Q Consensus 669 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 706 (728)
........+.+++.+||+.+|.+||++.+|++..
T Consensus 235 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 235 ----SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred ----CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 1112345678899999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=291.35 Aligned_cols=248 Identities=22% Similarity=0.337 Sum_probs=198.1
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc-chhhHHHHHHHHHHhcccc---ccceeeEeeeeecCCcceeEe
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL-AQEREREFKSEVSAIGRTH---HKNLVQLLGFCDEALNRLLVY 511 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lv~ 511 (728)
+.+.+.||+|+||.||+|... .+++.|++|.+... .......+.+|+.++++++ |+|++++++++......++||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHV-PTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhheeccCCceEEEEEEc-CCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 445678999999999999875 56889999998653 2334567889999999886 999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 512 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 512 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
||+++++|.+++... .+++..++.++.|++.||.|||+. +|+|+||+|+||++++++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06917 82 EYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS- 156 (277)
T ss_pred ecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc-
Confidence 999999999998664 788999999999999999999987 999999999999999999999999999987654332
Q ss_pred ccccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhh
Q 047292 592 THTMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEA 670 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 670 (728)
......|+..|+|||.+.+. .++.++||||||+++|||++|+.||...........+ .......+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~--------~~~~~~~~~----- 223 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI--------PKSKPPRLE----- 223 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc--------ccCCCCCCC-----
Confidence 22334588899999998654 5789999999999999999999999754332211100 000001100
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 671 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 671 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.......+.+++.+||+.||++||++.++++.
T Consensus 224 ---~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 224 ---DNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred ---cccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 00133467789999999999999999999863
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=298.86 Aligned_cols=248 Identities=23% Similarity=0.269 Sum_probs=197.4
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch---hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
.+.+.||+|+||.||++... .+++.||+|.+..... ...+.+..|+++++.++|+||+++++.+......++||||
T Consensus 4 ~~~~~ig~g~~g~vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (316)
T cd05574 4 KKIKLLGKGDVGRVFLVRLK-GTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDY 82 (316)
T ss_pred EEeeeecCCccEEEEEEEEc-CCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEe
Confidence 34567999999999999876 4678999999865332 2446789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 514 MGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 514 ~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
+.+++|.+++... ..+++..+..++.|+++||+|||+. +++|+||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (316)
T cd05574 83 CPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159 (316)
T ss_pred cCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccccc
Confidence 9999999998764 4678899999999999999999997 9999999999999999999999999998755322110
Q ss_pred ----------------------------ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHh
Q 047292 592 ----------------------------THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEE 643 (728)
Q Consensus 592 ----------------------------~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~ 643 (728)
......|+..|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 1112357889999999999999999999999999999999999997554332
Q ss_pred hhhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 047292 644 SRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPT----MKVVMQ 704 (728)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt----~~evl~ 704 (728)
....+ ..... ...........+.+++.+||+.+|++||+ ++++++
T Consensus 240 ~~~~~--------~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 240 TFSNI--------LKKEV--------TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHHHH--------hcCCc--------cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 11111 01110 00001113457788999999999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=290.99 Aligned_cols=249 Identities=27% Similarity=0.383 Sum_probs=202.0
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccC
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
+.+.+.||+|+||.||+|..+ .++..|++|++..... ....+.+|++++++++|+|++++++.+......++++||++
T Consensus 21 ~~~~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 98 (286)
T cd06614 21 YKNLEKIGEGASGEVYKATDR-ATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMD 98 (286)
T ss_pred chHhHhccCCCCeEEEEEEEc-cCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccC
Confidence 345578999999999999876 4578999999976443 56778999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccc
Q 047292 516 NGTLANLIFAIP-KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHT 594 (728)
Q Consensus 516 ~gsL~~~l~~~~-~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 594 (728)
+++|.+++.... .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 99 ~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~ 174 (286)
T cd06614 99 GGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-KRN 174 (286)
T ss_pred CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-hhc
Confidence 999999999876 889999999999999999999996 999999999999999999999999999876543221 222
Q ss_pred cccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhc
Q 047292 595 MIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMAD 674 (728)
Q Consensus 595 ~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 674 (728)
...++..|+|||.+.+..++.++||||||+++|||++|+.|+...........+ .......... .
T Consensus 175 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~~~~~-------~ 239 (286)
T cd06614 175 SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI--------TTKGIPPLKN-------P 239 (286)
T ss_pred cccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------HhcCCCCCcc-------h
Confidence 334788999999999889999999999999999999999998754332211111 0111111110 1
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 675 RSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 675 ~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
......+.+++.+||+.+|.+||++.+|++.
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 240 EKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred hhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1123467789999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=296.00 Aligned_cols=262 Identities=19% Similarity=0.249 Sum_probs=193.9
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
.+.+.||+|+||.||+|..+ .+|+.|++|+++... ......+.+|++++++++|+||+++++++.+....++|+||+
T Consensus 3 ~~~~~l~~g~~~~vy~~~~~-~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 3 EKLEKIGEGTYGTVFKAKNR-ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred eeEEEecccCCeEEEEEEEC-CCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 34578999999999999876 468899999986432 222356788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhc-CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccc
Q 047292 515 GNGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH 593 (728)
Q Consensus 515 ~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 593 (728)
+ ++|.+++.. ...+++..++.++.||++||.|||+. +|+|+||||+||+++.++.+||+|||+++...... ...
T Consensus 82 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~ 156 (284)
T cd07839 82 D-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-RCY 156 (284)
T ss_pred C-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC-CCc
Confidence 7 578887765 46789999999999999999999997 99999999999999999999999999998653322 122
Q ss_pred ccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhh-HhhhhhHHHH-------HHHhhhc---Ccc
Q 047292 594 TMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELE-EESRAILTDW-------AYDCYVE---GRL 661 (728)
Q Consensus 594 ~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~-~~~~~~~~~~-------~~~~~~~---~~~ 661 (728)
....++..|+|||.+.+. .++.++||||||+++|||+||+.|+..... ......+... .+..... ...
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence 234568899999998765 468999999999999999999988643222 1111111000 0000000 000
Q ss_pred ceeccchhh-hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 662 DALIDSDEA-AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 662 ~~~~d~~~~-~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
......... ..........+.+++.+||+.||.+|||++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000000000 0111223456778999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=293.76 Aligned_cols=255 Identities=25% Similarity=0.306 Sum_probs=199.5
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
+...+.||+|+||.||+++.. .++..||+|++... ..+....+.+|++++++++|+|++++++++......++|||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~-~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDV-RTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhheeccCCCeEEEEEEEc-CCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 445678999999999999876 46789999998642 22334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhc-CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 513 FMGNGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 513 ~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
|+++ +|.+.+.. ...+++..+..++.|++.||.|||+. +|+|+||+|+||+++.++.+||+|||++......
T Consensus 106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~--- 178 (317)
T cd06635 106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA--- 178 (317)
T ss_pred CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence 9975 77777654 45688999999999999999999997 9999999999999999999999999998754322
Q ss_pred ccccccCCccccCccccc---CCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccch
Q 047292 592 THTMIRGTRGYVAPEWLK---NAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSD 668 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~---~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 668 (728)
....+++.|+|||.+. ...++.++||||||+++|||++|+.||...........+ . ......
T Consensus 179 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~---~-----~~~~~~----- 243 (317)
T cd06635 179 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI---A-----QNESPT----- 243 (317)
T ss_pred --ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH---H-----hccCCC-----
Confidence 2235788999999974 456889999999999999999999998654322211111 0 010000
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCCC
Q 047292 669 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNPP 716 (728)
Q Consensus 669 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~~ 716 (728)
.........+.+++.+||+.+|.+||++.+|++.+-.....+.+.
T Consensus 244 ---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~~ 288 (317)
T cd06635 244 ---LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPETV 288 (317)
T ss_pred ---CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCcccc
Confidence 001123345778999999999999999999998776555444443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=288.05 Aligned_cols=243 Identities=24% Similarity=0.274 Sum_probs=196.0
Q ss_pred hCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCCCC
Q 047292 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGT 518 (728)
Q Consensus 442 lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 518 (728)
||.|+||.||+++.. .+++.+++|.+.... ....+.+.+|+.++++++|+||+++++.+.+....++++||+++++
T Consensus 1 lg~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVK-SKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEEC-CCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence 699999999999976 467899999986432 2345679999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccccccC
Q 047292 519 LANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRG 598 (728)
Q Consensus 519 L~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g 598 (728)
|.+++.....++...+..++.||+.||.|||++ +++|+||+|+||+++.++.++|+|||++....... ......+
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~ 154 (262)
T cd05572 80 LWTILRDRGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCG 154 (262)
T ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccC
Confidence 999998877889999999999999999999997 99999999999999999999999999998764432 1223457
Q ss_pred CccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHHHH
Q 047292 599 TRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRL 678 (728)
Q Consensus 599 t~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 678 (728)
+..|+|||.+.+..++.++|+||||+++|||++|+.||.....+... .. .....+.. ....+....
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~-----~~~~~~~~--------~~~~~~~~~ 220 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPME-IY-----NDILKGNG--------KLEFPNYID 220 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHH-HH-----HHHhccCC--------CCCCCcccC
Confidence 88999999998888999999999999999999999999755421110 00 00110000 001111124
Q ss_pred HHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 047292 679 HKWLMIAMWCIQEDPSKRPT-----MKVVMQ 704 (728)
Q Consensus 679 ~~l~~l~~~cl~~dp~~RPt-----~~evl~ 704 (728)
..+.+++.+||+.+|++||+ ++|+++
T Consensus 221 ~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 221 KAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 57788999999999999999 555554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=294.31 Aligned_cols=247 Identities=26% Similarity=0.352 Sum_probs=192.4
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccc-cccceeeEeeeeecC-----CcceeEe
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKNLVQLLGFCDEA-----LNRLLVY 511 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-----~~~~lv~ 511 (728)
+.+.||+|+||.||++..+ .+++.+|+|.+.... .....+.+|+.+++++ +|+|++++++++... ...++|+
T Consensus 26 ~~~~l~~g~~~~vy~~~~~-~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ 103 (291)
T cd06639 26 IIETIGKGTYGKVYKVTNK-KDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVL 103 (291)
T ss_pred EEEEeecCCCeEEEEEEEC-CCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEE
Confidence 4468999999999999876 567899999986532 2345678899999998 899999999998654 3579999
Q ss_pred eccCCCCHHHHHhc----CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcccccc
Q 047292 512 EFMGNGTLANLIFA----IPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS 587 (728)
Q Consensus 512 e~~~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 587 (728)
||+++++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||||+||++++++.+||+|||++.....
T Consensus 104 ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~ 180 (291)
T cd06639 104 ELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180 (291)
T ss_pred EECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccchhccc
Confidence 99999999998863 35678999999999999999999997 999999999999999999999999999886543
Q ss_pred CCCcccccccCCccccCcccccCC-----CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccc
Q 047292 588 DHSRTHTMIRGTRGYVAPEWLKNA-----PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLD 662 (728)
Q Consensus 588 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (728)
.... .....++..|+|||.+... .++.++||||||+++|||++|+.||.......... . .......
T Consensus 181 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~---~-----~~~~~~~ 251 (291)
T cd06639 181 TRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF---K-----IPRNPPP 251 (291)
T ss_pred cccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHH---H-----HhcCCCC
Confidence 2221 1224578899999998643 36889999999999999999999987543322111 1 1111111
Q ss_pred eeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 663 ALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 663 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.+.+ .......+.+++.+||+.+|++||++.++++.
T Consensus 252 ~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 252 TLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1111 11223457889999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=287.64 Aligned_cols=246 Identities=26% Similarity=0.377 Sum_probs=197.7
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
.+.+.||+|+||.||++... .+++.+++|.+... .......+.+|++++++++|+||+++++.+......++|+||+
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 3 EKIRVVGRGAFGIVHLCRRK-ADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred eEEEEecccCceEEEEEEEc-CCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence 44578999999999999876 46789999998543 2334578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCC-CceEEccccCccccccCCCc
Q 047292 515 GNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHY-FSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 515 ~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~-~~~kl~Dfgla~~~~~~~~~ 591 (728)
++++|.+++... ..+++..+..++.|++++|.|||++ +++|+||+|+||+++++ +.+||+|||++........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~- 157 (256)
T cd08220 82 PGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK- 157 (256)
T ss_pred CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc-
Confidence 999999999864 3578899999999999999999997 99999999999999854 4689999999987643321
Q ss_pred ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhh
Q 047292 592 THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAA 671 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 671 (728)
.....++..|+|||.+.+..++.++||||||+++++|++|+.||...........+ ..+....+
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~--------~~~~~~~~------- 221 (256)
T cd08220 158 -AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKI--------MSGTFAPI------- 221 (256)
T ss_pred -ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHH--------HhcCCCCC-------
Confidence 22345788999999999888999999999999999999999998754332211100 11111111
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 672 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 672 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.......+.+++.+||+.+|.+|||++|+++.
T Consensus 222 --~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 222 --SDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred --CCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11123467789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=322.94 Aligned_cols=261 Identities=26% Similarity=0.366 Sum_probs=207.9
Q ss_pred HHHHHHhhHHhhhCCCceeEEEEeeeeCCC------CcEEEEEEecccch-hhHHHHHHHHHHhccc-cccceeeEeeee
Q 047292 430 ELKDATDGFKEELGRGSFGIVYKGVLKTAS------GNAIAVKKLDRLAQ-EREREFKSEVSAIGRT-HHKNLVQLLGFC 501 (728)
Q Consensus 430 el~~~~~~~~~~lg~G~fg~Vy~g~~~~~~------~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~ 501 (728)
|+......+.+.||+|.||.|++|..+... ...||||.++.... .+.+.+..|+++++.+ +|+||+.++|+|
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 333333355669999999999999865222 35799999976544 4567899999999998 799999999999
Q ss_pred ecCCcceeEeeccCCCCHHHHHhcCC----------------CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCC
Q 047292 502 DEALNRLLVYEFMGNGTLANLIFAIP----------------KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQN 565 (728)
Q Consensus 502 ~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~N 565 (728)
..++..++|.||+..|+|.++|+..+ .++...++.++.|||.||+||++. ++|||||.++|
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRN 448 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARN 448 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhhh
Confidence 99999999999999999999998765 377889999999999999999997 89999999999
Q ss_pred EEEcCCCceEEccccCccccccCCCccccccc--CCccccCcccccCCCCCCccchhhHHHHHHHHHhC-CcCcchhh-h
Q 047292 566 ILLDHYFSPKISDFGLSKLLLSDHSRTHTMIR--GTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICC-RRSVEMEL-E 641 (728)
Q Consensus 566 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg-~~p~~~~~-~ 641 (728)
||+.++..+||+|||+|+.............. -+..|||||.+....|+.|+|||||||+||||+|. ..|+.... .
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 99999999999999999976544433322212 35679999999999999999999999999999994 56765421 1
Q ss_pred HhhhhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 047292 642 EESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710 (728)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 710 (728)
.+. .....+|. ....+..+..++.++++.||+.+|++||++.++++.|+.++
T Consensus 529 ~~l--------~~~l~~G~---------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 529 EEL--------LEFLKEGN---------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred HHH--------HHHHhcCC---------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 111 11222222 11223344567788999999999999999999999998843
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=292.59 Aligned_cols=260 Identities=24% Similarity=0.304 Sum_probs=193.8
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccC
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
..+.||+|+||.||+|+.+ .+++.|+||++.... ......+.+|++++++++|+||+++++++......++||||+.
T Consensus 4 ~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (284)
T cd07860 4 KVEKIGEGTYGVVYKARNK-LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH 82 (284)
T ss_pred eeeeecCCCceEEEEEEEC-CCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc
Confidence 4567999999999999876 567899999886432 2233578899999999999999999999999999999999996
Q ss_pred CCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccc
Q 047292 516 NGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH 593 (728)
Q Consensus 516 ~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 593 (728)
++|.+++... ..+++..+..++.|+++||+|||+. +++|+||+|+||++++++.+||+|||++........ ..
T Consensus 83 -~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~ 157 (284)
T cd07860 83 -QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TY 157 (284)
T ss_pred -cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-cc
Confidence 6898888653 4678999999999999999999987 999999999999999999999999999876533221 12
Q ss_pred ccccCCccccCcccccCCC-CCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHH-------HHhh-----hcCc
Q 047292 594 TMIRGTRGYVAPEWLKNAP-VSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWA-------YDCY-----VEGR 660 (728)
Q Consensus 594 ~~~~gt~~y~aPE~~~~~~-~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~-----~~~~ 660 (728)
....++..|+|||.+.+.. ++.++||||||+++|||+||+.||...........+.... +... ....
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence 2234678899999887654 5889999999999999999999986544322111110000 0000 0000
Q ss_pred cceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 661 LDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 661 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
.......... ...+.....+.+++.+||+.||.+|||++++++
T Consensus 238 ~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 238 FPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred cccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000000 001112345678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=284.13 Aligned_cols=247 Identities=27% Similarity=0.418 Sum_probs=202.9
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCCC
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNG 517 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 517 (728)
..+.||+|++|.||++... .+++.+++|++..........+.+|++++++++|+|++++++++......++++||++++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~ 82 (253)
T cd05122 4 ILEKIGKGGFGEVYKARHK-RTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGG 82 (253)
T ss_pred eeeeeccCCceEEEEEEEC-CCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCC
Confidence 4567999999999999876 467899999997765556688999999999999999999999999999999999999999
Q ss_pred CHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccccc
Q 047292 518 TLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMI 596 (728)
Q Consensus 518 sL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 596 (728)
+|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||.+........ ....
T Consensus 83 ~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~ 157 (253)
T cd05122 83 SLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTM 157 (253)
T ss_pred cHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--ccce
Confidence 999999876 5789999999999999999999996 999999999999999999999999999887654332 2334
Q ss_pred cCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHH
Q 047292 597 RGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRS 676 (728)
Q Consensus 597 ~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 676 (728)
.++..|+|||.+.+..++.++||||||++++||++|+.|+............ .......... ...
T Consensus 158 ~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~~~~~-------~~~ 222 (253)
T cd05122 158 VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI--------ATNGPPGLRN-------PEK 222 (253)
T ss_pred ecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH--------HhcCCCCcCc-------ccc
Confidence 5788999999999888999999999999999999999998755322211110 0011111111 111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 677 RLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 677 ~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
....+.+++.+||+.||++|||+.++++.
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 223 WSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 13567889999999999999999999863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=287.30 Aligned_cols=245 Identities=23% Similarity=0.300 Sum_probs=192.1
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccch---hhHHHHHHHHHHh-ccccccceeeEeeeeecCCcceeEeeccC
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ---EREREFKSEVSAI-GRTHHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l-~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
+.||+|+||.||+|... .+++.||+|.+..... .....+..|..++ ...+|+|++++++++......++|+||++
T Consensus 2 ~~l~~g~~~~v~~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (260)
T cd05611 2 KPISKGAFGSVYLAKKR-STGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN 80 (260)
T ss_pred ccCCcCCCeeEEEEEec-CCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence 46899999999999875 4678999999865321 2223445555544 45589999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccccc
Q 047292 516 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM 595 (728)
Q Consensus 516 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 595 (728)
+++|.+++.....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||+++.... ...
T Consensus 81 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~ 152 (260)
T cd05611 81 GGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKK 152 (260)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----ccc
Confidence 999999998878889999999999999999999997 999999999999999999999999999875432 223
Q ss_pred ccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcH
Q 047292 596 IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADR 675 (728)
Q Consensus 596 ~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 675 (728)
..++..|+|||.+.+..++.++||||||+++|||++|..||...........+ ..+... ... ....
T Consensus 153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~--~~~----~~~~ 218 (260)
T cd05611 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNI--------LSRRIN--WPE----EVKE 218 (260)
T ss_pred CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--------HhcccC--CCC----cccc
Confidence 45788999999998888999999999999999999999999754433221111 111100 000 0111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047292 676 SRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLE 707 (728)
Q Consensus 676 ~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~ 707 (728)
.....+.+++.+||+.+|++||++.++.+.|.
T Consensus 219 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 219 FCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred cCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 22356788999999999999998876666553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=316.73 Aligned_cols=199 Identities=21% Similarity=0.321 Sum_probs=159.3
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEe---------------c--ccchhhHHHHHHHHHHhccccccceee
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKL---------------D--RLAQEREREFKSEVSAIGRTHHKNLVQ 496 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l---------------~--~~~~~~~~~~~~E~~~l~~l~h~niv~ 496 (728)
..+.+.++||+|+||+||++..+...+...++|.+ + .........+.+|+.++++++|+||++
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 44666788999999999998776444433333311 0 011223456889999999999999999
Q ss_pred EeeeeecCCcceeEeeccCCCCHHHHHhcC-----CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCC
Q 047292 497 LLGFCDEALNRLLVYEFMGNGTLANLIFAI-----PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHY 571 (728)
Q Consensus 497 l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~ 571 (728)
+++++......++|+|++. ++|.+++... ..........|+.||+.||.|||++ +||||||||+|||++.+
T Consensus 228 l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 228 IEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCD 303 (501)
T ss_pred EeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCC
Confidence 9999999999999999985 5777776542 2234566778999999999999997 99999999999999999
Q ss_pred CceEEccccCccccccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCc
Q 047292 572 FSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSV 636 (728)
Q Consensus 572 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~ 636 (728)
+.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|+.++
T Consensus 304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 99999999999877544333333456899999999999999999999999999999999988543
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=291.32 Aligned_cols=248 Identities=26% Similarity=0.379 Sum_probs=193.0
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccc-cccceeeEeeeeec------CCcc
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKNLVQLLGFCDE------ALNR 507 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~------~~~~ 507 (728)
.+.+.+.||+|+||.||+|... .+++.+|+|.+.... .....+..|+.++.++ +|+||+++++++.. ....
T Consensus 17 ~~~~~~~lg~g~~~~v~~~~~~-~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 94 (282)
T cd06636 17 IFELVEVVGNGTYGQVYKGRHV-KTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL 94 (282)
T ss_pred hhhhheeeccCCCeEEEEEEEc-CCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence 3455678999999999999986 467899999986543 3345688899999998 79999999999843 4567
Q ss_pred eeEeeccCCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcccc
Q 047292 508 LLVYEFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLL 585 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~ 585 (728)
+++|||+++++|.+++... ..+++..+..++.||++||.|||+. +|+|+||+|+||++++++.++|+|||++...
T Consensus 95 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~~ 171 (282)
T cd06636 95 WLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 171 (282)
T ss_pred EEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhhh
Confidence 9999999999999999764 3577888899999999999999997 9999999999999999999999999998765
Q ss_pred ccCCCcccccccCCccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCc
Q 047292 586 LSDHSRTHTMIRGTRGYVAPEWLK-----NAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGR 660 (728)
Q Consensus 586 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (728)
..... ......|++.|+|||.+. ...++.++||||||+++|||++|+.||...........+ ....
T Consensus 172 ~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~--------~~~~ 242 (282)
T cd06636 172 DRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI--------PRNP 242 (282)
T ss_pred hcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhH--------hhCC
Confidence 32221 122345888999999886 346788999999999999999999999654322111100 0000
Q ss_pred cceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 661 LDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 661 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
... .........+.+++.+||+.||.+||++.||++
T Consensus 243 ~~~--------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 243 PPK--------LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred CCC--------CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000 001123346788999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=294.34 Aligned_cols=263 Identities=22% Similarity=0.265 Sum_probs=192.7
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch-hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
+.+.+.||+|++|.||+|..+ .+++.||+|.+..... .....+.+|++++++++|+||+++++++......++||||+
T Consensus 7 y~~~~~lg~g~~~~vy~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (291)
T cd07844 7 YKKLDKLGEGSYATVYKGRSK-LTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL 85 (291)
T ss_pred eeEEEEEeecCCeEEEEEEEc-CCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecC
Confidence 344578999999999999875 4678999999865322 22345778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccc
Q 047292 515 GNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH 593 (728)
Q Consensus 515 ~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 593 (728)
++ +|.+++... ..+++.....++.|+++||.|||+. +|+|+||||+||++++++.+||+|||+++...... ...
T Consensus 86 ~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~~~ 160 (291)
T cd07844 86 DT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS-KTY 160 (291)
T ss_pred CC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC-ccc
Confidence 85 899988764 4678899999999999999999997 99999999999999999999999999987543221 111
Q ss_pred ccccCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCcchhhhH-hhhhhHHHH-------HHHhhh------c
Q 047292 594 TMIRGTRGYVAPEWLKN-APVSAKVDVYSFGVMLLEIICCRRSVEMELEE-ESRAILTDW-------AYDCYV------E 658 (728)
Q Consensus 594 ~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvil~elltg~~p~~~~~~~-~~~~~~~~~-------~~~~~~------~ 658 (728)
....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... .....+... .+.... .
T Consensus 161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07844 161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKP 240 (291)
T ss_pred cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccc
Confidence 22346788999999875 45789999999999999999999998644311 111000000 000000 0
Q ss_pred Cccceeccchhhhhh-cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 659 GRLDALIDSDEAAMA-DRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 659 ~~~~~~~d~~~~~~~-~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
............... .......+.+++.+||+.+|++||++.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 241 YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000000000000000 0111256678999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=291.05 Aligned_cols=243 Identities=28% Similarity=0.340 Sum_probs=192.2
Q ss_pred hCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCCCC
Q 047292 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGT 518 (728)
Q Consensus 442 lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 518 (728)
||+|+||+||++..+ .+++.|++|.+.... ......+..|++++++++||||+++++.+...+..++|+||+++++
T Consensus 1 lg~g~~g~vy~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVK-ATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEc-CCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence 699999999999866 468899999986432 2234567789999999999999999999999999999999999999
Q ss_pred HHHHHhcCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccccc
Q 047292 519 LANLIFAIP--KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMI 596 (728)
Q Consensus 519 L~~~l~~~~--~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 596 (728)
|.+++.... .+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++....... .....
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~ 154 (277)
T cd05577 80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGR 154 (277)
T ss_pred HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--ccccc
Confidence 999998754 688999999999999999999997 99999999999999999999999999987654321 12234
Q ss_pred cCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHH
Q 047292 597 RGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRS 676 (728)
Q Consensus 597 ~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 676 (728)
.++..|+|||.+.+..++.++||||||++++||++|+.||...........+.. ..... .......
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------~~~~~------~~~~~~~ 220 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR--------RTLEM------AVEYPDK 220 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh--------ccccc------cccCCcc
Confidence 577899999999888899999999999999999999999965433111111100 00000 0011112
Q ss_pred HHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047292 677 RLHKWLMIAMWCIQEDPSKRP-----TMKVVMQ 704 (728)
Q Consensus 677 ~~~~l~~l~~~cl~~dp~~RP-----t~~evl~ 704 (728)
....+.+++.+||+.+|.+|| ++.++++
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 245677899999999999999 5555653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=290.76 Aligned_cols=254 Identities=27% Similarity=0.343 Sum_probs=195.9
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch-hhHHHHHHHHHHhccccccceeeEeeeeecC--CcceeEeecc
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKNLVQLLGFCDEA--LNRLLVYEFM 514 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv~e~~ 514 (728)
+.++||.|++|.||++..+ .+++.+|+|.+..... .....+.+|++++++++|+||+++++++... ...++||||+
T Consensus 5 ~~~~lg~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 83 (287)
T cd06621 5 ELSRLGEGAGGSVTKCRLK-NTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYC 83 (287)
T ss_pred EEEEeccCCceEEEEEEEC-CCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEec
Confidence 3468999999999999986 4678999999865322 3457789999999999999999999988543 4679999999
Q ss_pred CCCCHHHHHhc----CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC
Q 047292 515 GNGTLANLIFA----IPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 515 ~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 590 (728)
++++|.+++.. ...++...+..++.||+.||+|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 84 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (287)
T cd06621 84 EGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA 160 (287)
T ss_pred CCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccccccc
Confidence 99999988753 24578889999999999999999997 999999999999999999999999999876532221
Q ss_pred cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHh-hhhhHHHHHHHhhhcCccceeccchh
Q 047292 591 RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEE-SRAILTDWAYDCYVEGRLDALIDSDE 669 (728)
Q Consensus 591 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~d~~~ 669 (728)
....++..|+|||.+.+..++.++||||||+++|||++|+.||....... .......+. .......+.+.
T Consensus 161 ---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~-- 231 (287)
T cd06621 161 ---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYI----VNMPNPELKDE-- 231 (287)
T ss_pred ---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHH----hcCCchhhccC--
Confidence 23346888999999999999999999999999999999999997553210 000011111 11111111110
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 670 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 670 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
........+.+.+++.+||+.+|.+|||+.||++.
T Consensus 232 -~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 232 -PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred -CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 00011234567899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=292.22 Aligned_cols=260 Identities=26% Similarity=0.328 Sum_probs=195.9
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccC
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
+.++||.|++|.||+|..+ .++..|++|++.... ......+.+|+++++.++|+|++++++++......+++|||++
T Consensus 3 ~~~~l~~g~~~~vy~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~ 81 (283)
T cd07835 3 KVEKIGEGTYGVVYKARDK-LTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD 81 (283)
T ss_pred hheEecCCCCeEEEEEEEc-CCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC
Confidence 4578999999999999876 468899999986432 2233578899999999999999999999999999999999995
Q ss_pred CCCHHHHHhcCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccc
Q 047292 516 NGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH 593 (728)
Q Consensus 516 ~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 593 (728)
++|.+++...+ .+++..++.++.|+++||+|||+. +++|+||+|+||++++++.++|+|||+++....... ..
T Consensus 82 -~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~ 156 (283)
T cd07835 82 -LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-TY 156 (283)
T ss_pred -cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-cc
Confidence 68999988765 789999999999999999999997 999999999999999999999999999976532221 11
Q ss_pred ccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHH-------HHhh--h-c--Cc
Q 047292 594 TMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWA-------YDCY--V-E--GR 660 (728)
Q Consensus 594 ~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~--~-~--~~ 660 (728)
....++..|+|||++.+. .++.++||||||+++|||++|+.||...........+.... +... . + ..
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence 223467889999988664 57899999999999999999999987554322211111100 0000 0 0 00
Q ss_pred cceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 661 LDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 661 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
........ ...........+.+++.+||+.+|.+|||++++++
T Consensus 237 ~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 237 FPKWARQD-LSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred cccccccc-hhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000000 00111122356778999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=289.74 Aligned_cols=246 Identities=27% Similarity=0.384 Sum_probs=199.3
Q ss_pred hCCCceeEEEEeeeeCCCCcEEEEEEecccch---hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCCCC
Q 047292 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGT 518 (728)
Q Consensus 442 lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 518 (728)
||+|+||.||++... .+++.+++|.+..... .....+.+|++++++++|+||+++++.+......++++||+++++
T Consensus 1 lg~g~~~~vy~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKK-STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEEC-CCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCc
Confidence 689999999999876 4688999999865433 345678999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC-------c
Q 047292 519 LANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS-------R 591 (728)
Q Consensus 519 L~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-------~ 591 (728)
|.+++.....+++..+..++.||++||+|||+. +++|+||+|+||++++++.++|+|||++........ .
T Consensus 80 L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 80 LASLLENVGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 999998877889999999999999999999997 999999999999999999999999999876543321 1
Q ss_pred ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhh
Q 047292 592 THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAA 671 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 671 (728)
......++..|+|||.+.....+.++||||||++++||++|+.||...........+ ..+... ..
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~-~~------ 221 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNI--------LNGKIE-WP------ 221 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------hcCCcC-CC------
Confidence 223345788999999998888999999999999999999999999755433221111 111110 00
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047292 672 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLE 707 (728)
Q Consensus 672 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~ 707 (728)
........+..++.+||+.+|++|||+.++.+.|+
T Consensus 222 -~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 222 -EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred -ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 00012456778999999999999999977776665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=293.07 Aligned_cols=250 Identities=24% Similarity=0.350 Sum_probs=200.3
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
.+.+.+.||+|+||.||++... .++..|++|.+........+.+.+|+.+++.++||||+++++.+......++|+||+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 20 KYTRFEKIGQGASGTVYTAIDV-ATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hceeeeEecCCCCeEEEEEEEc-CCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 3445678999999999999865 457889999986554455678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccc
Q 047292 515 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHT 594 (728)
Q Consensus 515 ~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 594 (728)
++++|.+++... .+++..+..++.|++.||.|||++ +++|+||+|+||++++++.+||+|||++........ ...
T Consensus 99 ~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~~~ 173 (293)
T cd06647 99 AGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRS 173 (293)
T ss_pred CCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-ccc
Confidence 999999998753 577889999999999999999997 999999999999999999999999999876543322 222
Q ss_pred cccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhc
Q 047292 595 MIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMAD 674 (728)
Q Consensus 595 ~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 674 (728)
...+++.|+|||.+....++.++||||||+++||+++|+.||...........+ ...+. .. ....
T Consensus 174 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~-------~~~~~-~~-------~~~~ 238 (293)
T cd06647 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------ATNGT-PE-------LQNP 238 (293)
T ss_pred cccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh-------hcCCC-CC-------CCCc
Confidence 345788999999998888999999999999999999999999754332211100 00000 00 0011
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 675 RSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 675 ~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
......+.+++.+||+.+|.+||+++++++.
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 239 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1223457789999999999999999999965
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=289.76 Aligned_cols=245 Identities=26% Similarity=0.375 Sum_probs=198.1
Q ss_pred HhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCCCC
Q 047292 439 KEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGT 518 (728)
Q Consensus 439 ~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 518 (728)
..+||+|+||.||++..+ .+++.||+|++..........+.+|+.+++.++|+||+++++.+...+..+++|||+++++
T Consensus 25 ~~~lg~g~~g~v~~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 25 FIKIGEGSTGIVCIATVK-SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred HHHcCCCCCeEEEEEEEc-CCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 367999999999999876 4688999999876555556779999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccccccC
Q 047292 519 LANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRG 598 (728)
Q Consensus 519 L~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g 598 (728)
|.+++.. ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++........ ......+
T Consensus 104 L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~ 178 (292)
T cd06657 104 LTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVG 178 (292)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-ccccccc
Confidence 9998754 4678899999999999999999997 999999999999999999999999999876543321 1233457
Q ss_pred CccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHHHH
Q 047292 599 TRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRL 678 (728)
Q Consensus 599 t~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 678 (728)
++.|+|||.+.+..++.++||||||+++|||++|+.||...........+. . .....+.. .....
T Consensus 179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~----~-----~~~~~~~~------~~~~~ 243 (292)
T cd06657 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR----D-----NLPPKLKN------LHKVS 243 (292)
T ss_pred CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----h-----hCCcccCC------cccCC
Confidence 889999999988889999999999999999999999987543322111110 0 00000000 01123
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 679 HKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 679 ~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
..+.+++.+||+.+|.+||++.++++
T Consensus 244 ~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 35667899999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=293.48 Aligned_cols=253 Identities=21% Similarity=0.317 Sum_probs=197.1
Q ss_pred HHHHHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecc--cchhhHHHHHHHHHHhcccc-ccceeeEeeeeecCCcc
Q 047292 431 LKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDR--LAQEREREFKSEVSAIGRTH-HKNLVQLLGFCDEALNR 507 (728)
Q Consensus 431 l~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~ 507 (728)
++...|...++||+||.+.||++.- .+.+.+|+|++.. ...+....|.+|+..|.+|+ |.+||++++|-..++.+
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~--s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLN--SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeec--CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 3455677788999999999999865 3456788887743 34455688999999999994 99999999999999999
Q ss_pred eeEeeccCCCCHHHHHhcCCCCCh-HHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccc
Q 047292 508 LLVYEFMGNGTLANLIFAIPKPDW-NLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLL 586 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~l~~~~~~~~-~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 586 (728)
||||||- ..+|..+|........ -.++.+..|++.|+.++|++ +|||.||||.|+|+-. |.+||+|||+|..+.
T Consensus 436 YmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 436 YMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQ 510 (677)
T ss_pred EEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence 9999975 5699999987643322 37788999999999999998 9999999999999875 589999999999887
Q ss_pred cCCCcc-cccccCCccccCcccccCC-----------CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHH
Q 047292 587 SDHSRT-HTMIRGTRGYVAPEWLKNA-----------PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYD 654 (728)
Q Consensus 587 ~~~~~~-~~~~~gt~~y~aPE~~~~~-----------~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 654 (728)
.+.... .....||+.||+||.+... +.+.++||||||||||+|+.|+.||..-.-.- +
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~--------a-- 580 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQI--------A-- 580 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHH--------H--
Confidence 665433 3446799999999999533 25678999999999999999999997432111 0
Q ss_pred hhhcCccceeccchhhhhhcH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 655 CYVEGRLDALIDSDEAAMADR-SRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 655 ~~~~~~~~~~~d~~~~~~~~~-~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
++..+.++....+++. ..-.+++++++.||+.||++||++.++|+.
T Consensus 581 -----Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 581 -----KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred -----HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 1233344432222211 111228899999999999999999999864
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=288.36 Aligned_cols=249 Identities=28% Similarity=0.390 Sum_probs=195.6
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccc-cccceeeEeeeeecCC------cc
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKNLVQLLGFCDEAL------NR 507 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~------~~ 507 (728)
.+.+.+.||+|+||.||+|..+ .+++.+++|.+..... ....+.+|+.+++++ +|+||+++++++.... ..
T Consensus 7 ~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (275)
T cd06608 7 IFELVEVIGEGTYGKVYKARHK-KTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL 84 (275)
T ss_pred heeheeeecCCCCeEEEEEEEC-CCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence 3456688999999999999876 4578999999875433 346789999999998 7999999999997654 47
Q ss_pred eeEeeccCCCCHHHHHhcC----CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcc
Q 047292 508 LLVYEFMGNGTLANLIFAI----PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSK 583 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~ 583 (728)
++||||+++++|.+++... ..+++..+..++.|+++||.|||+. +++|+||+|+||++++++.+||+|||++.
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCccce
Confidence 9999999999999988753 4678999999999999999999997 99999999999999999999999999987
Q ss_pred ccccCCCcccccccCCccccCcccccC-----CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhc
Q 047292 584 LLLSDHSRTHTMIRGTRGYVAPEWLKN-----APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVE 658 (728)
Q Consensus 584 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 658 (728)
....... ......++..|+|||.+.. ..++.++||||||++++||++|+.||.......... . ...
T Consensus 162 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~---~-----~~~ 232 (275)
T cd06608 162 QLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF---K-----IPR 232 (275)
T ss_pred ecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHH---H-----hhc
Confidence 6543222 2233457889999998853 346789999999999999999999997433221111 0 111
Q ss_pred CccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 659 GRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 659 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
....... ........+.+++.+||..||++|||++++++
T Consensus 233 ~~~~~~~-------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 233 NPPPTLK-------SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred cCCCCCC-------chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1111111 11224456778999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=293.41 Aligned_cols=262 Identities=21% Similarity=0.272 Sum_probs=193.4
Q ss_pred HhhhCCC--ceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 439 KEELGRG--SFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 439 ~~~lg~G--~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
.++||+| +||+||++... .+++.||+|.+... ..+..+.+.+|+.+++.++|+||+++++++......++|+||+
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~ 81 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHT-PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFM 81 (328)
T ss_pred HHHhCCcccCceeEEEEEEc-CCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecc
Confidence 3567777 99999999875 57899999998642 2334478899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 515 GNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 515 ~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+..........
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 999999998864 3578888999999999999999987 99999999999999999999999998654332211110
Q ss_pred ------cccccCCccccCcccccCC--CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHH------------
Q 047292 593 ------HTMIRGTRGYVAPEWLKNA--PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWA------------ 652 (728)
Q Consensus 593 ------~~~~~gt~~y~aPE~~~~~--~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~------------ 652 (728)
.....++..|+|||++.+. .++.++||||||++++||++|+.||................
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence 0112245679999999764 57899999999999999999999997543221110000000
Q ss_pred -HH-------hhh----c-----CccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 653 -YD-------CYV----E-----GRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 653 -~~-------~~~----~-----~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
.. ... + .......+..............+.+++.+||+.||++|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00 000 0 0000011111111222345567889999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=288.05 Aligned_cols=243 Identities=23% Similarity=0.250 Sum_probs=187.7
Q ss_pred hhCCCceeEEEEeeeeCCCCcEEEEEEecccch---hhHHHHHHHHHHhc---cccccceeeEeeeeecCCcceeEeecc
Q 047292 441 ELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ---EREREFKSEVSAIG---RTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 441 ~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~---~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
.||+|+||.||++... .+++.+|+|.+..... .....+.+|..+++ ..+|+||+.+++.+...+..++||||+
T Consensus 1 ~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (279)
T cd05633 1 IIGRGGFGEVYGCRKA-DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLM 79 (279)
T ss_pred CcccCCCeEEEEEEEC-CCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecC
Confidence 3899999999999875 5688999998854321 12233444544433 347999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccc
Q 047292 515 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHT 594 (728)
Q Consensus 515 ~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 594 (728)
++++|.+++.....+++..+..++.|++.||+|||+. +|+|+||||+||++++++.++|+|||++....... ..
T Consensus 80 ~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~ 153 (279)
T cd05633 80 NGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PH 153 (279)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---cc
Confidence 9999999998888899999999999999999999997 99999999999999999999999999987553221 12
Q ss_pred cccCCccccCccccc-CCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhh
Q 047292 595 MIRGTRGYVAPEWLK-NAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMA 673 (728)
Q Consensus 595 ~~~gt~~y~aPE~~~-~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 673 (728)
...|+..|+|||.+. +..++.++||||||++++||++|+.||......... .+..... . .. ...
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~----~------~~----~~~ 218 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTL----T------VN----VEL 218 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhh----c------CC----cCC
Confidence 235899999999986 456899999999999999999999999643221111 0100000 0 00 011
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 047292 674 DRSRLHKWLMIAMWCIQEDPSKRP-----TMKVVMQM 705 (728)
Q Consensus 674 ~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~ 705 (728)
+......+.+++.+||+.||.+|| +++++++.
T Consensus 219 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 219 PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 122345677899999999999999 59998874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=289.18 Aligned_cols=246 Identities=26% Similarity=0.267 Sum_probs=199.6
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
.+.+.||.|+||.||++..+ .+++.|++|.+.... ....+.+.+|++++++++||||+++++++......++|+||
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 3 ELLRVIGKGAFGKVCIVQKR-DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred eEEEEeccCCCceEEEEEEc-cCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 45578999999999999875 568899999986532 23457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccc
Q 047292 514 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH 593 (728)
Q Consensus 514 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 593 (728)
+++++|.+++.....+++..+..++.||++||.|||+. +++|+||+|+||++++++.++|+|||++....... ..
T Consensus 82 ~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~ 156 (258)
T cd05578 82 LLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LT 156 (258)
T ss_pred CCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--cc
Confidence 99999999998877889999999999999999999997 99999999999999999999999999988764332 22
Q ss_pred ccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhh
Q 047292 594 TMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMA 673 (728)
Q Consensus 594 ~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 673 (728)
....++..|+|||.+.+..++.++|+||||+++|+|++|+.||............ ..... . ....
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-----~~~~~-~---------~~~~ 221 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR-----AKQET-A---------DVLY 221 (258)
T ss_pred cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH-----HHhcc-c---------cccC
Confidence 3345788999999999888999999999999999999999999865432111111 00000 0 0011
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCH--HHHH
Q 047292 674 DRSRLHKWLMIAMWCIQEDPSKRPTM--KVVM 703 (728)
Q Consensus 674 ~~~~~~~l~~l~~~cl~~dp~~RPt~--~evl 703 (728)
+......+.+++.+||+.+|.+||++ +|++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 222 PATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 11223567789999999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=288.60 Aligned_cols=257 Identities=27% Similarity=0.308 Sum_probs=206.1
Q ss_pred HhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch---hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccC
Q 047292 439 KEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 439 ~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
.++||+|+||.||-...+ .+|+.+|.|++.+... +.+...++|-.+|.+++.+.||.+--.++..+.+++|+..|.
T Consensus 190 ~RvlGkGGFGEV~acqvr-aTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMN 268 (591)
T KOG0986|consen 190 YRVLGKGGFGEVCACQVR-ATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMN 268 (591)
T ss_pred eEEEecccccceeEEEEe-cchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeec
Confidence 368999999999988766 6899999999965432 345667899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccc
Q 047292 516 NGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH 593 (728)
Q Consensus 516 ~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 593 (728)
||+|.-+|.+.. .+++..+.-++.+|+.||++||.. +||+|||||+|||+|+.|+++|+|+|+|..+..... .
T Consensus 269 GGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~--~ 343 (591)
T KOG0986|consen 269 GGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP--I 343 (591)
T ss_pred CCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCCc--c
Confidence 999999998874 789999999999999999999997 999999999999999999999999999998755433 3
Q ss_pred ccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhh
Q 047292 594 TMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMA 673 (728)
Q Consensus 594 ~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 673 (728)
....||.+|||||++.+..|+...|.|||||+||||+.|+.||...........+...... ....+
T Consensus 344 ~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~--------------~~~ey 409 (591)
T KOG0986|consen 344 RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE--------------DPEEY 409 (591)
T ss_pred ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc--------------chhhc
Confidence 3347999999999999999999999999999999999999999865443322211111100 11223
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCCCCCcc
Q 047292 674 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNPPWSSS 720 (728)
Q Consensus 674 ~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~~~~~~ 720 (728)
+....+++..+....|+.||.+|..-+. ++..++.++|....
T Consensus 410 ~~kFS~eakslc~~LL~Kdp~~RLGcrg-----~ga~evk~HpfFk~ 451 (591)
T KOG0986|consen 410 SDKFSEEAKSLCEGLLTKDPEKRLGCRG-----EGAQEVKEHPFFKD 451 (591)
T ss_pred ccccCHHHHHHHHHHHccCHHHhccCCC-----cCcchhhhCccccc
Confidence 3445556677888899999999964432 24445555554433
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=287.83 Aligned_cols=260 Identities=23% Similarity=0.248 Sum_probs=193.0
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHhcccc-ccceeeEeeeeecC--CcceeEeec
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA-QEREREFKSEVSAIGRTH-HKNLVQLLGFCDEA--LNRLLVYEF 513 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~--~~~~lv~e~ 513 (728)
+.++||+|+||.||+|..+ .+++.||+|+++... .........|+.++.++. |+|++++++++.+. +..++|+||
T Consensus 3 ~~~~lg~g~~~~v~~~~~~-~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 81 (282)
T cd07831 3 ILGKIGEGTFSEVLKAQSR-KTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL 81 (282)
T ss_pred eEeeccccccceEEEEEEc-CCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence 4578999999999999876 567899999986532 222334567888898885 99999999999887 889999999
Q ss_pred cCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 514 MGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 514 ~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
++ ++|.+++... ..+++..++.++.|++.||+|||+. +++|+||+|+||++++ +.+||+|||+++.......
T Consensus 82 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-- 154 (282)
T cd07831 82 MD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-- 154 (282)
T ss_pred CC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCC--
Confidence 97 5888887764 5689999999999999999999997 9999999999999999 9999999999987643322
Q ss_pred cccccCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHH-------HHhhhcCcccee
Q 047292 593 HTMIRGTRGYVAPEWLKN-APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWA-------YDCYVEGRLDAL 664 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~ 664 (728)
.....++..|+|||.+.. ..++.++||||||+++|||++|+.||......+....+.... ............
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07831 155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY 234 (282)
T ss_pred cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccc
Confidence 122457889999997754 567889999999999999999999997554332211111100 000000000000
Q ss_pred ccch-h---hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 665 IDSD-E---AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 665 ~d~~-~---~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
..+. . ...........+.+++.+||+.+|++||+++++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 235 NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000 0 001112335678899999999999999999999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=293.47 Aligned_cols=266 Identities=24% Similarity=0.304 Sum_probs=196.9
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhccc-cccceeeEeeeeecC--Ccce
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRT-HHKNLVQLLGFCDEA--LNRL 508 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~--~~~~ 508 (728)
..+.+.+.||+|+||.||+|... .+++.+++|++... .......+..|+.+++++ +|+||+++++++... ...+
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDR-RTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEc-CCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 34567789999999999999876 46789999988542 223345677899999999 999999999998643 4679
Q ss_pred eEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccC
Q 047292 509 LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD 588 (728)
Q Consensus 509 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 588 (728)
+||||++ ++|.+++... .+++..+..++.||+.||+|||+. +|+|+||||+||++++++.+||+|||+++.....
T Consensus 86 lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred EEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 9999997 5999988765 778889999999999999999997 9999999999999999999999999999876443
Q ss_pred CC----cccccccCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHH-------HHhh
Q 047292 589 HS----RTHTMIRGTRGYVAPEWLKN-APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWA-------YDCY 656 (728)
Q Consensus 589 ~~----~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~ 656 (728)
.. .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.... ....
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 22 12233458889999998865 467899999999999999999999986543322211111100 0000
Q ss_pred hcCccceecc----c--hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 657 VEGRLDALID----S--DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 657 ~~~~~~~~~d----~--~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.......+++ . .............+.+++.+||+.+|.+||++.++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000000 0 00000111134567899999999999999999999965
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=268.13 Aligned_cols=248 Identities=25% Similarity=0.411 Sum_probs=193.7
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch-hhHHHHHHHHHHhccc-cccceeeEeeeeecCCcceeEeeccC
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ-EREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
+...||.|+.|.|++...+ .+|..+|||.+..... +..+.++..+.++..- ++|.||+.+|+|..+...++.||.|.
T Consensus 96 ~l~dlGsGtcG~V~k~~~r-s~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs 174 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFR-STGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS 174 (391)
T ss_pred hHHhhcCCCccceEEEEEc-ccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence 4567999999999999987 5788999999966433 4457788888887766 49999999999999999999999984
Q ss_pred CCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccc
Q 047292 516 NGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHT 594 (728)
Q Consensus 516 ~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 594 (728)
- -++.++... .++++..+-++...+++||.||.++ ++|||||+||+|||+|+.|++||+|||++..+-... .++
T Consensus 175 ~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk--Aht 249 (391)
T KOG0983|consen 175 T-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--AHT 249 (391)
T ss_pred H-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeeccc--ccc
Confidence 3 445555543 4677888889999999999999986 599999999999999999999999999998774433 344
Q ss_pred cccCCccccCccccc---CCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhh
Q 047292 595 MIRGTRGYVAPEWLK---NAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAA 671 (728)
Q Consensus 595 ~~~gt~~y~aPE~~~---~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 671 (728)
...|-+.|||||.+. ...|+.++||||||+.|+||.||+.||.....+- ..+.. ..+ +....++..
T Consensus 250 rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF--e~ltk-----vln-~ePP~L~~~--- 318 (391)
T KOG0983|consen 250 RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF--EVLTK-----VLN-EEPPLLPGH--- 318 (391)
T ss_pred cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH--HHHHH-----HHh-cCCCCCCcc---
Confidence 556899999999995 3478999999999999999999999998643321 11111 111 111222221
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 672 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 672 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
......+++++..||+.|+.+||...++++.
T Consensus 319 ---~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 319 ---MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred ---cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 1144567789999999999999999988764
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=287.28 Aligned_cols=250 Identities=26% Similarity=0.385 Sum_probs=191.4
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHhcccc-ccceeeEeeeeecCCcceeEeeccC
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA-QEREREFKSEVSAIGRTH-HKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
..++||+|+||.||++... .+++.||+|.+.... ......+.+|+.++.++. |+||+++++++......+++|||++
T Consensus 8 ~~~~lg~G~~g~vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~ 86 (288)
T cd06616 8 DLGEIGRGAFGTVNKMLHK-PSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD 86 (288)
T ss_pred HHHHhCCCCceEEEEEEEC-CCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc
Confidence 4578999999999999876 567899999986432 234567889999999996 9999999999999999999999986
Q ss_pred CCCHHHHH---h--cCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC
Q 047292 516 NGTLANLI---F--AIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 516 ~gsL~~~l---~--~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 590 (728)
. +|.++. . ....+++..+..++.|++.||+|||+. .+++||||||+||++++++.+||+|||+++.......
T Consensus 87 ~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 163 (288)
T cd06616 87 I-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA 163 (288)
T ss_pred C-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc
Confidence 4 554432 2 235688899999999999999999974 3899999999999999999999999999976543322
Q ss_pred cccccccCCccccCcccccCC---CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccc
Q 047292 591 RTHTMIRGTRGYVAPEWLKNA---PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDS 667 (728)
Q Consensus 591 ~~~~~~~gt~~y~aPE~~~~~---~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 667 (728)
. ....++..|+|||.+.+. .++.++||||||+++|||++|+.||...... ...+ .....+....
T Consensus 164 ~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~-----~~~~~~~~~~---- 230 (288)
T cd06616 164 K--TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV--FDQL-----TQVVKGDPPI---- 230 (288)
T ss_pred c--ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH--HHHH-----hhhcCCCCCc----
Confidence 1 223578899999999766 6899999999999999999999998643210 0000 0000111111
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 668 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 668 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
............+.+++.+||+.+|.+||++++|++.
T Consensus 231 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 231 -LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred -CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111112244567889999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=298.51 Aligned_cols=261 Identities=23% Similarity=0.273 Sum_probs=194.3
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeeecC------Ccc
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEA------LNR 507 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~ 507 (728)
+...+.||+|+||.||++... .+++.||+|.+... .......+.+|+.++++++|+||+++++++... ...
T Consensus 18 y~~~~~lg~g~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 96 (353)
T cd07850 18 YQNLKPIGSGAQGIVCAAYDT-VTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDV 96 (353)
T ss_pred eEEEEEeccCCCEEEEEEEEC-CCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcE
Confidence 444578999999999999876 56889999998642 233446678899999999999999999988543 346
Q ss_pred eeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcccccc
Q 047292 508 LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS 587 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 587 (728)
++|+||+. ++|.+.+... ++...+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 97 ~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 97 YLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170 (353)
T ss_pred EEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence 99999996 4888887653 78889999999999999999997 999999999999999999999999999986543
Q ss_pred CCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHH---------------HH
Q 047292 588 DHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTD---------------WA 652 (728)
Q Consensus 588 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~---------------~~ 652 (728)
... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...........+.. ..
T Consensus 171 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (353)
T cd07850 171 SFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTV 248 (353)
T ss_pred CCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhh
Confidence 221 2234578899999999999999999999999999999999999865432211111100 00
Q ss_pred HHhhhcCc------cceeccch----hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 653 YDCYVEGR------LDALIDSD----EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 653 ~~~~~~~~------~~~~~d~~----~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
........ +...+... ............+.+++.+||+.||++|||+.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000 00000000 0000011234567899999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=285.94 Aligned_cols=247 Identities=23% Similarity=0.353 Sum_probs=197.5
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
.+.+.||+|+||.||+|..+ .++..+|+|.+.... ......+.+|+.+++.++|+||+++++.+......++|+||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (257)
T cd08225 3 EIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC 81 (257)
T ss_pred eEEEEecCCCcceEEEEEEc-CCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence 34578999999999999886 467889999986531 233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCC-ceEEccccCccccccCCCc
Q 047292 515 GNGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYF-SPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 515 ~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~~~~~ 591 (728)
++++|.+++.... .+++..+..++.|+++||.|||+. +++|+||||+||++++++ .+||+|||.+........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~- 157 (257)
T cd08225 82 DGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME- 157 (257)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc-
Confidence 9999999987643 468999999999999999999997 999999999999999875 469999999887643322
Q ss_pred ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhh
Q 047292 592 THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAA 671 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 671 (728)
......|++.|+|||.+.+..++.++||||||++++||++|+.|+.......... . ...+.....
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-------~-~~~~~~~~~------- 222 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVL-------K-ICQGYFAPI------- 222 (257)
T ss_pred cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHH-------H-HhcccCCCC-------
Confidence 2223458889999999988889999999999999999999999987543322111 1 011111111
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 672 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 672 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.......+.+++.+||+.+|++|||+.++++.
T Consensus 223 --~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 223 --SPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred --CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11223467789999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=289.51 Aligned_cols=247 Identities=23% Similarity=0.363 Sum_probs=188.5
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc-hhhHHHHHHHHHH-hccccccceeeEeeeeecCCcceeEeecc
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA-QEREREFKSEVSA-IGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
.+.+.||+|+||.||++..+ .+++.||+|+++... ......+..|+.. ++.++|+||+++++++......++++||+
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (283)
T cd06617 4 EVIEELGRGAYGVVDKMRHV-PTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVM 82 (283)
T ss_pred eEEEEecccCCeEEEEEEEc-CCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhh
Confidence 34577999999999999876 568999999986532 2334456666665 55678999999999999999999999999
Q ss_pred CCCCHHHHHhcC----CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC
Q 047292 515 GNGTLANLIFAI----PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 515 ~~gsL~~~l~~~----~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 590 (728)
+ ++|.+++... ..+++..++.++.||+.||+|||++ .+++||||||+||++++++.+||+|||++.......
T Consensus 83 ~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 158 (283)
T cd06617 83 D-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV- 158 (283)
T ss_pred c-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeeccccccccccc-
Confidence 7 6888777542 4678999999999999999999984 379999999999999999999999999988653322
Q ss_pred cccccccCCccccCcccccC----CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceecc
Q 047292 591 RTHTMIRGTRGYVAPEWLKN----APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALID 666 (728)
Q Consensus 591 ~~~~~~~gt~~y~aPE~~~~----~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 666 (728)
......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||....... ..+... ..+....+.
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~-----~~~~~~~~~- 229 (283)
T cd06617 159 -AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF--QQLKQV-----VEEPSPQLP- 229 (283)
T ss_pred -ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH--HHHHHH-----HhcCCCCCC-
Confidence 1222457889999998865 456889999999999999999999986422110 001000 011111111
Q ss_pred chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 667 SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 667 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
.......+.+++.+||+.+|.+||+++++++
T Consensus 230 -------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 230 -------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred -------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0112356778999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=289.64 Aligned_cols=262 Identities=22% Similarity=0.248 Sum_probs=190.9
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch-hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
+.+.+.||+|+||.||+|... .+++.|++|.+..... .....+.+|+.+++.++|+||+++.+++......++|+||+
T Consensus 7 y~~~~~ig~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 85 (291)
T cd07870 7 YLNLEKLGEGSYATVYKGISR-INGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYM 85 (291)
T ss_pred eEEEEEEEecCCEEEEEEEEc-CCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEecc
Confidence 334578999999999999876 4578999999865332 22346788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccc
Q 047292 515 GNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH 593 (728)
Q Consensus 515 ~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 593 (728)
+ ++|.+++... ..+.+..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||+++....... ..
T Consensus 86 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~ 160 (291)
T cd07870 86 H-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ-TY 160 (291)
T ss_pred c-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCC-CC
Confidence 6 6777766543 4567888899999999999999997 999999999999999999999999999876433221 11
Q ss_pred ccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHH---------Hhhh--cCcc
Q 047292 594 TMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAY---------DCYV--EGRL 661 (728)
Q Consensus 594 ~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~---------~~~~--~~~~ 661 (728)
....+++.|+|||.+.+. .++.++||||||+++|||++|+.||........ .....+.. .... ....
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07870 161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE-QLEKIWTVLGVPTEDTWPGVSKLPNYK 239 (291)
T ss_pred CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH-HHHHHHHHcCCCChhhhhhhhhccccc
Confidence 223468899999998764 578899999999999999999999975432211 00000000 0000 0000
Q ss_pred ceec----cchhhh-hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 662 DALI----DSDEAA-MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 662 ~~~~----d~~~~~-~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
.... ...... .........+.+++.+|++.||++|||++|++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000 000000 000011345678999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=293.41 Aligned_cols=265 Identities=22% Similarity=0.269 Sum_probs=194.3
Q ss_pred hHHhhhCCCceeEEEEeeeeCC-CCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecC--CcceeE
Q 047292 437 GFKEELGRGSFGIVYKGVLKTA-SGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEA--LNRLLV 510 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv 510 (728)
.+.++||+|+||.||+|..+.. .++.||+|.+.... ......+.+|+.++..++||||+++++++... ...++|
T Consensus 3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 82 (316)
T cd07842 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLL 82 (316)
T ss_pred eEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEE
Confidence 3457799999999999998743 67899999997632 33346778899999999999999999999888 789999
Q ss_pred eeccCCCCHHHHHhcC-----CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcC----CCceEEccccC
Q 047292 511 YEFMGNGTLANLIFAI-----PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDH----YFSPKISDFGL 581 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~-----~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~----~~~~kl~Dfgl 581 (728)
|||+++ +|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+||+++. ++.+||+|||+
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~ 158 (316)
T cd07842 83 FDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGL 158 (316)
T ss_pred EeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence 999975 676666432 2578889999999999999999997 9999999999999999 99999999999
Q ss_pred ccccccCCC--cccccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhh------hhhHHHHH
Q 047292 582 SKLLLSDHS--RTHTMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEES------RAILTDWA 652 (728)
Q Consensus 582 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~------~~~~~~~~ 652 (728)
+........ .......++..|+|||.+.+. .++.++||||||++++||++|+.||........ ...+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (316)
T cd07842 159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF 238 (316)
T ss_pred ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence 987643322 122234578899999988764 578999999999999999999999875433210 00000000
Q ss_pred H----------Hhhh----------cCccceeccchhhhhhcH--HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 653 Y----------DCYV----------EGRLDALIDSDEAAMADR--SRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 653 ~----------~~~~----------~~~~~~~~d~~~~~~~~~--~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
. .... ...........+....+. .....+.+++.+||+.||++|||+.|+++.
T Consensus 239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0 0000 000000000011111111 233567899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=297.32 Aligned_cols=269 Identities=24% Similarity=0.311 Sum_probs=196.2
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecC-----Cccee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEA-----LNRLL 509 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~l 509 (728)
+.+.++||+|+||.||+|... .+++.||+|+++... ......+.+|+.++++++|+||+++++++... ...++
T Consensus 7 y~i~~~lg~G~~g~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 85 (336)
T cd07849 7 YQNLSYIGEGAYGMVCSATHK-PTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYI 85 (336)
T ss_pred eEEEEEEEecCCeEEEEEEEc-CCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEE
Confidence 445578999999999999876 568899999986432 23346688899999999999999999987544 35799
Q ss_pred EeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCC
Q 047292 510 VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH 589 (728)
Q Consensus 510 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 589 (728)
++||+++ +|.+++.. ..+++..+..++.|+++||.|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 86 v~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 86 VQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred Eehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 9999975 78777754 5688899999999999999999997 99999999999999999999999999998654322
Q ss_pred Cc--ccccccCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceecc
Q 047292 590 SR--THTMIRGTRGYVAPEWLKN-APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALID 666 (728)
Q Consensus 590 ~~--~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 666 (728)
.. ......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||...........+..... ......+..+.+
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 239 (336)
T cd07849 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLG-TPSQEDLNCIIS 239 (336)
T ss_pred cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC-CCCHHHHHHhhc
Confidence 21 1223457899999998755 5689999999999999999999999964432211111100000 000000000000
Q ss_pred ch--------------hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcCcC
Q 047292 667 SD--------------EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM--LEGLLE 711 (728)
Q Consensus 667 ~~--------------~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~--L~~~~~ 711 (728)
.. ......+.....+.+++.+||+.+|++|||+.++++. ++....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 00 0000011224567899999999999999999999986 665543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=282.58 Aligned_cols=245 Identities=27% Similarity=0.333 Sum_probs=200.7
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
.+.++||+|+||.||++..+ .+++.+++|.+.... ......+.+|+++++.++|+||+++++++......++|+||+
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd08530 3 KVLKKLGKGSYGSVYKVKRL-SDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA 81 (256)
T ss_pred eEeeeecCCCceeEEEEEEC-CCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence 34578999999999999865 567899999986532 334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhc----CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC
Q 047292 515 GNGTLANLIFA----IPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 515 ~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 590 (728)
++++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||+++.....
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-- 156 (256)
T cd08530 82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN-- 156 (256)
T ss_pred CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC--
Confidence 99999999876 35678899999999999999999987 9999999999999999999999999999876544
Q ss_pred cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhh
Q 047292 591 RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEA 670 (728)
Q Consensus 591 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 670 (728)
......++..|+|||.+.+..++.++|+||||++++||++|+.||........... ...+....+
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~--------~~~~~~~~~------ 221 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYK--------VQRGKYPPI------ 221 (256)
T ss_pred -CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--------HhcCCCCCC------
Confidence 12224478899999999999999999999999999999999999975543321111 111111111
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 671 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 671 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.......+.+++.+||+.+|++||++.++++.
T Consensus 222 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 222 ---PPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred ---chhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 12334567889999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=288.80 Aligned_cols=266 Identities=24% Similarity=0.259 Sum_probs=196.5
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHhccccccceeeEeeeeecCC------
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEAL------ 505 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------ 505 (728)
..+.+.+.||+|+||.||+|..+ .+++.|++|+++... ......+.+|++++++++||||+++++++....
T Consensus 7 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 7 DKFDIIGQIGEGTYGQVYKARDK-DTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhheeeeecccCCEEEEEEEEC-CCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 34556688999999999999986 467899999986532 223356788999999999999999999987654
Q ss_pred ----cceeEeeccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEcccc
Q 047292 506 ----NRLLVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFG 580 (728)
Q Consensus 506 ----~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg 580 (728)
..++|+||+++ +|...+... ..+++..+..++.||+.||+|||+. +|+|+||||+||++++++.+||+|||
T Consensus 86 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 86 KDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred ccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCccc
Confidence 78999999986 677777654 4689999999999999999999997 99999999999999999999999999
Q ss_pred CccccccCCCcccccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHh----
Q 047292 581 LSKLLLSDHSRTHTMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDC---- 655 (728)
Q Consensus 581 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~---- 655 (728)
++...............++..|+|||.+.+. .++.++||||||++++||++|+.||...........+.......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (302)
T cd07864 162 LARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAV 241 (302)
T ss_pred ccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 9987654332222233457789999988654 57899999999999999999999997654333222221111000
Q ss_pred ---hhcCccceeccc------hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 656 ---YVEGRLDALIDS------DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 656 ---~~~~~~~~~~d~------~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
..+.......+. ..... .......+.+++.+||+.+|.+||+++++++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 242 WPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred cccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000000000000 00000 00123567889999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=280.95 Aligned_cols=246 Identities=26% Similarity=0.398 Sum_probs=201.5
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch--hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
.+.+.||+|++|.||++... .+++.|++|.+..... .....+.+|++++.+++|+|++++++++......++++||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 3 QLGDLIGRGAFGVVYKGLNL-ETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred eeeeEEcccCCeEEEEEEEc-CCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 45678999999999999876 4678999999976543 44578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccc
Q 047292 515 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHT 594 (728)
Q Consensus 515 ~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 594 (728)
++++|.+++.....+++..+..++.|++.||.|||+. +|+|+||+|+||+++.++.++|+|||++......... ..
T Consensus 82 ~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~ 157 (254)
T cd06627 82 ENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-DA 157 (254)
T ss_pred CCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-cc
Confidence 9999999998888899999999999999999999987 9999999999999999999999999999876543322 22
Q ss_pred cccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhc
Q 047292 595 MIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMAD 674 (728)
Q Consensus 595 ~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 674 (728)
...++..|+|||...+..++.++||||||+++++|++|+.|+.......... .. ........ +
T Consensus 158 ~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~-----~~---~~~~~~~~---------~ 220 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALF-----RI---VQDDHPPL---------P 220 (254)
T ss_pred ccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHH-----HH---hccCCCCC---------C
Confidence 3457889999999988888999999999999999999999987543221111 00 01111111 1
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 675 RSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 675 ~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
......+..++.+||+.+|++||++.+++.
T Consensus 221 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 221 EGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 112346678999999999999999999975
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=277.91 Aligned_cols=253 Identities=22% Similarity=0.293 Sum_probs=204.1
Q ss_pred hHHhhhCCCceeEEEEeeeeCCC----CcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeee-cCCcceeE
Q 047292 437 GFKEELGRGSFGIVYKGVLKTAS----GNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCD-EALNRLLV 510 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~~lv 510 (728)
.++..+-+|+||.||.|.+.+++ .+.|.+|.++... +-+...+..|.-.+..+.|||+..+.+++. +....+++
T Consensus 287 ~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~ 366 (563)
T KOG1024|consen 287 RLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVL 366 (563)
T ss_pred echhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEE
Confidence 44567999999999999876432 2467778775533 334567888999999999999999999984 55677999
Q ss_pred eeccCCCCHHHHHhcC--------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCc
Q 047292 511 YEFMGNGTLANLIFAI--------PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLS 582 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~--------~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla 582 (728)
|.++.-|+|..||... +.++..+...++.|++.||+|||.+ ++||.||.++|++||+..++||+|-.++
T Consensus 367 y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDsaLS 443 (563)
T KOG1024|consen 367 YPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDSALS 443 (563)
T ss_pred EeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEeccchhc
Confidence 9999999999999822 3456677889999999999999997 9999999999999999999999999999
Q ss_pred cccccCCCcc-cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCc
Q 047292 583 KLLLSDHSRT-HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGR 660 (728)
Q Consensus 583 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (728)
+.+....... ......+..||+||.+....|+.++|||||||+||||+| |+.|+..-.+.+....+.+
T Consensus 444 RDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkd---------- 513 (563)
T KOG1024|consen 444 RDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKD---------- 513 (563)
T ss_pred cccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhc----------
Confidence 9775544332 333445779999999999999999999999999999998 7788876666554443321
Q ss_pred cceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 047292 661 LDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGL 709 (728)
Q Consensus 661 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 709 (728)
..+...+..++.++..++..||...|++||+++|+++.|.+.
T Consensus 514 -------GyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 514 -------GYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred -------cceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 112223445677889999999999999999999999999764
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=281.31 Aligned_cols=248 Identities=27% Similarity=0.380 Sum_probs=202.2
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch--hhHHHHHHHHHHhccccccceeeEeeeeecC--CcceeEeec
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKNLVQLLGFCDEA--LNRLLVYEF 513 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv~e~ 513 (728)
..+.||+|++|.||+|... .+++.|++|++..... ...+.+.+|+.++++++|+||+++++.+... ...++++||
T Consensus 4 ~~~~i~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 82 (260)
T cd06606 4 RGELLGRGSFGSVYLALDK-DTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEY 82 (260)
T ss_pred eeeEeeecCceEEEEEEEC-CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEe
Confidence 3467999999999999876 4688999999865442 4567899999999999999999999999888 889999999
Q ss_pred cCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc-c
Q 047292 514 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR-T 592 (728)
Q Consensus 514 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~ 592 (728)
+++++|.+++.....+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+......... .
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 83 VSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 99999999999888899999999999999999999997 9999999999999999999999999999876544321 1
Q ss_pred cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAM 672 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 672 (728)
.....++..|+|||.+.+...+.++||||||+++++|++|+.||........ . ........... .
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~----~~~~~~~~~~~---------~ 224 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA--A----LYKIGSSGEPP---------E 224 (260)
T ss_pred ccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH--H----HHhccccCCCc---------C
Confidence 2234578899999999988899999999999999999999999875541110 0 00000000111 1
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 673 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 673 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
.+......+.+++.+|++.+|.+||++.++++
T Consensus 225 ~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 225 IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 11122456788999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=286.21 Aligned_cols=261 Identities=22% Similarity=0.300 Sum_probs=196.3
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch-hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccC
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
.+.++||+|++|.||+|+.+ .+++.||||+++.... .....+.+|+.++++++|+||+++++++...+..++||||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (284)
T cd07836 3 KQLEKLGEGTYATVYKGRNR-TTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD 81 (284)
T ss_pred eEeeeeccCCceEEEEEEEC-CCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence 34578999999999999876 5688999999865432 234667889999999999999999999999999999999998
Q ss_pred CCCHHHHHhcC---CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 516 NGTLANLIFAI---PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 516 ~gsL~~~l~~~---~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
+ +|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++........ .
T Consensus 82 ~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~ 156 (284)
T cd07836 82 K-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-T 156 (284)
T ss_pred c-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-c
Confidence 5 888887654 3578999999999999999999987 999999999999999999999999999976533221 1
Q ss_pred cccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHH-------HHhhhc-----C
Q 047292 593 HTMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWA-------YDCYVE-----G 659 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~~-----~ 659 (728)
.....++..|+|||.+.+. .++.++||||||+++|||++|+.||......+....+.... +..+.. .
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence 2223468889999988664 56889999999999999999999987554332221111100 000000 0
Q ss_pred ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 660 RLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 660 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
......+. ......+.....+.+++.+|++.+|.+||+++++++
T Consensus 237 ~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 237 TFPRYPPQ-DLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccCCChH-HHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000 001111223456778999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=281.84 Aligned_cols=248 Identities=23% Similarity=0.290 Sum_probs=195.4
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc-----chhhHHHHHHHHHHhccccccceeeEeeeeecC--Ccce
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL-----AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEA--LNRL 508 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~ 508 (728)
+.+.+.||+|+||.||+|... .++..|++|.+... ..+....+.+|++++++++|+||+++++++... ...+
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (264)
T cd06653 4 WRLGKLLGRGAFGEVYLCYDA-DTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS 82 (264)
T ss_pred eeeeeeEccCCCeEEEEEEEc-CCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence 345678999999999999876 56889999987421 123346789999999999999999999998654 4578
Q ss_pred eEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccC
Q 047292 509 LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD 588 (728)
Q Consensus 509 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 588 (728)
+++||+++++|.+++.....+++.....++.|++.||.|||++ +++|+||||+||+++.++.++|+|||+++.....
T Consensus 83 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 83 IFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence 9999999999999998777788999999999999999999997 9999999999999999999999999999865332
Q ss_pred CC--cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceecc
Q 047292 589 HS--RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALID 666 (728)
Q Consensus 589 ~~--~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 666 (728)
.. .......++..|+|||.+.+..++.++||||||++++||++|+.||.......... .. .....
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~-----~~~~~----- 226 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIF---KI-----ATQPT----- 226 (264)
T ss_pred cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHH---HH-----HcCCC-----
Confidence 11 11123457889999999999889999999999999999999999997542221110 10 00000
Q ss_pred chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 667 SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 667 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
....+......+.+++.+||+ +|..||+..+++.
T Consensus 227 ---~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 227 ---KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ---CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 011222334567789999998 5799999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=288.40 Aligned_cols=262 Identities=26% Similarity=0.321 Sum_probs=192.5
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
+.+.++||+|++|.||+|..+ .+++.|++|++.... ......+.+|++++++++|+||+++++++......++||||
T Consensus 4 y~~~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (294)
T PLN00009 4 YEKVEKIGEGTYGVVYKARDR-VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEY 82 (294)
T ss_pred eEEEEEecCCCCEEEEEEEec-CCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEec
Confidence 344578999999999999876 467899999985432 22346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCC--CChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcC-CCceEEccccCccccccCCC
Q 047292 514 MGNGTLANLIFAIPK--PDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDH-YFSPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 514 ~~~gsL~~~l~~~~~--~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~-~~~~kl~Dfgla~~~~~~~~ 590 (728)
++ ++|.+++..... .++..+..++.||+.||+|||++ +++|+||+|+||++++ ++.+||+|||++.......
T Consensus 83 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~- 157 (294)
T PLN00009 83 LD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV- 157 (294)
T ss_pred cc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc-
Confidence 96 588888765433 46778889999999999999997 9999999999999985 5679999999997653321
Q ss_pred cccccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCcc---ceecc
Q 047292 591 RTHTMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRL---DALID 666 (728)
Q Consensus 591 ~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~d 666 (728)
.......+++.|+|||++.+. .++.++||||||+++|||+||+.||......+....+...... ..+... ..+.+
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 236 (294)
T PLN00009 158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGT-PNEETWPGVTSLPD 236 (294)
T ss_pred cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC-CChhhccccccchh
Confidence 112233468899999998764 5789999999999999999999999754332221111000000 000000 00000
Q ss_pred ---------chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 667 ---------SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 667 ---------~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
........+.....+.+++.+|++.+|++||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000011223455778999999999999999999986
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=293.48 Aligned_cols=262 Identities=21% Similarity=0.216 Sum_probs=196.7
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhh--------------HHHHHHHHHHhccccccceeeEeeeeec
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQER--------------EREFKSEVSAIGRTHHKNLVQLLGFCDE 503 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~g~~~~ 503 (728)
+.+.||+|+||.||+|..+ .+++.||||++....... ...+.+|++++++++|+||+++++++..
T Consensus 13 ~~~~ig~G~~g~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 91 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDT-LTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVE 91 (335)
T ss_pred hhhcccCCCceeEEEEEEC-CCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEec
Confidence 3467999999999999876 467899999986432211 1257889999999999999999999999
Q ss_pred CCcceeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcc
Q 047292 504 ALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSK 583 (728)
Q Consensus 504 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~ 583 (728)
....++||||++ ++|.+++.....+++.....++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++.
T Consensus 92 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~dfg~~~ 167 (335)
T PTZ00024 92 GDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLAR 167 (335)
T ss_pred CCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCcccee
Confidence 999999999997 69999998877889999999999999999999987 99999999999999999999999999997
Q ss_pred ccccCC-------------CcccccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHH
Q 047292 584 LLLSDH-------------SRTHTMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILT 649 (728)
Q Consensus 584 ~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~ 649 (728)
...... ........++..|+|||.+.+. .++.++||||||+++|||++|+.||......+....+.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~ 247 (335)
T PTZ00024 168 RYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIF 247 (335)
T ss_pred ecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 664111 1111123467889999999765 46899999999999999999999997665433222211
Q ss_pred HHHHHh----hhcC---c----cceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 650 DWAYDC----YVEG---R----LDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 650 ~~~~~~----~~~~---~----~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
...... +... . ......... ..........+.+++.+||+.+|++||++++++..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 248 ELLGTPNEDNWPQAKKLPLYTEFTPRKPKDL-KTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHhCCCchhhCcchhhcccccccCcCCcccH-HHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 110000 0000 0 000000000 01111224567889999999999999999999864
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=287.37 Aligned_cols=258 Identities=18% Similarity=0.202 Sum_probs=182.9
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCC--CcEEEEEEecccchhh-----------HHHHHHHHHHhccccccceeeEeee
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTAS--GNAIAVKKLDRLAQER-----------EREFKSEVSAIGRTHHKNLVQLLGF 500 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~--~~~vavK~l~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l~g~ 500 (728)
..+.+.+.||+|+||.||+|...... +..+++|+........ ......+...+..++|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 34556788999999999999876321 4456666543211110 1122334455667789999999997
Q ss_pred eecCC----cceeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEE
Q 047292 501 CDEAL----NRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKI 576 (728)
Q Consensus 501 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl 576 (728)
+.... ..++++|+.. .++.+.+......++..+..++.|+++||+|||+. +|+||||||+|||++.++.++|
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcEEE
Confidence 65443 2367777664 36666666555567888999999999999999997 9999999999999999999999
Q ss_pred ccccCccccccCCC------cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhh--hH
Q 047292 577 SDFGLSKLLLSDHS------RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRA--IL 648 (728)
Q Consensus 577 ~Dfgla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~--~~ 648 (728)
+|||+++....... .......||+.|+|||++.+..++.++||||||++++||++|+.||.......... ..
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~ 247 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK 247 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence 99999987643211 11122468999999999999999999999999999999999999997653221111 00
Q ss_pred HHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047292 649 TDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLE 707 (728)
Q Consensus 649 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~ 707 (728)
.++ ......+.. . .......+.+++..|++.+|++||++.++++.|+
T Consensus 248 ~~~-~~~~~~~~~--------~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 248 CDF-IKRLHEGKI--------K---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHH-HHHhhhhhh--------c---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 111 111111111 0 0112345778999999999999999999999874
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=289.56 Aligned_cols=264 Identities=24% Similarity=0.270 Sum_probs=194.4
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch--hhHHHHHHHHHHhccccccceeeEeeeeecC--CcceeEe
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKNLVQLLGFCDEA--LNRLLVY 511 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv~ 511 (728)
+.+.+.||+|+||.||+|..+ .+++.||+|+++.... .....+.+|+.++++++|+||+++++++... ...++||
T Consensus 9 y~~~~~ig~g~~~~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (309)
T cd07845 9 FEKLNRIGEGTYGIVYRARDT-TSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVM 87 (309)
T ss_pred eeEeeeeeecCCEEEEEEEEC-CCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEE
Confidence 345578999999999999876 5688999999864322 2234567899999999999999999998654 4679999
Q ss_pred eccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC
Q 047292 512 EFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 512 e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 590 (728)
||+.+ +|.+++... ..+++..+..++.||++||+|||+. +++||||||+||++++++.+||+|||++.......
T Consensus 88 e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~- 162 (309)
T cd07845 88 EYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA- 162 (309)
T ss_pred ecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCcc-
Confidence 99975 888888754 5688999999999999999999997 99999999999999999999999999998764332
Q ss_pred cccccccCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHH-------HhhhcCccc
Q 047292 591 RTHTMIRGTRGYVAPEWLKN-APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAY-------DCYVEGRLD 662 (728)
Q Consensus 591 ~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~~~ 662 (728)
.......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...........+..... ..+......
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (309)
T cd07845 163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLV 242 (309)
T ss_pred CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccc
Confidence 12222335778999999875 4678999999999999999999999976544333222211100 000000000
Q ss_pred eec--c-chhh--hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 663 ALI--D-SDEA--AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 663 ~~~--d-~~~~--~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
..+ . .... ..........+.+++.+||+.||++|||++++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 243 GKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred ccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 0 0000 00001124556789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=294.76 Aligned_cols=267 Identities=22% Similarity=0.281 Sum_probs=199.0
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeeecC-----Cccee
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEA-----LNRLL 509 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~l 509 (728)
...+.||+|+||.||++... .+++.||||.+... .......+.+|+.+++.++|+||+++++++... ...++
T Consensus 8 ~~~~~lg~G~~~~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l 86 (337)
T cd07858 8 VPIKPIGRGAYGIVCSAKNS-ETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYI 86 (337)
T ss_pred eEEEEeccCCCeEEEEEEec-CCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEE
Confidence 34568999999999999875 57889999998653 223345678899999999999999999987644 34799
Q ss_pred EeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCC
Q 047292 510 VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH 589 (728)
Q Consensus 510 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 589 (728)
|+||+. ++|.+++.....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++......
T Consensus 87 v~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 162 (337)
T cd07858 87 VYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG 162 (337)
T ss_pred EEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence 999996 68999998878899999999999999999999997 99999999999999999999999999998664332
Q ss_pred CcccccccCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHH-------HHhhhcCcc
Q 047292 590 SRTHTMIRGTRGYVAPEWLKN-APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWA-------YDCYVEGRL 661 (728)
Q Consensus 590 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~~ 661 (728)
.......++..|+|||.+.. ..++.++||||||+++|||++|+.||...........+.... .........
T Consensus 163 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07858 163 -DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA 241 (337)
T ss_pred -ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhh
Confidence 12223457889999998865 468999999999999999999999997543222111111100 000000000
Q ss_pred -------ceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcCc
Q 047292 662 -------DALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM--LEGLL 710 (728)
Q Consensus 662 -------~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~--L~~~~ 710 (728)
....+.... .........+.+++.+||+.+|++||+++++++. ++.+.
T Consensus 242 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 242 RRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred hHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 000000000 0111234567899999999999999999999976 55543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=287.97 Aligned_cols=256 Identities=22% Similarity=0.260 Sum_probs=199.5
Q ss_pred hHHhhhCCCceeEEEEeeee--CCCCcEEEEEEecccc----hhhHHHHHHHHHHhccc-cccceeeEeeeeecCCccee
Q 047292 437 GFKEELGRGSFGIVYKGVLK--TASGNAIAVKKLDRLA----QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLL 509 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~--~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 509 (728)
.+.+.||+|+||.||++... ..+++.||||.++... ......+.+|+.++.++ +|+||+++++.+......++
T Consensus 3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~l 82 (288)
T cd05583 3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHL 82 (288)
T ss_pred eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEE
Confidence 34578999999999998754 2356789999986432 12335688999999999 69999999999999999999
Q ss_pred EeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCC
Q 047292 510 VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH 589 (728)
Q Consensus 510 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 589 (728)
||||+++++|.+++.....+++..+..++.|+++||.|||+. +++|+||+|+||+++.++.++|+|||+++......
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (288)
T cd05583 83 ILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE 159 (288)
T ss_pred EEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence 999999999999998777788999999999999999999987 99999999999999999999999999988764443
Q ss_pred CcccccccCCccccCcccccCCC--CCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccc
Q 047292 590 SRTHTMIRGTRGYVAPEWLKNAP--VSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDS 667 (728)
Q Consensus 590 ~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 667 (728)
........++..|+|||.+.+.. .+.++||||||++++||++|..||...........+.. .. .... .
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~---~~-~~~~------~ 229 (288)
T cd05583 160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR---RI-LKSK------P 229 (288)
T ss_pred ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHH---HH-HccC------C
Confidence 32223345788999999987665 78899999999999999999999864322111111101 00 0000 0
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 047292 668 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGL 709 (728)
Q Consensus 668 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 709 (728)
.........+.+++.+||+.+|++|||+.++.+.|+..
T Consensus 230 ----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 230 ----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred ----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 01111224567899999999999999999988887653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=287.99 Aligned_cols=263 Identities=21% Similarity=0.264 Sum_probs=192.3
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHhccccccceeeEeeeeecCCc-------
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALN------- 506 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------- 506 (728)
+.+.++||+|+||.||++..+ .+++.||||.+.... ......+.+|++++++++||||+++++++.....
T Consensus 14 y~~~~~lg~g~~~~v~~~~~~-~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 92 (310)
T cd07865 14 YEKLAKIGQGTFGEVFKARHK-KTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG 92 (310)
T ss_pred eEEEEEeecCCCEEEEEEEEC-CCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence 445678999999999999876 468899999885432 2223456789999999999999999999866543
Q ss_pred -ceeEeeccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccc
Q 047292 507 -RLLVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKL 584 (728)
Q Consensus 507 -~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~ 584 (728)
.++||||+++ +|.+.+... ..+++..+..++.||++||.|||++ +++|+||||+||++++++.+||+|||++..
T Consensus 93 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 93 SFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARA 168 (310)
T ss_pred eEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence 4999999975 788877655 3688999999999999999999997 999999999999999999999999999987
Q ss_pred cccCCCc---ccccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCc
Q 047292 585 LLSDHSR---THTMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGR 660 (728)
Q Consensus 585 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (728)
....... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||...........+.... .......
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 247 (310)
T cd07865 169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLC-GSITPEV 247 (310)
T ss_pred ccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh-CCCChhh
Confidence 6433221 11233467889999988765 46889999999999999999999987654433222211110 0000000
Q ss_pred ccee-----------ccc---hhhhh-hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 661 LDAL-----------IDS---DEAAM-ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 661 ~~~~-----------~d~---~~~~~-~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
.... ... ..... ........+.+++.+||+.||.+|||++++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0000 000 00000 00011245678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=285.83 Aligned_cols=260 Identities=25% Similarity=0.287 Sum_probs=198.7
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch--hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccC
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
..+.||+|++|.||++... .+++.+++|++..... .....+..|+.++++++|+||+++++++......++|+||++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (283)
T cd05118 3 KLGKIGEGTYGVVYKARDK-LTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD 81 (283)
T ss_pred cceeeecCCCceEEEEEcC-CCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC
Confidence 4567999999999999875 5688999999865432 245678899999999999999999999999999999999997
Q ss_pred CCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccc
Q 047292 516 NGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHT 594 (728)
Q Consensus 516 ~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 594 (728)
+ +|.+++... ..+++..+..++.|+++||.|||++ +|+|+||+|+||++++++.+||+|||.+....... ....
T Consensus 82 ~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~ 156 (283)
T cd05118 82 T-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYT 156 (283)
T ss_pred C-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cccc
Confidence 5 888887764 5789999999999999999999997 99999999999999999999999999998765443 1222
Q ss_pred cccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceecc-------
Q 047292 595 MIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALID------- 666 (728)
Q Consensus 595 ~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d------- 666 (728)
...++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+....+..... ...........+
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLG-TPDPEVWPKFTSLARNYKF 235 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC-CCchHhcccchhhhhhhhh
Confidence 34577889999999877 789999999999999999999999865443222111110000 000000000000
Q ss_pred ------chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 667 ------SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 667 ------~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
..............+.+++.+||+.||.+||++++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00001112234567889999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=287.06 Aligned_cols=261 Identities=22% Similarity=0.229 Sum_probs=191.1
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch--hhHHHHHHHHHHhccc-cccceeeEeeeeecCCc-----ce
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ--EREREFKSEVSAIGRT-HHKNLVQLLGFCDEALN-----RL 508 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~-----~~ 508 (728)
...+.||+|+||.||+|... .+++.||+|+++.... .....+.+|+.+++.+ +|+||+++++++..... .+
T Consensus 4 ~~~~~lg~g~~g~vy~~~~~-~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~ 82 (295)
T cd07837 4 EKLEKIGEGTYGKVYKARDK-NTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY 82 (295)
T ss_pred eEeeEecccCCeEEEEEEEC-CCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence 34578999999999999876 5688999998865322 2235788899999999 56999999999877665 79
Q ss_pred eEeeccCCCCHHHHHhcC-----CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcC-CCceEEccccCc
Q 047292 509 LVYEFMGNGTLANLIFAI-----PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDH-YFSPKISDFGLS 582 (728)
Q Consensus 509 lv~e~~~~gsL~~~l~~~-----~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~-~~~~kl~Dfgla 582 (728)
+||||+++ +|.+++... ..+++..++.++.||++||.|||+. +|+||||||+||+++. ++.+||+|||++
T Consensus 83 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 83 LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred EEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecccc
Confidence 99999986 888887643 3468899999999999999999997 9999999999999998 899999999998
Q ss_pred cccccCCCcccccccCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCcc
Q 047292 583 KLLLSDHSRTHTMIRGTRGYVAPEWLKN-APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRL 661 (728)
Q Consensus 583 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (728)
+........ .....+++.|+|||++.+ ..++.++||||||+++|||++|..||...........+...... ......
T Consensus 159 ~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 236 (295)
T cd07837 159 RAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGT-PTEQVW 236 (295)
T ss_pred eecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCC-CChhhC
Confidence 865332211 122246788999998865 45799999999999999999999998754433221111110000 000000
Q ss_pred cee---c--------cchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 662 DAL---I--------DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 662 ~~~---~--------d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
... . .+.......+.....+.+++.+||+.+|.+||++++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000 0 000000011123456788999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=294.50 Aligned_cols=269 Identities=23% Similarity=0.301 Sum_probs=204.8
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHhccccccceeeEeeeeecCC-----ccee
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEAL-----NRLL 509 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~l 509 (728)
.+.+.||+|+||.||++... .+++.|++|++.... ....+.+.+|+.+++.++|+||+++++++.... ..++
T Consensus 3 ~i~~~ig~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 3 ELLKPIGSGAYGVVCSAVDK-RTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred eeeeeecCCCCeEEEEEEeC-CCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 45678999999999999875 457899999987643 334578999999999999999999999987775 7899
Q ss_pred EeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCC
Q 047292 510 VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH 589 (728)
Q Consensus 510 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 589 (728)
+|||++ ++|.+++.....+++..++.++.||+.||+|||+. +|+|+||||+||++++++.++|+|||++.......
T Consensus 82 v~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 82 VTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157 (330)
T ss_pred Eecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeecccc
Confidence 999998 48999998877899999999999999999999997 99999999999999999999999999998765432
Q ss_pred C--cccccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHH-------hhhcC
Q 047292 590 S--RTHTMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYD-------CYVEG 659 (728)
Q Consensus 590 ~--~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~-------~~~~~ 659 (728)
. .......++..|+|||.+.+. .++.++||||||+++++|++|+.||...........+...... .....
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 237 (330)
T cd07834 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSE 237 (330)
T ss_pred cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcccc
Confidence 1 112334578899999999888 8899999999999999999999999765543322221111000 00000
Q ss_pred ccceecc------chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcCc
Q 047292 660 RLDALID------SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM--LEGLL 710 (728)
Q Consensus 660 ~~~~~~d------~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~--L~~~~ 710 (728)
.....+. ........+.....+.+++.+||+.+|.+||+++++++. +++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 238 KARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred chhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 0000000 000000111234567889999999999999999999974 55544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=294.89 Aligned_cols=246 Identities=23% Similarity=0.322 Sum_probs=204.3
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch--hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
+.+...||+|.|+.|.++.+. .++..||||.+++..- ...+.+.+|+++|..++|||||+++.+......+|+||||
T Consensus 58 y~i~~tig~g~f~~V~La~~~-~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ey 136 (596)
T KOG0586|consen 58 YVIIKTIGKGNFAKVKLARHI-LTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEY 136 (596)
T ss_pred eeeeeeeccceeEEEEeeEec-CCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEe
Confidence 445678999999999999987 5689999999976432 2335589999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccc
Q 047292 514 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH 593 (728)
Q Consensus 514 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 593 (728)
+.+|.+++++.++....+.....++.|+..|++|||++ .|+|||||++||||+.+.++||+|||++..+. .....
T Consensus 137 a~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--~~~~l 211 (596)
T KOG0586|consen 137 ASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD--YGLML 211 (596)
T ss_pred ccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec--ccccc
Confidence 99999999999998888889999999999999999998 99999999999999999999999999998875 33445
Q ss_pred ccccCCccccCcccccCCCC-CCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhh
Q 047292 594 TMIRGTRGYVAPEWLKNAPV-SAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAM 672 (728)
Q Consensus 594 ~~~~gt~~y~aPE~~~~~~~-s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 672 (728)
...+|++.|.|||++.+.+| .+++|+||+|++||-|+.|..||+.....+.+... ..++ ..
T Consensus 212 qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv--------l~gk----------~r 273 (596)
T KOG0586|consen 212 QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV--------LRGK----------YR 273 (596)
T ss_pred cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchh--------eeee----------ec
Confidence 66789999999999999987 67999999999999999999999855332221110 0000 00
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 673 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 673 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
++.-....+-++++++|-.+|.+|+++++|.+.
T Consensus 274 Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 274 IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 111122345578899999999999999998753
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=284.22 Aligned_cols=261 Identities=26% Similarity=0.348 Sum_probs=195.9
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch-hhHHHHHHHHHHhcccc-ccceeeEeeeeecCCcceeEeecc
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ-EREREFKSEVSAIGRTH-HKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
.+.+.||+|+||.||+|+.. .+++.|+||++..... .......+|+..+++++ |+||+++++++......++||||+
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNK-ETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred eeheeeccCCceEEEEEEEC-CCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 35678999999999999975 4578999999865332 22344567999999998 999999999999999999999999
Q ss_pred CCCCHHHHHhcCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 515 GNGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 515 ~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
+++|.+++.... .+++..+..++.|++.+|.|||++ +++|+||+|+||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-- 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence 889999887764 789999999999999999999997 999999999999999999999999999986543222
Q ss_pred cccccCCccccCccccc-CCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHH---------HHHHhhhcCccc
Q 047292 593 HTMIRGTRGYVAPEWLK-NAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTD---------WAYDCYVEGRLD 662 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~-~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~---------~~~~~~~~~~~~ 662 (728)
.....++..|+|||.+. ...++.++|+||||++++||++|+.||.............. |...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 22345788999999885 44679999999999999999999998865433222111110 000000000111
Q ss_pred eecc----chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 663 ALID----SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 663 ~~~d----~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
..+. ....... ......+.+++.+||+.+|++||+++|++..
T Consensus 235 ~~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 235 FRFPQFAPTSLHQLI-PNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccHHHHc-ccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0100 0011111 1114568899999999999999999999753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=282.00 Aligned_cols=242 Identities=23% Similarity=0.234 Sum_probs=187.1
Q ss_pred hhCCCceeEEEEeeeeCCCCcEEEEEEecccch---hhHHHHHHHHH---HhccccccceeeEeeeeecCCcceeEeecc
Q 047292 441 ELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ---EREREFKSEVS---AIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 441 ~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~---~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
.||+|+||.||++... .+++.||+|.+..... .....+..|.. .++..+|+||+++++.+......++|+||+
T Consensus 1 ~ig~g~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (278)
T cd05606 1 IIGRGGFGEVYGCRKA-DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM 79 (278)
T ss_pred CcccCCCeEEEEEEEe-cCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecC
Confidence 3899999999999865 5678999998864321 11223344443 344457999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccc
Q 047292 515 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHT 594 (728)
Q Consensus 515 ~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 594 (728)
++++|.+++.....+++..+..++.|+++||.|||+. +|+||||||+||++++++.+||+|||++........ .
T Consensus 80 ~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~---~ 153 (278)
T cd05606 80 NGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---H 153 (278)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC---c
Confidence 9999999998877899999999999999999999997 999999999999999999999999999876533221 2
Q ss_pred cccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhh
Q 047292 595 MIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMA 673 (728)
Q Consensus 595 ~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 673 (728)
...|+..|+|||.+.+. .++.++||||||+++|||++|+.||............ ...... .. ..
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~-----~~~~~~------~~----~~ 218 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-----RMTLTM------AV----EL 218 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH-----HHhhcc------CC----CC
Confidence 34589999999999754 6899999999999999999999999754221111000 000000 00 01
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047292 674 DRSRLHKWLMIAMWCIQEDPSKRP-----TMKVVMQ 704 (728)
Q Consensus 674 ~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~ 704 (728)
.......+.+++.+|++.+|.+|| ++.++++
T Consensus 219 ~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 219 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 111235677899999999999999 9999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=269.73 Aligned_cols=261 Identities=27% Similarity=0.356 Sum_probs=201.0
Q ss_pred ccccCHHHHHHHHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch-hhHHHHHHHHHHhccc-cccceeeEeee
Q 047292 423 LRFFSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ-EREREFKSEVSAIGRT-HHKNLVQLLGF 500 (728)
Q Consensus 423 ~~~~~~~el~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~ 500 (728)
+-.|+-+.|++ ..+||.|+||+|+|-.++ ..|+.+|||+++.... ...++++.|.+...+- +.||||+++|.
T Consensus 58 ~~~F~~~~Lqd-----lg~iG~G~fG~V~KM~hk-~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa 131 (361)
T KOG1006|consen 58 LHTFTSDNLQD-----LGEIGNGAFGTVNKMLHK-PSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGA 131 (361)
T ss_pred ccccccchHHH-----HHHhcCCcchhhhhhhcC-ccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhh
Confidence 34455555544 357999999999998887 6889999999976444 5567888888877665 79999999999
Q ss_pred eecCCcceeEeeccCCCCHHHHHh---c--CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceE
Q 047292 501 CDEALNRLLVYEFMGNGTLANLIF---A--IPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPK 575 (728)
Q Consensus 501 ~~~~~~~~lv~e~~~~gsL~~~l~---~--~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~k 575 (728)
+...+..|+.||.|. -+|+.+-. . ...+++..+-+|....++||.||.+. +.|||||+||+|||++..|.+|
T Consensus 132 ~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vK 208 (361)
T KOG1006|consen 132 LFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVK 208 (361)
T ss_pred hhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEe
Confidence 999999999999995 35554432 2 25678888888999999999999986 6899999999999999999999
Q ss_pred EccccCccccccCCCcccccccCCccccCccccc--CCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHH
Q 047292 576 ISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLK--NAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAY 653 (728)
Q Consensus 576 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 653 (728)
|+|||++..+.....+ +.-.|-..|||||.+. +..|+.++||||||++|+|+.||+.|+..-... ... .
T Consensus 209 LCDFGIcGqLv~SiAk--T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv--feq-----l 279 (361)
T KOG1006|consen 209 LCDFGICGQLVDSIAK--TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV--FEQ-----L 279 (361)
T ss_pred eecccchHhHHHHHHh--hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH--HHH-----H
Confidence 9999999877544333 3335888999999995 346899999999999999999999998744321 111 1
Q ss_pred HhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 654 DCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 654 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.....+....+..... ..+....+.+++-.|+-.|...||...++.++
T Consensus 280 ~~Vv~gdpp~l~~~~~----~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 280 CQVVIGDPPILLFDKE----CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HHHHcCCCCeecCccc----ccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 2233444444333211 23355678889999999999999999988754
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=286.33 Aligned_cols=251 Identities=24% Similarity=0.254 Sum_probs=195.6
Q ss_pred hHHhhhCCCceeEEEEeeeeC--CCCcEEEEEEecccch----hhHHHHHHHHHHhccc-cccceeeEeeeeecCCccee
Q 047292 437 GFKEELGRGSFGIVYKGVLKT--ASGNAIAVKKLDRLAQ----EREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLL 509 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~--~~~~~vavK~l~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 509 (728)
.+.+.||+|+||.||++.... .+|+.||+|.+..... ...+.+.+|+.++.++ +|+||+++++.+......++
T Consensus 3 ~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (290)
T cd05613 3 ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHL 82 (290)
T ss_pred eeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEE
Confidence 345789999999999987642 3678999999865322 2346788899999999 69999999999999999999
Q ss_pred EeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCC
Q 047292 510 VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH 589 (728)
Q Consensus 510 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 589 (728)
|+||+++++|.+++.....+++..+..++.|+++||.|||+. +++||||+|+|||+++++.+||+|||++.......
T Consensus 83 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 159 (290)
T cd05613 83 ILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE 159 (290)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence 999999999999998888888999999999999999999997 99999999999999999999999999998764433
Q ss_pred CcccccccCCccccCcccccCC--CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccc
Q 047292 590 SRTHTMIRGTRGYVAPEWLKNA--PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDS 667 (728)
Q Consensus 590 ~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 667 (728)
........|+..|+|||.+... .++.++||||||+++|||++|+.|+...........+.. .......
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~---~~~~~~~------- 229 (290)
T cd05613 160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR---RILKSEP------- 229 (290)
T ss_pred ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHH---HhhccCC-------
Confidence 3333345588899999998753 467899999999999999999999864322211111111 1000000
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047292 668 DEAAMADRSRLHKWLMIAMWCIQEDPSKRP-----TMKVVMQ 704 (728)
Q Consensus 668 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~ 704 (728)
..+......+.+++.+||+.+|++|| ++++++.
T Consensus 230 ----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 230 ----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 01111234567899999999999997 6666655
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=269.46 Aligned_cols=200 Identities=25% Similarity=0.339 Sum_probs=166.1
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCC---cEEEEEEecccchh--hHHHHHHHHHHhccccccceeeEeeeeec-CCccee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASG---NAIAVKKLDRLAQE--REREFKSEVSAIGRTHHKNLVQLLGFCDE-ALNRLL 509 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~---~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~l 509 (728)
++...+||+|+||.||+++-+..++ ..+|+|+++..... -.....+|+..++.++|+||+.+..++.. +...+|
T Consensus 26 ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l 105 (438)
T KOG0666|consen 26 YEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWL 105 (438)
T ss_pred hhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEE
Confidence 4455679999999999997654333 27899999764322 23567889999999999999999999876 788899
Q ss_pred EeeccCCCCHHHHHhcC-----CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCC----CceEEcccc
Q 047292 510 VYEFMGNGTLANLIFAI-----PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHY----FSPKISDFG 580 (728)
Q Consensus 510 v~e~~~~gsL~~~l~~~-----~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~----~~~kl~Dfg 580 (728)
++||.+. +|...|+.+ ..++...+..|+.||+.|+.|||++ -|+||||||.|||+..+ |.+||+|||
T Consensus 106 ~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 106 LFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred Eehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeeccc
Confidence 9999976 788887643 3567788899999999999999998 89999999999999876 999999999
Q ss_pred CccccccCCCc--ccccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchh
Q 047292 581 LSKLLLSDHSR--THTMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEME 639 (728)
Q Consensus 581 la~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~ 639 (728)
+++.+.+.-.. ....+.-|.-|.|||.+.+. .||++.|||+.|||+.||+|..+.|...
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 99998765432 33456679999999999876 6899999999999999999988776543
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=320.40 Aligned_cols=246 Identities=26% Similarity=0.347 Sum_probs=200.4
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCCC
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNG 517 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 517 (728)
..||.|.||.||-++.. .+|+..|+|.+.... ......+.+|+.++..++|||+|+++|+-.+.+..+|.||||.+|
T Consensus 1241 ~~Ig~G~fG~VYtavN~-~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNL-DTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred cccCCcceeeeEEeecC-CccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence 46999999999999865 688999999875432 233467889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC---cccc
Q 047292 518 TLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS---RTHT 594 (728)
Q Consensus 518 sL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~---~~~~ 594 (728)
+|.+.+......++.....+..|++.|++|||++ +||||||||.||+|+.+|.+|++|||.|..+..... ....
T Consensus 1320 sLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~ 1396 (1509)
T KOG4645|consen 1320 SLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQ 1396 (1509)
T ss_pred cHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHH
Confidence 9999999888888888888999999999999998 999999999999999999999999999998866532 1223
Q ss_pred cccCCccccCcccccCC---CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhh
Q 047292 595 MIRGTRGYVAPEWLKNA---PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAA 671 (728)
Q Consensus 595 ~~~gt~~y~aPE~~~~~---~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 671 (728)
...||+.|||||++.+. ...-+.|||||||++.||+||++||.....+ ..+ ..++..++.+++..
T Consensus 1397 ~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne---~aI----My~V~~gh~Pq~P~----- 1464 (1509)
T KOG4645|consen 1397 SMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE---WAI----MYHVAAGHKPQIPE----- 1464 (1509)
T ss_pred hhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch---hHH----HhHHhccCCCCCch-----
Confidence 46799999999999654 3566899999999999999999999743221 111 12233444433332
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 672 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 672 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
....+-.+++..||+.||++|-++.|+++.
T Consensus 1465 ----~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1465 ----RLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ----hhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 233455679999999999999888877654
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-32 Score=285.37 Aligned_cols=248 Identities=25% Similarity=0.305 Sum_probs=194.6
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeE
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 510 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 510 (728)
.++...+.||+|+||.||+|+.. .+++.+++|.+... .......+.+|+++++.++|+|++++++++......++|
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDV-RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEc-CCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 33455678999999999999876 46789999988532 223346788999999999999999999999999999999
Q ss_pred eeccCCCCHHHHHhc-CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCC
Q 047292 511 YEFMGNGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH 589 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 589 (728)
+||+. |+|.+.+.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++......
T Consensus 94 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 94 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred EEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 99997 578777654 35678899999999999999999987 9999999999999999999999999998765322
Q ss_pred CcccccccCCccccCccccc---CCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceecc
Q 047292 590 SRTHTMIRGTRGYVAPEWLK---NAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALID 666 (728)
Q Consensus 590 ~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 666 (728)
....+++.|+|||.+. ...++.++||||||+++|||++|+.|+........... ...+.....
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~--------~~~~~~~~~-- 234 (308)
T cd06634 169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH--------IAQNESPAL-- 234 (308)
T ss_pred ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHH--------HhhcCCCCc--
Confidence 2234788999999974 34678899999999999999999999865432211110 011111100
Q ss_pred chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047292 667 SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLE 707 (728)
Q Consensus 667 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~ 707 (728)
........+.+++.+||+.+|.+||+++++++..-
T Consensus 235 ------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 235 ------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred ------CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 01123345778999999999999999999997643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=279.77 Aligned_cols=247 Identities=27% Similarity=0.386 Sum_probs=201.8
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch--hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
.+.+.||+|+||.||++... .++..+++|++..... .....+.+|+++++.++|+|++++++.+......++|+||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd08215 3 EIIKQIGKGSFGKVYLVRRK-SDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA 81 (258)
T ss_pred eEEeeeccCCCeEEEEEEEc-CCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence 34567999999999999876 4678999999865432 45578899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC----CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC
Q 047292 515 GNGTLANLIFAI----PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 515 ~~gsL~~~l~~~----~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 590 (728)
++++|.+++... ..+++..+..++.+++.||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 157 (258)
T cd08215 82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV- 157 (258)
T ss_pred CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc-
Confidence 999999999864 6788999999999999999999997 99999999999999999999999999998764433
Q ss_pred cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhh
Q 047292 591 RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEA 670 (728)
Q Consensus 591 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 670 (728)
.......+++.|+|||.+.+..++.++||||||+++++|++|+.|+........... ........+
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~--------~~~~~~~~~------ 223 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALK--------ILKGQYPPI------ 223 (258)
T ss_pred ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHH--------HhcCCCCCC------
Confidence 122334578899999999999999999999999999999999999875543221111 111111111
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 671 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 671 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
+......+.+++.+||+.+|++||+++++++.
T Consensus 224 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 224 ---PSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ---CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11223467789999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=293.44 Aligned_cols=265 Identities=22% Similarity=0.296 Sum_probs=197.2
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHhccccccceeeEeeeeec----CCccee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDE----ALNRLL 509 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~l 509 (728)
+.+.+.||+|+||.||+|..+ .+++.|++|++.... ......+.+|+.++++++|+||+++++++.. ....++
T Consensus 7 y~~~~~lg~g~~g~v~~~~~~-~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 85 (334)
T cd07855 7 YKPIENIGSGAYGVVCSAIDT-RSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYV 85 (334)
T ss_pred eeeeeeeecCCCeEEEEEEEc-CCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEE
Confidence 345578999999999999876 568899999986532 2334677889999999999999999998753 346799
Q ss_pred EeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCC
Q 047292 510 VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH 589 (728)
Q Consensus 510 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 589 (728)
|+||+. ++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 86 v~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 86 VMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161 (334)
T ss_pred EEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence 999996 68999998777899999999999999999999997 99999999999999999999999999997664332
Q ss_pred Cc---ccccccCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHH-------HHHhhhc
Q 047292 590 SR---THTMIRGTRGYVAPEWLKN-APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDW-------AYDCYVE 658 (728)
Q Consensus 590 ~~---~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~-------~~~~~~~ 658 (728)
.. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+... .......
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~ 241 (334)
T cd07855 162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS 241 (334)
T ss_pred cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhch
Confidence 21 1123468889999999865 46899999999999999999999999654332211111000 0000000
Q ss_pred Cccceecc---ch---hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 659 GRLDALID---SD---EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 659 ~~~~~~~d---~~---~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
..+....+ .. ......+.....+.+++.+||+.+|.+||+++++++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000000 00 0001112235678899999999999999999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=271.46 Aligned_cols=239 Identities=26% Similarity=0.282 Sum_probs=199.1
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
..|.+.||+|.||.|.+.+.+ .+++.+|+|++++.. .+....-..|-++|+..+||.+..+--.++..+.+++|||
T Consensus 170 FdfLKvLGkGTFGKVIL~rEK-at~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMe 248 (516)
T KOG0690|consen 170 FDFLKVLGKGTFGKVILCREK-ATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVME 248 (516)
T ss_pred hhHHHHhcCCccceEEEEeec-ccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEE
Confidence 346789999999999999877 688999999997632 3334667789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 513 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 513 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
|..||.|.-+|.+...+++....-+-..|+.||.|||++ +||.||||.+|.|+|.+|++||+|||+++.--.. ...
T Consensus 249 yanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~-g~t 324 (516)
T KOG0690|consen 249 YANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY-GDT 324 (516)
T ss_pred EccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcccc-cce
Confidence 999999999999888899888888999999999999997 9999999999999999999999999999864332 334
Q ss_pred cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAM 672 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 672 (728)
....+|||.|+|||++....|....|.|.+||++|||++|+.||....-+....++.. .+ ..
T Consensus 325 ~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~------ed------------~k 386 (516)
T KOG0690|consen 325 TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM------ED------------LK 386 (516)
T ss_pred eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh------hh------------cc
Confidence 5668899999999999999999999999999999999999999986544443333321 11 11
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCC
Q 047292 673 ADRSRLHKWLMIAMWCIQEDPSKRP 697 (728)
Q Consensus 673 ~~~~~~~~l~~l~~~cl~~dp~~RP 697 (728)
+++....+...++...|..||++|.
T Consensus 387 FPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 387 FPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred CCccCCHHHHHHHHHHhhcChHhhc
Confidence 2223334555677778999999994
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=282.89 Aligned_cols=260 Identities=25% Similarity=0.284 Sum_probs=193.3
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch--hhHHHHHHHHHHhccc---cccceeeEeeeeecCCc-----c
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ--EREREFKSEVSAIGRT---HHKNLVQLLGFCDEALN-----R 507 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~~~-----~ 507 (728)
+.+.||+|+||.||+|+.+ .+++.||+|+++.... .....+.+|+.+++++ +|+|++++++++..... .
T Consensus 3 ~~~~l~~g~~~~v~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 81 (287)
T cd07838 3 ELAEIGEGAYGTVYKARDL-NTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL 81 (287)
T ss_pred EEEEecccCceEEEEEEEC-CCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence 4567999999999999986 3678999999964322 2234566777776655 69999999999987776 8
Q ss_pred eeEeeccCCCCHHHHHhcCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcccc
Q 047292 508 LLVYEFMGNGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLL 585 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~ 585 (728)
+++|||+++ +|.+++.... .+++..+..++.|+++||.|||+. +++|+||+|+||++++++.+||+|||++...
T Consensus 82 ~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 82 TLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred EEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcceec
Confidence 999999974 8988887643 588999999999999999999997 9999999999999999999999999999776
Q ss_pred ccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHH----hhhcCcc
Q 047292 586 LSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYD----CYVEGRL 661 (728)
Q Consensus 586 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~ 661 (728)
..... .....++..|+|||.+.+..++.++||||||+++|||++|+.||......+....+...... .+.....
T Consensus 158 ~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07838 158 SFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS 235 (287)
T ss_pred cCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence 43321 12234688899999999999999999999999999999999998765543322211110000 0000000
Q ss_pred --ceeccc---hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 662 --DALIDS---DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 662 --~~~~d~---~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
...+.. .............+.+++.+||+.||.+||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000000 0001111233466778999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-32 Score=278.27 Aligned_cols=235 Identities=20% Similarity=0.224 Sum_probs=183.6
Q ss_pred hCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccc-cccceeeEeeeeecCCcceeEeeccCCCCHH
Q 047292 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYEFMGNGTLA 520 (728)
Q Consensus 442 lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 520 (728)
||+|+||.||++..+ .+++.+++|.+....... .|+.....+ +|+||+++++.+...+..++||||+++++|.
T Consensus 24 lg~g~~g~v~~~~~~-~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~ 97 (267)
T PHA03390 24 LIDGKFGKVSVLKHK-PTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLF 97 (267)
T ss_pred ecCCCceEEEEEEEc-CCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHH
Confidence 599999999999876 567889999986432111 122222222 7999999999999999999999999999999
Q ss_pred HHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCC-ceEEccccCccccccCCCcccccccCC
Q 047292 521 NLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYF-SPKISDFGLSKLLLSDHSRTHTMIRGT 599 (728)
Q Consensus 521 ~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~~~~~~~~~~~gt 599 (728)
+++.....+++..+..++.|+++||.|||+. +++||||||+||+++.++ .++|+|||+++..... ....++
T Consensus 98 ~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-----~~~~~~ 169 (267)
T PHA03390 98 DLLKKEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-----SCYDGT 169 (267)
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-----ccCCCC
Confidence 9998877899999999999999999999997 899999999999999988 9999999998765322 123578
Q ss_pred ccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHHHHH
Q 047292 600 RGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLH 679 (728)
Q Consensus 600 ~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 679 (728)
..|+|||++.+..++.++||||||++++||++|+.||.....+... ...+.... ... .. .......
T Consensus 170 ~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~--~~~-~~---------~~~~~~~ 235 (267)
T PHA03390 170 LDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELD--LESLLKRQ--QKK-LP---------FIKNVSK 235 (267)
T ss_pred CcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhh--HHHHHHhh--ccc-CC---------cccccCH
Confidence 8999999999999999999999999999999999999744332211 11111110 000 00 1112345
Q ss_pred HHHHHHHHhcccCCCCCCC-HHHHHH
Q 047292 680 KWLMIAMWCIQEDPSKRPT-MKVVMQ 704 (728)
Q Consensus 680 ~l~~l~~~cl~~dp~~RPt-~~evl~ 704 (728)
.+.+++.+||+.+|.+||+ ++++++
T Consensus 236 ~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 236 NANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHHHHHHhccChhhCCchHHHHhc
Confidence 6778999999999999995 688874
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=283.68 Aligned_cols=260 Identities=26% Similarity=0.301 Sum_probs=199.1
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccC
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
+.+.||+|.||.||+|+.. .+++.+++|.+.... ......+..|+.++++++|+|++++++++......++|+||++
T Consensus 3 ~~~~ig~g~~~~vy~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (282)
T cd07829 3 KLEKLGEGTYGVVYKARDK-KTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD 81 (282)
T ss_pred eehcccccCcceEEEeeec-CCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC
Confidence 3467999999999999876 468899999997643 2334678889999999999999999999999999999999998
Q ss_pred CCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccc
Q 047292 516 NGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHT 594 (728)
Q Consensus 516 ~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 594 (728)
++|.+++... ..+++..+..++.|+++||+|||++ +|+|+||+|+||++++++.+||+|||+++....... ...
T Consensus 82 -~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~ 156 (282)
T cd07829 82 -MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYT 156 (282)
T ss_pred -cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-ccC
Confidence 5899999876 5789999999999999999999997 999999999999999999999999999987643322 122
Q ss_pred cccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHH-------HHhh-----hcCcc
Q 047292 595 MIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWA-------YDCY-----VEGRL 661 (728)
Q Consensus 595 ~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~-----~~~~~ 661 (728)
...++..|+|||.+.+. .++.++||||||++++||++|+.||...........+.... +... .....
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07829 157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF 236 (282)
T ss_pred ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence 23457789999998776 88999999999999999999999987654332211111100 0000 00000
Q ss_pred ceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 662 DALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 662 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
...... ......+.....+.+++.+||+.+|++||++++++.
T Consensus 237 ~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 237 PKFPPK-DLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccCcc-chHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000000 000111112456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=285.53 Aligned_cols=247 Identities=26% Similarity=0.331 Sum_probs=200.8
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHhcccc-ccceeeEeeeeecCCcceeEe
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL---AQEREREFKSEVSAIGRTH-HKNLVQLLGFCDEALNRLLVY 511 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~ 511 (728)
+.+.+.||+|+||.||++... .+++.|++|++... .......+.+|++++++++ |+||+++++++......++||
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 3 FKFGKIIGEGSFSTVVLAKEK-ETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred ceEeeeecCCCceEEEEEEEc-CCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 345578999999999999876 46889999998652 2234567889999999998 999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC-
Q 047292 512 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS- 590 (728)
Q Consensus 512 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~- 590 (728)
|++++++|.+++.....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 82 EYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 9999999999999888899999999999999999999997 999999999999999999999999999886643321
Q ss_pred ------------------cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHH
Q 047292 591 ------------------RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWA 652 (728)
Q Consensus 591 ------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~ 652 (728)
.......++..|+|||.+....++.++||||||++++|+++|+.|+............
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~---- 234 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI---- 234 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH----
Confidence 1122345788999999999888999999999999999999999999865432211111
Q ss_pred HHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCH----HHHHH
Q 047292 653 YDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTM----KVVMQ 704 (728)
Q Consensus 653 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~----~evl~ 704 (728)
.... ..........+.+++.+||+.+|.+||++ +++++
T Consensus 235 ----~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 235 ----LKLE----------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred ----HhcC----------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0000 00111224567789999999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-32 Score=285.44 Aligned_cols=262 Identities=16% Similarity=0.153 Sum_probs=192.6
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccC
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
+.+.+|.|+++.||++.. +++.||||++... .......+..|++++++++|+||+++++++......+++|||++
T Consensus 6 i~~~~~~~~~v~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP---TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhHhhcCCceEEEEEecC---CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 345566666666666543 6889999998653 34455789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc--
Q 047292 516 NGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR-- 591 (728)
Q Consensus 516 ~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-- 591 (728)
+++|.+++... ..+++..+..++.|+++||+|||++ +|+|+||||+||+++.++.+||+|||.+.........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 99999999864 4578888999999999999999997 9999999999999999999999999988755322111
Q ss_pred ----ccccccCCccccCcccccC--CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhh-hhHHHHHH-------Hhhh
Q 047292 592 ----THTMIRGTRGYVAPEWLKN--APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESR-AILTDWAY-------DCYV 657 (728)
Q Consensus 592 ----~~~~~~gt~~y~aPE~~~~--~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~-~~~~~~~~-------~~~~ 657 (728)
......++..|+|||++.. ..++.++||||||++++||++|+.||......... ........ ....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhh
Confidence 1122346778999999876 35889999999999999999999999754322110 00000000 0000
Q ss_pred cCccce----eccc----hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 658 EGRLDA----LIDS----DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 658 ~~~~~~----~~d~----~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
...+.. ..+. .............+.+++.+||+.||++|||++++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000000 0000 01111222334567889999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=283.99 Aligned_cols=241 Identities=25% Similarity=0.336 Sum_probs=190.0
Q ss_pred HhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccC
Q 047292 439 KEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 439 ~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
.++||+|+||.||+|+.. .+++.|++|++.... ......+.+|+++++.++|+|++++++++.+....++||||+.
T Consensus 26 ~~~lg~g~~g~v~~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 104 (313)
T cd06633 26 LHEIGHGSFGAVYFATNS-HTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL 104 (313)
T ss_pred ceeeccCCCeEEEEEEEC-CCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC
Confidence 357999999999999875 567899999986422 2334578899999999999999999999999999999999996
Q ss_pred CCCHHHHHhc-CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccc
Q 047292 516 NGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHT 594 (728)
Q Consensus 516 ~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 594 (728)
++|.+++.. ...+++..+..++.||+.||.|||+. +++|+||+|+||++++++.+||+|||++..... ..
T Consensus 105 -~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----~~ 175 (313)
T cd06633 105 -GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----AN 175 (313)
T ss_pred -CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC-----CC
Confidence 577777754 35688999999999999999999987 999999999999999999999999999864321 12
Q ss_pred cccCCccccCccccc---CCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhh
Q 047292 595 MIRGTRGYVAPEWLK---NAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAA 671 (728)
Q Consensus 595 ~~~gt~~y~aPE~~~---~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 671 (728)
...|+..|+|||++. ...++.++||||||+++|||++|..|+............ .........
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~--------~~~~~~~~~------ 241 (313)
T cd06633 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--------AQNDSPTLQ------ 241 (313)
T ss_pred CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--------HhcCCCCCC------
Confidence 345788999999984 456888999999999999999999998654332211110 001111111
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 672 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 672 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.......+.+++.+||+.+|.+||++.++++.
T Consensus 242 --~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 242 --SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred --ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11122356789999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=265.36 Aligned_cols=265 Identities=24% Similarity=0.316 Sum_probs=203.6
Q ss_pred CHHHHHHHHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhcccc-ccceeeEeeeeecCC
Q 047292 427 SYDELKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTH-HKNLVQLLGFCDEAL 505 (728)
Q Consensus 427 ~~~el~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~ 505 (728)
++.++-+.| .+.||+|+|+.|--.+.- .++.++|||++.+........+.+|++++.+.+ |+||+.++++|++..
T Consensus 74 ~F~d~YkLt---~e~LGeGAyasVqtcv~i-~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 74 KFEDMYKLT---SELLGEGAYASVQTCVSI-QTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred hHHHHHHhH---HHHhcCccceeeeeeeee-ccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 345555544 367999999999877644 678999999998877777788999999999984 999999999999999
Q ss_pred cceeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCc---eEEccccCc
Q 047292 506 NRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFS---PKISDFGLS 582 (728)
Q Consensus 506 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~---~kl~Dfgla 582 (728)
..|||||-|.||+|..+|.++..+++....++.++|+.||.|||.+ +|.||||||+|||-.+... +||+||.+.
T Consensus 150 ~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLg 226 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLG 226 (463)
T ss_pred eEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccc
Confidence 9999999999999999999999999999999999999999999997 9999999999999975443 799999987
Q ss_pred cccccCC--C----cccccccCCccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCcCcchhhhHh-------h
Q 047292 583 KLLLSDH--S----RTHTMIRGTRGYVAPEWLK-----NAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEE-------S 644 (728)
Q Consensus 583 ~~~~~~~--~----~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~-------~ 644 (728)
.-+.-.. + ....+..|+..|||||+.. ...|+.++|.||||||||-||+|..||...-..+ .
T Consensus 227 Sg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~ 306 (463)
T KOG0607|consen 227 SGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEV 306 (463)
T ss_pred cccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCc
Confidence 6542221 1 1223356888999999773 3368999999999999999999999997643321 1
Q ss_pred hhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 645 RAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
-..-....+....+|.. ++.|+. -.....+..+++...+..++.+|.++.++++
T Consensus 307 Cr~CQ~~LFesIQEGkY-eFPdkd-----WahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 307 CRVCQNKLFESIQEGKY-EFPDKD-----WAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred cHHHHHHHHHHHhccCC-cCChhh-----hHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 11112222233333321 122210 1112334556888888899999999988876
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-32 Score=289.24 Aligned_cols=266 Identities=21% Similarity=0.279 Sum_probs=193.0
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHhccccccceeeEeeeeecCC------ccee
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEAL------NRLL 509 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~~l 509 (728)
..+.||+|+||.||+|+.. .+++.||+|++.... ......+.+|+.+++.++|+||+++++++.... ..++
T Consensus 19 ~~~~ig~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l 97 (342)
T cd07879 19 SLKQVGSGAYGSVCSAIDK-RTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYL 97 (342)
T ss_pred EEEEeeecCCeEEEEEEeC-CCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEE
Confidence 3467999999999999875 467899999986432 222456889999999999999999999986543 4589
Q ss_pred EeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCC
Q 047292 510 VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH 589 (728)
Q Consensus 510 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 589 (728)
|+||+.. +|..++. ..+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||+++.....
T Consensus 98 v~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~- 170 (342)
T cd07879 98 VMPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAE- 170 (342)
T ss_pred Eeccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC-
Confidence 9999864 7766653 3678899999999999999999997 9999999999999999999999999998764321
Q ss_pred CcccccccCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHH-------HHhhhcCc-
Q 047292 590 SRTHTMIRGTRGYVAPEWLKN-APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWA-------YDCYVEGR- 660 (728)
Q Consensus 590 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~- 660 (728)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.... ........
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (342)
T cd07879 171 ---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAA 247 (342)
T ss_pred ---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccch
Confidence 122356888999999876 468899999999999999999999997543322111110000 00000000
Q ss_pred ------cceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcCcCCCCC
Q 047292 661 ------LDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM--LEGLLEVPNP 715 (728)
Q Consensus 661 ------~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~--L~~~~~~~~~ 715 (728)
........... ..+.....+.+++.+||+.||.+||+++++++. ++...+.+..
T Consensus 248 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~ 309 (342)
T cd07879 248 KSYIKSLPKYPRKDFST-LFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEE 309 (342)
T ss_pred HHHHhhcCCcccchHHH-HhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccccc
Confidence 00000000000 001123457789999999999999999999954 7776654433
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-32 Score=286.12 Aligned_cols=263 Identities=24% Similarity=0.286 Sum_probs=191.4
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchh--hHHHHHHHHHHhccccccceeeEeeeeecCC--------
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQE--REREFKSEVSAIGRTHHKNLVQLLGFCDEAL-------- 505 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-------- 505 (728)
+.+.++||+|+||.||+|..+ .+++.+++|++...... ....+.+|++++++++|+||+++++++....
T Consensus 10 y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 88 (311)
T cd07866 10 YEILGKLGEGTFGEVYKARQI-KTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRG 88 (311)
T ss_pred EEEEEEeccCCCEEEEEEEEC-CCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCc
Confidence 445678999999999999876 46789999998543222 2346788999999999999999999874433
Q ss_pred cceeEeeccCCCCHHHHHhc-CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccc
Q 047292 506 NRLLVYEFMGNGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKL 584 (728)
Q Consensus 506 ~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~ 584 (728)
..++|+||+.+ +|...+.. ...+++..+..++.|+++||.|||+. +|+|+||||+||++++++.+||+|||+++.
T Consensus 89 ~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 89 SVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred eEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccchh
Confidence 45999999875 67776664 35789999999999999999999997 999999999999999999999999999986
Q ss_pred cccCCCc----------ccccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHH-
Q 047292 585 LLSDHSR----------THTMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWA- 652 (728)
Q Consensus 585 ~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~- 652 (728)
....... ......+++.|+|||.+.+. .++.++||||||+++|||++|+.||...........+....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~ 244 (311)
T cd07866 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG 244 (311)
T ss_pred ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 5432211 11234568889999988654 57899999999999999999999987554432222111100
Q ss_pred ------HHhhhc--C----ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 653 ------YDCYVE--G----RLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 653 ------~~~~~~--~----~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
+..+.. . ............ ........+.+++.+||+.+|.+|||+.+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 245 TPTEETWPGWRSLPGCEGVHSFTNYPRTLEE-RFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred CCChhhchhhhhcccccccccCCCCCccHHH-HcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 000000 0 000000000000 11122356789999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=305.65 Aligned_cols=253 Identities=22% Similarity=0.254 Sum_probs=209.6
Q ss_pred HHHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCccee
Q 047292 433 DATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLL 509 (728)
Q Consensus 433 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 509 (728)
...+.+.+.||+|+||.|..++++ .+++.+|+|++.+.. ......|.+|-.+|..-+.+-|++++-.|.+...+|+
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k-~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl 152 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHK-STEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL 152 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEee-ccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence 344567789999999999999987 578899999997732 3345678999999999999999999999999999999
Q ss_pred EeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCC
Q 047292 510 VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH 589 (728)
Q Consensus 510 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 589 (728)
|||||+||+|..++.+...+++....-++..|+-||.-||+ +|+|||||||+|||||..|++||+|||-+-.+..+.
T Consensus 153 VMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG 229 (1317)
T KOG0612|consen 153 VMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG 229 (1317)
T ss_pred EEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchhHHhcCCCC
Confidence 99999999999999998889999999999999999999998 599999999999999999999999999998887666
Q ss_pred CcccccccCCccccCccccc----C-CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCcccee
Q 047292 590 SRTHTMIRGTRGYVAPEWLK----N-APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDAL 664 (728)
Q Consensus 590 ~~~~~~~~gt~~y~aPE~~~----~-~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (728)
.-.....+|||.|++||++. + +.|+..+|.||+||++|||+.|..||..+.-.+.+..|+.... ...+
T Consensus 230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~-------~l~F 302 (1317)
T KOG0612|consen 230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKE-------SLSF 302 (1317)
T ss_pred cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhh-------hcCC
Confidence 66666678999999999995 3 5789999999999999999999999998877776666654311 1111
Q ss_pred ccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 047292 665 IDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPT---MKVVMQ 704 (728)
Q Consensus 665 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt---~~evl~ 704 (728)
.+ .....+...++|++.+. +|..|.. ++++-.
T Consensus 303 P~-------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 303 PD-------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred Cc-------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 11 11233455567776554 7888877 777654
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-32 Score=302.84 Aligned_cols=246 Identities=32% Similarity=0.439 Sum_probs=184.6
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeec---------------
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDE--------------- 503 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--------------- 503 (728)
+.||+||||.|||++-+ -+|+.+|||++.-.. ......+.+|+..|.+|+|||||+++..+.+
T Consensus 485 ~lLGkGGFG~VvkVRNK-lDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~ 563 (1351)
T KOG1035|consen 485 ELLGKGGFGSVVKVRNK-LDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDS 563 (1351)
T ss_pred HHhcCCCCceEEEEeec-ccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccch
Confidence 56999999999999877 578999999996543 3445778999999999999999999743200
Q ss_pred ---------------------------------------------------------------C----------------
Q 047292 504 ---------------------------------------------------------------A---------------- 504 (728)
Q Consensus 504 ---------------------------------------------------------------~---------------- 504 (728)
.
T Consensus 564 ~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d 643 (1351)
T KOG1035|consen 564 ESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILD 643 (1351)
T ss_pred hhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccC
Confidence 0
Q ss_pred -------------------------CcceeEeeccCCCCHHHHHhcCCCC-ChHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 047292 505 -------------------------LNRLLVYEFMGNGTLANLIFAIPKP-DWNLRVRISLEIARGLVYLHEGCNVPIIH 558 (728)
Q Consensus 505 -------------------------~~~~lv~e~~~~gsL~~~l~~~~~~-~~~~~~~i~~qi~~~l~yLH~~~~~~iiH 558 (728)
..+||-||||+.-+|.+++...... .....++++++|++||+|+|++ +|||
T Consensus 644 ~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~---giIH 720 (1351)
T KOG1035|consen 644 DTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ---GIIH 720 (1351)
T ss_pred cchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC---ceee
Confidence 1247888999887777777765433 4677899999999999999997 8999
Q ss_pred cCCCCCCEEEcCCCceEEccccCccccc-----------------cCCCcccccccCCccccCcccccCC---CCCCccc
Q 047292 559 CDIKPQNILLDHYFSPKISDFGLSKLLL-----------------SDHSRTHTMIRGTRGYVAPEWLKNA---PVSAKVD 618 (728)
Q Consensus 559 ~dlk~~NIll~~~~~~kl~Dfgla~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~~D 618 (728)
|||||.||+++++..+||+|||+|.... .......+...||.-|+|||++.+. .|+.|+|
T Consensus 721 RDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiD 800 (1351)
T KOG1035|consen 721 RDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKID 800 (1351)
T ss_pred ccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhh
Confidence 9999999999999999999999998721 0111123446799999999999765 4999999
Q ss_pred hhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCC
Q 047292 619 VYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPT 698 (728)
Q Consensus 619 VwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt 698 (728)
+|||||||+||+. ||...-+ ....+ ..+..+.++.- ..+...+...-.+++.|+++.||.+|||
T Consensus 801 mYSLGIVlFEM~y---PF~TsME--Ra~iL-----~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~kRPt 864 (1351)
T KOG1035|consen 801 MYSLGIVLFEMLY---PFGTSME--RASIL-----TNLRKGSIPEP------ADFFDPEHPEEASLIRWLLSHDPSKRPT 864 (1351)
T ss_pred hHHHHHHHHHHhc---cCCchHH--HHHHH-----HhcccCCCCCC------cccccccchHHHHHHHHHhcCCCccCCC
Confidence 9999999999984 3442211 11111 22223333222 1122333445567999999999999999
Q ss_pred HHHHHHH
Q 047292 699 MKVVMQM 705 (728)
Q Consensus 699 ~~evl~~ 705 (728)
+.|+++-
T Consensus 865 A~eLL~s 871 (1351)
T KOG1035|consen 865 ATELLNS 871 (1351)
T ss_pred HHHHhhc
Confidence 9999864
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=280.73 Aligned_cols=250 Identities=25% Similarity=0.400 Sum_probs=190.6
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHhccc-cccceeeEeeeeecCCcceeEeec
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
+.+.+.||+|+||.||+|..+ .+++.||||.++... ......+..|+.++.+. .|+||+++++++......+++|||
T Consensus 17 ~~~~~~lg~g~~~~v~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 95 (296)
T cd06618 17 LENLGEIGSGTCGQVYKMRFK-KTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMEL 95 (296)
T ss_pred heeeeEeeccCCeEEEEEEEC-CCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeec
Confidence 345678999999999999986 457899999996532 23345667787777666 599999999999999999999999
Q ss_pred cCCCCHHHHHhc-CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 514 MGNGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 514 ~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
+++ +|.+++.. ...+++..+..++.|+++||+|||+. .+|+||||+|+||++++++.+||+|||++.........
T Consensus 96 ~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~- 171 (296)
T cd06618 96 MST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK- 171 (296)
T ss_pred cCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcc-
Confidence 854 77776655 35678899999999999999999973 38999999999999999999999999998765432222
Q ss_pred cccccCCccccCcccccCCC----CCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccch
Q 047292 593 HTMIRGTRGYVAPEWLKNAP----VSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSD 668 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~----~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 668 (728)
....++..|+|||.+.+.. ++.++||||||+++|||++|+.||....... ..+.. ...........
T Consensus 172 -~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~-----~~~~~~~~~~~-- 241 (296)
T cd06618 172 -TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF--EVLTK-----ILQEEPPSLPP-- 241 (296)
T ss_pred -cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH--HHHHH-----HhcCCCCCCCC--
Confidence 2234678999999997654 7889999999999999999999986532211 11101 01111111100
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 669 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 669 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.......+.+++.+||+.+|.+||+++++++.
T Consensus 242 -----~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 242 -----NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -----CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00123467889999999999999999999866
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=273.51 Aligned_cols=237 Identities=29% Similarity=0.299 Sum_probs=194.0
Q ss_pred hCCCceeEEEEeeeeCCCCcEEEEEEecccch---hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCCCC
Q 047292 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGT 518 (728)
Q Consensus 442 lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 518 (728)
||+|+||.||++... .+++.+++|.+..... .....+..|+.++++++|+||+++++.+......++||||+++++
T Consensus 1 lg~G~~~~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKK-DTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEEC-CCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence 699999999999876 4678999999865332 234678999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccccccC
Q 047292 519 LANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRG 598 (728)
Q Consensus 519 L~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g 598 (728)
|.+++.....+++..+..++.|+++||.|||+. +++|+||+|+||+++.++.++|+|||++....... .......+
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~ 155 (250)
T cd05123 80 LFSHLSKEGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCG 155 (250)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcC
Confidence 999998877889999999999999999999997 99999999999999999999999999988764332 12233457
Q ss_pred CccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHHHH
Q 047292 599 TRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRL 678 (728)
Q Consensus 599 t~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 678 (728)
+..|+|||.+.+...+.++|+||||+++||+++|+.||...........+ ..... ..+....
T Consensus 156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~--------~~~~~----------~~~~~~~ 217 (250)
T cd05123 156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI--------LKDPL----------RFPEFLS 217 (250)
T ss_pred CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--------hcCCC----------CCCCCCC
Confidence 88999999999888999999999999999999999999654432211111 00000 0111113
Q ss_pred HHHHHHHHHhcccCCCCCCCHHH
Q 047292 679 HKWLMIAMWCIQEDPSKRPTMKV 701 (728)
Q Consensus 679 ~~l~~l~~~cl~~dp~~RPt~~e 701 (728)
..+.+++.+||..||++||++.+
T Consensus 218 ~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 218 PEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHHHHhcCCHhhCCCccc
Confidence 46678999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-32 Score=291.20 Aligned_cols=196 Identities=28% Similarity=0.430 Sum_probs=170.1
Q ss_pred HhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch-hhHHHHHHHHHHhccccccceeeEeeeeecCC------cceeEe
Q 047292 439 KEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKNLVQLLGFCDEAL------NRLLVY 511 (728)
Q Consensus 439 ~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~~lv~ 511 (728)
.+.||+|+||.||+|+.+ .+|+.||||.+..... ...+...+|+++|++++|+|||+++++-++.. ...+||
T Consensus 18 ~e~LG~Ga~g~V~rgrnk-etG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm 96 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNK-ETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM 96 (732)
T ss_pred hhhhcCCccceeeeeccc-ccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence 467999999999999876 6899999999976432 23467789999999999999999999876544 568999
Q ss_pred eccCCCCHHHHHhcC---CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEc--CCCc--eEEccccCccc
Q 047292 512 EFMGNGTLANLIFAI---PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLD--HYFS--PKISDFGLSKL 584 (728)
Q Consensus 512 e~~~~gsL~~~l~~~---~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~--~~~~--~kl~Dfgla~~ 584 (728)
|||.+|+|+..|.+. ..+++...+.+...++.||.|||++ +|+||||||.||++- ++|+ -||+|||.|+.
T Consensus 97 EyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 97 EYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred eecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 999999999999864 4789999999999999999999997 999999999999984 4444 69999999998
Q ss_pred cccCCCcccccccCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCcchhh
Q 047292 585 LLSDHSRTHTMIRGTRGYVAPEWLKN-APVSAKVDVYSFGVMLLEIICCRRSVEMEL 640 (728)
Q Consensus 585 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvil~elltg~~p~~~~~ 640 (728)
+..+. ......||+.|++||.... +.|+...|.|||||++||.+||..||....
T Consensus 174 l~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 174 LDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred CCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence 75544 5566789999999999984 889999999999999999999999997543
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=284.50 Aligned_cols=262 Identities=21% Similarity=0.241 Sum_probs=191.0
Q ss_pred hHHhhhCCCceeEEEEeeeeCCC--CcEEEEEEecccc--hhhHHHHHHHHHHhccc-cccceeeEeeeeecC----Ccc
Q 047292 437 GFKEELGRGSFGIVYKGVLKTAS--GNAIAVKKLDRLA--QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEA----LNR 507 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~--~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~----~~~ 507 (728)
.+.+.||+|+||.||++... .. +..||+|++.... ....+.+.+|+.+++++ +|+||+++++.+... ...
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~-~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 3 ELIKELGQGAYGIVCSARNA-ETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred eEEEEccccCCeEEEEEEeC-CCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 34577999999999999876 34 6789999986432 22346788899999999 599999999875332 456
Q ss_pred eeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcccccc
Q 047292 508 LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS 587 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 587 (728)
++++||+. ++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 82 ~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~ 157 (332)
T cd07857 82 YLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSE 157 (332)
T ss_pred EEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence 78888886 68999998888899999999999999999999997 999999999999999999999999999986543
Q ss_pred CCCc---ccccccCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHH-------HHhh
Q 047292 588 DHSR---THTMIRGTRGYVAPEWLKN-APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWA-------YDCY 656 (728)
Q Consensus 588 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~ 656 (728)
.... ......|+..|+|||.+.+ ..++.++||||||+++++|++|+.||...........+.... ....
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI 237 (332)
T ss_pred ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 2211 1123458899999998866 468999999999999999999999987543222111110000 0000
Q ss_pred hcCc-------cceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 657 VEGR-------LDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 657 ~~~~-------~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
.... ......... ....+.....+.+++.+||+.+|++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 238 GSPKAQNYIRSLPNIPKKPF-ESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred hhhhHHHHHHhccccCCcch-HhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000 000000000 0001112346778999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=286.12 Aligned_cols=267 Identities=22% Similarity=0.267 Sum_probs=194.8
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHhccccccceeeEeeeeecCC------cc
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEAL------NR 507 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~ 507 (728)
+.+.+.||+|+||.||++... .++..||||++.... ......+.+|+.++++++|+||+++++++.... ..
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07880 17 YRDLKQVGSGAYGTVCSALDR-RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDF 95 (343)
T ss_pred eEEEEEeeecCCeEEEEEEEC-CCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceE
Confidence 334578999999999999865 568899999985422 223457889999999999999999999986553 34
Q ss_pred eeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcccccc
Q 047292 508 LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS 587 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 587 (728)
++||||+ +++|.+++.. ..+++..+..++.||++||+|||+. +|+||||||+||++++++.+||+|||++.....
T Consensus 96 ~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 170 (343)
T cd07880 96 YLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDS 170 (343)
T ss_pred EEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence 8999998 6789888764 5688999999999999999999997 999999999999999999999999999876532
Q ss_pred CCCcccccccCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHH-------HHhhhcC
Q 047292 588 DHSRTHTMIRGTRGYVAPEWLKN-APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWA-------YDCYVEG 659 (728)
Q Consensus 588 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~ 659 (728)
. .....+++.|+|||.+.+ ..++.++|+||||+++++|++|+.||...........+.... .......
T Consensus 171 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07880 171 E----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSE 246 (343)
T ss_pred C----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcch
Confidence 2 122356889999999876 468899999999999999999999997543322111110000 0000000
Q ss_pred -------ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHH--HHHhcCcCCC
Q 047292 660 -------RLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVM--QMLEGLLEVP 713 (728)
Q Consensus 660 -------~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl--~~L~~~~~~~ 713 (728)
.+....... ...........+.+++.+|++.||++|||+.+++ ..++...+.+
T Consensus 247 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~ 308 (343)
T cd07880 247 DAKNYVKKLPRFRKKD-FRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPE 308 (343)
T ss_pred hHHHHHHhccccCcch-HHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcc
Confidence 000000000 0001112234577899999999999999999999 4444444333
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=274.80 Aligned_cols=247 Identities=25% Similarity=0.329 Sum_probs=191.8
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc-----chhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeE
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL-----AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 510 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 510 (728)
+.+.++||+|+||.||++.... .+..+++|.++.. ......++..|+.+++.++||||+++++++.+....++|
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKK-AVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred ceeeeeecCCCCceEEEEEecC-CCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 3456789999999999998753 3445556655432 122345677899999999999999999999999999999
Q ss_pred eeccCCCCHHHHHhc----CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccc
Q 047292 511 YEFMGNGTLANLIFA----IPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLL 586 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 586 (728)
+||+++++|.+++.. ...+++..++.++.|+++||.|||+. +++|+||+|+||++++ +.+||+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998864 35688999999999999999999997 9999999999999976 569999999987664
Q ss_pred cCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceecc
Q 047292 587 SDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALID 666 (728)
Q Consensus 587 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 666 (728)
.... ......+++.|+|||.+.+..++.++|+||||+++++|++|..|+.......... ....+....
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~--------~~~~~~~~~--- 224 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVL--------RIVEGPTPS--- 224 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHH--------HHHcCCCCC---
Confidence 3222 2223457889999999988889999999999999999999999986433221111 011111111
Q ss_pred chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 667 SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 667 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.+......+.+++.+||+.+|++||++.++++.
T Consensus 225 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 225 ------LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred ------CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 112334567789999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=286.88 Aligned_cols=262 Identities=20% Similarity=0.257 Sum_probs=191.2
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecC-----------
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEA----------- 504 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~----------- 504 (728)
+.+.+.||.|+||.||+|... .+++.|++|++........+.+.+|++++++++|+||+++++++...
T Consensus 7 y~~~~~Lg~g~~g~vy~~~~~-~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (342)
T cd07854 7 YMDLRPLGCGSNGLVFSAVDS-DCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSL 85 (342)
T ss_pred eEEEEEecCCCCEEEEEEEEC-CCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccc
Confidence 445578999999999999875 56889999998665555567889999999999999999999776543
Q ss_pred ---CcceeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEc-CCCceEEcccc
Q 047292 505 ---LNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLD-HYFSPKISDFG 580 (728)
Q Consensus 505 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~-~~~~~kl~Dfg 580 (728)
...++|+||++ ++|.+++.. ..+++..+..++.||++||.|||+. +|+||||||+||+++ +++.+||+|||
T Consensus 86 ~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~dfg 160 (342)
T cd07854 86 TELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFG 160 (342)
T ss_pred cccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECCcc
Confidence 35789999997 588888764 4678899999999999999999987 999999999999997 56678999999
Q ss_pred CccccccCCCc--ccccccCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHH-----
Q 047292 581 LSKLLLSDHSR--THTMIRGTRGYVAPEWLKN-APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWA----- 652 (728)
Q Consensus 581 la~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~----- 652 (728)
+++........ ......++..|+|||.+.. ..++.++||||||+++|||++|+.||...........+..-.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07854 161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE 240 (342)
T ss_pred cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 99765332211 1122347888999998754 567889999999999999999999997544322211110000
Q ss_pred --HHhhhcCccceecc------chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 653 --YDCYVEGRLDALID------SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 653 --~~~~~~~~~~~~~d------~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
...... ....... ..............+.+++.+||+.||.+||+++++++
T Consensus 241 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 241 EDRNELLN-VIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHhhhhhh-hhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000000 0000000 00000001122346778999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-32 Score=260.41 Aligned_cols=245 Identities=23% Similarity=0.231 Sum_probs=190.5
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccc-cccceeeEeeeee----cCCcceeEeecc
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKNLVQLLGFCD----EALNRLLVYEFM 514 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~----~~~~~~lv~e~~ 514 (728)
++||-|-.|.|.....+ .+++..|+|++.+. ...++|++.-.+. .|+|||.++++++ ....+++|||.|
T Consensus 68 qvLG~GinGkV~~C~~k-~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~m 141 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHK-RTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECM 141 (400)
T ss_pred hhhccccCCceEEEEec-cchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecc
Confidence 68999999999998877 67899999998653 3346788876666 5999999999874 456678999999
Q ss_pred CCCCHHHHHhcCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcC---CCceEEccccCccccccCC
Q 047292 515 GNGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDH---YFSPKISDFGLSKLLLSDH 589 (728)
Q Consensus 515 ~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~---~~~~kl~Dfgla~~~~~~~ 589 (728)
+||.|...+..+. .+++...-.|..||..|+.|||+. +|.||||||+|+|... |..+||+|||+|+....
T Consensus 142 eGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~-- 216 (400)
T KOG0604|consen 142 EGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE-- 216 (400)
T ss_pred cchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccCC--
Confidence 9999999999875 489999999999999999999996 9999999999999964 56799999999987543
Q ss_pred CcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchh
Q 047292 590 SRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDE 669 (728)
Q Consensus 590 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 669 (728)
.....+.+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||.......... . -......+. .++.++
T Consensus 217 ~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aisp---g-Mk~rI~~gq-y~FP~p-- 289 (400)
T KOG0604|consen 217 PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---G-MKRRIRTGQ-YEFPEP-- 289 (400)
T ss_pred CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCCh---h-HHhHhhccC-ccCCCh--
Confidence 233444567999999999999999999999999999999999999997553321100 0 000001110 011111
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 670 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 670 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.-....+...++++.+|..+|.+|.|+++++..
T Consensus 290 ---EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 290 ---EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred ---hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 111224455679999999999999999998764
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-32 Score=271.85 Aligned_cols=245 Identities=28% Similarity=0.340 Sum_probs=201.3
Q ss_pred HHHHHHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccc-cccceeeEeeeeecCC
Q 047292 430 ELKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEAL 505 (728)
Q Consensus 430 el~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 505 (728)
.++....+|..+||+|+||.|.++..+ .+.+.+|||++++.. ..+.+--+.|-++|... +-|.+++++.+++..+
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerk-gtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD 423 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERK-GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD 423 (683)
T ss_pred ceeecccceEEEeccCccceeeeeccc-CcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh
Confidence 344455688899999999999999866 466889999997632 12223345677888876 6889999999999999
Q ss_pred cceeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcccc
Q 047292 506 NRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLL 585 (728)
Q Consensus 506 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~ 585 (728)
.+|+||||+.||+|.-++....++.+....-+|..||-||-+||++ +||.||||.+||+++.+|++||+|||+++.-
T Consensus 424 RLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 424 RLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred heeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccc
Confidence 9999999999999999999999999999999999999999999998 9999999999999999999999999999753
Q ss_pred ccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceec
Q 047292 586 LSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALI 665 (728)
Q Consensus 586 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (728)
--+ .....+.+|||.|+|||++..++|+...|.|||||+||||+.|+.||+.+.+++....+.+.
T Consensus 501 i~~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh-------------- 565 (683)
T KOG0696|consen 501 IFD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH-------------- 565 (683)
T ss_pred ccC-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc--------------
Confidence 222 23345578999999999999999999999999999999999999999988877655444321
Q ss_pred cchhhhhhcHHHHHHHHHHHHHhcccCCCCCC
Q 047292 666 DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRP 697 (728)
Q Consensus 666 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP 697 (728)
...++.....+...+....|...|.+|.
T Consensus 566 ----nvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 566 ----NVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ----cCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 1122333444566677778888999884
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=279.84 Aligned_cols=260 Identities=22% Similarity=0.276 Sum_probs=191.6
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeeec-CCcceeEee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDE-ALNRLLVYE 512 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lv~e 512 (728)
+.+.+.||+|+||.||++..+ .+++.||+|++... .....+.+..|++++++++||||+++.+++.. ....++++|
T Consensus 12 y~~~~~ig~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e 90 (328)
T cd07856 12 YVDLQPVGMGAFGLVCSARDQ-LTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTE 90 (328)
T ss_pred eEEEEeecccCCeEEEEEEEC-CCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEee
Confidence 344578999999999999865 56889999988542 22334678899999999999999999998865 567899999
Q ss_pred ccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 513 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 513 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
|+ +++|.+++.. ..+++.....++.|+++||.|||+. +|+|+||+|+||++++++.+||+|||++......
T Consensus 91 ~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~---- 161 (328)
T cd07856 91 LL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQ---- 161 (328)
T ss_pred hh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCCC----
Confidence 98 5689888764 3567788889999999999999997 9999999999999999999999999998754221
Q ss_pred cccccCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHH-------HHhhhcCcccee
Q 047292 593 HTMIRGTRGYVAPEWLKN-APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWA-------YDCYVEGRLDAL 664 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~ 664 (728)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.... ......+....+
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd07856 162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF 241 (328)
T ss_pred cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHH
Confidence 122346788999998866 578999999999999999999999986543322211111110 000000000000
Q ss_pred ccch------hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 665 IDSD------EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 665 ~d~~------~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
+... ............+.+++.+||+.+|++||++++++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 0000001123577889999999999999999999866
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-32 Score=285.70 Aligned_cols=237 Identities=24% Similarity=0.275 Sum_probs=193.5
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccc-cccceeeEeeeeecCCcceeEeecc
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
+.+...+|.|+|+.|-.+... .+++..+||++... ..+-.+|+.++... +|+||+++.+.+.+..+.|+|||.+
T Consensus 324 y~~~~~~~~gs~s~~~~~~~~-~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l 398 (612)
T KOG0603|consen 324 YEFREELGEGSFSAVKYCESS-PTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELL 398 (612)
T ss_pred hccccccCCCCccceeeeecc-ccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeehhc
Confidence 445667999999999998876 56788999999764 23446677776665 7999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEE-cCCCceEEccccCccccccCCCccc
Q 047292 515 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILL-DHYFSPKISDFGLSKLLLSDHSRTH 593 (728)
Q Consensus 515 ~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll-~~~~~~kl~Dfgla~~~~~~~~~~~ 593 (728)
.++-|.+.+...+... ..+..|+.+|+.|+.|||++ ++|||||||+|||+ ++.++++|+|||.++..... .
T Consensus 399 ~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----~ 470 (612)
T KOG0603|consen 399 DGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----C 470 (612)
T ss_pred cccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh----h
Confidence 9999999988776655 77778999999999999998 99999999999999 69999999999999876554 2
Q ss_pred ccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhH-hhhhhHHHHHHHhhhcCccceeccchhhhh
Q 047292 594 TMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEE-ESRAILTDWAYDCYVEGRLDALIDSDEAAM 672 (728)
Q Consensus 594 ~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 672 (728)
...+-|..|.|||++....+++++|+||||++||+||+|+.||.....+ +.. .....++..
T Consensus 471 ~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~--------~~i~~~~~s---------- 532 (612)
T KOG0603|consen 471 DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIH--------TRIQMPKFS---------- 532 (612)
T ss_pred cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHH--------HhhcCCccc----------
Confidence 2234578999999999999999999999999999999999999854433 111 111111111
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 673 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 673 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
........+++.+||+.||.+||+|.++...
T Consensus 533 --~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 533 --ECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred --cccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 2334456789999999999999999998754
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=279.05 Aligned_cols=241 Identities=25% Similarity=0.413 Sum_probs=192.3
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCCC
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNG 517 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 517 (728)
+.||+|.||+||-|+++ .+|+.||||++.+. ..+++.++++|+.+|+.++||.||.+.-.|+..+..++|||-+. |
T Consensus 570 evLGSGQFG~VYgg~hR-ktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G 647 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHR-KTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G 647 (888)
T ss_pred hhccCCcceeeecceec-ccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence 67999999999999987 78999999999653 35567899999999999999999999999999999999999995 5
Q ss_pred CHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCC---CceEEccccCccccccCCCcc
Q 047292 518 TLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHY---FSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 518 sL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~---~~~kl~Dfgla~~~~~~~~~~ 592 (728)
++.++|... ..+++..-.-+..||+.||.|||.+ +|+|+||||+|||+.+. -++||+|||+|+++... ..
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk--sF 722 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK--SF 722 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchh--hh
Confidence 666666543 5778877788899999999999997 99999999999999753 46999999999998543 23
Q ss_pred cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAM 672 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 672 (728)
...+.||+.|+|||+++.+.|+..-|+||.|||+|--|+|..||..+.+-. ..+..-.+ +..+..
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn--dQIQNAaF----------MyPp~P--- 787 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN--DQIQNAAF----------MYPPNP--- 787 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh--HHhhcccc----------ccCCCc---
Confidence 445779999999999999999999999999999999999999997543221 11111000 011111
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047292 673 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVM 703 (728)
Q Consensus 673 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl 703 (728)
-.+..+..++++-..||..-++|-+...-+
T Consensus 788 -W~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 788 -WSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred -hhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 123344567788888888888888776543
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=284.71 Aligned_cols=257 Identities=24% Similarity=0.293 Sum_probs=192.0
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeeecCCc------ce
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALN------RL 508 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------~~ 508 (728)
.+.+.||+|+||.||+|... .+++.||+|++... .......+.+|+.+++.++|+||+++++++..... .+
T Consensus 18 ~~~~~ig~g~~g~vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07851 18 QNLSPVGSGAYGQVCSAFDT-KTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVY 96 (343)
T ss_pred EEEEEeccCCceEEEEEEEC-CCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEE
Confidence 34578999999999999876 46789999998642 22334667889999999999999999998766554 89
Q ss_pred eEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccC
Q 047292 509 LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD 588 (728)
Q Consensus 509 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 588 (728)
+|+||+ +++|.+++.. ..+++..+..++.|+++||.|||+. +|+|+||||+||++++++.+||+|||++......
T Consensus 97 lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~ 171 (343)
T cd07851 97 LVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE 171 (343)
T ss_pred EEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccccccccc
Confidence 999998 5699998875 4689999999999999999999997 9999999999999999999999999999865332
Q ss_pred CCcccccccCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHH-------HhhhcCc
Q 047292 589 HSRTHTMIRGTRGYVAPEWLKN-APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAY-------DCYVEGR 660 (728)
Q Consensus 589 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~ 660 (728)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+..... .......
T Consensus 172 ----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07851 172 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSES 247 (343)
T ss_pred ----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchh
Confidence 223357888999999865 3678999999999999999999999865433222111111000 0000000
Q ss_pred cceecc-------chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 661 LDALID-------SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 661 ~~~~~d-------~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
....+. ..... ........+.+++.+||+.+|++|||+.+|++
T Consensus 248 ~~~~~~~~~~~~~~~~~~-~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 248 ARNYIQSLPQMPKKDFKE-VFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHHHHhccccCCCCHHH-HhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000000 00000 00112457889999999999999999999986
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=282.10 Aligned_cols=257 Identities=24% Similarity=0.274 Sum_probs=188.3
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHhccccccceeeEeeeeecC------Cccee
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEA------LNRLL 509 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~l 509 (728)
+.+.||+|+||.||++... .+++.||+|++.... ......+.+|+.++++++|+||+++++++... ...++
T Consensus 21 ~~~~lg~G~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l 99 (345)
T cd07877 21 NLSPVGSGAYGSVCAAFDT-KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 99 (345)
T ss_pred EEEEeeecCCeEEEEEEEc-CCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEE
Confidence 3467999999999999865 568899999986532 22346788899999999999999999988543 34577
Q ss_pred EeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCC
Q 047292 510 VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH 589 (728)
Q Consensus 510 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 589 (728)
+++++ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 100 v~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~- 173 (345)
T cd07877 100 VTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE- 173 (345)
T ss_pred Eehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEeccccccccccc-
Confidence 88776 7899888765 4688999999999999999999997 9999999999999999999999999998764322
Q ss_pred CcccccccCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHH-------HHhhhcCc-
Q 047292 590 SRTHTMIRGTRGYVAPEWLKN-APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWA-------YDCYVEGR- 660 (728)
Q Consensus 590 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~- 660 (728)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.... ........
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (345)
T cd07877 174 ---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 250 (345)
T ss_pred ---ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhH
Confidence 223457889999999876 568899999999999999999999986433222111111100 00000000
Q ss_pred ------cceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 661 ------LDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 661 ------~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
+......... .........+.+++.+|++.+|.+||++.++++.
T Consensus 251 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 251 RNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000000000 0000123457789999999999999999998865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=267.18 Aligned_cols=221 Identities=19% Similarity=0.141 Sum_probs=177.0
Q ss_pred CceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCCCCHHHHHh
Q 047292 445 GSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIF 524 (728)
Q Consensus 445 G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~ 524 (728)
|.||.||++... .+++.+|+|++.... .+..|...+....||||+++++++......++||||+++++|.+++.
T Consensus 4 g~~~~v~~~~~~-~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDT-RTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEc-cCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence 889999999876 578899999986532 23345555555679999999999999999999999999999999998
Q ss_pred cCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccccccCCccccC
Q 047292 525 AIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVA 604 (728)
Q Consensus 525 ~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~a 604 (728)
....+++..+..++.|+++||.|||+. +|+||||||+||++++++.++++|||.+...... .....++..|+|
T Consensus 78 ~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~a 150 (237)
T cd05576 78 KFLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCA 150 (237)
T ss_pred HhcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccC
Confidence 877899999999999999999999997 9999999999999999999999999987655322 122335677999
Q ss_pred cccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHH
Q 047292 605 PEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMI 684 (728)
Q Consensus 605 PE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l 684 (728)
||.+.+..++.++||||+|+++|||++|+.|+........ .. . ....+......+.++
T Consensus 151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-------------~~-----~----~~~~~~~~~~~~~~l 208 (237)
T cd05576 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN-------------TH-----T----TLNIPEWVSEEARSL 208 (237)
T ss_pred CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc-------------cc-----c----ccCCcccCCHHHHHH
Confidence 9999888899999999999999999999987643211000 00 0 000111223467789
Q ss_pred HHHhcccCCCCCCCHH
Q 047292 685 AMWCIQEDPSKRPTMK 700 (728)
Q Consensus 685 ~~~cl~~dp~~RPt~~ 700 (728)
+.+||+.||++||++.
T Consensus 209 i~~~l~~dp~~R~~~~ 224 (237)
T cd05576 209 LQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHccCCHHHhcCCC
Confidence 9999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=267.25 Aligned_cols=276 Identities=19% Similarity=0.269 Sum_probs=207.9
Q ss_pred CCCccccCHHHHHHHHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhcccc-c-c----c
Q 047292 420 ATNLRFFSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTH-H-K----N 493 (728)
Q Consensus 420 ~~~~~~~~~~el~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h-~----n 493 (728)
.....++...+.....+.+...+|+|+||.|-...+. ..+..||||+++... ...+..+-|+++|+++. + | -
T Consensus 75 ~dGH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~-~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~r 152 (415)
T KOG0671|consen 75 KDGHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDR-ETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFR 152 (415)
T ss_pred CCceEEEEeccccccceehhhhhcCCcccceEEEeec-CCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceE
Confidence 3445566666777788888999999999999998766 448999999998753 33456677999999984 2 2 3
Q ss_pred eeeEeeeeecCCcceeEeeccCCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcC-
Q 047292 494 LVQLLGFCDEALNRLLVYEFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDH- 570 (728)
Q Consensus 494 iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~- 570 (728)
+|.+.++++..++.+||+|.+ |-++.+++... .+++..++..++.|++++++|||+. +++|.||||+|||+.+
T Consensus 153 cv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss 228 (415)
T KOG0671|consen 153 CVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSS 228 (415)
T ss_pred EEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEecc
Confidence 788889999999999999988 55899999876 4678899999999999999999997 9999999999999942
Q ss_pred -------------------CCceEEccccCccccccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh
Q 047292 571 -------------------YFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC 631 (728)
Q Consensus 571 -------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt 631 (728)
+..+||+|||.|+.....+ ..+..|..|.|||++.+..++.++||||+||||.|+.|
T Consensus 229 ~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Elyt 304 (415)
T KOG0671|consen 229 EYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYT 304 (415)
T ss_pred ceEEEeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeec
Confidence 2348999999998754433 45667999999999999999999999999999999999
Q ss_pred CCcCcchhhhHhhhh---hHH---------HH-HHHhhhcCcc-----------ceeccch----hhhhhcHHHHHHHHH
Q 047292 632 CRRSVEMELEEESRA---ILT---------DW-AYDCYVEGRL-----------DALIDSD----EAAMADRSRLHKWLM 683 (728)
Q Consensus 632 g~~p~~~~~~~~~~~---~~~---------~~-~~~~~~~~~~-----------~~~~d~~----~~~~~~~~~~~~l~~ 683 (728)
|...|+.....+... .+. .. ....+..+.+ ....+.. ........+..+|++
T Consensus 305 G~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfD 384 (415)
T KOG0671|consen 305 GETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFD 384 (415)
T ss_pred cceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHH
Confidence 999887543221100 000 00 1111111111 1111110 011123345667999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 047292 684 IAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 684 l~~~cl~~dp~~RPt~~evl~~ 705 (728)
|+.++|..||.+|+|+.|+++.
T Consensus 385 Ll~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 385 LLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred HHHHHHccCccccccHHHHhcC
Confidence 9999999999999999998853
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=302.17 Aligned_cols=143 Identities=31% Similarity=0.426 Sum_probs=129.1
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
.+.++||+|+||.||+|... .+++.||||+++... ......+..|+.++..++|+||+++++++......+|||||
T Consensus 7 ~i~~~LG~G~fg~Vy~a~~~-~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy 85 (669)
T cd05610 7 VIVKPISRGAFGKVYLGRKK-NNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEY 85 (669)
T ss_pred EEEEEEecCCCeEEEEEEEC-CCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeC
Confidence 45678999999999999876 468899999986432 23346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcc
Q 047292 514 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSK 583 (728)
Q Consensus 514 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~ 583 (728)
+++++|.+++.....+++..++.|+.||+.||.|||.. +|+||||||+||||+.++.+||+|||+++
T Consensus 86 ~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 86 LIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999998877888999999999999999999997 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=256.34 Aligned_cols=263 Identities=21% Similarity=0.300 Sum_probs=197.2
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeeec--------CCcc
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDE--------ALNR 507 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--------~~~~ 507 (728)
-..+||+|.||+||++..+ .+++.||+|++-.. ...-.....+|+.+|..++|+|++.++..|.. ....
T Consensus 21 k~~kigqGtfgeVFkAr~~-n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ 99 (376)
T KOG0669|consen 21 KLAKIGQGTFGEVFKARSK-NTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATF 99 (376)
T ss_pred HHHhcCCchHHHHHHHhhc-CccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccccee
Confidence 3467999999999999887 46778998876332 22223567889999999999999999999843 3347
Q ss_pred eeEeeccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccc
Q 047292 508 LLVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLL 586 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 586 (728)
++|+.+++. +|.-+|.+. .+++...+.++.+++..||.|+|.. .|+|||+||.|+||+.++.+||+|||+++.+.
T Consensus 100 ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~fs 175 (376)
T KOG0669|consen 100 YLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARAFS 175 (376)
T ss_pred eeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccccccee
Confidence 999999976 788888776 5789999999999999999999997 99999999999999999999999999998764
Q ss_pred cCC---CcccccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHH-------HHHh
Q 047292 587 SDH---SRTHTMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDW-------AYDC 655 (728)
Q Consensus 587 ~~~---~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~-------~~~~ 655 (728)
... ....+....|..|++||.+.+. +|+++.|||.-|||+.||+|+.+.++..........+... +|..
T Consensus 176 ~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~ 255 (376)
T KOG0669|consen 176 TSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPN 255 (376)
T ss_pred cccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCC
Confidence 322 2223445568999999988765 7899999999999999999999998877665544444322 1111
Q ss_pred hhcCccceeccch--hhh--hhcHHH------HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 656 YVEGRLDALIDSD--EAA--MADRSR------LHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 656 ~~~~~~~~~~d~~--~~~--~~~~~~------~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
..+-++-+.+... ... ..-.+. ....++++.+++..||.+|+++.+++..
T Consensus 256 ~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 256 VDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred cccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 1111111111000 000 000111 2267789999999999999999998764
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=232.44 Aligned_cols=260 Identities=21% Similarity=0.270 Sum_probs=194.4
Q ss_pred HhhhCCCceeEEEEeeeeCCCCcEEEEEEecc--cchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCC
Q 047292 439 KEELGRGSFGIVYKGVLKTASGNAIAVKKLDR--LAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGN 516 (728)
Q Consensus 439 ~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 516 (728)
.++||+|+||+||||+.+ .+++.||+|+++- ..+.......+|+-+|+.++|+|||+++++...+..+.+|+||+.
T Consensus 7 mekigegtygtvfkarn~-~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd- 84 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNR-ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD- 84 (292)
T ss_pred HHhhcCCcceeeEecccC-CccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh-
Confidence 478999999999999876 5788999998854 233345778999999999999999999999999999999999995
Q ss_pred CCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccccc
Q 047292 517 GTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM 595 (728)
Q Consensus 517 gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 595 (728)
.+|..+.... ..++.+....++.|+++||.++|++ ++.||||||.|.||+.+|.+|++|||+++.+.-... ....
T Consensus 85 qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvr-cysa 160 (292)
T KOG0662|consen 85 QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR-CYSA 160 (292)
T ss_pred HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceE-eeec
Confidence 4787777664 6788899999999999999999997 999999999999999999999999999998765432 2223
Q ss_pred ccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhh-hHhhhhhHHHHHHHhhhcCc---cceeccchhh
Q 047292 596 IRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEL-EEESRAILTDWAYDCYVEGR---LDALIDSDEA 670 (728)
Q Consensus 596 ~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~---~~~~~d~~~~ 670 (728)
..-|.-|.+|.++.+. -|+...|+||-||++.|+....+|..... ..+....+ -+......+.. +..+.|...-
T Consensus 161 evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkri-f~~lg~p~ed~wps~t~lpdyk~y 239 (292)
T KOG0662|consen 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI-FRLLGTPTEDQWPSMTKLPDYKPY 239 (292)
T ss_pred eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHH-HHHhCCCccccCCccccCCCCccc
Confidence 3468899999999876 57999999999999999998666654332 22222211 12222222221 2333333221
Q ss_pred hhhc---------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 671 AMAD---------RSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 671 ~~~~---------~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
..++ +..-..=.+++.+.+.-+|.+|.+++..++.
T Consensus 240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 1111 1112223456667777799999999987753
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=263.19 Aligned_cols=257 Identities=25% Similarity=0.310 Sum_probs=198.0
Q ss_pred HHHHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecc---cchh----hHHHHHHHHHHhccccccceeeEeeeee-c
Q 047292 432 KDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDR---LAQE----REREFKSEVSAIGRTHHKNLVQLLGFCD-E 503 (728)
Q Consensus 432 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~---~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~-~ 503 (728)
....|-+...||+|+|+.|||+.+- ...+.||||+-.. ...+ ..+...+|.++-+.|+||.||++++++. +
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl-~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDL-TEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhccc-chhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 3445667789999999999999765 4578999997532 1111 2356778999999999999999999985 5
Q ss_pred CCcceeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcC---CCceEEcccc
Q 047292 504 ALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDH---YFSPKISDFG 580 (728)
Q Consensus 504 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~---~~~~kl~Dfg 580 (728)
.+..+-|+||++|.+|+-+|..+..+++.....|+.||+.||.||.+. ..+|||-||||.|||+-+ -|.+||+|||
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 567789999999999999999999999999999999999999999986 678999999999999954 5789999999
Q ss_pred CccccccCCCc------ccccccCCccccCcccccCC----CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHH
Q 047292 581 LSKLLLSDHSR------THTMIRGTRGYVAPEWLKNA----PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTD 650 (728)
Q Consensus 581 la~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~ 650 (728)
+++++..+... ......||..|++||.+.-. +++.|.||||.|||+|..+.|+.||........ .+ .
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd--IL-q 695 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD--IL-Q 695 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH--HH-h
Confidence 99999665433 12235699999999988432 578899999999999999999999986644321 11 0
Q ss_pred HHHHhhhcCccceeccchh-hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047292 651 WAYDCYVEGRLDALIDSDE-AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVM 703 (728)
Q Consensus 651 ~~~~~~~~~~~~~~~d~~~-~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl 703 (728)
+. .++.... .....+....+...++++||+...++|....++.
T Consensus 696 -------eN---TIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 696 -------EN---TILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred -------hh---chhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 00 0111110 1111122334566799999999999998766664
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=259.20 Aligned_cols=238 Identities=28% Similarity=0.345 Sum_probs=194.2
Q ss_pred ceeEEEEeeeeCCCCcEEEEEEecccchhh-HHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCCCCHHHHHh
Q 047292 446 SFGIVYKGVLKTASGNAIAVKKLDRLAQER-EREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIF 524 (728)
Q Consensus 446 ~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~ 524 (728)
+||.||+|+.. .+++.+++|++....... ...+.+|++.+++++|+|++++++++......++++||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDK-KTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEEC-CCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 58999999886 457899999997654444 6789999999999999999999999999999999999999999999998
Q ss_pred cCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccccccCCccccC
Q 047292 525 AIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVA 604 (728)
Q Consensus 525 ~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~a 604 (728)
....+++..+..++.++++++.|||+. +++|+||+|+||++++++.++|+|||.+....... ......++..|++
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~ 154 (244)
T smart00220 80 KRGRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMA 154 (244)
T ss_pred hccCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCC
Confidence 776688999999999999999999997 99999999999999999999999999998765432 2233457889999
Q ss_pred cccccCCCCCCccchhhHHHHHHHHHhCCcCcchh-hhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHH
Q 047292 605 PEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEME-LEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLM 683 (728)
Q Consensus 605 PE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~ 683 (728)
||.+....++.++||||||+++++|++|..|+... ........+ ........ .........+.+
T Consensus 155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~--------~~~~~~~~-------~~~~~~~~~~~~ 219 (244)
T smart00220 155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKI--------GKPKPPFP-------PPEWKISPEAKD 219 (244)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH--------hccCCCCc-------cccccCCHHHHH
Confidence 99999888999999999999999999999998752 222111111 01110000 000003356788
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 047292 684 IAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 684 l~~~cl~~dp~~RPt~~evl~ 704 (728)
++.+|+..+|++||++.++++
T Consensus 220 ~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 220 LIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHccCCchhccCHHHHhh
Confidence 999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=282.23 Aligned_cols=248 Identities=27% Similarity=0.382 Sum_probs=204.2
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccc-cccceeeEeeeee-----cCCcceeE
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKNLVQLLGFCD-----EALNRLLV 510 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~-----~~~~~~lv 510 (728)
.|.+.||.|.+|.||+++.+ .+++.+|+|++..... ...++..|.++|+.. +|||++.++|++. .++.+|||
T Consensus 22 ei~evig~Gtygkv~k~k~~-~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLV 99 (953)
T KOG0587|consen 22 EIIEVIGNGTYGKVYKGRHV-KTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLV 99 (953)
T ss_pred EEEEEEeeccceeEEEEeee-ecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEE
Confidence 35578999999999999876 5788899998866433 356788999999988 7999999999984 34678999
Q ss_pred eeccCCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccC
Q 047292 511 YEFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD 588 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 588 (728)
||||.+|+..+++.+. ..+.|..+.-|+..++.|+.+||.+ .+||||||-.|||++.++.+||.|||++..+...
T Consensus 100 MEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT 176 (953)
T KOG0587|consen 100 MEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST 176 (953)
T ss_pred eeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeeecc
Confidence 9999999999999875 5788899999999999999999997 8999999999999999999999999999887655
Q ss_pred CCcccccccCCccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccce
Q 047292 589 HSRTHTMIRGTRGYVAPEWLK-----NAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDA 663 (728)
Q Consensus 589 ~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (728)
..+..+ ..||+.|||||++. ...|+.++|+||||++..||--|.+|+..+.+......+
T Consensus 177 ~grRnT-~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I--------------- 240 (953)
T KOG0587|consen 177 VGRRNT-FIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI--------------- 240 (953)
T ss_pred cccccC-cCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC---------------
Confidence 544443 56999999999995 335788999999999999999999998766544322111
Q ss_pred eccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 664 LIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 664 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
..++......+.....++.+++..||..|-.+||++.++++.
T Consensus 241 pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 241 PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 112233333456677888999999999999999999988753
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-30 Score=235.20 Aligned_cols=194 Identities=29% Similarity=0.435 Sum_probs=164.2
Q ss_pred HhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHhccc-cccceeeEeeeeecCCcceeEeeccCC
Q 047292 439 KEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYEFMGN 516 (728)
Q Consensus 439 ~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 516 (728)
.+.||+|++|.|-+-++. .+|...|+|.+.... .+..+..+.|+.+..+. .+|.+|.++|........++.||.|.-
T Consensus 51 i~elGrGayG~vekmrh~-~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t 129 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHI-QSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT 129 (282)
T ss_pred hhhhcCCccchhhheeec-cCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh
Confidence 468999999999887776 678999999996533 34456788899887775 799999999999999999999999954
Q ss_pred CCHHHHH----hcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 517 GTLANLI----FAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 517 gsL~~~l----~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
+|+.+- ......++..+-+|+..+.+||.|||++ +.+||||+||+||||+.+|++|++|||++..+.+.....
T Consensus 130 -Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt 206 (282)
T KOG0984|consen 130 -SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKT 206 (282)
T ss_pred -hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhhHHH
Confidence 666553 3456788899999999999999999997 789999999999999999999999999998775543332
Q ss_pred cccccCCccccCccccc----CCCCCCccchhhHHHHHHHHHhCCcCcch
Q 047292 593 HTMIRGTRGYVAPEWLK----NAPVSAKVDVYSFGVMLLEIICCRRSVEM 638 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~----~~~~s~~~DVwSlGvil~elltg~~p~~~ 638 (728)
...|-..|||||.+. ...|+.|+||||||+.+.||.+++.|++.
T Consensus 207 --~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 207 --MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred --HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 234778899999985 33789999999999999999999999874
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-31 Score=271.07 Aligned_cols=237 Identities=21% Similarity=0.228 Sum_probs=199.0
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecc---cchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCC
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGN 516 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 516 (728)
..||-|+||.|=++..+.. ...+|+|.+++ ....+++++..|-++|...+.+.||+++-.+.+....|++||-|-|
T Consensus 426 aTLGvGgFGRVELV~~~~~-~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClG 504 (732)
T KOG0614|consen 426 ATLGVGGFGRVELVKVNSQ-KATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLG 504 (732)
T ss_pred hhcccCccceEEEEEeccc-chHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcC
Confidence 4599999999999887632 22467777754 4456678899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccccc
Q 047292 517 GTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMI 596 (728)
Q Consensus 517 gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 596 (728)
|.|...|+.++.++..+..-++..+++|++|||.+ +||+|||||+|.+++.+|-+||.|||+|+.+.... ..-+.
T Consensus 505 GElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~--KTwTF 579 (732)
T KOG0614|consen 505 GELWTILRDRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR--KTWTF 579 (732)
T ss_pred chhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccCC--ceeee
Confidence 99999999999999999999999999999999997 99999999999999999999999999999875432 33457
Q ss_pred cCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHH
Q 047292 597 RGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRS 676 (728)
Q Consensus 597 ~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 676 (728)
+|||.|.|||++.++..+.+.|.||||+++|||++|++||....+...+..+..... ....+..
T Consensus 580 cGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid----------------~i~~Pr~ 643 (732)
T KOG0614|consen 580 CGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID----------------KIEFPRR 643 (732)
T ss_pred cCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh----------------hhhcccc
Confidence 899999999999999999999999999999999999999998777665554433211 1112223
Q ss_pred HHHHHHHHHHHhcccCCCCCCC
Q 047292 677 RLHKWLMIAMWCIQEDPSKRPT 698 (728)
Q Consensus 677 ~~~~l~~l~~~cl~~dp~~RPt 698 (728)
......+++++.+..+|.+|..
T Consensus 644 I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 644 ITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred cchhHHHHHHHHHhcCcHhhhc
Confidence 3345567888888999999964
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-30 Score=253.27 Aligned_cols=245 Identities=25% Similarity=0.310 Sum_probs=196.7
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccc-cccceeeEeeeeecCCcceeEeec
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
+.++||+|+|..|.++.++ ++.+.+|+|++++.. .++..-.+.|-.+..+. +||.+|.+..++.....+++|.||
T Consensus 254 ll~vigrgsyakvl~~~~~-~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffviey 332 (593)
T KOG0695|consen 254 LLRVIGRGSYAKVLLVRLK-KTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEY 332 (593)
T ss_pred eeeeecCcchhhhhheehc-ccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEE
Confidence 4578999999999999987 567899999987632 23345567788887776 799999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccc
Q 047292 514 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH 593 (728)
Q Consensus 514 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 593 (728)
++||+|.-+.....+++++...-+...|.-||.|||+. +||.||||.+|+|+|..|++||+|+|+++.-..+. ...
T Consensus 333 v~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~~g-d~t 408 (593)
T KOG0695|consen 333 VNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG-DTT 408 (593)
T ss_pred ecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCCCC-ccc
Confidence 99999998888889999999999999999999999997 99999999999999999999999999998654333 234
Q ss_pred ccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhh
Q 047292 594 TMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMA 673 (728)
Q Consensus 594 ~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 673 (728)
.+.+|||.|+|||++++..|....|.|+|||+++||+.|+.||+....+.....-.++.++...+..+ .+
T Consensus 409 stfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi----------ri 478 (593)
T KOG0695|consen 409 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI----------RI 478 (593)
T ss_pred ccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc----------cc
Confidence 55789999999999999999999999999999999999999998544332222222333333222221 12
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCC
Q 047292 674 DRSRLHKWLMIAMWCIQEDPSKRP 697 (728)
Q Consensus 674 ~~~~~~~l~~l~~~cl~~dp~~RP 697 (728)
++...-+...+++.-|+.||++|.
T Consensus 479 prslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 479 PRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred cceeehhhHHHHHHhhcCCcHHhc
Confidence 222233445577778999999984
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-31 Score=250.68 Aligned_cols=262 Identities=25% Similarity=0.342 Sum_probs=199.2
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccchh--hHHHHHHHHHHhccccccceeeEeeeeecC-----CcceeEee
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQE--REREFKSEVSAIGRTHHKNLVQLLGFCDEA-----LNRLLVYE 512 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~lv~e 512 (728)
+.||.|+||.||...+. .+|+.|++|++...... .-+.+.+|+++|..++|.|++..+++..-. .+.|++.|
T Consensus 59 RPIGYGAFGVVWsVTDP-RdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDP-RSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CcccccceeEEEeccCC-CCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 57999999999998766 67899999999764332 236788999999999999999998876543 35688889
Q ss_pred ccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 513 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 513 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
.|.. +|...+-....++.+.+.-+..||++||+|||+. +|.||||||.|.|++.+..+||+|||+++....+....
T Consensus 138 LmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~h 213 (449)
T KOG0664|consen 138 LMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLN 213 (449)
T ss_pred HHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchhhhhh
Confidence 8854 7888888888899999999999999999999997 99999999999999999999999999999887666666
Q ss_pred cccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHH-------HHhhhcCcccee
Q 047292 593 HTMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWA-------YDCYVEGRLDAL 664 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~ 664 (728)
.+...-|..|.|||++++. .|+.+.||||.|||+.||+..+..|+..++-+....+.+.. ...--+|.-..+
T Consensus 214 MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~ 293 (449)
T KOG0664|consen 214 MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHV 293 (449)
T ss_pred hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHh
Confidence 6666678999999999876 68999999999999999998887777655444333333221 111111111111
Q ss_pred ccchh-----h----hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047292 665 IDSDE-----A----AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQML 706 (728)
Q Consensus 665 ~d~~~-----~----~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 706 (728)
+.... . .......-++.+.+.++++.+||++|.+..+.+..+
T Consensus 294 LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 294 LRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 10000 0 000112223455677889999999999998887665
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=282.98 Aligned_cols=256 Identities=23% Similarity=0.239 Sum_probs=165.3
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCC----CcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeee------eecCC
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTAS----GNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGF------CDEAL 505 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~------~~~~~ 505 (728)
+.+.++||+|+||.||+|.+. .+ +..||+|++...... +....| .+....+.+++.++.. +....
T Consensus 134 y~l~~~LG~G~FG~VYka~~~-~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (566)
T PLN03225 134 FVLGKKLGEGAFGVVYKASLV-NKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKED 208 (566)
T ss_pred eEEeEEEeeCCCeEEEEEEEc-CCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccccCC
Confidence 445678999999999999986 34 689999998643221 111111 1111122222221111 34567
Q ss_pred cceeEeeccCCCCHHHHHhcCCC--------------------CChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCC
Q 047292 506 NRLLVYEFMGNGTLANLIFAIPK--------------------PDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQN 565 (728)
Q Consensus 506 ~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~N 565 (728)
..++|+||+++++|.+++..... .....+..++.||+.||+|||++ +|+||||||+|
T Consensus 209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~N 285 (566)
T PLN03225 209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQN 285 (566)
T ss_pred ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHH
Confidence 88999999999999999875421 11234567999999999999997 99999999999
Q ss_pred EEEcC-CCceEEccccCccccccCCCcccccccCCccccCcccccCC----------------------CCCCccchhhH
Q 047292 566 ILLDH-YFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNA----------------------PVSAKVDVYSF 622 (728)
Q Consensus 566 Ill~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~~~DVwSl 622 (728)
||+++ ++.+||+|||+++.+............+++.|+|||.+... .++.++|||||
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 99985 68999999999987654433344456689999999965322 23456799999
Q ss_pred HHHHHHHHhCCcCcchhhhHhhhh------hHHHHHHHhhhcCccceeccchhhhhh--cHHHHHHHHHHHHHhcccCCC
Q 047292 623 GVMLLEIICCRRSVEMELEEESRA------ILTDWAYDCYVEGRLDALIDSDEAAMA--DRSRLHKWLMIAMWCIQEDPS 694 (728)
Q Consensus 623 Gvil~elltg~~p~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~d~~~~~~~--~~~~~~~l~~l~~~cl~~dp~ 694 (728)
||+||||+++..+.......-... .+..|. ...... ......... .........+++.+||+.||+
T Consensus 366 GviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~----~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 366 GLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWR--KLVEPR----ASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred HHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHH--Hhhccc----cchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 999999999876654322111000 001110 000000 000000000 000112345799999999999
Q ss_pred CCCCHHHHHHH
Q 047292 695 KRPTMKVVMQM 705 (728)
Q Consensus 695 ~RPt~~evl~~ 705 (728)
+|||++++++.
T Consensus 440 kR~ta~e~L~H 450 (566)
T PLN03225 440 QRISAKAALAH 450 (566)
T ss_pred cCCCHHHHhCC
Confidence 99999999874
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=273.63 Aligned_cols=257 Identities=21% Similarity=0.258 Sum_probs=174.7
Q ss_pred hhHHhhhCCCceeEEEEeeee---------------CCCCcEEEEEEecccchhhHHH--------------HHHHHHHh
Q 047292 436 DGFKEELGRGSFGIVYKGVLK---------------TASGNAIAVKKLDRLAQERERE--------------FKSEVSAI 486 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~---------------~~~~~~vavK~l~~~~~~~~~~--------------~~~E~~~l 486 (728)
+.+.++||+|+||.||+|.+. ...++.||||++........++ ...|+.++
T Consensus 147 F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l 226 (507)
T PLN03224 147 FQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMC 226 (507)
T ss_pred ceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHH
Confidence 445578999999999999642 1235689999986543322223 33466677
Q ss_pred ccccccce-----eeEeeeeec--------CCcceeEeeccCCCCHHHHHhcC------------------------CCC
Q 047292 487 GRTHHKNL-----VQLLGFCDE--------ALNRLLVYEFMGNGTLANLIFAI------------------------PKP 529 (728)
Q Consensus 487 ~~l~h~ni-----v~l~g~~~~--------~~~~~lv~e~~~~gsL~~~l~~~------------------------~~~ 529 (728)
.+++|.++ ++++++|.. ....+|||||+++++|.++++.. ...
T Consensus 227 ~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~ 306 (507)
T PLN03224 227 AKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKR 306 (507)
T ss_pred HHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccC
Confidence 77766554 677787743 35679999999999999998642 123
Q ss_pred ChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccccccCCccccCccccc
Q 047292 530 DWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLK 609 (728)
Q Consensus 530 ~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 609 (728)
++..+..++.|++.+|.|||+. +|+||||||+|||++.++.+||+|||+++..............+++.|+|||.+.
T Consensus 307 ~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~ 383 (507)
T PLN03224 307 DINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELV 383 (507)
T ss_pred CHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhc
Confidence 5667888999999999999997 9999999999999999999999999999765433222222233578999999885
Q ss_pred CCCC----------------------CCccchhhHHHHHHHHHhCCc-CcchhhhHhh-----hhhHHHHHHHhhhcCcc
Q 047292 610 NAPV----------------------SAKVDVYSFGVMLLEIICCRR-SVEMELEEES-----RAILTDWAYDCYVEGRL 661 (728)
Q Consensus 610 ~~~~----------------------s~~~DVwSlGvil~elltg~~-p~~~~~~~~~-----~~~~~~~~~~~~~~~~~ 661 (728)
.... ..+.||||+||+++||+++.. |+........ ...+..| ........
T Consensus 384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~--r~~~~~~~ 461 (507)
T PLN03224 384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRW--RMYKGQKY 461 (507)
T ss_pred CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHH--HhhcccCC
Confidence 4321 234799999999999999875 6543211100 0111111 11111111
Q ss_pred ceeccchhhhhhcHHHHHHHHHHHHHhcccCC---CCCCCHHHHHHH
Q 047292 662 DALIDSDEAAMADRSRLHKWLMIAMWCIQEDP---SKRPTMKVVMQM 705 (728)
Q Consensus 662 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp---~~RPt~~evl~~ 705 (728)
+-. ......+...+++.++|..+| .+|+|++|+++.
T Consensus 462 ----~~~----~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 462 ----DFS----LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred ----Ccc----cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 100 111223456778888998765 789999999853
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=264.63 Aligned_cols=207 Identities=25% Similarity=0.358 Sum_probs=176.5
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCC
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGN 516 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 516 (728)
+.||-|+||+|.++.-. ++...+|+|.|++.. .......+.|-.||...+.+-||+|+-.|.+++.+|+||+|++|
T Consensus 635 k~iGvGAFGeV~Lv~Kv-DT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPG 713 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKV-DTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG 713 (1034)
T ss_pred eeecccccceeEEEeec-chhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCC
Confidence 35999999999998643 567789999997643 33456788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccc---c------
Q 047292 517 GTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLL---S------ 587 (728)
Q Consensus 517 gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~---~------ 587 (728)
|++..+|....-+.+....-++.++..|+++.|. +|+|||||||+|||||.+|++||+||||+.-+. +
T Consensus 714 GDmMSLLIrmgIFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~ 790 (1034)
T KOG0608|consen 714 GDMMSLLIRMGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQE 790 (1034)
T ss_pred ccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccceeccccccccC
Confidence 9999999999999999999999999999999997 599999999999999999999999999986541 0
Q ss_pred -CCCc-------------------------------ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcC
Q 047292 588 -DHSR-------------------------------THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRS 635 (728)
Q Consensus 588 -~~~~-------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p 635 (728)
++.+ ......||+.|+|||++....++..+|.||.|||||||+.|+.|
T Consensus 791 gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~p 870 (1034)
T KOG0608|consen 791 GDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPP 870 (1034)
T ss_pred CCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCC
Confidence 0000 01113499999999999999999999999999999999999999
Q ss_pred cchhhhHhhhhhHHH
Q 047292 636 VEMELEEESRAILTD 650 (728)
Q Consensus 636 ~~~~~~~~~~~~~~~ 650 (728)
|......+....+..
T Consensus 871 f~~~tp~~tq~kv~n 885 (1034)
T KOG0608|consen 871 FLADTPGETQYKVIN 885 (1034)
T ss_pred ccCCCCCcceeeeee
Confidence 987766655444433
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.6e-29 Score=268.15 Aligned_cols=237 Identities=29% Similarity=0.368 Sum_probs=185.1
Q ss_pred hhhCCCcee-EEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccc-cccceeeEeeeeecCCcceeEeeccCCC
Q 047292 440 EELGRGSFG-IVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYEFMGNG 517 (728)
Q Consensus 440 ~~lg~G~fg-~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~g 517 (728)
+.+|.|+-| .||+|.. +++.||||++-. +......+|+..|+.- +|||||++++.-.+....||..|.|. .
T Consensus 515 eilG~Gs~Gt~Vf~G~y---e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~ 587 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVY---EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-C 587 (903)
T ss_pred HHcccCCCCcEEEEEee---CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-h
Confidence 678999887 5799998 488999999843 3345678999999988 69999999999999999999999995 5
Q ss_pred CHHHHHhcC-CC---CChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcC---C--CceEEccccCccccccC
Q 047292 518 TLANLIFAI-PK---PDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDH---Y--FSPKISDFGLSKLLLSD 588 (728)
Q Consensus 518 sL~~~l~~~-~~---~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~---~--~~~kl~Dfgla~~~~~~ 588 (728)
+|.+++... .. ...-..+.+..|+++||++||+- +||||||||.||||+. + .+++|+|||+++.+..+
T Consensus 588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 999999874 11 11134577889999999999995 9999999999999975 2 57899999999988655
Q ss_pred CCc--ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhC-CcCcchhhhHhhhhhHHHHHHHhhhcCccceec
Q 047292 589 HSR--THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICC-RRSVEMELEEESRAILTDWAYDCYVEGRLDALI 665 (728)
Q Consensus 589 ~~~--~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (728)
... ......||-+|+|||.+....-+.+.||+||||++|+.++| +.||......+..... .+..+..+-
T Consensus 665 ~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~--------~~~~L~~L~ 736 (903)
T KOG1027|consen 665 KSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILT--------GNYTLVHLE 736 (903)
T ss_pred cchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhc--------Cccceeeec
Confidence 432 24456799999999999998888899999999999999997 7899865443321110 000011110
Q ss_pred cchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047292 666 DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVM 703 (728)
Q Consensus 666 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl 703 (728)
+ ..++ +..++|.+|++++|..||++.+|+
T Consensus 737 -~------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 737 -P------LPDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred -c------CchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 0 1111 667899999999999999999997
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.5e-27 Score=230.35 Aligned_cols=210 Identities=38% Similarity=0.568 Sum_probs=183.4
Q ss_pred hCCCceeEEEEeeeeCCCCcEEEEEEecccchh-hHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCCCCHH
Q 047292 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQE-REREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLA 520 (728)
Q Consensus 442 lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 520 (728)
||+|.+|.||++... .+++.+++|++...... ....+.+|+..++.++|++++++++++......++++|++++++|.
T Consensus 1 l~~g~~~~v~~~~~~-~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDK-KTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEec-CCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 689999999999875 35789999999765432 3578999999999999999999999999999999999999999999
Q ss_pred HHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcC-CCceEEccccCccccccCCCcccccccC
Q 047292 521 NLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDH-YFSPKISDFGLSKLLLSDHSRTHTMIRG 598 (728)
Q Consensus 521 ~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~g 598 (728)
+++... ..+++..+..++.++++++.+||+. +++|+||+|.||+++. ++.++|+|||.+........ ......+
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~ 155 (215)
T cd00180 80 DLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVG 155 (215)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccC
Confidence 999876 5788999999999999999999997 9999999999999999 89999999999987644321 1223446
Q ss_pred CccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHHH
Q 047292 599 TRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSR 677 (728)
Q Consensus 599 t~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 677 (728)
...|++||.+... ..+.+.|+|++|+++++|
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------ 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------ 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence 7889999999887 888999999999999998
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 678 LHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 678 ~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
..+.+++..|++.+|.+||++.++++.
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 355678899999999999999999865
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-28 Score=252.81 Aligned_cols=192 Identities=24% Similarity=0.350 Sum_probs=167.9
Q ss_pred HhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch--------hhHHHHHHHHHHhcccc---ccceeeEeeeeecCCcc
Q 047292 439 KEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ--------EREREFKSEVSAIGRTH---HKNLVQLLGFCDEALNR 507 (728)
Q Consensus 439 ~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~ 507 (728)
.+++|+|+||.|+.++++. +...|+||.+.+... .+.-.+..|+.+|..++ |+||++++++|++.+..
T Consensus 566 lq~lG~GAyGkV~lai~K~-n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~y 644 (772)
T KOG1152|consen 566 LQPLGEGAYGKVNLAIHKE-NNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYY 644 (772)
T ss_pred eeeccccccceEEEeeecc-cceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCee
Confidence 3679999999999999984 467899999865321 11234667999999997 99999999999999999
Q ss_pred eeEeecc-CCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccc
Q 047292 508 LLVYEFM-GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLL 586 (728)
Q Consensus 508 ~lv~e~~-~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 586 (728)
||++|-. ++-+|.+++...+.+++....-|++||+.|+++||++ +|||||||-+|+.++.+|-+||+|||.+....
T Consensus 645 yl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgsaa~~k 721 (772)
T KOG1152|consen 645 YLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGSAAYTK 721 (772)
T ss_pred EEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccchhhhc
Confidence 9999976 5679999999999999999999999999999999998 99999999999999999999999999987654
Q ss_pred cCCCcccccccCCccccCcccccCCCC-CCccchhhHHHHHHHHHhCCcCcc
Q 047292 587 SDHSRTHTMIRGTRGYVAPEWLKNAPV-SAKVDVYSFGVMLLEIICCRRSVE 637 (728)
Q Consensus 587 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DVwSlGvil~elltg~~p~~ 637 (728)
+. .....+||..|.|||++.+.+| ...-|||++|++||-++....||.
T Consensus 722 sg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 722 SG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred CC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 33 3455779999999999999988 677999999999999988777764
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=214.40 Aligned_cols=259 Identities=19% Similarity=0.318 Sum_probs=189.7
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhcccc-ccceeeEeeeeecC--CcceeE
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTH-HKNLVQLLGFCDEA--LNRLLV 510 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~--~~~~lv 510 (728)
..+++.+++|+|-+++||.|..- .+.+.++||+++.. ..+.+.+|+.+|+.+. ||||++++++..+. ....||
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~-~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINI-TNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred chHHHHHHHcCccHhhHhccccc-CCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 45677899999999999999754 46788999999764 3567899999999997 99999999998655 456799
Q ss_pred eeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcC-CCceEEccccCccccccCC
Q 047292 511 YEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDH-YFSPKISDFGLSKLLLSDH 589 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~-~~~~kl~Dfgla~~~~~~~ 589 (728)
+||+.+.+...+- +.++...+...+.++++||.|+|+. ||+|||+||.|++||. .-.++|+|+|+|.+.....
T Consensus 114 FE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~ 187 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
T ss_pred hhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence 9999987765554 5677778889999999999999996 9999999999999995 5579999999999886554
Q ss_pred CcccccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhh-hhhHHH-----HHHHhhh-----
Q 047292 590 SRTHTMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEES-RAILTD-----WAYDCYV----- 657 (728)
Q Consensus 590 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~-~~~~~~-----~~~~~~~----- 657 (728)
.... ...+..|.-||.+... .|+..-|+|||||+|.+|+..+.||........ ...+.. .......
T Consensus 188 eYnV--RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~ 265 (338)
T KOG0668|consen 188 EYNV--RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID 265 (338)
T ss_pred eeee--eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence 4332 2356778999998654 678999999999999999999999964322111 111110 0011111
Q ss_pred -cCccceeccchh----hhhh---cHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 658 -EGRLDALIDSDE----AAMA---DRS-RLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 658 -~~~~~~~~d~~~----~~~~---~~~-~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
+.+...++.... .... +.. ...+.++++.+.|..|..+|||++|...
T Consensus 266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 111111111100 0000 011 1257788999999999999999998764
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.3e-28 Score=254.66 Aligned_cols=251 Identities=22% Similarity=0.296 Sum_probs=203.7
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccC
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
+.+...+|.|+||.|||++.+ .+++..|+|+++-....+..-++.|+-+++..+|+||+.++|-+......++.|||+.
T Consensus 17 yellqrvgsgTygdvyKaRd~-~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycg 95 (829)
T KOG0576|consen 17 YELLQRVGSGTYGDVYKARDK-RSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCG 95 (829)
T ss_pred hhheeeecCCcccchhhhccc-ccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecC
Confidence 345578999999999999987 5688999999988777778889999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccccc
Q 047292 516 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM 595 (728)
Q Consensus 516 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 595 (728)
+|+|.+.-+....+++.++....+..++||+|||+. +-+|||||-.|||+++.|.+|++|||.+..+.....+ ...
T Consensus 96 ggslQdiy~~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K-rks 171 (829)
T KOG0576|consen 96 GGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK-RKS 171 (829)
T ss_pred CCcccceeeecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhhhh-hhc
Confidence 999999998889999999999999999999999997 8899999999999999999999999998776543332 334
Q ss_pred ccCCccccCcccc---cCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhh
Q 047292 596 IRGTRGYVAPEWL---KNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAM 672 (728)
Q Consensus 596 ~~gt~~y~aPE~~---~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 672 (728)
..||+.|||||+. +...|..++|||++|+...|+--...|.....+........+ ..+++. ...
T Consensus 172 fiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTk------------S~~qpp-~lk 238 (829)
T KOG0576|consen 172 FIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTK------------SGFQPP-TLK 238 (829)
T ss_pred ccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhc------------cCCCCC-ccc
Confidence 5699999999977 456789999999999999999877777654443332211110 111111 011
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 673 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 673 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
......+.+-++++.|+-.+|++||+++.+++
T Consensus 239 Dk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 11233444556888899999999999987664
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.1e-26 Score=226.89 Aligned_cols=197 Identities=31% Similarity=0.459 Sum_probs=173.1
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchh-hHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCC
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQE-REREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGN 516 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 516 (728)
+.+.||+|++|.||++... .+++.+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++|++++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~ 81 (225)
T smart00221 3 LGKKLGEGAFGKVYLARDK-GTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG 81 (225)
T ss_pred eeeEeecCCCeEEEEEEEc-CCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence 4567999999999999876 45789999999765544 567899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCC-CChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccccc
Q 047292 517 GTLANLIFAIPK-PDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM 595 (728)
Q Consensus 517 gsL~~~l~~~~~-~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 595 (728)
++|.+++..... +++..+..++.+++.++.+||+. +++|+||+|+||+++.++.++|+|||.+.............
T Consensus 82 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (225)
T smart00221 82 GDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKT 158 (225)
T ss_pred CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccc
Confidence 999999988766 89999999999999999999997 99999999999999999999999999998775443112233
Q ss_pred ccCCccccCcccc-cCCCCCCccchhhHHHHHHHHHhCCcCcch
Q 047292 596 IRGTRGYVAPEWL-KNAPVSAKVDVYSFGVMLLEIICCRRSVEM 638 (728)
Q Consensus 596 ~~gt~~y~aPE~~-~~~~~s~~~DVwSlGvil~elltg~~p~~~ 638 (728)
..++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 159 ~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 159 VKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 4577889999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-26 Score=233.80 Aligned_cols=131 Identities=27% Similarity=0.387 Sum_probs=110.7
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhcccc--------ccceeeEeeeeec--
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTH--------HKNLVQLLGFCDE-- 503 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~g~~~~-- 503 (728)
.+|.+.++||=|.|++||++.+ ....+.||+|+.+.. ....+....||++|++++ ...||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawD-tq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWD-TQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred ceEEEEEeccccccceeEEEee-ccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 6677789999999999999865 467899999998753 344567788999999874 2469999999854
Q ss_pred --CCcceeEeeccCCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEc
Q 047292 504 --ALNRLLVYEFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLD 569 (728)
Q Consensus 504 --~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~ 569 (728)
+.+.+||+|++ |.+|..+|... +.++...+.+|++||+.||.|||.+| +|||.||||+|||+.
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 56789999998 56888888764 67889999999999999999999985 899999999999994
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.9e-27 Score=227.12 Aligned_cols=256 Identities=24% Similarity=0.283 Sum_probs=185.1
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeeecC------CcceeEe
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEA------LNRLLVY 511 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~lv~ 511 (728)
..+|.|.- .|-.+. ..-.+++||+|++... .....+...+|...+..++|+||++++.++.-. .+.|+||
T Consensus 23 ~p~~~g~~-~v~~a~-D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~ 100 (369)
T KOG0665|consen 23 KPIGSGAQ-IVVAAF-DQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVM 100 (369)
T ss_pred cccCCCCc-eEEecc-hhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHH
Confidence 34677766 444443 3356789999998542 123346778899999999999999999998543 4569999
Q ss_pred eccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 512 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 512 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
|+|. .+|.+.+. -.++-..+..|+.|++.|++|||+. +|+||||||+||++..++.+||.|||+|+....+ -
T Consensus 101 e~m~-~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~--~ 172 (369)
T KOG0665|consen 101 ELMD-ANLCQVIL--MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD--F 172 (369)
T ss_pred Hhhh-hHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccCcc--c
Confidence 9995 58888776 4566678889999999999999997 9999999999999999999999999999865333 3
Q ss_pred ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhh---------------HHHHHHHhh
Q 047292 592 THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAI---------------LTDWAYDCY 656 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~---------------~~~~~~~~~ 656 (728)
..+....|+.|.|||++.+..+.+..||||+||++.||++|+..|.....-+.... +...+....
T Consensus 173 ~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv 252 (369)
T KOG0665|consen 173 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYV 252 (369)
T ss_pred ccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHh
Confidence 55667789999999999999999999999999999999999987764322111111 111111111
Q ss_pred hc------Cccceeccch---hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 657 VE------GRLDALIDSD---EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 657 ~~------~~~~~~~d~~---~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.. -...+.+... ...+.++-....+.+++.+||-.+|++|.+++++++.
T Consensus 253 ~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 253 ENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 10 0111111000 0011112234456689999999999999999999875
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-26 Score=219.13 Aligned_cols=251 Identities=18% Similarity=0.278 Sum_probs=188.8
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccc-cccceeeEeee-eecCCcceeEee
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKNLVQLLGF-CDEALNRLLVYE 512 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~-~~~~~~~~lv~e 512 (728)
.+.+.+.||+|.||.+-++.++ .+...+++|.+... ....++|.+|..---.| .|.||+.-+++ |+..+...+++|
T Consensus 25 ~y~I~k~lgeG~FgkIlL~eHr-~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 25 VYTINKQLGEGRFGKILLAEHR-QSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhHHHHhcccceeeEEeeecc-CCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 4667789999999999999987 56789999998764 23457888888765556 59999987765 567777889999
Q ss_pred ccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEc--CCCceEEccccCccccccCCC
Q 047292 513 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLD--HYFSPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 513 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~--~~~~~kl~Dfgla~~~~~~~~ 590 (728)
|+|.|+|.+-+.. ..+.+..-.+++.|++.||.|||++ ++||||||.+||||- +..++||+|||+.+.......
T Consensus 103 ~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~ 178 (378)
T KOG1345|consen 103 FAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK 178 (378)
T ss_pred cCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCceeh
Confidence 9999999988865 4566777889999999999999998 999999999999994 445899999999886644333
Q ss_pred cccccccCCccccCcccccCC-----CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceec
Q 047292 591 RTHTMIRGTRGYVAPEWLKNA-----PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALI 665 (728)
Q Consensus 591 ~~~~~~~gt~~y~aPE~~~~~-----~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (728)
+. .-+..|.|||..... ...+.+|||.||++++.++||+.||+....... .-|.+..+..+....+.
T Consensus 179 ~~----~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~----~Y~~~~~w~~rk~~~~P 250 (378)
T KOG1345|consen 179 YL----EYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK----PYWEWEQWLKRKNPALP 250 (378)
T ss_pred hh----hhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc----hHHHHHHHhcccCccCc
Confidence 22 235679999977432 346789999999999999999999985433221 12344444444443332
Q ss_pred cchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 666 DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 666 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
+. .....+.++++.++-|.+++++|--+.++.++
T Consensus 251 ~~------F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 251 KK------FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred hh------hcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 21 12234567778888899999999555555444
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.4e-27 Score=240.58 Aligned_cols=279 Identities=18% Similarity=0.202 Sum_probs=208.8
Q ss_pred CcCCCCccccCHHHHHHHHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhcccc------
Q 047292 417 TTSATNLRFFSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTH------ 490 (728)
Q Consensus 417 ~~~~~~~~~~~~~el~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~------ 490 (728)
...+..+....+.|+....|.+.-..|+|-|++|-+|.+. ..|..||||++.+... ..+.=+.|+++|++|+
T Consensus 415 WdDaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~-~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Ed 492 (752)
T KOG0670|consen 415 WDDAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQ-ARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPED 492 (752)
T ss_pred cccccceEEEehhhhhcceeEEEeccccceeeeeeecccc-CCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchh
Confidence 3445556667777888888888888999999999999876 4567999999977533 3455678999999985
Q ss_pred ccceeeEeeeeecCCcceeEeeccCCCCHHHHHhcCC---CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEE
Q 047292 491 HKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIP---KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNIL 567 (728)
Q Consensus 491 h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIl 567 (728)
..|.++++..|....++|||+|-+ ..+|.+.|...+ .+....+..++.|+.-||..|..- +|+|.||||+|||
T Consensus 493 k~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiL 568 (752)
T KOG0670|consen 493 KFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNIL 568 (752)
T ss_pred hhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceE
Confidence 457899999999999999999976 458999998753 467788899999999999999975 9999999999999
Q ss_pred EcCC-CceEEccccCccccccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhh
Q 047292 568 LDHY-FSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRA 646 (728)
Q Consensus 568 l~~~-~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~ 646 (728)
+++. ..+||||||.|....... .+.+..+..|.|||++.+.+|+...|+||.||+||||.||+..|....-.....
T Consensus 569 VNE~k~iLKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLr 645 (752)
T KOG0670|consen 569 VNESKNILKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLR 645 (752)
T ss_pred eccCcceeeeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHH
Confidence 9975 457999999987654332 233445678999999999999999999999999999999998876543332222
Q ss_pred hHHHHH---------HHhhhcCcc----------------------ceeccc------hhh-----hhhcHHHHHHHHHH
Q 047292 647 ILTDWA---------YDCYVEGRL----------------------DALIDS------DEA-----AMADRSRLHKWLMI 684 (728)
Q Consensus 647 ~~~~~~---------~~~~~~~~~----------------------~~~~d~------~~~-----~~~~~~~~~~l~~l 684 (728)
+.+... ...+.+..+ ...+.+ .+. ...++..+..+.+|
T Consensus 646 l~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdL 725 (752)
T KOG0670|consen 646 LFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDL 725 (752)
T ss_pred HHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHH
Confidence 221110 001111100 011111 011 11224456678889
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 047292 685 AMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 685 ~~~cl~~dp~~RPt~~evl~ 704 (728)
+..||..||++|.|..+.|+
T Consensus 726 Ldkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 726 LDKMLILDPEKRITVNQALK 745 (752)
T ss_pred HHHHhccChhhcCCHHHHhc
Confidence 99999999999999998875
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.5e-27 Score=205.44 Aligned_cols=101 Identities=36% Similarity=0.565 Sum_probs=72.2
Q ss_pred CEEEEeCCCCCCCcCCCCcEEEEecCc-eEEeCCCCCeEeec-CC-CC--ceeeEEEecCcCEEEEeccccccccccccc
Q 047292 1 TIIWHANEDNHPVLAPRGSTLELTATG-LLLKDPGGQAIWDE-KP-NK--IVSDAAMLDTGNFVLIASGNHSDYAWQSFK 75 (728)
Q Consensus 1 t~vW~Anr~~~~~~~~~~~~l~~~~~g-l~l~~~~~~~vWst-~~-~~--~~~~a~lld~GNlVl~~~~~~~~~lWQSFD 75 (728)
||||+|||++|+...+..++|.|+.|| |+|++++++++|++ ++ +. .+..|+|+|+|||||++ ..+.+||||||
T Consensus 3 tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d--~~~~~lW~Sf~ 80 (114)
T PF01453_consen 3 TVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYD--SSGNVLWQSFD 80 (114)
T ss_dssp -------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEE--TTSEEEEESTT
T ss_pred ccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEe--ecceEEEeecC
Confidence 799999999876321245899999999 99999999999999 43 33 47889999999999976 47789999999
Q ss_pred cccccccccceeccc------cEEEeeccCCCCC
Q 047292 76 SPTDTILPTQILDLG------SVLVSRLTETNLS 103 (728)
Q Consensus 76 ~PtDtlLpg~~l~~~------~~L~S~~s~~d~s 103 (728)
|||||+||+|+|+.+ ..|+||++.+|||
T Consensus 81 ~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 81 YPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp SSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred CCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 999999999999874 3499999999996
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-26 Score=231.47 Aligned_cols=195 Identities=24% Similarity=0.336 Sum_probs=163.0
Q ss_pred hHHhhhCCCceeEEEEeeeeCC--CCcEEEEEEecccchhhHHHHHHHHHHhccc-cccceeeEeeeeecCCcceeEeec
Q 047292 437 GFKEELGRGSFGIVYKGVLKTA--SGNAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~--~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
...++||+|.|++||++.+... ..+.||+|.+... +....+.+|+++|..+ -+.||+++.+++..++...+|+||
T Consensus 39 ~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~ 116 (418)
T KOG1167|consen 39 KVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPY 116 (418)
T ss_pred hhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecc
Confidence 3457899999999999988753 5679999998653 3456789999999998 599999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcC-CCceEEccccCcccccc-----
Q 047292 514 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDH-YFSPKISDFGLSKLLLS----- 587 (728)
Q Consensus 514 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~-~~~~kl~Dfgla~~~~~----- 587 (728)
+++....++... ++...+..++..+++||+++|.+ |||||||||.|+|.+. .+.-.|.|||+|.....
T Consensus 117 ~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~ 190 (418)
T KOG1167|consen 117 FEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTE 190 (418)
T ss_pred cCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHHhhhhhh
Confidence 999999998865 55788999999999999999998 9999999999999984 67789999999972100
Q ss_pred ---C-----C------------------------------CcccccccCCccccCcccccCC-CCCCccchhhHHHHHHH
Q 047292 588 ---D-----H------------------------------SRTHTMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLE 628 (728)
Q Consensus 588 ---~-----~------------------------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~e 628 (728)
. . ........||++|.|||++... ..+.+.||||-|||++.
T Consensus 191 ~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Ls 270 (418)
T KOG1167|consen 191 HSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLS 270 (418)
T ss_pred hhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeeh
Confidence 0 0 0011123499999999999655 56899999999999999
Q ss_pred HHhCCcCcchh
Q 047292 629 IICCRRSVEME 639 (728)
Q Consensus 629 lltg~~p~~~~ 639 (728)
+++++.||...
T Consensus 271 lls~~~PFf~a 281 (418)
T KOG1167|consen 271 LLSRRYPFFKA 281 (418)
T ss_pred hhccccccccC
Confidence 99999998754
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.2e-25 Score=261.48 Aligned_cols=195 Identities=18% Similarity=0.210 Sum_probs=138.9
Q ss_pred cccc-cceeeEeeee-------ecCCcceeEeeccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 047292 488 RTHH-KNLVQLLGFC-------DEALNRLLVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIH 558 (728)
Q Consensus 488 ~l~h-~niv~l~g~~-------~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH 558 (728)
.++| .||+++++.| .+....++++|++ +++|.++|... ..+++..++.++.||++||.|||++ +|+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---gIvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQ---GIVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhC---Ceee
Confidence 3455 6788888877 2334567788887 56999999764 4689999999999999999999997 9999
Q ss_pred cCCCCCCEEEcC-------------------CCceEEccccCccccccCCC---------------cccccccCCccccC
Q 047292 559 CDIKPQNILLDH-------------------YFSPKISDFGLSKLLLSDHS---------------RTHTMIRGTRGYVA 604 (728)
Q Consensus 559 ~dlk~~NIll~~-------------------~~~~kl~Dfgla~~~~~~~~---------------~~~~~~~gt~~y~a 604 (728)
|||||+||||+. ++.+||+|||+++....... .......||+.|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 999999999954 44566677776654211000 00111347888999
Q ss_pred cccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHH
Q 047292 605 PEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMI 684 (728)
Q Consensus 605 PE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l 684 (728)
||++.+..++.++|||||||+||||++|..|+...... +...... .+.+. ..........+
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~-----~~~~~~~---------~~~~~-----~~~~~~~~~~~ 244 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT-----MSSLRHR---------VLPPQ-----ILLNWPKEASF 244 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH-----HHHHHHh---------hcChh-----hhhcCHHHHHH
Confidence 99999999999999999999999999998876532111 1010000 00000 01112344578
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 047292 685 AMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 685 ~~~cl~~dp~~RPt~~evl~~ 705 (728)
+.+||+++|.+||+|.||++.
T Consensus 245 ~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 245 CLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHhCCCChhhCcChHHHhhc
Confidence 889999999999999999863
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=202.52 Aligned_cols=166 Identities=20% Similarity=0.183 Sum_probs=125.4
Q ss_pred CCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccccc
Q 047292 517 GTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM 595 (728)
Q Consensus 517 gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 595 (728)
|+|.+++... ..+++..++.|+.||++||.|||++ + ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc------
Confidence 6899999874 5689999999999999999999996 3 999999999999999 99988654322
Q ss_pred ccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcH
Q 047292 596 IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADR 675 (728)
Q Consensus 596 ~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 675 (728)
..|++.|+|||++.+..++.++||||||+++|||+||+.||........ .+...... ..... .. ......
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~--~~~~~~~~-~~~~~----~~---~~~~~~ 133 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA--ILEILLNG-MPADD----PR---DRSNLE 133 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH--HHHHHHHH-hccCC----cc---ccccHH
Confidence 2578999999999999999999999999999999999999865432111 11111110 00000 00 000111
Q ss_pred HHH--HHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 047292 676 SRL--HKWLMIAMWCIQEDPSKRPTMKVVMQMLEGL 709 (728)
Q Consensus 676 ~~~--~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 709 (728)
... ..+.+++.+||+.+|.+||++.++++.+...
T Consensus 134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 122 2588899999999999999999999988654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-22 Score=213.03 Aligned_cols=171 Identities=21% Similarity=0.155 Sum_probs=131.0
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc-----chhhHHHHHHHHHHhccccccceee-EeeeeecCCccee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL-----AQEREREFKSEVSAIGRTHHKNLVQ-LLGFCDEALNRLL 509 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~-l~g~~~~~~~~~l 509 (728)
+.+.+.||+|+||+||+|.++..+++.||||++... .......|.+|+++|++++|+|++. ++.. ...++
T Consensus 20 Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~~~L 95 (365)
T PRK09188 20 FVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GKDGL 95 (365)
T ss_pred ceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CCcEE
Confidence 556688999999999999887556778899987532 1223567999999999999999985 4432 45799
Q ss_pred EeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCC-CCCCEEEcCCCceEEccccCccccccC
Q 047292 510 VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDI-KPQNILLDHYFSPKISDFGLSKLLLSD 588 (728)
Q Consensus 510 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dl-k~~NIll~~~~~~kl~Dfgla~~~~~~ 588 (728)
||||+++++|... .. .. ...++.|++++|.|||++ +|+|||| ||+|||++.++.+||+|||+|+.+...
T Consensus 96 VmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~ 165 (365)
T PRK09188 96 VRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRR 165 (365)
T ss_pred EEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccceecccC
Confidence 9999999999732 11 11 246788999999999997 9999999 999999999999999999999977543
Q ss_pred CCc-------ccccccCCccccCcccccCCC------CCCccchh
Q 047292 589 HSR-------THTMIRGTRGYVAPEWLKNAP------VSAKVDVY 620 (728)
Q Consensus 589 ~~~-------~~~~~~gt~~y~aPE~~~~~~------~s~~~DVw 620 (728)
... ..+...+++.|+|||++.-.+ .+..+|-|
T Consensus 166 ~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 166 GALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred cchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 211 113456888999999995332 23346666
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.6e-23 Score=197.12 Aligned_cols=248 Identities=23% Similarity=0.387 Sum_probs=190.9
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecc--cchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDR--LAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
..++..+|.+...|+.|+|++. |..+++|++.. ......++|.+|.-.|+.+.||||+.++|.|....++.++..
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwq---gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq 267 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQ---GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQ 267 (448)
T ss_pred hhhhhhhhccCCCccccccccc---CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeee
Confidence 3456778999999999999996 56778887743 233344789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCC--CChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEc--cccCccccccC
Q 047292 513 FMGNGTLANLIFAIPK--PDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKIS--DFGLSKLLLSD 588 (728)
Q Consensus 513 ~~~~gsL~~~l~~~~~--~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~--Dfgla~~~~~~ 588 (728)
||+.|+|+..|+.... .+-.+..+++.++++|++|||+- .+-|.---|....++||++.+++|. |--++...
T Consensus 268 ~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfqe--- 343 (448)
T KOG0195|consen 268 YMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE--- 343 (448)
T ss_pred eccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeeec---
Confidence 9999999999998743 46678899999999999999985 2234445688899999999988774 32221110
Q ss_pred CCcccccccCCccccCcccccCCCCC---CccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceec
Q 047292 589 HSRTHTMIRGTRGYVAPEWLKNAPVS---AKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALI 665 (728)
Q Consensus 589 ~~~~~~~~~gt~~y~aPE~~~~~~~s---~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (728)
....-.|.||+||.+..++-+ .++|+|||+++||||.|...||......+....+. .
T Consensus 344 -----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia---l------------ 403 (448)
T KOG0195|consen 344 -----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA---L------------ 403 (448)
T ss_pred -----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh---h------------
Confidence 111236789999999877543 36999999999999999999998665554333221 0
Q ss_pred cchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 047292 666 DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710 (728)
Q Consensus 666 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 710 (728)
+.+...+++.....+.+++.-|+..||.+||.+..|+-+||++.
T Consensus 404 -eglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 404 -EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred -ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 11222334444556778888899999999999999999998764
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.4e-22 Score=208.84 Aligned_cols=274 Identities=20% Similarity=0.246 Sum_probs=199.5
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccc----cceeeEeeee-ecCCccee
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHH----KNLVQLLGFC-DEALNRLL 509 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~g~~-~~~~~~~l 509 (728)
.+.+.++||+|+||.||++.........+|+|............+..|..++..+.. +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 455668899999999999987643345788888765433333367888888888763 6888888888 57778899
Q ss_pred EeeccCCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCC-----CceEEccccCc
Q 047292 510 VYEFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHY-----FSPKISDFGLS 582 (728)
Q Consensus 510 v~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~-----~~~kl~Dfgla 582 (728)
||+.+ |.+|.++.... ..++..+.+.|+.|++.+|++||+. +++||||||.|+++... ..+.|.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99977 77999988654 5789999999999999999999997 99999999999999854 46999999999
Q ss_pred c--ccccCCC------cc-cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHH
Q 047292 583 K--LLLSDHS------RT-HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAY 653 (728)
Q Consensus 583 ~--~~~~~~~------~~-~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 653 (728)
+ ....... +. ....+||.+|.++....+.+.+.+.|+||++.++.|++.|..||...........+.....
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 8 3322211 11 2335699999999999999999999999999999999999999965443222111111111
Q ss_pred HhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCCCCCccccccc
Q 047292 654 DCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNPPWSSSFSIAV 725 (728)
Q Consensus 654 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~~ 725 (728)
.. .... .....+. .+.++...+-..+..++|....+...|+.........+..++.|..
T Consensus 255 ~~--------~~~~--~~~~~~~---~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~dw~~ 313 (322)
T KOG1164|consen 255 KL--------LTDR--FGDLKPE---EFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPFDWEV 313 (322)
T ss_pred hh--------cccc--ccCCChH---HHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCCcccc
Confidence 00 0000 0111222 3333444444579999999999999998877665555556666654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.9e-21 Score=188.63 Aligned_cols=262 Identities=17% Similarity=0.231 Sum_probs=196.0
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccc-cccceeeEeeeeecCCcceeEeec
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
.+.+.++||+|.||+++.|+.- -++++||||.-... ....++..|.+..+.| ..++|..++-|-.++..-.||+|.
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl-~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNL-YNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred cceeccccccCcceeeeccccc-ccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 4556789999999999999754 57899999986542 3356788999999988 589999999988888888999998
Q ss_pred cCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCC-----CceEEccccCcccccc
Q 047292 514 MGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHY-----FSPKISDFGLSKLLLS 587 (728)
Q Consensus 514 ~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~-----~~~kl~Dfgla~~~~~ 587 (728)
+ |.+|+++..-. ..++.+++..+|.|++.-++|+|++ .+|.|||||+|+||... ..+.|+|||+|+...+
T Consensus 106 L-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred h-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 7 67898887654 6899999999999999999999997 99999999999999643 4589999999998866
Q ss_pred CCCc------ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCcc
Q 047292 588 DHSR------THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRL 661 (728)
Q Consensus 588 ~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (728)
.... ......||.+||+---..+.+-+.+.|+-|||-++++.|-|..||+.......+... +..-+.+
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kY-----eKIGe~K- 255 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKY-----EKIGETK- 255 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHH-----HHhcccc-
Confidence 5443 334466999999999999999999999999999999999999999876443332221 1111111
Q ss_pred ceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCC
Q 047292 662 DALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVP 713 (728)
Q Consensus 662 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~ 713 (728)
.......--.--+++....++.++. .+-.+-|..+-+...+..+++..
T Consensus 256 -r~T~i~~Lc~g~P~efa~Yl~yvR~---L~F~E~PDYdylr~Lf~dvldr~ 303 (449)
T KOG1165|consen 256 -RSTPIEVLCEGFPEEFATYLRYVRR---LDFFETPDYDYLRKLFDDVLDRL 303 (449)
T ss_pred -ccCCHHHHHhcCHHHHHHHHHHHHh---cCcccCCCHHHHHHHHHHHHHhc
Confidence 1111111111234444444455443 35556777766666655555433
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.7e-22 Score=221.02 Aligned_cols=253 Identities=21% Similarity=0.240 Sum_probs=188.6
Q ss_pred HhhhCCCceeEEEEeeeeCCCCcEEEEEEec-----ccchhh-HHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 439 KEELGRGSFGIVYKGVLKTASGNAIAVKKLD-----RLAQER-EREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 439 ~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~-----~~~~~~-~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
...+|.|++|.|+..... ......+.|... ...... ...+..|+.+-..++|+|++..+..+.+.....-+||
T Consensus 323 ~~~~g~ga~g~~~~~~~~-~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRR-SDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred cceeeecccCceEEEEec-CCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 357899999977766543 223333333321 111111 1236778888888999999988888877777777799
Q ss_pred ccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC--
Q 047292 513 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS-- 590 (728)
Q Consensus 513 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-- 590 (728)
|+++ +|..++.....++...+..+++|+..|+.|||+. +|.|||+|++|++++.++.+||+|||.+..+.....
T Consensus 402 ~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred cccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 9999 9999999877888899999999999999999997 999999999999999999999999999988765544
Q ss_pred -cccccccCCccccCcccccCCCCCC-ccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccch
Q 047292 591 -RTHTMIRGTRGYVAPEWLKNAPVSA-KVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSD 668 (728)
Q Consensus 591 -~~~~~~~gt~~y~aPE~~~~~~~s~-~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 668 (728)
.......|+..|+|||.+.+.+|.+ ..||||.|+++..|++|+.||......+... ... . .....-...
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~------~~~--~-~~~~~~~~~ 548 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF------KTN--N-YSDQRNIFE 548 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch------hhh--c-ccccccccc
Confidence 3344577999999999999999977 4899999999999999999997654433211 000 0 000011111
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 669 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 669 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
...........+...++.++|+.+|.+|.||++|++.
T Consensus 549 ~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 549 GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 1122233445566679999999999999999999864
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.4e-19 Score=191.95 Aligned_cols=256 Identities=29% Similarity=0.375 Sum_probs=193.3
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchh---hHHHHHHHHHHhcccccc-ceeeEeeeeecCCcceeEeec
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQE---REREFKSEVSAIGRTHHK-NLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~g~~~~~~~~~lv~e~ 513 (728)
+.+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++...+......++++++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~----~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 4 ILRKLGEGSFGEVYLARDR----KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred eEEeecCCCCeEEEEEEec----cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 4567999999999999875 68899998654333 367899999999999888 799999999777778999999
Q ss_pred cCCCCHHHHHhcCC---CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCC-ceEEccccCccccccCC
Q 047292 514 MGNGTLANLIFAIP---KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYF-SPKISDFGLSKLLLSDH 589 (728)
Q Consensus 514 ~~~gsL~~~l~~~~---~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~~~ 589 (728)
+.++++.+++.... .+.......+..|++.++.|+|+. +++|||+||+||+++..+ .++++|||+++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997777664 788899999999999999999997 899999999999999988 79999999998654433
Q ss_pred Cc-----ccccccCCccccCcccccC---CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCcc
Q 047292 590 SR-----THTMIRGTRGYVAPEWLKN---APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRL 661 (728)
Q Consensus 590 ~~-----~~~~~~gt~~y~aPE~~~~---~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (728)
.. ......|+..|+|||.+.+ ...+...|+||+|++++++++|..|+...................... ..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~ 235 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-SL 235 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-cc
Confidence 22 2355679999999999988 578899999999999999999999966543210000010111110000 00
Q ss_pred ceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 662 DALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 662 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
........ .......+.+++..++..+|..|.++.+....
T Consensus 236 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 236 ASPLSPSN----PELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccCccc----cchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00000000 01222456678888999999999998887764
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.6e-21 Score=178.65 Aligned_cols=205 Identities=20% Similarity=0.248 Sum_probs=170.8
Q ss_pred HHHHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhcccc-ccceeeEeeeeecCCcceeE
Q 047292 432 KDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTH-HKNLVQLLGFCDEALNRLLV 510 (728)
Q Consensus 432 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv 510 (728)
....+.+.++||+|+||.+|.|... .+|+.||||.-+... ...++..|..+.+.++ ...|..+..+..+...-.+|
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i-~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISI-TSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred eccceEEEEeecCCchhheeeeeec-cCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 3345667789999999999999876 678999999975532 2457788999999886 56788888888899999999
Q ss_pred eeccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcC---CCceEEccccCccccc
Q 047292 511 YEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDH---YFSPKISDFGLSKLLL 586 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~---~~~~kl~Dfgla~~~~ 586 (728)
|+.. |.+|.+++.-. ..++..+.+-++-|++.-++|+|.+ ++|||||||+|+|..- ...+.++|||+|+.+.
T Consensus 90 MdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 9987 67888887644 6788899999999999999999997 9999999999999963 4568999999999876
Q ss_pred cCCCc------ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHh
Q 047292 587 SDHSR------THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEE 643 (728)
Q Consensus 587 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~ 643 (728)
+.... ......||.+|.+--...+.+.+.+.|+-|+|.+|.++.-|..||+......
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t 228 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT 228 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhh
Confidence 54332 2344569999999999988888999999999999999999999998765543
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.8e-20 Score=160.82 Aligned_cols=110 Identities=25% Similarity=0.428 Sum_probs=83.1
Q ss_pred eeccCCCCCCCCCCceeeecccccEEEEecCceeEeccccccCCCCCceeEEEEEccCCcEEEEEeccCCCCCCCcceee
Q 047292 133 YTSNTSSANSSESGHQLVFNESADIYIVKNNGQIVQLPLWAQLSPRADHYFRATLDFDGVFAEYAHSKNSSTNQGWFPTR 212 (728)
Q Consensus 133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rl~L~~dG~l~~y~~~~~~~~~~~W~~~~ 212 (728)
|++|+|++. ...|.+.+.......|.+..+....++.+ ...+.+.++|++||.+|+|++|.|++. ++.|...|
T Consensus 1 wrsG~WnG~-~f~g~p~~~~~~~~~~~fv~~~~e~~~t~---~~~~~s~~~r~~ld~~G~l~~~~w~~~---~~~W~~~~ 73 (110)
T PF00954_consen 1 WRSGPWNGQ-RFSGIPEMSSNSLYNYSFVSNNEEVYYTY---SLSNSSVLSRLVLDSDGQLQRYIWNES---TQSWSVFW 73 (110)
T ss_pred CCccccCCe-EECCcccccccceeEEEEEECCCeEEEEE---ecCCCceEEEEEEeeeeEEEEEEEecC---CCcEEEEE
Confidence 788888874 23333322222333444555555555533 344678899999999999999999875 47899999
Q ss_pred ecCCcccccccccCCCCccCCCcccccCCCCCcccCCCCCcccC
Q 047292 213 TLPDSMCTRLATDIGSGICGFNSYCSLQNGRPFCDCPPGYVLVD 256 (728)
Q Consensus 213 ~~p~~~C~~~~~~~~~~~CG~~g~C~~~~~~~~C~C~~Gf~~~~ 256 (728)
.+|.++||+ |+.||+||+|+. +..+.|+||+||+|++
T Consensus 74 ~~p~d~Cd~------y~~CG~~g~C~~-~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 74 SAPKDQCDV------YGFCGPNGICNS-NNSPKCSCLPGFEPKN 110 (110)
T ss_pred EecccCCCC------ccccCCccEeCC-CCCCceECCCCcCCCc
Confidence 999999999 899999999975 5688999999999875
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.2e-20 Score=208.36 Aligned_cols=250 Identities=22% Similarity=0.244 Sum_probs=179.6
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc-hhhHHHHHHHHHH--hccccccceeeEeeeeecCCcceeEee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA-QEREREFKSEVSA--IGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~--l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
..+.+.||++.|=+|.+++++ .| .|+||++-+.. .-..+.|.++++- ...++|||.+++.-........|||-+
T Consensus 25 ~~~~~~LGstRFlKv~r~k~~--eG-~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 25 CHYVENLGSTRFLKVARAKDR--EG-LVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred eeeecccCchhhhhhhhccCC--Cc-eEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 445688999999999999874 45 48999884432 2223444444433 445689999999888888888899999
Q ss_pred ccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC--
Q 047292 513 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS-- 590 (728)
Q Consensus 513 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-- 590 (728)
|+.+ +|+|.|..++-+.....+.|+.|++.||.-+|.. +|.|+|||.+||||+.-.=+.|+||.--+...-.+.
T Consensus 102 yvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 9865 8999999988888889999999999999999997 999999999999999988899999987654321111
Q ss_pred ----cccccccCCccccCcccccCC----------C-CCCccchhhHHHHHHHHHhC-CcCcchhhhHhhhhhHHHHHHH
Q 047292 591 ----RTHTMIRGTRGYVAPEWLKNA----------P-VSAKVDVYSFGVMLLEIICC-RRSVEMELEEESRAILTDWAYD 654 (728)
Q Consensus 591 ----~~~~~~~gt~~y~aPE~~~~~----------~-~s~~~DVwSlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~ 654 (728)
....+...-..|+|||.+... . .+++-||||+||+++||++- +++|+...-- ++
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~---------aY- 247 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLL---------AY- 247 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHH---------hH-
Confidence 112222234469999987431 2 57789999999999999995 5666533211 11
Q ss_pred hhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 047292 655 CYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGL 709 (728)
Q Consensus 655 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 709 (728)
..+. ....+..+.. ++ ...+.+++..|++.||.+|.++++.++.-.+.
T Consensus 248 --r~~~-~~~~e~~Le~-Ie---d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 248 --RSGN-ADDPEQLLEK-IE---DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred --hccC-ccCHHHHHHh-Cc---CccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 1111 0011110111 11 12567789999999999999999999986554
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.3e-19 Score=175.74 Aligned_cols=138 Identities=17% Similarity=0.121 Sum_probs=107.4
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccchh--h------------------------HHHHHHHHHHhccccccc
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQE--R------------------------EREFKSEVSAIGRTHHKN 493 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~--~------------------------~~~~~~E~~~l~~l~h~n 493 (728)
..||+|+||.||+|... +|+.||||+++..... . ......|++.+.++.+++
T Consensus 3 ~~ig~G~~~~Vy~a~~~--~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 3 GCISTGKEANVYHATTA--NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CccccccceEEEEEECC--CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 57999999999999875 7899999999653211 0 112245999999998777
Q ss_pred eeeEeeeeecCCcceeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHh-hhcCCCCeeecCCCCCCEEEcCCC
Q 047292 494 LVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYL-HEGCNVPIIHCDIKPQNILLDHYF 572 (728)
Q Consensus 494 iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yL-H~~~~~~iiH~dlk~~NIll~~~~ 572 (728)
+.....+.. ...+|||||++++++.........++......++.|++.+|.|| |+. +|+||||||+|||++ ++
T Consensus 81 v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~~ 154 (190)
T cd05147 81 IPCPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCCCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-CC
Confidence 643332221 23489999999988766544446788899999999999999999 565 999999999999998 47
Q ss_pred ceEEccccCcccc
Q 047292 573 SPKISDFGLSKLL 585 (728)
Q Consensus 573 ~~kl~Dfgla~~~ 585 (728)
.++|+|||+|...
T Consensus 155 ~v~LiDFG~a~~~ 167 (190)
T cd05147 155 KLYIIDVSQSVEH 167 (190)
T ss_pred cEEEEEccccccC
Confidence 8999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.1e-19 Score=191.07 Aligned_cols=217 Identities=25% Similarity=0.441 Sum_probs=163.7
Q ss_pred hccccccceeeEeeeeecCCcceeEeeccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCe-eecCCCC
Q 047292 486 IGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPI-IHCDIKP 563 (728)
Q Consensus 486 l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~i-iH~dlk~ 563 (728)
|+.+.|.|+.+++|.+.++...++|.+|+..|+|.+.+... .++++.....+.++|++||.|||.. .| .|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeecc
Confidence 45789999999999999999999999999999999999985 5788999999999999999999986 44 9999999
Q ss_pred CCEEEcCCCceEEccccCccccccC-CCcccccccCCccccCcccccCC-------CCCCccchhhHHHHHHHHHhCCcC
Q 047292 564 QNILLDHYFSPKISDFGLSKLLLSD-HSRTHTMIRGTRGYVAPEWLKNA-------PVSAKVDVYSFGVMLLEIICCRRS 635 (728)
Q Consensus 564 ~NIll~~~~~~kl~Dfgla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~s~~~DVwSlGvil~elltg~~p 635 (728)
+|++++....+||+|||+....... .........-..-|.|||.++.. ..+.+.||||||++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 9999999999999999998776421 11111111223459999999764 146789999999999999999999
Q ss_pred cchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 047292 636 VEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEV 712 (728)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 712 (728)
|...........+...+.. .+ ...+-+..... .+..+.++.++..||..+|.+||++++|-..++.+...
T Consensus 158 ~~~~~~~~~~~eii~~~~~---~~--~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKK---GG--SNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred cccccccCChHHHHHHHHh---cC--CCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 9864433322112111111 01 11111111111 13334688899999999999999999999998877654
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.9e-19 Score=176.15 Aligned_cols=172 Identities=13% Similarity=0.072 Sum_probs=129.7
Q ss_pred HHHHHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHH---------HHHHHHHHhccccccceeeEeeee
Q 047292 431 LKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQERER---------EFKSEVSAIGRTHHKNLVQLLGFC 501 (728)
Q Consensus 431 l~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~---------~~~~E~~~l~~l~h~niv~l~g~~ 501 (728)
+.+..+...+.||.|+||.||.... ++..+|||.+.......+. .+.+|+..+.+++|++|..+..++
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~---~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~ 104 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT---DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY 104 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec---CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence 3344455667899999999998543 4668999999654332222 268999999999999999998875
Q ss_pred ecC--------CcceeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCc
Q 047292 502 DEA--------LNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFS 573 (728)
Q Consensus 502 ~~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~ 573 (728)
... ...+|+|||++|.+|.++.. .+. ....+++.+|..+|+. +++|||+||+||+++.++
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-
Confidence 432 35789999999999988742 222 3456999999999997 999999999999999988
Q ss_pred eEEccccCccccccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHH
Q 047292 574 PKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEII 630 (728)
Q Consensus 574 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ell 630 (728)
++|+|||.......+... . .+.....+..++|+|+||+++..+.
T Consensus 173 i~liDfg~~~~~~e~~a~--d-----------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAK--D-----------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhH--H-----------HHHHHhHhcccccccceeEeehHHH
Confidence 999999987654221111 0 1334445667999999999987654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-18 Score=168.92 Aligned_cols=139 Identities=17% Similarity=0.119 Sum_probs=109.3
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccchh--------------------------hHHHHHHHHHHhccccccc
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQE--------------------------REREFKSEVSAIGRTHHKN 493 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~--------------------------~~~~~~~E~~~l~~l~h~n 493 (728)
..||+|+||.||+|... +|+.||||+++..... ....+..|.+.+.++.|++
T Consensus 3 ~~ig~G~~~~Vy~a~~~--~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 3 GCISTGKEANVYHARTG--DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred ceeecCCCcEEEEEEcC--CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 56999999999999875 7899999998653210 0123467899999999988
Q ss_pred eeeEeeeeecCCcceeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCCEEEcCCC
Q 047292 494 LVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHE-GCNVPIIHCDIKPQNILLDHYF 572 (728)
Q Consensus 494 iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~-~~~~~iiH~dlk~~NIll~~~~ 572 (728)
+.....+... ..+|||||++++++.........++......++.|++.++.+||+ . +|+||||||+||+++ ++
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~~ 154 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-CC
Confidence 7544333322 348999999988654443333456778899999999999999999 6 999999999999999 78
Q ss_pred ceEEccccCccccc
Q 047292 573 SPKISDFGLSKLLL 586 (728)
Q Consensus 573 ~~kl~Dfgla~~~~ 586 (728)
.++|+|||++....
T Consensus 155 ~~~liDFG~a~~~~ 168 (190)
T cd05145 155 KPYIIDVSQAVELD 168 (190)
T ss_pred CEEEEEcccceecC
Confidence 99999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.7e-18 Score=162.59 Aligned_cols=185 Identities=16% Similarity=0.056 Sum_probs=139.4
Q ss_pred HhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhh----HHHHHHHHHHhcccc-ccceeeEeeeeecCCcceeEeec
Q 047292 439 KEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQER----EREFKSEVSAIGRTH-HKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 439 ~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~----~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
...|++|+||+||.+. ..+..++.+.+.....-. ...+.+|+++|++++ |+++++++++ ...+++|||
T Consensus 7 ~~~l~~~~f~~v~~~~---~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 7 NEPLKSDTFGRILLVR---GGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ceeecCCCcceEEEee---cCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3579999999999654 367788888776543311 235789999999994 6889999886 346999999
Q ss_pred cCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCC-CCCCEEEcCCCceEEccccCccccccCCCc-
Q 047292 514 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDI-KPQNILLDHYFSPKISDFGLSKLLLSDHSR- 591 (728)
Q Consensus 514 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dl-k~~NIll~~~~~~kl~Dfgla~~~~~~~~~- 591 (728)
+.|.+|.+.+.. ....++.|++++|.++|++ +|+|||| ||.|||+++++.++|+|||++.........
T Consensus 80 I~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 80 LAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred ecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 999998754421 1245788999999999997 9999999 799999999999999999999855432210
Q ss_pred ---c--------cccccCCccccCcccccCC-CCC-CccchhhHHHHHHHHHhCCcCcchhh
Q 047292 592 ---T--------HTMIRGTRGYVAPEWLKNA-PVS-AKVDVYSFGVMLLEIICCRRSVEMEL 640 (728)
Q Consensus 592 ---~--------~~~~~gt~~y~aPE~~~~~-~~s-~~~DVwSlGvil~elltg~~p~~~~~ 640 (728)
. ......++.|++|+...-. ..+ .+.+.++-|.-+|.++|++.+.-.+.
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 0112367788888755433 333 56889999999999999998865443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=5.7e-19 Score=188.57 Aligned_cols=188 Identities=27% Similarity=0.261 Sum_probs=159.0
Q ss_pred hhCCCceeEEEEeeee--CCCCcEEEEEEecccchh--hHHHHHHHHHHhcccc-ccceeeEeeeeecCCcceeEeeccC
Q 047292 441 ELGRGSFGIVYKGVLK--TASGNAIAVKKLDRLAQE--REREFKSEVSAIGRTH-HKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 441 ~lg~G~fg~Vy~g~~~--~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
.+|+|.||.|+...-- ...+..+|+|.+++.... .......|..++...+ ||.++++.-.++.+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 3789999999875321 123567888888654321 1224566778888886 9999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccccc
Q 047292 516 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM 595 (728)
Q Consensus 516 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 595 (728)
+|.|...+......++.....+...++-+++++|+. +|+|||+|++||+++.+|++++.|||+++..-.....
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---- 153 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc----
Confidence 999999999888888888888889999999999996 9999999999999999999999999999876443322
Q ss_pred ccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcch
Q 047292 596 IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEM 638 (728)
Q Consensus 596 ~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~ 638 (728)
+||..|||||++. ......|.||||++.+||+||..||..
T Consensus 154 -cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 -CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred -ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 7899999999998 567899999999999999999999987
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.73 E-value=7.4e-18 Score=170.00 Aligned_cols=226 Identities=22% Similarity=0.293 Sum_probs=143.6
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHhcccc----------ccceeeEeeeee----
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRL---AQEREREFKSEVSAIGRTH----------HKNLVQLLGFCD---- 502 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~----------h~niv~l~g~~~---- 502 (728)
+.||.|+++.||.+++. .+++.+|||++... .....+++++|.-....+. |-.++..++...
T Consensus 18 ~~i~~g~~~~v~~v~d~-~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 18 RIIGKGGFSIVFEVTDV-ETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEETTEEEEEEEET-TTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred cccccCCceEEEEEEEc-cCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 56999999999999876 67899999988432 2234467777776665532 223333322221
Q ss_pred -----cCC--------cceeEeeccCCCCHHHHHh---cCCC----CChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCC
Q 047292 503 -----EAL--------NRLLVYEFMGNGTLANLIF---AIPK----PDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIK 562 (728)
Q Consensus 503 -----~~~--------~~~lv~e~~~~gsL~~~l~---~~~~----~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk 562 (728)
... ..+++|+-+ -++|.+++. .... .....++.+..|+++.+++||+. +++|+||+
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi~ 172 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDIK 172 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-S
T ss_pred CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecccc
Confidence 111 235667766 457777654 2222 22334567778999999999997 99999999
Q ss_pred CCCEEEcCCCceEEccccCccccccCCCcccccccCCccccCcccccC--------CCCCCccchhhHHHHHHHHHhCCc
Q 047292 563 PQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKN--------APVSAKVDVYSFGVMLLEIICCRR 634 (728)
Q Consensus 563 ~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~~DVwSlGvil~elltg~~ 634 (728)
|+|++++++|.++|+||+........... ...+..|.|||.... ..++.+.|.|+||+++|.|.+++.
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred eeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 99999999999999999877654332111 234578999997743 257889999999999999999999
Q ss_pred CcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCC
Q 047292 635 SVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKR 696 (728)
Q Consensus 635 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R 696 (728)
||........... ...... ...+.+..++..+|+.+|.+|
T Consensus 249 Pf~~~~~~~~~~~---------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEADPEW---------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGSTSGG---------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCccccccc---------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9986644322110 011122 445667789999999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.4e-17 Score=158.17 Aligned_cols=133 Identities=18% Similarity=0.243 Sum_probs=103.8
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccc-----cccceeeEeeeeecCC---c-ceeE
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRT-----HHKNLVQLLGFCDEAL---N-RLLV 510 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~g~~~~~~---~-~~lv 510 (728)
+.||+|+||.||. +. .+... +||++........+.+.+|+.+++.+ +||||++++|+++++. . ..+|
T Consensus 8 ~~LG~G~~~~Vy~--hp-~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 8 SPLGTGRHRKCYA--HP-EDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred ceecCCCceEEEE--CC-CCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 5799999999996 33 23333 68988654444567899999999999 5799999999998874 3 2378
Q ss_pred eec--cCCCCHHHHHhcCCCCChHHHHHHHHHHHHHH-HHhhhcCCCCeeecCCCCCCEEEcC----CCceEEccccCc
Q 047292 511 YEF--MGNGTLANLIFAIPKPDWNLRVRISLEIARGL-VYLHEGCNVPIIHCDIKPQNILLDH----YFSPKISDFGLS 582 (728)
Q Consensus 511 ~e~--~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l-~yLH~~~~~~iiH~dlk~~NIll~~----~~~~kl~Dfgla 582 (728)
+|| +++++|.+++.+. .+++. ..++.|++.++ +|||++ +|+||||||+|||++. +.+++|+||+-+
T Consensus 84 ~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred ecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 999 5589999999764 34444 35677888777 999997 9999999999999974 347999995433
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.8e-17 Score=161.65 Aligned_cols=142 Identities=20% Similarity=0.182 Sum_probs=110.6
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchh------------------------hHHHHHHHHHHhccccc
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQE------------------------REREFKSEVSAIGRTHH 491 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~------------------------~~~~~~~E~~~l~~l~h 491 (728)
+.+.+.||+|+||.||+|.+...+|+.||+|+++..... ....+..|+..+.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 345678999999999999833357899999998643210 11346789999999975
Q ss_pred c--ceeeEeeeeecCCcceeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCC-eeecCCCCCCEEE
Q 047292 492 K--NLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVP-IIHCDIKPQNILL 568 (728)
Q Consensus 492 ~--niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~-iiH~dlk~~NIll 568 (728)
. .++++++. ...++||||+++.+|.................++.||+.+|.+||++ + |+|+||||+||++
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NIli 182 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNILV 182 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhEEE
Confidence 3 34455543 23589999999998877654444556666789999999999999997 8 9999999999999
Q ss_pred cCCCceEEccccCcccc
Q 047292 569 DHYFSPKISDFGLSKLL 585 (728)
Q Consensus 569 ~~~~~~kl~Dfgla~~~ 585 (728)
+ ++.++|+|||.+...
T Consensus 183 ~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 183 H-DGKVVIIDVSQSVEL 198 (237)
T ss_pred E-CCCEEEEEChhhhcc
Confidence 9 889999999998754
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.2e-16 Score=182.96 Aligned_cols=196 Identities=22% Similarity=0.232 Sum_probs=151.9
Q ss_pred HHHHHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhcccc---ccceeeEeeeeecCCcc
Q 047292 431 LKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTH---HKNLVQLLGFCDEALNR 507 (728)
Q Consensus 431 l~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~ 507 (728)
+....+.+.++||+|+||.||+|... +|+.||+|+-+....-. |.--.+++.+|+ -+-|..+...+...+.-
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~--~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHS--NGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecC--CCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 33444556678999999999999986 38999999976532211 111111122222 23344455555667778
Q ss_pred eeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEc-------CCCceEEcccc
Q 047292 508 LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLD-------HYFSPKISDFG 580 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~-------~~~~~kl~Dfg 580 (728)
+||+||.+-|+|.+++...+.+++...+.++.|+++.+++||.. +|||+||||+|+||. +...++|+|||
T Consensus 770 ~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred eeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEecc
Confidence 89999999999999999888999999999999999999999997 999999999999994 24568999999
Q ss_pred CccccccCC-CcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCc
Q 047292 581 LSKLLLSDH-SRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRR 634 (728)
Q Consensus 581 la~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~ 634 (728)
.+..+.--. .......++|-.+-.+|...+.+++.+.|-|.|+.+++-||-|+.
T Consensus 847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 987663221 224455668889999999999999999999999999999998863
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=4e-16 Score=154.97 Aligned_cols=134 Identities=23% Similarity=0.277 Sum_probs=112.7
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccch--------hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEe
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ--------EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 511 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 511 (728)
+.||+|++|.||+|.. .+..+++|+...... .....+.+|++++..++|++++....++......+++|
T Consensus 2 ~~l~~G~~~~vy~~~~---~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF---LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred cccccCceEEEEEEee---CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence 4689999999999986 467899997643211 11246788999999999999887777777778889999
Q ss_pred eccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccc
Q 047292 512 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKL 584 (728)
Q Consensus 512 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~ 584 (728)
||++|++|.+++..... .+..++.+++.+|.+||+. +++|+|++|.|||++ ++.++|+|||++..
T Consensus 79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999999865432 7889999999999999997 999999999999999 78999999998864
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.7e-16 Score=140.50 Aligned_cols=72 Identities=36% Similarity=0.686 Sum_probs=62.0
Q ss_pred CEEEEeCCCCCCCcCCCCcEEEEecCc-eEEeCCCCCeEeecCCC--CceeeEEEecCcCEEEEeccccccccccccccc
Q 047292 1 TIIWHANEDNHPVLAPRGSTLELTATG-LLLKDPGGQAIWDEKPN--KIVSDAAMLDTGNFVLIASGNHSDYAWQSFKSP 77 (728)
Q Consensus 1 t~vW~Anr~~~~~~~~~~~~l~~~~~g-l~l~~~~~~~vWst~~~--~~~~~a~lld~GNlVl~~~~~~~~~lWQSFD~P 77 (728)
++||.||++.|. ...++|.|+.+| |+|+|.+|.++|+++.. .....|+|+|+|||||++. ++.+||||||||
T Consensus 42 ~~vW~snt~~~~---~~~~~l~l~~dGnLvl~~~~g~~vW~S~~~~~~~~~~~~L~ddGnlvl~~~--~~~~~W~Sf~~P 116 (116)
T cd00028 42 TVVWVANRDNPS---GSSCTLTLQSDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDS--DGNFLWQSFDYP 116 (116)
T ss_pred eEEEECCCCCCC---CCCEEEEEecCCCeEEEcCCCcEEEEecccCCCCceEEEEeCCCCEEEECC--CCCEEEcCCCCC
Confidence 589999999752 456889999999 99999999999999853 4567899999999999654 578999999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.8e-16 Score=156.33 Aligned_cols=198 Identities=22% Similarity=0.232 Sum_probs=136.9
Q ss_pred cccceeeEeeeee---------------------------cCCcceeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHH
Q 047292 490 HHKNLVQLLGFCD---------------------------EALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIA 542 (728)
Q Consensus 490 ~h~niv~l~g~~~---------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~ 542 (728)
+|||||++.++|. ++..+|+||.-.+ .+|.+++.... .+.....-|+.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~-~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH-RSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC-CchHHHHHHHHHHH
Confidence 6899988888763 2344688888764 48999998754 44556677889999
Q ss_pred HHHHHhhhcCCCCeeecCCCCCCEEE--cCCC--ceEEccccCccccccCCCc-----ccccccCCccccCcccccCCCC
Q 047292 543 RGLVYLHEGCNVPIIHCDIKPQNILL--DHYF--SPKISDFGLSKLLLSDHSR-----THTMIRGTRGYVAPEWLKNAPV 613 (728)
Q Consensus 543 ~~l~yLH~~~~~~iiH~dlk~~NIll--~~~~--~~kl~Dfgla~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~ 613 (728)
+|+.|||.+ +|.|||+|++|||| ++++ .+.|+|||.+-......-+ -.-..-|...-||||+....+-
T Consensus 352 Eav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG 428 (598)
T KOG4158|consen 352 EAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG 428 (598)
T ss_pred HHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence 999999998 99999999999998 3444 4688999987543321111 1112346778999999864421
Q ss_pred ------CCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHH
Q 047292 614 ------SAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMW 687 (728)
Q Consensus 614 ------s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~ 687 (728)
-.|+|.|+.|.+.||+++...||....+.... . ..+.+..+..+.+. ....+.+++..
T Consensus 429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~----~---r~Yqe~qLPalp~~---------vpp~~rqlV~~ 492 (598)
T KOG4158|consen 429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD----T---RTYQESQLPALPSR---------VPPVARQLVFD 492 (598)
T ss_pred CceeeccchhhhhhhhhhHHHHhccCCcccccchheec----h---hhhhhhhCCCCccc---------CChHHHHHHHH
Confidence 24899999999999999999999863322111 0 11223333333322 22345678888
Q ss_pred hcccCCCCCCCHHHHHHHHhc
Q 047292 688 CIQEDPSKRPTMKVVMQMLEG 708 (728)
Q Consensus 688 cl~~dp~~RPt~~evl~~L~~ 708 (728)
.|+.||++|++..-....|.-
T Consensus 493 lL~r~pskRvsp~iAANvl~L 513 (598)
T KOG4158|consen 493 LLKRDPSKRVSPNIAANVLNL 513 (598)
T ss_pred HhcCCccccCCccHHHhHHHH
Confidence 999999999987766555543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.5e-17 Score=170.89 Aligned_cols=170 Identities=24% Similarity=0.330 Sum_probs=128.6
Q ss_pred CcceeEeeccCCCCHHHHHhcC---CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccC
Q 047292 505 LNRLLVYEFMGNGTLANLIFAI---PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGL 581 (728)
Q Consensus 505 ~~~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgl 581 (728)
..+++.|+++...+|.+||... ...++.....++.|++.|++| + +.+|+|+||.||+...+..+||.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 3578999999999999999765 356778889999999999999 4 899999999999999999999999999
Q ss_pred ccccccCC-----CcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHh
Q 047292 582 SKLLLSDH-----SRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDC 655 (728)
Q Consensus 582 a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 655 (728)
........ ...++...||..||+||.+.+..|+.|+||||||++|+|+++ -...++... ...-
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~-----------t~~d 471 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA-----------TLTD 471 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH-----------hhhh
Confidence 88775544 335566779999999999999999999999999999999997 333332111 1111
Q ss_pred hhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHH
Q 047292 656 YVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMK 700 (728)
Q Consensus 656 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ 700 (728)
+..+.++..+ ... . +.-..++.+++.+.|.+||++.
T Consensus 472 ~r~g~ip~~~----~~d-~----p~e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 472 IRDGIIPPEF----LQD-Y----PEEYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred hhcCCCChHH----hhc-C----cHHHHHHHHhcCCCcccCchHH
Confidence 2222222110 001 1 1223578889999999999433
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.2e-15 Score=150.08 Aligned_cols=130 Identities=22% Similarity=0.316 Sum_probs=105.6
Q ss_pred hhCCCceeEEEEeeeeCCCCcEEEEEEecccc--------hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 441 ELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA--------QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 441 ~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
.||+|+||.||+|.+ .+..|++|+..... ......+.+|++++..++|+++.....++......++|||
T Consensus 1 ~ig~G~~~~vy~~~~---~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF---LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVME 77 (199)
T ss_pred CCCCCceEEEEEeec---CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEE
Confidence 389999999999985 46789999864321 1123567889999999988876555555556667799999
Q ss_pred ccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccc
Q 047292 513 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKL 584 (728)
Q Consensus 513 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~ 584 (728)
|+++++|.+++..... .++.+++.+|.+||+. +++|+|++|.||+++ ++.++++|||++..
T Consensus 78 ~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 78 YIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999999988754321 7899999999999997 999999999999999 78999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.4e-16 Score=178.35 Aligned_cols=203 Identities=24% Similarity=0.274 Sum_probs=141.7
Q ss_pred HhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCCCC
Q 047292 439 KEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGT 518 (728)
Q Consensus 439 ~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 518 (728)
.+.|..|++|.||...++ .+.++.|+|+-+.... +++ ++.....|.+| |+
T Consensus 88 IklisngAygavylvrh~-~trqrfa~kiNkq~li-----lRn---ilt~a~npfvv---------------------gD 137 (1205)
T KOG0606|consen 88 IKLISNGAYGAVYLVRHK-ETRQRFAMKINKQNLI-----LRN---ILTFAGNPFVV---------------------GD 137 (1205)
T ss_pred eEeeccCCCCceeeeecc-ccccchhhcccccchh-----hhc---cccccCCccee---------------------ch
Confidence 357899999999999876 4556778754332111 011 22233344333 44
Q ss_pred HHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccC--------C-
Q 047292 519 LANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD--------H- 589 (728)
Q Consensus 519 L~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~--------~- 589 (728)
-...+...+.++... +.+++|||+. +|+|||+||+|.+|+.-|++|++|||+.+...-. +
T Consensus 138 c~tllk~~g~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I 206 (1205)
T KOG0606|consen 138 CATLLKNIGPLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHI 206 (1205)
T ss_pred hhhhcccCCCCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcch
Confidence 455555544444333 7889999996 9999999999999999999999999998764211 0
Q ss_pred -----CcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCcccee
Q 047292 590 -----SRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDAL 664 (728)
Q Consensus 590 -----~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (728)
......++||+.|+|||++..+.|....|.|++|+|+||.+-|..||..+..++....+....
T Consensus 207 ~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~------------ 274 (1205)
T KOG0606|consen 207 EKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD------------ 274 (1205)
T ss_pred HHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhh------------
Confidence 011233579999999999999999999999999999999999999999887766543322100
Q ss_pred ccchhhhhhcHHHHHHHHHHHHHhcccCCCCCC
Q 047292 665 IDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRP 697 (728)
Q Consensus 665 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP 697 (728)
....+.+.....++.+++.+.|+.+|..|-
T Consensus 275 ---i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 275 ---IEWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred ---ccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 001111223344667788889999999994
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.5e-15 Score=148.98 Aligned_cols=136 Identities=19% Similarity=0.155 Sum_probs=106.5
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch----------------------hhHHHHHHHHHHhcccccc-
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ----------------------EREREFKSEVSAIGRTHHK- 492 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~----------------------~~~~~~~~E~~~l~~l~h~- 492 (728)
+.+.+.||+|+||.||++..+ +++.||||++..... .....+..|+.++..+.|+
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP--DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhcCCccccCcceEEEEEEcC--CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 455678999999999999864 689999998643210 0112367788889888777
Q ss_pred -ceeeEeeeeecCCcceeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCC
Q 047292 493 -NLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHY 571 (728)
Q Consensus 493 -niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~ 571 (728)
.++..++. ...++||||+++++|...... .....++.+++.++.++|+. +|+|+||||+||+++++
T Consensus 95 i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~~~ 161 (198)
T cd05144 95 FPVPKPIDW----NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVDDD 161 (198)
T ss_pred CCCCceeec----CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEcCC
Confidence 44444442 345899999999998765431 34567889999999999996 99999999999999999
Q ss_pred CceEEccccCccccc
Q 047292 572 FSPKISDFGLSKLLL 586 (728)
Q Consensus 572 ~~~kl~Dfgla~~~~ 586 (728)
+.++|+|||++....
T Consensus 162 ~~~~liDfg~~~~~~ 176 (198)
T cd05144 162 EKIYIIDWPQMVSTD 176 (198)
T ss_pred CcEEEEECCccccCC
Confidence 999999999996553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.9e-15 Score=170.89 Aligned_cols=132 Identities=17% Similarity=0.291 Sum_probs=108.2
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEe-cc-cc------hhhHHHHHHHHHHhccccccceeeEeeeeecCCccee
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKL-DR-LA------QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLL 509 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l-~~-~~------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 509 (728)
..+.||+|+||.||+|.+. +..+++|+. .. .. ......+.+|++++..++|++++....++......++
T Consensus 337 ~~~~iG~G~~g~Vy~~~~~---~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l 413 (535)
T PRK09605 337 PDHLIGKGAEADIKKGEYL---GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTI 413 (535)
T ss_pred ccceeccCCcEEEEEEeec---CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEE
Confidence 3578999999999999864 333444432 11 11 1123568899999999999999988888777778899
Q ss_pred EeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccc
Q 047292 510 VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKL 584 (728)
Q Consensus 510 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~ 584 (728)
||||+++++|.+++. ....++.+++++|.|||+. +++||||||+|||+ +++.++|+|||+++.
T Consensus 414 v~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 414 VMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 999999999999885 4578999999999999997 99999999999999 677999999999875
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.9e-15 Score=133.52 Aligned_cols=71 Identities=34% Similarity=0.654 Sum_probs=60.2
Q ss_pred CEEEEeCCCCCCCcCCCCcEEEEecCc-eEEeCCCCCeEeecCC--CCceeeEEEecCcCEEEEecccccccccccccc
Q 047292 1 TIIWHANEDNHPVLAPRGSTLELTATG-LLLKDPGGQAIWDEKP--NKIVSDAAMLDTGNFVLIASGNHSDYAWQSFKS 76 (728)
Q Consensus 1 t~vW~Anr~~~~~~~~~~~~l~~~~~g-l~l~~~~~~~vWst~~--~~~~~~a~lld~GNlVl~~~~~~~~~lWQSFD~ 76 (728)
++||.|||+.|. ..++.|.|..+| |+|++.+|.+||++++ +.....|+|+|+|||||++ ..+.+|||||||
T Consensus 41 ~~vW~snt~~~~---~~~~~l~l~~dGnLvl~~~~g~~vW~S~t~~~~~~~~~~L~ddGnlvl~~--~~~~~~W~Sf~~ 114 (114)
T smart00108 41 TVVWVANRDNPV---SDSCTLTLQSDGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYD--SDGNFLWQSFDY 114 (114)
T ss_pred cEEEECCCCCCC---CCCEEEEEeCCCCEEEEeCCCCEEEEecccCCCCceEEEEeCCCCEEEEC--CCCCEEeCCCCC
Confidence 489999999764 234889999999 9999999999999985 3556789999999999954 456799999997
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.53 E-value=3.3e-14 Score=138.22 Aligned_cols=136 Identities=18% Similarity=0.182 Sum_probs=96.2
Q ss_pred HhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchh--hHHH----------------------HHHHHHHhcccccc--
Q 047292 439 KEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQE--RERE----------------------FKSEVSAIGRTHHK-- 492 (728)
Q Consensus 439 ~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~--~~~~----------------------~~~E~~~l~~l~h~-- 492 (728)
.+.||+|+||.||+|... +++.||||++...... .... ...|...+.++.+.
T Consensus 2 ~~~lg~G~~g~Vy~a~~~--~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 2 GGPIGTGKEADVYLALDG--DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CcccccccceeEEEEECC--CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 357999999999999865 6889999987642211 1111 13455666665433
Q ss_pred ceeeEeeeeecCCcceeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCCEEEcCC
Q 047292 493 NLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHE-GCNVPIIHCDIKPQNILLDHY 571 (728)
Q Consensus 493 niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~-~~~~~iiH~dlk~~NIll~~~ 571 (728)
.+.+.+++ ...++||||++++.+........... .....++.+++.++.++|. . +|+|+||||+||+++ +
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-D 150 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-C
Confidence 24444443 24689999999954322111110111 5678899999999999998 6 999999999999999 8
Q ss_pred CceEEccccCcccc
Q 047292 572 FSPKISDFGLSKLL 585 (728)
Q Consensus 572 ~~~kl~Dfgla~~~ 585 (728)
+.++|+|||.+...
T Consensus 151 ~~~~liDfg~a~~~ 164 (187)
T cd05119 151 GKVYIIDVPQAVEI 164 (187)
T ss_pred CcEEEEECcccccc
Confidence 99999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.52 E-value=5.9e-14 Score=130.94 Aligned_cols=133 Identities=20% Similarity=0.162 Sum_probs=113.5
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccc--cceeeEeeeeecCCcceeEeeccCCC
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHH--KNLVQLLGFCDEALNRLLVYEFMGNG 517 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lv~e~~~~g 517 (728)
+.||+|.++.||++... +..+++|....... ...+..|+.++..++| .++++++++....+..++++||++++
T Consensus 4 ~~i~~g~~~~v~~~~~~---~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 4 KLLKGGLTNRVYLLGTK---DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred eecccccccceEEEEec---CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 56999999999999864 36899999865433 5678899999999976 58999999988888899999999988
Q ss_pred CHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccc
Q 047292 518 TLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKL 584 (728)
Q Consensus 518 sL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~ 584 (728)
.+..+ +......++.+++++|++||.....+++|+|++|+||++++.+.+++.|||.+..
T Consensus 79 ~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77654 5567778899999999999986445799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.4e-15 Score=171.10 Aligned_cols=253 Identities=23% Similarity=0.307 Sum_probs=188.5
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHhcccc-ccceeeEeeeeecCCcceeEee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA--QEREREFKSEVSAIGRTH-HKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e 512 (728)
+.+.+.||+|+|+.|-...........+|+|.+.... .........|..+-..+. |+|++++++........+++.+
T Consensus 22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~ 101 (601)
T KOG0590|consen 22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLS 101 (601)
T ss_pred ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccC
Confidence 3445669999999998876654555678888776543 222345556777777776 9999999999999999999999
Q ss_pred ccCCCCHHHHH-hcCC-CCChHHHHHHHHHHHHHHHHhh-hcCCCCeeecCCCCCCEEEcCCC-ceEEccccCcccccc-
Q 047292 513 FMGNGTLANLI-FAIP-KPDWNLRVRISLEIARGLVYLH-EGCNVPIIHCDIKPQNILLDHYF-SPKISDFGLSKLLLS- 587 (728)
Q Consensus 513 ~~~~gsL~~~l-~~~~-~~~~~~~~~i~~qi~~~l~yLH-~~~~~~iiH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~- 587 (728)
|..++++.+.+ .... ..+....-.++.|+..++.|+| .. ++.|+|+||+|.+++..+ ..+++|||+|.....
T Consensus 102 ~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 102 YSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred cccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 99999999988 4443 5666777889999999999999 65 999999999999999999 999999999988765
Q ss_pred -CCCcccccccC-CccccCcccccCCC-CCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCcccee
Q 047292 588 -DHSRTHTMIRG-TRGYVAPEWLKNAP-VSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDAL 664 (728)
Q Consensus 588 -~~~~~~~~~~g-t~~y~aPE~~~~~~-~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (728)
..........| ++.|+|||...+.. ..+..|+||.|+++.-+++|..|++........ ...| .+... .
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~--~~~~-----~~~~~--~ 249 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR--YSSW-----KSNKG--R 249 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc--ceee-----ccccc--c
Confidence 33444455668 99999999998854 467899999999999999999998765443311 1111 11110 0
Q ss_pred ccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 665 IDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 665 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
..... .........++..+++..+|..|.+.+++..
T Consensus 250 ~~~~~----~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 250 FTQLP----WNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cccCc----cccCChhhhhcccccccCCchhccccccccc
Confidence 00000 0111224456777788899999999887653
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.9e-13 Score=137.51 Aligned_cols=135 Identities=16% Similarity=0.115 Sum_probs=104.0
Q ss_pred hhhC-CCceeEEEEeeeeCCCCcEEEEEEecccc-------------hhhHHHHHHHHHHhccccccce--eeEeeeeec
Q 047292 440 EELG-RGSFGIVYKGVLKTASGNAIAVKKLDRLA-------------QEREREFKSEVSAIGRTHHKNL--VQLLGFCDE 503 (728)
Q Consensus 440 ~~lg-~G~fg~Vy~g~~~~~~~~~vavK~l~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~g~~~~ 503 (728)
..|| .|+.|+||+... .+..++||...... ......+.+|++++.+++|+++ ++.+++...
T Consensus 37 ~~lg~~~g~gtv~~v~~---~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT---PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred ceeecCCCCccEEEEEe---CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 4587 888999998865 36789999875311 1223567889999999998775 677776543
Q ss_pred CCc----ceeEeeccCC-CCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEcc
Q 047292 504 ALN----RLLVYEFMGN-GTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISD 578 (728)
Q Consensus 504 ~~~----~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~D 578 (728)
... .++|+|++++ .+|.+++... .++. ..+.+|+.+|.+||+. +|+|+||||.|||++.++.++|+|
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~----~~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQEA-PLSE----EQWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhcC-CCCH----HHHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEEE
Confidence 322 2599999997 6899888653 3333 2467899999999997 999999999999999988999999
Q ss_pred ccCcccc
Q 047292 579 FGLSKLL 585 (728)
Q Consensus 579 fgla~~~ 585 (728)
||.+...
T Consensus 186 fg~~~~~ 192 (239)
T PRK01723 186 FDRGELR 192 (239)
T ss_pred CCCcccC
Confidence 9988753
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.4e-12 Score=127.21 Aligned_cols=199 Identities=19% Similarity=0.317 Sum_probs=136.4
Q ss_pred HHhccccccceeeEeeeeecC-----CcceeEeeccCCCCHHHHHhcC----CCCChHHHHHHHHHHHHHHHHhhhcCCC
Q 047292 484 SAIGRTHHKNLVQLLGFCDEA-----LNRLLVYEFMGNGTLANLIFAI----PKPDWNLRVRISLEIARGLVYLHEGCNV 554 (728)
Q Consensus 484 ~~l~~l~h~niv~l~g~~~~~-----~~~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~i~~qi~~~l~yLH~~~~~ 554 (728)
.-|-++.|.|||+++.|+.+. ....++.|||..|+|..+|++. ..+......+++.||..||.|||+ |.+
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence 334456799999999987543 4467899999999999999865 345666778999999999999998 578
Q ss_pred CeeecCCCCCCEEEcCCCceEEccccCccccccC----CCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHH
Q 047292 555 PIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD----HSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEII 630 (728)
Q Consensus 555 ~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ell 630 (728)
.|+|+++..+.|++..++-+|+.--. -...... .........+-++|.+||+=.....+.++|||+||+..+||.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~a-p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVA-PDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEecccC-ccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 99999999999999999988875321 1111110 001111234678999999988888889999999999999998
Q ss_pred hCCcC-cchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 631 CCRRS-VEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 631 tg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.+..- -.....-.....+.. ....+...+. ..++.+|++..|..||+|++++..
T Consensus 277 ilEiq~tnseS~~~~ee~ia~----------~i~~len~lq-----------r~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIAN----------VIIGLENGLQ-----------RGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HheeccCCCcceeehhhhhhh----------heeeccCccc-----------cCcCcccccCCCCCCcchhhhhcC
Confidence 76532 222111111111100 0001111111 135667999999999999987643
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.31 E-value=5.9e-12 Score=137.73 Aligned_cols=139 Identities=22% Similarity=0.230 Sum_probs=98.5
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhh----------------------------------------HHHH
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQER----------------------------------------EREF 479 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~----------------------------------------~~~~ 479 (728)
+.||.|++|.||+|+++ +|+.||||+.+....+. +-+|
T Consensus 123 ~plasaSigQVh~A~l~--~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV--DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred cceeeeehhheEEEEec--CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 35999999999999986 68999999986432110 0124
Q ss_pred HHHHHHhcccc----ccceeeEeeee-ecCCcceeEeeccCCCCHHHHHhcC-CCCChHHHHHHHHHHHH-HHHHhhhcC
Q 047292 480 KSEVSAIGRTH----HKNLVQLLGFC-DEALNRLLVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIAR-GLVYLHEGC 552 (728)
Q Consensus 480 ~~E~~~l~~l~----h~niv~l~g~~-~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~-~l~yLH~~~ 552 (728)
..|.+.+.+++ |.+-+.+-.++ ......+|||||++|++|.++.... ... .+.+++.+++. .+..+|..
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~- 276 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRD- 276 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhC-
Confidence 45555555542 22333333333 3345679999999999998876532 111 24556666666 46778876
Q ss_pred CCCeeecCCCCCCEEEcCCCceEEccccCccccc
Q 047292 553 NVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLL 586 (728)
Q Consensus 553 ~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 586 (728)
+++|+|++|.||+++++++++++|||++..+.
T Consensus 277 --g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 --GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred --CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999987664
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.25 E-value=3.9e-12 Score=99.55 Aligned_cols=56 Identities=27% Similarity=0.469 Sum_probs=48.6
Q ss_pred eeEEEecccCCCCCCcccc-CCCChhhHHHHhccCCCccccccc----CcccccccCCCCC
Q 047292 285 YEIREFNNVDWPLGDYERL-EPSNQTECEISCLQDCSCAVAIYD----GNRCWKKKLPLSN 340 (728)
Q Consensus 285 ~~f~~~~~~~~p~~~~~~~-~~~~~~~C~~~Cl~~CsC~a~~~~----~~~C~~~~~~l~~ 340 (728)
++|+++++|++|+++.... .+.++++|+..|++||||+||+|. +++|++|...|.+
T Consensus 5 d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~~L~d 65 (66)
T PF08276_consen 5 DGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYGDLVD 65 (66)
T ss_pred CEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcCEeec
Confidence 6899999999999876544 568999999999999999999995 4789999887764
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.5e-11 Score=132.41 Aligned_cols=252 Identities=22% Similarity=0.204 Sum_probs=179.2
Q ss_pred HHHHHHHhhHHhhhCC--CceeEEEEeee--eCCCCcEEEEEEecccch--hhHHHHHHHHHHhccc-cccceeeEeeee
Q 047292 429 DELKDATDGFKEELGR--GSFGIVYKGVL--KTASGNAIAVKKLDRLAQ--EREREFKSEVSAIGRT-HHKNLVQLLGFC 501 (728)
Q Consensus 429 ~el~~~~~~~~~~lg~--G~fg~Vy~g~~--~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~ 501 (728)
.+..+.+....+.+|. |.+|.||.+.. . .++..+|+|+-+.... .....=.+|+...+.+ .|+|.++....+
T Consensus 109 ~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~-~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~ 187 (524)
T KOG0601|consen 109 DSFFDQRFPISSRTGSLPGSKGSVFKSRCTNS-ESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW 187 (524)
T ss_pred cchhhhhcccccccccCCCCCceeecccCCcc-cCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc
Confidence 3455556666788999 99999999876 3 4567889998543222 2222334566666666 499999988999
Q ss_pred ecCCcceeEeeccCCCCHHHHHhcCCC-CChHHHHHHHHHHHH----HHHHhhhcCCCCeeecCCCCCCEEEcCC-CceE
Q 047292 502 DEALNRLLVYEFMGNGTLANLIFAIPK-PDWNLRVRISLEIAR----GLVYLHEGCNVPIIHCDIKPQNILLDHY-FSPK 575 (728)
Q Consensus 502 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~i~~qi~~----~l~yLH~~~~~~iiH~dlk~~NIll~~~-~~~k 575 (728)
+..+..++-.|++. .+|.++...... ++...++....+... ||.++|.. .++|-|+||.||++..+ ...+
T Consensus 188 e~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~ 263 (524)
T KOG0601|consen 188 EGSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCK 263 (524)
T ss_pred ccCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceee
Confidence 99999999999885 788888876643 677778888888888 99999997 99999999999999998 8899
Q ss_pred EccccCccccccCCCc----ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHH
Q 047292 576 ISDFGLSKLLLSDHSR----THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDW 651 (728)
Q Consensus 576 l~Dfgla~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~ 651 (728)
++|||+...+....-. ......|...|++||.+.+. ++...|+|++|.+++|..++........ ...|
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~-------~~~W 335 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGK-------NSSW 335 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCC-------CCCc
Confidence 9999999888655421 12223578889999998764 6789999999999999998875432110 0011
Q ss_pred HHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047292 652 AYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVM 703 (728)
Q Consensus 652 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl 703 (728)
.+ +.... ...++...-..++...+.++++.+|..|++.+.+.
T Consensus 336 ~~-------~r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 336 SQ-------LRQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred cc-------ccccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 00 00000 01111111123344477889999999999877654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.16 E-value=8.5e-11 Score=112.21 Aligned_cols=130 Identities=18% Similarity=0.124 Sum_probs=95.9
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccce-eeEeeeeecCCcceeEeeccCCCC
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNL-VQLLGFCDEALNRLLVYEFMGNGT 518 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~e~~~~gs 518 (728)
+.|+.|.++.||++.. .++.+++|....... ....+..|+.+++.+.+.++ .+++.+.. ...++|||++++.+
T Consensus 4 ~~l~~G~~~~vy~~~~---~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~ 77 (170)
T cd05151 4 SPLKGGMTNKNYRVEV---ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE 77 (170)
T ss_pred eecCCcccCceEEEEE---CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence 4688999999999875 367899999755322 12356788999998865554 45555433 34589999999988
Q ss_pred HHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcC--CCCeeecCCCCCCEEEcCCCceEEccccCccc
Q 047292 519 LANLIFAIPKPDWNLRVRISLEIARGLVYLHEGC--NVPIIHCDIKPQNILLDHYFSPKISDFGLSKL 584 (728)
Q Consensus 519 L~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~--~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~ 584 (728)
+.+.. .....++.+++++|+.||... ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 78 l~~~~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 78 LLTED--------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccccc--------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 76430 112346788999999999862 22369999999999999 66899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.14 E-value=5.4e-10 Score=121.41 Aligned_cols=170 Identities=17% Similarity=0.229 Sum_probs=127.6
Q ss_pred eeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCCCCHHHHHhcCCCCChH
Q 047292 453 GVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWN 532 (728)
Q Consensus 453 g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~ 532 (728)
|..+ .++.+|.|+..+...........+-++.|+.++||||++++...+.....|||+|-+. .|..++.+.. ..
T Consensus 31 ~t~k-~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~---~~ 104 (690)
T KOG1243|consen 31 GTRK-ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG---KE 104 (690)
T ss_pred ccee-ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH---HH
Confidence 4444 4677888888876655445667888999999999999999999999999999999873 4556665433 34
Q ss_pred HHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccccccCCccccCcccccCCC
Q 047292 533 LRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAP 612 (728)
Q Consensus 533 ~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 612 (728)
...-.+.||+.||.|||+.| +++|++|....|++++.|..||++|.++........ .......-..|..|+.+....
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc
Confidence 45566889999999999763 899999999999999999999999988754322111 111111223466676554332
Q ss_pred CCCccchhhHHHHHHHHHhCC
Q 047292 613 VSAKVDVYSFGVMLLEIICCR 633 (728)
Q Consensus 613 ~s~~~DVwSlGvil~elltg~ 633 (728)
...|.|-||++++|++.|.
T Consensus 182 --~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred --cchhhhhHHHHHHHHhCcc
Confidence 4579999999999999983
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.12 E-value=9.9e-11 Score=129.46 Aligned_cols=137 Identities=18% Similarity=0.115 Sum_probs=90.1
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccchh----------------------------------hH------HHH
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQE----------------------------------RE------REF 479 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~----------------------------------~~------~~~ 479 (728)
+.||+|++|.||+|+++ .+|+.||||+++....+ -. -++
T Consensus 125 ~PlasaSiaQVh~A~l~-~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~ 203 (537)
T PRK04750 125 KPLASASIAQVHFARLK-DNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDL 203 (537)
T ss_pred hhhcCCCccEEEEEEEC-CCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCH
Confidence 46999999999999987 34899999999643211 01 124
Q ss_pred HHHHHHhcccc----ccceeeEeeeee-cCCcceeEeeccCCCCHHHHH--hcCC----CCChHHHHHHHHHHHHHHHHh
Q 047292 480 KSEVSAIGRTH----HKNLVQLLGFCD-EALNRLLVYEFMGNGTLANLI--FAIP----KPDWNLRVRISLEIARGLVYL 548 (728)
Q Consensus 480 ~~E~~~l~~l~----h~niv~l~g~~~-~~~~~~lv~e~~~~gsL~~~l--~~~~----~~~~~~~~~i~~qi~~~l~yL 548 (728)
..|...+.+++ +.+.+.+-.++. .....+|||||++|+.+.++- ...+ .+.......++.|+.
T Consensus 204 ~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif------ 277 (537)
T PRK04750 204 MREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF------ 277 (537)
T ss_pred HHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH------
Confidence 44555554442 333344333332 245678999999999998742 2211 112222223333332
Q ss_pred hhcCCCCeeecCCCCCCEEEcCCC----ceEEccccCcccccc
Q 047292 549 HEGCNVPIIHCDIKPQNILLDHYF----SPKISDFGLSKLLLS 587 (728)
Q Consensus 549 H~~~~~~iiH~dlk~~NIll~~~~----~~kl~Dfgla~~~~~ 587 (728)
.. +++|+|+||.||+++.++ ++++.|||+...+..
T Consensus 278 -~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 -RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 33 999999999999999888 999999999887643
|
|
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.3e-10 Score=96.71 Aligned_cols=72 Identities=18% Similarity=0.302 Sum_probs=59.4
Q ss_pred ceeEEEecccCCCCCCccccCCCChhhHHHHhccCCCccccccc--CcccccccCCCCCCccccccCccEEEEEe
Q 047292 284 LYEIREFNNVDWPLGDYERLEPSNQTECEISCLQDCSCAVAIYD--GNRCWKKKLPLSNGWLRDTEFSKVLFKVR 356 (728)
Q Consensus 284 ~~~f~~~~~~~~p~~~~~~~~~~~~~~C~~~Cl~~CsC~a~~~~--~~~C~~~~~~l~~~~~~~~~~~~~~lk~~ 356 (728)
.+.|++++++++|+..+.. ...++++|++.|++||+|.||+|. +++|++|...+.+........+..|+|++
T Consensus 11 ~~~f~~~~~~~~~~~~~~~-~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~C~~~~~~~~~~~~~~~~~~~~yiKv~ 84 (84)
T cd01098 11 TDGFLKLPDVKLPDNASAI-TAISLEECREACLSNCSCTAYAYNNGSGGCLLWNGLLNNLRSLSSGGGTLYLRLA 84 (84)
T ss_pred CCEEEEeCCeeCCCchhhh-ccCCHHHHHHHHhcCCCcceeeecCCCCeEEEEeceecceEeecCCCcEEEEEeC
Confidence 3589999999999887655 677999999999999999999995 58899998888876654444578888873
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.5e-09 Score=104.32 Aligned_cols=137 Identities=14% Similarity=0.131 Sum_probs=97.7
Q ss_pred hhCCCceeEEEEeeeeCC-----CCcEEEEEEecccc----------------------hhhHHHHH----HHHHHhccc
Q 047292 441 ELGRGSFGIVYKGVLKTA-----SGNAIAVKKLDRLA----------------------QEREREFK----SEVSAIGRT 489 (728)
Q Consensus 441 ~lg~G~fg~Vy~g~~~~~-----~~~~vavK~l~~~~----------------------~~~~~~~~----~E~~~l~~l 489 (728)
.||.|--+.||.|...+. .+..+|||+.+... ....+.+. +|++.|.++
T Consensus 4 ~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~rl 83 (197)
T cd05146 4 CISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKRM 83 (197)
T ss_pred ccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 588999999999975421 34789999764210 00112233 799999998
Q ss_pred cc--cceeeEeeeeecCCcceeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHh-hhcCCCCeeecCCCCCCE
Q 047292 490 HH--KNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYL-HEGCNVPIIHCDIKPQNI 566 (728)
Q Consensus 490 ~h--~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yL-H~~~~~~iiH~dlk~~NI 566 (728)
.. -++++++++ ...+|||||+.+..+.........++......+..+++.+|..| |.. +|+|+||++.||
T Consensus 84 ~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs~~NI 156 (197)
T cd05146 84 QKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLSEYNM 156 (197)
T ss_pred HHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHE
Confidence 53 566777765 46789999998754432221222344456677889999999999 765 999999999999
Q ss_pred EEcCCCceEEccccCcccc
Q 047292 567 LLDHYFSPKISDFGLSKLL 585 (728)
Q Consensus 567 ll~~~~~~kl~Dfgla~~~ 585 (728)
++++ +.+.|+|||.+...
T Consensus 157 L~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 157 LWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred EEEC-CcEEEEECCCceeC
Confidence 9974 67999999988755
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.2e-10 Score=125.60 Aligned_cols=245 Identities=22% Similarity=0.217 Sum_probs=171.3
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHH--HHHHHHHhccc-cccceeeEeeeeecCCcceeEeec
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQERERE--FKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~--~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
++...||.|.|+.|++...+..++..+++|.+.+.......+ -..|+.+...+ .|.++++....+......++--||
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~ 347 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEF 347 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhh
Confidence 445679999999999987555677899999886644333222 23455555555 588888888888888888899999
Q ss_pred cCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCC-CceEEccccCccccccCCCcc
Q 047292 514 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHY-FSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 514 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~-~~~kl~Dfgla~~~~~~~~~~ 592 (728)
+.++++...+.-...+++..++++..|++.++.++|+. .++|+|+||+||++..+ +..++.|||.+..+.....
T Consensus 348 ~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~-- 422 (524)
T KOG0601|consen 348 CEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG-- 422 (524)
T ss_pred hcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccccceecc--
Confidence 99999888775556677888999999999999999985 99999999999999886 7889999999864211111
Q ss_pred cccccCCccc-cCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhh
Q 047292 593 HTMIRGTRGY-VAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAA 671 (728)
Q Consensus 593 ~~~~~gt~~y-~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 671 (728)
.....+..| .+++......+-.+.|++|||.-+.|.+++......... | .....+......
T Consensus 423 -~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---------~--~~i~~~~~p~~~------ 484 (524)
T KOG0601|consen 423 -VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---------S--LTIRSGDTPNLP------ 484 (524)
T ss_pred -cccccccccccchhhccccccccccccccccccccccccCcccCccccc---------c--eeeecccccCCC------
Confidence 111123334 466666778899999999999999999988743221100 0 000011111000
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 047292 672 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEG 708 (728)
Q Consensus 672 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 708 (728)
.....+..++..++.+++..||.+.++..+.+-
T Consensus 485 ----~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 485 ----GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred ----chHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 011233445666888999999998887765543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.97 E-value=2.7e-09 Score=106.63 Aligned_cols=142 Identities=17% Similarity=0.244 Sum_probs=108.9
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccch-hhHHHHHHHHHHhccccc--cceeeEeeeeecCC---cceeEeec
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ-EREREFKSEVSAIGRTHH--KNLVQLLGFCDEAL---NRLLVYEF 513 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~---~~~lv~e~ 513 (728)
+.|+.|..+.||++... +|+.+++|....... .....+..|.++++.+++ .++.+++.+..... ..++||||
T Consensus 4 ~~l~~G~~n~~~~v~~~--~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG--GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred eecCCCccceEEEEEec--CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 45899999999998764 357899999765322 134578899999999865 44677888776643 56899999
Q ss_pred cCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcC-----------------------------------------
Q 047292 514 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGC----------------------------------------- 552 (728)
Q Consensus 514 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~----------------------------------------- 552 (728)
+++.++.+.+.. ..++......++.+++++|.+||+..
T Consensus 82 i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 82 VDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred eCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 999988776542 34666777788888888888888521
Q ss_pred ------------CCCeeecCCCCCCEEEcC--CCceEEccccCccc
Q 047292 553 ------------NVPIIHCDIKPQNILLDH--YFSPKISDFGLSKL 584 (728)
Q Consensus 553 ------------~~~iiH~dlk~~NIll~~--~~~~kl~Dfgla~~ 584 (728)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=7e-09 Score=96.01 Aligned_cols=130 Identities=22% Similarity=0.296 Sum_probs=100.0
Q ss_pred hhCCCceeEEEEeeeeCCCCcEEEEEEe-ccc-c----h--hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 441 ELGRGSFGIVYKGVLKTASGNAIAVKKL-DRL-A----Q--EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 441 ~lg~G~fg~Vy~g~~~~~~~~~vavK~l-~~~-~----~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
.+.+|+-+.+|.+.+. |..+++|.= .+. . . -....-.+|.+++.+++--.|...+=+..+.....|+||
T Consensus 3 ~i~~GAEa~i~~~~~~---g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 3 LIKQGAEAIIYLTDFL---GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred hhhCCcceeEEeeecc---CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 5789999999998664 445666632 211 0 1 112567789999999876666555556667778889999
Q ss_pred ccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccc
Q 047292 513 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKL 584 (728)
Q Consensus 513 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~ 584 (728)
|++|..|.+.+... ...++..+-.-+.-||.. +|+|+||.++||++.... +.++||||+..
T Consensus 80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999998765 356777788888899998 999999999999998775 99999999874
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.94 E-value=2e-08 Score=105.97 Aligned_cols=166 Identities=22% Similarity=0.270 Sum_probs=128.7
Q ss_pred eeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeee----cCCcceeEeeccCC-CCHHH
Q 047292 447 FGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCD----EALNRLLVYEFMGN-GTLAN 521 (728)
Q Consensus 447 fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~----~~~~~~lv~e~~~~-gsL~~ 521 (728)
-.+.||+... .+|..|++|+++............-+++++++.|.|+|++..++. ....+++||+|.|+ ++|.+
T Consensus 289 ~~Ttyk~~s~-~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 289 SITTYKATSN-VDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred cceeEeeeec-cCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 3578888765 678999999996543333333455678899999999999999875 44567899999986 57777
Q ss_pred HHhcC---------------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccc
Q 047292 522 LIFAI---------------PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLL 586 (728)
Q Consensus 522 ~l~~~---------------~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 586 (728)
.-+.. .+.++..++.++.|+..||.++|+. |+.-+-|.+++||++.+.+++|...|+.....
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence 65532 2356788999999999999999998 89889999999999999999999999877664
Q ss_pred cCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCc
Q 047292 587 SDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRR 634 (728)
Q Consensus 587 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~ 634 (728)
.+... -+. --.+-|.=.||.+++-|.||..
T Consensus 445 ~d~~~---------------~le---~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 445 EDPTE---------------PLE---SQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCCCc---------------chh---HHhhhhHHHHHHHHHHHhhccc
Confidence 44311 111 1246799999999999999954
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.1e-08 Score=92.35 Aligned_cols=140 Identities=23% Similarity=0.303 Sum_probs=102.6
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEe-ccc----c---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEe
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKL-DRL----A---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 511 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l-~~~----~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 511 (728)
..|-+|+-+.|+++.+ .|+..+||.= .+. . .-..+...+|.+.|.+++--.|.-..-++.+...-.|+|
T Consensus 13 ~likQGAEArv~~~~~---~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSF---SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred eeeeccceeeEeeecc---CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4578899999999987 4777677642 211 0 112356788999999887555554444555666677899
Q ss_pred eccCC-CCHHHHHhcC-CCCCh-HHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCC---ceEEccccCcccc
Q 047292 512 EFMGN-GTLANLIFAI-PKPDW-NLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYF---SPKISDFGLSKLL 585 (728)
Q Consensus 512 e~~~~-gsL~~~l~~~-~~~~~-~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~---~~kl~Dfgla~~~ 585 (728)
||+++ .++.+++... ..... .....++..|-+.+.-||.+ +|||+||..+||++..++ .+.++|||++...
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 99977 5788888765 22223 33378899999999999998 999999999999997544 4589999998654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.87 E-value=5.4e-10 Score=126.41 Aligned_cols=242 Identities=18% Similarity=0.164 Sum_probs=159.8
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecc---cchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCC
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGN 516 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 516 (728)
+-+-+|.++.++.+.-. ..+...++|.... ....+.+....+-.++-..++|-++...--+.-....+|+++|..+
T Consensus 810 ~p~qS~sp~ss~p~~pa-~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~ 888 (1205)
T KOG0606|consen 810 KPSQSGSPSSSFPASPA-GSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNG 888 (1205)
T ss_pred ccccCCCCcccccCCcc-ccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhcc
Confidence 35778888888876432 2332233332221 1111122233333333333456666555445567788999999999
Q ss_pred CCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccc----------
Q 047292 517 GTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLL---------- 586 (728)
Q Consensus 517 gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~---------- 586 (728)
++|...|+..+..+..-.......+..+++|||.. .+.|+|++|.|+++..+++.+++||+......
T Consensus 889 ~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg 965 (1205)
T KOG0606|consen 889 GDLPSKLHNSGCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSG 965 (1205)
T ss_pred CCchhhhhcCCCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccccCcCCccc
Confidence 99999999887677666667777888999999985 58999999999999999999999998332210
Q ss_pred -----------cC---------CCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhh
Q 047292 587 -----------SD---------HSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRA 646 (728)
Q Consensus 587 -----------~~---------~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~ 646 (728)
.. ..+......+|+.|.+||.+.+......+|.|++|++++|.++|..||..+..+....
T Consensus 966 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ 1045 (1205)
T KOG0606|consen 966 PSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFE 1045 (1205)
T ss_pred ccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhh
Confidence 00 0011223458999999999999999999999999999999999999998776655432
Q ss_pred hHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHH
Q 047292 647 ILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMK 700 (728)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ 700 (728)
.+. .+.+.- .....+......+++...+..+|.+|..|.
T Consensus 1046 ni~--------~~~~~~-------p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1046 NIL--------NRDIPW-------PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred ccc--------cCCCCC-------CCCccccChhhhhhhhhhhccCchhccCcc
Confidence 221 111000 000111222334455667778888886665
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=98.82 E-value=4.4e-09 Score=84.95 Aligned_cols=64 Identities=11% Similarity=0.071 Sum_probs=51.1
Q ss_pred eEEEecccCCCCCCccccCCCChhhHHHHhcc---CCCccccccc--CcccccccCCC-CCCccccccCccEEEE
Q 047292 286 EIREFNNVDWPLGDYERLEPSNQTECEISCLQ---DCSCAVAIYD--GNRCWKKKLPL-SNGWLRDTEFSKVLFK 354 (728)
Q Consensus 286 ~f~~~~~~~~p~~~~~~~~~~~~~~C~~~Cl~---~CsC~a~~~~--~~~C~~~~~~l-~~~~~~~~~~~~~~lk 354 (728)
.|+++.++++|++.. .+++||++.|++ ||||+||+|. +.+|+.|...+ .+.+........+|+|
T Consensus 10 ~fl~~~~~klpd~~~-----~s~~eC~~~Cl~~~~nCsC~Aya~~~~~~gC~~W~~~l~~d~~~~~~~g~~Ly~r 79 (80)
T cd00129 10 TTLIKIALKIKTTKA-----NTADECANRCEKNGLPFSCKAFVFAKARKQCLWFPFNSMSGVRKEFSHGFDLYEN 79 (80)
T ss_pred eEEEeecccCCcccc-----cCHHHHHHHHhcCCCCCCceeeeccCCCCCeEEecCcchhhHHhccCCCceeEeE
Confidence 689999999998755 689999999999 9999999994 56899998888 6655443334556654
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.1e-07 Score=96.77 Aligned_cols=130 Identities=17% Similarity=0.138 Sum_probs=95.5
Q ss_pred EEEEeeeeCCCCcEEEEEEecccchh-----------hHHHHHHHHHHhccccccce--eeEeeeeec-----CCcceeE
Q 047292 449 IVYKGVLKTASGNAIAVKKLDRLAQE-----------REREFKSEVSAIGRTHHKNL--VQLLGFCDE-----ALNRLLV 510 (728)
Q Consensus 449 ~Vy~g~~~~~~~~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~h~ni--v~l~g~~~~-----~~~~~lv 510 (728)
.|.+..+ +|+.+.||+....... ....+.+|...+.++...+| +.++++.+. ...-+||
T Consensus 37 rvvr~~~---~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 37 RTLRFEL---AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred eEEEEEE---CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 4556554 4678999977442211 01247889999988854443 445556543 2346899
Q ss_pred eeccCCC-CHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcC-------CCceEEcccc
Q 047292 511 YEFMGNG-TLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDH-------YFSPKISDFG 580 (728)
Q Consensus 511 ~e~~~~g-sL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~-------~~~~kl~Dfg 580 (728)
+|++++. +|.+++... ...+......++.+++..+.-||+. +|+|+|+++.|||++. +..+.|+||+
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~ 190 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVIDLH 190 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEEEEECC
Confidence 9999986 899988642 3445667789999999999999997 9999999999999975 4689999999
Q ss_pred Cccc
Q 047292 581 LSKL 584 (728)
Q Consensus 581 la~~ 584 (728)
.++.
T Consensus 191 r~~~ 194 (268)
T PRK15123 191 RAQI 194 (268)
T ss_pred cccc
Confidence 8753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.5e-07 Score=90.26 Aligned_cols=125 Identities=22% Similarity=0.239 Sum_probs=81.6
Q ss_pred EEEEeeeeCCCCcEEEEEEecccc--------------h------------hhHHHHHHHHHHhcccccc--ceeeEeee
Q 047292 449 IVYKGVLKTASGNAIAVKKLDRLA--------------Q------------EREREFKSEVSAIGRTHHK--NLVQLLGF 500 (728)
Q Consensus 449 ~Vy~g~~~~~~~~~vavK~l~~~~--------------~------------~~~~~~~~E~~~l~~l~h~--niv~l~g~ 500 (728)
.||.|.. .++..+|||.-+... . .......+|.+.|.++... ++++++.+
T Consensus 1 ~Vy~~~~--~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~ 78 (188)
T PF01163_consen 1 DVYHAID--PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY 78 (188)
T ss_dssp EEEEEEE--CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE
T ss_pred CEEEEEC--CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE
Confidence 3888876 367899999764210 0 0124577899999999755 56777755
Q ss_pred eecCCcceeEeeccC--CCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHh-hhcCCCCeeecCCCCCCEEEcCCCceEEc
Q 047292 501 CDEALNRLLVYEFMG--NGTLANLIFAIPKPDWNLRVRISLEIARGLVYL-HEGCNVPIIHCDIKPQNILLDHYFSPKIS 577 (728)
Q Consensus 501 ~~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yL-H~~~~~~iiH~dlk~~NIll~~~~~~kl~ 577 (728)
- ...|||||++ +..+..+.... ++......++.+++..+..+ |.. +|+|+||.+.||+++++ .+.|+
T Consensus 79 ~----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 79 N----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp E----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE-
T ss_pred e----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEE
Confidence 3 4579999998 55554433221 11345567778888866664 565 99999999999999988 99999
Q ss_pred cccCcccc
Q 047292 578 DFGLSKLL 585 (728)
Q Consensus 578 Dfgla~~~ 585 (728)
|||.+...
T Consensus 149 Df~qav~~ 156 (188)
T PF01163_consen 149 DFGQAVDS 156 (188)
T ss_dssp -GTTEEET
T ss_pred ecCcceec
Confidence 99988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.55 E-value=5.9e-07 Score=88.44 Aligned_cols=107 Identities=21% Similarity=0.224 Sum_probs=86.8
Q ss_pred HHHHHHHHHHhcccc--ccceeeEeeeeecCC----cceeEeeccCC-CCHHHHHhcCCCCChHHHHHHHHHHHHHHHHh
Q 047292 476 EREFKSEVSAIGRTH--HKNLVQLLGFCDEAL----NRLLVYEFMGN-GTLANLIFAIPKPDWNLRVRISLEIARGLVYL 548 (728)
Q Consensus 476 ~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~----~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yL 548 (728)
.....+|...+.++. .-..++.+++.+... ..++|+|++++ .+|.+++......+......++.++++.+.-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 356788888888875 344556677765533 34799999988 48999998765577778889999999999999
Q ss_pred hhcCCCCeeecCCCCCCEEEcCCC---ceEEccccCcccc
Q 047292 549 HEGCNVPIIHCDIKPQNILLDHYF---SPKISDFGLSKLL 585 (728)
Q Consensus 549 H~~~~~~iiH~dlk~~NIll~~~~---~~kl~Dfgla~~~ 585 (728)
|+. +|+|+|+++.|||++.+. .+.++||+.++..
T Consensus 135 H~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 135 HDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 998 999999999999999887 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.48 E-value=4.1e-08 Score=107.47 Aligned_cols=149 Identities=19% Similarity=0.279 Sum_probs=99.7
Q ss_pred HHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccc--------ccccCCccccCcccccC
Q 047292 539 LEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH--------TMIRGTRGYVAPEWLKN 610 (728)
Q Consensus 539 ~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~--------~~~~gt~~y~aPE~~~~ 610 (728)
.+++.||.|+|.. .++||++|.|++|.++.++..||+.|+.+........... ........|.|||++.+
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 3455999999986 5899999999999999999999999998875543211111 01224557999999999
Q ss_pred CCCCCccchhhHHHHHHHHHhCCcC-cchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhc
Q 047292 611 APVSAKVDVYSFGVMLLEIICCRRS-VEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCI 689 (728)
Q Consensus 611 ~~~s~~~DVwSlGvil~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl 689 (728)
...+.++|+||+|+++|-+..|+.+ +.......... .....+......+..+...++.+=+.+.+
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~--------------~~~~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS--------------FSRNLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhh--------------hhhcccccccccccccCcHHHHHHHHHHh
Confidence 8889999999999999999954443 33221111110 00001110111112333455666667788
Q ss_pred ccCCCCCCCHHHHH
Q 047292 690 QEDPSKRPTMKVVM 703 (728)
Q Consensus 690 ~~dp~~RPt~~evl 703 (728)
..++..||++.++.
T Consensus 250 ~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLL 263 (700)
T ss_pred cCCcccCcchhhhh
Confidence 99999999877664
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.41 E-value=3.2e-06 Score=81.57 Aligned_cols=137 Identities=15% Similarity=0.032 Sum_probs=102.9
Q ss_pred hCCCceeEEEEeeeeCCCCcEEEEEEecccc------hhhHHHHHHHHHHhccccc--cceeeEeeeeecC----Cccee
Q 047292 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDRLA------QEREREFKSEVSAIGRTHH--KNLVQLLGFCDEA----LNRLL 509 (728)
Q Consensus 442 lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~----~~~~l 509 (728)
-|+||-+.|++-.+. |..+-+|+-.+.. .-....|.+|+..|.++.. -.+.+++.+.... -..+|
T Consensus 26 ~~rgG~SgV~r~~~~---g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVERN---GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEeC---CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEE
Confidence 466899999987664 4578999875311 2245789999999999863 3345555222221 22479
Q ss_pred EeeccCC-CCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCc--eEEccccCccc
Q 047292 510 VYEFMGN-GTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFS--PKISDFGLSKL 584 (728)
Q Consensus 510 v~e~~~~-gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~--~kl~Dfgla~~ 584 (728)
|+|-+++ .+|.+++... .+.+...+..++.++++.+.-||+. ++.|+|+.+.||+++.++. ++++||.-++.
T Consensus 103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 9997654 6899998764 4567778889999999999999997 9999999999999986666 99999987654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.37 E-value=5.9e-06 Score=85.45 Aligned_cols=251 Identities=14% Similarity=0.145 Sum_probs=146.2
Q ss_pred HhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccc-cccceeeEeeee-------ecCCcceeE
Q 047292 439 KEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKNLVQLLGFC-------DEALNRLLV 510 (728)
Q Consensus 439 ~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~-------~~~~~~~lv 510 (728)
...||+|+-+.+|-.- +-..-+.|+.+........+.. ..|... .||-+-.-+.+= ......-++
T Consensus 16 gr~LgqGgea~ly~l~----e~~d~VAKIYh~Pppa~~aqk~---a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 16 GRPLGQGGEADLYTLG----EVRDQVAKIYHAPPPAAQAQKV---AELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CccccCCccceeeecc----hhhchhheeecCCCchHHHHHH---HHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 4679999999999632 1122344665543332222222 223332 454332211110 111113345
Q ss_pred eeccCCCC-HHHHH------hcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcc
Q 047292 511 YEFMGNGT-LANLI------FAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSK 583 (728)
Q Consensus 511 ~e~~~~gs-L~~~l------~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~ 583 (728)
|..+++.. ...+. .+.+..+|...++.++.++.+.+-||.+ |.+-+|+.++|+|+++++.+.|.|-..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence 55555432 22222 2236778999999999999999999997 89999999999999999999998855433
Q ss_pred ccccCCCcccccccCCccccCccccc-----CCCCCCccchhhHHHHHHHHHhC-CcCcchhhhHh-----hhhhHHHHH
Q 047292 584 LLLSDHSRTHTMIRGTRGYVAPEWLK-----NAPVSAKVDVYSFGVMLLEIICC-RRSVEMELEEE-----SRAILTDWA 652 (728)
Q Consensus 584 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DVwSlGvil~elltg-~~p~~~~~~~~-----~~~~~~~~~ 652 (728)
.. .......-..|...|++||.-. +..-+...|.|.||+++++++.| +.||....... ....+..
T Consensus 166 i~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~-- 241 (637)
T COG4248 166 IN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH-- 241 (637)
T ss_pred ec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc--
Confidence 32 1222233345788999999654 44567889999999999999987 88886432110 0001111
Q ss_pred HHhhhcCccceeccch-----hhhhhcHHH-HHHHHHHHHHhccc--CCCCCCCHHHHHHHHhcC
Q 047292 653 YDCYVEGRLDALIDSD-----EAAMADRSR-LHKWLMIAMWCIQE--DPSKRPTMKVVMQMLEGL 709 (728)
Q Consensus 653 ~~~~~~~~~~~~~d~~-----~~~~~~~~~-~~~l~~l~~~cl~~--dp~~RPt~~evl~~L~~~ 709 (728)
+......+.. .....+.+. ...+..+..+|+.. ++.-|||++-.+..|..+
T Consensus 242 ------g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al 300 (637)
T COG4248 242 ------GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL 300 (637)
T ss_pred ------ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence 1111111110 011111121 12333455667764 356899999998888664
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.37 E-value=2.3e-06 Score=84.30 Aligned_cols=136 Identities=18% Similarity=0.168 Sum_probs=93.4
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchh----------------------hHHHHHHHHHHhcccccc-
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQE----------------------REREFKSEVSAIGRTHHK- 492 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~----------------------~~~~~~~E~~~l~~l~h~- 492 (728)
+.+.++||.|--+.||.|... .|.++|||.=+....+ .....++|.++|.+|.-.
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~--~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP--KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred HhhccccccCccceEEEEECC--CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 456688999999999999864 7889999954221100 123467899999998644
Q ss_pred -ceeeEeeeeecCCcceeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCC
Q 047292 493 -NLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHY 571 (728)
Q Consensus 493 -niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~ 571 (728)
.+++.+++ +...+|||++++-.|...-- +......|+..|++-+.-+-.. ||||+|+.+-||+++++
T Consensus 171 ~~VP~P~~~----nRHaVvMe~ieG~eL~~~r~-----~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~d 238 (304)
T COG0478 171 VKVPKPIAW----NRHAVVMEYIEGVELYRLRL-----DVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTED 238 (304)
T ss_pred CCCCCcccc----ccceeeeehcccceeecccC-----cccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecC
Confidence 66666654 34579999999866654321 2222333334444433333333 99999999999999999
Q ss_pred CceEEccccCcccc
Q 047292 572 FSPKISDFGLSKLL 585 (728)
Q Consensus 572 ~~~kl~Dfgla~~~ 585 (728)
|.+.++||--+...
T Consensus 239 g~~~vIDwPQ~v~~ 252 (304)
T COG0478 239 GDIVVIDWPQAVPI 252 (304)
T ss_pred CCEEEEeCcccccC
Confidence 99999999876543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.36 E-value=2.1e-06 Score=94.79 Aligned_cols=139 Identities=21% Similarity=0.247 Sum_probs=90.9
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccchh----------------------------------------hHHHH
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQE----------------------------------------REREF 479 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~----------------------------------------~~~~~ 479 (728)
+.|+.++-|.||+|+++ +|+.||||+.+....+ .+-++
T Consensus 131 ~PiAsASIaQVH~A~L~--sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy 208 (517)
T COG0661 131 EPIASASIAQVHRAVLK--SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDY 208 (517)
T ss_pred CchhhhhHhhheeEEec--CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCH
Confidence 34889999999999997 5999999998642211 01124
Q ss_pred HHHHHHhcccc-----ccceeeEeeee-ecCCcceeEeeccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcC
Q 047292 480 KSEVSAIGRTH-----HKNLVQLLGFC-DEALNRLLVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGC 552 (728)
Q Consensus 480 ~~E~~~l~~l~-----h~niv~l~g~~-~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~ 552 (728)
..|...+.+++ .+++ ++=.++ +......|+|||++|-.+.+..... ...+...+.....++.--.-+-|
T Consensus 209 ~~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~~d--- 284 (517)
T COG0661 209 RREAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLLRD--- 284 (517)
T ss_pred HHHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHHhc---
Confidence 45555555442 2332 232333 4456789999999999888874322 34443333222222221111222
Q ss_pred CCCeeecCCCCCCEEEcCCCceEEccccCccccc
Q 047292 553 NVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLL 586 (728)
Q Consensus 553 ~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 586 (728)
+++|.|.+|.||+++.++++-+.|||+...+.
T Consensus 285 --gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 285 --GFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred --CccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 89999999999999999999999999987664
|
|
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.10 E-value=4.6e-06 Score=67.90 Aligned_cols=58 Identities=21% Similarity=0.358 Sum_probs=46.6
Q ss_pred eeEEEecccCCCCCCccccCCCChhhHHHHhcc-CCCccccccc--Cccccccc-CCCCCCc
Q 047292 285 YEIREFNNVDWPLGDYERLEPSNQTECEISCLQ-DCSCAVAIYD--GNRCWKKK-LPLSNGW 342 (728)
Q Consensus 285 ~~f~~~~~~~~p~~~~~~~~~~~~~~C~~~Cl~-~CsC~a~~~~--~~~C~~~~-~~l~~~~ 342 (728)
..|++++++.+++.........++++|++.|++ +|+|.||.|. ++.|++|. ..+.+..
T Consensus 4 ~~f~~~~~~~l~~~~~~~~~~~s~~~C~~~C~~~~~~C~s~~y~~~~~~C~l~~~~~~~~~~ 65 (78)
T smart00473 4 DCFVRLPNTKLPGFSRIVISVASLEECASKCLNSNCSCRSFTYNNGTKGCLLWSESSLGDAR 65 (78)
T ss_pred ceeEEecCccCCCCcceeEcCCCHHHHHHHhCCCCCceEEEEEcCCCCEEEEeeCCccccce
Confidence 469999999998665544456799999999999 9999999996 68899887 5555444
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.04 E-value=4.5e-05 Score=76.07 Aligned_cols=136 Identities=14% Similarity=0.164 Sum_probs=84.9
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccc--eeeEeeeeecCCcceeEeeccCCC
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKN--LVQLLGFCDEALNRLLVYEFMGNG 517 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~~~~~~~~lv~e~~~~g 517 (728)
+.||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|.
T Consensus 7 ~~i~~G~t~~~y~~-----~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 7 TQTGEGGNGESYTH-----KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred eeecCCCCcceeEe-----cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 46899999999983 24467788876532 3345788999999886443 467888887777788999999986
Q ss_pred C-HHHHH---------------------hcC--CCCChHHH-HHHHH----------HHHH-HHHHhhhc-CCCCeeecC
Q 047292 518 T-LANLI---------------------FAI--PKPDWNLR-VRISL----------EIAR-GLVYLHEG-CNVPIIHCD 560 (728)
Q Consensus 518 s-L~~~l---------------------~~~--~~~~~~~~-~~i~~----------qi~~-~l~yLH~~-~~~~iiH~d 560 (728)
+ +...+ +.. +....... ..+.. .+.+ ...+|... ....++|+|
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 3 21111 111 11111110 00100 0111 11222211 123578999
Q ss_pred CCCCCEEEcCCCceEEccccCcc
Q 047292 561 IKPQNILLDHYFSPKISDFGLSK 583 (728)
Q Consensus 561 lk~~NIll~~~~~~kl~Dfgla~ 583 (728)
+.|.||++++++ +.|+||+.+.
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcC
Confidence 999999999888 9999999775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.02 E-value=2e-05 Score=69.50 Aligned_cols=73 Identities=21% Similarity=0.378 Sum_probs=51.8
Q ss_pred EEEecCc-eEEeCCC-CCeEeecCCC---CceeeEEEecCcCEEEEeccccccccccccccccccccccceeccccEEEe
Q 047292 21 LELTATG-LLLKDPG-GQAIWDEKPN---KIVSDAAMLDTGNFVLIASGNHSDYAWQSFKSPTDTILPTQILDLGSVLVS 95 (728)
Q Consensus 21 l~~~~~g-l~l~~~~-~~~vWst~~~---~~~~~a~lld~GNlVl~~~~~~~~~lWQSFD~PtDtlLpg~~l~~~~~L~S 95 (728)
+.+..+| +++.+.. +.+||+++.. .....+.|.++|||||.+ .++.++|+| .|. .
T Consensus 24 ~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~--~~g~~vW~S---~t~---~------------ 83 (114)
T smart00108 24 LIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYD--GDGRVVWSS---NTT---G------------ 83 (114)
T ss_pred cCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEe--CCCCEEEEe---ccc---C------------
Confidence 4445688 7887654 5899999842 233678999999999965 346789997 111 1
Q ss_pred eccCCCCCCccEEEEee-CCceEEee
Q 047292 96 RLTETNLSKGRFELHFS-NGSLEFIP 120 (728)
Q Consensus 96 ~~s~~d~s~G~~~l~~~-~~~~~~~~ 120 (728)
..|.|.+.|+ +|+++++-
T Consensus 84 -------~~~~~~~~L~ddGnlvl~~ 102 (114)
T smart00108 84 -------ANGNYVLVLLDDGNLVIYD 102 (114)
T ss_pred -------CCCceEEEEeCCCCEEEEC
Confidence 1467888888 88888864
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.98 E-value=2e-05 Score=75.95 Aligned_cols=102 Identities=24% Similarity=0.365 Sum_probs=82.6
Q ss_pred HHHHHHhccccc-cceeeEeeeeecCCcceeEeeccCCCCHHHH---HhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCC
Q 047292 480 KSEVSAIGRTHH-KNLVQLLGFCDEALNRLLVYEFMGNGTLANL---IFAIPKPDWNLRVRISLEIARGLVYLHEGCNVP 555 (728)
Q Consensus 480 ~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~---l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~ 555 (728)
..|.-+++.+++ +++++++|.|- .+++.||.+.+++... +...-..+|..+.+||.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357778888865 69999999993 4688999987765422 222235789999999999999999999865556
Q ss_pred eeecCCCCCCEEEcCCCceEEccccCcccc
Q 047292 556 IIHCDIKPQNILLDHYFSPKISDFGLSKLL 585 (728)
Q Consensus 556 iiH~dlk~~NIll~~~~~~kl~Dfgla~~~ 585 (728)
+...|++++|+-+++++++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 889999999999999999999999876544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.96 E-value=5.8e-05 Score=73.92 Aligned_cols=136 Identities=20% Similarity=0.227 Sum_probs=90.2
Q ss_pred hhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhH------------------------HHHHHHHHHhcccc--ccce
Q 047292 441 ELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQERE------------------------REFKSEVSAIGRTH--HKNL 494 (728)
Q Consensus 441 ~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~------------------------~~~~~E~~~l~~l~--h~ni 494 (728)
.|..|--+.||+|.- .++..+|||+.+....... .-..+|+.-|.++. +-.+
T Consensus 55 ~istGKEA~Vy~a~~--~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 55 CISTGKEANVYLAET--GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eecCCcceEEEeecc--CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 478888899999865 3678999999854221110 11345777777763 4444
Q ss_pred eeEeeeeecCCcceeEeeccCCCCHH-HHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCc
Q 047292 495 VQLLGFCDEALNRLLVYEFMGNGTLA-NLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFS 573 (728)
Q Consensus 495 v~l~g~~~~~~~~~lv~e~~~~gsL~-~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~ 573 (728)
.+.+++. .-.|||||++...+. =.|... .+.......+..++++.+.-|-.. -++||+||..-|||+. ++.
T Consensus 133 P~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv-~~e~~e~~~~~~~~v~~~~~l~~~--a~LVHgDLSEyNiL~~-~~~ 204 (268)
T COG1718 133 PEPIAFR----NNVLVMEFIGDDGLPAPRLKDV-PLELEEAEGLYEDVVEYMRRLYKE--AGLVHGDLSEYNILVH-DGE 204 (268)
T ss_pred CCceeec----CCeEEEEeccCCCCCCCCcccC-CcCchhHHHHHHHHHHHHHHHHHh--cCcccccchhhheEEE-CCe
Confidence 5555543 236999999754211 111111 122225667778888888877663 2899999999999999 889
Q ss_pred eEEccccCccccc
Q 047292 574 PKISDFGLSKLLL 586 (728)
Q Consensus 574 ~kl~Dfgla~~~~ 586 (728)
+.|+||+-|....
T Consensus 205 p~iID~~QaV~~~ 217 (268)
T COG1718 205 PYIIDVSQAVTID 217 (268)
T ss_pred EEEEECccccccC
Confidence 9999999887653
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.94 E-value=2.2e-06 Score=93.10 Aligned_cols=182 Identities=16% Similarity=0.120 Sum_probs=127.1
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccc-eeeEeeeeecCCcceeEeeccCC
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKN-LVQLLGFCDEALNRLLVYEFMGN 516 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lv~e~~~~ 516 (728)
+...+++|++++++|.+.- . .+...++.+.. .....-++++|.+++||| .+..++-++.+...++.++++..
T Consensus 246 ~fh~fvK~altknpKkRpt-a-eklL~h~fvs~-----~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~ 318 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPT-A-EKLLQHPFVSQ-----TLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST 318 (829)
T ss_pred HHHHHHHHHhcCCCccCCC-h-hhheeceeecc-----chhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence 4467889999999986532 2 22333444432 245567889999999999 77777777888888999999877
Q ss_pred C--CHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccc
Q 047292 517 G--TLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHT 594 (728)
Q Consensus 517 g--sL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 594 (728)
+ +........-.+..-+...+.+.-.+++++||+. .-+|+| ||+..+ +..|..||+....+.... ...
T Consensus 319 ~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~ 388 (829)
T KOG0576|consen 319 GRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPR 388 (829)
T ss_pred CccccccCChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--ccc
Confidence 6 1111111111122223344556667889999985 347888 777766 578999999887664433 344
Q ss_pred cccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCc
Q 047292 595 MIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSV 636 (728)
Q Consensus 595 ~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~ 636 (728)
...+++.++|||+.....+..+.|+|++|+-..++--|-.|-
T Consensus 389 t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 389 TAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred cCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 566899999999999999999999999998777776666553
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.93 E-value=4.1e-05 Score=74.18 Aligned_cols=68 Identities=21% Similarity=0.247 Sum_probs=53.3
Q ss_pred CcceeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccc
Q 047292 505 LNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKL 584 (728)
Q Consensus 505 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~ 584 (728)
...+|+|||++|..|.+... ++. .++..+.+++.-||+. |++|+|..|.|+++++++ ++++||+..+.
T Consensus 116 ~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~~-i~iID~~~k~~ 183 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNNG-IRIIDTQGKRM 183 (229)
T ss_pred eEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECCc-EEEEECccccc
Confidence 34568999999988776542 121 3556677889999997 999999999999999665 99999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.91 E-value=9.2e-05 Score=75.09 Aligned_cols=136 Identities=15% Similarity=0.108 Sum_probs=84.1
Q ss_pred hCCCce-eEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhcccc-ccceeeEeeeeecCCcceeEeeccCCCCH
Q 047292 442 LGRGSF-GIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTH-HKNLVQLLGFCDEALNRLLVYEFMGNGTL 519 (728)
Q Consensus 442 lg~G~f-g~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~~gsL 519 (728)
|..|.. ..||+... .+..+.||+..... ...+..|+++++.+. +--+.+++++....+..++|||+++|.+|
T Consensus 6 ~~~g~~~~~v~~~~~---~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 79 (244)
T cd05150 6 VTEGQSGATVYRLDG---KNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA 79 (244)
T ss_pred cCCCCCcCeEEEEcC---CCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence 444555 78898754 24678888876542 345677888888873 45566788887776778999999999877
Q ss_pred HHHH-------------------hcCCC--CCh----HHHHHHHH--------------------HHHHHHHHhhh----
Q 047292 520 ANLI-------------------FAIPK--PDW----NLRVRISL--------------------EIARGLVYLHE---- 550 (728)
Q Consensus 520 ~~~l-------------------~~~~~--~~~----~~~~~i~~--------------------qi~~~l~yLH~---- 550 (728)
.... +..+. ... ...+.... .+...+..|-.
T Consensus 80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 159 (244)
T cd05150 80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA 159 (244)
T ss_pred hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence 6432 11110 000 00000000 01111222211
Q ss_pred cCCCCeeecCCCCCCEEEcCCCceEEccccCcc
Q 047292 551 GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSK 583 (728)
Q Consensus 551 ~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~ 583 (728)
.....++|+|+.|.|||++++..+.|+||+.+.
T Consensus 160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred cCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 112458999999999999998778999999775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.91 E-value=4.3e-05 Score=84.13 Aligned_cols=140 Identities=21% Similarity=0.208 Sum_probs=88.3
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhh-------------------------------------HHHHHHH
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQER-------------------------------------EREFKSE 482 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~-------------------------------------~~~~~~E 482 (728)
+.|+.-+.|.||+|+++ +|+.||||+-+....+. +-+|..|
T Consensus 167 ~piaaASlaQVhrA~L~--~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLK--NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred chhhhcchhheEEEEec--CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 45999999999999997 49999999886422110 1124445
Q ss_pred HHHhccc----cccce---eeEeeee-ecCCcceeEeeccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCC
Q 047292 483 VSAIGRT----HHKNL---VQLLGFC-DEALNRLLVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCN 553 (728)
Q Consensus 483 ~~~l~~l----~h~ni---v~l~g~~-~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~ 553 (728)
.+-..+. .|.++ |.+=.++ .....+.|+||||+|..+.+.-.-. ..++...+..-+.+...-+-+-
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf~----- 319 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIFK----- 319 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHHh-----
Confidence 4444333 35551 1122222 3345678999999998776654321 2344443333333322222222
Q ss_pred CCeeecCCCCCCEEEcC----CCceEEccccCccccc
Q 047292 554 VPIIHCDIKPQNILLDH----YFSPKISDFGLSKLLL 586 (728)
Q Consensus 554 ~~iiH~dlk~~NIll~~----~~~~kl~Dfgla~~~~ 586 (728)
.|++|+|=+|.||++.. ++.+.+.|||+.....
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 28999999999999983 6789999999987654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.86 E-value=8.7e-05 Score=74.49 Aligned_cols=140 Identities=19% Similarity=0.157 Sum_probs=82.5
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhcccccc--ceeeEeeeee---cCCcceeEeecc
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHK--NLVQLLGFCD---EALNRLLVYEFM 514 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~g~~~---~~~~~~lv~e~~ 514 (728)
+.|+.|..+.||+.... + ..+++|..... .....+..|..+++.+... .+.+++.... .....+++|+++
T Consensus 3 ~~l~~G~~n~~~~v~~~--~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTD--D-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEESSSSEEEEEEET--T-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred ccCCCCCeeeEEEEEEC--C-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 45788999999998764 3 58999997654 4456778888888888533 3566776442 233468999999
Q ss_pred CCCCHHH----------------HHh---cC--C--CCChHH---------HHHH------------HHHHHH-HHHHhh
Q 047292 515 GNGTLAN----------------LIF---AI--P--KPDWNL---------RVRI------------SLEIAR-GLVYLH 549 (728)
Q Consensus 515 ~~gsL~~----------------~l~---~~--~--~~~~~~---------~~~i------------~~qi~~-~l~yLH 549 (728)
++..+.. .+. .. + ...... .... ...+.+ .+..++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9988777 111 11 0 001000 0000 111222 233333
Q ss_pred h----cCCCCeeecCCCCCCEEEc-CCCceEEccccCccc
Q 047292 550 E----GCNVPIIHCDIKPQNILLD-HYFSPKISDFGLSKL 584 (728)
Q Consensus 550 ~----~~~~~iiH~dlk~~NIll~-~~~~~kl~Dfgla~~ 584 (728)
+ .....++|+|+.|.||+++ +++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2 1234699999999999999 666678999987753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00016 Score=66.88 Aligned_cols=129 Identities=19% Similarity=0.292 Sum_probs=87.0
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceee-EeeeeecCCcceeEeeccC
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQ-LLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~g~~~~~~~~~lv~e~~~ 515 (728)
+..+.|++|++|.||+|.+. +..+|+|+-... .....+..|.++|..+.-.++-+ ++.+- ..++.|||+.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~---~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~ 95 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR---GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYID 95 (201)
T ss_pred hhhhhhhcccccEEEEeecc---CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhc
Confidence 34578999999999999875 568999987553 34578899999999887665543 33332 2335599999
Q ss_pred CCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCC-CCCEEEcCCCceEEccccCccc
Q 047292 516 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIK-PQNILLDHYFSPKISDFGLSKL 584 (728)
Q Consensus 516 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk-~~NIll~~~~~~kl~Dfgla~~ 584 (728)
|-.|.+.-... +-++++ .+++. +|.-+. ++|-|+.|. |..++|..+..+.|+||.-|..
T Consensus 96 G~~L~~~~~~~---~rk~l~----~vlE~-a~~LD~--~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 96 GRPLGKLEIGG---DRKHLL----RVLEK-AYKLDR--LGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred Ccchhhhhhcc---cHHHHH----HHHHH-HHHHHH--hccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 98887665432 223333 33333 333332 488888876 4555555555999999998874
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=97.79 E-value=8e-05 Score=65.80 Aligned_cols=83 Identities=16% Similarity=0.284 Sum_probs=57.5
Q ss_pred EEec-Cc-eEEeCCC-CCeEeecCCC---CceeeEEEecCcCEEEEeccccccccccccccccccccccceeccccEEEe
Q 047292 22 ELTA-TG-LLLKDPG-GQAIWDEKPN---KIVSDAAMLDTGNFVLIASGNHSDYAWQSFKSPTDTILPTQILDLGSVLVS 95 (728)
Q Consensus 22 ~~~~-~g-l~l~~~~-~~~vWst~~~---~~~~~a~lld~GNlVl~~~~~~~~~lWQSFD~PtDtlLpg~~l~~~~~L~S 95 (728)
.+.. +| |++.+.. +.+||++|.. .....+.|.++|||||.+ .++.++|||=-. +
T Consensus 25 ~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~--~~g~~vW~S~~~-------~----------- 84 (116)
T cd00028 25 IMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYD--GSGTVVWSSNTT-------R----------- 84 (116)
T ss_pred CCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEc--CCCcEEEEeccc-------C-----------
Confidence 3444 88 7887654 5899999842 345678999999999954 456789986421 0
Q ss_pred eccCCCCCCccEEEEee-CCceEEeeccCCcccceeeeeeccC
Q 047292 96 RLTETNLSKGRFELHFS-NGSLEFIPVAWPSRFQYKSYYTSNT 137 (728)
Q Consensus 96 ~~s~~d~s~G~~~l~~~-~~~~~~~~~~~~~~~~~~~y~~~~~ 137 (728)
+.|.+.+.|+ +|+++++-..+ ...|.+..
T Consensus 85 -------~~~~~~~~L~ddGnlvl~~~~~------~~~W~Sf~ 114 (116)
T cd00028 85 -------VNGNYVLVLLDDGNLVLYDSDG------NFLWQSFD 114 (116)
T ss_pred -------CCCceEEEEeCCCCEEEECCCC------CEEEcCCC
Confidence 2467888888 89988875432 35676653
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=97.53 E-value=6.8e-05 Score=60.08 Aligned_cols=50 Identities=28% Similarity=0.590 Sum_probs=40.5
Q ss_pred EEEecccCCCCCCccccCCCChhhHHHHhccCCCccccccc--CcccccccC
Q 047292 287 IREFNNVDWPLGDYERLEPSNQTECEISCLQDCSCAVAIYD--GNRCWKKKL 336 (728)
Q Consensus 287 f~~~~~~~~p~~~~~~~~~~~~~~C~~~Cl~~CsC~a~~~~--~~~C~~~~~ 336 (728)
|..++++++++.++......+.++|+..|+.+|+|.||.|+ .+.|+++..
T Consensus 6 ~~~~~~~~~~g~d~~~~~~~s~~~Cq~~C~~~~~C~afT~~~~~~~C~lk~~ 57 (73)
T cd01100 6 FRQGSNVDFRGGDLSTVFASSAEQCQAACTADPGCLAFTYNTKSKKCFLKSS 57 (73)
T ss_pred ccccCCCccccCCcceeecCCHHHHHHHcCCCCCceEEEEECCCCeEEcccC
Confidence 44456788888777655566999999999999999999995 578998766
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00073 Score=80.73 Aligned_cols=80 Identities=10% Similarity=0.226 Sum_probs=56.1
Q ss_pred hhhCCCceeEEEEeeeeCCCC-cEEEEEEecccc-hhhHHHHHHHHHHhcccc-ccce--eeEeeeeecC---CcceeEe
Q 047292 440 EELGRGSFGIVYKGVLKTASG-NAIAVKKLDRLA-QEREREFKSEVSAIGRTH-HKNL--VQLLGFCDEA---LNRLLVY 511 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~-~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~l~g~~~~~---~~~~lv~ 511 (728)
+.++.|.+..+|+........ ..+++|+..... ......+.+|+++++.+. |.++ .+++.+|.+. +..++||
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM 123 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM 123 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence 468899999999876542211 367777764322 123457889999999985 6665 7888888764 4678999
Q ss_pred eccCCCCH
Q 047292 512 EFMGNGTL 519 (728)
Q Consensus 512 e~~~~gsL 519 (728)
||+++..+
T Consensus 124 E~v~G~~~ 131 (822)
T PLN02876 124 EYLEGRIF 131 (822)
T ss_pred EecCCccc
Confidence 99988643
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00058 Score=68.80 Aligned_cols=73 Identities=15% Similarity=0.198 Sum_probs=45.2
Q ss_pred hhhCCCcee-EEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhcccccc---ceeeEeeeeecC---CcceeEee
Q 047292 440 EELGRGSFG-IVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHK---NLVQLLGFCDEA---LNRLLVYE 512 (728)
Q Consensus 440 ~~lg~G~fg-~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~g~~~~~---~~~~lv~e 512 (728)
+.|+.|+.. .||+. +..+++|..+.. .....+..|.+++..+... -+.++++..... ...+++|+
T Consensus 3 ~~~~~gG~~n~vy~~------~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~ 74 (235)
T cd05155 3 EPVDSGGTDNATFRL------GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYR 74 (235)
T ss_pred eeccCCCcccceEEc------CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEE
Confidence 346766665 58874 134677775542 2345788899998877532 344555544332 23488999
Q ss_pred ccCCCCHH
Q 047292 513 FMGNGTLA 520 (728)
Q Consensus 513 ~~~~gsL~ 520 (728)
+++|.++.
T Consensus 75 ~i~G~~l~ 82 (235)
T cd05155 75 WLEGETAT 82 (235)
T ss_pred eecCCCCC
Confidence 99987663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0017 Score=67.79 Aligned_cols=75 Identities=8% Similarity=0.051 Sum_probs=53.9
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccc---cceeeEeeeeecC---CcceeEeec
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHH---KNLVQLLGFCDEA---LNRLLVYEF 513 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~g~~~~~---~~~~lv~e~ 513 (728)
+.||.|..+.||+.... ++ .+.+|..+.. .....+..|.+.|+.+.. ..++++++++... +..+||||+
T Consensus 20 ~~i~~G~~~~vy~~~~~--~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 20 ECISEQPYAALWALYDS--QG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eecCCccceeEEEEEcC--CC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 45999999999986532 33 4666764331 123578899999988842 4688889887543 568999999
Q ss_pred cCCCCH
Q 047292 514 MGNGTL 519 (728)
Q Consensus 514 ~~~gsL 519 (728)
+++.++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998764
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.00075 Score=78.89 Aligned_cols=197 Identities=20% Similarity=0.204 Sum_probs=135.6
Q ss_pred HHHHHHHHhccccccceeeEeeeeecCCcc----eeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCC
Q 047292 478 EFKSEVSAIGRTHHKNLVQLLGFCDEALNR----LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCN 553 (728)
Q Consensus 478 ~~~~E~~~l~~l~h~niv~l~g~~~~~~~~----~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~ 553 (728)
....|+..+..+.|+|++.++++-.+.... .+..|++..-++...+......+....+.+..++.+||+|+|+.
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~-- 305 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL-- 305 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh--
Confidence 445677788888999999999987554433 34557888889999998888899999999999999999999996
Q ss_pred CCeeecCCCCC---CEEEcCCCceEEc--cccCccccccCCCcccccccCCccccCcccccCCCCCCc--cchhhHHHHH
Q 047292 554 VPIIHCDIKPQ---NILLDHYFSPKIS--DFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAK--VDVYSFGVML 626 (728)
Q Consensus 554 ~~iiH~dlk~~---NIll~~~~~~kl~--Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~--~DVwSlGvil 626 (728)
...|.-|..+ +--.+..+...+. ||+..+.......... ..-+..+.+||......+..+ .|+|.+|..+
T Consensus 306 -~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~--~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 306 -SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS--DLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred -ccceeEEecccccccccCccceeecchhhhcccccCCCcccchh--hcCccccccccccccccchhhhhhHHHHHHHHH
Confidence 3344333333 4445566667776 8888776543322111 123556788888877665544 7999999999
Q ss_pred HHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 047292 627 LEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQML 706 (728)
Q Consensus 627 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 706 (728)
..+..|..+-...... ..+++. .. ...+.....+|+..++++|+.+.+++...
T Consensus 383 ~~~~~~~~i~~~~~~~-------------------~~~l~~----~~----~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 383 LQLSQGEDISEKSAVP-------------------VSLLDV----LS----TSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred hhhhhcCcccccccch-------------------hhhhcc----cc----chhhhhhhhhhcchhhhhccchhhhhhch
Confidence 9998876543211100 000110 00 00344566789999999999999998765
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0028 Score=61.43 Aligned_cols=130 Identities=18% Similarity=0.219 Sum_probs=88.6
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccc----------------hhhHHHHHHHHHHhcccc------ccceeeE
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA----------------QEREREFKSEVSAIGRTH------HKNLVQL 497 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~l 497 (728)
..||+|+.-.||.= .......||+..... .....+..+|+....++. +.+|.++
T Consensus 7 ~~i~~G~~R~cy~H----P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 7 DLIAQGGERDCYQH----PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred cccccCCCceEEEC----CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 46899999999962 344567888886544 122355666666555544 8899999
Q ss_pred eeeeecCCcceeEeeccCC------CCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCC
Q 047292 498 LGFCDEALNRLLVYEFMGN------GTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHY 571 (728)
Q Consensus 498 ~g~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~ 571 (728)
+|+.+.+...-+|+|.+.+ .+|.+++.+. .++. .. ...+-+-..||-++ .|+.+|++|.||++...
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~~---~~~L~~f~~~l~~~---~Iv~~dl~~~NIv~~~~ 154 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-EL---RQALDEFKRYLLDH---HIVIRDLNPHNIVVQRR 154 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-CccH-HH---HHHHHHHHHHHHHc---CCeecCCCcccEEEEec
Confidence 9999999999999998743 3688888553 3333 33 33333445566665 89999999999999643
Q ss_pred --C--ceEEcc-ccC
Q 047292 572 --F--SPKISD-FGL 581 (728)
Q Consensus 572 --~--~~kl~D-fgl 581 (728)
+ .+.|+| ||-
T Consensus 155 ~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 155 DSGEFRLVLIDGLGE 169 (199)
T ss_pred CCCceEEEEEeCCCC
Confidence 2 466666 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0025 Score=61.31 Aligned_cols=125 Identities=31% Similarity=0.420 Sum_probs=86.9
Q ss_pred HHhhHHhhhCCCce-eEEEEeeeeCCCCcEEEEEEecc------------cch---------hhHHHHHHHHHHhcccc-
Q 047292 434 ATDGFKEELGRGSF-GIVYKGVLKTASGNAIAVKKLDR------------LAQ---------EREREFKSEVSAIGRTH- 490 (728)
Q Consensus 434 ~~~~~~~~lg~G~f-g~Vy~g~~~~~~~~~vavK~l~~------------~~~---------~~~~~~~~E~~~l~~l~- 490 (728)
....|.+.||.|.- |.||++.+ .|+.+|+|.++. ... .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I---~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke 113 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI---DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE 113 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE---CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence 44557788999999 99999988 478999999421 000 11246889999988885
Q ss_pred --ccce--eeEeeeeecC------------------CcceeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHh
Q 047292 491 --HKNL--VQLLGFCDEA------------------LNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYL 548 (728)
Q Consensus 491 --h~ni--v~l~g~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yL 548 (728)
+.++ |+.+|+..-. ...-||.||++... ....+-+.+|.+-|..+
T Consensus 114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQIRDIPQMLRDLKIL 180 (207)
T ss_pred ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccchhHHHHHHHHHHHH
Confidence 4456 8999987221 01246777765432 11233455667778888
Q ss_pred hhcCCCCeeecCCCCCCEEEcCCCceEEccccCc
Q 047292 549 HEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLS 582 (728)
Q Consensus 549 H~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla 582 (728)
|.. +|+-+|+++.|.. .-||+|||.+
T Consensus 181 ~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHC---CeeeccCcccccc-----CCEEEecccC
Confidence 986 9999999999985 3588999864
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0025 Score=64.10 Aligned_cols=75 Identities=17% Similarity=0.133 Sum_probs=45.8
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccc-cceeeEeeeeecCCcceeEeeccCCCC
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHH-KNLVQLLGFCDEALNRLLVYEFMGNGT 518 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lv~e~~~~gs 518 (728)
+.|..|-...+|+......+++.|++|+...... .......|+.+++.+.. .-.+++++... ..++|||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 3467788889998754311256888997654221 11233468888887743 33445555433 247999999876
Q ss_pred H
Q 047292 519 L 519 (728)
Q Consensus 519 L 519 (728)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 5
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.002 Score=65.73 Aligned_cols=135 Identities=12% Similarity=0.111 Sum_probs=76.6
Q ss_pred hCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccce-eeEeeeeecCCcceeEeeccCCCCHH
Q 047292 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNL-VQLLGFCDEALNRLLVYEFMGNGTLA 520 (728)
Q Consensus 442 lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~e~~~~gsL~ 520 (728)
+..|-...+|+.. .+++.+++|........-.....+|.++++.+....+ .+++.... .++|+||++|..+.
T Consensus 4 ~~~G~tn~~y~~~---~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 4 LSGGLTNRSWRIE---HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT 76 (256)
T ss_pred CCCcCcCCeEEEE---eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence 5567778999875 2466788887654222111234678888888753323 44554432 36899999986653
Q ss_pred HH-----------------HhcCC----CCChH-HHHHHHHHH---------HHHHHHhhhc-----CCCCeeecCCCCC
Q 047292 521 NL-----------------IFAIP----KPDWN-LRVRISLEI---------ARGLVYLHEG-----CNVPIIHCDIKPQ 564 (728)
Q Consensus 521 ~~-----------------l~~~~----~~~~~-~~~~i~~qi---------~~~l~yLH~~-----~~~~iiH~dlk~~ 564 (728)
.. |+..+ ..+.. .+.....++ ...+..+... ....++|+|+.|.
T Consensus 77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 21 11111 11111 111111111 1112222111 1235899999999
Q ss_pred CEEEcCCCceEEccccCccc
Q 047292 565 NILLDHYFSPKISDFGLSKL 584 (728)
Q Consensus 565 NIll~~~~~~kl~Dfgla~~ 584 (728)
||++++++ +.|+||..+..
T Consensus 157 Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 157 NLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cEEEeCCC-CEEEeccccCc
Confidence 99999877 78999987753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.016 Score=62.47 Aligned_cols=75 Identities=15% Similarity=0.192 Sum_probs=52.2
Q ss_pred hhhCCCceeEEEEeeeeCCCC-cEEEEEEecccc-------hhhHHHHHHHHHHhcccc---ccceeeEeeeeecCCcce
Q 047292 440 EELGRGSFGIVYKGVLKTASG-NAIAVKKLDRLA-------QEREREFKSEVSAIGRTH---HKNLVQLLGFCDEALNRL 508 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~-~~vavK~l~~~~-------~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~ 508 (728)
+.||.|.+..||++... +| +.|+||.-.... .-....+..|.+.|..+. -.++++++.+.. ...+
T Consensus 32 ~elggGn~N~VyrV~~~--~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~ 107 (401)
T PRK09550 32 REIGDGNLNLVFRVSDT--EGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAV 107 (401)
T ss_pred eEcCCCceEEEEEEEeC--CCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCE
Confidence 57999999999998864 34 589999853211 113356677788887762 345777887743 5578
Q ss_pred eEeeccCCCC
Q 047292 509 LVYEFMGNGT 518 (728)
Q Consensus 509 lv~e~~~~gs 518 (728)
+|||++++..
T Consensus 108 lVME~L~~~~ 117 (401)
T PRK09550 108 TVMEDLSDHK 117 (401)
T ss_pred EEEecCCCcc
Confidence 9999998643
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.0031 Score=65.96 Aligned_cols=138 Identities=14% Similarity=0.162 Sum_probs=82.0
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccc--eeeEeee------eecCCcceeEe
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKN--LVQLLGF------CDEALNRLLVY 511 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~------~~~~~~~~lv~ 511 (728)
+.|..|....+|+... ++..+++|+... .....+..|++++..+.+.+ +++++.. ....+..++++
T Consensus 20 ~~i~~G~~n~~y~v~~---~~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 20 EGISAGIENTNYFVTT---DSGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred ecccCccccceEEEEe---CCCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 3577787789998654 234788898764 22345667787777774332 4454442 12334568999
Q ss_pred eccCCCCHHH----H----------HhcC----C-------CCChHHHH----------HHHHHHHHHHHHhhh----cC
Q 047292 512 EFMGNGTLAN----L----------IFAI----P-------KPDWNLRV----------RISLEIARGLVYLHE----GC 552 (728)
Q Consensus 512 e~~~~gsL~~----~----------l~~~----~-------~~~~~~~~----------~i~~qi~~~l~yLH~----~~ 552 (728)
++++|..+.. . ++.. . ...|.... .....+..++.++.. ..
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9999876432 0 0100 0 00111110 011123334444443 12
Q ss_pred CCCeeecCCCCCCEEEcCCCceEEccccCcc
Q 047292 553 NVPIIHCDIKPQNILLDHYFSPKISDFGLSK 583 (728)
Q Consensus 553 ~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~ 583 (728)
..+++|+|+.|.||+++++..+.|+||+.+.
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 3469999999999999998778999998775
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.012 Score=61.76 Aligned_cols=139 Identities=23% Similarity=0.268 Sum_probs=79.6
Q ss_pred hhCCCceeEEEEeeeeC-----CCCcEEEEEEecccchhhHHHHHHHHHHhccccccc-eeeEeeeeecCCcceeEeecc
Q 047292 441 ELGRGSFGIVYKGVLKT-----ASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKN-LVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 441 ~lg~G~fg~Vy~g~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lv~e~~ 514 (728)
.|..|-...+|+..... ..++.+++|+..... ........|.+++..+.... ..++++++.. .+|+||+
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i 79 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI 79 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence 35556667888876532 124788899875432 22245567777777774322 3456665542 3589998
Q ss_pred CCCCHHHH-----------------HhcCC-CC------C----hHHHHH--------------------------HHHH
Q 047292 515 GNGTLANL-----------------IFAIP-KP------D----WNLRVR--------------------------ISLE 540 (728)
Q Consensus 515 ~~gsL~~~-----------------l~~~~-~~------~----~~~~~~--------------------------i~~q 540 (728)
+|.++... ++... .. . +..+.. +...
T Consensus 80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (302)
T cd05156 80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED 159 (302)
T ss_pred CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence 88765321 11111 10 0 001100 0112
Q ss_pred HHHHHHHhhh------cCCCCeeecCCCCCCEEEcCC----CceEEccccCccc
Q 047292 541 IARGLVYLHE------GCNVPIIHCDIKPQNILLDHY----FSPKISDFGLSKL 584 (728)
Q Consensus 541 i~~~l~yLH~------~~~~~iiH~dlk~~NIll~~~----~~~kl~Dfgla~~ 584 (728)
+.+.+..|.. .....++|+|+.+.||+++++ +.++++||..+..
T Consensus 160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 2222333432 134578999999999999985 8899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.011 Score=51.74 Aligned_cols=71 Identities=27% Similarity=0.434 Sum_probs=46.8
Q ss_pred EEEEeCCCCCCCcCCCCcEEEEecCc-eEEeCCCCCeEeecCCCCceeeEEEec--CcCEEEEeccccccccccccccc
Q 047292 2 IIWHANEDNHPVLAPRGSTLELTATG-LLLKDPGGQAIWDEKPNKIVSDAAMLD--TGNFVLIASGNHSDYAWQSFKSP 77 (728)
Q Consensus 2 ~vW~Anr~~~~~~~~~~~~l~~~~~g-l~l~~~~~~~vWst~~~~~~~~a~lld--~GNlVl~~~~~~~~~lWQSFD~P 77 (728)
++|..+..... ....+.+.|.++| |+|+|.++.++|++......+.+..++ .||++ .. +...+.|.|=+.|
T Consensus 40 ~iWss~~t~~~--~~~~~~~~L~~~GNlvl~d~~~~~lW~Sf~~ptdt~L~~q~l~~~~~~-~~--~~~~~sw~s~~dp 113 (114)
T PF01453_consen 40 VIWSSNNTSGR--GNSGCYLVLQDDGNLVLYDSSGNVLWQSFDYPTDTLLPGQKLGDGNVT-GK--NDSLTSWSSNTDP 113 (114)
T ss_dssp EEEE--S-TTS--S-SSEEEEEETTSEEEEEETTSEEEEESTTSSS-EEEEEET--TSEEE-EE--STSSEEEESS---
T ss_pred EEEEecccCCc--cccCeEEEEeCCCCEEEEeecceEEEeecCCCccEEEeccCcccCCCc-cc--cceEEeECCCCCC
Confidence 68999432211 0146899999999 999999999999997555566667777 88888 32 2346788886666
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.25 E-value=0.039 Score=58.29 Aligned_cols=31 Identities=23% Similarity=0.280 Sum_probs=26.6
Q ss_pred CCCeeecCCCCCCEEEcCCCceEEccccCcc
Q 047292 553 NVPIIHCDIKPQNILLDHYFSPKISDFGLSK 583 (728)
Q Consensus 553 ~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~ 583 (728)
..+++|+|+.+.||+++.+...-|+||+.+.
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 3479999999999999977666899999875
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.04 E-value=0.043 Score=56.54 Aligned_cols=31 Identities=26% Similarity=0.486 Sum_probs=25.8
Q ss_pred CCeeecCCCCCCEEEcCCCc-eEEccccCccc
Q 047292 554 VPIIHCDIKPQNILLDHYFS-PKISDFGLSKL 584 (728)
Q Consensus 554 ~~iiH~dlk~~NIll~~~~~-~kl~Dfgla~~ 584 (728)
..++|+|+++.||++++++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 35899999999999997555 56999998764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.04 E-value=0.0015 Score=78.04 Aligned_cols=157 Identities=12% Similarity=-0.026 Sum_probs=110.5
Q ss_pred HHHHHHhccccccceeeEeeee--ecCCcceeEeeccCCCCHHHHHhcC----CCCChHHHHHHHHHHHHHHHHhhhcCC
Q 047292 480 KSEVSAIGRTHHKNLVQLLGFC--DEALNRLLVYEFMGNGTLANLIFAI----PKPDWNLRVRISLEIARGLVYLHEGCN 553 (728)
Q Consensus 480 ~~E~~~l~~l~h~niv~l~g~~--~~~~~~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~i~~qi~~~l~yLH~~~~ 553 (728)
..|...++...|+++.....=. .+..+.+.+++|+.+|.+.+.|.+. +.++.......-++...+..-.|+..+
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 3444445556788876654433 3445668999999999999998765 222222233333333455555554432
Q ss_pred C--CeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh
Q 047292 554 V--PIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC 631 (728)
Q Consensus 554 ~--~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt 631 (728)
. -.+|+++|+-|.+|..+..+|+.++|+.+..... ........+++.|+.|+.....+++.++|+|..|+.+|+.--
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~-~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV-LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred CCccchhhhhhhhccceecCCcccccccccccccCch-HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence 2 3689999999999999999999999999843222 222333457889999999999999999999999999999887
Q ss_pred CCcCcc
Q 047292 632 CRRSVE 637 (728)
Q Consensus 632 g~~p~~ 637 (728)
|..++.
T Consensus 1436 ~n~~fi 1441 (2724)
T KOG1826|consen 1436 GNAYFI 1441 (2724)
T ss_pred ccHHHH
Confidence 776653
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=95.92 E-value=0.053 Score=56.95 Aligned_cols=139 Identities=15% Similarity=0.221 Sum_probs=78.3
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhcccccc--ceeeEeeee------ecCCcceeEe
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHK--NLVQLLGFC------DEALNRLLVY 511 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~g~~------~~~~~~~lv~ 511 (728)
+.++.|.-..+|+... .++ .+++|+.+... ....+..|++++..+... .+++++... ...+..++++
T Consensus 28 ~~~~~G~~n~~y~v~t--~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~ 102 (307)
T TIGR00938 28 KGIAEGVENSNYLLTT--DVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV 102 (307)
T ss_pred cccCCccccceEEEEe--CCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence 3467777789998653 233 57788765421 123445566666666322 244444422 2234568999
Q ss_pred eccCCCCHH-----------HH---HhcC-CC-----------CChHHHH------------HHHHHHHHHHHHhhh---
Q 047292 512 EFMGNGTLA-----------NL---IFAI-PK-----------PDWNLRV------------RISLEIARGLVYLHE--- 550 (728)
Q Consensus 512 e~~~~gsL~-----------~~---l~~~-~~-----------~~~~~~~------------~i~~qi~~~l~yLH~--- 550 (728)
||++|..+. .. ++.. .. ..|.... .....+.+.++++..
T Consensus 103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~ 182 (307)
T TIGR00938 103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP 182 (307)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence 999885431 00 1110 00 0111110 011123344555532
Q ss_pred -cCCCCeeecCCCCCCEEEcCCCceEEccccCcc
Q 047292 551 -GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSK 583 (728)
Q Consensus 551 -~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~ 583 (728)
....+++|+|+.+.||++++++...|+||+.+.
T Consensus 183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 224589999999999999998877899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.80 E-value=0.0097 Score=60.60 Aligned_cols=134 Identities=15% Similarity=0.109 Sum_probs=86.4
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc-------hh---------------hHHHHHHHHHHhccccc--
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA-------QE---------------REREFKSEVSAIGRTHH-- 491 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~-------~~---------------~~~~~~~E~~~l~~l~h-- 491 (728)
+.+.+.||-|--+.||.+... .|++.++|.-.-.. .. ..-...+|...|+.+..
T Consensus 94 ~svGnqIGVGKESDIY~v~d~--~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE--EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhccccccccccceEEEecC--CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 456788999999999999764 67888887431100 00 01234567777777742
Q ss_pred cceeeEeeeeecCCcceeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCC
Q 047292 492 KNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHY 571 (728)
Q Consensus 492 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~ 571 (728)
--+++.+++ ...++|||++.+-.|...-+-. +... +...+..-+.-|..+ |+||+|..-=||+++++
T Consensus 172 fpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~---d~~~---ly~~lm~~Iv~la~~---GlIHgDFNEFNimv~dd 238 (465)
T KOG2268|consen 172 FPVPKPIDH----NRHCVVMELVDGYPLRQVRHVE---DPPT---LYDDLMGLIVRLANH---GLIHGDFNEFNIMVKDD 238 (465)
T ss_pred CCCCCcccc----cceeeHHHhhcccceeeeeecC---ChHH---HHHHHHHHHHHHHHc---CceecccchheeEEecC
Confidence 234444444 3457899999888776554322 1222 222222233334444 99999999999999999
Q ss_pred CceEEccccCccc
Q 047292 572 FSPKISDFGLSKL 584 (728)
Q Consensus 572 ~~~kl~Dfgla~~ 584 (728)
+.++++||--...
T Consensus 239 ~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 239 DKIVVIDFPQMVS 251 (465)
T ss_pred CCEEEeechHhhc
Confidence 9999999975443
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.78 E-value=0.068 Score=55.61 Aligned_cols=126 Identities=21% Similarity=0.323 Sum_probs=74.2
Q ss_pred CcEEEEEEec-ccchhhHHHHHHHHHHhcccc--ccceeeEeeeeecCC--cceeEeeccCCCCHH--------------
Q 047292 460 GNAIAVKKLD-RLAQEREREFKSEVSAIGRTH--HKNLVQLLGFCDEAL--NRLLVYEFMGNGTLA-------------- 520 (728)
Q Consensus 460 ~~~vavK~l~-~~~~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~--~~~lv~e~~~~gsL~-------------- 520 (728)
++.+++.+-. ...........+|+++++.+. -.-+...++.|.++. ..+.||++++|..+.
T Consensus 48 ~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~~ 127 (321)
T COG3173 48 GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFAL 127 (321)
T ss_pred CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHHH
Confidence 6677777331 122334456677888887764 233456677787666 779999999883221
Q ss_pred ----HHHhc---CC--------CC---------ChHHHHHH--------HHHHHHHHHHhhhc-----CCCCeeecCCCC
Q 047292 521 ----NLIFA---IP--------KP---------DWNLRVRI--------SLEIARGLVYLHEG-----CNVPIIHCDIKP 563 (728)
Q Consensus 521 ----~~l~~---~~--------~~---------~~~~~~~i--------~~qi~~~l~yLH~~-----~~~~iiH~dlk~ 563 (728)
++|.. .+ .. .|...++. .-....-..+|+++ ....++|+|+++
T Consensus 128 ~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~ 207 (321)
T COG3173 128 DALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRP 207 (321)
T ss_pred HHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCccc
Confidence 11110 00 00 01111100 01122334445443 234699999999
Q ss_pred CCEEEcCCCceEEccccCcccc
Q 047292 564 QNILLDHYFSPKISDFGLSKLL 585 (728)
Q Consensus 564 ~NIll~~~~~~kl~Dfgla~~~ 585 (728)
.||+++...-+-+.||+++..-
T Consensus 208 gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 208 GNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred CCEEEeCCCeeEEEeccccccC
Confidence 9999999888999999998753
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.71 E-value=0.063 Score=57.31 Aligned_cols=138 Identities=17% Similarity=0.184 Sum_probs=77.3
Q ss_pred hCCCceeEEEEeeeeCC---CCcEEEEEEecccchhhHHHHHHHHHHhccccccce-eeEeeeeecCCcceeEeeccCCC
Q 047292 442 LGRGSFGIVYKGVLKTA---SGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNL-VQLLGFCDEALNRLLVYEFMGNG 517 (728)
Q Consensus 442 lg~G~fg~Vy~g~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~e~~~~g 517 (728)
|-.|-.-.+|+...... .++.|++|+...... ..-.-..|..+++.+...++ .++++.+... .|+||+++.
T Consensus 44 l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~ 118 (344)
T PLN02236 44 LKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-LFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHAR 118 (344)
T ss_pred cCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-eeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCC
Confidence 44466678888764321 236788888755322 11223668888887754333 3566665432 578998876
Q ss_pred CHHHH-----------------HhcCC-C----CC-hHHHHHHHHH-----------------HHHHHHHh----hh-cC
Q 047292 518 TLANL-----------------IFAIP-K----PD-WNLRVRISLE-----------------IARGLVYL----HE-GC 552 (728)
Q Consensus 518 sL~~~-----------------l~~~~-~----~~-~~~~~~i~~q-----------------i~~~l~yL----H~-~~ 552 (728)
+|... ++..+ + .. +..+.++..+ +...+..| .. ..
T Consensus 119 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~ 198 (344)
T PLN02236 119 TLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQ 198 (344)
T ss_pred CCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCC
Confidence 65321 11111 0 11 2222222211 11112222 21 22
Q ss_pred CCCeeecCCCCCCEEEcC-CCceEEccccCccc
Q 047292 553 NVPIIHCDIKPQNILLDH-YFSPKISDFGLSKL 584 (728)
Q Consensus 553 ~~~iiH~dlk~~NIll~~-~~~~kl~Dfgla~~ 584 (728)
...++|+|+++.||++++ ++.+.++||..+..
T Consensus 199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 346899999999999986 57899999988753
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.59 E-value=0.098 Score=54.01 Aligned_cols=72 Identities=17% Similarity=0.275 Sum_probs=45.9
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhcccc---ccceeeEeeeeecCCcceeEeeccCC
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTH---HKNLVQLLGFCDEALNRLLVYEFMGN 516 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lv~e~~~~ 516 (728)
+.++.|....+|+.. .+++.+.||.-.. .....|..|.+-|+.|. --.+++++++....+..+||+||++.
T Consensus 23 ~~v~GG~i~~a~~~~---~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 23 EPVSGGDINEAYRLD---TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp EEE--SSSSEEEEEE---TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred EecCCCChhheEEEE---CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 357888889999865 4678899998762 22356777887777773 55678899988877788999999987
Q ss_pred C
Q 047292 517 G 517 (728)
Q Consensus 517 g 517 (728)
+
T Consensus 97 ~ 97 (288)
T PF03881_consen 97 G 97 (288)
T ss_dssp -
T ss_pred C
Confidence 6
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.21 E-value=0.3 Score=52.58 Aligned_cols=72 Identities=17% Similarity=0.239 Sum_probs=48.1
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccch-------hhHHHHHHHHHHhcccc---ccceeeEeeeeecCCccee
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ-------EREREFKSEVSAIGRTH---HKNLVQLLGFCDEALNRLL 509 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~l 509 (728)
+.||.|....||+... .+..++||+-..... .....-..|.+.|+.+. ..++++++.++. +..++
T Consensus 38 ~eiggGn~N~VyrV~~---~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl 112 (418)
T PLN02756 38 KEVGDGNLNFVYIVVS---SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI 112 (418)
T ss_pred EEcCCCceeeEEEEEc---CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence 5689999999999664 345799998652111 12233344566666553 357888999887 44678
Q ss_pred EeeccCC
Q 047292 510 VYEFMGN 516 (728)
Q Consensus 510 v~e~~~~ 516 (728)
+||++++
T Consensus 113 vME~L~~ 119 (418)
T PLN02756 113 GMRYLEP 119 (418)
T ss_pred EEeecCC
Confidence 8999976
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=94.81 E-value=0.26 Score=52.13 Aligned_cols=74 Identities=19% Similarity=0.211 Sum_probs=45.9
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccch-------hhHHHHHHHHHHhcccc--cc-ceeeEeeeeecCCccee
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ-------EREREFKSEVSAIGRTH--HK-NLVQLLGFCDEALNRLL 509 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~--h~-niv~l~g~~~~~~~~~l 509 (728)
++||.|....||++... ..++.|+||.-..... -......-|.+.|+... -| .+++++.+ +.....+
T Consensus 1 ~EigdGnlN~VfrV~~~-~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~ 77 (370)
T TIGR01767 1 QEVGDGNLNLVFHVYDQ-EGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVT 77 (370)
T ss_pred CcCCCCceEEEEEEEcC-CCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--cccccee
Confidence 36899999999999863 2336899997643211 12244456667776552 34 34555544 3445568
Q ss_pred EeeccCC
Q 047292 510 VYEFMGN 516 (728)
Q Consensus 510 v~e~~~~ 516 (728)
|||+++.
T Consensus 78 vMEdL~~ 84 (370)
T TIGR01767 78 VMEDLSH 84 (370)
T ss_pred hHhhCcc
Confidence 8998854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.80 E-value=0.079 Score=57.39 Aligned_cols=164 Identities=22% Similarity=0.262 Sum_probs=90.5
Q ss_pred HHHHHHHHHHhccccccceeeEeeeeecCCc-ceeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCC
Q 047292 476 EREFKSEVSAIGRTHHKNLVQLLGFCDEALN-RLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNV 554 (728)
Q Consensus 476 ~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~ 554 (728)
..++.-...+++.+.|+|+...+.+...... ..+|+|++ +.+|.+.+..+. +-.... . -|
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~------~------~~----- 86 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESL------L------AH----- 86 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhh------c------cc-----
Confidence 3456677888889999999999998866554 46778877 568888887654 111100 0 11
Q ss_pred CeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCc
Q 047292 555 PIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRR 634 (728)
Q Consensus 555 ~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~ 634 (728)
++.|- || .+++| -++. + | |- ...+|+||||+|.++.|+.-|..
T Consensus 87 ~~~~~-----~~-------~~~td-~~~t-------~----------~--~~-----~~~pKsdVwsl~~i~~el~L~~~ 129 (725)
T KOG1093|consen 87 GVLHL-----NI-------IYITD-HFLT-------K----------Y--PS-----PIGPKSDVWSLGFIILELYLGIS 129 (725)
T ss_pred cccee-----hh-------hhccc-cccc-------c----------C--CC-----CCCcchhhhhHHHHHHHHHHhhH
Confidence 22221 11 22233 0000 0 0 00 11149999999999999998876
Q ss_pred CcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 047292 635 SVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKV 701 (728)
Q Consensus 635 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~e 701 (728)
-+......+....+..+. ..+.....+. ....+..+.....+++...|+-..|..||...+
T Consensus 130 l~~~~~~s~~l~~i~k~~---~~d~~~~~~a---~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~ 190 (725)
T KOG1093|consen 130 LEAELTESEYLEILLKYY---TDDQELLSTA---MEHLIQLLADKKRLPLLKKCLWLEPIIRPLPME 190 (725)
T ss_pred HHHHHHHHHHHHHHHHhc---cCchhHHHHH---HHHHHHHhhhHhHHHHhccCCccccccccchhH
Confidence 554333222222221110 0111111111 011333445566778889999999998885443
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.68 E-value=0.2 Score=52.30 Aligned_cols=138 Identities=18% Similarity=0.161 Sum_probs=88.8
Q ss_pred hhCCCceeEEEEeeeeCCCCcEEEEEEecccc-------------------------hhhH-HHHHHHHHHhccccccce
Q 047292 441 ELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA-------------------------QERE-REFKSEVSAIGRTHHKNL 494 (728)
Q Consensus 441 ~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~-------------------------~~~~-~~~~~E~~~l~~l~h~ni 494 (728)
.|..|--+.||.+.- .+|..+|||+.+... .... .-...|++-|.+++...|
T Consensus 151 CiSTGKEANVYHat~--~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 151 CISTGKEANVYHATE--EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccCccceeEeeec--CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 367788889999875 478889999874210 0000 123457777777765544
Q ss_pred eeEeeeeecCCcceeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCce
Q 047292 495 VQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSP 574 (728)
Q Consensus 495 v~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~ 574 (728)
.-.--+.. ....|||+|+....-..-.-..-.++...+..+-.|++.-|.-|-+.| ++||.||.--|+|+.+ |.+
T Consensus 229 P~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyhd-G~l 303 (520)
T KOG2270|consen 229 PCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHD-GKL 303 (520)
T ss_pred CCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEEC-CEE
Confidence 31111111 123689999864332221112234555667778888888888887775 7899999999998875 578
Q ss_pred EEccccCcccc
Q 047292 575 KISDFGLSKLL 585 (728)
Q Consensus 575 kl~Dfgla~~~ 585 (728)
.|+|-+-+...
T Consensus 304 yiIDVSQSVE~ 314 (520)
T KOG2270|consen 304 YIIDVSQSVEH 314 (520)
T ss_pred EEEEccccccC
Confidence 99998876543
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.52 E-value=0.17 Score=54.21 Aligned_cols=74 Identities=15% Similarity=0.220 Sum_probs=47.3
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccc------hhhHHHHHHHHHHhcccc--cc-ceeeEeeeeecCCcceeE
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA------QEREREFKSEVSAIGRTH--HK-NLVQLLGFCDEALNRLLV 510 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~--h~-niv~l~g~~~~~~~~~lv 510 (728)
++||.|.-..||++.... .++.|+||.-.... .-......-|.++|+... .| .+++++.+ +.....+|
T Consensus 35 ~eigdGnlN~VfrV~~~~-~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 35 KEIGDGNLNYVFRVWDEQ-KNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eEcCCCceEEEEEEeeCC-CCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 578999999999998632 35689999753321 112355666777777653 34 35556554 34455678
Q ss_pred eeccCC
Q 047292 511 YEFMGN 516 (728)
Q Consensus 511 ~e~~~~ 516 (728)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 888754
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 728 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-56 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-55 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-41 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-41 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-38 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-38 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-38 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-36 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-26 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-26 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-21 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 7e-21 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-21 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-21 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-20 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-20 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-20 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-20 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-20 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-20 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-20 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-20 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-20 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 8e-20 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 8e-20 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 9e-20 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 9e-20 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-19 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-19 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-19 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-19 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-19 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-19 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-19 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-19 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 7e-19 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-19 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 8e-19 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 8e-19 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 8e-19 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 8e-19 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 8e-19 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 8e-19 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 9e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-18 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-18 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-18 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-17 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-17 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-17 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-17 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-17 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-17 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-17 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-17 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-17 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-17 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-17 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-17 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-17 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-17 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-17 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-17 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-17 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-17 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-17 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-17 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-17 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 7e-17 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 7e-17 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 8e-17 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-16 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-16 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-16 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-16 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-16 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-16 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-16 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-16 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 8e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-16 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-16 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-16 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 9e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-15 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-15 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-15 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-15 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-15 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-15 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-15 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-15 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-15 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-15 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-15 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-15 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-15 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-15 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-15 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-15 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-14 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-14 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-14 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-13 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-13 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-13 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-13 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 7e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-13 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-13 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 8e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 8e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-13 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 9e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-12 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-12 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-12 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-12 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 8e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 8e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-12 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 9e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 9e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 9e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-11 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-11 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 7e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-11 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 7e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 7e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 8e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 8e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 9e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 9e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 9e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 9e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 9e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 9e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 9e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 9e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 9e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 9e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 9e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 9e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 9e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-09 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 7e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 7e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 8e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 8e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 9e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 9e-09 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 9e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-08 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 4e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 5e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 8e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 8e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 9e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-07 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-07 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-07 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-07 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-07 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 4e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-07 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 4e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 5e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 6e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 6e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 6e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 6e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 6e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 6e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 7e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 7e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 7e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 8e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 8e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 8e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 8e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 8e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 8e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 9e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 9e-07 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 1e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-06 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-06 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 8e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 9e-06 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 9e-06 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-05 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-05 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 375 bits (965), Expect = e-125
Identities = 125/305 (40%), Positives = 176/305 (57%), Gaps = 14/305 (4%)
Query: 414 QDSTTSATNLRFFSYDELKDATDGFKEE--LGRGSFGIVYKGVLKTASGNAIAVKKLDR- 470
+D L+ FS EL+ A+D F + LGRG FG VYKG L G +AVK+L
Sbjct: 8 EDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA--DGTLVAVKRLKEE 65
Query: 471 LAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP- 529
Q E +F++EV I H+NL++L GFC RLLVY +M NG++A+ + P+
Sbjct: 66 RTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ 125
Query: 530 ---DWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLL 586
DW R RI+L ARGL YLH+ C+ IIH D+K NILLD F + DFGL+KL+
Sbjct: 126 PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM- 184
Query: 587 SDHSRTH--TMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEM-ELEEE 643
D+ TH T +RGT G++APE+L S K DV+ +GVMLLE+I +R+ ++ L +
Sbjct: 185 -DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 243
Query: 644 SRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVM 703
+L DW E +L+AL+D D + + + +A+ C Q P +RP M V+
Sbjct: 244 DDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 303
Query: 704 QMLEG 708
+MLEG
Sbjct: 304 RMLEG 308
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 346 bits (889), Expect = e-114
Identities = 107/322 (33%), Positives = 166/322 (51%), Gaps = 15/322 (4%)
Query: 402 FKWRRRKYENNVQDSTTSATNLRFFSYDELKDATDGFKEE--LGRGSFGIVYKGVLKTAS 459
+ + + S +L++AT+ F + +G G FG VYKGVL+
Sbjct: 5 YSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR--D 62
Query: 460 GNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTL 519
G +A+K+ + + EF++E+ + H +LV L+GFCDE +L+Y++M NG L
Sbjct: 63 GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122
Query: 520 ANLIFAIPKP----DWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPK 575
++ P W R+ I + ARGL YLH IIH D+K NILLD F PK
Sbjct: 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPK 179
Query: 576 ISDFGLSKLLLSDHSRTH--TMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCR 633
I+DFG+SK +TH T+++GT GY+ PE+ ++ K DVYSFGV+L E++C R
Sbjct: 180 ITDFGISKKGTEL-DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238
Query: 634 RSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDP 693
++ L E L +WA + + G+L+ ++D + A L K+ A+ C+
Sbjct: 239 SAIVQSLPREMV-NLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSS 297
Query: 694 SKRPTMKVVMQMLEGLLEVPNP 715
RP+M V+ LE L +
Sbjct: 298 EDRPSMGDVLWKLEYALRLQES 319
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 334 bits (859), Expect = e-110
Identities = 106/317 (33%), Positives = 163/317 (51%), Gaps = 34/317 (10%)
Query: 414 QDSTTSATNLRFFSYDELKDATDGFKEE--------LGRGSFGIVYKGVLKTASGNAIAV 465
+ S T FS+ ELK+ T+ F E +G G FG+VYKG + +AV
Sbjct: 3 KSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN---NTTVAV 59
Query: 466 KKLDRLAQER----EREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLAN 521
KKL + +++F E+ + + H+NLV+LLGF + + LVY +M NG+L +
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 522 LIFAIPKP---DWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISD 578
+ + W++R +I+ A G+ +LHE IH DIK NILLD F+ KISD
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISD 176
Query: 579 FGLSKLLLSDHSRTH--TMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSV 636
FGL++ ++T + I GT Y+APE L+ ++ K D+YSFGV+LLEII +V
Sbjct: 177 FGLARASEKF-AQTVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAV 234
Query: 637 EMELEEESRAILTDWAYDCYVEGR-LDALIDSDEAAMADRSR--LHKWLMIAMWCIQEDP 693
+ E + L D + E + ++ ID M D + +A C+ E
Sbjct: 235 DEHREPQL---LLDIKEEIEDEEKTIEDYIDKK---MNDADSTSVEAMYSVASQCLHEKK 288
Query: 694 SKRPTMKVVMQMLEGLL 710
+KRP +K V Q+L+ +
Sbjct: 289 NKRPDIKKVQQLLQEMT 305
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 239 bits (611), Expect = 5e-73
Identities = 72/332 (21%), Positives = 131/332 (39%), Gaps = 40/332 (12%)
Query: 411 NNVQDSTTSATNLRFFSYDELKDATDGFK--EELGRGSFGIVYKGVLKTASGNAIAVKKL 468
+ +S + + L + + E RG FG V+K L +AVK
Sbjct: 2 GHHHHHHSSGVD---LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL---NEYVAVKIF 55
Query: 469 DRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALN----RLLVYEFMGNGTLANLIF 524
++ + + EV ++ H+N++Q +G + L+ F G+L++ +
Sbjct: 56 PI-QDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK 114
Query: 525 AIPKPDWNLRVRISLEIARGLVYLHE-------GCNVPIIHCDIKPQNILLDHYFSPKIS 577
A WN I+ +ARGL YLHE G I H DIK +N+LL + + I+
Sbjct: 115 A-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173
Query: 578 DFGLSKLLLSDHSRTHTMIR-GTRGYVAPEWLKNAP-----VSAKVDVYSFGVMLLEIIC 631
DFGL+ + S T + GTR Y+APE L+ A ++D+Y+ G++L E+
Sbjct: 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233
Query: 632 CRRSVEMELEEESRAILTDWA---------YDCYVEGRLDALIDSDEAAMADRSRLHKWL 682
+ + + +E + + V + ++ + +
Sbjct: 234 RCTAADGPV-DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDY---WQKHAGMAMLC 289
Query: 683 MIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPN 714
C D R + V + + + + N
Sbjct: 290 ETIEECWDHDAEARLSAGCVGERITQMQRLTN 321
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 3e-65
Identities = 85/300 (28%), Positives = 146/300 (48%), Gaps = 35/300 (11%)
Query: 428 YDELKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKL--DRLAQEREREFKSEVSA 485
+ +L KE++G GSFG V++ G+ +AVK L ER EF EV+
Sbjct: 36 WCDLN-----IKEKIGAGSFGTVHRAEWH---GSDVAVKILMEQDFHAERVNEFLREVAI 87
Query: 486 IGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLI---FAIPKPDWNLRVRISLEIA 542
+ R H N+V +G + N +V E++ G+L L+ A + D R+ ++ ++A
Sbjct: 88 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVA 147
Query: 543 RGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGY 602
+G+ YLH N PI+H ++K N+L+D ++ K+ DFGLS+ L + + GT +
Sbjct: 148 KGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR-LKASTFLSSKSAAGTPEW 205
Query: 603 VAPEWLKNAPVSAKVDVYSFGVMLLEIICCRR-SVEMELEEESRAILTDWAYDCYVEG-R 660
+APE L++ P + K DVYSFGV+L E+ ++ + + R
Sbjct: 206 MAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN--------PAQVVAAVGFKCKR 257
Query: 661 LDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNPPWSSS 720
L+ + + +A ++ C +P KRP+ +M +L L++ PP + S
Sbjct: 258 LE-IPRNLNPQVAA-------II--EGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRS 307
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 5e-65
Identities = 77/288 (26%), Positives = 140/288 (48%), Gaps = 35/288 (12%)
Query: 428 YDELKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIG 487
Y E++ +E +GRG+FG+V K + +A+K++ ++ + F E+ +
Sbjct: 7 YKEIE-----VEEVVGRGAFGVVCKAKWR---AKDVAIKQI--ESESERKAFIVELRQLS 56
Query: 488 RTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFA---IPKPDWNLRVRISLEIARG 544
R +H N+V+L G C + LV E+ G+L N++ +P + L+ ++G
Sbjct: 57 RVNHPNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQG 114
Query: 545 LVYLHEGCNVPIIHCDIKPQNILLD-HYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYV 603
+ YLH +IH D+KP N+LL KI DFG + D T +G+ ++
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWM 170
Query: 604 APEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDA 663
APE + + S K DV+S+G++L E+I R+ + E+ + I + + R
Sbjct: 171 APEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD-EIGGPAFRI----MWAVHNGTRPP- 224
Query: 664 LIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711
LI + + LM W +DPS+RP+M+ +++++ L+
Sbjct: 225 LIKNLPKPIES-------LMTRCW--SKDPSQRPSMEEIVKIMTHLMR 263
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 4e-60
Identities = 73/312 (23%), Positives = 135/312 (43%), Gaps = 42/312 (13%)
Query: 413 VQDSTTSATNLRFFSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKL---- 468
+ S + L + +E++ +++++G+G FG+V+KG L + +A+K L
Sbjct: 3 MGGSEFPKSRLPTLADNEIE-----YEKQIGKGGFGLVHKGRLVK-DKSVVAIKSLILGD 56
Query: 469 ---DRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFA 525
+ E+ +EF+ EV + +H N+V+L G +V EF+ G L + +
Sbjct: 57 SEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD 114
Query: 526 IPKP-DWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHY-----FSPKISDF 579
P W++++R+ L+IA G+ Y+ N PI+H D++ NI L K++DF
Sbjct: 115 KAHPIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173
Query: 580 GLSKLLLSDHSRTHTMIRGTRGYVAPEWL--KNAPVSAKVDVYSFGVMLLEIICCRRSVE 637
GLS+ + + + G ++APE + + + K D YSF ++L I+ +
Sbjct: 174 GLSQ----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229
Query: 638 MELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRP 697
E + + R D + + C DP KRP
Sbjct: 230 -EYSYGKIKFINMIREEGL---RPTIPEDCPP----------RLRNVIELCWSGDPKKRP 275
Query: 698 TMKVVMQMLEGL 709
+++ L L
Sbjct: 276 HFSYIVKELSEL 287
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 7e-60
Identities = 75/328 (22%), Positives = 120/328 (36%), Gaps = 44/328 (13%)
Query: 426 FSYDELKDATDGFK--EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSE- 482
+ E D K E +GRG +G VYKG L +AVK + F +E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD---ERPVAVKVFS---FANRQNFINEK 56
Query: 483 -VSAIGRTHHKNLVQLLGFC-----DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR 536
+ + H N+ + + D + LLV E+ NG+L + DW R
Sbjct: 57 NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-HTSDWVSSCR 115
Query: 537 ISLEIARGLVYLHE------GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS 590
++ + RGL YLH I H D+ +N+L+ + + ISDFGLS L +
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 591 R-------THTMIRGTRGYVAPEWLKNA-------PVSAKVDVYSFGVMLLEIIC-CRRS 635
GT Y+APE L+ A +VD+Y+ G++ EI C
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 636 VEMELEEESRAILTDWAYDCYVEGRLDALIDSD-------EAAMADRSRLHKWLMIAMWC 688
E E + + + L+ + EA + + C
Sbjct: 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDC 295
Query: 689 IQEDPSKRPTMKVVMQMLEGLLEVPNPP 716
+D R T + + + L+ +
Sbjct: 296 WDQDAEARLTAQXAEERMAELMMIWERN 323
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 8e-60
Identities = 71/296 (23%), Positives = 120/296 (40%), Gaps = 44/296 (14%)
Query: 428 YDELKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKL----DRLAQEREREFKSEV 483
+ EL +E +G G FG VY+ G+ +AVK D + + E
Sbjct: 6 FAELT-----LEEIIGIGGFGKVYRAFWI---GDEVAVKAARHDPDEDISQTIENVRQEA 57
Query: 484 SAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIAR 543
H N++ L G C + N LV EF G L ++ + + ++ V +++IAR
Sbjct: 58 KLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL-SGKRIPPDILVNWAVQIAR 116
Query: 544 GLVYLHEGCNVPIIHCDIKPQNILLDHYFSP--------KISDFGLSKLLLSDHSRTHTM 595
G+ YLH+ VPIIH D+K NIL+ KI+DFGL++ +
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA- 175
Query: 596 IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRR-SVEMELEEESRAILTDWAYD 654
G ++APE ++ + S DV+S+GV+L E++ ++ + +
Sbjct: 176 --GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVA------ 227
Query: 655 CYVEG-RLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGL 709
+ L E + + C DP RP+ ++ L +
Sbjct: 228 --MNKLALPIPSTCPEP----------FAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 2e-58
Identities = 72/306 (23%), Positives = 125/306 (40%), Gaps = 40/306 (13%)
Query: 426 FSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSA 485
F +L E LG+G FG K + +G + +K+L R +E +R F EV
Sbjct: 7 FRPSDLI-----HGEVLGKGCFGQAIKVTHRE-TGEVMVMKELIRFDEETQRTFLKEVKV 60
Query: 486 IGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRVRISLEIARG 544
+ H N+++ +G + + E++ GTL +I ++ W+ RV + +IA G
Sbjct: 61 MRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASG 120
Query: 545 LVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM--------- 595
+ YLH N IIH D+ N L+ + ++DFGL++L++ + ++ +
Sbjct: 121 MAYLHS-MN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRK 177
Query: 596 ----IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVE-MELEEESRAILTD 650
+ G ++APE + KVDV+SFG++L EII + +
Sbjct: 178 KRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR 237
Query: 651 WAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710
+ + + I + C DP KRP+ + LE L
Sbjct: 238 GFL------DRYCPPNCPPS----------FFPITVRCCDLDPEKRPSFVKLEHWLETLR 281
Query: 711 EVPNPP 716
Sbjct: 282 MHLAGH 287
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 1e-57
Identities = 65/295 (22%), Positives = 120/295 (40%), Gaps = 44/295 (14%)
Query: 428 YDELKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKL--DRLAQEREREFKSEVSA 485
+ +L F +L G ++KG + GN I VK L + + R+F E
Sbjct: 9 FKQLN-----FLTKLNENHSGELWKGRWQ---GNDIVVKVLKVRDWSTRKSRDFNEECPR 60
Query: 486 IGRTHHKNLVQLLGFCDE--ALNRLLVYEFMGNGTLANLIFAIPKP--DWNLRVRISLEI 541
+ H N++ +LG C A + L+ +M G+L N++ D + V+ +L++
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120
Query: 542 ARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRG 601
ARG+ +LH I + +++++D + +IS + S
Sbjct: 121 ARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPA 173
Query: 602 YVAPEWLKNAPVSA---KVDVYSFGVMLLEIICCRR-SVEMELEEESRAILTDWAYDCYV 657
+VAPE L+ P D++SF V+L E++ ++ E +
Sbjct: 174 WVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVAL-------- 225
Query: 658 EG-RLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711
EG R + ++ LM EDP+KRP +++ +LE + +
Sbjct: 226 EGLRPT-IPPGISPHVSK-------LMKICM--NEDPAKRPKFDMIVPILEKMQD 270
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 2e-56
Identities = 67/307 (21%), Positives = 123/307 (40%), Gaps = 49/307 (15%)
Query: 428 YDELKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKL--DRLAQEREREFKSEVSA 485
+++L+ E +G+G FG VY G +A++ + +R +++ + FK EV A
Sbjct: 32 FEQLE-----IGELIGKGRFGQVYHGRWH----GEVAIRLIDIERDNEDQLKAFKREVMA 82
Query: 486 IGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARG 544
+T H+N+V +G C + ++ TL +++ D N +I+ EI +G
Sbjct: 83 YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKG 142
Query: 545 LVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKL----LLSDHSRTHTMIRGTR 600
+ YLH I+H D+K +N+ D+ I+DFGL + + G
Sbjct: 143 MGYLH---AKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWL 198
Query: 601 GYVAPEWLKNA---------PVSAKVDVYSFGVMLLEIICCRRS-VEMELEEESRAILTD 650
++APE ++ P S DV++ G + E+ E +
Sbjct: 199 CHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM--- 255
Query: 651 WAYDCYVEGRLDALIDSD-EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGL 709
G L ++D ++ ++C + +RPT +M MLE L
Sbjct: 256 ------GTGMKPNLSQIGMGKEISD-------IL--LFCWAFEQEERPTFTKLMDMLEKL 300
Query: 710 LEVPNPP 716
+
Sbjct: 301 PKRNRRL 307
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 7e-55
Identities = 68/290 (23%), Positives = 122/290 (42%), Gaps = 47/290 (16%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKL--DRLAQEREREFKSEVSAIGRTHHKNLV 495
+ +G GSFG VYKG +AVK L ++ + FK+EV + +T H N++
Sbjct: 28 VGQRIGSGSFGTVYKGKWH----GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 496 QLLGFCDEALNRLLVYEFMGNGTLANLI-FAIPKPDWNLRVRISLEIARGLVYLHEGCNV 554
+G+ +V ++ +L + + + K + + I+ + ARG+ YLH
Sbjct: 84 LFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AK 139
Query: 555 PIIHCDIKPQNILLDHYFSPKISDFGLSKLL-LSDHSRTHTMIRGTRGYVAPEWLKNA-- 611
IIH D+K NI L + KI DFGL+ S + G+ ++APE ++
Sbjct: 140 SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 199
Query: 612 -PVSAKVDVYSFGVMLLEIICCRR----------SVEMELEEESRAILTDWAYDCYVEGR 660
P S + DVY+FG++L E++ + +EM L+ +C
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNC----- 254
Query: 661 LDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710
+ + C+++ +RP+ ++ +E L
Sbjct: 255 -----------------PKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 4e-51
Identities = 66/307 (21%), Positives = 120/307 (39%), Gaps = 43/307 (14%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
+++G+G +G V+ G + G +AVK +E ++E+ H+N++
Sbjct: 41 MVKQIGKGRYGEVWMGKWR---GEKVAVKVF-FTTEEASWFRETEIYQTVLMRHENILGF 96
Query: 498 LGFCDEALNR----LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHE--- 550
+ + L+ ++ NG+L + + D ++++ GL +LH
Sbjct: 97 IAADIKGTGSWTQLYLITDYHENGSLYDYL-KSTTLDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 551 --GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH---TMIRGTRGYVAP 605
I H D+K +NIL+ + I+D GL+ +SD + GT+ Y+ P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 606 EWL------KNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEG 659
E L + D+YSFG++L E+ RR V + EE + Y V
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEV--ARRCVSGGIVEEYQL-----PYHDLV-P 267
Query: 660 RLDALIDSDEAAMADRSR------------LHKWLMIAMWCIQEDPSKRPTMKVVMQMLE 707
+ D E + R L + + C +P+ R T V + L
Sbjct: 268 SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
Query: 708 GLLEVPN 714
+ E +
Sbjct: 328 KMSESQD 334
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 3e-50
Identities = 68/304 (22%), Positives = 123/304 (40%), Gaps = 47/304 (15%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
E +G+G +G V++G + G +AVK E+ ++E+ H+N++
Sbjct: 12 LLECVGKGRYGEVWRGSWQ---GENVAVKIF-SSRDEKSWFRETELYNTVMLRHENILGF 67
Query: 498 LGFC----DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHE--- 550
+ + L+ + G+L + + + D +RI L IA GL +LH
Sbjct: 68 IASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 551 --GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMI---RGTRGYVAP 605
I H D+K +NIL+ I+D GL+ + ++ GT+ Y+AP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 606 EWLKNAPVSA------KVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEG 659
E L +VD+++FG++L E+ RR V + E+ + + V
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMVSNGIVEDYKP-----PFYDVV-P 238
Query: 660 RLDALIDSDEAAMADRSRL---HKW-----------LMIAMWCIQEDPSKRPTMKVVMQM 705
+ D + D+ R ++W LM W ++PS R T + +
Sbjct: 239 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECW--YQNPSARLTALRIKKT 296
Query: 706 LEGL 709
L +
Sbjct: 297 LTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 173 bits (439), Expect = 2e-48
Identities = 60/306 (19%), Positives = 117/306 (38%), Gaps = 47/306 (15%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
+E +G+G FG V++G + G +AVK +ER ++E+ H+N++
Sbjct: 46 LQESIGKGRFGEVWRGKWR---GEEVAVKIF-SSREERSWFREAEIYQTVMLRHENILGF 101
Query: 498 LGFC----DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHE--- 550
+ LV ++ +G+L + + ++++L A GL +LH
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHMEIV 160
Query: 551 --GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMI---RGTRGYVAP 605
I H D+K +NIL+ + I+D GL+ S GT+ Y+AP
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 606 EWLKNA------PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEG 659
E L ++ + D+Y+ G++ EI + + + Y V
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL-------PYYDLV-P 272
Query: 660 RLDALIDSDEAAMADRSRLH---KW-----------LMIAMWCIQEDPSKRPTMKVVMQM 705
++ + + + R + +W +M W + + R T + +
Sbjct: 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECW--YANGAARLTALRIKKT 330
Query: 706 LEGLLE 711
L L +
Sbjct: 331 LSQLSQ 336
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 6e-43
Identities = 68/268 (25%), Positives = 112/268 (41%), Gaps = 28/268 (10%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVK--KLDRLAQEREREFKSEVSAIGRTHHKNLV 495
F E+GRGSF VYKG L T + +A + +L + + FK E + H N+V
Sbjct: 30 FDIEIGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIV 88
Query: 496 QLLGFC---DEALNRLLVY-EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEG 551
+ + +++ E M +GTL + + +I +GL +LH
Sbjct: 89 RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT- 147
Query: 552 CNVPIIHCDIKPQNILLDHYF-SPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKN 610
PIIH D+K NI + S KI D GL+ L + ++ + GT ++APE +
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA---VIGTPEFMAPEMYEE 204
Query: 611 APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEA 670
VDVY+FG+ +LE+ E ++ A + Y G A D
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSEYPY---SECQNAAQI----YRRVTSGVKPASFDKVAI 256
Query: 671 AMADRSRLHKWLMIAMWCIQEDPSKRPT 698
+ + CI+++ +R +
Sbjct: 257 PEV-KEIIEG-------CIRQNKDERYS 276
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-40
Identities = 60/292 (20%), Positives = 110/292 (37%), Gaps = 50/292 (17%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQERERE-FKSEVSAIGRTHHKNLVQLL 498
+ LGRG FG+V++ A+K++ +E RE EV A+ + H +V+
Sbjct: 11 QCLGRGGFGVVFE-AKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYF 69
Query: 499 GFCDEALN---------RLLVY---EFMGNGTLANLIFA---IPKPDWNLRVRISLEIAR 543
E ++ +Y + L + + I + + ++ + I L+IA
Sbjct: 70 NAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAE 129
Query: 544 GLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIR------ 597
+ +LH ++H D+KP NI K+ DFGL + D +
Sbjct: 130 AVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAR 186
Query: 598 -----GTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWA 652
GT+ Y++PE + S KVD++S G++L E + S +ME +
Sbjct: 187 HTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE-LLYPFSTQMERVRTLTDV----- 240
Query: 653 YDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704
+ L M+ + P +RP +++
Sbjct: 241 ----RNLKFPPLFTQKYPCEYV--------MVQ-DMLSPSPMERPEAINIIE 279
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-38
Identities = 65/285 (22%), Positives = 114/285 (40%), Gaps = 35/285 (12%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQERER-EFKSEVSAIGRTHHKNLVQ 496
E++GRG+FG V+ G L+ + +AVK + +F E + + H N+V+
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTL-VAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 176
Query: 497 LLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVP 555
L+G C + +V E + G L + +++ + A G+ YL
Sbjct: 177 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES---KC 233
Query: 556 IIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM-----IRGTRGYVAPEWLKN 610
IH D+ +N L+ KISDFG+S+ ++ T APE L
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT----APEALNY 289
Query: 611 APVSAKVDVYSFGVMLLEIICCRRS--VEMELEEESRAILTDWAYDCYVEGRLDALIDSD 668
S++ DV+SFG++L E S + ++ + GRL
Sbjct: 290 GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG--------GRLPCPELCP 341
Query: 669 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVP 713
+ + + LM W +P +RP+ + Q L+ + +
Sbjct: 342 D-------AVFR-LMEQCW--AYEPGQRPSFSTIYQELQSIRKRH 376
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 67/279 (24%), Positives = 119/279 (42%), Gaps = 35/279 (12%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ-EREREF-KSEVSAIGRTHHKNLVQL 497
+G GS+G K + + + G + K+LD + E E++ SEV+ + H N+V+
Sbjct: 12 YTIGTGSYGRCQK-IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70
Query: 498 LG-FCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLR----VRISLEIARGLVYLHEG 551
D L +V E+ G LA++I K L +R+ ++ L H
Sbjct: 71 YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 552 CNVP--IIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLK 609
+ ++H D+KP N+ LD + K+ DFGL+++L D S T + GT Y++PE +
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMN 189
Query: 610 NAPVSAKVDVYSFGVMLLEIICCRRSVE-MELEEESRAILTDWAYDCYVEGRLDALID-- 666
+ K D++S G +L E+ +E + I EG+ +
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI---------REGKFRRIPYRY 240
Query: 667 SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705
SDE I + RP+++ +++
Sbjct: 241 SDELN-----------EIITRMLNLKDYHRPSVEEILEN 268
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 77/314 (24%), Positives = 126/314 (40%), Gaps = 62/314 (19%)
Query: 422 NLRFFS-YDELKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFK 480
+LR+ S ++E+ LG+G+FG V K A+KK+ +E+
Sbjct: 1 SLRYASDFEEIA--------VLGQGAFGQVVKARNAL-DSRYYAIKKIR-HTEEKLSTIL 50
Query: 481 SEVSAIGRTHHKNLVQLLGFCDEALNRL-------------LVYEFMGNGTLANLIFAIP 527
SEV + +H+ +V+ E N + + E+ NGTL +LI +
Sbjct: 51 SEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN 110
Query: 528 KP-DWNLRVRISLEIARGLVYLHE-GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLL 585
+ R+ +I L Y+H G IIH D+KP NI +D + KI DFGL+K +
Sbjct: 111 LNQQRDEYWRLFRQILEALSYIHSQG----IIHRDLKPMNIFIDESRNVKIGDFGLAKNV 166
Query: 586 --------------LSDHSRTHTMIRGTRGYVAPEWLKNAPV-SAKVDVYSFGVMLLEII 630
+ I GT YVA E L + K+D+YS G++ E +
Sbjct: 167 HRSLDILKLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE-M 224
Query: 631 CCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQ 690
S ME + + + V D ++ + + +I I
Sbjct: 225 IYPFSTGMERVNILKKLRS-------VSIEFPPDFDDNKMKVEKK-------IIR-LLID 269
Query: 691 EDPSKRPTMKVVMQ 704
DP+KRP + ++
Sbjct: 270 HDPNKRPGARTLLN 283
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 62/280 (22%), Positives = 113/280 (40%), Gaps = 40/280 (14%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKK--LDRLAQEREREF-KSEVSAIGRTHHKNLVQ 496
+++GRG F VY+ G +A+KK + L + R E+ + + +H N+++
Sbjct: 38 KKIGRGQFSEVYR-AACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK 96
Query: 497 LLGFCDEALNRLLVY-EFMGNGTLANLIFAIPKPDWNLR----VRISLEIARGLVYLHEG 551
E N L + E G L+ +I K + + +++ L ++H
Sbjct: 97 YYASFIED-NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR 155
Query: 552 CNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNA 611
++H DIKP N+ + K+ D GL + S + H+++ GT Y++PE +
Sbjct: 156 R---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHEN 211
Query: 612 PVSAKVDVYSFGVMLLEIICCRR---SVEMELEEESRAILTDWAYDCYVEGRLDALID-- 666
+ K D++S G +L E+ + +M L + I + L
Sbjct: 212 GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI---------EQCDYPPLPSDH 262
Query: 667 -SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705
S+E + CI DP KRP + V +
Sbjct: 263 YSEELR-----------QLVNMCINPDPEKRPDVTYVYDV 291
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-36
Identities = 72/303 (23%), Positives = 117/303 (38%), Gaps = 43/303 (14%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQERERE-FKSEVSAIGRTHHKNLVQ 496
KE LG G FG V + + + +G +A+K+ + + RE + E+ + + +H N+V
Sbjct: 18 MKERLGTGGFGYVLRWIHQD-TGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS 76
Query: 497 LLGFCDEALN------RLLVYEFMGNGTLANLIFAIPKPDWNLR---VRISL-EIARGLV 546
D LL E+ G L + + L+ +R L +I+ L
Sbjct: 77 AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQ-FENCCGLKEGPIRTLLSDISSALR 135
Query: 547 YLHEGCNVPIIHCDIKPQNILLDHYFSP---KISDFGLSKLLLSDHSRTHTMIRGTRGYV 603
YLHE IIH D+KP+NI+L KI D G +K L + GT Y+
Sbjct: 136 YLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL-DQGELCTEFV-GTLQYL 190
Query: 604 APEWLKNAPVSAKVDVYSFGVMLLEIIC-------CRRSVEME--LEEESRAILTDWAYD 654
APE L+ + VD +SFG + E I + V+ + E+S + +
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDL 250
Query: 655 CYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPN 714
L + + +L +WL + +R T + PN
Sbjct: 251 TGAVKFSSVLPTPNHLSGILAGKLERWLQCML---MWHQRQRGTDP----------QNPN 297
Query: 715 PPW 717
Sbjct: 298 VGC 300
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-36
Identities = 70/317 (22%), Positives = 110/317 (34%), Gaps = 53/317 (16%)
Query: 405 RRRKYENNVQDSTTSATNLRFFSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGNAIA 464
E + D TS + S+ K+ LG G+ G + + +A
Sbjct: 3 SSPSLEQDDGDEETSVVIVGKISFC--------PKDVLGHGAEGTIVYRGMFD--NRDVA 52
Query: 465 VKKLDRLAQEREREFKSEVSAIGR-THHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLI 523
VK R+ E EV + H N+++ + + + E TL +
Sbjct: 53 VK---RILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYV 108
Query: 524 FAIPKPDWNLRVR-ISLEIARGLVYLHEGCNVPIIHCDIKPQNILL-----DHYFSPKIS 577
L + + GL +LH N I+H D+KP NIL+ IS
Sbjct: 109 EQKDFAHLGLEPITLLQQTTSGLAHLHS-LN--IVHRDLKPHNILISMPNAHGKIKAMIS 165
Query: 578 DFGLSKLLLSDHSRTHTM--IRGTRGYVAPEWLK---NAPVSAKVDVYSFGVMLLEIICC 632
DFGL K L + GT G++APE L + VD++S G + +I
Sbjct: 166 DFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
Query: 633 RR-----SVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMW 687
S++ + A LD L + + L+
Sbjct: 226 GSHPFGKSLQRQANILLGA------------CSLDCLHPEK-----HEDVIARELI--EK 266
Query: 688 CIQEDPSKRPTMKVVMQ 704
I DP KRP+ K V++
Sbjct: 267 MIAMDPQKRPSAKHVLK 283
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 5e-36
Identities = 79/282 (28%), Positives = 127/282 (45%), Gaps = 27/282 (9%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
K +LG G +G VY+GV K +AVK L E E EF E + + H NLVQL
Sbjct: 224 MKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQL 281
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEIARGLVYLHEGCNVP 555
LG C ++ EFM G L + + + + + + ++ +I+ + YL +
Sbjct: 282 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--- 338
Query: 556 IIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSA 615
IH ++ +N L+ K++DFGLS+L+ D H + + APE L S
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 616 KVDVYSFGVMLLEIICCRRSV--EMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMA 673
K DV++FGV+L EI S ++L + + D R++ E
Sbjct: 399 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD--------YRMERPEGCPEK--- 447
Query: 674 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNP 715
+++ LM A W Q +PS RP+ + Q E + + +
Sbjct: 448 ----VYE-LMRACW--QWNPSDRPSFAEIHQAFETMFQESSI 482
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-35
Identities = 69/282 (24%), Positives = 116/282 (41%), Gaps = 29/282 (10%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
+ +LG+G FG V+ G + +A+K L E F E + + H+ LVQL
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTT--RVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL 244
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEIARGLVYLHEGCNVP 555
E +V E+M G+L + + L V ++ +IA G+ Y+
Sbjct: 245 YAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--- 300
Query: 556 IIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSA 615
+H D++ NIL+ K++DFGL++L+ + + + APE +
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 616 KVDVYSFGVMLLEIICCRRS--VEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMA 673
K DV+SFG++L E+ R M E + R+ + E+
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG--------YRMPCPPECPES--- 409
Query: 674 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNP 715
LH LM W +++P +RPT + + LE P
Sbjct: 410 ----LHD-LMCQCW--RKEPEERPTFEYLQAFLEDYFTSTEP 444
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 78/308 (25%), Positives = 127/308 (41%), Gaps = 43/308 (13%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNA---IAVKKLDRLAQEREREFKSEVSAIGRTHHKNL 494
+ +LG+G+FG V N +AVK+L +++R+F+ E+ + H +
Sbjct: 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 495 VQLLGFCDEALNR--LLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIARGLVYLHE- 550
V+ G + LV E++ +G L + L + D + + S +I +G+ YL
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR 146
Query: 551 GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH----SRTHTM--IRGTRGYVA 604
C +H D+ +NIL++ KI+DFGL+KLL D R I A
Sbjct: 147 RC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY----A 198
Query: 605 PEWLKNAPVSAKVDVYSFGVMLLEII-CCRRSVEMELEEESRAILTDWAYDCYVEGRLDA 663
PE L + S + DV+SFGV+L E+ C +S E + D RL
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR---MMGCERDVPALSRLLE 255
Query: 664 LIDSDEAAMADRSRLHK---------WLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPN 714
L++ + RL LM W P RP+ + L+ L
Sbjct: 256 LLEEGQ-------RLPAPPACPAEVHELMKLCW--APSPQDRPSFSALGPQLDMLWSGSR 306
Query: 715 PPWSSSFS 722
+ +F+
Sbjct: 307 GCETHAFT 314
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 73/294 (24%), Positives = 126/294 (42%), Gaps = 51/294 (17%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAI--AVKKLDRLAQERER-EFKSEVSAIGRTHHKNL 494
F E +GRG FG VY G L G I AVK L+R+ E +F +E + H N+
Sbjct: 29 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 88
Query: 495 VQLLGFC-DEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIARGLVYLHE-G 551
+ LLG C + L+V +M +G L N + P + L++A+G+ YL
Sbjct: 89 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 148
Query: 552 CNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD-----HSRTHTM--IRGTRGYVA 604
+H D+ +N +LD F+ K++DFGL++ + H++T ++ A
Sbjct: 149 F----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM----A 200
Query: 605 PEWLKNAPVSAKVDVYSFGVMLLEIICCRRSV------EMELEEESRAILTDWAYDCYVE 658
E L+ + K DV+SFGV+L E++ + ++ + + +L
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELM----TRGAPPYPDVNTFDITVYLLQG-------- 248
Query: 659 GRLDALID-SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711
RL D L++ +M+ W RP+ ++ + +
Sbjct: 249 RRLLQPEYCPDP--------LYE-VMLKCW--HPKAEMRPSFSELVSRISAIFS 291
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 55/193 (28%), Positives = 98/193 (50%), Gaps = 10/193 (5%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG 499
++G GS GIV K SG +AVK +D Q+R +EV + H N+V++
Sbjct: 51 VKIGEGSTGIVCLAREK-HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYK 109
Query: 500 --FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPII 557
E L ++ EF+ G L +++ + + + + + + L YLH +I
Sbjct: 110 SYLVGEEL--WVLMEFLQGGALTDIVSQVRLNEEQIAT-VCEAVLQALAYLHAQ---GVI 163
Query: 558 HCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKV 617
H DIK +ILL K+SDFG + D + +++ GT ++APE + + + +V
Sbjct: 164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLYATEV 222
Query: 618 DVYSFGVMLLEII 630
D++S G+M++E++
Sbjct: 223 DIWSLGIMVIEMV 235
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 4e-35
Identities = 69/284 (24%), Positives = 123/284 (43%), Gaps = 35/284 (12%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
F +ELG G FG+V G + +A+K + + + EF E + H+ LVQL
Sbjct: 28 FLKELGTGQFGVVKYGKWRGQ--YDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQL 84
Query: 498 LGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPI 556
G C + ++ E+M NG L N L + + + ++ + YL E
Sbjct: 85 YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL-ESKQF-- 141
Query: 557 IHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH--SRTHTM--IRGTRGYVAPEWLKNAP 612
+H D+ +N L++ K+SDFGLS+ +L D S + +R + PE L +
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS----PPEVLMYSK 197
Query: 613 VSAKVDVYSFGVMLLEIICCRRSV--EMELEEESRAILTDWAYDCYVEGRLDALIDSDEA 670
S+K D+++FGV++ EI + E + I RL + E
Sbjct: 198 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG--------LRLYRPHLASEK 249
Query: 671 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPN 714
++ +M + W E +RPT K+++ + +++ +
Sbjct: 250 -------VYT-IMYSCW--HEKADERPTFKILLSNILDVMDEES 283
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-35
Identities = 77/290 (26%), Positives = 129/290 (44%), Gaps = 37/290 (12%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAI--AVKKLDRLAQERER-EFKSEVSAIGRTHHKNL 494
++ +G G G V G L+ + A+K L ER+R +F SE S +G+ H N+
Sbjct: 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 495 VQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIARGLVYLHEGCN 553
++L G ++V E+M NG+L L + V + + G+ YL
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL-SDLG 171
Query: 554 VPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD----HSRTHTM--IRGTRGYVAPEW 607
+H D+ +N+L+D K+SDFGLS++L D ++ T IR T APE
Sbjct: 172 Y--VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT----APEA 225
Query: 608 LKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMELEEESRAILTDWAYDCYVEGRLDALI 665
+ S+ DV+SFGV++ E++ M + ++ RL A +
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG--------YRLPAPM 277
Query: 666 DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNP 715
A LH+ LM+ W +D ++RP ++ +L+ L+ P
Sbjct: 278 GCPHA-------LHQ-LMLDCW--HKDRAQRPRFSQIVSVLDALIRSPES 317
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 5e-35
Identities = 69/282 (24%), Positives = 116/282 (41%), Gaps = 29/282 (10%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
+ +LG+G FG V+ G + +A+K L E F E + + H+ LVQL
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTT--RVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL 327
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEIARGLVYLHEGCNVP 555
E +V E+M G+L + + L V ++ +IA G+ Y+
Sbjct: 328 YAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--- 383
Query: 556 IIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSA 615
+H D++ NIL+ K++DFGL++L+ + + + APE +
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 443
Query: 616 KVDVYSFGVMLLEIICCRRS--VEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMA 673
K DV+SFG++L E+ R M E + R+ + E+
Sbjct: 444 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG--------YRMPCPPECPES--- 492
Query: 674 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNP 715
LH LM W +++P +RPT + + LE P
Sbjct: 493 ----LHD-LMCQCW--RKEPEERPTFEYLQAFLEDYFTSTEP 527
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 6e-35
Identities = 64/289 (22%), Positives = 110/289 (38%), Gaps = 58/289 (20%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG 499
E +G G FG V+K G +K++ E+ + EV A+ + H N+V G
Sbjct: 17 ELIGSGGFGQVFK-AKHRIDGKTYVIKRVK---YNNEKA-EREVKALAKLDHVNIVHYNG 71
Query: 500 -FCDEALNRL---------------LVYEFMGNGTLANLI-----FAIPKPD-WNLRVRI 537
+ + + EF GTL I + K +
Sbjct: 72 CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL----EL 127
Query: 538 SLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIR 597
+I +G+ Y+H +I+ D+KP NI L KI DFGL L +D RT +
Sbjct: 128 FEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK-- 182
Query: 598 GTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYV 657
GT Y++PE + + +VD+Y+ G++L E + E + +
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAE-LLHVCDTAFETSKFFTDL---------R 232
Query: 658 EGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQML 706
+G + + D E ++ + + P RP +++ L
Sbjct: 233 DGIISDIFDKKEKT-----------LLQ-KLLSKKPEDRPNTSEILRTL 269
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 7e-35
Identities = 65/305 (21%), Positives = 107/305 (35%), Gaps = 53/305 (17%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
F ++LG G F V V G+ A+K++ Q+ E + E +H N+++L
Sbjct: 33 FIQKLGEGGFSYVDL-VEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRL 91
Query: 498 LGFCDEALNR----LLVYEFMGNGTLANLIFAIPKPDWNLR----VRISLEIARGLVYLH 549
+ +C L+ F GTL N I + L + + L I RGL +H
Sbjct: 92 VAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH 151
Query: 550 EGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIR--------GTRG 601
H D+KP NILL P + D G + + T
Sbjct: 152 A---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208
Query: 602 YVAPEWL---KNAPVSAKVDVYSFGVMLLEIICCRRS----VEMELEEESRAILTDW--- 651
Y APE + + + DV+S G +L + V + + + A+
Sbjct: 209 YRAPELFSVQSHCVIDERTDVWSLGCVLYA-MMFGEGPYDMVFQKGDSVALAVQNQLSIP 267
Query: 652 AYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711
+ L L++ + DP +RP + +++ LE L
Sbjct: 268 QSPRHSS-ALWQLLN--------------------SMMTVDPHQRPHIPLLLSQLEALQP 306
Query: 712 VPNPP 716
P P
Sbjct: 307 -PAPG 310
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 53/193 (27%), Positives = 100/193 (51%), Gaps = 10/193 (5%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG 499
E++G+G+ G VY + A+G +A+++++ Q ++ +E+ + + N+V L
Sbjct: 26 EKIGQGASGTVYTAMDV-ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 500 --FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPII 557
+ L +V E++ G+L +++ + + + E + L +LH +I
Sbjct: 85 SYLVGDEL--WVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLHSN---QVI 138
Query: 558 HCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKV 617
H DIK NILL S K++DFG + + S+ TM+ GT ++APE + KV
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 197
Query: 618 DVYSFGVMLLEII 630
D++S G+M +E+I
Sbjct: 198 DIWSLGIMAIEMI 210
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 63/288 (21%), Positives = 109/288 (37%), Gaps = 36/288 (12%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAI--AVKKLDRLAQERER-EFKSEVSAIGRTHHKNL 494
+G G FG V++G+ + A+ A+K + R +F E + + H ++
Sbjct: 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 495 VQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIARGLVYLHEGCN 553
V+L+G E ++ E G L + L D + + +++ L YL E
Sbjct: 79 VKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL-ESKR 136
Query: 554 VPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH--SRTHTM--IRGTRGYVAPEWLK 609
+H DI +N+L+ K+ DFGLS+ + + I+ APE +
Sbjct: 137 --FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----APESIN 190
Query: 610 NAPVSAKVDVYSFGVMLLEIICCRRS--VEMELEEESRAILTDWAYDCYVEGRLDALIDS 667
++ DV+ FGV + EI+ ++ + I RL +
Sbjct: 191 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG--------ERLPMPPNC 242
Query: 668 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNP 715
L+ LM W DPS+RP + L +LE
Sbjct: 243 PPT-------LYS-LMTKCW--AYDPSRRPRFTELKAQLSTILEEEKA 280
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-34
Identities = 79/290 (27%), Positives = 135/290 (46%), Gaps = 37/290 (12%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAI--AVKKLDRLAQERER-EFKSEVSAIGRTHHKNL 494
+ +G G FG V G LK S I A+K L E++R +F E S +G+ H N+
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108
Query: 495 VQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIARGLVYLHEGCN 553
++L G ++ ++V E+M NG+L + L + V + IA G+ YL
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL-SDMG 167
Query: 554 VPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM------IRGTRGYVAPEW 607
+H D+ +NIL++ K+SDFGL ++L D +T IR T +PE
Sbjct: 168 Y--VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT----SPEA 221
Query: 608 LKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMELEEESRAILTDWAYDCYVEGRLDALI 665
+ ++ DV+S+G++L E++ EM ++ +A+ RL +
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG--------YRLPPPM 273
Query: 666 DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNP 715
D A L++ LM+ W Q+D + RP + ++ +L+ L+ P
Sbjct: 274 DCPAA-------LYQ-LMLDCW--QKDRNNRPKFEQIVSILDKLIRNPGS 313
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 83/291 (28%), Positives = 141/291 (48%), Gaps = 38/291 (13%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNA---IAVKKLDRLAQERER-EFKSEVSAIGRTHHKN 493
++ +G G FG VYKG+LKT+SG +A+K L E++R +F E +G+ H N
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 494 LVQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIARGLVYLHEGC 552
+++L G + +++ E+M NG L L + V + IA G+ YL
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL-ANM 166
Query: 553 NVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM------IRGTRGYVAPE 606
N +H D+ +NIL++ K+SDFGLS++L D T+T IR T APE
Sbjct: 167 N--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT----APE 220
Query: 607 WLKNAPVSAKVDVYSFGVMLLEIICCRRSV--EMELEEESRAILTDWAYDCYVEGRLDAL 664
+ ++ DV+SFG+++ E++ E+ E +AI RL
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG--------FRLPTP 272
Query: 665 IDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNP 715
+D A +++ LM+ W Q++ ++RP ++ +L+ L+ P+
Sbjct: 273 MDCPSA-------IYQ-LMMQCW--QQERARRPKFADIVSILDKLIRAPDS 313
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 71/301 (23%), Positives = 124/301 (41%), Gaps = 44/301 (14%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNA---IAVKKLDRLAQEREREFKSEVSAIGRTHHKNL 494
F ++LG+G+FG V N +AVKKL +E R+F+ E+ + H N+
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 495 VQLLGFCDEALNR--LLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIARGLVYLHE- 550
V+ G C A R L+ E++ G+L + L + D ++ + +I +G+ YL
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 133
Query: 551 GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH----SRTHTM--IRGTRGYVA 604
IH D+ +NIL+++ KI DFGL+K+L D + I A
Sbjct: 134 RY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY----A 185
Query: 605 PEWLKNAPVSAKVDVYSFGVMLLEII--CCRRSVEMELEEESRAILTDWAYDCYVEGRLD 662
PE L + S DV+SFGV+L E+ + + L
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF---HLI 242
Query: 663 ALIDSDEAAMADRSRLHK---------WLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVP 713
L+ ++ RL + +M W + ++RP+ + + ++ + +
Sbjct: 243 ELLKNNG-------RLPRPDGCPDEIYMIMTECW--NNNVNQRPSFRDLALRVDQIRDNM 293
Query: 714 N 714
Sbjct: 294 A 294
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-34
Identities = 69/281 (24%), Positives = 121/281 (43%), Gaps = 35/281 (12%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
+ELG G FG+V G K +AVK + + + EF E + + H LV+
Sbjct: 12 LLKELGSGQFGVVKLGKWKGQY--DVAVKMIKEGSMSED-EFFQEAQTMMKLSHPKLVKF 68
Query: 498 LGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPI 556
G C + +V E++ NG L N L + + + + ++ G+ +L E
Sbjct: 69 YGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL-ESHQF-- 125
Query: 557 IHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH--SRTHTM--IRGTRGYVAPEWLKNAP 612
IH D+ +N L+D K+SDFG+++ +L D S T ++ + APE
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS----APEVFHYFK 181
Query: 613 VSAKVDVYSFGVMLLEIICCRRS--VEMELEEESRAILTDWAYDCYVEGRLDALIDSDEA 670
S+K DV++FG+++ E+ + E + RL + +
Sbjct: 182 YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG--------HRLYRPHLASDT 233
Query: 671 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711
+++ +M + W E P KRPT + ++ +E L E
Sbjct: 234 -------IYQ-IMYSCW--HELPEKRPTFQQLLSSIEPLRE 264
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 3e-34
Identities = 72/294 (24%), Positives = 126/294 (42%), Gaps = 51/294 (17%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAI--AVKKLDRLAQERER-EFKSEVSAIGRTHHKNL 494
F E +GRG FG VY G L G I AVK L+R+ E +F +E + H N+
Sbjct: 93 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 152
Query: 495 VQLLGFC-DEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIARGLVYLHE-G 551
+ LLG C + L+V +M +G L N + P + L++A+G+ +L
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 212
Query: 552 CNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD-----HSRTHTM--IRGTRGYVA 604
+H D+ +N +LD F+ K++DFGL++ + H++T ++ A
Sbjct: 213 F----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM----A 264
Query: 605 PEWLKNAPVSAKVDVYSFGVMLLEIICCRRSV------EMELEEESRAILTDWAYDCYVE 658
E L+ + K DV+SFGV+L E++ + ++ + + +L
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWELM----TRGAPPYPDVNTFDITVYLLQG-------- 312
Query: 659 GRLDALID-SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711
RL D L++ +M+ W RP+ ++ + +
Sbjct: 313 RRLLQPEYCPDP--------LYE-VMLKCW--HPKAEMRPSFSELVSRISAIFS 355
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-34
Identities = 69/286 (24%), Positives = 111/286 (38%), Gaps = 36/286 (12%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAI--AVKKLDRLAQERER-EFKSEVSAIGRTHHKNL 494
LG G FG VY+GV G I AVK + + +F SE + H ++
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 495 VQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIARGLVYLHEGCN 553
V+L+G +E ++ E G L + L V SL+I + + YL E N
Sbjct: 76 VKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL-ESIN 133
Query: 554 VPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH--SRTHTM--IRGTRGYVAPEWLK 609
+H DI +NIL+ K+ DFGLS+ + + + T I+ +PE +
Sbjct: 134 C--VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM----SPESIN 187
Query: 610 NAPVSAKVDVYSFGVMLLEIICCRRS--VEMELEEESRAILTDWAYDCYVEGRLDALIDS 667
+ DV+ F V + EI+ + +E ++ + RL
Sbjct: 188 FRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG--------DRLPKPDLC 239
Query: 668 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVP 713
L+ LM W DPS RP ++ L + ++
Sbjct: 240 PPV-------LYT-LMTRCW--DYDPSDRPRFTELVCSLSDVYQME 275
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 71/298 (23%), Positives = 124/298 (41%), Gaps = 44/298 (14%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNA---IAVKKLDRLAQEREREFKSEVSAIGRTHHKNL 494
F ++LG+G+FG V N +AVKKL +E R+F+ E+ + H N+
Sbjct: 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 495 VQLLGFCDEALNR--LLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIARGLVYLHE- 550
V+ G C A R L+ E++ G+L + L + D ++ + +I +G+ YL
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 164
Query: 551 GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH----SRTHTM--IRGTRGYVA 604
IH D+ +NIL+++ KI DFGL+K+L D + I A
Sbjct: 165 RY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY----A 216
Query: 605 PEWLKNAPVSAKVDVYSFGVMLLEII--CCRRSVEMELEEESRAILTDWAYDCYVEGRLD 662
PE L + S DV+SFGV+L E+ + + L
Sbjct: 217 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF---HLI 273
Query: 663 ALIDSDEAAMADRSRLHK---------WLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711
L+ ++ RL + +M W + ++RP+ + + ++ + +
Sbjct: 274 ELLKNNG-------RLPRPDGCPDEIYMIMTECW--NNNVNQRPSFRDLALRVDQIRD 322
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 5e-34
Identities = 63/293 (21%), Positives = 112/293 (38%), Gaps = 48/293 (16%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNA------IAVKKLDRLAQEREREFKSEVSAIGRTHH 491
F E LG+G+F ++KGV + + +K LD+ + F S + + H
Sbjct: 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 492 KNLVQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIARGLVYLHE 550
K+LV G C +LV EF+ G+L L + ++ ++ ++A + +L E
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFL-E 130
Query: 551 GCNVPIIHCDIKPQNILLDHYFSP--------KISDFGLSKLLLSDHSRTHTMIRGTRGY 602
+ IH ++ +NILL K+SD G+S +L I
Sbjct: 131 ENTL--IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK-DILQERIPWV--- 184
Query: 603 VAPEWLKNAPV-SAKVDVYSFGVMLLEIICCRRS--VEMELEEESRAILTDWAYDCYVEG 659
PE ++N + D +SFG L EI ++ + Y +
Sbjct: 185 -PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR---------KLQFYEDR 234
Query: 660 -RLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711
+L A ++ L L+ +P RP+ + +++ L L
Sbjct: 235 HQLPAPKAAE---------LAN-LINNCM--DYEPDHRPSFRAIIRDLNSLFT 275
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 6e-34
Identities = 61/193 (31%), Positives = 94/193 (48%), Gaps = 11/193 (5%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFC 501
LG+G++GIVY G + + IA+K++ + E++ HKN+VQ LG
Sbjct: 30 LGKGTYGIVYAGRDLS-NQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 502 DEALNRLLVYEFMGNGTLANLI---FAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIH 558
E + E + G+L+ L+ + K + + +I GL YLH+ I+H
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVH 145
Query: 559 CDIKPQNILLDHYFSP-KISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPV--SA 615
DIK N+L++ Y KISDFG SK L + T T GT Y+APE + P
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF-TGTLQYMAPEIIDKGPRGYGK 204
Query: 616 KVDVYSFGVMLLE 628
D++S G ++E
Sbjct: 205 AADIWSLGCTIIE 217
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 6e-34
Identities = 53/203 (26%), Positives = 95/203 (46%), Gaps = 17/203 (8%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ-EREREF-KSEVSAIGRTHHKNLVQL 497
+++G GSFG V T G +K+++ +ERE + EV+ + H N+VQ
Sbjct: 30 QKIGEGSFGKAIL-VKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQY 88
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR------VRISLEIARGLVYLHEG 551
+E + +V ++ G L I + + ++I L ++H+
Sbjct: 89 RESFEENGSLYIVMDYCEGGDLFKRI----NAQKGVLFQEDQILDWFVQICLALKHVHDR 144
Query: 552 CNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNA 611
I+H DIK QNI L + ++ DFG++++L S I GT Y++PE +N
Sbjct: 145 ---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICENK 200
Query: 612 PVSAKVDVYSFGVMLLEIICCRR 634
P + K D+++ G +L E+ +
Sbjct: 201 PYNNKSDIWALGCVLYELCTLKH 223
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 7e-34
Identities = 57/197 (28%), Positives = 85/197 (43%), Gaps = 18/197 (9%)
Query: 439 KEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLL 498
+ +GRGSFG V++ K +G AVKK+ E E+ A +V L
Sbjct: 63 QPRVGRGSFGEVHRMKDKQ-TGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLY 116
Query: 499 GFC--DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPI 556
G +N + E + G+L LI + + + + GL YLH I
Sbjct: 117 GAVREGPWVN--IFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---I 171
Query: 557 IHCDIKPQNILLDHYFSP-KISDFGLSKLLLSDHSRTHTM----IRGTRGYVAPEWLKNA 611
+H D+K N+LL S + DFG + L D + I GT ++APE +
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231
Query: 612 PVSAKVDVYSFGVMLLE 628
P AKVD++S M+L
Sbjct: 232 PCDAKVDIWSSCCMMLH 248
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 7e-34
Identities = 71/299 (23%), Positives = 122/299 (40%), Gaps = 46/299 (15%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNA---IAVKKLDRLAQERER-EFKSEVSAIGRTHHKN 493
+LG G FG V N +AVK L + + K E+ + +H+N
Sbjct: 25 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 84
Query: 494 LVQLLGFCDEALNR--LLVYEFMGNGTLANLIFAIPKPDWNLR----VRISLEIARGLVY 547
+V+ G C E L+ EF+ +G+L + +PK + ++ +++I +G+ Y
Sbjct: 85 IVKYKGICTEDGGNGIKLIMEFLPSGSL--KEY-LPKNKNKINLKQQLKYAVQICKGMDY 141
Query: 548 LHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH----SRTHTM--IRGTRG 601
L +H D+ +N+L++ KI DFGL+K + +D + +
Sbjct: 142 LGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY-- 196
Query: 602 YVAPEWLKNAPVSAKVDVYSFGVMLLEII-CCRRSVEMELEEESRAILTDW------AYD 654
APE L + DV+SFGV L E++ C T +
Sbjct: 197 --APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254
Query: 655 CYVEG-RLDALID-SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711
EG RL + DE +++ LM W + PS R + + +++ E LL+
Sbjct: 255 TLKEGKRLPCPPNCPDE--------VYQ-LMRKCW--EFQPSNRTSFQNLIEGFEALLK 302
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 9e-34
Identities = 70/298 (23%), Positives = 111/298 (37%), Gaps = 52/298 (17%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKNLVQ 496
++ LG GS G V G +AVK++ + E+ + + H N+++
Sbjct: 19 SEKILGYGSSGTVVFQGSFQ--GRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNVIR 73
Query: 497 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLE-------IARGLVYLH 549
+ E L +L+ + D NL+++ IA G+ +LH
Sbjct: 74 YYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 550 EGCNVPIIHCDIKPQNILLDHYFSP-------------KISDFGLSKLLLSDHSRTHTMI 596
IIH D+KPQNIL+ ISDFGL K L S S T +
Sbjct: 133 S-LK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 597 R---GTRGYVAPEWLKNA-------PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRA 646
GT G+ APE L+ + ++ +D++S G + I+ + +
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 249
Query: 647 ILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704
I+ + L EA L+ M I DP KRPT V++
Sbjct: 250 IIRG-IFSLDEMKCLHDRSLIAEA---------TDLISQM--IDHDPLKRPTAMKVLR 295
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 9e-34
Identities = 75/283 (26%), Positives = 122/283 (43%), Gaps = 35/283 (12%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
F +E+G G FG+V+ G + +A+K + A E +F E + + H LVQL
Sbjct: 12 FVQEIGSGQFGLVHLGYWLNK--DKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQL 68
Query: 498 LGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPI 556
G C E LV EFM +G L++ L + + L++ G+ YL E V
Sbjct: 69 YGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL-EEACV-- 125
Query: 557 IHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH--SRTHTM--IRGTRGYVAPEWLKNAP 612
IH D+ +N L+ K+SDFG+++ +L D S T T ++ +PE +
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA----SPEVFSFSR 181
Query: 613 VSAKVDVYSFGVMLLEIICCRRSV--EMELEEESRAILTDWAYDCYVEGRLDALIDSDEA 670
S+K DV+SFGV++ E+ + E I T RL +
Sbjct: 182 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG--------FRLYKPRLASTH 233
Query: 671 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVP 713
+++ +M W +E P RP +++ L + E
Sbjct: 234 -------VYQ-IMNHCW--RERPEDRPAFSRLLRQLAEIAESG 266
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 9e-34
Identities = 69/285 (24%), Positives = 124/285 (43%), Gaps = 35/285 (12%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
+++LG G FG V+ + +AVK + + E F +E + + H LV+L
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHT--KVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKL 248
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEIARGLVYLHEGCNVP 555
+ ++ EFM G+L + + + L + S +IA G+ ++ E N
Sbjct: 249 HAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI-EQRN-- 304
Query: 556 IIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYV---APEWLKNAP 612
IH D++ NIL+ KI+DFGL++++ + +T G + + APE +
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDN---EYTAREGAKFPIKWTAPEAINFGS 361
Query: 613 VSAKVDVYSFGVMLLEIICCRRSV--EMELEEESRAILTDWAYDCYVEGRLDALIDSDEA 670
+ K DV+SFG++L+EI+ R M E RA+ R+ + E
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG--------YRMPRPENCPEE 413
Query: 671 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNP 715
L+ +M+ W + P +RPT + + +L+
Sbjct: 414 -------LYN-IMMRCW--KNRPEERPTFEYIQSVLDDFYTATES 448
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-33
Identities = 63/288 (21%), Positives = 109/288 (37%), Gaps = 36/288 (12%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAI--AVKKLDRLAQERER-EFKSEVSAIGRTHHKNL 494
+G G FG V++G+ + A+ A+K + R +F E + + H ++
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453
Query: 495 VQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIARGLVYLHEGCN 553
V+L+G E ++ E G L + L D + + +++ L YL E
Sbjct: 454 VKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL-ESKR 511
Query: 554 VPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH--SRTHTM--IRGTRGYVAPEWLK 609
+H DI +N+L+ K+ DFGLS+ + + I+ APE +
Sbjct: 512 --FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----APESIN 565
Query: 610 NAPVSAKVDVYSFGVMLLEIICCRRS--VEMELEEESRAILTDWAYDCYVEGRLDALIDS 667
++ DV+ FGV + EI+ ++ + I RL +
Sbjct: 566 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG--------ERLPMPPNC 617
Query: 668 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNP 715
L+ LM W DPS+RP + L +LE
Sbjct: 618 PP-------TLYS-LMTKCW--AYDPSRRPRFTELKAQLSTILEEEKL 655
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-33
Identities = 62/307 (20%), Positives = 114/307 (37%), Gaps = 43/307 (14%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQERERE-FKSEVSAIGRTHHKNLVQ 496
+ LG+G+ V++G K +G+ A+K + ++ R + E + + +HKN+V+
Sbjct: 13 LSDILGQGATANVFRGRHKK-TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 497 LLGFCDEALNRL--LVYEFMGNGTLANLIFAIPKPDWNLR----VRISLEIARGLVYLHE 550
L +E R L+ EF G+L ++ P + L + + ++ G+ +L E
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEE-PSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 551 GCNVPIIHCDIKPQNILL----DHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPE 606
I+H +IKP NI+ D K++DFG ++ L D + ++ GT Y+ P+
Sbjct: 131 NG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-EDDEQFVSLY-GTEEYLHPD 185
Query: 607 WLKNAPV--------SAKVDVYSFGVMLLEIIC---------CRRSVEMELEEESRAILT 649
+ A + A VD++S GV R + + + +
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 650 DWAYDCYVEGRLDALIDSDEAAMADRSR-----LHKWLMIAMWCIQEDPSKRPTMKVVMQ 704
D SR L L ++ D K
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLAN---ILEADQEKCWGFDQFFA 302
Query: 705 MLEGLLE 711
+L
Sbjct: 303 ETSDILH 309
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 71/301 (23%), Positives = 122/301 (40%), Gaps = 51/301 (16%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNA----IAVKKLDRLAQERER-EFKSEVSAIGRTHHK 492
LG G+FG VY+G + + +AVK L + E++ +F E I + +H+
Sbjct: 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 493 NLVQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLR------VRISLEIARGL 545
N+V+ +G ++L R ++ E M G L + L P+P + ++ +IA G
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 546 VYLHEGCNVPIIHCDIKPQNILLDHYFSP---KISDFGLSKLLLSDH---SRTHTM--IR 597
YL E IH DI +N LL KI DFG+++ + M ++
Sbjct: 154 QYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 210
Query: 598 GTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMELEEESRAILTDWAYDC 655
PE ++K D +SFGV+L EI +E +
Sbjct: 211 WM----PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---------VLEF 257
Query: 656 YVEG-RLDALID-SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVP 713
G R+D + +++ +M W Q P RP ++++ +E + P
Sbjct: 258 VTSGGRMDPPKNCPGP--------VYR-IMTQCW--QHQPEDRPNFAIILERIEYCTQDP 306
Query: 714 N 714
+
Sbjct: 307 D 307
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 84/286 (29%), Positives = 131/286 (45%), Gaps = 37/286 (12%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
K +LG G +G VY+GV K S +AVK L E E EF E + + H NLVQL
Sbjct: 17 MKHKLGGGQYGEVYEGVWKKYS-LTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQL 74
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEIARGLVYLHEGCNVP 555
LG C ++ EFM G L + + + + + + ++ +I+ + YL E N
Sbjct: 75 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL-EKKNF- 132
Query: 556 IIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM----IRGTRGYVAPEWLKNA 611
IH D+ +N L+ K++DFGLS+L+ D H I+ T APE L
Sbjct: 133 -IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYN 187
Query: 612 PVSAKVDVYSFGVMLLEIICCRRSV--EMELEEESRAILTDWAYDCYVEGRLDALID-SD 668
S K DV++FGV+L EI S ++L + + D R++ +
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD--------YRMERPEGCPE 239
Query: 669 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPN 714
+ +++ LM A W Q +PS RP+ + Q E + + +
Sbjct: 240 K--------VYE-LMRACW--QWNPSDRPSFAEIHQAFETMFQESS 274
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 65/302 (21%), Positives = 117/302 (38%), Gaps = 41/302 (13%)
Query: 423 LRFFSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGNA---IAVKKLDRLAQERER-E 478
LR E K + LG G+FG VYKG+ +A+K+L + E
Sbjct: 9 LRILKETEFK-----KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 63
Query: 479 FKSEVSAIGRTHHKNLVQLLGFC-DEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRVR 536
E + + ++ +LLG C + L+ + M G L + + +
Sbjct: 64 ILDEAYVMASVDNPHVCRLLGICLTSTV--QLITQLMPFGCLLDYVREHKDNIGSQYLLN 121
Query: 537 ISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMI 596
++IA+G+ YL E ++H D+ +N+L+ KI+DFGL+KLL ++ H
Sbjct: 122 WCVQIAKGMNYL-EDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-- 176
Query: 597 RGTRGYV---APEWLKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMELEEESRAILTDW 651
G + + A E + + + + DV+S+GV + E++ + E S +
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG- 235
Query: 652 AYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711
RL ++ +M W D RP + ++ +
Sbjct: 236 -------ERLPQPPICTID-------VYM-IMRKCW--MIDADSRPKFRELIIEFSKMAR 278
Query: 712 VP 713
P
Sbjct: 279 DP 280
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 68/289 (23%), Positives = 125/289 (43%), Gaps = 41/289 (14%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAI--AVKKLDRLAQERER-EFKSEVSAIGRTHHKNL 494
+G+G FG+VY G + N I A+K L R+ + ++ F E + +H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 495 VQLLGFC-DEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIARGLVYLHEGC 552
+ L+G ++ +M +G L + P + L++ARG+ YL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL-AEQ 143
Query: 553 NVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD-----HSRTHTM--IRGTRGYVAP 605
+H D+ +N +LD F+ K++DFGL++ +L H ++ T A
Sbjct: 144 K--FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT----AL 197
Query: 606 EWLKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMELEEESRAILTDWAYDCYVEGRLDA 663
E L+ + K DV+SFGV+L E++ ++ + + + RL
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG--------RRLPQ 249
Query: 664 LID-SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711
D L++ +M W + DP+ RPT +V++ +E ++
Sbjct: 250 PEYCPDS--------LYQ-VMQQCW--EADPAVRPTFRVLVGEVEQIVS 287
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 5e-33
Identities = 61/227 (26%), Positives = 106/227 (46%), Gaps = 18/227 (7%)
Query: 410 ENNVQDSTTSATNLRFFSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVK--K 467
++ NL F S + + +ELGRG F +V + + K ++G A K K
Sbjct: 5 HHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISK-STGQEYAAKFLK 63
Query: 468 LDRLAQEREREFKSEVSAIGR-THHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAI 526
R Q+ E E++ + ++ L + +L+ E+ G + +L +
Sbjct: 64 KRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLC--L 121
Query: 527 PKPDWNLR----VRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSP---KISDF 579
P+ + +R+ +I G+ YLH+ N I+H D+KPQNILL + KI DF
Sbjct: 122 PELAEMVSENDVIRLIKQILEGVYYLHQ-NN--IVHLDLKPQNILLSSIYPLGDIKIVDF 178
Query: 580 GLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVML 626
G+S+ + H+ I GT Y+APE L P++ D+++ G++
Sbjct: 179 GMSRKI--GHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 6e-33
Identities = 38/217 (17%), Positives = 69/217 (31%), Gaps = 28/217 (12%)
Query: 438 FKEELGRGSFGIVYKGVLKTA----SGNAIAVKKLD-RLAQEREREFKSEVSAIGRTHHK 492
LG G+F VY+ + +K E + + + +
Sbjct: 69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQ-LMERLKPSMQH 127
Query: 493 NLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDW-----NLRVRISLEIARGLVY 547
++ +LV E GTL N I L + ++ + +
Sbjct: 128 MFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQ 187
Query: 548 LHEGCNVPIIHCDIKPQNILLDHYFSP-----------KISDFGLSKLL--LSDHSRTHT 594
+H+ IIH DIKP N +L + F + D G S + +
Sbjct: 188 VHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTA 244
Query: 595 MIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC 631
T G+ E L N P + ++D + + ++
Sbjct: 245 KC-ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLF 280
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-33
Identities = 77/279 (27%), Positives = 125/279 (44%), Gaps = 35/279 (12%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
+ +G+G FG V G + GN +AVK + A + F +E S + + H NLVQL
Sbjct: 197 LLQTIGKGEFGDVMLGDYR---GNKVAVKCIKNDATAQA--FLAEASVMTQLRHSNLVQL 251
Query: 498 LGFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEIARGLVYLHEGCNV 554
LG E L +V E+M G+L + + + + ++ SL++ + YL EG N
Sbjct: 252 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-EGNN- 309
Query: 555 PIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVS 614
+H D+ +N+L+ K+SDFGL+K S ++ T APE L+ S
Sbjct: 310 -FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFS 364
Query: 615 AKVDVYSFGVMLLEIICCRRSV--EMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAM 672
K DV+SFG++L EI R + L++ + ++DA A
Sbjct: 365 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG--------YKMDAPDGCPPA-- 414
Query: 673 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711
++ +M W D + RPT + + LE +
Sbjct: 415 -----VYD-VMKNCW--HLDAATRPTFLQLREQLEHIRT 445
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-33
Identities = 74/297 (24%), Positives = 121/297 (40%), Gaps = 44/297 (14%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNA---IAVKKLDRLAQERER-EFKSEVSAIGRTHHKN 493
+LG G FG V + +AVK L A + R +K E+ + +H++
Sbjct: 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94
Query: 494 LVQLLGFCDEALNR--LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHE- 550
+++ G C++A LV E++ G+L + + + + +I G+ YLH
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLHAQ 153
Query: 551 GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH----SRTHTM--IRGTRGYVA 604
IH D+ +N+LLD+ KI DFGL+K + H R + A
Sbjct: 154 HY----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY----A 205
Query: 605 PEWLKNAPVSAKVDVYSFGVMLLEII-CCRRSVEMELEEESRAILTDWAYDCYVEGRLDA 663
PE LK DV+SFGV L E++ C S + + RL
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIA---QGQMTVLRLTE 262
Query: 664 LIDSDEAAMADRSRLHK---------WLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711
L++ E RL + LM W + + S RPT + ++ +L+ + E
Sbjct: 263 LLERGE-------RLPRPDKCPAEVYHLMKNCW--ETEASFRPTFENLIPILKTVHE 310
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 9e-33
Identities = 68/271 (25%), Positives = 103/271 (38%), Gaps = 33/271 (12%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDR-LAQERERE-FKSEVSAIGR-THHKNLVQ 496
LG GS+G V+K V G AVK+ ++R +EV + + H V+
Sbjct: 63 SRLGHGSYGEVFK-VRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVR 121
Query: 497 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPK--PDWNLRVRISLEIARGLVYLHEGCNV 554
L +E L E G +L A P+ + + L +LH
Sbjct: 122 LEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVW-GYLRDTLLALAHLHSQ--- 176
Query: 555 PIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVS 614
++H D+KP NI L K+ DFGL L G Y+APE L+
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLV-ELGTAGAGEVQE-GDPRYMAPELLQG-SYG 233
Query: 615 AKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMAD 674
DV+S G+ +LE+ C E+ E L Y+ A + S E
Sbjct: 234 TAADVFSLGLTILEVACNM---ELPHGGEGWQQL----RQGYLPPEFTAGL-SSEL---- 281
Query: 675 RSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705
RS L + ++ DP R T + ++ +
Sbjct: 282 RSVL-------VMMLEPDPKLRATAEALLAL 305
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-32
Identities = 73/301 (24%), Positives = 123/301 (40%), Gaps = 51/301 (16%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNA----IAVKKLDRLAQERER-EFKSEVSAIGRTHHK 492
LG G+FG VY+G + + +AVK L + E++ +F E I + +H+
Sbjct: 75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134
Query: 493 NLVQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLR------VRISLEIARGL 545
N+V+ +G ++L R ++ E M G L + L P+P + ++ +IA G
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 546 VYLHEGCNVPIIHCDIKPQNILLDHYFSP---KISDFGLSKLLLSDHSRTHTMIRGTRGY 602
YL E IH DI +N LL KI DFG+++ D R +G
Sbjct: 195 QYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYRKGGCAM 247
Query: 603 V-----APEWLKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMELEEESRAILTDWAYDC 655
+ PE ++K D +SFGV+L EI +E +
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---------VLEF 298
Query: 656 YVEG-RLDALID-SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVP 713
G R+D + +++ +M W Q P RP ++++ +E + P
Sbjct: 299 VTSGGRMDPPKNCPGP--------VYR-IMTQCW--QHQPEDRPNFAIILERIEYCTQDP 347
Query: 714 N 714
+
Sbjct: 348 D 348
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 80/309 (25%), Positives = 134/309 (43%), Gaps = 51/309 (16%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGN----AIAVKKLDRLAQERER-EFKSEVSAIGRTHHK 492
ELG+GSFG+VY+GV K + +A+K ++ A RER EF +E S + +
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 493 NLVQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLR---------VRISLEIA 542
++V+LLG + L++ E M G L + L P N ++++ EIA
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 543 RGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH---SRTHTM--IR 597
G+ YL+ +H D+ +N ++ F+ KI DFG+++ + + +R
Sbjct: 149 DGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 598 GTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMELEEESRAILTDWAYDC 655
+PE LK+ + DV+SFGV+L EI + E+
Sbjct: 206 WM----SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---------VLRF 252
Query: 656 YVEG-RLDALID-SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVP 713
+EG LD + D L + LM W Q +P RP+ ++ ++ +E
Sbjct: 253 VMEGGLLDKPDNCPDM--------LFE-LMRMCW--QYNPKMRPSFLEIISSIKEEMEPG 301
Query: 714 NPPWSSSFS 722
S +S
Sbjct: 302 FREVSFYYS 310
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 74/288 (25%), Positives = 126/288 (43%), Gaps = 41/288 (14%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
E LG G FG V+ G +AVK L + + + F +E + + + H+ LV+L
Sbjct: 17 LVERLGAGQFGEVWMGYYNGH--TKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRL 73
Query: 498 LGFC-DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEIARGLVYLHEGCNV 554
E + ++ E+M NG+L + + + + ++ +IA G+ ++ E N
Sbjct: 74 YAVVTQEPI--YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI-EERNY 130
Query: 555 PIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH--SRTHT--MIRGTRGYVAPEWLKN 610
IH D++ NIL+ S KI+DFGL++L+ + +R I+ T APE +
Sbjct: 131 --IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT----APEAINY 184
Query: 611 APVSAKVDVYSFGVMLLEIICCRRSV--EMELEEESRAILTDWAYDCYVEGRLDALID-S 667
+ K DV+SFG++L EI+ R M E + + R+ +
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG--------YRMVRPDNCP 236
Query: 668 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNP 715
+E L++ LM W +E P RPT + +LE
Sbjct: 237 EE--------LYQ-LMRLCW--KERPEDRPTFDYLRSVLEDFFTATEG 273
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 54/214 (25%), Positives = 99/214 (46%), Gaps = 28/214 (13%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQERERE-FKSEVSAIGRTHHKNLVQ 496
+ LG+G+ V++G K +G+ A+K + ++ R + E + + +HKN+V+
Sbjct: 13 LSDILGQGATANVFRGRHKK-TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 497 LLGFCDEALNRL--LVYEFMGNGTLANLIFAIPKPDWNLR----VRISLEIARGLVYLHE 550
L +E R L+ EF G+L ++ P + L + + ++ G+ +L E
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEE-PSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 551 -GCNVPIIHCDIKPQNILL----DHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAP 605
G I+H +IKP NI+ D K++DFG ++ L D + ++ GT Y+ P
Sbjct: 131 NG----IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR-ELEDDEQFVSLY-GTEEYLHP 184
Query: 606 EWLKNAPV--------SAKVDVYSFGVMLLEIIC 631
+ + A + A VD++S GV
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 55/193 (28%), Positives = 88/193 (45%), Gaps = 10/193 (5%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNLVQLL 498
LG+G FG VY K + +A+K L + + E + + E+ H N++++
Sbjct: 22 LGKGKFGNVYLAREKQ-NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 499 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIH 558
+ + L+ EF G L + + D E+A L Y HE +IH
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK---VIH 137
Query: 559 CDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVD 618
DIKP+N+L+ + KI+DFG S + R TM GT Y+ PE ++ KVD
Sbjct: 138 RDIKPENLLMGYKGELKIADFGWSV--HAPSLRRRTMC-GTLDYLPPEMIEGKTHDEKVD 194
Query: 619 VYSFGVMLLEIIC 631
++ GV+ E +
Sbjct: 195 LWCAGVLCYEFLV 207
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 61/193 (31%), Positives = 90/193 (46%), Gaps = 10/193 (5%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNLVQLL 498
LG+G FG VY K S +A+K L + E + + EV H N+++L
Sbjct: 17 LGKGKFGNVYLAREKQ-SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 499 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIH 558
G+ +A L+ E+ GT+ + + K D E+A L Y H V IH
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS-KRV--IH 132
Query: 559 CDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVD 618
DIKP+N+LL KI+DFG S + SR + GT Y+ PE ++ KVD
Sbjct: 133 RDIKPENLLLGSAGELKIADFGWSV--HAPSSRRTDLC-GTLDYLPPEMIEGRMHDEKVD 189
Query: 619 VYSFGVMLLEIIC 631
++S GV+ E +
Sbjct: 190 LWSLGVLCYEFLV 202
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 53/194 (27%), Positives = 95/194 (48%), Gaps = 9/194 (4%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDR--LAQERERE-FKSEVSAIGRTHHKNLVQLL 498
LG+GSF VY+ +G +A+K +D+ + + + ++EV + H ++++L
Sbjct: 19 LGKGSFAGVYRAESIH-TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 499 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR-ISLEIARGLVYLHEGCNVPII 557
+ +++ LV E NG + + KP R +I G++YLH I+
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---IL 134
Query: 558 HCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKV 617
H D+ N+LL + KI+DFGL+ L H + +T+ GT Y++PE + +
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-GTPNYISPEIATRSAHGLES 193
Query: 618 DVYSFGVMLLEIIC 631
DV+S G M ++
Sbjct: 194 DVWSLGCMFYTLLI 207
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 74/303 (24%), Positives = 126/303 (41%), Gaps = 52/303 (17%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAI--AVK--KLDRLAQEREREFKSEVSAIGRTHHKN 493
LG+G FG V + LK G+ + AVK K D +A EF E + + H +
Sbjct: 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 494 LVQLLGFC------DEALNRLLVYEFMGNGTLANLIFA--IPKPDWNLR----VRISLEI 541
+ +L+G +++ FM +G L + A I + +NL VR ++I
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 542 ARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH---SRTHTM--I 596
A G+ YL IH D+ +N +L + ++DFGLS+ + S + +
Sbjct: 147 ACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPV 203
Query: 597 RGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMELEEESRAILTDWAYD 654
+ A E L + + DV++FGV + EI+ ++ +E E Y+
Sbjct: 204 KWL----ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---------IYN 250
Query: 655 CYVEG-RLDALID-SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEV 712
+ G RL + +E ++ LM W DP +RP+ + LE +L
Sbjct: 251 YLIGGNRLKQPPECMEE--------VYD-LMYQCW--SADPKQRPSFTCLRMELENILGH 299
Query: 713 PNP 715
+
Sbjct: 300 LSV 302
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 5e-32
Identities = 79/297 (26%), Positives = 127/297 (42%), Gaps = 49/297 (16%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAI--AVK--KLDRLAQEREREFKSEVSAIGRTHHKN 493
+ LG G FG V +G LK G ++ AVK KLD +Q EF SE + + H N
Sbjct: 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 494 LVQLLGFC-----DEALNRLLVYEFMGNGTLANLIFA--IPKPDWNLR----VRISLEIA 542
+++LLG C +++ FM G L + + ++ ++ ++IA
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 543 RGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD---HSRTHTM--IR 597
G+ YL +H D+ +N +L + ++DFGLSK + S ++
Sbjct: 158 LGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 214
Query: 598 GTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMELEEESRAILTDWAYDC 655
A E L + ++K DV++FGV + EI + ++ E +L
Sbjct: 215 WI----AIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG----- 265
Query: 656 YVEGRLDALID-SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711
RL D DE L++ +M + W + DP RPT V+ LE LLE
Sbjct: 266 ---HRLKQPEDCLDE--------LYE-IMYSCW--RTDPLDRPTFSVLRLQLEKLLE 308
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 7e-32
Identities = 69/288 (23%), Positives = 118/288 (40%), Gaps = 37/288 (12%)
Query: 439 KEELGRGSFGIVYKGVLKTASGN-AIAVKKLDRLAQERER-EFKSEVSAIGRTHHKNLVQ 496
ELG G+FG V +GV + +A+K L + ++ + E E + + + +V+
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 497 LLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVP 555
L+G C +LV E G G L L+ + + + +++ G+ YL E N
Sbjct: 75 LIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL-EEKN-- 130
Query: 556 IIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD----HSRTHTM--IRGTRGYVAPEWLK 609
+H D+ +N+LL + KISDFGLSK L +D +R+ ++ APE +
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----APECIN 186
Query: 610 NAPVSAKVDVYSFGVMLLEIICCRRS--VEMELEEESRAILTDWAYDCYVEGRLDALIDS 667
S++ DV+S+GV + E + + +M+ E I R++ +
Sbjct: 187 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG--------KRMECPPEC 238
Query: 668 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNP 715
L+ LM W RP V Q +
Sbjct: 239 PPE-------LYA-LMSDCW--IYKWEDRPDFLTVEQRMRACYYSLAS 276
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 9e-32
Identities = 75/304 (24%), Positives = 121/304 (39%), Gaps = 55/304 (18%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGN----AIAVKKLDRLAQERER-EFKSEVSAIGRTHHK 492
K ELG G+FG V+ +AVK L + A E R +F+ E + H+
Sbjct: 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQDFQREAELLTMLQHQ 103
Query: 493 NLVQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLR--------------VRI 537
++V+ G C E L+V+E+M +G L L P + +
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 538 SLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD---HSRTHT 594
+ ++A G+VYL +H D+ +N L+ KI DFG+S+ + S T
Sbjct: 164 ASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 220
Query: 595 M--IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMELEEESRAILTD 650
M IR PE + + + DV+SFGV+L EI + ++ E I
Sbjct: 221 MLPIRWM----PPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG 276
Query: 651 WAYDCYVEGRLDALID-SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGL 709
L+ E ++ +M W Q +P +R ++K V L+ L
Sbjct: 277 --------RELERPRACPPE--------VYA-IMRGCW--QREPQQRHSIKDVHARLQAL 317
Query: 710 LEVP 713
+ P
Sbjct: 318 AQAP 321
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-31
Identities = 52/202 (25%), Positives = 81/202 (40%), Gaps = 19/202 (9%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVK-----KLDRLAQEREREFKSEVSAIGRTHHK 492
E +G+G F +V + + + +G AVK K + K E S H
Sbjct: 28 LCEVIGKGPFSVVRRCINR-ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHP 86
Query: 493 NLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIAR----GLVYL 548
++V+LL +V+EFM L I + ++ R L Y
Sbjct: 87 HIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 549 HE-GCNVPIIHCDIKPQNILLDHYFSP---KISDFGLSKLLLSDHSRTHTMIRGTRGYVA 604
H+ IIH D+KP +LL + K+ FG++ L + GT ++A
Sbjct: 147 HDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMA 201
Query: 605 PEWLKNAPVSAKVDVYSFGVML 626
PE +K P VDV+ GV+L
Sbjct: 202 PEVVKREPYGKPVDVWGCGVIL 223
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 66/294 (22%), Positives = 122/294 (41%), Gaps = 37/294 (12%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREF-KSEVSAIGRTHHKNLVQLL 498
ELG G+ G+V+K K SG +A K + + R E+ + + +V
Sbjct: 39 SELGAGNGGVVFKVSHKP-SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 97
Query: 499 G--FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPI 556
G + D ++ + E M G+L ++ + + ++S+ + +GL YL E I
Sbjct: 98 GAFYSDGEIS--ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--I 153
Query: 557 IHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAK 616
+H D+KP NIL++ K+ DFG+S L S ++ + GTR Y++PE L+ S +
Sbjct: 154 MHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV-GTRSYMSPERLQGTHYSVQ 210
Query: 617 VDVYSFGVMLLEI------ICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEA 670
D++S G+ L+E+ I + E+EL + L
Sbjct: 211 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMD 270
Query: 671 AMADRSRLHKWLMI----------AMW----------CIQEDPSKRPTMKVVMQ 704
+ + I ++ C+ ++P++R +K +M
Sbjct: 271 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 41/210 (19%), Positives = 85/210 (40%), Gaps = 23/210 (10%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVK--KLDRLAQEREREFKSEVSAIGRTHHKNL--V 495
+++G G V++ + + A+K L+ + +++E++ + + + +
Sbjct: 34 KQIGSGGSSKVFQVLNEK--KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 91
Query: 496 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVP 555
+L + +V E GN L + + D R + + +H+
Sbjct: 92 RLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ-HG-- 147
Query: 556 IIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH-TMIRGTRGYVAPEWLKNAP-- 612
I+H D+KP N L+ K+ DFG++ + D + GT Y+ PE +K+
Sbjct: 148 IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 206
Query: 613 ---------VSAKVDVYSFGVMLLEIICCR 633
+S K DV+S G +L + +
Sbjct: 207 RENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 49/197 (24%), Positives = 86/197 (43%), Gaps = 20/197 (10%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
E+LGRG FGIV++ V +S K + ++ K E+S + H+N++ L
Sbjct: 9 IAEDLGRGEFGIVHRCVET-SSKKTYMAKFVKVKGTDQV-LVKKEISILNIARHRNILHL 66
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLIF-AIPKPDWNLR----VRISLEIARGLVYLHE-G 551
+ ++++EF+ + F I + L V ++ L +LH
Sbjct: 67 HESFESMEELVMIFEFISGLDI----FERINTSAFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 552 CNVPIIHCDIKPQNILLDHYFSP--KISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLK 609
I H DI+P+NI+ S KI +FG ++ L ++ Y APE +
Sbjct: 123 ----IGHFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRLLFTAPEYYAPEVHQ 176
Query: 610 NAPVSAKVDVYSFGVML 626
+ VS D++S G ++
Sbjct: 177 HDVVSTATDMWSLGTLV 193
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 74/284 (26%), Positives = 125/284 (44%), Gaps = 37/284 (13%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
+ +G+G FG V G + GN +AVK + A + F +E S + + H NLVQL
Sbjct: 25 LLQTIGKGEFGDVMLGDYR---GNKVAVKCIKNDATAQA--FLAEASVMTQLRHSNLVQL 79
Query: 498 LGFC-DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEIARGLVYLHEGCNV 554
LG +E +V E+M G+L + + + + ++ SL++ + YL EG N
Sbjct: 80 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-EGNNF 138
Query: 555 PIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVS 614
+H D+ +N+L+ K+SDFGL+K S ++ T APE L+ S
Sbjct: 139 --VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFS 192
Query: 615 AKVDVYSFGVMLLEIICCRRSV--EMELEEESRAILTDWAYDCYVEGRLDALID-SDEAA 671
K DV+SFG++L EI R + L++ + ++DA
Sbjct: 193 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG--------YKMDAPDGCPPA-- 242
Query: 672 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNP 715
+++ +M W D + RP+ + + LE +
Sbjct: 243 ------VYE-VMKNCW--HLDAAMRPSFLQLREQLEHIKTHELH 277
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 71/310 (22%), Positives = 122/310 (39%), Gaps = 66/310 (21%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGN----AIAVKKLDRLAQEREREFKSEVSAIGRTHHKN 493
K ELG G+FG V+ S +AVK L ++F+ E + H++
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 494 LVQLLGFCDEALNRLLVYEFMGNGTL------------ANLIFAIPKPDWNLR----VRI 537
+V+ G C + ++V+E+M +G L + + L + I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 538 SLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD---HSRTHT 594
+ +IA G+VYL +H D+ +N L+ KI DFG+S+ + S HT
Sbjct: 139 ASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195
Query: 595 M--IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEII-CCRR-----SVEMELEEESRA 646
M IR PE + + + DV+SFGV+L EI ++ S +E
Sbjct: 196 MLPIRWM----PPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE----- 246
Query: 647 ILTDWAYDCYVE--GRLDALID-SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVM 703
+ L+ E ++ +M+ W Q +P +R +K +
Sbjct: 247 ---------CITQGRVLERPRVCPKE--------VYD-VMLGCW--QREPQQRLNIKEIY 286
Query: 704 QMLEGLLEVP 713
++L L +
Sbjct: 287 KILHALGKAT 296
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 61/287 (21%), Positives = 117/287 (40%), Gaps = 36/287 (12%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNA---IAVKKLDRLAQERER-EFKSEVSAIGRTHHKN 493
+ LG G FG V+KGV + + +K ++ + + + AIG H +
Sbjct: 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 494 LVQLLGFC-DEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIARGLVYLHEG 551
+V+LLG C +L LV +++ G+L + + L + ++IA+G+ YL E
Sbjct: 77 IVRLLGLCPGSSL--QLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH 134
Query: 552 CNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYV---APEWL 608
++H ++ +N+LL +++DFG++ LL D + + + A E +
Sbjct: 135 G---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY--SEAKTPIKWMALESI 189
Query: 609 KNAPVSAKVDVYSFGVMLLEIICCRRS--VEMELEEESRAILTDWAYDCYVEGRLDALID 666
+ + DV+S+GV + E++ + L E + RL
Sbjct: 190 HFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG--------ERLAQPQI 241
Query: 667 SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVP 713
++ +M+ W D + RPT K + + P
Sbjct: 242 CTID-------VYM-VMVKCW--MIDENIRPTFKELANEFTRMARDP 278
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 54/199 (27%), Positives = 99/199 (49%), Gaps = 15/199 (7%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG 499
ELG G+FG VYK K +G A K ++ ++E ++ E+ + H +V+LLG
Sbjct: 25 GELGDGAFGKVYKAKNKE-TGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLG 83
Query: 500 --FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR-ISLEIARGLVYLHEGCNVPI 556
+ D L ++ EF G + ++ + + +++ + ++ L +LH I
Sbjct: 84 AYYHDGKL--WIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RI 138
Query: 557 IHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPE-----WLKNA 611
IH D+K N+L+ +++DFG+S L + + I GT ++APE +K+
Sbjct: 139 IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMKDT 197
Query: 612 PVSAKVDVYSFGVMLLEII 630
P K D++S G+ L+E+
Sbjct: 198 PYDYKADIWSLGITLIEMA 216
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 77/286 (26%), Positives = 115/286 (40%), Gaps = 43/286 (15%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAI--AVK--KLDRLAQERER-EFKSEVSAIGRTHHK 492
E+LG GSFG+V +G SG + AVK K D L+Q +F EV+A+ H+
Sbjct: 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81
Query: 493 NLVQLLGFC-DEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIARGLVYLHE 550
NL++L G + +V E G+L + L R ++++A G+ YL E
Sbjct: 82 NLIRLYGVVLTPPM--KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL-E 138
Query: 551 GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD----HSRTHTM--IRGTRGYVA 604
IH D+ +N+LL KI DFGL + L + + H A
Sbjct: 139 SKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC----A 192
Query: 605 PEWLKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMELEEESRAILTDWAYDCYVEG-RL 661
PE LK S D + FGV L E+ + + + + I EG RL
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK--------EGERL 244
Query: 662 DALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLE 707
D + ++ +M+ W P RPT + L
Sbjct: 245 PRPEDCPQD-------IYN-VMVQCW--AHKPEDRPTFVALRDFLL 280
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-31
Identities = 57/196 (29%), Positives = 95/196 (48%), Gaps = 17/196 (8%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
EELG G+FG+V++ V K A+G K ++ + K+E+S + + HH L+ L
Sbjct: 55 ILEELGSGAFGVVHRCVEK-ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINL 113
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLIF-AIPKPDWNLRVRISLEIAR----GLVYLHEGC 552
++ +L+ EF+ G L F I D+ + + R GL ++HE
Sbjct: 114 HDAFEDKYEMVLILEFLSGGEL----FDRIAAEDYKMSEAEVINYMRQACEGLKHMHE-H 168
Query: 553 NVPIIHCDIKPQNILLDHYFSP--KISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKN 610
+ I+H DIKP+NI+ + + KI DFGL+ L + + T + APE +
Sbjct: 169 S--IVHLDIKPENIMCETKKASSVKIIDFGLATKL--NPDEIVKVTTATAEFAAPEIVDR 224
Query: 611 APVSAKVDVYSFGVML 626
PV D+++ GV+
Sbjct: 225 EPVGFYTDMWAIGVLG 240
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 69/282 (24%), Positives = 114/282 (40%), Gaps = 37/282 (13%)
Query: 441 ELGRGSFGIVYKGVLKTASGN-AIAVK--KLDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
ELG G+FG V KG + +AVK K + + E +E + + + + +V++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPII 557
+G C+ + +LV E G L + + + +++ G+ YL E N +
Sbjct: 84 IGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL-EESN--FV 139
Query: 558 HCDIKPQNILLDHYFSPKISDFGLSKLLLSD----HSRTHTM--IRGTRGYVAPEWLKNA 611
H D+ +N+LL KISDFGLSK L +D ++TH ++ APE +
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY----APECINYY 195
Query: 612 PVSAKVDVYSFGVMLLEIICCRRS--VEMELEEESRAILTDWAYDCYVEGRLDALIDSDE 669
S+K DV+SFGV++ E + M+ E + + R+
Sbjct: 196 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG--------ERMGCPAGCPR 247
Query: 670 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711
++ LM W D RP V L
Sbjct: 248 E-------MYD-LMNLCW--TYDVENRPGFAAVELRLRNYYY 279
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-31
Identities = 53/201 (26%), Positives = 85/201 (42%), Gaps = 24/201 (11%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDR--LAQERERE-FKSEVSAIGRTHHKNLVQLL 498
LG+G F ++ + A K + + L + +RE E+S H+++V
Sbjct: 49 LGKGGFAKCFEISDAD-TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 499 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIAR--------GLVYLHE 550
GF ++ +V E +L L R ++ AR G YLH
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKR--------RKALTEPEARYYLRQIVLGCQYLHR 159
Query: 551 GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKN 610
+IH D+K N+ L+ KI DFGL+ + D R + GT Y+APE L
Sbjct: 160 NR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLSK 215
Query: 611 APVSAKVDVYSFGVMLLEIIC 631
S +VDV+S G ++ ++
Sbjct: 216 KGHSFEVDVWSIGCIMYTLLV 236
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 4e-31
Identities = 51/283 (18%), Positives = 110/283 (38%), Gaps = 42/283 (14%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVK--KLDRLAQEREREFKSEVSAIG--RTHHKNLV 495
+++G G V++ + + A+K L+ + +++E++ + + H ++
Sbjct: 15 KQIGSGGSSKVFQVLNEK--KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 72
Query: 496 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVP 555
+L + +V E GN L + + D R + + +H+
Sbjct: 73 RLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ-HG-- 128
Query: 556 IIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH-TMIRGTRGYVAPEWLKNAP-- 612
I+H D+KP N L+ K+ DFG++ + D + GT Y+ PE +K+
Sbjct: 129 IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 187
Query: 613 ---------VSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDA 663
+S K DV+S G +L + + T + +L A
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYYMTYGK---------------TPFQQIINQISKLHA 232
Query: 664 LIDSDEAAM--ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704
+ID + + + ++ C++ DP +R ++ ++
Sbjct: 233 IIDPNHEIEFPDIPEKDLQDVL--KCCLKRDPKQRISIPELLA 273
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 53/201 (26%), Positives = 85/201 (42%), Gaps = 24/201 (11%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDR--LAQERERE-FKSEVSAIGRTHHKNLVQLL 498
LG+G F ++ + A K + + L + +RE E+S H+++V
Sbjct: 23 LGKGGFAKCFEISDA-DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 499 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIAR--------GLVYLHE 550
GF ++ +V E +L L R ++ AR G YLH
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELHKR--------RKALTEPEARYYLRQIVLGCQYLHR 133
Query: 551 GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKN 610
+IH D+K N+ L+ KI DFGL+ + D R + GT Y+APE L
Sbjct: 134 NR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLSK 189
Query: 611 APVSAKVDVYSFGVMLLEIIC 631
S +VDV+S G ++ ++
Sbjct: 190 KGHSFEVDVWSIGCIMYTLLV 210
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 5e-31
Identities = 32/306 (10%), Positives = 66/306 (21%), Gaps = 58/306 (18%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQERERE---FKSEVSAIGRTHHKNL 494
E L G +V+ A+K A+ E A R ++
Sbjct: 66 LVEPLRVGDRSVVFLVRDV-ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESP 124
Query: 495 VQLLGFC--------------------------DEALNRLLVYEFMGNGTLANLIFAIPK 528
+ N LL+ L L +
Sbjct: 125 EEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF 183
Query: 529 -------PDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGL 581
++ ++ R L ++H P N+ + + D
Sbjct: 184 VYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSA 240
Query: 582 SKLLLSDHSRTHTMIRGTRGYVAPEWL--KNAPVSAKVDVYSFGVMLLEIICCRR-SVEM 638
+R Y E+L A + ++ + G+ + + C +
Sbjct: 241 LW---KVGTRGPASS-VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296
Query: 639 ELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPT 698
+ + + R + D +R
Sbjct: 297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRF----------LNFDRRRRLL 346
Query: 699 MKVVMQ 704
M+
Sbjct: 347 PLEAME 352
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 6e-31
Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 20/201 (9%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVK-----KLDRLAQERERE-FKSEVSAIGRTHH 491
EELG G F IV K K ++G A K + + RE + EVS + + H
Sbjct: 16 IGEELGSGQFAIVKKCREK-STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74
Query: 492 KNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISL--EIARGLVYLH 549
N++ L + + +L+ E + G L + + K + S +I G+ YLH
Sbjct: 75 HNVITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYLH 132
Query: 550 EGCNVPIIHCDIKPQNILLDHYFSP----KISDFGLSKLLLSDHSRTHTMIRGTRGYVAP 605
I H D+KP+NI+L P K+ DFGL+ + + I GT +VAP
Sbjct: 133 T---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFVAP 187
Query: 606 EWLKNAPVSAKVDVYSFGVML 626
E + P+ + D++S GV+
Sbjct: 188 EIVNYEPLGLEADMWSIGVIT 208
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 7e-31
Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 20/201 (9%)
Query: 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQ 496
E LG G FG V+K A+G +A K + + + E K+E+S + + H NL+Q
Sbjct: 92 SKTEILGGGRFGQVHKCEET-ATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 497 LLGFCDEALNRLLVYEFMGNGTLANLIF-AIPKPDWNLR----VRISLEIARGLVYLHEG 551
L + + +LV E++ G L F I +NL + +I G+ ++H+
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGEL----FDRIIDESYNLTELDTILFMKQICEGIRHMHQ- 205
Query: 552 CNVPIIHCDIKPQNILLDHYFSP--KISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLK 609
I+H D+KP+NIL + + KI DFGL++ + GT ++APE +
Sbjct: 206 MY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRY--KPREKLKVNFGTPEFLAPEVVN 261
Query: 610 NAPVSAKVDVYSFGV---MLL 627
VS D++S GV MLL
Sbjct: 262 YDFVSFPTDMWSVGVIAYMLL 282
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-31
Identities = 76/364 (20%), Positives = 141/364 (38%), Gaps = 78/364 (21%)
Query: 402 FKWRR-RKYENNVQDSTTSAT-NLRFFSYDELKDATDG----------FKEELGRGSFGI 449
K+++ +YE+ +Q + + + +F D + D F + LG G+FG
Sbjct: 1 HKYKKQFRYESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGK 60
Query: 450 VYKGVLKTASGNA----IAVKKLDRLAQERER-EFKSEV---SAIGRTHHKNLVQLLGFC 501
V S +AVK L A ER SE+ + +G H+N+V LLG C
Sbjct: 61 VMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS--HENIVNLLGAC 118
Query: 502 DEALNRLLVYEFMGNGTL-------------------ANLIFAIPKPDWNLR----VRIS 538
+ L++E+ G L + L + +
Sbjct: 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFA 178
Query: 539 LEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH---SRTHTM 595
++A+G+ +L +H D+ +N+L+ H KI DFGL++ ++SD R +
Sbjct: 179 YQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNAR 235
Query: 596 --IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMELEEESRAILTDW 651
++ APE L + K DV+S+G++L EI + + ++ ++ +
Sbjct: 236 LPVKWM----APESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQN- 290
Query: 652 AYDCYVEGRLDALID-SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710
++D ++E ++ +M + W D KRP+ + L L
Sbjct: 291 ------GFKMDQPFYATEE--------IYI-IMQSCW--AFDSRKRPSFPNLTSFLGCQL 333
Query: 711 EVPN 714
Sbjct: 334 ADAE 337
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 7e-31
Identities = 64/301 (21%), Positives = 118/301 (39%), Gaps = 39/301 (12%)
Query: 423 LRFFSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGNA---IAVKKLDRLAQERER-E 478
LR E K + LG G+FG VYKG+ +A+K+L + E
Sbjct: 9 LRILKETEFK-----KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 63
Query: 479 FKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRVRI 537
E + + ++ +LLG C + L+ + M G L + + +
Sbjct: 64 ILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 122
Query: 538 SLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIR 597
++IA+G+ YL + ++H D+ +N+L+ KI+DFGL+KLL ++ H
Sbjct: 123 CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--E 177
Query: 598 GTRGYV---APEWLKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMELEEESRAILTDWA 652
G + + A E + + + + DV+S+GV + E++ + E S +
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-- 235
Query: 653 YDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEV 712
RL ++ +M+ W D RP + ++ +
Sbjct: 236 ------ERLPQPPICTID-------VYM-IMVKCW--MIDADSRPKFRELIIEFSKMARD 279
Query: 713 P 713
P
Sbjct: 280 P 280
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 72/235 (30%), Positives = 112/235 (47%), Gaps = 30/235 (12%)
Query: 416 STTSATNLRFFSYDELKDATDGFK--EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ 473
S + A +L L+D F+ E +G G++G VYKG +G A+K +D +
Sbjct: 4 SDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHV-KTGQLAAIKVMD-VTG 61
Query: 474 EREREFKSEVSAIGRT-HHKNLVQLLG-----FCDEALNRL-LVYEFMGNGTLANLIFAI 526
+ E E K E++ + + HH+N+ G ++L LV EF G G++ +LI
Sbjct: 62 DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--- 118
Query: 527 PKPDWNLRVR------ISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFG 580
K ++ I EI RGL +LH+ +IH DIK QN+LL K+ DFG
Sbjct: 119 -KNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFG 174
Query: 581 LSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVS-----AKVDVYSFGVMLLEII 630
+S L R +T I GT ++APE + K D++S G+ +E+
Sbjct: 175 VSAQLDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMA 228
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 61/203 (30%), Positives = 96/203 (47%), Gaps = 29/203 (14%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLD--RLAQEREREFKSEVSAIGRTHHKNLV 495
KEELG+G+F +V + V K +G A K ++ +L+ ++ + E + H N+V
Sbjct: 10 VKEELGKGAFSVVRRCVHK-TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68
Query: 496 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLV--------Y 547
+L E LV++ + G L I A R S A + Y
Sbjct: 69 RLHDSIQEESFHYLVFDLVTGGELFEDIVA--------REFYSEADASHCIQQILESIAY 120
Query: 548 LHE-GCNVPIIHCDIKPQNILLDHYFSP---KISDFGLSKLLLSDHSRTHTMIRGTRGYV 603
H G I+H ++KP+N+LL K++DFGL+ + +D H GT GY+
Sbjct: 121 CHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV-NDSEAWHGFA-GTPGYL 174
Query: 604 APEWLKNAPVSAKVDVYSFGVML 626
+PE LK P S VD+++ GV+L
Sbjct: 175 SPEVLKKDPYSKPVDIWACGVIL 197
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 59/312 (18%), Positives = 108/312 (34%), Gaps = 53/312 (16%)
Query: 439 KEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGR-THHKNLVQL 497
+ L G F VY+ SG A+K+L +E+ R EV + + + H N+VQ
Sbjct: 33 RRVLAEGGFAFVYE-AQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQF 91
Query: 498 LGFCDEALNR--------LLVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEIARGLVY 547
LL+ E + L + + ++I + R + +
Sbjct: 92 CSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 548 LHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMI----------- 596
+H PIIH D+K +N+LL + + K+ DFG + + + +
Sbjct: 152 MHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 597 RGTRGYVAPE---WLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILT---D 650
T Y PE N P+ K D+++ G +L + + E + I+
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE---DGAKLRIVNGKYS 267
Query: 651 WAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710
+LI +Q +P +R ++ V+ L+ +
Sbjct: 268 IPPHDTQYTVFHSLIR--------------------AMLQVNPEERLSIAEVVHQLQEIA 307
Query: 711 EVPNPPWSSSFS 722
N S +
Sbjct: 308 AARNVNPKSPIT 319
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 49/283 (17%), Positives = 108/283 (38%), Gaps = 42/283 (14%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVK--KLDRLAQEREREFKSEVSAIGRTHHKNL--V 495
+++G G V++ + + A+K L+ + +++E++ + + + +
Sbjct: 62 KQIGSGGSSKVFQVLNEK--KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 119
Query: 496 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVP 555
+L + +V E GN L + + D R + + +H+
Sbjct: 120 RLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ-HG-- 175
Query: 556 IIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH-TMIRGTRGYVAPEWLKNAP-- 612
I+H D+KP N L+ K+ DFG++ + D + G Y+ PE +K+
Sbjct: 176 IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234
Query: 613 ---------VSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDA 663
+S K DV+S G +L + + T + +L A
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGK---------------TPFQQIINQISKLHA 279
Query: 664 LIDSDEAAM--ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704
+ID + + + ++ C++ DP +R ++ ++
Sbjct: 280 IIDPNHEIEFPDIPEKDLQDVL--KCCLKRDPKQRISIPELLA 320
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 56/202 (27%), Positives = 89/202 (44%), Gaps = 22/202 (10%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVK-----KLDRLAQERERE-FKSEVSAIGRTHH 491
EELG G F IV K K +G A K +L + RE + EV+ + H
Sbjct: 9 MGEELGSGQFAIVRKCRQK-GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67
Query: 492 KNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEIARGLVYLH 549
N++ L + + +L+ E + G L + + K + +I G+ YLH
Sbjct: 68 PNIITLHDIFENKTDVVLILELVSGGELFDFL--AEKESLTEDEATQFLKQILDGVHYLH 125
Query: 550 E-GCNVPIIHCDIKPQNILLDHYFSP----KISDFGLSKLLLSDHSRTHTMIRGTRGYVA 604
I H D+KP+NI+L P K+ DFG++ + + I GT +VA
Sbjct: 126 SKR----IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFKNIFGTPEFVA 179
Query: 605 PEWLKNAPVSAKVDVYSFGVML 626
PE + P+ + D++S GV+
Sbjct: 180 PEIVNYEPLGLEADMWSIGVIT 201
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-30
Identities = 77/319 (24%), Positives = 132/319 (41%), Gaps = 64/319 (20%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNA------IAVKKLDRLAQERER-EFKSEVS---AIG 487
+ LG G+FG V + +AVK L A E++ + SE+ IG
Sbjct: 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 488 RTHHKNLVQLLGFCDEALNRLLVYEFMGNGTL------------ANLIFAIPKPDWNLR- 534
+ HKN++ LLG C + ++ E+ G L P+ L
Sbjct: 133 K--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 190
Query: 535 ---VRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD--- 588
V + ++ARG+ YL IH D+ +N+L+ KI+DFGL++ +
Sbjct: 191 KDLVSCAYQVARGMEYL-ASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 247
Query: 589 HSRTHTM--IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMELEEES 644
T+ ++ APE L + + + DV+SFGV+L EI S + +EE
Sbjct: 248 KKTTNGRLPVKWM----APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-- 301
Query: 645 RAILTDWAYDCYVEG-RLDALID-SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVV 702
+ EG R+D + ++E L+ +M W PS+RPT K +
Sbjct: 302 -------LFKLLKEGHRMDKPSNCTNE--------LYM-MMRDCW--HAVPSQRPTFKQL 343
Query: 703 MQMLEGLLEVPNPPWSSSF 721
++ L+ ++ + + +
Sbjct: 344 VEDLDRIVALTSNQEMGYY 362
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 73/300 (24%), Positives = 112/300 (37%), Gaps = 57/300 (19%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGN----AIAVKKLDRLAQERER-EFKSEVSAIGRTHHK 492
F EELG FG VYKG L + A+A+K L A+ R EF+ E R H
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 493 NLVQLLGFCDEALNRLLVYEFMGNGTL------------ANLIFAIPKPDWNLR----VR 536
N+V LLG + +++ + +G L L V
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 537 ISLEIARGLVYLHE-GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD---HSRT 592
+ +IA G+ YL +H D+ +N+L+ + KISD GL + + +
Sbjct: 133 LVAQIAAGMEYLSSHHV----VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188
Query: 593 HTM--IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMELEEESRAIL 648
+++ IR APE + S D++S+GV+L E+ ++ I
Sbjct: 189 NSLLPIRWM----APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR 244
Query: 649 TDWAYDCYVEGRLDALID-SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLE 707
L D ++ LMI W E PS+RP K + L
Sbjct: 245 NR--------QVLPCPDDCPAW--------VYA-LMIECW--NEFPSRRPRFKDIHSRLR 285
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-30
Identities = 57/196 (29%), Positives = 94/196 (47%), Gaps = 17/196 (8%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
EELG G+FG+V++ + A+GN A K + + + + E+ + H LV L
Sbjct: 161 IHEELGTGAFGVVHRVTER-ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 219
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLIF-AIPKPDWNLRVRISLEIAR----GLVYLHEGC 552
++ +++YEFM G L F + + ++E R GL ++HE
Sbjct: 220 HDAFEDDNEMVMIYEFMSGGEL----FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE-N 274
Query: 553 NVPIIHCDIKPQNILLDHYFSP--KISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKN 610
N +H D+KP+NI+ S K+ DFGL+ L D ++ + GT + APE +
Sbjct: 275 N--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL--DPKQSVKVTTGTAEFAAPEVAEG 330
Query: 611 APVSAKVDVYSFGVML 626
PV D++S GV+
Sbjct: 331 KPVGYYTDMWSVGVLS 346
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-30
Identities = 57/203 (28%), Positives = 90/203 (44%), Gaps = 24/203 (11%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVK-----KLDRLAQERERE-FKSEVSAIGRTHH 491
EELG G F IV K K ++G A K + + RE + EVS + + H
Sbjct: 16 IGEELGSGQFAIVKKCREK-STGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74
Query: 492 KNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR----VRISLEIARGLVY 547
N++ L + + +L+ E + G L + + +L +I G+ Y
Sbjct: 75 PNIITLHDVYENRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNY 130
Query: 548 LHEGCNVPIIHCDIKPQNILLDHYFSP----KISDFGLSKLLLSDHSRTHTMIRGTRGYV 603
LH I H D+KP+NI+L P K+ DFGL+ + + I GT +V
Sbjct: 131 LHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFV 185
Query: 604 APEWLKNAPVSAKVDVYSFGVML 626
APE + P+ + D++S GV+
Sbjct: 186 APEIVNYEPLGLEADMWSIGVIT 208
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 57/194 (29%), Positives = 102/194 (52%), Gaps = 12/194 (6%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG 499
E+LG GS+G VYK + K +G +A+K++ + +E E+S + + ++V+ G
Sbjct: 35 EKLGEGSYGSVYKAIHK-ETGQIVAIKQVP--VESDLQEIIKEISIMQQCDSPHVVKYYG 91
Query: 500 --FCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRVRISLEIARGLVYLHEGCNVPI 556
F + L +V E+ G G+++++I K + I +GL YLH
Sbjct: 92 SYFKNTDL--WIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RK 146
Query: 557 IHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAK 616
IH DIK NILL+ K++DFG++ L ++ +T+I GT ++APE ++ +
Sbjct: 147 IHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNCV 205
Query: 617 VDVYSFGVMLLEII 630
D++S G+ +E+
Sbjct: 206 ADIWSLGITAIEMA 219
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-30
Identities = 71/284 (25%), Positives = 118/284 (41%), Gaps = 49/284 (17%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGR-THHKNLVQ 496
KE++G GS+ + + + K A+ AVK +D+ +R+ E+ + R H N++
Sbjct: 26 VKEDIGVGSYSVCKRCIHK-ATNMEFAVKIIDK----SKRDPTEEIEILLRYGQHPNIIT 80
Query: 497 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEIARGLVYLHEGCNV 554
L D+ +V E M G L + I + ++ R + I + + YLH
Sbjct: 81 LKDVYDDGKYVYVVTELMKGGELLDKILR--QKFFSEREASAVLFTITKTVEYLHA-QG- 136
Query: 555 PIIHCDIKPQNILL----DHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKN 610
++H D+KP NIL + S +I DFG +K L +++ T T +VAPE L+
Sbjct: 137 -VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFVAPEVLER 194
Query: 611 APVSAKVDVYSFGVMLLEIICC-----RRSVEMELEEESRAILTDWAYDCYVEGRLDALI 665
A D++S GV+L + + EE I G+
Sbjct: 195 QGYDAACDIWSLGVLLY-TMLTGYTPFANGPDDTPEEILARIG---------SGKFSLSG 244
Query: 666 D-----SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704
SD A K L+ M + DP +R T +V++
Sbjct: 245 GYWNSVSDTA---------KDLVSKMLHV--DPHQRLTAALVLR 277
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 55/194 (28%), Positives = 104/194 (53%), Gaps = 11/194 (5%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLD-RLAQEREREFKSEVSAIGRTHHKNLVQLL 498
E++G+GSFG V+KG+ + +A+K +D A++ + + E++ + + + +
Sbjct: 28 EKIGKGSFGEVFKGIDN-RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 86
Query: 499 G--FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPI 556
G D L ++ E++G G+ +L+ P + + I EI +GL YLH +
Sbjct: 87 GSYLKDTKL--WIIMEYLGGGSALDLLEPGPLDETQIAT-ILREILKGLDYLH---SEKK 140
Query: 557 IHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAK 616
IH DIK N+LL + K++DFG++ L + +T + GT ++APE +K + +K
Sbjct: 141 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSK 199
Query: 617 VDVYSFGVMLLEII 630
D++S G+ +E+
Sbjct: 200 ADIWSLGITAIELA 213
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-30
Identities = 70/316 (22%), Positives = 121/316 (38%), Gaps = 65/316 (20%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGN----AIAVKKLDRLAQERER-EFKSEVSAIGRTHHK 492
+ ++G G+FG V++ +AVK L A + +F+ E + + +
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 493 NLVQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLR----------------- 534
N+V+LLG C L++E+M G L L P +L
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 535 ------VRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD 588
+ I+ ++A G+ YL E +H D+ +N L+ KI+DFGLS+ + S
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 589 H---SRTHTM--IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMELE 641
+ + IR PE + + + DV+++GV+L EI M E
Sbjct: 228 DYYKADGNDAIPIRWM----PPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 283
Query: 642 EESRAILTDWAYDCYVEG-RLDALID-SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTM 699
E +G L + E L+ LM W + P+ RP+
Sbjct: 284 E---------VIYYVRDGNILACPENCPLE--------LYN-LMRLCW--SKLPADRPSF 323
Query: 700 KVVMQMLEGLLEVPNP 715
+ ++L+ + E
Sbjct: 324 CSIHRILQRMCERAEG 339
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 59/201 (29%), Positives = 93/201 (46%), Gaps = 28/201 (13%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
F E LG G+F V+ + +G A+K + + R+ ++E++ + + H+N+V L
Sbjct: 13 FMEVLGSGAFSEVFLVKQR-LTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTL 71
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--------VRISLEIARGLVYLH 549
+ + LV + + G L + I R + ++ + YLH
Sbjct: 72 EDIYESTTHYYLVMQLVSGGELFDRILE--------RGVYTEKDASLVIQQVLSAVKYLH 123
Query: 550 E-GCNVPIIHCDIKPQNILLDHYF--SP-KISDFGLSKLLLSDHSRTHTMIRGTRGYVAP 605
E G I+H D+KP+N+L S I+DFGLSK+ + T GT GYVAP
Sbjct: 124 ENG----IVHRDLKPENLLYLTPEENSKIMITDFGLSKME--QNGIMSTAC-GTPGYVAP 176
Query: 606 EWLKNAPVSAKVDVYSFGVML 626
E L P S VD +S GV+
Sbjct: 177 EVLAQKPYSKAVDCWSIGVIT 197
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 9e-30
Identities = 61/203 (30%), Positives = 96/203 (47%), Gaps = 29/203 (14%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLD--RLAQEREREFKSEVSAIGRTHHKNLV 495
KEELG+G+F +V + V K +G A K ++ +L+ ++ + E + H N+V
Sbjct: 33 VKEELGKGAFSVVRRCVHK-TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 91
Query: 496 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLV--------Y 547
+L E LV++ + G L I A R S A + Y
Sbjct: 92 RLHDSIQEESFHYLVFDLVTGGELFEDIVA--------REFYSEADASHCIQQILESIAY 143
Query: 548 LHE-GCNVPIIHCDIKPQNILLDHYFSP---KISDFGLSKLLLSDHSRTHTMIRGTRGYV 603
H G I+H ++KP+N+LL K++DFGL+ + +D H GT GY+
Sbjct: 144 CHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV-NDSEAWHGFA-GTPGYL 197
Query: 604 APEWLKNAPVSAKVDVYSFGVML 626
+PE LK P S VD+++ GV+L
Sbjct: 198 SPEVLKKDPYSKPVDIWACGVIL 220
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 9e-30
Identities = 64/228 (28%), Positives = 102/228 (44%), Gaps = 21/228 (9%)
Query: 416 STTSATNLRFFSYDELKDATDGFK--EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ 473
S S+ L+ + K E+GRG++G V K V K SG +AVK++
Sbjct: 2 SIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKP-SGQIMAVKRIRSTVD 60
Query: 474 ERERE-FKSEVSAIGRT-HHKNLVQLLG--FCDEALNRLLVYEFMGNGTLANLIFAIPKP 529
E+E++ ++ + R+ +VQ G F + + E M +
Sbjct: 61 EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCW--ICMELMSTSFDKFYKYVYSVL 118
Query: 530 DWNLRV----RISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLL 585
D + +I+L + L +L E IIH DIKP NILLD + K+ DFG+S L
Sbjct: 119 DDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176
Query: 586 LSDHSRTHTMIRGTRGYVAPEWLKNAPV----SAKVDVYSFGVMLLEI 629
+ ++T G R Y+APE + + + DV+S G+ L E+
Sbjct: 177 VDSIAKTRDA--GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYEL 222
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 78/310 (25%), Positives = 127/310 (40%), Gaps = 65/310 (20%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNA----IAVKKLDRLAQERER-EFKSEV---SAIGRT 489
F + LG G+FG V + + +AVK L A ER SE+ S +G
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN- 85
Query: 490 HHKNLVQLLGFCDEALNRLLVYEFMGNGTL--------------ANLIFAIPKPDWNLR- 534
H N+V LLG C L++ E+ G L + + L
Sbjct: 86 -HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 535 ---VRISLEIARGLVYLHE-GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH- 589
+ S ++A+G+ +L C IH D+ +NILL H KI DFGL++ + +D
Sbjct: 145 EDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 590 --SRTHTM--IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMELEEE 643
+ + ++ APE + N + + DV+S+G+ L E+ S M ++ +
Sbjct: 201 YVVKGNARLPVKWM----APESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256
Query: 644 SRAILTDWAYDCYVEG-RLDALID-SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKV 701
Y EG R+ + E ++ +M W DP KRPT K
Sbjct: 257 --------FYKMIKEGFRMLSPEHAPAE--------MYD-IMKTCW--DADPLKRPTFKQ 297
Query: 702 VMQMLEGLLE 711
++Q++E +
Sbjct: 298 IVQLIEKQIS 307
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 60/203 (29%), Positives = 89/203 (43%), Gaps = 24/203 (11%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVK-------KLDRLAQEREREFKSEVSAIGRTH 490
EELG G F +V K K ++G A K K R RE + + EVS +
Sbjct: 15 TGEELGSGQFAVVKKCREK-STGLQYAAKFIKKRRTKSSRRGVSRE-DIEREVSILKEIQ 72
Query: 491 HKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEIARGLVYL 548
H N++ L + + +L+ E + G L + + K +I G+ YL
Sbjct: 73 HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 549 HE-GCNVPIIHCDIKPQNILLDHYFSP----KISDFGLSKLLLSDHSRTHTMIRGTRGYV 603
H I H D+KP+NI+L P KI DFGL+ + D I GT +V
Sbjct: 131 HSLQ----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFV 184
Query: 604 APEWLKNAPVSAKVDVYSFGVML 626
APE + P+ + D++S GV+
Sbjct: 185 APEIVNYEPLGLEADMWSIGVIT 207
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 40/214 (18%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDR---------LAQEREREFKSEVSAIGR 488
KE LGRG +V + + K + AVK +D QE EV + +
Sbjct: 21 PKEILGRGVSSVVRRCIHK-PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 79
Query: 489 -THHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLV- 546
+ H N++QL + LV++ M G L + + +V +S + R ++
Sbjct: 80 VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE--------KVTLSEKETRKIMR 131
Query: 547 -------YLHE-GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRG 598
LH+ I+H D+KP+NILLD + K++DFG S L + + G
Sbjct: 132 ALLEVICALHKLN----IVHRDLKPENILLDDDMNIKLTDFGFSC-QLDPGEKLREVC-G 185
Query: 599 TRGYVAPEWLKNAPVSA------KVDVYSFGVML 626
T Y+APE ++ + +VD++S GV++
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 78/307 (25%), Positives = 125/307 (40%), Gaps = 60/307 (19%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNA----IAVKKLDRLAQERER-EFKSEVS---AIGRT 489
+ LGRG+FG V + A +AVK L A E SE+ IG
Sbjct: 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH- 89
Query: 490 HHKNLVQLLGFC-DEALNRLLVYEFMGNGTL--------------ANLIFAIPKPDWNLR 534
H N+V LLG C +++ EF G L + K L
Sbjct: 90 -HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 535 --VRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH--- 589
+ S ++A+G+ +L IH D+ +NILL KI DFGL++ + D
Sbjct: 149 HLICYSFQVAKGMEFL-ASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 205
Query: 590 SRTHTM--IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMELEEESR 645
+ ++ APE + + + + DV+SFGV+L EI S ++++EE
Sbjct: 206 RKGDARLPLKWM----APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261
Query: 646 AILTDWAYDCYVEGRLDALID-SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704
L + R+ A + E +++ M+ W +PS+RPT +++
Sbjct: 262 RRLKE-------GTRMRAPDYTTPE--------MYQ-TMLDCW--HGEPSQRPTFSELVE 303
Query: 705 MLEGLLE 711
L LL+
Sbjct: 304 HLGNLLQ 310
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 60/296 (20%), Positives = 111/296 (37%), Gaps = 64/296 (21%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDR-LAQEREREFK-SEVSAIGR-THHKNLVQ 496
E++G G FG V+K +K G A+K+ + LA + + EV A H ++V+
Sbjct: 17 EKIGSGEFGSVFK-CVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR 75
Query: 497 LLG-FCDEALNRLLVY-EFMGNGTLANLIFAIPKPDWNLR----VRISLEIARGLVYLHE 550
+ ++ + +L+ E+ G+LA+ I + + + L++ RGL Y+H
Sbjct: 76 YFSAWAED--DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS 133
Query: 551 GCNVPIIHCDIKPQNILLDH-------------------YFSPKISDFGLSKLLLSDHSR 591
+ ++H DIKP NI + KI D G + S
Sbjct: 134 -MS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI----SS 186
Query: 592 THTMIRGTRGYVAPE-WLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTD 650
G ++A E +N K D+++ + ++ ++ I
Sbjct: 187 PQVEE-GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP--LPRNGDQWHEI--- 240
Query: 651 WAYDCYVEGRLDALID--SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704
+GRL + S E + L I DP +RP+ +++
Sbjct: 241 ------RQGRLPRIPQVLSQE--------FTELL---KVMIHPDPERRPSAMALVK 279
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 52/217 (23%), Positives = 87/217 (40%), Gaps = 35/217 (16%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREF-----------------KSEVS 484
L +G F + L A+KK ++ E++R+F K+E+
Sbjct: 39 LNQGKFNKII---LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95
Query: 485 AIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIAR- 543
I ++ + G ++YE+M N ++ D N I +++ +
Sbjct: 96 IITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155
Query: 544 -------GLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMI 596
Y+H N I H D+KP NIL+D K+SDFG S+ +
Sbjct: 156 IIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESE--YMVDKKIKGS- 210
Query: 597 RGTRGYVAPEWLKNAPV--SAKVDVYSFGVMLLEIIC 631
RGT ++ PE+ N AKVD++S G+ L +
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFY 247
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-29
Identities = 51/203 (25%), Positives = 91/203 (44%), Gaps = 28/203 (13%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDR--LAQEREREFKSEVSAIGRTHHKNLV 495
EELG+G+F +V + V +G A ++ L+ ++ + E H N+V
Sbjct: 15 LFEELGKGAFSVVRRCVKV-LAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIV 73
Query: 496 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLV--------Y 547
+L E + L+++ + G L I A R S A + +
Sbjct: 74 RLHDSISEEGHHYLIFDLVTGGELFEDIVA--------REYYSEADASHCIQQILEAVLH 125
Query: 548 LHE-GCNVPIIHCDIKPQNILLDHYF--SP-KISDFGLSKLLLSDHSRTHTMIRGTRGYV 603
H+ G ++H ++KP+N+LL + K++DFGL+ + + GT GY+
Sbjct: 126 CHQMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYL 180
Query: 604 APEWLKNAPVSAKVDVYSFGVML 626
+PE L+ P VD+++ GV+L
Sbjct: 181 SPEVLRKDPYGKPVDLWACGVIL 203
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 59/196 (30%), Positives = 98/196 (50%), Gaps = 11/196 (5%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLD-RLAQERE--REFKSEVSAIGRTHHKNLVQ 496
++LG G VY T +A+K + ++ E + F+ EV + H+N+V
Sbjct: 17 DKLGGGGMSTVYLA-EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 497 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHE-GCNVP 555
++ +E LV E++ TL+ I + + + + +I G+ + H+
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR---- 131
Query: 556 IIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHT-MIRGTRGYVAPEWLKNAPVS 614
I+H DIKPQNIL+D + KI DFG++K LS+ S T T + GT Y +PE K
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAK-ALSETSLTQTNHVLGTVQYFSPEQAKGEATD 190
Query: 615 AKVDVYSFGVMLLEII 630
D+YS G++L E++
Sbjct: 191 ECTDIYSIGIVLYEML 206
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 2e-29
Identities = 70/285 (24%), Positives = 117/285 (41%), Gaps = 31/285 (10%)
Query: 439 KEELGRGSFGIVYKGVLKTASGN-AIAVKKLDRLAQERER-EFKSEVSAIGRTHHKNLVQ 496
ELG G+FG V +GV + +A+K L + ++ + E E + + + +V+
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 497 LLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVP 555
L+G C +LV E G G L L+ + + + +++ G+ YL E N
Sbjct: 401 LIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL-EEKN-- 456
Query: 556 IIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYV---APEWLKNAP 612
+H ++ +N+LL + KISDFGLSK L +D S +T + + APE +
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS-YYTARSAGKWPLKWYAPECINFRK 515
Query: 613 VSAKVDVYSFGVMLLEIICCRRS--VEMELEEESRAILTDWAYDCYVEGRLDALIDSDEA 670
S++ DV+S+GV + E + + +M+ E I R+ E
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG--------KRM-------EC 560
Query: 671 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNP 715
L+ LM W RP V Q +
Sbjct: 561 PPECPPELYA-LMSDCW--IYKWEDRPDFLTVEQRMRACYYSLAS 602
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 76/314 (24%), Positives = 131/314 (41%), Gaps = 64/314 (20%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNA------IAVKKLDRLAQERER-EFKSEVS---AIG 487
+ LG G+FG V + +AVK L A E++ + SE+ IG
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 488 RTHHKNLVQLLGFCDEALNRLLVYEFMGNGTL------------ANLIFAIPKPDWNLR- 534
+ HKN++ LLG C + ++ E+ G L P+ +
Sbjct: 99 K--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 535 ---VRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH-- 589
V + ++ARG+ YL IH D+ +N+L+ KI+DFGL++ + +
Sbjct: 157 KDLVSCTYQLARGMEYL-ASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 590 -SRTHTM--IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMELEEES 644
T+ ++ APE L + + + DV+SFGV++ EI S + +EE
Sbjct: 214 KKTTNGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-- 267
Query: 645 RAILTDWAYDCYVEG-RLDALID-SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVV 702
+ EG R+D + ++E L+ +M W PS+RPT K +
Sbjct: 268 -------LFKLLKEGHRMDKPANCTNE--------LYM-MMRDCW--HAVPSQRPTFKQL 309
Query: 703 MQMLEGLLEVPNPP 716
++ L+ +L +
Sbjct: 310 VEDLDRILTLTTNE 323
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 3e-29
Identities = 42/208 (20%), Positives = 78/208 (37%), Gaps = 36/208 (17%)
Query: 512 EFMGNGTLANLI---FAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILL 568
+ L + + ++ + + + I ++IA + +LH ++H D+KP NI
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFF 197
Query: 569 DHYFSPKISDFGLSKLLLSDHSR-----------THTMIRGTRGYVAPEWLKNAPVSAKV 617
K+ DFGL + D THT GT+ Y++PE + S KV
Sbjct: 198 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKV 257
Query: 618 DVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSR 677
D++S G++L E + S +ME + + L
Sbjct: 258 DIFSLGLILFE-LLYSFSTQMERVRIITDV---------RNLKFPLLFTQKYPQEHM--- 304
Query: 678 LHKWLMIAMWCIQEDPSKRPTMKVVMQM 705
M+ + P++RP +++
Sbjct: 305 -----MVQ-DMLSPSPTERPEATDIIEN 326
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 16/58 (27%), Positives = 29/58 (50%), Gaps = 2/58 (3%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQERERE-FKSEVSAIGRTHHKNLVQ 496
+ +GRG FG+V++ A+K++ +E RE EV A+ + H +V+
Sbjct: 12 QCMGRGGFGVVFE-AKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVR 68
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-29
Identities = 67/278 (24%), Positives = 119/278 (42%), Gaps = 38/278 (13%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLD--RLAQEREREFKSEVSAIGRTHHKNLV 495
++LG G++G V K + A+K + ++ + EV+ + H N++
Sbjct: 41 RVKKLGSGAYGEVLLCRDK-VTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIM 99
Query: 496 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVP 555
+L F ++ N LV E G L + I K + I ++ G+ YLH+
Sbjct: 100 KLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN--- 156
Query: 556 IIHCDIKPQNILL---DHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAP 612
I+H D+KP+N+LL + KI DFGLS + ++ + GT Y+APE L+
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF--ENQKKMKERLGTAYYIAPEVLRK-K 213
Query: 613 VSAKVDVYSFGVMLLEIICCRRSVEMELEEE-SRAILTDWAYDCYVEGRLDALID----- 666
K DV+S GV+L ++ + ++E R + +G+
Sbjct: 214 YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVE---------KGKYTFDSPEWKNV 264
Query: 667 SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704
S+ A K L+ M +Q D +R + + ++
Sbjct: 265 SEGA---------KDLIKQM--LQFDSQRRISAQQALE 291
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 55/198 (27%), Positives = 93/198 (46%), Gaps = 17/198 (8%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLD-RLAQEREREFKSEVSAIGRTHHKNLVQ 496
FK +LG G+FG V+ + +SG +K ++ +Q + ++E+ + H N+++
Sbjct: 26 FKRKLGSGAFGDVHLVEER-SSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84
Query: 497 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR----VRISLEIARGLVYLHE-G 551
+ ++ N +V E G L I + L + ++ L Y H
Sbjct: 85 IFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH 144
Query: 552 CNVPIIHCDIKPQNILL---DHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWL 608
++H D+KP+NIL + KI DFGL++L SD T GT Y+APE
Sbjct: 145 ----VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE--HSTNAAGTALYMAPEVF 198
Query: 609 KNAPVSAKVDVYSFGVML 626
K V+ K D++S GV++
Sbjct: 199 KR-DVTFKCDIWSAGVVM 215
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-29
Identities = 44/337 (13%), Positives = 94/337 (27%), Gaps = 90/337 (26%)
Query: 421 TNLRFFSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVK---KLDRLAQERER 477
R S + T LG+ + +G + V +R +
Sbjct: 60 QPFRVESELGERPRTLVRGTVLGQEDPYAYLEAT-DQETGESFEVHVPYFTERPPSNAIK 118
Query: 478 EFKSEVSAIGR-------------------------THHKNLVQLLGFCD--EALNRLLV 510
+ K EV + K ++++ L+R +
Sbjct: 119 QMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFL 178
Query: 511 YEFMGN------GTLANLIFAIPKPDWNLRVRISLEIARGLVYLHE-GCNVPIIHCDIKP 563
Y M + L + + R++++L++ R L LH G ++H ++P
Sbjct: 179 YPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRP 234
Query: 564 QNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLK-----------NAP 612
+I+LD ++ F + +RG+ PE
Sbjct: 235 VDIVLDQRGGVFLTGFEHLV-----RDGARVVSSVSRGFEPPELEARRATISYHRDRRTL 289
Query: 613 VSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRL----DALIDSD 668
++ D ++ G+++ I C L DA +
Sbjct: 290 MTFSFDAWALGLVIYWIWC---------------------------ADLPITKDAALGGS 322
Query: 669 EAAMADRSRLHKWLM-IAMWCIQEDPSKRPTMKVVMQ 704
E + + + + ++ R M+
Sbjct: 323 EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-29
Identities = 73/312 (23%), Positives = 131/312 (41%), Gaps = 65/312 (20%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNA----IAVKKLDRLAQERER-EFKSEVSAIGRTHHK 492
+ LG G FG V K G A +AVK L A E + SE + + + +H
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 493 NLVQLLGFCDEALNRLLVYEFMGNGTL--------------------ANLIFAIPKPDWN 532
++++L G C + LL+ E+ G+L N +
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 533 LR----VRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD 588
L + + +I++G+ YL E ++H D+ +NIL+ KISDFGLS+ + +
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 589 H---SRTHTM--IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMELE 641
R+ ++ A E L + + + DV+SFGV+L EI+ + + E
Sbjct: 204 DSYVKRSQGRIPVKWM----AIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259
Query: 642 EESRAILTDWAYDCYVEG-RLDALID-SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTM 699
++ G R++ + S+E +++ LM+ W +++P KRP
Sbjct: 260 R---------LFNLLKTGHRMERPDNCSEE--------MYR-LMLQCW--KQEPDKRPVF 299
Query: 700 KVVMQMLEGLLE 711
+ + LE ++
Sbjct: 300 ADISKDLEKMMV 311
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 8e-29
Identities = 52/202 (25%), Positives = 91/202 (45%), Gaps = 20/202 (9%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQERERE-FKSEVSAIGRT-HHKNLVQL 497
ELGRG++G+V K SG +AVK++ +E++ ++ RT V
Sbjct: 13 MELGRGAYGVVEKMRHVP-SGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTF 71
Query: 498 LG--FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRV----RISLEIARGLVYLHEG 551
G F + + + E M +L + + +I++ I + L +LH
Sbjct: 72 YGALFREGDV--WICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128
Query: 552 CNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPE----W 607
+ +IH D+KP N+L++ K+ DFG+S L + G + Y+APE
Sbjct: 129 LS--VIHRDVKPSNVLINALGQVKMCDFGISGYL--VDDVAKDIDAGCKPYMAPERINPE 184
Query: 608 LKNAPVSAKVDVYSFGVMLLEI 629
L S K D++S G+ ++E+
Sbjct: 185 LNQKGYSVKSDIWSLGITMIEL 206
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 8e-29
Identities = 76/309 (24%), Positives = 129/309 (41%), Gaps = 64/309 (20%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGN------AIAVKKLDRLAQERER-EFKSEV---SAIG 487
+ LG G FG V + +AVK L A E++ + SE+ IG
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144
Query: 488 RTHHKNLVQLLGFCDEALNRLLVYEFMGNGTL------------ANLIFAIPKPDWNLR- 534
+ HKN++ LLG C + ++ E+ G L P+ +
Sbjct: 145 K--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 202
Query: 535 ---VRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD--- 588
V + ++ARG+ YL IH D+ +N+L+ KI+DFGL++ + +
Sbjct: 203 KDLVSCTYQLARGMEYL-ASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 259
Query: 589 HSRTHTM--IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMELEEES 644
T+ ++ APE L + + + DV+SFGV++ EI S + +EE
Sbjct: 260 KKTTNGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-- 313
Query: 645 RAILTDWAYDCYVEG-RLDALID-SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVV 702
+ EG R+D + ++E L+ +M W PS+RPT K +
Sbjct: 314 -------LFKLLKEGHRMDKPANCTNE--------LYM-MMRDCW--HAVPSQRPTFKQL 355
Query: 703 MQMLEGLLE 711
++ L+ +L
Sbjct: 356 VEDLDRILT 364
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 71/289 (24%), Positives = 114/289 (39%), Gaps = 51/289 (17%)
Query: 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGR-THHKNL 494
D + LG GSF I K V K S A AVK + + + ++ E++A+ H N+
Sbjct: 13 DLKDKPLGEGSFSICRKCVHK-KSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNI 68
Query: 495 VQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEIARGLVYLHE-G 551
V+L + L+ LV E + G L I K ++ I ++ + ++H+ G
Sbjct: 69 VKLHEVFHDQLHTFLVMELLNGGELFERIKK--KKHFSETEASYIMRKLVSAVSHMHDVG 126
Query: 552 CNVPIIHCDIKPQNILLDHYF--SP-KISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWL 608
++H D+KP+N+L KI DFG ++L D+ T T Y APE L
Sbjct: 127 ----VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELL 181
Query: 609 KNAPVSAKVDVYSFGVMLLEIIC--------CRRSVEMELEEESRAILTDWAYDCYVEGR 660
D++S GV+L ++ R E + I +G
Sbjct: 182 NQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIK---------KGD 232
Query: 661 LDALID-----SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704
+ S EA K L+ + + DP+KR M +
Sbjct: 233 FSFEGEAWKNVSQEA---------KDLIQGL--LTVDPNKRLKMSGLRY 270
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 74/305 (24%), Positives = 128/305 (41%), Gaps = 56/305 (18%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGN-AIAVKKLDRLAQERER-EFKSEVSAIGR-THHKNL 494
F++ +G G+FG V K +K A+K++ A + + +F E+ + + HH N+
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 495 VQLLGFCDEALNRLLVYEFMGNGTL------------ANLIFAIPKPDWNLR----VRIS 538
+ LLG C+ L E+ +G L L + +
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 539 LEIARGLVYLHE-GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM-- 595
++ARG+ YL + IH D+ +NIL+ + KI+DFGLS+ + TM
Sbjct: 149 ADVARGMDYLSQKQF----IHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGR 202
Query: 596 --IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMELEEESRAILTDW 651
+R A E L + + DV+S+GV+L EI+ + M E
Sbjct: 203 LPVRWM----AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--------- 249
Query: 652 AYDCYVEG-RLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710
Y+ +G RL+ ++ D+ ++ LM W +E P +RP+ ++ L +L
Sbjct: 250 LYEKLPQGYRLEKPLNCDDE-------VYD-LMRQCW--REKPYERPSFAQILVSLNRML 299
Query: 711 EVPNP 715
E
Sbjct: 300 EERKT 304
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 57/195 (29%), Positives = 92/195 (47%), Gaps = 14/195 (7%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLD--RLAQEREREFKSEVSAIGRTHHKNLV 495
LG+GSFG V K + + AVK ++ + EV + + H N++
Sbjct: 26 IVCMLGKGSFGEVLKCKDR-ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 496 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHE-GCNV 554
+L +++ + +V E G L + I + + RI ++ G+ Y+H+
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--- 141
Query: 555 PIIHCDIKPQNILL---DHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNA 611
I+H D+KP+NILL + KI DFGLS + ++ I GT Y+APE L+
Sbjct: 142 -IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GTAYYIAPEVLRG- 197
Query: 612 PVSAKVDVYSFGVML 626
K DV+S GV+L
Sbjct: 198 TYDEKCDVWSAGVIL 212
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 64/274 (23%), Positives = 114/274 (41%), Gaps = 58/274 (21%)
Query: 400 IFFKWR-RRKYENNVQDSTTSATNLRF--------------FSYDELKDATDGFKEELGR 444
+ +K++ + KY+ + + N F + L+ F + LG
Sbjct: 2 VDYKYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQ-----FGKTLGA 56
Query: 445 GSFGIVYKGVLKTASGNA----IAVKKLDRLAQERER-EFKSEV---SAIGRTHHKNLVQ 496
G+FG V + +AVK L A E+ SE+ S +G H+N+V
Sbjct: 57 GAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLG--QHENIVN 114
Query: 497 LLGFCDEALNRLLVYEFMGNGTLAN----------LIFAIPKPDWNLR----VRISLEIA 542
LLG C L++ E+ G L N A + + S ++A
Sbjct: 115 LLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVA 174
Query: 543 RGLVYLHE-GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH---SRTHTM--I 596
+G+ +L C IH D+ +N+LL + KI DFGL++ +++D + + +
Sbjct: 175 QGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 230
Query: 597 RGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEII 630
+ APE + + + + DV+S+G++L EI
Sbjct: 231 KWM----APESIFDCVYTVQSDVWSYGILLWEIF 260
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-28
Identities = 68/275 (24%), Positives = 115/275 (41%), Gaps = 31/275 (11%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNL 494
+ LG+GSFG V K +G AVK + + + + EV + + H N+
Sbjct: 30 GQRVLGKGSFGEVILCKDK-ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88
Query: 495 VQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHE-GCN 553
++L F ++ LV E G L + I + + RI ++ G+ Y+H+
Sbjct: 89 MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK-- 146
Query: 554 VPIIHCDIKPQNILL---DHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKN 610
I+H D+KP+N+LL + +I DFGLS + S+ GT Y+APE L
Sbjct: 147 --IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMKDKIGTAYYIAPEVLHG 202
Query: 611 APVSAKVDVYSFGVMLLEIICCRRSVEMELEEE-SRAILTDWAYDCYVEGRLDALIDSDE 669
K DV+S GV+L ++ E + + + Y + + + S+
Sbjct: 203 -TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKG-KYT-FELPQWKKV--SES 257
Query: 670 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704
A K L+ M + PS R + + +
Sbjct: 258 A---------KDLIRKM--LTYVPSMRISARDALD 281
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-28
Identities = 57/214 (26%), Positives = 98/214 (45%), Gaps = 41/214 (19%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDR--------LAQEREREFKSEVSAIGR- 488
K+ +GRG +V + V + A+G+ AVK ++ +E + E I R
Sbjct: 98 PKDVIGRGVSSVVRRCVHR-ATGHEFAVKIMEVTAERLSPEQLEEVREATRRET-HILRQ 155
Query: 489 -THHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLV- 546
H +++ L+ + + LV++ M G L + + +V +S + R ++
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTE--------KVALSEKETRSIMR 207
Query: 547 -------YLHE-GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRG 598
+LH I+H D+KP+NILLD ++SDFG S L + + G
Sbjct: 208 SLLEAVSFLHANN----IVHRDLKPENILLDDNMQIRLSDFGFSC-HLEPGEKLRELC-G 261
Query: 599 TRGYVAPEWLKNAPVSA------KVDVYSFGVML 626
T GY+APE LK + +VD+++ GV+L
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 5e-28
Identities = 55/325 (16%), Positives = 102/325 (31%), Gaps = 56/325 (17%)
Query: 422 NLRFFSYDELKDATDGFK--EELGRG--SFGIVYKGVLKTASGNAIAVKK--LDRLAQER 475
NL F ++ +G+G V K +G + V++ L+ + E
Sbjct: 11 NLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYK-PTGEYVTVRRINLEACSNEM 69
Query: 476 EREFKSEVSAIGRTHHKNLVQLLG--FCDEALNRLLVYEFMGNGTLANLI-FAIPKP-DW 531
+ E+ +H N+V D L +V FM G+ +LI +
Sbjct: 70 VTFLQGELHVSKLFNHPNIVPYRATFIADNELW--VVTSFMAYGSAKDLICTHFMDGMNE 127
Query: 532 NLRVRISLEIARGLVYLH-EGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS 590
I + + L Y+H G +H +K +IL+ +S + ++S
Sbjct: 128 LAIAYILQGVLKALDYIHHMGY----VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ 183
Query: 591 RTHTMIRGTRGYV------APEWLK--NAPVSAKVDVYSFGVMLLEII------------ 630
R + + V +PE L+ AK D+YS G+ E+
Sbjct: 184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT 243
Query: 631 ------------CCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRL 678
C + + EE + + A + +
Sbjct: 244 QMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYH 303
Query: 679 HKW-----LMIAMWCIQEDPSKRPT 698
+ + C+Q +P RP+
Sbjct: 304 RTFSPHFHHFVEQ-CLQRNPDARPS 327
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-28
Identities = 59/271 (21%), Positives = 96/271 (35%), Gaps = 60/271 (22%)
Query: 416 STTSATNLRFFSYDELKDATDG--FKEELGRGSFGIVYKGVLKTASGNAIAVK-----KL 468
+S +F L + K +G+GS+G+V + + A+K K+
Sbjct: 6 HHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIEN-QTRAIRAIKIMNKNKI 64
Query: 469 DRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPK 528
++ + K+EV + + HH N+ +L ++ LV E G L + +
Sbjct: 65 RQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFID 124
Query: 529 PDWNLRVRISLE----------------------------------------IARGLVYL 548
++ I L YL
Sbjct: 125 DSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184
Query: 549 HE-GCNVPIIHCDIKPQNILL--DHYFSPKISDFGLSKLLLSDHSRTHTMIR---GTRGY 602
H G I H DIKP+N L + F K+ DFGLSK ++ + + GT +
Sbjct: 185 HNQG----ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYF 240
Query: 603 VAPEWLKNA--PVSAKVDVYSFGVMLLEIIC 631
VAPE L K D +S GV+L ++
Sbjct: 241 VAPEVLNTTNESYGPKCDAWSAGVLLHLLLM 271
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-28
Identities = 57/200 (28%), Positives = 93/200 (46%), Gaps = 14/200 (7%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLD--RLAQEREREFKSEVSAIGRTHHKNLV 495
LG+GSFG V K + + AVK ++ + EV + + H N++
Sbjct: 26 IVCMLGKGSFGEVLKCKDR-ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 496 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHE-GCNV 554
+L +++ + +V E G L + I + + RI ++ G+ Y+H+
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--- 141
Query: 555 PIIHCDIKPQNILL---DHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNA 611
I+H D+KP+NILL + KI DFGLS + + I GT Y+APE L+
Sbjct: 142 -IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-KMKDRI-GTAYYIAPEVLRG- 197
Query: 612 PVSAKVDVYSFGVMLLEIIC 631
K DV+S GV+L ++
Sbjct: 198 TYDEKCDVWSAGVILYILLS 217
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 7e-28
Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 34/214 (15%)
Query: 427 SYDELKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAI 486
+ D L D + + ELGRG+ IVY+ K + A+K L + ++ ++E+ +
Sbjct: 47 NRDALSDFFE-VESELGRGATSIVYRCKQK-GTQKPYALKVLKK--TVDKKIVRTEIGVL 102
Query: 487 GRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRIS-------- 538
R H N+++L + LV E + G L + I + S
Sbjct: 103 LRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVE--------KGYYSERDAADAV 154
Query: 539 LEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSP------KISDFGLSKLLLSDHSRT 592
+I + YLHE I+H D+KP+N+L Y +P KI+DFGLSK++ +H
Sbjct: 155 KQILEAVAYLHE-NG--IVHRDLKPENLL---YATPAPDAPLKIADFGLSKIV--EHQVL 206
Query: 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVML 626
+ GT GY APE L+ +VD++S G++
Sbjct: 207 MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-27
Identities = 53/211 (25%), Positives = 93/211 (44%), Gaps = 37/211 (17%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDR--------LAQEREREFKSEVSAIGRT 489
+ LG G+ G V + + +A++ + + + ++E+ + +
Sbjct: 139 MSKTLGSGACGEVKLAFER-KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL 197
Query: 490 HHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRIS--------LEI 541
+H ++++ F D + +V E M G L + + R+ ++
Sbjct: 198 NHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVG--------NKRLKEATCKLYFYQM 248
Query: 542 ARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSP---KISDFGLSKLLLSDHSRTHTMIRG 598
+ YLHE IIH D+KP+N+LL KI+DFG SK +L + S T+ G
Sbjct: 249 LLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-ILGETSLMRTLC-G 303
Query: 599 TRGYVAPEWLKN---APVSAKVDVYSFGVML 626
T Y+APE L + A + VD +S GV+L
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 49/193 (25%), Positives = 81/193 (41%), Gaps = 12/193 (6%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
+ +GRGS+G V V K + A KK+ + E FK E+ + H N+++L
Sbjct: 13 LENTIGRGSWGEVKIAVQK-GTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 71
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHE-GCNVPI 556
++ + LV E G L + + RI ++ + Y H+ +
Sbjct: 72 YETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN----V 127
Query: 557 IHCDIKPQNILL---DHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPV 613
H D+KP+N L K+ DFGL+ + GT YV+P+ L+
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARF--KPGKMMRTKVGTPYYVSPQVLEG-LY 184
Query: 614 SAKVDVYSFGVML 626
+ D +S GVM+
Sbjct: 185 GPECDEWSAGVMM 197
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 55/200 (27%), Positives = 95/200 (47%), Gaps = 18/200 (9%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQERERE-FKSEVSAIGRTH-HKNLVQL 497
E+G G+ G V+K + +G+ IAVK++ R + E + ++ + ++H +VQ
Sbjct: 31 GEMGSGTCGQVWKMRFR-KTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQC 89
Query: 498 LG--FCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRVRISLEIARGLVYLHEGCNV 554
G + + + E MG L + P + ++++ I + L YL E
Sbjct: 90 FGTFITNTDVF--IAMELMGTCAEK-LKKRMQGPIPERILGKMTVAIVKALYYLKEKHG- 145
Query: 555 PIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPE-----WLK 609
+IH D+KP NILLD K+ DFG+S L+ D ++ + G Y+APE
Sbjct: 146 -VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA--GCAAYMAPERIDPPDPT 202
Query: 610 NAPVSAKVDVYSFGVMLLEI 629
+ DV+S G+ L+E+
Sbjct: 203 KPDYDIRADVWSLGISLVEL 222
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-27
Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 25/211 (11%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDR-------------LAQEREREFKSEVS 484
+LG G++G V K + A+K + + ++ E +E+S
Sbjct: 40 KVRKLGSGAYGEVLLCKEK-NGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEIS 98
Query: 485 AIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARG 544
+ H N+++L ++ LV EF G L I K D I +I G
Sbjct: 99 LLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSG 158
Query: 545 LVYLHE-GCNVPIIHCDIKPQNILL---DHYFSPKISDFGLSKLLLSDHSRTHTMIRGTR 600
+ YLH+ I+H DIKP+NILL + + KI DFGLS D+ + + GT
Sbjct: 159 ICYLHKHN----IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY-KLRDRL-GTA 212
Query: 601 GYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC 631
Y+APE LK + K DV+S GV++ ++C
Sbjct: 213 YYIAPEVLKK-KYNEKCDVWSCGVIMYILLC 242
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 70/291 (24%), Positives = 120/291 (41%), Gaps = 62/291 (21%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLD-RLAQEREREFKSEVSAIGRTHHKNLVQLL 498
E +G G+ +V +A+K+++ Q E E+ A+ + HH N+V
Sbjct: 21 EVIGSGATAVVQAAYCAP-KKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYY 79
Query: 499 G--FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR--------ISLEIARGLVYL 548
+ L LV + + G++ ++I I + I E+ GL YL
Sbjct: 80 TSFVVKDEL--WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL 137
Query: 549 H-EGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLL-----LSDHSRTHTMIRGTRGY 602
H G IH D+K NILL S +I+DFG+S L ++ + T + GT +
Sbjct: 138 HKNG----QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV-GTPCW 192
Query: 603 VAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEME---LEEE-SRAILTDWAYDCYV 657
+APE ++ K D++SFG+ +E+ + + ++
Sbjct: 193 MAPEVMEQVRGYDFKADIWSFGITAIELA------TGAAPYHKYPPMKVLM--------- 237
Query: 658 EGRLDALIDSD-----EAAMADRSRLHKW-----LMIAMWCIQEDPSKRPT 698
L + E + D+ L K+ MI++ C+Q+DP KRPT
Sbjct: 238 ------LTLQNDPPSLETGVQDKEMLKKYGKSFRKMISL-CLQKDPEKRPT 281
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 52/204 (25%), Positives = 91/204 (44%), Gaps = 21/204 (10%)
Query: 440 EELGRGSFGIVYKG---VLKTASGNAIAVKKLD-RLAQERE--REFKSEVSAIGRTHHKN 493
E LG G V+ +AVK L LA++ F+ E +H
Sbjct: 18 EILGFGGMSEVHLARDLRD----HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 494 LVQLL--GFCDEALNRL--LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLH 549
+V + G + L +V E++ TL +++ + + + + L + H
Sbjct: 74 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 550 E-GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR-THT-MIRGTRGYVAPE 606
+ G IIH D+KP NI++ + K+ DFG+++ + + T T + GT Y++PE
Sbjct: 134 QNG----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 607 WLKNAPVSAKVDVYSFGVMLLEII 630
+ V A+ DVYS G +L E++
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVL 213
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 8e-27
Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 27/203 (13%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKS---EVSAIGRTHHKNLVQ 496
E+G GSFG VY + +A+KK+ ++ +++ EV + + H N +Q
Sbjct: 60 REIGHGSFGAVYFARDV-RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 118
Query: 497 LLG--FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR----ISLEIARGLVYLHE 550
G + LV E+ G+ ++L+ KP L+ ++ +GL YLH
Sbjct: 119 YRGCYLREHTA--WLVMEYCL-GSASDLLEVHKKP---LQEVEIAAVTHGALQGLAYLHS 172
Query: 551 GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPE---W 607
+IH D+K NILL K+ DFG + ++ + ++ + GT ++APE
Sbjct: 173 H---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANSFV-GTPYWMAPEVILA 224
Query: 608 LKNAPVSAKVDVYSFGVMLLEII 630
+ KVDV+S G+ +E+
Sbjct: 225 MDEGQYDGKVDVWSLGITCIELA 247
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 37/211 (17%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDR--------LAQEREREFKSEVSAIGRT 489
+ LG G+ G V + + +A+K + + + ++E+ + +
Sbjct: 14 MSKTLGSGACGEVKLAFER-KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72
Query: 490 HHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLV--- 546
+H ++++ F D + +V E M G L + + R+ +
Sbjct: 73 NHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVG--------NKRLKEATCKLYFYQM 123
Query: 547 -----YLHEGCNVPIIHCDIKPQNILLDHYFSP---KISDFGLSKLLLSDHSRTHTMIRG 598
YLHE IIH D+KP+N+LL KI+DFG SK +L + S T+ G
Sbjct: 124 LLAVQYLHE-NG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSK-ILGETSLMRTLC-G 178
Query: 599 TRGYVAPEWLKN---APVSAKVDVYSFGVML 626
T Y+APE L + A + VD +S GV+L
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 47/195 (24%), Positives = 78/195 (40%), Gaps = 13/195 (6%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLD-RLAQE---REREFKSEVSAIGRTHHKNLV 495
+GRG G VY+ T +A+K + L+ + R R + E GR ++V
Sbjct: 40 RLVGRGGMGDVYEAE-DTVRERIVALKLMSETLSSDPVFRTR-MQREARTAGRLQEPHVV 97
Query: 496 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHE-GCNV 554
+ F + + + LA ++ V I +I L H G
Sbjct: 98 PIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG--- 154
Query: 555 PIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHT-MIRGTRGYVAPEWLKNAPV 613
H D+KP+NIL+ + DFG++ +D T GT Y+APE +
Sbjct: 155 -ATHRDVKPENILVSADDFAYLVDFGIAS-ATTDEKLTQLGNTVGTLYYMAPERFSESHA 212
Query: 614 SAKVDVYSFGVMLLE 628
+ + D+Y+ +L E
Sbjct: 213 TYRADIYALTCVLYE 227
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 51/198 (25%), Positives = 84/198 (42%), Gaps = 22/198 (11%)
Query: 439 KEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGR-THHKNLVQL 497
K+ LG G G V + + +G A+K L + R+ EV + + ++V +
Sbjct: 34 KQVLGLGVNGKVLECFHR-RTGQKCALKLLYDSPKARQ-----EVDHHWQASGGPHIVCI 87
Query: 498 LGFCDEALNR----LLVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEIARGLVYLHEG 551
L + + L++ E M G L + I + R I +I + +LH
Sbjct: 88 LDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS- 146
Query: 552 CNVPIIHCDIKPQNILL---DHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWL 608
N I H D+KP+N+L + K++DFG +K + T T YVAPE L
Sbjct: 147 HN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNALQTPC-YTPYYVAPEVL 201
Query: 609 KNAPVSAKVDVYSFGVML 626
D++S GV++
Sbjct: 202 GPEKYDKSCDMWSLGVIM 219
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-26
Identities = 67/222 (30%), Positives = 106/222 (47%), Gaps = 19/222 (8%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKL--DRLAQEREREF-KSEVSAIGRTHHKNLVQLL 498
LGRG FG V+ A+G A KKL RL + + + E + + H + +V L
Sbjct: 193 LGRGGFGEVF-ACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 499 GFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNL---RVRI-SLEIARGLVYLHEGCN 553
+ E L LV M G + I+ + + + R + +I GL +LH+
Sbjct: 252 -YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN- 309
Query: 554 VPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPV 613
II+ D+KP+N+LLD + +ISD GL+ L + ++T GT G++APE L
Sbjct: 310 --IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLLGEEY 366
Query: 614 SAKVDVYSFGVMLLEIICCR-----RSVEMELEEESRAILTD 650
VD ++ GV L E+I R R ++E +E + +L
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ 408
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 51/206 (24%), Positives = 90/206 (43%), Gaps = 25/206 (12%)
Query: 439 KEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGR-THHKNLVQL 497
++ LG G+ V + + AVK +++ EV + + H+N+++L
Sbjct: 18 EDVLGEGAHARVQTCINL-ITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEIARGLVYLHE-GCNV 554
+ F +E LV+E M G++ + I + +N + ++A L +LH G
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHI--HKRRHFNELEASVVVQDVASALDFLHNKG--- 131
Query: 555 PIIHCDIKPQNILLDHYFSP---KISDFGLSKLLLSDHSRTHTMIR------GTRGYVAP 605
I H D+KP+NIL +H KI DF L + + + G+ Y+AP
Sbjct: 132 -IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190
Query: 606 EWLKNAPVSAK-----VDVYSFGVML 626
E ++ A D++S GV+L
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 43/332 (12%), Positives = 89/332 (26%), Gaps = 84/332 (25%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVK---KLDRLAQEREREFKSEVSAIGRTHH----- 491
LG+ + +G + V +R ++ K EV +
Sbjct: 84 TVLGQEDPYAYLEAT-DQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQK 142
Query: 492 -----------KNLVQLLGFCD-----------EALNRLLVYEFMGN------GTLANLI 523
+LV+ L+R +Y M + L +
Sbjct: 143 QAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHS 202
Query: 524 FAIPKPDWNLRVRISLEIARGLVYLHE-GCNVPIIHCDIKPQNILLDHYFSPKISDFGLS 582
+ R++++L++ R L LH G ++H ++P +I+LD ++ F
Sbjct: 203 STHKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHL 258
Query: 583 KLLLSDHSRTHTMIRGTRGYVAPEWLKNAP-----VSAKVDVYSFGVMLLEIICCRRSVE 637
+ A L ++ D ++ G+ + I C
Sbjct: 259 VRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC------ 312
Query: 638 MELEEESRAILTDWAYDCYVEGRL----DALIDSDEAAMADRSRLHKWLM-IAMWCIQED 692
L DA + E + + + + ++
Sbjct: 313 ---------------------ADLPNTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYP 351
Query: 693 PSKRPTMKVVM-----QMLEGLLEVPNPPWSS 719
R M + L L P + +
Sbjct: 352 KEDRLLPLQAMETPEYEQLRTELSAALPLYQT 383
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-25
Identities = 52/199 (26%), Positives = 82/199 (41%), Gaps = 21/199 (10%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGR-THHKNLVQ 496
+ LG G G V + K + A+K L + R EV R + ++V+
Sbjct: 66 TSQVLGLGINGKVLQIFNK-RTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVR 119
Query: 497 LLGFCDEALNR----LLVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEIARGLVYLHE 550
++ + L+V E + G L + I + R I I + YLH
Sbjct: 120 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 179
Query: 551 GCNVPIIHCDIKPQNILLDHYF--SP-KISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEW 607
N I H D+KP+N+L + K++DFG +K + H+ T T YVAPE
Sbjct: 180 -IN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSHNSLTTPC-YTPYYVAPEV 234
Query: 608 LKNAPVSAKVDVYSFGVML 626
L D++S GV++
Sbjct: 235 LGPEKYDKSCDMWSLGVIM 253
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 8e-25
Identities = 47/205 (22%), Positives = 81/205 (39%), Gaps = 26/205 (12%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKL----DRLAQEREREFKSEVSAIGRTHHKNLV 495
+ G G +Y + + +G + +K L D AQ +E + H ++V
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAM---AMAERQFLAEVVHPSIV 142
Query: 496 QLLGFCDEALNRL-----LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHE 550
Q+ F + +V E++G +L K + LEI L YLH
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHS 200
Query: 551 GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHT-MIRGTRGYVAPEWLK 609
+ +++ D+KP+NI+L K+ D G + + GT G+ APE ++
Sbjct: 201 ---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI------NSFGYLYGTPGFQAPEIVR 250
Query: 610 NAPVSAKVDVYSFGVMLLEIICCRR 634
P A D+Y+ G L +
Sbjct: 251 TGPTVAT-DIYTVGRTLAALTLDLP 274
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 5e-24
Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 18/220 (8%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKL--DRLAQEREREF-KSEVSAIGRTHHKNLVQLL 498
LG+G FG V A+G A KKL R+ + + +E + + + + +V L
Sbjct: 192 LGKGGFGEVC-ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL- 249
Query: 499 GFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNL-RVRI-SLEIARGLVYLHEGCNVP 555
+ E + L LV M G L I+ + + + R + EI GL LH
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR---ER 306
Query: 556 IIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSA 615
I++ D+KP+NILLD + +ISD GL+ + + + GT GY+APE +KN +
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIKGRV-GTVGYMAPEVVKNERYTF 364
Query: 616 KVDVYSFGVMLLEIICCR-----RSVEMELEEESRAILTD 650
D ++ G +L E+I + R +++ EE R +
Sbjct: 365 SPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV 404
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-24
Identities = 58/244 (23%), Positives = 100/244 (40%), Gaps = 47/244 (19%)
Query: 415 DSTTSATNLRFFSYDELKDATDGFK--EELGRGSFGIVYKGVLKTASGNAIAVKK--LDR 470
+ + N + + + D F+ G+G+FG V G K+ +G ++A+KK D
Sbjct: 2 PGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKS-TGMSVAIKKVIQDP 60
Query: 471 LAQERE-REFKSEVSAIGRTHHKNLVQLL---------GFCDEALNRLLVYEFMGNGTLA 520
+ RE + + + HH N+VQL D LN +V E++ + TL
Sbjct: 61 RFRNRELQIMQD----LAVLHHPNIVQLQSYFYTLGERDRRDIYLN--VVMEYVPD-TLH 113
Query: 521 NLIFAIPKPDWNLRVRISLE--------IARGLVYLHEGCNVPIIHCDIKPQNILLDHYF 572
+ + +V + R + LH V + H DIKP N+L++
Sbjct: 114 RCC----RNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVN--- 165
Query: 573 SP-----KISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPV-SAKVDVYSFGVML 626
K+ DFG +K L + +R Y APE + + VD++S G +
Sbjct: 166 -EADGTLKLCDFGSAKKLSPSEPNVAYIC--SRYYRAPELIFGNQHYTTAVDIWSVGCIF 222
Query: 627 LEII 630
E++
Sbjct: 223 AEMM 226
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-23
Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 35/212 (16%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG 499
+ +G GSFG+VY+ L SG +A+KK+ Q++ + + E+ + + H N+V+L
Sbjct: 60 KVIGNGSFGVVYQAKLCD-SGELVAIKKV---LQDKRFKNR-ELQIMRKLDHCNIVRLRY 114
Query: 500 F--------CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLE--------IAR 543
F + LN LV +++ T+ + + + + + + R
Sbjct: 115 FFYSSGEKKDEVYLN--LVLDYVPE-TVYRVA----RHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 544 GLVYLHEGCNVPIIHCDIKPQNILLD-HYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGY 602
L Y+H + I H DIKPQN+LLD K+ DFG +K L+ + +R Y
Sbjct: 168 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYY 222
Query: 603 VAPEWLKNAPV-SAKVDVYSFGVMLLEIICCR 633
APE + A ++ +DV+S G +L E++ +
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 59/305 (19%), Positives = 105/305 (34%), Gaps = 59/305 (19%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDR------LAQEREREFKSEVS----AIGRT 489
LG+G FG V+ G + +A+K + R EV+
Sbjct: 37 PLLGKGGFGTVFAGH-RLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGG 95
Query: 490 HHKNLVQLLGFCDEALNRLLVYEFMGNGT-LANLIFAIPKPDWNLRVRISLEIARGLVYL 548
H +++LL + + +LV E L + I ++ + +
Sbjct: 96 GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHC 155
Query: 549 HEGCNVPIIHCDIKPQNILLD-HYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEW 607
H ++H DIK +NIL+D K+ DFG LL + GTR Y PEW
Sbjct: 156 HSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD---GTRVYSPPEW 209
Query: 608 LKNAP-VSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALID 666
+ + V+S G++L +++C G + +
Sbjct: 210 ISRHQYHALPATVWSLGILLYDMVC---------------------------GDIP--FE 240
Query: 667 SDEAAMADRSRLHKWL------MIAMWCIQEDPSKRPTMKVVMQ---MLEGLLEVPNPPW 717
D+ + + +I C+ PS RP+++ ++ M +VP P
Sbjct: 241 RDQEILEAELHFPAHVSPDCCALIR-RCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPS 299
Query: 718 SSSFS 722
+
Sbjct: 300 KGGPA 304
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-23
Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 32/210 (15%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG 499
+ +G GSFG+V++ L + +A+KK+ Q++ + + E+ + H N+V L
Sbjct: 46 KVIGNGSFGVVFQAKLVE--SDEVAIKKV---LQDKRFKNR-ELQIMRIVKHPNVVDLKA 99
Query: 500 FCDEALNRL------LVYEFMGNGTLANLIFAIPKPDWNLRVRISLE--------IARGL 545
F ++ LV E++ T+ + L+ + + + R L
Sbjct: 100 FFYSNGDKKDEVFLNLVLEYVPE-TVYRAS----RHYAKLKQTMPMLLIKLYMYQLLRSL 154
Query: 546 VYLHEGCNVPIIHCDIKPQNILLD-HYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVA 604
Y+H ++ I H DIKPQN+LLD K+ DFG +K+L++ + +R Y A
Sbjct: 155 AYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC--SRYYRA 209
Query: 605 PEWLKNAPV-SAKVDVYSFGVMLLEIICCR 633
PE + A + +D++S G ++ E++ +
Sbjct: 210 PELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-23
Identities = 60/222 (27%), Positives = 98/222 (44%), Gaps = 22/222 (9%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKL--DRLAQEREREF-KSE---VSAIGRTHHKNLV 495
+GRG FG VY G K +G A+K L R+ ++ +E +S + +V
Sbjct: 197 IGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 496 QLLGFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRI-SLEIARGLVYLHEGCN 553
+ + ++L + + M G L + +R + EI GL ++H
Sbjct: 256 CM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-DMRFYAAEIILGLEHMHN--- 310
Query: 554 VPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWL-KNAP 612
+++ D+KP NILLD + +ISD GL+ + H + GT GY+APE L K
Sbjct: 311 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASV-GTHGYMAPEVLQKGVA 367
Query: 613 VSAKVDVYSFGVMLLEIIC----CRRSVEMELEEESRAILTD 650
+ D +S G ML +++ R+ + E R LT
Sbjct: 368 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 409
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 2e-22
Identities = 54/205 (26%), Positives = 97/205 (47%), Gaps = 22/205 (10%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQERE-------REFKSEVSAIGRTHHK 492
E+G G++G V+K G +A+K++ R+ E RE + + H
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAV-LRHLETFEHP 74
Query: 493 NLVQLL----GFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRV--RISLEIARGL 545
N+V+L + +L LV+E + + L + +P+P + ++ RGL
Sbjct: 75 NVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 133
Query: 546 VYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAP 605
+LH ++H D+KPQNIL+ K++DFGL+++ + T ++ T Y AP
Sbjct: 134 DFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAP 188
Query: 606 EWLKNAPVSAKVDVYSFGVMLLEII 630
E L + + VD++S G + E+
Sbjct: 189 EVLLQSSYATPVDLWSVGCIFAEMF 213
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 2e-22
Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 16/202 (7%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDR--------LAQEREREFKSEVSAIGRTHH 491
LG G+FG V+ V K + VK + + + + + E++ + R H
Sbjct: 30 SPLGSGAFGFVWTAVDKE-KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEH 88
Query: 492 KNLVQLLGFCDEALNRLLVYEFMGNGT-LANLIFAIPKPDWNLRVRISLEIARGLVYLHE 550
N++++L + LV E G+G L I P+ D L I ++ + YL
Sbjct: 89 ANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRL 148
Query: 551 GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKN 610
IIH DIK +NI++ F+ K+ DFG + L +T GT Y APE L
Sbjct: 149 KD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-LFYTFC-GTIEYCAPEVLMG 203
Query: 611 AP-VSAKVDVYSFGVMLLEIIC 631
P +++++S GV L ++
Sbjct: 204 NPYRGPELEMWSLGVTLYTLVF 225
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 26/207 (12%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLD--RLAQEREREF-KSEVSAIGRTHHKNL 494
F + LG GSF V + A+ A+K L+ + +E + + E + R H
Sbjct: 34 FGKILGEGSFSTVVL-ARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 495 VQLLG-FCDEALNRL-LVYEFMGNGTLANLI-----FAIPKPDWNLRVRI-SLEIARGLV 546
V+L F D+ +L + NG L I F R + EI L
Sbjct: 93 VKLYFTFQDD--EKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFYTAEIVSALE 144
Query: 547 YLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLL--LSDHSRTHTMIRGTRGYVA 604
YLH IIH D+KP+NILL+ +I+DFG +K+L S +R ++ + GT YV+
Sbjct: 145 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTAQYVS 200
Query: 605 PEWLKNAPVSAKVDVYSFGVMLLEIIC 631
PE L D+++ G ++ +++
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVA 227
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 60/297 (20%), Positives = 108/297 (36%), Gaps = 57/297 (19%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDR------LAQEREREFKSEVSAIGRTHHK- 492
LG G FG VY G+ + + +A+K +++ EV + +
Sbjct: 49 PLLGSGGFGSVYSGI-RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 107
Query: 493 -NLVQLLGFCDEALNRLLVYEF-MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHE 550
+++LL + + + +L+ E L + I L ++ + + H
Sbjct: 108 SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 167
Query: 551 GCNVPIIHCDIKPQNILLD-HYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLK 609
++H DIK +NIL+D + K+ DFG LL GTR Y PEW++
Sbjct: 168 CG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---GTRVYSPPEWIR 221
Query: 610 NAP-VSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSD 668
V+S G++L +++C G + + D
Sbjct: 222 YHRYHGRSAAVWSLGILLYDMVC---------------------------GDIP--FEHD 252
Query: 669 EAAMADRSRLHKWL------MIAMWCIQEDPSKRPTMKVVMQ---MLEGLLEVPNPP 716
E + + + + +I WC+ PS RPT + + M + LL
Sbjct: 253 EEIIRGQVFFRQRVSSECQHLIR-WCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 308
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 6e-22
Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 24/207 (11%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAI---------GRTH 490
E+G G++G VYK SG+ +A+K + R+ +S +
Sbjct: 15 AEIGVGAYGTVYKARDPH-SGHFVALKSV-RVPNGGGGGGGLPISTVREVALLRRLEAFE 72
Query: 491 HKNLVQLL----GFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRV--RISLEIAR 543
H N+V+L+ + ++ LV+E + + L + P P + + R
Sbjct: 73 HPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLR 131
Query: 544 GLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYV 603
GL +LH C I+H D+KP+NIL+ + K++DFGL+++ + T ++ T Y
Sbjct: 132 GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV--TLWYR 186
Query: 604 APEWLKNAPVSAKVDVYSFGVMLLEII 630
APE L + + VD++S G + E+
Sbjct: 187 APEVLLQSTYATPVDMWSVGCIFAEMF 213
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 6e-22
Identities = 51/197 (25%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKS----EVSAIGRTHHKNLV 495
++G GS+G+V+K + +G +A+KK +++ K E+ + + H NLV
Sbjct: 9 GKIGEGSYGVVFKCRNRD-TGQIVAIKKF-LESEDDP-VIKKIALREIRMLKQLKHPNLV 65
Query: 496 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRVRISLEIARGLVYLHEGCNV 554
LL LV+E+ + T+ + + + +L I+ + + + + H+
Sbjct: 66 NLLEVFRRKRRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN-- 122
Query: 555 PIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPV- 613
IH D+KP+NIL+ + K+ DFG ++ LL+ S + TR Y +PE L
Sbjct: 123 -CIHRDVKPENILITKHSVIKLCDFGFAR-LLTGPSDYYDDEVATRWYRSPELLVGDTQY 180
Query: 614 SAKVDVYSFGVMLLEII 630
VDV++ G + E++
Sbjct: 181 GPPVDVWAIGCVFAELL 197
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 7e-22
Identities = 57/197 (28%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKS----EVSAIGRTHHKNLV 495
+G GS+G+V K K +G +A+KK + + + K E+ + + H+NLV
Sbjct: 31 GLVGEGSYGMVMKCRNKD-TGRIVAIKKF-LESDDDK-MVKKIAMREIKLLKQLRHENLV 87
Query: 496 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRVRISLEIARGLVYLHEGCNV 554
LL C + LV+EF+ + T+ + + P D+ + + +I G+ + H
Sbjct: 88 NLLEVCKKKKRWYLVFEFV-DHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN-- 144
Query: 555 PIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPV- 613
IIH DIKP+NIL+ K+ DFG ++ L+ + TR Y APE L
Sbjct: 145 -IIHRDIKPENILVSQSGVVKLCDFGFAR-TLAAPGEVYDDEVATRWYRAPELLVGDVKY 202
Query: 614 SAKVDVYSFGVMLLEII 630
VDV++ G ++ E+
Sbjct: 203 GKAVDVWAIGCLVTEMF 219
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 7e-22
Identities = 56/232 (24%), Positives = 90/232 (38%), Gaps = 53/232 (22%)
Query: 439 KEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREF------------------- 479
K+E+G+GS+G+V A+K L + R+ F
Sbjct: 18 KDEIGKGSYGVVKLAY-NENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQP 76
Query: 480 -------KSEVSAIGRTHHKNLVQLLGFCDEALNRLL--VYEFMGNGTLANLIFAIPKPD 530
E++ + + H N+V+L+ D+ L V+E + G + +P
Sbjct: 77 RGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV----MEVPT-- 130
Query: 531 WNLRVRISLEIAR--------GLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLS 582
+S + AR G+ YLH IIH DIKP N+L+ KI+DFG+S
Sbjct: 131 ---LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVS 184
Query: 583 KLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVS---AKVDVYSFGVMLLEIIC 631
+ GT ++APE L +DV++ GV L +
Sbjct: 185 NEFKGSDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF 235
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 7e-22
Identities = 50/206 (24%), Positives = 95/206 (46%), Gaps = 24/206 (11%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQERE-------REFKSEVSAIGRTHHK 492
E++G G++G V+K + + +A+K++ RL + E RE + + HK
Sbjct: 8 EKIGEGTYGTVFKAKNRE-THEIVALKRV-RLDDDDEGVPSSALRE----ICLLKELKHK 61
Query: 493 NLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR-ISLEIARGLVYLHEG 551
N+V+L LV+EF + L + V+ ++ +GL + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 552 CNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR--THTMIRGTRGYVAPEWLK 609
++H D+KPQN+L++ K+++FGL++ R + ++ T Y P+ L
Sbjct: 121 N---VLHRDLKPQNLLINRNGELKLANFGLAR-AFGIPVRCYSAEVV--TLWYRPPDVLF 174
Query: 610 NAPV-SAKVDVYSFGVMLLEIICCRR 634
A + S +D++S G + E+ R
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 8e-22
Identities = 61/202 (30%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKL--DRLAQEREREF-KSEVSAIGRTHHKNLVQLL 498
LG+G+FG V V + A+G A+K L + + + E +E + + H L L
Sbjct: 156 LGKGTFGKVIL-VKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 499 GFCDEALNRL-LVYEFMGNGTLANLI-----FAIPKPDWNLRVRI-SLEIARGLVYLHEG 551
+ + +RL V E+ G L + F+ R R EI L YLH
Sbjct: 215 -YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED------RARFYGAEIVSALDYLHSE 267
Query: 552 CNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNA 611
N +++ D+K +N++LD KI+DFGL K + D + T GT Y+APE L++
Sbjct: 268 KN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEVLEDN 324
Query: 612 PVSAKVDVYSFGVMLLEIICCR 633
VD + GV++ E++C R
Sbjct: 325 DYGRAVDWWGLGVVMYEMMCGR 346
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 61/286 (21%), Positives = 119/286 (41%), Gaps = 36/286 (12%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDR--LAQEREREFKSEVSAIGRTHHKNLVQL 497
+ +G+G+F V +G +A+K +D+ L ++ EV + +H N+V+L
Sbjct: 21 KTIGKGNFAKVKLAR-HILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPII 557
+ L+ E+ G + + + A + +I + Y H+ I+
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IV 136
Query: 558 HCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAP-VSAK 616
H D+K +N+LLD + KI+DFG S + G Y APE + +
Sbjct: 137 HRDLKAENLLLDADMNIKIADFGFSNEFTVGG-KLDAFC-GAPPYAAPELFQGKKYDGPE 194
Query: 617 VDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDA---LIDSDEAAMA 673
VDV+S GV+L ++ + + ++ L + + G+ + S +
Sbjct: 195 VDVWSLGVILYTLVSGS----LPFDGQNLKEL----RERVLRGKYRIPFYM--STDC--- 241
Query: 674 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ---MLEGLLEVPNPP 716
+ L ++L++ +P KR T++ +M+ + G E P
Sbjct: 242 -ENLLKRFLVL-------NPIKRGTLEQIMKDRWINAGHEEDELKP 279
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 62/204 (30%), Positives = 95/204 (46%), Gaps = 29/204 (14%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDR--LAQEREREFKSEVSAIGRTHHKNLVQLLG 499
LG G++G V V + A+AVK +D E K E+ +H+N+V+ G
Sbjct: 15 LGEGAYGEVQLAV-NRVTEEAVAVKIVDMKRAVDCPEN-IKKEICINKMLNHENVVKFYG 72
Query: 500 FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIAR--------GLVYLHEG 551
E + L E+ G L + I + + A+ G+VYLH
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEP--------DIGMPEPDAQRFFHQLMAGVVYLH-- 122
Query: 552 CNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIR---GTRGYVAPEWL 608
+ I H DIKP+N+LLD + KISDFGL+ + ++ ++ GT YVAPE L
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLAT--VFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 609 KNAP-VSAKVDVYSFGVMLLEIIC 631
K + VDV+S G++L ++
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLA 203
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 63/202 (31%), Positives = 95/202 (47%), Gaps = 22/202 (10%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKL--DRLAQEREREF-KSEVSAIGRTHHKNLVQLL 498
LG+G+FG V V + A+G A+K L + + + E +E + T H L L
Sbjct: 13 LGKGTFGKVIL-VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 499 GFCDEALNRL-LVYEFMGNGTLANLI-----FAIPKPDWNLRVRI-SLEIARGLVYLHEG 551
+ + +RL V E+ G L + F R R EI L YLH
Sbjct: 72 -YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE------RARFYGAEIVSALEYLHS- 123
Query: 552 CNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNA 611
+++ DIK +N++LD KI+DFGL K +SD + T GT Y+APE L++
Sbjct: 124 --RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDN 180
Query: 612 PVSAKVDVYSFGVMLLEIICCR 633
VD + GV++ E++C R
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGR 202
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 59/202 (29%), Positives = 102/202 (50%), Gaps = 25/202 (12%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQERE-------REFKSEVSAIGRTHHK 492
E++G G++G+VYK G +A+K++ RL E E RE +S + HH
Sbjct: 27 EKVGEGTYGVVYKAKDSQ--GRIVALKRI-RLDAEDEGIPSTAIRE----ISLLKELHHP 79
Query: 493 NLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR-ISLEIARGLVYLHEG 551
N+V L+ LV+EFM L ++ + +++ ++ RG+ + H+
Sbjct: 80 NIVSLIDVIHSERCLTLVFEFM-EKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH 138
Query: 552 CNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR--THTMIRGTRGYVAPEWLK 609
I+H D+KPQN+L++ + K++DFGL++ R TH ++ T Y AP+ L
Sbjct: 139 R---ILHRDLKPQNLLINSDGALKLADFGLAR-AFGIPVRSYTHEVV--TLWYRAPDVLM 192
Query: 610 NAPV-SAKVDVYSFGVMLLEII 630
+ S VD++S G + E+I
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMI 214
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 93.3 bits (233), Expect = 3e-21
Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 21/200 (10%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQERE-------REFKSEVSAIGRTHHK 492
E++G G++G+VYK G A+KK+ RL +E E RE +S + H
Sbjct: 8 EKIGEGTYGVVYKAQNNY--GETFALKKI-RLEKEDEGIPSTTIRE----ISILKELKHS 60
Query: 493 NLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR-ISLEIARGLVYLHEG 551
N+V+L +LV+E + + L L+ ++ + L++ G+ Y H+
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 552 CNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNA 611
++H D+KPQN+L++ KI+DFGL++ R +T T Y AP+ L +
Sbjct: 120 R---VLHRDLKPQNLLINREGELKIADFGLAR-AFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 612 PV-SAKVDVYSFGVMLLEII 630
S +D++S G + E++
Sbjct: 176 KKYSTTIDIWSVGCIFAEMV 195
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 8e-21
Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 24/204 (11%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQERE-------REFKSEVSAIGRTHHK 492
+LG G++G VYK + + +A+K++ RL E E RE VS + H+
Sbjct: 40 TKLGEGTYGEVYKAIDTV-TNETVAIKRI-RLEHEEEGVPGTAIRE----VSLLKELQHR 93
Query: 493 NLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGC 552
N+++L L++E+ L + P + ++ G+ + H
Sbjct: 94 NIIELKSVIHHNHRLHLIFEYA-ENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR 152
Query: 553 NVPIIHCDIKPQNILLDHYFSP-----KISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEW 607
+H D+KPQN+LL + KI DFGL++ R T T Y PE
Sbjct: 153 ---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR-AFGIPIRQFTHEIITLWYRPPEI 208
Query: 608 LKNAPV-SAKVDVYSFGVMLLEII 630
L + S VD++S + E++
Sbjct: 209 LLGSRHYSTSVDIWSIACIWAEML 232
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 1e-20
Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 442 LGRGSFGIVY--KGVLKTASGNAIAVKKL--DRLAQEREREFKSEVSAIGRTHHKNLVQL 497
LG+GSFG V+ K + + + A+K L L K E + +H +V+L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 498 LGFCDEALNRL-LVYEFMGNGTLANLI-----FAIPKPDWNLRVRI-SLEIARGLVYLHE 550
+ + +L L+ +F+ G L + F V+ E+A L +LH
Sbjct: 92 H-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE------DVKFYLAELALALDHLHS 144
Query: 551 GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKN 610
+ II+ D+KP+NILLD K++DFGLSK + + ++ GT Y+APE +
Sbjct: 145 ---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPEVVNR 200
Query: 611 APVSAKVDVYSFGVMLLEIICCR 633
+ D +SFGV++ E++
Sbjct: 201 RGHTQSADWWSFGVLMFEMLTGT 223
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 62/203 (30%), Positives = 96/203 (47%), Gaps = 27/203 (13%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDR-LAQEREREFKSEVSAIGRTHHKNLVQLLGF 500
LG G++G V V + A+AVK +D A + K E+ +H+N+V+ G
Sbjct: 15 LGEGAYGEVQLAV-NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 501 CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIAR--------GLVYLHEGC 552
E + L E+ G L + I + + A+ G+VYLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEP--------DIGMPEPDAQRFFHQLMAGVVYLH--- 122
Query: 553 NVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIR---GTRGYVAPEWLK 609
+ I H DIKP+N+LLD + KISDFGL+ + ++ ++ GT YVAPE LK
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLAT--VFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 610 NAP-VSAKVDVYSFGVMLLEIIC 631
+ VDV+S G++L ++
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLA 203
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 56/203 (27%), Positives = 85/203 (41%), Gaps = 26/203 (12%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFC 501
+G G+FG+ + +AVK ++R A E + E+ H N+V+
Sbjct: 28 IGSGNFGVARLMR-DKLTKELVAVKYIERGAAIDEN-VQREIINHRSLRHPNIVRFKEVI 85
Query: 502 DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIAR--------GLVYLHEGCN 553
+ ++ E+ G L I R S + AR G+ Y H +
Sbjct: 86 LTPTHLAIIMEYASGGELYERICN--------AGRFSEDEARFFFQQLLSGVSYCH---S 134
Query: 554 VPIIHCDIKPQNILLDHYFSP--KISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNA 611
+ I H D+K +N LLD +P KI DFG SK HS+ + + GT Y+APE L
Sbjct: 135 MQICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTV-GTPAYIAPEVLLRQ 192
Query: 612 P-VSAKVDVYSFGVMLLEIICCR 633
DV+S GV L ++
Sbjct: 193 EYDGKIADVWSCGVTLYVMLVGA 215
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 4e-20
Identities = 53/202 (26%), Positives = 87/202 (43%), Gaps = 19/202 (9%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKL--DRLAQERERE-FKSEVSAIGRTHHKNLVQLL 498
+GRG+FG V V + A+K L + + E F+ E + K + L
Sbjct: 82 IGRGAFGEVAV-VKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH 140
Query: 499 G-FCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISL-EIARGLVYLHEGCNVP 555
F D+ N L LV ++ G L L+ R L E+ + +H +
Sbjct: 141 YAFQDD--NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLH 195
Query: 556 IIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS-RTHTMIRGTRGYVAPEWLKNAPVS 614
+H DIKP NIL+D +++DFG L+ D + ++ + GT Y++PE L+
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAMEGG 254
Query: 615 AK-----VDVYSFGVMLLEIIC 631
D +S GV + E++
Sbjct: 255 KGRYGPECDWWSLGVCMYEMLY 276
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 5e-20
Identities = 48/199 (24%), Positives = 87/199 (43%), Gaps = 23/199 (11%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQER-EREFKSEVSAIGR--THHKNLVQ 496
+LGRG + V++ + + + VK L + +++ +RE K I N++
Sbjct: 42 RKLGRGKYSEVFEAI-NITNNEKVVVKILKPVKKKKIKREIK-----ILENLRGGPNIIT 95
Query: 497 LLG-FCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISL-EIARGLVYLHEGCN 553
L D LV+E + N L + D +R + EI + L Y H
Sbjct: 96 LADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD----IRFYMYEILKALDYCHSMG- 150
Query: 554 VPIIHCDIKPQNILLDHYFSP-KISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAP 612
I+H D+KP N+++DH ++ D+GL++ + +R + PE L +
Sbjct: 151 --IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV--ASRYFKGPELLVDYQ 206
Query: 613 V-SAKVDVYSFGVMLLEII 630
+ +D++S G ML +I
Sbjct: 207 MYDYSLDMWSLGCMLASMI 225
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 6e-20
Identities = 68/221 (30%), Positives = 101/221 (45%), Gaps = 24/221 (10%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKL--DRLAQEREREF-KSEVSAIGR-THHKNLVQL 497
LG+GSFG V + + AVK L D + Q+ + E E + L QL
Sbjct: 28 LGKGSFGKVML-SERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 498 LGFCDEALNRL-LVYEFMGNGTL-----ANLIFAIPKPDWNLRVRI-SLEIARGLVYLHE 550
C + ++RL V E++ G L F P + EIA GL +L
Sbjct: 87 H-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP------HAVFYAAEIAIGLFFLQS 139
Query: 551 GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKN 610
II+ D+K N++LD KI+DFG+ K + D T T GT Y+APE +
Sbjct: 140 ---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPEIIAY 195
Query: 611 APVSAKVDVYSFGVMLLEIICCRRSVEMELEEE-SRAILTD 650
P VD ++FGV+L E++ + E E E+E ++I+
Sbjct: 196 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 236
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 8e-20
Identities = 57/209 (27%), Positives = 85/209 (40%), Gaps = 32/209 (15%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDR----LAQEREREFKSEVSAIGRTHHKNLVQL 497
LG GS+G V + + + + AVK L + E K E+ + R HKN++QL
Sbjct: 13 LGEGSYGKVKEVL-DSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 498 LG-FCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIAR--------GLVY 547
+ +E ++ +V E+ G + D R + A GL Y
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQE--ML-----DSVPEKRFPVCQAHGYFCQLIDGLEY 124
Query: 548 LHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIR---GTRGYVA 604
LH I+H DIKP N+LL + KIS G+++ L R G+ +
Sbjct: 125 LHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEAL--HPFAADDTCRTSQGSPAFQP 179
Query: 605 PEWLKNAPV--SAKVDVYSFGVMLLEIIC 631
PE KVD++S GV L I
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITT 208
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 8e-20
Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 28/207 (13%)
Query: 442 LGRGSFGIVY---KGVLKTASGNAIAVK---KLDRLAQEREREF-KSEVSAIGRTHHKNL 494
LG+G +G V+ K +G A+K K + ++ K+E + + H +
Sbjct: 25 LGKGGYGKVFQVRKVTGA-NTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 495 VQLLGFCDEALNRL-LVYEFMGNGTLANLI-----FAIPKPDWNLRVRI-SLEIARGLVY 547
V L+ + + +L L+ E++ G L + F EI+ L +
Sbjct: 84 VDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMED------TACFYLAEISMALGH 136
Query: 548 LHE-GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPE 606
LH+ G II+ D+KP+NI+L+H K++DFGL K + D + THT GT Y+APE
Sbjct: 137 LHQKG----IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC-GTIEYMAPE 191
Query: 607 WLKNAPVSAKVDVYSFGVMLLEIICCR 633
L + + VD +S G ++ +++
Sbjct: 192 ILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 92.0 bits (228), Expect = 2e-19
Identities = 68/221 (30%), Positives = 101/221 (45%), Gaps = 24/221 (10%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKL--DRLAQEREREF-KSEVSAIGR-THHKNLVQL 497
LG+GSFG V + + AVK L D + Q+ + E E + L QL
Sbjct: 349 LGKGSFGKVML-SERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 498 LGFCDEALNRL-LVYEFMGNGTL-----ANLIFAIPKPDWNLRVRI-SLEIARGLVYLHE 550
C + ++RL V E++ G L F P + EIA GL +L
Sbjct: 408 H-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP------HAVFYAAEIAIGLFFLQS 460
Query: 551 GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKN 610
II+ D+K N++LD KI+DFG+ K + D T T GT Y+APE +
Sbjct: 461 ---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPEIIAY 516
Query: 611 APVSAKVDVYSFGVMLLEIICCRRSVEMELEEE-SRAILTD 650
P VD ++FGV+L E++ + E E E+E ++I+
Sbjct: 517 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 557
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 3e-19
Identities = 57/203 (28%), Positives = 93/203 (45%), Gaps = 23/203 (11%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKL--DRLAQEREREF-KSEVSAIGR-THHKNLVQL 497
+GRGS+ V V + A+K + + + + + ++ ++E + ++H LV L
Sbjct: 17 IGRGSYAKVLL-VRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 498 LGFCDEALNRL-LVYEFMGNGTL-----ANLIFAIPKPDWNLRVRI-SLEIARGLVYLHE 550
C + +RL V E++ G L R S EI+ L YLHE
Sbjct: 76 H-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE------HARFYSAEISLALNYLHE 128
Query: 551 GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKN 610
II+ D+K N+LLD K++D+G+ K L T T GT Y+APE L+
Sbjct: 129 ---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPEILRG 184
Query: 611 APVSAKVDVYSFGVMLLEIICCR 633
VD ++ GV++ E++ R
Sbjct: 185 EDYGFSVDWWALGVLMFEMMAGR 207
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 26/202 (12%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNLVQLL 498
LG G+FG V G +G+ +AVK L+R + + + K E+ + H ++++L
Sbjct: 19 LGVGTFGKVKIGE-HQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 499 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIAR--------GLVYLHE 550
+ +V E++ G L + I R+ AR + Y H
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYICK--------HGRVEEMEARRLFQQILSAVDYCHR 129
Query: 551 GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKN 610
++H D+KP+N+LLD + + KI+DFGLS ++ T G+ Y APE +
Sbjct: 130 HM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRTSC-GSPNYAAPEVISG 184
Query: 611 AP-VSAKVDVYSFGVMLLEIIC 631
+VD++S GV+L ++C
Sbjct: 185 RLYAGPEVDIWSCGVILYALLC 206
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 4e-19
Identities = 73/222 (32%), Positives = 109/222 (49%), Gaps = 26/222 (11%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKL--DRLAQEREREF-KSE--VSAIGRTHHKNLVQ 496
LG+GSFG V +G+ AVK L D + Q+ + E +E + ++ +H L Q
Sbjct: 31 LGKGSFGKVML-ARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA-RNHPFLTQ 88
Query: 497 LLGFCDEALNRL-LVYEFMGNGTL-----ANLIFAIPKPDWNLRVRI-SLEIARGLVYLH 549
L C + +RL V EF+ G L + F R R + EI L++LH
Sbjct: 89 LF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA------RARFYAAEIISALMFLH 141
Query: 550 EGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLK 609
+ II+ D+K N+LLDH K++DFG+ K + + T T GT Y+APE L+
Sbjct: 142 DK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC-GTPDYIAPEILQ 197
Query: 610 NAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEE-SRAILTD 650
VD ++ GV+L E++C E E E++ AIL D
Sbjct: 198 EMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 239
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 4e-19
Identities = 64/203 (31%), Positives = 95/203 (46%), Gaps = 23/203 (11%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKL--DRLAQEREREF-KSEVSAIGR-THHKNLVQL 497
+G+GSFG V A AVK L + +++E + SE + + + H LV L
Sbjct: 46 IGKGSFGKVLL-ARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 498 LGFCDEALNRL-LVYEFMGNGTL-----ANLIFAIPKPDWNLRVRI-SLEIARGLVYLHE 550
F + ++L V +++ G L F P R R + EIA L YLH
Sbjct: 105 H-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEP------RARFYAAEIASALGYLHS 157
Query: 551 GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKN 610
+ I++ D+KP+NILLD ++DFGL K + +S T T GT Y+APE L
Sbjct: 158 ---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC-GTPEYLAPEVLHK 213
Query: 611 APVSAKVDVYSFGVMLLEIICCR 633
P VD + G +L E++
Sbjct: 214 QPYDRTVDWWCLGAVLYEMLYGL 236
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 4e-19
Identities = 54/210 (25%), Positives = 87/210 (41%), Gaps = 28/210 (13%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQERE--REFKSEVSAIGRT-------- 489
+ GS+G V GV G +A+K++ + R
Sbjct: 28 RFISSGSYGAVCAGVDSE--GIPVAIKRVFNTVSDGRTVNILSDSFLCK-RVLREIRLLN 84
Query: 490 --HHKNLVQLLG----FCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISL-EI 541
HH N++ L F + A+++L LV E M LA +I ++ + I
Sbjct: 85 HFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHI 143
Query: 542 ARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRG 601
GL LHE ++H D+ P NILL I DF L++ +D ++TH + R
Sbjct: 144 LLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT--HRW 198
Query: 602 YVAPEWLKNAPV-SAKVDVYSFGVMLLEII 630
Y APE + + VD++S G ++ E+
Sbjct: 199 YRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 5e-19
Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 23/203 (11%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKL--DRLAQEREREF-KSEVSAIGR-THHKNLVQL 497
+GRGS+ V V + A++ + + + + + ++ ++E + ++H LV L
Sbjct: 60 IGRGSYAKVLL-VRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 498 LGFCDEALNRL-LVYEFMGNGTL-----ANLIFAIPKPDWNLRVRI-SLEIARGLVYLHE 550
C + +RL V E++ G L R S EI+ L YLHE
Sbjct: 119 H-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE------HARFYSAEISLALNYLHE 171
Query: 551 GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKN 610
II+ D+K N+LLD K++D+G+ K L T T GT Y+APE L+
Sbjct: 172 ---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPEILRG 227
Query: 611 APVSAKVDVYSFGVMLLEIICCR 633
VD ++ GV++ E++ R
Sbjct: 228 EDYGFSVDWWALGVLMFEMMAGR 250
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 7e-19
Identities = 50/239 (20%), Positives = 93/239 (38%), Gaps = 63/239 (26%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG 499
+ LG GSFGIV + SG A+KK+ + + + RE + H N+++L+
Sbjct: 13 KTLGTGSFGIVCEVFD-IESGKRFALKKVLQDPRYKNRELD----IMKVLDHVNIIKLVD 67
Query: 500 FCDEALNRL--------------------------------------LVYEFMGNGTLAN 521
+ + ++ E++ + TL
Sbjct: 68 YFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHK 126
Query: 522 LIFAIPKPDWNLRVRISLE--------IARGLVYLHEGCNVPIIHCDIKPQNILLD-HYF 572
++ K I + + R + ++H + H DIKPQN+L++
Sbjct: 127 VL----KSFIRSGRSIPMNLISIYIYQLFRAVGFIH-SLGI--CHRDIKPQNLLVNSKDN 179
Query: 573 SPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPV-SAKVDVYSFGVMLLEII 630
+ K+ DFG +K L+ + +R Y APE + A + +D++S G + E+I
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAYIC--SRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 35/206 (16%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRT----------HH 491
+G G+ GIV +A+KKL R F+++ A R +H
Sbjct: 33 IGSGAQGIVCA-AYDAILERNVAIKKLSRP-------FQNQTHAK-RAYRELVLMKCVNH 83
Query: 492 KNLVQLL-----GFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISL-EIARG 544
KN++ LL E + +V E M ANL I + R+ L ++ G
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCG 139
Query: 545 LVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVA 604
+ +LH IIH D+KP NI++ + KI DFGL++ + T ++ TR Y A
Sbjct: 140 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRA 194
Query: 605 PEWLKNAPVSAKVDVYSFGVMLLEII 630
PE + VD++S G ++ E+I
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMI 220
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 57/204 (27%), Positives = 103/204 (50%), Gaps = 24/204 (11%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKS----EVSAIGRTHHKNLV 495
E+LG G++ VYKG+ KT +G +A+K++ +L + E S E+S + H+N+V
Sbjct: 11 EKLGNGTYATVYKGLNKT-TGVYVALKEV-KL--DSEEGTPSTAIREISLMKELKHENIV 66
Query: 496 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRIS------LEIARGLVYLH 549
+L LV+EFM + L + + + + ++ ++ +GL + H
Sbjct: 67 RLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH 125
Query: 550 EGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR--THTMIRGTRGYVAPEW 607
E I+H D+KPQN+L++ K+ DFGL++ + ++ T Y AP+
Sbjct: 126 ENK---ILHRDLKPQNLLINKRGQLKLGDFGLAR-AFGIPVNTFSSEVV--TLWYRAPDV 179
Query: 608 LKNAPV-SAKVDVYSFGVMLLEII 630
L + S +D++S G +L E+I
Sbjct: 180 LMGSRTYSTSIDIWSCGCILAEMI 203
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-18
Identities = 66/222 (29%), Positives = 100/222 (45%), Gaps = 26/222 (11%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKL--DRLAQERERE-FKSE--VSAIGRTHHKNLVQ 496
LG+GSFG V+ + A+K L D + + + E E V ++ H L
Sbjct: 25 LGKGSFGKVFL-AEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLTH 82
Query: 497 LLGFCDEALNRL-LVYEFMGNGTLANLI-----FAIPKPDWNLRVRI-SLEIARGLVYLH 549
+ + L V E++ G L I F + R + EI GL +LH
Sbjct: 83 MF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS------RATFYAAEIILGLQFLH 135
Query: 550 EGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLK 609
I++ D+K NILLD KI+DFG+ K + ++T+T GT Y+APE L
Sbjct: 136 S---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILL 191
Query: 610 NAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEE-SRAILTD 650
+ VD +SFGV+L E++ + + EEE +I D
Sbjct: 192 GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD 233
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 19/201 (9%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQERERE--FKS----EVSAIGRTHHKN 493
+ LG G F VYK K + +A+KK+ +L E + E+ + H N
Sbjct: 16 DFLGEGQFATVYKARDKN-TNQIVAIKKI-KLGHRSEAKDGINRTALREIKLLQELSHPN 73
Query: 494 LVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR-ISLEIARGLVYLHEGC 552
++ LL N LV++FM L +I ++ L +GL YLH+
Sbjct: 74 IIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 132
Query: 553 NVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR--THTMIRGTRGYVAPEWLKN 610
I+H D+KP N+LLD K++DFGL+K +R TH ++ TR Y APE L
Sbjct: 133 ---ILHRDLKPNNLLLDENGVLKLADFGLAK-SFGSPNRAYTHQVV--TRWYRAPELLFG 186
Query: 611 APV-SAKVDVYSFGVMLLEII 630
A + VD+++ G +L E++
Sbjct: 187 ARMYGVGVDMWAVGCILAELL 207
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 60/207 (28%), Positives = 94/207 (45%), Gaps = 28/207 (13%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNLVQLL 498
+G+GSFG V V K + A+K +++ + + R E+ + H LV L
Sbjct: 23 IGKGSFGKVCI-VQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 499 G-FCDEALNRL-LVYEFMGNGTLANLI-----FAIPKPDWNLRVRISL-EIARGLVYLHE 550
F DE + +V + + G L + F V++ + E+ L YL
Sbjct: 82 YSFQDE--EDMFMVVDLLLGGDLRYHLQQNVHFKEE------TVKLFICELVMALDYLQN 133
Query: 551 GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKN 610
IIH D+KP NILLD + I+DF ++ +L ++ TM GT+ Y+APE +
Sbjct: 134 ---QRIIHRDMKPDNILLDEHGHVHITDFNIAA-MLPRETQITTMA-GTKPYMAPEMFSS 188
Query: 611 APV---SAKVDVYSFGVMLLEIICCRR 634
S VD +S GV E++ RR
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-18
Identities = 55/210 (26%), Positives = 86/210 (40%), Gaps = 33/210 (15%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKL--DRLAQERERE-FKSEVSAIGRTHHKNLVQLL 498
+GRG+F V V +G A+K + + + E F+ E + + + QL
Sbjct: 69 IGRGAFSEVAV-VKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127
Query: 499 GFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIAR--------GLVYLH 549
F + N L LV E+ G L L+ RI E+AR + +H
Sbjct: 128 -FAFQDENYLYLVMEYYVGGDLLTLLS-------KFGERIPAEMARFYLAEIVMAIDSVH 179
Query: 550 EGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS-RTHTMIRGTRGYVAPEWL 608
+ +H DIKP NILLD +++DFG L +D + R+ + GT Y++PE L
Sbjct: 180 R---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEIL 235
Query: 609 KNAPVSAKVDVY-------SFGVMLLEIIC 631
+ Y + GV E+
Sbjct: 236 QAVGGGPGTGSYGPECDWWALGVFAYEMFY 265
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 44/199 (22%), Positives = 72/199 (36%), Gaps = 42/199 (21%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGR-THHKNLVQ 496
+ LG G G V + K + A+K L + R EV R + ++V+
Sbjct: 22 TSQVLGLGINGKVLQIFNK-RTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVR 75
Query: 497 LLGFCDEALNR----LLVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEIARGLVYLHE 550
++ + L+V E + G L + I + R I I + YLH
Sbjct: 76 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 135
Query: 551 GCNVPIIHCDIKPQNILLDHYF--SP-KISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEW 607
N I H D+KP+N+L + K++DFG +K Y
Sbjct: 136 -IN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG------------EKY----- 175
Query: 608 LKNAPVSAKVDVYSFGVML 626
D++S GV++
Sbjct: 176 ------DKSCDMWSLGVIM 188
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-18
Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 15/197 (7%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKS----EVSAIGRTHHKNLV 495
++LG G++ VYKG K + N +A+K++ RL E E EVS + H N+V
Sbjct: 8 DKLGEGTYATVYKGKSKL-TDNLVALKEI-RL--EHEEGAPCTAIREVSLLKDLKHANIV 63
Query: 496 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRVRISLEIARGLVYLHEGCNV 554
L + LV+E++ + L + + + ++ RGL Y H
Sbjct: 64 TLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK-- 120
Query: 555 PIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPV- 613
++H D+KPQN+L++ K++DFGL++ S ++T+ T Y P+ L +
Sbjct: 121 -VLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYDNEVVTLWYRPPDILLGSTDY 178
Query: 614 SAKVDVYSFGVMLLEII 630
S ++D++ G + E+
Sbjct: 179 STQIDMWGVGCIFYEMA 195
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 3e-18
Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 24/203 (11%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNLVQLL 498
+GRG+FG V V ++ A+K L + + + F E + + +VQL
Sbjct: 77 IGRGAFGEVQL-VRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135
Query: 499 G-FCDEALNRL-LVYEFMGNGTLANLI--FAIPKPDWNLRVRI-SLEIARGLVYLHEGCN 553
F D+ L +V E+M G L NL+ + +P+ R + E+ L +H
Sbjct: 136 YAFQDD--RYLYMVMEYMPGGDLVNLMSNYDVPEK----WARFYTAEVVLALDAIHS--- 186
Query: 554 VPIIHCDIKPQNILLDHYFSPKISDFGLSK-LLLSDHSRTHTMIRGTRGYVAPEWLKNAP 612
+ IH D+KP N+LLD K++DFG + R T + GT Y++PE LK+
Sbjct: 187 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQG 245
Query: 613 VSAK----VDVYSFGVMLLEIIC 631
D +S GV L E++
Sbjct: 246 GDGYYGRECDWWSVGVFLYEMLV 268
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 6e-18
Identities = 57/201 (28%), Positives = 101/201 (50%), Gaps = 27/201 (13%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKL--DRLAQERERE-FKSEVSAIGRTHHKNLVQLL 498
LG GSFG V+ + +G A+K L + + + ++ E E + H ++++
Sbjct: 14 LGTGSFGRVHL-IRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 72
Query: 499 G-FCDEALNRL-LVYEFMGNGTLANLI-----FAIPKPDWNLRVRI-SLEIARGLVYLHE 550
G F D ++ ++ +++ G L +L+ F P + + E+ L YLH
Sbjct: 73 GTFQDA--QQIFMIMDYIEGGELFSLLRKSQRFPNP------VAKFYAAEVCLALEYLHS 124
Query: 551 GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKN 610
+ II+ D+KP+NILLD KI+DFG +K T+T+ GT Y+APE +
Sbjct: 125 -KD--IIYRDLKPENILLDKNGHIKITDFGFAKY---VPDVTYTLC-GTPDYIAPEVVST 177
Query: 611 APVSAKVDVYSFGVMLLEIIC 631
P + +D +SFG+++ E++
Sbjct: 178 KPYNKSIDWWSFGILIYEMLA 198
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 6e-18
Identities = 52/202 (25%), Positives = 91/202 (45%), Gaps = 27/202 (13%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNLVQLL 498
LG GSFG V + +A+K + R + + E+S + H ++++L
Sbjct: 17 LGEGSFGKVKLAT-HYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 499 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIAR--------GLVYLHE 550
+ ++V E+ G G L + I + R++ + R + Y H
Sbjct: 76 DVITTPTDIVMVIEYAG-GELFDYIVE--------KKRMTEDEGRRFFQQIICAIEYCHR 126
Query: 551 GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKN 610
I+H D+KP+N+LLD + KI+DFGLS ++ + T G+ Y APE +
Sbjct: 127 HK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-FLKTSC-GSPNYAAPEVING 181
Query: 611 AP-VSAKVDVYSFGVMLLEIIC 631
+VDV+S G++L ++
Sbjct: 182 KLYAGPEVDVWSCGIVLYVMLV 203
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 9e-18
Identities = 38/281 (13%), Positives = 78/281 (27%), Gaps = 51/281 (18%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLD---RLAQEREREFKSEVSAIGRTHHKNLVQ 496
G ++ + TA +A+ +D L + +E S + R + +
Sbjct: 37 IFHGGVPPLQFWQAL-DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 497 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPI 556
+L L+V E++ G+L + P P +R +A H +
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVG--AIRAMQSLAAAADAAHR---AGV 150
Query: 557 IHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAK 616
P + +S G L + + +
Sbjct: 151 ALSIDHPSRVR--------VSIDGDVVL-------------AYPATM-------PDANPQ 182
Query: 617 VDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVE-GRLDALIDSDEAAMADR 675
D+ G L ++ R + A +E +D I +A
Sbjct: 183 DDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISA---- 238
Query: 676 SRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNPP 716
+A +Q D R ++ +++ V +
Sbjct: 239 --------VAARSVQGDGGIRSASTLL-NLMQQATAVADRT 270
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 54/199 (27%), Positives = 95/199 (47%), Gaps = 23/199 (11%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKL--DRLAQERERE-FKSEVSAIGRTHHKNLVQLL 498
LG GSFG V V SGN A+K L ++ + ++ E +E + + LV+L
Sbjct: 49 LGTGSFGRVML-VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 499 GFCDEALNRLLVYEFMGNGTLANLI-----FAIPKPDWNLRVRI-SLEIARGLVYLHEGC 552
+ N +V E++ G + + + F+ P R + +I YLH
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP------HARFYAAQIVLTFEYLHS-L 160
Query: 553 NVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAP 612
+ +I+ D+KP+N+L+D +++DFG +K RT T+ GT +APE + +
Sbjct: 161 D--LIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWTL-CGTPEALAPEIILSKG 214
Query: 613 VSAKVDVYSFGVMLLEIIC 631
+ VD ++ GV++ E+
Sbjct: 215 YNKAVDWWALGVLIYEMAA 233
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 1e-17
Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 27/204 (13%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDR------LAQEREREFKSEVSAIGRTHHKN 493
+ +G G+ GIV +A+KKL R A+ RE + +HKN
Sbjct: 68 KPIGSGAQGIVCA-AYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV----LMKCVNHKN 122
Query: 494 LVQLL-----GFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISL-EIARGLV 546
++ LL E + LV E M ANL I + R+ L ++ G+
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIK 178
Query: 547 YLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPE 606
+LH IIH D+KP NI++ + KI DFGL++ + T ++ TR Y APE
Sbjct: 179 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPE 233
Query: 607 WLKNAPVSAKVDVYSFGVMLLEII 630
+ VD++S G ++ E++
Sbjct: 234 VILGMGYKENVDIWSVGCIMGEMV 257
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 1e-17
Identities = 54/202 (26%), Positives = 96/202 (47%), Gaps = 26/202 (12%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNLVQLL 498
LG G+FG V G +G+ +AVK L+R + + + + E+ + H ++++L
Sbjct: 24 LGVGTFGKVKVGK-HELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 499 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIAR--------GLVYLHE 550
+ +V E++ G L + I R+ + +R G+ Y H
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYICK--------NGRLDEKESRRLFQQILSGVDYCHR 134
Query: 551 GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKN 610
++H D+KP+N+LLD + + KI+DFGLS ++ T G+ Y APE +
Sbjct: 135 HM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRTSC-GSPNYAAPEVISG 189
Query: 611 AP-VSAKVDVYSFGVMLLEIIC 631
+VD++S GV+L ++C
Sbjct: 190 RLYAGPEVDIWSSGVILYALLC 211
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 3e-17
Identities = 57/219 (26%), Positives = 90/219 (41%), Gaps = 42/219 (19%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVK-----KLDRLAQEREREFKSEVSAIGRTHH--- 491
+LG G F V+ + +A+K K+ A E E + V+ T
Sbjct: 25 RKLGWGHFSTVWL-AKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 492 --KNLVQLLG---FCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIAR-- 543
++++LL + +V+E +G NL+ I K I L +
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVLG----ENLLALIKK---YEHRGIPLIYVKQI 136
Query: 544 ------GLVYLHEGCNVPIIHCDIKPQNILLDHYFSP------KISDFGLSKLLLSDHSR 591
GL Y+H C IIH DIKP+N+L++ SP KI+D G + +
Sbjct: 137 SKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CWYDE 190
Query: 592 THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEII 630
+T TR Y +PE L AP D++S ++ E+I
Sbjct: 191 HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELI 229
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 4e-17
Identities = 49/213 (23%), Positives = 97/213 (45%), Gaps = 34/213 (15%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKS----EVSAIGRTHHKNLV 495
++G+G+FG V+K + +G +A+KK+ + E+E F E+ + H+N+V
Sbjct: 23 AKIGQGTFGEVFKARHRK-TGQKVALKKV-LMENEKE-GFPITALREIKILQLLKHENVV 79
Query: 496 QLLGFCDEALNRL--------LVYEFMGN---GTLANLIFAIPKPDWNLRVR-ISLEIAR 543
L+ C + LV++F + G L+N++ + ++ + +
Sbjct: 80 NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE----IKRVMQMLLN 135
Query: 544 GLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLL---LSDHSR--THTMIRG 598
GL Y+H I+H D+K N+L+ K++DFGL++ + T+ ++
Sbjct: 136 GLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV-- 190
Query: 599 TRGYVAPEWLKNAPV-SAKVDVYSFGVMLLEII 630
T Y PE L +D++ G ++ E+
Sbjct: 191 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMW 223
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 40/215 (18%)
Query: 442 LGRGSFGIVY--KGVLKTASGNAIAVKKL--DRLAQER--------EREFKSEVSAIGRT 489
LG G++G V+ + + +G A+K L + Q+ ER+ +
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR----- 116
Query: 490 HHKNLVQLLGFCDEALNRL-LVYEFMGNGTLANLI-----FAIPKPDWNLRVRI-SLEIA 542
LV L + + +L L+ +++ G L + F V+I EI
Sbjct: 117 QSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEH------EVQIYVGEIV 169
Query: 543 RGLVYLHE-GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH-SRTHTMIRGTR 600
L +LH+ G II+ DIK +NILLD ++DFGLSK ++D R + GT
Sbjct: 170 LALEHLHKLG----IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTI 224
Query: 601 GYVAPEWLKNAPV--SAKVDVYSFGVMLLEIICCR 633
Y+AP+ ++ VD +S GV++ E++
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 23/204 (11%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDR-----LAQEREREFKSEVSAIGRTHHKNL 494
+G G++G+V + +A+KK+ Q RE K + R H+N+
Sbjct: 33 SYIGEGAYGMVCS-AYDNLNKVRVAIKKISPFEHQTYCQRTLREIK----ILLRFRHENI 87
Query: 495 VQLLG-FCDEALNRL----LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLH 549
+ + + ++ +V + M L L+ + ++ +I RGL Y+H
Sbjct: 88 IGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICY-FLYQILRGLKYIH 145
Query: 550 EGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIR--GTRGYVAPEW 607
++H D+KP N+LL+ KI DFGL+++ DH T + TR Y APE
Sbjct: 146 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 608 LKNAPV-SAKVDVYSFGVMLLEII 630
+ N+ + +D++S G +L E++
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEML 226
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 52/217 (23%), Positives = 98/217 (45%), Gaps = 34/217 (15%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKL----DRLAQEREREFKSEVSAIGRTHHKNLV 495
+ LG G G+V+ V +A+KK+ + + RE K I R H N+V
Sbjct: 17 KPLGCGGNGLVFSAV-DNDCDKRVAIKKIVLTDPQSVKHALREIK----IIRRLDHDNIV 71
Query: 496 QLL-------------GFCDEALNRL-LVYEFMGNGT-LANLIFAIPKPDWNLRVRISLE 540
++ LN + +V E+M T LAN++ P + + R+ +
Sbjct: 72 KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME--TDLANVLEQGPLLEEHARL-FMYQ 128
Query: 541 IARGLVYLHEGCNVPIIHCDIKPQNILLDHYF-SPKISDFGLSKLLLSDHSRTHTMIR-- 597
+ RGL Y+H ++H D+KP N+ ++ KI DFGL++++ +S +
Sbjct: 129 LLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGL 185
Query: 598 GTRGYVAPEWLKNAPV-SAKVDVYSFGVMLLEIICCR 633
T+ Y +P L + + +D+++ G + E++ +
Sbjct: 186 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 51/205 (24%), Positives = 93/205 (45%), Gaps = 30/205 (14%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDR------LAQEREREFKSEVSAIGRTHHKN 493
+G G++G V + SG +A+KKL R A+ RE + H+N
Sbjct: 30 THVGSGAYGSVCS-AIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELL----LLKHMQHEN 84
Query: 494 LVQLL-----GFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISL-EIARGLV 546
++ LL LV FM L ++ + +++ + ++ +GL
Sbjct: 85 VIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEE---KIQYLVYQMLKGLK 140
Query: 547 YLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPE 606
Y+H ++H D+KP N+ ++ KI DFGL++ +D T ++ TR Y APE
Sbjct: 141 YIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTGYVV--TRWYRAPE 193
Query: 607 WLKNAPV-SAKVDVYSFGVMLLEII 630
+ + + VD++S G ++ E++
Sbjct: 194 VILSWMHYNQTVDIWSVGCIMAEML 218
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 48/218 (22%), Positives = 89/218 (40%), Gaps = 39/218 (17%)
Query: 439 KEELGRGSFGIVYKGVLK-TASGNAIAVKKLDRLAQEREREFKSEVSAIGRT------HH 491
++GRG++G VYK K A+K++ +SA H
Sbjct: 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQI--------EGTGISMSACREIALLRELKH 77
Query: 492 KNLVQLLG-FCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVR---------ISLE 540
N++ L F A ++ L++++ + L ++I N + + +
Sbjct: 78 PNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 136
Query: 541 IARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSP----KISDFGLSKLLLSDHSRTHTMI 596
I G+ YLH ++H D+KP NIL+ KI+D G ++ L + + +
Sbjct: 137 ILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR-LFNSPLKPLADL 192
Query: 597 RG---TRGYVAPEWLKNAPV-SAKVDVYSFGVMLLEII 630
T Y APE L A + +D+++ G + E++
Sbjct: 193 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 230
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 3e-15
Identities = 51/239 (21%), Positives = 87/239 (36%), Gaps = 70/239 (29%)
Query: 439 KEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRT--------- 489
K +GRGS+G VY + +A+KK++R+ F+ + R
Sbjct: 31 KHLIGRGSYGYVYL-AYDKNTEKNVAIKKVNRM-------FEDLIDCK-RILREITILNR 81
Query: 490 -HHKNLVQLLG-FCDEALNRL----LVYEFMGNGTLANLIFAIPKPDWNLRVRISLE--- 540
+++L + L + +V E + L L + I L
Sbjct: 82 LKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLF----------KTPIFLTEEH 130
Query: 541 -------IARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH 593
+ G ++HE IIH D+KP N LL+ S K+ DFGL++ + S+
Sbjct: 131 IKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNI 187
Query: 594 TMIRG---------------------TRGYVAPEWLKNAPV-SAKVDVYSFGVMLLEII 630
TR Y APE + + +D++S G + E++
Sbjct: 188 VNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 5e-15
Identities = 50/208 (24%), Positives = 80/208 (38%), Gaps = 36/208 (17%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVK-----KLDRLAQEREREFKSEVSAIGRTHHKNL 494
+ +G+GSFG V K +A+K K E + + + N+
Sbjct: 103 KVIGKGSFGQVVK-AYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 495 VQLLGFCD---------EALNRLLVYEFMGNGTLANLIFAIPKPDWNLRV--RISLEIAR 543
+ +L E L+ L YE + +L + + + I +
Sbjct: 162 IHMLENFTFRNHICMTFELLSMNL-YELIKKNKFQGF---------SLPLVRKFAHSILQ 211
Query: 544 GLVYLHEGCNVPIIHCDIKPQNILLDHYFSP--KISDFGLSKLLLSDHSRTHTMIRGTRG 601
L LH+ IIHCD+KP+NILL K+ DFG S + +R
Sbjct: 212 CLDALHK-NR--IIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVYTYIQSRF 264
Query: 602 YVAPEWLKNAPVSAKVDVYSFGVMLLEI 629
Y APE + A +D++S G +L E+
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAEL 292
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 6e-15
Identities = 47/245 (19%), Positives = 86/245 (35%), Gaps = 77/245 (31%)
Query: 439 KEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRT--------- 489
+ +G GS+G V + +A+KK+ R F+ + R
Sbjct: 58 RHLIGTGSYGHVCE-AYDKLEKRVVAIKKILR-------VFEDLIDCK-RILREIAILNR 108
Query: 490 -HHKNLVQLLGFC----DEALNRL-LVYEFMGNGT-LANLIFAIPKPDWNLRVRISLE-- 540
+H ++V++L E + L +V E + L R + L
Sbjct: 109 LNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD--SDFKKLF----------RTPVYLTEL 156
Query: 541 --------IARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592
+ G+ Y+H + +H D+KP N L++ S K+ DFGL++ + +
Sbjct: 157 HIKTLLYNLLVGVKYVHSA-GI--LHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGN 213
Query: 593 HTMIRG--------------------------TRGYVAPEWLKNAPV-SAKVDVYSFGVM 625
+ TR Y APE + + +DV+S G +
Sbjct: 214 SQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCI 273
Query: 626 LLEII 630
E++
Sbjct: 274 FAELL 278
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 7e-15
Identities = 49/218 (22%), Positives = 89/218 (40%), Gaps = 40/218 (18%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRT-------- 489
K LG G++G+V +G +A+KK+ F + A+ RT
Sbjct: 15 LKSLLGEGAYGVVCS-ATHKPTGEIVAIKKI--------EPFDKPLFAL-RTLREIKILK 64
Query: 490 --HHKNLVQLLG-FCDEALNRL----LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIA 542
H+N++ + ++ ++ E M L +I D +++ +
Sbjct: 65 HFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQY-FIYQTL 122
Query: 543 RGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRG---- 598
R + LH +IH D+KP N+L++ K+ DFGL++++ +
Sbjct: 123 RAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 599 -----TRGYVAPEWLKNAPV-SAKVDVYSFGVMLLEII 630
TR Y APE + + S +DV+S G +L E+
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 61/231 (26%), Positives = 105/231 (45%), Gaps = 50/231 (21%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDR------LAQE--RE----REFKSEVSA 485
++LG+G++GIV+K + +G +AVKK+ AQ RE E
Sbjct: 13 LVKKLGKGAYGIVWK-SIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELS----- 66
Query: 486 IGRTHHKNLVQLLG-FCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIAR 543
H+N+V LL + + LV+++M L +I A + + + ++ +
Sbjct: 67 ----GHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQY-VVYQLIK 120
Query: 544 GLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRG----- 598
+ YLH G + +H D+KP NILL+ K++DFGLS+ ++ T+ +
Sbjct: 121 VIKYLHSG-GL--LHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 599 ---------------TRGYVAPEWLKNAPV-SAKVDVYSFGVMLLEIICCR 633
TR Y APE L + + +D++S G +L EI+C +
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 27/204 (13%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDR------LAQEREREFKSEVSAIGRTHHKN 493
+ +G G++G V + +G +A+KKL R A+ RE + + H+N
Sbjct: 31 QPVGSGAYGAVCS-AVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR----LLKHMRHEN 85
Query: 494 LVQLL-----GFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVY 547
++ LL + LV FMG L L+ + ++ + ++ +GL Y
Sbjct: 86 VIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQF-LVYQMLKGLRY 143
Query: 548 LHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEW 607
+H IIH D+KP N+ ++ KI DFGL++ S+ T TR Y APE
Sbjct: 144 IHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRAPEV 196
Query: 608 LKNAPV-SAKVDVYSFGVMLLEII 630
+ N + VD++S G ++ E+I
Sbjct: 197 ILNWMRYTQTVDIWSVGCIMAEMI 220
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 50/208 (24%), Positives = 80/208 (38%), Gaps = 36/208 (17%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVK-----KLDRLAQEREREFKSEVSAIGRTHHKNL 494
+G+GSFG V K +A+K K + E ++ +
Sbjct: 60 SLIGKGSFGQVVK-AYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYI 118
Query: 495 VQLLGF-------CDEALNRLLVYEFMGNGTLANLIFAIPKPDWN----LRVR-ISLEIA 542
V L C LV+E + NL + ++ R + ++
Sbjct: 119 VHLKRHFMFRNHLC-------LVFEMLS----YNLYDLLRNTNFRGVSLNLTRKFAQQMC 167
Query: 543 RGLVYLHEGCNVPIIHCDIKPQNILLDHYFSP--KISDFGLSKLLLSDHSRTHTMIRGTR 600
L++L + IIHCD+KP+NILL + KI DFG S + +R
Sbjct: 168 TALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS----CQLGQRIYQYIQSR 222
Query: 601 GYVAPEWLKNAPVSAKVDVYSFGVMLLE 628
Y +PE L P +D++S G +L+E
Sbjct: 223 FYRSPEVLLGMPYDLAIDMWSLGCILVE 250
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-14
Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 35/208 (16%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRT---------- 489
+G G++G V T +G +AVKKL R F+S + A RT
Sbjct: 35 SPVGSGAYGSVCA-AFDTKTGLRVAVKKLSRP-------FQSIIHAK-RTYRELRLLKHM 85
Query: 490 HHKNLVQLL-----GFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIAR 543
H+N++ LL E N + LV MG L N++ D +++ + +I R
Sbjct: 86 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQF-LIYQILR 143
Query: 544 GLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYV 603
GL Y+H IIH D+KP N+ ++ KI DFGL++ + + TR Y
Sbjct: 144 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVA----TRWYR 196
Query: 604 APEWLKNAPV-SAKVDVYSFGVMLLEII 630
APE + N + VD++S G ++ E++
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELL 224
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 69.6 bits (170), Expect = 7e-13
Identities = 47/184 (25%), Positives = 83/184 (45%), Gaps = 31/184 (16%)
Query: 535 VRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHT 594
+ S ++A+G+ +L IH D+ +NILL KI DFGL++ D +
Sbjct: 196 ICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPD 248
Query: 595 MIRGTRGYV-----APEWLKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMELEEESRAI 647
+R + APE + + + + DV+SFGV+L EI S ++++EE
Sbjct: 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 308
Query: 648 LTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLE 707
L + R+ A + +++ M+ W +PS+RPT +++ L
Sbjct: 309 LKE-------GTRMRAPDYTTP-------EMYQ-TMLDCW--HGEPSQRPTFSELVEHLG 351
Query: 708 GLLE 711
LL+
Sbjct: 352 NLLQ 355
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 7e-10
Identities = 43/153 (28%), Positives = 60/153 (39%), Gaps = 14/153 (9%)
Query: 438 FKEELGRGSFGIVYKGVL----KTASGNAIAVKKLDRLAQERER-EFKSEVS-AIGRTHH 491
+ LGRG+FG V + KTA+ +AVK L A E SE+ I HH
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85
Query: 492 KNLVQLLGFCDEALNRLLV-YEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHE 550
N+V LLG C + L+V EF G L+ + + R +G +
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-------RSKRNEFVPYKTKGARFRQG 138
Query: 551 GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSK 583
V I D+K + + S S F K
Sbjct: 139 KDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 61.8 bits (149), Expect = 2e-10
Identities = 33/250 (13%), Positives = 64/250 (25%), Gaps = 66/250 (26%)
Query: 434 ATDGFK--EELGRGSFGIVYKGVLKTASGNAIAVKKL--------DRLAQEREREFKSEV 483
T+ + E++G G FG V++ + +A+K + + Q+ E E+
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIAD---HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74
Query: 484 ---------SAIGRTHHKNLVQLL------GFCDEAL----------------------- 505
S + + L G L
Sbjct: 75 IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134
Query: 506 NRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQN 565
++L + G + I ++ L H D+ N
Sbjct: 135 DQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGN 192
Query: 566 ILLDHYFSPKISDFGLSKLL----------LSDHSRTHTMIRGTRGY---VAPEWLKNAP 612
+LL K+ K + D++ + G + E L
Sbjct: 193 VLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGD 252
Query: 613 VSAKVDVYSF 622
+ D+Y
Sbjct: 253 GDYQFDIYRL 262
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 6e-10
Identities = 52/251 (20%), Positives = 78/251 (31%), Gaps = 70/251 (27%)
Query: 442 LGRGSFGIVYKGVLKTASGNAIAVK-----KLDRLAQEREREFKSEVSAIGRTH--HKNL 494
LG G F V+ +A+K + E V + +
Sbjct: 45 LGWGHFSTVWL-SWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 495 VQLLG-FCDEALN---RLLVYEFMGNGTLANLIFAIPKPDWNLRV--RISLEIARGLVYL 548
VQLL F +N +V+E +G+ L I L +I ++ +GL YL
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYL 162
Query: 549 HEGCNVPIIHCDIKPQNILL---------------------------------------- 568
H C IIH DIKP+NILL
Sbjct: 163 HTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNF 220
Query: 569 ---------DHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDV 619
KI+D G + + + TR Y + E L + + D+
Sbjct: 221 LVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ----TRQYRSLEVLIGSGYNTPADI 276
Query: 620 YSFGVMLLEII 630
+S M E+
Sbjct: 277 WSTACMAFELA 287
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 8e-10
Identities = 45/224 (20%), Positives = 79/224 (35%), Gaps = 52/224 (23%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVK-----KLDRLAQEREREFKSEVSAIGRTHHKNL 494
LG G+FG V + + + +A+K R A E ++ + +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC 84
Query: 495 VQLLGFCD---------EALNRLLVYEFMGNGTLANLIFAIPKPDWNLRV--RISLEIAR 543
V + + + E L + +EF+ L ++ ++
Sbjct: 85 VLMSDWFNFHGHMCIAFELLGKNT-FEFLKENNFQPY---------PLPHVRHMAYQLCH 134
Query: 544 GLVYLHEGCNVPIIHCDIKPQNILLDHYFSP-------------------KISDFGLSKL 584
L +LHE + H D+KP+NIL + +++DFG +
Sbjct: 135 ALRFLHE-NQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA-- 189
Query: 585 LLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLE 628
+ HT I TR Y PE + + DV+S G +L E
Sbjct: 190 --TFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFE 231
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 34/118 (28%), Positives = 49/118 (41%), Gaps = 32/118 (27%)
Query: 536 RISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSP--------------------- 574
+EI + L YL + + + H D+KP+NILLD +
Sbjct: 141 LYCIEILKALNYLRK-MS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197
Query: 575 ----KISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLE 628
K+ DFG + + S H I TR Y APE + N D++SFG +L E
Sbjct: 198 STGIKLIDFGCA----TFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 41/204 (20%), Positives = 86/204 (42%), Gaps = 24/204 (11%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVK--KLDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
+G GSFG++++G + +A+K A + E+++ G T + +
Sbjct: 16 RRIGEGSFGVIFEGT-NLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTG---IPNV 71
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEIARGLVYLHEGCNVP 555
F E L+ +LV + +G +L +L + ++++ + ++ + +HE
Sbjct: 72 YYFGQEGLHNVLVIDLLGP-SLEDL-LDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--- 126
Query: 556 IIHCDIKPQNILLDHYFSPK-----ISDFGLSKLLLSDHSRTHTMIR------GTRGYVA 604
+++ DIKP N L+ S + DFG+ K ++ H R GT Y++
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 186
Query: 605 PEWLKNAPVSAKVDVYSFGVMLLE 628
S + D+ + G + +
Sbjct: 187 INTHLGREQSRRDDLEALGHVFMY 210
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 8e-09
Identities = 53/224 (23%), Positives = 86/224 (38%), Gaps = 52/224 (23%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVK-----KLDRLAQEREREFKSEVSAIGRTHHKNL 494
+ LG G+FG V + + A G +AVK A E + ++
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRC 79
Query: 495 VQLLGFCD---------EALNRLLVYEFM-GNGTLANLIFAIPKPDWNLRVR-ISLEIAR 543
VQ+L + + E L Y+F+ NG L F + +R ++ +I +
Sbjct: 80 VQMLEWFEHHGHICIVFELLGLST-YDFIKENGFLP---FRLD------HIRKMAYQICK 129
Query: 544 GLVYLHEGCNVPIIHCDIKPQNILLDHYFSP-------------------KISDFGLSKL 584
+ +LH + H D+KP+NIL K+ DFG +
Sbjct: 130 SVNFLHS-NK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA-- 184
Query: 585 LLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLE 628
+ H+ + TR Y APE + S DV+S G +L+E
Sbjct: 185 --TYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIE 226
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 41/204 (20%), Positives = 87/204 (42%), Gaps = 24/204 (11%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVK--KLDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
+++G G+FG + G + +A+K + A + E++ + Q+
Sbjct: 15 KKIGCGNFGELRLGK-NLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDG---IPQV 70
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEIARGLVYLHEGCNVP 555
F +V E +G +L +L F + ++L+ + I++++ + Y+H +
Sbjct: 71 YYFGPCGKYNAMVLELLGP-SLEDL-FDLCDRTFSLKTVLMIAIQLISRMEYVH---SKN 125
Query: 556 IIHCDIKPQNILLDHYFSPK-----ISDFGLSKLLLSDHSRTHTMIR------GTRGYVA 604
+I+ D+KP+N L+ + I DF L+K + ++ H R GT Y++
Sbjct: 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMS 185
Query: 605 PEWLKNAPVSAKVDVYSFGVMLLE 628
S + D+ + G M +
Sbjct: 186 INTHLGKEQSRRDDLEALGHMFMY 209
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 45/204 (22%), Positives = 80/204 (39%), Gaps = 26/204 (12%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ----EREREFKSEVSAIGRTHHKNLV 495
++G GSFG +Y G A+G +A+K + E + + +
Sbjct: 15 RKIGSGSFGDIYLGT-DIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGG-----VGIP 68
Query: 496 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEIARGLVYLHEGCN 553
+ E ++V E +G +L +L F ++L+ + ++ ++ + Y+H
Sbjct: 69 TIRWCGAEGDYNVMVMELLGP-SLEDL-FNFCSRKFSLKTVLLLADQMISRIEYIHSKN- 125
Query: 554 VPIIHCDIKPQNILLDHYFSPK---ISDFGLSKLLLSDHSRTHTMIR------GTRGYVA 604
IH D+KP N L+ I DFGL+K + H R GT Y +
Sbjct: 126 --FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 183
Query: 605 PEWLKNAPVSAKVDVYSFGVMLLE 628
S + D+ S G +L+
Sbjct: 184 INTHLGIEQSRRDDLESLGYVLMY 207
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 33/171 (19%), Positives = 63/171 (36%), Gaps = 23/171 (13%)
Query: 442 LGRGSFGIVYKGV-LKTASGNAIAVKKLDRLAQER-EREFK-----SEVSAIGRTHHKNL 494
+G G FG++Y +A V K++ E K ++ I + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 495 VQLLGF----------CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARG 544
+ LG R +V E +G L + + +++ + +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKISGQNGTFKKSTVLQLGIRMLDV 163
Query: 545 LVYLHEGCNVPIIHCDIKPQNILLDHYFSPKI--SDFGLSKLLLSDHSRTH 593
L Y+HE +H DIK N+LL + ++ +D+GLS + +
Sbjct: 164 LEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQ 211
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 54.6 bits (131), Expect = 7e-08
Identities = 42/204 (20%), Positives = 79/204 (38%), Gaps = 26/204 (12%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ----EREREFKSEVSAIGRTHHKNLV 495
++G GSFG +Y G + +A+K + + E + + +
Sbjct: 13 RKIGSGSFGEIYLGT-NIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGG-----TGIP 66
Query: 496 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEIARGLVYLHEGCN 553
+ F E +LV + +G +L +L + +L+ + ++ ++ + ++H
Sbjct: 67 NVRWFGVEGDYNVLVMDLLGP-SLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHS--- 121
Query: 554 VPIIHCDIKPQNILLDHYFSPK---ISDFGLSKLLLSDHSRTHTMIR------GTRGYVA 604
+H DIKP N L+ I DFGL+K + H R GT Y +
Sbjct: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181
Query: 605 PEWLKNAPVSAKVDVYSFGVMLLE 628
S + D+ S G +L+
Sbjct: 182 VNTHLGIEQSRRDDLESLGYVLMY 205
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 39/224 (17%), Positives = 79/224 (35%), Gaps = 44/224 (19%)
Query: 442 LGRGSFGIVYKGVLKT----ASGNAIAVKKLDRLAQEREREFK-----SEVSAIGRTHHK 492
+G+G FG +Y + + S VK E K ++ I +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 493 NLVQLLGFC----------DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR-------V 535
++ LG + R ++ + G+ L + + N + +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIY------EANAKRFSRKTVL 155
Query: 536 RISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKI--SDFGLSKLLLSDHSRTH 593
++SL I L Y+HE +H DIK N+LL++ ++ D+GL+ +
Sbjct: 156 QLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKA 212
Query: 594 ------TMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC 631
GT + + + S + D+ G +++ +
Sbjct: 213 YAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLT 256
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 9e-07
Identities = 31/164 (18%), Positives = 63/164 (38%), Gaps = 26/164 (15%)
Query: 442 LGRGSFGIVYKGV------LKTASGNAIAVKKLD----RLAQER---EREFKSEVSAIGR 488
R + GI+Y+ + KLD RL E+ +R K +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 489 THHKNLV----QLLGF-CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEI 541
+ + +GF + R LV +G +L + + PK + R ++++ +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHVLSERSVLQVACRL 168
Query: 542 ARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKI--SDFGLSK 583
L +LHE +H ++ +NI +D ++ + +G +
Sbjct: 169 LDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 728 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.84 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.72 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.53 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.45 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.43 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.41 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.38 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.37 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.32 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.31 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.23 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.16 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.16 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.11 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.05 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.98 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.92 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.89 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.88 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.88 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.86 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 98.86 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.77 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 98.74 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.73 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 98.68 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.68 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 98.63 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 98.57 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.37 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.2 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.11 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.06 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.98 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.92 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.71 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.41 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.4 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.31 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.04 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.62 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.59 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.42 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.38 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.31 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.18 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.03 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.76 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.63 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.32 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 94.53 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 92.74 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 89.18 | |
| 1edm_B | 39 | Factor IX; epidermal growth factor, EGF, calcium- | 85.67 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 84.82 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 83.23 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-52 Score=437.96 Aligned_cols=256 Identities=26% Similarity=0.399 Sum_probs=206.3
Q ss_pred hHHhhhCCCceeEEEEeeeeC----CCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 437 GFKEELGRGSFGIVYKGVLKT----ASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
.+.++||+|+||.||+|.++. .+++.||||+++.......++|.+|+++|++++|||||+++|+|.+....+||||
T Consensus 44 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E 123 (329)
T 4aoj_A 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFE 123 (329)
T ss_dssp EEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 456789999999999998752 3578999999987777777899999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcC---------------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEc
Q 047292 513 FMGNGTLANLIFAI---------------PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKIS 577 (728)
Q Consensus 513 ~~~~gsL~~~l~~~---------------~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~ 577 (728)
|+++|+|.+++... ..+++.+++.|+.||++||+|||++ +||||||||+||||++++++||+
T Consensus 124 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki~ 200 (329)
T 4aoj_A 124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIG 200 (329)
T ss_dssp CCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEEC
T ss_pred cCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEEEc
Confidence 99999999999754 2588999999999999999999997 99999999999999999999999
Q ss_pred cccCccccccCCC-cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHh
Q 047292 578 DFGLSKLLLSDHS-RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDC 655 (728)
Q Consensus 578 Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 655 (728)
|||+++....... .......||+.|||||++.+..++.++|||||||+||||+| |+.||......+....+
T Consensus 201 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i------- 273 (329)
T 4aoj_A 201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI------- 273 (329)
T ss_dssp CCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH-------
T ss_pred ccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH-------
Confidence 9999987644332 23344679999999999999999999999999999999999 89999865443322111
Q ss_pred hhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 047292 656 YVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEV 712 (728)
Q Consensus 656 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 712 (728)
..+.-.. .+....+.+.+++.+||+.||++||||+||++.|+.+.+.
T Consensus 274 -~~g~~~~---------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 274 -TQGRELE---------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp -HHTCCCC---------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -HcCCCCC---------CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 1121111 1112335678899999999999999999999999998764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=437.60 Aligned_cols=262 Identities=24% Similarity=0.330 Sum_probs=213.9
Q ss_pred HHHHHHhhHHhhhCCCceeEEEEeeee----CCCCcEEEEEEecccch-hhHHHHHHHHHHhccccccceeeEeeeeecC
Q 047292 430 ELKDATDGFKEELGRGSFGIVYKGVLK----TASGNAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKNLVQLLGFCDEA 504 (728)
Q Consensus 430 el~~~~~~~~~~lg~G~fg~Vy~g~~~----~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 504 (728)
|+...+..|.++||+|+||+||+|.+. ..+++.||||+++.... ...++|.+|+.++++++|||||+++|+|.+.
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~ 101 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD 101 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence 444455667889999999999999874 23567899999975432 3457899999999999999999999999999
Q ss_pred CcceeEeeccCCCCHHHHHhcC----------------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEE
Q 047292 505 LNRLLVYEFMGNGTLANLIFAI----------------PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILL 568 (728)
Q Consensus 505 ~~~~lv~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll 568 (728)
...+|||||+++|+|.++|... ..+++..+++|+.|||+||+|||++ +||||||||+||||
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl 178 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLV 178 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEE
Confidence 9999999999999999999653 3578999999999999999999997 99999999999999
Q ss_pred cCCCceEEccccCccccccCC-CcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhh
Q 047292 569 DHYFSPKISDFGLSKLLLSDH-SRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRA 646 (728)
Q Consensus 569 ~~~~~~kl~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~ 646 (728)
++++++||+|||+++...... ........||+.|||||++.+..++.++|||||||+||||+| |+.||......+...
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~ 258 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 258 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999998764432 233345679999999999999999999999999999999999 889997655433221
Q ss_pred hHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 647 ILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
....+..... +......+.+++.+||+.||++||||+||++.|+....
T Consensus 259 --------~i~~~~~~~~---------p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n 306 (308)
T 4gt4_A 259 --------MIRNRQVLPC---------PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN 306 (308)
T ss_dssp --------HHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred --------HHHcCCCCCC---------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence 1122222111 12234567789999999999999999999999987654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-53 Score=436.25 Aligned_cols=257 Identities=25% Similarity=0.400 Sum_probs=212.4
Q ss_pred HhhHHhhhCCCceeEEEEeeeeC----CCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeE
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKT----ASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 510 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 510 (728)
.+.+.++||+|+||+||+|.+.. .++..||||+++.......++|.+|+++|++++|||||+++|+|.+.+..+||
T Consensus 14 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV 93 (299)
T 4asz_A 14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMV 93 (299)
T ss_dssp GEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 34466889999999999998752 35678999999887777778999999999999999999999999999999999
Q ss_pred eeccCCCCHHHHHhcC-------------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEc
Q 047292 511 YEFMGNGTLANLIFAI-------------PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKIS 577 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~-------------~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~ 577 (728)
|||+++|+|.++|... ..+++..++.|+.||++||+|||++ +||||||||+||||++++++||+
T Consensus 94 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~ 170 (299)
T 4asz_A 94 FEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIG 170 (299)
T ss_dssp EECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEEC
T ss_pred EEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEEC
Confidence 9999999999999753 3689999999999999999999997 99999999999999999999999
Q ss_pred cccCccccccCCC-cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHh
Q 047292 578 DFGLSKLLLSDHS-RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDC 655 (728)
Q Consensus 578 Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 655 (728)
|||+|+....... .......||+.|||||++.+..++.++|||||||+||||+| |+.||......+....
T Consensus 171 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~-------- 242 (299)
T 4asz_A 171 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC-------- 242 (299)
T ss_dssp CCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH--------
T ss_pred CcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--------
Confidence 9999987644332 22334568999999999999999999999999999999999 8999986554332211
Q ss_pred hhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 656 YVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 656 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
...+..... +......+.+++.+||+.||++||||++|++.|+++.+
T Consensus 243 i~~~~~~~~---------p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 243 ITQGRVLQR---------PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp HHHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHcCCCCCC---------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 122221111 11234567889999999999999999999999998654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-51 Score=425.66 Aligned_cols=255 Identities=25% Similarity=0.380 Sum_probs=199.7
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
..+.++||+|+||+||+|+++ ..||||+++.. ..+..+.|.+|+.++++++|||||+++|++.+ +..+|||||
T Consensus 38 l~l~~~iG~G~fG~Vy~~~~~----~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 38 VMLSTRIGSGSFGTVYKGKWH----GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp CCEEEECCCCSSSEEEEEESS----SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred eEEeeEEeeCCCcEEEEEEEC----CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 346688999999999999874 35999998643 33455789999999999999999999999865 568999999
Q ss_pred cCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCC-Cc
Q 047292 514 MGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH-SR 591 (728)
Q Consensus 514 ~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~-~~ 591 (728)
+++|+|.++|... ..+++..++.|+.||++||+|||++ +||||||||+||||++++++||+|||+|+...... ..
T Consensus 113 ~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 189 (307)
T 3omv_A 113 CEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189 (307)
T ss_dssp CSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence 9999999999765 5799999999999999999999997 99999999999999999999999999998764332 22
Q ss_pred ccccccCCccccCcccccC---CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccch
Q 047292 592 THTMIRGTRGYVAPEWLKN---APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSD 668 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~---~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 668 (728)
......||+.|||||++.+ .+|+.++|||||||+||||+||+.||.......... . ....+.....+.
T Consensus 190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~---~----~~~~~~~~p~~~-- 260 (307)
T 3omv_A 190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQII---F----MVGRGYASPDLS-- 260 (307)
T ss_dssp ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH---H----HHHTTCCCCCST--
T ss_pred eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHH---H----HHhcCCCCCCcc--
Confidence 3345679999999999964 468999999999999999999999997543322111 1 111111110000
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 047292 669 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710 (728)
Q Consensus 669 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 710 (728)
.........+.+++.+||+.||++||||.||++.|+.+.
T Consensus 261 ---~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 261 ---KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp ---TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred ---cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 111223456778999999999999999999999998654
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-50 Score=419.61 Aligned_cols=260 Identities=24% Similarity=0.259 Sum_probs=209.3
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCCC
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNG 517 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 517 (728)
+.++||+|+||.||+|..+ .+|+.||||+++... ...+|+.++++++|||||++++++.+....||||||+++|
T Consensus 62 ~~~~lG~G~fG~Vy~a~~~-~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg 135 (336)
T 4g3f_A 62 HQPRVGRGSFGEVHRMKDK-QTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGG 135 (336)
T ss_dssp EEEEEEEETTEEEEEEEET-TTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred eCcEeccCCCeEEEEEEEC-CCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence 4467999999999999876 578999999996532 2257999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCC-ceEEccccCccccccCCCc----c
Q 047292 518 TLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYF-SPKISDFGLSKLLLSDHSR----T 592 (728)
Q Consensus 518 sL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~~~~~----~ 592 (728)
+|.++|.....+++..+..++.||+.||+|||++ +||||||||+||||+.++ ++||+|||+|+....+... .
T Consensus 136 ~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~ 212 (336)
T 4g3f_A 136 SLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT 212 (336)
T ss_dssp BHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----------
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceec
Confidence 9999999888899999999999999999999997 999999999999999987 6999999999977543221 2
Q ss_pred cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAM 672 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 672 (728)
.....||+.|||||++.+..|+.++|||||||+||||+||+.||...........+. .+.. ....
T Consensus 213 ~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~--------~~~~-------~~~~ 277 (336)
T 4g3f_A 213 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA--------SEPP-------PIRE 277 (336)
T ss_dssp -CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHH--------HSCC-------GGGG
T ss_pred CCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH--------cCCC-------Cchh
Confidence 233579999999999999999999999999999999999999997654433221111 1110 0011
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC---CCCCCCCccc
Q 047292 673 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE---VPNPPWSSSF 721 (728)
Q Consensus 673 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~---~~~~~~~~~~ 721 (728)
.+......+.+++.+||+.||++|||+.|+++.|...+. .-.+||...+
T Consensus 278 ~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 278 IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred cCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence 122334567789999999999999999999999877542 3356765443
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-50 Score=420.28 Aligned_cols=248 Identities=25% Similarity=0.344 Sum_probs=207.2
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccC
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
+.+.++||+|+||.||+|..+ .+|+.||||+++.......+.+.+|+.+|++++|||||++++++.+.+..||||||++
T Consensus 76 y~~~~~iG~G~fG~V~~a~~~-~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~ 154 (346)
T 4fih_A 76 LDNFIKIGEGSTGIVCIATVR-SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 154 (346)
T ss_dssp EEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred cEEeEEeecCcCeEEEEEEEC-CCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCC
Confidence 345578999999999999876 5789999999976555555678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccccc
Q 047292 516 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM 595 (728)
Q Consensus 516 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 595 (728)
+|+|.+++.. ..+++..+..++.||+.||+|||++ +||||||||+||||++++++||+|||+|+.+..... ....
T Consensus 155 gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~ 229 (346)
T 4fih_A 155 GGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKS 229 (346)
T ss_dssp TEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CBCC
T ss_pred CCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-cccc
Confidence 9999999976 5689999999999999999999997 999999999999999999999999999987754432 2344
Q ss_pred ccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcH
Q 047292 596 IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADR 675 (728)
Q Consensus 596 ~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 675 (728)
..||+.|||||++.+..|+.++|||||||++|||++|+.||......+....+ ........ . ...
T Consensus 230 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i--------~~~~~~~~-~------~~~ 294 (346)
T 4fih_A 230 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI--------RDNLPPRL-K------NLH 294 (346)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--------HHSSCCCC-S------CGG
T ss_pred cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH--------HcCCCCCC-C------ccc
Confidence 67999999999999999999999999999999999999999865544322211 11110000 0 011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 676 SRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 676 ~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
.....+.+++.+||+.||++|||++|+++
T Consensus 295 ~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 295 KVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 22346778999999999999999999876
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=415.77 Aligned_cols=246 Identities=24% Similarity=0.299 Sum_probs=208.7
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
+.+.+.||+|+||+||++..+ .+++.||||++.... ....+.+.+|+++|++++|||||++++++.+.+..|||||
T Consensus 34 y~i~~~lG~G~fg~V~~a~~~-~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE 112 (311)
T 4aw0_A 34 FKFGKILGEGSFSTVVLAREL-ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 112 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cEEEEEEecccCeEEEEEEEC-CCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 567789999999999999876 578999999996532 2335789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC-c
Q 047292 513 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS-R 591 (728)
Q Consensus 513 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-~ 591 (728)
|+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+||||++++++||+|||+|+.+..... .
T Consensus 113 y~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~ 189 (311)
T 4aw0_A 113 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189 (311)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence 999999999999888999999999999999999999997 999999999999999999999999999998754332 2
Q ss_pred ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhh
Q 047292 592 THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAA 671 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 671 (728)
......||+.|||||++.+..|+.++|||||||+||||+||+.||......+....+ ..+... +
T Consensus 190 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i--------~~~~~~-~------- 253 (311)
T 4aw0_A 190 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKI--------IKLEYD-F------- 253 (311)
T ss_dssp CBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHTCCC-C-------
T ss_pred cccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------HcCCCC-C-------
Confidence 344567999999999999999999999999999999999999999866544332222 111110 1
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047292 672 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVM 703 (728)
Q Consensus 672 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl 703 (728)
+.....++.+++.+||+.||++|||++|++
T Consensus 254 --p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 254 --PEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp --CTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred --CcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 111234577899999999999999999864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=418.06 Aligned_cols=247 Identities=22% Similarity=0.321 Sum_probs=200.3
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
|.+.++||+|+||+||+|..+ .+++.||||+++.. .....+.+.+|++++++++|||||++++++.+.+..||||||
T Consensus 26 Y~~~~~lG~G~fg~V~~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy 104 (350)
T 4b9d_A 26 YVRLQKIGEGSFGKAILVKST-EDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY 104 (350)
T ss_dssp EEEEEEC------CEEEEEET-TTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eEEeEEEecCCCeEEEEEEEC-CCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 556788999999999999876 57899999999643 334457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 514 MGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 514 ~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
+++|+|.++|... ..+++..+..|+.||+.||+|||++ +||||||||+||||++++++||+|||+|+...... .
T Consensus 105 ~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~ 180 (350)
T 4b9d_A 105 CEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-E 180 (350)
T ss_dssp CTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-H
T ss_pred CCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCc-c
Confidence 9999999999754 3568889999999999999999997 99999999999999999999999999998764321 1
Q ss_pred ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhh
Q 047292 592 THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAA 671 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 671 (728)
......||+.|||||++.+..|+.++|||||||+||||+||+.||......+....+ ..+.....
T Consensus 181 ~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i--------~~~~~~~~------- 245 (350)
T 4b9d_A 181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI--------ISGSFPPV------- 245 (350)
T ss_dssp HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--------HHTCCCCC-------
T ss_pred cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH--------HcCCCCCC-------
Confidence 223457999999999999999999999999999999999999999866544322211 11221111
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 672 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 672 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
.......+.+++.+||+.||++|||++|+++
T Consensus 246 --~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 246 --SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1122346778999999999999999999986
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=407.26 Aligned_cols=246 Identities=28% Similarity=0.405 Sum_probs=197.5
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeeec----CCcceeEe
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDE----ALNRLLVY 511 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lv~ 511 (728)
+.++||+|+||.||+|.++ .+++.||+|++... .....+.|.+|++++++++|||||++++++.. ....+|||
T Consensus 30 ~~~~iG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 30 FDIEIGRGSFKTVYKGLDT-ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEECSSEEEEEEEET-TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred eeeEEecCcCcEEEEEEEC-CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 4567999999999999876 57889999999643 23445789999999999999999999999864 35579999
Q ss_pred eccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEc-CCCceEEccccCccccccCCC
Q 047292 512 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLD-HYFSPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 512 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~-~~~~~kl~Dfgla~~~~~~~~ 590 (728)
||+++|+|.+++.....+++..+..++.||+.||+|||++ +.+||||||||+||||+ +++++||+|||+|+.....
T Consensus 109 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~-- 185 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-- 185 (290)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT--
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC--
Confidence 9999999999999888999999999999999999999986 12399999999999998 4899999999999864332
Q ss_pred cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhh
Q 047292 591 RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEA 670 (728)
Q Consensus 591 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 670 (728)
......||+.|||||++.+ +|+.++|||||||+||||+||+.||........ .......+.....+
T Consensus 186 -~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~-------~~~~i~~~~~~~~~----- 251 (290)
T 3fpq_A 186 -FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-------IYRRVTSGVKPASF----- 251 (290)
T ss_dssp -SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-------HHHHHTTTCCCGGG-----
T ss_pred -ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH-------HHHHHHcCCCCCCC-----
Confidence 2345679999999999875 699999999999999999999999964322111 11111111111111
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 671 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 671 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
+....+++.+++.+||+.||++|||++|+++
T Consensus 252 ---~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 252 ---DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ---GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112235778999999999999999999975
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=422.45 Aligned_cols=263 Identities=26% Similarity=0.351 Sum_probs=210.6
Q ss_pred HHHHHhhHHhhhCCCceeEEEEeeeeCC----CCcEEEEEEecccch-hhHHHHHHHHHHhcccc-ccceeeEeeeeecC
Q 047292 431 LKDATDGFKEELGRGSFGIVYKGVLKTA----SGNAIAVKKLDRLAQ-EREREFKSEVSAIGRTH-HKNLVQLLGFCDEA 504 (728)
Q Consensus 431 l~~~~~~~~~~lg~G~fg~Vy~g~~~~~----~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~ 504 (728)
+....+.+.++||+|+||.||+|.+... .++.||||+++.... ...+.|.+|+++|.+++ |||||+++|+|.+.
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 3344566778999999999999987632 236899999976433 34578999999999995 59999999999664
Q ss_pred -CcceeEeeccCCCCHHHHHhcC----------------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEE
Q 047292 505 -LNRLLVYEFMGNGTLANLIFAI----------------PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNIL 567 (728)
Q Consensus 505 -~~~~lv~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIl 567 (728)
...+||||||++|+|.++|+.. ..+++..++.++.|||+||+|||++ +||||||||+|||
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NIL 217 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNIL 217 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCcccee
Confidence 5689999999999999999753 2478999999999999999999997 9999999999999
Q ss_pred EcCCCceEEccccCccccccCCCc-ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhh
Q 047292 568 LDHYFSPKISDFGLSKLLLSDHSR-THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESR 645 (728)
Q Consensus 568 l~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~ 645 (728)
+++++++||+|||+|+....+... ......||+.|||||++.+..|+.++|||||||+||||+| |+.||........
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~- 296 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE- 296 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-
T ss_pred eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH-
Confidence 999999999999999977544332 3344678999999999999999999999999999999998 8999975432211
Q ss_pred hhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 047292 646 AILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEV 712 (728)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 712 (728)
+ ......+..... +.....++.+++.+||+.||++||||+||++.|+.+++.
T Consensus 297 --~----~~~i~~g~~~~~---------p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 297 --F----CRRLKEGTRMRA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp --H----HHHHHHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --H----HHHHHcCCCCCC---------CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 1 111112211111 112234677899999999999999999999999987653
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=408.28 Aligned_cols=267 Identities=22% Similarity=0.280 Sum_probs=199.6
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCC----cceeEee
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEAL----NRLLVYE 512 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~lv~e 512 (728)
.+.++||+|+||+||+|++ +|+.||||+++.... ....+..|+..+.+++|||||+++|+|.+.. ..+||||
T Consensus 6 ~L~~~iG~G~fG~Vy~~~~---~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 6 VLQESIGKGRFGEVWRGKW---RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp EEEEEEEECSSSEEEEEEE---TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEeeCCCeEEEEEEE---CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 3557899999999999987 478999999975432 2233455777778899999999999997654 5799999
Q ss_pred ccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcC-----CCCeeecCCCCCCEEEcCCCceEEccccCcccccc
Q 047292 513 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGC-----NVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS 587 (728)
Q Consensus 513 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~-----~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 587 (728)
|+++|+|.++|... .+++..+.+++.|+++||+|||+++ ..+||||||||+||||++++++||+|||+|+....
T Consensus 82 y~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 160 (303)
T 3hmm_A 82 YHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp CCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred CCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccC
Confidence 99999999999764 6889999999999999999999852 45899999999999999999999999999987754
Q ss_pred CCCc---ccccccCCccccCcccccCC------CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhh-------hhHHHH
Q 047292 588 DHSR---THTMIRGTRGYVAPEWLKNA------PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESR-------AILTDW 651 (728)
Q Consensus 588 ~~~~---~~~~~~gt~~y~aPE~~~~~------~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~-------~~~~~~ 651 (728)
.... ......||+.|||||++.+. .++.++|||||||+||||+||+.|+......... ......
T Consensus 161 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~ 240 (303)
T 3hmm_A 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240 (303)
T ss_dssp TTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred CCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHH
Confidence 3322 22335699999999999765 4678999999999999999998776432211100 000001
Q ss_pred HHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 652 AYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 652 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
.........+...+. ......+....+.+++.+||+.||++||||.||+++|+++.+
T Consensus 241 ~~~~~~~~~~rp~~p---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 241 MRKVVCEQKLRPNIP---NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHHTTSCCCCCCC---GGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhcccCCCCCC---ccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 111111222111111 111233556678899999999999999999999999988654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=421.16 Aligned_cols=248 Identities=25% Similarity=0.341 Sum_probs=207.2
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccC
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
+.+.++||+|+||.||+|..+ .+|+.||||++........+.+.+|+.+|++++|||||++++++...+..||||||++
T Consensus 153 y~~~~~iG~G~fG~V~~a~~~-~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~ 231 (423)
T 4fie_A 153 LDNFIKIGEGSTGIVCIATVR-SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 231 (423)
T ss_dssp EEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred cEeeeEeccCcCcEEEEEEEC-CCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCC
Confidence 445678999999999999876 5789999999976555555678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccccc
Q 047292 516 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM 595 (728)
Q Consensus 516 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 595 (728)
+|+|.+++.. ..+++..+..++.||+.||+|||++ +||||||||+||||+.++++||+|||+|+.+..... ....
T Consensus 232 gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~ 306 (423)
T 4fie_A 232 GGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKS 306 (423)
T ss_dssp TEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-CBCC
T ss_pred CCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-cccc
Confidence 9999999875 4689999999999999999999997 999999999999999999999999999987754432 2345
Q ss_pred ccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcH
Q 047292 596 IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADR 675 (728)
Q Consensus 596 ~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 675 (728)
..||+.|||||++.+..|+.++|||||||++|||++|+.||...........+ .......+. ...
T Consensus 307 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i--------~~~~~~~~~-------~~~ 371 (423)
T 4fie_A 307 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI--------RDNLPPRLK-------NLH 371 (423)
T ss_dssp CEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--------HHSCCCCCS-------CTT
T ss_pred cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH--------HcCCCCCCc-------ccc
Confidence 67999999999999999999999999999999999999999865544322211 111100000 011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 676 SRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 676 ~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
.....+.+|+.+||+.||++|||++|+++
T Consensus 372 ~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 372 KVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp SSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 12346778999999999999999999986
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=396.74 Aligned_cols=245 Identities=24% Similarity=0.357 Sum_probs=192.5
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEe
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 511 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 511 (728)
.|.+.+.||+|+||+||+|..+ .+++.||||+++... ......+.+|++++++++|||||++++++.+.+..|+||
T Consensus 14 ~Y~i~~~lG~G~fg~V~~~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 14 NYQIVKTLGEGSFGKVKLAYHT-TTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp CCEEEEEEEC---CCEEEEECT-TTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 3566789999999999999876 578999999996532 223467999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 512 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 512 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
||+ +|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||+++++++||+|||+|+......
T Consensus 93 Ey~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-- 166 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-- 166 (275)
T ss_dssp ECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred eCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCC--
Confidence 999 689999999888999999999999999999999997 99999999999999999999999999998754322
Q ss_pred ccccccCCccccCcccccCCCC-CCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhh
Q 047292 592 THTMIRGTRGYVAPEWLKNAPV-SAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEA 670 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~~~~-s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 670 (728)
......||+.|||||++.+..+ +.++|||||||++|||+||+.||...........+ ..+... +
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i--------~~~~~~--~----- 231 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNI--------SNGVYT--L----- 231 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHTCCC--C-----
T ss_pred ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--------HcCCCC--C-----
Confidence 2334679999999999998886 57999999999999999999999865443322211 111110 0
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 671 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 671 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
+......+.+++.+||+.||++|||++|+++
T Consensus 232 ---p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 232 ---PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp ---CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---CCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1112345678999999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=401.69 Aligned_cols=248 Identities=23% Similarity=0.262 Sum_probs=197.8
Q ss_pred HhhHHhhhCCCceeEEEEeeee--CCCCcEEEEEEecccc--hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeE
Q 047292 435 TDGFKEELGRGSFGIVYKGVLK--TASGNAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 510 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~--~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 510 (728)
.|.+.+.||+|+||+||+|+.. ..+++.||||+++... ......+.+|++++++++|||||++++++.+.+..|||
T Consensus 25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 104 (304)
T 3ubd_A 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLI 104 (304)
T ss_dssp GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEE
T ss_pred ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 3567789999999999999764 2357899999996532 22234688999999999999999999999999999999
Q ss_pred eeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC
Q 047292 511 YEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 590 (728)
|||+++|+|.+++.+...+++..+..++.||+.||+|||++ +|+||||||+|||+++++++||+|||+|+.......
T Consensus 105 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 181 (304)
T 3ubd_A 105 LDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 181 (304)
T ss_dssp ECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-----C
T ss_pred EEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccCCCc
Confidence 99999999999999888999999999999999999999997 999999999999999999999999999986543322
Q ss_pred cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhh
Q 047292 591 RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEA 670 (728)
Q Consensus 591 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 670 (728)
......||+.|||||++.+..|+.++|||||||+||||+||+.||......+....+ ..+... .
T Consensus 182 -~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i--------~~~~~~-~------ 245 (304)
T 3ubd_A 182 -KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI--------LKAKLG-M------ 245 (304)
T ss_dssp -CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHCCCC-C------
T ss_pred -cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHH--------HcCCCC-C------
Confidence 233467999999999999999999999999999999999999999876554332222 111110 0
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 047292 671 AMADRSRLHKWLMIAMWCIQEDPSKRPT-----MKVVMQ 704 (728)
Q Consensus 671 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----~~evl~ 704 (728)
+......+.+++.+||+.||++||| ++|+++
T Consensus 246 ---p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 246 ---PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred ---CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 1112345778999999999999998 466664
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=388.67 Aligned_cols=246 Identities=23% Similarity=0.345 Sum_probs=186.0
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch-hhHHHHHHHHHHhccccccceeeEeeeeecCC---------
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKNLVQLLGFCDEAL--------- 505 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--------- 505 (728)
+.+.+.||+|+||+||+|..+ .+++.||||+++.... ...+.+.+|+++|++++|||||++++++.+.+
T Consensus 7 y~~~~~lG~G~fg~V~~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 7 FEPIQCLGRGGFGVVFEAKNK-VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp EEEEEEEEECC--EEEEEEET-TTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred CEEeeEEecCCCeEEEEEEEC-CCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 455678999999999999876 5789999999965433 34467999999999999999999999986544
Q ss_pred ---cceeEeeccCCCCHHHHHhcCCC---CChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccc
Q 047292 506 ---NRLLVYEFMGNGTLANLIFAIPK---PDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDF 579 (728)
Q Consensus 506 ---~~~lv~e~~~~gsL~~~l~~~~~---~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Df 579 (728)
..|+||||+++|+|.+++..... .++..++.++.||++||+|||++ +||||||||+||||+.++++||+||
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEccC
Confidence 36899999999999999987643 34566889999999999999997 9999999999999999999999999
Q ss_pred cCccccccCCCc-----------ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhH
Q 047292 580 GLSKLLLSDHSR-----------THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAIL 648 (728)
Q Consensus 580 gla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~ 648 (728)
|+|+........ ..+...||+.|||||++.+..|+.++|||||||++|||++ ||....... ..+
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~--~~~ 237 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERV--RTL 237 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH--HHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHH--HHH
Confidence 999877543221 1233569999999999999999999999999999999996 665432211 111
Q ss_pred HHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 649 TDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 649 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
........... .....+.+.+++.+||+.||++|||+.|+++
T Consensus 238 -----~~~~~~~~p~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 238 -----TDVRNLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp -----HHHHTTCCCHH---------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----HHHhcCCCCCC---------CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111111111 1122334567999999999999999999987
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=388.35 Aligned_cols=263 Identities=20% Similarity=0.275 Sum_probs=203.0
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHhccccccceeeEeeeeec------CCcc
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDE------ALNR 507 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~~~ 507 (728)
|.+.++||+|+||.||+|..+ .+|+.||||+++... ....+.+.+|+++|+.++|||||++++++.. ....
T Consensus 56 Y~~~~~lG~G~fG~V~~a~~~-~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~ 134 (398)
T 4b99_A 56 YEIIETIGNGAYGVVSSARRR-LTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV 134 (398)
T ss_dssp EEEEEEEEECSSCEEEEEEET-TTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred eEEEEEEecccCeEEEEEEEC-CCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence 556689999999999999876 678999999996532 3345678899999999999999999998754 3578
Q ss_pred eeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcccccc
Q 047292 508 LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS 587 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 587 (728)
||||||++ |+|.+++.....+++..+..++.||+.||.|||++ +||||||||+|||++.++.+||+|||+|+.+..
T Consensus 135 ~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~ 210 (398)
T 4b99_A 135 YVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210 (398)
T ss_dssp EEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred EEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence 99999996 68999999988999999999999999999999997 999999999999999999999999999987643
Q ss_pred CC---CcccccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccce
Q 047292 588 DH---SRTHTMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDA 663 (728)
Q Consensus 588 ~~---~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (728)
.. ........||+.|||||++.+. .++.++||||+||++|||++|+.||......+....+....... .......
T Consensus 211 ~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p-~~~~~~~ 289 (398)
T 4b99_A 211 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTP-SPAVIQA 289 (398)
T ss_dssp -----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCC-CGGGTC-
T ss_pred CccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCC-ChHHhhh
Confidence 32 2233456799999999998876 56999999999999999999999998765544333332211000 0000000
Q ss_pred ------------ecc--chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 664 ------------LID--SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 664 ------------~~d--~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
+.. +.......+.....+.+|+.+||+.||++|||++|+++
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 00000001112346788999999999999999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=375.12 Aligned_cols=196 Identities=19% Similarity=0.320 Sum_probs=167.5
Q ss_pred hhHHhhhCCCceeEEEEeeee--CCCCcEEEEEEecccchhhHHHHHHHHHHhccc-cccceeeEeeeeecCCcceeEee
Q 047292 436 DGFKEELGRGSFGIVYKGVLK--TASGNAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~--~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e 512 (728)
|.+.++||+|+||+||+|+.+ ..+++.||||++... .....+.+|+++|+.+ +||||+++++++.+.+..++|||
T Consensus 23 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE 100 (361)
T 4f9c_A 23 FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMP 100 (361)
T ss_dssp CEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEE
T ss_pred EEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEe
Confidence 456678999999999999865 245689999998653 2345688999999988 69999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCC-CceEEccccCccccccCCC-
Q 047292 513 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHY-FSPKISDFGLSKLLLSDHS- 590 (728)
Q Consensus 513 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~-~~~kl~Dfgla~~~~~~~~- 590 (728)
|+++|+|.+++. .+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.......
T Consensus 101 ~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~ 174 (361)
T 4f9c_A 101 YLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIE 174 (361)
T ss_dssp CCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCG
T ss_pred CCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccc
Confidence 999999999984 588999999999999999999997 99999999999999876 7999999999986543211
Q ss_pred --------------------------cccccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchh
Q 047292 591 --------------------------RTHTMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEME 639 (728)
Q Consensus 591 --------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~ 639 (728)
.......||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 175 LLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp GGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 112335699999999999876 5899999999999999999999999643
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=370.89 Aligned_cols=288 Identities=42% Similarity=0.704 Sum_probs=241.7
Q ss_pred CCccccCHHHHHHHHhhH--HhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchh-hHHHHHHHHHHhccccccceeeE
Q 047292 421 TNLRFFSYDELKDATDGF--KEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQE-REREFKSEVSAIGRTHHKNLVQL 497 (728)
Q Consensus 421 ~~~~~~~~~el~~~~~~~--~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l 497 (728)
...+.+++.++.....+| .+.||+|+||.||+|..+ +++.||||++...... ....+.+|+++++.++||||+++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 92 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA--DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 92 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS--SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCC
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEec--CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccce
Confidence 446678888888777665 478999999999999754 6889999999764322 23478999999999999999999
Q ss_pred eeeeecCCcceeEeeccCCCCHHHHHhcCC----CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCc
Q 047292 498 LGFCDEALNRLLVYEFMGNGTLANLIFAIP----KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFS 573 (728)
Q Consensus 498 ~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~----~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~ 573 (728)
++++......++||||+++|+|.+++.... .+++..+..++.|++.||+|||+++..+|+||||||+|||+++++.
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~ 172 (326)
T 3uim_A 93 RGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 172 (326)
T ss_dssp CEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC
T ss_pred EEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC
Confidence 999999999999999999999999998753 4889999999999999999999976669999999999999999999
Q ss_pred eEEccccCccccccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhH-hhhhhHHHHH
Q 047292 574 PKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEE-ESRAILTDWA 652 (728)
Q Consensus 574 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~-~~~~~~~~~~ 652 (728)
+||+|||+++..............||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .....+..+.
T Consensus 173 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 252 (326)
T 3uim_A 173 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252 (326)
T ss_dssp EEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred EEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence 999999999877655544455566999999999999888999999999999999999999999754322 2222344555
Q ss_pred HHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 047292 653 YDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710 (728)
Q Consensus 653 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 710 (728)
........+....+..............+.+++.+||+.||.+|||+++|+++|++..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp TTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred HHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 5555566677777777777777888899999999999999999999999999998754
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=397.72 Aligned_cols=249 Identities=24% Similarity=0.353 Sum_probs=208.0
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccC
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
|.+.++||+|+||.||++..+ .+|+.||+|++........+.+.+|+.+|+.++|||||++++++.+....+|||||++
T Consensus 159 Y~i~~~lG~G~fg~V~~~~~~-~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~ 237 (573)
T 3uto_A 159 YDIHEELGTGAFGVVHRVTER-ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 237 (573)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred cEEEEEEeeccCeEEEEEEEC-CCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecC
Confidence 556788999999999999876 6789999999977666667789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCC--CceEEccccCccccccCCCcc
Q 047292 516 NGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHY--FSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 516 ~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~--~~~kl~Dfgla~~~~~~~~~~ 592 (728)
+|+|.++|... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.+.... .
T Consensus 238 gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~--~ 312 (573)
T 3uto_A 238 GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--S 312 (573)
T ss_dssp CCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS--E
T ss_pred CCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCC--c
Confidence 99999999754 5789999999999999999999997 99999999999999854 899999999999774432 2
Q ss_pred cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAM 672 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 672 (728)
.....||+.|||||++.+..|+.++|||||||++|||++|+.||......+....+ ..... .+.....
T Consensus 313 ~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i--------~~~~~--~~~~~~~-- 380 (573)
T 3uto_A 313 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV--------KSCDW--NMDDSAF-- 380 (573)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH--------HTTCC--CCCSGGG--
T ss_pred eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH--------HhCCC--CCCcccc--
Confidence 34457999999999999999999999999999999999999999866554332211 11111 0111111
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 673 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 673 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
......+.+|+.+||+.||.+|||+.|+++
T Consensus 381 --~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 381 --SGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp --TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112345678999999999999999999987
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=366.03 Aligned_cols=272 Identities=37% Similarity=0.660 Sum_probs=229.3
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCCC
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNG 517 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 517 (728)
+.+.||+|+||.||+|.++ +++.||||++........+.+.+|+.++++++||||+++++++......++||||+++|
T Consensus 43 ~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 120 (321)
T 2qkw_B 43 HKFLIGHGVFGKVYKGVLR--DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENG 120 (321)
T ss_dssp CCCCSCBCSSSEEEEEECT--TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTC
T ss_pred ccceeecCCCeeEEEEEEC--CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCC
Confidence 4467999999999999864 68899999987766666788999999999999999999999999999999999999999
Q ss_pred CHHHHHhcCC----CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCC-Ccc
Q 047292 518 TLANLIFAIP----KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH-SRT 592 (728)
Q Consensus 518 sL~~~l~~~~----~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~-~~~ 592 (728)
+|.+++.... .+++..++.++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 121 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 197 (321)
T 2qkw_B 121 NLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL 197 (321)
T ss_dssp BTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCC
T ss_pred cHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence 9999997653 588999999999999999999997 99999999999999999999999999998654322 222
Q ss_pred cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAM 672 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 672 (728)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... ...+.......+.+...+++.....
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (321)
T 2qkw_B 198 STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN-LAEWAVESHNNGQLEQIVDPNLADK 276 (321)
T ss_dssp BCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCC-HHHHTHHHHTTTCCCSSSSSSCTTC
T ss_pred ccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHH-HHHHhhhccccccHHHhcChhhccc
Confidence 334558999999999998999999999999999999999999997554332221 2233344445556666677666666
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCC
Q 047292 673 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNP 715 (728)
Q Consensus 673 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~ 715 (728)
........+.+++.+||+.||++|||+++|++.|+.++...+.
T Consensus 277 ~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~~ 319 (321)
T 2qkw_B 277 IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQES 319 (321)
T ss_dssp SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSCC
T ss_pred cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcccC
Confidence 6778888999999999999999999999999999988765543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=389.43 Aligned_cols=247 Identities=22% Similarity=0.233 Sum_probs=198.2
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch---hhHHHH---HHHHHHhccccccceeeEeeeeecCCccee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ---EREREF---KSEVSAIGRTHHKNLVQLLGFCDEALNRLL 509 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~---~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 509 (728)
+.+.+.||+|+||.||++..+ .+|+.||||++++... .....+ ..++.+++.++|||||++++++.+....||
T Consensus 191 f~i~k~LG~G~fG~V~la~~~-~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lyl 269 (689)
T 3v5w_A 191 FSVHRIIGRGGFGEVYGCRKA-DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 269 (689)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred eEEEEEEecccCeEEEEEEEC-CCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEE
Confidence 345678999999999999876 6789999999965321 122333 344677788899999999999999999999
Q ss_pred EeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCC
Q 047292 510 VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH 589 (728)
Q Consensus 510 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 589 (728)
||||++||+|.++|.....+++..+..++.||+.||+|||++ +||||||||+||||+.+|++||+|||+|+......
T Consensus 270 VmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~ 346 (689)
T 3v5w_A 270 ILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 346 (689)
T ss_dssp EECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecCCCC
Confidence 999999999999999888999999999999999999999997 99999999999999999999999999998764432
Q ss_pred CcccccccCCccccCccccc-CCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccch
Q 047292 590 SRTHTMIRGTRGYVAPEWLK-NAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSD 668 (728)
Q Consensus 590 ~~~~~~~~gt~~y~aPE~~~-~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 668 (728)
.....||+.|||||++. +..|+.++|+|||||+||||++|+.||............ . ....... .
T Consensus 347 ---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~-~----~i~~~~~-~----- 412 (689)
T 3v5w_A 347 ---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-R----MTLTMAV-E----- 412 (689)
T ss_dssp ---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHH-H----HHHHCCC-C-----
T ss_pred ---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-H----hhcCCCC-C-----
Confidence 23457999999999996 457999999999999999999999999765432221111 1 1111111 0
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 047292 669 EAAMADRSRLHKWLMIAMWCIQEDPSKRPT-----MKVVMQ 704 (728)
Q Consensus 669 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----~~evl~ 704 (728)
.+......+.+++.+||+.||.+|++ ++||++
T Consensus 413 ----~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 413 ----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ----CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 11112346778999999999999998 677764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=356.69 Aligned_cols=260 Identities=31% Similarity=0.483 Sum_probs=200.9
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
.+.+.+.||+|+||.||+|.. .++.||||++.... ....+.+.+|++++++++||||+++++++......++|||
T Consensus 38 ~y~i~~~lG~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 38 DLNIKEKIGAGSFGTVHRAEW---HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GEEEEEEEEECSSEEEEEEEE---TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred HceeeeEeecCCCeEEEEEEE---CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 445567899999999999976 47889999986533 3445789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCC---CChHHHHHHHHHHHHHHHHhhhcCCCC--eeecCCCCCCEEEcCCCceEEccccCcccccc
Q 047292 513 FMGNGTLANLIFAIPK---PDWNLRVRISLEIARGLVYLHEGCNVP--IIHCDIKPQNILLDHYFSPKISDFGLSKLLLS 587 (728)
Q Consensus 513 ~~~~gsL~~~l~~~~~---~~~~~~~~i~~qi~~~l~yLH~~~~~~--iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 587 (728)
|+++++|.+++..... +++..++.++.||+.||+|||++ + |+||||||+|||++.++.+||+|||+++....
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence 9999999999987653 88999999999999999999997 7 99999999999999999999999999986533
Q ss_pred CCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccc
Q 047292 588 DHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDS 667 (728)
Q Consensus 588 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 667 (728)
.. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+ . .......
T Consensus 192 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~----~---~~~~~~~---- 259 (309)
T 3p86_A 192 TF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV----G---FKCKRLE---- 259 (309)
T ss_dssp -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH----H---HSCCCCC----
T ss_pred cc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----H---hcCCCCC----
Confidence 22 1223456899999999999999999999999999999999999999865443321111 0 0000000
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCCCC
Q 047292 668 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNPPW 717 (728)
Q Consensus 668 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~~~ 717 (728)
.+......+.+++.+||+.||.+|||+++|++.|+.+++...||-
T Consensus 260 -----~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~ 304 (309)
T 3p86_A 260 -----IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304 (309)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC------
T ss_pred -----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCC
Confidence 111223457789999999999999999999999999887655543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=356.55 Aligned_cols=257 Identities=28% Similarity=0.432 Sum_probs=209.6
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccC
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
+.+.+.||+|+||.||++... .+++.||+|++........+.+.+|++++++++||||+++++++.+....++||||++
T Consensus 12 ~~~~~~lG~G~~g~V~~~~~~-~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 90 (310)
T 3s95_A 12 LIHGEVLGKGCFGQAIKVTHR-ETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIK 90 (310)
T ss_dssp EEEEEEEECCSSEEEEEEEET-TTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eeccceecCCCCEEEEEEEEC-CCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecC
Confidence 445678999999999999876 5688999999977667777899999999999999999999999999999999999999
Q ss_pred CCCHHHHHhc-CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc--
Q 047292 516 NGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT-- 592 (728)
Q Consensus 516 ~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~-- 592 (728)
+++|.+++.. ...+++..+..++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++.........
T Consensus 91 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 167 (310)
T 3s95_A 91 GGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEG 167 (310)
T ss_dssp TCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC--------
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccccccc
Confidence 9999999987 46789999999999999999999997 99999999999999999999999999998764332211
Q ss_pred -----------cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCcc
Q 047292 593 -----------HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRL 661 (728)
Q Consensus 593 -----------~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (728)
.....||+.|+|||.+.+..++.++||||||+++|||++|..|+............
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~------------- 234 (310)
T 3s95_A 168 LRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL------------- 234 (310)
T ss_dssp ------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB-------------
T ss_pred cccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh-------------
Confidence 11456999999999999999999999999999999999999887643221111000
Q ss_pred ceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 662 DALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 662 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
..........+......+.+++.+||+.||++|||++++++.|+.+..
T Consensus 235 --~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 235 --NVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp --CHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --hhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 000000011111223457789999999999999999999999988753
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=347.87 Aligned_cols=264 Identities=23% Similarity=0.310 Sum_probs=209.7
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEe
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 511 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 511 (728)
.+.+.+.||+|+||.||++... .+++.||+|++... .....+.+.+|+.++++++||||+++++++......++||
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 12 RYKIVDKLGGGGMSTVYLAEDT-ILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TEEEEEEEEEETTEEEEEEEET-TTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cEEEEEEEccCCCEEEEEEEEC-CCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 3456688999999999999865 56889999998432 2334578999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 512 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 512 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
||+++++|.+++.....+++..+..++.|++.||+|||++ +|+||||||+||+++.++++||+|||+++........
T Consensus 91 e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 167 (294)
T 4eqm_A 91 EYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT 167 (294)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc
Confidence 9999999999999888899999999999999999999997 9999999999999999999999999999876544433
Q ss_pred ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhh
Q 047292 592 THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAA 671 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 671 (728)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... ... ..... ....
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~-------~~~-~~~~~-----~~~~ 234 (294)
T 4eqm_A 168 QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAI-------KHI-QDSVP-----NVTT 234 (294)
T ss_dssp -------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHH-------HHH-SSCCC-----CHHH
T ss_pred ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH-------HHh-hccCC-----Ccch
Confidence 3444569999999999999999999999999999999999999997654432211 000 11110 0111
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhcCcCCCCC
Q 047292 672 MADRSRLHKWLMIAMWCIQEDPSKRP-TMKVVMQMLEGLLEVPNP 715 (728)
Q Consensus 672 ~~~~~~~~~l~~l~~~cl~~dp~~RP-t~~evl~~L~~~~~~~~~ 715 (728)
.........+.+++.+||+.||.+|| +++++.+.|+.++.....
T Consensus 235 ~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~ 279 (294)
T 4eqm_A 235 DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRA 279 (294)
T ss_dssp HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSST
T ss_pred hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccC
Confidence 11222345677899999999999998 999999999998755443
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=360.25 Aligned_cols=257 Identities=27% Similarity=0.361 Sum_probs=209.0
Q ss_pred HhhHHhhhCCCceeEEEEeeeeC------CCCcEEEEEEecccc-hhhHHHHHHHHHHhccc-cccceeeEeeeeecCCc
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKT------ASGNAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALN 506 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 506 (728)
.+.+.+.||+|+||.||+|.... .++..||||+++... ....+.+.+|+.+++++ +||||+++++++.....
T Consensus 82 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~ 161 (370)
T 2psq_A 82 KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 161 (370)
T ss_dssp GEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSS
T ss_pred HCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCC
Confidence 34556789999999999998642 345679999997543 34457899999999999 89999999999999999
Q ss_pred ceeEeeccCCCCHHHHHhcCC----------------CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcC
Q 047292 507 RLLVYEFMGNGTLANLIFAIP----------------KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDH 570 (728)
Q Consensus 507 ~~lv~e~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~ 570 (728)
.++||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.
T Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~ 238 (370)
T 2psq_A 162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTE 238 (370)
T ss_dssp CEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT
T ss_pred EEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEECC
Confidence 999999999999999998643 468899999999999999999997 9999999999999999
Q ss_pred CCceEEccccCccccccCCC-cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhH
Q 047292 571 YFSPKISDFGLSKLLLSDHS-RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAIL 648 (728)
Q Consensus 571 ~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~ 648 (728)
++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...........
T Consensus 239 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~- 317 (370)
T 2psq_A 239 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL- 317 (370)
T ss_dssp TCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-
T ss_pred CCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-
Confidence 99999999999987644322 22233457889999999999999999999999999999999 9999876543322111
Q ss_pred HHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 649 TDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 649 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
...+.... .+......+.+++.+||+.||.+||+++|+++.|+.++.
T Consensus 318 -------~~~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 318 -------LKEGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp -------HHTTCCCC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------HhcCCCCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11111111 111233467789999999999999999999999998764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=349.63 Aligned_cols=249 Identities=24% Similarity=0.356 Sum_probs=205.5
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccC
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
+.+.+.||+|+||.||+|... .+++.||||++........+.+.+|+.++++++||||+++++++......++||||++
T Consensus 22 y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 100 (297)
T 3fxz_A 22 YTRFEKIGQGASGTVYTAMDV-ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (297)
T ss_dssp BCCCEEEEEETTEEEEEEEBT-TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eeeeeeeccCCCeEEEEEEEC-CCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCC
Confidence 445578999999999999865 5788999999976555566789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccccc
Q 047292 516 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM 595 (728)
Q Consensus 516 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 595 (728)
+++|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++........ ....
T Consensus 101 ~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 175 (297)
T 3fxz_A 101 GGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRST 175 (297)
T ss_dssp TCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CBCC
T ss_pred CCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-ccCC
Confidence 99999999764 688999999999999999999997 999999999999999999999999999987654332 2334
Q ss_pred ccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcH
Q 047292 596 IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADR 675 (728)
Q Consensus 596 ~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 675 (728)
..||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+. .... ..... ..
T Consensus 176 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~-------~~~~-~~~~~-------~~ 240 (297)
T 3fxz_A 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA-------TNGT-PELQN-------PE 240 (297)
T ss_dssp CCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-------HHCS-CCCSC-------GG
T ss_pred ccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------hCCC-CCCCC-------cc
Confidence 569999999999999999999999999999999999999997654432211110 0110 00000 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 676 SRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 676 ~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.....+.+++.+||+.||++|||++|+++.
T Consensus 241 ~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 241 KLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 223457789999999999999999999874
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=353.15 Aligned_cols=246 Identities=22% Similarity=0.328 Sum_probs=205.6
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
+.+.+.||+|+||.||+|... .+++.||||++... .....+.+.+|+++++.++||||+++++++......++||||
T Consensus 17 y~~~~~lG~G~~g~V~~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 95 (328)
T 3fe3_A 17 YRLLKTIGKGNFAKVKLARHI-LTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEY 95 (328)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEEC
Confidence 445678999999999999875 57899999999653 234457789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccc
Q 047292 514 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH 593 (728)
Q Consensus 514 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 593 (728)
+++++|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 96 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--~~ 170 (328)
T 3fe3_A 96 ASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG--KL 170 (328)
T ss_dssp CTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC--GG
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC--cc
Confidence 99999999998888899999999999999999999997 99999999999999999999999999998664332 23
Q ss_pred ccccCCccccCcccccCCCCC-CccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhh
Q 047292 594 TMIRGTRGYVAPEWLKNAPVS-AKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAM 672 (728)
Q Consensus 594 ~~~~gt~~y~aPE~~~~~~~s-~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 672 (728)
....||+.|+|||++.+..+. .++||||||+++|||++|+.||...........+ ..+...
T Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i--------~~~~~~---------- 232 (328)
T 3fe3_A 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV--------LRGKYR---------- 232 (328)
T ss_dssp GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHCCCC----------
T ss_pred ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHH--------HhCCCC----------
Confidence 446799999999999988875 7999999999999999999999866544322211 111110
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 673 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 673 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.+......+.+++.+||+.||.+|||++|+++.
T Consensus 233 ~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 233 IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 011123456789999999999999999999864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=356.62 Aligned_cols=261 Identities=26% Similarity=0.387 Sum_probs=209.7
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCC--CCcEEEEEEeccc-chhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeE
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTA--SGNAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 510 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~--~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 510 (728)
..+.+.+.||+|+||.||+|.+... .+..||||+++.. .....+.+.+|+.++++++||||+++++++......++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 3445567899999999999988632 2346999999764 344457899999999999999999999999999999999
Q ss_pred eeccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCC
Q 047292 511 YEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH 589 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 589 (728)
|||+++++|.+++... ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 205 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205 (325)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence 9999999999999765 5789999999999999999999997 99999999999999999999999999998775433
Q ss_pred Cc--ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceecc
Q 047292 590 SR--THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALID 666 (728)
Q Consensus 590 ~~--~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 666 (728)
.. ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...........+ ..+...
T Consensus 206 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~--------~~~~~~---- 273 (325)
T 3kul_A 206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV--------EEGYRL---- 273 (325)
T ss_dssp -CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH--------HTTCCC----
T ss_pred cceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH--------HcCCCC----
Confidence 22 2222346778999999999999999999999999999999 99999765443322111 111000
Q ss_pred chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCC
Q 047292 667 SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPN 714 (728)
Q Consensus 667 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 714 (728)
.........+.+++.+||+.||.+||++++|+++|+.++..+.
T Consensus 274 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 274 -----PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred -----CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 0111233567789999999999999999999999999876554
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=348.64 Aligned_cols=261 Identities=23% Similarity=0.307 Sum_probs=212.7
Q ss_pred cccCHHHHHHHHhh------------HHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccc
Q 047292 424 RFFSYDELKDATDG------------FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHH 491 (728)
Q Consensus 424 ~~~~~~el~~~~~~------------~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h 491 (728)
..+++++++.++.. ..+.||+|+||.||+|..+ .+|+.||||++........+.+.+|+.++++++|
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREK-HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEEC-CCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence 45788888887754 2347999999999999875 4689999999976555566789999999999999
Q ss_pred cceeeEeeeeecCCcceeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCC
Q 047292 492 KNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHY 571 (728)
Q Consensus 492 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~ 571 (728)
|||+++++++......++||||+++++|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.+
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLD 177 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCC
Confidence 9999999999999999999999999999999875 4689999999999999999999997 99999999999999999
Q ss_pred CceEEccccCccccccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHH
Q 047292 572 FSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDW 651 (728)
Q Consensus 572 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~ 651 (728)
+.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+
T Consensus 178 ~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~--- 253 (321)
T 2c30_A 178 GRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL--- 253 (321)
T ss_dssp CCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---
T ss_pred CcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---
Confidence 9999999999987654322 223456999999999999999999999999999999999999999765433221111
Q ss_pred HHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 652 AYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 652 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.......... .......+.+++.+||+.||++|||++++++.
T Consensus 254 -----~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 254 -----RDSPPPKLKN-------SHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp -----HHSSCCCCTT-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -----hcCCCCCcCc-------cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111111100 11123457789999999999999999999874
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=342.74 Aligned_cols=280 Identities=37% Similarity=0.614 Sum_probs=222.9
Q ss_pred CCccccCHHHHHHHHhhHH--------hhhCCCceeEEEEeeeeCCCCcEEEEEEeccc----chhhHHHHHHHHHHhcc
Q 047292 421 TNLRFFSYDELKDATDGFK--------EELGRGSFGIVYKGVLKTASGNAIAVKKLDRL----AQEREREFKSEVSAIGR 488 (728)
Q Consensus 421 ~~~~~~~~~el~~~~~~~~--------~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~----~~~~~~~~~~E~~~l~~ 488 (728)
..+..|++.++..++.+|. +.||+|+||.||+|.. +++.||||++... .....+.+.+|+.++++
T Consensus 10 ~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~ 86 (307)
T 2nru_A 10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV---NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAK 86 (307)
T ss_dssp -CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES---SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHH
T ss_pred CCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE---CCceEEEEEEecccCcchHHHHHHHHHHHHHHHh
Confidence 3467899999999998886 4599999999999986 4789999998642 23345789999999999
Q ss_pred ccccceeeEeeeeecCCcceeEeeccCCCCHHHHHhc---CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCC
Q 047292 489 THHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFA---IPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQN 565 (728)
Q Consensus 489 l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~N 565 (728)
++||||+++++++......++||||+++++|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+|
T Consensus 87 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~N 163 (307)
T 2nru_A 87 CQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSAN 163 (307)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGG
T ss_pred cCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHH
Confidence 9999999999999999999999999999999999874 35689999999999999999999997 99999999999
Q ss_pred EEEcCCCceEEccccCccccccCCCc-ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhh
Q 047292 566 ILLDHYFSPKISDFGLSKLLLSDHSR-THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEES 644 (728)
Q Consensus 566 Ill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~ 644 (728)
|++++++.+||+|||+++........ ......|++.|+|||.+.+ .++.++||||||+++|||++|+.||........
T Consensus 164 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 242 (307)
T 2nru_A 164 ILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL 242 (307)
T ss_dssp EEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB
T ss_pred EEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH
Confidence 99999999999999999876443222 2233568999999998875 478999999999999999999999976443221
Q ss_pred hhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 047292 645 RAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710 (728)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 710 (728)
...+..... .....+...++... ........+.+.+++.+||+.||.+||++++|++.|+++.
T Consensus 243 ~~~~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 243 LLDIKEEIE--DEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp TTHHHHHHH--TTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHHHHhh--hhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 111111000 01111222222211 1234556778889999999999999999999999998764
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=355.21 Aligned_cols=267 Identities=25% Similarity=0.386 Sum_probs=207.2
Q ss_pred HHHhhHHhhhCCCceeEEEEeee---eCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecC--Ccc
Q 047292 433 DATDGFKEELGRGSFGIVYKGVL---KTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEA--LNR 507 (728)
Q Consensus 433 ~~~~~~~~~lg~G~fg~Vy~g~~---~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~ 507 (728)
...+.+.++||+|+||.||++.+ ...+++.||||++........+.+.+|++++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 34456678899999999999985 3456789999999877666678899999999999999999999998543 558
Q ss_pred eeEeeccCCCCHHHHHhcCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccc
Q 047292 508 LLVYEFMGNGTLANLIFAIP-KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLL 586 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 586 (728)
++||||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++++||+|||+++...
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 99999999999999998764 589999999999999999999997 99999999999999999999999999998764
Q ss_pred cCCC--cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhh--------hHHHHHHHhh
Q 047292 587 SDHS--RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRA--------ILTDWAYDCY 656 (728)
Q Consensus 587 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~--------~~~~~~~~~~ 656 (728)
.... .......++..|+|||.+.+..++.++||||||+++|||++|..|+.......... ..........
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHH
Confidence 4322 22233457778999999999999999999999999999999999887543321100 0000111111
Q ss_pred hcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 657 VEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 657 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
..+... ..+......+.+++.+||+.||++|||++++++.|+.+.+
T Consensus 246 ~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 246 KNNGRL---------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HTTCCC---------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hccCcC---------CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 111110 1112234567889999999999999999999999988653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=361.65 Aligned_cols=258 Identities=24% Similarity=0.380 Sum_probs=197.9
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeC--CCCcEEEEEEeccc-chhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeE
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKT--ASGNAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 510 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~--~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 510 (728)
..+.+.+.||+|+||.||+|.++. ..+..||||+++.. .....+.|.+|+.++++++||||+++++++.+....++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 344556789999999999998752 34678999999754 334457899999999999999999999999999999999
Q ss_pred eeccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCC
Q 047292 511 YEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH 589 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 589 (728)
|||+++++|.+++... ..+++..++.++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 201 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201 (373)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence 9999999999999876 4689999999999999999999997 99999999999999999999999999998765433
Q ss_pred Ccc--cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceecc
Q 047292 590 SRT--HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALID 666 (728)
Q Consensus 590 ~~~--~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 666 (728)
... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||........... ...+..
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~--------i~~~~~----- 268 (373)
T 2qol_A 202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA--------VDEGYR----- 268 (373)
T ss_dssp ------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHH--------HHTTEE-----
T ss_pred ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--------HHcCCC-----
Confidence 221 122235778999999999999999999999999999998 9999975543322111 111100
Q ss_pred chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 667 SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 667 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
..........+.+++.+||+.||.+||++++|+++|+.++.
T Consensus 269 ----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 269 ----LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp ----CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 00111233567889999999999999999999999988754
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=344.41 Aligned_cols=257 Identities=25% Similarity=0.406 Sum_probs=210.1
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
..+.+.+.||+|+||.||++..+ ++..||+|+++.... ...++.+|++++.+++||||+++++++......++||||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 8 EEITLLKELGSGQFGVVKLGKWK--GQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hheeeeeeeccCCCceEEEEEec--CceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 34556688999999999999775 567899999976432 346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 514 MGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 514 ~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..........
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 161 (268)
T 3sxs_A 85 ISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS 161 (268)
T ss_dssp CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE
T ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhhc
Confidence 9999999999875 3589999999999999999999997 99999999999999999999999999998765544333
Q ss_pred cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAA 671 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 671 (728)
.....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...........+ ..+... ..
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~--------~~~~~~--~~----- 226 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV--------SQGHRL--YR----- 226 (268)
T ss_dssp CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH--------HTTCCC--CC-----
T ss_pred ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHH--------HcCCCC--CC-----
Confidence 344456778999999999899999999999999999999 99999755443321111 111100 00
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCC
Q 047292 672 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVP 713 (728)
Q Consensus 672 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~ 713 (728)
+......+.+++.+||+.||.+|||++++++.|+.+.+..
T Consensus 227 --~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 227 --PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp --CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred --CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 0111235778999999999999999999999999987654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=349.07 Aligned_cols=247 Identities=26% Similarity=0.297 Sum_probs=205.0
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
+.+.+.||+|+||.||++..+ .+++.||+|+++... ......+.+|+.+++.++||||+++++++......++|||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E 85 (337)
T 1o6l_A 7 FDYLKLLGKGTFGKVILVREK-ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEe
Confidence 345678999999999999876 578999999996532 2345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 513 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 513 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
|+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++....... .
T Consensus 86 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~-~ 161 (337)
T 1o6l_A 86 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-T 161 (337)
T ss_dssp CCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-C
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC-c
Confidence 999999999998888899999999999999999999997 999999999999999999999999999986432222 2
Q ss_pred cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAM 672 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 672 (728)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...........+ ......
T Consensus 162 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i--------~~~~~~---------- 223 (337)
T 1o6l_A 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI--------LMEEIR---------- 223 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHCCCC----------
T ss_pred ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHH--------HcCCCC----------
Confidence 33456999999999999999999999999999999999999999765443322211 111110
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 047292 673 ADRSRLHKWLMIAMWCIQEDPSKRP-----TMKVVMQM 705 (728)
Q Consensus 673 ~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~ 705 (728)
.+......+.+++.+||+.||++|| ++++|++.
T Consensus 224 ~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 224 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 1112234677899999999999999 89999753
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=369.48 Aligned_cols=259 Identities=24% Similarity=0.379 Sum_probs=210.2
Q ss_pred HHHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 433 DATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 433 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
...+.+.++||+|+||.||+|.++ .+..||||+++... ...+.|.+|+.++++++||||+++++++. ....++|||
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYN--KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEET--TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred hHHeEEEEEcccCCceEEEEEEEC--CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 344556688999999999999875 46789999997643 34678999999999999999999999987 567899999
Q ss_pred ccCCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC
Q 047292 513 FMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 513 ~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 590 (728)
|+++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 263 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp CCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 99999999999865 3678899999999999999999997 999999999999999999999999999987643322
Q ss_pred cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchh
Q 047292 591 RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDE 669 (728)
Q Consensus 591 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 669 (728)
.......++..|+|||++....++.++||||||+++|||+| |+.||......+....+ ..+...
T Consensus 340 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i--------~~~~~~------- 404 (454)
T 1qcf_A 340 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL--------ERGYRM------- 404 (454)
T ss_dssp HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH--------HHTCCC-------
T ss_pred eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH--------HcCCCC-------
Confidence 22233446788999999998999999999999999999999 99999765433322111 111000
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCC
Q 047292 670 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNP 715 (728)
Q Consensus 670 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~ 715 (728)
..+......+.+++.+||+.||++|||+++|+++|+.+.....+
T Consensus 405 --~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~ 448 (454)
T 1qcf_A 405 --PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATES 448 (454)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCC
T ss_pred --CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcccc
Confidence 00112335678899999999999999999999999998765443
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=351.98 Aligned_cols=249 Identities=24% Similarity=0.320 Sum_probs=205.2
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchh------hHHHHHHHHHHhccccccceeeEeeeeecCCccee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQE------REREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLL 509 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 509 (728)
+.+.+.||+|+||.||++..+ .+++.||+|.++..... ..+.+.+|+.++++++||||+++++++......++
T Consensus 14 y~~~~~LG~G~fg~V~~~~~~-~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 92 (361)
T 2yab_A 14 YDIGEELGSGQFAIVKKCREK-STGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVL 92 (361)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred eEEeeEEeeCcCEEEEEEEEC-CCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEE
Confidence 456688999999999999876 57889999999653321 24689999999999999999999999999999999
Q ss_pred EeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCC----ceEEccccCcccc
Q 047292 510 VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYF----SPKISDFGLSKLL 585 (728)
Q Consensus 510 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~----~~kl~Dfgla~~~ 585 (728)
||||+++|+|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||+++++ .+||+|||+++..
T Consensus 93 v~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 93 ILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp EEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 999999999999999888899999999999999999999997 999999999999998877 7999999999876
Q ss_pred ccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceec
Q 047292 586 LSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALI 665 (728)
Q Consensus 586 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (728)
.... ......||+.|+|||++.+..++.++||||||+++|||++|..||......+....+ ..+.. .+
T Consensus 170 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i--------~~~~~--~~ 237 (361)
T 2yab_A 170 EDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI--------TAVSY--DF 237 (361)
T ss_dssp CTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH--------HTTCC--CC
T ss_pred CCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------HhcCC--CC
Confidence 4432 223456999999999999999999999999999999999999999765443322211 11110 01
Q ss_pred cchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 666 DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 666 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
+.... ......+.+++.+||+.||.+|||+.|+++
T Consensus 238 ~~~~~----~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 238 DEEFF----SQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred Cchhc----cCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11111 112345778999999999999999999875
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=346.30 Aligned_cols=252 Identities=24% Similarity=0.321 Sum_probs=206.0
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchh------hHHHHHHHHHHhccccccceeeEeeeeecCCcc
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQE------REREFKSEVSAIGRTHHKNLVQLLGFCDEALNR 507 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 507 (728)
..+.+.+.||+|+||.||++..+ .+++.||+|++...... ....+.+|+.++++++||||+++++++......
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREK-STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEET-TTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cceEeceEEeeCCCeEEEEEEEC-CCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 34566788999999999999876 56889999998653221 357899999999999999999999999999999
Q ss_pred eeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCC----ceEEccccCcc
Q 047292 508 LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYF----SPKISDFGLSK 583 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~----~~kl~Dfgla~ 583 (728)
++||||+++++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||+++
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 99999999999999998888899999999999999999999997 999999999999999887 89999999998
Q ss_pred ccccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccce
Q 047292 584 LLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDA 663 (728)
Q Consensus 584 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (728)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+. ....
T Consensus 167 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~--------~~~~-- 234 (326)
T 2y0a_A 167 KIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS--------AVNY-- 234 (326)
T ss_dssp ECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH--------HTCC--
T ss_pred ECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH--------hcCC--
Confidence 764332 2234568999999999999999999999999999999999999997654433221111 0000
Q ss_pred eccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 664 LIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 664 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.+.... .......+.+++.+||+.||.+|||++++++.
T Consensus 235 ~~~~~~----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 235 EFEDEY----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp CCCHHH----HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CcCccc----cccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000000 01123457789999999999999999999873
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=342.26 Aligned_cols=254 Identities=28% Similarity=0.437 Sum_probs=208.6
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
.+.+.+.||+|+||.||+|... +++.||+|++..... ..+.+.+|++++++++||||+++++++.+....++||||+
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 11 ELTFVQEIGSGQFGLVHLGYWL--NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GEEEEEEEEECSSCEEEEEEET--TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hceeeheecCCCccEEEEEEec--CCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 3455678999999999999875 577899999975432 3467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccc
Q 047292 515 GNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH 593 (728)
Q Consensus 515 ~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 593 (728)
++++|.+++... ..+++..++.++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++..........
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (269)
T 4hcu_A 88 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 164 (269)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence 999999999765 5689999999999999999999997 999999999999999999999999999987644333333
Q ss_pred ccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhh
Q 047292 594 TMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAM 672 (728)
Q Consensus 594 ~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 672 (728)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...........+ ..+.. ..
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~--------~~~~~--~~------- 227 (269)
T 4hcu_A 165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI--------STGFR--LY------- 227 (269)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH--------HTTCC--CC-------
T ss_pred cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH--------hcCcc--CC-------
Confidence 34457788999999999999999999999999999999 89999765443322111 11100 00
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 673 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 673 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
.+......+.+++.+||+.||.+||+++++++.|+++.+
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 228 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 011123457789999999999999999999999988754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=359.78 Aligned_cols=275 Identities=25% Similarity=0.372 Sum_probs=211.9
Q ss_pred HHHHhhHHhhhCCCceeEEEEeeee----CCCCcEEEEEEeccc-chhhHHHHHHHHHHhccccccceeeEeeeeecCCc
Q 047292 432 KDATDGFKEELGRGSFGIVYKGVLK----TASGNAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALN 506 (728)
Q Consensus 432 ~~~~~~~~~~lg~G~fg~Vy~g~~~----~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 506 (728)
....+.+.+.||+|+||.||+|.+. ..+++.||||+++.. .......+.+|+.++++++||||+++++++.....
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 3345566788999999999999864 235678999999653 34455689999999999999999999999999999
Q ss_pred ceeEeeccCCCCHHHHHhcC-------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCC---ceEE
Q 047292 507 RLLVYEFMGNGTLANLIFAI-------PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYF---SPKI 576 (728)
Q Consensus 507 ~~lv~e~~~~gsL~~~l~~~-------~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~---~~kl 576 (728)
.++||||+++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEE
Confidence 99999999999999999754 3578899999999999999999997 999999999999999554 5999
Q ss_pred ccccCccccccCC-CcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHH
Q 047292 577 SDFGLSKLLLSDH-SRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYD 654 (728)
Q Consensus 577 ~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 654 (728)
+|||+++...... ........+|+.|+|||++.+..++.++||||||+++|||++ |+.||...........+
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i------ 299 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV------ 299 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH------
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH------
Confidence 9999998653322 222334557899999999999999999999999999999998 99999765443322111
Q ss_pred hhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCC---CCCCCcccccccc
Q 047292 655 CYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVP---NPPWSSSFSIAVT 726 (728)
Q Consensus 655 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~---~~~~~~~~~~~~~ 726 (728)
..+.... ........+.+++.+||+.||.+||++.+|++.|+.+...+ ..+.|..+.-.++
T Consensus 300 --~~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~~~~~~p~~~~~~~e 363 (367)
T 3l9p_A 300 --TSGGRMD---------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVE 363 (367)
T ss_dssp --HTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHHTCCCCCC------
T ss_pred --HcCCCCC---------CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhhccCCCccccCCchh
Confidence 1111100 01122345778999999999999999999999998875322 3444444443333
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=372.95 Aligned_cols=260 Identities=27% Similarity=0.383 Sum_probs=213.1
Q ss_pred HHHHHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeE
Q 047292 431 LKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 510 (728)
Q Consensus 431 l~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 510 (728)
+....+.+.++||+|+||.||+|.++ .++..||||+++... ...+.|.+|+.++++++||||+++++++......++|
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEG-GGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEc-CCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence 33444566788999999999999986 457899999997643 2357899999999999999999999999999999999
Q ss_pred eeccCCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccC
Q 047292 511 YEFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD 588 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 588 (728)
|||+++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 9999999999999864 4588999999999999999999997 9999999999999999999999999999876544
Q ss_pred CCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccc
Q 047292 589 HSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDS 667 (728)
Q Consensus 589 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 667 (728)
.........+++.|+|||++.+..++.++||||||+++|||+| |+.||...........+ ..+..
T Consensus 372 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~--------~~~~~------ 437 (495)
T 1opk_A 372 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL--------EKDYR------ 437 (495)
T ss_dssp CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH--------HTTCC------
T ss_pred ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH--------HcCCC------
Confidence 3333333456789999999999999999999999999999999 88998755433221111 11100
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 047292 668 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEV 712 (728)
Q Consensus 668 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 712 (728)
...+......+.+++.+||+.||.+|||+.+|++.|+.++..
T Consensus 438 ---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 438 ---MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred ---CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 011112335677899999999999999999999999998643
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=361.32 Aligned_cols=256 Identities=23% Similarity=0.361 Sum_probs=207.4
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
..+.+.+.||+|+||.||+|.++ .+++.||||.++... ......|.+|++++++++||||+++++++......++|||
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLR-ADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHeEEeeEeccCCCCeEEEEEEe-cCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 34456688999999999999986 467899999987543 3334678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 513 FMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 513 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
|+++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++........
T Consensus 193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 99999999999865 4688999999999999999999997 9999999999999999999999999999865332211
Q ss_pred c-cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchh
Q 047292 592 T-HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDE 669 (728)
Q Consensus 592 ~-~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 669 (728)
. .....+++.|+|||.+.+..++.++||||||+++|||+| |+.||...........+ ..+....
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~--------~~~~~~~------ 335 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV--------EKGGRLP------ 335 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHH--------HTTCCCC------
T ss_pred ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH--------HcCCCCC------
Confidence 1 112235778999999998899999999999999999998 89998765443322111 1111000
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 047292 670 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710 (728)
Q Consensus 670 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 710 (728)
.+......+.+++.+||+.||++|||+++|++.|+.+.
T Consensus 336 ---~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 336 ---CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 11112346778999999999999999999999998764
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=341.89 Aligned_cols=255 Identities=25% Similarity=0.408 Sum_probs=206.5
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
..+.+.+.||+|+||.||++... ++..||+|+++.... ..+++.+|++++.+++|+||+++++++......++||||
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 24 KDLTFLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp GGEEEEEECC---CEEEEEEEET--TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred HHHHhHhhcCCCCCceEEEEEEc--CCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 34556688999999999999875 577899999976432 346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhc-CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 514 MGNGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 514 ~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
+++++|.+++.. ...+++..++.++.|++.||.|||++ +|+||||||+||++++++.+||+|||+++.........
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (283)
T 3gen_A 101 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 177 (283)
T ss_dssp CTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHS
T ss_pred cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccccc
Confidence 999999999987 46789999999999999999999997 99999999999999999999999999998764433333
Q ss_pred cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAA 671 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 671 (728)
.....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...........+ ..+. ....
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~--------~~~~-~~~~------ 242 (283)
T 3gen_A 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI--------AQGL-RLYR------ 242 (283)
T ss_dssp TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH--------HTTC-CCCC------
T ss_pred ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHH--------hccc-CCCC------
Confidence 333456788999999998999999999999999999998 99999765443322211 1110 0000
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 672 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 672 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
+......+.+++.+||+.+|.+|||++++++.|+++++
T Consensus 243 --~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 243 --PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp --CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 11112467789999999999999999999999988764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=356.55 Aligned_cols=266 Identities=26% Similarity=0.336 Sum_probs=214.2
Q ss_pred HHHHHhhHHhhhCCCceeEEEEeeeeC------CCCcEEEEEEecccc-hhhHHHHHHHHHHhccc-cccceeeEeeeee
Q 047292 431 LKDATDGFKEELGRGSFGIVYKGVLKT------ASGNAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKNLVQLLGFCD 502 (728)
Q Consensus 431 l~~~~~~~~~~lg~G~fg~Vy~g~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~ 502 (728)
+....+.+.++||+|+||.||+|.... ..+..||||+++... ......+.+|+++++++ +||||+++++++.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 334456667899999999999998642 233579999997543 34457899999999999 8999999999999
Q ss_pred cCCcceeEeeccCCCCHHHHHhcCC----------------CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCE
Q 047292 503 EALNRLLVYEFMGNGTLANLIFAIP----------------KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNI 566 (728)
Q Consensus 503 ~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NI 566 (728)
.....++||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceE
Confidence 9999999999999999999998653 488999999999999999999997 999999999999
Q ss_pred EEcCCCceEEccccCccccccCCC-cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhh
Q 047292 567 LLDHYFSPKISDFGLSKLLLSDHS-RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEES 644 (728)
Q Consensus 567 ll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~ 644 (728)
|+++++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||........
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~ 302 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 302 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999987644322 22333457889999999999999999999999999999999 9999876543332
Q ss_pred hhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCCC
Q 047292 645 RAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNPP 716 (728)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~~ 716 (728)
... ...+..... .......+.+++.+||+.||++||++++|++.|+.++......
T Consensus 303 ~~~--------~~~~~~~~~---------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 357 (382)
T 3tt0_A 303 FKL--------LKEGHRMDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 357 (382)
T ss_dssp HHH--------HHTTCCCCC---------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred HHH--------HHcCCCCCC---------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence 111 111111111 1122346778999999999999999999999999987544433
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=362.22 Aligned_cols=252 Identities=20% Similarity=0.242 Sum_probs=204.1
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchh---hHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQE---REREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
.+.++||+|+||.||+|..+ .+++.||+|+++..... ....+.+|..++..++||||+++++++.+....++||||
T Consensus 77 ~~~~~LG~G~fG~V~~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey 155 (437)
T 4aw2_A 77 EILKVIGRGAFGEVAVVKLK-NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDY 155 (437)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEeCCCEEEEEEEEc-CCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEec
Confidence 34578999999999999986 56789999999653221 223488999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhc-CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 514 MGNGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 514 ~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+||||+.++++||+|||+++.........
T Consensus 156 ~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 232 (437)
T 4aw2_A 156 YVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 232 (437)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEE
T ss_pred CCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcc
Confidence 999999999987 46899999999999999999999997 99999999999999999999999999998765544444
Q ss_pred cccccCCccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccc
Q 047292 593 HTMIRGTRGYVAPEWLK-----NAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDS 667 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~-----~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 667 (728)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||......+....+...... -......
T Consensus 233 ~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~----~~~p~~~-- 306 (437)
T 4aw2_A 233 SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER----FQFPTQV-- 306 (437)
T ss_dssp CCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH----CCCCSSC--
T ss_pred cccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc----ccCCccc--
Confidence 44567999999999997 567899999999999999999999999876554433332211110 0111110
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 047292 668 DEAAMADRSRLHKWLMIAMWCIQEDPSK--RPTMKVVMQM 705 (728)
Q Consensus 668 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~--RPt~~evl~~ 705 (728)
......+.+++.+||+.+|++ ||+++|+++.
T Consensus 307 -------~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 307 -------TDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp -------CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred -------ccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 012345678999999888888 9999999863
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=356.09 Aligned_cols=253 Identities=22% Similarity=0.292 Sum_probs=205.5
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEe
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 511 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 511 (728)
..+.+.++||+|+||.||++..+ .+++.||+|++... .....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~-~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKV-LAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEET-TTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred CCeEEEEEeccCCCeEEEEEEEC-CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 34566788999999999999876 57899999998643 2344577899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEc---CCCceEEccccCccccccC
Q 047292 512 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLD---HYFSPKISDFGLSKLLLSD 588 (728)
Q Consensus 512 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~---~~~~~kl~Dfgla~~~~~~ 588 (728)
||+++|+|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||++ +++.+||+|||+++.....
T Consensus 90 E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 90 DLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp CCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 9999999999999888899999999999999999999997 999999999999998 5688999999999876443
Q ss_pred CCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccch
Q 047292 589 HSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSD 668 (728)
Q Consensus 589 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 668 (728)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+ ..+... ...+
T Consensus 167 ~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i--------~~~~~~-~~~~- 235 (444)
T 3soa_A 167 QQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI--------KAGAYD-FPSP- 235 (444)
T ss_dssp CC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--------HHTCCC-CCTT-
T ss_pred Cc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHH--------HhCCCC-CCcc-
Confidence 22 223456999999999999999999999999999999999999999765543322211 111111 0000
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 669 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 669 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
. .......+.+++.+||+.||.+|||+.|+++.
T Consensus 236 ~----~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 236 E----WDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp T----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred c----cccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0 01123467789999999999999999999873
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=340.39 Aligned_cols=269 Identities=20% Similarity=0.258 Sum_probs=208.6
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCC--cceeEee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEAL--NRLLVYE 512 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lv~e 512 (728)
+.+.+.||+|+||.||+|... .+++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++|||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (319)
T 4euu_A 11 WLLSDILGQGATANVFRGRHK-KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89 (319)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEE
T ss_pred EEEEEEecCCCCeEEEEEEEC-CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEe
Confidence 455678999999999999876 568899999997543 233567889999999999999999999987665 6799999
Q ss_pred ccCCCCHHHHHhcCC---CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEE----cCCCceEEccccCcccc
Q 047292 513 FMGNGTLANLIFAIP---KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILL----DHYFSPKISDFGLSKLL 585 (728)
Q Consensus 513 ~~~~gsL~~~l~~~~---~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll----~~~~~~kl~Dfgla~~~ 585 (728)
|+++++|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+++..
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp CCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred CCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 999999999998753 389999999999999999999997 99999999999999 78888999999999876
Q ss_pred ccCCCcccccccCCccccCccccc--------CCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhh
Q 047292 586 LSDHSRTHTMIRGTRGYVAPEWLK--------NAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYV 657 (728)
Q Consensus 586 ~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 657 (728)
..... .....||+.|+|||++. +..++.++||||||+++|||++|+.||...........+.........
T Consensus 167 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p 244 (319)
T 4euu_A 167 EDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (319)
T ss_dssp CTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred CCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence 44332 23356899999999986 578899999999999999999999999743322211111111111111
Q ss_pred cCccceec-----------cchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 047292 658 EGRLDALI-----------DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710 (728)
Q Consensus 658 ~~~~~~~~-----------d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 710 (728)
...+.... +..............+.+++.+||+.||++|||++|+++...+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 11111100 001112334556677889999999999999999999999987643
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=343.98 Aligned_cols=272 Identities=16% Similarity=0.197 Sum_probs=215.9
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccc-cccceeeEeeeeecCCcceeEeecc
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
+.+.+.||+|+||.||+|... .+++.||||++.... ....+.+|+.+++++ +|+|++++++++......++||||+
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (298)
T 1csn_A 12 YKVGRRIGEGSFGVIFEGTNL-LNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 88 (298)
T ss_dssp EEEEEEEEECSSCEEEEEEET-TTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred eEEEEEEeecCCEEEEEEEEC-CCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence 445678999999999999865 578999999986432 234678899999999 7999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCc-----eEEccccCccccccC
Q 047292 515 GNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFS-----PKISDFGLSKLLLSD 588 (728)
Q Consensus 515 ~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~-----~kl~Dfgla~~~~~~ 588 (728)
+++|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++. +||+|||+++.....
T Consensus 89 -~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~ 164 (298)
T 1csn_A 89 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 164 (298)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred -CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence 99999999875 4589999999999999999999997 9999999999999987766 999999999877543
Q ss_pred CCc------ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccc
Q 047292 589 HSR------THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLD 662 (728)
Q Consensus 589 ~~~------~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (728)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+....... .....
T Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~- 242 (298)
T 1csn_A 165 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK-QSTPL- 242 (298)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH-HHSCH-
T ss_pred cccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc-cCccH-
Confidence 321 2334569999999999999999999999999999999999999997643221111111111000 00000
Q ss_pred eeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCCCCCcccccc
Q 047292 663 ALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNPPWSSSFSIA 724 (728)
Q Consensus 663 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~ 724 (728)
..........+.+++.+||+.||.+||++++|++.|+++++.........+.|.
T Consensus 243 --------~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~ 296 (298)
T 1csn_A 243 --------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWN 296 (298)
T ss_dssp --------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGG
T ss_pred --------HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccC
Confidence 001112235678899999999999999999999999998876666666667765
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=347.48 Aligned_cols=268 Identities=26% Similarity=0.370 Sum_probs=204.5
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCc----ceeE
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALN----RLLV 510 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~----~~lv 510 (728)
.+.+.++||+|+||.||+|... ++.||||++.... .....+..|+.++++++||||+++++++..... .++|
T Consensus 25 ~y~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 25 PLQLLEVKARGRFGCVWKAQLL---NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp EEEEEEEEECSTTCEEEEEEET---TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hchhhheecccCceEEEEEEEC---CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 3456688999999999999864 6899999997543 334556679999999999999999999987543 6999
Q ss_pred eeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhc-------CCCCeeecCCCCCCEEEcCCCceEEccccCcc
Q 047292 511 YEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEG-------CNVPIIHCDIKPQNILLDHYFSPKISDFGLSK 583 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~-------~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~ 583 (728)
|||+++|+|.+++... .+++..+..++.|++.||+|||+. +..+|+||||||+|||++.++.+||+|||+++
T Consensus 101 ~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~ 179 (322)
T 3soc_A 101 TAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179 (322)
T ss_dssp EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccc
Confidence 9999999999999764 589999999999999999999984 12389999999999999999999999999998
Q ss_pred ccccCCCc-ccccccCCccccCcccccCC-----CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhh---------hH
Q 047292 584 LLLSDHSR-THTMIRGTRGYVAPEWLKNA-----PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRA---------IL 648 (728)
Q Consensus 584 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~---------~~ 648 (728)
........ ......||+.|+|||++.+. .++.++||||||+++|||+||+.||.......... ..
T Consensus 180 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 259 (322)
T 3soc_A 180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSL 259 (322)
T ss_dssp EECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCH
T ss_pred ccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCch
Confidence 76543322 23335689999999999873 45668899999999999999999986532211100 00
Q ss_pred HHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 649 TDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 649 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
... ............+.. ..........+.+++.+||+.||++|||+++|++.|+.+.+
T Consensus 260 ~~~-~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 260 EDM-QEVVVHKKKRPVLRD---YWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp HHH-HHHHTTSCCCCCCCG---GGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhh-hhhhhcccCCCCccc---cccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 011 111111111111111 11122445678899999999999999999999999988653
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=353.53 Aligned_cols=280 Identities=16% Similarity=0.159 Sum_probs=210.3
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCC----CCcEEEEEEecccchhh-----------HHHHHHHHHHhccccccceeeEee
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTA----SGNAIAVKKLDRLAQER-----------EREFKSEVSAIGRTHHKNLVQLLG 499 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~----~~~~vavK~l~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l~g 499 (728)
.+.+.+.||+|+||.||+|.++.. .++.||||++....... ...+..|+..+..++|+||+++++
T Consensus 36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~ 115 (364)
T 3op5_A 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG 115 (364)
T ss_dssp EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEE
T ss_pred eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEe
Confidence 455678899999999999988643 25789999986533211 123455677788889999999999
Q ss_pred eeecC----CcceeEeeccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEc--CCC
Q 047292 500 FCDEA----LNRLLVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLD--HYF 572 (728)
Q Consensus 500 ~~~~~----~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~--~~~ 572 (728)
++... ...++||||+ +++|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++ .++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 116 SGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESSCTT
T ss_pred eeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecCCCC
Confidence 98765 4479999999 99999999876 6789999999999999999999997 999999999999999 889
Q ss_pred ceEEccccCccccccCCCc------ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhh
Q 047292 573 SPKISDFGLSKLLLSDHSR------THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRA 646 (728)
Q Consensus 573 ~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~ 646 (728)
.+||+|||+++........ ......||+.|+|||++.+..++.++||||||+++|||+||+.||..........
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~ 271 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV 271 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHH
Confidence 9999999999876433211 1133459999999999999999999999999999999999999998543322111
Q ss_pred hHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCCCCCccccccc
Q 047292 647 ILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNPPWSSSFSIAV 725 (728)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~~ 725 (728)
....... ...+..+++.... .......+.+++.+||+.+|.+||++++|++.|+.+++....+....+.|.+
T Consensus 272 ~~~~~~~----~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~ 343 (364)
T 3op5_A 272 RDSKIRY----RENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSV 343 (364)
T ss_dssp HHHHHHH----HHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC--
T ss_pred HHHHHHh----hhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccceEe
Confidence 1111000 0011111111110 0112356778999999999999999999999999987665555555555543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=344.56 Aligned_cols=249 Identities=20% Similarity=0.282 Sum_probs=204.6
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccC
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
+.+.+.||+|+||.||++..+ .+++.||+|.+... ......+.+|+.+++.++||||+++++++.+....++||||++
T Consensus 7 y~~~~~lG~G~~g~Vy~~~~~-~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 84 (321)
T 1tki_A 7 YMIAEDLGRGEFGIVHRCVET-SSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred eEeeeEEecCCCeEEEEEEEC-CCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCC
Confidence 445678999999999999876 57889999998754 3345678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcC--CCceEEccccCccccccCCCcc
Q 047292 516 NGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDH--YFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 516 ~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~--~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
+++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||+++...... .
T Consensus 85 g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~--~ 159 (321)
T 1tki_A 85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--N 159 (321)
T ss_dssp CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--E
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC--c
Confidence 99999999876 4789999999999999999999997 9999999999999987 7899999999998764332 2
Q ss_pred cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAM 672 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 672 (728)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...........+ ..+... +.....
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i--------~~~~~~--~~~~~~-- 227 (321)
T 1tki_A 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI--------MNAEYT--FDEEAF-- 227 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--------HHTCCC--CCHHHH--
T ss_pred cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH--------HcCCCC--CChhhh--
Confidence 33456899999999999988999999999999999999999999765543322211 111110 011000
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 673 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 673 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
......+.+++.+||+.||.+|||+.|+++.
T Consensus 228 --~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 228 --KEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp --TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1123467789999999999999999999973
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=349.88 Aligned_cols=258 Identities=24% Similarity=0.387 Sum_probs=209.9
Q ss_pred HhhHHhhhCCCceeEEEEeeeeC----CCCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCccee
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKT----ASGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLL 509 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 509 (728)
.+.+.+.||+|+||.||+|.... .+++.||||+++... ......+.+|+.++++++||||+++++++......++
T Consensus 48 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 127 (343)
T 1luf_A 48 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCL 127 (343)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEE
Confidence 34456789999999999999864 345899999997543 3445789999999999999999999999999999999
Q ss_pred EeeccCCCCHHHHHhcC------------------------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCC
Q 047292 510 VYEFMGNGTLANLIFAI------------------------PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQN 565 (728)
Q Consensus 510 v~e~~~~gsL~~~l~~~------------------------~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~N 565 (728)
||||+++++|.+++... ..+++..++.++.||++||.|||++ +|+||||||+|
T Consensus 128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~N 204 (343)
T 1luf_A 128 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRN 204 (343)
T ss_dssp EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred EEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcce
Confidence 99999999999999864 4688899999999999999999997 99999999999
Q ss_pred EEEcCCCceEEccccCccccccCCC-cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHh
Q 047292 566 ILLDHYFSPKISDFGLSKLLLSDHS-RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEE 643 (728)
Q Consensus 566 Ill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~ 643 (728)
||+++++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......
T Consensus 205 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 284 (343)
T 1luf_A 205 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 284 (343)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred EEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHH
Confidence 9999999999999999987643322 22334557899999999999999999999999999999999 999997654332
Q ss_pred hhhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 047292 644 SRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEV 712 (728)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 712 (728)
... ....+..... +......+.+++.+||+.||.+||++.+|++.|+++.+.
T Consensus 285 ~~~--------~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 285 VIY--------YVRDGNILAC---------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp HHH--------HHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred HHH--------HHhCCCcCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 211 1122222111 112234677899999999999999999999999998754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=365.51 Aligned_cols=260 Identities=23% Similarity=0.366 Sum_probs=205.4
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
..+.+.++||+|+||.||+|.++ .+..||||+++... ...+.|.+|+.++++++||||+++++++.+ ...++||||
T Consensus 184 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 184 ESLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET--TTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred hHceeeeeecCCCCeEEEEEEEC--CCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 34556688999999999999885 45679999997643 235689999999999999999999999976 678999999
Q ss_pred cCCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 514 MGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 514 ~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
+++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++........
T Consensus 260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 336 (452)
T 1fmk_A 260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 336 (452)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCcee
Confidence 9999999999753 4688999999999999999999997 9999999999999999999999999999876543333
Q ss_pred ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhh
Q 047292 592 THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEA 670 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 670 (728)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.... ...+...
T Consensus 337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~--------i~~~~~~-------- 400 (452)
T 1fmk_A 337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ--------VERGYRM-------- 400 (452)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH--------HHTTCCC--------
T ss_pred cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH--------HHcCCCC--------
Confidence 3333457889999999999999999999999999999999 8999975543322111 1111100
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCCCC
Q 047292 671 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNPPW 717 (728)
Q Consensus 671 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~~~ 717 (728)
..+......+.+++.+||+.||++|||+++|++.|+.+.....|+.
T Consensus 401 -~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~ 446 (452)
T 1fmk_A 401 -PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 446 (452)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCC
T ss_pred -CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCccc
Confidence 0112234567789999999999999999999999999887665543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=353.14 Aligned_cols=250 Identities=26% Similarity=0.327 Sum_probs=201.8
Q ss_pred HHHHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccc-cccceeeEeeeeecCCcc
Q 047292 432 KDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNR 507 (728)
Q Consensus 432 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 507 (728)
.-..+.+.+.||+|+||.||++..+ .+++.||||+++... ......+..|..++..+ +||||+++++++......
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~-~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVK-ETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEc-CCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 3344566788999999999999876 568899999997532 23346788999999988 799999999999999999
Q ss_pred eeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcccccc
Q 047292 508 LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS 587 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 587 (728)
++||||+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++....
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 99999999999999999888899999999999999999999997 999999999999999999999999999985432
Q ss_pred CCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccc
Q 047292 588 DHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDS 667 (728)
Q Consensus 588 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 667 (728)
.. .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+....+. .+...
T Consensus 177 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~--------~~~~~----- 242 (353)
T 3txo_A 177 NG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL--------NDEVV----- 242 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--------HCCCC-----
T ss_pred CC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHH--------cCCCC-----
Confidence 22 22334569999999999999999999999999999999999999998765543322221 11110
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 047292 668 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTM------KVVMQ 704 (728)
Q Consensus 668 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~------~evl~ 704 (728)
.+......+.+++.+||+.||.+||++ ++|++
T Consensus 243 -----~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 243 -----YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred -----CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 011123457789999999999999998 67664
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=354.76 Aligned_cols=259 Identities=28% Similarity=0.375 Sum_probs=206.4
Q ss_pred HHhhHHhhhCCCceeEEEEeeee----CCCCcEEEEEEecccc-hhhHHHHHHHHHHhccc-cccceeeEeeeeecCCc-
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLK----TASGNAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALN- 506 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~----~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~- 506 (728)
..+.+.+.||+|+||.||+|.+. ..+++.||||+++... ....+.+.+|++++.++ +||||+++++++.....
T Consensus 22 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 101 (359)
T 3vhe_A 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 101 (359)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred cceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCc
Confidence 34556688999999999999853 3456899999997643 33457899999999999 79999999999877554
Q ss_pred ceeEeeccCCCCHHHHHhcCCC----------------------------------------------------------
Q 047292 507 RLLVYEFMGNGTLANLIFAIPK---------------------------------------------------------- 528 (728)
Q Consensus 507 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 528 (728)
.++||||+++|+|.+++.....
T Consensus 102 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (359)
T 3vhe_A 102 LMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 181 (359)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------------
T ss_pred eEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccc
Confidence 8999999999999999986532
Q ss_pred --------CChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC-cccccccCC
Q 047292 529 --------PDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS-RTHTMIRGT 599 (728)
Q Consensus 529 --------~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt 599 (728)
+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .......||
T Consensus 182 ~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t 258 (359)
T 3vhe_A 182 PEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258 (359)
T ss_dssp --CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEEC
T ss_pred ccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCC
Confidence 78889999999999999999997 999999999999999999999999999986644322 233345688
Q ss_pred ccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHHHH
Q 047292 600 RGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRL 678 (728)
Q Consensus 600 ~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 678 (728)
+.|+|||++.+..++.++||||||+++|||+| |+.||.......... .....+..... .....
T Consensus 259 ~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~-------~~~~~~~~~~~---------~~~~~ 322 (359)
T 3vhe_A 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC-------RRLKEGTRMRA---------PDYTT 322 (359)
T ss_dssp GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH-------HHHHHTCCCCC---------CTTCC
T ss_pred ceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHH-------HHHHcCCCCCC---------CCCCC
Confidence 99999999999999999999999999999998 999997543222111 11111111111 11123
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 679 HKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 679 ~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
..+.+++.+||+.||.+|||+++|++.|+.+++
T Consensus 323 ~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 323 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 457789999999999999999999999998763
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=350.77 Aligned_cols=255 Identities=23% Similarity=0.352 Sum_probs=199.7
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCCc----EEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCcce
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASGN----AIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRL 508 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 508 (728)
..+.+.+.||+|+||.||+|.+.. +++ .||+|.+.... ....+.+.+|+.++++++||||+++++++.... .+
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC-----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHcccceEEeeCCCeEEEEEEEcC-CCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 345566889999999999998753 333 46888885432 344578999999999999999999999998754 78
Q ss_pred eEeeccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcccccc
Q 047292 509 LVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS 587 (728)
Q Consensus 509 lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 587 (728)
+|+||+++|+|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++++||+|||+++....
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 999999999999999874 5789999999999999999999997 999999999999999999999999999987654
Q ss_pred CCCc-ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceec
Q 047292 588 DHSR-THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALI 665 (728)
Q Consensus 588 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (728)
.... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...........+ ..+...
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~--------~~~~~~--- 238 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL--------EKGERL--- 238 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH--------HTTCCC---
T ss_pred CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHH--------HcCCCC---
Confidence 4322 2233456889999999999999999999999999999999 99999765443322111 111100
Q ss_pred cchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 047292 666 DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710 (728)
Q Consensus 666 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 710 (728)
.........+.+++.+||+.||.+||+++++++.|+.+.
T Consensus 239 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 239 ------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp ------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred ------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 011122346778999999999999999999999998765
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=347.69 Aligned_cols=252 Identities=26% Similarity=0.342 Sum_probs=205.7
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEe
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 511 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 511 (728)
..+.+.+.||+|+||.||++..+ .+++.||+|++... .....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHK-TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEEC-CCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 45666788999999999999876 56889999999643 2344577899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCC---CceEEccccCccccccC
Q 047292 512 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHY---FSPKISDFGLSKLLLSD 588 (728)
Q Consensus 512 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~---~~~kl~Dfgla~~~~~~ 588 (728)
||+++|+|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||++......
T Consensus 108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 108 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp CCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 9999999999999888899999999999999999999997 99999999999999865 45999999999876433
Q ss_pred CCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccch
Q 047292 589 HSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSD 668 (728)
Q Consensus 589 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 668 (728)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+ ..+... .. ..
T Consensus 185 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i--------~~~~~~-~~-~~ 252 (362)
T 2bdw_A 185 E--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--------KAGAYD-YP-SP 252 (362)
T ss_dssp C--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHTCCC-CC-TT
T ss_pred c--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--------HhCCCC-CC-cc
Confidence 2 223456999999999999999999999999999999999999999765443322111 111110 00 00
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 669 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 669 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.. ......+.+++.+||+.||.+||++.++++.
T Consensus 253 ~~----~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 253 EW----DTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp GG----GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cc----cCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 1123457789999999999999999998854
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=344.74 Aligned_cols=255 Identities=24% Similarity=0.366 Sum_probs=203.5
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCC------cEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcc
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASG------NAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNR 507 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 507 (728)
..+.+.+.||+|+||.||+|..+.... ..||+|++........+.+.+|+.++++++||||+++++++......
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 445567889999999999998763321 47999999876666778899999999999999999999999999999
Q ss_pred eeEeeccCCCCHHHHHhcCCC-CChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCc--------eEEcc
Q 047292 508 LLVYEFMGNGTLANLIFAIPK-PDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFS--------PKISD 578 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~--------~kl~D 578 (728)
++||||+++++|.+++..... +++..++.++.||+.||.|||++ +|+||||||+|||++.++. +||+|
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D 164 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred EEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeecc
Confidence 999999999999999987654 89999999999999999999997 9999999999999998887 99999
Q ss_pred ccCccccccCCCcccccccCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCcchh-hhHhhhhhHHHHHHHhh
Q 047292 579 FGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKN-APVSAKVDVYSFGVMLLEIICCRRSVEME-LEEESRAILTDWAYDCY 656 (728)
Q Consensus 579 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvil~elltg~~p~~~~-~~~~~~~~~~~~~~~~~ 656 (728)
||++..... .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.|+... ......... .
T Consensus 165 fg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~-------~ 232 (289)
T 4fvq_A 165 PGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY-------E 232 (289)
T ss_dssp CCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-------H
T ss_pred CcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh-------h
Confidence 999865422 223457889999999987 67899999999999999999966554432 222111100 0
Q ss_pred hcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCC
Q 047292 657 VEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNP 715 (728)
Q Consensus 657 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~ 715 (728)
....+... ....+.+++.+||+.||.+|||++++++.|+.++....+
T Consensus 233 ~~~~~~~~------------~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~ 279 (289)
T 4fvq_A 233 DRHQLPAP------------KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLV 279 (289)
T ss_dssp TTCCCCCC------------SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-----
T ss_pred ccCCCCCC------------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCC
Confidence 01111111 123466799999999999999999999999999865433
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=346.03 Aligned_cols=257 Identities=16% Similarity=0.191 Sum_probs=205.1
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccc-cccceeeEeeeeecCCcceeEeecc
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
+.+.+.||+|+||.||+|... .+++.||||++.... ....+.+|+.+++++ +|+||+++++++......++||||+
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (330)
T 2izr_A 11 FRVGKKIGCGNFGELRLGKNL-YTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL 87 (330)
T ss_dssp EEEEEECCC-CTTSEEEEEET-TTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred eEEEEEeeccCCceEEEEEEC-CCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence 345678999999999999865 578999999986532 234688999999999 9999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCc-----eEEccccCccccccC
Q 047292 515 GNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFS-----PKISDFGLSKLLLSD 588 (728)
Q Consensus 515 ~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~-----~kl~Dfgla~~~~~~ 588 (728)
+++|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++. +||+|||+++.....
T Consensus 88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~ 163 (330)
T 2izr_A 88 -GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP 163 (330)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence 99999999864 6789999999999999999999997 9999999999999998887 999999999876443
Q ss_pred CCc------ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccc
Q 047292 589 HSR------THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLD 662 (728)
Q Consensus 589 ~~~------~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (728)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+.......... ..
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~-~~- 241 (330)
T 2izr_A 164 ETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT-PI- 241 (330)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS-CH-
T ss_pred CCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC-CH-
Confidence 321 1234679999999999999999999999999999999999999998643322221111111100000 00
Q ss_pred eeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 047292 663 ALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710 (728)
Q Consensus 663 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 710 (728)
...... ...+.+++.+||+.||.+||++++|++.|+.+.
T Consensus 242 --------~~~~~~-~p~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 242 --------EVLCEN-FPEMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp --------HHHTTT-CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred --------HHHhcc-ChHHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 000000 127788999999999999999999999998765
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=341.88 Aligned_cols=257 Identities=21% Similarity=0.313 Sum_probs=196.0
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCC--CCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeE
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTA--SGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 510 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~--~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 510 (728)
..+.+.+.||+|+||.||+|..... .+..||+|++.... ....+.+.+|+.++++++||||+++++++. ....++|
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv 93 (281)
T 1mp8_A 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 93 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEE
Confidence 4455678899999999999987532 34579999987533 334578999999999999999999999985 4678999
Q ss_pred eeccCCCCHHHHHhcCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCC
Q 047292 511 YEFMGNGTLANLIFAIP-KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH 589 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 589 (728)
|||+++++|.+++.... .+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (281)
T 1mp8_A 94 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170 (281)
T ss_dssp EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCccc
Confidence 99999999999998654 689999999999999999999997 99999999999999999999999999998775443
Q ss_pred CcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccch
Q 047292 590 SRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSD 668 (728)
Q Consensus 590 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 668 (728)
........+++.|+|||.+.+..++.++||||||+++|||++ |+.||...........+ ..+....
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i--------~~~~~~~----- 237 (281)
T 1mp8_A 171 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI--------ENGERLP----- 237 (281)
T ss_dssp --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH--------HTTCCCC-----
T ss_pred ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHH--------HcCCCCC-----
Confidence 333334457889999999999999999999999999999997 88999755433221111 1111111
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 669 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 669 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
........+.+++.+||+.||.+||++.++++.|+.+++
T Consensus 238 ----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 238 ----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 111223567789999999999999999999999988653
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=340.18 Aligned_cols=243 Identities=23% Similarity=0.301 Sum_probs=203.5
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch---hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
+.+.+.||+|+||.||++..+ .+++.||+|+++.... ...+.+.+|..+++.++||||+++++++.+....++|||
T Consensus 8 y~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e 86 (318)
T 1fot_A 8 FQILRTLGTGSFGRVHLIRSR-HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 86 (318)
T ss_dssp EEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred cEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEe
Confidence 445678999999999999876 5789999999965322 235678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 513 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 513 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
|+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++.....
T Consensus 87 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~---- 159 (318)
T 1fot_A 87 YIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---- 159 (318)
T ss_dssp CCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC----
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc----
Confidence 999999999999888899999999999999999999997 9999999999999999999999999999865332
Q ss_pred cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAM 672 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 672 (728)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...........+ ......
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i--------~~~~~~---------- 221 (318)
T 1fot_A 160 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI--------LNAELR---------- 221 (318)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--------HHCCCC----------
T ss_pred cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH--------HhCCCC----------
Confidence 23456999999999999999999999999999999999999999765443322211 111110
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047292 673 ADRSRLHKWLMIAMWCIQEDPSKRP-----TMKVVMQ 704 (728)
Q Consensus 673 ~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~ 704 (728)
.+......+.+++.+||+.||++|| ++++|++
T Consensus 222 ~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 222 FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 0111234677899999999999999 8898884
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=340.81 Aligned_cols=259 Identities=23% Similarity=0.324 Sum_probs=196.5
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhcc--ccccceeeEeeeeec----CCcce
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGR--THHKNLVQLLGFCDE----ALNRL 508 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~----~~~~~ 508 (728)
.+.+.+.||+|+||.||+|.. +++.||||++... ....+..|.+++.. ++||||+++++++.. ....+
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 9 DITLLECVGKGRYGEVWRGSW---QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GCEEEEEEEECSSEEEEEEEE---TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cEEEEEeeccCCCcEEEEEEE---CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 345568899999999999986 4789999998653 23455556666655 799999999998644 34579
Q ss_pred eEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhh--------hcCCCCeeecCCCCCCEEEcCCCceEEcccc
Q 047292 509 LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLH--------EGCNVPIIHCDIKPQNILLDHYFSPKISDFG 580 (728)
Q Consensus 509 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH--------~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg 580 (728)
+||||+++|+|.+++.. ..+++..++.++.||+.||+||| +. +|+||||||+|||++.++.+||+|||
T Consensus 83 lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg 158 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADLG 158 (301)
T ss_dssp EEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeCC
Confidence 99999999999999954 57899999999999999999999 65 99999999999999999999999999
Q ss_pred CccccccCCCcc---cccccCCccccCcccccCC------CCCCccchhhHHHHHHHHHhC----------CcCcchhhh
Q 047292 581 LSKLLLSDHSRT---HTMIRGTRGYVAPEWLKNA------PVSAKVDVYSFGVMLLEIICC----------RRSVEMELE 641 (728)
Q Consensus 581 la~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~s~~~DVwSlGvil~elltg----------~~p~~~~~~ 641 (728)
+++......... .....||+.|+|||.+.+. .++.++||||||+++|||++| +.||.....
T Consensus 159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~ 238 (301)
T 3q4u_A 159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238 (301)
T ss_dssp TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence 998765433221 2234689999999999877 455799999999999999999 777754322
Q ss_pred HhhhhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 047292 642 EESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGL 709 (728)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 709 (728)
...... ................ ...........+.+++.+||+.||++|||+++|++.|+++
T Consensus 239 ~~~~~~--~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 239 NDPSFE--DMRKVVCVDQQRPNIP----NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SSCCHH--HHHHHHTTSCCCCCCC----GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcchh--hhhHHHhccCCCCCCC----hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 111100 0000001111111111 1112334567888999999999999999999999999864
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=347.62 Aligned_cols=253 Identities=23% Similarity=0.282 Sum_probs=202.7
Q ss_pred HHHHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch-----hhHHHHHHHHHHhccccccceeeEeeeeecCCc
Q 047292 432 KDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ-----EREREFKSEVSAIGRTHHKNLVQLLGFCDEALN 506 (728)
Q Consensus 432 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 506 (728)
....+.+.+.||+|+||.||++..+ .+++.||||++..... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 100 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINR-ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM 100 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cccceEEeeEEeeCCCEEEEEEEEC-CCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 3456677789999999999999876 5789999999864321 135779999999999999999999999999999
Q ss_pred ceeEeeccCCCCHHHHHhcC----CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCc---eEEccc
Q 047292 507 RLLVYEFMGNGTLANLIFAI----PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFS---PKISDF 579 (728)
Q Consensus 507 ~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~---~kl~Df 579 (728)
.++||||+++++|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+||
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecC
Confidence 99999999999998887643 3578999999999999999999997 9999999999999986554 999999
Q ss_pred cCccccccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcC
Q 047292 580 GLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEG 659 (728)
Q Consensus 580 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 659 (728)
|+++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......... ....+
T Consensus 178 g~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---------~i~~~ 247 (351)
T 3c0i_A 178 GVAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFE---------GIIKG 247 (351)
T ss_dssp TTCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHH---------HHHHT
T ss_pred cceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHH---------HHHcC
Confidence 99987654322 223456999999999999999999999999999999999999999764322111 11111
Q ss_pred ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 660 RLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 660 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
... ...... ......+.+++.+||+.||++|||+.++++
T Consensus 248 ~~~--~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 248 KYK--MNPRQW----SHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CCC--CCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCC--CCcccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 110 011000 112346778999999999999999999985
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=341.89 Aligned_cols=264 Identities=19% Similarity=0.259 Sum_probs=200.1
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcc----
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNR---- 507 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~---- 507 (728)
.+.+.+.||+|+||.||++... .+++.||||+++... ......+.+|+.++++++||||+++++++......
T Consensus 13 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 13 RYELGEILGFGGMSEVHLARDL-RDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred cEEEEEEEccCCCEEEEEEEEC-CCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 3456688999999999999875 568899999996532 23346789999999999999999999998776654
Q ss_pred eeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcccccc
Q 047292 508 LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS 587 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 587 (728)
++||||+++++|.+++.....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 92 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIAD 168 (311)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence 99999999999999998888899999999999999999999997 999999999999999999999999999987644
Q ss_pred CCC--cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceec
Q 047292 588 DHS--RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALI 665 (728)
Q Consensus 588 ~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (728)
... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... .........
T Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~-------~~~~~~~~~--- 238 (311)
T 3ork_A 169 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY-------QHVREDPIP--- 238 (311)
T ss_dssp -------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-------HHHHCCCCC---
T ss_pred cccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH-------HHhcCCCCC---
Confidence 322 12233568999999999999999999999999999999999999997654433211 111111100
Q ss_pred cchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHH-HHHHHhcCcCCCCCC
Q 047292 666 DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKV-VMQMLEGLLEVPNPP 716 (728)
Q Consensus 666 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~e-vl~~L~~~~~~~~~~ 716 (728)
...........+.+++.+||+.||.+||++.+ +.+.|........|+
T Consensus 239 ----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~~ 286 (311)
T 3ork_A 239 ----PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPE 286 (311)
T ss_dssp ----HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCCS
T ss_pred ----cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCCC
Confidence 00111123346778999999999999996554 556665554443333
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=346.90 Aligned_cols=245 Identities=25% Similarity=0.304 Sum_probs=197.4
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCCCCH
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTL 519 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 519 (728)
+.||+|+||.||+|... .+++.||+|+++.......+.+.+|++++++++||||+++++++......++||||+++++|
T Consensus 95 ~~lG~G~~g~Vy~a~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 95 EILGGGRFGQVHKCEET-ATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EECC-----CEEEEEET-TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred eEEecCcCEEEEEEEEc-CCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 56999999999999876 56889999999876556678899999999999999999999999999999999999999999
Q ss_pred HHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEE--cCCCceEEccccCccccccCCCcccccc
Q 047292 520 ANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILL--DHYFSPKISDFGLSKLLLSDHSRTHTMI 596 (728)
Q Consensus 520 ~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll--~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 596 (728)
.+++... ..+++..++.++.||++||+|||+. +|+||||||+|||+ +.++.+||+|||+++....... ....
T Consensus 174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~~~ 248 (373)
T 2x4f_A 174 FDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKVN 248 (373)
T ss_dssp HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CCCC
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--cccc
Confidence 9988765 4688999999999999999999997 99999999999999 5678999999999987643322 2334
Q ss_pred cCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHH
Q 047292 597 RGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRS 676 (728)
Q Consensus 597 ~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 676 (728)
.||+.|+|||++.+..++.++||||||+++|||++|+.||...........+. ..... +..... ..
T Consensus 249 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~--------~~~~~--~~~~~~----~~ 314 (373)
T 2x4f_A 249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNIL--------ACRWD--LEDEEF----QD 314 (373)
T ss_dssp CSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--------HTCCC--SCSGGG----TT
T ss_pred cCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--------hccCC--CChhhh----cc
Confidence 58999999999999999999999999999999999999998654433221111 11100 000000 11
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 677 RLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 677 ~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
....+.+++.+||+.||.+|||++|+++
T Consensus 315 ~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 315 ISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 2346788999999999999999999987
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=342.17 Aligned_cols=257 Identities=26% Similarity=0.366 Sum_probs=209.0
Q ss_pred HhhHHhhhCCCceeEEEEeeeeC----CCCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCccee
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKT----ASGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLL 509 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 509 (728)
.+.+.+.||+|+||.||++.... .+++.||||+++... ....+.+.+|++++++++||||+++++++......++
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 103 (314)
T 2ivs_A 24 NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLL 103 (314)
T ss_dssp GEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred heeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEE
Confidence 44556889999999999998642 345789999997543 3445789999999999999999999999999999999
Q ss_pred EeeccCCCCHHHHHhcCCC------------------------CChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCC
Q 047292 510 VYEFMGNGTLANLIFAIPK------------------------PDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQN 565 (728)
Q Consensus 510 v~e~~~~gsL~~~l~~~~~------------------------~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~N 565 (728)
||||+++++|.+++..... +++..++.++.||++||.|||++ +|+||||||+|
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~N 180 (314)
T 2ivs_A 104 IVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARN 180 (314)
T ss_dssp EEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGG
T ss_pred EEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccchhe
Confidence 9999999999999986533 78889999999999999999997 99999999999
Q ss_pred EEEcCCCceEEccccCccccccCCCc-ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHh
Q 047292 566 ILLDHYFSPKISDFGLSKLLLSDHSR-THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEE 643 (728)
Q Consensus 566 Ill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~ 643 (728)
|++++++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......
T Consensus 181 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 260 (314)
T 2ivs_A 181 ILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER 260 (314)
T ss_dssp EEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999999876443322 2233457889999999999999999999999999999999 999997654433
Q ss_pred hhhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 644 SRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
....+ ..+.... ........+.+++.+||+.||.+||++.++++.|++++.
T Consensus 261 ~~~~~--------~~~~~~~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 261 LFNLL--------KTGHRME---------RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp HHHHH--------HTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHh--------hcCCcCC---------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 22111 1111111 111223567889999999999999999999999998754
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=348.86 Aligned_cols=250 Identities=27% Similarity=0.357 Sum_probs=205.4
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccC
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
+.+.+.||+|+||.||+|..+ .+++.||+|++..........+.+|+.++++++||||+++++++.+....++||||++
T Consensus 53 y~i~~~LG~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 131 (387)
T 1kob_A 53 YDILEELGSGAFGVVHRCVEK-ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131 (387)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred eEEEEEEecCCCEEEEEEEEC-CCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCC
Confidence 456688999999999999876 5688999999976655566789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcC--CCceEEccccCccccccCCCcc
Q 047292 516 NGTLANLIFAIP-KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDH--YFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 516 ~gsL~~~l~~~~-~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~--~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
+|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+++...... .
T Consensus 132 gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~--~ 206 (387)
T 1kob_A 132 GGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--I 206 (387)
T ss_dssp CCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS--C
T ss_pred CCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCc--c
Confidence 999999998654 789999999999999999999997 9999999999999974 5789999999998764432 2
Q ss_pred cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAM 672 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 672 (728)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...........+ ...... ++...
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i--------~~~~~~--~~~~~--- 273 (387)
T 1kob_A 207 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV--------KRCDWE--FDEDA--- 273 (387)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH--------HHCCCC--CCSST---
T ss_pred eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHH--------HhCCCC--CCccc---
Confidence 23346899999999999999999999999999999999999999865443221111 111100 01100
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 673 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 673 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.......+.+++.+||+.||.+|||+.|+++.
T Consensus 274 -~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 274 -FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp -TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -cccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 11123467789999999999999999999874
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=344.59 Aligned_cols=260 Identities=28% Similarity=0.387 Sum_probs=210.2
Q ss_pred HHHhhHHhhhCCCceeEEEEeee----eCCCCcEEEEEEecccch-hhHHHHHHHHHHhccc-cccceeeEeeeeecCCc
Q 047292 433 DATDGFKEELGRGSFGIVYKGVL----KTASGNAIAVKKLDRLAQ-EREREFKSEVSAIGRT-HHKNLVQLLGFCDEALN 506 (728)
Q Consensus 433 ~~~~~~~~~lg~G~fg~Vy~g~~----~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 506 (728)
...+.+.+.||+|+||.||+|.. +..+++.||||+++.... ...+.+.+|+.+++++ +||||+++++++.....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 34556678899999999999986 335678999999975433 3457899999999999 99999999999999999
Q ss_pred ceeEeeccCCCCHHHHHhcCC------------------CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEE
Q 047292 507 RLLVYEFMGNGTLANLIFAIP------------------KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILL 568 (728)
Q Consensus 507 ~~lv~e~~~~gsL~~~l~~~~------------------~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll 568 (728)
.++||||+++|+|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEE
Confidence 999999999999999998653 378999999999999999999997 99999999999999
Q ss_pred cCCCceEEccccCccccccCCCc-ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhh
Q 047292 569 DHYFSPKISDFGLSKLLLSDHSR-THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRA 646 (728)
Q Consensus 569 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~ 646 (728)
++++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||..........
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 258 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHH
Confidence 99999999999999876544332 2223457889999999999999999999999999999999 999987543322111
Q ss_pred hHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 647 ILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
... .... .... .......+.+++.+||+.||.+|||++++++.|+++++
T Consensus 259 ---~~~----~~~~-~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 259 ---KMI----KEGF-RMLS--------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp ---HHH----HHTC-CCCC--------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHh----ccCC-CCCC--------cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 101 1110 0000 11223467789999999999999999999999998663
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=348.89 Aligned_cols=262 Identities=25% Similarity=0.328 Sum_probs=207.1
Q ss_pred HHHhhHHhhhCCCceeEEEEeeee----CCCCcEEEEEEecccc-hhhHHHHHHHHHHhccc-cccceeeEeeeeecCCc
Q 047292 433 DATDGFKEELGRGSFGIVYKGVLK----TASGNAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALN 506 (728)
Q Consensus 433 ~~~~~~~~~lg~G~fg~Vy~g~~~----~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 506 (728)
...+.+.+.||+|+||.||+|... ...+..||||++.... ......+.+|+.++.++ +||||+++++++.....
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 345566788999999999999873 3456789999997543 23347899999999999 89999999999999999
Q ss_pred ceeEeeccCCCCHHHHHhcCC-----------------------CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 047292 507 RLLVYEFMGNGTLANLIFAIP-----------------------KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKP 563 (728)
Q Consensus 507 ~~lv~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~ 563 (728)
.++||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp 200 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA 200 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCh
Confidence 999999999999999998653 268899999999999999999997 999999999
Q ss_pred CCEEEcCCCceEEccccCccccccCCCc-ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhh
Q 047292 564 QNILLDHYFSPKISDFGLSKLLLSDHSR-THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELE 641 (728)
Q Consensus 564 ~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~ 641 (728)
+|||++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.....
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 9999999999999999999876544322 2233457889999999999999999999999999999998 9999975433
Q ss_pred HhhhhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCC
Q 047292 642 EESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVP 713 (728)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~ 713 (728)
..... . ....+.... .+......+.+++.+||+.||.+||++.+|++.|+.++...
T Consensus 281 ~~~~~---~----~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 281 DANFY---K----LIQNGFKMD---------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp SHHHH---H----HHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred HHHHH---H----HHhcCCCCC---------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 22111 1 111111000 01112346778999999999999999999999999876543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=338.68 Aligned_cols=261 Identities=23% Similarity=0.261 Sum_probs=198.8
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch--hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
+.+.++||+|+||.||++... +++.||+|++..... .....+.+|++++++++||||+++++++......++||||
T Consensus 23 y~~~~~lG~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 100 (311)
T 3niz_A 23 YQKLEKVGEGTYGVVYKAKDS--QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEF 100 (311)
T ss_dssp EEEEEEEEECSSCEEEEEEET--TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEEC
T ss_pred hHhhhhccCCCCeEEEEEEEC--CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcC
Confidence 445678999999999999874 588999999965322 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 514 MGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 514 ~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
+++ +|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 101 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~ 175 (311)
T 3niz_A 101 MEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR-S 175 (311)
T ss_dssp CSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC--
T ss_pred CCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCcc-c
Confidence 985 788877765 4689999999999999999999997 999999999999999999999999999987643322 2
Q ss_pred cccccCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcC------------
Q 047292 593 HTMIRGTRGYVAPEWLKN-APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEG------------ 659 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------------ 659 (728)
.....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||...........+...... ....
T Consensus 176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~~~~~ 254 (311)
T 3niz_A 176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGT-PNPREWPQVQELPLWK 254 (311)
T ss_dssp --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCC-CCTTTSGGGTTSHHHH
T ss_pred ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCC-CChHHhhhhhccchhh
Confidence 233468999999999976 56899999999999999999999999765443322221111000 0000
Q ss_pred -ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 660 -RLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 660 -~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
......+.............++.+++.+||+.||++|||++|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000111111111112223456788999999999999999999986
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=340.94 Aligned_cols=257 Identities=28% Similarity=0.384 Sum_probs=212.3
Q ss_pred HHHHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEe
Q 047292 432 KDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 511 (728)
Q Consensus 432 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 511 (728)
....+.+.+.||+|+||.||+|..+ .++..||+|++... ....+.+.+|+.++++++||||+++++++......++||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEG-GGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEec-CCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 3444556788999999999999886 46789999999754 334578899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCC
Q 047292 512 EFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH 589 (728)
Q Consensus 512 e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 589 (728)
||+++++|.+++... ..+++..++.++.||+.||.|||++ +|+|+||||+||+++.++.+||+|||++.......
T Consensus 89 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 89 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp ECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred EcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 999999999999864 4588999999999999999999998 99999999999999999999999999998776554
Q ss_pred CcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccch
Q 047292 590 SRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSD 668 (728)
Q Consensus 590 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 668 (728)
........+++.|+|||.+.+..++.++||||||+++|||++ |+.||...........+ ......
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~--------~~~~~~------ 231 (288)
T 3kfa_A 166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL--------EKDYRM------ 231 (288)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH--------HTTCCC------
T ss_pred cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH--------hccCCC------
Confidence 444444567889999999999999999999999999999999 88998755433222111 011000
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 047292 669 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710 (728)
Q Consensus 669 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 710 (728)
.........+.+++.+||+.||.+||+++++++.|+.+.
T Consensus 232 ---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 232 ---ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 011122346778999999999999999999999998865
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=338.41 Aligned_cols=262 Identities=17% Similarity=0.203 Sum_probs=200.4
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch---hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
+.+.+.||+|+||.||++... .+++.||+|++..... ...+.+.+|+.++++++||||+++++++......++|+|
T Consensus 36 y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 2h34_A 36 YRLRRLVGRGGMGDVYEAEDT-VRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMR 114 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEET-TTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EEEEEEEcCCCCeeEEEEEEc-CCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEE
Confidence 455688999999999999875 4678999999965432 234778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 513 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 513 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
|+++++|.+++.....+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++..........
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 191 (309)
T 2h34_A 115 LINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ 191 (309)
T ss_dssp CCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccccccccc
Confidence 999999999998878899999999999999999999997 99999999999999999999999999998765443333
Q ss_pred cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAM 672 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 672 (728)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||...........+ .. .... ...
T Consensus 192 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--------~~-~~~~------~~~ 256 (309)
T 2h34_A 192 LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI--------NQ-AIPR------PST 256 (309)
T ss_dssp -----CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH--------HS-CCCC------GGG
T ss_pred ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh--------cc-CCCC------ccc
Confidence 34456899999999999999999999999999999999999999865443211111 00 0000 001
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhcCcCCCCCC
Q 047292 673 ADRSRLHKWLMIAMWCIQEDPSKRP-TMKVVMQMLEGLLEVPNPP 716 (728)
Q Consensus 673 ~~~~~~~~l~~l~~~cl~~dp~~RP-t~~evl~~L~~~~~~~~~~ 716 (728)
........+.+++.+||+.||++|| +++++++.|+..+....+.
T Consensus 257 ~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~ 301 (309)
T 2h34_A 257 VRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQD 301 (309)
T ss_dssp TSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-----
T ss_pred cCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhccc
Confidence 1122234577899999999999999 9999999999987655443
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=360.30 Aligned_cols=247 Identities=28% Similarity=0.370 Sum_probs=201.4
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCC-cceeEeecc
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEAL-NRLLVYEFM 514 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~lv~e~~ 514 (728)
+.+.+.||+|+||.||+|.++ ++.||||+++... ..+.|.+|+.++++++||||+++++++.... ..++||||+
T Consensus 195 ~~~~~~lG~G~fg~V~~~~~~---~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 195 LKLLQTIGKGEFGDVMLGDYR---GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp EEEEEEEEECSSEEEEEEEET---TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred eEEEeeecCcCCeeEEEEEec---CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 445678999999999999874 6799999997643 4568999999999999999999999987655 789999999
Q ss_pred CCCCHHHHHhcCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 515 GNGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 515 ~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 270 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---- 342 (450)
T 1k9a_A 270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 342 (450)
T ss_dssp TTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc----
Confidence 9999999998653 368899999999999999999997 9999999999999999999999999999854322
Q ss_pred cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAA 671 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 671 (728)
.....+++.|+|||.+.+..++.++||||||+++|||+| |+.||......+.... ...+...
T Consensus 343 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~--------i~~~~~~--------- 405 (450)
T 1k9a_A 343 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR--------VEKGYKM--------- 405 (450)
T ss_dssp ----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHH--------HHTTCCC---------
T ss_pred ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--------HHcCCCC---------
Confidence 122356889999999999999999999999999999999 9999975543322111 1111100
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 672 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 672 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
..+......+.+++.+||+.||.+|||+++|++.|+.+.+
T Consensus 406 ~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 406 DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 0111234567789999999999999999999999988754
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=345.27 Aligned_cols=251 Identities=28% Similarity=0.365 Sum_probs=201.0
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch-hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
+.+.+.||+|+||.||+|... .+++.||||++..... ...+.+.+|+.+++.++||||+++++++.+....++||||+
T Consensus 9 y~i~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 87 (323)
T 3tki_A 9 WDLVQTLGEGAYGEVQLAVNR-VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 87 (323)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred ceeeeEEecCCCEEEEEEEEC-CCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcC
Confidence 445678999999999999876 5788999999864332 23467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCC-Cccc
Q 047292 515 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH-SRTH 593 (728)
Q Consensus 515 ~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~ 593 (728)
++++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 164 (323)
T 3tki_A 88 SGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (323)
T ss_dssp TTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCccccc
Confidence 9999999998888899999999999999999999997 99999999999999999999999999998764332 2223
Q ss_pred ccccCCccccCcccccCCCC-CCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhh
Q 047292 594 TMIRGTRGYVAPEWLKNAPV-SAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAM 672 (728)
Q Consensus 594 ~~~~gt~~y~aPE~~~~~~~-s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 672 (728)
....||+.|+|||++.+..+ +.++||||||+++|||++|+.||......... ...+ ...... ...
T Consensus 165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--~~~~-----~~~~~~--~~~----- 230 (323)
T 3tki_A 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDW-----KEKKTY--LNP----- 230 (323)
T ss_dssp CSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH--HHHH-----HTTCTT--STT-----
T ss_pred CCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH--HHHH-----hccccc--CCc-----
Confidence 34679999999999988775 77999999999999999999999754332111 1111 111000 000
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 673 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 673 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.......+.+++.+||+.||.+|||++|+++.
T Consensus 231 -~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 231 -WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp -GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 01123456789999999999999999999864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=348.31 Aligned_cols=249 Identities=25% Similarity=0.309 Sum_probs=197.7
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch---hhHHHHHHHHHHhccc-cccceeeEeeeeecCCcceeEe
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ---EREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVY 511 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~ 511 (728)
+.+.+.||+|+||.||++..+ .+++.||+|+++.... .....+..|..++.++ +||||+++++++......++||
T Consensus 54 y~~~~~LG~G~fG~V~~~~~~-~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~ 132 (396)
T 4dc2_A 54 FDLLRVIGRGSYAKVLLVRLK-KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 132 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred cEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEE
Confidence 455678999999999999876 5688999999975432 2235688899999887 8999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 512 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 512 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
||+++|+|..++.....+++..+..++.||+.||+|||++ +|+||||||+||||+.++++||+|||+++...... .
T Consensus 133 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~-~ 208 (396)
T 4dc2_A 133 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-D 208 (396)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-C
T ss_pred EcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecccCC-C
Confidence 9999999999999888899999999999999999999997 99999999999999999999999999998633222 2
Q ss_pred ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhh-hhHHHHHHHhhhcCccceeccchhh
Q 047292 592 THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESR-AILTDWAYDCYVEGRLDALIDSDEA 670 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~~~ 670 (728)
......||+.|+|||++.+..++.++||||||+++|||++|+.||......... ...............+.
T Consensus 209 ~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~-------- 280 (396)
T 4dc2_A 209 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR-------- 280 (396)
T ss_dssp CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC--------
T ss_pred ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC--------
Confidence 234467999999999999999999999999999999999999999643221110 00001111111111110
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCH
Q 047292 671 AMADRSRLHKWLMIAMWCIQEDPSKRPTM 699 (728)
Q Consensus 671 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~ 699 (728)
.+......+.+++.+||+.||.+||++
T Consensus 281 --~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 281 --IPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp --CCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred --CCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 111223467789999999999999985
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=334.92 Aligned_cols=263 Identities=19% Similarity=0.224 Sum_probs=197.6
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
+.+.++||+|+||.||+|..+ .+++.||||++.... ......+.+|+.++++++||||+++++++......++||||
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 82 (292)
T 3o0g_A 4 YEKLEKIGEGTYGTVFKAKNR-ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ceeeeEecCCCCeEEEEEEEC-CCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEec
Confidence 345678999999999999876 568899999986432 33347788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccc
Q 047292 514 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH 593 (728)
Q Consensus 514 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 593 (728)
++++.+..+......+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 158 (292)
T 3o0g_A 83 CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CY 158 (292)
T ss_dssp CSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS-CC
T ss_pred CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCccc-cc
Confidence 98754444444467899999999999999999999997 999999999999999999999999999987643322 22
Q ss_pred ccccCCccccCcccccCCC-CCCccchhhHHHHHHHHHhCCcCcchh-hhHhhhhhHHHHHHHhhhcCccc---eecc--
Q 047292 594 TMIRGTRGYVAPEWLKNAP-VSAKVDVYSFGVMLLEIICCRRSVEME-LEEESRAILTDWAYDCYVEGRLD---ALID-- 666 (728)
Q Consensus 594 ~~~~gt~~y~aPE~~~~~~-~s~~~DVwSlGvil~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~---~~~d-- 666 (728)
....||+.|+|||++.+.. ++.++||||||+++|||++|+.|+... ........+.... ......... ...+
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~ 237 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL-GTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHH-CCCCTTTCTTGGGSTTCC
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHh-CCCChhhhhhhccccccc
Confidence 3456899999999998765 799999999999999999998886433 2222111111100 000000000 0000
Q ss_pred -------chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 667 -------SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 667 -------~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
..............+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00000111123456778999999999999999999986
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=346.66 Aligned_cols=246 Identities=26% Similarity=0.304 Sum_probs=202.6
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccc-cccceeeEeeeeecCCcceeE
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLV 510 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv 510 (728)
.+.+.+.||+|+||.||++..+ .+++.||||+++... ......+..|..++..+ +||||+++++++......++|
T Consensus 18 ~y~~~~~lG~G~fg~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv 96 (345)
T 1xjd_A 18 DFILHKMLGKGSFGKVFLAEFK-KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 96 (345)
T ss_dssp TEEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred HeEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEE
Confidence 3445678999999999999876 578999999997532 23346788899999877 899999999999999999999
Q ss_pred eeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC
Q 047292 511 YEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 590 (728)
|||+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++.......
T Consensus 97 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 173 (345)
T 1xjd_A 97 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 173 (345)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCC
Confidence 99999999999998878899999999999999999999997 999999999999999999999999999986432222
Q ss_pred cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhh
Q 047292 591 RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEA 670 (728)
Q Consensus 591 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 670 (728)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+ ..+.. .
T Consensus 174 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i--------~~~~~-~------- 236 (345)
T 1xjd_A 174 -KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI--------RMDNP-F------- 236 (345)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHCCC-C-------
T ss_pred -cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH--------HhCCC-C-------
Confidence 233457999999999999999999999999999999999999999865543322211 11110 0
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 047292 671 AMADRSRLHKWLMIAMWCIQEDPSKRPTMK-VVM 703 (728)
Q Consensus 671 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~-evl 703 (728)
.+......+.+++.+||+.||++||++. +|+
T Consensus 237 --~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 237 --YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp --CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred --CCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 0111234677899999999999999997 654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=343.71 Aligned_cols=266 Identities=24% Similarity=0.350 Sum_probs=206.3
Q ss_pred HHHhhHHhhhCCCceeEEEEeee---eCCCCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecC--Cc
Q 047292 433 DATDGFKEELGRGSFGIVYKGVL---KTASGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEA--LN 506 (728)
Q Consensus 433 ~~~~~~~~~lg~G~fg~Vy~g~~---~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~ 506 (728)
...+.+.+.||+|+||.||++.+ ...+++.||||+++... ......+.+|+.++++++|+||+++++++... ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 33455668899999999999985 23568899999997533 23357899999999999999999999999876 66
Q ss_pred ceeEeeccCCCCHHHHHhc-CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcccc
Q 047292 507 RLLVYEFMGNGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLL 585 (728)
Q Consensus 507 ~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~ 585 (728)
.++||||+++++|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccccc
Confidence 8999999999999999954 46789999999999999999999997 9999999999999999999999999999877
Q ss_pred ccCCC--cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhh-------hHHHHHHHhh
Q 047292 586 LSDHS--RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRA-------ILTDWAYDCY 656 (728)
Q Consensus 586 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~-------~~~~~~~~~~ 656 (728)
..... .......+|..|+|||.+.+..++.++||||||+++|||++|+.|+.......... ..........
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 256 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence 54432 22234557888999999999999999999999999999999999875432211100 0000001111
Q ss_pred hcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 047292 657 VEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710 (728)
Q Consensus 657 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 710 (728)
..+.. ..........+.+++.+||+.||.+|||+++++++|+.++
T Consensus 257 ~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 257 KEGKR---------LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HTTCC---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hccCC---------CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 11110 0111223356788999999999999999999999998865
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=343.51 Aligned_cols=243 Identities=23% Similarity=0.237 Sum_probs=203.9
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
+.+.+.||+|+||.||++..+ .+++.||||++.... ......+.+|+.+++.++||||+++++++.+....++|||
T Consensus 43 y~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 121 (350)
T 1rdq_E 43 FDRIKTLGTGSFGRVMLVKHK-ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp EEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CEEEEEeecCcCcEEEEEEEC-CCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEc
Confidence 445678999999999999876 578899999996532 2334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 513 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 513 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
|+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++.....
T Consensus 122 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~---- 194 (350)
T 1rdq_E 122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---- 194 (350)
T ss_dssp CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC----
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC----
Confidence 999999999999888899999999999999999999997 9999999999999999999999999999876432
Q ss_pred cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAM 672 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 672 (728)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...........+ ..+...
T Consensus 195 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i--------~~~~~~---------- 256 (350)
T 1rdq_E 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI--------VSGKVR---------- 256 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHCCCC----------
T ss_pred cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHH--------HcCCCC----------
Confidence 23356899999999999999999999999999999999999999865443322211 111110
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 047292 673 ADRSRLHKWLMIAMWCIQEDPSKRPT-----MKVVMQ 704 (728)
Q Consensus 673 ~~~~~~~~l~~l~~~cl~~dp~~RPt-----~~evl~ 704 (728)
.+......+.+++.+||+.||.+||+ +++|++
T Consensus 257 ~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 257 FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 01122346778999999999999998 888875
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=345.16 Aligned_cols=245 Identities=24% Similarity=0.333 Sum_probs=200.9
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch---hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
+.+.+.||+|+||.||+|... .+++.||||++..... .....+.+|+.+++.++||||+++++++......++|||
T Consensus 11 Y~i~~~lG~G~~g~V~~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 89 (336)
T 3h4j_B 11 YIIRETLGEGSFGKVKLATHY-KTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE 89 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred EEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEE
Confidence 445678999999999999875 5788999999865322 223578999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 513 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 513 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
|+ +|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||++....... .
T Consensus 90 ~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~--~ 163 (336)
T 3h4j_B 90 YA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN--F 163 (336)
T ss_dssp CC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB--T
T ss_pred CC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCc--c
Confidence 99 789999998888899999999999999999999998 99999999999999999999999999998764332 2
Q ss_pred cccccCCccccCcccccCCCC-CCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPV-SAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAA 671 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~-s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 671 (728)
.....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||........... +... ..
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~-----------------i~~~-~~ 225 (336)
T 3h4j_B 164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK-----------------VNSC-VY 225 (336)
T ss_dssp TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC-----------------CCSS-CC
T ss_pred cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH-----------------HHcC-CC
Confidence 234569999999999998876 7899999999999999999999975432221110 0000 00
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 672 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 672 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
..+......+.+++.+||+.||.+|||++|+++.
T Consensus 226 ~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 226 VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 0111223457789999999999999999999863
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=345.66 Aligned_cols=249 Identities=23% Similarity=0.309 Sum_probs=202.8
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEe
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 511 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 511 (728)
.+.+.+.||+|+||.||++..+ .+++.||+|++.... ......+.+|+.+++.++||||+++++++......++||
T Consensus 16 ~y~i~~~LG~G~fG~V~~~~~~-~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 16 HFEILRAIGKGSFGKVCIVQKN-DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GEEEEEEEECCTTCCEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HeEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 3456688999999999999876 568899999986532 233467899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 512 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 512 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
||+++|+|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||++.++++||+|||+++..... .
T Consensus 95 e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--~ 169 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE--T 169 (384)
T ss_dssp CCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT--C
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCC--C
Confidence 9999999999999888899999999999999999999997 9999999999999999999999999999876432 2
Q ss_pred ccccccCCccccCcccccC---CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccch
Q 047292 592 THTMIRGTRGYVAPEWLKN---APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSD 668 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~---~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 668 (728)
......||+.|+|||++.. ..++.++||||||+++|||++|+.||.............. ......
T Consensus 170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~-----~~~~~~------- 237 (384)
T 4fr4_A 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT-----FETTVV------- 237 (384)
T ss_dssp CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHH-----HHHCCC-------
T ss_pred ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHH-----Hhhccc-------
Confidence 2344679999999999964 4589999999999999999999999975433222111111 011100
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 047292 669 EAAMADRSRLHKWLMIAMWCIQEDPSKRPT-MKVVMQ 704 (728)
Q Consensus 669 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt-~~evl~ 704 (728)
..+......+.+++.+||+.||.+||+ +++|++
T Consensus 238 ---~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 ---TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ---CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 011122346778999999999999998 777764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=337.92 Aligned_cols=263 Identities=24% Similarity=0.313 Sum_probs=191.2
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch-hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
.+.+.+.||+|+||.||+|..+ .+++.||+|+++.... .....+.+|+.++++++||||+++++++......++||||
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 84 (317)
T 2pmi_A 6 QFKQLEKLGNGTYATVYKGLNK-TTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEF 84 (317)
T ss_dssp -------------CEEEEEECS-SSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEEC
T ss_pred ceeEeeEECCCCCEEEEEEEEC-CCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEe
Confidence 3556789999999999999876 5688999999865332 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcccccc
Q 047292 514 MGNGTLANLIFAI------PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS 587 (728)
Q Consensus 514 ~~~gsL~~~l~~~------~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 587 (728)
++ ++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 85 MD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp CC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred cC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 98 5999988653 3578899999999999999999997 999999999999999999999999999987643
Q ss_pred CCCcccccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcC-------
Q 047292 588 DHSRTHTMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEG------- 659 (728)
Q Consensus 588 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------- 659 (728)
... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||......+....+...... ....
T Consensus 161 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~ 238 (317)
T 2pmi_A 161 PVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGT-PNESLWPSVTK 238 (317)
T ss_dssp CCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS-CCTTTCGGGGG
T ss_pred Ccc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC-CChhHhhhhhh
Confidence 322 22334689999999999764 6899999999999999999999999866544332222111000 0000
Q ss_pred ------ccceecc----chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 660 ------RLDALID----SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 660 ------~~~~~~d----~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
.+..... ..............+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0000000 00000011122346789999999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=347.49 Aligned_cols=266 Identities=25% Similarity=0.341 Sum_probs=211.1
Q ss_pred HHhhHHhhhCCCceeEEEEeee---eCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeee--cCCcce
Q 047292 434 ATDGFKEELGRGSFGIVYKGVL---KTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCD--EALNRL 508 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~---~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~~~ 508 (728)
..+.+.+.||+|+||.||++.+ ...+++.||||++........+.+.+|++++++++|+||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 3455668899999999999985 33567899999998776666788999999999999999999999886 456688
Q ss_pred eEeeccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcccccc
Q 047292 509 LVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS 587 (728)
Q Consensus 509 lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 587 (728)
+||||+++++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 999999999999999864 5689999999999999999999997 999999999999999999999999999987654
Q ss_pred CCCc--ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhH-------HHHHHHhhhc
Q 047292 588 DHSR--THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAIL-------TDWAYDCYVE 658 (728)
Q Consensus 588 ~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~-------~~~~~~~~~~ 658 (728)
.... ......+|+.|+|||.+.+..++.++||||||+++|||++|+.||............ ..........
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE 259 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHT
T ss_pred CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhc
Confidence 3322 223345788899999999999999999999999999999999998755433211000 0000011111
Q ss_pred CccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 659 GRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 659 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
+. ...........+.+++.+||+.||.+|||++++++.|+.+..
T Consensus 260 ~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 260 GQ---------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp TC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred cc---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11 011122334567889999999999999999999999998763
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=330.04 Aligned_cols=249 Identities=22% Similarity=0.304 Sum_probs=205.1
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
.+.+.+.||+|+||.||+|..+ .++..||+|++........+.+.+|++++++++||||+++++++......++||||+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (277)
T 3f3z_A 10 YYTLENTIGRGSWGEVKIAVQK-GTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC 88 (277)
T ss_dssp HEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hEEeeeEEeecCCEEEEEEEeC-CCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence 4556678999999999999876 567899999997765566788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEE---cCCCceEEccccCccccccCCCc
Q 047292 515 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILL---DHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 515 ~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll---~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
++++|.+++.....+++..+..++.|++.||.|||++ +|+||||||+||++ +.++.+||+|||++.......
T Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~-- 163 (277)
T 3f3z_A 89 TGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-- 163 (277)
T ss_dssp CSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS--
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc--
Confidence 9999999998888899999999999999999999997 99999999999999 788999999999998764332
Q ss_pred ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhh
Q 047292 592 THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAA 671 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 671 (728)
......||+.|+|||.+.+. ++.++||||||+++|||++|+.||...........+ ..+... ......
T Consensus 164 ~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~--~~~~~~- 231 (277)
T 3f3z_A 164 MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI--------REGTFT--FPEKDW- 231 (277)
T ss_dssp CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHCCCC--CCHHHH-
T ss_pred chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHH--------HhCCCC--CCchhh-
Confidence 22345689999999998765 899999999999999999999999765443322111 111110 000000
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 672 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 672 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
......+.+++.+||+.||.+||++.++++
T Consensus 232 ---~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 232 ---LNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp ---TTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---hcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 012346778999999999999999999985
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=337.96 Aligned_cols=247 Identities=21% Similarity=0.323 Sum_probs=194.0
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCc--------
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALN-------- 506 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-------- 506 (728)
+.+.+.||+|+||.||+|..+ .+++.||||+++... ....+.+.+|+.++++++||||+++++++.+...
T Consensus 8 y~~~~~lG~G~~g~V~~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~ 86 (332)
T 3qd2_B 8 FEPIQCMGRGGFGVVFEAKNK-VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMD 86 (332)
T ss_dssp EEEEEEEECC-CSEEEEEEET-TTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHH
T ss_pred CceeeEecCCCCeEEEEEEEc-CCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhh
Confidence 445678999999999999876 578899999986433 3345789999999999999999999999855432
Q ss_pred -------------------------------------------------ceeEeeccCCCCHHHHHhcCCC---CChHHH
Q 047292 507 -------------------------------------------------RLLVYEFMGNGTLANLIFAIPK---PDWNLR 534 (728)
Q Consensus 507 -------------------------------------------------~~lv~e~~~~gsL~~~l~~~~~---~~~~~~ 534 (728)
.++||||+++++|.+++..... .++..+
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~ 166 (332)
T 3qd2_B 87 EIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC 166 (332)
T ss_dssp C--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHH
T ss_pred hhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHH
Confidence 7899999999999999987643 455678
Q ss_pred HHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC-----------cccccccCCcccc
Q 047292 535 VRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS-----------RTHTMIRGTRGYV 603 (728)
Q Consensus 535 ~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-----------~~~~~~~gt~~y~ 603 (728)
+.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .......||+.|+
T Consensus 167 ~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 243 (332)
T 3qd2_B 167 LHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243 (332)
T ss_dssp HHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred HHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence 99999999999999997 999999999999999999999999999987754321 1223356899999
Q ss_pred CcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHH
Q 047292 604 APEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLM 683 (728)
Q Consensus 604 aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~ 683 (728)
|||.+.+..++.++||||||+++|||++|..|+....... ......... .........+.+
T Consensus 244 aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~~----------~~~~~~~~~---------~~~~~~~~~~~~ 304 (332)
T 3qd2_B 244 SPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRII----------TDVRNLKFP---------LLFTQKYPQEHM 304 (332)
T ss_dssp CHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHH----------HHHHTTCCC---------HHHHHHCHHHHH
T ss_pred ChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHHH----------HHhhccCCC---------cccccCChhHHH
Confidence 9999999999999999999999999999987753221110 001111111 011223345678
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 047292 684 IAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 684 l~~~cl~~dp~~RPt~~evl~~ 705 (728)
++.+||+.||++|||++|+++.
T Consensus 305 li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 305 MVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHccCCCCcCCCHHHHhhc
Confidence 9999999999999999999863
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=334.07 Aligned_cols=251 Identities=27% Similarity=0.460 Sum_probs=198.8
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhh-------HHHHHHHHHHhccccccceeeEeeeeecCCcc
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQER-------EREFKSEVSAIGRTHHKNLVQLLGFCDEALNR 507 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~-------~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 507 (728)
.+.+.+.||+|+||.||+|... .+++.||+|++....... .+.+.+|+.++++++||||+++++++....
T Consensus 20 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 20 EIEYEKQIGKGGFGLVHKGRLV-KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TEEEEEECCCCSSSCEEEEEET-TTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred cceehhccccCCceeEEEEEEc-CCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 4556688999999999999876 568899999985432211 167899999999999999999999986654
Q ss_pred eeEeeccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCC--eeecCCCCCCEEEcCCCc-----eEEccc
Q 047292 508 LLVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVP--IIHCDIKPQNILLDHYFS-----PKISDF 579 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~--iiH~dlk~~NIll~~~~~-----~kl~Df 579 (728)
++||||+++++|.+++... ..+++..++.++.|++.||+|||++ + |+||||||+||+++.++. +||+||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 7999999999999988765 4789999999999999999999997 7 999999999999988776 999999
Q ss_pred cCccccccCCCcccccccCCccccCcccc--cCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhh
Q 047292 580 GLSKLLLSDHSRTHTMIRGTRGYVAPEWL--KNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYV 657 (728)
Q Consensus 580 gla~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 657 (728)
|+++.... ......||+.|+|||.+ ....++.++||||||+++|||++|+.||........... . ...
T Consensus 174 g~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~--~----~~~ 243 (287)
T 4f0f_A 174 GLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI--N----MIR 243 (287)
T ss_dssp TTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHH--H----HHH
T ss_pred Cccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHH--H----HHh
Confidence 99975432 23345689999999999 455678999999999999999999999975433221110 0 001
Q ss_pred cCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 047292 658 EGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGL 709 (728)
Q Consensus 658 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 709 (728)
.......+ .......+.+++.+||+.||.+|||++++++.|+++
T Consensus 244 ~~~~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 244 EEGLRPTI--------PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HSCCCCCC--------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ccCCCCCC--------CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 11111111 112234677899999999999999999999999864
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=343.70 Aligned_cols=247 Identities=28% Similarity=0.317 Sum_probs=203.1
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccc-cccceeeEeeeeecCCcceeE
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLV 510 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv 510 (728)
.+.+.+.||+|+||.||++..+ .+++.||||+++... ......+..|..++..+ +||||+++++++......++|
T Consensus 21 ~y~~~~~lG~G~fg~V~~~~~~-~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 99 (353)
T 2i0e_A 21 DFNFLMVLGKGSFGKVMLSERK-GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 99 (353)
T ss_dssp TEEEEEEEEEETTEEEEEEEET-TEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred HcEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence 3455678999999999999876 567899999997532 23346788999999988 899999999999999999999
Q ss_pred eeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC
Q 047292 511 YEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 590 (728)
|||+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++......
T Consensus 100 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~- 175 (353)
T 2i0e_A 100 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG- 175 (353)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC-
Confidence 99999999999999878899999999999999999999997 99999999999999999999999999998643222
Q ss_pred cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhh
Q 047292 591 RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEA 670 (728)
Q Consensus 591 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 670 (728)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||......+....+ ......
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i--------~~~~~~-------- 239 (353)
T 2i0e_A 176 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI--------MEHNVA-------- 239 (353)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHCCCC--------
T ss_pred cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHH--------HhCCCC--------
Confidence 2233456999999999999999999999999999999999999999865544322221 111110
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 047292 671 AMADRSRLHKWLMIAMWCIQEDPSKRPT-----MKVVMQ 704 (728)
Q Consensus 671 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----~~evl~ 704 (728)
.+......+.+++.+||+.||.+||+ +++|++
T Consensus 240 --~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 240 --YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp --CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred --CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 01122346778999999999999995 567664
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=336.39 Aligned_cols=250 Identities=23% Similarity=0.240 Sum_probs=195.3
Q ss_pred HHHHHHHHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHhccc-cccceeeEeeeeecC
Q 047292 428 YDELKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA--QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEA 504 (728)
Q Consensus 428 ~~el~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 504 (728)
..++....+.+.++||+|+||+||+|... .+++.||||++.... ......+..|+..+.++ +|+||+++++++.+.
T Consensus 51 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~ 129 (311)
T 3p1a_A 51 PESFFQQSFQRLSRLGHGSYGEVFKVRSK-EDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG 129 (311)
T ss_dssp SSCHHHHHEEEEEEEEEETTEEEEEEEET-TTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred ccchhhhheeeeheeccCCCeEEEEEEEC-CCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC
Confidence 34455566777789999999999999876 568999999985432 23344555666666555 899999999999999
Q ss_pred CcceeEeeccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcc
Q 047292 505 LNRLLVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSK 583 (728)
Q Consensus 505 ~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~ 583 (728)
...++||||+ +++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~ 205 (311)
T 3p1a_A 130 GILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLV 205 (311)
T ss_dssp TEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCE
T ss_pred CEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeee
Confidence 9999999999 67898888764 4689999999999999999999997 99999999999999999999999999998
Q ss_pred ccccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccce
Q 047292 584 LLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDA 663 (728)
Q Consensus 584 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (728)
...... ......||+.|+|||++.+ .++.++||||||+++|||++|..++....... ....+..
T Consensus 206 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~-----------~~~~~~~-- 269 (311)
T 3p1a_A 206 ELGTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQ-----------QLRQGYL-- 269 (311)
T ss_dssp ECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH-----------HHTTTCC--
T ss_pred ecccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH-----------HHhccCC--
Confidence 764332 2234568999999999886 78999999999999999999977665332111 1111111
Q ss_pred eccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 664 LIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 664 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
... ........+.+++.+||+.||++|||++|+++
T Consensus 270 --~~~----~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 270 --PPE----FTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp --CHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --Ccc----cccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 011 11122356788999999999999999999986
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=332.18 Aligned_cols=251 Identities=27% Similarity=0.403 Sum_probs=191.9
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch----hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEe
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ----EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 511 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 511 (728)
+.+.+.||+|+||.||+|.+. ++.||||+++.... ...+.+.+|+++++.++||||+++++++......++||
T Consensus 9 ~~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 9 LTLEEIIGIGGFGKVYRAFWI---GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEET---TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred eeeeeeeccCCCeEEEEEEEc---CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 445678999999999999863 78999999865332 22467899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcC--------CCceEEccccCcc
Q 047292 512 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDH--------YFSPKISDFGLSK 583 (728)
Q Consensus 512 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~--------~~~~kl~Dfgla~ 583 (728)
||+++++|.+++.. ..+++..+..++.|++.||+|||++...+|+||||||+||++++ ++.+||+|||+++
T Consensus 86 e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~ 164 (271)
T 3dtc_A 86 EFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164 (271)
T ss_dssp ECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--
T ss_pred EcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccc
Confidence 99999999999864 57899999999999999999999972223999999999999986 7789999999998
Q ss_pred ccccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccce
Q 047292 584 LLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDA 663 (728)
Q Consensus 584 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (728)
....... ....|++.|+|||.+.+..++.++||||||+++|||++|+.||........... ........
T Consensus 165 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~--------~~~~~~~~ 233 (271)
T 3dtc_A 165 EWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYG--------VAMNKLAL 233 (271)
T ss_dssp --------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH--------HHTSCCCC
T ss_pred ccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh--------hhcCCCCC
Confidence 6543322 234689999999999999999999999999999999999999976543322111 01111110
Q ss_pred eccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 047292 664 LIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGL 709 (728)
Q Consensus 664 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 709 (728)
. ........+.+++.+||+.||.+|||++|+++.|+.+
T Consensus 234 ~--------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 234 P--------IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp C--------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred C--------CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 0 1112234677899999999999999999999999864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=352.39 Aligned_cols=250 Identities=22% Similarity=0.250 Sum_probs=203.1
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch---hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
.+.+.||+|+||.||++..+ .+++.||+|+++.... .....+.+|+.+++.++||||+++++++.+....++||||
T Consensus 72 ~~~~~LG~G~fG~V~~~~~~-~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~ 150 (410)
T 3v8s_A 72 EVVKVIGRGAFGEVQLVRHK-STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEY 150 (410)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEcCCCEEEEEEEEC-CCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 34578999999999999876 5688999999965322 1234588999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccc
Q 047292 514 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH 593 (728)
Q Consensus 514 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 593 (728)
+++|+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++..........
T Consensus 151 ~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~ 226 (410)
T 3v8s_A 151 MPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC 226 (410)
T ss_dssp CTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEEC
T ss_pred CCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcccc
Confidence 999999999976 4688999999999999999999997 999999999999999999999999999987655443334
Q ss_pred ccccCCccccCcccccCCC----CCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchh
Q 047292 594 TMIRGTRGYVAPEWLKNAP----VSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDE 669 (728)
Q Consensus 594 ~~~~gt~~y~aPE~~~~~~----~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 669 (728)
....||+.|+|||++.+.. ++.++||||||+++|||++|+.||...........+...... -... .
T Consensus 227 ~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~----~~~p---~--- 296 (410)
T 3v8s_A 227 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS----LTFP---D--- 296 (410)
T ss_dssp CSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH----CCCC---T---
T ss_pred cCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccc----ccCC---C---
Confidence 4567999999999998765 789999999999999999999999866554433322211110 0000 0
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 047292 670 AAMADRSRLHKWLMIAMWCIQEDPSK--RPTMKVVMQM 705 (728)
Q Consensus 670 ~~~~~~~~~~~l~~l~~~cl~~dp~~--RPt~~evl~~ 705 (728)
.......+.+++.+||+.+|.+ ||+++||++.
T Consensus 297 ----~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 297 ----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp ----TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ----cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 0012345778999999999988 9999999864
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=333.17 Aligned_cols=254 Identities=28% Similarity=0.422 Sum_probs=207.6
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
.+.+.+.||+|+||.||++... +++.||+|++..... ..+.+.+|++++++++||||+++++++......++||||+
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~--~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 9 ELTFVQEIGSGQFGLVHLGYWL--NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred heeeeeEecCCCceeEEEEEec--CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 3445678999999999999875 567899999976433 3467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccc
Q 047292 515 GNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH 593 (728)
Q Consensus 515 ~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 593 (728)
++++|.+++... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++...........
T Consensus 86 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (267)
T 3t9t_A 86 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 162 (267)
T ss_dssp TTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence 999999999875 5688999999999999999999997 999999999999999999999999999987643322222
Q ss_pred ccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhh
Q 047292 594 TMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAM 672 (728)
Q Consensus 594 ~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 672 (728)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...........+ ..+.. ..
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i--------~~~~~-~~-------- 225 (267)
T 3t9t_A 163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI--------STGFR-LY-------- 225 (267)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH--------HTTCC-CC--------
T ss_pred ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHH--------hcCCc-CC--------
Confidence 33457788999999998899999999999999999999 89998765433221111 11110 00
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 673 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 673 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
.+......+.+++.+||+.||.+||+++++++.|+++.+
T Consensus 226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 226 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 011123467789999999999999999999999988754
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=344.68 Aligned_cols=261 Identities=27% Similarity=0.357 Sum_probs=209.9
Q ss_pred HHHHhhHHhhhCCCceeEEEEeeeeC------CCCcEEEEEEecccc-hhhHHHHHHHHHHhccc-cccceeeEeeeeec
Q 047292 432 KDATDGFKEELGRGSFGIVYKGVLKT------ASGNAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKNLVQLLGFCDE 503 (728)
Q Consensus 432 ~~~~~~~~~~lg~G~fg~Vy~g~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~ 503 (728)
....+.+.+.||+|+||.||+|.... .++..||||+++... ......+.+|+.+++++ +||||+++++++..
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 34456667889999999999998642 356789999997543 34457899999999999 89999999999999
Q ss_pred CCcceeEeeccCCCCHHHHHhcCC----------------CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEE
Q 047292 504 ALNRLLVYEFMGNGTLANLIFAIP----------------KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNIL 567 (728)
Q Consensus 504 ~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIl 567 (728)
....++||||+++++|.+++.... .+++..++.++.||++||.|||++ +|+||||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEE
Confidence 999999999999999999998653 378899999999999999999997 9999999999999
Q ss_pred EcCCCceEEccccCccccccCCCc-ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhh
Q 047292 568 LDHYFSPKISDFGLSKLLLSDHSR-THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESR 645 (728)
Q Consensus 568 l~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~ 645 (728)
++.++.+||+|||+++........ ......+++.|+|||++.+..++.++||||||+++|||++ |+.||......+..
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 269 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence 999999999999999876543321 2233457889999999998889999999999999999999 99999765433322
Q ss_pred hhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 047292 646 AILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEV 712 (728)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 712 (728)
..+ ..+.... ........+.+++.+||+.||.+||+++++++.|+.++..
T Consensus 270 ~~~--------~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~ 319 (334)
T 2pvf_A 270 KLL--------KEGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319 (334)
T ss_dssp HHH--------HHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHH--------hcCCCCC---------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 111 1111111 1112234677899999999999999999999999998753
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=368.59 Aligned_cols=261 Identities=23% Similarity=0.359 Sum_probs=210.9
Q ss_pred HHHHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEe
Q 047292 432 KDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 511 (728)
Q Consensus 432 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 511 (728)
....+.+.++||+|+||.||+|.++ .+..||||+++... ...+.|.+|++++++++|+||+++++++.+ ...+|||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~ 340 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 340 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET--TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred chhhhhhheecccCCCeEEEEEEEC--CCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEee
Confidence 3344556788999999999999885 45689999997643 235679999999999999999999999976 6789999
Q ss_pred eccCCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCC
Q 047292 512 EFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH 589 (728)
Q Consensus 512 e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 589 (728)
||+++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+||||++++.+||+|||+++......
T Consensus 341 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp CCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred ehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 999999999999753 4688999999999999999999997 99999999999999999999999999998764332
Q ss_pred CcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccch
Q 047292 590 SRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSD 668 (728)
Q Consensus 590 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 668 (728)
........++..|+|||++.+..++.++||||||++||||++ |+.||......+.... ...+...
T Consensus 418 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~--------i~~~~~~------ 483 (535)
T 2h8h_A 418 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ--------VERGYRM------ 483 (535)
T ss_dssp HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHH--------HHTTCCC------
T ss_pred eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--------HHcCCCC------
Confidence 222223446788999999999999999999999999999999 8999975543322111 1111100
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCCC
Q 047292 669 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNPP 716 (728)
Q Consensus 669 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~~ 716 (728)
.........+.+++.+||+.||++|||+++|+++|+.+.....|.
T Consensus 484 ---~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~ 528 (535)
T 2h8h_A 484 ---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 528 (535)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCS
T ss_pred ---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCcc
Confidence 011123346778999999999999999999999999988766554
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=340.11 Aligned_cols=249 Identities=25% Similarity=0.313 Sum_probs=198.4
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccc-cccceeeEeeeeecCCcceeEe
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVY 511 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~ 511 (728)
+.+.+.||+|+||.||++..+ .+++.||+|+++... ......+.+|..++.++ +||||+++++++......++||
T Consensus 11 y~~~~~lG~G~fg~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~ 89 (345)
T 3a8x_A 11 FDLLRVIGRGSYAKVLLVRLK-KTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 89 (345)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred eEEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEE
Confidence 445678999999999999876 568899999996532 33456788999999987 8999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 512 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 512 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
||+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++...... .
T Consensus 90 e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~-~ 165 (345)
T 3a8x_A 90 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-D 165 (345)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT-C
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCCC-C
Confidence 9999999999998878899999999999999999999997 99999999999999999999999999998643222 2
Q ss_pred ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhh-hhHHHHHHHhhhcCccceeccchhh
Q 047292 592 THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESR-AILTDWAYDCYVEGRLDALIDSDEA 670 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~~~ 670 (728)
......||+.|+|||++.+..++.++||||||+++|||++|+.||......... .................
T Consensus 166 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~-------- 237 (345)
T 3a8x_A 166 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR-------- 237 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC--------
T ss_pred cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC--------
Confidence 234457999999999999999999999999999999999999999643211100 00001111111111110
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCH
Q 047292 671 AMADRSRLHKWLMIAMWCIQEDPSKRPTM 699 (728)
Q Consensus 671 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~ 699 (728)
.+......+.+++.+||+.||.+||++
T Consensus 238 --~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 238 --IPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred --CCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 111223467789999999999999995
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=336.18 Aligned_cols=247 Identities=22% Similarity=0.316 Sum_probs=193.3
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch--------------------------hhHHHHHHHHHHhccc
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ--------------------------EREREFKSEVSAIGRT 489 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~--------------------------~~~~~~~~E~~~l~~l 489 (728)
+.+.+.||+|+||.||+|... .+++.||||++..... ...+.+.+|+++++++
T Consensus 15 y~~~~~lG~G~~g~Vy~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 93 (298)
T 2zv2_A 15 YTLKDEIGKGSYGVVKLAYNE-NDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL 93 (298)
T ss_dssp EEEEEEEEC--CCEEEEEEET-TTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred eEEEeEEeecCCEEEEEEEEC-CCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence 455678999999999999875 5688999999864321 1125688999999999
Q ss_pred cccceeeEeeeeec--CCcceeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEE
Q 047292 490 HHKNLVQLLGFCDE--ALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNIL 567 (728)
Q Consensus 490 ~h~niv~l~g~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIl 567 (728)
+||||+++++++.. ....++||||+++++|.+++. ...+++..+..++.||+.||+|||++ +|+||||||+|||
T Consensus 94 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil 169 (298)
T 2zv2_A 94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLL 169 (298)
T ss_dssp CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEE
T ss_pred CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEE
Confidence 99999999999986 567899999999999988654 35789999999999999999999997 9999999999999
Q ss_pred EcCCCceEEccccCccccccCCCcccccccCCccccCcccccCCC---CCCccchhhHHHHHHHHHhCCcCcchhhhHhh
Q 047292 568 LDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAP---VSAKVDVYSFGVMLLEIICCRRSVEMELEEES 644 (728)
Q Consensus 568 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~~DVwSlGvil~elltg~~p~~~~~~~~~ 644 (728)
++.++.+||+|||+++....... ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||........
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 248 (298)
T 2zv2_A 170 VGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL 248 (298)
T ss_dssp ECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred ECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHH
Confidence 99999999999999987644322 223456899999999998765 37789999999999999999999976543322
Q ss_pred hhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 645 RAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
...+ ...... ... .......+.+++.+||+.||++||+++|+++
T Consensus 249 ~~~~--------~~~~~~-~~~-------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 249 HSKI--------KSQALE-FPD-------QPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHHH--------HHCCCC-CCS-------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHH--------hcccCC-CCC-------ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 1111 111110 000 0112345778999999999999999999875
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=336.71 Aligned_cols=251 Identities=24% Similarity=0.316 Sum_probs=205.8
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchh------hHHHHHHHHHHhccccccceeeEeeeeecCCcc
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQE------REREFKSEVSAIGRTHHKNLVQLLGFCDEALNR 507 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 507 (728)
..+.+.+.||+|+||.||++..+ .+++.||+|++...... ....+.+|+.++++++||||+++++++......
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREK-STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccEEEeeEeeecCCEEEEEEEEC-CCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 34566788999999999999876 56889999998653221 357799999999999999999999999999999
Q ss_pred eeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCC----ceEEccccCcc
Q 047292 508 LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYF----SPKISDFGLSK 583 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~----~~kl~Dfgla~ 583 (728)
++||||+++++|.+++.....+++..+..++.||+.||+|||++ +|+||||||+||+++.++ .+||+|||++.
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 99999999999999999888899999999999999999999997 999999999999999887 79999999998
Q ss_pred ccccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccce
Q 047292 584 LLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDA 663 (728)
Q Consensus 584 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (728)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....+ .....
T Consensus 168 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i--------~~~~~-- 235 (321)
T 2a2a_A 168 EIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI--------TSVSY-- 235 (321)
T ss_dssp ECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH--------HTTCC--
T ss_pred ecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--------Hhccc--
Confidence 764432 223346899999999999999999999999999999999999999765443322111 11110
Q ss_pred eccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 664 LIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 664 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
.++.... ......+.+++.+||+.||++|||++++++
T Consensus 236 ~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 236 DFDEEFF----SHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CCCHHHH----TTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred ccChhhh----cccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0111111 112345778999999999999999999987
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=345.16 Aligned_cols=265 Identities=25% Similarity=0.339 Sum_probs=206.6
Q ss_pred hHHhhhCCCceeEEEEeeee---CCCCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecC--CcceeE
Q 047292 437 GFKEELGRGSFGIVYKGVLK---TASGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEA--LNRLLV 510 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~---~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv 510 (728)
.+.++||+|+||.||++.++ ..+++.||||+++... ......+.+|++++++++||||+++++++... ...++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 56688999999999888653 2367899999997643 34457899999999999999999999999774 567999
Q ss_pred eeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC
Q 047292 511 YEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 590 (728)
|||+++++|.+++... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 114 ~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 189 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 189 (318)
T ss_dssp ECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCS
T ss_pred EecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccccccccc
Confidence 9999999999999765 488999999999999999999997 999999999999999999999999999987754332
Q ss_pred --cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhh------hHHH-HHHHhhhcCcc
Q 047292 591 --RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRA------ILTD-WAYDCYVEGRL 661 (728)
Q Consensus 591 --~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~------~~~~-~~~~~~~~~~~ 661 (728)
.......+|..|+|||.+.+..++.++||||||+++|||++|+.||.......... .... ........+.
T Consensus 190 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 268 (318)
T 3lxp_A 190 YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE- 268 (318)
T ss_dssp EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTC-
T ss_pred ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhccc-
Confidence 12233457888999999999999999999999999999999999987543321100 0000 0001111111
Q ss_pred ceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCC
Q 047292 662 DALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPN 714 (728)
Q Consensus 662 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 714 (728)
...........+.+++.+||+.||.+|||++++++.|+.+.+.-.
T Consensus 269 --------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 269 --------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred --------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 111122234568889999999999999999999999998765433
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=343.17 Aligned_cols=260 Identities=25% Similarity=0.367 Sum_probs=194.1
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCC--cEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeeecCCcc--
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASG--NAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNR-- 507 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~--~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~-- 507 (728)
..+.+.+.||+|+||.||+|......+ ..||||+++.. .....+.+.+|++++++++||||+++++++......
T Consensus 23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (323)
T 3qup_A 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGR 102 (323)
T ss_dssp --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-----
T ss_pred hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccC
Confidence 345566889999999999998763322 37999998653 334467899999999999999999999999877665
Q ss_pred ----eeEeeccCCCCHHHHHhcCC------CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEc
Q 047292 508 ----LLVYEFMGNGTLANLIFAIP------KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKIS 577 (728)
Q Consensus 508 ----~lv~e~~~~gsL~~~l~~~~------~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~ 577 (728)
++||||+++++|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+
T Consensus 103 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~ 179 (323)
T 3qup_A 103 LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVA 179 (323)
T ss_dssp --CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEEC
T ss_pred CCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEEe
Confidence 99999999999999996432 588999999999999999999997 99999999999999999999999
Q ss_pred cccCccccccCCC-cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHh
Q 047292 578 DFGLSKLLLSDHS-RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDC 655 (728)
Q Consensus 578 Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 655 (728)
|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...........+
T Consensus 180 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~------- 252 (323)
T 3qup_A 180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL------- 252 (323)
T ss_dssp CCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-------
T ss_pred eccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH-------
Confidence 9999987644322 22233456889999999999999999999999999999999 89998765443322111
Q ss_pred hhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCC
Q 047292 656 YVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVP 713 (728)
Q Consensus 656 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~ 713 (728)
..+.... ........+.+++.+||+.||.+|||+.++++.|++++.-+
T Consensus 253 -~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 253 -IGGNRLK---------QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp -HTTCCCC---------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred -hcCCCCC---------CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 1111110 11122346788999999999999999999999999877443
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=329.96 Aligned_cols=249 Identities=24% Similarity=0.393 Sum_probs=201.6
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeeecC--CcceeE
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEA--LNRLLV 510 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv 510 (728)
.+.+.+.||+|+||.||+|.++ ++.||||+++.. .....+.+.+|+.++++++||||+++++++... ...++|
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 11 QLNFLTKLNENHSGELWKGRWQ---GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GCEEEEEEEEETTEEEEEEEET---TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HhHHHHHhcCCCcceEEEEEEC---CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 3445678999999999999873 788999999653 234457899999999999999999999999877 778999
Q ss_pred eeccCCCCHHHHHhcCC--CCChHHHHHHHHHHHHHHHHhhhcCCCC--eeecCCCCCCEEEcCCCceEEccccCccccc
Q 047292 511 YEFMGNGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEGCNVP--IIHCDIKPQNILLDHYFSPKISDFGLSKLLL 586 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~l~yLH~~~~~~--iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 586 (728)
|||+++|+|.+++.... .+++..++.++.||+.||+|||++ + |+||||||+||++++++.++|.|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 99999999999998865 489999999999999999999986 7 9999999999999999999999998875432
Q ss_pred cCCCcccccccCCccccCcccccCCCCCC---ccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccce
Q 047292 587 SDHSRTHTMIRGTRGYVAPEWLKNAPVSA---KVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDA 663 (728)
Q Consensus 587 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~---~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (728)
. ....||+.|+|||.+.+..++. ++||||||+++|||++|+.||............ ...+....
T Consensus 165 ~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~-------~~~~~~~~ 231 (271)
T 3kmu_A 165 S------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV-------ALEGLRPT 231 (271)
T ss_dssp C------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHH-------HHSCCCCC
T ss_pred c------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHH-------HhcCCCCC
Confidence 2 2245799999999998765544 799999999999999999999765443321111 11111111
Q ss_pred eccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 664 LIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 664 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
. +......+.+++.+||+.||++|||++++++.|+.+.+
T Consensus 232 ~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 232 I---------PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp C---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred C---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1 11223457789999999999999999999999988653
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=342.53 Aligned_cols=255 Identities=26% Similarity=0.397 Sum_probs=199.5
Q ss_pred hHHhhhCCCceeEEEEeeeeCCC---CcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 437 GFKEELGRGSFGIVYKGVLKTAS---GNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~---~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
.+.+.||+|+||.||+|..+..+ +..||||+++... ......+.+|+.++++++||||+++++++......++|||
T Consensus 47 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 126 (333)
T 1mqb_A 47 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITE 126 (333)
T ss_dssp EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEe
Confidence 34578999999999999886433 2469999997543 3445679999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 513 FMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 513 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
|+++++|.+++... ..+++..++.++.||++||.|||++ +|+||||||+||+++.++.+||+|||+++........
T Consensus 127 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 203 (333)
T 1mqb_A 127 YMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 203 (333)
T ss_dssp CCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred CCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhcccccc
Confidence 99999999999865 5789999999999999999999997 9999999999999999999999999999876543221
Q ss_pred --ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccch
Q 047292 592 --THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSD 668 (728)
Q Consensus 592 --~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 668 (728)
......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........... ...+....
T Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~--------~~~~~~~~----- 270 (333)
T 1mqb_A 204 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA--------INDGFRLP----- 270 (333)
T ss_dssp -------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH--------HHTTCCCC-----
T ss_pred ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHH--------HHCCCcCC-----
Confidence 1222346788999999999999999999999999999999 9999975443322111 11111000
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 669 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 669 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
........+.+++.+||+.||.+||++.++++.|+.++.
T Consensus 271 ----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 271 ----TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309 (333)
T ss_dssp ----CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 011223467789999999999999999999999988653
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=332.76 Aligned_cols=255 Identities=23% Similarity=0.326 Sum_probs=201.9
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCC--CcEEEEEEeccc-chhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEe
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTAS--GNAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 511 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~--~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 511 (728)
.+.+.+.||+|+||.||+|.+.... +..||+|.+... .....+.+.+|+.++++++||||+++++++.+ ...++||
T Consensus 13 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 91 (281)
T 3cc6_A 13 DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIM 91 (281)
T ss_dssp GEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEE
T ss_pred ceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEE
Confidence 3445678999999999999876433 346999999764 33456789999999999999999999999875 4568999
Q ss_pred eccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC
Q 047292 512 EFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 512 e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 590 (728)
||+++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++........
T Consensus 92 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 168 (281)
T 3cc6_A 92 ELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY 168 (281)
T ss_dssp ECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC-----
T ss_pred ecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcccccccc
Confidence 999999999999765 4589999999999999999999997 999999999999999999999999999987654433
Q ss_pred cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchh
Q 047292 591 RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDE 669 (728)
Q Consensus 591 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 669 (728)
.......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...........+ ..+.....
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~--------~~~~~~~~----- 235 (281)
T 3cc6_A 169 YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL--------EKGDRLPK----- 235 (281)
T ss_dssp ----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHH--------HHTCCCCC-----
T ss_pred cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHH--------hcCCCCCC-----
Confidence 33344557889999999999999999999999999999998 99999754333221111 11110000
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 047292 670 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710 (728)
Q Consensus 670 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 710 (728)
.......+.+++.+||+.||.+||++.++++.|+.+.
T Consensus 236 ----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 236 ----PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 1112345778999999999999999999999998765
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=356.46 Aligned_cols=246 Identities=26% Similarity=0.289 Sum_probs=194.7
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
+.+.+.||+|+||.||++... .+++.||||+++.. .......+.+|+.+++.++||||+++++++......++|||
T Consensus 150 y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 228 (446)
T 4ejn_A 150 FEYLKLLGKGTFGKVILVKEK-ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVME 228 (446)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEEC
T ss_pred cEEeEEEeeCcCEEEEEEEEc-CCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEe
Confidence 445678999999999999876 57899999999753 22334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 513 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHE-GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 513 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~-~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
|+++|+|.+++.....+++..+..++.||+.||+|||+ . +|+||||||+||||+.++.+||+|||+++.......
T Consensus 229 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~- 304 (446)
T 4ejn_A 229 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA- 304 (446)
T ss_dssp CCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC----
T ss_pred eCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccCCCc-
Confidence 99999999999888889999999999999999999997 6 899999999999999999999999999986433222
Q ss_pred ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhh
Q 047292 592 THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAA 671 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 671 (728)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+. .....
T Consensus 305 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~--------~~~~~--------- 367 (446)
T 4ejn_A 305 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--------MEEIR--------- 367 (446)
T ss_dssp --CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--------HCCCC---------
T ss_pred ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHH--------hCCCC---------
Confidence 2334679999999999999999999999999999999999999997654433222111 11110
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047292 672 MADRSRLHKWLMIAMWCIQEDPSKRP-----TMKVVMQ 704 (728)
Q Consensus 672 ~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~ 704 (728)
.+......+.+++.+||+.||.+|| +++|+++
T Consensus 368 -~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 368 -FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 0111234677899999999999999 9999985
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=338.45 Aligned_cols=251 Identities=24% Similarity=0.309 Sum_probs=181.8
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhcccc-ccceeeEeeeeecCCcceeEeeccCCCC
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTH-HKNLVQLLGFCDEALNRLLVYEFMGNGT 518 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~~gs 518 (728)
+.||+|+||.||++..+ .+++.||||++... ....+.+|+.+++.+. ||||+++++++.+....++||||+++|+
T Consensus 17 ~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHK-KSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp CCSEEETTEEEEEEEET-TTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CccccCCCeEEEEEEEC-CCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 56999999999999876 56889999999643 3467788999999996 9999999999999999999999999999
Q ss_pred HHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCC---ceEEccccCccccccCCCccccc
Q 047292 519 LANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYF---SPKISDFGLSKLLLSDHSRTHTM 595 (728)
Q Consensus 519 L~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~---~~kl~Dfgla~~~~~~~~~~~~~ 595 (728)
|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++....... ....
T Consensus 93 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~ 168 (325)
T 3kn6_A 93 LFERIKKKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PLKT 168 (325)
T ss_dssp HHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--------
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-cccc
Confidence 999999988899999999999999999999997 999999999999998765 899999999986543322 2234
Q ss_pred ccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcH
Q 047292 596 IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADR 675 (728)
Q Consensus 596 ~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 675 (728)
..||+.|+|||++.+..++.++||||||+++|||++|+.||.............. .......+... +.... ..
T Consensus 169 ~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~-~~~~i~~~~~~--~~~~~----~~ 241 (325)
T 3kn6_A 169 PCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVE-IMKKIKKGDFS--FEGEA----WK 241 (325)
T ss_dssp ---------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHH-HHHHHTTTCCC--CCSHH----HH
T ss_pred cCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHH-HHHHHHcCCCC--CCccc----cc
Confidence 5589999999999999999999999999999999999999976443211111101 11112222111 01100 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 676 SRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 676 ~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.....+.+++.+||+.||.+|||++++++.
T Consensus 242 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 242 NVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp TSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred CCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 224567889999999999999999998754
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=335.85 Aligned_cols=255 Identities=26% Similarity=0.408 Sum_probs=206.7
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
..+.+.+.||+|+||.||+|... ++..||||++.... ...+.+.+|++++++++||||+++++++.. ...++||||
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 88 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HhhhheeeecCCCCeEEEEEEEc--CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence 34556688999999999999864 56789999997543 235688999999999999999999999864 568999999
Q ss_pred cCCCCHHHHHhcCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 514 MGNGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 514 ~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
+++++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||++++++.+||+|||++.........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence 99999999997653 689999999999999999999997 9999999999999999999999999999877544333
Q ss_pred ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhh
Q 047292 592 THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEA 670 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 670 (728)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||........... ...+... .
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~--------~~~~~~~-~------ 230 (279)
T 1qpc_A 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN--------LERGYRM-V------ 230 (279)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH--------HHTTCCC-C------
T ss_pred cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHH--------HhcccCC-C------
Confidence 3334457889999999998889999999999999999999 8899875443322111 1111100 0
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 047292 671 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEV 712 (728)
Q Consensus 671 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 712 (728)
........+.+++.+||+.||++|||++++++.|+.+...
T Consensus 231 --~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 231 --RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 0112234677899999999999999999999999987643
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=334.11 Aligned_cols=265 Identities=22% Similarity=0.287 Sum_probs=200.5
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch--hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
+.+.++||+|+||.||+|... .+++.||||++..... ...+.+.+|++++++++||||+++++++......++||||
T Consensus 5 y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (311)
T 4agu_A 5 YEKIGKIGEGSYGVVFKCRNR-DTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEY 83 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ceEeeEEeecCCeEEEEEEeC-CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEe
Confidence 345678999999999999876 5688999999855332 3356788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccc
Q 047292 514 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH 593 (728)
Q Consensus 514 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 593 (728)
+++++|.+++.....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++........ ..
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 159 (311)
T 4agu_A 84 CDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-YY 159 (311)
T ss_dssp CSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred CCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-cc
Confidence 99999999998888899999999999999999999997 999999999999999999999999999987643322 22
Q ss_pred ccccCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHH-------HHhhhcC------
Q 047292 594 TMIRGTRGYVAPEWLKN-APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWA-------YDCYVEG------ 659 (728)
Q Consensus 594 ~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~------ 659 (728)
....||+.|+|||++.+ ..++.++||||||+++|||++|+.||...........+.... ...+...
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
T 4agu_A 160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGV 239 (311)
T ss_dssp ------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTC
T ss_pred CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccC
Confidence 33468999999999976 578999999999999999999999997655443322221110 0000000
Q ss_pred ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 660 RLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 660 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.+....+..............+.+++.+||+.||.+|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 240 KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000000000000111234467889999999999999999999863
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=329.69 Aligned_cols=245 Identities=28% Similarity=0.381 Sum_probs=200.6
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch---hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
+.+.+.||+|+||.||++... .+++.||+|++..... .....+.+|+.++++++||||+++++++.+....++|||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (279)
T 3fdn_A 11 FEIGRPLGKGKFGNVYLAREK-QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 89 (279)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred EEEeeEEecCCCeEEEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEe
Confidence 445678999999999999876 5678999999865322 224678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 513 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 513 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
|+++++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++...... .
T Consensus 90 ~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~---~ 163 (279)
T 3fdn_A 90 YAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---R 163 (279)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-------
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCcc---c
Confidence 999999999998888899999999999999999999997 9999999999999999999999999998654322 2
Q ss_pred cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAM 672 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 672 (728)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||...........+.. .....
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------~~~~~----------- 226 (279)
T 3fdn_A 164 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR------VEFTF----------- 226 (279)
T ss_dssp ----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH------TCCCC-----------
T ss_pred ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHh------CCCCC-----------
Confidence 2335689999999999999999999999999999999999999986544332221110 00011
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 673 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 673 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
+......+.+++.+||+.||.+||+++|+++.
T Consensus 227 -~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 227 -PDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp -CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred -CCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 11123456789999999999999999999964
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=342.78 Aligned_cols=249 Identities=26% Similarity=0.343 Sum_probs=188.3
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccC
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
+.+.+.||+|+||.||+|..+ .+++.||||+++... ..+.+.+|+.++++++||||+++++++......++||||++
T Consensus 55 y~~~~~lG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 131 (349)
T 2w4o_A 55 FEVESELGRGATSIVYRCKQK-GTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT 131 (349)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEeeEEeeCCCEEEEEEEEC-CCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCC
Confidence 445678999999999999876 467899999997532 34678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcC---CCceEEccccCccccccCCCcc
Q 047292 516 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDH---YFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 516 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~---~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
+++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++...... .
T Consensus 132 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~ 206 (349)
T 2w4o_A 132 GGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--L 206 (349)
T ss_dssp SCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC------------
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCccc--c
Confidence 999999999888899999999999999999999997 9999999999999975 8899999999998654322 2
Q ss_pred cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAM 672 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 672 (728)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||......... .......... ...+
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-------~~~i~~~~~~-~~~~----- 273 (349)
T 2w4o_A 207 MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM-------FRRILNCEYY-FISP----- 273 (349)
T ss_dssp ------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHH-------HHHHHTTCCC-CCTT-----
T ss_pred cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHH-------HHHHHhCCCc-cCCc-----
Confidence 23456899999999999999999999999999999999999999754332210 1111111110 0000
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 673 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 673 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
........+.+++.+||+.||++|||+.++++.
T Consensus 274 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 274 WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011223467789999999999999999999873
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=338.21 Aligned_cols=249 Identities=22% Similarity=0.260 Sum_probs=194.6
Q ss_pred HHhhHHhhhCCCceeEEEEeeee--CCCCcEEEEEEecccc----hhhHHHHHHHHHHhccccccceeeEeeeeecCCcc
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLK--TASGNAIAVKKLDRLA----QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNR 507 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~--~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 507 (728)
..+.+.+.||+|+||.||++... ..+++.||+|+++... ......+.+|+.++++++||||+++++++......
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 34556788999999999999864 2468899999997542 22345688999999999999999999999999999
Q ss_pred eeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcccccc
Q 047292 508 LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS 587 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 587 (728)
++||||+++++|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 173 (327)
T 3a62_A 97 YLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH 173 (327)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence 99999999999999998878899999999999999999999997 999999999999999999999999999976433
Q ss_pred CCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccc
Q 047292 588 DHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDS 667 (728)
Q Consensus 588 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 667 (728)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+. .....
T Consensus 174 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--------~~~~~----- 239 (327)
T 3a62_A 174 DGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL--------KCKLN----- 239 (327)
T ss_dssp ------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH--------HTCCC-----
T ss_pred CCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHH--------hCCCC-----
Confidence 222 2233568999999999999999999999999999999999999998654433221111 11100
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047292 668 DEAAMADRSRLHKWLMIAMWCIQEDPSKRP-----TMKVVMQ 704 (728)
Q Consensus 668 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~ 704 (728)
.+......+.+++.+||+.||.+|| +++++++
T Consensus 240 -----~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 240 -----LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp -----CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred -----CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 0111234677899999999999999 7778875
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=341.92 Aligned_cols=252 Identities=23% Similarity=0.261 Sum_probs=192.6
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
.+.+.+.||+|+||.||++..+ .+++.||||++..... ....+.+|+.+++.++||||+++++++......++||||+
T Consensus 21 ~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 21 RYDFVKDIGSGNFGVARLMRDK-LTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TEEEEEEESSSTTSSEEEEEET-TTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cEEEEEEeccCCCEEEEEEEEC-CCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 3556788999999999999876 5788999999965332 2356889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCc--eEEccccCccccccCCCcc
Q 047292 515 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFS--PKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 515 ~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~--~kl~Dfgla~~~~~~~~~~ 592 (728)
++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+|||+++...... .
T Consensus 99 ~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~--~ 173 (361)
T 3uc3_A 99 SGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--Q 173 (361)
T ss_dssp CSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccC--C
Confidence 9999999998888899999999999999999999997 9999999999999987765 9999999997542221 2
Q ss_pred cccccCCccccCcccccCCCCCCc-cchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPVSAK-VDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAA 671 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~s~~-~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 671 (728)
.....||+.|+|||++.+..++.+ +||||||+++|||++|+.||.............. ........ ..
T Consensus 174 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~----~~~~~~~~-~~------ 242 (361)
T 3uc3_A 174 PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ----RILSVKYS-IP------ 242 (361)
T ss_dssp -------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHH----HHHTTCCC-CC------
T ss_pred CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHH----HHhcCCCC-CC------
Confidence 233468999999999988887665 8999999999999999999976443221111111 00111000 00
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 672 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 672 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
........+.+++.+||+.||.+|||++|+++.
T Consensus 243 -~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 243 -DDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp -TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred -CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 000123467789999999999999999999864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=345.40 Aligned_cols=267 Identities=17% Similarity=0.203 Sum_probs=202.0
Q ss_pred HhhHHhhhCCC--ceeEEEEeeeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeE
Q 047292 435 TDGFKEELGRG--SFGIVYKGVLKTASGNAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 510 (728)
Q Consensus 435 ~~~~~~~lg~G--~fg~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 510 (728)
.+.+.++||+| +||.||++..+ .+++.||||++.... ....+.+.+|+.++++++||||+++++++......++|
T Consensus 26 ~y~~~~~lG~G~~~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 104 (389)
T 3gni_B 26 CYELLTVIGKGFEDLMTVNLARYK-PTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 104 (389)
T ss_dssp GEEEEEEEEEETTTTEEEEEEEET-TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cEEEEecccCCcCCceEEEEEEEc-CCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence 35566889999 99999999876 578999999996543 34457788999999999999999999999999999999
Q ss_pred eeccCCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccC
Q 047292 511 YEFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD 588 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 588 (728)
|||+++++|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 105 TSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp EECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred EEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 9999999999999875 6789999999999999999999997 9999999999999999999999999998755322
Q ss_pred CC------cccccccCCccccCcccccC--CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhh---
Q 047292 589 HS------RTHTMIRGTRGYVAPEWLKN--APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYV--- 657 (728)
Q Consensus 589 ~~------~~~~~~~gt~~y~aPE~~~~--~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--- 657 (728)
.. .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.....................
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 261 (389)
T 3gni_B 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTS 261 (389)
T ss_dssp TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------------
T ss_pred cccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccc
Confidence 11 11222468999999999987 67899999999999999999999999754332211100000000000
Q ss_pred ---cC-------------ccceeccc---------hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 658 ---EG-------------RLDALIDS---------DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 658 ---~~-------------~~~~~~d~---------~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.. .....+.. .............+.+++.+||+.||++|||++|+++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp --------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00 00000000 00001112234568889999999999999999999864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=344.76 Aligned_cols=246 Identities=28% Similarity=0.282 Sum_probs=193.4
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHH-hccccccceeeEeeeeecCCcceeE
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSA-IGRTHHKNLVQLLGFCDEALNRLLV 510 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~g~~~~~~~~~lv 510 (728)
.+.+.+.||+|+||.||++..+ .+++.||||+++... ......+..|..+ ++.++||||+++++++......++|
T Consensus 39 ~y~~~~~lG~G~fg~V~~~~~~-~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 39 DFHFLKVIGKGSFGKVLLARHK-AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GEEEEEEEECCTTCEEEEEEET-TTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred heEEEEEEeeCCCeEEEEEEEc-CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 3456688999999999999876 568899999996543 2234566777777 5678999999999999999999999
Q ss_pred eeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC
Q 047292 511 YEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 590 (728)
|||+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++.......
T Consensus 118 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~ 194 (373)
T 2r5t_A 118 LDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS 194 (373)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccCCC
Confidence 99999999999998888899999999999999999999997 999999999999999999999999999986433222
Q ss_pred cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhh
Q 047292 591 RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEA 670 (728)
Q Consensus 591 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 670 (728)
......||+.|+|||++.+..++.++||||||+++|||++|+.||......+....+. ...+. +
T Consensus 195 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~--------~~~~~--~----- 258 (373)
T 2r5t_A 195 -TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL--------NKPLQ--L----- 258 (373)
T ss_dssp -CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHH--------HSCCC--C-----
T ss_pred -ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH--------hcccC--C-----
Confidence 2344579999999999999999999999999999999999999998655443322221 11110 0
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047292 671 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVM 703 (728)
Q Consensus 671 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl 703 (728)
.......+.+++.+||+.||.+||++.+.+
T Consensus 259 ---~~~~~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 259 ---KPNITNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp ---CSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred ---CCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 111234567899999999999999985433
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=337.22 Aligned_cols=261 Identities=23% Similarity=0.289 Sum_probs=204.8
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeee----cCCccee
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCD----EALNRLL 509 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~----~~~~~~l 509 (728)
..+.+.+.||+|+||.||++... .+++.||||++........+.+.+|+.+++.++||||+++++++. .....++
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGL-HDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEET-TTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEec-CCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 34556788999999999999875 568899999987666666788999999999999999999999986 3457799
Q ss_pred EeeccCCCCHHHHHhc----CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcccc
Q 047292 510 VYEFMGNGTLANLIFA----IPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLL 585 (728)
Q Consensus 510 v~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~ 585 (728)
|+||+++++|.+++.. ...+++..++.++.||++||.|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 9999999999999875 46789999999999999999999997 9999999999999999999999999998765
Q ss_pred ccCCCc--------ccccccCCccccCcccccCCC---CCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHH
Q 047292 586 LSDHSR--------THTMIRGTRGYVAPEWLKNAP---VSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYD 654 (728)
Q Consensus 586 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 654 (728)
...... ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||......... +....
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~~-- 260 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS--VALAV-- 260 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC--HHHHH--
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch--hhHHh--
Confidence 321111 112245799999999997654 689999999999999999999999753222111 00000
Q ss_pred hhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCC
Q 047292 655 CYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVP 713 (728)
Q Consensus 655 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~ 713 (728)
.. .. .. .........+.+++.+||+.||.+||+++++++.|+.+....
T Consensus 261 --~~-~~-~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 308 (317)
T 2buj_A 261 --QN-QL-SI-------PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA 308 (317)
T ss_dssp --HC-C---C-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred --hc-cC-CC-------CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence 00 00 00 001122346788999999999999999999999999876433
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=330.72 Aligned_cols=261 Identities=22% Similarity=0.262 Sum_probs=196.9
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch--hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
+.+.+.||+|+||.||+|.. .+++.||+|++..... .....+.+|+.++++++||||+++++++......++||||
T Consensus 4 y~~~~~lg~G~~g~V~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 4 YHGLEKIGEGTYGVVYKAQN--NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEE--TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred chhhhhcccCCCEEEEEEEc--CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 34567899999999999987 4688999999865332 2246788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 514 MGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 514 ~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
+++ +|.+++... ..+++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++....... .
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 156 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-K 156 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-c
Confidence 986 899988765 6789999999999999999999997 999999999999999999999999999987643222 2
Q ss_pred cccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCcc---cee--cc
Q 047292 593 HTMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRL---DAL--ID 666 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~--~d 666 (728)
.....||+.|+|||++.+. .++.++||||||+++|||++|+.||...........+...... ...... ... .+
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGT-PNSKNWPNVTELPKYD 235 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC-CCTTTSTTGGGSTTCC
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCC-CChhhchhhhcccccc
Confidence 2334589999999999764 5899999999999999999999999765443322211110000 000000 000 00
Q ss_pred -------chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 667 -------SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 667 -------~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
+.............+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000111123456778999999999999999999986
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=366.22 Aligned_cols=250 Identities=25% Similarity=0.356 Sum_probs=200.5
Q ss_pred hhCCCceeEEEEeeeeC-CCCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCCCC
Q 047292 441 ELGRGSFGIVYKGVLKT-ASGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGT 518 (728)
Q Consensus 441 ~lg~G~fg~Vy~g~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 518 (728)
+||+|+||.||+|.++. .++..||||+++... ....+.|.+|++++++++||||+++++++.. ...++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 69999999999998763 345689999997643 3356789999999999999999999999976 56899999999999
Q ss_pred HHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc--cccc
Q 047292 519 LANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR--THTM 595 (728)
Q Consensus 519 L~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~--~~~~ 595 (728)
|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+||||++++.+||+|||+++........ ....
T Consensus 422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 498 (613)
T 2ozo_A 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 498 (613)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence 99999765 4689999999999999999999997 9999999999999999999999999999876433221 1122
Q ss_pred ccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhc
Q 047292 596 IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMAD 674 (728)
Q Consensus 596 ~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 674 (728)
..+++.|+|||++.+..++.++||||||+++|||++ |+.||......+.... ...+.... .+
T Consensus 499 ~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~--------i~~~~~~~---------~p 561 (613)
T 2ozo_A 499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF--------IEQGKRME---------CP 561 (613)
T ss_dssp ---CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHH--------HHTTCCCC---------CC
T ss_pred CCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH--------HHcCCCCC---------CC
Confidence 345689999999999999999999999999999998 9999976544332211 11111111 11
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 675 RSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 675 ~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
......+.+++.+||+.+|.+||++++|++.|+.+..
T Consensus 562 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 598 (613)
T 2ozo_A 562 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 598 (613)
T ss_dssp TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 2234567889999999999999999999999998653
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=332.64 Aligned_cols=249 Identities=29% Similarity=0.484 Sum_probs=194.1
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccC
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
+.+.+.||+|+||.||++... ++.||||++... ...+.+.+|++++++++||||+++++++.+ ..++||||++
T Consensus 10 ~~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 10 IEVEEVVGRGAFGVVCKAKWR---AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp EEEEEEEECCSSSEEEEEEET---TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred eeeeeEeecCCCceEEEEEEC---CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 445678999999999999874 678999999653 345789999999999999999999999874 5899999999
Q ss_pred CCCHHHHHhcCC---CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCc-eEEccccCccccccCCCc
Q 047292 516 NGTLANLIFAIP---KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFS-PKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 516 ~gsL~~~l~~~~---~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~-~kl~Dfgla~~~~~~~~~ 591 (728)
+++|.+++.... .+++..++.++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 999999998764 4678899999999999999999943348999999999999998886 799999999765332
Q ss_pred ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhh
Q 047292 592 THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAA 671 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 671 (728)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... .+. ...+......
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~---~~~---~~~~~~~~~~------ 226 (307)
T 2eva_A 160 -MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI---MWA---VHNGTRPPLI------ 226 (307)
T ss_dssp ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHH---HHH---HHTTCCCCCB------
T ss_pred -cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHH---HHH---HhcCCCCCcc------
Confidence 223458999999999999999999999999999999999999997543221110 000 1111111111
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 047292 672 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710 (728)
Q Consensus 672 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 710 (728)
......+.+++.+||+.||.+|||++++++.|+.+.
T Consensus 227 ---~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 227 ---KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp ---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred ---cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 112345778999999999999999999999998865
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=367.86 Aligned_cols=250 Identities=27% Similarity=0.385 Sum_probs=201.8
Q ss_pred hhhCCCceeEEEEeeeeC-CCCcEEEEEEecccch--hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCC
Q 047292 440 EELGRGSFGIVYKGVLKT-ASGNAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGN 516 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 516 (728)
++||+|+||.||+|.+.. ..++.||||+++.... ...+++.+|++++++++||||+++++++.. ...++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 469999999999997653 3457899999976433 335789999999999999999999999965 458899999999
Q ss_pred CCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC--cccc
Q 047292 517 GTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS--RTHT 594 (728)
Q Consensus 517 gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~--~~~~ 594 (728)
|+|.+++.....+++..++.|+.||+.||+|||++ +|+||||||+||||++++.+||+|||+++....... ....
T Consensus 454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 530 (635)
T 4fl3_A 454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 530 (635)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---------
T ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccccc
Confidence 99999999888899999999999999999999997 999999999999999999999999999987654332 2223
Q ss_pred cccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhh
Q 047292 595 MIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMA 673 (728)
Q Consensus 595 ~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 673 (728)
...+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+....+ ..+.....
T Consensus 531 ~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i--------~~~~~~~~--------- 593 (635)
T 4fl3_A 531 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML--------EKGERMGC--------- 593 (635)
T ss_dssp ----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH--------HTTCCCCC---------
T ss_pred CCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH--------HcCCCCCC---------
Confidence 3456789999999999999999999999999999998 99999765543322211 11111111
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 047292 674 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710 (728)
Q Consensus 674 ~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 710 (728)
+......+.+++.+||+.||++||++++|+++|+.+.
T Consensus 594 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 594 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1123356788999999999999999999999998753
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=333.87 Aligned_cols=264 Identities=23% Similarity=0.268 Sum_probs=199.5
Q ss_pred HHHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch-----hhHHHHHHHHHHhcccc---ccceeeEeeeeecC
Q 047292 433 DATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ-----EREREFKSEVSAIGRTH---HKNLVQLLGFCDEA 504 (728)
Q Consensus 433 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~ 504 (728)
...+.+.++||+|+||.||+|... .+++.||||++..... .....+.+|+.++++++ ||||+++++++...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDP-HSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECT-TTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEEC-CCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 345666789999999999999865 5688999999864321 11245667777777664 99999999999765
Q ss_pred C-----cceeEeeccCCCCHHHHHhcCCC--CChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEc
Q 047292 505 L-----NRLLVYEFMGNGTLANLIFAIPK--PDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKIS 577 (728)
Q Consensus 505 ~-----~~~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~ 577 (728)
. ..++||||++ ++|.+++..... +++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEe
Confidence 5 4789999997 599999987654 89999999999999999999997 99999999999999999999999
Q ss_pred cccCccccccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhh
Q 047292 578 DFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYV 657 (728)
Q Consensus 578 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 657 (728)
|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+..... ...
T Consensus 163 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~-~~~ 239 (308)
T 3g33_A 163 DFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG-LPP 239 (308)
T ss_dssp SCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHC-CCC
T ss_pred eCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC-CCC
Confidence 999998664322 23445689999999999999999999999999999999999999986655443322211110 000
Q ss_pred cCccceec----------cchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 658 EGRLDALI----------DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 658 ~~~~~~~~----------d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
........ .+........+..+.+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 00000000 000001111223456788999999999999999999986
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=351.64 Aligned_cols=245 Identities=25% Similarity=0.391 Sum_probs=203.9
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch---hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
+.+.+.||+|+||.||+|... .+|+.||||++..... .....+.+|+.+++.++||||+++++++......++|||
T Consensus 18 Y~l~~~LG~G~fg~V~~a~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E 96 (476)
T 2y94_A 18 YILGDTLGVGTFGKVKVGKHE-LTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVME 96 (476)
T ss_dssp EEEEEEEECCSSSCEEEEEET-TTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 445678999999999999876 5789999999965322 234678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 513 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 513 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
|+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 97 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~--~ 171 (476)
T 2y94_A 97 YVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--F 171 (476)
T ss_dssp CCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC--C
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccccc--c
Confidence 999999999999888899999999999999999999997 99999999999999999999999999998764332 2
Q ss_pred cccccCCccccCcccccCCCC-CCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPV-SAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAA 671 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~-s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 671 (728)
.....||+.|+|||++.+..+ +.++||||||+++|||++|+.||........... ...+... .
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~--------i~~~~~~-~------- 235 (476)
T 2y94_A 172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKK--------ICDGIFY-T------- 235 (476)
T ss_dssp BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHH--------HHTTCCC-C-------
T ss_pred ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHH--------HhcCCcC-C-------
Confidence 334569999999999998876 6899999999999999999999986543322111 1111110 0
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 672 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 672 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
+......+.+++.+||+.||.+|||++++++
T Consensus 236 --p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 236 --PQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp --CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --CccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 0112245778999999999999999999997
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=348.08 Aligned_cols=251 Identities=21% Similarity=0.246 Sum_probs=202.0
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch---hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
.+.+.||+|+||.||++..+ .+++.||||+++.... .....+.+|..++..++|+||+++++++.+....++||||
T Consensus 64 ~~~~~lG~G~fG~V~~~~~~-~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~ 142 (412)
T 2vd5_A 64 EILKVIGRGAFSEVAVVKMK-QTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEY 142 (412)
T ss_dssp EEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcC
Confidence 34578999999999999876 5789999999965322 2234588999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 514 MGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 514 ~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++++||+|||+++.........
T Consensus 143 ~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~ 219 (412)
T 2vd5_A 143 YVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR 219 (412)
T ss_dssp CCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEE
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccCCCccc
Confidence 9999999999875 4789999999999999999999997 99999999999999999999999999998765544333
Q ss_pred cccccCCccccCccccc-------CCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceec
Q 047292 593 HTMIRGTRGYVAPEWLK-------NAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALI 665 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~-------~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (728)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||......+....+...... .....
T Consensus 220 ~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~----~~~p~-- 293 (412)
T 2vd5_A 220 SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH----LSLPL-- 293 (412)
T ss_dssp CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH----CCCC---
T ss_pred cceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC----cCCCc--
Confidence 34467999999999997 457899999999999999999999999876554433322211100 00000
Q ss_pred cchhhhhhcHHHHHHHHHHHHHhcccCCCCC---CCHHHHHHH
Q 047292 666 DSDEAAMADRSRLHKWLMIAMWCIQEDPSKR---PTMKVVMQM 705 (728)
Q Consensus 666 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R---Pt~~evl~~ 705 (728)
........+.+++.+||+ +|.+| |+++||++.
T Consensus 294 -------~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 294 -------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp ----------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred -------cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 011123467789999999 99998 689998753
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=343.42 Aligned_cols=253 Identities=24% Similarity=0.357 Sum_probs=199.7
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcE----EEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeE
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNA----IAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 510 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~----vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 510 (728)
+.+.+.||+|+||.||+|.+.. +++. |++|.+.... ......+.+|+.++++++||||+++++++. ....++|
T Consensus 15 y~~~~~lG~G~~g~Vy~~~~~~-~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v 92 (325)
T 3kex_A 15 LRKLKVLGSGVFGTVHKGVWIP-EGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLV 92 (325)
T ss_dssp EEEEEEEECCSSCEEEEEEECC-TTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEE
T ss_pred ceeeeeeeecCCceEEEEEEcC-CCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEE
Confidence 4456789999999999998763 3443 7888875432 222356788999999999999999999986 4668899
Q ss_pred eeccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCC
Q 047292 511 YEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH 589 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 589 (728)
+||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++......
T Consensus 93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 169 (325)
T 3kex_A 93 TQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169 (325)
T ss_dssp EECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCT
T ss_pred EEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCccc
Confidence 9999999999999875 5788999999999999999999997 99999999999999999999999999998775443
Q ss_pred Cc-ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccc
Q 047292 590 SR-THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDS 667 (728)
Q Consensus 590 ~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 667 (728)
.. ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...........+ ..+.....
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~--------~~~~~~~~--- 238 (325)
T 3kex_A 170 KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL--------EKGERLAQ--- 238 (325)
T ss_dssp TCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHH--------HTTCBCCC---
T ss_pred ccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHH--------HcCCCCCC---
Confidence 22 2344567889999999999999999999999999999999 99999765433322111 11111000
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 047292 668 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710 (728)
Q Consensus 668 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 710 (728)
.......+.+++.+||+.||.+||+++++++.|+.+.
T Consensus 239 ------~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 239 ------PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp ------CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred ------CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0011224567999999999999999999999998865
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=339.30 Aligned_cols=253 Identities=23% Similarity=0.277 Sum_probs=196.7
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc-----chhhHHHHHHHHHHhccccccceeeEeeeeecCCcce
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL-----AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRL 508 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 508 (728)
..+.+.+.||+|+||.||+|..+ .+++.||+|++... .....+.+.+|++++++++||||+++++++.+....+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIEN-QTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hheeecceeeecCCeEEEEEEEC-CCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 34566788999999999999875 56889999998653 2334578999999999999999999999999999999
Q ss_pred eEeeccCCCCHHHHHhcC----------------------------------------CCCChHHHHHHHHHHHHHHHHh
Q 047292 509 LVYEFMGNGTLANLIFAI----------------------------------------PKPDWNLRVRISLEIARGLVYL 548 (728)
Q Consensus 509 lv~e~~~~gsL~~~l~~~----------------------------------------~~~~~~~~~~i~~qi~~~l~yL 548 (728)
+||||+++|+|.+++... ..+++..+..++.||+.||+||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 999999999999998521 1124667888999999999999
Q ss_pred hhcCCCCeeecCCCCCCEEEcCCC--ceEEccccCccccccCCC---cccccccCCccccCcccccC--CCCCCccchhh
Q 047292 549 HEGCNVPIIHCDIKPQNILLDHYF--SPKISDFGLSKLLLSDHS---RTHTMIRGTRGYVAPEWLKN--APVSAKVDVYS 621 (728)
Q Consensus 549 H~~~~~~iiH~dlk~~NIll~~~~--~~kl~Dfgla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~s~~~DVwS 621 (728)
|+. +|+||||||+|||++.++ .+||+|||+++....... .......||+.|+|||.+.+ ..++.++||||
T Consensus 185 H~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws 261 (345)
T 3hko_A 185 HNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261 (345)
T ss_dssp HHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred HHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence 997 999999999999998776 899999999987643221 12344568999999999975 67899999999
Q ss_pred HHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 047292 622 FGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKV 701 (728)
Q Consensus 622 lGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~e 701 (728)
||+++|||++|+.||......+....+. ..... +... ........+.+++.+||+.||.+||++.+
T Consensus 262 lG~il~el~~g~~pf~~~~~~~~~~~~~--------~~~~~--~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 327 (345)
T 3hko_A 262 AGVLLHLLLMGAVPFPGVNDADTISQVL--------NKKLC--FENP----NYNVLSPLARDLLSNLLNRNVDERFDAMR 327 (345)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHH--------HCCCC--TTSG----GGGGSCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred HHHHHHHHHHCCCCCCCCChHHHHHHHH--------hcccc--cCCc----ccccCCHHHHHHHHHHcCCChhHCCCHHH
Confidence 9999999999999997654433221111 11100 0000 01112346778999999999999999999
Q ss_pred HHH
Q 047292 702 VMQ 704 (728)
Q Consensus 702 vl~ 704 (728)
+++
T Consensus 328 ~l~ 330 (345)
T 3hko_A 328 ALQ 330 (345)
T ss_dssp HHH
T ss_pred Hhc
Confidence 987
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=332.94 Aligned_cols=273 Identities=18% Similarity=0.226 Sum_probs=211.4
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeee-ecCCcceeEeecc
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFC-DEALNRLLVYEFM 514 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-~~~~~~~lv~e~~ 514 (728)
+.+.+.||+|+||.||+|... .+++.||||++..... ...+.+|+.+++.++|++++..+..+ ......++||||+
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 3uzp_A 11 YRLGRKIGSGSFGDIYLGTDI-AAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEEEEEccCCCeEEEEEEEc-CCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence 445678999999999999875 5789999999865322 34688999999999887766655555 6667779999999
Q ss_pred CCCCHHHHHhc-CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEE---cCCCceEEccccCccccccCCC
Q 047292 515 GNGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILL---DHYFSPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 515 ~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll---~~~~~~kl~Dfgla~~~~~~~~ 590 (728)
+++|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||+ ++++.+||+|||+++.......
T Consensus 88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (296)
T 3uzp_A 88 -GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred -CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence 9999999974 45789999999999999999999997 99999999999999 4889999999999987654432
Q ss_pred c------ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCcccee
Q 047292 591 R------THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDAL 664 (728)
Q Consensus 591 ~------~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (728)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+........ ....
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~--- 239 (296)
T 3uzp_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM-STPI--- 239 (296)
T ss_dssp CCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH-HSCH---
T ss_pred ccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc-CCch---
Confidence 1 12345689999999999999999999999999999999999999975432221111111111000 0000
Q ss_pred ccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCCCCCccccccc
Q 047292 665 IDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNPPWSSSFSIAV 725 (728)
Q Consensus 665 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~~ 725 (728)
..........+.+++.+||+.||.+||++++|++.|+.+......+....+.|..
T Consensus 240 ------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~~ 294 (296)
T 3uzp_A 240 ------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNM 294 (296)
T ss_dssp ------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGGG
T ss_pred ------HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcccccccccc
Confidence 0001112346788999999999999999999999999988766666666677754
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=340.03 Aligned_cols=266 Identities=16% Similarity=0.174 Sum_probs=199.1
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeC--CCCcEEEEEEecccchh-----------hHHHHHHHHHHhccccccceeeEeee
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKT--ASGNAIAVKKLDRLAQE-----------REREFKSEVSAIGRTHHKNLVQLLGF 500 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~--~~~~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~g~ 500 (728)
..+.+.+.||+|+||.||+|.... ..+..||||++...... ....+.+|+..+..++|+||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 345567889999999999998863 15678999998653221 11346788899999999999999999
Q ss_pred eec----CCcceeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCC--ce
Q 047292 501 CDE----ALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYF--SP 574 (728)
Q Consensus 501 ~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~--~~ 574 (728)
+.. ....++||||+ +++|.+++.....+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTTSE
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCCcE
Confidence 977 77889999999 999999998877899999999999999999999997 999999999999999877 99
Q ss_pred EEccccCccccccCCC------cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhH
Q 047292 575 KISDFGLSKLLLSDHS------RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAIL 648 (728)
Q Consensus 575 kl~Dfgla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~ 648 (728)
||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||............
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 272 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT 272 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence 9999999987643221 1123456999999999999999999999999999999999999999653222111100
Q ss_pred HHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 047292 649 TDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710 (728)
Q Consensus 649 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 710 (728)
.. ..... .+...+. ...........+.+++.+||+.||++||++++|++.|+.+.
T Consensus 273 ~~---~~~~~-~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 273 AK---TNLLD-ELPQSVL---KWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HH---HHHHH-TTTHHHH---HHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HH---Hhhcc-cccHHHH---hhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 00 00000 0000000 00000023346788999999999999999999999998754
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=327.72 Aligned_cols=249 Identities=25% Similarity=0.335 Sum_probs=203.4
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
+.+.+.||+|+||.||+|..+ .+++.||+|++... .....+.+.+|+.++++++||||+++++++......++||||
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 86 (284)
T 3kk8_A 8 YDVKEELGKGAFSVVRRCVHK-TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 86 (284)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hhhhhhhcCcCCeEEEEEEEc-CCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEec
Confidence 445678999999999999876 56889999998653 233457789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCc---eEEccccCccccccCCC
Q 047292 514 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFS---PKISDFGLSKLLLSDHS 590 (728)
Q Consensus 514 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~---~kl~Dfgla~~~~~~~~ 590 (728)
+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++.++. +||+|||++.......
T Consensus 87 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~- 162 (284)
T 3kk8_A 87 VTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE- 162 (284)
T ss_dssp CCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC-
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc-
Confidence 99999999998888899999999999999999999997 9999999999999986655 9999999997664332
Q ss_pred cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhh
Q 047292 591 RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEA 670 (728)
Q Consensus 591 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 670 (728)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+ ..+... ...+
T Consensus 163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~--------~~~~~~-~~~~--- 229 (284)
T 3kk8_A 163 -AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--------KAGAYD-YPSP--- 229 (284)
T ss_dssp -BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHTCCC-CCTT---
T ss_pred -cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHH--------Hhcccc-CCch---
Confidence 223356899999999999999999999999999999999999999765443322211 111110 0000
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 671 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 671 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
........+.+++.+||+.||++|||++|+++
T Consensus 230 --~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 230 --EWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp --TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --hhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00112345778999999999999999999987
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=332.76 Aligned_cols=274 Identities=18% Similarity=0.231 Sum_probs=210.6
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeee-ecCCcceeEeec
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFC-DEALNRLLVYEF 513 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-~~~~~~~lv~e~ 513 (728)
.+.+.+.||+|+||.||+|... .+++.||||++.... ....+.+|+.+++.++|++++..++.+ ......++||||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 4hgt_A 10 RYRLGRKIGSGSFGDIYLGTDI-AAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp -CEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred ceEEeeeecCCCCeEEEEEEEc-CCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence 3556688999999999999865 578899999875432 224678899999999887766666655 667778999999
Q ss_pred cCCCCHHHHHhc-CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEE---cCCCceEEccccCccccccCC
Q 047292 514 MGNGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILL---DHYFSPKISDFGLSKLLLSDH 589 (728)
Q Consensus 514 ~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll---~~~~~~kl~Dfgla~~~~~~~ 589 (728)
+ +++|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||+ ++++.+||+|||+++......
T Consensus 87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 87 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp C-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 9 9999999985 46789999999999999999999997 99999999999999 789999999999998765433
Q ss_pred C------cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccce
Q 047292 590 S------RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDA 663 (728)
Q Consensus 590 ~------~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (728)
. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+........ ....
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~-- 239 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM-STPI-- 239 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH-HSCH--
T ss_pred cCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc-cchh--
Confidence 2 122345689999999999999999999999999999999999999975433222111111111100 0000
Q ss_pred eccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCCCCCccccccc
Q 047292 664 LIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNPPWSSSFSIAV 725 (728)
Q Consensus 664 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~~ 725 (728)
..........+.+++.+||+.||++||++++|++.|+.+++....++...+.|..
T Consensus 240 -------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~~ 294 (296)
T 4hgt_A 240 -------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNM 294 (296)
T ss_dssp -------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGGG
T ss_pred -------hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchhh
Confidence 0000112346788999999999999999999999999988766666666666643
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=333.70 Aligned_cols=262 Identities=27% Similarity=0.435 Sum_probs=196.3
Q ss_pred HHHHHHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeeecCCcc
Q 047292 430 ELKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNR 507 (728)
Q Consensus 430 el~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 507 (728)
|+....+.+.++||+|+||.||+|... ..||+|+++.. .....+.+.+|+.++++++|+||+++++++ .....
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~ 94 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWH----GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQL 94 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESS----SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSC
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEc----CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCcc
Confidence 444555667789999999999999764 35999998643 234457899999999999999999999965 45668
Q ss_pred eeEeeccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccc
Q 047292 508 LLVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLL 586 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 586 (728)
++||||+++++|.+++... ..+++..++.++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 95 AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccc
Confidence 9999999999999999654 5789999999999999999999997 99999999999999999999999999998654
Q ss_pred cCC-CcccccccCCccccCccccc---CCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccc
Q 047292 587 SDH-SRTHTMIRGTRGYVAPEWLK---NAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLD 662 (728)
Q Consensus 587 ~~~-~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (728)
... ........||+.|+|||.+. +..++.++||||||+++|||++|+.||.......... . ....+...
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~---~----~~~~~~~~ 244 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII---E----MVGRGSLS 244 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHH---H----HHHHTSCC
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHH---H----HhcccccC
Confidence 322 22233456899999999996 6678889999999999999999999997543322111 1 11111111
Q ss_pred eeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 663 ALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 663 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
..+.. ........+.+++.+||+.+|.+||++++++++|+++.+
T Consensus 245 ~~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 245 PDLSK-----VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CCTTS-----SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cchhh-----ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 11110 111223567889999999999999999999999998753
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=337.24 Aligned_cols=258 Identities=26% Similarity=0.435 Sum_probs=208.8
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeC----CCCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCcce
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKT----ASGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRL 508 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 508 (728)
..+.+.+.||+|+||.||+|.... .+++.||||++.... ......+.+|+.+++.++|+||+++++++......+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 104 (322)
T 1p4o_A 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 104 (322)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred hheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccE
Confidence 445667889999999999998752 346789999997543 334567899999999999999999999999999999
Q ss_pred eEeeccCCCCHHHHHhcC----------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEcc
Q 047292 509 LVYEFMGNGTLANLIFAI----------PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISD 578 (728)
Q Consensus 509 lv~e~~~~gsL~~~l~~~----------~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~D 578 (728)
+||||+++++|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+||+++.++.+||+|
T Consensus 105 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl~D 181 (322)
T 1p4o_A 105 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD 181 (322)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEECc
Confidence 999999999999998752 3568899999999999999999997 999999999999999999999999
Q ss_pred ccCccccccCCC-cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhh
Q 047292 579 FGLSKLLLSDHS-RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCY 656 (728)
Q Consensus 579 fgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 656 (728)
||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........... .
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~--------~ 253 (322)
T 1p4o_A 182 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF--------V 253 (322)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH--------H
T ss_pred CccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHH--------H
Confidence 999986643322 22233456889999999999999999999999999999999 7888875543322111 1
Q ss_pred hcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 657 VEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 657 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
..+..... .......+.+++.+||+.||.+||++.++++.|++.+.
T Consensus 254 ~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 254 MEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HcCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 11111111 11223457789999999999999999999999998764
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=343.38 Aligned_cols=260 Identities=25% Similarity=0.354 Sum_probs=206.7
Q ss_pred HHHHhhHHhhhCCCceeEEEEeeeeCCC----CcEEEEEEecccc-hhhHHHHHHHHHHhccc-cccceeeEeeeeecCC
Q 047292 432 KDATDGFKEELGRGSFGIVYKGVLKTAS----GNAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEAL 505 (728)
Q Consensus 432 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 505 (728)
....+.+.+.||+|+||.||+|...... ...||+|.+.... ......+.+|+.+++++ +||||+++++++....
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 3344556688999999999999875322 2479999997543 33457799999999999 8999999999999999
Q ss_pred cceeEeeccCCCCHHHHHhcC--------------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCC
Q 047292 506 NRLLVYEFMGNGTLANLIFAI--------------PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHY 571 (728)
Q Consensus 506 ~~~lv~e~~~~gsL~~~l~~~--------------~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~ 571 (728)
..++||||+++|+|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCC
Confidence 999999999999999998742 3578899999999999999999997 99999999999999999
Q ss_pred CceEEccccCccccccCCCc-ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHH
Q 047292 572 FSPKISDFGLSKLLLSDHSR-THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILT 649 (728)
Q Consensus 572 ~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~ 649 (728)
+.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||+| |..||..........
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~--- 277 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY--- 277 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH---
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH---
Confidence 99999999999876443322 2233457889999999999999999999999999999999 888987543222111
Q ss_pred HHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 047292 650 DWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710 (728)
Q Consensus 650 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 710 (728)
.... .+.... .+......+.+++.+||+.||.+|||+++|++.|+.+.
T Consensus 278 ~~~~----~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 278 KLVK----DGYQMA---------QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp HHHH----HTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHh----cCCCCC---------CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 1111 110000 01111346778999999999999999999999998764
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=344.92 Aligned_cols=275 Identities=14% Similarity=0.151 Sum_probs=209.8
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCC-------CCcEEEEEEecccchhhHHHHHHHHHHhccccccceee-----------
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTA-------SGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQ----------- 496 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~-------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 496 (728)
.+.+.+.||+|+||.||+|..... .++.||||.+... ..+.+|++++++++||||++
T Consensus 43 ~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (352)
T 2jii_A 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL 117 (352)
T ss_dssp EEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred eEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence 455668899999999999988642 4789999998653 46789999999999999987
Q ss_pred ----Eeeeeec-CCcceeEeeccCCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEc
Q 047292 497 ----LLGFCDE-ALNRLLVYEFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLD 569 (728)
Q Consensus 497 ----l~g~~~~-~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~ 569 (728)
+++++.. ....++||||+ +++|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++
T Consensus 118 ~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 118 AIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVD 193 (352)
T ss_dssp SCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEEE
T ss_pred CccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEc
Confidence 5667665 67889999999 99999999976 6899999999999999999999997 999999999999999
Q ss_pred CCC--ceEEccccCccccccCCCc------ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhh
Q 047292 570 HYF--SPKISDFGLSKLLLSDHSR------THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELE 641 (728)
Q Consensus 570 ~~~--~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~ 641 (728)
.++ .+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 273 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP 273 (352)
T ss_dssp TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence 998 9999999999876433211 12334689999999999999999999999999999999999999986532
Q ss_pred HhhhhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCCCCCccc
Q 047292 642 EESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNPPWSSSF 721 (728)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~~~~~~~ 721 (728)
.... +...... +. .....+.+.... .......+.+++.+||+.||++||++++|+++|+++++.........+
T Consensus 274 ~~~~--~~~~~~~-~~-~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~ 346 (352)
T 2jii_A 274 NTED--IMKQKQK-FV-DKPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDPI 346 (352)
T ss_dssp CHHH--HHHHHHH-HH-HSCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSCC
T ss_pred CHHH--HHHHHHh-cc-CChhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCccc
Confidence 2111 1111111 11 111111111100 001134677899999999999999999999999998765555544555
Q ss_pred cccc
Q 047292 722 SIAV 725 (728)
Q Consensus 722 ~~~~ 725 (728)
.|..
T Consensus 347 dw~~ 350 (352)
T 2jii_A 347 GLPM 350 (352)
T ss_dssp CCCC
T ss_pred cCcC
Confidence 5543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=345.11 Aligned_cols=255 Identities=26% Similarity=0.428 Sum_probs=193.5
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCC--cEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeee-cCCcceeEee
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASG--NAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCD-EALNRLLVYE 512 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~--~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~~lv~e 512 (728)
.+.+.||+|+||.||+|.+...++ ..||||.++... ....+.+.+|+.++++++||||+++++++. .....++|||
T Consensus 92 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e 171 (373)
T 3c1x_A 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 171 (373)
T ss_dssp EEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEE
T ss_pred ecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEE
Confidence 345789999999999998764443 468999986533 344678999999999999999999999875 4567899999
Q ss_pred ccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 513 FMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 513 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
|+++|+|.+++... ..+++..++.++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++........
T Consensus 172 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 248 (373)
T 3c1x_A 172 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 248 (373)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred CCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccccccc
Confidence 99999999999875 4688999999999999999999997 9999999999999999999999999999866433211
Q ss_pred ---ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccc
Q 047292 592 ---THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDS 667 (728)
Q Consensus 592 ---~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 667 (728)
......+|+.|+|||.+.+..++.++||||||+++|||+| |..||......+.... ...+... ..
T Consensus 249 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~--------~~~~~~~--~~- 317 (373)
T 3c1x_A 249 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY--------LLQGRRL--LQ- 317 (373)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHH--------HHTTCCC--CC-
T ss_pred cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHH--------HHcCCCC--CC-
Confidence 1233457889999999999999999999999999999999 5666654432221111 1111110 00
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 668 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 668 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
+......+.+++.+||+.||++||+++++++.|+.++.
T Consensus 318 ------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~ 355 (373)
T 3c1x_A 318 ------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 355 (373)
T ss_dssp ------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11123467789999999999999999999999998764
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=343.20 Aligned_cols=265 Identities=26% Similarity=0.374 Sum_probs=208.3
Q ss_pred HHhhHHhhhCCCceeEEEEeee---eCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCC--cce
Q 047292 434 ATDGFKEELGRGSFGIVYKGVL---KTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEAL--NRL 508 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~---~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~ 508 (728)
..+.+.+.||+|+||.||++.+ ...+++.||||++........+.+.+|+.++++++|+||+++++++.... ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 3455668899999999999985 23568899999998766666788999999999999999999999986654 789
Q ss_pred eEeeccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcccccc
Q 047292 509 LVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS 587 (728)
Q Consensus 509 lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 587 (728)
+||||+++++|.+++... ..+++..++.++.||++||.|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 121 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp EEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred EEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence 999999999999999876 4689999999999999999999997 999999999999999999999999999987654
Q ss_pred CCCc--ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhh--------hhHHHHHHHhhh
Q 047292 588 DHSR--THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESR--------AILTDWAYDCYV 657 (728)
Q Consensus 588 ~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~ 657 (728)
.... ......++..|+|||.+.+..++.++||||||+++|||+||+.|+......-.. ............
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred cccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhh
Confidence 4321 122345677899999999888999999999999999999999988644221100 000000111111
Q ss_pred cCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 047292 658 EGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710 (728)
Q Consensus 658 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 710 (728)
.+... .........+.+++.+||+.||++||++++|++.|+.+.
T Consensus 278 ~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 278 NNGRL---------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp TTCCC---------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCCC---------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11100 011223356788999999999999999999999998764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=329.42 Aligned_cols=250 Identities=26% Similarity=0.364 Sum_probs=203.4
Q ss_pred hhCCCceeEEEEeeee-CCCCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCCCC
Q 047292 441 ELGRGSFGIVYKGVLK-TASGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGT 518 (728)
Q Consensus 441 ~lg~G~fg~Vy~g~~~-~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 518 (728)
.||+|+||.||+|.+. ..++..||||+++... ....+.+.+|++++++++||||+++++++ .....++||||+++++
T Consensus 17 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~ 95 (287)
T 1u59_A 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGP 95 (287)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEE
T ss_pred cccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCC
Confidence 7999999999999864 3357789999997643 34567899999999999999999999999 4566899999999999
Q ss_pred HHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc--cccc
Q 047292 519 LANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR--THTM 595 (728)
Q Consensus 519 L~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~--~~~~ 595 (728)
|.+++... ..+++..++.++.||+.||.|||+. +|+||||||+||++++++.+||+|||++......... ....
T Consensus 96 L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 172 (287)
T 1u59_A 96 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 172 (287)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCS
T ss_pred HHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeecccc
Confidence 99999754 5689999999999999999999997 9999999999999999999999999999876443322 1223
Q ss_pred ccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhc
Q 047292 596 IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMAD 674 (728)
Q Consensus 596 ~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 674 (728)
..+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........... ...+.... .+
T Consensus 173 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~--------i~~~~~~~---------~~ 235 (287)
T 1u59_A 173 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF--------IEQGKRME---------CP 235 (287)
T ss_dssp SCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH--------HHTTCCCC---------CC
T ss_pred ccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHH--------HhcCCcCC---------CC
Confidence 446889999999998889999999999999999999 9999976543322111 11111111 11
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 675 RSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 675 ~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
......+.+++.+||+.||.+||++.++++.|+.++.
T Consensus 236 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 272 (287)
T 1u59_A 236 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 272 (287)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1234567889999999999999999999999998763
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=330.99 Aligned_cols=254 Identities=27% Similarity=0.381 Sum_probs=204.0
Q ss_pred hhHHh-hhCCCceeEEEEeeee-CCCCcEEEEEEecccch--hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEe
Q 047292 436 DGFKE-ELGRGSFGIVYKGVLK-TASGNAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 511 (728)
Q Consensus 436 ~~~~~-~lg~G~fg~Vy~g~~~-~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 511 (728)
+.+.+ .||+|+||.||+|.+. ...++.||||+++.... ...+.+.+|+.+++.++||||+++++++ .....++||
T Consensus 18 y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~ 96 (291)
T 1xbb_A 18 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVM 96 (291)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred hhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEE
Confidence 34445 8999999999999654 23468899999975432 2357899999999999999999999999 566789999
Q ss_pred eccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 512 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 512 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
||+++++|.+++.....+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++.........
T Consensus 97 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 173 (291)
T 1xbb_A 97 EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173 (291)
T ss_dssp ECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred EeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCc
Confidence 9999999999999888899999999999999999999997 9999999999999999999999999999876544322
Q ss_pred --ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccch
Q 047292 592 --THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSD 668 (728)
Q Consensus 592 --~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 668 (728)
......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...........+ ..+....
T Consensus 174 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~--------~~~~~~~----- 240 (291)
T 1xbb_A 174 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML--------EKGERMG----- 240 (291)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH--------HTTCCCC-----
T ss_pred ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH--------HcCCCCC-----
Confidence 1222346788999999998889999999999999999999 99999765443321111 1111111
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 047292 669 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710 (728)
Q Consensus 669 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 710 (728)
.+......+.+++.+||+.||.+||++.+|++.|+.+.
T Consensus 241 ----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 241 ----CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11122346778999999999999999999999999875
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=338.69 Aligned_cols=256 Identities=23% Similarity=0.346 Sum_probs=198.3
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCc----EEEEEEeccc-chhhHHHHHHHHHHhccccccceeeEeeeeecCCccee
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGN----AIAVKKLDRL-AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLL 509 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 509 (728)
.+.+.+.||+|+||.||+|.+.. +++ .|++|.+... .......+.+|+.++++++||||+++++++.... .++
T Consensus 16 ~y~~~~~lG~G~~g~Vy~~~~~~-~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 16 EFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC-TTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred HceEEEEeeeCCCeEEEEEEEcC-CCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 34556889999999999998763 344 3577777543 2345678999999999999999999999998764 789
Q ss_pred EeeccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccC
Q 047292 510 VYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD 588 (728)
Q Consensus 510 v~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 588 (728)
|+||+++|+|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 94 v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~ 170 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence 99999999999999875 5789999999999999999999997 9999999999999999999999999999876443
Q ss_pred CCc-ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceecc
Q 047292 589 HSR-THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALID 666 (728)
Q Consensus 589 ~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 666 (728)
... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...........+ ..+....
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~--------~~~~~~~--- 239 (327)
T 3lzb_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL--------EKGERLP--- 239 (327)
T ss_dssp ---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH--------HTTCCCC---
T ss_pred cccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH--------HcCCCCC---
Confidence 222 2223446889999999999999999999999999999999 99999765443322111 1111000
Q ss_pred chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 047292 667 SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEV 712 (728)
Q Consensus 667 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 712 (728)
........+.+++.+||+.||.+||+++++++.|+.+...
T Consensus 240 ------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 240 ------QPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred ------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 1111234577899999999999999999999999987643
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=330.94 Aligned_cols=255 Identities=26% Similarity=0.378 Sum_probs=204.5
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
..+.+.+.||+|+||.||++... .+++.||+|+++.........+.+|+.++++++||||+++++++......++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQR-LTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ccceeeeeccCCCCceEEEEEEC-CCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 34556688999999999999876 56889999999765555557789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEE---cCCCceEEccccCccccccCCC
Q 047292 514 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILL---DHYFSPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 514 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll---~~~~~~kl~Dfgla~~~~~~~~ 590 (728)
+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||++ ++++.+||+|||++......
T Consensus 88 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-- 162 (304)
T 2jam_A 88 VSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-- 162 (304)
T ss_dssp CCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB--
T ss_pred CCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC--
Confidence 99999999998878899999999999999999999997 99999999999999 78899999999998764322
Q ss_pred cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhh
Q 047292 591 RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEA 670 (728)
Q Consensus 591 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 670 (728)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||...........+ ..+... +...
T Consensus 163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i--------~~~~~~--~~~~-- 229 (304)
T 2jam_A 163 -IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKI--------KEGYYE--FESP-- 229 (304)
T ss_dssp -TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--------HHCCCC--CCTT--
T ss_pred -ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--------HcCCCC--CCcc--
Confidence 223345899999999999999999999999999999999999999765433221111 111110 0000
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhcC
Q 047292 671 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ--MLEGL 709 (728)
Q Consensus 671 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~--~L~~~ 709 (728)
........+.+++.+||+.||.+||+++++++ .+++.
T Consensus 230 --~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 230 --FWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp --TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred --ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 01122346778999999999999999999986 34443
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=327.82 Aligned_cols=251 Identities=24% Similarity=0.336 Sum_probs=202.3
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch------hhHHHHHHHHHHhccccccceeeEeeeeecCCcc
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ------EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNR 507 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 507 (728)
..+.+.+.||+|+||.||++..+ .+++.||+|.++.... ...+.+.+|+.++++++||||+++++++......
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQK-GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhHHhhcccCceEEEEEEEc-CCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 34566788999999999999876 4688999999865321 1357899999999999999999999999999999
Q ss_pred eeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCC----ceEEccccCcc
Q 047292 508 LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYF----SPKISDFGLSK 583 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~----~~kl~Dfgla~ 583 (728)
++||||+++++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+||+++.++ .+||+|||++.
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 99999999999999998878899999999999999999999997 999999999999999877 89999999998
Q ss_pred ccccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccce
Q 047292 584 LLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDA 663 (728)
Q Consensus 584 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (728)
...... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...........+ .....
T Consensus 161 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--------~~~~~-- 228 (283)
T 3bhy_A 161 KIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI--------SAVNY-- 228 (283)
T ss_dssp ECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--------HTTCC--
T ss_pred eccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHh--------Hhccc--
Confidence 764332 223345899999999999999999999999999999999999999765443321111 11110
Q ss_pred eccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 664 LIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 664 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
...... .......+.+++.+||+.||++||++.++++
T Consensus 229 ~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 229 DFDEEY----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp CCCHHH----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCcchh----cccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 001100 1112345778999999999999999999987
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=345.88 Aligned_cols=270 Identities=20% Similarity=0.271 Sum_probs=208.7
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch-hhHHHHHHHHHHhccccccceeeEeeeeecCC--cceeEee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKNLVQLLGFCDEAL--NRLLVYE 512 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lv~e 512 (728)
+.+.+.||+|+||.||+|... .+++.||||++..... .....+.+|++++++++||||+++++++.... ..++|||
T Consensus 11 y~i~~~LG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e 89 (396)
T 4eut_A 11 WLLSDILGQGATANVFRGRHK-KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEC
T ss_pred eEEEEEEEcCCCeEEEEEEEC-CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEe
Confidence 455678999999999999876 5688999999975432 33567889999999999999999999997765 6799999
Q ss_pred ccCCCCHHHHHhcCC---CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEE----cCCCceEEccccCcccc
Q 047292 513 FMGNGTLANLIFAIP---KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILL----DHYFSPKISDFGLSKLL 585 (728)
Q Consensus 513 ~~~~gsL~~~l~~~~---~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll----~~~~~~kl~Dfgla~~~ 585 (728)
|+++|+|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++..
T Consensus 90 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (396)
T ss_dssp CCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred cCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence 999999999998653 389999999999999999999997 99999999999999 77888999999999876
Q ss_pred ccCCCcccccccCCccccCcccccC--------CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhh-hhhHHHHHHHhh
Q 047292 586 LSDHSRTHTMIRGTRGYVAPEWLKN--------APVSAKVDVYSFGVMLLEIICCRRSVEMELEEES-RAILTDWAYDCY 656 (728)
Q Consensus 586 ~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~-~~~~~~~~~~~~ 656 (728)
.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ ...+.... ...
T Consensus 167 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~-~~~ 243 (396)
T 4eut_A 167 EDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII-TGK 243 (396)
T ss_dssp CCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH-HSC
T ss_pred cCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh-cCC
Confidence 4332 2233568999999999865 5677899999999999999999999975332211 11111111 110
Q ss_pred hcCccceec-----------cchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 047292 657 VEGRLDALI-----------DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEV 712 (728)
Q Consensus 657 ~~~~~~~~~-----------d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 712 (728)
....+.... +..............+.+++.+||+.||++||++.++++.|+.++..
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 000010000 00111123355666778899999999999999999999999887754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=339.05 Aligned_cols=241 Identities=25% Similarity=0.340 Sum_probs=200.3
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch--------hhHHHHHHHHHHhccccccceeeEeeeeecCCc
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ--------EREREFKSEVSAIGRTHHKNLVQLLGFCDEALN 506 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 506 (728)
.+.+.+.||+|+||.||+|... .+++.||||+++.... .....+.+|+.++++++||||+++++++.....
T Consensus 25 ~y~~~~~lG~G~~g~Vy~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 25 KYSTMSPLGSGAFGFVWTAVDK-EKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HEEEEEECSSSSSCSEEEEEET-TTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred ceEEEeEEEecCCEEEEEEEEC-CCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 3445578999999999999876 5688999999865321 123467789999999999999999999999999
Q ss_pred ceeEeeccCCC-CHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcccc
Q 047292 507 RLLVYEFMGNG-TLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLL 585 (728)
Q Consensus 507 ~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~ 585 (728)
.++||||+.+| +|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 99999999777 9999999988999999999999999999999997 9999999999999999999999999999876
Q ss_pred ccCCCcccccccCCccccCcccccCCCC-CCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCcccee
Q 047292 586 LSDHSRTHTMIRGTRGYVAPEWLKNAPV-SAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDAL 664 (728)
Q Consensus 586 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (728)
.... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||........ . .
T Consensus 181 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--------------~----~ 240 (335)
T 3dls_A 181 ERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVE--------------A----A 240 (335)
T ss_dssp CTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTT--------------T----C
T ss_pred CCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHh--------------h----c
Confidence 4432 2234568999999999998877 7899999999999999999999974322110 0 0
Q ss_pred ccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 665 IDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 665 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
... +......+.+++.+||+.||++|||++++++.
T Consensus 241 ~~~------~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 241 IHP------PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp CCC------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred cCC------CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 00123457789999999999999999999985
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=337.44 Aligned_cols=263 Identities=21% Similarity=0.248 Sum_probs=195.0
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch--hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
.+.+.++||+|+||.||++... .+++.||||+++.... .....+.+|+.++++++||||+++++++......++|||
T Consensus 35 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 113 (329)
T 3gbz_A 35 RYRRITKLGEGTYGEVYKAIDT-VTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFE 113 (329)
T ss_dssp GEEEEEEEEECSSSEEEEEEET-TTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hEEEEEEEEecCCeEEEEEEEC-CCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEe
Confidence 3556688999999999999865 5789999999965432 224577899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEE-----cCCCceEEccccCcccccc
Q 047292 513 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILL-----DHYFSPKISDFGLSKLLLS 587 (728)
Q Consensus 513 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll-----~~~~~~kl~Dfgla~~~~~ 587 (728)
|+++ +|.+++...+.+++..+..++.||+.||+|||++ +|+||||||+|||+ ++++.+||+|||+++....
T Consensus 114 ~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~ 189 (329)
T 3gbz_A 114 YAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI 189 (329)
T ss_dssp CCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-
T ss_pred cCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCccccCC
Confidence 9985 9999999888899999999999999999999997 99999999999999 4555699999999987643
Q ss_pred CCCcccccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhc--------
Q 047292 588 DHSRTHTMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVE-------- 658 (728)
Q Consensus 588 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------- 658 (728)
... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||...........+.... .....
T Consensus 190 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 267 (329)
T 3gbz_A 190 PIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVL-GLPDDTTWPGVTA 267 (329)
T ss_dssp -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH-CCCCTTTSTTGGG
T ss_pred ccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHh-CCCchhhhhhhhh
Confidence 322 22334579999999999875 58999999999999999999999997654433222211110 00000
Q ss_pred -----CccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 659 -----GRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 659 -----~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
......................+.+++.+||+.||++|||++|+++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp STTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0001111111111111123356788999999999999999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=329.57 Aligned_cols=253 Identities=26% Similarity=0.422 Sum_probs=201.0
Q ss_pred HhhhCCCceeEEEEeeeeCC--CCcEEEEEEecccch-hhHHHHHHHHHHhccccccceeeEeeeeecCCcc-eeEeecc
Q 047292 439 KEELGRGSFGIVYKGVLKTA--SGNAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNR-LLVYEFM 514 (728)
Q Consensus 439 ~~~lg~G~fg~Vy~g~~~~~--~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~-~lv~e~~ 514 (728)
.+.||+|+||.||+|.+... .+..||+|++..... ...+.+.+|+.++++++||||+++++++...... ++|+||+
T Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~ 105 (298)
T 3pls_A 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYM 105 (298)
T ss_dssp EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCC
T ss_pred CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecc
Confidence 36799999999999987532 233799999975433 4457899999999999999999999999776665 9999999
Q ss_pred CCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCC---C
Q 047292 515 GNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH---S 590 (728)
Q Consensus 515 ~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~---~ 590 (728)
.+++|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++...... .
T Consensus 106 ~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 182 (298)
T 3pls_A 106 CHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSV 182 (298)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCS
T ss_pred cCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccccc
Confidence 999999999874 5688999999999999999999997 99999999999999999999999999998654322 1
Q ss_pred cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcch-hhhHhhhhhHHHHHHHhhhcCccceeccchh
Q 047292 591 RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEM-ELEEESRAILTDWAYDCYVEGRLDALIDSDE 669 (728)
Q Consensus 591 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 669 (728)
.......+++.|+|||.+.+..++.++||||||+++|||++|+.|+.. .........+ ..+....
T Consensus 183 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~--------~~~~~~~------ 248 (298)
T 3pls_A 183 QQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL--------AQGRRLP------ 248 (298)
T ss_dssp CCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHH--------HTTCCCC------
T ss_pred ccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHh--------hcCCCCC------
Confidence 222335578899999999999999999999999999999996665443 2222211111 1111000
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 670 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 670 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
........+.+++.+||+.||.+|||++++++.|+++++
T Consensus 249 ---~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 287 (298)
T 3pls_A 249 ---QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS 287 (298)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 011123467789999999999999999999999998754
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=339.93 Aligned_cols=248 Identities=19% Similarity=0.294 Sum_probs=192.4
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhccccc--cceeeEeeeeecCCcceeEe
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTHH--KNLVQLLGFCDEALNRLLVY 511 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lv~ 511 (728)
+.+.+.||+|+||.||++... +++.||||++... .......+.+|+.++.+++| +||+++++++......++||
T Consensus 11 y~i~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 88 (343)
T 3dbq_A 11 YSILKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 88 (343)
T ss_dssp EEEEEEESCCSSEEEEEEECT--TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred EEEEEEEecCCCeEEEEEEeC--CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence 456688999999999999874 5889999998643 33445789999999999976 99999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 512 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 512 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
| +.+++|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||++ ++.+||+|||+++........
T Consensus 89 e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 163 (343)
T 3dbq_A 89 E-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 163 (343)
T ss_dssp C-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred e-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence 9 56889999999988899999999999999999999997 999999999999997 578999999999876543322
Q ss_pred -ccccccCCccccCcccccC-----------CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcC
Q 047292 592 -THTMIRGTRGYVAPEWLKN-----------APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEG 659 (728)
Q Consensus 592 -~~~~~~gt~~y~aPE~~~~-----------~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 659 (728)
......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......... + .. ....
T Consensus 164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~----~~-~~~~ 236 (343)
T 3dbq_A 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK--L----HA-IIDP 236 (343)
T ss_dssp ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH--H----HH-HHCT
T ss_pred ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH--H----HH-HhcC
Confidence 2334569999999999864 67899999999999999999999999753221110 0 00 0010
Q ss_pred ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 660 RLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 660 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
... ...+......+.+++.+||+.||.+|||+.|+++.
T Consensus 237 ~~~--------~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 237 NHE--------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp TSC--------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred Ccc--------cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 000 00111112356789999999999999999999864
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=336.43 Aligned_cols=264 Identities=25% Similarity=0.347 Sum_probs=201.6
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
+.+.+.||+|+||.||++... .+++.||||++.... ....+.+.+|+.++++++||||+++++++......++||||
T Consensus 27 y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 105 (331)
T 4aaa_A 27 YENLGLVGEGSYGMVMKCRNK-DTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEF 105 (331)
T ss_dssp EEEEEEGGGGTTSSEEEEEET-TTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred heeeeEEeecCCEEEEEEEEC-CCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEec
Confidence 445678999999999999876 568899999985432 23356788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccc
Q 047292 514 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH 593 (728)
Q Consensus 514 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 593 (728)
+++++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 106 ~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 181 (331)
T 4aaa_A 106 VDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-VY 181 (331)
T ss_dssp CSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----------
T ss_pred CCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc-cc
Confidence 99999999988888899999999999999999999997 999999999999999999999999999986543322 22
Q ss_pred ccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHH-------HHHhh------hcC
Q 047292 594 TMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDW-------AYDCY------VEG 659 (728)
Q Consensus 594 ~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~-------~~~~~------~~~ 659 (728)
....|++.|+|||.+.+. .++.++||||||+++|||++|+.||...........+... ....+ ...
T Consensus 182 ~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (331)
T 4aaa_A 182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGV 261 (331)
T ss_dssp --CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTC
T ss_pred CCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccc
Confidence 334689999999999875 7899999999999999999999999765443322211110 00000 011
Q ss_pred ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 660 RLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 660 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
.+...................+.+++.+||+.||.+|||++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 262 RLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 111111111111112233567889999999999999999998875
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=336.92 Aligned_cols=259 Identities=28% Similarity=0.374 Sum_probs=206.7
Q ss_pred HHhhHHhhhCCCceeEEEEeeee----CCCCcEEEEEEecccc-hhhHHHHHHHHHHhccc-cccceeeEeeeeecCC-c
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLK----TASGNAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEAL-N 506 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~----~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~-~ 506 (728)
..+.+.+.||+|+||.||+|... ..+++.||||+++... ....+.+.+|+.++.++ +||||+++++++.... .
T Consensus 27 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 106 (316)
T 2xir_A 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 106 (316)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred hheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCc
Confidence 34556688999999999999863 2456899999997643 33456899999999999 7999999999987654 4
Q ss_pred ceeEeeccCCCCHHHHHhcCCC----------------CChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcC
Q 047292 507 RLLVYEFMGNGTLANLIFAIPK----------------PDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDH 570 (728)
Q Consensus 507 ~~lv~e~~~~gsL~~~l~~~~~----------------~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~ 570 (728)
.++||||+++++|.+++..... +++..++.++.||++||.|||++ +|+||||||+||+++.
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~ 183 (316)
T 2xir_A 107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE 183 (316)
T ss_dssp CEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECG
T ss_pred eEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECC
Confidence 8999999999999999987643 78899999999999999999997 9999999999999999
Q ss_pred CCceEEccccCccccccCCCc-ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhH
Q 047292 571 YFSPKISDFGLSKLLLSDHSR-THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAIL 648 (728)
Q Consensus 571 ~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~ 648 (728)
++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||..........
T Consensus 184 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~-- 261 (316)
T 2xir_A 184 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC-- 261 (316)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH--
T ss_pred CCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHH--
Confidence 999999999999876443322 2233557889999999999999999999999999999998 999987543221110
Q ss_pred HHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 649 TDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 649 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
.....+..... .......+.+++.+||+.||.+|||+++|++.|+.+++
T Consensus 262 -----~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 262 -----RRLKEGTRMRA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp -----HHHHHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----HHhccCccCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11111111111 11123457789999999999999999999999998763
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=339.92 Aligned_cols=262 Identities=26% Similarity=0.378 Sum_probs=204.8
Q ss_pred HHHHHHhhHHhhhCCCceeEEEEeeee----CCCCcEEEEEEeccc-chhhHHHHHHHHHHhccccccceeeEeeeeecC
Q 047292 430 ELKDATDGFKEELGRGSFGIVYKGVLK----TASGNAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEA 504 (728)
Q Consensus 430 el~~~~~~~~~~lg~G~fg~Vy~g~~~----~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 504 (728)
++....+.+.+.||+|+||.||+|.+. ..+++.||||++... .......+.+|+.++++++||||+++++++...
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence 344556677789999999999999853 245678999999643 344567899999999999999999999999999
Q ss_pred CcceeEeeccCCCCHHHHHhcC-------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcC---CCce
Q 047292 505 LNRLLVYEFMGNGTLANLIFAI-------PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDH---YFSP 574 (728)
Q Consensus 505 ~~~~lv~e~~~~gsL~~~l~~~-------~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~---~~~~ 574 (728)
...++||||+++++|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++. +..+
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCE
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceE
Confidence 9999999999999999999865 2478889999999999999999997 9999999999999984 4569
Q ss_pred EEccccCccccccCCC-cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHH
Q 047292 575 KISDFGLSKLLLSDHS-RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWA 652 (728)
Q Consensus 575 kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 652 (728)
||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||+| |+.||...........
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~----- 257 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF----- 257 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH-----
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHH-----
Confidence 9999999986543322 22233457899999999999999999999999999999998 8899875543322111
Q ss_pred HHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 653 YDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 653 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
...+..... .......+.+++.+||+.||.+||++.+|++.|+.+..
T Consensus 258 ---~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 258 ---VTSGGRMDP---------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp ---HHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HhcCCCCCC---------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 111111110 11223467789999999999999999999999988653
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=326.04 Aligned_cols=252 Identities=25% Similarity=0.367 Sum_probs=203.3
Q ss_pred HHHHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeec--------
Q 047292 432 KDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDE-------- 503 (728)
Q Consensus 432 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-------- 503 (728)
....+.+.+.||+|+||.||+|... .+++.||+|++.... ..+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHR-IDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEET-TTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred hccccceeeeeccCCceEEEEEEEc-CCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 3445566788999999999999875 468899999996543 356789999999999999999998854
Q ss_pred --------CCcceeEeeccCCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCc
Q 047292 504 --------ALNRLLVYEFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFS 573 (728)
Q Consensus 504 --------~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~ 573 (728)
....++||||+++++|.+++... ..+++..++.++.||+.||.|||++ +|+|+||||+||++++++.
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCC
Confidence 45579999999999999999754 5788999999999999999999997 9999999999999999999
Q ss_pred eEEccccCccccccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHH
Q 047292 574 PKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAY 653 (728)
Q Consensus 574 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 653 (728)
+||+|||++........ .....|++.|+|||.+.+..++.++||||||+++|||++|..|+...... .
T Consensus 161 ~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~----------~ 228 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKF----------F 228 (284)
T ss_dssp EEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHH----------H
T ss_pred EEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHH----------H
Confidence 99999999987644322 23345899999999999999999999999999999999999887532110 1
Q ss_pred HhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCC
Q 047292 654 DCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNP 715 (728)
Q Consensus 654 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~ 715 (728)
.....+.+.. .....+.+++.+||+.||.+||++.++++.|+.+...+..
T Consensus 229 ~~~~~~~~~~------------~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~ 278 (284)
T 2a19_B 229 TDLRDGIISD------------IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278 (284)
T ss_dssp HHHHTTCCCT------------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred HHhhcccccc------------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence 1111121111 1123467899999999999999999999999988765544
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=333.39 Aligned_cols=256 Identities=21% Similarity=0.277 Sum_probs=195.6
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccc-cccceeeEeeeeecCCcceeEeeccCCCC
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYEFMGNGT 518 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~gs 518 (728)
+.||+|+||.||++... .+++.||||++..........+.+|++++.++ +||||+++++++......++||||+++++
T Consensus 19 ~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 97 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINL-ITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGS 97 (316)
T ss_dssp CCCCCCSSEEEEEEECS-SSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred ceecCCceEEEEEEEEc-CCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCc
Confidence 56999999999999865 56889999999765555567899999999885 79999999999999999999999999999
Q ss_pred HHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCc---eEEccccCccccccCCC-----
Q 047292 519 LANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFS---PKISDFGLSKLLLSDHS----- 590 (728)
Q Consensus 519 L~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~---~kl~Dfgla~~~~~~~~----- 590 (728)
|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+|||++........
T Consensus 98 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 174 (316)
T 2ac3_A 98 ILSHIHKRRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174 (316)
T ss_dssp HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------------
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcccccc
Confidence 999998888899999999999999999999997 9999999999999998776 99999999986532211
Q ss_pred -cccccccCCccccCcccccC-----CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhh-------hhHHHHHHHhhh
Q 047292 591 -RTHTMIRGTRGYVAPEWLKN-----APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESR-------AILTDWAYDCYV 657 (728)
Q Consensus 591 -~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~-------~~~~~~~~~~~~ 657 (728)
.......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......... ............
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 254 (316)
T 2ac3_A 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQ 254 (316)
T ss_dssp -------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHH
T ss_pred ccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHh
Confidence 11223458999999999975 46789999999999999999999999754321100 000000111111
Q ss_pred cCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 658 EGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 658 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.+... .. .... ......+.+++.+||+.||.+|||++|+++.
T Consensus 255 ~~~~~-~~-~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 255 EGKYE-FP-DKDW----AHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HCCCC-CC-HHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccCcc-cC-chhc----ccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11110 00 0000 1123467789999999999999999999874
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=343.14 Aligned_cols=265 Identities=23% Similarity=0.320 Sum_probs=190.8
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhcccc-ccceeeEeeeeecCC--ccee
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTH-HKNLVQLLGFCDEAL--NRLL 509 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~--~~~l 509 (728)
.+.+.+.||+|+||.||+|... .+++.||||++... .......+.+|+.++..+. |+||+++++++...+ ..++
T Consensus 10 ~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 88 (388)
T 3oz6_A 10 KYELVKKLGKGAYGIVWKSIDR-RTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL 88 (388)
T ss_dssp TEEEEEC-------CEEEEEET-TTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred ceEEEEEeeeCCCeEEEEEEEC-CCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence 4556688999999999999876 57899999998543 2344577889999999997 999999999997544 6799
Q ss_pred EeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCC
Q 047292 510 VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH 589 (728)
Q Consensus 510 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 589 (728)
||||++ ++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 89 v~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 89 VFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp EEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred EecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 999998 589998876 4788899999999999999999997 99999999999999999999999999998653211
Q ss_pred --------------------CcccccccCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhH
Q 047292 590 --------------------SRTHTMIRGTRGYVAPEWLKN-APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAIL 648 (728)
Q Consensus 590 --------------------~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~ 648 (728)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i 243 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 112234569999999999986 67899999999999999999999999765443332222
Q ss_pred HHHHHHh----h---h------------------cCccceeccchh----hhhhcHHHHHHHHHHHHHhcccCCCCCCCH
Q 047292 649 TDWAYDC----Y---V------------------EGRLDALIDSDE----AAMADRSRLHKWLMIAMWCIQEDPSKRPTM 699 (728)
Q Consensus 649 ~~~~~~~----~---~------------------~~~~~~~~d~~~----~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~ 699 (728)
....... + . .......+.... ...........+.+++.+||+.||++|||+
T Consensus 244 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~ 323 (388)
T 3oz6_A 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA 323 (388)
T ss_dssp HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence 1110000 0 0 000000000000 000000123467899999999999999999
Q ss_pred HHHHHH
Q 047292 700 KVVMQM 705 (728)
Q Consensus 700 ~evl~~ 705 (728)
+|+++.
T Consensus 324 ~e~l~H 329 (388)
T 3oz6_A 324 NDALKH 329 (388)
T ss_dssp HHHTTS
T ss_pred HHHhCC
Confidence 999875
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=326.10 Aligned_cols=256 Identities=25% Similarity=0.309 Sum_probs=207.7
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch---hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
+.+.+.||+|+||.||+|... .+++.||+|++..... .....+.+|++++++++||||+++++++......++|||
T Consensus 16 y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 94 (284)
T 2vgo_A 16 FDIGRPLGKGKFGNVYLAREK-QNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLE 94 (284)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceeeheecCCCCeEEEEEEEc-CCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEE
Confidence 455678999999999999875 5678999999865322 224678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 513 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 513 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
|+++++|.+++.....+++..+..++.||++||.|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 168 (284)
T 2vgo_A 95 FAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR--- 168 (284)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC---
T ss_pred eCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcccc---
Confidence 999999999998878899999999999999999999997 99999999999999999999999999987653322
Q ss_pred cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAM 672 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 672 (728)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||...........+ ......
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--------~~~~~~---------- 230 (284)
T 2vgo_A 169 RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRI--------VNVDLK---------- 230 (284)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--------HTTCCC----------
T ss_pred cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHH--------hccccC----------
Confidence 23356899999999999999999999999999999999999999765443322111 111110
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhcCcCCCCCC
Q 047292 673 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ--MLEGLLEVPNPP 716 (728)
Q Consensus 673 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~--~L~~~~~~~~~~ 716 (728)
.+......+.+++.+||+.||.+||+++++++ .+........||
T Consensus 231 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~~~p~ 276 (284)
T 2vgo_A 231 FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPP 276 (284)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCCCCCCC
T ss_pred CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhccccCCC
Confidence 01112345678999999999999999999986 444433333333
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=330.90 Aligned_cols=256 Identities=26% Similarity=0.419 Sum_probs=199.3
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCC--CcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeee-ecCCcceeEe
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTAS--GNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFC-DEALNRLLVY 511 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~--~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~-~~~~~~~lv~ 511 (728)
+.+.+.||+|+||.||+|.+...+ ...||+|.+.... ....+.+.+|+.++++++||||+++++++ ......++||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 106 (298)
T 3f66_A 27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 106 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEE
Confidence 345578999999999999875333 2368999987543 34457899999999999999999999986 4556789999
Q ss_pred eccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC
Q 047292 512 EFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 512 e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 590 (728)
||+++++|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++.......
T Consensus 107 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 183 (298)
T 3f66_A 107 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183 (298)
T ss_dssp ECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred eCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccccch
Confidence 999999999999864 5688999999999999999999997 999999999999999999999999999987643322
Q ss_pred ---cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCC-cCcchhhhHhhhhhHHHHHHHhhhcCccceecc
Q 047292 591 ---RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCR-RSVEMELEEESRAILTDWAYDCYVEGRLDALID 666 (728)
Q Consensus 591 ---~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 666 (728)
.......+|+.|+|||.+.+..++.++||||||+++|||++|+ .|+...........+ ..+.....
T Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~-- 253 (298)
T 3f66_A 184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL--------LQGRRLLQ-- 253 (298)
T ss_dssp CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH--------HTTCCCCC--
T ss_pred hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH--------hcCCCCCC--
Confidence 1223345788999999999999999999999999999999955 555443322211111 11110000
Q ss_pred chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 667 SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 667 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
+......+.+++.+||+.||.+||+++++++.|+.++.
T Consensus 254 -------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 254 -------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp -------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11122457789999999999999999999999998764
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=333.49 Aligned_cols=262 Identities=20% Similarity=0.314 Sum_probs=197.5
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEe
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 511 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 511 (728)
.+.+.+.||+|+||.||+|... .+++.||||++... .......+.+|+.++++++|+||+++++++......++||
T Consensus 33 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 33 NFRIEKKIGRGQFSEVYRAACL-LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GEEEEEEEECC--CEEEEEEET-TTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceEEEEeecCCCCceEEEEEEc-CCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 3556688999999999999875 56889999998642 2344578899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhc----CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcccccc
Q 047292 512 EFMGNGTLANLIFA----IPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS 587 (728)
Q Consensus 512 e~~~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 587 (728)
||+++++|.+++.. ...+++..++.++.||+.||.|||+. +|+|+||||+||+++.++.+||+|||++.....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999874 45688999999999999999999997 999999999999999999999999999986643
Q ss_pred CCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccc
Q 047292 588 DHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDS 667 (728)
Q Consensus 588 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 667 (728)
... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||........ . +. .............
T Consensus 189 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~-~~----~~~~~~~~~~~~~- 260 (310)
T 2wqm_A 189 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-S-LC----KKIEQCDYPPLPS- 260 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH-H-HH----HHHHTTCSCCCCT-
T ss_pred CCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH-H-HH----HHhhcccCCCCcc-
Confidence 322 12234589999999999999999999999999999999999999864322111 0 00 1111111111110
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCC
Q 047292 668 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNP 715 (728)
Q Consensus 668 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~ 715 (728)
......+.+++.+||+.||.+||++++|++.|+.+.....+
T Consensus 261 -------~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 261 -------DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp -------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred -------cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 11234677899999999999999999999999998754433
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=326.40 Aligned_cols=249 Identities=25% Similarity=0.349 Sum_probs=196.3
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
..+.+.++||+|+||.||++..+ .+++.||+|++.... ....+.+.+|++++++++||||+++++++......++|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEER-SSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hheeecceeccCCCeEEEEEEEc-cCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 34566789999999999999876 568899999986543 2345789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcC----CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEE---cCCCceEEccccCcccc
Q 047292 513 FMGNGTLANLIFAI----PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILL---DHYFSPKISDFGLSKLL 585 (728)
Q Consensus 513 ~~~~gsL~~~l~~~----~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll---~~~~~~kl~Dfgla~~~ 585 (728)
|+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||++ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999998643 6789999999999999999999997 99999999999999 45688999999999866
Q ss_pred ccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceec
Q 047292 586 LSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALI 665 (728)
Q Consensus 586 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (728)
.... ......|++.|+|||.+. ..++.++||||||+++|||++|+.||............ ...........
T Consensus 178 ~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~------~~~~~~~~~~~ 248 (285)
T 3is5_A 178 KSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA------TYKEPNYAVEC 248 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCCCCCCC--
T ss_pred CCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhh------ccCCccccccc
Confidence 4332 223456899999999986 46899999999999999999999999765443322111 00010000000
Q ss_pred cchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 666 DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 666 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
. .....+.+++.+||+.||++|||++|+++
T Consensus 249 -----~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 249 -----R----PLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -----C----CCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred -----C----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 01345678999999999999999999985
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=332.43 Aligned_cols=257 Identities=28% Similarity=0.406 Sum_probs=194.8
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCC--CCcEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeeecCCc----
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTA--SGNAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALN---- 506 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~--~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~---- 506 (728)
.+.+.+.||+|+||.||+|..... +++.||+|+++.. .....+.+.+|+.++++++||||+++++++.....
T Consensus 35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 114 (313)
T 3brb_A 35 LLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIP 114 (313)
T ss_dssp GEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------
T ss_pred HeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCc
Confidence 344567899999999999987643 3458999998643 23445779999999999999999999999977653
Q ss_pred -ceeEeeccCCCCHHHHHh------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccc
Q 047292 507 -RLLVYEFMGNGTLANLIF------AIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDF 579 (728)
Q Consensus 507 -~~lv~e~~~~gsL~~~l~------~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Df 579 (728)
.++||||+++++|.+++. ....+++..++.++.||++||.|||++ +|+||||||+||++++++.+||+||
T Consensus 115 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~Df 191 (313)
T 3brb_A 115 KPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADF 191 (313)
T ss_dssp CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEECSC
T ss_pred ccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEeec
Confidence 499999999999999984 335689999999999999999999997 9999999999999999999999999
Q ss_pred cCccccccCCC-cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhh
Q 047292 580 GLSKLLLSDHS-RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYV 657 (728)
Q Consensus 580 gla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 657 (728)
|+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||...........+ .
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~--------~ 263 (313)
T 3brb_A 192 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL--------L 263 (313)
T ss_dssp SCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH--------H
T ss_pred CcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH--------H
Confidence 99987644322 22233457889999999999999999999999999999999 88888755433221111 1
Q ss_pred cCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 658 EGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 658 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
.+..... .......+.+++.+||+.||.+||+++++++.|+.+++
T Consensus 264 ~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 264 HGHRLKQ---------PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp TTCCCCC---------BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCC---------CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1111111 11223467889999999999999999999999998753
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=345.55 Aligned_cols=261 Identities=23% Similarity=0.257 Sum_probs=194.1
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeeecCC------cc
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEAL------NR 507 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~ 507 (728)
+.+.+.||+|+||.||++... .+++.||||++... .....+.+.+|+.+++.++||||+++++++.... ..
T Consensus 64 y~~~~~lG~G~~g~V~~a~~~-~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 142 (464)
T 3ttj_A 64 YQNLKPIGSGAQGIVCAAYDA-VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 142 (464)
T ss_dssp EEEEEEEEECSSCEEEEEEET-TTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred eEEEEEeecCCCeEEEEEEEC-CCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeE
Confidence 445678999999999999876 56889999999653 3344578899999999999999999999996553 46
Q ss_pred eeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcccccc
Q 047292 508 LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS 587 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 587 (728)
++||||++++ |.+.+.. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 143 ~lv~E~~~~~-l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 143 YLVMELMDAN-LCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp EEEEECCSEE-HHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred EEEEeCCCCC-HHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 9999999864 6666643 488999999999999999999997 999999999999999999999999999987643
Q ss_pred CCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHH---------------
Q 047292 588 DHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWA--------------- 652 (728)
Q Consensus 588 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~--------------- 652 (728)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+....
T Consensus 217 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~ 294 (464)
T 3ttj_A 217 S--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294 (464)
T ss_dssp C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHH
T ss_pred C--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhh
Confidence 2 22344678999999999999999999999999999999999999997654433222221110
Q ss_pred HHhhhcCc------cceeccchh---hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 653 YDCYVEGR------LDALIDSDE---AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 653 ~~~~~~~~------~~~~~d~~~---~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
........ +...+.... ...........+.+++.+||+.||++|||++|+++.
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 000000000 000111225678899999999999999999999874
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=330.76 Aligned_cols=270 Identities=21% Similarity=0.315 Sum_probs=200.7
Q ss_pred HHHHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhcc--ccccceeeEeeeeecC----C
Q 047292 432 KDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGR--THHKNLVQLLGFCDEA----L 505 (728)
Q Consensus 432 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~~----~ 505 (728)
....+.+.+.||+|+||.||+|... ++.||||++.... ...+..|.+++.. ++|+||+++++++... .
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWR---GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEET---TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cccceEEEeEeecCCCeEEEEEEEC---CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 3455667789999999999999863 7899999986432 3344455555554 4899999999999877 6
Q ss_pred cceeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcC-----CCCeeecCCCCCCEEEcCCCceEEcccc
Q 047292 506 NRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGC-----NVPIIHCDIKPQNILLDHYFSPKISDFG 580 (728)
Q Consensus 506 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~-----~~~iiH~dlk~~NIll~~~~~~kl~Dfg 580 (728)
..++||||+++|+|.+++... .+++..++.++.|++.||+|||+++ ..+|+||||||+|||++.++.+||+|||
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 187 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 187 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred ceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCC
Confidence 789999999999999999764 6889999999999999999999741 2389999999999999999999999999
Q ss_pred CccccccCCCcc---cccccCCccccCcccccCCCCCCc------cchhhHHHHHHHHHhC----------CcCcchhhh
Q 047292 581 LSKLLLSDHSRT---HTMIRGTRGYVAPEWLKNAPVSAK------VDVYSFGVMLLEIICC----------RRSVEMELE 641 (728)
Q Consensus 581 la~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~~------~DVwSlGvil~elltg----------~~p~~~~~~ 641 (728)
+++......... .....||+.|+|||.+.+.....+ +||||||+++|||++| +.||.....
T Consensus 188 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~ 267 (337)
T 3mdy_A 188 LAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267 (337)
T ss_dssp TCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcC
Confidence 998764433221 123568999999999988777665 9999999999999999 555543221
Q ss_pred HhhhhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCC
Q 047292 642 EESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPN 714 (728)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 714 (728)
..... .. .............+. ...........+.+++.+||+.||.+|||+.+|++.|+.+.+...
T Consensus 268 ~~~~~--~~-~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 268 SDPSY--ED-MREIVCIKKLRPSFP---NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp SSCCH--HH-HHHHHTTSCCCCCCC---GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred CCCch--hh-hHHHHhhhccCcccc---ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 11100 00 001111111111111 111223566778899999999999999999999999998876543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=327.00 Aligned_cols=246 Identities=23% Similarity=0.344 Sum_probs=180.1
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch---hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
+.+.+.||+|+||.||+|... .+++.||||++..... ...+.+.+|+.++++++||||+++++++......++|||
T Consensus 13 y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (278)
T 3cok_A 13 FKVGNLLGKGSFAGVYRAESI-HTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLE 91 (278)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ceeeeeecCCCceEEEEEEEc-cCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEe
Confidence 345578999999999999875 4688999999965322 224678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 513 FMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 513 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
|+++++|.+++... ..+++..++.++.|+++||.|||++ +|+||||||+||+++.++.+||+|||++.........
T Consensus 92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 168 (278)
T 3cok_A 92 MCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK 168 (278)
T ss_dssp CCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred cCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc
Confidence 99999999999876 6789999999999999999999997 9999999999999999999999999999876433221
Q ss_pred ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhh
Q 047292 592 THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAA 671 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 671 (728)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||........... ..... .
T Consensus 169 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~--------~~~~~------~---- 229 (278)
T 3cok_A 169 -HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK--------VVLAD------Y---- 229 (278)
T ss_dssp ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------CCSSC------C----
T ss_pred -ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHH--------Hhhcc------c----
Confidence 2234689999999999999999999999999999999999999975432211100 00000 0
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 672 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 672 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
..+......+.+++.+||+.||++||+++++++
T Consensus 230 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 230 EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 011112346778999999999999999999976
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=335.84 Aligned_cols=256 Identities=27% Similarity=0.400 Sum_probs=203.0
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcE--EEEEEecccc-hhhHHHHHHHHHHhccc-cccceeeEeeeeecCCcceeE
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNA--IAVKKLDRLA-QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLV 510 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~--vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv 510 (728)
.+.+.+.||+|+||.||+|.... ++.. |++|.++... ....+.+.+|+++++++ +||||+++++++......++|
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 26 DIKFQDVIGEGNFGQVLKARIKK-DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GCEEEEEEECGGGCEEEEEEEEE-TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HccceeeeecCCCceEEEEEEcc-CCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 34567889999999999998863 4554 5999886532 33456789999999999 899999999999999999999
Q ss_pred eeccCCCCHHHHHhcCC----------------CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCce
Q 047292 511 YEFMGNGTLANLIFAIP----------------KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSP 574 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~ 574 (728)
|||+++++|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 99999999999998654 688999999999999999999997 99999999999999999999
Q ss_pred EEccccCccccccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHH
Q 047292 575 KISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAY 653 (728)
Q Consensus 575 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 653 (728)
||+|||+++..... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...........
T Consensus 182 kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~------ 253 (327)
T 1fvr_A 182 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK------ 253 (327)
T ss_dssp EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH------
T ss_pred EEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHH------
Confidence 99999998743221 11223446889999999998889999999999999999998 9999976543322111
Q ss_pred HhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCC
Q 047292 654 DCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVP 713 (728)
Q Consensus 654 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~ 713 (728)
...+.... ........+.+++.+||+.||.+||+++++++.|+.+++..
T Consensus 254 --~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 254 --LPQGYRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp --GGGTCCCC---------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred --hhcCCCCC---------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 11111000 01122346778999999999999999999999998876443
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=336.75 Aligned_cols=244 Identities=25% Similarity=0.324 Sum_probs=196.9
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
+...+.||+|+||.||+|... .+++.||||++... .....+.+.+|++++++++||||+++++++......++|||
T Consensus 56 y~~~~~lG~G~~g~Vy~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 134 (348)
T 1u5q_A 56 FSDLREIGHGSFGAVYFARDV-RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 134 (348)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeeeeEEccCCCEEEEEEEEc-cCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence 445578999999999999865 57889999998643 23334678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhc-CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 513 FMGNGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 513 ~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
|++ |+|.+++.. ...+++..+..++.|+++||.|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 135 ~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--- 207 (348)
T 1u5q_A 135 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 207 (348)
T ss_dssp CCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred cCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---
Confidence 997 578777753 46789999999999999999999997 9999999999999999999999999999865332
Q ss_pred ccccccCCccccCccccc---CCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccch
Q 047292 592 THTMIRGTRGYVAPEWLK---NAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSD 668 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~---~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 668 (728)
....||+.|+|||++. ...++.++||||||+++|||++|+.||...........+ ..+.......
T Consensus 208 --~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~--------~~~~~~~~~~-- 275 (348)
T 1u5q_A 208 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--------AQNESPALQS-- 275 (348)
T ss_dssp --CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--------HHSCCCCCCC--
T ss_pred --CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--------HhcCCCCCCC--
Confidence 2346899999999984 567899999999999999999999998755432211111 1111111111
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 669 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 669 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
......+.+++.+||+.||++|||++++++.
T Consensus 276 ------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 276 ------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp ------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ------CCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1123456789999999999999999999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=343.11 Aligned_cols=248 Identities=18% Similarity=0.291 Sum_probs=193.8
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhcccc--ccceeeEeeeeecCCcceeEe
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTH--HKNLVQLLGFCDEALNRLLVY 511 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~~lv~ 511 (728)
+.+.+.||+|+||.||++... .++.||||++... .......+.+|+.++++++ |+||+++++++......++||
T Consensus 58 y~~~~~LG~G~fg~Vy~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 58 YSILKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEECCSSEEEEEEECT--TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred eEEEEEEccCCCeEEEEEEcC--CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 556688999999999999875 4889999998543 3345578999999999996 599999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 512 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 512 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
| +.+++|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||++ ++.+||+|||+++........
T Consensus 136 E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp E-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred e-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 9 67889999999888899999999999999999999997 999999999999996 579999999999876443322
Q ss_pred -ccccccCCccccCcccccC-----------CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcC
Q 047292 592 -THTMIRGTRGYVAPEWLKN-----------APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEG 659 (728)
Q Consensus 592 -~~~~~~gt~~y~aPE~~~~-----------~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 659 (728)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .+ ......
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~--~~-----~~~~~~ 283 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--KL-----HAIIDP 283 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--HH-----HHHHCT
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH--HH-----HHHhCc
Confidence 2334569999999999965 3688999999999999999999999975322111 01 001111
Q ss_pred ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 660 RLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 660 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.....+ +......+.+++.+||+.||.+||++.|+++.
T Consensus 284 ~~~~~~--------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 284 NHEIEF--------PDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp TSCCCC--------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccCCC--------CccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 110000 11112457789999999999999999999864
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=335.89 Aligned_cols=261 Identities=23% Similarity=0.258 Sum_probs=200.4
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhcccc-----ccceeeEeeeeecCCcce
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTH-----HKNLVQLLGFCDEALNRL 508 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~g~~~~~~~~~ 508 (728)
..+.+.++||+|+||.||+|... .+++.||||+++.. ......+..|+.+++.++ |+||+++++++......+
T Consensus 35 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~ 112 (360)
T 3llt_A 35 NAFLVIRKMGDGTFGRVLLCQHI-DNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMC 112 (360)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEE
T ss_pred CEEEEEEEEcccCCeEEEEEEEC-CCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeE
Confidence 44556688999999999999876 56889999999753 334566788999998886 999999999999999999
Q ss_pred eEeeccCCCCHHHHHhcCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcC----------------
Q 047292 509 LVYEFMGNGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDH---------------- 570 (728)
Q Consensus 509 lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~---------------- 570 (728)
+||||+ +++|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||+++
T Consensus 113 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~ 188 (360)
T 3llt_A 113 LIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDG 188 (360)
T ss_dssp EEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEECTTTC
T ss_pred EEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchhccccc
Confidence 999999 999999998754 588999999999999999999997 9999999999999975
Q ss_pred ---------CCceEEccccCccccccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhh
Q 047292 571 ---------YFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELE 641 (728)
Q Consensus 571 ---------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~ 641 (728)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 189 ~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 264 (360)
T 3llt_A 189 KKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEH 264 (360)
T ss_dssp CEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcH
Confidence 789999999999864332 2345689999999999999999999999999999999999999976544
Q ss_pred HhhhhhHHHHH-------HHhhhcCccceeccch---------hh---------h---hhcHHHHHHHHHHHHHhcccCC
Q 047292 642 EESRAILTDWA-------YDCYVEGRLDALIDSD---------EA---------A---MADRSRLHKWLMIAMWCIQEDP 693 (728)
Q Consensus 642 ~~~~~~~~~~~-------~~~~~~~~~~~~~d~~---------~~---------~---~~~~~~~~~l~~l~~~cl~~dp 693 (728)
.+....+.... ............++.. .. . .........+.+++.+||+.||
T Consensus 265 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 344 (360)
T 3llt_A 265 MEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDP 344 (360)
T ss_dssp HHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCCh
Confidence 33222211100 0000000000000000 00 0 0000011467789999999999
Q ss_pred CCCCCHHHHHH
Q 047292 694 SKRPTMKVVMQ 704 (728)
Q Consensus 694 ~~RPt~~evl~ 704 (728)
++|||++|+++
T Consensus 345 ~~Rpta~elL~ 355 (360)
T 3llt_A 345 TLRPSPAELLK 355 (360)
T ss_dssp GGSCCHHHHTT
T ss_pred hhCCCHHHHhc
Confidence 99999999975
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=328.00 Aligned_cols=247 Identities=22% Similarity=0.292 Sum_probs=204.4
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
+.+.+.||+|+||.||++... .+++.||+|++.... ....+.+.+|+.+++.++|+||+++++++......++|||
T Consensus 17 y~~~~~lg~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 95 (294)
T 2rku_A 17 YVRGRFLGKGGFAKCFEISDA-DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE 95 (294)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEeecCCEEEEEEEEC-CCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEe
Confidence 445678999999999999876 567899999986532 3345778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 513 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 513 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
|+++++|.+++.....+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++........ .
T Consensus 96 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~ 171 (294)
T 2rku_A 96 LCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-R 171 (294)
T ss_dssp CCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCcc-c
Confidence 999999999998878899999999999999999999997 999999999999999999999999999987643322 2
Q ss_pred cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAM 672 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 672 (728)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||......+....+ ..... ..
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~--------~~~~~-~~-------- 234 (294)
T 2rku_A 172 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI--------KKNEY-SI-------- 234 (294)
T ss_dssp BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--------HTTCC-CC--------
T ss_pred cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------hhccC-CC--------
Confidence 23356899999999999999999999999999999999999999765443321111 11110 00
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 673 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 673 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
+......+.+++.+||+.||++||+++++++.
T Consensus 235 -~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 235 -PKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -ccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11122456789999999999999999999973
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=325.65 Aligned_cols=245 Identities=27% Similarity=0.395 Sum_probs=196.6
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeeec----CCcceeE
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDE----ALNRLLV 510 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lv 510 (728)
.+.+.||+|+||.||+|... .++..||+|++... .....+.+.+|+.++++++||||+++++++.. ....++|
T Consensus 29 ~~~~~lg~G~~g~Vy~~~~~-~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 29 KFDIEIGRGSFKTVYKGLDT-ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EeeeeccCCCCeEEEEeEec-CCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 34567999999999999876 56789999998653 23445789999999999999999999998865 4557999
Q ss_pred eeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCC--eeecCCCCCCEEEc-CCCceEEccccCcccccc
Q 047292 511 YEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVP--IIHCDIKPQNILLD-HYFSPKISDFGLSKLLLS 587 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~--iiH~dlk~~NIll~-~~~~~kl~Dfgla~~~~~ 587 (728)
|||+++++|.+++.....+++..+..++.||+.||.|||++ + |+||||||+||+++ +++.+||+|||++.....
T Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~ 184 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence 99999999999998878899999999999999999999997 6 99999999999998 789999999999975433
Q ss_pred CCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccc
Q 047292 588 DHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDS 667 (728)
Q Consensus 588 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 667 (728)
. ......|++.|+|||.+.+ .++.++||||||+++|||++|+.||......... ......+.....+
T Consensus 185 ~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-------~~~~~~~~~~~~~-- 251 (290)
T 1t4h_A 185 S---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI-------YRRVTSGVKPASF-- 251 (290)
T ss_dssp T---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH-------HHHHTTTCCCGGG--
T ss_pred c---ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH-------HHHHhccCCcccc--
Confidence 2 2233568999999998875 5899999999999999999999999753322111 1111111111111
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 668 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 668 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
+......+.+++.+||+.||.+|||++++++
T Consensus 252 ------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 252 ------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ------CCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1111245778999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=337.89 Aligned_cols=253 Identities=22% Similarity=0.309 Sum_probs=186.7
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhcccc-ccceeeEeeeee--------cC
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTH-HKNLVQLLGFCD--------EA 504 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~--------~~ 504 (728)
..+.+.++||+|+||.||++... .+++.||||++........+.+.+|+.++.++. ||||+++++++. ..
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDV-GSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEET-TTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred ceEEEEEEEccCCceEEEEEEEC-CCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 34566789999999999999875 568899999997666666788999999999995 999999999983 44
Q ss_pred CcceeEeeccCCCCHHHHHhc---CCCCChHHHHHHHHHHHHHHHHhhhcCCCC--eeecCCCCCCEEEcCCCceEEccc
Q 047292 505 LNRLLVYEFMGNGTLANLIFA---IPKPDWNLRVRISLEIARGLVYLHEGCNVP--IIHCDIKPQNILLDHYFSPKISDF 579 (728)
Q Consensus 505 ~~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~--iiH~dlk~~NIll~~~~~~kl~Df 579 (728)
...++|+||+. |+|.+++.. ...+++..++.++.||+.||.|||++ + |+||||||+|||++.++.+||+||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecC
Confidence 45789999996 799888865 45689999999999999999999997 7 999999999999999999999999
Q ss_pred cCccccccCCCcc-----------cccccCCccccCcccc---cCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhh
Q 047292 580 GLSKLLLSDHSRT-----------HTMIRGTRGYVAPEWL---KNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESR 645 (728)
Q Consensus 580 gla~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~ 645 (728)
|+++......... .....||+.|+|||++ .+..++.++||||||+++|||++|+.||.........
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~ 262 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV 262 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhh
Confidence 9998764432211 1134589999999998 5667899999999999999999999999643322110
Q ss_pred hhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 646 AILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
........ .......+.+++.+||+.||.+||+++|+++.|+.+..
T Consensus 263 ------------~~~~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 263 ------------NGKYSIPP--------HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp ---------------CCCCT--------TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------------cCcccCCc--------ccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 00000000 00111236679999999999999999999999988764
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=353.95 Aligned_cols=249 Identities=26% Similarity=0.282 Sum_probs=202.2
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
+.+.+.||+|+||.||++..+ .+++.||||++.... ......+.+|+.+++.++||||+++++++.+....++|||
T Consensus 186 f~~~~~LG~G~fG~Vy~a~~~-~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE 264 (576)
T 2acx_A 186 FRQYRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 264 (576)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred eEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEE
Confidence 344578999999999999876 578999999996532 2334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC
Q 047292 513 FMGNGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 513 ~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 590 (728)
|+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||||+.++++||+|||+++......
T Consensus 265 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~- 340 (576)
T 2acx_A 265 LMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ- 340 (576)
T ss_dssp CCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC-
T ss_pred cCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccCc-
Confidence 999999999998764 489999999999999999999997 99999999999999999999999999998764332
Q ss_pred cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhh
Q 047292 591 RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEA 670 (728)
Q Consensus 591 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 670 (728)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+..... ....
T Consensus 341 -~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~----~~~~--------- 406 (576)
T 2acx_A 341 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK----EVPE--------- 406 (576)
T ss_dssp -CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHH----HCCC---------
T ss_pred -cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhh----cccc---------
Confidence 22335799999999999999999999999999999999999999986532211111111111 1110
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047292 671 AMADRSRLHKWLMIAMWCIQEDPSKRP-----TMKVVMQ 704 (728)
Q Consensus 671 ~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~ 704 (728)
.........+.+++.+||+.||.+|| +++||++
T Consensus 407 -~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 407 -EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred -cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 01112234677899999999999999 7888875
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=334.68 Aligned_cols=247 Identities=22% Similarity=0.296 Sum_probs=204.6
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc---chhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEe
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 511 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 511 (728)
.+.+.+.||+|+||.||++... .+++.||+|++... .....+.+.+|+.+++.++|+||+++++++.+....++||
T Consensus 42 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 42 RYVRGRFLGKGGFAKCFEISDA-DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ceEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 3445678999999999999876 56789999998653 2344577899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 512 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 512 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
||+++++|.+++.....+++..++.++.||++||.|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 121 e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~- 196 (335)
T 2owb_A 121 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE- 196 (335)
T ss_dssp CCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred ecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCcc-
Confidence 9999999999998878899999999999999999999997 999999999999999999999999999987643322
Q ss_pred ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhh
Q 047292 592 THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAA 671 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 671 (728)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+....+ ...... +
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--------~~~~~~-~------- 260 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI--------KKNEYS-I------- 260 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--------HHTCCC-C-------
T ss_pred cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH--------hcCCCC-C-------
Confidence 223356899999999999999999999999999999999999999765433321111 111100 0
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 672 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 672 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
.......+.+++.+||+.||++||+++|+++
T Consensus 261 --~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 261 --PKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred --CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112235678999999999999999999986
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=324.65 Aligned_cols=251 Identities=28% Similarity=0.367 Sum_probs=202.9
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
.+.+.+.||+|+||.||+|..+ .+++.||||++.... ....+.+.+|+.+++.++||||+++++++.+....++|+||
T Consensus 8 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 8 DWDLVQTLGEGAYGEVQLAVNR-VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ceEEEEEeecCCCcEEEEEEEC-CCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 3455678999999999999875 568899999986433 33457889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC-cc
Q 047292 514 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS-RT 592 (728)
Q Consensus 514 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-~~ 592 (728)
+++++|.+++.....+++..+..++.|++.||.|||++ +|+|+||||+||+++.++.+||+|||++........ ..
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 163 (276)
T 2yex_A 87 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (276)
T ss_dssp CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred cCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence 99999999998878899999999999999999999997 999999999999999999999999999987643321 22
Q ss_pred cccccCCccccCcccccCCCC-CCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPV-SAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAA 671 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~-s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 671 (728)
.....|++.|+|||.+.+..+ +.++||||||+++|||++|+.||......... +..+ ...... ...
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~~-----~~~~~~--~~~---- 230 (276)
T 2yex_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDW-----KEKKTY--LNP---- 230 (276)
T ss_dssp BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH--HHHH-----HTTCTT--STT----
T ss_pred ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH--HHHh-----hhcccc--cCc----
Confidence 334568999999999988765 77999999999999999999999764332111 1111 111000 000
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 672 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 672 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
.......+.+++.+||+.||.+|||++|+++
T Consensus 231 --~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 231 --WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp --GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 0112345678999999999999999999976
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=339.09 Aligned_cols=264 Identities=23% Similarity=0.314 Sum_probs=202.8
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc-chhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
.+.+.+.||+|+||.||++... .+++.||+|++... .....+.+.+|+.++++++||||+++++++......++||||
T Consensus 34 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 34 DFEKISELGAGNGGVVFKVSHK-PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred cceeeeeecCCCCeEEEEEEEC-CCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 3445678999999999999876 56889999998654 334457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccc
Q 047292 514 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH 593 (728)
Q Consensus 514 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 593 (728)
+++++|.+++.....+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||++...... ..
T Consensus 113 ~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~ 187 (360)
T 3eqc_A 113 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MA 187 (360)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---C-
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCcccccc---cc
Confidence 99999999999888899999999999999999999983 27999999999999999999999999999765322 12
Q ss_pred ccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHH-------------------
Q 047292 594 TMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYD------------------- 654 (728)
Q Consensus 594 ~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~------------------- 654 (728)
....||+.|+|||++.+..++.++||||||+++|||++|+.||...........+......
T Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (360)
T 3eqc_A 188 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267 (360)
T ss_dssp ---CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------
T ss_pred cCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccccc
Confidence 2346899999999999999999999999999999999999999765443321111000000
Q ss_pred ---hhhcCccceeccchhh----hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 655 ---CYVEGRLDALIDSDEA----AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 655 ---~~~~~~~~~~~d~~~~----~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
..........++.... ..........+.+++.+||+.||.+|||++|+++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0000000000000000 0000112346788999999999999999999985
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=335.71 Aligned_cols=265 Identities=24% Similarity=0.271 Sum_probs=195.8
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeeecCC------cc
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEAL------NR 507 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~ 507 (728)
+.+.+.||+|+||.||+|... .+++.||||++... .....+.+.+|+.+++.++||||+++++++.... ..
T Consensus 27 y~~~~~lG~G~~g~V~~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 105 (367)
T 1cm8_A 27 YRDLQPVGSGAYGAVCSAVDG-RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 105 (367)
T ss_dssp EEEEEEC------CEEEEEET-TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred EEEeEEeeecCCeEEEEEEEC-CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceE
Confidence 445678999999999999875 57899999999543 2334577899999999999999999999997653 45
Q ss_pred eeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcccccc
Q 047292 508 LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS 587 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 587 (728)
++||||+ +++|.+++.. ..+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 106 ~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 106 YLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADS 180 (367)
T ss_dssp EEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence 9999999 7899999876 5688999999999999999999997 999999999999999999999999999987543
Q ss_pred CCCcccccccCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHH-------HhhhcC
Q 047292 588 DHSRTHTMIRGTRGYVAPEWLKN-APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAY-------DCYVEG 659 (728)
Q Consensus 588 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~-------~~~~~~ 659 (728)
. .....+|+.|+|||++.+ ..++.++||||||++++||++|+.||...........+..... ......
T Consensus 181 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~ 256 (367)
T 1cm8_A 181 E----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 256 (367)
T ss_dssp S----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred c----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhH
Confidence 2 233568999999999987 6899999999999999999999999976544332221111000 000000
Q ss_pred -------ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhcCcC
Q 047292 660 -------RLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ--MLEGLLE 711 (728)
Q Consensus 660 -------~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~--~L~~~~~ 711 (728)
.+........ ..........+.+++.+||+.||.+|||++++++ .++.+.+
T Consensus 257 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~ 316 (367)
T 1cm8_A 257 EAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316 (367)
T ss_dssp HHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred HHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence 0000000000 0111122456788999999999999999999998 3555443
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=331.04 Aligned_cols=253 Identities=25% Similarity=0.374 Sum_probs=200.8
Q ss_pred HHHhhHH-hhhCCCceeEEEEeeeeCCCCcEEEEEEecccch--hhHHHHHHHHHHhccc-cccceeeEeeeeecCCcce
Q 047292 433 DATDGFK-EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ--EREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRL 508 (728)
Q Consensus 433 ~~~~~~~-~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 508 (728)
...+.+. ++||+|+||.||++..+ .+++.||+|++..... .....+.+|+.++.++ +||||+++++++......+
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~ 105 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISK-STGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEII 105 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEEC-CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEE
Confidence 3344444 78999999999999876 5689999999865332 2357889999999998 5799999999999999999
Q ss_pred eEeeccCCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcC---CCceEEccccCcc
Q 047292 509 LVYEFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDH---YFSPKISDFGLSK 583 (728)
Q Consensus 509 lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~---~~~~kl~Dfgla~ 583 (728)
+||||+++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+++
T Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~ 182 (327)
T 3lm5_A 106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR 182 (327)
T ss_dssp EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCGGGCE
T ss_pred EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeCcccc
Confidence 999999999999999654 6789999999999999999999997 9999999999999997 7899999999998
Q ss_pred ccccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccce
Q 047292 584 LLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDA 663 (728)
Q Consensus 584 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (728)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+.. ....
T Consensus 183 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~--------~~~~- 251 (327)
T 3lm5_A 183 KIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQ--------VNVD- 251 (327)
T ss_dssp EC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------TCCC-
T ss_pred ccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHh--------cccc-
Confidence 764332 22335689999999999999999999999999999999999999976544332221110 0000
Q ss_pred eccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 664 LIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 664 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
. . ..........+.+++.+||+.||.+|||++++++.
T Consensus 252 ~-~----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 252 Y-S----EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp C-C----TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred c-C----chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 0 0 00111223457789999999999999999999864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=336.39 Aligned_cols=250 Identities=25% Similarity=0.331 Sum_probs=198.2
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccc-cccceeeEeeeeecCCcceeEeec
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
.+.+.+.||+|+||.||++..+ .+++.||||+++.... ...+|++++.++ +||||+++++++.+....++||||
T Consensus 23 ~y~~~~~lG~G~~g~V~~~~~~-~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 23 GYEVKEDIGVGSYSVCKRCIHK-ATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp HEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 4556688999999999999876 5788999999965432 245688888887 799999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCC----CceEEccccCccccccCC
Q 047292 514 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHY----FSPKISDFGLSKLLLSDH 589 (728)
Q Consensus 514 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~----~~~kl~Dfgla~~~~~~~ 589 (728)
+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||+.++ +.+||+|||+++......
T Consensus 98 ~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~ 174 (342)
T 2qr7_A 98 MKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174 (342)
T ss_dssp CCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence 99999999999888899999999999999999999997 99999999999998543 359999999998764433
Q ss_pred CcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchh
Q 047292 590 SRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDE 669 (728)
Q Consensus 590 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 669 (728)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+ .....+.... ..
T Consensus 175 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~-----~~i~~~~~~~--~~-- 244 (342)
T 2qr7_A 175 G-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL-----ARIGSGKFSL--SG-- 244 (342)
T ss_dssp C-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHH-----HHHHHCCCCC--CS--
T ss_pred C-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHH-----HHHccCCccc--Cc--
Confidence 2 223456899999999998888999999999999999999999999753221111111 1111121110 00
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 670 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 670 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
.........+.+++.+||+.||++||++.++++
T Consensus 245 --~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 245 --GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp --TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 001122346778999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=340.57 Aligned_cols=255 Identities=22% Similarity=0.255 Sum_probs=202.5
Q ss_pred HhhHHhhhCCCceeEEEEeeeeC--CCCcEEEEEEecccc----hhhHHHHHHHHHHhccc-cccceeeEeeeeecCCcc
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKT--ASGNAIAVKKLDRLA----QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNR 507 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~--~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 507 (728)
.+.+.+.||+|+||.||++.... .+++.||||+++... ......+.+|+++++.+ +|+||+++++++......
T Consensus 55 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 134 (355)
T 1vzo_A 55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL 134 (355)
T ss_dssp GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred ceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceE
Confidence 35566889999999999998742 468899999986532 12335677899999999 699999999999999999
Q ss_pred eeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcccccc
Q 047292 508 LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS 587 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 587 (728)
++||||+++++|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 135 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 211 (355)
T 1vzo_A 135 HLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 211 (355)
T ss_dssp EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred EEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCeeccc
Confidence 99999999999999998888899999999999999999999997 999999999999999999999999999987654
Q ss_pred CCCcccccccCCccccCcccccC--CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceec
Q 047292 588 DHSRTHTMIRGTRGYVAPEWLKN--APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALI 665 (728)
Q Consensus 588 ~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (728)
..........||+.|+|||++.+ ..++.++||||||+++|||++|+.||...........+..... ....
T Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~----~~~~---- 283 (355)
T 1vzo_A 212 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL----KSEP---- 283 (355)
T ss_dssp GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH----HCCC----
T ss_pred CCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh----ccCC----
Confidence 44334445679999999999986 3578999999999999999999999975433221111111111 0000
Q ss_pred cchhhhhhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 047292 666 DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRP-----TMKVVMQML 706 (728)
Q Consensus 666 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~L 706 (728)
.........+.+++.+||+.||.+|| +++++++..
T Consensus 284 ------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 284 ------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ------CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 01112234567899999999999999 999998754
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=347.84 Aligned_cols=272 Identities=17% Similarity=0.213 Sum_probs=210.4
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccc-cceeeEeeeeecCCcceeEeecc
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHH-KNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
+.+.++||+|+||.||+|... .+++.||||++..... ...+..|+++++.++| +++..+..++......+|||||+
T Consensus 9 y~i~~~LG~G~fG~Vy~a~~~-~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~ 85 (483)
T 3sv0_A 9 FRLGRKIGSGSFGEIYLGTNI-QTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (483)
T ss_dssp EECCCCCEECSSCEEEEEEET-TTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEEEEEeeCCCEEEEEEEEC-CCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence 445678999999999999875 5688999998764322 2457889999999975 66667777778888889999999
Q ss_pred CCCCHHHHHhc-CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEE---cCCCceEEccccCccccccCCC
Q 047292 515 GNGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILL---DHYFSPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 515 ~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll---~~~~~~kl~Dfgla~~~~~~~~ 590 (728)
+++|.+++.. ...+++..++.|+.||+.||+|||++ +|+||||||+|||| +.++.+||+|||+++.......
T Consensus 86 -g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (483)
T 3sv0_A 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (483)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred -CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence 9999999985 46799999999999999999999997 99999999999999 6889999999999987754332
Q ss_pred c------ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCcccee
Q 047292 591 R------THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDAL 664 (728)
Q Consensus 591 ~------~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (728)
. ......||+.|+|||.+.+..++.++||||||++||||++|+.||...........+....... +...
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~-----~~~~ 236 (483)
T 3sv0_A 162 HQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK-----VATS 236 (483)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHH-----HHSC
T ss_pred ccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcc-----cccc
Confidence 1 1224669999999999999999999999999999999999999997643322222221111111 0000
Q ss_pred ccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCCCCCcccccc
Q 047292 665 IDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNPPWSSSFSIA 724 (728)
Q Consensus 665 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~ 724 (728)
+.. .......++.+++.+||+.+|++||++++|+++|+.++.....++...+.|.
T Consensus 237 ~~~-----l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~ 291 (483)
T 3sv0_A 237 IEA-----LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWT 291 (483)
T ss_dssp HHH-----HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHH
T ss_pred HHH-----HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCch
Confidence 000 0011234678899999999999999999999999998665555544444443
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=343.76 Aligned_cols=193 Identities=24% Similarity=0.343 Sum_probs=154.3
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeeec-----CCcc
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDE-----ALNR 507 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-----~~~~ 507 (728)
.+.+.+.||+|+||.||+|..+ .+++.||||++... .....+.+.+|+.+|+.++|+||+++++++.. ....
T Consensus 54 ~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 54 RYEIRHLIGTGSYGHVCEAYDK-LEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TEEECCC-------CEEEEEEC-C--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CeEEeeEeeecCCeEEEEEEEC-CCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 3556688999999999999876 57889999999653 23345789999999999999999999999843 3568
Q ss_pred eeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcccccc
Q 047292 508 LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS 587 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 587 (728)
|+||||+ +++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++....
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp EEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred EEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 9999998 479999999888899999999999999999999997 999999999999999999999999999987643
Q ss_pred CCC--------------------------cccccccCCccccCcccc-cCCCCCCccchhhHHHHHHHHHhC
Q 047292 588 DHS--------------------------RTHTMIRGTRGYVAPEWL-KNAPVSAKVDVYSFGVMLLEIICC 632 (728)
Q Consensus 588 ~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~~DVwSlGvil~elltg 632 (728)
... .......||+.|+|||++ ....++.++|||||||+||||++|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 211 122345689999999986 566799999999999999999993
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=347.35 Aligned_cols=252 Identities=25% Similarity=0.318 Sum_probs=204.0
Q ss_pred HHHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeE
Q 047292 433 DATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 510 (728)
Q Consensus 433 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 510 (728)
...|.+.+.||+|+||.||++..+ .+++.||||++.... ......+.+|++++++++||||+++++++......++|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDR-ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEET-TTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEEC-CCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 345667789999999999999876 578899999986432 23457889999999999999999999999999999999
Q ss_pred eeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEc---CCCceEEccccCcccccc
Q 047292 511 YEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLD---HYFSPKISDFGLSKLLLS 587 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~---~~~~~kl~Dfgla~~~~~ 587 (728)
|||+++++|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+++....
T Consensus 100 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 99999999999998888899999999999999999999997 999999999999995 566899999999986643
Q ss_pred CCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccc
Q 047292 588 DHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDS 667 (728)
Q Consensus 588 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 667 (728)
.. ......||+.|+|||++.+ .++.++||||||+++|||++|+.||......+....+ ..+.... +.
T Consensus 177 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i--------~~~~~~~--~~ 243 (486)
T 3mwu_A 177 NT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV--------ETGKYAF--DL 243 (486)
T ss_dssp C------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHTCCCS--CS
T ss_pred CC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------HhCCCCC--CC
Confidence 32 2234568999999999976 5899999999999999999999999765443322211 1111110 00
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 668 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 668 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.. .......+.+++.+||+.||.+|||+.++++.
T Consensus 244 ~~----~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 244 PQ----WRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp GG----GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred cc----cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 11123457789999999999999999999974
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=331.10 Aligned_cols=267 Identities=23% Similarity=0.308 Sum_probs=206.0
Q ss_pred HHHHHHHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhcc--ccccceeeEeeeeecCC-
Q 047292 429 DELKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGR--THHKNLVQLLGFCDEAL- 505 (728)
Q Consensus 429 ~el~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~~~- 505 (728)
.+.....+.+.+.||+|+||.||+|.. +++.||||++... ....+..|.+++.. ++||||+++++++....
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKW---RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEE---TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred cccccccEEEEeeecCCCCcEEEEEEE---cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 344455677778999999999999986 4789999999643 34567788888876 78999999999998776
Q ss_pred ---cceeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhh--------hcCCCCeeecCCCCCCEEEcCCCce
Q 047292 506 ---NRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLH--------EGCNVPIIHCDIKPQNILLDHYFSP 574 (728)
Q Consensus 506 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH--------~~~~~~iiH~dlk~~NIll~~~~~~ 574 (728)
..++||||+++|+|.+++.. ..+++..++.++.|++.||.||| +. +|+||||||+|||+++++++
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSCE
T ss_pred ccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCCE
Confidence 78999999999999999976 46889999999999999999999 54 99999999999999999999
Q ss_pred EEccccCccccccCCCc---ccccccCCccccCcccccCCC------CCCccchhhHHHHHHHHHhC----------CcC
Q 047292 575 KISDFGLSKLLLSDHSR---THTMIRGTRGYVAPEWLKNAP------VSAKVDVYSFGVMLLEIICC----------RRS 635 (728)
Q Consensus 575 kl~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~s~~~DVwSlGvil~elltg----------~~p 635 (728)
||+|||++......... ......||+.|+|||.+.+.. ++.++||||||+++|||++| ..|
T Consensus 187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 99999999876544322 223456899999999998763 33689999999999999999 667
Q ss_pred cchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 636 VEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
|......... ... .............+.. .....+....+.+++.+||+.||++|||+++|++.|+.+.+
T Consensus 267 ~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~ 336 (342)
T 1b6c_B 267 YYDLVPSDPS--VEE-MRKVVCEQKLRPNIPN---RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336 (342)
T ss_dssp TTTTSCSSCC--HHH-HHHHHTTSCCCCCCCG---GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccccCcCccc--HHH-HHHHHHHHHhCCCCcc---cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 7543221100 000 1111111111111111 11233556778899999999999999999999999998764
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=339.30 Aligned_cols=245 Identities=23% Similarity=0.262 Sum_probs=187.7
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhcc-ccccceeeEeeeeec----CCcceeEeecc
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGR-THHKNLVQLLGFCDE----ALNRLLVYEFM 514 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~----~~~~~lv~e~~ 514 (728)
+.||+|+||.||++..+ .+++.||||+++.. ..+.+|+.++.+ .+|+||+++++++.. ....++||||+
T Consensus 68 ~~LG~G~~g~V~~~~~~-~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~ 141 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNK-RTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 141 (400)
T ss_dssp EEEEEETTEEEEEEEET-TTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred ceeeeccCeEEEEEEEC-CCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeC
Confidence 57999999999999876 57889999998642 356778888754 489999999998865 66789999999
Q ss_pred CCCCHHHHHhcCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcC---CCceEEccccCccccccCC
Q 047292 515 GNGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDH---YFSPKISDFGLSKLLLSDH 589 (728)
Q Consensus 515 ~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~---~~~~kl~Dfgla~~~~~~~ 589 (728)
++|+|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++......
T Consensus 142 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~ 218 (400)
T 1nxk_A 142 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218 (400)
T ss_dssp CSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC---
T ss_pred CCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCCCC
Confidence 9999999998753 589999999999999999999997 9999999999999997 7899999999998654322
Q ss_pred CcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchh
Q 047292 590 SRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDE 669 (728)
Q Consensus 590 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 669 (728)
......||+.|+|||++.+..++.++|||||||++|||++|+.||............... ...+... ....
T Consensus 219 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~----i~~~~~~-~~~~-- 289 (400)
T 1nxk_A 219 --SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR----IRMGQYE-FPNP-- 289 (400)
T ss_dssp ----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHH----HHHTCCC-CCTT--
T ss_pred --ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHH----HHcCccc-CCCc--
Confidence 223456899999999999999999999999999999999999999754332211000000 0111110 0000
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 670 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 670 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
........+.+++.+||+.||.+|||++++++.
T Consensus 290 ---~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 290 ---EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp ---TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 001123467789999999999999999999974
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=333.51 Aligned_cols=249 Identities=26% Similarity=0.377 Sum_probs=200.4
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc--------hhhHHHHHHHHHHhccc-cccceeeEeeeeecCCc
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA--------QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALN 506 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 506 (728)
+.+.+.||+|+||.||+|.++ .+|+.||||++.... ....+.+.+|+.+++++ +||||+++++++.....
T Consensus 96 y~~~~~lg~G~~g~Vy~a~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 174 (365)
T 2y7j_A 96 YDPKDVIGRGVSSVVRRCVHR-ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSF 174 (365)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSE
T ss_pred cccceEEecCCCEEEEEEEEC-CCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCE
Confidence 444578999999999999875 468899999985432 12245788999999999 79999999999999999
Q ss_pred ceeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccc
Q 047292 507 RLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLL 586 (728)
Q Consensus 507 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 586 (728)
.++||||+++++|.+++.....+++..+..++.||+.||.|||+. +|+|+||||+|||++.++.+||+|||++....
T Consensus 175 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 175 MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 999999999999999998878899999999999999999999997 99999999999999999999999999998764
Q ss_pred cCCCcccccccCCccccCcccccC------CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCc
Q 047292 587 SDHSRTHTMIRGTRGYVAPEWLKN------APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGR 660 (728)
Q Consensus 587 ~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (728)
... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...........+ ..+.
T Consensus 252 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i--------~~~~ 321 (365)
T 2y7j_A 252 PGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI--------MEGQ 321 (365)
T ss_dssp TTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHTC
T ss_pred CCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHH--------HhCC
Confidence 332 2234568999999999863 36889999999999999999999999764433221111 1111
Q ss_pred cceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 661 LDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 661 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
... ..... ......+.+++.+||+.||++||+++++++
T Consensus 322 ~~~--~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 322 YQF--SSPEW----DDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp CCC--CHHHH----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCC--CCccc----ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 100 00000 012345778999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=328.38 Aligned_cols=258 Identities=26% Similarity=0.325 Sum_probs=197.5
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCCc--EEEEEEeccc---chhhHHHHHHHHHHhccccccceeeEeeeeecCCcce
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASGN--AIAVKKLDRL---AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRL 508 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~~--~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 508 (728)
..+.+.+.||+|+||.||+|.+...+++ .||||+++.. .....+.+.+|++++++++||||+++++++.... .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 3455668899999999999987644444 6899998653 2334578999999999999999999999998765 88
Q ss_pred eEeeccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcccccc
Q 047292 509 LVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS 587 (728)
Q Consensus 509 lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 587 (728)
+|+||+++++|.+++... ..+++..+..++.||++||.|||++ +|+|+||||+||+++.++.+||+|||++.....
T Consensus 97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 999999999999999864 5688999999999999999999997 999999999999999999999999999987654
Q ss_pred CCCc--ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCcccee
Q 047292 588 DHSR--THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDAL 664 (728)
Q Consensus 588 ~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (728)
.... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...........+ ........
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~-------~~~~~~~~- 245 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI-------DKEGERLP- 245 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-------HTSCCCCC-
T ss_pred cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHH-------HccCCCCC-
Confidence 3322 2223457888999999998889999999999999999999 99999765433221111 01111000
Q ss_pred ccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 665 IDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 665 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
........+.+++.+||+.||.+||++.++++.|+++..
T Consensus 246 --------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 246 --------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp --------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred --------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 011223567889999999999999999999999988764
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=360.79 Aligned_cols=246 Identities=28% Similarity=0.321 Sum_probs=204.5
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccc-cccceeeEeeeeecCCcceeEe
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVY 511 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~ 511 (728)
+.+.+.||+|+||.||++..+ .+++.||||+++... ......+..|..++..+ +|+||+++++++.+....+|||
T Consensus 343 f~~~~~LG~G~fG~V~~~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~ 421 (674)
T 3pfq_A 343 FNFLMVLGKGSFGKVMLSERK-GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 421 (674)
T ss_dssp EEEEEESSBTTTBCEEEEEES-SSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEE
T ss_pred eEEEEEEccCCCEEEEEEEEC-CCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEE
Confidence 455678999999999999986 568899999997532 23346788899999987 7999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 512 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 512 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
||+++|+|.+++.....+++..+..++.||+.||+|||++ +||||||||+||||+.++++||+|||+++.......
T Consensus 422 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~- 497 (674)
T 3pfq_A 422 EYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV- 497 (674)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC-
T ss_pred eCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccccCCc-
Confidence 9999999999999888899999999999999999999997 999999999999999999999999999986433222
Q ss_pred ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhh
Q 047292 592 THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAA 671 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 671 (728)
......||+.|+|||++.+..++.++||||||+++|||++|+.||......+....+ ....+.
T Consensus 498 ~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i--------~~~~~~--------- 560 (674)
T 3pfq_A 498 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI--------MEHNVA--------- 560 (674)
T ss_dssp CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HSSCCC---------
T ss_pred ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHH--------HhCCCC---------
Confidence 234467999999999999999999999999999999999999999876544332222 111110
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 047292 672 MADRSRLHKWLMIAMWCIQEDPSKRPTM-----KVVMQ 704 (728)
Q Consensus 672 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~-----~evl~ 704 (728)
.+......+.+++.+||+.||++||++ +||++
T Consensus 561 -~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 561 -YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp -CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred -CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 111233467789999999999999997 66654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=347.57 Aligned_cols=250 Identities=26% Similarity=0.331 Sum_probs=199.5
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEe
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 511 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 511 (728)
..|.+.++||+|+||.||++..+ .++..||+|++.... ......+.+|+.+++.++||||+++++++......++||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDK-VTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEET-TTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEEC-CCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 45666788999999999999876 568899999986533 233567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcC---CCceEEccccCccccccC
Q 047292 512 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDH---YFSPKISDFGLSKLLLSD 588 (728)
Q Consensus 512 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~---~~~~kl~Dfgla~~~~~~ 588 (728)
||+++|+|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 9999999999998888899999999999999999999997 9999999999999976 455999999999876443
Q ss_pred CCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccch
Q 047292 589 HSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSD 668 (728)
Q Consensus 589 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 668 (728)
. ......||+.|+|||++. ..++.++||||||+++|||++|+.||......+....+ ..+... +...
T Consensus 193 ~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i--------~~~~~~--~~~~ 259 (494)
T 3lij_A 193 K--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV--------EKGKYT--FDSP 259 (494)
T ss_dssp B--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHTCCC--CCSG
T ss_pred c--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------HhCCCC--CCch
Confidence 2 233456999999999986 46899999999999999999999999866544322211 111110 0110
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 669 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 669 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
.. ......+.+++.+||+.||.+|||++++++
T Consensus 260 ~~----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 260 EW----KNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp GG----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hc----ccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 01 112345778999999999999999999885
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=334.15 Aligned_cols=262 Identities=22% Similarity=0.252 Sum_probs=194.4
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhh-HHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQER-EREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
+.+.+.||+|+||.||+|... .+++.||||++....... ...+.+|+.++++++||||+++++++......++||||+
T Consensus 4 y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (324)
T 3mtl_A 4 YIKLDKLGEGTYATVYKGKSK-LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 82 (324)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred eEEEEEEcCCCCEEEEEEEEC-CCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccc
Confidence 345578999999999999876 568899999996533222 124567999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccc
Q 047292 515 GNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH 593 (728)
Q Consensus 515 ~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 593 (728)
+ ++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~~ 157 (324)
T 3mtl_A 83 D-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-TY 157 (324)
T ss_dssp S-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred c-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-cc
Confidence 8 5898888765 4588999999999999999999997 999999999999999999999999999986543222 22
Q ss_pred ccccCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchh---
Q 047292 594 TMIRGTRGYVAPEWLKN-APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDE--- 669 (728)
Q Consensus 594 ~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~--- 669 (728)
....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+..... ...............
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~ 236 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILG-TPTEETWPGILSNEEFKT 236 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC-CCCTTTSTTGGGCHHHHH
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC-CCChHhchhhhcchhhcc
Confidence 33458999999999976 5789999999999999999999999987655443222211100 000001111111000
Q ss_pred ----------hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 670 ----------AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 670 ----------~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
...........+.+++.+||+.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00111122356788999999999999999999987
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=335.24 Aligned_cols=251 Identities=19% Similarity=0.224 Sum_probs=200.0
Q ss_pred HHhhHHhhhCCCceeEEEEeee----eCCCCcEEEEEEecccchhhHHHHHHHHHHhcccc---ccceeeEeeeeecCCc
Q 047292 434 ATDGFKEELGRGSFGIVYKGVL----KTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTH---HKNLVQLLGFCDEALN 506 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~----~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~ 506 (728)
..+.+.+.||+|+||.||+|.. ...+++.||||+++... ..++..|++++.+++ |+||+++++++...+.
T Consensus 65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~ 141 (365)
T 3e7e_A 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG 141 (365)
T ss_dssp SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSC
T ss_pred EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCC
Confidence 3455667899999999999953 23567899999997643 345666666666665 9999999999999999
Q ss_pred ceeEeeccCCCCHHHHHhc-----CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcC-----------
Q 047292 507 RLLVYEFMGNGTLANLIFA-----IPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDH----------- 570 (728)
Q Consensus 507 ~~lv~e~~~~gsL~~~l~~-----~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~----------- 570 (728)
.++||||+++|+|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+||||+.
T Consensus 142 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~ 218 (365)
T 3e7e_A 142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDL 218 (365)
T ss_dssp EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------
T ss_pred cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccccc
Confidence 9999999999999999973 45789999999999999999999997 9999999999999998
Q ss_pred CCceEEccccCccccccC-CCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHH
Q 047292 571 YFSPKISDFGLSKLLLSD-HSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILT 649 (728)
Q Consensus 571 ~~~~kl~Dfgla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~ 649 (728)
++.+||+|||+++..... .........||+.|+|||++.+..++.++||||||+++|||+||+.||.........
T Consensus 219 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---- 294 (365)
T 3e7e_A 219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK---- 294 (365)
T ss_dssp CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE----
T ss_pred cCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee----
Confidence 899999999999765422 222334567999999999999999999999999999999999999998644321100
Q ss_pred HHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHhcCcCC
Q 047292 650 DWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKR-PTMKVVMQMLEGLLEV 712 (728)
Q Consensus 650 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R-Pt~~evl~~L~~~~~~ 712 (728)
+...+. ... ..+.+.+++..|++.+|.+| |+++++.+.|++.++.
T Consensus 295 -----------~~~~~~----~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 295 -----------PEGLFR----RLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp -----------ECSCCT----TCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred -----------echhcc----ccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 011111 111 13355678888999999999 7899999999887643
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=327.51 Aligned_cols=251 Identities=23% Similarity=0.310 Sum_probs=200.5
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeee--cCCcceeEe
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCD--EALNRLLVY 511 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~~~lv~ 511 (728)
+.+.+.||+|+||.||++..+ .+++.||+|++... .....+.+.+|+.++++++||||+++++++. .....++||
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 86 (279)
T 2w5a_A 8 YEVLYTIGTGSYGRCQKIRRK-SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 86 (279)
T ss_dssp EEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEE
T ss_pred eeeehhccCCCCcEEEEEEEC-CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEE
Confidence 445678999999999999876 56889999999643 2344578999999999999999999999874 466789999
Q ss_pred eccCCCCHHHHHhcC----CCCChHHHHHHHHHHHHHHHHhhhcCCCC-----eeecCCCCCCEEEcCCCceEEccccCc
Q 047292 512 EFMGNGTLANLIFAI----PKPDWNLRVRISLEIARGLVYLHEGCNVP-----IIHCDIKPQNILLDHYFSPKISDFGLS 582 (728)
Q Consensus 512 e~~~~gsL~~~l~~~----~~~~~~~~~~i~~qi~~~l~yLH~~~~~~-----iiH~dlk~~NIll~~~~~~kl~Dfgla 582 (728)
||+++++|.+++... ..+++..++.++.|++.||+|||+. + |+||||||+||++++++.+||+|||++
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 87 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp ECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred eCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 999999999999753 3489999999999999999999997 6 999999999999999999999999999
Q ss_pred cccccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccc
Q 047292 583 KLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLD 662 (728)
Q Consensus 583 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (728)
+....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||........... ...+...
T Consensus 164 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~--------i~~~~~~ 234 (279)
T 2w5a_A 164 RILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK--------IREGKFR 234 (279)
T ss_dssp HHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--------HHHTCCC
T ss_pred eeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHH--------Hhhcccc
Confidence 87643321 12234689999999999999999999999999999999999999986543322111 1122211
Q ss_pred eeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 047292 663 ALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEG 708 (728)
Q Consensus 663 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 708 (728)
.+ +......+.+++.+||+.||.+||+++||++.+..
T Consensus 235 ~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 235 RI---------PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp CC---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred cC---------CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 11 11223467789999999999999999999987643
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=346.63 Aligned_cols=236 Identities=14% Similarity=0.173 Sum_probs=183.7
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecc---cchhhHHHHHHHH---HHhccccccceeeEe-------eeeec
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDR---LAQEREREFKSEV---SAIGRTHHKNLVQLL-------GFCDE 503 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~---~~~~~~~~~~~E~---~~l~~l~h~niv~l~-------g~~~~ 503 (728)
.+.+.||+|+||.||+|... .+++.||||++.. ......+.+.+|+ +++++++||||++++ +++..
T Consensus 76 ~~~~~lG~G~~g~V~~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~ 154 (377)
T 3byv_A 76 VRGTVLGQEDPYAYLEATDQ-ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD 154 (377)
T ss_dssp EEEEEEEEETTEEEEEEEC--CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEEC
T ss_pred EEcceeecCCCEEEEEEEEC-CCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhc
Confidence 34578999999999999875 5688999999963 2334557899999 455566899999998 55554
Q ss_pred CC-----------------cceeEeeccCCCCHHHHHhcCCCCC-------hHHHHHHHHHHHHHHHHhhhcCCCCeeec
Q 047292 504 AL-----------------NRLLVYEFMGNGTLANLIFAIPKPD-------WNLRVRISLEIARGLVYLHEGCNVPIIHC 559 (728)
Q Consensus 504 ~~-----------------~~~lv~e~~~~gsL~~~l~~~~~~~-------~~~~~~i~~qi~~~l~yLH~~~~~~iiH~ 559 (728)
.+ ..++||||+ +|+|.+++.....++ +..++.|+.||+.||+|||++ +|+||
T Consensus 155 ~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHr 230 (377)
T 3byv_A 155 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHT 230 (377)
T ss_dssp TTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred cCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence 43 278999999 689999998654344 478889999999999999997 99999
Q ss_pred CCCCCCEEEcCCCceEEccccCccccccCCCcccccccCCccccCcccccCC-----------CCCCccchhhHHHHHHH
Q 047292 560 DIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNA-----------PVSAKVDVYSFGVMLLE 628 (728)
Q Consensus 560 dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~~~DVwSlGvil~e 628 (728)
||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++||||||+++||
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e 305 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence 9999999999999999999999985322 2334457 999999999887 89999999999999999
Q ss_pred HHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 629 IICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 629 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
|++|+.||...........+ ... .......+.+++.+||+.||.+||++.++++
T Consensus 306 lltg~~Pf~~~~~~~~~~~~----------------~~~------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 306 IWCADLPITKDAALGGSEWI----------------FRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHSSCCC------CCSGGG----------------GSS------CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHCCCCCcccccccchhhh----------------hhh------ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999754332211110 000 0112346778999999999999999999985
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=325.83 Aligned_cols=248 Identities=27% Similarity=0.364 Sum_probs=194.9
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecC-CcceeEeec
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEA-LNRLLVYEF 513 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~lv~e~ 513 (728)
.+.+.+.||+|+||.||++.. .++.||||.++... ..+.+.+|+.++++++||||+++++++.+. ...++||||
T Consensus 22 ~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 22 ELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GEEEEEEEEECSSCEEEEEEE---TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hceEEeEEecCCCceEEEEEE---cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 345668899999999999976 37899999997532 456789999999999999999999997544 578999999
Q ss_pred cCCCCHHHHHhcCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 514 MGNGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 514 ~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
+++++|.+++.... .+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 171 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 171 (278)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence 99999999998653 378899999999999999999997 99999999999999999999999999987653321
Q ss_pred ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhh
Q 047292 592 THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEA 670 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 670 (728)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||........... ...+....
T Consensus 172 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~--------~~~~~~~~------- 234 (278)
T 1byg_A 172 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR--------VEKGYKMD------- 234 (278)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH--------HTTTCCCC-------
T ss_pred --cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--------HhcCCCCC-------
Confidence 22347889999999999999999999999999999998 9999875543322111 11111000
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 671 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 671 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
........+.+++.+||+.||.+||++.++++.|+.+.+
T Consensus 235 --~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 235 --APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 111223467789999999999999999999999988653
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=333.34 Aligned_cols=269 Identities=23% Similarity=0.319 Sum_probs=192.6
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeee-----cCCcceeE
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCD-----EALNRLLV 510 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-----~~~~~~lv 510 (728)
+.+.+.||+|+||.||+|.. +++.||||++...... ......|+..+..++|+||+++++.+. .....++|
T Consensus 15 y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~~-~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv 90 (336)
T 3g2f_A 15 LKLLELIGRGRYGAVYKGSL---DERPVAVKVFSFANRQ-NFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLV 90 (336)
T ss_dssp EEEEEEEEECSSEEEEEEEE---TTEEEEEEEEEGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEE
T ss_pred hheeeecccCCCeEEEEEEE---CCeEEEEEEeeccchh-hHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEE
Confidence 44567899999999999976 5789999999653221 122234444455689999999998543 33356899
Q ss_pred eeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcC------CCCeeecCCCCCCEEEcCCCceEEccccCccc
Q 047292 511 YEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGC------NVPIIHCDIKPQNILLDHYFSPKISDFGLSKL 584 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~------~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~ 584 (728)
|||+++|+|.+++.... .++..+..++.||++||+|||+.+ ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~ 169 (336)
T 3g2f_A 91 MEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR 169 (336)
T ss_dssp ECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceee
Confidence 99999999999997654 488899999999999999999852 22899999999999999999999999999987
Q ss_pred cccCCC-------cccccccCCccccCcccccC-------CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhh-hhhHH
Q 047292 585 LLSDHS-------RTHTMIRGTRGYVAPEWLKN-------APVSAKVDVYSFGVMLLEIICCRRSVEMELEEES-RAILT 649 (728)
Q Consensus 585 ~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~-~~~~~ 649 (728)
...... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.|+........ ...+.
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~ 249 (336)
T 3g2f_A 170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQ 249 (336)
T ss_dssp CSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTH
T ss_pred cccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhh
Confidence 643221 12223469999999999987 4566789999999999999999877643221110 00000
Q ss_pred ---------HHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 650 ---------DWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 650 ---------~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
...............+.. ...........+.+++.+||+.||++|||++|+++.|++++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 250 TEVGNHPTFEDMQVLVSREKQRPKFPE--AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp HHHCSSCCHHHHHHHHTTSCCCCCCCT--TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccCCCchHHHHHhhhcccccCCCCCc--ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 000000111111111110 111123345678899999999999999999999999999763
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=348.68 Aligned_cols=251 Identities=25% Similarity=0.300 Sum_probs=205.9
Q ss_pred HHHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCccee
Q 047292 433 DATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLL 509 (728)
Q Consensus 433 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 509 (728)
...|.+.+.||+|+||.||++..+ .+++.||||++.... ......+.+|+.++++++||||+++++++......++
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDK-ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEEC-CCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 345667788999999999999876 578899999985432 3346789999999999999999999999999999999
Q ss_pred EeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEE---cCCCceEEccccCccccc
Q 047292 510 VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILL---DHYFSPKISDFGLSKLLL 586 (728)
Q Consensus 510 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll---~~~~~~kl~Dfgla~~~~ 586 (728)
||||+.+++|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||+++...
T Consensus 104 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp EECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 999999999999999888999999999999999999999997 99999999999999 567899999999998764
Q ss_pred cCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceecc
Q 047292 587 SDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALID 666 (728)
Q Consensus 587 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 666 (728)
... ......||+.|+|||++.+ .++.++||||||+++|||++|+.||...........+ ..+......
T Consensus 181 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i--------~~~~~~~~~- 248 (484)
T 3nyv_A 181 ASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV--------EKGKYTFEL- 248 (484)
T ss_dssp CCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHCCCCCCS-
T ss_pred ccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--------HcCCCCCCC-
Confidence 332 2334569999999999976 6899999999999999999999999866543322211 111111000
Q ss_pred chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 667 SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 667 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
.. .......+.+++.+||+.||.+|||++|+++
T Consensus 249 -~~----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 249 -PQ----WKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp -GG----GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -cc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 00 0112346778999999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=321.47 Aligned_cols=246 Identities=26% Similarity=0.387 Sum_probs=194.8
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch---hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
+.+.+.||+|+||.||+|..+ .+++.||||++..... .....+.+|+.+++.++||||+++++++......++|||
T Consensus 13 y~i~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (276)
T 2h6d_A 13 YVLGDTLGVGTFGKVKIGEHQ-LTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME 91 (276)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred EEEEeeecCCCCeEEEEEEEC-CCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEe
Confidence 445678999999999999876 4688999999865322 234678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 513 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 513 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
|+++++|.+++.....+++..+..++.||+.||.|||++ +|+|+||||+||+++.++.+||+|||++....... .
T Consensus 92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~ 166 (276)
T 2h6d_A 92 YVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--F 166 (276)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-----
T ss_pred ccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCc--c
Confidence 999999999998878899999999999999999999998 99999999999999999999999999998764332 1
Q ss_pred cccccCCccccCcccccCCCC-CCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPV-SAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAA 671 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~-s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 671 (728)
.....+++.|+|||.+.+..+ +.++||||||+++|||++|+.||...........+ ..+.. ..
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~--------~~~~~-~~------- 230 (276)
T 2h6d_A 167 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI--------RGGVF-YI------- 230 (276)
T ss_dssp ----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHCCC-CC-------
T ss_pred eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh--------hcCcc-cC-------
Confidence 223458999999999988765 68999999999999999999999765433221111 11110 00
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 672 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 672 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
+......+.+++.+||+.||.+|||++++++.
T Consensus 231 --~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 231 --PEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11122456789999999999999999999874
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=343.66 Aligned_cols=252 Identities=23% Similarity=0.316 Sum_probs=191.1
Q ss_pred HHHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch--------hhHHHHHHHHHHhccccccceeeEeeeeecC
Q 047292 433 DATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ--------EREREFKSEVSAIGRTHHKNLVQLLGFCDEA 504 (728)
Q Consensus 433 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 504 (728)
...+.+.+.||+|+||.||+|..+ .+++.||||++..... .....+.+|+.++++++||||+++++++..
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFER-KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hccEEEEeEEeeCCCeEEEEEEEC-CCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 344566788999999999999876 5788999999865321 122358899999999999999999999865
Q ss_pred CcceeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCC---CceEEccccC
Q 047292 505 LNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHY---FSPKISDFGL 581 (728)
Q Consensus 505 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~---~~~kl~Dfgl 581 (728)
...++||||+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DFG~ 288 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGH 288 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeeccc
Confidence 45799999999999999999888999999999999999999999997 99999999999999754 4599999999
Q ss_pred ccccccCCCcccccccCCccccCcccccC---CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhc
Q 047292 582 SKLLLSDHSRTHTMIRGTRGYVAPEWLKN---APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVE 658 (728)
Q Consensus 582 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 658 (728)
++..... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.......... .....
T Consensus 289 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~-------~~i~~ 359 (419)
T 3i6u_A 289 SKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK-------DQITS 359 (419)
T ss_dssp TTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHH-------HHHHT
T ss_pred ceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHH-------HHHhc
Confidence 9876432 22334568999999999863 577889999999999999999999997532221100 00111
Q ss_pred CccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 659 GRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 659 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
+..... +.. .......+.+++.+||+.||++||+++|+++
T Consensus 360 ~~~~~~--~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 360 GKYNFI--PEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp TCCCCC--HHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCC--chh----hcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 111100 000 0112346788999999999999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=347.45 Aligned_cols=248 Identities=27% Similarity=0.340 Sum_probs=199.6
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch---hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
+.+.||+|+||.||++..+ .+++.||+|++..... .....+..|+.++++++||||+++++++......++||||+
T Consensus 189 ~~~~LG~G~fG~Vy~a~~~-~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~ 267 (543)
T 3c4z_A 189 DFRVLGRGGFGEVFACQMK-ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIM 267 (543)
T ss_dssp EEEEEEECSSSEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEeeCCCeEEEEEEEC-CCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEec
Confidence 3467999999999999876 5789999999965332 23467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC----CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC
Q 047292 515 GNGTLANLIFAI----PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 515 ~~gsL~~~l~~~----~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 590 (728)
++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++++||+|||+++.......
T Consensus 268 ~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~ 344 (543)
T 3c4z_A 268 NGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT 344 (543)
T ss_dssp TTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred cCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCc
Confidence 999999999764 3688999999999999999999997 999999999999999999999999999987644332
Q ss_pred cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhh
Q 047292 591 RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEA 670 (728)
Q Consensus 591 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 670 (728)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.. .......
T Consensus 345 ~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~----~i~~~~~--------- 410 (543)
T 3c4z_A 345 K-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ----RVLEQAV--------- 410 (543)
T ss_dssp C-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHH----HHHHCCC---------
T ss_pred c-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHH----HHhhccc---------
Confidence 2 2335799999999999999999999999999999999999999976532111111111 1111111
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 047292 671 AMADRSRLHKWLMIAMWCIQEDPSKRPTM-----KVVMQ 704 (728)
Q Consensus 671 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~-----~evl~ 704 (728)
..+......+.+++.+||+.||.+||++ ++|++
T Consensus 411 -~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 411 -TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp -CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred -CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 0111223467789999999999999975 56653
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=340.88 Aligned_cols=197 Identities=26% Similarity=0.368 Sum_probs=166.4
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeeecC-----Ccc
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEA-----LNR 507 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~ 507 (728)
.+.+.+.||+|+||.||+|..+ .+++.||||++... .....+.+.+|+.++++++|+||+++++++... ...
T Consensus 27 ~y~~~~~lG~G~~g~V~~a~~~-~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 105 (432)
T 3n9x_A 27 NYIIKHLIGRGSYGYVYLAYDK-NTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105 (432)
T ss_dssp TEEEEEEEEEETTEEEEEEEET-TTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CEEEEEEEeecCCEEEEEEEEC-CCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence 3556688999999999999876 57889999999653 233457899999999999999999999999766 568
Q ss_pred eeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcccccc
Q 047292 508 LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS 587 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 587 (728)
++||||++ ++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 106 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 106 YIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp EEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred EEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 99999987 59999999888899999999999999999999997 999999999999999999999999999987643
Q ss_pred CCC---------------------cccccccCCccccCcccc-cCCCCCCccchhhHHHHHHHHHhCCcCc
Q 047292 588 DHS---------------------RTHTMIRGTRGYVAPEWL-KNAPVSAKVDVYSFGVMLLEIICCRRSV 636 (728)
Q Consensus 588 ~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~~DVwSlGvil~elltg~~p~ 636 (728)
... .......||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 321 122456789999999986 5667999999999999999999865444
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=324.74 Aligned_cols=247 Identities=24% Similarity=0.373 Sum_probs=202.9
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
+.+.+.||+|+||.||+|... .+++.||||++.... ....+.+.+|+.++++++||||+++++++......++||||+
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 102 (303)
T 3a7i_A 24 FTKLEKIGKGSFGEVFKGIDN-RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 102 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HHHhhhhcccCCeEEEEEEEC-CCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeC
Confidence 445678999999999999865 568899999986533 334578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccc
Q 047292 515 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHT 594 (728)
Q Consensus 515 ~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 594 (728)
++++|.+++.. ..+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++........ ...
T Consensus 103 ~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 177 (303)
T 3a7i_A 103 GGGSALDLLEP-GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRN 177 (303)
T ss_dssp TTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-CBC
T ss_pred CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcccc-ccC
Confidence 99999999875 5688999999999999999999997 999999999999999999999999999987644322 223
Q ss_pred cccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhc
Q 047292 595 MIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMAD 674 (728)
Q Consensus 595 ~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 674 (728)
...|++.|+|||.+.+..++.++||||||+++|||++|+.||...........+ ........ .
T Consensus 178 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~~~---------~ 240 (303)
T 3a7i_A 178 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI--------PKNNPPTL---------E 240 (303)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--------HHSCCCCC---------C
T ss_pred ccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHh--------hcCCCCCC---------c
Confidence 456899999999999999999999999999999999999999755433221111 11111111 1
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 675 RSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 675 ~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
......+.+++.+||+.||.+|||++++++.
T Consensus 241 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 241 GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred cccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1123457789999999999999999999874
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=324.68 Aligned_cols=249 Identities=23% Similarity=0.331 Sum_probs=198.2
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
..+.+.+.||+|+||.||+|..+ .+++.||+|++.... ....+.+|+.++++++||||+++++++......++||||
T Consensus 29 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (314)
T 3com_A 29 EVFDVLEKLGEGSYGSVYKAIHK-ETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY 105 (314)
T ss_dssp -CEEEEEECC----CEEEEEEET-TTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhhhhheeeccCCCeEEEEEEEC-CCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence 33455678999999999999876 568899999986532 346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhc-CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 514 MGNGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 514 ~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
+++++|.+++.. ...+++..+..++.||+.||.|||+. +|+|+||||+||+++.++.+||+|||++........ .
T Consensus 106 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~ 181 (314)
T 3com_A 106 CGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-K 181 (314)
T ss_dssp CTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-C
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-c
Confidence 999999999973 46789999999999999999999997 999999999999999999999999999987643322 2
Q ss_pred cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAM 672 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 672 (728)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||...........+ ..........
T Consensus 182 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~~~~~------ 247 (314)
T 3com_A 182 RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMI--------PTNPPPTFRK------ 247 (314)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--------HHSCCCCCSS------
T ss_pred cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--------hcCCCcccCC------
Confidence 23346899999999999999999999999999999999999999754432211111 0111111100
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 673 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 673 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
.......+.+++.+||+.||.+|||+.++++
T Consensus 248 -~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 248 -PELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp -GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 1112346778999999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=346.08 Aligned_cols=250 Identities=27% Similarity=0.343 Sum_probs=200.7
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch-------------hhHHHHHHHHHHhccccccceeeEeeee
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ-------------EREREFKSEVSAIGRTHHKNLVQLLGFC 501 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~g~~ 501 (728)
.|.+.++||+|+||.||++..+ .+++.||||++..... ...+.+.+|+.++++++||||+++++++
T Consensus 37 ~Y~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 37 SYFKVRKLGSGAYGEVLLCKEK-NGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp TEEEEEEEEC--CEEEEEEEET-TTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceEEEeEecccCCeEEEEEEEC-CCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 3555688999999999999876 5678999999865321 2346789999999999999999999999
Q ss_pred ecCCcceeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCC---ceEEcc
Q 047292 502 DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYF---SPKISD 578 (728)
Q Consensus 502 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~---~~kl~D 578 (728)
......++||||+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++ .+||+|
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 99999999999999999999998888899999999999999999999997 999999999999998775 699999
Q ss_pred ccCccccccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhc
Q 047292 579 FGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVE 658 (728)
Q Consensus 579 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 658 (728)
||++....... ......||+.|+|||++.+ .++.++||||||+++|||++|+.||...........+ ..
T Consensus 193 fg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i--------~~ 261 (504)
T 3q5i_A 193 FGLSSFFSKDY--KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV--------EK 261 (504)
T ss_dssp CTTCEECCTTS--CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HH
T ss_pred CCCCEEcCCCC--ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------Hc
Confidence 99998764432 2334569999999999874 6899999999999999999999999866544322211 11
Q ss_pred CccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 659 GRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 659 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
+... ++.... ......+.+++.+||+.||.+|||++|+++.
T Consensus 262 ~~~~--~~~~~~----~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 262 GKYY--FDFNDW----KNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp CCCC--CCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCC--CCcccc----CCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1110 000000 1123467789999999999999999999853
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=330.35 Aligned_cols=265 Identities=21% Similarity=0.275 Sum_probs=199.1
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch--hhHHHHHHHHHHhccccccceeeEeeeeec--------C
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKNLVQLLGFCDE--------A 504 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--------~ 504 (728)
.+.+.++||+|+||.||+|... .+++.||||++..... .....+.+|+.++++++||||+++++++.. .
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 18 KYEKLAKIGQGTFGEVFKARHR-KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GEEEEEECSSCSTTSEEEEEET-TTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred ceeEEEEEecCCCcEEEEEEEC-CCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 3556688999999999999876 5788999999854322 224578899999999999999999999876 3
Q ss_pred CcceeEeeccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcc
Q 047292 505 LNRLLVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSK 583 (728)
Q Consensus 505 ~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~ 583 (728)
...++||||+++ +|.+.+... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred ceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 467999999986 777776654 6789999999999999999999997 99999999999999999999999999998
Q ss_pred ccccCC---CcccccccCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcC
Q 047292 584 LLLSDH---SRTHTMIRGTRGYVAPEWLKN-APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEG 659 (728)
Q Consensus 584 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 659 (728)
...... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||...........+...... ....
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-~~~~ 251 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS-ITPE 251 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC-CCTT
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC-CChh
Confidence 764322 122234568999999999976 46899999999999999999999999876554433322211100 0000
Q ss_pred cccee--------c---c---chhhh-hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 660 RLDAL--------I---D---SDEAA-MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 660 ~~~~~--------~---d---~~~~~-~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
..... + . ..... .........+.+++.+||+.||++|||++|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 00000 0 0 00000 0000113457789999999999999999999874
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=321.46 Aligned_cols=243 Identities=23% Similarity=0.316 Sum_probs=196.4
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhccc-cccceeeEeeeeecCCcceeE
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLV 510 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv 510 (728)
..+.+.+.||+|+||.||+|... .+++.||||++... .......+.+|+..+..+ +||||+++++++.+....++|
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKR-LDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEc-CCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 34556678999999999999876 56889999998653 234457888999999998 999999999999999999999
Q ss_pred eeccCCCCHHHHHhcC----CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcC----------------
Q 047292 511 YEFMGNGTLANLIFAI----PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDH---------------- 570 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~----~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~---------------- 570 (728)
|||+++++|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 9999999999999864 5689999999999999999999997 9999999999999984
Q ss_pred ---CCceEEccccCccccccCCCcccccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhh
Q 047292 571 ---YFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRA 646 (728)
Q Consensus 571 ---~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~ 646 (728)
...+||+|||++....... ...||+.|+|||.+.+. .++.++||||||+++|||++|..++......
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~---- 237 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW---- 237 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH----
T ss_pred cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH----
Confidence 4479999999998764332 23489999999999876 6678999999999999999998776533211
Q ss_pred hHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 647 ILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.....+...... ......+.+++.+||+.||.+|||++++++.
T Consensus 238 -------~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 238 -------HEIRQGRLPRIP---------QVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -------HHHHTTCCCCCS---------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -------HHHHcCCCCCCC---------cccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 111122221111 1123467789999999999999999999763
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=321.68 Aligned_cols=249 Identities=24% Similarity=0.298 Sum_probs=201.4
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---------hhhHHHHHHHHHHhcccc-ccceeeEeeeeecCC
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---------QEREREFKSEVSAIGRTH-HKNLVQLLGFCDEAL 505 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~ 505 (728)
+.+.+.||+|+||.||++..+ .+++.||||+++... ....+.+.+|+.+++++. ||||+++++++....
T Consensus 19 y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (298)
T 1phk_A 19 YEPKEILGRGVSSVVRRCIHK-PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 97 (298)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cceeeeecCCCceEEEEEEEc-CcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCC
Confidence 445578999999999999876 568899999985432 123467889999999995 999999999999999
Q ss_pred cceeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcccc
Q 047292 506 NRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLL 585 (728)
Q Consensus 506 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~ 585 (728)
..++||||+++++|.+++.....+++..+..++.||+.||.|||+. +|+|+||||+||+++.++.+||+|||++...
T Consensus 98 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 174 (298)
T 1phk_A 98 FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174 (298)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence 9999999999999999998878899999999999999999999997 9999999999999999999999999999876
Q ss_pred ccCCCcccccccCCccccCccccc------CCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcC
Q 047292 586 LSDHSRTHTMIRGTRGYVAPEWLK------NAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEG 659 (728)
Q Consensus 586 ~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 659 (728)
.... ......+++.|+|||++. ...++.++||||||+++|||++|+.||...........+ ..+
T Consensus 175 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~--------~~~ 244 (298)
T 1phk_A 175 DPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI--------MSG 244 (298)
T ss_dssp CTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHT
T ss_pred CCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHH--------hcC
Confidence 4332 223356899999999985 456889999999999999999999999765433221111 111
Q ss_pred ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 660 RLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 660 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
.... ..+ ........+.+++.+||+.||.+|||+.++++
T Consensus 245 ~~~~-~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 245 NYQF-GSP-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp CCCC-CTT-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred Cccc-Ccc-----cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1110 000 01122346778999999999999999999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=321.37 Aligned_cols=246 Identities=26% Similarity=0.348 Sum_probs=194.7
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCCCCH
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTL 519 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 519 (728)
..||+|+||.||+|... .+++.||||.+........+.+.+|+.+++.++||||+++++++......++||||+++++|
T Consensus 28 ~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 106 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDL-SNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSL 106 (295)
T ss_dssp CEEEECSSSEEEEEEET-TTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEH
T ss_pred EEEeecCcEEEEEEEEC-CCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCH
Confidence 37999999999999875 56789999999776555667899999999999999999999999999999999999999999
Q ss_pred HHHHhcC---CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcC-CCceEEccccCccccccCCCccccc
Q 047292 520 ANLIFAI---PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDH-YFSPKISDFGLSKLLLSDHSRTHTM 595 (728)
Q Consensus 520 ~~~l~~~---~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~ 595 (728)
.+++... ...++..+..++.||+.||.|||++ +|+|+||||+||+++. ++.+||+|||++........ ....
T Consensus 107 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 182 (295)
T 2clq_A 107 SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-CTET 182 (295)
T ss_dssp HHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------CC
T ss_pred HHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-cccc
Confidence 9999865 2456888999999999999999997 9999999999999987 89999999999987643221 2233
Q ss_pred ccCCccccCcccccCCC--CCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhh
Q 047292 596 IRGTRGYVAPEWLKNAP--VSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMA 673 (728)
Q Consensus 596 ~~gt~~y~aPE~~~~~~--~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 673 (728)
..|++.|+|||++.+.. ++.++||||||+++|||++|+.||........... . ... ...... .
T Consensus 183 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~--~~~--~~~~~~---------~ 247 (295)
T 2clq_A 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF--K--VGM--FKVHPE---------I 247 (295)
T ss_dssp CCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHH--H--HHH--HCCCCC---------C
T ss_pred cCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHH--h--hcc--cccccc---------c
Confidence 56899999999997643 78999999999999999999999975432211100 0 000 000000 1
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 674 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 674 ~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
+......+.+++.+||+.||++||+++++++.
T Consensus 248 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 248 PESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11223467789999999999999999999863
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=327.07 Aligned_cols=258 Identities=24% Similarity=0.335 Sum_probs=182.0
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
.+.+.+.||+|+||.||+|... .+++.||||++.... ......+.+|+.++++++||||+++++++......++||||
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 94 (303)
T 2vwi_A 16 DYELQEVIGSGATAVVQAAYCA-PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKL 94 (303)
T ss_dssp CCEEEEECC---CCCEEEEEC-----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEEC
T ss_pred hhhhhheeccccceEEEEEEEC-CCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehh
Confidence 3455678999999999999865 467899999986532 23356788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhc--------CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcccc
Q 047292 514 MGNGTLANLIFA--------IPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLL 585 (728)
Q Consensus 514 ~~~gsL~~~l~~--------~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~ 585 (728)
+++++|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 95 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 171 (303)
T 2vwi_A 95 LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFL 171 (303)
T ss_dssp CTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHC
T ss_pred ccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchhee
Confidence 999999999874 35688999999999999999999997 9999999999999999999999999999766
Q ss_pred ccCCC----cccccccCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCc
Q 047292 586 LSDHS----RTHTMIRGTRGYVAPEWLKN-APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGR 660 (728)
Q Consensus 586 ~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (728)
..... .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||........... . . ...
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----~---~-~~~ 243 (303)
T 2vwi_A 172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML----T---L-QND 243 (303)
T ss_dssp C---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH----H---H-TSS
T ss_pred ccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH----H---h-ccC
Confidence 43221 12233568999999999976 5689999999999999999999999976443221110 0 0 011
Q ss_pred cceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 661 LDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 661 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
....................+.+++.+||+.||.+||+++++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 00000000000011112346778999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=326.12 Aligned_cols=249 Identities=22% Similarity=0.328 Sum_probs=196.1
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccC
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
+.+.+.||+|+||.||+|... .+++.||+|++..........+.+|+.+++.++||||+++++++......++||||++
T Consensus 21 y~i~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 99 (302)
T 2j7t_A 21 WEIVGELGDGAFGKVYKAKNK-ETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCP 99 (302)
T ss_dssp EEEEEEEECSTTCCEEEEEET-TTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCT
T ss_pred eeecceeccCCCeEEEEEEEc-CCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCC
Confidence 445678999999999999876 5678999999977655666889999999999999999999999999999999999999
Q ss_pred CCCHHHHHhc-CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccc
Q 047292 516 NGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHT 594 (728)
Q Consensus 516 ~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 594 (728)
+++|.+++.. ...+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||++....... ....
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 175 (302)
T 2j7t_A 100 GGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-QKRD 175 (302)
T ss_dssp TEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-HC--
T ss_pred CCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc-cccc
Confidence 9999999876 46789999999999999999999997 99999999999999999999999999876432211 1122
Q ss_pred cccCCccccCcccc-----cCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchh
Q 047292 595 MIRGTRGYVAPEWL-----KNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDE 669 (728)
Q Consensus 595 ~~~gt~~y~aPE~~-----~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 669 (728)
...|++.|+|||++ .+..++.++||||||+++|||++|+.||...........+ ..........
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~~~~~--- 244 (302)
T 2j7t_A 176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI--------AKSDPPTLLT--- 244 (302)
T ss_dssp ---CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--------HHSCCCCCSS---
T ss_pred cccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH--------hccCCcccCC---
Confidence 34589999999998 4677899999999999999999999999765433221111 1111111110
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 670 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 670 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
.......+.+++.+||+.||.+|||++++++
T Consensus 245 ----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 245 ----PSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp ----GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ----ccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1112345778999999999999999999875
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=357.39 Aligned_cols=257 Identities=21% Similarity=0.309 Sum_probs=203.7
Q ss_pred HHHhhHHhhhCCCceeEEEEeeeeCC--CCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCccee
Q 047292 433 DATDGFKEELGRGSFGIVYKGVLKTA--SGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLL 509 (728)
Q Consensus 433 ~~~~~~~~~lg~G~fg~Vy~g~~~~~--~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 509 (728)
...+.+.+.||+|+||.||+|.+... .+..||||+++... ....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEE
Confidence 34455668899999999999987532 34679999987543 3345789999999999999999999999854 56899
Q ss_pred EeeccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccC
Q 047292 510 VYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD 588 (728)
Q Consensus 510 v~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 588 (728)
||||+++|+|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 468 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~ 544 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544 (656)
T ss_dssp EEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred EEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence 99999999999999865 3689999999999999999999997 9999999999999999999999999999877544
Q ss_pred CCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccc
Q 047292 589 HSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDS 667 (728)
Q Consensus 589 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 667 (728)
.........+|+.|+|||.+.+..++.++||||||+++|||++ |..||......+....+ ..+....
T Consensus 545 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i--------~~~~~~~---- 612 (656)
T 2j0j_A 545 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI--------ENGERLP---- 612 (656)
T ss_dssp ---------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH--------HHTCCCC----
T ss_pred cceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH--------HcCCCCC----
Confidence 3333344557889999999999999999999999999999997 88999765443321111 1111111
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 047292 668 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710 (728)
Q Consensus 668 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 710 (728)
.+......+.+++.+||+.||.+||++.+|++.|+.++
T Consensus 613 -----~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 613 -----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp -----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11122356778999999999999999999999998865
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=329.52 Aligned_cols=264 Identities=26% Similarity=0.254 Sum_probs=198.5
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhh-----HHHHHHHHHHhccccccceeeEeeeeecCCccee
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQER-----EREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLL 509 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 509 (728)
.+.+.+.||+|+||.||+|... .+++.||||++....... .+.+.+|+.++++++||||+++++++......++
T Consensus 11 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (346)
T 1ua2_A 11 RYEKLDFLGEGQFATVYKARDK-NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL 89 (346)
T ss_dssp --CEEEEEEEETTEEEEEEECS-SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred ccEEEeEEeecCCEEEEEEEEC-CCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEE
Confidence 3455678999999999999876 468899999986432211 2468899999999999999999999999999999
Q ss_pred EeeccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccC
Q 047292 510 VYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD 588 (728)
Q Consensus 510 v~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 588 (728)
||||+++ +|.+++... ..+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 90 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 90 VFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp EEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred EEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 9999986 888888765 4688999999999999999999997 9999999999999999999999999999876433
Q ss_pred CCcccccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccce---e
Q 047292 589 HSRTHTMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDA---L 664 (728)
Q Consensus 589 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 664 (728)
.. ......||+.|+|||.+.+. .++.++||||||+++|||++|..||...........+..... ......... .
T Consensus 166 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~ 243 (346)
T 1ua2_A 166 NR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLG-TPTEEQWPDMCSL 243 (346)
T ss_dssp CC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC-CCCTTTSSSTTSS
T ss_pred cc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcC-CCChhhhhhhccC
Confidence 22 23345689999999999764 589999999999999999999999876554332222111000 000000000 0
Q ss_pred ccc--------hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 665 IDS--------DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 665 ~d~--------~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.+. .............+.+++.+||+.||.+|||++|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 244 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000 00000112223578889999999999999999999875
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=329.53 Aligned_cols=259 Identities=24% Similarity=0.269 Sum_probs=181.7
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeeecC------Ccc
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEA------LNR 507 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~ 507 (728)
+.+.+.||+|+||.||+|... .+++.||||++... .....+.+.+|+.+++.++||||+++++++... ...
T Consensus 31 y~~~~~lG~G~~g~V~~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 109 (367)
T 2fst_X 31 YQNLSPVGSGAYGSVCAAFDT-KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 109 (367)
T ss_dssp EEEEEECC----CCEEEEEET-TTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred eEEeeEEeecCCeEEEEEEEC-CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeE
Confidence 455678999999999999865 57899999999653 234457888999999999999999999998654 567
Q ss_pred eeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcccccc
Q 047292 508 LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS 587 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 587 (728)
++|+|++ +++|.+++.. ..+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 110 ~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~ 184 (367)
T 2fst_X 110 YLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184 (367)
T ss_dssp EEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred EEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence 9999998 6899988865 5789999999999999999999997 999999999999999999999999999986533
Q ss_pred CCCcccccccCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHH-------hhhcC
Q 047292 588 DHSRTHTMIRGTRGYVAPEWLKN-APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYD-------CYVEG 659 (728)
Q Consensus 588 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~-------~~~~~ 659 (728)
. .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||...........+...... .....
T Consensus 185 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 260 (367)
T 2fst_X 185 E----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 260 (367)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCH
T ss_pred c----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence 2 233568999999999987 68899999999999999999999999765443322222111000 00000
Q ss_pred -------ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 660 -------RLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 660 -------~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.+........ ..........+.+++.+||+.||.+|||++++++.
T Consensus 261 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 261 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHHHHTSCCCCCCCH-HHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhccCCCCCCCH-HHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0000000000 00001123467889999999999999999999864
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=334.70 Aligned_cols=198 Identities=26% Similarity=0.310 Sum_probs=170.1
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccc------cccceeeEeeeeecCCccee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRT------HHKNLVQLLGFCDEALNRLL 509 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~g~~~~~~~~~l 509 (728)
+.+.+.||+|+||.||+|... .+++.||||++... ......+.+|+++++.+ +|+||+++++++......++
T Consensus 99 y~~~~~LG~G~fg~V~~a~~~-~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l 176 (429)
T 3kvw_A 99 YEVLKVIGKGSFGQVVKAYDH-KVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICM 176 (429)
T ss_dssp EEEEEEEEESSSEEEEEEEET-TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEE
T ss_pred EEEEEEcccCccEEEEEEEEC-CCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEE
Confidence 556688999999999999876 56889999999753 23345677788877776 57799999999999999999
Q ss_pred EeeccCCCCHHHHHhcCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCc--eEEccccCcccc
Q 047292 510 VYEFMGNGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFS--PKISDFGLSKLL 585 (728)
Q Consensus 510 v~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~--~kl~Dfgla~~~ 585 (728)
||||+. ++|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+|||++...
T Consensus 177 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~ 252 (429)
T 3kvw_A 177 TFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE 252 (429)
T ss_dssp EECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred EEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccceec
Confidence 999996 69999988653 589999999999999999999998 9999999999999999887 999999999764
Q ss_pred ccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHh
Q 047292 586 LSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEE 643 (728)
Q Consensus 586 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~ 643 (728)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+
T Consensus 253 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~ 306 (429)
T 3kvw_A 253 HQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD 306 (429)
T ss_dssp TCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred CCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 322 233568999999999999999999999999999999999999997665443
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=318.34 Aligned_cols=251 Identities=24% Similarity=0.269 Sum_probs=197.2
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc----hhhHHHHHHHHHHhccccccceeeEeeee--ecCCccee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA----QEREREFKSEVSAIGRTHHKNLVQLLGFC--DEALNRLL 509 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~~~l 509 (728)
+.+.+.||+|+||.||++... .+++.||+|+++... ......+.+|+.++++++|+||+++++++ .+....++
T Consensus 7 y~i~~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (305)
T 2wtk_C 7 YLMGDLLGEGSYGKVKEVLDS-ETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYM 85 (305)
T ss_dssp BCCCCEEEECSSCEEEEEEBT-TTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEE
T ss_pred eeEeeEEecCCCeEEEEEEEC-CCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEE
Confidence 445678999999999999875 568899999997543 23457899999999999999999999998 45567899
Q ss_pred EeeccCCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcccccc
Q 047292 510 VYEFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS 587 (728)
Q Consensus 510 v~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 587 (728)
||||++++ |.+++... ..+++..+..++.||+.||.|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 86 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 86 VMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 99999887 77777653 5688999999999999999999997 999999999999999999999999999987643
Q ss_pred CC-CcccccccCCccccCcccccCCCC--CCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCcccee
Q 047292 588 DH-SRTHTMIRGTRGYVAPEWLKNAPV--SAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDAL 664 (728)
Q Consensus 588 ~~-~~~~~~~~gt~~y~aPE~~~~~~~--s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (728)
.. ........|++.|+|||.+.+... +.++||||||+++|||++|+.||...........+ ..+...
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i--------~~~~~~-- 231 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI--------GKGSYA-- 231 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--------HHCCCC--
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHH--------hcCCCC--
Confidence 22 222234568999999999987543 77999999999999999999999865433322111 111110
Q ss_pred ccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcC
Q 047292 665 IDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM--LEGL 709 (728)
Q Consensus 665 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~--L~~~ 709 (728)
........+.+++.+||+.||.+||+++++++. +.+.
T Consensus 232 --------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 232 --------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp --------CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred --------CCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 011123456789999999999999999999964 4443
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=333.57 Aligned_cols=259 Identities=23% Similarity=0.269 Sum_probs=193.8
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecC----------
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEA---------- 504 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~---------- 504 (728)
.+.+.+.||+|+||.||+|... .+++.||||++..... ...+|+++++.++|+||+++++++...
T Consensus 8 ~y~~~~~lG~G~fg~V~~a~~~-~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 82 (383)
T 3eb0_A 8 KYSLGKTLGTGSFGIVCEVFDI-ESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQP 82 (383)
T ss_dssp TEEEEEEEECC-CEEEEEEEET-TTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC----------
T ss_pred eEEEEEEEEeccCEEEEEEEEC-CCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccccccc
Confidence 3456688999999999999875 5789999999864322 234799999999999999999998433
Q ss_pred ----------------------------CcceeEeeccCCCCHHHHHh----cCCCCChHHHHHHHHHHHHHHHHhhhcC
Q 047292 505 ----------------------------LNRLLVYEFMGNGTLANLIF----AIPKPDWNLRVRISLEIARGLVYLHEGC 552 (728)
Q Consensus 505 ----------------------------~~~~lv~e~~~~gsL~~~l~----~~~~~~~~~~~~i~~qi~~~l~yLH~~~ 552 (728)
...++||||+++ +|.+.+. ....+++..+..++.||++||+|||+.
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~- 160 (383)
T 3eb0_A 83 PDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL- 160 (383)
T ss_dssp ---------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT-
T ss_pred ccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 337899999985 7766665 456789999999999999999999997
Q ss_pred CCCeeecCCCCCCEEEc-CCCceEEccccCccccccCCCcccccccCCccccCcccccCC-CCCCccchhhHHHHHHHHH
Q 047292 553 NVPIIHCDIKPQNILLD-HYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEII 630 (728)
Q Consensus 553 ~~~iiH~dlk~~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~ell 630 (728)
+|+||||||+|||++ +++.+||+|||+++...... ......+|+.|+|||.+.+. .++.++||||||+++|||+
T Consensus 161 --gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 236 (383)
T 3eb0_A 161 --GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236 (383)
T ss_dssp --TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred --cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHH
Confidence 999999999999998 68999999999998764332 22334689999999998875 5899999999999999999
Q ss_pred hCCcCcchhhhHhhhhhHHHHHH-------Hh----hhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCH
Q 047292 631 CCRRSVEMELEEESRAILTDWAY-------DC----YVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTM 699 (728)
Q Consensus 631 tg~~p~~~~~~~~~~~~~~~~~~-------~~----~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~ 699 (728)
+|+.||......+....+..... .. +.+......................+.+++.+||+.||.+|||+
T Consensus 237 ~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 316 (383)
T 3eb0_A 237 LGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINP 316 (383)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence 99999986554433222211100 00 00111111111111122222334568899999999999999999
Q ss_pred HHHHH
Q 047292 700 KVVMQ 704 (728)
Q Consensus 700 ~evl~ 704 (728)
.|+++
T Consensus 317 ~e~l~ 321 (383)
T 3eb0_A 317 YEAMA 321 (383)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 99984
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=327.46 Aligned_cols=261 Identities=23% Similarity=0.244 Sum_probs=190.6
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeeecCC------cc
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEAL------NR 507 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~ 507 (728)
+.+.+.||+|+||.||+|... .+++.||||++... .......+.+|+.+++.++||||+++++++.... ..
T Consensus 27 y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 105 (371)
T 2xrw_A 27 YQNLKPIGSGAQGIVCAAYDA-ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 105 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEE
T ss_pred eeEeeeeEecCCEEEEEEEEC-CCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccce
Confidence 445678999999999999875 56889999998653 2344577889999999999999999999997655 67
Q ss_pred eeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcccccc
Q 047292 508 LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS 587 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 587 (728)
++||||+++ +|.+++. ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 106 ~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 106 YIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp EEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred EEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 999999975 7888886 3588899999999999999999997 999999999999999999999999999986543
Q ss_pred CCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHH---------------HH
Q 047292 588 DHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTD---------------WA 652 (728)
Q Consensus 588 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~---------------~~ 652 (728)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+.. ..
T Consensus 180 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 257 (371)
T 2xrw_A 180 SF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257 (371)
T ss_dssp ------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHH
T ss_pred cc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 21 22345689999999999999999999999999999999999999976543322111100 00
Q ss_pred HHhhhcCc------cceeccchh---hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 653 YDCYVEGR------LDALIDSDE---AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 653 ~~~~~~~~------~~~~~d~~~---~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
........ +...+.... ...........+.+++.+||+.||++|||++|+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00000000 000000000 000112235678899999999999999999999873
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=320.87 Aligned_cols=261 Identities=21% Similarity=0.306 Sum_probs=202.2
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccc------eeeEeeeeecCCcce
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKN------LVQLLGFCDEALNRL 508 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~g~~~~~~~~~ 508 (728)
.+.+.+.||+|+||.||++.....+++.||||+++.. ......+.+|+.+++.++|++ ++++++++......+
T Consensus 15 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~ 93 (339)
T 1z57_A 15 RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC 93 (339)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEE
T ss_pred ceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEE
Confidence 4556788999999999999875567899999999754 334567889999999987765 999999999999999
Q ss_pred eEeeccCCCCHHHHHhcCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcC----------------
Q 047292 509 LVYEFMGNGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDH---------------- 570 (728)
Q Consensus 509 lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~---------------- 570 (728)
+||||+ +++|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.
T Consensus 94 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~ 169 (339)
T 1z57_A 94 IVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDER 169 (339)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CEEE
T ss_pred EEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccccccc
Confidence 999999 889999998764 678999999999999999999997 9999999999999987
Q ss_pred ---CCceEEccccCccccccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhh
Q 047292 571 ---YFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAI 647 (728)
Q Consensus 571 ---~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~ 647 (728)
++.+||+|||+++..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 245 (339)
T 1z57_A 170 TLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAM 245 (339)
T ss_dssp EESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHH
T ss_pred cccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 678999999999864322 2334689999999999999999999999999999999999999976544332221
Q ss_pred HHHHHHH----hhhcCccceec---------------------cc-hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 047292 648 LTDWAYD----CYVEGRLDALI---------------------DS-DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKV 701 (728)
Q Consensus 648 ~~~~~~~----~~~~~~~~~~~---------------------d~-~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~e 701 (728)
+...... ........... .. .............+.+++.+||+.||.+|||++|
T Consensus 246 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e 325 (339)
T 1z57_A 246 MERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLRE 325 (339)
T ss_dssp HHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHH
Confidence 1110000 00000000000 00 0000112344567889999999999999999999
Q ss_pred HHH
Q 047292 702 VMQ 704 (728)
Q Consensus 702 vl~ 704 (728)
+++
T Consensus 326 ll~ 328 (339)
T 1z57_A 326 ALK 328 (339)
T ss_dssp HTT
T ss_pred Hhc
Confidence 975
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=325.83 Aligned_cols=252 Identities=24% Similarity=0.302 Sum_probs=196.3
Q ss_pred HHHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch--------hhHHHHHHHHHHhccccccceeeEeeeeecC
Q 047292 433 DATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ--------EREREFKSEVSAIGRTHHKNLVQLLGFCDEA 504 (728)
Q Consensus 433 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 504 (728)
...+.+.+.||+|+||.||+|... .+++.||||++..... .....+.+|++++++++||||+++++++...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFER-KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhceeEeeEEecCCCEEEEEEEEc-CCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 345667789999999999999876 5678999999864321 1234588999999999999999999998765
Q ss_pred CcceeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCc---eEEccccC
Q 047292 505 LNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFS---PKISDFGL 581 (728)
Q Consensus 505 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~---~kl~Dfgl 581 (728)
. .++||||+++++|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||++.++. +||+|||+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred c-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 5 899999999999999999888899999999999999999999997 9999999999999987654 99999999
Q ss_pred ccccccCCCcccccccCCccccCccccc---CCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhc
Q 047292 582 SKLLLSDHSRTHTMIRGTRGYVAPEWLK---NAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVE 658 (728)
Q Consensus 582 a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 658 (728)
++..... .......||+.|+|||++. ...++.++||||||+++|||++|+.||......... .. ....
T Consensus 164 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~----~~~~ 234 (322)
T 2ycf_A 164 SKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---KD----QITS 234 (322)
T ss_dssp CEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH---HH----HHHH
T ss_pred ceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH---HH----HHHh
Confidence 9876432 1223356899999999974 567899999999999999999999999754322110 00 0111
Q ss_pred CccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 659 GRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 659 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
+.... .+.. .......+.+++.+||+.||++||++.++++
T Consensus 235 ~~~~~--~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 235 GKYNF--IPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp TCCCC--CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred Ccccc--Cchh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 11100 0000 0112346778999999999999999999884
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=321.65 Aligned_cols=258 Identities=19% Similarity=0.270 Sum_probs=195.5
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhcccc-ccceeeEeeeeec--CCcceeEe
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTH-HKNLVQLLGFCDE--ALNRLLVY 511 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~--~~~~~lv~ 511 (728)
.+.+.+.||+|+||.||+|... .+++.||||+++.. ..+.+.+|+.++++++ |+||+++++++.. ....++||
T Consensus 37 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 37 DYQLVRKLGRGKYSEVFEAINI-TNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred ceEEEEEecccCCeEEEEEEEC-CCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 3456688999999999999875 56889999999753 2467899999999997 9999999999987 66789999
Q ss_pred eccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCC-ceEEccccCccccccCCC
Q 047292 512 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYF-SPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 512 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~~~~ 590 (728)
||+++++|.+++. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++.......
T Consensus 113 e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~ 186 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 186 (330)
T ss_dssp ECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC
T ss_pred eccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc
Confidence 9999999999985 478889999999999999999997 999999999999999776 899999999987643322
Q ss_pred cccccccCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhh-hhhHHH-----HHHHhhhcCcc--
Q 047292 591 RTHTMIRGTRGYVAPEWLKN-APVSAKVDVYSFGVMLLEIICCRRSVEMELEEES-RAILTD-----WAYDCYVEGRL-- 661 (728)
Q Consensus 591 ~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~-~~~~~~-----~~~~~~~~~~~-- 661 (728)
.....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||........ ...+.. ...........
T Consensus 187 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 264 (330)
T 3nsz_A 187 --YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264 (330)
T ss_dssp --CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred --cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccc
Confidence 233468999999999987 6789999999999999999999999953222111 000000 00000000000
Q ss_pred ------------ceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 662 ------------DALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 662 ------------~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
...................+.+++.+||+.||.+|||++|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp CTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000000011113456788999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=335.74 Aligned_cols=251 Identities=12% Similarity=0.037 Sum_probs=177.9
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccc--cccceeeEe-------eeeec
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRT--HHKNLVQLL-------GFCDE 503 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l--~h~niv~l~-------g~~~~ 503 (728)
+.+.+.||+|+||.||+|.+. .+++.||||++.... ....+.+.+|+.+++.+ +||||++++ +++..
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~ 142 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDV-ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred eeeeeeccCCCCEEEEEEEEC-CCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence 345678999999999999876 568899999997643 23456778885544444 699988855 34332
Q ss_pred C-----------------CcceeEeeccCCCCHHHHHhcC-CCCChHHH------HHHHHHHHHHHHHhhhcCCCCeeec
Q 047292 504 A-----------------LNRLLVYEFMGNGTLANLIFAI-PKPDWNLR------VRISLEIARGLVYLHEGCNVPIIHC 559 (728)
Q Consensus 504 ~-----------------~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~------~~i~~qi~~~l~yLH~~~~~~iiH~ 559 (728)
. ...++||||++ ++|.+++... ..+.+..+ ..++.||+.||+|||++ +|+||
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivHr 218 (371)
T 3q60_A 143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHG 218 (371)
T ss_dssp TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCccC
Confidence 2 33799999999 8999999864 33455556 78889999999999997 99999
Q ss_pred CCCCCCEEEcCCCceEEccccCccccccCCCcccccccCCccccCcccccC--CCCCCccchhhHHHHHHHHHhCCcCcc
Q 047292 560 DIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKN--APVSAKVDVYSFGVMLLEIICCRRSVE 637 (728)
Q Consensus 560 dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DVwSlGvil~elltg~~p~~ 637 (728)
||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||.
T Consensus 219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 294 (371)
T 3q60_A 219 HFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294 (371)
T ss_dssp TCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred cCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999865322 113456799999999987 689999999999999999999999997
Q ss_pred hhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 638 MELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
......... +........................+.+++.+||+.||++|||+.++++
T Consensus 295 ~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 295 LVTPGIKGS---------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp BCCTTCTTC---------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CcCcccccc---------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 653321110 0000000000000000111123456778999999999999999999874
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=335.65 Aligned_cols=258 Identities=24% Similarity=0.260 Sum_probs=191.1
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecC------Cccee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEA------LNRLL 509 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~l 509 (728)
+.+.+.||+|+||.||+|.+. .+++.||||++.... ..+.+|++++++++|+||+++++++... ...++
T Consensus 56 y~~~~~lG~G~fg~Vy~~~~~-~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 56 YTDTKVIGNGSFGVVYQAKLC-DSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred EEeeeEEeeCCCEEEEEEEEC-CCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 445678999999999999886 568899999986432 2235799999999999999999998432 23579
Q ss_pred EeeccCCCCHHHHHh----cCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCC-CceEEccccCccc
Q 047292 510 VYEFMGNGTLANLIF----AIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHY-FSPKISDFGLSKL 584 (728)
Q Consensus 510 v~e~~~~gsL~~~l~----~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~-~~~kl~Dfgla~~ 584 (728)
||||+++ +|.+.+. ....+++..+..++.||++||+|||++ +|+||||||+||||+.+ +.+||+|||+++.
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 9999986 5655554 346789999999999999999999997 99999999999999955 6789999999987
Q ss_pred cccCCCcccccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHH-------HHhh
Q 047292 585 LLSDHSRTHTMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWA-------YDCY 656 (728)
Q Consensus 585 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~ 656 (728)
...... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+....+.... ....
T Consensus 207 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~ 284 (420)
T 1j1b_A 207 LVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 284 (420)
T ss_dssp CCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred cccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 643322 2335689999999999765 78999999999999999999999998654433222111100 0000
Q ss_pred h----cCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 657 V----EGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 657 ~----~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
. +..+..+................+.+++.+||+.||.+||++.|+++
T Consensus 285 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 0 00011111111111112223457889999999999999999999985
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=321.54 Aligned_cols=249 Identities=24% Similarity=0.332 Sum_probs=182.7
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch--hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
.+.+.+.||+|+||.||++... .+++.||||+++.... ...+.+.++...++.++||||+++++++......++|||
T Consensus 8 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e 86 (290)
T 3fme_A 8 DLEPIMELGRGAYGVVEKMRHV-PSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME 86 (290)
T ss_dssp GEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEE
T ss_pred hhhhHHhcCCCCCeEEEEEEec-CCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEe
Confidence 3456678999999999999875 5789999999965422 223445556666888899999999999999999999999
Q ss_pred ccCCCCHHHHHhc----CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccC
Q 047292 513 FMGNGTLANLIFA----IPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD 588 (728)
Q Consensus 513 ~~~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 588 (728)
|+++ +|.+++.. ...+++..+..++.|++.||+|||++ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 87 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 163 (290)
T 3fme_A 87 LMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD 163 (290)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC---------
T ss_pred hhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCccccccc
Confidence 9985 88777653 46789999999999999999999984 38999999999999999999999999999876443
Q ss_pred CCcccccccCCccccCcccc----cCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCcccee
Q 047292 589 HSRTHTMIRGTRGYVAPEWL----KNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDAL 664 (728)
Q Consensus 589 ~~~~~~~~~gt~~y~aPE~~----~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (728)
.. .....||+.|+|||.+ .+..++.++||||||+++|||++|+.||......... +.. ... ......
T Consensus 164 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~----~~~-~~~~~~ 234 (290)
T 3fme_A 164 VA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ--LKQ----VVE-EPSPQL 234 (290)
T ss_dssp --------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH--HHH----HHH-SCCCCC
T ss_pred cc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH--HHH----Hhc-cCCCCc
Confidence 22 2234589999999996 5667899999999999999999999999743221110 100 011 111111
Q ss_pred ccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 665 IDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 665 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
. .......+.+++.+||+.||++|||++|+++
T Consensus 235 ~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 235 P--------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp C--------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred c--------cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 1 0112345778999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=327.27 Aligned_cols=255 Identities=26% Similarity=0.366 Sum_probs=196.2
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
+.+.+.||+|+||.||+|..+ ..||+|+++... ....+.+.+|+.++++++|+||+++++++......++|+||
T Consensus 35 ~~~~~~lg~G~~g~V~~~~~~----~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~ 110 (319)
T 2y4i_B 35 LEIGELIGKGRFGQVYHGRWH----GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSL 110 (319)
T ss_dssp EECCCBCCCSSSSEEEEEEES----SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBC
T ss_pred eEEeeEeccCCceEEEEEEEc----CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeec
Confidence 445688999999999999874 259999986432 22235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCC---
Q 047292 514 MGNGTLANLIFAIP-KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH--- 589 (728)
Q Consensus 514 ~~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~--- 589 (728)
+++++|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++ ++.+||+|||+++......
T Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~ 186 (319)
T 2y4i_B 111 CKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGR 186 (319)
T ss_dssp CCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC---------
T ss_pred ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccccccccc
Confidence 99999999998764 689999999999999999999997 999999999999998 6799999999987653211
Q ss_pred -CcccccccCCccccCcccccC---------CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcC
Q 047292 590 -SRTHTMIRGTRGYVAPEWLKN---------APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEG 659 (728)
Q Consensus 590 -~~~~~~~~gt~~y~aPE~~~~---------~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 659 (728)
........|++.|+|||.+.+ ..++.++||||||+++|||++|+.||........... ...+
T Consensus 187 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~--------~~~~ 258 (319)
T 2y4i_B 187 REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ--------MGTG 258 (319)
T ss_dssp -CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHH--------HHTT
T ss_pred cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--------hccC
Confidence 122233458999999999874 4578899999999999999999999986544332111 1111
Q ss_pred ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCC
Q 047292 660 RLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPN 714 (728)
Q Consensus 660 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 714 (728)
........ .....+.+++.+||+.||.+|||+++++++|+.+.+...
T Consensus 259 ~~~~~~~~--------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~ 305 (319)
T 2y4i_B 259 MKPNLSQI--------GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305 (319)
T ss_dssp CCCCCCCS--------SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred CCCCCCcC--------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence 11111110 112346789999999999999999999999999876543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=314.74 Aligned_cols=252 Identities=25% Similarity=0.307 Sum_probs=202.5
Q ss_pred HHHHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHhccccccceeeEeeeeecCCccee
Q 047292 432 KDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLL 509 (728)
Q Consensus 432 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 509 (728)
....+.+.+.||+|+||.||++..+ .+++.||+|++.... ......+.+|++++++++||||+++++++......++
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~-~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDR-ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEc-CCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 3445666788999999999999875 468899999986532 2345789999999999999999999999999999999
Q ss_pred EeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCC---CceEEccccCccccc
Q 047292 510 VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHY---FSPKISDFGLSKLLL 586 (728)
Q Consensus 510 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~---~~~kl~Dfgla~~~~ 586 (728)
|+||+++++|.+++.....+++..++.++.||+.||.|||++ +|+|+||||+||+++.+ +.+||+|||++....
T Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 999999999999998878899999999999999999999997 99999999999999754 479999999998764
Q ss_pred cCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceecc
Q 047292 587 SDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALID 666 (728)
Q Consensus 587 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 666 (728)
.... .....+++.|+|||.+.+. ++.++||||||+++|||++|+.||........... ...+.......
T Consensus 176 ~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~--------~~~~~~~~~~~ 244 (287)
T 2wei_A 176 QNTK--MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKR--------VETGKYAFDLP 244 (287)
T ss_dssp CCSS--CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--------HHHCCCCCCSG
T ss_pred CCCc--cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHH--------HHcCCCCCCch
Confidence 3322 2233478899999998764 89999999999999999999999976544332111 11111110000
Q ss_pred chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 667 SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 667 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
. .......+.+++.+||+.||.+|||+.++++
T Consensus 245 --~----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 245 --Q----WRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp --G----GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --h----hhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0 0112346778999999999999999999987
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=326.00 Aligned_cols=263 Identities=21% Similarity=0.267 Sum_probs=197.0
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecC-----Cccee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEA-----LNRLL 509 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~l 509 (728)
+.+.+.||+|+||.||+|... .+++.||||++.... ......+.+|+.++++++||||+++++++... ...++
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 91 (353)
T 2b9h_A 13 FQLKSLLGEGAYGVVCSATHK-PTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYI 91 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEE
T ss_pred eEEeeEEcCCCCeEEEEEEEC-CCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEE
Confidence 345678999999999999876 568899999996533 33456788999999999999999999988654 67899
Q ss_pred EeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCC
Q 047292 510 VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH 589 (728)
Q Consensus 510 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 589 (728)
||||++ ++|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 92 v~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (353)
T 2b9h_A 92 IQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166 (353)
T ss_dssp EECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccccccccc
Confidence 999997 589998876 4689999999999999999999997 99999999999999999999999999998764322
Q ss_pred Cc---------ccccccCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcC
Q 047292 590 SR---------THTMIRGTRGYVAPEWLKN-APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEG 659 (728)
Q Consensus 590 ~~---------~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 659 (728)
.. ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...........+...........
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 246 (353)
T 2b9h_A 167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246 (353)
T ss_dssp -------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTT
T ss_pred ccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhc
Confidence 11 1123468999999998764 6789999999999999999999999986544332221111000000000
Q ss_pred ccceeccc--------------hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 660 RLDALIDS--------------DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 660 ~~~~~~d~--------------~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
........ .............+.+++.+||+.||++|||++++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp TTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000000 0000011123456788999999999999999999987
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=327.40 Aligned_cols=264 Identities=22% Similarity=0.278 Sum_probs=199.7
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecC-----Ccce
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEA-----LNRL 508 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~ 508 (728)
.+.+.+.||+|+||.||++... .+++.||||++.... ....+.+.+|++++.+++||||+++++++... ...+
T Consensus 28 ~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 106 (364)
T 3qyz_A 28 RYTNLSYIGEGAYGMVCSAYDN-LNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 106 (364)
T ss_dssp TEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred cEEEEEEeecCCCeEEEEEEEC-CCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence 3556688999999999999875 568899999997533 33347889999999999999999999998655 3679
Q ss_pred eEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccC
Q 047292 509 LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD 588 (728)
Q Consensus 509 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 588 (728)
+|+||++ ++|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 107 iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 107 IVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp EEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 9999997 489998876 4688999999999999999999997 9999999999999999999999999999876543
Q ss_pred CCc--ccccccCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceec
Q 047292 589 HSR--THTMIRGTRGYVAPEWLKN-APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALI 665 (728)
Q Consensus 589 ~~~--~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (728)
... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...........+....... ....+....
T Consensus 182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~ 260 (364)
T 3qyz_A 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP-SQEDLNCII 260 (364)
T ss_dssp GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSC-CHHHHHTCC
T ss_pred CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCC-CHHHHHHhh
Confidence 222 1234579999999998754 458999999999999999999999997654433222221100000 000000000
Q ss_pred c--------------chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 666 D--------------SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 666 d--------------~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
+ ..............+.+++.+||+.||.+|||++|+++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 000001111223567889999999999999999999863
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=327.68 Aligned_cols=253 Identities=20% Similarity=0.308 Sum_probs=200.1
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhh-----------------HHHHHHHHHHhccccccceeeE
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQER-----------------EREFKSEVSAIGRTHHKNLVQL 497 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~l 497 (728)
.+.+.+.||+|+||.||++.. +++.||||++....... ...+.+|+.++++++||||+++
T Consensus 32 ~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 32 DYRIIRTLNQGKFNKIILCEK---DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp TEEEEEEEECCSSCCEEEEEE---TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred ceEEEEEEcCCCCeEEEEEEc---CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 345567899999999999987 68999999986532221 1789999999999999999999
Q ss_pred eeeeecCCcceeEeeccCCCCHHHH------Hhc--CCCCChHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCCEEE
Q 047292 498 LGFCDEALNRLLVYEFMGNGTLANL------IFA--IPKPDWNLRVRISLEIARGLVYLHE-GCNVPIIHCDIKPQNILL 568 (728)
Q Consensus 498 ~g~~~~~~~~~lv~e~~~~gsL~~~------l~~--~~~~~~~~~~~i~~qi~~~l~yLH~-~~~~~iiH~dlk~~NIll 568 (728)
++++......++||||+++++|.++ +.. ...+++..+..++.||+.||.|||+ . +|+|+||||+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEE
Confidence 9999999999999999999999999 665 4678999999999999999999998 6 99999999999999
Q ss_pred cCCCceEEccccCccccccCCCcccccccCCccccCcccccCC-CCCC-ccchhhHHHHHHHHHhCCcCcchhhh-Hhhh
Q 047292 569 DHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNA-PVSA-KVDVYSFGVMLLEIICCRRSVEMELE-EESR 645 (728)
Q Consensus 569 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-~~DVwSlGvil~elltg~~p~~~~~~-~~~~ 645 (728)
+.++.+||+|||++...... ......|++.|+|||.+.+. .++. ++||||||+++|||++|+.||..... ....
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 262 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 99999999999999876433 23345689999999999887 6666 99999999999999999999976543 2111
Q ss_pred hhHHHHHHHhhhcCccceecc---------chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 646 AILTDWAYDCYVEGRLDALID---------SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~d---------~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
. ....+......+ ..............+.+++.+||+.||.+||+++|+++
T Consensus 263 ~--------~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 263 N--------NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp H--------HHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred H--------HHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1 111111100000 00000001223456788999999999999999999987
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=319.08 Aligned_cols=262 Identities=20% Similarity=0.263 Sum_probs=192.1
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeee-------------
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCD------------- 502 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~------------- 502 (728)
+.+.+.||+|+||.||+|... .+++.||+|++........+.+.+|++++++++||||+++++++.
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 91 (320)
T 2i6l_A 13 YMDLKPLGCGGNGLVFSAVDN-DCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSL 91 (320)
T ss_dssp EEEEEECC-----CEEEEEET-TTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----C
T ss_pred eeEEEEeccCCCeEEEEEEEC-CCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccc
Confidence 445578999999999999876 568899999997666666788999999999999999999999873
Q ss_pred -cCCcceeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEc-CCCceEEcccc
Q 047292 503 -EALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLD-HYFSPKISDFG 580 (728)
Q Consensus 503 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~-~~~~~kl~Dfg 580 (728)
+....++||||++ |+|.+++.. ..+++..+..++.||++||+|||++ +|+||||||+||+++ +++.+||+|||
T Consensus 92 ~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~Dfg 166 (320)
T 2i6l_A 92 TELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFG 166 (320)
T ss_dssp CSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECCCT
T ss_pred cccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEccCc
Confidence 3467799999998 599999865 5688999999999999999999997 999999999999997 57799999999
Q ss_pred CccccccCCC--cccccccCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHH-----
Q 047292 581 LSKLLLSDHS--RTHTMIRGTRGYVAPEWLKN-APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWA----- 652 (728)
Q Consensus 581 la~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~----- 652 (728)
+++....... .......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...........+....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 246 (320)
T 2i6l_A 167 LARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHE 246 (320)
T ss_dssp TCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCH
T ss_pred cccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCch
Confidence 9987643221 12233457899999998865 678999999999999999999999998654433221111100
Q ss_pred --HHhhhcCccceeccch------hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 653 --YDCYVEGRLDALIDSD------EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 653 --~~~~~~~~~~~~~d~~------~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
..... ..+...+... ............+.+++.+||+.||.+|||++++++
T Consensus 247 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 247 EDRQELL-SVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHHH-TTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hhhhhhh-hcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 00000 0000000000 000011123456888999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=331.68 Aligned_cols=264 Identities=22% Similarity=0.239 Sum_probs=198.9
Q ss_pred HHHHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhcccc--------ccceeeEeeeee-
Q 047292 432 KDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTH--------HKNLVQLLGFCD- 502 (728)
Q Consensus 432 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~g~~~- 502 (728)
....+.+.++||+|+||.||+|... .+++.||||+++.. ......+.+|+.+++.++ |+||+++++++.
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDI-QGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEec-CCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 3445667789999999999999865 56889999999753 334567889999999885 888999999987
Q ss_pred ---cCCcceeEeeccCCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCC-----
Q 047292 503 ---EALNRLLVYEFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYF----- 572 (728)
Q Consensus 503 ---~~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~----- 572 (728)
.....++||||+ +++|.+++... ..+++..+..++.||+.||+|||++ .+|+||||||+|||++.++
T Consensus 113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~--~givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 113 SGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTK--CRIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp EETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECCCCSGGGEEECCCHHHHHH
T ss_pred cCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHeeEeccchhhhh
Confidence 566889999999 55666666543 5689999999999999999999984 2899999999999999775
Q ss_pred --------------------------------------------ceEEccccCccccccCCCcccccccCCccccCcccc
Q 047292 573 --------------------------------------------SPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWL 608 (728)
Q Consensus 573 --------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~ 608 (728)
.+||+|||+++..... .....||+.|+|||++
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhh
Confidence 7999999999876432 2334689999999999
Q ss_pred cCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhh------hhhHHHHHH----HhhhcCc-----------cceeccc
Q 047292 609 KNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEES------RAILTDWAY----DCYVEGR-----------LDALIDS 667 (728)
Q Consensus 609 ~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~------~~~~~~~~~----~~~~~~~-----------~~~~~d~ 667 (728)
.+..++.++||||||+++|||++|+.||........ ...+..... .....+. +..+.+.
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL 345 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence 999999999999999999999999999975332110 000100000 0000000 0000000
Q ss_pred h---------hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 668 D---------EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 668 ~---------~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
. .......+....+.+++.+||+.||++|||++|+++
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0 001123556678889999999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=333.04 Aligned_cols=194 Identities=23% Similarity=0.355 Sum_probs=152.0
Q ss_pred hhhCCCceeEEEEeeeeC-CCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeee--cCCcceeEeeccCC
Q 047292 440 EELGRGSFGIVYKGVLKT-ASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCD--EALNRLLVYEFMGN 516 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~~~lv~e~~~~ 516 (728)
++||+|+||.||+|..+. .+++.||||++.... ....+.+|+.++++++||||+++++++. .....++||||+++
T Consensus 27 ~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~ 104 (405)
T 3rgf_A 27 CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 104 (405)
T ss_dssp CCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSE
T ss_pred cEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCC
Confidence 479999999999998753 357899999997532 2346789999999999999999999994 46788999999975
Q ss_pred CCHHHHHhcC---------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEE----cCCCceEEccccCcc
Q 047292 517 GTLANLIFAI---------PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILL----DHYFSPKISDFGLSK 583 (728)
Q Consensus 517 gsL~~~l~~~---------~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll----~~~~~~kl~Dfgla~ 583 (728)
+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||| +.++.+||+|||+++
T Consensus 105 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 180 (405)
T 3rgf_A 105 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 180 (405)
T ss_dssp -EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC
T ss_pred -CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECCCce
Confidence 787777532 2488999999999999999999997 99999999999999 778999999999998
Q ss_pred ccccCCC--cccccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchh
Q 047292 584 LLLSDHS--RTHTMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEME 639 (728)
Q Consensus 584 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~ 639 (728)
....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 181 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred ecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 7654322 223346789999999999874 5899999999999999999999999644
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=323.41 Aligned_cols=262 Identities=22% Similarity=0.291 Sum_probs=197.6
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchh--hHHHHHHHHHHhccc---cccceeeEeeeee-----cCC
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQE--REREFKSEVSAIGRT---HHKNLVQLLGFCD-----EAL 505 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l---~h~niv~l~g~~~-----~~~ 505 (728)
+.+.+.||+|+||.||+|.....+++.||+|+++..... ....+.+|+.+++.+ +||||+++++++. ...
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 92 (326)
T 1blx_A 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 92 (326)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred eeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCc
Confidence 445678999999999999875457889999998643321 123566777777666 8999999999987 567
Q ss_pred cceeEeeccCCCCHHHHHhcCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcc
Q 047292 506 NRLLVYEFMGNGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSK 583 (728)
Q Consensus 506 ~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~ 583 (728)
..++||||++ |+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 93 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 93 KLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp EEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred eEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 7899999998 69999998753 488999999999999999999997 99999999999999999999999999998
Q ss_pred ccccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccce
Q 047292 584 LLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDA 663 (728)
Q Consensus 584 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (728)
...... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...........+...... ........
T Consensus 169 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~ 245 (326)
T 1blx_A 169 IYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL-PGEEDWPR 245 (326)
T ss_dssp CCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC-CCGGGSCT
T ss_pred cccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCC-CCcccCcc
Confidence 654322 223456899999999999999999999999999999999999999865543322222111000 00000000
Q ss_pred -------ec---cchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 664 -------LI---DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 664 -------~~---d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
.+ ...............+.+++.+||+.||.+||++.++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 246 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 000001111223456778999999999999999999985
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=315.07 Aligned_cols=250 Identities=29% Similarity=0.382 Sum_probs=189.2
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeec-----------
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDE----------- 503 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----------- 503 (728)
.+.+.+.||+|+||.||+|... .+++.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 7 DFEEIAVLGQGAFGQVVKARNA-LDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred cchhhheeccCCcEEEEEEEEc-CCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 3455678999999999999875 56889999999653 3445789999999999999999999998754
Q ss_pred --CCcceeEeeccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEcccc
Q 047292 504 --ALNRLLVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFG 580 (728)
Q Consensus 504 --~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg 580 (728)
....++||||+++++|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred ccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeCc
Confidence 45679999999999999999854 3567889999999999999999997 99999999999999999999999999
Q ss_pred CccccccCC-------------CcccccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhh
Q 047292 581 LSKLLLSDH-------------SRTHTMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRA 646 (728)
Q Consensus 581 la~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~ 646 (728)
++....... ........|++.|+|||.+.+. .++.++||||||+++|||++ |+....... .
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~--~ 236 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV--N 236 (303)
T ss_dssp CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH--H
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH--H
Confidence 998764321 1122335589999999999865 78999999999999999998 443221111 0
Q ss_pred hHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 647 ILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.. ........ . + ...........+.+++.+||+.||.+|||++++++.
T Consensus 237 ~~-----~~~~~~~~-~-~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 237 IL-----KKLRSVSI-E-F----PPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HH-----HHHHSTTC-C-C----CTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HH-----Hhcccccc-c-c----CccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 01 01111100 0 0 011122233457789999999999999999999873
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=329.25 Aligned_cols=260 Identities=22% Similarity=0.252 Sum_probs=192.4
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCc------ce
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALN------RL 508 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------~~ 508 (728)
.|.+.+.||+|+||.||+|... .+..||+|++..... ...+|+++++.++||||+++++++..... .+
T Consensus 41 ~Y~~~~~lG~G~~g~V~~a~~~--~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 41 AYTNCKVIGNGSFGVVFQAKLV--ESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEETTEEEEEEEET--TTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred eEEEeEEEeeCCCeEEEEEEEC--CCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 3556688999999999999875 344589998854322 22469999999999999999999855443 78
Q ss_pred eEeeccCCCCHHHHH---hcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEc-CCCceEEccccCccc
Q 047292 509 LVYEFMGNGTLANLI---FAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLD-HYFSPKISDFGLSKL 584 (728)
Q Consensus 509 lv~e~~~~gsL~~~l---~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~-~~~~~kl~Dfgla~~ 584 (728)
+||||++++.+.... .....+++..+..++.||++||+|||++ +|+||||||+|||++ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 999999875443332 2346789999999999999999999997 999999999999999 799999999999987
Q ss_pred cccCCCcccccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHH-------H---
Q 047292 585 LLSDHSRTHTMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWA-------Y--- 653 (728)
Q Consensus 585 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~-------~--- 653 (728)
...... .....+|+.|+|||++.+. .++.++||||||+++|||++|+.||...........+.... .
T Consensus 192 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 192 LIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM 269 (394)
T ss_dssp CCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred ccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 643322 2334689999999999765 58999999999999999999999998665433322221110 0
Q ss_pred -HhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 654 -DCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 654 -~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
..+.+..+...................+.+++.+||+.||.+|||+.|+++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0011111111111111111222234578899999999999999999999874
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=322.93 Aligned_cols=247 Identities=28% Similarity=0.393 Sum_probs=191.4
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccc-cccceeeEeeeeec------CCcce
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKNLVQLLGFCDE------ALNRL 508 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~------~~~~~ 508 (728)
+.+.+.||+|+||.||+|... .+++.||||++.... .....+.+|+.+++++ +||||+++++++.. ....+
T Consensus 26 y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~ 103 (326)
T 2x7f_A 26 FELVELVGNGTYGQVYKGRHV-KTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 103 (326)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEE
T ss_pred EEEEEEeccCCCEEEEEEEEC-CCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEE
Confidence 345678999999999999875 568899999986532 3346789999999998 89999999999976 46789
Q ss_pred eEeeccCCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccc
Q 047292 509 LVYEFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLL 586 (728)
Q Consensus 509 lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 586 (728)
+||||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+|+||||+||+++.++.+||+|||++....
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 180 (326)
T 2x7f_A 104 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 180 (326)
T ss_dssp EEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC---
T ss_pred EEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceecC
Confidence 999999999999999865 4688999999999999999999997 99999999999999999999999999998664
Q ss_pred cCCCcccccccCCccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCcc
Q 047292 587 SDHSRTHTMIRGTRGYVAPEWLK-----NAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRL 661 (728)
Q Consensus 587 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (728)
.... ......|++.|+|||++. +..++.++||||||+++|||++|+.||...........+ .....
T Consensus 181 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--------~~~~~ 251 (326)
T 2x7f_A 181 RTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI--------PRNPA 251 (326)
T ss_dssp -----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--------HHSCC
T ss_pred cCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh--------hcCcc
Confidence 3221 123346899999999997 567899999999999999999999999754433221111 11111
Q ss_pred ceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 662 DALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 662 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
..... ......+.+++.+||+.||.+||+++++++
T Consensus 252 ~~~~~--------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 252 PRLKS--------KKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp CCCSC--------SCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccCCc--------cccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 11111 112346778999999999999999999987
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=324.28 Aligned_cols=258 Identities=22% Similarity=0.257 Sum_probs=194.5
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeeecCCcc------
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNR------ 507 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~------ 507 (728)
+.+.+.||+|+||.||+|... .+++.||||++... .......+.+|+.+++.++||||+++++++......
T Consensus 44 y~~~~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 122 (371)
T 4exu_A 44 YVSPTHVGSGAYGSVCSAIDK-RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 122 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCC
T ss_pred EEEEeEEecCCCeEEEEEEEC-CCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeE
Confidence 445678999999999999876 57899999999653 233457889999999999999999999999877665
Q ss_pred eeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcccccc
Q 047292 508 LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS 587 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 587 (728)
++||||+. ++|.+++.. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 123 ~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 196 (371)
T 4exu_A 123 YLVMPFMQ-TDLQKIMGM--EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADA 196 (371)
T ss_dssp EEEEECCC-EEHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred EEEEcccc-ccHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence 99999998 588888743 488999999999999999999997 999999999999999999999999999986533
Q ss_pred CCCcccccccCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHH---hhhcC----
Q 047292 588 DHSRTHTMIRGTRGYVAPEWLKN-APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYD---CYVEG---- 659 (728)
Q Consensus 588 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~---- 659 (728)
. .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+...... .+...
T Consensus 197 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 272 (371)
T 4exu_A 197 E----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 272 (371)
T ss_dssp -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCH
T ss_pred C----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhh
Confidence 2 233568999999999987 68899999999999999999999999865443322211110000 00000
Q ss_pred -------ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 660 -------RLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 660 -------~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.+....... ...........+.+++.+||+.||.+|||++|+++.
T Consensus 273 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 273 AAKSYIQSLPQTPRKD-FTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHHHHHSCCCCCCC-HHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhccCCCcchh-HHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 000000000 000111224578899999999999999999999864
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=323.01 Aligned_cols=263 Identities=20% Similarity=0.199 Sum_probs=184.2
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCc-------c
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALN-------R 507 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-------~ 507 (728)
.+.+.+.||+|+||.||+|... .+++.||||++.... .....+.++++.+..++||||+++++++..... .
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 101 (360)
T 3e3p_A 24 RFQVERMAGQGTFGTVQLGKEK-STGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL 101 (360)
T ss_dssp TEEEC----------CEEEEET-TTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred ceEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence 3455688999999999999876 568899999985432 223456778888888999999999999865443 7
Q ss_pred eeEeeccCCCCHHHH----HhcCCCCChHHHHHHHHHHHHHHHHhh--hcCCCCeeecCCCCCCEEEcC-CCceEEcccc
Q 047292 508 LLVYEFMGNGTLANL----IFAIPKPDWNLRVRISLEIARGLVYLH--EGCNVPIIHCDIKPQNILLDH-YFSPKISDFG 580 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~----l~~~~~~~~~~~~~i~~qi~~~l~yLH--~~~~~~iiH~dlk~~NIll~~-~~~~kl~Dfg 580 (728)
++||||++++ |... +.....+++..+..++.|++.||.||| +. +|+||||||+|||++. ++.+||+|||
T Consensus 102 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~Dfg 177 (360)
T 3e3p_A 102 NVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDFG 177 (360)
T ss_dssp EEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEECCCT
T ss_pred EEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEeeCC
Confidence 8999999874 4433 335567889999999999999999999 65 9999999999999996 8999999999
Q ss_pred CccccccCCCcccccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHH-------
Q 047292 581 LSKLLLSDHSRTHTMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWA------- 652 (728)
Q Consensus 581 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~------- 652 (728)
+++....... .....||+.|+|||++.+. .++.++||||||+++|||++|+.||...........+....
T Consensus 178 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (360)
T 3e3p_A 178 SAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREV 255 (360)
T ss_dssp TCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred CceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHH
Confidence 9987644322 2334689999999999765 48999999999999999999999998665443322221110
Q ss_pred HHhhhcCcc-ceecc------chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 653 YDCYVEGRL-DALID------SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 653 ~~~~~~~~~-~~~~d------~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
......... ....+ ..............+.+++.+||+.||.+|||+.|+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 256 LRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000000000 00000 000011111235678899999999999999999999864
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=318.22 Aligned_cols=262 Identities=19% Similarity=0.268 Sum_probs=199.6
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccc------eeeEeeeeecCCcc
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKN------LVQLLGFCDEALNR 507 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~g~~~~~~~~ 507 (728)
..+.+.+.||+|+||.||++.....+++.||+|+++.. ......+.+|+.++++++|++ ++.+++++......
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 34566788999999999999887555579999999753 334567889999999998776 99999999999999
Q ss_pred eeEeeccCCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEE-----------------
Q 047292 508 LLVYEFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILL----------------- 568 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll----------------- 568 (728)
++||||+ +++|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||+
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred EEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccccc
Confidence 9999999 66777777654 4689999999999999999999997 99999999999999
Q ss_pred --cCCCceEEccccCccccccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhh
Q 047292 569 --DHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRA 646 (728)
Q Consensus 569 --~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~ 646 (728)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||..........
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 249 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV 249 (355)
T ss_dssp EEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred cccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 66889999999999864322 233568999999999999999999999999999999999999998654433222
Q ss_pred hHHHHHHH----hhhcCccce-------eccc---------------hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHH
Q 047292 647 ILTDWAYD----CYVEGRLDA-------LIDS---------------DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMK 700 (728)
Q Consensus 647 ~~~~~~~~----~~~~~~~~~-------~~d~---------------~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ 700 (728)
.+...... ......... ..+. .............+.+++.+||+.||++|||++
T Consensus 250 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ 329 (355)
T 2eu9_A 250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLA 329 (355)
T ss_dssp HHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHH
Confidence 11110000 000000000 0000 000011223355788999999999999999999
Q ss_pred HHHH
Q 047292 701 VVMQ 704 (728)
Q Consensus 701 evl~ 704 (728)
|+++
T Consensus 330 e~l~ 333 (355)
T 2eu9_A 330 EALL 333 (355)
T ss_dssp HHTT
T ss_pred HHhc
Confidence 9985
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=319.08 Aligned_cols=250 Identities=18% Similarity=0.291 Sum_probs=192.7
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhcccc--ccceeeEeeeeecCCccee
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTH--HKNLVQLLGFCDEALNRLL 509 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~~l 509 (728)
..+.+.+.||+|+||.||++... +++.||||++... .......+.+|+.++.+++ |+||+++++++......++
T Consensus 28 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 28 RIYSILKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp EEEEEEEEEECCSSEEEEEEECT--TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred ceEEEEEEecCCCCEEEEEEEcC--CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 34556688999999999999874 5889999998542 3345578999999999997 5999999999999999999
Q ss_pred EeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCC
Q 047292 510 VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH 589 (728)
Q Consensus 510 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 589 (728)
||| +.+++|.+++.....+++..+..++.||++||.|||++ +|+||||||+|||+++ +.+||+|||+++......
T Consensus 106 v~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~ 180 (313)
T 3cek_A 106 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDT 180 (313)
T ss_dssp EEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC-----
T ss_pred EEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccCcc
Confidence 999 67889999999888899999999999999999999997 9999999999999975 899999999998764432
Q ss_pred Cc-ccccccCCccccCcccccC-----------CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhh
Q 047292 590 SR-THTMIRGTRGYVAPEWLKN-----------APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYV 657 (728)
Q Consensus 590 ~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 657 (728)
.. ......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||......... + .. ..
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~--~----~~-~~ 253 (313)
T 3cek_A 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK--L----HA-II 253 (313)
T ss_dssp ---------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH--H----HH-HH
T ss_pred ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH--H----HH-HH
Confidence 21 2233568999999999976 46888999999999999999999999754222110 0 00 11
Q ss_pred cCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 658 EGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 658 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
....... ........+.+++.+||+.||.+||+++++++.
T Consensus 254 ~~~~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 254 DPNHEIE--------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp CTTSCCC--------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hcccccC--------CcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 1110000 011112457789999999999999999999864
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=327.83 Aligned_cols=261 Identities=21% Similarity=0.222 Sum_probs=190.1
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch-----------hhHHHHHHHHHHhccccccceeeEeeeeec-
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ-----------EREREFKSEVSAIGRTHHKNLVQLLGFCDE- 503 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~-----------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~- 503 (728)
+.+.+.||+|+||.||+|... .++.||||++..... ...+.+.+|++++++++||||+++++++..
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 101 (362)
T 3pg1_A 24 YTVQRFISSGSYGAVCAGVDS--EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHF 101 (362)
T ss_dssp CEEEEEEEEETTEEEEEEECT--TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEEC
T ss_pred eEEeEEeccCCCEEEEEEECC--CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEec
Confidence 334578999999999999874 489999999854221 123789999999999999999999999843
Q ss_pred ----CCcceeEeeccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEcc
Q 047292 504 ----ALNRLLVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISD 578 (728)
Q Consensus 504 ----~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~D 578 (728)
....++||||++ |+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|
T Consensus 102 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 102 EEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp CTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred cCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCCEEEEe
Confidence 345799999998 5888887765 4789999999999999999999997 999999999999999999999999
Q ss_pred ccCccccccCCCcccccccCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHH----
Q 047292 579 FGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKN-APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAY---- 653 (728)
Q Consensus 579 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~---- 653 (728)
||+++...... ......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.....
T Consensus 178 fg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 255 (362)
T 3pg1_A 178 FNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255 (362)
T ss_dssp TTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred cCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence 99997543322 2233568999999999977 6789999999999999999999999986544332222211100
Q ss_pred -----------HhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 654 -----------DCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 654 -----------~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.............. ............+.+++.+||+.||.+|||++|+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 256 EDVVMFSSPSARDYLRNSLSNVPAR-AWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHTSCHHHHHHTTTCCCCCCCC-CHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHhhhccchhhhHHHHhhcccCChh-hHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 00000111111110 1111112234567889999999999999999999864
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=320.74 Aligned_cols=201 Identities=26% Similarity=0.341 Sum_probs=169.3
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhcccc-cc-----ceeeEeeeeecCCcce
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTH-HK-----NLVQLLGFCDEALNRL 508 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~g~~~~~~~~~ 508 (728)
.+.+.+.||+|+||.||+|... .+++.||||+++.. .....++..|+.+++.++ |+ +|+++++++......+
T Consensus 55 ~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 132 (382)
T 2vx3_A 55 RYEIDSLIGKGSFGQVVKAYDR-VEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC 132 (382)
T ss_dssp TEEEEEEEEEETTEEEEEEEET-TTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred eEEEEEEEeecCCEEEEEEEEc-CCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence 4556678999999999999875 56789999999753 233466778888888774 44 5999999999999999
Q ss_pred eEeeccCCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEc--CCCceEEccccCccc
Q 047292 509 LVYEFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLD--HYFSPKISDFGLSKL 584 (728)
Q Consensus 509 lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~--~~~~~kl~Dfgla~~ 584 (728)
+||||++ ++|.+++... ..+++..+..++.||+.||.|||++ ..+|+||||||+|||++ .++.+||+|||+++.
T Consensus 133 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~ 210 (382)
T 2vx3_A 133 LVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 210 (382)
T ss_dssp EEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCcee
Confidence 9999996 5999999875 4689999999999999999999952 24899999999999995 578899999999987
Q ss_pred cccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHh
Q 047292 585 LLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEE 643 (728)
Q Consensus 585 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~ 643 (728)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 211 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~ 265 (382)
T 2vx3_A 211 LGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVD 265 (382)
T ss_dssp TTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred cccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 6432 233568999999999999999999999999999999999999998654433
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=324.71 Aligned_cols=270 Identities=23% Similarity=0.268 Sum_probs=199.9
Q ss_pred HHHHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhcccc-----------ccceeeEeee
Q 047292 432 KDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTH-----------HKNLVQLLGF 500 (728)
Q Consensus 432 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~g~ 500 (728)
....+.+.+.||+|+||.||+|... .+++.||||++... ......+.+|+.++++++ |+||++++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDM-VNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEec-CCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 3445667789999999999999875 56889999999753 334567888999998876 8999999999
Q ss_pred eecCC----cceeEeeccCCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEc-----
Q 047292 501 CDEAL----NRLLVYEFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLD----- 569 (728)
Q Consensus 501 ~~~~~----~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~----- 569 (728)
+.... ..++||||+ +++|.+++... ..+++..+..++.||+.||+|||++ .+|+||||||+|||++
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~--~~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETT
T ss_pred hhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChHHeEEeccCCC
Confidence 87654 789999999 89999999864 4588999999999999999999984 2899999999999994
Q ss_pred -CCCceEEccccCccccccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhh---
Q 047292 570 -HYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESR--- 645 (728)
Q Consensus 570 -~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~--- 645 (728)
..+.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.........
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred cCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 4458999999999876432 22346899999999999999999999999999999999999999754321110
Q ss_pred hhHHHHHHH-----------------hhhcCccceecc--------c--hhhhhhcHHHHHHHHHHHHHhcccCCCCCCC
Q 047292 646 AILTDWAYD-----------------CYVEGRLDALID--------S--DEAAMADRSRLHKWLMIAMWCIQEDPSKRPT 698 (728)
Q Consensus 646 ~~~~~~~~~-----------------~~~~~~~~~~~d--------~--~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt 698 (728)
..+...... .+........+. . .............+.+++.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 000000000 000000000000 0 0011233556778889999999999999999
Q ss_pred HHHHHH--HHhcCc
Q 047292 699 MKVVMQ--MLEGLL 710 (728)
Q Consensus 699 ~~evl~--~L~~~~ 710 (728)
++|+++ .+.+..
T Consensus 328 ~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 328 AGGLVNHPWLKDTL 341 (373)
T ss_dssp HHHHHTCGGGTTCT
T ss_pred HHHHhhChhhhccc
Confidence 999997 344443
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=320.03 Aligned_cols=245 Identities=24% Similarity=0.343 Sum_probs=191.7
Q ss_pred HHHHHHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch------hhHHHHHHHHHHhccc----cccceeeEee
Q 047292 430 ELKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ------EREREFKSEVSAIGRT----HHKNLVQLLG 499 (728)
Q Consensus 430 el~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l----~h~niv~l~g 499 (728)
+.....+.+.+.||+|+||.||+|... .+++.||||+++.... .....+.+|+.++.++ +|+||+++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRL-TDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECT-TTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEc-cCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 344455677789999999999999875 5678999999965332 1233466788888888 8999999999
Q ss_pred eeecCCcceeEeec-cCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEc-CCCceEEc
Q 047292 500 FCDEALNRLLVYEF-MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLD-HYFSPKIS 577 (728)
Q Consensus 500 ~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~-~~~~~kl~ 577 (728)
++......++|+|+ +.+++|.+++.....+++..++.++.||+.||.|||++ +|+||||||+||+++ +++.+||+
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~ 182 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLI 182 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEEC
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEEE
Confidence 99999999999999 78999999998878899999999999999999999998 999999999999999 89999999
Q ss_pred cccCccccccCCCcccccccCCccccCcccccCCCCC-CccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhh
Q 047292 578 DFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVS-AKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCY 656 (728)
Q Consensus 578 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 656 (728)
|||+++...... .....|++.|+|||++.+..+. .++||||||+++|||++|+.||........
T Consensus 183 dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------------ 247 (312)
T 2iwi_A 183 DFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILE------------ 247 (312)
T ss_dssp CCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHH------------
T ss_pred EcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHhh------------
Confidence 999998764432 2335589999999999877664 589999999999999999999975421100
Q ss_pred hcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 657 VEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 657 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
... . ........+.+++.+||+.||++||+++|+++.
T Consensus 248 --~~~-~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 248 --AEL-H---------FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp --TCC-C---------CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred --hcc-C---------CcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0 011123456789999999999999999999973
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=318.47 Aligned_cols=258 Identities=22% Similarity=0.252 Sum_probs=193.7
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHhccccccceeeEeeeeecCCc------c
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALN------R 507 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------~ 507 (728)
+.+.+.||+|+||.||+|..+ .+++.||||++.... ......+.+|+.+++.++||||+++++++..... .
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 104 (353)
T 3coi_A 26 YVSPTHVGSGAYGSVCSAIDK-RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 104 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred EEEeeeEecCCCeEEEEEEEC-CCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeE
Confidence 345578999999999999876 578999999996532 3335778999999999999999999999987654 4
Q ss_pred eeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcccccc
Q 047292 508 LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS 587 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 587 (728)
++||||++ ++|.+++.. .+++..+..++.||+.||.|||++ +|+||||||+||++++++.+||+|||+++....
T Consensus 105 ~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 105 YLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp EEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred EEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 99999997 588887753 588999999999999999999997 999999999999999999999999999986532
Q ss_pred CCCcccccccCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHH---hhhcC----
Q 047292 588 DHSRTHTMIRGTRGYVAPEWLKN-APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYD---CYVEG---- 659 (728)
Q Consensus 588 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~---- 659 (728)
. .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||...........+...... .+...
T Consensus 179 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 254 (353)
T 3coi_A 179 E----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 254 (353)
T ss_dssp ---------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCH
T ss_pred C----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhH
Confidence 2 233468999999999987 67899999999999999999999999865443322111110000 00000
Q ss_pred -------ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 660 -------RLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 660 -------~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.+........ ..........+.+++.+||+.||++|||++++++.
T Consensus 255 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 255 AAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000000000 00112234567889999999999999999999863
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=321.95 Aligned_cols=240 Identities=24% Similarity=0.394 Sum_probs=196.9
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchh------hHHHHHHHHHHhcccc--ccceeeEeeeeecCCc
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQE------REREFKSEVSAIGRTH--HKNLVQLLGFCDEALN 506 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~ 506 (728)
.+.+.+.||+|+||.||+|... .+++.||||++...... ....+.+|+.++++++ |+||+++++++.....
T Consensus 44 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~ 122 (320)
T 3a99_A 44 QYQVGPLLGSGGFGSVYSGIRV-SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122 (320)
T ss_dssp TEEEEEECSSSSSCEEEEEEET-TTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred ceEEEEEEeeCCCeEEEEEEEC-CCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCc
Confidence 3556688999999999999875 56889999998653221 2245678999999986 6999999999999999
Q ss_pred ceeEeeccCC-CCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEc-CCCceEEccccCccc
Q 047292 507 RLLVYEFMGN-GTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLD-HYFSPKISDFGLSKL 584 (728)
Q Consensus 507 ~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~-~~~~~kl~Dfgla~~ 584 (728)
.++|+|++.+ ++|.+++.....+++..+..++.||++||+|||+. +|+||||||+|||++ +++.+||+|||+++.
T Consensus 123 ~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~ 199 (320)
T 3a99_A 123 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL 199 (320)
T ss_dssp EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCccccc
Confidence 9999999976 89999998888899999999999999999999997 999999999999999 789999999999987
Q ss_pred cccCCCcccccccCCccccCcccccCCCC-CCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccce
Q 047292 585 LLSDHSRTHTMIRGTRGYVAPEWLKNAPV-SAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDA 663 (728)
Q Consensus 585 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 663 (728)
..... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||....... ....
T Consensus 200 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--------------~~~~-- 260 (320)
T 3a99_A 200 LKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII--------------RGQV-- 260 (320)
T ss_dssp CCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH--------------HCCC--
T ss_pred ccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhh--------------cccc--
Confidence 64332 233468999999999987765 678999999999999999999997542210 0000
Q ss_pred eccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 664 LIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 664 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.+ .......+.+++.+||+.||++||++++|++.
T Consensus 261 ~~--------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 261 FF--------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp CC--------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cc--------cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 01123457789999999999999999999873
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=315.86 Aligned_cols=256 Identities=21% Similarity=0.249 Sum_probs=171.9
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeec----CCcceeEeeccC
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDE----ALNRLLVYEFMG 515 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lv~e~~~ 515 (728)
+.||+|+||.||++..+ .+++.||||++..... ...+....++.++|+||+++++++.. ....++||||++
T Consensus 35 ~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~----~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 109 (336)
T 3fhr_A 35 QVLGLGVNGKVLECFHR-RTGQKCALKLLYDSPK----ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECME 109 (336)
T ss_dssp EEEEEETTEEEEEEEET-TTCCEEEEEEEESSHH----HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCT
T ss_pred eeeeeCCCeEEEEEEEC-CCCCEEEEEEecCcHH----HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccC
Confidence 46999999999999876 5689999999865321 11222233556689999999999876 455899999999
Q ss_pred CCCHHHHHhcCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcC---CCceEEccccCccccccCCC
Q 047292 516 NGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDH---YFSPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 516 ~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~---~~~~kl~Dfgla~~~~~~~~ 590 (728)
+|+|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 110 gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~-- 184 (336)
T 3fhr_A 110 GGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-- 184 (336)
T ss_dssp TEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-----
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccceecccc--
Confidence 999999998763 689999999999999999999997 9999999999999986 456999999999865432
Q ss_pred cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhh
Q 047292 591 RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEA 670 (728)
Q Consensus 591 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 670 (728)
......+|+.|+|||++.+..++.++||||||+++|||++|+.||............... ...... ...
T Consensus 185 -~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~----~~~~~~-~~~----- 253 (336)
T 3fhr_A 185 -ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRR----IRLGQY-GFP----- 253 (336)
T ss_dssp --------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------------CCC-----
T ss_pred -ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHh----hhcccc-ccC-----
Confidence 223345799999999999889999999999999999999999999755433211100000 000000 000
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhcCcCCCCCC
Q 047292 671 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ--MLEGLLEVPNPP 716 (728)
Q Consensus 671 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~--~L~~~~~~~~~~ 716 (728)
..........+.+++.+||+.||.+|||++|+++ .+.+....+..|
T Consensus 254 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~ 301 (336)
T 3fhr_A 254 NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTP 301 (336)
T ss_dssp TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSCCCB
T ss_pred chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCCCCc
Confidence 0001122446778999999999999999999997 455544444333
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=317.73 Aligned_cols=251 Identities=27% Similarity=0.372 Sum_probs=174.6
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc-hhhHHHHHHHHH-HhccccccceeeEeeeeecCCcceeEeec
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA-QEREREFKSEVS-AIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
+.+.+.||+|+||.||++..+ .+++.||||++.... ......+..|+. +++.++||||+++++++......++||||
T Consensus 24 y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~ 102 (327)
T 3aln_A 24 LKDLGEIGRGAYGSVNKMVHK-PSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMEL 102 (327)
T ss_dssp EEC-CEEEECSSEEEEEEEET-TTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hhehheeccCCCEEEEEEEEc-CCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEee
Confidence 345578999999999999876 568899999996542 233445556665 77778999999999999999999999999
Q ss_pred cCCCCHHHHHhc-----CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccC
Q 047292 514 MGNGTLANLIFA-----IPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD 588 (728)
Q Consensus 514 ~~~gsL~~~l~~-----~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 588 (728)
+++ +|.+++.. ...+++..+..++.|++.||.|||++ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 103 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 179 (327)
T 3aln_A 103 MST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS 179 (327)
T ss_dssp CSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC----
T ss_pred cCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceecccc
Confidence 985 88777763 46788999999999999999999984 38999999999999999999999999999876433
Q ss_pred CCcccccccCCccccCcccc----cCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCcccee
Q 047292 589 HSRTHTMIRGTRGYVAPEWL----KNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDAL 664 (728)
Q Consensus 589 ~~~~~~~~~gt~~y~aPE~~----~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (728)
.. .....|++.|+|||.+ .+..++.++||||||+++|||++|+.||......... + .....+....+
T Consensus 180 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~-----~~~~~~~~~~~ 250 (327)
T 3aln_A 180 IA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ--L-----TQVVKGDPPQL 250 (327)
T ss_dssp ----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------CCCCCSCCCCC
T ss_pred cc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH--H-----HHHhcCCCCCC
Confidence 22 2233589999999999 5667899999999999999999999999753221100 0 00011111111
Q ss_pred ccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 665 IDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 665 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
.. .........+.+++.+||+.||.+||++.+|++
T Consensus 251 ~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 251 SN-----SEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CC-----CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CC-----cccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 10 011122346788999999999999999999875
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=325.66 Aligned_cols=244 Identities=27% Similarity=0.319 Sum_probs=183.0
Q ss_pred HhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccc-cccceeeEeeeeecCCcceeEeeccCCC
Q 047292 439 KEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYEFMGNG 517 (728)
Q Consensus 439 ~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~g 517 (728)
.+.||+|+||+||.+.. .+|+.||||++... ....+.+|+.+++++ +||||+++++++......++||||+. |
T Consensus 20 ~~~LG~G~~g~V~~~~~--~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-g 93 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGS--FQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-L 93 (434)
T ss_dssp EEEEEECSTTCEEEEEE--SSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-E
T ss_pred cCeEeeCCCeEEEEEEE--ECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-C
Confidence 36799999999976533 36899999998643 235678899999886 89999999999999999999999996 6
Q ss_pred CHHHHHhcCCCC-------ChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCC-------------CceEEc
Q 047292 518 TLANLIFAIPKP-------DWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHY-------------FSPKIS 577 (728)
Q Consensus 518 sL~~~l~~~~~~-------~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~-------------~~~kl~ 577 (728)
+|.+++...... .+..++.++.||+.||+|||++ +|+||||||+|||++.+ +.+||+
T Consensus 94 sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~ 170 (434)
T 2rio_A 94 NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170 (434)
T ss_dssp EHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence 999999876432 2334578999999999999997 99999999999999754 489999
Q ss_pred cccCccccccCCCc---ccccccCCccccCcccccC-------CCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhh
Q 047292 578 DFGLSKLLLSDHSR---THTMIRGTRGYVAPEWLKN-------APVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRA 646 (728)
Q Consensus 578 Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~ 646 (728)
|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.........
T Consensus 171 DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~- 249 (434)
T 2rio_A 171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN- 249 (434)
T ss_dssp CCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHHH-
T ss_pred ccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHHH-
Confidence 99999877543321 1234569999999999976 678999999999999999999 89999754332211
Q ss_pred hHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 647 ILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
+ .... ..... ............+.+++.+||+.||.+|||+.+|++
T Consensus 250 -i---~~~~---~~~~~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 250 -I---IRGI---FSLDE-----MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp -H---HHTC---CCCCC-----CTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -H---hcCC---CCccc-----ccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 0 0000 00110 111123445677889999999999999999999985
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-35 Score=308.19 Aligned_cols=249 Identities=24% Similarity=0.346 Sum_probs=175.1
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch--hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
+.+.+.||+|+||.||+|..+ .+++.||||++..... ...+.+.++..+++.++||||+++++++......++||||
T Consensus 27 y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 105 (318)
T 2dyl_A 27 LENLGEMGSGTCGQVWKMRFR-KTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMEL 105 (318)
T ss_dssp EEEEEEC------CEEEEEET-TTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred ccccceeeecCCeeEEEEEEe-cCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Confidence 345578999999999999876 4688999999965322 2234455555678888999999999999999999999999
Q ss_pred cCCCCHHHHHhc-CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 514 MGNGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 514 ~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
+ ++.+..+... ...+++..+..++.||++||.|||++ .+|+|+||||+||+++.++.+||+|||++....... .
T Consensus 106 ~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--~ 180 (318)
T 2dyl_A 106 M-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK--A 180 (318)
T ss_dssp C-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHH--HCCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred c-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhh--CCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc--c
Confidence 9 4455555443 46789999999999999999999982 189999999999999999999999999997654332 2
Q ss_pred cccccCCccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccc
Q 047292 593 HTMIRGTRGYVAPEWLK-----NAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDS 667 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~-----~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 667 (728)
.....+++.|+|||.+. ...++.++||||||+++|||++|+.||........ .+.. ...+.......
T Consensus 181 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~-----~~~~~~~~~~~- 252 (318)
T 2dyl_A 181 KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE--VLTK-----VLQEEPPLLPG- 252 (318)
T ss_dssp ------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--HHHH-----HHHSCCCCCCS-
T ss_pred ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH--HHHH-----HhccCCCCCCc-
Confidence 23345899999999994 55788999999999999999999999975322111 1111 01111111100
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 668 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 668 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
.......+.+++.+||+.||.+||+++++++
T Consensus 253 ------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 253 ------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp ------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ------cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0012345778999999999999999999985
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=334.13 Aligned_cols=271 Identities=25% Similarity=0.297 Sum_probs=200.6
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc-chhhHHHHHHHHHHhccccccceeeEeeeeec------CCc
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKNLVQLLGFCDE------ALN 506 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~~ 506 (728)
..+.+.+.||+|+||.||+|... .+++.||||++... .......+.+|++++++++||||+++++++.. ...
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~-~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQ-DTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCT-TTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCeEEEEEEeeCCCeEEEEEEEC-CCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 34566789999999999999876 56889999998653 34446789999999999999999999999765 677
Q ss_pred ceeEeeccCCCCHHHHHhcCC---CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCc---eEEcccc
Q 047292 507 RLLVYEFMGNGTLANLIFAIP---KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFS---PKISDFG 580 (728)
Q Consensus 507 ~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~---~kl~Dfg 580 (728)
.++||||+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 899999999999999998754 688999999999999999999997 9999999999999997665 9999999
Q ss_pred CccccccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhh-hhHHHHHHH-hhhc
Q 047292 581 LSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESR-AILTDWAYD-CYVE 658 (728)
Q Consensus 581 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~-~~~~~~~~~-~~~~ 658 (728)
++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ..+...... ....
T Consensus 170 ~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~ 247 (676)
T 3qa8_A 170 YAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247 (676)
T ss_dssp CCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred ccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence 998764332 223456899999999999999999999999999999999999999653221110 000000000 0000
Q ss_pred Cccceec--cc--hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHH-----HHHHHhcCc
Q 047292 659 GRLDALI--DS--DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKV-----VMQMLEGLL 710 (728)
Q Consensus 659 ~~~~~~~--d~--~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~e-----vl~~L~~~~ 710 (728)
......+ .. .............+.+++.+||+.||++|||+++ ..+.++.++
T Consensus 248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL 308 (676)
T 3qa8_A 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL 308 (676)
T ss_dssp CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence 0000000 00 0011122335567889999999999999999977 445555544
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-35 Score=319.95 Aligned_cols=245 Identities=23% Similarity=0.303 Sum_probs=181.1
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccc-cccceeeEeeeeecCCcceeEeecc
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
+...+.||+|+||+|+.... .+++.||||++..... ..+.+|+.+++++ +||||+++++++.+....++||||+
T Consensus 26 y~~~~~LG~G~~G~V~~~~~--~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 26 FCPKDVLGHGAEGTIVYRGM--FDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEECGGGCEEEEEE--SSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EecCCeeecCcCEEEEEEEE--eCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 33457899999998654322 3678999999864322 2356799999998 7999999999999999999999999
Q ss_pred CCCCHHHHHhcCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcC-----CCceEEccccCccccccC
Q 047292 515 GNGTLANLIFAIP-KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDH-----YFSPKISDFGLSKLLLSD 588 (728)
Q Consensus 515 ~~gsL~~~l~~~~-~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~-----~~~~kl~Dfgla~~~~~~ 588 (728)
+ |+|.+++.... ......++.++.||+.||.|||++ +|+||||||+|||++. ...+||+|||+++.....
T Consensus 101 ~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 101 A-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp S-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred C-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 6 59999998763 445556789999999999999997 9999999999999953 335889999999876533
Q ss_pred CC--cccccccCCccccCccccc---CCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccc
Q 047292 589 HS--RTHTMIRGTRGYVAPEWLK---NAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLD 662 (728)
Q Consensus 589 ~~--~~~~~~~gt~~y~aPE~~~---~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (728)
.. .......||+.|+|||++. ...++.++|||||||++|||++ |+.||........... ......
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~--------~~~~~~- 247 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL--------LGACSL- 247 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHH--------TTCCCC-
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHH--------hccCCc-
Confidence 21 2233456999999999997 4577889999999999999999 8889864433221110 000011
Q ss_pred eeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 663 ALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 663 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
.... ........+.+++.+||+.||.+|||+++|++
T Consensus 248 ~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 248 DCLH------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TTSC------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccC------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0111 11123345678999999999999999999983
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-35 Score=338.45 Aligned_cols=239 Identities=23% Similarity=0.322 Sum_probs=191.8
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc-chhhHHHHHHHHHHhccccccceeeEeeeeecCCc-----ce
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALN-----RL 508 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-----~~ 508 (728)
.+.+.+.||+|+||.||++.+...+++.||||++... .......+.+|+.++++++||||+++++++..... .+
T Consensus 81 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~ 160 (681)
T 2pzi_A 81 QYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGY 160 (681)
T ss_dssp TEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred ceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeE
Confidence 3556688999999999999987556889999998643 23445678999999999999999999999987766 69
Q ss_pred eEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccC
Q 047292 509 LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD 588 (728)
Q Consensus 509 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 588 (728)
|||||+++++|.+++.. .+++..++.++.||+.||.|||++ +|+||||||+|||++++ .+||+|||+++.....
T Consensus 161 lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~ 234 (681)
T 2pzi_A 161 IVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF 234 (681)
T ss_dssp EEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred EEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence 99999999999988765 789999999999999999999997 99999999999999986 8999999999876432
Q ss_pred CCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccch
Q 047292 589 HSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSD 668 (728)
Q Consensus 589 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 668 (728)
....||+.|+|||++.+.. +.++||||||++++||++|..|+....... +...
T Consensus 235 -----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~--------------------~~~~- 287 (681)
T 2pzi_A 235 -----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG--------------------LPED- 287 (681)
T ss_dssp -----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS--------------------CCTT-
T ss_pred -----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc--------------------cccc-
Confidence 3456899999999997654 889999999999999999988876321110 0000
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhcC
Q 047292 669 EAAMADRSRLHKWLMIAMWCIQEDPSKRP-TMKVVMQMLEGL 709 (728)
Q Consensus 669 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-t~~evl~~L~~~ 709 (728)
.........+.+++.+||+.||.+|| +++++.+.|.++
T Consensus 288 ---~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 288 ---DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp ---CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ---ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 00111234677899999999999999 567777777654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=297.51 Aligned_cols=233 Identities=14% Similarity=0.094 Sum_probs=182.6
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeE
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 510 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 510 (728)
..|.+.+.||+|+||.||+|... .+++.||||++.... ....+.+.+|+.++.+++|+||+++++++...+..++|
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDT-ALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEET-TTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEec-CCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 34566788999999999999875 568999999996542 23347899999999999999999999999999999999
Q ss_pred eeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC
Q 047292 511 YEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 590 (728)
|||+++++|.+++... .....+.+++.||+.||+|||++ +|+||||||+|||+++++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~---------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA---------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred EEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc----------
Confidence 9999999999999653 35567889999999999999997 99999999999999999999998543
Q ss_pred cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhh
Q 047292 591 RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEA 670 (728)
Q Consensus 591 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 670 (728)
|++ +++.++||||||+++|||+||+.||............ ...+..... ..
T Consensus 175 -----------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~---------~~~~~~~~~--~~ 225 (286)
T 3uqc_A 175 -----------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA---------ERDTAGQPI--EP 225 (286)
T ss_dssp -----------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC---------CBCTTSCBC--CH
T ss_pred -----------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH---------HHHhccCCC--Ch
Confidence 333 3688999999999999999999999754332110000 000000000 00
Q ss_pred hhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 047292 671 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEV 712 (728)
Q Consensus 671 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 712 (728)
..........+.+++.+||+.||++| |+.++++.|+.+...
T Consensus 226 ~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 226 ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 11112234567889999999999999 999999999986543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=293.89 Aligned_cols=235 Identities=20% Similarity=0.237 Sum_probs=178.4
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHh-ccccccceeeEeeeeec----CCcceeEeecc
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAI-GRTHHKNLVQLLGFCDE----ALNRLLVYEFM 514 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~g~~~~----~~~~~lv~e~~ 514 (728)
+.||+|+||.||++... .+++.||+|+++.. ..+.+|+.++ +..+||||+++++++.. ....++||||+
T Consensus 24 ~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~ 97 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNK-RTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 97 (299)
T ss_dssp EEEEEETTEEEEEEEET-TTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCC
T ss_pred cccccCCCeEEEEEEEc-CCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeec
Confidence 56999999999999876 56889999998642 3567788887 45589999999999876 67789999999
Q ss_pred CCCCHHHHHhcCC--CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcC---CCceEEccccCccccccCC
Q 047292 515 GNGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDH---YFSPKISDFGLSKLLLSDH 589 (728)
Q Consensus 515 ~~gsL~~~l~~~~--~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~---~~~~kl~Dfgla~~~~~~~ 589 (728)
++++|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+||+++. ++.+||+|||++....
T Consensus 98 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~--- 171 (299)
T 3m2w_A 98 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--- 171 (299)
T ss_dssp CSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT---
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccccccc---
Confidence 9999999998764 689999999999999999999997 9999999999999998 7899999999986532
Q ss_pred CcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchh
Q 047292 590 SRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDE 669 (728)
Q Consensus 590 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 669 (728)
+..++.++||||||+++|||++|+.||............ .......... .
T Consensus 172 --------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~--------~~~~~~~~~~--~ 221 (299)
T 3m2w_A 172 --------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM--------KTRIRMGQYE--F 221 (299)
T ss_dssp --------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS--------CCSSCTTCCS--S
T ss_pred --------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH--------HHHHhhcccc--C
Confidence 234678999999999999999999999754332211000 0000000000 0
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhcCcCCCCCC
Q 047292 670 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ--MLEGLLEVPNPP 716 (728)
Q Consensus 670 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~--~L~~~~~~~~~~ 716 (728)
...........+.+++.+||+.||.+|||++|+++ .+.+....+.++
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~~~ 270 (299)
T 3m2w_A 222 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 270 (299)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCCCB
T ss_pred CchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCCCC
Confidence 00000122456788999999999999999999997 345544444443
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-34 Score=309.63 Aligned_cols=233 Identities=16% Similarity=0.171 Sum_probs=172.0
Q ss_pred HhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch---hhHHHHHHHHHHhccccc-ccee---------------e---
Q 047292 439 KEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ---EREREFKSEVSAIGRTHH-KNLV---------------Q--- 496 (728)
Q Consensus 439 ~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h-~niv---------------~--- 496 (728)
.+.||+|+||.||+|.+. .+++.||||++..... ...+.+.+|+.+++.++| +|.. .
T Consensus 83 ~~~LG~G~fG~Vy~a~~~-~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (413)
T 3dzo_A 83 GTVLGQEDPYAYLEATDQ-ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ 161 (413)
T ss_dssp EEEEEEETTEEEEEEEET-TTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC
T ss_pred ecccccCCCEEEEEEEec-CCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCC
Confidence 467999999999999876 5688999999873322 224779999999999976 2211 1
Q ss_pred ---Eeeeeec-----CCcceeEeeccCCCCHHHHHhc-------CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCC
Q 047292 497 ---LLGFCDE-----ALNRLLVYEFMGNGTLANLIFA-------IPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDI 561 (728)
Q Consensus 497 ---l~g~~~~-----~~~~~lv~e~~~~gsL~~~l~~-------~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dl 561 (728)
++.+... ....+++|+++ +++|.+++.. ...+++..++.++.||++||+|||++ +|+||||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHrDi 237 (413)
T 3dzo_A 162 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYL 237 (413)
T ss_dssp ---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred CCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCc
Confidence 1111111 12345666654 6899988841 23466778899999999999999997 9999999
Q ss_pred CCCCEEEcCCCceEEccccCccccccCCCcccccccCCccccCcccc----------cCCCCCCccchhhHHHHHHHHHh
Q 047292 562 KPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWL----------KNAPVSAKVDVYSFGVMLLEIIC 631 (728)
Q Consensus 562 k~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~~~DVwSlGvil~ellt 631 (728)
||+||||+.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++|||++
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt 312 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred ccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence 999999999999999999998865332 333457 999999999 55678899999999999999999
Q ss_pred CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 047292 632 CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVM 703 (728)
Q Consensus 632 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl 703 (728)
|+.||...........+ +... ......+.+++.+||+.||++||++.+++
T Consensus 313 g~~Pf~~~~~~~~~~~~----------------~~~~------~~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 313 ADLPNTDDAALGGSEWI----------------FRSC------KNIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp SSCCCCTTGGGSCSGGG----------------GSSC------CCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred CCCCCCCcchhhhHHHH----------------Hhhc------ccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 99999765433211110 1100 01124677899999999999999976654
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=300.23 Aligned_cols=242 Identities=15% Similarity=0.083 Sum_probs=181.5
Q ss_pred HHHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc--------hhhHHHHHHHHHHhcccc---------cccee
Q 047292 433 DATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA--------QEREREFKSEVSAIGRTH---------HKNLV 495 (728)
Q Consensus 433 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv 495 (728)
...+.+.+.||+|+||.||+|+. +++.||||++.... ....+.+.+|+.++++++ |+||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA---DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE---TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred cccchheeeecccCceEEEEEEe---CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 44566778999999999999986 57899999996532 122367888888888875 66666
Q ss_pred eEeeee-----------------ec-------------CCcceeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHH
Q 047292 496 QLLGFC-----------------DE-------------ALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGL 545 (728)
Q Consensus 496 ~l~g~~-----------------~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l 545 (728)
++.+++ .. ....++||||+++|++.+.+.. ..+++..+..++.||+.||
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHH
Confidence 666653 22 6788999999999987777654 5678999999999999999
Q ss_pred HHhh-hcCCCCeeecCCCCCCEEEcCCC--------------------ceEEccccCccccccCCCcccccccCCccccC
Q 047292 546 VYLH-EGCNVPIIHCDIKPQNILLDHYF--------------------SPKISDFGLSKLLLSDHSRTHTMIRGTRGYVA 604 (728)
Q Consensus 546 ~yLH-~~~~~~iiH~dlk~~NIll~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~a 604 (728)
+||| +. +|+||||||+|||++.++ .+||+|||+++..... ...||+.|+|
T Consensus 175 ~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~a 245 (336)
T 2vuw_A 175 AVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMD 245 (336)
T ss_dssp HHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTC
T ss_pred HHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccC
Confidence 9999 77 999999999999999887 8999999999876432 3468999999
Q ss_pred cccccCCCCCCccchhhHHHH-HHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHH
Q 047292 605 PEWLKNAPVSAKVDVYSFGVM-LLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLM 683 (728)
Q Consensus 605 PE~~~~~~~s~~~DVwSlGvi-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~ 683 (728)
||++.+.. +.++|||||+++ .+++++|..||........ +.... ......... ............+.+
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~---~~~~~---~~~~~~~~~----~~~~~~~~~s~~~~d 314 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHY---LTDKM---LKQMTFKTK----CNTPAMKQIKRKIQE 314 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHH---HHHHH---HHTCCCSSC----CCSHHHHHHHHHHHH
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhH---HHHhh---hhhhccCcc----cchhhhhhcCHHHHH
Confidence 99998776 889999998777 7789999999854211000 00000 000011100 011122345667889
Q ss_pred HHHHhcccCCCCCCCHHHHH
Q 047292 684 IAMWCIQEDPSKRPTMKVVM 703 (728)
Q Consensus 684 l~~~cl~~dp~~RPt~~evl 703 (728)
++.+||+.| |++|++
T Consensus 315 li~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 315 FHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHGGGSS-----SHHHHH
T ss_pred HHHHHhccC-----CHHHHH
Confidence 999999966 888887
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-32 Score=276.97 Aligned_cols=185 Identities=19% Similarity=0.245 Sum_probs=145.2
Q ss_pred EEEEeCCCCCCCcCC---CCcEEEEecCc-eEE--eCCCCCeEeecCCC-------CceeeEEEecCcCEEEEecccccc
Q 047292 2 IIWHANEDNHPVLAP---RGSTLELTATG-LLL--KDPGGQAIWDEKPN-------KIVSDAAMLDTGNFVLIASGNHSD 68 (728)
Q Consensus 2 ~vW~Anr~~~~~~~~---~~~~l~~~~~g-l~l--~~~~~~~vWst~~~-------~~~~~a~lld~GNlVl~~~~~~~~ 68 (728)
|||+|||++|+. ++ .+++|+|+.+| |+| .|++|++||||+.. ..++.|+|+|+|||||++ +.
T Consensus 54 vvW~Anr~~p~~-~~~~~~~~~l~l~~~G~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~----~~ 128 (276)
T 3m7h_A 54 TVWVANEQQPFS-STIPLRNKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD----SL 128 (276)
T ss_dssp EEEECSTTSTTE-EEEECCCTTCCSEEEESSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE----EE
T ss_pred eEEECCCCCCcC-CcccccceEEEEeCCCcEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC----Cc
Confidence 799999999763 21 26789999999 999 78889999999843 245789999999999976 57
Q ss_pred ccccccccccccccccce----eccccEEEeeccCCCCCCccEEEEee-CCceEEeeccCCcccceeeeeeccCCCCCCC
Q 047292 69 YAWQSFKSPTDTILPTQI----LDLGSVLVSRLTETNLSKGRFELHFS-NGSLEFIPVAWPSRFQYKSYYTSNTSSANSS 143 (728)
Q Consensus 69 ~lWQSFD~PtDtlLpg~~----l~~~~~L~S~~s~~d~s~G~~~l~~~-~~~~~~~~~~~~~~~~~~~y~~~~~~~~~~~ 143 (728)
+|||| ||||||||||| |..|+.| ++.+||++|.|+++++ +|.++++ ... ...||+++++..+
T Consensus 129 ~lWqS--~ptdtlLpg~~~~~~l~~g~~L---~S~~dps~G~fsl~l~~dGnlvLy--~~~----~~~yW~Sgt~~~~-- 195 (276)
T 3m7h_A 129 ALWNG--TPAIPLVPGAIDSLLLAPGSEL---VQGVVYGAGASKLVFQGDGNLVAY--GPN----GAATWNAGTQGKG-- 195 (276)
T ss_dssp EEEES--CTTSCCCCSCTTCEEECSSEEE---CTTCEEEETTEEEEECTTSCEEEE--CTT----SSEEEECCCTTTT--
T ss_pred eeeCc--ccccccccccccccccccCccc---ccCCCCCCceEEEeecCCceEEEE--eCC----CeEEEECCCCCCc--
Confidence 99999 99999999999 7778888 5678999999999999 7766654 221 2689999988652
Q ss_pred CCCceeeecccccEEEEecCceeEeccccccCCCCCceeEEEEEccCCcEEEEEeccCCCCCCCcceeeecCCc
Q 047292 144 ESGHQLVFNESADIYIVKNNGQIVQLPLWAQLSPRADHYFRATLDFDGVFAEYAHSKNSSTNQGWFPTRTLPDS 217 (728)
Q Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rl~L~~dG~l~~y~~~~~~~~~~~W~~~~~~p~~ 217 (728)
...+.++.+|.+++++.++..+..... .....+|++|+.||+|++|.|. ..|..++.+|..
T Consensus 196 --~~~l~l~~dGnLvl~d~~~~~vWsS~t-----~~~~~~rl~Ld~dGnLvly~~~------~~Wqsf~~~P~~ 256 (276)
T 3m7h_A 196 --AVRAVFQGDGNLVVYGAGNAVLWHSHT-----GGHASAVLRLQANGSIAILDEK------PVWARFGFQPTY 256 (276)
T ss_dssp --CCEEEECTTSCEEEECTTSCEEEECSC-----TTCTTCEEEECTTSCEEEEEEE------EEEESSSCCTTS
T ss_pred --cEEEEEcCCCeEEEEeCCCcEEEEecC-----CCCCCEEEEEcCCccEEEEcCC------CeEEccCccCCc
Confidence 156788889999888776654443221 1123479999999999999982 458888877764
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-28 Score=278.49 Aligned_cols=187 Identities=18% Similarity=0.091 Sum_probs=133.3
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEeccc----------chhhHHHHHHHHHHhccc-cccceeeEeeeeecCCcce
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRL----------AQEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRL 508 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~----------~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 508 (728)
..++.|++|.+..+... ..|+.+++|.+... .....++|.+|+++|+++ +|+||+++++++++....|
T Consensus 240 ~~~~~~~~~~h~~~rr~-~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~y 318 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRY-FFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGW 318 (569)
T ss_dssp CC-C--------CCEEE-EECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEE
T ss_pred hccccCCcccccccccc-cccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEE
Confidence 34677777766654433 35788999998542 122346799999999999 7999999999999999999
Q ss_pred eEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccC
Q 047292 509 LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD 588 (728)
Q Consensus 509 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 588 (728)
|||||++|++|.++|.....++.. +|+.||+.||+|+|++ +||||||||+||||++++++||+|||+|+.....
T Consensus 319 LVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 319 LVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred EEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 999999999999999988777754 5889999999999998 9999999999999999999999999999876544
Q ss_pred CCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcC
Q 047292 589 HSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRS 635 (728)
Q Consensus 589 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p 635 (728)
... .....||+.|||||++.+. +..++|+||+|++++++.++..+
T Consensus 393 ~~~-~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 CSW-PTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -CC-SHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred Ccc-ccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 332 2345699999999999764 56789999999999998776544
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-27 Score=238.20 Aligned_cols=170 Identities=16% Similarity=0.222 Sum_probs=127.2
Q ss_pred CEEEEeCCCCCCCcCCCCcEEEEecCc-eEEeCCCCCeEeecCCC--CceeeEEEecCcCEEEEeccccccccccccccc
Q 047292 1 TIIWHANEDNHPVLAPRGSTLELTATG-LLLKDPGGQAIWDEKPN--KIVSDAAMLDTGNFVLIASGNHSDYAWQSFKSP 77 (728)
Q Consensus 1 t~vW~Anr~~~~~~~~~~~~l~~~~~g-l~l~~~~~~~vWst~~~--~~~~~a~lld~GNlVl~~~~~~~~~lWQSFD~P 77 (728)
|+||+|||+.| .+++|+|+.+| |+|+|++|.+||+|+.. .+...|+|+|+|||||++ .++|||||||
T Consensus 45 ~~vW~an~~~~-----~~~~l~l~~dGnLvl~d~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~-----~~~W~S~~~p 114 (236)
T 1dlp_A 45 VRVWASNTAGA-----TGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYG-----PGLWDSGTSN 114 (236)
T ss_dssp SEEECCCCCSC-----SCCBCCBCSSSCBCCBCTTTCCSCCCCCCCCSSCCEEEECSSSCEEEEC-----SEEEECSCCC
T ss_pred EEEEECCCCCC-----CCeEEEEcCCCcEEEEcCCCcEEEeCCccccCCcEEEEEeCCCCEEEec-----CCEEECCCCC
Confidence 79999999964 45789999999 99999999999999842 234579999999999953 2899999999
Q ss_pred cccc----------cccceeccc-cEEEeeccCCCCCCccEEEEee-CCceEEeeccCCcccceeeeeeccCCCCCCCCC
Q 047292 78 TDTI----------LPTQILDLG-SVLVSRLTETNLSKGRFELHFS-NGSLEFIPVAWPSRFQYKSYYTSNTSSANSSES 145 (728)
Q Consensus 78 tDtl----------Lpg~~l~~~-~~L~S~~s~~d~s~G~~~l~~~-~~~~~~~~~~~~~~~~~~~y~~~~~~~~~~~~~ 145 (728)
|||+ +|||+++.+ ++|+| .+||++|.|+|+++ +|.+++ +... ..||+++++... .
T Consensus 115 ~~t~~lp~~g~d~L~~gq~~~~~~~~L~s---~~d~s~G~~~l~l~~dG~LvL--~~~~-----~~~W~s~~~~~~---~ 181 (236)
T 1dlp_A 115 KGSVVVANNGNSILYSTQGNDNHPQTLHA---TQSLQLSPYRLSMETDCNLVL--FDRD-----DRVWSTNTAGKG---T 181 (236)
T ss_dssp SSCCCCSSCCCEECCCC--CCCCCCEECS---SCCCBCSSCEEEEETTTEEEE--EBTT-----BCCSCCCCCSSC---S
T ss_pred CcccccCCccceEEecCCcCCCccceEEc---CcEeecCcEEEEECCCCcEEE--EcCC-----EeEEeCCCcCCC---C
Confidence 8554 777777664 46774 68999999999999 665544 3433 578999988542 2
Q ss_pred CceeeecccccEEEEecCceeEeccccccCCCCCceeEEEEEccCCcEEEEE
Q 047292 146 GHQLVFNESADIYIVKNNGQIVQLPLWAQLSPRADHYFRATLDFDGVFAEYA 197 (728)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rl~L~~dG~l~~y~ 197 (728)
+..+.++.+|.+++++.++..+...+.. .....+|++|++||++++|.
T Consensus 182 ~~~~~L~~~Gnl~ly~~~~~~vw~s~~~----~~~~~~rl~Ld~dG~l~ly~ 229 (236)
T 1dlp_A 182 GCRAVLQPNGRMDVLTNQNIAVWTSGNS----RSAGRYVFVLQPDRNLAIYG 229 (236)
T ss_dssp SCEEEEETTTEEEEEETTTEEEEECCCC----CSSSCCEEEECSSSCEEEEC
T ss_pred ceEEEECCCCcEEEEeCCCcEEEEeCCC----CCCCCEEEEEcCCCcEEEeC
Confidence 3456677888877777666555442211 12235799999999999995
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=7.5e-25 Score=246.34 Aligned_cols=182 Identities=16% Similarity=0.197 Sum_probs=145.4
Q ss_pred HhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc--------hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeE
Q 047292 439 KEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA--------QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 510 (728)
Q Consensus 439 ~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 510 (728)
.+.||+|+||.||+|.. .++.+++|+..... ....+.+.+|++++++++||||+++..++......++|
T Consensus 341 ~~~LG~G~fg~Vy~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY---LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp -------CCEEEEEEEC---SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCEEeeCCCEEEEEEEE---CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 46899999999999954 46789999863311 11235689999999999999999666666677788999
Q ss_pred eeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC
Q 047292 511 YEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 590 (728)
|||+++++|.+++.. +..++.|+++||.|||++ +|+||||||+|||+++ ++||+|||+++.......
T Consensus 418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 999999999999976 568999999999999997 9999999999999999 999999999998754322
Q ss_pred cc------cccccCCccccCcccccC--CCCCCccchhhHHHHHHHHHhCCcCc
Q 047292 591 RT------HTMIRGTRGYVAPEWLKN--APVSAKVDVYSFGVMLLEIICCRRSV 636 (728)
Q Consensus 591 ~~------~~~~~gt~~y~aPE~~~~--~~~s~~~DVwSlGvil~elltg~~p~ 636 (728)
.. .....||+.|||||++.. ..|+...|+|+..+-..+-+.++.+|
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 21 234679999999999987 56788899999999988888777665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=5.6e-22 Score=204.37 Aligned_cols=140 Identities=16% Similarity=0.068 Sum_probs=114.1
Q ss_pred HhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch------------------hhHHHHHHHHHHhccccccceeeEeee
Q 047292 439 KEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ------------------EREREFKSEVSAIGRTHHKNLVQLLGF 500 (728)
Q Consensus 439 ~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~g~ 500 (728)
.+.||+|+||.||+|.. .+++.||||.++.... .....+.+|+.++++++ | +++.++
T Consensus 95 ~~~iG~G~~g~Vy~~~~--~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~ 169 (282)
T 1zar_A 95 GKLMGEGKESAVFNCYS--EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKV 169 (282)
T ss_dssp EEEEEECSSEEEEEEEE--TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCE
T ss_pred cCEeccCCCceEEEEEe--CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeE
Confidence 37899999999999987 5789999999964221 13467899999999998 4 556665
Q ss_pred eecCCcceeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEcccc
Q 047292 501 CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFG 580 (728)
Q Consensus 501 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg 580 (728)
+.. +..++||||+++++|.+ +.. .....++.|++.||.|||+. +|+||||||+|||++ ++.+||+|||
T Consensus 170 ~~~-~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~DFG 237 (282)
T 1zar_A 170 YAW-EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFP 237 (282)
T ss_dssp EEE-ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEECCCT
T ss_pred Eec-cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEEECC
Confidence 433 56799999999999998 421 23457999999999999997 999999999999999 9999999999
Q ss_pred CccccccCCCcccccccCCccccCccccc
Q 047292 581 LSKLLLSDHSRTHTMIRGTRGYVAPEWLK 609 (728)
Q Consensus 581 la~~~~~~~~~~~~~~~gt~~y~aPE~~~ 609 (728)
+++. +..++|||++.
T Consensus 238 ~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 238 QSVE--------------VGEEGWREILE 252 (282)
T ss_dssp TCEE--------------TTSTTHHHHHH
T ss_pred CCeE--------------CCCCCHHHHHH
Confidence 9873 34578899875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=7.1e-18 Score=171.52 Aligned_cols=135 Identities=19% Similarity=0.181 Sum_probs=104.9
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcE--EEEEEecccch------------------------hhHHHHHHHHHHhccccc
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNA--IAVKKLDRLAQ------------------------EREREFKSEVSAIGRTHH 491 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~--vavK~l~~~~~------------------------~~~~~~~~E~~~l~~l~h 491 (728)
+.+.||+|+||.||+|... .+|+. ||||+++.... .....+.+|+.++.+++|
T Consensus 51 i~~~ig~G~~g~Vy~a~~~-~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 129 (258)
T 1zth_A 51 MGGVISTGKEANVFYADGV-FDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKE 129 (258)
T ss_dssp EEEEEEECSSEEEEEEEEE-ETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHH
T ss_pred hCCEEeecceEEEEEEEEc-CCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHh
Confidence 4467999999999999873 35778 99998743211 112468899999999988
Q ss_pred cce--eeEeeeeecCCcceeEeeccCC-C----CHHHHHhcCCCCChHHHHHHHHHHHHHHHHhh-hcCCCCeeecCCCC
Q 047292 492 KNL--VQLLGFCDEALNRLLVYEFMGN-G----TLANLIFAIPKPDWNLRVRISLEIARGLVYLH-EGCNVPIIHCDIKP 563 (728)
Q Consensus 492 ~ni--v~l~g~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH-~~~~~~iiH~dlk~ 563 (728)
+++ +.++.. ...+|||||+.+ | +|.++... .++..+..++.|++.+|.||| +. +|+||||||
T Consensus 130 ~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~---givHrDlkp 199 (258)
T 1zth_A 130 AGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEA---ELVHADLSE 199 (258)
T ss_dssp TTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTS---CEECSSCST
T ss_pred CCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCH
Confidence 754 444443 467899999943 4 67766543 234567889999999999999 76 999999999
Q ss_pred CCEEEcCCCceEEccccCcccc
Q 047292 564 QNILLDHYFSPKISDFGLSKLL 585 (728)
Q Consensus 564 ~NIll~~~~~~kl~Dfgla~~~ 585 (728)
+|||+++ .++|+|||+|...
T Consensus 200 ~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEESS--SEEECCCTTCEET
T ss_pred HHEEEcC--cEEEEECcccccC
Confidence 9999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.53 E-value=1.9e-15 Score=159.53 Aligned_cols=135 Identities=12% Similarity=0.070 Sum_probs=96.6
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch--------------hhHH--------HHHHHHHHhccccccc
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ--------------ERER--------EFKSEVSAIGRTHHKN 493 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~--------------~~~~--------~~~~E~~~l~~l~h~n 493 (728)
+.+...||+|+||.||+|... +|+.||||+++.... .... ....|...|.++.+.+
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~--~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE--KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT--TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEecCEeeeCCceEEEEEECC--CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 345567999999999999864 689999998743110 0011 1234566666665444
Q ss_pred ee--eEeeeeecCCcceeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCC
Q 047292 494 LV--QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHY 571 (728)
Q Consensus 494 iv--~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~ 571 (728)
+. ..++. ...+|||||+++++|.++... .....++.||+.+|.|||+. +||||||||.|||++++
T Consensus 175 v~vp~p~~~----~~~~LVME~i~G~~L~~l~~~------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 175 FPVPEPIAQ----SRHTIVMSLVDALPMRQVSSV------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREE 241 (397)
T ss_dssp CSCCCEEEE----ETTEEEEECCSCEEGGGCCCC------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEE
T ss_pred CCCCeeeec----cCceEEEEecCCccHhhhccc------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCC
Confidence 32 22222 234799999999888765421 23457889999999999997 99999999999999887
Q ss_pred C----------ceEEccccCcccc
Q 047292 572 F----------SPKISDFGLSKLL 585 (728)
Q Consensus 572 ~----------~~kl~Dfgla~~~ 585 (728)
+ .+.|+||+-+...
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCcccccccccceEEEEeCCcccC
Confidence 6 3899999987654
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.45 E-value=1.2e-13 Score=118.37 Aligned_cols=65 Identities=20% Similarity=0.454 Sum_probs=54.8
Q ss_pred CEEEEeCCCCCCCcCCCCcEEEEecCc-eEEeCCCCCeEeecCC--CCceeeEEEecCcCEEEEeccccccccccc
Q 047292 1 TIIWHANEDNHPVLAPRGSTLELTATG-LLLKDPGGQAIWDEKP--NKIVSDAAMLDTGNFVLIASGNHSDYAWQS 73 (728)
Q Consensus 1 t~vW~Anr~~~~~~~~~~~~l~~~~~g-l~l~~~~~~~vWst~~--~~~~~~a~lld~GNlVl~~~~~~~~~lWQS 73 (728)
++||+|||+.|. ..+++|.|+.|| |+|+|+++.+||+|++ ......|+|+|+|||||++ ..||||
T Consensus 38 ~~vW~ant~~~~---~~~~~L~l~~dGnLvL~d~~~~~vWss~t~~~~~~~~l~L~ddGNlVly~-----~~~W~S 105 (105)
T 4h3o_A 38 TSTWASNTEIGG---KSGCSAVLQSDGNFVVYDSSGRSLWASHSTRGSGNYILILQDDGNVIIYG-----SDIWST 105 (105)
T ss_dssp EEEEECCCCCTT---CCSCEEEECTTSCEEEECTTCCEEEECCCCCCSSCEEEEECTTSCEEEEE-----SEEEEC
T ss_pred EEEEEecCCCCC---CccEEEEEeCCccEEEECCCcEEEEEecCCCCCCCEEEEEeCCCeEEEEC-----CcEecC
Confidence 589999999864 456899999999 9999999999999984 2345679999999999964 259998
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.43 E-value=4.7e-13 Score=116.48 Aligned_cols=89 Identities=20% Similarity=0.328 Sum_probs=70.2
Q ss_pred CCcEEEEecCc-eEEeCCCCCeEeecCCC--CceeeEEEecCcCEEEEeccccccccccccccccccccccceeccccEE
Q 047292 17 RGSTLELTATG-LLLKDPGGQAIWDEKPN--KIVSDAAMLDTGNFVLIASGNHSDYAWQSFKSPTDTILPTQILDLGSVL 93 (728)
Q Consensus 17 ~~~~l~~~~~g-l~l~~~~~~~vWst~~~--~~~~~a~lld~GNlVl~~~~~~~~~lWQSFD~PtDtlLpg~~l~~~~~L 93 (728)
...+|.|..+| |+|++. +++||+++.. .....|+|+|+|||||++ .+.++||||+
T Consensus 19 ~~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d---~~~~~W~S~~------------------ 76 (112)
T 1xd5_A 19 GGYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS---GSRAIWASNT------------------ 76 (112)
T ss_dssp TTEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE---TTEEEEECCC------------------
T ss_pred CCEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc---CCEEEEECCc------------------
Confidence 45789999999 999987 7899999843 234679999999999975 4579999994
Q ss_pred EeeccCCCCCCccEEEEee-CCceEEeeccCCcccceeeeeeccCCCC
Q 047292 94 VSRLTETNLSKGRFELHFS-NGSLEFIPVAWPSRFQYKSYYTSNTSSA 140 (728)
Q Consensus 94 ~S~~s~~d~s~G~~~l~~~-~~~~~~~~~~~~~~~~~~~y~~~~~~~~ 140 (728)
++++|.|+++++ +|.++++- ... ..||+++++.+
T Consensus 77 -------~~~~g~~~l~l~~dGnlvl~~-~~~-----~~~W~S~~~~g 111 (112)
T 1xd5_A 77 -------NRQNGNYYLILQRDRNVVIYD-NSN-----NAIWATHTNVG 111 (112)
T ss_dssp -------CCSCCCCEEEECTTSCEEEEC-TTS-----CEEEECCCCCC
T ss_pred -------cCCCCCEEEEEeCCCcEEEEC-CCC-----ceEEECCCccC
Confidence 446789999999 77777653 112 57999998864
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=5.7e-13 Score=115.35 Aligned_cols=86 Identities=16% Similarity=0.353 Sum_probs=67.5
Q ss_pred CCCcEEEEecCc-eEEeCCCCCeEeecCCC--CceeeEEEecCcCEEEEeccccccccccccccccccccccceeccccE
Q 047292 16 PRGSTLELTATG-LLLKDPGGQAIWDEKPN--KIVSDAAMLDTGNFVLIASGNHSDYAWQSFKSPTDTILPTQILDLGSV 92 (728)
Q Consensus 16 ~~~~~l~~~~~g-l~l~~~~~~~vWst~~~--~~~~~a~lld~GNlVl~~~~~~~~~lWQSFD~PtDtlLpg~~l~~~~~ 92 (728)
....+|.|..|| |+|++ .+++||+++.. .....++|+|+|||||++ .++.++||||
T Consensus 19 ~~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~--~~~~~~W~S~------------------ 77 (110)
T 3a0c_A 19 GPSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYD--QSNRVIWQTK------------------ 77 (110)
T ss_dssp TTTEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEEC--TTCCEEEECC------------------
T ss_pred CCCEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEEC--CCCcEEEecC------------------
Confidence 345789999999 99998 57899999842 234679999999999965 3567999999
Q ss_pred EEeeccCCCCCCccEEEEee-CCceEEeeccCCcccceeeeeeccCC
Q 047292 93 LVSRLTETNLSKGRFELHFS-NGSLEFIPVAWPSRFQYKSYYTSNTS 138 (728)
Q Consensus 93 L~S~~s~~d~s~G~~~l~~~-~~~~~~~~~~~~~~~~~~~y~~~~~~ 138 (728)
.++++|.|+++++ +|+++++- . .||++++.
T Consensus 78 -------t~~~~g~~~l~l~~dGnlvl~~---~------~~W~S~~~ 108 (110)
T 3a0c_A 78 -------TNGKEDHYVLVLQQDRNVVIYG---P------VVWATGSG 108 (110)
T ss_dssp -------CCCSSSCCEEEECTTSCEEEEC---S------EEEECSCC
T ss_pred -------CCCCCCCEEEEEeCCccEEEEC---C------CEecCCCc
Confidence 3456799999999 77776642 1 58988765
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=8e-13 Score=114.40 Aligned_cols=69 Identities=23% Similarity=0.453 Sum_probs=56.9
Q ss_pred CEEEEeCCCCCCCcCCCCcEEEEecCc-eEEeCCCCCeEeecCCC--CceeeEEEecCcCEEEEeccccccccccccccc
Q 047292 1 TIIWHANEDNHPVLAPRGSTLELTATG-LLLKDPGGQAIWDEKPN--KIVSDAAMLDTGNFVLIASGNHSDYAWQSFKSP 77 (728)
Q Consensus 1 t~vW~Anr~~~~~~~~~~~~l~~~~~g-l~l~~~~~~~vWst~~~--~~~~~a~lld~GNlVl~~~~~~~~~lWQSFD~P 77 (728)
++||.||++.+ ..++.|+|.++| |||.|.++.++|+|+.. .+...++|+|+|||||++ . ++||||+||
T Consensus 39 ~~vW~sn~~~~----~~~~~l~l~~dGNLVl~~~~~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~--~---~~W~S~~~~ 109 (110)
T 3a0c_A 39 KPVWASNTGGL----GSGCRLTLHNNGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYG--P---VVWATGSGP 109 (110)
T ss_dssp EEEEECCCTTS----CSSCEEEECTTSCEEEECTTCCEEEECCCCCSSSCCEEEECTTSCEEEEC--S---EEEECSCCC
T ss_pred EEEEECCCCCC----CCcEEEEEeCCCCEEEECCCCcEEEecCCCCCCCCEEEEEeCCccEEEEC--C---CEecCCCcC
Confidence 58999999864 346789999999 99999999999999842 334579999999999954 2 799999998
Q ss_pred c
Q 047292 78 T 78 (728)
Q Consensus 78 t 78 (728)
.
T Consensus 110 ~ 110 (110)
T 3a0c_A 110 A 110 (110)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.37 E-value=1.4e-12 Score=114.46 Aligned_cols=84 Identities=19% Similarity=0.300 Sum_probs=66.1
Q ss_pred CcEEEEecCc-eEEeCCCCCeEeecCCC--CceeeEEEecCcCEEEEeccccccccccccccccccccccceeccccEEE
Q 047292 18 GSTLELTATG-LLLKDPGGQAIWDEKPN--KIVSDAAMLDTGNFVLIASGNHSDYAWQSFKSPTDTILPTQILDLGSVLV 94 (728)
Q Consensus 18 ~~~l~~~~~g-l~l~~~~~~~vWst~~~--~~~~~a~lld~GNlVl~~~~~~~~~lWQSFD~PtDtlLpg~~l~~~~~L~ 94 (728)
..+|.|..+| |+|++. +++||+++.. .....++|+|+|||||++ .++.++||||
T Consensus 31 ~~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d--~~~~~lW~S~-------------------- 87 (119)
T 1b2p_A 31 VYRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVIT--NENVTVWQSP-------------------- 87 (119)
T ss_dssp EEEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEEC--TTCCEEEECS--------------------
T ss_pred CEEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEe--CCCcEEEcCC--------------------
Confidence 3578888999 999987 8999999842 234679999999999965 4568999999
Q ss_pred eeccCCCCCCccEEEEee-CCceEEeeccCCcccceeeeeeccCC
Q 047292 95 SRLTETNLSKGRFELHFS-NGSLEFIPVAWPSRFQYKSYYTSNTS 138 (728)
Q Consensus 95 S~~s~~d~s~G~~~l~~~-~~~~~~~~~~~~~~~~~~~y~~~~~~ 138 (728)
.+|++|.|+++++ +|.++++- ..||++++.
T Consensus 88 -----~~~~~g~~~l~l~~~Gnlvl~~---------~~~W~Sg~~ 118 (119)
T 1b2p_A 88 -----VAGKAGHYVLVLQPDRNVVIYG---------DALWATQTV 118 (119)
T ss_dssp -----CCCCSSCEEEEECTTSCEEEEE---------SEEEECCCC
T ss_pred -----CCCCCCCEEEEEECCCcEEEEC---------ccEeCCCCC
Confidence 4567899999999 77766652 268988763
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=3e-12 Score=111.89 Aligned_cols=70 Identities=21% Similarity=0.415 Sum_probs=56.1
Q ss_pred CEEEEeCCCCCCCcCCCCcEEEEecCc-eEEeCCCCCeEeecCC--CCceeeEEEecCcCEEEEeccccccccccccccc
Q 047292 1 TIIWHANEDNHPVLAPRGSTLELTATG-LLLKDPGGQAIWDEKP--NKIVSDAAMLDTGNFVLIASGNHSDYAWQSFKSP 77 (728)
Q Consensus 1 t~vW~Anr~~~~~~~~~~~~l~~~~~g-l~l~~~~~~~vWst~~--~~~~~~a~lld~GNlVl~~~~~~~~~lWQSFD~P 77 (728)
++||.||++.| ..+++|.|.++| |+|.|.++.++|+++. +.+...++|+|+|||||++ . ++||||.++
T Consensus 39 ~~vW~sn~~~~----~~~~~l~l~~~GnLvl~d~~~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~--~---~~W~S~~~~ 109 (115)
T 2dpf_A 39 RQIWASNTDRR----GSGCRLTLLSDGNLVIYDHNNNDVWGSACWGDNGKYALVLQKDGRFVIYG--P---VLWSLGPNG 109 (115)
T ss_dssp EEEEECSCTTS----CSSCEEEECTTSCEEEECTTCCEEEECCCCCSSSCCEEEECTTSCEEEEC--S---EEECSSTTC
T ss_pred EEEEeCCCCCC----CCceEEEECCCCcEEEECCCceEEEEcCCCCCCCCEEEEEeCCCeEEEEC--C---CEEECCCCC
Confidence 47999999865 245789999999 9999988899999984 2344579999999999953 2 799999987
Q ss_pred cc
Q 047292 78 TD 79 (728)
Q Consensus 78 tD 79 (728)
+.
T Consensus 110 ~~ 111 (115)
T 2dpf_A 110 CR 111 (115)
T ss_dssp BC
T ss_pred Cc
Confidence 64
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=5.5e-12 Score=110.22 Aligned_cols=86 Identities=17% Similarity=0.368 Sum_probs=68.3
Q ss_pred CcEEEEecCc-eEEeCCCCCeEeecCCC--CceeeEEEecCcCEEEEeccccccccccccccccccccccceeccccEEE
Q 047292 18 GSTLELTATG-LLLKDPGGQAIWDEKPN--KIVSDAAMLDTGNFVLIASGNHSDYAWQSFKSPTDTILPTQILDLGSVLV 94 (728)
Q Consensus 18 ~~~l~~~~~g-l~l~~~~~~~vWst~~~--~~~~~a~lld~GNlVl~~~~~~~~~lWQSFD~PtDtlLpg~~l~~~~~L~ 94 (728)
..+|.|..+| |+|++ .+++||+++.. .....++|+++|||||++ .++.++|||||+
T Consensus 21 ~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d--~~~~~vW~S~~~------------------ 79 (115)
T 2dpf_A 21 AYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYD--HNNNDVWGSACW------------------ 79 (115)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEEC--TTCCEEEECCCC------------------
T ss_pred CEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEEC--CCceEEEEcCCC------------------
Confidence 4679999999 99988 57899999842 234679999999999965 356799999998
Q ss_pred eeccCCCCCCccEEEEee-CCceEEeeccCCcccceeeeeeccCCCC
Q 047292 95 SRLTETNLSKGRFELHFS-NGSLEFIPVAWPSRFQYKSYYTSNTSSA 140 (728)
Q Consensus 95 S~~s~~d~s~G~~~l~~~-~~~~~~~~~~~~~~~~~~~y~~~~~~~~ 140 (728)
+++|.|+++++ +|.++++ . ..||++++|..
T Consensus 80 -------~~~g~~~l~l~~dGnlvl~--~-------~~~W~S~~~~~ 110 (115)
T 2dpf_A 80 -------GDNGKYALVLQKDGRFVIY--G-------PVLWSLGPNGC 110 (115)
T ss_dssp -------CSSSCCEEEECTTSCEEEE--C-------SEEECSSTTCB
T ss_pred -------CCCCCEEEEEeCCCeEEEE--C-------CCEEECCCCCC
Confidence 34688999999 7877665 2 16899999854
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.23 E-value=1.2e-11 Score=107.53 Aligned_cols=70 Identities=19% Similarity=0.446 Sum_probs=57.1
Q ss_pred CEEEEeCCCCCCCcCCCCcEEEEecCc-eEEeCCCCCeEeecCC--CCceeeEEEecCcCEEEEeccccccccccccccc
Q 047292 1 TIIWHANEDNHPVLAPRGSTLELTATG-LLLKDPGGQAIWDEKP--NKIVSDAAMLDTGNFVLIASGNHSDYAWQSFKSP 77 (728)
Q Consensus 1 t~vW~Anr~~~~~~~~~~~~l~~~~~g-l~l~~~~~~~vWst~~--~~~~~~a~lld~GNlVl~~~~~~~~~lWQSFD~P 77 (728)
++||.||++.+ ..+++|+|.++| |||+| ++.++|+|.. ..+...++|+++|||||++ ..+.++||||++.
T Consensus 38 ~~vW~sn~~~~----~~~~~l~l~~~GNLvl~d-~~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~--~~~~~~W~S~~~~ 110 (112)
T 1xd5_A 38 RAVWASGTNGK----ASGCVLKMQNDGNLVIYS-GSRAIWASNTNRQNGNYYLILQRDRNVVIYD--NSNNAIWATHTNV 110 (112)
T ss_dssp EEEEECCCTTS----CSSEEEEECTTSCEEEEE-TTEEEEECCCCCSCCCCEEEECTTSCEEEEC--TTSCEEEECCCCC
T ss_pred EEEEeCCCcCC----CCCEEEEEeCCCCEEEEc-CCEEEEECCccCCCCCEEEEEeCCCcEEEEC--CCCceEEECCCcc
Confidence 48999999752 345789999999 99999 8889999984 2334579999999999964 3467999999985
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.16 E-value=6.9e-11 Score=102.05 Aligned_cols=65 Identities=20% Similarity=0.397 Sum_probs=52.8
Q ss_pred CEEEEeCCCCCCCcCCCCcEEEEecCc-eEEeCCCCCeEeecCCC-C-ceeeEEEecCcCEEEEecccccccccccc
Q 047292 1 TIIWHANEDNHPVLAPRGSTLELTATG-LLLKDPGGQAIWDEKPN-K-IVSDAAMLDTGNFVLIASGNHSDYAWQSF 74 (728)
Q Consensus 1 t~vW~Anr~~~~~~~~~~~~l~~~~~g-l~l~~~~~~~vWst~~~-~-~~~~a~lld~GNlVl~~~~~~~~~lWQSF 74 (728)
++||.+|++.+ ..++.|.|.++| |+|.|.++.++|++++. . ....|+|+|+|||||++ .++|||=
T Consensus 38 ~~vW~snt~~~----~~~~~l~l~~dGNLvl~~~~~~~~W~S~t~~~~~~~~~~L~ddGNlvly~-----~~~W~s~ 105 (109)
T 3dzw_A 38 KPIWATNTGGL----DRRCHLSMQSDGNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVIYG-----TARWATG 105 (109)
T ss_dssp EEEEECCCTTS----SSSCEEEECTTSCEEEECTTSCEEEECCCCCSSSCEEEEECTTSCEEEEE-----SCCCCCC
T ss_pred EEEEECCcccC----CCCEEEEEeCCCCEEEECCCCCEEEECCCCCCCCCEEEEEeCCCEEEEEC-----CCEEeCC
Confidence 47999999863 345789999999 99999989999999842 2 33579999999999964 2799984
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.16 E-value=6.9e-11 Score=103.53 Aligned_cols=64 Identities=19% Similarity=0.338 Sum_probs=53.7
Q ss_pred CEEEEeCCCCCCCcCCCCcEEEEecCc-eEEeCCCCCeEeecCC--CCceeeEEEecCcCEEEEeccccccccccc
Q 047292 1 TIIWHANEDNHPVLAPRGSTLELTATG-LLLKDPGGQAIWDEKP--NKIVSDAAMLDTGNFVLIASGNHSDYAWQS 73 (728)
Q Consensus 1 t~vW~Anr~~~~~~~~~~~~l~~~~~g-l~l~~~~~~~vWst~~--~~~~~~a~lld~GNlVl~~~~~~~~~lWQS 73 (728)
++||+||++.+ ..++.|+|.++| |||+|+++.++|+|+. ..+...++|+|+|||||++ .++|||
T Consensus 49 ~~vW~sn~~~~----~~~~~l~l~~dGNLVl~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~-----~~~W~S 115 (119)
T 1b2p_A 49 NPIWATNTGGL----GNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG-----DALWAT 115 (119)
T ss_dssp EEEEECCCTTS----CSSCEEEECTTSCEEEECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE-----SEEEEC
T ss_pred EEEEeCCCccC----CCceEEEEccCCEEEEEeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEEC-----ccEeCC
Confidence 58999999864 346799999999 9999999999999984 2345679999999999965 279998
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.11 E-value=1.2e-10 Score=118.30 Aligned_cols=139 Identities=16% Similarity=0.027 Sum_probs=108.1
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhcccc-ccceeeEeeeeecCCcceeEeeccCC
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTH-HKNLVQLLGFCDEALNRLLVYEFMGN 516 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~~ 516 (728)
+...++.|+.+.||+... .++.+++|............+.+|+++++.+. +..+.++++++...+..++|||+++|
T Consensus 18 ~~~~~~g~s~~~v~~~~~---~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 94 (263)
T 3tm0_A 18 CVKDTEGMSPAKVYKLVG---ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADG 94 (263)
T ss_dssp EEECCSCCSSSEEEEEEC---SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSS
T ss_pred eEeeccCCCCCeEEEEEC---CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCC
Confidence 345677788899999864 36789999986532223346888999999884 77888999999888889999999999
Q ss_pred CCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcC--------------------------------------------
Q 047292 517 GTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGC-------------------------------------------- 552 (728)
Q Consensus 517 gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~-------------------------------------------- 552 (728)
.+|.+.+. +......++.+++++|..||+..
T Consensus 95 ~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (263)
T 3tm0_A 95 VLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRE 169 (263)
T ss_dssp EEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHH
T ss_pred eehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHH
Confidence 99987632 12234578899999999999810
Q ss_pred ------------CCCeeecCCCCCCEEEcCCCceEEccccCccc
Q 047292 553 ------------NVPIIHCDIKPQNILLDHYFSPKISDFGLSKL 584 (728)
Q Consensus 553 ------------~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~ 584 (728)
...++|+|++|.||+++++..+.|+||+.+..
T Consensus 170 l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 170 LYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13589999999999998766678999997753
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.05 E-value=3.4e-10 Score=98.26 Aligned_cols=63 Identities=14% Similarity=0.255 Sum_probs=43.0
Q ss_pred EEEEeCCCCCCCcCCCCcEEEEecCc-eEEeCCCCCeEeecCCC--CceeeEEEecCcCEEEEeccccccccccc
Q 047292 2 IIWHANEDNHPVLAPRGSTLELTATG-LLLKDPGGQAIWDEKPN--KIVSDAAMLDTGNFVLIASGNHSDYAWQS 73 (728)
Q Consensus 2 ~vW~Anr~~~~~~~~~~~~l~~~~~g-l~l~~~~~~~vWst~~~--~~~~~a~lld~GNlVl~~~~~~~~~lWQS 73 (728)
+||.+|+..+ ..++.|.|.++| |+|.|.++.++|++++. .+...|+|+|+|||||++ ..+|+|
T Consensus 46 ~vWssnt~~~----~~~~~l~l~~dGNLVl~d~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~-----~~~W~s 111 (113)
T 3mez_B 46 IVWESGTSGR----GQHCFMRLGHSGELDITDDRLNTVFVSNTVGQEGDYVLILQINGQAVVYG-----PAVWST 111 (113)
T ss_dssp EEEECCCTTS----CSSCEEEECTTSCEEEECTTSCEEEECSCCCSSSCCEEEECTTSCEEEEC-----SEEEES
T ss_pred EEEECCcccC----CcCEEEEEeCCCcEEEECCCCCEEEECCCcCCCCCEEEEEcCCceEEEec-----CCEecC
Confidence 6788887643 234677777777 78877777778887742 223567788888888843 357776
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.98 E-value=7.1e-10 Score=95.66 Aligned_cols=63 Identities=21% Similarity=0.347 Sum_probs=48.3
Q ss_pred EEEEeCCCCCCCcCCCCcEEEEecCc-eEEeCCCCCeEeecCCC--CceeeEEEecCcCEEEEeccccccccccc
Q 047292 2 IIWHANEDNHPVLAPRGSTLELTATG-LLLKDPGGQAIWDEKPN--KIVSDAAMLDTGNFVLIASGNHSDYAWQS 73 (728)
Q Consensus 2 ~vW~Anr~~~~~~~~~~~~l~~~~~g-l~l~~~~~~~vWst~~~--~~~~~a~lld~GNlVl~~~~~~~~~lWQS 73 (728)
+||.+|++.. ..++.|.|.++| |+|.|.++.++|++++. .+...|+|+|+|||||++ ..+|+|
T Consensus 43 ~vW~snt~~~----~~~~~l~l~~dGNLvl~d~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~-----~~~W~t 108 (110)
T 3r0e_B 43 YGWQSNTHGN----GEHCFLRLNHKGELIIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYG-----PAIFET 108 (110)
T ss_dssp SCEECCCTTS----SSSCEEEECTTSCEEEECTTCCEEEECCCCCSSSCCEEEECTTSCEEEEC-----SEEEES
T ss_pred EEEECCCcCC----CcCEEEEEeCCCcEEEEeCCCCEEEEcCCcCCCCCEEEEEcCCccEEEec-----CCEecC
Confidence 5899998752 345788999999 99998888899998842 233578899999999954 368886
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.92 E-value=1.7e-09 Score=109.31 Aligned_cols=129 Identities=16% Similarity=0.039 Sum_probs=96.3
Q ss_pred CCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccc--eeeEeeeeecCCcceeEeeccCCCCHH
Q 047292 443 GRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKN--LVQLLGFCDEALNRLLVYEFMGNGTLA 520 (728)
Q Consensus 443 g~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~~~~~~~~lv~e~~~~gsL~ 520 (728)
+.|..+.||+... .+|+.+++|..... ....+..|+.+++.+.+.+ +.+++++....+..++||||++|.+|.
T Consensus 29 ~gg~~~~v~~~~~--~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~ 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSA--QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 103 (264)
T ss_dssp CTTSSCEEEEEEC--TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCCCceEEEEec--CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence 3556699999854 35678999997653 2245778999998885444 566888888888889999999998884
Q ss_pred HHHhcCCCCChHHHHHHHHHHHHHHHHhhhcC------------------------------------------------
Q 047292 521 NLIFAIPKPDWNLRVRISLEIARGLVYLHEGC------------------------------------------------ 552 (728)
Q Consensus 521 ~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~------------------------------------------------ 552 (728)
.. .. ....++.++++.|..||+..
T Consensus 104 --~~---~~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (264)
T 1nd4_A 104 --SS---HL---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK 175 (264)
T ss_dssp --TS---CC---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred --cC---cC---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHH
Confidence 21 11 12367788888888888641
Q ss_pred -------CCCeeecCCCCCCEEEcCCCceEEccccCccc
Q 047292 553 -------NVPIIHCDIKPQNILLDHYFSPKISDFGLSKL 584 (728)
Q Consensus 553 -------~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~ 584 (728)
...++|+|++|.||+++++..+.|+||+.+..
T Consensus 176 ~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 176 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998876678999998753
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.89 E-value=2.6e-09 Score=91.89 Aligned_cols=62 Identities=26% Similarity=0.486 Sum_probs=50.4
Q ss_pred EEEeCCCCCCCcCCCCcEEEEecCc-eEEeCCCCCeEeecCCC--CceeeEEEecCcCEEEEeccccccccccc
Q 047292 3 IWHANEDNHPVLAPRGSTLELTATG-LLLKDPGGQAIWDEKPN--KIVSDAAMLDTGNFVLIASGNHSDYAWQS 73 (728)
Q Consensus 3 vW~Anr~~~~~~~~~~~~l~~~~~g-l~l~~~~~~~vWst~~~--~~~~~a~lld~GNlVl~~~~~~~~~lWQS 73 (728)
+|.+|+..+ ..+++|+|.++| |+|.|.++.++|++++. .....|+|+|+|||||++ ..+|+|
T Consensus 39 ~Wssnt~~~----~~~~~l~l~~dGnLvl~d~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~-----~~~W~s 103 (109)
T 3r0e_A 39 NWQSNTANN----GRDCKLTLTDYGELVIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG-----PSVFKI 103 (109)
T ss_dssp TEECCCTTS----CSSCEEEECTTSCEEEECTTSCEEEECCCCCSSSCCEEEEETTTEEEEEC-----SEEEEE
T ss_pred eEEcCCCCC----CCcEEEEEcCCCeEEEEeCCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe-----cCEECC
Confidence 599998753 346799999999 99999989999999842 234579999999999954 469997
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.88 E-value=1.3e-08 Score=101.12 Aligned_cols=138 Identities=16% Similarity=0.275 Sum_probs=89.6
Q ss_pred CcEEEEecCc-eEEeCCCCCeEeecCC-CCceeeEEEecCcCEEEEeccccccccccccccccccccccceeccccEEEe
Q 047292 18 GSTLELTATG-LLLKDPGGQAIWDEKP-NKIVSDAAMLDTGNFVLIASGNHSDYAWQSFKSPTDTILPTQILDLGSVLVS 95 (728)
Q Consensus 18 ~~~l~~~~~g-l~l~~~~~~~vWst~~-~~~~~~a~lld~GNlVl~~~~~~~~~lWQSFD~PtDtlLpg~~l~~~~~L~S 95 (728)
..+|.|..+| +++.++ +++||++|. ......++|.++||||| .+.++.++|+|+++.
T Consensus 27 ~f~l~f~~~gnl~ly~~-~~~vW~an~~~~~~~~l~l~~dGnLvl--~d~~~~~vW~s~~~~------------------ 85 (236)
T 1dlp_A 27 SFRFTMQSDCNLVLFDS-DVRVWASNTAGATGCRAVLQSDGLLVI--LTAQNTIRWSSGTKG------------------ 85 (236)
T ss_dssp TEEEEECTTSCEEEEES-SSEEECCCCCSCSCCBCCBCSSSCBCC--BCTTTCCSCCCCCCC------------------
T ss_pred CEEEEECCCCcEEEEEC-CEEEEECCCCCCCCeEEEEcCCCcEEE--EcCCCcEEEeCCccc------------------
Confidence 4578887888 888886 789999984 33456789999999999 445678999999761
Q ss_pred eccCCCCCCccEEEEee-CCceEEeeccCCcccceeeeeeccCCCCC------------C------------------CC
Q 047292 96 RLTETNLSKGRFELHFS-NGSLEFIPVAWPSRFQYKSYYTSNTSSAN------------S------------------SE 144 (728)
Q Consensus 96 ~~s~~d~s~G~~~l~~~-~~~~~~~~~~~~~~~~~~~y~~~~~~~~~------------~------------------~~ 144 (728)
+.|.|.+.++ +|+++++- ..+|.+.....+ . ..
T Consensus 86 -------~~~~~~~~l~d~Gnlvl~~---------~~~W~S~~~p~~t~~lp~~g~d~L~~gq~~~~~~~~L~s~~d~s~ 149 (236)
T 1dlp_A 86 -------SIGNYVLVLQPDRTVTIYG---------PGLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHATQSLQL 149 (236)
T ss_dssp -------CSSCCEEEECSSSCEEEEC---------SEEEECSCCCSSCCCCSSCCCEECCCC--CCCCCCEECSSCCCBC
T ss_pred -------cCCcEEEEEeCCCCEEEec---------CCEEECCCCCCcccccCCccceEEecCCcCCCccceEEcCcEeec
Confidence 2466778887 88888751 145666544211 0 01
Q ss_pred CCceeeecccccEEEEecCceeEeccccccCCCCCceeEEEEEccCCcEEEEE
Q 047292 145 SGHQLVFNESADIYIVKNNGQIVQLPLWAQLSPRADHYFRATLDFDGVFAEYA 197 (728)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rl~L~~dG~l~~y~ 197 (728)
..+.+.++.++.+++...+. .+|.....+.....+++|+.+|+|++|.
T Consensus 150 G~~~l~l~~dG~LvL~~~~~-----~~W~s~~~~~~~~~~~~L~~~Gnl~ly~ 197 (236)
T 1dlp_A 150 SPYRLSMETDCNLVLFDRDD-----RVWSTNTAGKGTGCRAVLQPNGRMDVLT 197 (236)
T ss_dssp SSCEEEEETTTEEEEEBTTB-----CCSCCCCCSSCSSCEEEEETTTEEEEEE
T ss_pred CcEEEEECCCCcEEEEcCCE-----eEEeCCCcCCCCceEEEECCCCcEEEEe
Confidence 23345666666666654331 1333222222223578899999999886
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.88 E-value=4.9e-09 Score=111.60 Aligned_cols=141 Identities=17% Similarity=0.240 Sum_probs=105.6
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEec--ccc-hhhHHHHHHHHHHhcccc--ccceeeEeeeeecC---CcceeEe
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLD--RLA-QEREREFKSEVSAIGRTH--HKNLVQLLGFCDEA---LNRLLVY 511 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~---~~~~lv~ 511 (728)
+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+.+++.+. +..+++++.++.+. +..++||
T Consensus 44 ~~l~~G~sn~~y~v~~~---~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTP---GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EECCC-CCSCEEEEECS---SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred EEcCCcccceEEEEEEC---CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 46899999999997653 4678888876 322 122457888999999886 55688999998776 4479999
Q ss_pred eccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcC---------------------------------------
Q 047292 512 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGC--------------------------------------- 552 (728)
Q Consensus 512 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~--------------------------------------- 552 (728)
||++|..+.+.. ...++...+..++.++++.|+.||+..
T Consensus 121 e~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (359)
T 3dxp_A 121 EFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD 198 (359)
T ss_dssp ECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred EecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence 999998875422 234677888899999999999999721
Q ss_pred ----------------CCCeeecCCCCCCEEEcCCCc--eEEccccCcccc
Q 047292 553 ----------------NVPIIHCDIKPQNILLDHYFS--PKISDFGLSKLL 585 (728)
Q Consensus 553 ----------------~~~iiH~dlk~~NIll~~~~~--~kl~Dfgla~~~ 585 (728)
...++|+|+++.||+++.++. +.|+||+.+..-
T Consensus 199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 246999999999999997653 689999988753
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.86 E-value=6.8e-09 Score=89.29 Aligned_cols=94 Identities=21% Similarity=0.336 Sum_probs=71.6
Q ss_pred cccccccceeccccEEEeeccCCCCCCccEEEEee-CCceEEeeccCCcccceeeeeeccCCCCCCCCCCceeeeccccc
Q 047292 78 TDTILPTQILDLGSVLVSRLTETNLSKGRFELHFS-NGSLEFIPVAWPSRFQYKSYYTSNTSSANSSESGHQLVFNESAD 156 (728)
Q Consensus 78 tDtlLpg~~l~~~~~L~S~~s~~d~s~G~~~l~~~-~~~~~~~~~~~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~ 156 (728)
+|||+|||.|..|..| +.|.|.|.++ +|+++++- .||.+++... ..+..+.++.+|.
T Consensus 3 ~dtL~~gq~L~~g~~L---------~~g~~~L~~q~dGNLvl~~----------~~Wssnt~~~---~~~~~l~l~~dGn 60 (109)
T 3r0e_A 3 TNYLLSGQTLDTEGHL---------KNGDFDLVMQDDCNLVLYN----------GNWQSNTANN---GRDCKLTLTDYGE 60 (109)
T ss_dssp CSEEETTCEECTTCEE---------EETTEEEEECTTSCEEEET----------TTEECCCTTS---CSSCEEEECTTSC
T ss_pred cCCcCCCCCcCCCCEe---------ECCCEEEEEecCCeEEEEe----------CeEEcCCCCC---CCcEEEEEcCCCe
Confidence 6999999999999999 3599999999 99998862 3688766532 3356788999999
Q ss_pred EEEEecCceeEeccccccCCCCCceeEEEEEccCCcEEEEE
Q 047292 157 IYIVKNNGQIVQLPLWAQLSPRADHYFRATLDFDGVFAEYA 197 (728)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~rl~L~~dG~l~~y~ 197 (728)
+++++.++..+.. .........++++|+.||||++|.
T Consensus 61 Lvl~d~~~~~vWs----s~t~~~~~~~~~~L~~dGNlvly~ 97 (109)
T 3r0e_A 61 LVIKNGDGSTVWK----SGAQSVKGNYAAVVHPDGRLVVFG 97 (109)
T ss_dssp EEEECTTSCEEEE----CCCCCSSSCCEEEEETTTEEEEEC
T ss_pred EEEEeCCCCEEEc----CCCcCCCcCEEEEEcCCCeEEEEe
Confidence 9998776654432 222223345689999999999996
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=98.86 E-value=8.6e-09 Score=88.96 Aligned_cols=85 Identities=11% Similarity=0.298 Sum_probs=63.6
Q ss_pred CCcEEEEecCc-eEEeCCCCCeEeecCCC-C-ceeeEEEecCcCEEEEecccccc-ccccccccccccccccceeccccE
Q 047292 17 RGSTLELTATG-LLLKDPGGQAIWDEKPN-K-IVSDAAMLDTGNFVLIASGNHSD-YAWQSFKSPTDTILPTQILDLGSV 92 (728)
Q Consensus 17 ~~~~l~~~~~g-l~l~~~~~~~vWst~~~-~-~~~~a~lld~GNlVl~~~~~~~~-~lWQSFD~PtDtlLpg~~l~~~~~ 92 (728)
...+|.+..|| |+|++.++ +|+++.. . ....++|+++|||||++. ++. ++|||..+
T Consensus 20 g~~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~--~~~~~vW~S~t~---------------- 79 (111)
T 3mez_A 20 ESAAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSA--NSNTPVWVYPRS---------------- 79 (111)
T ss_dssp TTEEEEECTTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECS--SCSSCSEEESSS----------------
T ss_pred CCEEEEEccCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeC--CCCEEEEEeccc----------------
Confidence 34689999999 99999876 9999852 2 236899999999999643 343 59999831
Q ss_pred EEeeccCCCCCCccEEEEee-CCceEEeeccCCcccceeeeeeccC
Q 047292 93 LVSRLTETNLSKGRFELHFS-NGSLEFIPVAWPSRFQYKSYYTSNT 137 (728)
Q Consensus 93 L~S~~s~~d~s~G~~~l~~~-~~~~~~~~~~~~~~~~~~~y~~~~~ 137 (728)
.....|.|.+.++ +|++++|- ..+|.+++
T Consensus 80 -------~~~~~~~~~l~Lq~dGNlvly~---------~~~W~s~t 109 (111)
T 3mez_A 80 -------VNTVRGNYAATLGPDQHVTIYG---------PAIWSTPA 109 (111)
T ss_dssp -------CCCCSSCCEEEECTTSCEEEEC---------SEEEECCC
T ss_pred -------cCCCCcCEEEEECCCCeEEEec---------cCEEccCC
Confidence 1113578999999 99999883 35787764
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.77 E-value=3.4e-08 Score=85.03 Aligned_cols=96 Identities=18% Similarity=0.162 Sum_probs=71.5
Q ss_pred cccccccceeccccEEEeeccCCCCCCccEEEEee-CCceEEeeccCCcccceeeeeeccCCCCCCCCCCceeeeccccc
Q 047292 78 TDTILPTQILDLGSVLVSRLTETNLSKGRFELHFS-NGSLEFIPVAWPSRFQYKSYYTSNTSSANSSESGHQLVFNESAD 156 (728)
Q Consensus 78 tDtlLpg~~l~~~~~L~S~~s~~d~s~G~~~l~~~-~~~~~~~~~~~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~ 156 (728)
+|||+|||.|..|+.|+| |.|.|.++ +|+++++-. ..||.+.+.. ...+..+.+..+|+
T Consensus 6 ~dtL~~gq~L~~g~~L~s---------g~~~L~~q~dGnLvl~~~--------~~vW~snt~~---~~~~~~l~l~~dGN 65 (110)
T 3r0e_B 6 NNLLFSGQVLYGDGRLTA---------KNHQLVMQGDCNLVLYGG--------KYGWQSNTHG---NGEHCFLRLNHKGE 65 (110)
T ss_dssp TTEEETTCEEETTEEEEC---------SSCEEEECTTSCEEEECS--------SSCEECCCTT---SSSSCEEEECTTSC
T ss_pred cCEECCCCEecCCCEEEe---------CCEEEEEcCCCeEEEECC--------eEEEECCCcC---CCcCEEEEEeCCCc
Confidence 799999999999999975 78999999 899888621 3678876653 22345788899999
Q ss_pred EEEEecCceeEeccccccCCCCCceeEEEEEccCCcEEEEE
Q 047292 157 IYIVKNNGQIVQLPLWAQLSPRADHYFRATLDFDGVFAEYA 197 (728)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~rl~L~~dG~l~~y~ 197 (728)
+++++.++..+.. ........-++++|+.||||++|.
T Consensus 66 Lvl~d~~~~~iW~----S~t~~~~~~~~~~L~~dGNlvly~ 102 (110)
T 3r0e_B 66 LIIKDDDFKTIWS----SRSSSKQGEYVLILQDDGFGVIYG 102 (110)
T ss_dssp EEEECTTCCEEEE----CCCCCSSSCCEEEECTTSCEEEEC
T ss_pred EEEEeCCCCEEEE----cCCcCCCCCEEEEEcCCccEEEec
Confidence 9998876654433 222222223689999999999996
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=98.74 E-value=7.8e-08 Score=83.25 Aligned_cols=99 Identities=13% Similarity=0.181 Sum_probs=73.7
Q ss_pred cccccccceeccccEEEeeccCCCCCCccEEEEee-CCceEEeeccCCcccceeeeeeccCCCCCCCCCCceeeeccccc
Q 047292 78 TDTILPTQILDLGSVLVSRLTETNLSKGRFELHFS-NGSLEFIPVAWPSRFQYKSYYTSNTSSANSSESGHQLVFNESAD 156 (728)
Q Consensus 78 tDtlLpg~~l~~~~~L~S~~s~~d~s~G~~~l~~~-~~~~~~~~~~~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~ 156 (728)
.|||+|||.|..|..|+ .|.|.|.|+ +|+++++-... ...||.+++... ..+..+.+..+|.
T Consensus 6 ~~tL~~gq~L~~g~~L~---------~g~~~L~~q~dGNLvL~~~~~-----~~~vWssnt~~~---~~~~~l~l~~dGN 68 (113)
T 3mez_B 6 RNVLFSSQVMYDNAQLA---------TRDYSLVMRDDCNLVLTKGSK-----TNIVWESGTSGR---GQHCFMRLGHSGE 68 (113)
T ss_dssp SSEEETTCEEETTCEEE---------ETTEEEEECTTSCEEEEETTT-----TEEEEECCCTTS---CSSCEEEECTTSC
T ss_pred CCEeCCCCEECCCCEeE---------cCCEEEEEcCCCEEEEEECCC-----CEEEEECCcccC---CcCEEEEEeCCCc
Confidence 69999999999999995 389999999 99999874321 167898876532 2456788999999
Q ss_pred EEEEecCceeEeccccccCCCCCceeEEEEEccCCcEEEEE
Q 047292 157 IYIVKNNGQIVQLPLWAQLSPRADHYFRATLDFDGVFAEYA 197 (728)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~rl~L~~dG~l~~y~ 197 (728)
+++++.++..+ |..........++++|+.||+|++|.
T Consensus 69 LVl~d~~~~~i----W~S~t~~~~~~~~~~L~~dGnlvly~ 105 (113)
T 3mez_B 69 LDITDDRLNTV----FVSNTVGQEGDYVLILQINGQAVVYG 105 (113)
T ss_dssp EEEECTTSCEE----EECSCCCSSSCCEEEECTTSCEEEEC
T ss_pred EEEECCCCCEE----EECCCcCCCCCEEEEEcCCceEEEec
Confidence 99988766543 22222222223689999999999995
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.73 E-value=9e-09 Score=106.80 Aligned_cols=186 Identities=17% Similarity=0.100 Sum_probs=122.5
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccc-cccc--eeeEeeeeecCC---cceeEeec
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKN--LVQLLGFCDEAL---NRLLVYEF 513 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~n--iv~l~g~~~~~~---~~~lv~e~ 513 (728)
+.++.|....||+.. ..+++|+.... .....+.+|.++++.+ .+.. +.+++....... ..|+|||+
T Consensus 26 ~~~~~G~~n~v~~v~------~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN------RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CEEEECSSEEEEEST------TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred EecCCCCcceEEEEC------CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 347889999999852 46889986542 3456788999999887 3332 445555544333 34889999
Q ss_pred cCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhc------------------------------------------
Q 047292 514 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEG------------------------------------------ 551 (728)
Q Consensus 514 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~------------------------------------------ 551 (728)
++|.+|.+... ..++..++..++.++++.|+.||+.
T Consensus 98 i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 98 IKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp CCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred cCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 99988865433 3456677778888888888888851
Q ss_pred -------------CCCCeeecCCCCCCEEEcC--CCceEEccccCccccccCCCcccccccCCccc---cCccccc----
Q 047292 552 -------------CNVPIIHCDIKPQNILLDH--YFSPKISDFGLSKLLLSDHSRTHTMIRGTRGY---VAPEWLK---- 609 (728)
Q Consensus 552 -------------~~~~iiH~dlk~~NIll~~--~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y---~aPE~~~---- 609 (728)
....++|+|++|.||++++ ...+.|+||+.+........-. ..... ..|+...
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~-----~~~~~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFI-----SLMEDDEEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHH-----TTCCTTTSCCHHHHHHHHH
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHH-----HHHhhccccCHHHHHHHHH
Confidence 1135899999999999998 5568999999886542110000 00000 1222111
Q ss_pred C-CCC---------CCccchhhHHHHHHHHHhCCcCcchhh
Q 047292 610 N-APV---------SAKVDVYSFGVMLLEIICCRRSVEMEL 640 (728)
Q Consensus 610 ~-~~~---------s~~~DVwSlGvil~elltg~~p~~~~~ 640 (728)
. ... ....+.|+++.+++++.+|..++....
T Consensus 251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~~~g 291 (304)
T 3sg8_A 251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWYEEG 291 (304)
T ss_dssp HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHHHHH
T ss_pred HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHHHHH
Confidence 0 001 112689999999999999998775443
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=98.68 E-value=1.7e-07 Score=80.54 Aligned_cols=96 Identities=16% Similarity=0.268 Sum_probs=72.5
Q ss_pred ccccccceeccccEEEeeccCCCCCCccEEEEee-CCceEEeeccCCcccceeeeeeccCCCCCCCCCCceeeecccccE
Q 047292 79 DTILPTQILDLGSVLVSRLTETNLSKGRFELHFS-NGSLEFIPVAWPSRFQYKSYYTSNTSSANSSESGHQLVFNESADI 157 (728)
Q Consensus 79 DtlLpg~~l~~~~~L~S~~s~~d~s~G~~~l~~~-~~~~~~~~~~~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (728)
+||+|||.|..|+.|+ .|.|.|.|+ +|+++++-. . ..+|.+++... ..+..+.+..+|.+
T Consensus 2 ntL~~gq~L~~g~~L~---------~g~~~L~~q~dGnLvly~~--~-----~~vW~snt~~~---~~~~~l~l~~dGNL 62 (109)
T 3dzw_A 2 NILYSGETLSPGEFLN---------NGRYVFIMQEDCNLVLYDV--D-----KPIWATNTGGL---DRRCHLSMQSDGNL 62 (109)
T ss_dssp CEEETTEEECTTCEEE---------ETTEEEEECTTSCEEEEET--T-----EEEEECCCTTS---SSSCEEEECTTSCE
T ss_pred CCcCCCCEeCCCCEEE---------CCCEEEEEcCCCcEEEEeC--C-----EEEEECCcccC---CCCEEEEEeCCCCE
Confidence 6999999999999994 599999999 999888642 2 67898876532 23467888999999
Q ss_pred EEEecCceeEeccccccCCCCCceeEEEEEccCCcEEEEE
Q 047292 158 YIVKNNGQIVQLPLWAQLSPRADHYFRATLDFDGVFAEYA 197 (728)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~rl~L~~dG~l~~y~ 197 (728)
++.+.++..+. ..........++++|+.||||++|.
T Consensus 63 vl~~~~~~~~W----~S~t~~~~~~~~~~L~ddGNlvly~ 98 (109)
T 3dzw_A 63 VVYSPRNNPIW----ASNTGGENGNYVCVLQKDRNVVIYG 98 (109)
T ss_dssp EEECTTSCEEE----ECCCCCSSSCEEEEECTTSCEEEEE
T ss_pred EEECCCCCEEE----ECCCCCCCCCEEEEEeCCCEEEEEC
Confidence 98876665433 2222223345799999999999996
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.68 E-value=1.9e-07 Score=79.56 Aligned_cols=97 Identities=19% Similarity=0.240 Sum_probs=74.0
Q ss_pred ccccccceeccccEEEeeccCCCCCCccEEEEee-CCceEEeeccCCcccceeeeeeccCCCCCCCCCCceeeecccccE
Q 047292 79 DTILPTQILDLGSVLVSRLTETNLSKGRFELHFS-NGSLEFIPVAWPSRFQYKSYYTSNTSSANSSESGHQLVFNESADI 157 (728)
Q Consensus 79 DtlLpg~~l~~~~~L~S~~s~~d~s~G~~~l~~~-~~~~~~~~~~~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (728)
|+|+|||.|..|+.|+| |.|+|.|+ +|++++|- .. ...|.+++.... ..+..+.++.+|.+
T Consensus 2 n~L~~g~~L~~g~~L~s---------g~y~l~~q~DgNLvly~--~~-----~~vW~ant~~~~--~~~~~L~l~~dGnL 63 (105)
T 4h3o_A 2 NILDNNEGLYAGQSLDV---------EPYHFIMQDDCNLVLYD--HS-----TSTWASNTEIGG--KSGCSAVLQSDGNF 63 (105)
T ss_dssp CEECTTEEECTTCEEEE---------TTEEEEECTTSCEEEEE--TT-----EEEEECCCCCTT--CCSCEEEECTTSCE
T ss_pred CCcCCCCEEcCCCEEEE---------CCEEEEECCCCeEEEEE--CC-----EEEEEecCCCCC--CccEEEEEeCCccE
Confidence 89999999999999976 89999999 99999874 22 567888765432 23457888999999
Q ss_pred EEEecCceeEeccccccCCCCCceeEEEEEccCCcEEEEE
Q 047292 158 YIVKNNGQIVQLPLWAQLSPRADHYFRATLDFDGVFAEYA 197 (728)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~rl~L~~dG~l~~y~ 197 (728)
.+++.++..+.. ........-.+++|..||||++|.
T Consensus 64 vL~d~~~~~vWs----s~t~~~~~~~~l~L~ddGNlVly~ 99 (105)
T 4h3o_A 64 VVYDSSGRSLWA----SHSTRGSGNYILILQDDGNVIIYG 99 (105)
T ss_dssp EEECTTCCEEEE----CCCCCCSSCEEEEECTTSCEEEEE
T ss_pred EEECCCcEEEEE----ecCCCCCCCEEEEEeCCCeEEEEC
Confidence 998887766533 222233344689999999999984
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=98.63 E-value=1e-07 Score=82.17 Aligned_cols=97 Identities=19% Similarity=0.249 Sum_probs=71.0
Q ss_pred cccccccceeccccEEEeeccCCCCCCccEEEEee-CCceEEeeccCCcccceeeeeeccCCCCCCCCCCceeeeccccc
Q 047292 78 TDTILPTQILDLGSVLVSRLTETNLSKGRFELHFS-NGSLEFIPVAWPSRFQYKSYYTSNTSSANSSESGHQLVFNESAD 156 (728)
Q Consensus 78 tDtlLpg~~l~~~~~L~S~~s~~d~s~G~~~l~~~-~~~~~~~~~~~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~ 156 (728)
+|||+|||.|..|..| +.|.|.|.|+ +|+++++-. . . +|.+.+... ..+..+.+..+|.
T Consensus 2 ~~~l~~gq~L~~g~~L---------~~g~~~L~~q~dGnLvl~~~--~-----~-vW~snt~~~---~~~~~l~l~~dGN 61 (111)
T 3mez_A 2 NNVLLTGDVIHTDNQL---------SYESAAFVMQGDCNLVLYNE--A-----G-GFQSNTHGR---GVDCTLRLNNRGQ 61 (111)
T ss_dssp TTEEETTCEECTTCEE---------EETTEEEEECTTSCEEEECS--S-----C-CEECCCTTS---CSSCEEEECTTSC
T ss_pred cCEeCCCCEeCCCCEE---------ecCCEEEEEccCCeEEEECC--C-----C-EEECCcccC---CcCEEEEEcCCCc
Confidence 6999999999999999 2599999999 999988632 1 3 888766422 3356788899999
Q ss_pred EEEEecCceeEeccccccC--CCCCceeEEEEEccCCcEEEEE
Q 047292 157 IYIVKNNGQIVQLPLWAQL--SPRADHYFRATLDFDGVFAEYA 197 (728)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~rl~L~~dG~l~~y~ 197 (728)
+.+++.++.. ++|... .......++++|+.||||++|.
T Consensus 62 LVl~~~~~~~---~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~ 101 (111)
T 3mez_A 62 LEIHSANSNT---PVWVYPRSVNTVRGNYAATLGPDQHVTIYG 101 (111)
T ss_dssp EEEECSSCSS---CSEEESSSCCCCSSCCEEEECTTSCEEEEC
T ss_pred EEEEeCCCCE---EEEEeccccCCCCcCEEEEECCCCeEEEec
Confidence 9988776532 122212 1123345789999999999996
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=98.57 E-value=9.5e-08 Score=96.58 Aligned_cols=67 Identities=13% Similarity=0.391 Sum_probs=55.4
Q ss_pred CEEEEeCCCCCCCcCCCCcEEEEecCc-eEEeCCCCCeEeecCC-CCceeeEEEecCcCEEEEecccccccccccccc
Q 047292 1 TIIWHANEDNHPVLAPRGSTLELTATG-LLLKDPGGQAIWDEKP-NKIVSDAAMLDTGNFVLIASGNHSDYAWQSFKS 76 (728)
Q Consensus 1 t~vW~Anr~~~~~~~~~~~~l~~~~~g-l~l~~~~~~~vWst~~-~~~~~~a~lld~GNlVl~~~~~~~~~lWQSFD~ 76 (728)
+++|.+++..+ .. ..|.+..+| |++.|.++.++|+++. ......|+|+++|||||++. .++||||||
T Consensus 184 ~~yW~Sgt~~~----~~-~~l~l~~dGnLvl~d~~~~~vWsS~t~~~~~~rl~Ld~dGnLvly~~----~~~Wqsf~~ 252 (276)
T 3m7h_A 184 AATWNAGTQGK----GA-VRAVFQGDGNLVVYGAGNAVLWHSHTGGHASAVLRLQANGSIAILDE----KPVWARFGF 252 (276)
T ss_dssp SEEEECCCTTT----TC-CEEEECTTSCEEEECTTSCEEEECSCTTCTTCEEEECTTSCEEEEEE----EEEEESSSC
T ss_pred eEEEECCCCCC----cc-EEEEEcCCCeEEEEeCCCcEEEEecCCCCCCEEEEEcCCccEEEEcC----CCeEEccCc
Confidence 47899998764 22 689999999 9999998899999984 33457899999999999653 579999998
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.20 E-value=6.8e-06 Score=83.26 Aligned_cols=135 Identities=16% Similarity=0.083 Sum_probs=95.5
Q ss_pred hCCCcee-EEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhcccc-ccceeeEeeeeecCCcceeEeeccCCCCH
Q 047292 442 LGRGSFG-IVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTH-HKNLVQLLGFCDEALNRLLVYEFMGNGTL 519 (728)
Q Consensus 442 lg~G~fg-~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~~gsL 519 (728)
+..|..| .||+.... .++..+++|+-... ....+..|...|+.+. +--+.++++++.+.+..++|||++++.++
T Consensus 32 ~~~G~S~~~v~rl~~~-~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGK-PNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EECSSSSCEEEEEECC-TTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred ccCCCcCCeEEEEEec-CCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 4445554 68886544 34567889986532 3456788999888773 44577899999988899999999999888
Q ss_pred HHHHhcCCCCChHHHHHHHHHHHHHHHHhhhc------------------------------------------------
Q 047292 520 ANLIFAIPKPDWNLRVRISLEIARGLVYLHEG------------------------------------------------ 551 (728)
Q Consensus 520 ~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~------------------------------------------------ 551 (728)
.+..... ......+..++++.|..||..
T Consensus 108 ~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 183 (272)
T 4gkh_A 108 FQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEM 183 (272)
T ss_dssp HHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHH
T ss_pred cccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHH
Confidence 7665321 122334555666666666631
Q ss_pred -------CCCCeeecCCCCCCEEEcCCCceEEccccCccc
Q 047292 552 -------CNVPIIHCDIKPQNILLDHYFSPKISDFGLSKL 584 (728)
Q Consensus 552 -------~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~ 584 (728)
....++|+|+.+.||++++++.+-|+||+.+..
T Consensus 184 ~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 184 HKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 012379999999999999887778999998753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.11 E-value=1.6e-05 Score=82.12 Aligned_cols=134 Identities=18% Similarity=0.157 Sum_probs=93.3
Q ss_pred hhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhcccccc---ceeeEeeeee-cCCcceeEeeccCC
Q 047292 441 ELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHK---NLVQLLGFCD-EALNRLLVYEFMGN 516 (728)
Q Consensus 441 ~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~g~~~-~~~~~~lv~e~~~~ 516 (728)
.++.|....||+. +..+++|+... ......+..|.++|+.+.+. .+.+++.+.. ..+..++|||+++|
T Consensus 26 ~l~~G~~n~v~~v------g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 26 SLGEGFRNYAILV------NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEECSSEEEEEE------TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred ecCCCcceeEEEE------CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 4678888899986 35688888543 23456789999999998642 3567777764 45567899999999
Q ss_pred CCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhc---------------------------------------------
Q 047292 517 GTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEG--------------------------------------------- 551 (728)
Q Consensus 517 gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~--------------------------------------------- 551 (728)
.+|.+... ..++......++.++++.|+.||+.
T Consensus 98 ~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 175 (306)
T 3tdw_A 98 QILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR 175 (306)
T ss_dssp EECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred eECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence 88876322 1234445555555555555555542
Q ss_pred ------------CCCCeeecCCCCCCEEEcC---CCc-eEEccccCccc
Q 047292 552 ------------CNVPIIHCDIKPQNILLDH---YFS-PKISDFGLSKL 584 (728)
Q Consensus 552 ------------~~~~iiH~dlk~~NIll~~---~~~-~kl~Dfgla~~ 584 (728)
....++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1235799999999999997 455 48999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.92 E-value=1.7e-05 Score=83.94 Aligned_cols=81 Identities=2% Similarity=-0.060 Sum_probs=54.9
Q ss_pred hhh-CCCceeEEEEeeee--CC---CCcEEEEEEecccc---hhhHHHHHHHHHHhcccc-c--cceeeEeeeeecC---
Q 047292 440 EEL-GRGSFGIVYKGVLK--TA---SGNAIAVKKLDRLA---QEREREFKSEVSAIGRTH-H--KNLVQLLGFCDEA--- 504 (728)
Q Consensus 440 ~~l-g~G~fg~Vy~g~~~--~~---~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~g~~~~~--- 504 (728)
+.| +.|....+|+.... .. +++.+++|+..... ......+..|+.+++.+. + ..+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 346 78889999987643 00 15678888865432 001245778888888874 3 3577888887665
Q ss_pred CcceeEeeccCCCCHH
Q 047292 505 LNRLLVYEFMGNGTLA 520 (728)
Q Consensus 505 ~~~~lv~e~~~~gsL~ 520 (728)
+..++|||+++|.++.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3568999999987654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.71 E-value=8e-05 Score=79.96 Aligned_cols=75 Identities=17% Similarity=0.123 Sum_probs=48.2
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccch-------hhHHHHHHHHHHhcccc---ccceeeEeeeeecCCccee
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ-------EREREFKSEVSAIGRTH---HKNLVQLLGFCDEALNRLL 509 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~l 509 (728)
+.||.|..+.||++... .+++.++||....... .....+..|.++++.+. ...+.+++.+. ....++
T Consensus 36 ~~lg~G~~n~vyrv~~~-~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l 112 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQ-EHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 112 (397)
T ss_dssp EECCSSSSEEEEEEEC-----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EECCCCceEEEEEEEEC-CCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence 46899999999998654 2467899998643211 11235677888888763 23445666543 345689
Q ss_pred EeeccCCC
Q 047292 510 VYEFMGNG 517 (728)
Q Consensus 510 v~e~~~~g 517 (728)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00057 Score=70.33 Aligned_cols=134 Identities=16% Similarity=0.134 Sum_probs=89.1
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhcccc---ccceeeEeeeeecCCcceeEeeccCC
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTH---HKNLVQLLGFCDEALNRLLVYEFMGN 516 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lv~e~~~~ 516 (728)
+.|+.|....+|+... ++..+++|+.... ....+..|.+.|+.+. ...+++++.++...+..++|||++++
T Consensus 42 ~~l~gG~~n~~y~v~~---~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND---EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEECCSSSSEEEEEES---SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred EEeCCccceeeeEEEE---CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 4588999999999764 4678889987542 3567888999988874 35688899988888889999999998
Q ss_pred CCHH--------H---HHhcCCC----------------------CChHHHH---HHH----------------HHHHHH
Q 047292 517 GTLA--------N---LIFAIPK----------------------PDWNLRV---RIS----------------LEIARG 544 (728)
Q Consensus 517 gsL~--------~---~l~~~~~----------------------~~~~~~~---~i~----------------~qi~~~ 544 (728)
..+. + .|+.... -+|.... ++. ..+++.
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 7642 1 1221110 1233211 111 111111
Q ss_pred -HHHhhh-cCCCCeeecCCCCCCEEEcCCCceEEcccc
Q 047292 545 -LVYLHE-GCNVPIIHCDIKPQNILLDHYFSPKISDFG 580 (728)
Q Consensus 545 -l~yLH~-~~~~~iiH~dlk~~NIll~~~~~~kl~Dfg 580 (728)
...|.. .....++|+|+.+.|++++.++ +.|.|+.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 223421 2245799999999999999887 8899984
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00061 Score=71.16 Aligned_cols=136 Identities=16% Similarity=0.141 Sum_probs=77.0
Q ss_pred hhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccc--cceeeEeee------eecCCcceeEee
Q 047292 441 ELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHH--KNLVQLLGF------CDEALNRLLVYE 512 (728)
Q Consensus 441 ~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~------~~~~~~~~lv~e 512 (728)
.|+.|..+.||+.... + ..+++|+.... ...+..|..+++.+.. -.+++++.. ....+..+++++
T Consensus 39 ~l~gG~~n~~~~v~~~--~-~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 39 VIQGNQMALVWKVHTD--S-GAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp ECC----CEEEEEEET--T-EEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eccccccCcEEEEEeC--C-CCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 3566778899997653 3 35889998652 1233445555555531 123444431 123556789999
Q ss_pred ccCCCCHH--------------HHHhc----C--C--------CCChHHH------------------------------
Q 047292 513 FMGNGTLA--------------NLIFA----I--P--------KPDWNLR------------------------------ 534 (728)
Q Consensus 513 ~~~~gsL~--------------~~l~~----~--~--------~~~~~~~------------------------------ 534 (728)
|++|.++. ..++. . + ...|...
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986542 11111 1 1 0122110
Q ss_pred -HHHHHHHHHHHHHhhh----------cCCCCeeecCCCCCCEEEcCCCceEEccccCcc
Q 047292 535 -VRISLEIARGLVYLHE----------GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSK 583 (728)
Q Consensus 535 -~~i~~qi~~~l~yLH~----------~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~ 583 (728)
..+..++.+++.+|++ .....++|+|+++.||+++.++.+.|+||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 0111223445666653 124589999999999999888899999999775
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.31 E-value=0.00084 Score=72.51 Aligned_cols=80 Identities=10% Similarity=-0.017 Sum_probs=49.1
Q ss_pred CCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccccccCCccccCcccccCCC---CCCccchhhHHHHHHHH
Q 047292 553 NVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAP---VSAKVDVYSFGVMLLEI 629 (728)
Q Consensus 553 ~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~~DVwSlGvil~el 629 (728)
...++|+|+++.||+++.++ ++|+||+.+..-.....-......-...|.+|+...... -....++......+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 35799999999999999876 999999988754211110000000123466666554211 12235566788888887
Q ss_pred HhCC
Q 047292 630 ICCR 633 (728)
Q Consensus 630 ltg~ 633 (728)
++++
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7653
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.04 E-value=0.0012 Score=67.21 Aligned_cols=73 Identities=22% Similarity=0.284 Sum_probs=52.0
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhcccc-c--cceeeEeeeeecCCcceeEeeccCC
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTH-H--KNLVQLLGFCDEALNRLLVYEFMGN 516 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h--~niv~l~g~~~~~~~~~lv~e~~~~ 516 (728)
+.+|.|..+.||+..+. +|+.|++|+...........|..|.+.|+.+. . --++++++.. ..++||||+++
T Consensus 21 ~~~g~G~~~~vyrv~l~--DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~ 94 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELA--DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDE 94 (288)
T ss_dssp EEEEEETTEEEEEEEET--TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCC
T ss_pred EecCCCCCeEEEEEEEC--CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecc
Confidence 45899999999998764 78899999875543333456788988888774 2 2345555542 45789999887
Q ss_pred CC
Q 047292 517 GT 518 (728)
Q Consensus 517 gs 518 (728)
+.
T Consensus 95 ~~ 96 (288)
T 3f7w_A 95 RP 96 (288)
T ss_dssp CC
T ss_pred cC
Confidence 64
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.62 E-value=0.0033 Score=67.86 Aligned_cols=74 Identities=14% Similarity=0.174 Sum_probs=48.7
Q ss_pred hhhCCCceeEEEEeeeeCC------CCcEEEEEEecccchhhHHHHHHHHHHhccccccce-eeEeeeeecCCcceeEee
Q 047292 440 EELGRGSFGIVYKGVLKTA------SGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNL-VQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~e 512 (728)
+.|+.|....+|+...... .++.+++|+..... ....+..|..+++.+...++ +++++.+.. .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 4577888899999876421 24688999874321 11345578888888853333 667776643 28999
Q ss_pred ccCCCCH
Q 047292 513 FMGNGTL 519 (728)
Q Consensus 513 ~~~~gsL 519 (728)
|++|.+|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9986443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.59 E-value=0.0048 Score=65.22 Aligned_cols=139 Identities=17% Similarity=0.190 Sum_probs=81.2
Q ss_pred hhCCCceeEEEEeeeeC------CCCcEEEEEEecccchhhHHHHHHHHHHhcccc-ccceeeEeeeeecCCcceeEeec
Q 047292 441 ELGRGSFGIVYKGVLKT------ASGNAIAVKKLDRLAQEREREFKSEVSAIGRTH-HKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 441 ~lg~G~fg~Vy~g~~~~------~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
.|..|-...+|+..... .+++.+++|+.... ......+.+|.++++.+. +.-..++++++... +|+||
T Consensus 57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e~ 131 (379)
T 3feg_A 57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQY 131 (379)
T ss_dssp EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEEC
T ss_pred EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEEE
Confidence 45667778889876531 13468899986332 223455678999988874 33346777776542 89999
Q ss_pred cCCCCHHHH-----------------HhcC-----CCCC--hHHHHHHHHHHHH-------------------HHHHhhh
Q 047292 514 MGNGTLANL-----------------IFAI-----PKPD--WNLRVRISLEIAR-------------------GLVYLHE 550 (728)
Q Consensus 514 ~~~gsL~~~-----------------l~~~-----~~~~--~~~~~~i~~qi~~-------------------~l~yLH~ 550 (728)
++|.+|..- |+.. .... +.++.++..++.. .+..|.+
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 998654311 1111 1112 3444444443321 2233321
Q ss_pred -----cCCCCeeecCCCCCCEEEcCC----CceEEccccCccc
Q 047292 551 -----GCNVPIIHCDIKPQNILLDHY----FSPKISDFGLSKL 584 (728)
Q Consensus 551 -----~~~~~iiH~dlk~~NIll~~~----~~~kl~Dfgla~~ 584 (728)
.....++|+|+.+.||+++.+ +.+.|+||..+..
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 123468999999999999876 7899999998753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.42 E-value=0.0049 Score=63.09 Aligned_cols=134 Identities=16% Similarity=0.161 Sum_probs=72.6
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccce-eeEeeeeecCCcceeEeecc-CCC
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNL-VQLLGFCDEALNRLLVYEFM-GNG 517 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~e~~-~~g 517 (728)
+.|+.|....+|+. +.+++|+....... ......|..+++.+...++ .+++++. ...-++++||+ ++.
T Consensus 24 ~~l~gG~tN~~~~~-------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ 93 (301)
T ss_dssp EEEESCSSEEEEEE-------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred eEcCCcccccccee-------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence 56788888999987 45888887543111 1123457777776643222 4566554 33457899999 654
Q ss_pred CHHHH------------------HhcCC-CC----C-hHHHHHHHH--------------HHHHHHH----Hhhh-cCCC
Q 047292 518 TLANL------------------IFAIP-KP----D-WNLRVRISL--------------EIARGLV----YLHE-GCNV 554 (728)
Q Consensus 518 sL~~~------------------l~~~~-~~----~-~~~~~~i~~--------------qi~~~l~----yLH~-~~~~ 554 (728)
+|... ++..+ .. . +..+..+.. .+.+.+. .+.. ....
T Consensus 94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~ 173 (301)
T 3dxq_A 94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL 173 (301)
T ss_dssp ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence 44210 11111 01 1 111111100 0111111 1111 1234
Q ss_pred CeeecCCCCCCEEEcCCCceEEccccCccc
Q 047292 555 PIIHCDIKPQNILLDHYFSPKISDFGLSKL 584 (728)
Q Consensus 555 ~iiH~dlk~~NIll~~~~~~kl~Dfgla~~ 584 (728)
.++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 5899999999999 5667789999987764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.38 E-value=0.01 Score=61.52 Aligned_cols=32 Identities=28% Similarity=0.268 Sum_probs=27.6
Q ss_pred CCeeecCCCCCCEEEcCC----CceEEccccCcccc
Q 047292 554 VPIIHCDIKPQNILLDHY----FSPKISDFGLSKLL 585 (728)
Q Consensus 554 ~~iiH~dlk~~NIll~~~----~~~kl~Dfgla~~~ 585 (728)
..++|+|+.+.||+++.+ ..+.|+||+.+..-
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 479999999999999874 67999999988653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.31 E-value=0.0048 Score=63.74 Aligned_cols=138 Identities=12% Similarity=0.100 Sum_probs=75.8
Q ss_pred hhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccc--eeeEeeee------ecCCcceeEee
Q 047292 441 ELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKN--LVQLLGFC------DEALNRLLVYE 512 (728)
Q Consensus 441 ~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~------~~~~~~~lv~e 512 (728)
.|+.|....+|+.... ++ .+++|..... .....+..|+.+++.+...+ +.+++... ...+..+++++
T Consensus 29 ~i~~G~~n~~~~v~~~--~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~ 103 (322)
T 2ppq_A 29 GIAEGVENSNFLLHTT--KD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS 103 (322)
T ss_dssp EECC---EEEEEEEES--SC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred ccCCCcccceEEEEeC--Cc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence 4677888899987653 33 6888987652 11234556777777664222 33343221 12345689999
Q ss_pred ccCCCCHHH--------------HHhc----C--CC---C---ChHHHHH------------HHHHHHHHHHHhhhc---
Q 047292 513 FMGNGTLAN--------------LIFA----I--PK---P---DWNLRVR------------ISLEIARGLVYLHEG--- 551 (728)
Q Consensus 513 ~~~~gsL~~--------------~l~~----~--~~---~---~~~~~~~------------i~~qi~~~l~yLH~~--- 551 (728)
+++|..+.. .++. . +. . .|..... +...+.+.++.+++.
T Consensus 104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~ 183 (322)
T 2ppq_A 104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 183 (322)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence 998865311 0111 0 10 0 1211100 011234445555432
Q ss_pred -CCCCeeecCCCCCCEEEcCCCceEEccccCcc
Q 047292 552 -CNVPIIHCDIKPQNILLDHYFSPKISDFGLSK 583 (728)
Q Consensus 552 -~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~ 583 (728)
....++|+|+.+.||+++++..+.|+||+.+.
T Consensus 184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 13469999999999999987666899998775
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.18 E-value=0.017 Score=54.97 Aligned_cols=102 Identities=10% Similarity=0.002 Sum_probs=66.7
Q ss_pred CCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccccc
Q 047292 517 GTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM 595 (728)
Q Consensus 517 gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 595 (728)
-+|.+.|... .++++.+++.++.|.+++|.-+-.... . ..+=+.|..|+|..+|.+.+.+ ..+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc------------
Confidence 3788998865 689999999999999999877622111 1 1233456899999999998764 1111
Q ss_pred ccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcC
Q 047292 596 IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRS 635 (728)
Q Consensus 596 ~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p 635 (728)
.....+.|||... ...+.+.=|||||+++|..+--..|
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0122466888764 3456788999999999998864444
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.03 E-value=0.022 Score=58.79 Aligned_cols=137 Identities=14% Similarity=0.079 Sum_probs=76.1
Q ss_pred hCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccc--eeeEeee-----eecCCcceeEeecc
Q 047292 442 LGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKN--LVQLLGF-----CDEALNRLLVYEFM 514 (728)
Q Consensus 442 lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~-----~~~~~~~~lv~e~~ 514 (728)
|+ |....||+... .+|+.+++|...... .....+..|..+++.+.... +++++.. ....+..+++++++
T Consensus 34 l~-g~~n~~y~v~~--~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 34 LN-SYENRVYQFQD--EDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EC-CSSSEEEEECC--TTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred ec-CcccceEEEEc--CCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 55 77788998654 346679999986321 12345667777777764222 3444443 11234457899999
Q ss_pred CCCCHH-----H------H---Hh----cC-----CCCChHHH----HHH---------------HHHHHHHHHHhhhc-
Q 047292 515 GNGTLA-----N------L---IF----AI-----PKPDWNLR----VRI---------------SLEIARGLVYLHEG- 551 (728)
Q Consensus 515 ~~gsL~-----~------~---l~----~~-----~~~~~~~~----~~i---------------~~qi~~~l~yLH~~- 551 (728)
+|.++. . . ++ .. +..++... ..+ ...+.+.++.+.+.
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 875431 0 0 11 00 11121110 001 11111222333221
Q ss_pred ---CCCCeeecCCCCCCEEEcCCCceEEccccCccc
Q 047292 552 ---CNVPIIHCDIKPQNILLDHYFSPKISDFGLSKL 584 (728)
Q Consensus 552 ---~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~ 584 (728)
....++|+|+++.||+++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234689999999999999 4 899999987753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.76 E-value=0.017 Score=62.69 Aligned_cols=74 Identities=16% Similarity=0.085 Sum_probs=45.0
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccce-eeEeeeeecCCcceeEeeccCCCC
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNL-VQLLGFCDEALNRLLVYEFMGNGT 518 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~e~~~~gs 518 (728)
+.|+.|-...+|+..... .+..+++|+....... .-....|..+++.+...++ .++++.+.. .+|+||++|.+
T Consensus 114 ~~lsgG~tN~~y~v~~~~-~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~ 187 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMS-KQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYA 187 (458)
T ss_dssp EEECC--CEEEEEEEETT-TTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEE
T ss_pred EEcCCCeEeEEEEEEECC-CCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCcc
Confidence 457888889999987531 2467888886432111 1112578888888754334 567777632 25999998754
Q ss_pred H
Q 047292 519 L 519 (728)
Q Consensus 519 L 519 (728)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.63 E-value=0.027 Score=59.26 Aligned_cols=75 Identities=16% Similarity=0.103 Sum_probs=42.9
Q ss_pred hhhCCCceeEEEEeeeeCC-------CCcEEEEEEecccchhhHHHHHHHHHHhccccccc-eeeEeeeeecCCcceeEe
Q 047292 440 EELGRGSFGIVYKGVLKTA-------SGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKN-LVQLLGFCDEALNRLLVY 511 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~-------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lv~ 511 (728)
+.|+.|....+|+...... .++.+++|+....... ......|.++++.+...+ ..++++.. .-++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec----CCcEEE
Confidence 3467788889998765320 1257888887543221 112356778887775333 44666554 237899
Q ss_pred eccCCCCH
Q 047292 512 EFMGNGTL 519 (728)
Q Consensus 512 e~~~~gsL 519 (728)
||++|.++
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=94.53 E-value=0.18 Score=52.24 Aligned_cols=31 Identities=29% Similarity=0.315 Sum_probs=27.6
Q ss_pred CCeeecCCCCCCEEEcCCCceEEccccCccc
Q 047292 554 VPIIHCDIKPQNILLDHYFSPKISDFGLSKL 584 (728)
Q Consensus 554 ~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~ 584 (728)
..++|+|+.+.||++++++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4799999999999999888899999987754
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=92.74 E-value=0.099 Score=55.89 Aligned_cols=75 Identities=11% Similarity=0.061 Sum_probs=45.4
Q ss_pred hhhCCCceeEEEEeeeeCCC------CcEEEEEEecccchhhHHHHHHHHHHhcccc-ccceeeEeeeeecCCcceeEee
Q 047292 440 EELGRGSFGIVYKGVLKTAS------GNAIAVKKLDRLAQEREREFKSEVSAIGRTH-HKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e 512 (728)
+.|..|-...+|+......+ ++.+++|+..... ...-...+|..+++.+. +.-..++++.+. -++|+|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence 34667777889987764211 4788888864322 11112356777777774 222455665442 378999
Q ss_pred ccCCCCH
Q 047292 513 FMGNGTL 519 (728)
Q Consensus 513 ~~~~gsL 519 (728)
|++|.+|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9998653
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=89.18 E-value=0.63 Score=31.52 Aligned_cols=6 Identities=0% Similarity=0.041 Sum_probs=2.3
Q ss_pred hhHHHH
Q 047292 379 LGAFLL 384 (728)
Q Consensus 379 ~~~~~~ 384 (728)
+++.++
T Consensus 14 Ia~~vV 19 (44)
T 2jwa_A 14 IISAVV 19 (44)
T ss_dssp HHHHHH
T ss_pred hHHHHH
Confidence 333333
|
| >1edm_B Factor IX; epidermal growth factor, EGF, calcium- binding, EGF-like domain, structure and function, coagulation factor; 1.50A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ixa_A | Back alignment and structure |
|---|
Probab=85.67 E-value=0.22 Score=33.06 Aligned_cols=25 Identities=24% Similarity=0.414 Sum_probs=20.8
Q ss_pred CccCCCcccccCCCCCcccCCCCCc
Q 047292 229 GICGFNSYCSLQNGRPFCDCPPGYV 253 (728)
Q Consensus 229 ~~CG~~g~C~~~~~~~~C~C~~Gf~ 253 (728)
..|...|.|.....+..|.|++||+
T Consensus 9 ~pC~ngg~C~~~~~~~~C~C~~G~~ 33 (39)
T 1edm_B 9 NPCLNGGSCKDDINSYECWCPFGFE 33 (39)
T ss_dssp CCCCTTCEEEEETTEEEEECCTTCC
T ss_pred CCCCCCCEeEcCCCceEeECCCCCc
Confidence 5688889998656678999999996
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=84.82 E-value=1.9 Score=40.85 Aligned_cols=117 Identities=15% Similarity=0.143 Sum_probs=78.4
Q ss_pred cccceeeEeeeeecCCcceeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEc
Q 047292 490 HHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLD 569 (728)
Q Consensus 490 ~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~ 569 (728)
.||+++.. .+-...+...+.|+.-+.+ ..+-. ....+...+++++.+|+....+++. -+|--|.|+||+++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~--~~f~~-ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~f~ 113 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNH--TPFDN-IKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELFFT 113 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTS--EEGGG-GGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEEEC
T ss_pred cCCcccce-EEEEcccEEEEEEEcCccc--CCHHH-HHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEEEc
Confidence 47877755 4555556666656554322 22211 2456788899999999998877764 37889999999999
Q ss_pred CCCceEEccccCccccccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcch
Q 047292 570 HYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEM 638 (728)
Q Consensus 570 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~ 638 (728)
.++.+++.-.|+-..+ +|. ..+...=.-.+=+++..+++++..|+.
T Consensus 114 ~~~~p~i~~RGik~~l------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 114 RDGLPIAKTRGLQNVV------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp TTSCEEESCCEETTTB------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred CCCCEEEEEccCccCC------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 9999999877764322 221 112222344566788889999888764
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=83.23 E-value=4 Score=40.41 Aligned_cols=62 Identities=10% Similarity=0.111 Sum_probs=38.7
Q ss_pred EEEEeCCCCCCCc---CCCCcEEEEecC-c-eEEeCCC-CCeEeecCC----C---CceeeEEEecCcCEEEEec
Q 047292 2 IIWHANEDNHPVL---APRGSTLELTAT-G-LLLKDPG-GQAIWDEKP----N---KIVSDAAMLDTGNFVLIAS 63 (728)
Q Consensus 2 ~vW~Anr~~~~~~---~~~~~~l~~~~~-g-l~l~~~~-~~~vWst~~----~---~~~~~a~lld~GNlVl~~~ 63 (728)
++|...+..+|.. .+.+-.+..+.+ + ++.+|.+ |.++|.... + .-...+.++.+||+++.+.
T Consensus 157 ~~w~~~~~~~~~~~~~~~~g~~~v~~~~~~~v~~~d~~tG~~~w~~~~~~~~~~~l~~~~~~~~~~~G~i~v~~~ 231 (276)
T 3no2_A 157 LLNSVKLSGTPFSSAFLDNGDCLVACGDAHCFVQLNLESNRIVRRVNANDIEGVQLFFVAQLFPLQNGGLYICNW 231 (276)
T ss_dssp EEEEEECSSCCCEEEECTTSCEEEECBTTSEEEEECTTTCCEEEEEEGGGSBSCCCSEEEEEEECTTSCEEEEEE
T ss_pred EEEEEECCCCccceeEcCCCCEEEEeCCCCeEEEEeCcCCcEEEEecCCCCCCccccccccceEcCCCCEEEEec
Confidence 6787776433311 223334444443 4 7778887 999999752 1 1246688899999999763
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 728 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-69 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-66 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-64 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-64 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-62 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-62 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-61 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-61 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-60 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-59 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-59 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-59 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-59 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-59 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-59 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-58 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-58 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-58 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-57 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-57 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-56 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-56 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-56 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-56 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-55 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-54 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-54 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-53 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-51 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-50 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-49 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-47 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-47 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-45 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-44 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-44 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 8e-44 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-43 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-43 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-43 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-43 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-42 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-42 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-41 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-41 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 9e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-38 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-38 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-35 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-20 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 2e-05 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 4e-04 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (575), Expect = 5e-69
Identities = 65/279 (23%), Positives = 122/279 (43%), Gaps = 23/279 (8%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
+ +G GSFG VYKG A+ + + ++ + FK+EV + +T H N++
Sbjct: 12 VGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRVRISLEIARGLVYLHEGCNVPI 556
+G+ +V ++ +L + + I + + I+ + A+G+ YLH I
Sbjct: 70 MGYSTAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SI 125
Query: 557 IHCDIKPQNILLDHYFSPKISDFGLSKLLLS-DHSRTHTMIRGTRGYVAPEWLK---NAP 612
IH D+K NI L + KI DFGL+ + S + G+ ++APE ++ P
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 613 VSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAM 672
S + DVY+FG++L E++ + +R + Y+ L + + AM
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLPYS---NINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 242
Query: 673 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711
+ C+++ +RP ++ +E L
Sbjct: 243 KR---------LMAECLKKKRDERPLFPQILASIELLAR 272
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 218 bits (556), Expect = 5e-66
Identities = 76/310 (24%), Positives = 138/310 (44%), Gaps = 42/310 (13%)
Query: 426 FSYDELKDATDGFKEE-----------LGRGSFGIVYKGVLKTASGN--AIAVKKLDR-L 471
F++++ +A F +E +G G FG V G LK +A+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 472 AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-D 530
+++ R+F SE S +G+ H N++ L G ++ +++ EFM NG+L + +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 531 WNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS 590
V + IA G+ YL + +H D+ +NIL++ K+SDFGLS+ L D S
Sbjct: 127 VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 591 RTHTM----IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMELEEES 644
+ + APE ++ ++ DV+S+G+++ E++ +M ++
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVI 243
Query: 645 RAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704
AI D+ RL +D A + + C Q+D + RP ++
Sbjct: 244 NAIEQDY--------RLPPPMDCPSALHQ----------LMLDCWQKDRNHRPKFGQIVN 285
Query: 705 MLEGLLEVPN 714
L+ ++ PN
Sbjct: 286 TLDKMIRNPN 295
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 4e-64
Identities = 69/275 (25%), Positives = 117/275 (42%), Gaps = 23/275 (8%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
F +E+G G FG+V+ G + +A+K + A E +F E + + H LVQL
Sbjct: 9 FVQEIGSGQFGLVHLGYWLN--KDKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQL 65
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEGCNVPI 556
G C E LV+EFM +G L++ + + + L++ G+ YL E C +
Sbjct: 66 YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 122
Query: 557 IHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAK 616
IH D+ +N L+ K+SDFG+++ +L D + T + + +PE + S+K
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 182
Query: 617 VDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRS 676
DV+SFGV++ E+ + + I + R
Sbjct: 183 SDVWSFGVLMWEVFSEGKIPYENRSNS----------------EVVEDISTGFRLYKPRL 226
Query: 677 RLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711
I C +E P RP +++ L + E
Sbjct: 227 ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (539), Expect = 6e-64
Identities = 64/272 (23%), Positives = 115/272 (42%), Gaps = 25/272 (9%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
E LG G FG V+ G +AVK L + + + F +E + + + H+ LV+L
Sbjct: 17 LVERLGAGQFGEVWMGYYNG--HTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRL 73
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKP--DWNLRVRISLEIARGLVYLHEGCNVP 555
+ ++ E+M NG+L + + N + ++ +IA G+ ++ E
Sbjct: 74 YAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--- 129
Query: 556 IIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSA 615
IH D++ NIL+ S KI+DFGL++L+ + + + APE + +
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 616 KVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADR 675
K DV+SFG++L EI+ R Y + ++ +
Sbjct: 190 KSDVWSFGILLTEIVTHGR----------------IPYPGMTNPEVIQNLERGYRMVRPD 233
Query: 676 SRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLE 707
+ + + C +E P RPT + +LE
Sbjct: 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 1e-62
Identities = 64/271 (23%), Positives = 110/271 (40%), Gaps = 23/271 (8%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
F +ELG G FG+V G + +A+K + E EF E + H+ LVQL
Sbjct: 8 FLKELGTGQFGVVKYGKWRG--QYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRVRISLEIARGLVYLHEGCNVPI 556
G C + ++ E+M NG L N + + + + ++ + YL +
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQF 121
Query: 557 IHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAK 616
+H D+ +N L++ K+SDFGLS+ +L D + + + PE L + S+K
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 181
Query: 617 VDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRS 676
D+++FGV++ EI + Y+ + I
Sbjct: 182 SDIWAFGVLMWEIYSLGK----------------MPYERFTNSETAEHIAQGLRLYRPHL 225
Query: 677 RLHKWLMIAMWCIQEDPSKRPTMKVVMQMLE 707
K I C E +RPT K+++ +
Sbjct: 226 ASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 7e-62
Identities = 59/296 (19%), Positives = 116/296 (39%), Gaps = 27/296 (9%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
+E +G+G FG V++G + G +AVK +ER ++E+ H+N++
Sbjct: 7 LQESIGKGRFGEVWRGKWR---GEEVAVKIFSS-REERSWFREAEIYQTVMLRHENILGF 62
Query: 498 LGFCDE----ALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGC- 552
+ ++ LV ++ +G+L + + ++++L A GL +LH
Sbjct: 63 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 553 ----NVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH---TMIRGTRGYVAP 605
I H D+K +NIL+ + I+D GL+ S GT+ Y+AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 606 EWL------KNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAI---LTDWAYDCY 656
E L K+ + D+Y+ G++ EI + + + +D + +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 657 VEGRLDALIDSD-EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711
+ + + + L I C + + R T + + L L +
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 1e-61
Identities = 70/304 (23%), Positives = 125/304 (41%), Gaps = 37/304 (12%)
Query: 430 ELKDATDGFK--EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQERERE-FKSEVSAI 486
ELKD D F+ ELG G+ G+V+K K SG +A K + + R E+ +
Sbjct: 2 ELKD--DDFEKISELGAGNGGVVFKVSHKP-SGLVMARKLIHLEIKPAIRNQIIRELQVL 58
Query: 487 GRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLV 546
+ +V G + E M G+L ++ + + ++S+ + +GL
Sbjct: 59 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLT 118
Query: 547 YLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPE 606
YL E I+H D+KP NIL++ K+ DFG+S L+ + + GTR Y++PE
Sbjct: 119 YLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPE 173
Query: 607 WLKNAPVSAKVDVYSFGVMLLEIICCRR--------SVEMELEEESRAILTDWAYDCYVE 658
L+ S + D++S G+ L+E+ R +E+ + +
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233
Query: 659 GRLDALIDSDEAAMADRSRLHKWLMIAMW------------------CIQEDPSKRPTMK 700
GR + D L +++ C+ ++P++R +K
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293
Query: 701 VVMQ 704
+M
Sbjct: 294 QLMV 297
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 7e-61
Identities = 70/275 (25%), Positives = 117/275 (42%), Gaps = 31/275 (11%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
+ +G+G FG V G + GN +AVK + + F +E S + + H NLVQL
Sbjct: 11 LLQTIGKGEFGDVMLGDYR---GNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQL 65
Query: 498 LGFCDEALNRL-LVYEFMGNGTLANLIFAIPKP--DWNLRVRISLEIARGLVYLHEGCNV 554
LG E L +V E+M G+L + + + + + ++ SL++ + YL
Sbjct: 66 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---N 122
Query: 555 PIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVS 614
+H D+ +N+L+ K+SDFGL+K S T + + APE L+ S
Sbjct: 123 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALREKKFS 178
Query: 615 AKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMAD 674
K DV+SFG++L EI R + + +G D A+ +
Sbjct: 179 TKSDVWSFGILLWEIYSFGRVPYPRIPLK-------DVVPRVEKGYKMDAPDGCPPAVYE 231
Query: 675 RSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGL 709
+ C D + RP+ + + LE +
Sbjct: 232 ---------VMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 1e-60
Identities = 63/282 (22%), Positives = 110/282 (39%), Gaps = 25/282 (8%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
+ +LG+G FG V+ G +A+K L E F E + + H+ LVQL
Sbjct: 21 LEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL 77
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKP--DWNLRVRISLEIARGLVYLHEGCNVP 555
E +V E+M G+L + + V ++ +IA G+ Y+
Sbjct: 78 YAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--- 133
Query: 556 IIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSA 615
+H D++ NIL+ K++DFGL++L+ + + + APE +
Sbjct: 134 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 193
Query: 616 KVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADR 675
K DV+SFG++L E+ R + D G ++ D
Sbjct: 194 KSDVWSFGILLTELTTKGRVPYPGMVNR-------EVLDQVERGYRMPCPPECPESLHD- 245
Query: 676 SRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNPPW 717
+ C +++P +RPT + + LE P +
Sbjct: 246 --------LMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 279
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 1e-59
Identities = 65/272 (23%), Positives = 109/272 (40%), Gaps = 25/272 (9%)
Query: 441 ELGRGSFGIVYKGVLK-TASGNAIAVKKLDRLAQERE--REFKSEVSAIGRTHHKNLVQL 497
ELG G+FG V KG + +AVK L A + E +E + + + + +V++
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPII 557
+G C+ + +LV E G L + + + +++ G+ YL +
Sbjct: 74 IGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE---ESNFV 129
Query: 558 HCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS--RTHTMIRGTRGYVAPEWLKNAPVSA 615
H D+ +N+LL KISDFGLSK L +D + + T + + APE + S+
Sbjct: 130 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 189
Query: 616 KVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADR 675
K DV+SFGV++ E + Y + A+++ E
Sbjct: 190 KSDVWSFGVLMWEAFSYGQ----------------KPYRGMKGSEVTAMLEKGERMGCPA 233
Query: 676 SRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLE 707
+ + C D RP V L
Sbjct: 234 GCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 200 bits (510), Expect = 2e-59
Identities = 76/276 (27%), Positives = 119/276 (43%), Gaps = 23/276 (8%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
K +LG G +G VY+GV K +AVK L E E EF E + + H NLVQL
Sbjct: 21 MKHKLGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQL 78
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKP--DWNLRVRISLEIARGLVYLHEGCNVP 555
LG C ++ EFM G L + + + + + ++ +I+ + YL +
Sbjct: 79 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---N 135
Query: 556 IIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSA 615
IH D+ +N L+ K++DFGLS+L+ D H + + APE L S
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 195
Query: 616 KVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADR 675
K DV++FGV+L EI S ++ ++ L++ D
Sbjct: 196 KSDVWAFGVLLWEIATYGMSPYPGIDLS----------------QVYELLEKDYRMERPE 239
Query: 676 SRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711
K + C Q +PS RP+ + Q E + +
Sbjct: 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 3e-59
Identities = 60/272 (22%), Positives = 111/272 (40%), Gaps = 25/272 (9%)
Query: 441 ELGRGSFGIVYKGVLK-TASGNAIAVKKLDRLAQERERE-FKSEVSAIGRTHHKNLVQLL 498
ELG G+FG V +GV + +A+K L + ++ + E E + + + +V+L+
Sbjct: 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 75
Query: 499 GFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRVRISLEIARGLVYLHEGCNVPII 557
G C +A +LV E G G L + + + + +++ G+ YL +
Sbjct: 76 GVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFV 131
Query: 558 HCDIKPQNILLDHYFSPKISDFGLSKLLLSD--HSRTHTMIRGTRGYVAPEWLKNAPVSA 615
H D+ +N+LL + KISDFGLSK L +D + + + + APE + S+
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 191
Query: 616 KVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADR 675
+ DV+S+GV + E + + +++ +G+ +
Sbjct: 192 RSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKRMECPPECPPELYA- 243
Query: 676 SRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLE 707
+ C RP V Q +
Sbjct: 244 --------LMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 3e-59
Identities = 70/274 (25%), Positives = 112/274 (40%), Gaps = 28/274 (10%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLD--RLAQEREREFKSEVSAIGRTHHKNLV 495
F E+GRGSF VYKG+ + +A +L +L + + FK E + H N+V
Sbjct: 13 FDIEIGRGSFKTVYKGLDTE-TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIV 71
Query: 496 QLLGFCDEALNR----LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEG 551
+ + + +LV E M +GTL + + +I +GL +LH
Sbjct: 72 RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT- 130
Query: 552 CNVPIIHCDIKPQNILL-DHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKN 610
PIIH D+K NI + S KI D GL+ L + ++ + GT ++APE +
Sbjct: 131 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA---VIGTPEFMAPEMYEE 187
Query: 611 APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEA 670
VDVY+FG+ +LE+ S Y G A D
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSEYPY-------SECQNAAQIYRRVTSGVKPASFDKVAI 239
Query: 671 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704
I CI+++ +R ++K ++
Sbjct: 240 PEVKE--------IIEGCIRQNKDERYSIKDLLN 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 3e-59
Identities = 66/282 (23%), Positives = 118/282 (41%), Gaps = 27/282 (9%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGN--AIAVKKLDRLAQERE-REFKSEVSAIGRTHHKNL 494
F E +GRG FG VY G L G AVK L+R+ E +F +E + H N+
Sbjct: 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 90
Query: 495 VQLLGFCDEALNR-LLVYEFMGNGTLANLIF-AIPKPDWNLRVRISLEIARGLVYLHEGC 552
+ LLG C + L+V +M +G L N I P + L++A+G+
Sbjct: 91 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM---KFLA 147
Query: 553 NVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH---TMIRGTRGYVAPEWLK 609
+ +H D+ +N +LD F+ K++DFGL++ + + T + ++A E L+
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 610 NAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDE 669
+ K DV+SFGV+L E++ ++ ++GR +
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVYLLQGRRLLQPEYCP 260
Query: 670 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711
+ + + + C RP+ ++ + +
Sbjct: 261 DPLYE---------VMLKCWHPKAEMRPSFSELVSRISAIFS 293
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 199 bits (506), Expect = 8e-59
Identities = 60/304 (19%), Positives = 121/304 (39%), Gaps = 49/304 (16%)
Query: 438 FKEELGRGSFGIVYKGVLKTA----SGNAIAVKKLDR-LAQEREREFKSEVSAIGRTHHK 492
+ ++G G+FG V++ +AVK L + + + +F+ E + + +
Sbjct: 17 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 76
Query: 493 NLVQLLGFCDEALNRLLVYEFMGNGTLANLIF------------------------AIPK 528
N+V+LLG C L++E+M G L + P
Sbjct: 77 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 136
Query: 529 PDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS- 587
++ I+ ++A G+ YL E +H D+ +N L+ KI+DFGLS+ + S
Sbjct: 137 LSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 193
Query: 588 DHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAI 647
D+ + ++ PE + + + DV+++GV+L EI + E
Sbjct: 194 DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE---- 249
Query: 648 LTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLE 707
+G + A ++ + + + C + P+ RP+ + ++L+
Sbjct: 250 ---EVIYYVRDGNILACPENCPLELYN---------LMRLCWSKLPADRPSFCSIHRILQ 297
Query: 708 GLLE 711
+ E
Sbjct: 298 RMCE 301
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 1e-58
Identities = 56/278 (20%), Positives = 105/278 (37%), Gaps = 24/278 (8%)
Query: 438 FKEELGRGSFGIVYKGVLKTA--SGNAIAVKKLDRLAQERERE-FKSEVSAIGRTHHKNL 494
+G G FG V++G+ + A+A+K + RE F E + + H ++
Sbjct: 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 495 VQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRVRISLEIARGLVYLHEGCN 553
V+L+G E ++ E G L + + D + + +++ L YL
Sbjct: 71 VKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES--- 126
Query: 554 VPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPV 613
+H DI +N+L+ K+ DFGLS+ + + + ++APE +
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 614 SAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMA 673
++ DV+ FGV + EI+ ++ G + + +
Sbjct: 187 TSASDVWMFGVCMWEILMHGVKPFQGVKNN-------DVIGRIENGERLPMPPNCPPTLY 239
Query: 674 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711
+ C DPS+RP + L +LE
Sbjct: 240 S---------LMTKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 2e-58
Identities = 73/286 (25%), Positives = 129/286 (45%), Gaps = 28/286 (9%)
Query: 438 FKEE--LGRGSFGIVYKGVLKTASGN---AIAVKKLDRLAQERER-EFKSEVSAIGRTHH 491
+ +G G FG VYKG+LKT+SG +A+K L E++R +F E +G+ H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 492 KNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRVRISLEIARGLVYLHE 550
N+++L G + +++ E+M NG L + V + IA G+ YL
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA- 127
Query: 551 GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM--IRGTRGYVAPEWL 608
N+ +H D+ +NIL++ K+SDFGLS++L D T+T + + APE +
Sbjct: 128 --NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185
Query: 609 KNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSD 668
++ DV+SFG+++ E++ EL + I+
Sbjct: 186 SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH----------------EVMKAINDG 229
Query: 669 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPN 714
+ M C Q++ ++RP ++ +L+ L+ P+
Sbjct: 230 FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 8e-58
Identities = 60/277 (21%), Positives = 112/277 (40%), Gaps = 29/277 (10%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDR--LAQEREREFKSEVSAIGRTHHKNLV 495
+G GS+G K K+ G + K+LD + + ++ SEV+ + H N+V
Sbjct: 8 VLYTIGTGSYGRCQKIRRKS-DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 66
Query: 496 QLLGFCDEALNRLL--VYEFMGNGTLANLIFAIPKP----DWNLRVRISLEIARGLVYLH 549
+ + N L V E+ G LA++I K D +R+ ++ L H
Sbjct: 67 RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 126
Query: 550 E--GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEW 607
++H D+KP N+ LD + K+ DFGL+++L D S + T Y++PE
Sbjct: 127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG-TPYYMSPEQ 185
Query: 608 LKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDS 667
+ + K D++S G +L E+ ++E EG+ +
Sbjct: 186 MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--------LAGKIREGKFRRIPYR 237
Query: 668 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704
+ + I + RP+++ +++
Sbjct: 238 YSDELNE---------IITRMLNLKDYHRPSVEEILE 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 2e-57
Identities = 72/312 (23%), Positives = 132/312 (42%), Gaps = 49/312 (15%)
Query: 421 TNLRFFSYDELKDATDGFKEELGRGSFGIVYKGVLK-TASGNAIAVKKLDRLA-QERERE 478
T ++++K F++ +G G+FG V K +K A+K++ A ++ R+
Sbjct: 2 TIYPVLDWNDIK-----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 56
Query: 479 FKSEVSAIGR-THHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-------- 529
F E+ + + HH N++ LLG C+ L E+ +G L + +
Sbjct: 57 FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 116
Query: 530 --------DWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGL 581
+ + ++ARG+ YL + IH D+ +NIL+ + KI+DFGL
Sbjct: 117 ANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL 173
Query: 582 SKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRS--VEME 639
S+ + TM R ++A E L + + DV+S+GV+L EI+ + M
Sbjct: 174 SR--GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 231
Query: 640 LEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTM 699
E + + RL+ ++ D+ + C +E P +RP+
Sbjct: 232 CAELYEKLPQGY--------RLEKPLNCDDEVYD----------LMRQCWREKPYERPSF 273
Query: 700 KVVMQMLEGLLE 711
++ L +LE
Sbjct: 274 AQILVSLNRMLE 285
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 4e-57
Identities = 77/311 (24%), Positives = 126/311 (40%), Gaps = 48/311 (15%)
Query: 426 FSYDELKDATDGFKEELGRGSFGIVYKGVL----KTASGNAIAVKKLDRLAQERERE-FK 480
F + L F + LG G+FG V + K+ + +AVK L A ERE
Sbjct: 20 FPRNRLS-----FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM 74
Query: 481 SEVSAIGR-THHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIF--------------- 524
SE+ + +H N+V LLG C L++ E+ G L N +
Sbjct: 75 SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 525 ---AIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGL 581
D + S ++A+G+ +L IH D+ +NILL H KI DFGL
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGL 191
Query: 582 SKLLLSDHSRTH-TMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEL 640
++ + +D + R ++APE + N + + DV+S+G+ L E+ S +
Sbjct: 192 ARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251
Query: 641 EEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMK 700
+S+ +I ++ + I C DP KRPT K
Sbjct: 252 PVDSK---------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFK 296
Query: 701 VVMQMLEGLLE 711
++Q++E +
Sbjct: 297 QIVQLIEKQIS 307
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 2e-56
Identities = 73/342 (21%), Positives = 134/342 (39%), Gaps = 63/342 (18%)
Query: 409 YENNVQDSTTSATNLRFFSYDELKDATDGFK-----------EELGRGSFGIVYKGVL-- 455
YE+ +Q + ++ + Y + ++ K + LG G+FG V
Sbjct: 1 YESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYG 60
Query: 456 --KTASGNAIAVKKLDRLAQERERE-FKSEVSAIGR-THHKNLVQLLGFCDEALNRLLVY 511
KT +AVK L A ERE SE+ + + H+N+V LLG C + L++
Sbjct: 61 ISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIF 120
Query: 512 EFMGNGTLANLIFAIPKP-----------------------DWNLRVRISLEIARGLVYL 548
E+ G L N + + + + + + ++A+G+ +L
Sbjct: 121 EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL 180
Query: 549 HEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT-HTMIRGTRGYVAPEW 607
+H D+ +N+L+ H KI DFGL++ ++SD + R ++APE
Sbjct: 181 EFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPES 237
Query: 608 LKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMELEEESRAILTDWAYDCYVEGRLDALI 665
L + K DV+S+G++L EI + + ++ ++ + ++D
Sbjct: 238 LFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQN-------GFKMDQPF 290
Query: 666 DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLE 707
+ E I C D KRP+ + L
Sbjct: 291 YATEEIYI----------IMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 2e-56
Identities = 71/270 (26%), Positives = 112/270 (41%), Gaps = 28/270 (10%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQER---EREFKSEVSAIGRTHHKNL 494
LG+G FG VY K S +A+K L + E+ E + + EV H N+
Sbjct: 10 IGRPLGKGKFGNVYLAREKQ-SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 68
Query: 495 VQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNV 554
++L G+ +A L+ E+ GT+ + + K D E+A L Y H
Sbjct: 69 LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK--- 125
Query: 555 PIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVS 614
+IH DIKP+N+LL KI+DFG S S T + GT Y+ PE ++
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT---LCGTLDYLPPEMIEGRMHD 182
Query: 615 AKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMAD 674
KVD++S GV+ E + + E +E Y E A
Sbjct: 183 EKVDLWSLGVLCYEFLVGKPPFEANTYQE--------TYKRISRVEFTFPDFVTEGARD- 233
Query: 675 RSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704
+ ++ +PS+RP ++ V++
Sbjct: 234 ---------LISRLLKHNPSQRPMLREVLE 254
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 3e-56
Identities = 68/281 (24%), Positives = 117/281 (41%), Gaps = 30/281 (10%)
Query: 433 DATDGFK--EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTH 490
+ D ++ ELG G+FG VYK K + A K +D ++E ++ E+ +
Sbjct: 9 NPEDFWEIIGELGDGAFGKVYKAQNKE-TSVLAAAKVIDTKSEEELEDYMVEIDILASCD 67
Query: 491 HKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRVRISLEIARGLVYLH 549
H N+V+LL N ++ EF G + ++ + +P + + + L YLH
Sbjct: 68 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 127
Query: 550 EGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWL- 608
+ IIH D+K NIL K++DFG+S R + I GT ++APE +
Sbjct: 128 D---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVM 183
Query: 609 ----KNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDAL 664
K+ P K DV+S G+ L+E+ ++ L +
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEP----------------PHHELNPMRVLLKI 227
Query: 665 IDSDEAAMADRSRLHKWLM-IAMWCIQEDPSKRPTMKVVMQ 704
S+ +A SR C++++ R T ++Q
Sbjct: 228 AKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 6e-56
Identities = 69/280 (24%), Positives = 107/280 (38%), Gaps = 31/280 (11%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGN--AIAVKKLDRLA---QEREREFKSEVSAIGRTHHK 492
E+LG GSFG+V +G SG ++AVK L E +F EV+A+ H+
Sbjct: 12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71
Query: 493 NLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRVRISLEIARGLVYLHEG 551
NL++L G +V E G+L + + R ++++A G+ YL
Sbjct: 72 NLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 130
Query: 552 CNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS--DHSRTHTMIRGTRGYVAPEWLK 609
IH D+ +N+LL KI DFGL + L DH + + APE LK
Sbjct: 131 R---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 610 NAPVSAKVDVYSFGVMLLEIICCRRS--VEMELEEESRAILTDWAYDCYVEGRLDALIDS 667
S D + FGV L E+ + + + + I + E + +
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYN- 246
Query: 668 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLE 707
+ + C P RPT + L
Sbjct: 247 ----------------VMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 2e-55
Identities = 61/296 (20%), Positives = 116/296 (39%), Gaps = 29/296 (9%)
Query: 423 LRFFSYDELKDATDGFKEELGRGSFGIVYKGVLK---TASGNAIAVKKLDRLAQER-ERE 478
LR E K + LG G+FG VYKG+ +A+K+L + +E
Sbjct: 3 LRILKETEFK-----KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 57
Query: 479 FKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRIS 538
E + + ++ +LLG C + +L+ L + +
Sbjct: 58 ILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC 117
Query: 539 LEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM-IR 597
++IA+G+ YL + ++H D+ +N+L+ KI+DFGL+KLL ++ H +
Sbjct: 118 VQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 174
Query: 598 GTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYV 657
++A E + + + + DV+S+GV + E++ YD
Sbjct: 175 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS----------------KPYDGIP 218
Query: 658 EGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVP 713
+ ++++ E MI + C D RP + ++ + P
Sbjct: 219 ASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 274
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 3e-55
Identities = 72/270 (26%), Positives = 116/270 (42%), Gaps = 22/270 (8%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLD-RLAQEREREFKSEVSAIGRTHHKNLVQ 496
+ LG G++G V V + + A+AVK +D + A + K E+ +H+N+V+
Sbjct: 9 LVQTLGEGAYGEVQLAVNRV-TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK 67
Query: 497 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPI 556
G E + L E+ G L + I R ++ G+VYLH I
Sbjct: 68 FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---I 124
Query: 557 IHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH-SRTHTMIRGTRGYVAPEWLKNAPV-S 614
H DIKP+N+LLD + KISDFGL+ + ++ R + GT YVAPE LK +
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184
Query: 615 AKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMAD 674
VDV+S G++L ++ + +S +DW +
Sbjct: 185 EPVDVWSCGIVLTAMLAGEL--PWDQPSDSCQEYSDWKEKKTYLNPWKKI--DSAP---- 236
Query: 675 RSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704
L + + E+PS R T+ + +
Sbjct: 237 -------LALLHKILVENPSARITIPDIKK 259
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 1e-54
Identities = 64/266 (24%), Positives = 117/266 (43%), Gaps = 23/266 (8%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG 499
E++G+G+ G VY + A+G +A+++++ Q ++ +E+ + + N+V L
Sbjct: 26 EKIGQGASGTVYTAMDV-ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 500 FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHC 559
+V E++ G+L +++ D + E + L +LH +IH
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ---VIHR 140
Query: 560 DIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDV 619
DIK NILL S K++DFG + + S+ TM+ GT ++APE + KVD+
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 199
Query: 620 YSFGVMLLEIICCRRSVEMELEEES-RAILTDWAYDCYVEGRLDALIDSDEAAMADRSRL 678
+S G+M +E+I E + I T+ + +L A+
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD----------- 248
Query: 679 HKWLMIAMWCIQEDPSKRPTMKVVMQ 704
C+ D KR + K ++Q
Sbjct: 249 -----FLNRCLDMDVEKRGSAKELLQ 269
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 185 bits (472), Expect = 8e-54
Identities = 63/282 (22%), Positives = 105/282 (37%), Gaps = 35/282 (12%)
Query: 432 KDATDGFK--EELGRGSFGIVYKGVLKTASGNAIAVKKLD---RLAQEREREFKSEVSAI 486
D F E+G GSFG VY + +A+KK+ + + E+ ++ EV +
Sbjct: 11 DDPEKLFSDLREIGHGSFGAVYFARDVR-NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFL 69
Query: 487 GRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLV 546
+ H N +Q G LV E+ L ++ +GL
Sbjct: 70 QKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLA 129
Query: 547 YLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPE 606
YLH +IH D+K NILL K+ DFG + ++ +S GT ++APE
Sbjct: 130 YLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS-----FVGTPYWMAPE 181
Query: 607 WL---KNAPVSAKVDVYSFGVMLLEIICCRRS-VEMELEEESRAILTDWAYDCYVEGRLD 662
+ KVDV+S G+ +E+ + M I + + +
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSE 241
Query: 663 ALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704
+ C+Q+ P RPT +V+++
Sbjct: 242 YFRN-----------------FVDSCLQKIPQDRPTSEVLLK 266
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 5e-53
Identities = 76/301 (25%), Positives = 132/301 (43%), Gaps = 35/301 (11%)
Query: 438 FKEELGRGSFGIVYKGVLKTA----SGNAIAVKKLDRLAQERER-EFKSEVSAIGRTHHK 492
ELG+GSFG+VY+GV K +A+K ++ A RER EF +E S + +
Sbjct: 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83
Query: 493 NLVQLLGFCDEALNRLLVYEFMGNGTLANLIF----------AIPKPDWNLRVRISLEIA 542
++V+LLG + L++ E M G L + + + P + ++++ EIA
Sbjct: 84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143
Query: 543 RGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS-DHSRTHTMIRGTRG 601
G+ YL +H D+ +N ++ F+ KI DFG+++ + D+ R
Sbjct: 144 DGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200
Query: 602 YVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRL 661
+++PE LK+ + DV+SFGV+L EI L E +EG L
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-------QVLRFVMEGGL 253
Query: 662 DALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNPPWSSSF 721
D+ + + + C Q +P RP+ ++ ++ +E S +
Sbjct: 254 LDKPDNCPDMLFE---------LMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYY 304
Query: 722 S 722
S
Sbjct: 305 S 305
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 6e-51
Identities = 79/310 (25%), Positives = 123/310 (39%), Gaps = 47/310 (15%)
Query: 426 FSYDELKDATDGFKEELGRGSFGIVYKGVL----KTASGNAIAVKKLDR-LAQEREREFK 480
F D LK + LGRG+FG V + KTA+ +AVK L R
Sbjct: 10 FPRDRLK-----LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM 64
Query: 481 SEVSAIGRT-HHKNLVQLLGFCDEALNRL-LVYEFMGNGTLANLIFAIPKP--------- 529
SE+ + HH N+V LLG C + L ++ EF G L+ + +
Sbjct: 65 SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 124
Query: 530 -------DWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLS 582
+ S ++A+G+ +L IH D+ +NILL KI DFGL+
Sbjct: 125 DLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLA 181
Query: 583 KLLLSDHSRTH-TMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELE 641
+ + D R ++APE + + + + DV+SFGV+L EI S ++
Sbjct: 182 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241
Query: 642 EESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKV 701
+ + EG D M + C +PS+RPT
Sbjct: 242 ID------EEFCRRLKEGTRMRAPDYTTPEMYQ---------TMLDCWHGEPSQRPTFSE 286
Query: 702 VMQMLEGLLE 711
+++ L LL+
Sbjct: 287 LVEHLGNLLQ 296
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 2e-50
Identities = 71/300 (23%), Positives = 118/300 (39%), Gaps = 44/300 (14%)
Query: 438 FKEELGRGSFGIVYKGVL------KTASGNAIAVKKLDRLAQERE-REFKSEVSAIGR-T 489
+ LG G+FG V K +AVK L A E++ + SE+ +
Sbjct: 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 490 HHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP----------------DWNL 533
HKN++ LLG C + ++ E+ G L + A P
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 534 RVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH 593
V + ++ARG+ YL IH D+ +N+L+ KI+DFGL++ +
Sbjct: 137 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 594 TM-IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWA 652
T R ++APE L + + + DV+SFGV+L EI S + E
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-------EL 246
Query: 653 YDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEV 712
+ EG + + + C PS+RPT K +++ L+ ++ +
Sbjct: 247 FKLLKEGHRMDKPSNCTNELYM---------MMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 174 bits (443), Expect = 2e-49
Identities = 64/270 (23%), Positives = 119/270 (44%), Gaps = 23/270 (8%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
EELG G+FG+V++ + A+GN A K + + + + E+ + H LV L
Sbjct: 30 IHEELGTGAFGVVHRVTER-ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 88
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRVRISLEIARGLVYLHEGCNVPI 556
++ +++YEFM G L + + V ++ +GL ++HE
Sbjct: 89 HDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---Y 145
Query: 557 IHCDIKPQNILLDHYFSP--KISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVS 614
+H D+KP+NI+ S K+ DFGL+ L D ++ + GT + APE + PV
Sbjct: 146 VHLDLKPENIMFTTKRSNELKLIDFGLTAHL--DPKQSVKVTTGTAEFAAPEVAEGKPVG 203
Query: 615 AKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMAD 674
D++S GV+ ++ E ++E+ + + + D++A +
Sbjct: 204 YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW------------NMDDSAFSG 251
Query: 675 RSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704
S K + + DP+ R T+ ++
Sbjct: 252 ISEDGKDFI--RKLLLADPNTRMTIHQALE 279
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 168 bits (426), Expect = 2e-47
Identities = 67/280 (23%), Positives = 113/280 (40%), Gaps = 20/280 (7%)
Query: 428 YDELKDATDGFK--EELGRGSFGIVYKGVLKTASGNAIAVKKLDR-LAQEREREFKSEVS 484
+ + +D D + + LG G+F V K + +A+K + + + +E ++E++
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKR-TQKLVAIKCIAKKALEGKEGSMENEIA 59
Query: 485 AIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARG 544
+ + H N+V L + + L+ + + G L + I R+ ++
Sbjct: 60 VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA 119
Query: 545 LVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVA 604
+ YLH+ V LD ISDFGLSK+ D + GT GYVA
Sbjct: 120 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTPGYVA 177
Query: 605 PEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDAL 664
PE L P S VD +S GV+ ++C E + + E L A
Sbjct: 178 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK------------LFEQILKAE 225
Query: 665 IDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704
+ D D S K + +++DP KR T + +Q
Sbjct: 226 YEFDSPYWDDISDSAKDFI--RHLMEKDPEKRFTCEQALQ 263
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 169 bits (429), Expect = 2e-47
Identities = 67/270 (24%), Positives = 119/270 (44%), Gaps = 23/270 (8%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
EELG G+FG+V++ V K A+G K ++ + K+E+S + + HH L+ L
Sbjct: 33 ILEELGSGAFGVVHRCVEK-ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINL 91
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRVRISLEIARGLVYLHEGCNVPI 556
++ +L+ EF+ G L + I A + + GL ++HE I
Sbjct: 92 HDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSI 148
Query: 557 IHCDIKPQNILLDHYFSP--KISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVS 614
+H DIKP+NI+ + + KI DFGL+ L + + T + APE + PV
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKL--NPDEIVKVTTATAEFAAPEIVDREPVG 206
Query: 615 AKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMAD 674
D+++ GV+ ++ E + E+ ++ + DE A +
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSPFAGEDDLET------------LQNVKRCDWEFDEDAFSS 254
Query: 675 RSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704
S K + +Q++P KR T+ ++
Sbjct: 255 VSPEAKDFI--KNLLQKEPRKRLTVHDALE 282
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 3e-47
Identities = 59/276 (21%), Positives = 99/276 (35%), Gaps = 26/276 (9%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNL 494
F + LG GSF V + A+K L++ + + + E + R H
Sbjct: 12 FGKILGEGSFSTVVLARELA-TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 70
Query: 495 VQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNV 554
V+L + + NG L I I D + EI L YLH
Sbjct: 71 VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG-- 128
Query: 555 PIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH-TMIRGTRGYVAPEWLKNAPV 613
IIH D+KP+NILL+ +I+DFG +K+L + + GT YV+PE L
Sbjct: 129 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 187
Query: 614 SAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMA 673
D+++ G ++ +++ E + ++ D A
Sbjct: 188 CKSSDLWALGCIIYQLVAGLPPFRAGNEYL--------IFQKIIKLEYDFPEKFFPKA-- 237
Query: 674 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGL 709
+ L+ + D +KR + +
Sbjct: 238 ------RDLV--EKLLVLDATKRLGCEEMEGYGPLK 265
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 2e-45
Identities = 56/270 (20%), Positives = 107/270 (39%), Gaps = 24/270 (8%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
E+LGRG FGIV++ V + S K + ++ K E+S + H+N++ L
Sbjct: 9 IAEDLGRGEFGIVHRCVETS-SKKTYMAKFVKVKGTDQVL-VKKEISILNIARHRNILHL 66
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRVRISLEIARGLVYLHEGCNVPI 556
+ ++++EF+ + I + V ++ L +LH I
Sbjct: 67 HESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNI 123
Query: 557 IHCDIKPQNILLDH--YFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVS 614
H DI+P+NI+ + KI +FG ++ L ++ Y APE ++ VS
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRLLFTAPEYYAPEVHQHDVVS 181
Query: 615 AKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMAD 674
D++S G ++ ++ E ++ +E ++A DE A +
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLAETNQQ------------IIENIMNAEYTFDEEAFKE 229
Query: 675 RSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704
S + + ++ R T +Q
Sbjct: 230 ISIEAMDFV--DRLLVKERKSRMTASEALQ 257
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 157 bits (398), Expect = 5e-44
Identities = 50/280 (17%), Positives = 99/280 (35%), Gaps = 28/280 (10%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNL 494
E LG G V+ +AVK L F+ E +H +
Sbjct: 11 LGEILGFGGMSEVHLARDLR-LHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAI 69
Query: 495 VQLLGFCDEALNRL----LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHE 550
V + + +V E++ TL +++ + + + + L + H+
Sbjct: 70 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ 129
Query: 551 GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM--IRGTRGYVAPEWL 608
IIH D+KP NI++ + K+ DFG+++ + + + GT Y++PE
Sbjct: 130 NG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 609 KNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSD 668
+ V A+ DVYS G +L E++ + ++ + + S
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGEPPFT---GDSPVSVAYQHVREDPIPPSARHEGLSA 243
Query: 669 EAAMADRSRLHKWLMIAMWCIQEDPSKRP-TMKVVMQMLE 707
+ + + + ++P R T + L
Sbjct: 244 DLD-----------AVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 157 bits (397), Expect = 7e-44
Identities = 64/283 (22%), Positives = 108/283 (38%), Gaps = 36/283 (12%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLD---------RLAQEREREFKSEVSAIGR 488
KE LGRG +V + + K + AVK +D QE EV + +
Sbjct: 7 PKEILGRGVSSVVRRCIHKP-TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 65
Query: 489 TH-HKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVY 547
H N++QL + LV++ M G L + + +I + +
Sbjct: 66 VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICA 125
Query: 548 LHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEW 607
LH+ + I+H D+KP+NILLD + K++DFG S L D + GT Y+APE
Sbjct: 126 LHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPSYLAPEI 180
Query: 608 LKNAPV------SAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRL 661
++ + +VD++S GV++ ++ + ++ Y
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240
Query: 662 DALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704
D SD + + P KR T + +
Sbjct: 241 DY---SDTVK-----------DLVSRFLVVQPQKRYTAEEALA 269
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 8e-44
Identities = 67/267 (25%), Positives = 108/267 (40%), Gaps = 27/267 (10%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDR---LAQEREREFKSEVSAIGRT-HHKN 493
+ LG+GSFG V+ K + A+K L + L + E + H
Sbjct: 6 LHKMLGKGSFGKVFLAEFKK-TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 64
Query: 494 LVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCN 553
L + N V E++ G L I + K D + + EI GL +LH
Sbjct: 65 LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG- 123
Query: 554 VPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPV 613
I++ D+K NILLD KI+DFG+ K + ++ GT Y+APE L
Sbjct: 124 --IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNTFCGTPDYIAPEILLGQKY 180
Query: 614 SAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMA 673
+ VD +SFGV+L E++ + + EEE + ++ A
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--------LFHSIRMDNPFYPRWLEKEA-- 230
Query: 674 DRSRLHKWLMIAMWCIQEDPSKRPTMK 700
K L++ ++ +P KR ++
Sbjct: 231 ------KDLLVKLF--VREPEKRLGVR 249
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 155 bits (393), Expect = 4e-43
Identities = 51/294 (17%), Positives = 93/294 (31%), Gaps = 26/294 (8%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 497
++G GSFG +Y G A+G +A+K + + + E +
Sbjct: 11 LGRKIGSGSFGDIYLGTDI-AAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVGIPT 67
Query: 498 LGFC-DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPI 556
+ +C E ++V E +G F K + ++ ++ + Y+H
Sbjct: 68 IRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---F 124
Query: 557 IHCDIKPQNIL---LDHYFSPKISDFGLSKLLLSDHSRTH------TMIRGTRGYVAPEW 607
IH D+KP N L I DFGL+K + H + GT Y +
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 608 LKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDS 667
S + D+ S G +L+ + R + + ++ L
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI-SEKKMSTPIEVLCKG 243
Query: 668 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNPPWSSSF 721
+ A +C +P + Q+ L + F
Sbjct: 244 YPSEFAT---------YLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVF 288
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 4e-43
Identities = 67/282 (23%), Positives = 104/282 (36%), Gaps = 21/282 (7%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDR-----LAQEREREFKSEVSAIGRTHHKNL 494
+ LG G F VYK K + +A+KK+ R E+ + H N+
Sbjct: 4 DFLGEGQFATVYKARDKN-TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI 62
Query: 495 VQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNV 554
+ LL N LV++FM + + L +GL YLH+
Sbjct: 63 IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 120
Query: 555 PIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNA-PV 613
I+H D+KP N+LLD K++DFGL+K S + R +T TR Y APE L A
Sbjct: 121 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RAYTHQVVTRWYRAPELLFGARMY 178
Query: 614 SAKVDVYSFGVMLLEIICCR-----RSVEMELEEESRAILTDWAYDCYVEGRLDALIDSD 668
VD+++ G +L E++ S +L + T L +
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 669 EAAMADRSRLHKWLM-----IAMWCIQEDPSKRPTMKVVMQM 705
+ + +P R T ++M
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 157 bits (398), Expect = 4e-43
Identities = 61/287 (21%), Positives = 99/287 (34%), Gaps = 34/287 (11%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLD------RLAQEREREFKSEVSAIGRTHH 491
+GRG FG VY +G A+K LD + + + +S +
Sbjct: 8 VHRIIGRGGFGEVYGCRKAD-TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 66
Query: 492 KNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEG 551
+V + + + M G L + + EI GL ++H
Sbjct: 67 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR 126
Query: 552 CNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWL-KN 610
+++ D+KP NILLD + +ISD GL+ GT GY+APE L K
Sbjct: 127 F---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HASVGTHGYMAPEVLQKG 180
Query: 611 APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEA 670
+ D +S G ML +++ ++ I L S E
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV---ELPDSF-SPEL 236
Query: 671 AMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNPPW 717
+ L+ +Q D ++R + G EV P+
Sbjct: 237 ---------RSLL--EGLLQRDVNRRLGC-----LGRGAQEVKESPF 267
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 154 bits (389), Expect = 9e-43
Identities = 51/278 (18%), Positives = 101/278 (36%), Gaps = 18/278 (6%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKL--DRLAQEREREFKSEVSAIGRTHHKNLVQL 497
E++G G++G+VYK G A+KK+ ++ + E+S + H N+V+L
Sbjct: 8 EKIGEGTYGVVYKAQNNY--GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPII 557
+LV+E + L + L++ G+ Y H+ ++
Sbjct: 66 YDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVL 122
Query: 558 HCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKV 617
H D+KPQN+L++ KI+DFGL++ + I + + S +
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTI 182
Query: 618 DVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSR 677
D++S G + E++ E + + + +
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242
Query: 678 LHKWLMIA-----------MWCIQEDPSKRPTMKVVMQ 704
W ++ DP++R T K ++
Sbjct: 243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 4e-42
Identities = 71/289 (24%), Positives = 124/289 (42%), Gaps = 31/289 (10%)
Query: 426 FSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQERER------EF 479
F + + D D EELG G F +V K K+ +G A K + + + R +
Sbjct: 3 FRQENVDDYYD-TGEELGSGQFAVVKKCREKS-TGLQYAAKFIKKRRTKSSRRGVSREDI 60
Query: 480 KSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISL 539
+ EVS + H N++ L + + +L+ E + G L + +
Sbjct: 61 EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK 120
Query: 540 EIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSP----KISDFGLSKLLLSDHSRTHTM 595
+I G+ YLH I H D+KP+NI+L P KI DFGL+ + D
Sbjct: 121 QILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKN 175
Query: 596 IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDC 655
I GT +VAPE + P+ + D++S GV+ ++ + ++E+ A ++ Y
Sbjct: 176 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY-- 233
Query: 656 YVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704
+ ++ ++ S L K + + +DP KR T++ +Q
Sbjct: 234 ----------EFEDEYFSNTSALAKDFI--RRLLVKDPKKRMTIQDSLQ 270
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 152 bits (384), Expect = 7e-42
Identities = 45/296 (15%), Positives = 94/296 (31%), Gaps = 28/296 (9%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGR-THHKNLVQ 496
+G GSFG++++G + +A+K R + + + E +
Sbjct: 9 VGRRIGEGSFGVIFEGTNLL-NNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTGIPN 65
Query: 497 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPI 556
+ F E L+ +LV + +G L K + ++ + +HE +
Sbjct: 66 VYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSL 122
Query: 557 IHCDIKPQNILLDHYFSP-----KISDFGLSKLLLSDHSRTHTM------IRGTRGYVAP 605
++ DIKP N L+ S + DFG+ K ++ H + GT Y++
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182
Query: 606 EWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALI 665
S + D+ + G + + + + ++ + + L L
Sbjct: 183 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY-ERIGEKKQSTPLRELC 241
Query: 666 DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNPPWSSSF 721
+ P + + +LE N +F
Sbjct: 242 AGFPEEFYK---------YMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENF 288
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 152 bits (385), Expect = 1e-41
Identities = 63/285 (22%), Positives = 115/285 (40%), Gaps = 38/285 (13%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNL 494
LG GSFG V+ + +G A+K L + + ++ E + H +
Sbjct: 8 ILRTLGTGSFGRVHLIRSRH-NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFI 66
Query: 495 VQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNV 554
+++ G +A ++ +++ G L +L+ + + + E+ L YLH
Sbjct: 67 IRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS---K 123
Query: 555 PIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVS 614
II+ D+KP+NILLD KI+DFG +K + + GT Y+APE + P +
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGTPDYIAPEVVSTKPYN 179
Query: 615 AKVDVYSFGVMLLEIICCRRS-VEMELEEESRAILT-DWAYDCYVEGRLDALIDSDEAAM 672
+D +SFG+++ E++ + + IL + + + + L+
Sbjct: 180 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSR----- 234
Query: 673 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNPPW 717
I D S+R + G +V N PW
Sbjct: 235 ---------------LITRDLSQRLGN-----LQNGTEDVKNHPW 259
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 1e-41
Identities = 62/285 (21%), Positives = 110/285 (38%), Gaps = 25/285 (8%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKL--DRLAQEREREFKSEV---SAIGRTHHKNL 494
E+G G++G V+K G +A+K++ + EV + H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 495 VQLLGFC-----DEALNRLLVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYL 548
V+L C D LV+E + L P + ++ RGL +L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 549 HEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWL 608
H ++H D+KPQNIL+ K++DFGL+++ T + T Y APE L
Sbjct: 133 HSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYRAPEVL 187
Query: 609 KNAPVSAKVDVYSFGVMLLEIICCRR-----SVEMELEEESRAILTDWAYDCYVEGRLDA 663
+ + VD++S G + E+ + S +L + I D + L
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 247
Query: 664 LIDSDEAAMADRSRLHKWLMIA----MWCIQEDPSKRPTMKVVMQ 704
++A + + + C+ +P+KR + +
Sbjct: 248 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 5e-41
Identities = 55/285 (19%), Positives = 111/285 (38%), Gaps = 24/285 (8%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQERERE-FKSEVSAIGRTHHKNLVQLL 498
+G G++G+V + +A+KK+ + + E+ + R H+N++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNV-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 72
Query: 499 GFCDEALNRLLVYEFMGNGTLANLIFAIPKP---DWNLRVRISLEIARGLVYLHEGCNVP 555
+ ++ + ++ + K + +I RGL Y+H
Sbjct: 73 DIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---N 129
Query: 556 IIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR--THTMIRGTRGYVAPEWLKN-AP 612
++H D+KP N+LL+ KI DFGL+++ DH T TR Y APE + N
Sbjct: 130 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 189
Query: 613 VSAKVDVYSFGVMLLEIICCR-----RSVEMELEEESRAILTDWAYDCYVEGRLDALIDS 667
+ +D++S G +L E++ R + +L + + D L A
Sbjct: 190 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 249
Query: 668 DEAAMADRSRLHKW--------LMIAMWCIQEDPSKRPTMKVVMQ 704
++ ++ L + + +P KR ++ +
Sbjct: 250 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 2e-40
Identities = 61/294 (20%), Positives = 103/294 (35%), Gaps = 33/294 (11%)
Query: 439 KEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGR-THHKNLVQL 497
+ LG G G V + K + A+K L + + EV R + ++V++
Sbjct: 17 SQVLGLGINGKVLQIFNKR-TQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRI 70
Query: 498 LGFCDEALNR----LLVYEFMGNGTLANLIFAIPKP--DWNLRVRISLEIARGLVYLHEG 551
+ + L+V E + G L + I I I + YLH
Sbjct: 71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 130
Query: 552 CNVPIIHCDIKPQNILLDHYFSP---KISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWL 608
I H D+KP+N+L K++DFG +K S +S T T YVAPE L
Sbjct: 131 N---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVL 185
Query: 609 KNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSD 668
D++S GV++ ++C + E +
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 245
Query: 669 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM--LEGLLEVPNPPWSSS 720
E + ++ +P++R T+ M + +VP P +S
Sbjct: 246 EEVKM----------LIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 289
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 9e-40
Identities = 60/278 (21%), Positives = 102/278 (36%), Gaps = 42/278 (15%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKL------DRLAQEREREFKSEVSAIGR--T 489
LG G FG VY G+ + +A+K + D EV + + +
Sbjct: 8 VGPLLGSGGFGSVYSGIRVS-DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 490 HHKNLVQLLGFCDEALNRLLVYEFM-GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYL 548
+++LL + + + +L+ E L + I L ++ + +
Sbjct: 67 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 126
Query: 549 HEGCNVPIIHCDIKPQNILLD-HYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEW 607
H ++H DIK +NIL+D + K+ DFG LL +T GTR Y PEW
Sbjct: 127 HN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEW 180
Query: 608 LKNAPV-SAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALID 666
++ V+S G++L +++C + E + I + V LI
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGD----IPFEHDEEIIRGQVFFRQRVSSECQHLI- 235
Query: 667 SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704
WC+ PS RPT + +
Sbjct: 236 -------------------RWCLALRPSDRPTFEEIQN 254
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 4e-39
Identities = 56/281 (19%), Positives = 105/281 (37%), Gaps = 22/281 (7%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKL--DRLAQEREREFKSEVSAIGRTHHKNLVQL 497
E++G G++G+VYK K +G +A+KK+ D + E+S + +H N+V+L
Sbjct: 8 EKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRVRISLEIARGLVYLHEGCNVPI 556
L LV+EF+ + + L ++ +GL + H +
Sbjct: 67 LDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---V 123
Query: 557 IHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAK 616
+H D+KPQN+L++ + K++DFGL++ + L S
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 183
Query: 617 VDVYSFGVMLLEIICCR-------------RSVEMELEEESRAILTDWAYDCYVEGRLDA 663
VD++S G + E++ R R + + Y
Sbjct: 184 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 243
Query: 664 LIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704
+ + L+ + DP+KR + K +
Sbjct: 244 ARQDFSKVVPPLDEDGRSLL--SQMLHYDPNKRISAKAALA 282
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 4e-38
Identities = 55/293 (18%), Positives = 112/293 (38%), Gaps = 32/293 (10%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKL--DRLAQEREREFKSEVSAIGRTHHKNLVQL 497
++G+G+FG V+K + +G +A+KK+ + + E+ + H+N+V L
Sbjct: 16 AKIGQGTFGEVFKARHRK-TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNL 74
Query: 498 LGFCDEALNR--------LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLH 549
+ C + LV++F + L + K + R+ + GL +
Sbjct: 75 IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL---Y 131
Query: 550 EGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLL---LSDHSRTHTMIRGTRGYVAPE 606
I+H D+K N+L+ K++DFGL++ + +T T Y PE
Sbjct: 132 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191
Query: 607 WLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAY----------DC 655
L +D++ G ++ E+ ++ E+ A+++ D
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN 251
Query: 656 YVEGRLDALIDSDEAAMADRSRLHKWLMIA----MWCIQEDPSKRPTMKVVMQ 704
Y L+ + + DR + + A + DP++R +
Sbjct: 252 YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 4e-38
Identities = 46/279 (16%), Positives = 101/279 (36%), Gaps = 18/279 (6%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKL--DRLAQEREREFKSEVSAIGRTHHKNLVQL 497
E++G G++G V+K + + +A+K++ D + E+ + HKN+V+L
Sbjct: 8 EKIGEGTYGTVFKAKNRE-THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 66
Query: 498 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPII 557
LV+EF D + ++ +GL + H ++
Sbjct: 67 HDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VL 123
Query: 558 HCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKV 617
H D+KPQN+L++ K+++FGL++ + S +
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 183
Query: 618 DVYSFGVMLLEIICCRR-----SVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAM 672
D++S G + E+ R + + + +L + +
Sbjct: 184 DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYP 243
Query: 673 ADRSRLHKWLMIA-------MWCIQEDPSKRPTMKVVMQ 704
A S ++ + ++ +P +R + + +Q
Sbjct: 244 ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 5e-38
Identities = 62/324 (19%), Positives = 115/324 (35%), Gaps = 44/324 (13%)
Query: 426 FSYDELKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSA 485
SY + K +G GSFG+VY+ L SG +A+KK+ + +R E+
Sbjct: 20 VSYTDTK--------VIGNGSFGVVYQAKLCD-SGELVAIKKVLQ----DKRFKNRELQI 66
Query: 486 IGRTHHKNLVQLLGFCDEALNR------LLVYEFMGNGTLANLIFAIPKP---DWNLRVR 536
+ + H N+V+L F + + LV +++
Sbjct: 67 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 126
Query: 537 ISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDH-YFSPKISDFGLSKLLLSDHSRTHTM 595
++ R L Y+H I H DIKPQN+LLD K+ DFG +K L +
Sbjct: 127 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSY 182
Query: 596 IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRR-----SVEMELEEESRAILTD 650
I ++ +DV+S G +L E++ + S +L E + + T
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 242
Query: 651 WAYDCYVEGRLDALIDSDEAAMADRSRLHKWLM------IAMWCIQEDPSKRPTMKVVMQ 704
+ +++ + + ++ P+ R T
Sbjct: 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
Query: 705 ------MLEGLLEVPNPPWSSSFS 722
+ + +++PN + +
Sbjct: 303 HSFFDELRDPNVKLPNGRDTPALF 326
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 3e-37
Identities = 61/266 (22%), Positives = 103/266 (38%), Gaps = 26/266 (9%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNL 494
+ + LG+G+FG V K A+G A+K L + +A++ +E + T H L
Sbjct: 9 YLKLLGKGTFGKVILVREK-ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 495 VQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNV 554
L V E+ G L + EI L +
Sbjct: 68 TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSAL---EYLHSR 124
Query: 555 PIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVS 614
+++ DIK +N++LD KI+DFGL K +SD + GT Y+APE L++
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK-TFCGTPEYLAPEVLEDNDYG 183
Query: 615 AKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMAD 674
VD + GV++ E++C R + E ++ + + A
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHER--------LFELILMEEIRFPRTLSPEA--- 232
Query: 675 RSRLHKWLMIAMWCIQEDPSKRPTMK 700
K L+ +++DP +R
Sbjct: 233 -----KSLL--AGLLKKDPKQRLGGG 251
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 134 bits (337), Expect = 6e-35
Identities = 59/285 (20%), Positives = 113/285 (39%), Gaps = 34/285 (11%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNLVQ 496
+ LG GSFG V K SGN A+K LD+ + ++ +E + + LV+
Sbjct: 47 KTLGTGSFGRVMLVKHKE-SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 497 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPI 556
L + N +V E++ G + + + I + + +I YLH +
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---L 162
Query: 557 IHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAK 616
I+ D+KP+N+L+D +++DFG +K + GT +APE + + +
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEIILSKGYNKA 218
Query: 617 VDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRS 676
VD ++ GV++ E+ + + Y+ V G++
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQ--------IYEKIVSGKVRFPSHFSSDLK---- 266
Query: 677 RLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNPPWSSSF 721
+ +Q D +KR + G+ ++ N W ++
Sbjct: 267 ------DLLRNLLQVDLTKRFG-----NLKNGVNDIKNHKWFATT 300
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 1e-34
Identities = 70/328 (21%), Positives = 121/328 (36%), Gaps = 44/328 (13%)
Query: 426 FSYDELKDATDGFK------EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQERE--R 477
F E+ + + +G G++G V V +G +A+KKL R Q +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGR-TGAKVAIKKLYRPFQSELFAK 62
Query: 478 EFKSEVSAIGRTHHKNLVQLLGFC------DEALNRLLVYEFMGNGTLANLIFAIPKPDW 531
E+ + H+N++ LL D+ + LV FMG + K
Sbjct: 63 RAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT--DLGKLMKHEKLGE 120
Query: 532 NLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591
+ + ++ +GL Y+H IH D+KP N+ ++ KI DFGL++
Sbjct: 121 DRIQFLVYQMLKGLRYIHAAGI---IHRDLKPGNLAVNEDCELKILDFGLARQA----DS 173
Query: 592 THTMIRGTRGYVAPEWLKN-APVSAKVDVYSFGVMLLEIICCR---------------RS 635
T TR Y APE + N + VD++S G ++ E+I +
Sbjct: 174 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 233
Query: 636 VEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSK 695
V E L Y++G + + + + S L L+ + D +
Sbjct: 234 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLL--EKMLVLDAEQ 291
Query: 696 RPTMKVVMQM--LEGLLEVPNPPWSSSF 721
R T + E L + + P +
Sbjct: 292 RVTAGEALAHPYFESLHDTEDEPQVQKY 319
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 129 bits (325), Expect = 1e-33
Identities = 56/292 (19%), Positives = 116/292 (39%), Gaps = 37/292 (12%)
Query: 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGR-THHKNLVQ 496
+LGRG + V++ + T + + VK L ++++ K E+ + N++
Sbjct: 39 LVRKLGRGKYSEVFEAINIT-NNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIIT 94
Query: 497 LLGFCDEALNRL--LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNV 554
L + ++R LV+E + N L + D EI + L Y H
Sbjct: 95 LADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD---IRFYMYEILKALDYCHSMG-- 149
Query: 555 PIIHCDIKPQNILLDH-YFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPE-WLKNAP 612
I+H D+KP N+++DH + ++ D+GL++ + + + +R + PE +
Sbjct: 150 -IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY--HPGQEYNVRVASRYFKGPELLVDYQM 206
Query: 613 VSAKVDVYSFGVMLLEIICCR------RSVEMELEEESRAILTDWAYDCYVEGRLDALID 666
+D++S G ML +I + +L ++ + T+ YD + ++
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266
Query: 667 -SDEAAMADRSRLHKWLMIAMW-------------CIQEDPSKRPTMKVVMQ 704
+D R R +++ ++ D R T + M+
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 1e-32
Identities = 61/271 (22%), Positives = 113/271 (41%), Gaps = 26/271 (9%)
Query: 438 FKEELGRGSFGIVYKGVLKTA--SGNAIAVKKLDRLAQERE----REFKSEVSAIGR-TH 490
+ LG G++G V+ + +G A+K L + ++ ++E +
Sbjct: 28 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 87
Query: 491 HKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHE 550
LV L L+ +++ G L + + + EI L +LH+
Sbjct: 88 SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK 147
Query: 551 GCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWL-- 608
+ II+ DIK +NILLD ++DFGLSK ++D + GT Y+AP+ +
Sbjct: 148 ---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG 204
Query: 609 KNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSD 668
++ VD +S GV++ E++ ++ E+ S+A + ++ S+
Sbjct: 205 GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI------------SRRILKSE 252
Query: 669 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTM 699
+ S L K L+ + +DP KR
Sbjct: 253 PPYPQEMSALAKDLI--QRLLMKDPKKRLGC 281
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 3e-32
Identities = 67/299 (22%), Positives = 116/299 (38%), Gaps = 45/299 (15%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDR--LAQEREREFKSEVSAIGRTHHKNLVQL 497
+ +G G+ GIV +A+KKL R Q + E+ + +HKN++ L
Sbjct: 23 KPIGSGAQGIVCAAYDAV-LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 498 LGFC------DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEG 551
L +E + LV E M + + D + ++ G+ +LH
Sbjct: 82 LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA 138
Query: 552 CNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNA 611
IH D+KP NI++ + KI DFGL++ + S T TR Y APE +
Sbjct: 139 GI---IHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGM 193
Query: 612 PVSAKVDVYSFGVMLLEIICCR-----RSVEMELEEESRAILT---------DWAYDCYV 657
VD++S G ++ E++ + R + + + T YV
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253
Query: 658 EGR------------LDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704
E R D+L +D ++ + L+ + DP+KR ++ +Q
Sbjct: 254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL--SKMLVIDPAKRISVDDALQ 310
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 7e-30
Identities = 62/286 (21%), Positives = 105/286 (36%), Gaps = 30/286 (10%)
Query: 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQERE--REFKSEVSAIGRTHHKNLVQL 497
+G G++G V +G +AVKKL R Q + E+ + H+N++ L
Sbjct: 24 SPVGSGAYGSVCAAFDTK-TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 82
Query: 498 LGFCDEA-----LNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGC 552
L A N + + + G N I K + + +I RGL Y+H
Sbjct: 83 LDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 553 NVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEW-LKNA 611
IH D+KP N+ ++ KI DFGL++ T TR Y APE L
Sbjct: 142 I---IHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 194
Query: 612 PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAA 671
+ VD++S G ++ E++ R + ++ E +S
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 254
Query: 672 MADRSRLHKWLMIAMW-------------CIQEDPSKRPTMKVVMQ 704
+ +++ K ++ + D KR T +
Sbjct: 255 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 112 bits (279), Expect = 3e-27
Identities = 60/324 (18%), Positives = 106/324 (32%), Gaps = 52/324 (16%)
Query: 429 DELKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGR 488
+ KDA +LG G F V+ + +A+K + R + + E+ + R
Sbjct: 8 EPYKDARYILVRKLGWGHFSTVWLAKDMV-NNTHVAMKIV-RGDKVYTEAAEDEIKLLQR 65
Query: 489 THHKNLVQLLGFCDEALNRLLVY--EFMGNGTLANLIFAI--------------PKPDWN 532
+ + + + +LL + NG ++F +
Sbjct: 66 VNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLI 125
Query: 533 LRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHY-FSPKISDFGLSKLLLSDHSR 591
+IS ++ GL Y+H C IIH DIKP+N+L++ + ++ L +
Sbjct: 126 YVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD 183
Query: 592 THTM-IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTD 650
H TR Y +PE L AP D++S ++ E+I E +
Sbjct: 184 EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243
Query: 651 WAYDCYVEGRLDALI----DSDEAAMADRSRLHKWLMIAMW------------------- 687
A + G L + + R L + W
Sbjct: 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKE 303
Query: 688 -------CIQEDPSKRPTMKVVMQ 704
+Q DP KR ++
Sbjct: 304 ISDFLSPMLQLDPRKRADAGGLVN 327
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 86.4 bits (213), Expect = 4e-20
Identities = 26/207 (12%), Positives = 55/207 (26%), Gaps = 31/207 (14%)
Query: 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVK----------KLDRLAQEREREFKSEVSA 485
D + +G G V+ + VK K+ + F
Sbjct: 2 DAIGKLMGEGKESAVFNCYSEK--FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIR 59
Query: 486 IGRTHHKNLVQLLGFCD----EALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEI 541
R + L +L G ++ E + + + + I
Sbjct: 60 SARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKE-------LYRVRVENPDEVLDMI 112
Query: 542 ARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTMIRGTRG 601
+ + I+H D+ N+L+ I DF S + ++
Sbjct: 113 LEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDFPQSVEV--GEEGWREILERDVR 166
Query: 602 YVAPEWLKNAPVSAKVDVYSFGVMLLE 628
+ + + D+ S +L+
Sbjct: 167 NII-TYFSR-TYRTEKDINSAIDRILQ 191
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 41.9 bits (98), Expect = 2e-05
Identities = 14/77 (18%), Positives = 30/77 (38%), Gaps = 11/77 (14%)
Query: 1 TIIWHANEDNHPVLAPRGSTLELTATG-LLLKDPGGQAIWDEKPNKIVSD--AAMLDTGN 57
T +W +N L +G L + G ++ D G+++W + + + + GN
Sbjct: 38 TSVWASNTGI---LGKKGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGN 94
Query: 58 FVLIASGNHSDYAWQSF 74
V+ + W +
Sbjct: 95 VVI-----YGSDIWSTG 106
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 38.6 bits (89), Expect = 4e-04
Identities = 26/134 (19%), Positives = 39/134 (29%), Gaps = 27/134 (20%)
Query: 78 TDTILPTQILDLGSVLVSRLTETNLSKGRFELHFSNGSLEFIPVAWPSRFQYKSYYTSNT 137
+D + LD G L G + N + Y +
Sbjct: 1 SDRLNSGHQLDTGGSLAE---------GGYLFIIQNDC---------NLVLYDNNRAVWA 42
Query: 138 SSANSSESGHQLVFNESADIYIVKNNGQIVQLPLWAQLSPRADHYFRATLDFDGVFAEYA 197
S N SG L ++ I + I WA + R + + L D Y
Sbjct: 43 SGTNGKASGCVLKMQNDGNLVIYSGSRAI-----WASNTNRQNGNYYLILQRDRNVVIYD 97
Query: 198 HSKN----SSTNQG 207
+S N + TN G
Sbjct: 98 NSNNAIWATHTNVG 111
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 36.1 bits (83), Expect = 0.002
Identities = 15/140 (10%), Positives = 37/140 (26%), Gaps = 27/140 (19%)
Query: 69 YAWQSFKSPTDTILPTQILDLGSVLVSRLTETNLSKGRFELHF-SNGSLEFIPVAWPSRF 127
++ Q + + T+ L E + ++ +L
Sbjct: 5 FSKQPDDNHPQILHATESL-----------EILFGTHVYRFIMQTDCNL----------V 43
Query: 128 QYKSYYTSNTSSANSSESGHQLVFNESADIYIVKNNGQIVQLPLWAQLSPRADHYFRATL 187
Y + ++ +G + V + ++ N V W ++ L
Sbjct: 44 LYDNNNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTV----WQSPVAGKAGHYVLVL 99
Query: 188 DFDGVFAEYAHSK-NSSTNQ 206
D Y + + T +
Sbjct: 100 QPDRNVVIYGDALWATQTVR 119
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 728 | |||
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.84 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.38 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.38 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.37 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.35 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.27 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.12 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.07 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.97 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.82 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 98.7 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.66 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 98.48 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.06 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.55 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.41 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.21 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.31 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 94.33 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 93.6 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 93.13 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 92.96 | |
| d1lmja2 | 42 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 92.83 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 92.73 | |
| d2vj3a2 | 39 | Neurogenic locus notch homolog protein 1, Notch1 { | 92.41 | |
| d1uzka2 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 91.85 | |
| d2vj3a3 | 35 | Neurogenic locus notch homolog protein 1, Notch1 { | 90.93 | |
| d1edmb_ | 39 | Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606 | 90.7 | |
| d1i0ua2 | 41 | Low density lipoprotein (LDL) receptor, different | 90.68 | |
| d1uzka1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 90.11 | |
| d1gl4a2 | 40 | EGF-like domain of nidogen-1 {Mouse (Mus musculus) | 89.4 | |
| d1lmja1 | 44 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 89.17 | |
| d1autl1 | 48 | Activated protein c (autoprothrombin IIa) {Human ( | 88.42 | |
| d2c4fl1 | 37 | Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} | 87.89 | |
| d1g1ta2 | 39 | E-selectin, EGF-domain {Human (Homo sapiens) [TaxI | 87.69 | |
| d1g1sa2 | 40 | E-selectin, EGF-domain {Human (Homo sapiens) [TaxI | 87.4 | |
| d1apqa_ | 53 | Complement protease C1R {Human (Homo sapiens) [Tax | 87.02 | |
| d1dx5i3 | 40 | Thrombomodulin, different EGF-like domains {Human | 86.93 | |
| d1szba2 | 45 | Mannose-binding protein associated serine protease | 84.1 | |
| d1nt0a3 | 45 | Mannose-binding protein associated serine protease | 83.62 | |
| d3bpse1 | 40 | Low density lipoprotein (LDL) receptor, different | 80.99 | |
| d1q4ga2 | 42 | Prostaglandin H2 synthase-1, EGF-like module {Shee | 80.81 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-49 Score=411.24 Aligned_cols=268 Identities=25% Similarity=0.383 Sum_probs=205.8
Q ss_pred ccCHHHHHHHHhhHH-----------hhhCCCceeEEEEeeeeCCCC--cEEEEEEeccc-chhhHHHHHHHHHHhcccc
Q 047292 425 FFSYDELKDATDGFK-----------EELGRGSFGIVYKGVLKTASG--NAIAVKKLDRL-AQEREREFKSEVSAIGRTH 490 (728)
Q Consensus 425 ~~~~~el~~~~~~~~-----------~~lg~G~fg~Vy~g~~~~~~~--~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~ 490 (728)
.++++++.+++.+|. ++||+|+||+||+|.++..++ ..||||++... .....+.|.+|+++|++++
T Consensus 6 ~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~ 85 (299)
T d1jpaa_ 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 85 (299)
T ss_dssp GGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC
T ss_pred CCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC
Confidence 355667777776653 569999999999999864332 36899998653 3444578999999999999
Q ss_pred ccceeeEeeeeecCCcceeEeeccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEc
Q 047292 491 HKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLD 569 (728)
Q Consensus 491 h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~ 569 (728)
|||||+++|++......++||||+++|+|.+++... +.+++..++.++.||++||+|||++ +|+||||||+||||+
T Consensus 86 HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~ 162 (299)
T d1jpaa_ 86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVN 162 (299)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred CCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEEC
Confidence 999999999999999999999999999999988875 5789999999999999999999997 999999999999999
Q ss_pred CCCceEEccccCccccccCCCcc----cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhh
Q 047292 570 HYFSPKISDFGLSKLLLSDHSRT----HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEES 644 (728)
Q Consensus 570 ~~~~~kl~Dfgla~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~ 644 (728)
+++++||+|||+++......... .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+.
T Consensus 163 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~ 242 (299)
T d1jpaa_ 163 SNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV 242 (299)
T ss_dssp TTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred CCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999998775433221 122457899999999999999999999999999999998 8999976544332
Q ss_pred hhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 047292 645 RAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEV 712 (728)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 712 (728)
...+ ..+... ..+......+.+++.+||+.||++||||+||++.|+.+++-
T Consensus 243 ~~~i--------~~~~~~---------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 243 INAI--------EQDYRL---------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp HHHH--------HTTCCC---------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHH--------HcCCCC---------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 1111 111100 01122345677899999999999999999999999987653
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=404.57 Aligned_cols=252 Identities=28% Similarity=0.439 Sum_probs=196.4
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCC
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGN 516 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 516 (728)
.+.++||+|+||.||+|.++ +++.||||+++... ...++|.+|++++++++||||++++|+|...+..++||||+++
T Consensus 8 ~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~ 84 (263)
T d1sm2a_ 8 TFVQEIGSGQFGLVHLGYWL--NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 84 (263)
T ss_dssp EEEEEEECCSSCCEEEEEET--TTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred EEEEEEeeCCCeEEEEEEEC--CCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence 45678999999999999875 56789999997643 3456899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccccc
Q 047292 517 GTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM 595 (728)
Q Consensus 517 gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 595 (728)
|+|.+++... ..+++..++.++.||++||+|||++ +|+||||||+|||+++++++||+|||+++............
T Consensus 85 g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~ 161 (263)
T d1sm2a_ 85 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 161 (263)
T ss_dssp CBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---------------
T ss_pred CcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceeecc
Confidence 9999998765 5678999999999999999999997 99999999999999999999999999998776554444445
Q ss_pred ccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCC-cCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhc
Q 047292 596 IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCR-RSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMAD 674 (728)
Q Consensus 596 ~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 674 (728)
..||+.|+|||++.+..++.++|||||||++|||+|++ .|+......+....+ ..+.. ... +
T Consensus 162 ~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i--------~~~~~--~~~-------p 224 (263)
T d1sm2a_ 162 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI--------STGFR--LYK-------P 224 (263)
T ss_dssp ---CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHH--------HHTCC--CCC-------C
T ss_pred eecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHH--------HhcCC--CCC-------c
Confidence 67899999999999999999999999999999999965 455443332221111 11110 001 1
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 675 RSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 675 ~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
....+++.+++.+||+.||++||||+||++.|+++.+
T Consensus 225 ~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 1123467889999999999999999999999998653
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.9e-49 Score=408.61 Aligned_cols=259 Identities=28% Similarity=0.398 Sum_probs=213.6
Q ss_pred HHHHHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeE
Q 047292 431 LKDATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 510 (728)
Q Consensus 431 l~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 510 (728)
+....+.+.++||+|+||+||+|.++ .+++.||||+++... ...++|.+|++++++++|||||++++++.+....++|
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 91 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEG-GGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEEC-CCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence 34445566789999999999999986 467899999997543 3356799999999999999999999999999999999
Q ss_pred eeccCCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccC
Q 047292 511 YEFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD 588 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 588 (728)
|||+++|+|.+++... ..+++..++.++.||++||+|||++ +|+||||||+||||++++++||+|||+++.....
T Consensus 92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 9999999999999754 5788999999999999999999997 9999999999999999999999999999987665
Q ss_pred CCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhh-HhhhhhHHHHHHHhhhcCccceeccc
Q 047292 589 HSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELE-EESRAILTDWAYDCYVEGRLDALIDS 667 (728)
Q Consensus 589 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~d~ 667 (728)
.........|++.|+|||++.+..++.++|||||||++|||++|+.|+..... ..... ....+....
T Consensus 169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~--------~i~~~~~~~---- 236 (287)
T d1opja_ 169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE--------LLEKDYRME---- 236 (287)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH--------HHHTTCCCC----
T ss_pred CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHH--------HHhcCCCCC----
Confidence 55444556689999999999999999999999999999999998776653322 21111 111111111
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 668 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 668 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
.+....+.+.+++.+||+.||++||||+||++.|+.+.+
T Consensus 237 -----~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 237 -----RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp -----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred -----CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 111233567889999999999999999999999988764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-49 Score=401.64 Aligned_cols=256 Identities=25% Similarity=0.407 Sum_probs=199.9
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
+.+.++||+|+||+||+|+++ ..||||+++.. .....+.|.+|+.++++++|||||++++++.+ ...++||||
T Consensus 10 ~~~~~~lG~G~fg~Vy~~~~~----~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey 84 (276)
T d1uwha_ 10 ITVGQRIGSGSFGTVYKGKWH----GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW 84 (276)
T ss_dssp CCCCSEEEECSSCEEEEEESS----SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred EEEEEEEeeCCCcEEEEEEEC----CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence 445678999999999999764 36999998643 34456789999999999999999999999865 568999999
Q ss_pred cCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC-c
Q 047292 514 MGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS-R 591 (728)
Q Consensus 514 ~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-~ 591 (728)
+++|+|.+++... ..+++..++.++.||++||+|||++ +||||||||+||||++++++||+|||+|+....... .
T Consensus 85 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~ 161 (276)
T d1uwha_ 85 CEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161 (276)
T ss_dssp CCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred CCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence 9999999999765 5689999999999999999999997 999999999999999999999999999987654322 2
Q ss_pred ccccccCCccccCcccccCC---CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccch
Q 047292 592 THTMIRGTRGYVAPEWLKNA---PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSD 668 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~~---~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 668 (728)
......||+.|||||++.+. .++.++|||||||+||||+||+.||.......... ... ..+.....+
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~---~~~----~~~~~~p~~--- 231 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII---FMV----GRGYLSPDL--- 231 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH---HHH----HHTSCCCCG---
T ss_pred cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHH---HHH----hcCCCCCcc---
Confidence 33456799999999999643 58999999999999999999999997543322111 111 111111100
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 669 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 669 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
........+.+.+++.+||+.||++||||+||++.|+.+..
T Consensus 232 --~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 232 --SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp --GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11122234567889999999999999999999999988653
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-48 Score=395.10 Aligned_cols=244 Identities=27% Similarity=0.379 Sum_probs=206.2
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
+.+.+.||+|+||.||+|+.+ .+++.||+|++.... ......+.+|++++++++||||+++++++.+....++|||
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE 86 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREK-QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 86 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEecCCCcEEEEEEEC-CCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence 456688999999999999876 578899999986532 2335778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 513 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 513 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
|+++|+|.+++.....+++..+..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+|+......
T Consensus 87 y~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~--- 160 (263)
T d2j4za1 87 YAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--- 160 (263)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC---
T ss_pred ecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCCc---
Confidence 999999999999888899999999999999999999997 99999999999999999999999999998654332
Q ss_pred cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAM 672 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 672 (728)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ......
T Consensus 161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i--------~~~~~~---------- 222 (263)
T d2j4za1 161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI--------SRVEFT---------- 222 (263)
T ss_dssp CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--------HTTCCC----------
T ss_pred ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHH--------HcCCCC----------
Confidence 23456999999999999999999999999999999999999999865544322211 111110
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 673 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 673 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
.+....+.+.+++.+||+.||++|||++|+++
T Consensus 223 ~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 223 FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 01112346778999999999999999999986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-49 Score=403.04 Aligned_cols=252 Identities=27% Similarity=0.405 Sum_probs=205.3
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
.+.+.++||+|+||.||+|.++ +++.||||+++... ...+.|.+|++++++++|||||+++|++.+ +..++||||+
T Consensus 14 ~~~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 14 TLKLVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HeEEeEEEecCCCcEEEEEEEC--CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 4556688999999999999975 56789999997543 335679999999999999999999998865 5679999999
Q ss_pred CCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 515 GNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 515 ~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
++|+|.+++... ..+++..+++|+.||++||.|||++ +|+||||||+||||++++.+||+|||+|+.........
T Consensus 90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~ 166 (272)
T d1qpca_ 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (272)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCcccc
Confidence 999999988655 3689999999999999999999997 99999999999999999999999999999876554444
Q ss_pred cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcch-hhhHhhhhhHHHHHHHhhhcCccceeccchhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEM-ELEEESRAILTDWAYDCYVEGRLDALIDSDEAA 671 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 671 (728)
.....||+.|+|||++.+..++.++|||||||++|||+||+.|+.. ....+... ....+.-..
T Consensus 167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~--------~i~~~~~~~-------- 230 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ--------NLERGYRMV-------- 230 (272)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH--------HHHTTCCCC--------
T ss_pred ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHH--------HHHhcCCCC--------
Confidence 4556789999999999999999999999999999999997665543 32222111 111111110
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 047292 672 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710 (728)
Q Consensus 672 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 710 (728)
.+....+.+.+++.+||+.||++||||++|+++|+.+.
T Consensus 231 -~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 231 -RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 11122346778999999999999999999999998754
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-48 Score=396.68 Aligned_cols=248 Identities=25% Similarity=0.358 Sum_probs=205.8
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccC
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
|.+.++||+|+||+||+|..+ .+|+.||||+++.......+.+.+|++++++++|||||++++++...+..++||||++
T Consensus 22 Y~~~~~iG~G~fg~Vy~a~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 100 (293)
T d1yhwa1 22 YTRFEKIGQGASGTVYTAMDV-ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (293)
T ss_dssp BCSCEECCCSSSCEEEEEEBT-TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred cEEEEEEecCcCcEEEEEEEC-CCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecC
Confidence 455678999999999999876 5789999999976555556789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccccc
Q 047292 516 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM 595 (728)
Q Consensus 516 ~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 595 (728)
+|+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++....... ....
T Consensus 101 gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~~~ 175 (293)
T d1yhwa1 101 GGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRST 175 (293)
T ss_dssp TCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CBCC
T ss_pred CCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc-cccc
Confidence 9999998866 4689999999999999999999997 999999999999999999999999999987654332 2344
Q ss_pred ccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhcH
Q 047292 596 IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMADR 675 (728)
Q Consensus 596 ~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 675 (728)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ . ..+. .... .+.
T Consensus 176 ~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~---~----~~~~-~~~~-------~~~ 240 (293)
T d1yhwa1 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI---A----TNGT-PELQ-------NPE 240 (293)
T ss_dssp CCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---H----HHCS-CCCS-------SGG
T ss_pred cccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHH---H----hCCC-CCCC-------Ccc
Confidence 56999999999999999999999999999999999999999765433221111 0 1111 0000 011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 676 SRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 676 ~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
.....+.+++.+||+.||++|||++|+++
T Consensus 241 ~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22346778999999999999999999975
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-48 Score=396.58 Aligned_cols=250 Identities=28% Similarity=0.346 Sum_probs=202.0
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
+.+.++||+|+||+||+|+.+ .+++.||||+++... .+..+.+.+|++++++++||||+++++++.+....++||||+
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 85 (271)
T d1nvra_ 7 WDLVQTLGEGAYGEVQLAVNR-VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 85 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEecc
Confidence 445688999999999999876 568999999986533 233467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC-ccc
Q 047292 515 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS-RTH 593 (728)
Q Consensus 515 ~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~ 593 (728)
++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||+++++++||+|||+|+....... ...
T Consensus 86 ~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~ 162 (271)
T d1nvra_ 86 SGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 162 (271)
T ss_dssp TTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred CCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCccccc
Confidence 9999999998888899999999999999999999997 999999999999999999999999999997754432 334
Q ss_pred ccccCCccccCcccccCCCC-CCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhh
Q 047292 594 TMIRGTRGYVAPEWLKNAPV-SAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAM 672 (728)
Q Consensus 594 ~~~~gt~~y~aPE~~~~~~~-s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 672 (728)
....||+.|+|||++.+..+ +.++|||||||++|||+||+.||.......... .. ........ .
T Consensus 163 ~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~--~~-----~~~~~~~~--~------ 227 (271)
T d1nvra_ 163 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY--SD-----WKEKKTYL--N------ 227 (271)
T ss_dssp CCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH--HH-----HHTTCTTS--T------
T ss_pred cceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH--HH-----HhcCCCCC--C------
Confidence 45679999999999988876 578999999999999999999997543322111 00 01111000 0
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 673 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 673 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
........+.+++.+||+.||++|||++|+++
T Consensus 228 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 228 PWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00112345678999999999999999999865
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-48 Score=396.32 Aligned_cols=249 Identities=27% Similarity=0.374 Sum_probs=202.4
Q ss_pred hhhCCCceeEEEEeeeeC-CCCcEEEEEEecccc--hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCC
Q 047292 440 EELGRGSFGIVYKGVLKT-ASGNAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGN 516 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 516 (728)
++||+|+||+||+|.++. ..++.||||+++... ....+.|.+|++++++++|||||+++|+|.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999998763 345789999996532 2335689999999999999999999999965 467899999999
Q ss_pred CCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc--ccc
Q 047292 517 GTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR--THT 594 (728)
Q Consensus 517 gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~--~~~ 594 (728)
|+|.+++.....+++..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++........ ...
T Consensus 92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 168 (277)
T d1xbba_ 92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168 (277)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence 99999999988999999999999999999999997 9999999999999999999999999999877544332 223
Q ss_pred cccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhh
Q 047292 595 MIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMA 673 (728)
Q Consensus 595 ~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 673 (728)
...||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+.... ...+.....
T Consensus 169 ~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~--------i~~~~~~~~--------- 231 (277)
T d1xbba_ 169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM--------LEKGERMGC--------- 231 (277)
T ss_dssp --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH--------HHTTCCCCC---------
T ss_pred ccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHH--------HHcCCCCCC---------
Confidence 4568999999999999999999999999999999998 8999976544332211 112211111
Q ss_pred cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 047292 674 DRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGL 709 (728)
Q Consensus 674 ~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 709 (728)
+......+.+++.+||+.||++||||++|+++|+..
T Consensus 232 p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 112235677899999999999999999999998764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-48 Score=390.60 Aligned_cols=250 Identities=26% Similarity=0.416 Sum_probs=210.1
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCC
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGN 516 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 516 (728)
.+.++||+|+||+||+|+++ +++.||||+++... ...++|.+|+.++++++||||++++|+|.+.+..++||||+++
T Consensus 7 ~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~ 83 (258)
T d1k2pa_ 7 TFLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 83 (258)
T ss_dssp CCCCCCCEETTEEEEEEEET--TTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred EEeEEEecCCCeEEEEEEEC--CCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCC
Confidence 45688999999999999975 67899999997643 3456899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccccc
Q 047292 517 GTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHTM 595 (728)
Q Consensus 517 gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 595 (728)
|+|.+++... ..+++..+++++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++............
T Consensus 84 g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 160 (258)
T d1k2pa_ 84 GCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 160 (258)
T ss_dssp EEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCC
T ss_pred CcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceeecc
Confidence 9999997765 5788999999999999999999997 99999999999999999999999999998776555444455
Q ss_pred ccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhc
Q 047292 596 IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMAD 674 (728)
Q Consensus 596 ~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 674 (728)
..||+.|+|||.+.+..++.++||||||+++|||+| |+.||......+....+ ..+... .. +
T Consensus 161 ~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i--------~~~~~~--~~-------p 223 (258)
T d1k2pa_ 161 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI--------AQGLRL--YR-------P 223 (258)
T ss_dssp SCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH--------HTTCCC--CC-------C
T ss_pred cCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHH--------HhCCCC--CC-------c
Confidence 678999999999999999999999999999999998 78899866544322211 111111 11 1
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 047292 675 RSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGL 709 (728)
Q Consensus 675 ~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 709 (728)
....+.+.+++.+||+.||++|||+++|++.|.++
T Consensus 224 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 12234677899999999999999999999998653
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-48 Score=399.04 Aligned_cols=257 Identities=27% Similarity=0.417 Sum_probs=200.0
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCC---cEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASG---NAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
.+.+.||+|+||.||+|.++..++ ..||||+++... .....+|.+|++++++++|||||+++|++.+....++|||
T Consensus 10 ~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e 89 (283)
T d1mqba_ 10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITE 89 (283)
T ss_dssp EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEE
Confidence 345789999999999999875433 479999996543 3345679999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 513 FMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 513 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
|+.++++.+++... ..+++..++.++.||+.||+|||++ +|+||||||+||||++++.+||+|||+++........
T Consensus 90 ~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~ 166 (283)
T d1mqba_ 90 YMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 166 (283)
T ss_dssp CCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred ecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCCCcc
Confidence 99999999988765 6789999999999999999999997 9999999999999999999999999999876543322
Q ss_pred --ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchh-hhHhhhhhHHHHHHHhhhcCccceeccch
Q 047292 592 --THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEME-LEEESRAILTDWAYDCYVEGRLDALIDSD 668 (728)
Q Consensus 592 --~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 668 (728)
......||+.|+|||++.+..++.++|||||||++|||++++.|+... ...+.. .....+...
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~--------~~i~~~~~~------ 232 (283)
T d1mqba_ 167 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM--------KAINDGFRL------ 232 (283)
T ss_dssp -------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH--------HHHHTTCCC------
T ss_pred ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHH--------HHHhccCCC------
Confidence 223356899999999999999999999999999999999976665433 222211 111121111
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCC
Q 047292 669 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVP 713 (728)
Q Consensus 669 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~ 713 (728)
..+......+.+++.+||+.||++||||+||+++|+.+++.|
T Consensus 233 ---~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p 274 (283)
T d1mqba_ 233 ---PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274 (283)
T ss_dssp ---CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred ---CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence 111123356788999999999999999999999999887654
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=389.03 Aligned_cols=247 Identities=28% Similarity=0.402 Sum_probs=197.3
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeeec----CCcceeE
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDE----ALNRLLV 510 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lv 510 (728)
.|.++||+|+||+||+|..+ .+++.||+|++... .....+.|.+|++++++++|||||++++++.. ....++|
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~-~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDT-ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEEC-CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 34568999999999999876 57889999998653 23445679999999999999999999999864 3457999
Q ss_pred eeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEc-CCCceEEccccCccccccCC
Q 047292 511 YEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLD-HYFSPKISDFGLSKLLLSDH 589 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~-~~~~~kl~Dfgla~~~~~~~ 589 (728)
|||+++|+|.+++.....+++..+..++.||++||+|||++ +.+|+||||||+|||++ +++.+||+|||+++.....
T Consensus 91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~- 168 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 168 (270)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-
Confidence 99999999999999888899999999999999999999986 12399999999999996 5889999999999864332
Q ss_pred CcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchh
Q 047292 590 SRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDE 669 (728)
Q Consensus 590 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 669 (728)
......||+.|+|||++.+ +++.++|||||||++|||++|+.||........ .......+.....+
T Consensus 169 --~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~-------~~~~i~~~~~~~~~---- 234 (270)
T d1t4ha_ 169 --FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-------IYRRVTSGVKPASF---- 234 (270)
T ss_dssp --SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-------HHHHHTTTCCCGGG----
T ss_pred --ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH-------HHHHHHcCCCCccc----
Confidence 2234679999999999876 599999999999999999999999964322211 11111111111111
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 670 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 670 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
+....+++.+++.+||+.||++|||++|+++
T Consensus 235 ----~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 235 ----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----CccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1112335778999999999999999999976
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-48 Score=395.98 Aligned_cols=260 Identities=23% Similarity=0.364 Sum_probs=204.5
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
.+.+.+.||+|+||.||+|.++ +++.||||+++... ...+.|.+|+.++++++|+|||+++|++.+ +..++||||+
T Consensus 18 ~~~i~~~iG~G~fg~Vy~~~~~--~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 18 SLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GEEEEEEEEECSSCEEEEEEET--TTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HEEEeeEEeeCCCeEEEEEEEC--CCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 4567788999999999999885 45689999997543 345789999999999999999999999854 5689999999
Q ss_pred CCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 515 GNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 515 ~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
++|+|..++... ..+++..++.++.||+.||+|||++ +|+||||||+||||++++++||+|||+++.........
T Consensus 94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence 999999998754 5789999999999999999999997 99999999999999999999999999998775554444
Q ss_pred cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchh-hhHhhhhhHHHHHHHhhhcCccceeccchhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEME-LEEESRAILTDWAYDCYVEGRLDALIDSDEAA 671 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 671 (728)
.....||+.|+|||++.+..++.++||||||+++|||+||+.|+... ...+.... ...+...
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~--------i~~~~~~--------- 233 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ--------VERGYRM--------- 233 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH--------HHTTCCC---------
T ss_pred eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHH--------HHhcCCC---------
Confidence 45567899999999999999999999999999999999977665433 22221111 1111111
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCCCCC
Q 047292 672 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNPPWS 718 (728)
Q Consensus 672 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~~~~ 718 (728)
..+....+++.+++.+||+.||++||+|++|+++|+..+....|+++
T Consensus 234 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~ 280 (285)
T d1fmka3 234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 280 (285)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCC
T ss_pred CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCC
Confidence 11122334678899999999999999999999999998876666554
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-48 Score=403.65 Aligned_cols=265 Identities=23% Similarity=0.319 Sum_probs=204.0
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc-chhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
..+.+.++||+|+||+||+|... .+++.||+|+++.. .......+.+|+.+|++++|||||++++++.+....++|||
T Consensus 6 d~y~~~~~iG~G~fg~V~~~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKVSHK-PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEEEET-TTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCCEEEEEEecCCCeEEEEEEEC-CCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 34556688999999999999876 57899999998653 23445789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 513 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 513 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
|+++|+|.+++.+...+++..+..++.||+.||.|||++ .+|+||||||+||||++++++||+|||+|+......
T Consensus 85 y~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~--- 159 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 159 (322)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT---
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc---
Confidence 999999999999888899999999999999999999973 279999999999999999999999999998764322
Q ss_pred cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhh---------------
Q 047292 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYV--------------- 657 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------------- 657 (728)
.....||+.|+|||++.+.+++.++|||||||++|||++|+.||.....................
T Consensus 160 ~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
T d1s9ja_ 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239 (322)
T ss_dssp C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------
T ss_pred cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccc
Confidence 23457999999999999999999999999999999999999999754332211100000000000
Q ss_pred ---cC----ccceeccchh----hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 658 ---EG----RLDALIDSDE----AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 658 ---~~----~~~~~~d~~~----~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
.. ...+..+... ..........++.+++.+||+.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 00 0000000000 00000011346788999999999999999999986
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=391.17 Aligned_cols=250 Identities=23% Similarity=0.329 Sum_probs=192.3
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeeec--CCcceeEe
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDE--ALNRLLVY 511 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lv~ 511 (728)
+.+.+.||+|+||+||+|+.+ .+|+.||||+++.. .....+.+.+|++++++++|||||++++++.+ ....++||
T Consensus 6 y~~~~~iG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivm 84 (269)
T d2java1 6 YEVLYTIGTGSYGRCQKIRRK-SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 84 (269)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEE
T ss_pred CEEeEEEecCCCeEEEEEEEC-CCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEE
Confidence 456688999999999999876 57899999998653 23445779999999999999999999999854 45679999
Q ss_pred eccCCCCHHHHHhc----CCCCChHHHHHHHHHHHHHHHHhhhcC--CCCeeecCCCCCCEEEcCCCceEEccccCcccc
Q 047292 512 EFMGNGTLANLIFA----IPKPDWNLRVRISLEIARGLVYLHEGC--NVPIIHCDIKPQNILLDHYFSPKISDFGLSKLL 585 (728)
Q Consensus 512 e~~~~gsL~~~l~~----~~~~~~~~~~~i~~qi~~~l~yLH~~~--~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~ 585 (728)
||+++|+|.+++.. ...+++..++.++.||+.||.|||++. ..+|+||||||+||||+.++.+||+|||+++..
T Consensus 85 Ey~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~ 164 (269)
T d2java1 85 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 164 (269)
T ss_dssp ECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC
T ss_pred ecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeec
Confidence 99999999999864 357899999999999999999999862 124999999999999999999999999999887
Q ss_pred ccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceec
Q 047292 586 LSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALI 665 (728)
Q Consensus 586 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (728)
..... ......||+.|+|||++.+..++.++|||||||++|||+||+.||......+.... ...+....+.
T Consensus 165 ~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~--------i~~~~~~~~~ 235 (269)
T d2java1 165 NHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK--------IREGKFRRIP 235 (269)
T ss_dssp ------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH--------HHHTCCCCCC
T ss_pred ccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHH--------HHcCCCCCCC
Confidence 54332 23346799999999999999999999999999999999999999986544332211 1222222111
Q ss_pred cchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 666 DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 666 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
....+++.+++.+||+.||++|||++|+++
T Consensus 236 ---------~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 236 ---------YRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---------cccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 122346778999999999999999999975
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=391.55 Aligned_cols=248 Identities=25% Similarity=0.361 Sum_probs=202.8
Q ss_pred hhCCCceeEEEEeeeeC-CCCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccCCCC
Q 047292 441 ELGRGSFGIVYKGVLKT-ASGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGT 518 (728)
Q Consensus 441 ~lg~G~fg~Vy~g~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 518 (728)
+||+|+||.||+|.++. .++..||||+++... ....+.|.+|+++|++++|||||+++|++.. +..++||||+++|+
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~ 94 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 94 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence 49999999999998753 334579999997543 3445789999999999999999999999975 46899999999999
Q ss_pred HHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc--cccc
Q 047292 519 LANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR--THTM 595 (728)
Q Consensus 519 L~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~--~~~~ 595 (728)
|.+++... ..+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++........ ....
T Consensus 95 L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~ 171 (285)
T d1u59a_ 95 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 171 (285)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCS
T ss_pred HHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcccccccccccccc
Confidence 99998764 5789999999999999999999997 9999999999999999999999999999987544322 2233
Q ss_pred ccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhhhc
Q 047292 596 IRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAMAD 674 (728)
Q Consensus 596 ~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 674 (728)
..||+.|+|||++.+..++.++|||||||++|||+| |+.||......+... ....+..... +
T Consensus 172 ~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~--------~i~~~~~~~~---------p 234 (285)
T d1u59a_ 172 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA--------FIEQGKRMEC---------P 234 (285)
T ss_dssp SCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH--------HHHTTCCCCC---------C
T ss_pred cccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHH--------HHHcCCCCCC---------C
Confidence 568999999999999999999999999999999998 899997654333221 1122221111 1
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 047292 675 RSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGL 709 (728)
Q Consensus 675 ~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 709 (728)
......+.+++.+||+.||++||||.+|++.|+..
T Consensus 235 ~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 235 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 12335677899999999999999999999999764
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-48 Score=396.31 Aligned_cols=249 Identities=24% Similarity=0.308 Sum_probs=204.3
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccC
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
+.+.++||+|+||.||+|..+ .+++.||||+++.......+.+.+|++++++++|||||++++++.+.+..++||||++
T Consensus 14 Y~i~~~iG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~ 92 (288)
T d2jfla1 14 WEIIGELGDGAFGKVYKAQNK-ETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 92 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eEEeEEEeeCCCcEEEEEEEC-CCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCC
Confidence 445678999999999999876 5788999999976655666789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccc
Q 047292 516 NGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHT 594 (728)
Q Consensus 516 ~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 594 (728)
+|+|.+++.+. ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++++||+|||+|+....... ...
T Consensus 93 ~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~-~~~ 168 (288)
T d2jfla1 93 GGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RRD 168 (288)
T ss_dssp TEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-HHT
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCcc-ccc
Confidence 99999997654 5689999999999999999999997 999999999999999999999999999976533221 223
Q ss_pred cccCCccccCccccc-----CCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchh
Q 047292 595 MIRGTRGYVAPEWLK-----NAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDE 669 (728)
Q Consensus 595 ~~~gt~~y~aPE~~~-----~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 669 (728)
...||+.|+|||++. +..++.++|||||||++|||+||+.||......+....+ ..+....+..
T Consensus 169 ~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i--------~~~~~~~~~~--- 237 (288)
T d2jfla1 169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI--------AKSEPPTLAQ--- 237 (288)
T ss_dssp CCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH--------HHSCCCCCSS---
T ss_pred ccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHH--------HcCCCCCCCc---
Confidence 456999999999984 456899999999999999999999999765443322111 1111111111
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 670 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 670 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
+......+.+++.+||+.||++|||++|+++
T Consensus 238 ----~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 238 ----PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1122346778999999999999999999876
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-48 Score=395.47 Aligned_cols=247 Identities=24% Similarity=0.289 Sum_probs=204.0
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
+.+.+.||+|+||+||+|..+ .+++.||||+++... ....+.+.+|++++++++||||+++++++.+....|+|||
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE 88 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLAREL-ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 88 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred CEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEE
Confidence 556789999999999999876 568999999996532 2334679999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC-c
Q 047292 513 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS-R 591 (728)
Q Consensus 513 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-~ 591 (728)
|+++|+|.+++.....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+....... .
T Consensus 89 y~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 165 (288)
T d1uu3a_ 89 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 165 (288)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred ccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence 999999999999888999999999999999999999997 999999999999999999999999999987754332 2
Q ss_pred ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhh
Q 047292 592 THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAA 671 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 671 (728)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ ..+... +
T Consensus 166 ~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i--------~~~~~~--~------ 229 (288)
T d1uu3a_ 166 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI--------IKLEYD--F------ 229 (288)
T ss_dssp ----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HTTCCC--C------
T ss_pred ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHH--------HcCCCC--C------
Confidence 334467999999999999999999999999999999999999999865443322211 111110 1
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 672 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 672 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
+....+.+.+++.+||+.||++|||++|+++
T Consensus 230 --p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 230 --PEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp --CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred --CccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 1112345778999999999999999998643
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-47 Score=400.63 Aligned_cols=255 Identities=25% Similarity=0.334 Sum_probs=204.0
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeCCCC----cEEEEEEecccc-hhhHHHHHHHHHHhccc-cccceeeEeeeeecCCcc
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKTASG----NAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNR 507 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~----~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 507 (728)
..+.+.++||+|+||+||+|.+...+. ..||+|++.... ......+.+|+.++.++ +|||||++++++.+....
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 345567899999999999998863322 369999986533 33346789999999998 899999999999999999
Q ss_pred eeEeeccCCCCHHHHHhcCC-----------------------CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCC
Q 047292 508 LLVYEFMGNGTLANLIFAIP-----------------------KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQ 564 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~ 564 (728)
++||||+++|+|.++|.... .+++..++.++.||++||+|||++ +||||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchh
Confidence 99999999999999997642 478899999999999999999997 9999999999
Q ss_pred CEEEcCCCceEEccccCccccccCCCc-ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhH
Q 047292 565 NILLDHYFSPKISDFGLSKLLLSDHSR-THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEE 642 (728)
Q Consensus 565 NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~ 642 (728)
|||++.++++||+|||+|+........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||......
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999999876554332 2334568999999999999999999999999999999998 89999754332
Q ss_pred hhhhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 047292 643 ESRAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLE 707 (728)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~ 707 (728)
.... .. ...+.-. ..+....+.+.+++.+||+.||++||||+||+++|.
T Consensus 274 ~~~~---~~----~~~~~~~---------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 ANFY---KL----IQNGFKM---------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHHH---HH----HHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHH---HH----HhcCCCC---------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 2111 11 1111100 111122356788999999999999999999999995
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.2e-47 Score=393.02 Aligned_cols=250 Identities=26% Similarity=0.351 Sum_probs=191.2
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
|.+.+.||+|+||+||+|..+ .+++.||||++.... ......+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 11 Y~~~~~lG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~ 89 (307)
T d1a06a_ 11 YDFRDVLGTGAFSEVILAEDK-RTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLV 89 (307)
T ss_dssp EEEEEESBSGGGGGEEEEEET-TTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred eEEEEEEeeccCeEEEEEEEC-CCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 566788999999999999876 578899999986533 233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEc---CCCceEEccccCccccccCCCc
Q 047292 515 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLD---HYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 515 ~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~---~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||+. +++.+||+|||+++......
T Consensus 90 ~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~-- 164 (307)
T d1a06a_ 90 SGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS-- 164 (307)
T ss_dssp CSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred CCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCCC--
Confidence 9999999999888999999999999999999999997 999999999999995 57899999999998654322
Q ss_pred ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhh
Q 047292 592 THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAA 671 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 671 (728)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ ..+... +..
T Consensus 165 ~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i--------~~~~~~--~~~---- 230 (307)
T d1a06a_ 165 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI--------LKAEYE--FDS---- 230 (307)
T ss_dssp --------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--------HTTCCC--CCT----
T ss_pred eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH--------hccCCC--CCC----
Confidence 233456999999999999999999999999999999999999999765443322111 111110 000
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 672 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 672 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.......+.+.+++.+||+.||++|||++|+++.
T Consensus 231 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 231 PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0111223467789999999999999999999873
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-46 Score=391.04 Aligned_cols=245 Identities=24% Similarity=0.298 Sum_probs=202.3
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEe
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 511 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 511 (728)
.+...++||+|+||+||+|... .+++.||||+++... ....+.+.+|+.++++++|||||++++++.+....++||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDV-RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEEC-CCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 3455678999999999999876 578899999986432 233467999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 512 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 512 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
||+++|+|..++.....+++..+..++.||+.||.|||++ +|+||||||+||||++++++||+|||+|+.....
T Consensus 95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~--- 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (309)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC---
Confidence 9999999988888888899999999999999999999997 9999999999999999999999999999865332
Q ss_pred ccccccCCccccCcccccC---CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccch
Q 047292 592 THTMIRGTRGYVAPEWLKN---APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSD 668 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~---~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 668 (728)
....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||...........+ ..+.......
T Consensus 169 --~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i--------~~~~~~~~~~-- 236 (309)
T d1u5ra_ 169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--------AQNESPALQS-- 236 (309)
T ss_dssp --CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--------HHSCCCCCSC--
T ss_pred --CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHH--------HhCCCCCCCC--
Confidence 23569999999999864 46899999999999999999999999755433221111 1111111111
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 669 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 669 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
....+.+.+++.+||+.||.+|||++|+++
T Consensus 237 ------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 237 ------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ------CCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 112346778999999999999999999976
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.6e-46 Score=395.05 Aligned_cols=251 Identities=24% Similarity=0.352 Sum_probs=208.2
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
.|.+.+.||+|+||.||+|..+ .+|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..++||||+
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~-~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTER-ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEET-TTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred CeEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 3566788999999999999876 578999999997766666788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEc--CCCceEEccccCccccccCCCc
Q 047292 515 GNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLD--HYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 515 ~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~--~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
++|+|.+++... ..+++..+..++.||+.||+|||++ +||||||||+|||++ .++.+||+|||+++......
T Consensus 106 ~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~-- 180 (350)
T d1koaa2 106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-- 180 (350)
T ss_dssp CSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS--
T ss_pred CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccccc--
Confidence 999999999654 5799999999999999999999997 999999999999996 46889999999998764332
Q ss_pred ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhh
Q 047292 592 THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAA 671 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 671 (728)
......||+.|||||++.+..++.++|||||||++|||++|+.||......+....+. .... .+.....
T Consensus 181 ~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~--------~~~~--~~~~~~~- 249 (350)
T d1koaa2 181 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK--------SCDW--NMDDSAF- 249 (350)
T ss_dssp CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--------HTCC--CSCCGGG-
T ss_pred ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH--------hCCC--CCCcccc-
Confidence 2344679999999999999999999999999999999999999998665443222111 1110 0011111
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 672 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 672 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
....+.+.+++.+||+.||++|||++|+++.
T Consensus 250 ---~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 250 ---SGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp ---GGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ---cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1123457789999999999999999999874
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.5e-46 Score=392.88 Aligned_cols=250 Identities=27% Similarity=0.348 Sum_probs=207.5
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccC
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
|.+.++||+|+||.||+|..+ .+|+.||||+++.........+.+|+.+|++++|||||++++++.+....++||||++
T Consensus 31 Y~i~~~lG~G~fg~V~~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 109 (352)
T d1koba_ 31 YDILEELGSGAFGVVHRCVEK-ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 109 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred eEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 556789999999999999876 5789999999977655566788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEc--CCCceEEccccCccccccCCCcc
Q 047292 516 NGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLD--HYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 516 ~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~--~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
+|+|.+++... ..+++..+..|+.||+.||+|||++ +|+||||||+||||+ .++.+||+|||+|+...... .
T Consensus 110 gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~--~ 184 (352)
T d1koba_ 110 GGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--I 184 (352)
T ss_dssp CCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS--C
T ss_pred CChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCC--c
Confidence 99999988765 4689999999999999999999997 999999999999998 67899999999998775432 2
Q ss_pred cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAM 672 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 672 (728)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||...........+ ..+... +.. .
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i--------~~~~~~--~~~----~ 250 (352)
T d1koba_ 185 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV--------KRCDWE--FDE----D 250 (352)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH--------HHCCCC--CCS----S
T ss_pred eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------HhCCCC--CCc----c
Confidence 34456899999999999999999999999999999999999999865443322111 111110 000 0
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 673 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 673 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
........+.+++.+||+.||.+|||++|+++.
T Consensus 251 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 251 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111223467789999999999999999999873
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-46 Score=388.42 Aligned_cols=256 Identities=24% Similarity=0.394 Sum_probs=208.4
Q ss_pred hhHHhhhCCCceeEEEEeeeeC----CCCcEEEEEEecccch-hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeE
Q 047292 436 DGFKEELGRGSFGIVYKGVLKT----ASGNAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 510 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~----~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 510 (728)
+.+.++||+|+||+||+|+.+. .+++.||||+++.... +..++|.+|++++++++||||++++++|......+++
T Consensus 15 ~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v 94 (301)
T d1lufa_ 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL 94 (301)
T ss_dssp CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred cEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEE
Confidence 4456889999999999998763 3457899999975433 3457899999999999999999999999999999999
Q ss_pred eeccCCCCHHHHHhcC------------------------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCE
Q 047292 511 YEFMGNGTLANLIFAI------------------------PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNI 566 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~------------------------~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NI 566 (728)
|||+++|+|.+++... ..+++..++.|+.||+.||+|||++ +||||||||+||
T Consensus 95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~NI 171 (301)
T d1lufa_ 95 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNC 171 (301)
T ss_dssp EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred EEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccce
Confidence 9999999999999743 2378889999999999999999997 999999999999
Q ss_pred EEcCCCceEEccccCccccccCCC-cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCC-cCcchhhhHhh
Q 047292 567 LLDHYFSPKISDFGLSKLLLSDHS-RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCR-RSVEMELEEES 644 (728)
Q Consensus 567 ll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~-~p~~~~~~~~~ 644 (728)
|++.++++||+|||+++....... .......|++.|+|||.+.+..++.++|||||||++|||++|. .||......+.
T Consensus 172 Lld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~ 251 (301)
T d1lufa_ 172 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 251 (301)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred EECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHH
Confidence 999999999999999987644332 2334456889999999999999999999999999999999996 56665544332
Q ss_pred hhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 645 RAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
.. ...++...... .....++.+++.+||+.+|++||||.||+++|+++.+
T Consensus 252 ~~--------~v~~~~~~~~p---------~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 252 IY--------YVRDGNILACP---------ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp HH--------HHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HH--------HHHcCCCCCCC---------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 21 12223222211 1223467789999999999999999999999998764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-46 Score=384.64 Aligned_cols=250 Identities=24% Similarity=0.320 Sum_probs=205.8
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch------hhHHHHHHHHHHhccccccceeeEeeeeecCCcce
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ------EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRL 508 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 508 (728)
.|.+.++||+|+||+||+|..+ .+|+.||||+++.... ...+.+.+|+.+|++++|||||++++++.+....+
T Consensus 11 ~Y~~~~~lG~G~fg~Vy~~~~~-~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 11 YYDTGEELGSGQFAVVKKCREK-STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp TEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CEEEeEEEecCCCeEEEEEEEC-CCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 3566788999999999999876 5789999999854221 23578999999999999999999999999999999
Q ss_pred eEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCC----ceEEccccCccc
Q 047292 509 LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYF----SPKISDFGLSKL 584 (728)
Q Consensus 509 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~----~~kl~Dfgla~~ 584 (728)
|||||+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++.
T Consensus 90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhhhh
Confidence 9999999999999998888899999999999999999999997 999999999999998776 599999999987
Q ss_pred cccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCcccee
Q 047292 585 LLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDAL 664 (728)
Q Consensus 585 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (728)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ......
T Consensus 167 ~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i--------~~~~~~-- 234 (293)
T d1jksa_ 167 IDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV--------SAVNYE-- 234 (293)
T ss_dssp CTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HTTCCC--
T ss_pred cCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHH--------HhcCCC--
Confidence 64332 233456899999999999999999999999999999999999999865544322211 111110
Q ss_pred ccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 665 IDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 665 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
+.. .........+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 235 FED----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CCH----HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCc----hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 011112346778999999999999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=386.24 Aligned_cols=255 Identities=20% Similarity=0.306 Sum_probs=196.5
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCC--CcEEEEEEecccch-hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEe
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTAS--GNAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 511 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~--~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 511 (728)
.+.+.+.||+|+||.||+|++.... +..||||+++.... ...+.|.+|+.++++++||||++++|++. ....++||
T Consensus 8 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~ 86 (273)
T d1mp8a_ 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIM 86 (273)
T ss_dssp GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEE
Confidence 4556788999999999999876333 35789999865433 33567999999999999999999999996 46789999
Q ss_pred eccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC
Q 047292 512 EFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 512 e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 590 (728)
||+++|+|.+++... ..+++..++.++.||++||.|||++ +|+||||||+||++++++.+||+|||+++.......
T Consensus 87 E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~ 163 (273)
T d1mp8a_ 87 ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 163 (273)
T ss_dssp ECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred EeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCCcc
Confidence 999999999987664 5789999999999999999999997 999999999999999999999999999987755544
Q ss_pred cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchh
Q 047292 591 RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDE 669 (728)
Q Consensus 591 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 669 (728)
.......||+.|+|||.+.+..++.++|||||||++|||+| |..||......+.... ...+.....
T Consensus 164 ~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~--------i~~~~~~~~----- 230 (273)
T d1mp8a_ 164 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR--------IENGERLPM----- 230 (273)
T ss_dssp -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH--------HHTTCCCCC-----
T ss_pred eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHH--------HHcCCCCCC-----
Confidence 44455678999999999999999999999999999999998 7888876554432211 112211111
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 047292 670 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710 (728)
Q Consensus 670 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 710 (728)
+......+.+++.+||+.||++|||++||++.|+.++
T Consensus 231 ----~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 231 ----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1123356788999999999999999999999998765
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=380.00 Aligned_cols=246 Identities=27% Similarity=0.369 Sum_probs=194.5
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeec-CCcceeEeecc
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDE-ALNRLLVYEFM 514 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lv~e~~ 514 (728)
+.+.+.||+|+||.||+|.++ |..||||+++.. ...+.|.+|++++++++||||++++|+|.+ ....++||||+
T Consensus 9 ~~~~~~lG~G~fg~Vy~~~~~---~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 9 LKLLQTIGKGEFGDVMLGDYR---GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp EEEEEEEEECSSCEEEEEEET---TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred eEEeEEEecCCCeEEEEEEEC---CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 345678999999999999874 678999999763 345679999999999999999999999854 56689999999
Q ss_pred CCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 515 GNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 515 ~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
++|+|.+++... ..+++..+++|+.||+.||.|||+. +|+||||||+|||++.++++||+|||+++.....
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---- 156 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 156 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC----
Confidence 999999999765 3589999999999999999999997 9999999999999999999999999999865332
Q ss_pred cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAA 671 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 671 (728)
.....++..|+|||++.+..++.++||||||+++|||+| |+.|+...........+ ..+....+
T Consensus 157 ~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i--------~~~~~~~~------- 221 (262)
T d1byga_ 157 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV--------EKGYKMDA------- 221 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH--------TTTCCCCC-------
T ss_pred CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHH--------HcCCCCCC-------
Confidence 223457889999999999999999999999999999998 67777655433322111 11111111
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 047292 672 MADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710 (728)
Q Consensus 672 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 710 (728)
+.....++.+++.+||+.||.+||||.+|+++|+.+.
T Consensus 222 --~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 222 --PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp --CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 1122346778999999999999999999999998764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-45 Score=384.37 Aligned_cols=246 Identities=26% Similarity=0.298 Sum_probs=206.8
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
+.+.+.||+|+||.||+++.+ .+++.||||++++.. ....+.+.+|+.+|++++||||+++++++.+....++|||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~-~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~e 85 (337)
T d1o6la_ 7 FDYLKLLGKGTFGKVILVREK-ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccccee
Confidence 445678999999999999876 578999999996532 2335778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 513 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 513 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
|+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||+++++++||+|||+|+....... .
T Consensus 86 y~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~-~ 161 (337)
T d1o6la_ 86 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-T 161 (337)
T ss_dssp CCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-C
T ss_pred ccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCCc-c
Confidence 999999999999988999999999999999999999997 999999999999999999999999999987643322 2
Q ss_pred cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAM 672 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 672 (728)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ ..+.+ .
T Consensus 162 ~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i--------~~~~~-~--------- 223 (337)
T d1o6la_ 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI--------LMEEI-R--------- 223 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHCCC-C---------
T ss_pred cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHH--------hcCCC-C---------
Confidence 34467999999999999999999999999999999999999999876554332211 11111 0
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 047292 673 ADRSRLHKWLMIAMWCIQEDPSKRPT-----MKVVMQ 704 (728)
Q Consensus 673 ~~~~~~~~l~~l~~~cl~~dp~~RPt-----~~evl~ 704 (728)
.+......+.+++.+||+.||.+||+ ++|+++
T Consensus 224 ~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 224 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 01112345778999999999999994 888876
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-46 Score=378.76 Aligned_cols=254 Identities=26% Similarity=0.326 Sum_probs=196.4
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCC--cEEEEEEeccc---chhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeE
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASG--NAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 510 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~--~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 510 (728)
+.+.+.||+|+||.||+|++...++ ..||||+++.. ..+..+.|.+|+.++++++||||++++|++.+ ...++|
T Consensus 10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv 88 (273)
T d1u46a_ 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMV 88 (273)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhee
Confidence 4566889999999999998865544 37899998653 23345789999999999999999999999976 467899
Q ss_pred eeccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCC
Q 047292 511 YEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH 589 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 589 (728)
|||+++|+|.+++... ..+++..++.++.||++||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 89 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 89 TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp EECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred eeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence 9999999999887764 5689999999999999999999997 99999999999999999999999999999875443
Q ss_pred Cc--ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceecc
Q 047292 590 SR--THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALID 666 (728)
Q Consensus 590 ~~--~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 666 (728)
.. ......|+..|+|||.+.+..++.++||||||+++|||+| |+.||......+....+ ...+.....
T Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i-------~~~~~~~~~-- 236 (273)
T d1u46a_ 166 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI-------DKEGERLPR-- 236 (273)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-------HTSCCCCCC--
T ss_pred CcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHH-------HhCCCCCCC--
Confidence 32 2334568889999999999999999999999999999998 89999765544322111 111111111
Q ss_pred chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 047292 667 SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGL 709 (728)
Q Consensus 667 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 709 (728)
.......+.+++.+||+.||++||||++|+++|++.
T Consensus 237 -------~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 237 -------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111224677899999999999999999999999763
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=382.78 Aligned_cols=256 Identities=26% Similarity=0.441 Sum_probs=203.3
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCC--cEEEEEEeccc-chhhHHHHHHHHHHhccccccceeeEeeeeec-CCcceeEee
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASG--NAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKNLVQLLGFCDE-ALNRLLVYE 512 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~--~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lv~e 512 (728)
+|.++||+|+||+||+|.+...++ ..||||+++.. .....++|.+|++++++++||||++++|++.. +...++|||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 345789999999999999864433 36899999753 34455789999999999999999999999865 567899999
Q ss_pred ccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 513 FMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 513 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
|+++|+|.+++... ...++..+++++.|+++||.|||+. +|+||||||+||||++++.+||+|||+++........
T Consensus 110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999999998865 4677888999999999999999997 9999999999999999999999999999877543322
Q ss_pred ---ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccch
Q 047292 592 ---THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSD 668 (728)
Q Consensus 592 ---~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 668 (728)
......||+.|+|||.+.+..++.++||||||+++|||+||+.|+........ +... ...+.-.. .+
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~---~~~~----i~~g~~~~--~p- 256 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVY----LLQGRRLL--QP- 256 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---------CHHH----HHTTCCCC--CC-
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH---HHHH----HHcCCCCC--Cc-
Confidence 22335689999999999999999999999999999999998888764432211 1111 11121111 11
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 669 EAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 669 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
......+.+++.+||+.||++||+|+||++.|+.++.
T Consensus 257 ------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 257 ------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp ------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1123467789999999999999999999999998864
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.2e-45 Score=379.49 Aligned_cols=243 Identities=23% Similarity=0.301 Sum_probs=205.3
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
+.+.++||+|+||+||+|+.+ .+|+.||||+++... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 84 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSR-HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 84 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred eEEEEEEecCcCcEEEEEEEC-CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEee
Confidence 456688999999999999876 578999999996532 2335789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 513 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 513 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
|+++|+|..++.....+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+.....
T Consensus 85 ~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---- 157 (316)
T d1fota_ 85 YIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---- 157 (316)
T ss_dssp CCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC----
T ss_pred ecCCccccccccccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc----
Confidence 999999999999998999999999999999999999997 9999999999999999999999999999876432
Q ss_pred cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAM 672 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 672 (728)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||......+....+ ..+...
T Consensus 158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i--------~~~~~~---------- 219 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI--------LNAELR---------- 219 (316)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--------HHCCCC----------
T ss_pred cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHH--------HcCCCC----------
Confidence 23467999999999999999999999999999999999999999866544322211 111110
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047292 673 ADRSRLHKWLMIAMWCIQEDPSKRP-----TMKVVMQ 704 (728)
Q Consensus 673 ~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~ 704 (728)
.+......+.+++.+||+.||.+|| |++++++
T Consensus 220 ~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 220 FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 0111234577899999999999996 8999985
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=384.05 Aligned_cols=253 Identities=23% Similarity=0.356 Sum_probs=199.9
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCc----EEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeE
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGN----AIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 510 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 510 (728)
+.+.++||+|+||+||+|.+.. +|+ .||+|+++... .+..++|.+|++++++++|||||+++|+|.+. ..+++
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v 88 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI 88 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC-----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred CEEeeEEecCCCeEEEEEEEcC-CCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEE
Confidence 4566899999999999998763 333 68999986533 34467899999999999999999999999875 56788
Q ss_pred eeccCCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCC
Q 047292 511 YEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH 589 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 589 (728)
+||+.+|+|.+++... ..+++..+++++.||++||+|||++ +|+||||||+||||+.++++||+|||+++......
T Consensus 89 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred EEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 9999999999888765 6789999999999999999999997 99999999999999999999999999999875543
Q ss_pred Cc-ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccc
Q 047292 590 SR-THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDS 667 (728)
Q Consensus 590 ~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 667 (728)
.. ......||+.|+|||++.+..++.++|||||||++|||+| |+.||......+....+ ..+...
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i--------~~~~~~----- 232 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL--------EKGERL----- 232 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH--------HHTCCC-----
T ss_pred ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHH--------HcCCCC-----
Confidence 32 2233568999999999999999999999999999999999 78888765443322211 111100
Q ss_pred hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 047292 668 DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710 (728)
Q Consensus 668 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 710 (728)
..+......+.+++.+||+.||.+|||++||++.|+.+.
T Consensus 233 ----~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 233 ----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp ----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 011123346778999999999999999999999987653
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-46 Score=385.08 Aligned_cols=259 Identities=27% Similarity=0.362 Sum_probs=196.5
Q ss_pred HHhhHHhhhCCCceeEEEEeeeeC----CCCcEEEEEEecccc-hhhHHHHHHHHHHhccc-cccceeeEeeeeecC-Cc
Q 047292 434 ATDGFKEELGRGSFGIVYKGVLKT----ASGNAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEA-LN 506 (728)
Q Consensus 434 ~~~~~~~~lg~G~fg~Vy~g~~~~----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-~~ 506 (728)
..+.+.++||+|+||.||+|.+.. .+++.||||+++... ....+.+..|..++.++ +|+||+.+++++... ..
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 345667899999999999998753 234689999996533 34456788888888877 799999999998654 56
Q ss_pred ceeEeeccCCCCHHHHHhcC----------------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcC
Q 047292 507 RLLVYEFMGNGTLANLIFAI----------------PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDH 570 (728)
Q Consensus 507 ~~lv~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~ 570 (728)
.++||||+++|+|.+++... ..+++..+..++.||++||.|||++ +||||||||+||||++
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECC
Confidence 89999999999999999753 2478899999999999999999997 9999999999999999
Q ss_pred CCceEEccccCccccccCCCc-ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCC-cCcchhhhHhhhhhH
Q 047292 571 YFSPKISDFGLSKLLLSDHSR-THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCR-RSVEMELEEESRAIL 648 (728)
Q Consensus 571 ~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~-~p~~~~~~~~~~~~~ 648 (728)
++++||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+||. .||..........
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~-- 247 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC-- 247 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH--
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHH--
Confidence 999999999999876544332 334467999999999999999999999999999999999975 5665433221111
Q ss_pred HHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 649 TDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 649 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
.....+...... ......+.+++.+||+.||++||||+||++.|+.+++
T Consensus 248 -----~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 248 -----RRLKEGTRMRAP---------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp -----HHHHHTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----HHHhcCCCCCCC---------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 111112111111 1123467889999999999999999999999998764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.7e-45 Score=374.70 Aligned_cols=257 Identities=19% Similarity=0.258 Sum_probs=201.9
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCc----ce
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALN----RL 508 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~----~~ 508 (728)
|.+.+.||+|+||.||+|... .+++.||||+++... ......|.+|+++++.++||||+++++++..... .|
T Consensus 9 Y~i~~~lG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~ 87 (277)
T d1o6ya_ 9 YELGEILGFGGMSEVHLARDL-RLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 87 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred eEEeEEEeeCCCeEEEEEEEC-CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEE
Confidence 456688999999999999876 578999999996532 2334679999999999999999999999876543 78
Q ss_pred eEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccC
Q 047292 509 LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD 588 (728)
Q Consensus 509 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 588 (728)
+||||+++++|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++..+|+|||.+......
T Consensus 88 lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 88 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp EEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred EEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhhccc
Confidence 9999999999999998888999999999999999999999997 9999999999999999999999999998765433
Q ss_pred CC--cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceecc
Q 047292 589 HS--RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALID 666 (728)
Q Consensus 589 ~~--~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 666 (728)
.. .......||+.|+|||++.+..++.++|||||||++|||+||+.||......+... .........
T Consensus 165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~-------~~~~~~~~~---- 233 (277)
T d1o6ya_ 165 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY-------QHVREDPIP---- 233 (277)
T ss_dssp --------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-------HHHHCCCCC----
T ss_pred cccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHH-------HHHhcCCCC----
Confidence 22 23344679999999999999999999999999999999999999998654433211 111111110
Q ss_pred chhhhhhcHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhcCc
Q 047292 667 SDEAAMADRSRLHKWLMIAMWCIQEDPSKRP-TMKVVMQMLEGLL 710 (728)
Q Consensus 667 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-t~~evl~~L~~~~ 710 (728)
.........+.+.+++.+||+.||.+|| |++++++.|..+.
T Consensus 234 ---~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 234 ---PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp ---GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ---CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 0011112235677899999999999999 8999999887653
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=374.97 Aligned_cols=259 Identities=24% Similarity=0.238 Sum_probs=199.0
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhh-----HHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQER-----EREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
++||+|+||+||+|..+ .+|+.||||+++...... .+.+.+|+.++++++|||||++++++...+..++||||+
T Consensus 4 ~~lG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDK-NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEETTEEEEEEECS-SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred eEeccCcCeEEEEEEEC-CCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 57999999999999876 578999999986532221 246889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcccc
Q 047292 515 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTHT 594 (728)
Q Consensus 515 ~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 594 (728)
.++++..++.....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++........ ..
T Consensus 83 ~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~-~~ 158 (299)
T d1ua2a_ 83 ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA-YT 158 (299)
T ss_dssp SEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC-CC
T ss_pred cchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCccc-cc
Confidence 9988887777777899999999999999999999997 9999999999999999999999999999876544322 23
Q ss_pred cccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccce----------
Q 047292 595 MIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDA---------- 663 (728)
Q Consensus 595 ~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------- 663 (728)
...||+.|+|||++... .++.++|||||||++|||+||+.||......+....+...... ........
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~-~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGT-PTEEQWPDMCSLPDYVTF 237 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC-CCTTTSSSTTSSTTCCCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCC-CChhhccchhccchhhhh
Confidence 35689999999998654 6799999999999999999999999766544332222111000 00000000
Q ss_pred -eccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 664 -LIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 664 -~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
...............+.+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00000000111122356889999999999999999999987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-45 Score=380.70 Aligned_cols=253 Identities=26% Similarity=0.411 Sum_probs=201.7
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCc--EEEEEEeccc-chhhHHHHHHHHHHhccc-cccceeeEeeeeecCCcceeEee
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGN--AIAVKKLDRL-AQEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e 512 (728)
.+.++||+|+||.||+|.++. ++. .||||+++.. ..+..+.|.+|+++|+++ +||||++++|++.+.+..++|||
T Consensus 13 ~~~~~iG~G~fg~Vy~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~e 91 (309)
T d1fvra_ 13 KFQDVIGEGNFGQVLKARIKK-DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 91 (309)
T ss_dssp EEEEEEECGGGCEEEEEEEEE-TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred EEEEEEeeCCCcEEEEEEECC-CCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEE
Confidence 456789999999999999874 343 5888988543 333456899999999998 79999999999999999999999
Q ss_pred ccCCCCHHHHHhcC----------------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEE
Q 047292 513 FMGNGTLANLIFAI----------------PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKI 576 (728)
Q Consensus 513 ~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl 576 (728)
|+++|+|.++|... ..+++..+.+++.||++||.|||++ +|+||||||+|||++.++.+||
T Consensus 92 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl 168 (309)
T d1fvra_ 92 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKI 168 (309)
T ss_dssp CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEE
T ss_pred ecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceEE
Confidence 99999999999754 5689999999999999999999997 9999999999999999999999
Q ss_pred ccccCccccccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCc-CcchhhhHhhhhhHHHHHHHh
Q 047292 577 SDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRR-SVEMELEEESRAILTDWAYDC 655 (728)
Q Consensus 577 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~-p~~~~~~~~~~~~~~~~~~~~ 655 (728)
+|||+++....... .....||..|+|||.+.+..++.++|||||||++|||++|.. ||......+....
T Consensus 169 ~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~-------- 238 (309)
T d1fvra_ 169 ADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK-------- 238 (309)
T ss_dssp CCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH--------
T ss_pred cccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHH--------
Confidence 99999986533222 223458999999999999999999999999999999999765 5655443332111
Q ss_pred hhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 047292 656 YVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEV 712 (728)
Q Consensus 656 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 712 (728)
...+.... .+....+++.+++.+||+.||++||||+||++.|+.+++.
T Consensus 239 i~~~~~~~---------~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 239 LPQGYRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp GGGTCCCC---------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHhcCCCC---------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 11111111 1112235678899999999999999999999999887643
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.7e-44 Score=368.85 Aligned_cols=249 Identities=24% Similarity=0.311 Sum_probs=203.5
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---------hhhHHHHHHHHHHhcccc-ccceeeEeeeeecCC
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---------QEREREFKSEVSAIGRTH-HKNLVQLLGFCDEAL 505 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~ 505 (728)
+.+.+.||+|+||+||+++.+ .+++.||||+++... ....+.+.+|+.++++++ ||||+++++++.+++
T Consensus 5 y~~~~~iG~G~~g~V~~~~~~-~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 83 (277)
T d1phka_ 5 YEPKEILGRGVSSVVRRCIHK-PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 83 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CEEceEEecCcCeEEEEEEEC-CCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc
Confidence 445678999999999999875 578999999985422 112356889999999996 999999999999999
Q ss_pred cceeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcccc
Q 047292 506 NRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLL 585 (728)
Q Consensus 506 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~ 585 (728)
..||||||+++|+|.++|.....+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 84 ~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 84 FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred ceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchheeEc
Confidence 9999999999999999999888999999999999999999999997 9999999999999999999999999999876
Q ss_pred ccCCCcccccccCCccccCccccc------CCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcC
Q 047292 586 LSDHSRTHTMIRGTRGYVAPEWLK------NAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEG 659 (728)
Q Consensus 586 ~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 659 (728)
.... ......||+.|+|||++. ...++.++||||+||+||||++|+.||...........+ ..+
T Consensus 161 ~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i--------~~~ 230 (277)
T d1phka_ 161 DPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI--------MSG 230 (277)
T ss_dssp CTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHT
T ss_pred cCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHH--------HhC
Confidence 4432 234467999999999985 335688999999999999999999999876544332222 111
Q ss_pred ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 660 RLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 660 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
... . ... ......+++.+++.+||+.||++|||++||++
T Consensus 231 ~~~-~-~~~----~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 231 NYQ-F-GSP----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp CCC-C-CTT----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCC-C-CCc----ccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111 0 000 01122346788999999999999999999865
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-45 Score=381.92 Aligned_cols=261 Identities=27% Similarity=0.378 Sum_probs=209.1
Q ss_pred HHHHHhhHHhhhCCCceeEEEEeeee----CCCCcEEEEEEecccc-hhhHHHHHHHHHHhccc-cccceeeEeeeeecC
Q 047292 431 LKDATDGFKEELGRGSFGIVYKGVLK----TASGNAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEA 504 (728)
Q Consensus 431 l~~~~~~~~~~lg~G~fg~Vy~g~~~----~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 504 (728)
+....+.+.++||+|+||.||+|++. ..+++.||||+++... ......|.+|+.+++++ +|||||+++++|.+.
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 33345567789999999999999864 3456789999997543 33456799999999999 799999999999999
Q ss_pred CcceeEeeccCCCCHHHHHhcCC------------------CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCE
Q 047292 505 LNRLLVYEFMGNGTLANLIFAIP------------------KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNI 566 (728)
Q Consensus 505 ~~~~lv~e~~~~gsL~~~l~~~~------------------~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NI 566 (728)
...++||||+++|+|.++++... .+++..+..++.||++||+|||++ +|+||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccc
Confidence 99999999999999999997542 578899999999999999999998 999999999999
Q ss_pred EEcCCCceEEccccCccccccCCC-cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCc-CcchhhhHhh
Q 047292 567 LLDHYFSPKISDFGLSKLLLSDHS-RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRR-SVEMELEEES 644 (728)
Q Consensus 567 ll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~-p~~~~~~~~~ 644 (728)
+++.++.+||+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||+|++. |+......+.
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~ 256 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999997754433 23344678999999999999999999999999999999999554 4543332221
Q ss_pred hhhHHHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 047292 645 RAILTDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710 (728)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 710 (728)
.. .... .+. .. ..+......+.+++.+||+.||++||||++|+++|++.+
T Consensus 257 ~~---~~i~----~~~-~~--------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 257 FY---KMIK----EGF-RM--------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp HH---HHHH----HTC-CC--------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH---HHHh----cCC-CC--------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 11 1111 111 00 111122356788999999999999999999999998754
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=374.76 Aligned_cols=257 Identities=27% Similarity=0.327 Sum_probs=204.2
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCC------CCcEEEEEEecccch-hhHHHHHHHHHHhccc-cccceeeEeeeeecCCc
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTA------SGNAIAVKKLDRLAQ-EREREFKSEVSAIGRT-HHKNLVQLLGFCDEALN 506 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 506 (728)
.+.+.++||+|+||.||+|+.... .+..||||+++.... ....++.+|...+.++ +|||||+++++|.+...
T Consensus 14 ~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~ 93 (299)
T d1fgka_ 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP 93 (299)
T ss_dssp GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCe
Confidence 445668899999999999987532 224799999966443 3457889999999888 89999999999999999
Q ss_pred ceeEeeccCCCCHHHHHhcC----------------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcC
Q 047292 507 RLLVYEFMGNGTLANLIFAI----------------PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDH 570 (728)
Q Consensus 507 ~~lv~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~ 570 (728)
.++||||+++|+|.+++... ..+++..++.++.||+.||+|||++ +||||||||+|||++.
T Consensus 94 ~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~~ 170 (299)
T d1fgka_ 94 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTE 170 (299)
T ss_dssp CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECT
T ss_pred EEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeecC
Confidence 99999999999999999754 2478999999999999999999997 9999999999999999
Q ss_pred CCceEEccccCccccccCCCc-ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHh-CCcCcchhhhHhhhhhH
Q 047292 571 YFSPKISDFGLSKLLLSDHSR-THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMELEEESRAIL 648 (728)
Q Consensus 571 ~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~ellt-g~~p~~~~~~~~~~~~~ 648 (728)
++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..||..........
T Consensus 171 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~-- 248 (299)
T d1fgka_ 171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK-- 248 (299)
T ss_dssp TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH--
T ss_pred CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHH--
Confidence 999999999999977554332 2344568999999999999999999999999999999998 677876554433221
Q ss_pred HHHHHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 649 TDWAYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 649 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
....+..... +......+.+++.+||+.||.+||||.||++.|++++.
T Consensus 249 ------~i~~~~~~~~---------p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 249 ------LLKEGHRMDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp ------HHHTTCCCCC---------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------HHHcCCCCCC---------CccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 1122211111 11123467889999999999999999999999998753
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=377.36 Aligned_cols=257 Identities=26% Similarity=0.431 Sum_probs=209.1
Q ss_pred HhhHHhhhCCCceeEEEEeeeeC----CCCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCccee
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKT----ASGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLL 509 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 509 (728)
.+.+.++||+|+||+||+|.++. ..+..||||+++... ......|.+|+.++++++||||++++|++......++
T Consensus 21 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 100 (308)
T d1p4oa_ 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV 100 (308)
T ss_dssp GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEE
T ss_pred HeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeE
Confidence 44566889999999999998752 235689999997533 3444679999999999999999999999999999999
Q ss_pred EeeccCCCCHHHHHhcC----------CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccc
Q 047292 510 VYEFMGNGTLANLIFAI----------PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDF 579 (728)
Q Consensus 510 v~e~~~~gsL~~~l~~~----------~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Df 579 (728)
||||+++|+|.+++... ..+++..+.+++.|+++||.|||++ +|+||||||+|||+++++++||+||
T Consensus 101 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~DF 177 (308)
T d1p4oa_ 101 IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDF 177 (308)
T ss_dssp EEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCT
T ss_pred EEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEeec
Confidence 99999999999998642 3468899999999999999999997 9999999999999999999999999
Q ss_pred cCccccccCCC-cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCC-cCcchhhhHhhhhhHHHHHHHhhh
Q 047292 580 GLSKLLLSDHS-RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCR-RSVEMELEEESRAILTDWAYDCYV 657 (728)
Q Consensus 580 gla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~ 657 (728)
|+++....... .......||+.|+|||.+.+..++.++||||||+++|||+||+ .|+......+.... ..
T Consensus 178 Gla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~--------i~ 249 (308)
T d1p4oa_ 178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF--------VM 249 (308)
T ss_dssp TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH--------HH
T ss_pred ccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHH--------HH
Confidence 99987754433 2233456899999999999999999999999999999999985 66655443332211 12
Q ss_pred cCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 047292 658 EGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLE 711 (728)
Q Consensus 658 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 711 (728)
.+...... ......+.+++.+||+.+|++||||++|+++|++.++
T Consensus 250 ~~~~~~~p---------~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 250 EGGLLDKP---------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp TTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred hCCCCCCc---------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 22221111 1223468889999999999999999999999988765
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-44 Score=374.06 Aligned_cols=248 Identities=21% Similarity=0.283 Sum_probs=204.3
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeeccC
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 515 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 515 (728)
|.+.++||+|+||+||+|..+ .+++.||||+++... .....+.+|+++|++++||||+++++++.+....||||||++
T Consensus 7 Y~i~~~lG~G~fg~Vy~~~~~-~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~ 84 (321)
T d1tkia_ 7 YMIAEDLGRGEFGIVHRCVET-SSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred eEEEEEEecCCCeEEEEEEEC-CCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCC
Confidence 456688999999999999876 578899999997643 334678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCC-CCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcC--CCceEEccccCccccccCCCcc
Q 047292 516 NGTLANLIFAIP-KPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDH--YFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 516 ~gsL~~~l~~~~-~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~--~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
+|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+|||++. ..++||+|||+++..... ..
T Consensus 85 gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~--~~ 159 (321)
T d1tkia_ 85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DN 159 (321)
T ss_dssp CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--CE
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccC--Cc
Confidence 999999998765 789999999999999999999997 9999999999999985 458999999999876432 22
Q ss_pred cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAM 672 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 672 (728)
.....+|+.|+|||.+.+..++.++|||||||++|||++|+.||...........+. .+.. .++.....
T Consensus 160 ~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~--------~~~~--~~~~~~~~- 228 (321)
T d1tkia_ 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM--------NAEY--TFDEEAFK- 228 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--------HTCC--CCCHHHHT-
T ss_pred ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHH--------hCCC--CCChhhcc-
Confidence 334568999999999999999999999999999999999999998765543322221 1110 01111111
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 673 ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 673 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
.....+.+++.+||+.||.+|||++|+++
T Consensus 229 ---~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 229 ---EISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ---TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 12345778999999999999999999987
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.1e-44 Score=379.43 Aligned_cols=243 Identities=23% Similarity=0.237 Sum_probs=204.8
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 512 (728)
+.+.++||+|+||.||+|..+ .+|+.||||+++... ....+.+.+|+++|+.++||||+++++++......++|||
T Consensus 43 y~i~~~lG~G~fg~Vy~a~~~-~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e 121 (350)
T d1rdqe_ 43 FDRIKTLGTGSFGRVMLVKHK-ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp EEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEeecCcCcEEEEEEEC-CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence 455688999999999999876 578999999986432 2234678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCcc
Q 047292 513 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRT 592 (728)
Q Consensus 513 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 592 (728)
|+.+|+|.+++.....+++..+..++.||+.||.|||++ +||||||||+||||+.++++||+|||+|+.....
T Consensus 122 ~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~---- 194 (350)
T d1rdqe_ 122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---- 194 (350)
T ss_dssp CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC----
T ss_pred cccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc----
Confidence 999999999999888999999999999999999999997 9999999999999999999999999999876432
Q ss_pred cccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhhh
Q 047292 593 HTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAAM 672 (728)
Q Consensus 593 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 672 (728)
.....||+.|||||++.+..++.++|||||||++|||+||+.||...........+ ..+...
T Consensus 195 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i--------~~~~~~---------- 256 (350)
T d1rdqe_ 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI--------VSGKVR---------- 256 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHCCCC----------
T ss_pred cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHH--------hcCCCC----------
Confidence 23456999999999999999999999999999999999999999865443322211 111110
Q ss_pred hcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047292 673 ADRSRLHKWLMIAMWCIQEDPSKRP-----TMKVVMQ 704 (728)
Q Consensus 673 ~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~ 704 (728)
.+......+.+++.+||+.||.+|+ |++++++
T Consensus 257 ~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 257 FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 0112234677899999999999994 8999985
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-44 Score=372.09 Aligned_cols=266 Identities=22% Similarity=0.273 Sum_probs=197.8
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecCC----cceeEee
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEAL----NRLLVYE 512 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~lv~e 512 (728)
-+.++||+|+||.||+|++ +|+.||||+++.... .......|+..+.+++||||+++++++.... ..++|||
T Consensus 6 ~l~~~iG~G~fg~Vy~~~~---~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 6 VLQESIGKGRFGEVWRGKW---RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp EEEEEEECCSSSEEEEEEE---TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEeeCCCeEEEEEEE---CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 3457899999999999986 478999999965322 2223344666667889999999999997654 5789999
Q ss_pred ccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcC-----CCCeeecCCCCCCEEEcCCCceEEccccCcccccc
Q 047292 513 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGC-----NVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS 587 (728)
Q Consensus 513 ~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~-----~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 587 (728)
|+++|+|.++|.+. .+++..+++++.|++.||+|||+.. ..+|+||||||+||||++++++||+|||+++....
T Consensus 82 y~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~ 160 (303)
T d1vjya_ 82 YHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp CCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred cccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccC
Confidence 99999999999864 6889999999999999999999731 35899999999999999999999999999987754
Q ss_pred CCCc---ccccccCCccccCcccccCCC------CCCccchhhHHHHHHHHHhCCcCcchhhhHhhhh-------hHHHH
Q 047292 588 DHSR---THTMIRGTRGYVAPEWLKNAP------VSAKVDVYSFGVMLLEIICCRRSVEMELEEESRA-------ILTDW 651 (728)
Q Consensus 588 ~~~~---~~~~~~gt~~y~aPE~~~~~~------~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~-------~~~~~ 651 (728)
.... ......||+.|+|||++.+.. ++.++|||||||+||||+||..|+.......... .....
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (303)
T d1vjya_ 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240 (303)
T ss_dssp TTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred CCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHH
Confidence 3322 223467999999999987653 5678999999999999999988764322111000 00011
Q ss_pred HHHhhhcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 047292 652 AYDCYVEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLL 710 (728)
Q Consensus 652 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 710 (728)
.........+..-+. ......+....+.+++.+||+.||++||||.||++.|+++.
T Consensus 241 ~~~~~~~~~~~p~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 241 MRKVVCEQKLRPNIP---NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp HHHHHTTSCCCCCCC---GGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhccccCCCCC---cccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 111111222111111 11123345667889999999999999999999999998765
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-44 Score=376.51 Aligned_cols=246 Identities=26% Similarity=0.302 Sum_probs=202.5
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc---hhhHHHHHHHHHHhc-cccccceeeEeeeeecCCcceeEe
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA---QEREREFKSEVSAIG-RTHHKNLVQLLGFCDEALNRLLVY 511 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~-~l~h~niv~l~g~~~~~~~~~lv~ 511 (728)
+.+.++||+|+||+||+|+.+ .+++.||||+++... ....+.+..|..++. .++||||+++++++.++...||||
T Consensus 4 y~i~~~iG~G~fg~Vy~~~~~-~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm 82 (320)
T d1xjda_ 4 FILHKMLGKGSFGKVFLAEFK-KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 82 (320)
T ss_dssp EEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred eEEeeEEecCCCcEEEEEEEC-CCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence 456688999999999999876 578999999996532 223455667777665 689999999999999999999999
Q ss_pred eccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCc
Q 047292 512 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSR 591 (728)
Q Consensus 512 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 591 (728)
||+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||+++++++||+|||+++...... .
T Consensus 83 Ey~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~-~ 158 (320)
T d1xjda_ 83 EYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-A 158 (320)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-C
T ss_pred eecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccccc-c
Confidence 9999999999999888899999999999999999999997 99999999999999999999999999998654332 2
Q ss_pred ccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchhhh
Q 047292 592 THTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDEAA 671 (728)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 671 (728)
......||+.|+|||++.+..++.++|||||||++|||+||+.||...........+ ..+.. .
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i--------~~~~~-~-------- 221 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI--------RMDNP-F-------- 221 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------HHCCC-C--------
T ss_pred cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH--------HcCCC-C--------
Confidence 334457999999999999999999999999999999999999999876554332221 11111 0
Q ss_pred hhcHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 047292 672 MADRSRLHKWLMIAMWCIQEDPSKRPTMK-VVMQ 704 (728)
Q Consensus 672 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~-evl~ 704 (728)
.+......+.+++.+||+.||.+||+++ ++++
T Consensus 222 -~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 222 -YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 0111234577899999999999999996 6753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=9.7e-44 Score=377.62 Aligned_cols=247 Identities=22% Similarity=0.221 Sum_probs=197.2
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch---hhHHHHH---HHHHHhccccccceeeEeeeeecCCccee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ---EREREFK---SEVSAIGRTHHKNLVQLLGFCDEALNRLL 509 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~---~~~~~~~---~E~~~l~~l~h~niv~l~g~~~~~~~~~l 509 (728)
+.+.+.||+|+||.||+|+.+ .+|+.||||++..... .....+. .|+.+++.++|||||++++++...+..|+
T Consensus 6 y~i~~~lG~G~fg~Vy~~~~~-~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~i 84 (364)
T d1omwa3 6 FSVHRIIGRGGFGEVYGCRKA-DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 84 (364)
T ss_dssp EEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred CeeeeEEecCCCeEEEEEEEC-CCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEE
Confidence 445678999999999999876 5789999999864221 1223333 44777888899999999999999999999
Q ss_pred EeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCC
Q 047292 510 VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDH 589 (728)
Q Consensus 510 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 589 (728)
||||+++|+|.+++.....+++..+..++.||+.||.|||++ +||||||||+|||+++++.+||+|||+|+......
T Consensus 85 vmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~ 161 (364)
T d1omwa3 85 ILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 161 (364)
T ss_dssp EECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC
T ss_pred EEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCCCc
Confidence 999999999999999888899999999999999999999997 99999999999999999999999999998764432
Q ss_pred CcccccccCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccch
Q 047292 590 SRTHTMIRGTRGYVAPEWLKN-APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSD 668 (728)
Q Consensus 590 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 668 (728)
.....||+.|+|||++.. ..++.++|||||||+||||+||+.||............ ....... ..
T Consensus 162 ---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~-----~~~~~~~-~~----- 227 (364)
T d1omwa3 162 ---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-----RMTLTMA-VE----- 227 (364)
T ss_dssp ---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH-----HHSSSCC-CC-----
T ss_pred ---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH-----HhcccCC-CC-----
Confidence 234569999999999964 57899999999999999999999999754332211111 0000100 00
Q ss_pred hhhhhcHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 047292 669 EAAMADRSRLHKWLMIAMWCIQEDPSKRPT-----MKVVMQ 704 (728)
Q Consensus 669 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----~~evl~ 704 (728)
.+......+.+++.+||+.||++||| ++|+++
T Consensus 228 ----~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 228 ----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp ----CCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred ----CCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 01112345778999999999999999 688874
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=372.93 Aligned_cols=255 Identities=23% Similarity=0.249 Sum_probs=197.5
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccc-cccceeeEeeeeec----CCcceeEeecc
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKNLVQLLGFCDE----ALNRLLVYEFM 514 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~----~~~~~lv~e~~ 514 (728)
+.||+|+||.||+|... .+++.||||+++.. ..+.+|+.++.++ +|||||++++++.+ ....|+||||+
T Consensus 18 ~~lG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~ 91 (335)
T d2ozaa1 18 QVLGLGINGKVLQIFNK-RTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 91 (335)
T ss_dssp EEEEECSSCEEEEEEET-TTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred EEeeeccCeEEEEEEEC-CCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECC
Confidence 45999999999999876 56899999998642 3567899887654 89999999999865 46689999999
Q ss_pred CCCCHHHHHhcC--CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcC---CCceEEccccCccccccCC
Q 047292 515 GNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDH---YFSPKISDFGLSKLLLSDH 589 (728)
Q Consensus 515 ~~gsL~~~l~~~--~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~---~~~~kl~Dfgla~~~~~~~ 589 (728)
++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||+++ .+.+||+|||+|+......
T Consensus 92 ~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~ 168 (335)
T d2ozaa1 92 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 168 (335)
T ss_dssp CSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC
T ss_pred CCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceeeeccCCC
Confidence 999999999875 4689999999999999999999997 9999999999999985 5679999999998765433
Q ss_pred CcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceeccchh
Q 047292 590 SRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALIDSDE 669 (728)
Q Consensus 590 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 669 (728)
......||+.|+|||++.+..++.++|||||||+||||+||+.||...........+ ......+. .+ .
T Consensus 169 --~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~----~~~i~~~~----~~--~ 236 (335)
T d2ozaa1 169 --SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM----KTRIRMGQ----YE--F 236 (335)
T ss_dssp --CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------CCCSCS----SS--C
T ss_pred --ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH----HHHHhcCC----CC--C
Confidence 234456999999999999999999999999999999999999999765433211111 00000000 00 0
Q ss_pred hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcCcCCCCC
Q 047292 670 AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM--LEGLLEVPNP 715 (728)
Q Consensus 670 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~--L~~~~~~~~~ 715 (728)
.........+.+.+++.+||+.||++|||++|+++. +.+..+.+.+
T Consensus 237 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~~ 284 (335)
T d2ozaa1 237 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 284 (335)
T ss_dssp CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSSCCC
T ss_pred CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCCCCC
Confidence 001112234568889999999999999999999873 4444444433
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-42 Score=361.07 Aligned_cols=263 Identities=24% Similarity=0.285 Sum_probs=197.4
Q ss_pred hHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch--hhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeecc
Q 047292 437 GFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 437 ~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
.+.++||+|+||+||+|+.. .+++.||||+++.... .....+.+|++++++++|||||++++++.+....++||||+
T Consensus 5 ~~~~~lG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~ 83 (298)
T d1gz8a_ 5 QKVEKIGEGTYGVVYKARNK-LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 83 (298)
T ss_dssp EEEEEEEECSSSEEEEEEET-TTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EeccEEecCcCeEEEEEEEC-CCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeec
Confidence 44578999999999999876 5788999999965332 23468899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhc-CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccc
Q 047292 515 GNGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH 593 (728)
Q Consensus 515 ~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 593 (728)
.++.+...... ...+++..+..++.||+.||+|||++ +||||||||+|||++.++++||+|||+|+....... ..
T Consensus 84 ~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~-~~ 159 (298)
T d1gz8a_ 84 HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TY 159 (298)
T ss_dssp SEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB-CT
T ss_pred CCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCcc-cc
Confidence 76555444333 35789999999999999999999997 999999999999999999999999999987644332 33
Q ss_pred ccccCCccccCcccccCCC-CCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCc---cceecc---
Q 047292 594 TMIRGTRGYVAPEWLKNAP-VSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGR---LDALID--- 666 (728)
Q Consensus 594 ~~~~gt~~y~aPE~~~~~~-~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~d--- 666 (728)
....||+.|+|||.+.... ++.++|||||||++|||++|+.||...........+..... ...+.. .....+
T Consensus 160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~ 238 (298)
T d1gz8a_ 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG-TPDEVVWPGVTSMPDYKP 238 (298)
T ss_dssp TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC-CCCTTTSTTGGGSTTCCT
T ss_pred eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcC-CCchhhcccccccccccc
Confidence 3456999999999987765 47899999999999999999999976543322111110000 000000 000000
Q ss_pred ------chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 667 ------SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 667 ------~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
..............+.+++.+||+.||++|||++|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000001111223567889999999999999999999874
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2e-42 Score=356.90 Aligned_cols=263 Identities=21% Similarity=0.247 Sum_probs=199.6
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
|.+.++||+|+||+||+|..+ +++.||||+++... ....+.+.+|+.+|++++||||+++++++...+..++++|+
T Consensus 4 Y~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 4 YHGLEKIGEGTYGVVYKAQNN--YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp EEEEEEEEEETTEEEEEEEET--TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ceeccEEecCCCcEEEEEEeC--CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 345678999999999999874 67899999996533 22357899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccc
Q 047292 514 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH 593 (728)
Q Consensus 514 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 593 (728)
+.++.+..+......+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++......... .
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~-~ 157 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK-Y 157 (286)
T ss_dssp CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred ehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCccc-c
Confidence 99988888888788899999999999999999999997 9999999999999999999999999999876543322 2
Q ss_pred ccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhc--Ccccee------
Q 047292 594 TMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVE--GRLDAL------ 664 (728)
Q Consensus 594 ~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~------ 664 (728)
....+++.|+|||.+.+. .++.++|||||||++|||++|+.||......+....+.......... ......
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence 334589999999999765 56999999999999999999999997654433221111100000000 000000
Q ss_pred ---ccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 665 ---IDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 665 ---~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
................+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000001111122346778999999999999999999974
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=361.96 Aligned_cols=238 Identities=24% Similarity=0.395 Sum_probs=195.1
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch------hhHHHHHHHHHHhcccc--ccceeeEeeeeecCCcc
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ------EREREFKSEVSAIGRTH--HKNLVQLLGFCDEALNR 507 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~ 507 (728)
|.+.+.||+|+||+||+|+.. .+++.||||+++.... .....+.+|+.++++++ ||||+++++++...+..
T Consensus 6 Y~i~~~lG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~ 84 (273)
T d1xwsa_ 6 YQVGPLLGSGGFGSVYSGIRV-SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 84 (273)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred EEEeEEEeeCCCeEEEEEEEC-CCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeE
Confidence 556688999999999999876 5789999999864221 11234678999999986 89999999999999999
Q ss_pred eeEeeccCC-CCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcC-CCceEEccccCcccc
Q 047292 508 LLVYEFMGN-GTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDH-YFSPKISDFGLSKLL 585 (728)
Q Consensus 508 ~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~-~~~~kl~Dfgla~~~ 585 (728)
++||||+.+ +++.+++.....+++..+..++.||++||+|||++ +|+||||||+|||++. ++.+||+|||+|+..
T Consensus 85 ~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 85 VLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp EEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccceec
Confidence 999999975 68888888888899999999999999999999997 9999999999999985 579999999999865
Q ss_pred ccCCCcccccccCCccccCcccccCCCC-CCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCcccee
Q 047292 586 LSDHSRTHTMIRGTRGYVAPEWLKNAPV-SAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDAL 664 (728)
Q Consensus 586 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (728)
... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||....... .+.. .
T Consensus 162 ~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~--------------~~~~--~ 222 (273)
T d1xwsa_ 162 KDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII--------------RGQV--F 222 (273)
T ss_dssp CSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH--------------HCCC--C
T ss_pred ccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHh--------------hccc--C
Confidence 432 2334679999999999987765 567999999999999999999997542110 0100 0
Q ss_pred ccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 665 IDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 665 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
+.. ....++.+++.+||+.||++|||++|+++
T Consensus 223 ~~~--------~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 223 FRQ--------RVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp CSS--------CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCC--------CCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 111 12346778999999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=362.53 Aligned_cols=264 Identities=22% Similarity=0.263 Sum_probs=196.0
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccch--hhHHHHHHHHHHhccc---cccceeeEeeeee-----cC
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ--EREREFKSEVSAIGRT---HHKNLVQLLGFCD-----EA 504 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~g~~~-----~~ 504 (728)
.|.+.++||+|+||+||+|.+...+++.||||+++.... .....+.+|+.+++.+ +||||+++++++. ..
T Consensus 8 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~ 87 (305)
T d1blxa_ 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 87 (305)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred CEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccC
Confidence 345667899999999999987645577899999864322 1223566777777665 7999999999985 33
Q ss_pred CcceeEeeccCCCCHHHHHhc-CCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcc
Q 047292 505 LNRLLVYEFMGNGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSK 583 (728)
Q Consensus 505 ~~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~ 583 (728)
...++++||++++.+...... ...+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++
T Consensus 88 ~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 88 TKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp EEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred ceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 567999999998877655443 36788999999999999999999997 99999999999999999999999999988
Q ss_pred ccccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccc-
Q 047292 584 LLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLD- 662 (728)
Q Consensus 584 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 662 (728)
..... .......||+.|+|||++.+.+++.++|||||||++|||++|+.||......+....+....... ......
T Consensus 165 ~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~ 241 (305)
T d1blxa_ 165 IYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP-GEEDWPR 241 (305)
T ss_dssp CCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC-CGGGSCT
T ss_pred hhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCC-chhcccc
Confidence 65332 23345679999999999999999999999999999999999999998665443322221111000 000000
Q ss_pred ------ee---ccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 663 ------AL---IDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 663 ------~~---~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
.. ..............+.+.+++.+||+.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00 0000001111122345778999999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-41 Score=353.47 Aligned_cols=265 Identities=20% Similarity=0.247 Sum_probs=198.1
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHhccccccceeeEeeeeec--------CC
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDE--------AL 505 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--------~~ 505 (728)
|.+.++||+|+||+||+|... .+|+.||||++.... ......+.+|+.+|++++|+||+++++++.. ..
T Consensus 12 Y~i~~~LG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~ 90 (318)
T d3blha1 12 YEKLAKIGQGTFGEVFKARHR-KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG 90 (318)
T ss_dssp EEEEEEEEECSSSEEEEEEET-TTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------
T ss_pred EEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCc
Confidence 455678999999999999876 578999999985432 2234678899999999999999999999855 34
Q ss_pred cceeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcccc
Q 047292 506 NRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLL 585 (728)
Q Consensus 506 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~ 585 (728)
..++||||+.++.+.........+++..+..++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+++..
T Consensus 91 ~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 91 SIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred eEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecceeeec
Confidence 5789999999888877777777889999999999999999999997 9999999999999999999999999999876
Q ss_pred ccCCC---cccccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCcc
Q 047292 586 LSDHS---RTHTMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRL 661 (728)
Q Consensus 586 ~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 661 (728)
..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+...... ......
T Consensus 168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~ 246 (318)
T d3blha1 168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS-ITPEVW 246 (318)
T ss_dssp CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC-CCTTTS
T ss_pred ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCC-CChhhc
Confidence 53322 122335699999999999765 6899999999999999999999999865544433322221110 000000
Q ss_pred ce--------ecc------chhhhh-hcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 662 DA--------LID------SDEAAM-ADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 662 ~~--------~~d------~~~~~~-~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
.. .+. ...... ........+++++.+||+.||++|||++|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 00 000 000000 011113456789999999999999999999864
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-41 Score=352.90 Aligned_cols=272 Identities=18% Similarity=0.231 Sum_probs=201.1
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccc-eeeEeeeeecCCcceeEeecc
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKN-LVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lv~e~~ 514 (728)
|.+.++||+|+||.||+|.+. .+++.||||++.... ...++..|++++++++|+| |+.+..+..+....++||||+
T Consensus 9 Y~l~~~iG~G~fG~Vy~a~~~-~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 9 YRLGRKIGSGSFGDIYLGTDI-AAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEeEEEeeCCCcEEEEEEEC-CCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 556788999999999999876 568899999886532 2346788999999997666 555566667888889999999
Q ss_pred CCCCHHHHH-hcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEc---CCCceEEccccCccccccCCC
Q 047292 515 GNGTLANLI-FAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLD---HYFSPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 515 ~~gsL~~~l-~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~---~~~~~kl~Dfgla~~~~~~~~ 590 (728)
++ +|.+.+ .....+++..+..++.|++.||+|||++ +||||||||+|||++ .+..+||+|||+|+.......
T Consensus 86 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 86 GP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp CC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred CC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 55 555554 4456899999999999999999999997 999999999999986 356799999999998754332
Q ss_pred ------cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCcccee
Q 047292 591 ------RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDAL 664 (728)
Q Consensus 591 ------~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 664 (728)
.......||+.|+|||.+.+..++.++|||||||++|||+||+.||...........+........ ....
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~-~~~~--- 237 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM-STPI--- 237 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH-HSCH---
T ss_pred ccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC-CCCh---
Confidence 123345799999999999999999999999999999999999999976544332222211111000 0000
Q ss_pred ccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCCCCCcccccc
Q 047292 665 IDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNPPWSSSFSIA 724 (728)
Q Consensus 665 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~ 724 (728)
.........++.+++.+||+.+|++||+++++.+.|+.+...........|+|.
T Consensus 238 ------~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw~ 291 (299)
T d1ckia_ 238 ------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN 291 (299)
T ss_dssp ------HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHHH
T ss_pred ------hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcCch
Confidence 000112235677899999999999999999999999886543333333445543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.5e-41 Score=349.26 Aligned_cols=273 Identities=16% Similarity=0.201 Sum_probs=210.9
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhcccc-ccceeeEeeeeecCCcceeEeecc
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTH-HKNLVQLLGFCDEALNRLLVYEFM 514 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~ 514 (728)
+.+.++||+|+||+||+|+.. .+++.||||++.... ....+.+|+++++.++ |+|++.+++++......++||||+
T Consensus 7 Y~i~~~iG~G~fG~Vy~a~~~-~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 7 YKVGRRIGEGSFGVIFEGTNL-LNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp EEEEEEEEECSSCEEEEEEET-TTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred eEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 456788999999999999876 568999999885432 2345778889999886 589999999999999999999998
Q ss_pred CCCCHHHHHhcC-CCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcC-----CCceEEccccCccccccC
Q 047292 515 GNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDH-----YFSPKISDFGLSKLLLSD 588 (728)
Q Consensus 515 ~~gsL~~~l~~~-~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~-----~~~~kl~Dfgla~~~~~~ 588 (728)
+++|.+++... ..++...+..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+|+.....
T Consensus 84 -~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~ 159 (293)
T d1csna_ 84 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 159 (293)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred -CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence 68999988765 4789999999999999999999997 9999999999999974 578999999999876543
Q ss_pred CC------cccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccc
Q 047292 589 HS------RTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLD 662 (728)
Q Consensus 589 ~~------~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (728)
.. .......||+.|+|||.+.+..++.++||||||+++|||+||+.||................... ......
T Consensus 160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~-~~~~~~ 238 (293)
T d1csna_ 160 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK-QSTPLR 238 (293)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH-HHSCHH
T ss_pred ccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc-CCCChH
Confidence 22 12334579999999999999999999999999999999999999997543322211111111000 000000
Q ss_pred eeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCCCCCccccccc
Q 047292 663 ALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQMLEGLLEVPNPPWSSSFSIAV 725 (728)
Q Consensus 663 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~~ 725 (728)
+ .....++++.+++..|++.+|++||+++.+.+.|+++++.........|.|.+
T Consensus 239 ~---------l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw~~ 292 (293)
T d1csna_ 239 E---------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNL 292 (293)
T ss_dssp H---------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGC
T ss_pred H---------hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCCCc
Confidence 0 01112245778888999999999999999999998877555555556666653
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-41 Score=354.89 Aligned_cols=269 Identities=21% Similarity=0.237 Sum_probs=197.3
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc-hhhHHHHHHHHHHhccccccceeeEeeeeecCCc----ceeE
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALN----RLLV 510 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~----~~lv 510 (728)
|.+.++||+|+||+||+|+.+ .+++.||||+++... ....+.+.+|+.+|++++||||+++++++..... .+++
T Consensus 10 Y~~~~~LG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l 88 (345)
T d1pmea_ 10 YTNLSYIGEGAYGMVCSAYDN-VNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL 88 (345)
T ss_dssp EEEEEECC---CCCEEEEEET-TTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred eEEEEEEeeccCeEEEEEEEC-CCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEE
Confidence 445688999999999999865 678999999996543 3345688999999999999999999999966543 3555
Q ss_pred eeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCC
Q 047292 511 YEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 511 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 590 (728)
++|+.+|+|.+++... .+++..+..++.||+.||+|||++ +||||||||+||||++++.+||+|||+++.......
T Consensus 89 ~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 89 VTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp EEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 6677899999999764 689999999999999999999997 999999999999999999999999999987644322
Q ss_pred --cccccccCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHh----hhcC----
Q 047292 591 --RTHTMIRGTRGYVAPEWLKN-APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDC----YVEG---- 659 (728)
Q Consensus 591 --~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~----~~~~---- 659 (728)
.......||+.|+|||++.. ..++.++||||+||++|||++|+.||................... ....
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhh
Confidence 22344669999999999854 567899999999999999999999997654332221111000000 0000
Q ss_pred ------ccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcCc
Q 047292 660 ------RLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM--LEGLL 710 (728)
Q Consensus 660 ------~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~--L~~~~ 710 (728)
..... ..............++.+++.+||+.||.+|||++|+++. |+...
T Consensus 245 ~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 245 ARNYLLSLPHK-NKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp HHHHHHTSCCC-CCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred hhcccccCCcc-CCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence 00000 0000000011122467889999999999999999999975 44433
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-40 Score=353.11 Aligned_cols=271 Identities=24% Similarity=0.266 Sum_probs=193.7
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeeecCC------cc
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEAL------NR 507 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~ 507 (728)
|.+.++||+|+||+||+|..+ .+|+.||||+++.. .....+.+.+|+.+|++++|||||++++++...+ ..
T Consensus 20 Y~~i~~lG~G~fg~V~~~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 98 (346)
T d1cm8a_ 20 YRDLQPVGSGAYGAVCSAVDG-RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 98 (346)
T ss_dssp EEEEEEC------CEEEEEET-TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred EEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceE
Confidence 445678999999999999876 57899999999653 2334578899999999999999999999997655 46
Q ss_pred eeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcccccc
Q 047292 508 LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS 587 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 587 (728)
++||||+ +.+|..++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 99 ~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 99 YLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADS 173 (346)
T ss_dssp EEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceeccCC
Confidence 9999999 5567766644 5799999999999999999999997 999999999999999999999999999987643
Q ss_pred CCCcccccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHH----hhhc----
Q 047292 588 DHSRTHTMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYD----CYVE---- 658 (728)
Q Consensus 588 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~----~~~~---- 658 (728)
. .+...||+.|+|||.+.+. .++.++|||||||++|||++|+.||.................. ....
T Consensus 174 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (346)
T d1cm8a_ 174 E----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249 (346)
T ss_dssp S----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred c----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcch
Confidence 2 2345689999999998764 5689999999999999999999999765433221111110000 0000
Q ss_pred ------CccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcCcCCCCCCC
Q 047292 659 ------GRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM--LEGLLEVPNPPW 717 (728)
Q Consensus 659 ------~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~--L~~~~~~~~~~~ 717 (728)
..+........ ..........+.+++.+||+.||++|||++|+++. ++++.+....|.
T Consensus 250 ~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~~ 315 (346)
T d1cm8a_ 250 EAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQ 315 (346)
T ss_dssp HHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------C
T ss_pred hhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCcccccc
Confidence 00000000000 00111123456789999999999999999999985 666554443333
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-41 Score=355.17 Aligned_cols=259 Identities=22% Similarity=0.243 Sum_probs=192.2
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhccccccceeeEeeeeecC------Cccee
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEA------LNRLL 509 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~l 509 (728)
|...++||+|+||+||+|+++ .+++.||||++..... .+.+|+++|++++|+||+++++++... ...+|
T Consensus 22 Y~~~k~LG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 22 YTDTKVIGNGSFGVVYQAKLC-DSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred cEeeeEEeeCcCeEEEEEEEC-CCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 445578999999999999976 5789999999965322 235799999999999999999998433 34689
Q ss_pred EeeccCCCCHHHH---HhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCC-ceEEccccCcccc
Q 047292 510 VYEFMGNGTLANL---IFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYF-SPKISDFGLSKLL 585 (728)
Q Consensus 510 v~e~~~~gsL~~~---l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~-~~kl~Dfgla~~~ 585 (728)
||||++++.+..+ ......+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987644333 33456789999999999999999999997 999999999999999765 8999999999876
Q ss_pred ccCCCcccccccCCccccCcccccC-CCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHH-------HHHhh-
Q 047292 586 LSDHSRTHTMIRGTRGYVAPEWLKN-APVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDW-------AYDCY- 656 (728)
Q Consensus 586 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~-------~~~~~- 656 (728)
.... ......|++.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+... .+...
T Consensus 174 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 174 VRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp CTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred cCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence 4432 2233568999999998865 47899999999999999999999999765443322211110 00000
Q ss_pred ---hcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 657 ---VEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 657 ---~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
........................+.+++.+||+.||++|||++|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011111111111111112223456788999999999999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-40 Score=343.07 Aligned_cols=263 Identities=19% Similarity=0.222 Sum_probs=202.6
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeeecCCcceeEeec
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 513 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 513 (728)
+.+.++||+|+||+||+|++. .+++.||||+++.. .......+.+|+.+++.++||||+++++++......++|+|+
T Consensus 4 y~~i~~LG~G~fg~V~~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~ 82 (292)
T d1unla_ 4 YEKLEKIGEGTYGTVFKAKNR-ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CEeeeEEecCcCeEEEEEEEC-CCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeee
Confidence 345678999999999999976 57899999998543 234467899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccCCCccc
Q 047292 514 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSDHSRTH 593 (728)
Q Consensus 514 ~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 593 (728)
+.+++|..++.....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++....... ..
T Consensus 83 ~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-~~ 158 (292)
T d1unla_ 83 CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CY 158 (292)
T ss_dssp CSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-CC
T ss_pred ccccccccccccccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCc-cc
Confidence 99999999998888999999999999999999999997 999999999999999999999999999987654332 22
Q ss_pred ccccCCccccCcccccCCC-CCCccchhhHHHHHHHHHhCCcCcchhhh-HhhhhhHHHHHHHhhhcCcc---cee----
Q 047292 594 TMIRGTRGYVAPEWLKNAP-VSAKVDVYSFGVMLLEIICCRRSVEMELE-EESRAILTDWAYDCYVEGRL---DAL---- 664 (728)
Q Consensus 594 ~~~~gt~~y~aPE~~~~~~-~s~~~DVwSlGvil~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~---~~~---- 664 (728)
....+++.|+|||.+.... ++.++|||||||++|||++|+.||..... .+....+..... ...+... ...
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 237 (292)
T d1unla_ 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG-TPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHC-CCCTTTCTTGGGSTTCC
T ss_pred eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcC-CCChhhhhhhhhccccc
Confidence 3345788899999987765 68999999999999999999999753322 211111111000 0000000 000
Q ss_pred ----cc-chhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 665 ----ID-SDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 665 ----~d-~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
.. ............+.+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00001111222346778999999999999999999976
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-41 Score=352.62 Aligned_cols=252 Identities=22% Similarity=0.252 Sum_probs=204.1
Q ss_pred hhHHhhhCCCceeEEEEeeee--CCCCcEEEEEEecccc----hhhHHHHHHHHHHhccccc-cceeeEeeeeecCCcce
Q 047292 436 DGFKEELGRGSFGIVYKGVLK--TASGNAIAVKKLDRLA----QEREREFKSEVSAIGRTHH-KNLVQLLGFCDEALNRL 508 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~--~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~ 508 (728)
+.+.++||+|+||+||+|... ..+|+.||||+++... ....+.+.+|++++++++| |||+++++++.+....+
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence 566789999999999999763 2357899999986432 2234678899999999966 89999999999999999
Q ss_pred eEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccC
Q 047292 509 LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD 588 (728)
Q Consensus 509 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 588 (728)
++|||+.+|+|.+++.......+..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 106 ~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~ 182 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 182 (322)
T ss_dssp EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred eeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhhccc
Confidence 9999999999999999888888999999999999999999997 9999999999999999999999999999877555
Q ss_pred CCcccccccCCccccCcccccCC--CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHhhhcCccceecc
Q 047292 589 HSRTHTMIRGTRGYVAPEWLKNA--PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDCYVEGRLDALID 666 (728)
Q Consensus 589 ~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 666 (728)
.........|++.|+|||.+.+. .++.++|||||||+||||++|+.||...........+..... ....
T Consensus 183 ~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~----~~~~----- 253 (322)
T d1vzoa_ 183 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL----KSEP----- 253 (322)
T ss_dssp GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH----HCCC-----
T ss_pred ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc----cCCC-----
Confidence 44444556799999999999765 468899999999999999999999986654433222211111 1110
Q ss_pred chhhhhhcHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 047292 667 SDEAAMADRSRLHKWLMIAMWCIQEDPSKRP-----TMKVVMQ 704 (728)
Q Consensus 667 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~ 704 (728)
..+.....++.+++.+||+.||++|| |++|+++
T Consensus 254 -----~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 254 -----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -----CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 01122345778899999999999999 5888876
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.8e-39 Score=341.67 Aligned_cols=258 Identities=19% Similarity=0.290 Sum_probs=193.6
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhcccc-ccceeeEeeeeec--CCcceeEe
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTH-HKNLVQLLGFCDE--ALNRLLVY 511 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~--~~~~~lv~ 511 (728)
.+.+.++||+|+||+||+|+.. .+++.||||+++... .+.+.+|+.+|+.++ ||||+++++++.. ....++||
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~-~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINI-TNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 3556788999999999999876 578999999997532 457889999999995 9999999999874 45689999
Q ss_pred eccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCC-ceEEccccCccccccCCC
Q 047292 512 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYF-SPKISDFGLSKLLLSDHS 590 (728)
Q Consensus 512 e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~~~~ 590 (728)
||+++++|..+. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+|+......
T Consensus 112 e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~- 184 (328)
T d3bqca1 112 EHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ- 184 (328)
T ss_dssp ECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC-
T ss_pred eecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCCC-
Confidence 999999997764 4688999999999999999999997 999999999999998654 69999999998764432
Q ss_pred cccccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhh-hhHHHH-----HHHhhhcCccc-
Q 047292 591 RTHTMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESR-AILTDW-----AYDCYVEGRLD- 662 (728)
Q Consensus 591 ~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~-~~~~~~-----~~~~~~~~~~~- 662 (728)
......+|+.|+|||.+.+. .++.++||||+|++++||++|+.||......... ..+... ...........
T Consensus 185 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 263 (328)
T d3bqca1 185 -EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263 (328)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred -cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccccc
Confidence 23345689999999998765 5799999999999999999999998654322111 101000 00000000000
Q ss_pred -----eec--------cchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 047292 663 -----ALI--------DSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ 704 (728)
Q Consensus 663 -----~~~--------d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 704 (728)
... ..............++.+++.+||+.||++|||++|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 000000011122346788999999999999999999976
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-39 Score=343.89 Aligned_cols=261 Identities=22% Similarity=0.246 Sum_probs=188.2
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEeccc--chhhHHHHHHHHHHhccccccceeeEeeeeec------CCcc
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDE------ALNR 507 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~~~ 507 (728)
|.+.++||+|+||+||+|.+. .+|+.||||++... .......+.+|+.++++++||||+++++++.. ....
T Consensus 19 Y~i~~~LG~G~fg~V~~~~d~-~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~ 97 (355)
T d2b1pa1 19 YQNLKPIGSGAQGIVCAAYDA-VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 97 (355)
T ss_dssp EEEEEECSCC--CEEEEEEET-TTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred eEEEEEeecCcCeEEEEEEEC-CCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCcee
Confidence 445578999999999999876 57899999999643 23445678999999999999999999999853 3677
Q ss_pred eeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCcccccc
Q 047292 508 LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLS 587 (728)
Q Consensus 508 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 587 (728)
|+||||+.++.+. .+. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+|++|||+++....
T Consensus 98 ~iv~Ey~~~~l~~-~~~--~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 98 YLVMELMDANLCQ-VIQ--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_dssp EEEEECCSEEHHH-HHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEEeccchHHHH-hhh--cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhcccc
Confidence 9999999766554 443 4688999999999999999999997 999999999999999999999999999886543
Q ss_pred CCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHH---------------H
Q 047292 588 DHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDW---------------A 652 (728)
Q Consensus 588 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~---------------~ 652 (728)
.. ......+|+.|+|||++.+..++.++||||+||+++||++|+.||...........+... .
T Consensus 172 ~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 249 (355)
T d2b1pa1 172 SF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_dssp -----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHH
T ss_pred cc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhH
Confidence 32 334456899999999999999999999999999999999999999754433221111100 0
Q ss_pred HHhhhcCc-c-----ceeccchh---hhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 047292 653 YDCYVEGR-L-----DALIDSDE---AAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQM 705 (728)
Q Consensus 653 ~~~~~~~~-~-----~~~~d~~~---~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 705 (728)
........ . ...+.... ...........+.+++.+||+.||++|||++|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000000 0 00000000 011123345678899999999999999999999854
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-39 Score=340.77 Aligned_cols=277 Identities=22% Similarity=0.249 Sum_probs=200.7
Q ss_pred hhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc--hhhHHHHHHHHHHhccccccceeeEeeeeecC-----Ccce
Q 047292 436 DGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEA-----LNRL 508 (728)
Q Consensus 436 ~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~ 508 (728)
|.+.++||+|+||+||+|... .+++.||||+++... ....+.+.+|+.+|++++|+||+++++++... ...+
T Consensus 20 Y~i~~~LG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~ 98 (348)
T d2gfsa1 20 YQNLSPVGSGAYGSVCAAFDT-KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 98 (348)
T ss_dssp EEEEEECGGGTTSSEEEEEET-TTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCC
T ss_pred eEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceE
Confidence 455688999999999999865 578999999996532 33456789999999999999999999998643 3447
Q ss_pred eEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccccCccccccC
Q 047292 509 LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDFGLSKLLLSD 588 (728)
Q Consensus 509 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 588 (728)
++++|+.+|+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++.....
T Consensus 99 ~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~- 173 (348)
T d2gfsa1 99 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD- 173 (348)
T ss_dssp EEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCTG-
T ss_pred EEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcccCc-
Confidence 77888899999999865 5799999999999999999999997 999999999999999999999999999875432
Q ss_pred CCcccccccCCccccCcccccCC-CCCCccchhhHHHHHHHHHhCCcCcchhhhHhhhhhHHHHHHHh----h-------
Q 047292 589 HSRTHTMIRGTRGYVAPEWLKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMELEEESRAILTDWAYDC----Y------- 656 (728)
Q Consensus 589 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~----~------- 656 (728)
......|++.|+|||.+.+. .++.++|||||||++|||++|+.||...........+....... .
T Consensus 174 ---~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 250 (348)
T d2gfsa1 174 ---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250 (348)
T ss_dssp ---GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHH
T ss_pred ---ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchh
Confidence 23345688999999987765 46899999999999999999999997654433222221110000 0
Q ss_pred ---hcCccceeccchhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhcCcCCCCCCCCcccc
Q 047292 657 ---VEGRLDALIDSDEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVVMQ--MLEGLLEVPNPPWSSSFS 722 (728)
Q Consensus 657 ---~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~--~L~~~~~~~~~~~~~~~~ 722 (728)
.............. .........+.+++.+||+.||++|||++|+++ .+.+..+....|...++.
T Consensus 251 ~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~~~~~~~ 320 (348)
T d2gfsa1 251 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYD 320 (348)
T ss_dssp HHHHHTTSCCCCCCCHH-HHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCCCCCCCC
T ss_pred hhhhhhhcccCCCcchh-hhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCCCCCCCC
Confidence 00000000000000 001112345778999999999999999999997 455554433333333333
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-34 Score=308.82 Aligned_cols=263 Identities=22% Similarity=0.229 Sum_probs=185.5
Q ss_pred HhhHHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhcccc-----------ccceeeEeeeeec
Q 047292 435 TDGFKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTH-----------HKNLVQLLGFCDE 503 (728)
Q Consensus 435 ~~~~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~g~~~~ 503 (728)
.|.+.++||+|+||+||+|+.+ .+|+.||||+++... ...+.+.+|+.++++++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~-~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDM-VNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 3667789999999999999876 578999999997643 23456788888888775 5789999988865
Q ss_pred C--CcceeEeeccCCCC-HHHHH--hcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCc-----
Q 047292 504 A--LNRLLVYEFMGNGT-LANLI--FAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFS----- 573 (728)
Q Consensus 504 ~--~~~~lv~e~~~~gs-L~~~l--~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~----- 573 (728)
. ...++++++...+. ..... ......++..+..++.||+.||+|||+. .+|+||||||+||||+.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCcccccc
Confidence 4 34455555554443 22222 2335778899999999999999999983 38999999999999986553
Q ss_pred -eEEccccCccccccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHHHHHHhCCcCcchhhhHhhh---hhHH
Q 047292 574 -PKISDFGLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVMLLEIICCRRSVEMELEEESR---AILT 649 (728)
Q Consensus 574 -~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil~elltg~~p~~~~~~~~~~---~~~~ 649 (728)
+|++|||.+...... .....||+.|+|||.+....++.++||||+||+++||++|+.||......... ..+.
T Consensus 170 ~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp EEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred eeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence 899999999765332 23456899999999999999999999999999999999999998754322111 0010
Q ss_pred HHHHH-----------------hhhcC----ccceeccc------hhhhhhcHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 047292 650 DWAYD-----------------CYVEG----RLDALIDS------DEAAMADRSRLHKWLMIAMWCIQEDPSKRPTMKVV 702 (728)
Q Consensus 650 ~~~~~-----------------~~~~~----~~~~~~d~------~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev 702 (728)
..... .+... .+...... .............+.+++.+||+.||.+|||++|+
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 00000 00000 00000000 00112235567788999999999999999999999
Q ss_pred HHH
Q 047292 703 MQM 705 (728)
Q Consensus 703 l~~ 705 (728)
++.
T Consensus 326 L~H 328 (362)
T d1q8ya_ 326 VNH 328 (362)
T ss_dssp HTC
T ss_pred hcC
Confidence 874
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.84 E-value=1.1e-21 Score=187.95 Aligned_cols=168 Identities=14% Similarity=0.056 Sum_probs=119.3
Q ss_pred HHhhhCCCceeEEEEeeeeCCCCcEEEEEEecccc------------------hhhHHHHHHHHHHhccccccceeeEee
Q 047292 438 FKEELGRGSFGIVYKGVLKTASGNAIAVKKLDRLA------------------QEREREFKSEVSAIGRTHHKNLVQLLG 499 (728)
Q Consensus 438 ~~~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~------------------~~~~~~~~~E~~~l~~l~h~niv~l~g 499 (728)
+.++||+|+||.||+|... +|+.||||+++... ......+..|...+.++.|.+++..++
T Consensus 4 vg~~IG~G~~g~Vy~a~~~--~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSE--KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEECSSEEEEEEEET--TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred hCCEeeeCcceEEEEEECC--CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 4578999999999999874 68899999874311 011234567888999999999998886
Q ss_pred eeecCCcceeEeeccCCCCHHHHHhcCCCCChHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCEEEcCCCceEEccc
Q 047292 500 FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEGCNVPIIHCDIKPQNILLDHYFSPKISDF 579 (728)
Q Consensus 500 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~qi~~~l~yLH~~~~~~iiH~dlk~~NIll~~~~~~kl~Df 579 (728)
+. ..+++|||+++..+.+ ++......++.|++++|+|||++ +|+||||||+|||++++ .++|+||
T Consensus 82 ~~----~~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECCC
T ss_pred ec----CCEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEEC
Confidence 63 2479999998866543 33445678999999999999997 99999999999999976 4899999
Q ss_pred cCccccccCCCcccccccCCccccCcccccCCCCCCccchhhHHHHH
Q 047292 580 GLSKLLLSDHSRTHTMIRGTRGYVAPEWLKNAPVSAKVDVYSFGVML 626 (728)
Q Consensus 580 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvil 626 (728)
|+|+............ ....- -.|. ..+.|+.++|+||..--+
T Consensus 147 G~a~~~~~~~~~~~l~--rd~~~-~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEGWREILE--RDVRN-IITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTTHHHHHH--HHHHH-HHHH-HHHHHCCCCCHHHHHHHH
T ss_pred CCcccCCCCCcHHHHH--HHHHH-HHHH-HcCCCCCcccHHHHHHHH
Confidence 9997654322211000 00000 0011 135678889999975443
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.38 E-value=3.8e-13 Score=113.73 Aligned_cols=67 Identities=19% Similarity=0.395 Sum_probs=55.4
Q ss_pred CEEEEeCCCCCCCcCCCCcEEEEecCc-eEEeCCCCCeEeecCC-C-CceeeEEEecCcCEEEEecccccccccccccc
Q 047292 1 TIIWHANEDNHPVLAPRGSTLELTATG-LLLKDPGGQAIWDEKP-N-KIVSDAAMLDTGNFVLIASGNHSDYAWQSFKS 76 (728)
Q Consensus 1 t~vW~Anr~~~~~~~~~~~~l~~~~~g-l~l~~~~~~~vWst~~-~-~~~~~a~lld~GNlVl~~~~~~~~~lWQSFD~ 76 (728)
++||.||++.| ...+.|.+..+| |+|.+++|.+|||+++ . .....|+|+|+|||||++ ..+||||+|
T Consensus 38 ~~vW~s~~~~~----~~~~~l~l~~~Gnlvl~~~~g~~vWsS~t~~~~~~~~l~L~ddGNlVly~-----~~~W~S~t~ 107 (108)
T d1jpca_ 38 KPIWATNTGGL----SRSCFLSMQTDGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIYG-----TDRWATGTH 107 (108)
T ss_dssp EEEEECCCTTS----CSSCEEEECTTSCEEEECTTCCEEEECCCCCSCSCEEEEECTTSCEEEEE-----CCCCCCCCC
T ss_pred ceeeEeCCCCC----CCccEEEEeccceEEEECCCccceEEccccCCCCcEEEEEcCCCCEEEeC-----CCcccCCCC
Confidence 47999999864 346789999999 9999999999999984 2 334468999999999963 248999998
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.38 E-value=3.9e-13 Score=113.68 Aligned_cols=68 Identities=19% Similarity=0.408 Sum_probs=56.7
Q ss_pred CEEEEeCCCCCCCcCCCCcEEEEecCc-eEEeCCCCCeEeecCC--CCceeeEEEecCcCEEEEecccccccccccccc
Q 047292 1 TIIWHANEDNHPVLAPRGSTLELTATG-LLLKDPGGQAIWDEKP--NKIVSDAAMLDTGNFVLIASGNHSDYAWQSFKS 76 (728)
Q Consensus 1 t~vW~Anr~~~~~~~~~~~~l~~~~~g-l~l~~~~~~~vWst~~--~~~~~~a~lld~GNlVl~~~~~~~~~lWQSFD~ 76 (728)
++||+||++.|. ..+++|.|+.+| |+|.|++|.+||+|++ +.+...|+|+|+|||||++ ..+|||+-|
T Consensus 38 ~~vW~ant~~~~---~~~~~l~l~~dGnLvl~~~~g~~vW~s~t~~~~~~~~l~L~ddGNlvly~-----~~~W~S~t~ 108 (109)
T d1kj1a_ 38 TSVWASNTGILG---KKGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYG-----SDIWSTGTY 108 (109)
T ss_dssp EEEEECCCCCTT---CCCCEEEECTTSCEEEECSSSCEEEECCCCCCSSCCEEEECTTSCEEEEC-----CEEEECCCC
T ss_pred EEEEEeCCCCCC---ceeEEEEEcCCceEEEEeCCCcEEEEEeeECCCCCEEEEEeCCCcEEEEC-----CCEecCCCc
Confidence 479999999864 456889999999 9999999999999984 3445679999999999953 249999865
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.37 E-value=3.2e-13 Score=115.32 Aligned_cols=72 Identities=17% Similarity=0.397 Sum_probs=57.6
Q ss_pred CEEEEeCCCCCCCcCCCCcEEEEecCc-eEEeCCCCCeEeecC-C-CCceeeEEEecCcCEEEEeccccccccccccccc
Q 047292 1 TIIWHANEDNHPVLAPRGSTLELTATG-LLLKDPGGQAIWDEK-P-NKIVSDAAMLDTGNFVLIASGNHSDYAWQSFKSP 77 (728)
Q Consensus 1 t~vW~Anr~~~~~~~~~~~~l~~~~~g-l~l~~~~~~~vWst~-~-~~~~~~a~lld~GNlVl~~~~~~~~~lWQSFD~P 77 (728)
++||.||++.+ ..++.|.|+.+| |+|.+++ .++|+++ + ..+...|+|+|+|||||++ .++.++|||+.+|
T Consensus 38 ~~vW~s~~~~~----~~~~~l~l~~dGnLvl~~~~-~~~w~s~t~~~~~~~~l~L~ddGNlvly~--~~~~~~W~S~t~~ 110 (112)
T d1xd5a_ 38 RAVWASGTNGK----ASGCVLKMQNDGNLVIYSGS-RAIWASNTNRQNGNYYLILQRDRNVVIYD--NSNNAIWATHTNV 110 (112)
T ss_dssp EEEEECCCTTS----CSSEEEEECTTSCEEEEETT-EEEEECCCCCSCCCCEEEECTTSCEEEEC--TTSCEEEECCCCC
T ss_pred cEEEEccCccC----CCCcEEEEeccccEEEEecC-CeEEEEeeccCCCceEEEEcCCCCEEEEC--CCCcEEecCCCcc
Confidence 47999999864 346789999999 9999864 5677766 3 3345679999999999964 4667899999999
Q ss_pred cc
Q 047292 78 TD 79 (728)
Q Consensus 78 tD 79 (728)
++
T Consensus 111 ~n 112 (112)
T d1xd5a_ 111 GN 112 (112)
T ss_dssp CC
T ss_pred CC
Confidence 85
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.35 E-value=7.4e-13 Score=113.81 Aligned_cols=89 Identities=15% Similarity=0.227 Sum_probs=71.2
Q ss_pred CEEEEeCCCCCCCcCCCCcEEEEecCc-eEEeCCCCCeEeecCC-C-CceeeEEEecCcCEEEEeccccccccccccccc
Q 047292 1 TIIWHANEDNHPVLAPRGSTLELTATG-LLLKDPGGQAIWDEKP-N-KIVSDAAMLDTGNFVLIASGNHSDYAWQSFKSP 77 (728)
Q Consensus 1 t~vW~Anr~~~~~~~~~~~~l~~~~~g-l~l~~~~~~~vWst~~-~-~~~~~a~lld~GNlVl~~~~~~~~~lWQSFD~P 77 (728)
+++|++|++.++. ....+|.+..|| |+|.+. +.++|+++. . .....|.|+++|||||++. ++.++||||.
T Consensus 21 ~~~~~l~~~q~l~--~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~--~~~~lW~S~t-- 93 (120)
T d1dlpa2 21 NHPQTLHATQSLQ--LSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTN--QNIAVWTSGN-- 93 (120)
T ss_dssp CCCCEECSSCCCB--CSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEET--TTEEEEECCC--
T ss_pred CcccEEcCCCeeE--cCCEEEEEcCCCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEcC--CCCEEEEeCC--
Confidence 4579999998763 334689999999 999986 678999984 2 2346799999999999654 5689999983
Q ss_pred cccccccceeccccEEEeeccCCCCCCccEEEEee-CCceEEe
Q 047292 78 TDTILPTQILDLGSVLVSRLTETNLSKGRFELHFS-NGSLEFI 119 (728)
Q Consensus 78 tDtlLpg~~l~~~~~L~S~~s~~d~s~G~~~l~~~-~~~~~~~ 119 (728)
+.++|.|.+.++ +|.+++|
T Consensus 94 -----------------------~~~~~~~~l~Lq~DGnlvlY 113 (120)
T d1dlpa2 94 -----------------------SRSAGRYVFVLQPDRNLAIY 113 (120)
T ss_dssp -----------------------CCSSSCCEEEECSSSCEEEE
T ss_pred -----------------------CCCCCcEEEEECCCCcEEEe
Confidence 235788999999 8999887
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.27 E-value=1.2e-12 Score=111.13 Aligned_cols=97 Identities=15% Similarity=0.209 Sum_probs=74.7
Q ss_pred EEEeCCCCCCCcCCCCcEEEEecCc-eEEeCCCCCeEeecCC-CCceeeEEEecCcCEEEEecccccccccccccccccc
Q 047292 3 IWHANEDNHPVLAPRGSTLELTATG-LLLKDPGGQAIWDEKP-NKIVSDAAMLDTGNFVLIASGNHSDYAWQSFKSPTDT 80 (728)
Q Consensus 3 vW~Anr~~~~~~~~~~~~l~~~~~g-l~l~~~~~~~vWst~~-~~~~~~a~lld~GNlVl~~~~~~~~~lWQSFD~PtDt 80 (728)
.|..+.+.++. ....+|.|..|| |+|.+ ++.++|+++. +..++.+.|+|+||||| .+.++.+||||+.
T Consensus 14 ~~tl~~~~~l~--~g~~~l~~q~DGNLvL~~-~~~~vW~s~t~~~~~~~l~l~~dGNLvl--~d~~~~~vWsS~t----- 83 (115)
T d1dlpa1 14 PQTLHAAQSLE--LSSFRFTMQSDCNLVLFD-SDVRVWASNTAGATGCRAVLQSDGLLVI--LTAQNTIRWSSGT----- 83 (115)
T ss_dssp CSCCCTTCEEC--STTEEEEECTTSCEEEEE-SSSEEECCCCCSCSCCBCCBCSSSCBCC--BCTTTCCSCCCCC-----
T ss_pred cceecCCCcEE--cCCEEEEECCCCeEEEEc-CCeeEEEcccCCCCceEEEEeccCCEEE--EccCCCEEEEcCC-----
Confidence 35566776542 344689999999 99988 5688999984 45677899999999999 5556789999873
Q ss_pred ccccceeccccEEEeeccCCCCCCccEEEEee-CCceEEeeccCCcccceeeeeeccCC
Q 047292 81 ILPTQILDLGSVLVSRLTETNLSKGRFELHFS-NGSLEFIPVAWPSRFQYKSYYTSNTS 138 (728)
Q Consensus 81 lLpg~~l~~~~~L~S~~s~~d~s~G~~~l~~~-~~~~~~~~~~~~~~~~~~~y~~~~~~ 138 (728)
+.++|.|.|.|+ +|.+++| . ..+|.+++.
T Consensus 84 --------------------~~~~g~y~l~Lq~DGNlvlY---~------~~~Wssgt~ 113 (115)
T d1dlpa1 84 --------------------KGSIGNYVLVLQPDRTVTIY---G------PGLWDSGTS 113 (115)
T ss_dssp --------------------CCCSSCCEEEECSSSCEEEE---C------SEEEECSCC
T ss_pred --------------------CCCCCCEEEEECCCCcEEEe---C------CCeecCCCC
Confidence 345799999999 8998876 2 357888754
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.12 E-value=3.8e-10 Score=95.84 Aligned_cols=110 Identities=16% Similarity=0.204 Sum_probs=81.5
Q ss_pred cccccccceeccccEEEeeccCCCCCCccEEEEee-CCceEEeeccCCcccceeeeeeccCCCCCCCCCCceeeeccccc
Q 047292 78 TDTILPTQILDLGSVLVSRLTETNLSKGRFELHFS-NGSLEFIPVAWPSRFQYKSYYTSNTSSANSSESGHQLVFNESAD 156 (728)
Q Consensus 78 tDtlLpg~~l~~~~~L~S~~s~~d~s~G~~~l~~~-~~~~~~~~~~~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~ 156 (728)
||||+|||.|..|+.|+| |+|+|.++ +|+++++.. . ..+|.++.... ..+..+.+..+|.
T Consensus 1 tDtL~~gq~L~~g~~l~~---------g~~~l~~q~DGNLvly~~--~-----~~vW~s~~~~~---~~~~~l~l~~dGn 61 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLAE---------GGYLFIIQNDCNLVLYDN--N-----RAVWASGTNGK---ASGCVLKMQNDGN 61 (112)
T ss_dssp CCEEETTEEECTTCEEEE---------TTEEEEECTTSCEEEEET--T-----EEEEECCCTTS---CSSEEEEECTTSC
T ss_pred CCEecCCCEecCCCEEEE---------CCEEEEEcCCCCEEEEcC--C-----cEEEEccCccC---CCCcEEEEecccc
Confidence 899999999999999965 99999999 999988742 2 56787765432 3455788999999
Q ss_pred EEEEecCceeEeccccccCCCCCceeEEEEEccCCcEEEEEeccCCCCCCCcceeeecCCccc
Q 047292 157 IYIVKNNGQIVQLPLWAQLSPRADHYFRATLDFDGVFAEYAHSKNSSTNQGWFPTRTLPDSMC 219 (728)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~rl~L~~dG~l~~y~~~~~~~~~~~W~~~~~~p~~~C 219 (728)
+.+++.++..... ........++++|+.||+|++|.- .....|+...+.|
T Consensus 62 Lvl~~~~~~~w~s-----~t~~~~~~~~l~L~ddGNlvly~~--------~~~~~W~S~t~~~ 111 (112)
T d1xd5a_ 62 LVIYSGSRAIWAS-----NTNRQNGNYYLILQRDRNVVIYDN--------SNNAIWATHTNVG 111 (112)
T ss_dssp EEEEETTEEEEEC-----CCCCSCCCCEEEECTTSCEEEECT--------TSCEEEECCCCCC
T ss_pred EEEEecCCeEEEE-----eeccCCCceEEEEcCCCCEEEECC--------CCcEEecCCCccC
Confidence 9888765544433 223333457999999999999942 2346777766554
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.07 E-value=2.5e-10 Score=97.70 Aligned_cols=110 Identities=19% Similarity=0.268 Sum_probs=76.3
Q ss_pred EEecCcCEEEEeccccccccccccccccccccccceeccccEEEeeccCCCCCCccEEEEee-CCceEEeeccCCcccce
Q 047292 51 AMLDTGNFVLIASGNHSDYAWQSFKSPTDTILPTQILDLGSVLVSRLTETNLSKGRFELHFS-NGSLEFIPVAWPSRFQY 129 (728)
Q Consensus 51 ~lld~GNlVl~~~~~~~~~lWQSFD~PtDtlLpg~~l~~~~~L~S~~s~~d~s~G~~~l~~~-~~~~~~~~~~~~~~~~~ 129 (728)
+|+|+||+|| .+. +|+|.|+++|.++|.|. .|.|+|.++ +|+++++-. .
T Consensus 4 v~~~~~n~il--~~~------~~~~~~~~~l~~~q~l~---------------~g~y~L~~q~DGNLvL~~~--~----- 53 (120)
T d1dlpa2 4 VVANNGNSIL--YST------QGNDNHPQTLHATQSLQ---------------LSPYRLSMETDCNLVLFDR--D----- 53 (120)
T ss_dssp CCSSCCCEEC--CCC--------CCCCCCEECSSCCCB---------------CSSCEEEEETTTEEEEEBT--T-----
T ss_pred EEEeCCCeEE--EcC------CCCCCcccEEcCCCeeE---------------cCCEEEEEcCCCcEEEecC--C-----
Confidence 4556666665 211 67899999999999986 578999999 999988732 2
Q ss_pred eeeeeccCCCCCCCCCCceeeecccccEEEEecCceeEeccccccCCCCCceeEEEEEccCCcEEEEE
Q 047292 130 KSYYTSNTSSANSSESGHQLVFNESADIYIVKNNGQIVQLPLWAQLSPRADHYFRATLDFDGVFAEYA 197 (728)
Q Consensus 130 ~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rl~L~~dG~l~~y~ 197 (728)
..+|.+.... ...+..+.+..+|.+.+.+.++..+... ........++++|++||+|++|.
T Consensus 54 ~~vW~s~t~~---~~~~~~~~l~~~GnLvl~d~~~~~lW~S----~t~~~~~~~~l~Lq~DGnlvlY~ 114 (120)
T d1dlpa2 54 DRVWSTNTAG---KGTGCRAVLQPNGRMDVLTNQNIAVWTS----GNSRSAGRYVFVLQPDRNLAIYG 114 (120)
T ss_dssp BCCSCCCCCS---SCSSCEEEEETTTEEEEEETTTEEEEEC----CCCCSSSCCEEEECSSSCEEEEC
T ss_pred cEEEEEcccc---CCCcEEEEEeCCeeEEEEcCCCCEEEEe----CCCCCCCcEEEEECCCCcEEEeC
Confidence 4567665432 2345568888999999988887665431 22222234589999999999994
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.97 E-value=4.8e-10 Score=95.57 Aligned_cols=66 Identities=18% Similarity=0.310 Sum_probs=53.8
Q ss_pred CEEEEeCCCCCCCcCCCCcEEEEecCc-eEEeCCCCCeEeecCCC--CceeeEEEecCcCEEEEeccccccccccccc
Q 047292 1 TIIWHANEDNHPVLAPRGSTLELTATG-LLLKDPGGQAIWDEKPN--KIVSDAAMLDTGNFVLIASGNHSDYAWQSFK 75 (728)
Q Consensus 1 t~vW~Anr~~~~~~~~~~~~l~~~~~g-l~l~~~~~~~vWst~~~--~~~~~a~lld~GNlVl~~~~~~~~~lWQSFD 75 (728)
++||.||+..+ ..+++|.|..+| |+|.|++|.+||++++. .....++|+|+|||||.+ ..+|||-.
T Consensus 49 ~~vWssnt~~~----~~~~~l~l~~dGnLvL~d~~g~~vWsS~t~~~~~~~~l~Lq~DGNlvlYg-----~~~W~S~T 117 (119)
T d1b2pa_ 49 NPIWATNTGGL----GNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG-----DALWATQT 117 (119)
T ss_dssp EEEEECCCTTS----CSSCEEEECTTSCEEEECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE-----SEEEECCC
T ss_pred eEEEEecCCCC----CcceEEEEEeCCCEEEECCCCcEEEECCCcCCCCceEEEEcCCCCEEEEC-----CCEeccCC
Confidence 47999999754 345799999999 99999999999999842 334568999999999953 36999964
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.82 E-value=1e-08 Score=87.11 Aligned_cols=104 Identities=13% Similarity=0.161 Sum_probs=78.9
Q ss_pred ccccccccccccccccceeccccEEEeeccCCCCCCccEEEEee-CCceEEeeccCCcccceeeeeeccCCCCCCCCCCc
Q 047292 69 YAWQSFKSPTDTILPTQILDLGSVLVSRLTETNLSKGRFELHFS-NGSLEFIPVAWPSRFQYKSYYTSNTSSANSSESGH 147 (728)
Q Consensus 69 ~lWQSFD~PtDtlLpg~~l~~~~~L~S~~s~~d~s~G~~~l~~~-~~~~~~~~~~~~~~~~~~~y~~~~~~~~~~~~~~~ 147 (728)
+-||++|.|.+||-++|.|..+ .+.|+|+|.|+ ||+++++- .. ..+|.+.... ...+.
T Consensus 5 ~s~~~~~~~~~~l~~~q~l~~~-----------~~~~~y~l~mQ~DGNLVLy~--~~-----~~vWssnt~~---~~~~~ 63 (119)
T d1b2pa_ 5 FSKQPDDNHPQILHATESLEIL-----------FGTHVYRFIMQTDCNLVLYD--NN-----NPIWATNTGG---LGNGC 63 (119)
T ss_dssp ECSCSSSCCCCEEETTCEEEEE-----------ETTEEEEEEECTTSCEEEEE--TT-----EEEEECCCTT---SCSSC
T ss_pred EeeecCCCCCCEEeCCCeEEEe-----------cCCceEEEEECCCCcEEEEE--CC-----eEEEEecCCC---CCcce
Confidence 3599999999999999998421 24799999999 99999872 22 5688887642 23456
Q ss_pred eeeecccccEEEEecCceeEeccccccCCCCCceeEEEEEccCCcEEEEE
Q 047292 148 QLVFNESADIYIVKNNGQIVQLPLWAQLSPRADHYFRATLDFDGVFAEYA 197 (728)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rl~L~~dG~l~~y~ 197 (728)
.+.++.+|.+.+.+.++..+.. .........++++|+.||+|++|.
T Consensus 64 ~l~l~~dGnLvL~d~~g~~vWs----S~t~~~~~~~~l~Lq~DGNlvlYg 109 (119)
T d1b2pa_ 64 RAVLQPDGVLVVITNENVTVWQ----SPVAGKAGHYVLVLQPDRNVVIYG 109 (119)
T ss_dssp EEEECTTSCEEEECTTCCEEEE----CSCCCCSSCEEEEECTTSCEEEEE
T ss_pred EEEEEeCCCEEEECCCCcEEEE----CCCcCCCCceEEEEcCCCCEEEEC
Confidence 7889999999999888776543 222333445689999999999995
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=98.70 E-value=1e-07 Score=79.58 Aligned_cols=96 Identities=14% Similarity=0.204 Sum_probs=73.0
Q ss_pred ccccccceeccccEEEeeccCCCCCCccEEEEee-CCceEEeeccCCcccceeeeeeccCCCCCCCCCCceeeecccccE
Q 047292 79 DTILPTQILDLGSVLVSRLTETNLSKGRFELHFS-NGSLEFIPVAWPSRFQYKSYYTSNTSSANSSESGHQLVFNESADI 157 (728)
Q Consensus 79 DtlLpg~~l~~~~~L~S~~s~~d~s~G~~~l~~~-~~~~~~~~~~~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (728)
|||+|||.|..|+.|. .|+|+|.|+ +|+++++- .. ..+|.+..... ..+..+.+..+|.+
T Consensus 2 ~~L~~g~~L~~G~~l~---------ng~~~l~~q~DGNLvly~--~~-----~~vW~s~~~~~---~~~~~l~l~~~Gnl 62 (108)
T d1jpca_ 2 NILYSGETLSTGEFLN---------YGSFVFIMQEDCNLVLYD--VD-----KPIWATNTGGL---SRSCFLSMQTDGNL 62 (108)
T ss_dssp CEEETTEEECTTCEEE---------ETTEEEEECTTSCEEEEE--TT-----EEEEECCCTTS---CSSCEEEECTTSCE
T ss_pred CCccCCCEecCCCEEE---------cCCEEEEECCCCeEEEEe--CC-----ceeeEeCCCCC---CCccEEEEeccceE
Confidence 8999999999999994 499999999 99998863 22 56888776532 34456888899999
Q ss_pred EEEecCceeEeccccccCCCCCceeEEEEEccCCcEEEEE
Q 047292 158 YIVKNNGQIVQLPLWAQLSPRADHYFRATLDFDGVFAEYA 197 (728)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~rl~L~~dG~l~~y~ 197 (728)
.+.+.++..+.. .........++++|+.||||++|.
T Consensus 63 vl~~~~g~~vWs----S~t~~~~~~~~l~L~ddGNlVly~ 98 (108)
T d1jpca_ 63 VVYNPSNKPIWA----SNTGGQNGNYVCILQKDRNVVIYG 98 (108)
T ss_dssp EEECTTCCEEEE----CCCCCSCSCEEEEECTTSCEEEEE
T ss_pred EEECCCccceEE----ccccCCCCcEEEEEcCCCCEEEeC
Confidence 888887766543 222333445689999999999995
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.66 E-value=8.4e-08 Score=80.19 Aligned_cols=97 Identities=18% Similarity=0.236 Sum_probs=72.8
Q ss_pred ccccccceeccccEEEeeccCCCCCCccEEEEee-CCceEEeeccCCcccceeeeeeccCCCCCCCCCCceeeecccccE
Q 047292 79 DTILPTQILDLGSVLVSRLTETNLSKGRFELHFS-NGSLEFIPVAWPSRFQYKSYYTSNTSSANSSESGHQLVFNESADI 157 (728)
Q Consensus 79 DtlLpg~~l~~~~~L~S~~s~~d~s~G~~~l~~~-~~~~~~~~~~~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (728)
|||.|||.|..|+.|++ |.|+|.|+ +|+++++.. . ..+|.+.+.... ..+..+.++.+|.+
T Consensus 2 ~~L~~g~~L~~g~~l~~---------g~~~l~~q~dgnLvl~~~--~-----~~vW~ant~~~~--~~~~~l~l~~dGnL 63 (109)
T d1kj1a_ 2 NLLTNGEGLYAGQSLDV---------EPYHFIMQEDCNLVLYDH--S-----TSVWASNTGILG--KKGCKAVLQSDGNF 63 (109)
T ss_dssp CEEETTCEEETTCEEEE---------TTEEEEECTTSCEEEEET--T-----EEEEECCCCCTT--CCCCEEEECTTSCE
T ss_pred CCccCCCEEeCCCEEEe---------CCEEEEecCCCeEEEEeC--C-----EEEEEeCCCCCC--ceeEEEEEcCCceE
Confidence 89999999999999965 89999999 999988742 2 567887654322 23556888999999
Q ss_pred EEEecCceeEeccccccCCCCCceeEEEEEccCCcEEEEE
Q 047292 158 YIVKNNGQIVQLPLWAQLSPRADHYFRATLDFDGVFAEYA 197 (728)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~rl~L~~dG~l~~y~ 197 (728)
.+.+.++..+... ........++++|.+||||++|.
T Consensus 64 vl~~~~g~~vW~s----~t~~~~~~~~l~L~ddGNlvly~ 99 (109)
T d1kj1a_ 64 VVYDAEGRSLWAS----HSVRGNGNYVLVLQEDGNVVIYG 99 (109)
T ss_dssp EEECSSSCEEEEC----CCCCCSSCCEEEECTTSCEEEEC
T ss_pred EEEeCCCcEEEEE----eeECCCCCEEEEEeCCCcEEEEC
Confidence 9888887765431 22222334689999999999994
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.48 E-value=2.8e-08 Score=83.75 Aligned_cols=65 Identities=14% Similarity=0.239 Sum_probs=51.7
Q ss_pred CEEEEeCCCCCCCcCCCCcEEEEecCc-eEEeCCCCCeEeecCC--CCceeeEEEecCcCEEEEeccccccccccccc
Q 047292 1 TIIWHANEDNHPVLAPRGSTLELTATG-LLLKDPGGQAIWDEKP--NKIVSDAAMLDTGNFVLIASGNHSDYAWQSFK 75 (728)
Q Consensus 1 t~vW~Anr~~~~~~~~~~~~l~~~~~g-l~l~~~~~~~vWst~~--~~~~~~a~lld~GNlVl~~~~~~~~~lWQSFD 75 (728)
++||.+|... ..++++.|.++| |+|.|.++.+||++.+ ..+.-.++|+++|||||++ ..+|+|-.
T Consensus 45 ~~vW~s~t~~-----~~~~~l~l~~dGNLvl~d~~~~~vWsS~t~~~~g~y~l~Lq~DGNlvlY~-----~~~Wssgt 112 (115)
T d1dlpa1 45 VRVWASNTAG-----ATGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYG-----PGLWDSGT 112 (115)
T ss_dssp SEEECCCCCS-----CSCCBCCBCSSSCBCCBCTTTCCSCCCCCCCCSSCCEEEECSSSCEEEEC-----SEEEECSC
T ss_pred eeEEEcccCC-----CCceEEEEeccCCEEEEccCCCEEEEcCCCCCCCCEEEEECCCCcEEEeC-----CCeecCCC
Confidence 4789999754 345789999999 9999999999999984 2334469999999999942 36899854
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.06 E-value=6.4e-06 Score=80.53 Aligned_cols=132 Identities=16% Similarity=0.025 Sum_probs=90.3
Q ss_pred CceeEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhcccc-ccceeeEeeeeecCCcceeEeeccCCCCHHHHH
Q 047292 445 GSFGIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTH-HKNLVQLLGFCDEALNRLLVYEFMGNGTLANLI 523 (728)
Q Consensus 445 G~fg~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l 523 (728)
++.+.||+... +++.+++|+...........+.+|...+..+. +--+.+++.+....+..++||+++++.++.+..
T Consensus 25 ~s~~~v~rv~~---~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~ 101 (263)
T d1j7la_ 25 MSPAKVYKLVG---ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEY 101 (263)
T ss_dssp CSSSEEEEEEC---SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHT
T ss_pred CCCCcEEEEEe---CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccc
Confidence 33468998653 45678889886654444456777888877663 444678888888888899999999998876544
Q ss_pred hcCCCCChHHHHHHHHHHHHHHHHhhhc----------------------------------------------------
Q 047292 524 FAIPKPDWNLRVRISLEIARGLVYLHEG---------------------------------------------------- 551 (728)
Q Consensus 524 ~~~~~~~~~~~~~i~~qi~~~l~yLH~~---------------------------------------------------- 551 (728)
... .....++.++++.+..||+.
T Consensus 102 ~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 176 (263)
T d1j7la_ 102 EDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKT 176 (263)
T ss_dssp TTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHH
T ss_pred ccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHh
Confidence 321 11223444455555555531
Q ss_pred ----CCCCeeecCCCCCCEEEcCCCceEEccccCccc
Q 047292 552 ----CNVPIIHCDIKPQNILLDHYFSPKISDFGLSKL 584 (728)
Q Consensus 552 ----~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~ 584 (728)
....++|+|+.|.||++++++.+-|+||+.+..
T Consensus 177 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 177 EKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 012379999999999999877778999998753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.55 E-value=0.00013 Score=70.31 Aligned_cols=130 Identities=15% Similarity=0.071 Sum_probs=81.3
Q ss_pred hCCCce-eEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhcccc--ccceeeEeeeeecCCcceeEeeccCCCC
Q 047292 442 LGRGSF-GIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTH--HKNLVQLLGFCDEALNRLLVYEFMGNGT 518 (728)
Q Consensus 442 lg~G~f-g~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~~lv~e~~~~gs 518 (728)
+..|.. +.||+... .++..+++|...... ...+..|...++.+. .-.+.+++.+....+..++||++++|.+
T Consensus 18 ~~~G~s~~~v~r~~~--~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSA--QGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp CSCTTSSCEEEEEEC--TTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred cCCcccCCeEEEEEe--CCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence 444443 67898754 356678888765432 234667777777663 3346778888888888999999998866
Q ss_pred HHHHHhcCCCCChHHHHHHHHHHHHH---------------------------------------------------HHH
Q 047292 519 LANLIFAIPKPDWNLRVRISLEIARG---------------------------------------------------LVY 547 (728)
Q Consensus 519 L~~~l~~~~~~~~~~~~~i~~qi~~~---------------------------------------------------l~y 547 (728)
+.+... . ...++.++++. +..
T Consensus 93 ~~~~~~-----~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (255)
T d1nd4a_ 93 LLSSHL-----A---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 164 (255)
T ss_dssp TTTSCC-----C---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred cccccc-----c---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence 532100 0 00111112222 222
Q ss_pred hhhc----CCCCeeecCCCCCCEEEcCCCceEEccccCccc
Q 047292 548 LHEG----CNVPIIHCDIKPQNILLDHYFSPKISDFGLSKL 584 (728)
Q Consensus 548 LH~~----~~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~~ 584 (728)
+... ....++|+|+.|.||+++++..+-|+||+.+..
T Consensus 165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 2221 122489999999999999887778999997753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.41 E-value=0.00021 Score=73.81 Aligned_cols=76 Identities=17% Similarity=0.122 Sum_probs=47.4
Q ss_pred hhhCCCceeEEEEeeeeCCCCcEEEEEEecccch-------hhHHHHHHHHHHhcccc---ccceeeEeeeeecCCccee
Q 047292 440 EELGRGSFGIVYKGVLKTASGNAIAVKKLDRLAQ-------EREREFKSEVSAIGRTH---HKNLVQLLGFCDEALNRLL 509 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~~~~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~l 509 (728)
+.||.|....||+.... .+++.|+||.-..... ........|.+.|+.+. ...+++++.+. ....++
T Consensus 32 ~eig~G~~N~vfrV~~~-~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l 108 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQ-EHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 108 (392)
T ss_dssp EECCSSSSEEEEEEEC-----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEeCCCceEeEEEEEeC-CCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence 46899999999998754 3567899997543111 11223456777776652 24566676654 445689
Q ss_pred EeeccCCCC
Q 047292 510 VYEFMGNGT 518 (728)
Q Consensus 510 v~e~~~~gs 518 (728)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997644
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.21 E-value=0.0053 Score=61.12 Aligned_cols=132 Identities=14% Similarity=0.111 Sum_probs=72.8
Q ss_pred eEEEEeeeeCCCCcEEEEEEecccchhhHHHHHHHHHHhcccccccee--eEee-----eeecCCcceeEeeccCCCCHH
Q 047292 448 GIVYKGVLKTASGNAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLV--QLLG-----FCDEALNRLLVYEFMGNGTLA 520 (728)
Q Consensus 448 g~Vy~g~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv--~l~g-----~~~~~~~~~lv~e~~~~gsL~ 520 (728)
-.||+... .+|+.+++|+-+.. .....++..|...+..|....+. ..+. ........+.++++++|..+.
T Consensus 36 N~vy~v~~--~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 36 NRVYQFQD--EDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SEEEEECC--TTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred ceeEEEEc--CCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 37999876 46788999987543 22345677888888777533322 1111 123445567888888763321
Q ss_pred -----HH---------Hh----cC-----CCCChH----------------------HHHHHHHHHHHHHHHh-hhcCCC
Q 047292 521 -----NL---------IF----AI-----PKPDWN----------------------LRVRISLEIARGLVYL-HEGCNV 554 (728)
Q Consensus 521 -----~~---------l~----~~-----~~~~~~----------------------~~~~i~~qi~~~l~yL-H~~~~~ 554 (728)
.+ ++ .. ...++. .....+.++...+.-. .+....
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 00 00 00 111111 1112222232222221 122235
Q ss_pred CeeecCCCCCCEEEcCCCceEEccccCccc
Q 047292 555 PIIHCDIKPQNILLDHYFSPKISDFGLSKL 584 (728)
Q Consensus 555 ~iiH~dlk~~NIll~~~~~~kl~Dfgla~~ 584 (728)
++||+|+.+.|||++++ ..++||+-+..
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eeecCCCCcccEEEeCC--ceEEechhccc
Confidence 78999999999999754 45899998753
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.31 E-value=0.018 Score=58.69 Aligned_cols=74 Identities=14% Similarity=0.126 Sum_probs=48.4
Q ss_pred hhhCCCceeEEEEeeeeCC------CCcEEEEEEecccchhhHHHHHHHHHHhcccc-ccceeeEeeeeecCCcceeEee
Q 047292 440 EELGRGSFGIVYKGVLKTA------SGNAIAVKKLDRLAQEREREFKSEVSAIGRTH-HKNLVQLLGFCDEALNRLLVYE 512 (728)
Q Consensus 440 ~~lg~G~fg~Vy~g~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e 512 (728)
+.|+.|-.=.+|+...... ..+.|.+++.... .......+|..+++.+. +.-..++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 3577788889999876532 2345777765432 22345567888888885 4334578888754 58899
Q ss_pred ccCCCCH
Q 047292 513 FMGNGTL 519 (728)
Q Consensus 513 ~~~~gsL 519 (728)
|+++.+|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987543
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.33 E-value=0.0088 Score=36.17 Aligned_cols=32 Identities=28% Similarity=0.589 Sum_probs=25.5
Q ss_pred cccccccccCCCCccCCCcccccCCCCCcccCCCCCccc
Q 047292 217 SMCTRLATDIGSGICGFNSYCSLQNGRPFCDCPPGYVLV 255 (728)
Q Consensus 217 ~~C~~~~~~~~~~~CG~~g~C~~~~~~~~C~C~~Gf~~~ 255 (728)
|+|.+ -..|| +|.|++--..-.|.|-+||+|.
T Consensus 2 dECsi------gnpCG-nGTCtNviGgFec~C~~GFepg 33 (39)
T d1emoa2 2 DECSV------GNPCG-NGTCKNVIGGFECTCEEGFEPG 33 (39)
T ss_dssp CGGGT------TCSSS-SSCEEECSSSEEECCSSSSCCC
T ss_pred Ccccc------CCccC-CceeeecccceEEeecCCcCCC
Confidence 56887 57898 7889865557799999999874
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.60 E-value=0.011 Score=38.72 Aligned_cols=26 Identities=27% Similarity=0.586 Sum_probs=23.1
Q ss_pred CCccCCCcccccCCCCCcccCCCCCc
Q 047292 228 SGICGFNSYCSLQNGRPFCDCPPGYV 253 (728)
Q Consensus 228 ~~~CG~~g~C~~~~~~~~C~C~~Gf~ 253 (728)
...|..+|.|.....+..|.|++||+
T Consensus 10 ~~pC~n~g~C~n~~g~y~C~C~~G~~ 35 (42)
T d2vj3a1 10 ANPCEHAGKCINTLGSFECQCLQGYT 35 (42)
T ss_dssp SCSSSTTCEEEECSSSEEEECCTTEE
T ss_pred CCCCCCCcEeECCCCCEEeECCCCCc
Confidence 46799999999877789999999996
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.13 E-value=0.025 Score=37.04 Aligned_cols=31 Identities=29% Similarity=0.642 Sum_probs=25.0
Q ss_pred cccccccccCCCCccCCCcccccCCCCCcccCCCCCcc
Q 047292 217 SMCTRLATDIGSGICGFNSYCSLQNGRPFCDCPPGYVL 254 (728)
Q Consensus 217 ~~C~~~~~~~~~~~CG~~g~C~~~~~~~~C~C~~Gf~~ 254 (728)
++|.. +.|+.++.|.+...+..|.|++||+.
T Consensus 6 dEC~~-------~~~~~~~~C~Nt~Gsy~C~C~~Gy~~ 36 (43)
T d1emoa1 6 DECKE-------PDVCKHGQCINTDGSYRCECPFGYIL 36 (43)
T ss_dssp CSSSS-------TTSCSSSCCCCCSSCCCCCCCTTEEE
T ss_pred eccCC-------cCCCCCCEeECCCCCeEeECCCCccc
Confidence 66765 34556889998888999999999975
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.96 E-value=0.023 Score=36.30 Aligned_cols=26 Identities=23% Similarity=0.526 Sum_probs=22.5
Q ss_pred CCccCCCcccccCCCCCcccCCCCCc
Q 047292 228 SGICGFNSYCSLQNGRPFCDCPPGYV 253 (728)
Q Consensus 228 ~~~CG~~g~C~~~~~~~~C~C~~Gf~ 253 (728)
+..|...|.|........|.|++||+
T Consensus 5 ~~PC~ngg~C~~~~~~y~C~C~~G~~ 30 (39)
T d1xkba1 5 TSPCQNQGKCKDGLGEYTCTCLEGFE 30 (39)
T ss_dssp TCCCCSSCEECCCSSSCCEECCTTEE
T ss_pred CCCCCCCcEEECCCCCEEEECCCCCC
Confidence 46799999998776689999999996
|
| >d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.83 E-value=0.0094 Score=38.95 Aligned_cols=27 Identities=33% Similarity=0.803 Sum_probs=23.0
Q ss_pred CCccCCCcccccCCCCCcccCCCCCccc
Q 047292 228 SGICGFNSYCSLQNGRPFCDCPPGYVLV 255 (728)
Q Consensus 228 ~~~CG~~g~C~~~~~~~~C~C~~Gf~~~ 255 (728)
++.|. ++.|.+...+..|.|++||.+.
T Consensus 9 ~~~C~-~~~C~Nt~Gsy~C~C~~Gy~l~ 35 (42)
T d1lmja2 9 PLLCR-GGVCHNTEGSYRCECPPGHQLS 35 (42)
T ss_dssp SSTTT-TSEEEEETTEEEEESCTTSCCC
T ss_pred CCCCC-CCEeECCCCCeEEeCCCCCeEC
Confidence 67784 7899988889999999999864
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=92.73 E-value=0.11 Score=50.81 Aligned_cols=31 Identities=19% Similarity=0.229 Sum_probs=27.6
Q ss_pred CCCeeecCCCCCCEEEcCCCceEEccccCcc
Q 047292 553 NVPIIHCDIKPQNILLDHYFSPKISDFGLSK 583 (728)
Q Consensus 553 ~~~iiH~dlk~~NIll~~~~~~kl~Dfgla~ 583 (728)
..++||+|+.++||+++.+...-|.||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 3479999999999999998877899999875
|
| >d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.41 E-value=0.019 Score=36.71 Aligned_cols=26 Identities=38% Similarity=0.662 Sum_probs=22.6
Q ss_pred CCccCCCcccccCCCCCcccCCCCCc
Q 047292 228 SGICGFNSYCSLQNGRPFCDCPPGYV 253 (728)
Q Consensus 228 ~~~CG~~g~C~~~~~~~~C~C~~Gf~ 253 (728)
+..|...|.|.....+..|.|++||+
T Consensus 6 ~~PC~n~g~C~~~~~~y~C~C~~G~~ 31 (39)
T d2vj3a2 6 SNPCQNDATCLDQIGEFQCICMPGYE 31 (39)
T ss_dssp TCCCCSSCEEEECSSCEEEECCTTEE
T ss_pred CCCCCCCCEEECCCCCEEEeCCCCCc
Confidence 36799999998776789999999996
|
| >d1uzka2 g.3.11.1 (A:1605-1647) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.85 E-value=0.019 Score=37.67 Aligned_cols=28 Identities=36% Similarity=0.842 Sum_probs=23.1
Q ss_pred CCccCCCcccccCCCCCcccCCCCCcccC
Q 047292 228 SGICGFNSYCSLQNGRPFCDCPPGYVLVD 256 (728)
Q Consensus 228 ~~~CG~~g~C~~~~~~~~C~C~~Gf~~~~ 256 (728)
++.|. ++.|.+...+..|.|++||.+..
T Consensus 10 ~~~c~-~~~C~Nt~Gsy~C~C~~Gy~l~~ 37 (43)
T d1uzka2 10 PGLCQ-GGKCINTFGSFQCRCPTGYYLNE 37 (43)
T ss_dssp GGGGB-TSEEEECSSCEEEECCTTCCBCT
T ss_pred CCCcC-CCEEECCCCCeEeECCCCCeECc
Confidence 56775 68999888899999999998643
|
| >d2vj3a3 g.3.11.1 (A:492-526) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.93 E-value=0.034 Score=34.55 Aligned_cols=26 Identities=31% Similarity=0.680 Sum_probs=22.4
Q ss_pred CCccCCCcccccCCCCCcccCCCCCc
Q 047292 228 SGICGFNSYCSLQNGRPFCDCPPGYV 253 (728)
Q Consensus 228 ~~~CG~~g~C~~~~~~~~C~C~~Gf~ 253 (728)
+..|...|.|.....+..|.|++||+
T Consensus 5 ~~PC~ngg~C~~~~~~y~C~C~~g~~ 30 (35)
T d2vj3a3 5 SSPCLHNGRCLDKINEFQCECPTGFT 30 (35)
T ss_dssp TCCSTTTCEEEECSSCEEEECCTTEE
T ss_pred CCCCCCCcEEECCCCCeEEECCCCCC
Confidence 46799999998766689999999996
|
| >d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.70 E-value=0.031 Score=35.68 Aligned_cols=30 Identities=23% Similarity=0.464 Sum_probs=25.2
Q ss_pred cccccccccCCCCccCCCcccccCCCCCcccCCCCCc
Q 047292 217 SMCTRLATDIGSGICGFNSYCSLQNGRPFCDCPPGYV 253 (728)
Q Consensus 217 ~~C~~~~~~~~~~~CG~~g~C~~~~~~~~C~C~~Gf~ 253 (728)
|+|.. ..|-..|.|........|.|++||+
T Consensus 4 d~C~~-------~PC~ngg~C~~~~~~y~C~C~~g~~ 33 (39)
T d1edmb_ 4 DQCES-------NPCLNGGSCKDDINSYECWCPFGFE 33 (39)
T ss_dssp CTTTT-------CCCCTTCEEEEETTEEEEECCTTCC
T ss_pred ccCCC-------CCCCCCcEEEcCCCCEEEECCCCCC
Confidence 56774 6799999998767789999999996
|
| >d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Low density lipoprotein (LDL) receptor, different EGF domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.68 E-value=0.058 Score=34.79 Aligned_cols=26 Identities=27% Similarity=0.676 Sum_probs=21.0
Q ss_pred CCccCCCcccccCCCCCcccCCCCCccc
Q 047292 228 SGICGFNSYCSLQNGRPFCDCPPGYVLV 255 (728)
Q Consensus 228 ~~~CG~~g~C~~~~~~~~C~C~~Gf~~~ 255 (728)
.+.| ..+|.+...+..|.|++||++.
T Consensus 7 ~~~C--~~~C~n~~Gsy~C~C~~Gy~L~ 32 (41)
T d1i0ua2 7 PDTC--SQLCVNLEGGYKCQCEEGFQLD 32 (41)
T ss_dssp TTSC--SSCEECSSSCCEECCCTTEEEC
T ss_pred CCCC--CCEeECCCCCEEeECCCCCeEC
Confidence 4556 4589887889999999999863
|
| >d1uzka1 g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.11 E-value=0.034 Score=36.40 Aligned_cols=32 Identities=31% Similarity=0.820 Sum_probs=24.5
Q ss_pred cccccccccCCCCccCCCcccccCCCCCcccCCCCCccc
Q 047292 217 SMCTRLATDIGSGICGFNSYCSLQNGRPFCDCPPGYVLV 255 (728)
Q Consensus 217 ~~C~~~~~~~~~~~CG~~g~C~~~~~~~~C~C~~Gf~~~ 255 (728)
++|.. +..| -.+.|.+...+..|.|++||++.
T Consensus 4 dEC~~------~~~~-c~~~C~Nt~G~y~C~C~~Gy~l~ 35 (43)
T d1uzka1 4 NECLD------PTTC-ISGNCVNTPGSYICDCPPDFELN 35 (43)
T ss_dssp CGGGS------TTSS-BTSEEEEETTEEEEECCTTCEEC
T ss_pred cccCC------CCcC-cCCEeECCCCCEEEecCCCCEEC
Confidence 56765 3334 46899988889999999999864
|
| >d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-like domain of nidogen-1 domain: EGF-like domain of nidogen-1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=89.40 E-value=0.03 Score=35.87 Aligned_cols=25 Identities=20% Similarity=0.485 Sum_probs=22.4
Q ss_pred CccCCCcccccCCCCCcccCCCCCc
Q 047292 229 GICGFNSYCSLQNGRPFCDCPPGYV 253 (728)
Q Consensus 229 ~~CG~~g~C~~~~~~~~C~C~~Gf~ 253 (728)
..|.+++.|.+...+..|.|.+||.
T Consensus 7 ~~C~~~A~C~Nt~Gsy~C~C~~Gy~ 31 (40)
T d1gl4a2 7 HQCSVHAECRDYATGFCCRCVANYT 31 (40)
T ss_dssp GGSCTTEEEEECSSCEEEEECTTEE
T ss_pred CCCCCCCEeecCCCCeEeECCCCCc
Confidence 4699999999887889999999996
|
| >d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.17 E-value=0.043 Score=35.95 Aligned_cols=33 Identities=27% Similarity=0.635 Sum_probs=25.2
Q ss_pred cccccccccCCCCccCCCcccccCCCCCcccCCCCCccc
Q 047292 217 SMCTRLATDIGSGICGFNSYCSLQNGRPFCDCPPGYVLV 255 (728)
Q Consensus 217 ~~C~~~~~~~~~~~CG~~g~C~~~~~~~~C~C~~Gf~~~ 255 (728)
++|.. ....|. ++.|.+...+..|.|++||+..
T Consensus 4 dEC~~-----~~~~C~-~~~C~Nt~Gsy~C~C~~Gy~~~ 36 (44)
T d1lmja1 4 DECRI-----SPDLCG-RGQCVNTPGDFECKCDEGYESG 36 (44)
T ss_dssp CTTTT-----CSSTTT-TSCEEEETTEEEECCCSSEEEC
T ss_pred cccCC-----CCCCCC-CCEeEcCCCCeEEeCCCCCccC
Confidence 55655 245674 6899988889999999999753
|
| >d1autl1 g.3.11.1 (L:49-96) Activated protein c (autoprothrombin IIa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Activated protein c (autoprothrombin IIa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.42 E-value=0.087 Score=35.16 Aligned_cols=31 Identities=29% Similarity=0.642 Sum_probs=25.0
Q ss_pred CCcccccccccCCCCccCCCcccccCCCCCcccCCCCCc
Q 047292 215 PDSMCTRLATDIGSGICGFNSYCSLQNGRPFCDCPPGYV 253 (728)
Q Consensus 215 p~~~C~~~~~~~~~~~CG~~g~C~~~~~~~~C~C~~Gf~ 253 (728)
+.+.|+. ..|. +|.|.....+..|.|++||+
T Consensus 7 ~~~~C~~-------~PC~-nG~C~~~~~~y~C~C~~G~~ 37 (48)
T d1autl1 7 LEHPCAS-------LCCG-HGTCIDGIGSFSCDCRSGWE 37 (48)
T ss_dssp SCCSSSS-------TTTT-SEEECCCSSCCCEEECTTEE
T ss_pred CCCcccC-------CCCC-CCEEECCCCCCeEeCCCCCc
Confidence 4567884 6797 59998776689999999996
|
| >d2c4fl1 g.3.11.1 (L:46-82) Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Pig (Sus scrofa) [TaxId: 9823]
Probab=87.89 E-value=0.051 Score=34.15 Aligned_cols=26 Identities=27% Similarity=0.485 Sum_probs=22.2
Q ss_pred CCccCCCcccccCCCCCcccCCCCCc
Q 047292 228 SGICGFNSYCSLQNGRPFCDCPPGYV 253 (728)
Q Consensus 228 ~~~CG~~g~C~~~~~~~~C~C~~Gf~ 253 (728)
...|-..|.|........|.|++||+
T Consensus 7 ~~PC~ngg~C~~~~~~y~C~C~~g~~ 32 (37)
T d2c4fl1 7 SSPCQNGGSCKDQLQSYICFCLPAFE 32 (37)
T ss_dssp GCCCCTTCEEEEETTEEEEECCTTEE
T ss_pred CCCCCCCCEEECCCCCeEEECCCCCc
Confidence 36799999998766689999999996
|
| >d1g1ta2 g.3.11.1 (A:119-157) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: E-selectin, EGF-domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.69 E-value=0.035 Score=35.44 Aligned_cols=26 Identities=23% Similarity=0.577 Sum_probs=22.4
Q ss_pred CCccCCCcccccCCCCCcccCCCCCc
Q 047292 228 SGICGFNSYCSLQNGRPFCDCPPGYV 253 (728)
Q Consensus 228 ~~~CG~~g~C~~~~~~~~C~C~~Gf~ 253 (728)
+..|...|.|........|.|++||+
T Consensus 6 ~~pC~ngg~C~~~~~~~~C~C~~g~~ 31 (39)
T d1g1ta2 6 NTSCSGHGECVETINNYTCKCDPGFS 31 (39)
T ss_dssp TTGGGGSEEEEEETTEEEEEECTTEE
T ss_pred CCcCCCCcEEECCCCCEEEeCCCCCc
Confidence 46799999998766689999999996
|
| >d1g1sa2 g.3.11.1 (A:119-158) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: E-selectin, EGF-domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.40 E-value=0.055 Score=34.67 Aligned_cols=26 Identities=27% Similarity=0.593 Sum_probs=22.4
Q ss_pred CCccCCCcccccCCCCCcccCCCCCc
Q 047292 228 SGICGFNSYCSLQNGRPFCDCPPGYV 253 (728)
Q Consensus 228 ~~~CG~~g~C~~~~~~~~C~C~~Gf~ 253 (728)
+..|-..|.|........|.|++||.
T Consensus 6 ~~pC~ngg~C~~~~~~y~C~C~~g~~ 31 (40)
T d1g1sa2 6 DMSCSKQGECLETIGNYTCSCYPGFY 31 (40)
T ss_dssp TTGGGGSEEEEECSSSEEEEECTTEE
T ss_pred CCcCCCCcEEECCCCCeEEeCCCCcc
Confidence 46799999998776689999999996
|
| >d1apqa_ g.3.11.1 (A:) Complement protease C1R {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Complement protease C1R species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.02 E-value=0.11 Score=35.69 Aligned_cols=26 Identities=35% Similarity=0.677 Sum_probs=20.9
Q ss_pred ccCCCcccccCCCCCcccCCCCCccc
Q 047292 230 ICGFNSYCSLQNGRPFCDCPPGYVLV 255 (728)
Q Consensus 230 ~CG~~g~C~~~~~~~~C~C~~Gf~~~ 255 (728)
.|+...+|.+...+..|+|++||++.
T Consensus 19 ~~~c~~~C~Nt~GsY~C~C~~Gy~l~ 44 (53)
T d1apqa_ 19 QPQCQHLCHNYVGGYFCSCRPGYELQ 44 (53)
T ss_dssp SCTTSSEEEEETTEEEEECSTTCEEC
T ss_pred CCCccCEeEcCCCCeEeECCCCCeEC
Confidence 34555689988889999999999864
|
| >d1dx5i3 g.3.11.1 (I:423-462) Thrombomodulin, different EGF-like domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Thrombomodulin, different EGF-like domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.93 E-value=0.057 Score=34.46 Aligned_cols=26 Identities=31% Similarity=0.658 Sum_probs=20.9
Q ss_pred CCccCCCcccccCCCCCcccCCCCCccc
Q 047292 228 SGICGFNSYCSLQNGRPFCDCPPGYVLV 255 (728)
Q Consensus 228 ~~~CG~~g~C~~~~~~~~C~C~~Gf~~~ 255 (728)
.+.|. ..|.+...+..|.|++||+..
T Consensus 8 ~~~C~--~~C~N~~Gsy~C~C~~Gy~l~ 33 (40)
T d1dx5i3 8 GGFCS--GVCHNLPGTFECICGPDSALA 33 (40)
T ss_dssp CSSCS--SEEEECSSSEEEEECSSSSCE
T ss_pred CcCcc--CEeeCCCCCeEeECCCCCeeC
Confidence 34573 589888889999999999864
|
| >d1szba2 g.3.11.1 (A:124-168) Mannose-binding protein associated serine protease 2, MASP2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Mannose-binding protein associated serine protease 2, MASP2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.10 E-value=0.14 Score=33.63 Aligned_cols=25 Identities=32% Similarity=0.716 Sum_probs=20.7
Q ss_pred CCCcccccCCCCCcccCCCCCcccC
Q 047292 232 GFNSYCSLQNGRPFCDCPPGYVLVD 256 (728)
Q Consensus 232 G~~g~C~~~~~~~~C~C~~Gf~~~~ 256 (728)
|-..+|.+...+..|.|++||++..
T Consensus 13 ~C~~~C~Nt~Gsy~C~C~~Gy~l~~ 37 (45)
T d1szba2 13 TCDHHCHNHLGGFYCSCRAGYVLHR 37 (45)
T ss_dssp SSSSEEEEETTEEEEECCTTEEECT
T ss_pred CCCCCCccCCCCeEEECCCCCeECC
Confidence 4567898878899999999998754
|
| >d1nt0a3 g.3.11.1 (A:120-164) Mannose-binding protein associated serine protease 2, MASP2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Mannose-binding protein associated serine protease 2, MASP2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=83.62 E-value=0.11 Score=34.17 Aligned_cols=24 Identities=33% Similarity=0.818 Sum_probs=19.8
Q ss_pred CCCcccccCCCCCcccCCCCCccc
Q 047292 232 GFNSYCSLQNGRPFCDCPPGYVLV 255 (728)
Q Consensus 232 G~~g~C~~~~~~~~C~C~~Gf~~~ 255 (728)
+-..+|.+...+..|+|++||.+.
T Consensus 13 ~C~~~C~Nt~gsy~C~C~~Gy~L~ 36 (45)
T d1nt0a3 13 PCDHYCHNYLGGYYCSCRVGYILH 36 (45)
T ss_dssp CCSSEEEEETTEEEEECCTTEEEC
T ss_pred CCCCEeecCCCCEEEeCCCCCEEC
Confidence 346689887889999999999864
|
| >d3bpse1 g.3.11.1 (E:293-332) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Low density lipoprotein (LDL) receptor, different EGF domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.99 E-value=0.21 Score=31.81 Aligned_cols=22 Identities=32% Similarity=0.561 Sum_probs=18.2
Q ss_pred cccccCCCCCcccCCCCCcccC
Q 047292 235 SYCSLQNGRPFCDCPPGYVLVD 256 (728)
Q Consensus 235 g~C~~~~~~~~C~C~~Gf~~~~ 256 (728)
-+|.+...+..|.|++||...|
T Consensus 14 h~C~n~~g~~~C~C~~Gy~L~d 35 (40)
T d3bpse1 14 HVCNDLKIGYECLCPDGFQLVA 35 (40)
T ss_dssp SEEEECSSSEEEECCTTCCEET
T ss_pred CEEEcCCCCEEEECCCCCEECC
Confidence 4787777789999999998854
|
| >d1q4ga2 g.3.11.1 (A:32-73) Prostaglandin H2 synthase-1, EGF-like module {Sheep (Ovis aries) [TaxId: 9940]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Prostaglandin H2 synthase-1, EGF-like module species: Sheep (Ovis aries) [TaxId: 9940]
Probab=80.81 E-value=0.22 Score=32.07 Aligned_cols=32 Identities=31% Similarity=0.612 Sum_probs=24.5
Q ss_pred CCcccccccccCCCCccCCCcccccC-CCCCcccCCC-CCc
Q 047292 215 PDSMCTRLATDIGSGICGFNSYCSLQ-NGRPFCDCPP-GYV 253 (728)
Q Consensus 215 p~~~C~~~~~~~~~~~CG~~g~C~~~-~~~~~C~C~~-Gf~ 253 (728)
|-+.|.. ..|...|.|... .....|.|++ ||+
T Consensus 1 Pid~C~~-------nPC~ngG~C~~~~~~~y~C~C~~~G~~ 34 (42)
T d1q4ga2 1 PVNPCCY-------YPCQHQGICVRFGLDRYQCDCTRTGYS 34 (42)
T ss_dssp CCCGGGG-------CCCCTTCEEEEETTTEEEEECTTSSEE
T ss_pred CCccCcC-------CCCCCCCEeeeCCCCCEEEECCCCCcC
Confidence 4467774 789999999753 4568999986 886
|